Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AANAT SNAT ENSG00000129673 "Aralkylamine N-acetyltransferase" Q16613 17 76453351-76470117 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Melatonin biosynthesis" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 27.7;testis: 8.2" "Cell type enriched" "Detected in some" 9 "Bipolar cells: 269.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.6;Daudi: 3.8;SCLC-21H: 5.7;U-266/70: 4.6;U-266/84: 4.8;U-698: 6.8" "Not detected" "Not detected" HPA054321 Supported Cytosol "Intracellular and membrane" NA NA Cytosol "HPA054321: AB_2682449" "unprognostic (7.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-1)" "unprognostic (1.83e-2)" "unprognostic (2.03e-2)" "unprognostic (1.05e-2)" "unprognostic (3.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.61e-1)" "unprognostic (9.30e-2)" "unprognostic (4.19e-1)" "unprognostic (2.81e-7)" "unprognostic (1.04e-1)" "unprognostic (6.00e-2)" "unprognostic (4.47e-2)" "unprognostic (1.34e-2)" 0.3 0.2 1.2 3.8 0.8 2.7 0.3 1.3 1.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.8 0.4 1.8 0.3 1.2 1.5 0.3 0.3 0.3 3.3 1.7 0.7 0.4 0.3 0.0 0.9 0.3 1.9 0.3 0.0 27.7 0.3 0.3 1.8 3.3 0.7 0.3 1.2 2.2 0.2 8.2 0.3 0.3 0.8 0.3 0.3 0.9 0.3 1.3 1.3 2.2 0.1 1.8 0.2 0.0 0.9 4.6 0.7 0.5 0.0 0.1 0.5 0.0 0.4 0.3 0.1 0.1 3.3 3.8 0.5 0.0 0.7 1.2 0.0 0.0 0.3 0.0 1.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.4 0.0 2.0 0.4 0.6 0.1 0.1 1.2 1.5 0.4 0.2 0.2 2.0 0.0 0.1 5.7 0.4 0.1 0.2 1.6 0.6 2.8 0.7 0.0 0.0 1.8 0.2 0.1 4.6 4.8 6.8 1.2 0.4 0.8 2.0 0.1 2.2 0.2 0.0 0.0 0.6 0.1 0.0 0.0 1.3 0.0 0.2 0.6 1.8 0.0 1.3 0.1 0.0 1.2 0.8 1.3 0.9 1.2 1.5 1.7 0.7 1.9 0.3 0.0 0.0 0.0 0.0 0.0 269.2 0.3 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 1.2 0.0 0.0 12.3 0.3 0.0 0.0 0.0 0.0 6.6 0.2 0.0 0.0 0.3 29.7 0.0 0.0 1.7 1.0 0.0 0.1 0.0 0.0 0.0 AAR2 "bA234K24.2, C20orf4" ENSG00000131043 "AAR2 splicing factor homolog" Q9Y312 20 36236459-36270918 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034220, HPA048645" Uncertain Approved Cytosol NA NA Cytosol "CAB034220: AB_1564205, HPA048645: AB_2680475" "unprognostic (1.73e-1)" "unprognostic (1.30e-1)" "unprognostic (3.92e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.54e-3)" "prognostic unfavorable (1.83e-6)" "unprognostic (5.09e-2)" "unprognostic (6.84e-2)" "unprognostic (6.38e-2)" "unprognostic (3.79e-1)" "unprognostic (3.31e-1)" "unprognostic (4.61e-3)" "unprognostic (4.58e-2)" "unprognostic (5.85e-2)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" 18.8 22.3 9.8 11.6 14.0 18.4 20.0 11.3 19.0 17.0 21.9 21.3 12.9 12.3 27.3 21.3 16.1 19.7 16.5 16.2 9.9 9.2 16.2 22.2 15.5 23.1 13.2 12.5 19.5 21.0 19.5 9.5 20.6 13.6 22.8 14.3 20.3 22.7 18.7 19.3 21.9 17.8 23.2 13.0 16.8 20.4 38.5 10.8 28.8 17.8 17.1 15.6 23.1 19.4 20.6 27.5 28.4 30.1 31.7 30.9 28.7 11.8 14.3 13.4 15.3 23.0 15.4 11.0 11.6 15.5 27.7 21.7 32.2 16.2 8.3 16.5 16.9 21.4 17.1 21.9 22.4 17.6 7.4 13.0 26.0 9.6 19.4 17.3 17.7 13.2 18.8 31.8 19.8 15.0 13.8 16.8 16.5 16.1 16.4 14.9 14.5 24.4 21.5 11.5 18.0 23.6 13.7 22.4 18.8 15.5 9.3 15.5 16.7 17.4 46.3 14.7 13.0 26.7 19.0 11.9 26.0 16.6 15.3 14.5 14.6 18.4 16.3 18.5 11.8 13.6 28.4 25.5 22.9 25.8 27.3 25.8 19.0 24.3 24.7 27.5 20.6 30.9 26.2 5.2 31.7 30.1 22.4 27.5 28.7 9.8 14.0 11.3 19.0 9.9 9.2 13.2 12.5 13.6 10.8 6.0 12.2 11.0 8.4 5.0 4.7 5.1 10.2 12.0 4.5 8.7 7.9 17.7 10.0 16.4 2.3 11.2 6.4 0.0 18.1 13.6 9.3 8.9 16.1 10.4 13.0 14.3 10.9 10.4 16.2 3.1 10.3 8.4 10.1 10.8 10.6 5.7 14.2 5.8 14.2 6.8 2.8 6.5 9.8 14.4 14.4 6.6 15.6 7.7 9.8 7.4 AARS "AlaRS, CMT2N" ENSG00000090861 "Alanyl-tRNA synthetase" P49588 16 70252295-70289543 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease mutation, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034261, HPA040870" Supported Supported Cytosol NA NA 700000 Cytosol "CAB034261: AB_1562673, HPA040870: AB_10794995" "unprognostic (1.98e-2)" "unprognostic (6.87e-2)" "unprognostic (8.02e-2)" "unprognostic (5.72e-2)" "unprognostic (3.58e-1)" "unprognostic (2.50e-2)" "unprognostic (7.99e-2)" "unprognostic (2.36e-1)" "unprognostic (1.99e-1)" "unprognostic (1.76e-1)" "unprognostic (8.33e-2)" "unprognostic (2.92e-1)" "unprognostic (3.42e-2)" "unprognostic (3.75e-2)" "unprognostic (2.05e-3)" "unprognostic (8.22e-2)" "unprognostic (3.83e-3)" 22.8 25.3 28.0 19.6 34.8 5.9 22.6 36.4 54.0 22.3 18.4 30.6 21.4 16.8 22.0 33.9 14.5 20.4 14.1 20.9 29.5 31.7 25.5 36.4 19.5 17.9 40.3 40.5 18.7 45.4 61.2 23.1 21.0 37.5 23.2 17.5 17.3 30.1 30.0 25.2 14.1 14.4 28.4 33.2 16.7 21.1 12.2 32.7 10.3 42.1 10.6 20.9 17.7 26.9 13.4 11.6 3.9 13.3 21.3 13.4 11.6 23.3 39.3 10.8 40.3 25.4 23.1 26.2 18.5 25.7 23.4 29.6 32.2 31.5 26.5 24.9 18.6 17.9 27.3 31.3 25.2 32.9 12.0 11.3 26.1 16.7 28.5 67.3 15.6 15.7 27.3 38.1 44.9 100.6 18.6 23.1 41.9 33.2 35.0 17.4 52.8 16.8 18.3 20.4 30.1 22.7 32.1 6.9 57.9 15.9 12.0 13.5 11.6 51.4 12.1 45.5 16.1 37.9 34.5 15.3 17.3 16.8 17.1 15.4 49.4 32.4 48.9 29.5 24.5 33.8 3.9 8.6 3.9 12.6 12.7 12.8 13.4 10.9 12.1 11.6 11.4 13.1 13.4 1.3 21.3 13.3 7.9 8.4 11.6 28.0 34.8 36.4 54.0 29.5 31.7 40.3 40.5 37.5 32.7 8.9 17.3 8.2 15.7 7.3 35.7 22.2 17.8 14.7 11.4 8.7 17.7 53.2 29.9 24.7 8.6 14.3 9.8 46.7 25.3 24.1 12.2 18.2 20.7 43.2 23.5 52.4 22.4 19.0 9.4 5.2 29.1 9.8 11.8 34.3 13.3 35.9 23.6 8.6 38.2 27.4 38.4 0.0 13.9 17.5 29.0 7.4 43.5 10.5 12.1 13.3 ABCA4 "ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1" ENSG00000198691 "ATP binding cassette subfamily A member 4" P78363 1 93992835-94121132 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" Translocase "Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 142.7" "Group enriched" "Detected in some" 14 "Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0" "Cancer enhanced" "Detected in many" "lung cancer: 3.1" "Region enriched" "Detected in some" 13 "pons and medulla: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064420, HPA078826" Enhanced Approved Cytosol NA NA Cytosol "HPA064420: , HPA078826: " "unprognostic (1.25e-1)" "unprognostic (3.93e-1)" "unprognostic (3.29e-2)" "unprognostic (7.17e-4)" "unprognostic (1.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.45e-4)" "unprognostic (3.77e-2)" "unprognostic (5.25e-1)" "unprognostic (3.70e-1)" "unprognostic (5.18e-2)" "unprognostic (1.17e-9)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.72e-4)" 0.7 0.0 0.3 0.2 0.4 0.0 1.1 0.2 0.9 0.7 0.2 3.2 0.2 3.7 0.2 12.9 0.2 0.6 0.2 0.2 2.0 0.2 6.7 1.2 0.4 0.3 0.3 0.2 0.3 0.2 0.0 0.2 0.8 25.5 0.3 0.0 142.7 0.2 2.1 0.2 3.5 4.2 0.2 0.2 0.2 0.1 2.1 0.2 0.2 0.7 0.2 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 5.0 0.2 0.3 0.0 0.2 0.1 0.0 0.0 11.2 0.5 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.7 3.5 1.2 0.6 0.0 0.0 0.5 0.0 0.5 0.0 0.2 1.0 0.0 0.0 0.2 0.0 1.4 0.5 0.0 2.0 0.0 0.0 0.2 0.3 0.3 0.5 0.5 0.0 0.0 1.0 4.2 0.2 5.1 0.4 0.0 0.2 0.3 2.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.9 2.0 0.2 0.3 0.2 25.5 0.2 0.0 0.6 0.0 0.2 0.1 14.3 0.8 0.0 2.7 0.0 7.0 424.1 0.1 0.0 0.0 8.5 0.8 0.0 0.0 0.0 1.1 0.2 1.5 0.0 0.0 0.1 9.5 0.0 0.6 0.0 15.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 455.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.5 ABCE1 "OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I" ENSG00000164163 "ATP binding cassette subfamily E member 1" P61221 4 145097932-145129179 "Predicted intracellular proteins" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012476, HPA036846" Approved Enhanced Cytosol No No Cytosol "CAB012476: , HPA036846: AB_2675346" "unprognostic (2.22e-3)" "unprognostic (8.11e-3)" "prognostic favorable (8.69e-4)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (5.51e-3)" "prognostic unfavorable (6.29e-4)" "unprognostic (5.68e-3)" "unprognostic (6.77e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (1.56e-2)" "unprognostic (1.38e-3)" "unprognostic (2.85e-1)" "unprognostic (2.40e-1)" "unprognostic (2.08e-2)" "unprognostic (2.21e-1)" 27.5 19.4 17.5 23.3 23.7 17.5 25.3 21.0 23.2 20.8 16.5 17.7 14.7 14.4 19.5 15.8 28.5 19.4 16.4 19.5 19.5 18.0 23.1 40.1 17.3 27.3 22.1 15.5 28.2 34.2 23.0 31.7 21.2 26.0 18.4 21.1 11.0 19.0 15.1 33.1 19.9 14.1 20.7 22.1 29.0 16.7 21.2 20.7 36.5 20.1 29.7 29.5 26.0 19.0 9.9 13.2 1.0 8.8 10.4 18.2 9.9 26.7 14.0 21.7 15.0 18.9 27.4 21.2 29.3 21.1 35.7 25.3 21.1 25.4 43.9 9.5 26.1 18.8 18.0 32.3 38.2 48.4 24.4 19.0 24.7 10.5 18.6 24.9 56.9 20.0 20.2 26.7 37.8 53.4 18.4 38.3 33.5 49.6 32.9 38.1 16.1 54.5 19.0 17.9 41.4 32.5 29.0 26.1 31.3 26.8 17.8 27.1 13.3 17.8 30.3 20.9 17.2 18.1 22.3 25.2 35.4 21.8 24.6 35.3 29.5 47.0 47.0 21.7 49.7 39.1 1.0 6.7 0.7 9.2 8.8 18.2 9.9 11.1 11.1 13.2 9.2 15.6 12.9 0.6 10.4 8.1 7.4 12.4 9.9 17.5 23.7 21.0 23.2 19.5 18.0 22.1 15.5 26.0 20.7 23.8 16.0 38.8 65.1 53.1 33.8 21.0 15.3 32.1 52.4 24.4 19.6 32.6 33.2 31.5 22.0 37.2 6.4 23.3 24.2 35.3 34.5 51.8 31.3 28.0 37.4 39.7 19.7 22.1 22.2 9.3 43.4 34.8 18.6 27.9 22.3 17.5 33.7 3.5 32.5 29.3 34.2 32.3 31.6 76.0 70.9 51.9 22.2 27.7 30.4 68.4 ABCF1 "ABC50, EST123147" ENSG00000204574 "ATP binding cassette subfamily F member 1" Q8NE71 6 30571376-30597179 "Plasma proteins, Predicted intracellular proteins" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017578 Approved Enhanced Cytosol NA NA Cytosol "HPA017578: AB_1844438" "unprognostic (5.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.41e-3)" "unprognostic (4.31e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (5.50e-2)" "unprognostic (3.45e-2)" "unprognostic (1.70e-2)" "unprognostic (2.35e-1)" "unprognostic (2.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.65e-1)" "unprognostic (3.65e-1)" "unprognostic (1.68e-3)" "unprognostic (7.16e-2)" 16.1 12.5 12.1 11.8 13.9 31.9 12.4 12.1 15.7 11.4 13.7 9.8 9.5 7.1 17.0 9.6 14.6 10.9 10.6 13.1 12.0 7.3 15.5 18.3 13.5 9.4 10.6 10.5 12.5 14.0 23.1 16.6 21.6 13.7 12.4 13.6 9.2 14.1 15.3 70.6 21.3 17.6 15.2 12.7 13.9 19.6 22.0 13.2 14.7 13.8 14.9 13.0 14.2 13.5 10.1 9.3 4.1 7.9 11.9 14.3 6.5 12.1 5.4 7.1 9.7 8.0 5.2 3.2 10.3 5.3 7.1 9.9 18.0 3.0 10.2 11.2 6.4 9.8 8.8 10.5 6.0 13.9 7.2 9.1 12.4 7.6 5.6 2.5 12.6 4.1 4.7 6.2 11.1 2.8 1.9 2.3 2.9 22.6 3.7 7.9 2.7 6.6 2.8 4.9 4.2 3.3 20.8 7.0 10.7 5.5 11.0 6.5 13.4 5.6 15.6 3.1 3.5 3.9 3.4 7.1 13.9 4.2 3.3 5.6 13.6 22.0 17.7 1.5 14.7 10.1 4.1 7.9 3.4 14.3 6.7 12.2 10.1 10.4 12.8 7.1 9.1 9.5 9.7 3.7 11.9 7.3 9.3 5.9 6.5 12.1 13.9 12.1 15.7 12.0 7.3 10.6 10.5 13.7 13.2 47.6 84.6 56.7 79.8 76.5 41.7 75.9 38.2 49.5 78.5 55.8 62.8 83.9 51.4 84.1 80.0 46.5 74.6 46.7 75.7 116.4 50.0 62.6 85.4 115.0 44.1 52.4 48.7 34.4 39.0 122.9 35.9 46.8 33.7 67.7 40.5 42.0 84.8 38.6 48.8 58.5 108.2 71.1 55.1 135.4 94.1 74.2 138.9 55.4 45.7 74.3 ABCF2 "ABC28, EST133090, HUSSY-18, M-ABC1" ENSG00000033050 "ATP binding cassette subfamily F member 2" Q9UG63 7 151212490-151227230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 228 "Cardiomyocytes: 20.9;Cytotrophoblasts: 24.9;Extravillous trophoblasts: 22.8;Hofbauer cells: 18.5;Syncytiotrophoblasts: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020091, CAB020682, HPA021815, HPA030388" Approved Enhanced Cytosol NA NA Cytosol "CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" "unprognostic (6.80e-2)" "unprognostic (4.23e-1)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.52e-6)" "unprognostic (1.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.73e-1)" "unprognostic (6.31e-2)" "unprognostic (5.58e-2)" "unprognostic (9.93e-2)" "unprognostic (1.16e-2)" "unprognostic (1.95e-1)" "unprognostic (6.07e-2)" "unprognostic (7.84e-3)" 18.3 15.4 14.9 15.9 18.8 9.7 12.6 19.0 29.6 10.9 14.2 16.3 12.9 9.5 14.9 17.7 16.1 13.7 13.6 22.2 14.5 17.4 14.2 10.6 12.4 16.1 16.4 23.3 13.6 17.7 25.1 14.9 15.2 17.1 13.9 17.7 13.7 12.5 16.8 46.6 17.4 10.7 21.7 12.7 15.5 13.9 20.7 16.7 15.8 14.8 16.5 22.4 14.5 11.2 13.0 14.2 6.8 15.0 15.7 22.4 14.5 17.9 29.2 10.2 36.4 20.9 17.5 13.9 21.8 18.8 28.4 24.2 24.8 12.6 29.5 18.9 24.4 23.9 14.2 32.1 26.7 27.7 14.7 26.7 12.3 14.5 15.0 24.6 29.0 19.6 23.1 22.6 31.6 18.6 12.3 23.9 17.7 35.1 12.4 25.3 45.6 32.2 34.6 24.7 21.9 31.7 20.7 16.4 27.2 19.5 13.1 17.8 17.3 20.8 21.9 14.6 11.3 9.3 15.0 21.4 18.2 7.3 21.7 32.9 24.1 25.7 21.8 25.1 29.2 34.3 6.8 12.1 4.0 15.9 14.3 22.4 12.7 16.2 15.9 14.2 13.0 15.3 15.8 1.7 15.7 15.0 10.2 16.9 14.5 14.9 18.8 19.0 29.6 14.5 17.4 16.4 23.3 17.1 16.7 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 ABCF2 "ABC28, EST133090, HUSSY-18, M-ABC1" ENSG00000285292 "ATP binding cassette subfamily F member 2" Q9UG63 7 151207837-151227166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 41.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA020091, HPA021815, HPA030388" Approved Uncertain Cytosol NA NA Cytosol "HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" 7.9 4.3 4.4 6.5 6.4 2.4 6.1 4.2 10.8 5.5 5.4 5.4 4.0 3.6 5.7 3.3 6.1 5.8 4.3 4.5 4.1 6.2 5.2 5.8 6.1 5.0 8.3 4.0 6.0 10.8 2.7 4.1 5.7 4.1 5.2 4.4 2.9 5.8 20.3 5.6 3.1 6.0 3.1 5.9 3.3 7.2 5.6 5.2 4.9 5.5 6.8 4.8 3.3 8.5 11.3 8.7 9.8 10.0 24.2 13.4 12.7 11.8 9.0 18.8 10.4 12.2 5.0 18.2 10.0 8.7 11.4 9.3 10.3 19.5 13.8 16.7 18.9 10.0 14.3 14.3 18.4 7.8 4.2 12.1 9.5 5.6 18.9 24.3 4.7 11.5 9.9 20.7 17.8 8.5 15.0 9.6 26.5 8.9 15.5 9.7 26.4 0.9 8.2 16.5 9.5 8.7 10.1 20.3 4.0 10.3 3.5 9.7 20.2 10.9 8.0 8.1 5.9 10.3 14.1 8.4 2.4 12.9 20.6 12.4 13.1 22.8 16.0 19.5 7.7 8.7 9.8 2.3 10.3 7.1 24.2 8.5 14.4 12.6 11.3 8.4 12.7 12.0 0.7 10.0 5.5 6.8 12.7 13.4 0.0 0.3 9.0 17.6 24.2 17.5 0.0 7.6 0.0 0.0 0.0 7.9 0.0 0.0 0.0 37.1 11.3 15.3 0.0 0.0 0.0 1.0 10.7 10.3 11.4 0.0 9.5 6.4 10.4 10.5 41.5 9.8 4.6 18.6 0.0 8.0 12.9 0.0 20.1 13.8 0.0 11.9 12.9 17.6 22.3 8.4 22.0 0.0 14.9 12.2 13.9 ABHD13 "bA153I24.2, BEM46L1, C13orf6, FLJ14906" ENSG00000139826 "Abhydrolase domain containing 13" Q7L211 13 108218379-108234255 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032143, HPA032144" Approved Approved Cytosol NA NA Cytosol "HPA032143: AB_2674178, HPA032144: AB_10602304" "unprognostic (2.69e-1)" "unprognostic (2.81e-1)" "unprognostic (1.36e-2)" "unprognostic (2.91e-2)" "unprognostic (8.36e-2)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (2.63e-1)" "unprognostic (8.75e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (6.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.73e-2)" "unprognostic (1.61e-1)" "unprognostic (1.14e-1)" "unprognostic (5.62e-2)" 13.6 12.5 13.8 14.3 14.2 26.7 14.9 17.0 15.5 13.6 17.0 6.8 14.5 13.8 16.3 21.0 15.2 13.5 13.8 12.9 11.7 10.4 12.5 20.1 15.4 14.8 10.1 10.4 13.2 12.4 9.6 14.1 16.5 11.1 13.0 15.0 10.5 14.7 18.1 12.9 12.7 16.7 13.7 10.1 20.0 13.9 8.9 8.2 26.4 15.4 11.3 14.5 13.3 18.6 8.5 8.9 19.2 10.4 11.8 11.8 10.1 9.0 3.8 10.2 5.6 8.0 9.5 4.9 9.0 9.1 7.9 9.5 5.8 8.7 7.7 9.5 7.0 7.8 8.3 7.5 10.4 12.7 10.3 6.6 9.4 5.4 5.7 8.0 19.4 11.6 9.7 10.0 6.2 8.1 7.5 9.3 10.7 5.0 4.4 8.1 3.8 9.4 8.2 4.8 13.5 4.5 8.1 7.3 4.5 11.2 8.2 7.7 9.6 4.8 8.0 9.7 9.4 7.4 18.1 9.7 5.7 5.9 6.6 6.0 8.5 6.7 8.4 13.4 12.2 10.2 8.7 10.4 19.2 8.0 9.5 11.8 8.5 10.9 9.5 8.9 8.1 10.5 8.7 11.3 11.8 8.4 6.7 10.2 10.1 13.8 14.2 17.0 15.5 11.7 10.4 10.1 10.4 11.1 8.2 20.8 11.0 23.1 17.8 39.4 12.5 6.1 22.9 8.1 9.1 10.4 0.0 18.2 8.3 16.4 13.8 17.2 11.8 0.0 18.5 12.2 20.3 17.8 13.9 24.5 17.6 17.5 29.3 19.0 17.3 14.3 14.4 18.7 25.3 17.2 11.7 11.8 16.0 11.5 16.3 10.0 11.6 19.4 18.8 12.8 10.9 44.7 17.8 24.5 10.0 19.0 ABLIM1 "abLIM, LIMAB1, limatin" ENSG00000099204 "Actin binding LIM protein 1" O14639 10 114431113-114685003 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 294.8;Cardiomyocytes: 567.5;Peritubular cells: 388.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 84.9" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 43.9" "Group enriched" "Detected in many" 11 "B-cells: 14.8;NK-cells: 17.1;T-cells: 43.9" "Cell line enhanced" "Detected in many" "hTCEpi: 42.8;OE19: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038951, HPA038952" Approved Supported Cytosol NA NA Cytosol "HPA038951: AB_10673017, HPA038952: AB_10670915" "unprognostic (2.25e-2)" "unprognostic (3.96e-2)" "unprognostic (2.91e-1)" "unprognostic (1.26e-1)" "unprognostic (5.89e-3)" "unprognostic (1.07e-2)" "unprognostic (3.19e-2)" "unprognostic (5.07e-2)" "unprognostic (4.39e-2)" "unprognostic (1.05e-1)" "unprognostic (3.20e-2)" "unprognostic (3.23e-1)" "prognostic favorable (2.72e-5)" "unprognostic (2.77e-2)" "unprognostic (1.92e-1)" "unprognostic (3.22e-1)" "unprognostic (5.87e-2)" 66.7 23.6 11.2 16.8 14.1 3.0 21.2 84.9 14.1 18.7 14.7 6.8 10.7 9.6 16.9 9.8 73.5 13.7 14.1 55.9 10.0 9.2 14.1 7.3 15.7 13.8 10.1 5.6 64.4 7.4 12.8 22.7 8.3 12.8 14.0 15.3 26.6 53.8 18.6 18.6 25.3 16.0 15.4 9.9 8.4 31.3 17.2 3.1 38.3 75.8 44.3 70.4 20.3 28.0 14.8 0.1 2.3 0.0 17.1 43.9 12.7 11.6 8.5 31.0 7.0 0.3 0.1 0.3 2.4 0.8 0.6 1.4 11.7 18.8 15.5 33.4 2.7 4.1 25.6 10.2 16.5 0.7 5.2 9.0 0.1 24.8 32.1 0.1 6.0 0.1 0.4 42.8 4.1 13.6 12.9 12.2 5.4 0.0 23.9 0.1 4.3 1.2 2.7 11.8 39.9 9.9 0.5 6.5 20.0 9.9 26.4 10.8 13.4 10.0 15.3 5.6 14.6 7.8 0.0 8.3 0.0 11.2 0.2 4.5 0.1 0.0 35.9 0.5 13.5 0.2 2.3 0.0 0.2 8.8 0.0 17.0 12.4 16.5 9.9 0.1 14.8 43.9 27.8 0.7 17.1 0.0 0.1 8.9 12.7 11.2 14.1 84.9 11.1 10.0 9.2 10.1 5.6 12.8 3.1 294.8 29.0 14.3 27.1 77.0 38.7 567.5 48.4 101.7 104.6 50.6 17.7 0.8 29.9 34.2 88.3 105.0 50.6 0.0 48.7 0.8 28.6 31.2 1.1 36.6 0.6 55.6 16.1 37.4 1.0 104.4 210.9 5.9 20.3 1.8 87.8 58.6 40.5 31.7 388.2 31.6 105.4 0.0 16.5 3.6 3.9 165.6 0.6 20.3 46.1 115.5 ABRAXAS2 "ABRO1, Em:AC068896.4, FAM175B, KIAA0157" ENSG00000165660 "Abraxas 2, BRISC complex subunit" Q15018 10 124801785-124836670 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 23.8;Ciliated cells: 22.7;Collecting duct cells: 22.7;monocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037591, HPA037592, HPA074089" Approved Supported Cytosol Yes No Cytosol "HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (6.81e-2)" "unprognostic (3.72e-2)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.09e-2)" "unprognostic (1.58e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" 18.4 17.3 16.1 13.1 16.5 14.3 17.0 16.3 20.5 15.6 14.8 10.6 8.1 13.7 16.0 13.3 17.9 13.9 11.2 13.2 15.1 14.5 18.6 19.9 12.5 15.4 13.1 14.4 15.1 11.8 17.5 13.9 17.7 15.9 13.5 14.5 8.5 14.9 13.5 32.2 19.1 20.8 14.4 16.1 20.3 13.2 11.1 12.1 23.9 20.5 16.0 17.4 16.2 16.2 12.2 13.9 18.5 15.2 7.8 12.2 7.7 14.2 9.8 10.6 14.4 13.7 13.6 9.1 14.7 23.3 17.7 16.4 7.8 13.8 16.0 12.6 15.9 9.6 16.1 16.5 13.8 18.7 13.9 11.4 12.1 8.1 9.7 17.5 20.8 12.8 14.8 16.9 17.4 31.5 19.2 13.3 14.3 12.6 11.1 14.3 9.3 15.9 18.6 9.0 12.9 9.1 12.9 11.1 9.7 13.0 7.2 7.3 13.4 11.7 11.4 15.9 11.1 9.3 14.4 11.4 9.5 7.6 11.1 17.5 11.6 10.7 15.5 12.5 10.3 6.7 18.5 11.4 10.4 8.9 15.2 12.2 12.1 10.3 12.1 13.9 12.2 11.2 12.1 4.6 7.8 12.0 9.4 11.9 7.7 16.1 16.5 16.3 20.5 15.1 14.5 13.1 14.4 15.9 12.1 23.8 11.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 11.4 22.7 0.0 14.6 14.9 11.6 0.0 0.0 0.0 0.0 11.0 10.8 0.0 0.0 11.6 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 36.1 0.0 0.0 7.8 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 AC008687.1 ENSG00000267335 19 49022953-49036895 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "pancreas: 8.2;pituitary gland: 19.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 7.4;U-251 MG: 10.6" HPA038925 Uncertain Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA038925: AB_2676272" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 19.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.9 0.2 0.1 0.2 0.0 1.9 0.0 0.0 0.1 0.3 0.1 1.2 0.0 0.3 0.0 0.3 1.1 0.0 0.0 0.6 0.2 0.9 0.0 0.9 0.1 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.0 0.2 0.5 0.2 0.0 0.0 0.1 0.2 1.2 0.2 0.0 0.0 0.0 0.7 0.2 0.1 0.4 0.1 0.5 0.0 0.2 0.4 0.0 2.7 2.3 0.7 10.6 0.5 2.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC008878.3 ENSG00000268861 19 7382834-7472477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.7;bone marrow: 7.1;lymphoid tissue: 8.6" "Cell type enhanced" "Detected in single" 40 "Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 18.3;HL-60: 8.3;MOLT-4: 11.7;REH: 9.6;THP-1: 13.8;U-698: 10.9;U-937: 8.6" "HPA042689, HPA071867" Supported Uncertain Cytosol NA NA Cytosol "HPA042689: AB_10794385, HPA071867: AB_2686466" "unprognostic (1.46e-1)" "unprognostic (2.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.20e-2)" "unprognostic (3.92e-2)" "unprognostic (2.45e-4)" 0.0 1.2 4.3 7.1 0.0 0.0 0.0 0.5 0.0 0.9 0.1 1.5 0.0 2.1 0.0 0.2 0.0 1.0 8.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 2.3 4.9 0.0 0.0 0.7 4.8 2.4 7.4 1.4 7.7 3.3 0.1 4.2 1.4 0.0 0.2 0.5 0.0 1.3 0.3 0.0 0.0 1.1 0.0 0.3 0.0 0.0 18.3 0.0 4.5 0.0 0.0 2.5 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.4 8.3 7.3 2.8 0.1 0.1 2.2 0.0 1.0 4.7 0.0 0.0 3.7 0.0 11.7 3.0 0.0 0.9 0.0 9.6 0.1 3.7 0.2 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 13.8 0.0 0.1 0.3 0.2 0.0 0.1 0.0 10.9 0.3 8.6 0.0 0.9 1.7 7.7 2.7 1.9 1.5 7.4 3.6 1.8 1.1 6.7 4.2 1.4 4.3 0.1 3.3 1.4 1.7 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011005.1 ENSG00000230626 7 129126518-129130793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 7.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.7;MCF7: 2.3;RT4: 1.9" HPA051993 Uncertain Approved Cytosol NA NA Cytosol "HPA051993: AB_2681685" "unprognostic (2.03e-1)" "unprognostic (7.97e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-3)" "unprognostic (1.58e-1)" "unprognostic (2.67e-3)" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (3.11e-2)" "unprognostic (3.61e-1)" "unprognostic (2.60e-2)" "unprognostic (3.01e-1)" "unprognostic (1.06e-1)" "unprognostic (4.36e-5)" "unprognostic (3.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.6 0.4 0.9 0.3 0.7 0.6 0.1 0.2 0.6 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.7 1.7 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.5 0.0 2.3 0.4 0.1 0.2 0.1 0.5 0.2 0.0 0.0 0.0 1.9 0.3 0.1 0.0 0.0 0.8 0.1 0.0 0.7 0.0 0.2 0.0 0.9 0.3 0.2 0.1 0.3 0.4 0.0 0.0 0.5 0.3 0.9 0.3 0.3 0.5 0.4 0.3 0.6 0.4 0.6 0.4 0.4 0.8 0.7 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC104662.2 ENSG00000281028 4 25160663-25277306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004099 Uncertain Uncertain Cytosol NA NA Cytosol "HPA004099: AB_1855353" "unprognostic (3.59e-2)" 1.7 2.3 6.7 5.5 11.1 6.7 3.7 9.7 9.3 2.0 4.1 4.3 5.0 7.8 1.7 2.5 5.4 3.5 1.6 1.5 7.3 2.8 10.1 4.0 4.4 10.0 2.4 1.5 1.8 2.9 14.9 2.8 7.1 1.1 5.4 2.1 4.5 2.5 1.8 0.0 6.0 2.6 11.3 2.5 3.6 9.2 10.6 6.1 5.3 1.6 5.3 3.1 4.8 2.1 2.0 7.5 1.9 1.4 4.3 0.9 5.3 3.7 4.4 2.4 3.2 6.1 4.1 8.9 9.1 11.4 12.2 4.0 7.5 13.5 2.1 11.4 10.7 2.9 9.3 3.8 6.9 5.8 2.6 6.3 9.1 3.8 0.6 12.4 3.6 3.1 0.7 4.5 4.6 2.2 3.9 6.0 4.2 15.7 3.5 6.1 10.8 0.9 3.6 6.7 2.4 6.3 12.0 5.9 2.7 9.8 5.0 1.0 3.6 1.3 2.6 4.4 2.9 1.7 7.4 6.3 1.8 2.9 5.2 10.6 12.0 19.1 5.4 6.5 4.6 7.5 1.9 6.2 2.4 1.8 1.6 2.1 2.4 2.3 1.4 1.9 1.8 2.1 3.2 1.4 1.3 2.0 4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACCSL ENSG00000205126 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like" Q4AC99 11 44047981-44059977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.6;testis: 2.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 22 "melanoma: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 4.1;U-266/70: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA065042 Approved Cytosol NA NA Cytosol "HPA065042: " "unprognostic (2.37e-2)" "unprognostic (2.91e-1)" "unprognostic (9.76e-5)" "unprognostic (7.42e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACOT11 "BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1" ENSG00000162390 "Acyl-CoA thioesterase 11" Q8WXI4 1 54542257-54639192 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 80.9;Late spermatids: 73.7;Muller glia cells: 81.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.3" "Cell line enhanced" "Detected in many" "HaCaT: 12.6;OE19: 17.6;RT4: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041047 Enhanced Supported Cytosol NA NA Cytosol "HPA041047: AB_2677273" "unprognostic (9.73e-2)" "unprognostic (1.28e-1)" "prognostic favorable (9.37e-4)" "unprognostic (3.61e-4)" "unprognostic (5.42e-2)" "unprognostic (1.94e-1)" "unprognostic (2.20e-3)" "unprognostic (5.12e-4)" "unprognostic (1.05e-1)" "unprognostic (2.84e-2)" "unprognostic (9.60e-2)" "unprognostic (1.02e-1)" "prognostic favorable (3.07e-8)" "unprognostic (5.89e-2)" "unprognostic (1.08e-1)" "unprognostic (3.83e-2)" "unprognostic (8.49e-3)" 1.3 4.1 5.7 1.9 7.3 3.0 1.2 3.7 8.6 3.7 10.9 9.6 10.0 28.2 3.6 5.2 14.8 2.7 4.0 22.2 5.9 2.6 15.1 1.2 1.7 1.5 3.1 9.5 4.6 3.0 9.4 18.8 1.4 11.1 3.9 9.5 22.0 9.4 4.5 6.8 2.6 22.5 14.6 6.2 1.3 9.0 6.6 3.9 0.0 10.1 5.7 2.7 9.1 5.5 1.3 1.3 8.3 1.3 0.9 0.9 0.6 4.3 2.8 1.4 0.9 0.6 1.3 2.2 2.5 0.2 0.9 0.6 4.2 11.1 1.0 4.2 2.1 2.7 12.6 0.6 2.2 0.5 2.6 1.0 10.3 4.0 1.8 0.2 1.2 1.7 1.4 2.5 0.4 1.1 1.2 2.3 0.8 0.6 1.5 2.9 1.4 0.5 1.7 2.3 17.6 0.6 0.9 7.5 1.0 1.0 26.2 2.9 2.9 1.2 0.9 0.5 4.9 1.1 3.3 2.4 2.0 1.7 1.3 1.0 1.7 0.8 1.1 0.9 7.7 0.9 2.0 1.3 8.3 0.8 0.7 0.7 0.7 0.7 0.5 1.3 1.3 0.9 0.9 2.8 0.9 0.9 0.9 0.6 0.6 5.7 7.3 3.7 8.6 5.9 2.6 3.1 9.5 11.1 3.9 0.0 8.5 2.7 14.4 4.2 46.5 21.5 12.7 12.0 10.3 24.4 0.0 1.8 10.0 4.7 13.0 1.8 80.9 0.0 2.2 5.4 3.5 4.9 15.0 0.0 7.6 14.3 45.7 1.8 5.6 73.7 12.7 9.1 8.5 2.8 31.3 81.2 3.9 34.5 16.6 31.2 4.0 0.0 3.8 0.5 0.2 2.5 2.1 0.0 34.5 20.9 ACP5 "HPAP, TRAP" ENSG00000102575 "Acid phosphatase 5, tartrate resistant" P13686 19 11574660-11579008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 117.9;lung: 151.9" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 439.8;Ito cells: 434.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 51.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 14.6;BJ hTERT+: 9.8;K-562: 10.3;RPMI-8226: 13.9;SK-MEL-30: 41.4;U-138 MG: 38.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002584, HPA057655, HPA059463" Enhanced Uncertain Cytosol "Intracellular and membrane" NA NA 3700000 Cytosol "CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028" "unprognostic (4.27e-2)" "unprognostic (2.05e-2)" "unprognostic (2.93e-1)" "unprognostic (8.60e-3)" "unprognostic (2.96e-1)" "unprognostic (1.95e-2)" "unprognostic (5.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.13e-2)" "unprognostic (3.80e-1)" "unprognostic (3.66e-3)" "unprognostic (9.09e-2)" "unprognostic (1.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 117.9 2.8 0.9 21.1 1.1 1.4 7.7 0.7 1.0 11.9 10.2 1.2 2.1 7.7 7.7 6.5 12.1 3.5 9.1 6.8 0.9 0.4 28.0 16.3 151.9 30.8 1.0 1.0 13.2 8.7 0.2 1.6 9.2 1.2 6.4 8.7 19.1 8.6 2.8 3.0 10.4 15.6 3.3 1.9 20.7 15.0 3.5 0.7 9.2 2.2 8.2 18.4 11.4 10.1 51.4 13.9 16.8 9.4 2.6 16.0 8.1 3.3 0.4 0.0 0.0 0.2 0.0 14.6 0.4 9.8 0.0 0.0 0.0 0.1 0.5 0.6 2.9 2.4 0.1 0.0 1.5 0.0 3.7 0.3 0.1 0.0 1.8 0.6 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.7 0.3 0.5 0.3 0.1 0.3 0.1 0.7 13.9 0.0 0.1 0.2 0.3 0.0 0.0 41.4 0.4 0.0 0.1 0.3 38.9 0.4 0.7 0.1 0.2 1.8 0.2 8.0 0.0 1.2 0.0 9.4 16.8 4.1 9.1 2.1 51.4 6.4 4.7 1.7 23.5 8.3 4.7 2.6 2.6 8.7 13.9 16.0 8.1 0.9 1.1 0.7 1.0 0.9 0.4 1.0 1.0 1.2 0.7 8.9 8.5 68.7 8.2 9.2 6.0 1.1 22.9 2.7 2.3 7.0 17.7 29.7 8.3 1.6 0.1 2.9 5.9 0.0 9.9 23.7 12.1 16.2 65.4 6.4 439.8 1.6 2.9 434.6 101.6 0.0 1.7 100.7 13.5 131.7 4.5 43.7 4.7 21.0 11.3 91.3 31.7 0.0 3.2 0.0 0.1 9.7 21.9 25.4 8.3 4.3 ACSBG2 "BGR, DKFZp434K1635, PRTD-NY3" ENSG00000130377 "Acyl-CoA synthetase bubblegum family member 2" Q5FVE4 19 6135247-6193094 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 71.3" "Group enriched" "Detected in some" 68 "Early spermatids: 443.1;Late spermatids: 1482.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;HEL: 3.4;Karpas-707: 2.6;MCF7: 1.0" "Not detected" "Not detected" "HPA043421, HPA051013" Enhanced Supported Cytosol NA NA Cytosol "HPA043421: AB_10794182, HPA051013: AB_2681311" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-1)" "unprognostic (3.27e-2)" "unprognostic (4.33e-2)" "unprognostic (1.92e-4)" "unprognostic (1.96e-2)" "unprognostic (4.17e-2)" "unprognostic (2.07e-1)" "unprognostic (2.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.13e-2)" "unprognostic (3.91e-3)" "unprognostic (2.20e-1)" "unprognostic (9.23e-2)" "unprognostic (8.78e-2)" "unprognostic (4.70e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.6 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 2.6 0.0 1.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.5 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 443.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1482.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.0 0.0 6.5 0.0 14.2 5.7 0.0 1.1 0.0 0.0 0.0 ACTL8 CT57 ENSG00000117148 "Actin like 8" Q9H568 1 17755313-17827063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 42 "testis: 23.6" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 42.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-266/84: 72.4" HPA027176 Approved Cytosol NA NA Cytosol "HPA027176: AB_1844553" "unprognostic (1.79e-3)" "unprognostic (3.18e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (6.18e-2)" "prognostic unfavorable (7.02e-4)" "unprognostic (1.63e-3)" "unprognostic (2.33e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (3.69e-1)" "unprognostic (4.89e-1)" "unprognostic (1.43e-1)" "unprognostic (5.49e-2)" "unprognostic (4.68e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.2 0.0 0.7 0.0 0.0 2.9 1.8 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 72.4 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 42.7 0.0 0.0 0.0 0.6 0.0 ACTR2 ARP2 ENSG00000138071 "ARP2 actin related protein 2 homolog" P61160 2 65227753-65271253 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005083, HPA015050" Approved Approved Cytosol NA NA 76000000 Cytosol "CAB005083: AB_2221848, HPA015050: AB_1844556" "unprognostic (2.23e-1)" "unprognostic (1.15e-3)" "unprognostic (3.89e-2)" "unprognostic (2.52e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.50e-4)" "unprognostic (3.88e-2)" "unprognostic (3.16e-2)" "unprognostic (7.06e-2)" "unprognostic (1.16e-2)" "unprognostic (8.59e-2)" "unprognostic (2.36e-3)" "unprognostic (3.18e-2)" "unprognostic (4.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.03e-2)" 31.7 22.3 40.0 58.1 46.1 41.0 24.9 38.5 53.8 24.9 39.3 19.2 16.1 29.1 23.9 18.9 39.5 17.8 26.0 28.9 39.5 35.6 25.8 30.3 32.0 63.1 36.8 39.4 20.9 19.3 19.8 19.6 31.2 30.2 21.1 40.2 16.0 26.7 19.3 28.8 21.2 33.1 29.7 42.6 56.6 29.6 13.7 28.1 59.6 20.9 19.4 69.2 31.9 25.2 21.2 44.9 54.9 53.2 21.3 25.2 59.3 36.4 30.7 29.3 31.4 31.2 42.5 30.6 51.7 39.7 39.9 27.8 34.4 29.9 80.9 26.5 56.3 25.0 27.5 25.2 35.8 65.3 46.6 21.1 89.4 21.8 32.3 35.6 83.8 104.5 36.7 28.1 44.4 42.9 32.2 48.9 28.4 37.9 29.5 66.0 27.0 43.7 43.8 24.4 33.3 22.2 47.5 38.0 33.7 45.6 47.6 15.0 24.6 33.5 38.2 35.4 27.7 23.6 56.2 65.3 44.0 26.9 28.8 56.3 22.7 20.9 115.0 37.8 82.0 49.7 54.3 38.9 45.3 23.6 51.5 25.2 21.2 21.2 22.1 44.9 18.0 16.7 23.3 54.9 21.3 53.2 16.8 23.5 59.3 40.0 46.1 38.5 53.8 39.5 35.6 36.8 39.4 30.2 28.1 80.4 111.6 136.8 71.7 66.3 77.0 65.9 48.4 108.4 77.3 92.5 62.8 71.7 43.1 90.0 29.2 109.9 187.6 0.0 111.8 119.6 73.2 98.2 183.9 89.4 243.0 98.5 106.4 111.1 406.7 68.0 60.4 280.8 84.4 189.4 124.2 80.7 125.1 196.0 70.0 71.7 76.6 122.9 96.6 23.6 47.2 79.3 104.0 175.7 110.8 175.4 ACVR1B "ActRIB, ACVRLK4, ALK4, SKR2" ENSG00000135503 "Activin A receptor type 1B" P36896 12 51951667-51997078 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026126, HPA063761" Approved Approved Cytosol NA NA Cytosol "CAB026126: , HPA063761: AB_2685115" "unprognostic (8.66e-2)" "unprognostic (5.72e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.21e-3)" "unprognostic (1.00e-1)" "unprognostic (7.68e-2)" "unprognostic (5.29e-2)" "unprognostic (2.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.52e-2)" "unprognostic (9.02e-2)" "unprognostic (6.60e-2)" "unprognostic (8.96e-2)" "unprognostic (4.79e-2)" 11.1 7.4 12.0 6.4 14.6 7.9 14.3 14.2 24.4 8.6 16.7 5.1 28.0 19.2 6.7 13.1 14.4 10.9 11.1 7.6 11.2 10.5 24.6 21.0 10.3 7.1 8.1 14.7 7.1 35.1 24.9 10.9 7.5 7.3 10.0 17.1 8.7 21.7 34.3 11.7 30.6 19.8 8.2 5.8 6.7 17.2 10.6 4.8 3.9 9.9 5.8 8.4 10.1 12.1 0.5 1.3 6.8 4.0 0.1 1.6 0.6 6.4 14.1 11.0 6.0 12.6 9.9 6.2 7.3 8.3 7.8 5.9 28.4 10.0 2.8 10.2 7.9 8.6 11.4 10.4 8.8 8.1 4.1 12.3 6.9 3.5 8.8 14.4 11.2 26.0 19.3 11.5 8.8 11.1 8.3 10.9 10.3 7.4 8.8 6.9 13.1 10.6 9.7 10.6 13.6 4.9 5.7 8.5 3.6 21.9 9.8 14.0 11.6 7.8 11.2 5.1 8.1 12.4 7.3 6.9 5.4 8.2 6.0 3.5 5.4 3.7 3.9 5.8 5.4 6.9 4.5 2.2 6.8 0.7 3.3 1.0 0.1 0.6 0.7 1.3 0.5 1.6 0.9 1.9 0.1 4.0 0.7 1.0 0.6 12.0 14.6 14.2 24.4 11.2 10.5 8.1 14.7 7.3 4.8 3.0 12.0 3.4 9.2 16.6 41.6 5.4 22.9 13.4 14.8 24.4 27.5 0.5 3.3 12.7 2.3 9.8 23.9 0.0 12.5 0.6 5.7 12.2 10.5 19.5 3.7 35.0 23.6 14.7 16.7 6.3 9.2 7.7 6.8 2.8 32.6 10.6 12.7 24.6 8.9 16.5 23.8 6.5 15.9 3.9 16.5 22.1 0.5 2.5 22.6 11.2 ACVR2A "ACTRII, ACVR2" ENSG00000121989 "Activin A receptor type 2A" P27037 2 147844517-147930826 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 21.0;RH-30: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046997 Approved Approved Cytosol NA NA Cytosol "HPA046997: AB_10970077" "unprognostic (4.55e-2)" "unprognostic (2.26e-2)" "unprognostic (2.09e-1)" "unprognostic (7.34e-3)" "unprognostic (2.75e-1)" "unprognostic (1.17e-1)" "unprognostic (4.41e-3)" "unprognostic (8.73e-3)" "unprognostic (1.30e-2)" "unprognostic (3.61e-1)" "unprognostic (1.34e-2)" "unprognostic (1.52e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.95e-1)" "unprognostic (3.99e-2)" 12.0 6.0 13.6 8.2 9.9 3.8 10.7 14.5 14.2 10.2 14.1 4.7 9.7 10.4 9.3 9.9 13.6 7.6 17.7 5.6 10.0 9.0 9.0 10.3 7.5 4.7 5.9 10.6 7.6 9.8 8.6 15.9 10.6 7.3 12.2 9.1 7.6 12.2 12.0 19.6 29.5 17.8 13.8 5.4 6.5 9.3 11.0 6.4 1.5 9.5 6.9 6.8 13.5 11.8 0.7 3.0 0.5 3.6 7.7 4.6 1.4 1.3 1.6 10.0 3.7 5.9 3.8 4.1 3.1 3.7 5.3 9.3 4.3 6.0 0.0 2.8 4.9 1.9 4.7 9.1 4.5 6.8 1.0 5.5 0.6 2.8 7.4 21.0 0.6 0.7 6.3 5.7 3.4 6.8 4.1 4.0 1.2 1.4 2.6 3.6 3.5 0.3 0.5 11.3 4.0 2.6 0.1 17.5 0.9 4.2 8.5 9.9 5.6 2.6 3.1 3.8 4.5 1.9 1.0 3.1 4.9 5.8 4.6 2.1 0.7 0.2 1.8 3.0 0.3 3.9 0.4 3.0 0.5 1.2 3.6 0.5 0.3 4.6 2.1 2.3 0.7 3.0 0.7 0.1 7.7 3.1 3.0 0.4 1.4 13.6 9.9 14.5 14.2 10.0 9.0 5.9 10.6 7.3 6.4 6.0 6.5 0.5 6.7 26.4 15.8 7.8 10.2 8.1 11.4 7.0 13.7 3.9 1.7 5.0 4.1 9.8 13.2 0.0 5.6 2.1 13.5 6.7 0.0 8.6 4.7 11.1 8.6 12.9 9.4 0.8 9.2 7.6 10.1 8.2 13.8 3.7 6.3 8.6 10.6 5.0 8.5 32.3 14.4 13.8 12.8 26.1 4.5 5.1 8.5 7.1 ADAM17 "CD156B, cSVP, TACE" ENSG00000151694 "ADAM metallopeptidase domain 17" P78536 2 9488486-9555792 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010738, HPA051575" Approved Supported Cytosol "Intracellular and membrane" NA NA 27000 Cytosol "HPA010738: AB_1078100, HPA051575: AB_2681539" "unprognostic (2.28e-1)" "unprognostic (1.29e-3)" "unprognostic (1.28e-1)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "unprognostic (5.15e-2)" "unprognostic (2.12e-3)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (3.69e-1)" "unprognostic (3.53e-3)" "unprognostic (3.13e-1)" "unprognostic (3.82e-3)" "unprognostic (8.63e-2)" "unprognostic (2.61e-1)" "unprognostic (4.48e-2)" "prognostic unfavorable (4.23e-5)" 18.6 11.0 13.6 15.4 13.8 21.9 14.7 20.4 15.5 14.0 11.7 13.8 8.3 8.7 14.2 15.8 18.7 10.7 17.4 13.4 11.2 12.4 12.4 7.8 24.7 15.0 11.6 11.7 18.1 9.6 10.9 11.9 29.0 11.2 8.2 9.4 10.6 12.5 9.8 12.3 16.7 11.1 13.9 14.3 21.4 8.9 17.4 12.3 14.7 12.5 13.9 20.3 12.3 14.4 7.0 7.7 16.0 10.2 6.0 7.9 6.0 7.7 12.7 13.4 13.9 26.4 19.7 24.1 8.1 13.8 9.3 13.9 11.2 18.6 22.0 11.7 10.1 27.3 14.1 9.8 17.2 12.8 8.8 9.8 11.2 9.6 9.9 37.3 11.0 12.6 22.0 17.3 14.9 29.0 20.8 23.4 8.4 15.3 8.5 10.0 7.3 8.2 11.0 11.0 10.8 5.1 9.6 13.1 10.4 12.4 12.8 7.9 19.7 9.0 11.0 19.2 15.1 5.7 14.2 18.7 16.6 8.7 11.6 15.4 11.1 9.9 19.2 13.8 7.1 19.7 16.0 9.8 7.6 6.1 10.2 7.9 7.0 5.0 5.1 7.7 5.1 4.5 4.6 11.8 6.0 9.5 4.3 5.7 6.0 13.6 13.8 20.4 13.1 11.2 12.4 11.6 11.7 11.2 12.3 44.7 76.6 33.0 41.9 115.4 24.9 2.8 12.7 25.4 40.9 29.6 51.1 25.3 5.0 20.9 64.8 44.9 15.5 23.3 16.8 39.0 58.0 41.4 29.0 11.0 32.9 9.5 18.9 42.4 70.5 10.4 17.5 74.4 38.8 26.2 13.4 12.3 18.2 17.3 15.2 7.5 38.2 38.8 26.7 25.4 37.8 135.3 46.8 26.2 12.5 92.9 ADAMTS15 ENSG00000166106 "ADAM metallopeptidase with thrombospondin type 1 motif 15" Q8TE58 11 130448974-130476641 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.4" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 9.6;Fibroblasts: 8.2;Leydig cells: 4.6;Melanocytes: 3.3;Smooth muscle cells: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 36.6;ASC TERT1: 22.1;EFO-21: 18.4;hTERT-RPE1: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA042867 Uncertain Approved Cytosol "Secreted to extracellular matrix" NA NA Cytosol "HPA042867: AB_10794535" "unprognostic (7.64e-2)" "unprognostic (1.49e-3)" "unprognostic (7.15e-2)" "unprognostic (1.34e-3)" "unprognostic (1.07e-3)" "unprognostic (7.07e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (6.18e-2)" "unprognostic (4.37e-2)" "unprognostic (2.56e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (5.95e-3)" "unprognostic (6.68e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.63e-5)" 47.4 1.1 0.2 1.7 0.3 0.1 14.5 0.1 0.8 3.4 3.8 0.8 3.0 0.6 3.7 9.8 3.8 9.3 9.1 12.6 0.4 0.3 9.1 0.4 6.6 5.6 0.8 0.2 7.0 1.6 0.9 1.0 16.4 1.3 3.7 2.1 10.9 1.0 1.3 1.6 4.1 3.1 6.9 1.4 1.9 4.9 2.4 0.6 0.7 9.8 2.5 0.8 8.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.4 36.6 22.1 0.0 1.3 2.6 0.5 0.1 0.2 0.6 0.0 18.4 0.1 1.3 3.4 0.3 0.3 0.1 0.0 0.8 0.0 1.6 0.0 0.3 0.0 0.0 7.2 0.0 0.3 0.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.0 2.8 0.0 2.0 0.0 0.0 0.0 0.3 0.0 5.9 0.0 0.0 2.7 1.9 0.0 0.0 0.3 4.3 3.5 1.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.4 0.3 0.8 0.2 1.3 0.6 0.0 0.0 0.0 0.1 0.5 0.0 9.6 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.5 8.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.3 0.0 0.5 0.0 0.7 0.0 0.7 0.8 0.0 0.0 3.3 0.1 0.3 0.3 0.7 0.0 2.1 0.0 ADCY7 "AC7, KIAA0037" ENSG00000121281 "Adenylate cyclase 7" P51828 16 50246137-50318135 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 34.7;granulocytes: 48.6;Hofbauer cells: 30.2;Kupffer cells: 61.4;Macrophages: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 23.3;HMC-1: 65.3;RPMI-8226: 32.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041218, HPA048241" Uncertain Approved Cytosol NA NA Cytosol "HPA041218: AB_2677365, HPA048241: AB_2680326" "unprognostic (1.98e-1)" "prognostic unfavorable (5.31e-4)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (3.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.90e-2)" "unprognostic (7.75e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.59e-3)" "unprognostic (7.34e-2)" "unprognostic (2.15e-3)" "unprognostic (2.18e-1)" "unprognostic (9.52e-4)" 6.3 4.3 7.0 17.4 9.7 14.9 3.9 1.2 5.2 3.7 5.0 9.8 0.8 2.8 3.7 4.8 13.2 5.3 6.9 7.3 5.3 4.2 3.3 3.6 16.4 16.5 8.8 4.4 17.1 3.7 1.0 3.4 9.7 8.6 3.5 5.9 6.2 6.5 1.6 1.8 7.9 10.4 5.0 12.3 26.9 4.9 2.1 9.2 21.8 3.7 3.1 26.0 6.6 6.1 3.6 12.5 6.5 16.7 8.4 7.0 5.0 4.0 5.5 0.2 0.8 0.6 7.1 0.5 2.8 1.3 2.2 2.0 5.2 8.4 1.6 7.6 11.4 0.1 14.7 5.8 2.4 2.7 15.4 2.0 23.3 4.2 1.5 6.5 4.4 65.3 3.8 2.4 1.6 2.6 1.2 0.6 5.3 8.5 3.2 3.1 2.3 1.7 10.4 1.0 1.9 7.9 1.6 2.1 32.4 1.5 0.4 1.0 2.7 1.5 0.6 1.3 1.4 0.1 13.0 5.2 0.3 7.6 0.8 0.8 0.3 0.1 3.5 2.4 9.5 1.0 6.5 7.8 2.9 7.0 11.7 5.1 3.2 2.8 5.0 12.5 3.6 2.6 3.7 4.4 8.4 16.7 6.5 3.9 5.0 7.0 9.7 1.2 5.2 5.3 4.2 8.8 4.4 8.6 9.2 17.9 34.7 6.9 0.3 3.3 1.0 0.6 0.0 0.0 12.5 0.0 5.9 9.3 0.0 1.6 1.3 1.0 1.7 0.0 0.2 0.9 11.4 0.3 48.6 0.2 30.2 0.0 0.0 1.8 61.4 0.5 0.6 41.8 5.0 3.6 0.5 0.9 3.1 7.0 1.1 0.0 0.4 6.5 1.4 0.0 0.7 3.4 3.3 18.5 2.1 1.0 ADCY9 AC9 ENSG00000162104 "Adenylate cyclase 9" O60503 16 3953387-4116185 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.4" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041328, HPA044225" Approved Approved Cytosol NA NA Cytosol "HPA041328: AB_2677414, HPA044225: AB_2678863" "unprognostic (1.78e-1)" "unprognostic (5.54e-2)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (6.62e-2)" "unprognostic (1.30e-2)" "unprognostic (2.52e-1)" "unprognostic (3.61e-2)" "unprognostic (6.93e-2)" "unprognostic (4.76e-3)" "unprognostic (5.40e-2)" "unprognostic (1.37e-1)" "prognostic favorable (5.24e-8)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (1.55e-2)" 5.2 4.8 7.1 3.2 10.9 0.9 5.4 8.5 9.6 7.0 6.4 4.1 4.4 6.5 6.5 4.4 6.8 7.7 6.5 13.3 6.2 3.0 8.0 9.6 11.1 2.5 3.0 6.2 9.4 12.5 12.3 5.8 7.8 7.7 3.6 5.5 9.0 10.1 5.0 36.4 4.4 10.9 6.3 2.2 3.2 5.5 4.4 3.4 0.7 21.8 7.7 3.0 7.9 4.8 0.1 1.0 3.2 1.5 1.0 1.9 0.9 4.9 7.6 2.3 4.3 8.3 10.2 3.5 8.8 9.2 4.9 4.0 6.3 4.4 0.0 13.5 24.0 3.0 4.8 9.1 5.4 3.4 6.1 8.8 0.2 17.4 12.1 9.1 0.6 4.0 10.8 8.5 5.7 3.0 4.1 3.3 1.6 2.7 0.0 5.0 9.1 0.0 2.6 4.2 2.1 4.1 7.8 11.1 0.2 1.8 1.3 5.3 2.3 6.8 8.1 5.9 2.7 20.5 8.9 3.0 9.8 2.7 9.5 3.8 1.9 1.1 1.0 2.1 2.7 3.8 3.2 1.5 1.0 1.9 1.5 1.7 0.0 0.6 0.6 0.1 0.1 0.1 1.1 0.3 1.0 0.0 1.0 0.0 0.9 7.1 10.9 8.5 9.6 6.2 3.0 3.0 6.2 7.7 3.4 11.9 10.9 0.5 1.0 5.7 9.3 15.1 28.1 6.7 7.9 12.2 11.8 1.4 0.0 3.8 0.6 5.2 13.6 0.0 4.6 1.7 6.9 0.6 0.0 17.4 1.4 1.6 1.2 8.0 5.9 1.5 7.8 2.6 6.8 1.0 8.4 7.5 2.8 0.0 7.1 4.7 12.8 0.0 13.8 1.1 5.2 3.3 0.8 4.3 5.2 0.9 ADGRE5 "CD97, TM7LN1" ENSG00000123146 "Adhesion G protein-coupled receptor E5" P48960 19 14380501-14408725 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 102.4;Kupffer cells: 83.8;T-cells: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA013707 Enhanced Approved Cytosol "Secreted to blood" NA Yes 10000000 930000 Cytosol "HPA013707: AB_1846345" "unprognostic (3.16e-1)" "unprognostic (1.80e-1)" "unprognostic (5.10e-2)" "unprognostic (2.30e-1)" "unprognostic (2.85e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.51e-2)" "unprognostic (6.06e-3)" "unprognostic (3.14e-2)" "unprognostic (1.08e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.87e-6)" "unprognostic (2.08e-2)" "unprognostic (4.14e-2)" "unprognostic (2.44e-2)" "unprognostic (6.41e-2)" 17.7 8.9 2.5 23.0 4.0 55.3 14.3 1.1 5.2 21.7 15.9 12.9 0.5 12.9 56.9 18.5 11.6 19.1 27.1 16.4 3.0 2.4 10.7 15.5 30.3 41.1 6.3 3.2 10.7 16.2 2.4 3.3 18.2 5.9 11.3 9.0 6.9 17.0 3.6 12.5 6.0 22.2 36.2 4.2 56.9 15.0 6.9 4.9 24.3 8.6 3.7 22.5 34.7 12.4 3.9 13.3 95.3 43.2 22.8 25.8 23.3 30.8 21.9 0.2 21.0 9.3 15.3 3.3 21.4 34.5 15.4 16.9 6.2 31.3 3.5 21.7 27.5 22.0 7.3 5.7 10.4 6.9 19.2 6.4 6.9 32.5 2.7 11.5 14.9 32.3 6.7 0.3 15.7 5.4 5.0 1.5 6.1 9.0 27.7 16.8 6.9 0.9 20.0 0.6 24.5 27.3 2.0 9.2 16.1 5.2 2.7 0.2 0.7 12.2 17.5 15.2 0.5 4.5 13.8 3.7 5.2 8.7 21.7 35.2 0.0 0.1 0.2 18.7 26.7 19.5 42.0 18.6 95.3 25.8 36.7 17.3 3.9 13.1 17.8 13.3 2.6 9.4 12.8 82.7 22.8 43.2 6.4 9.0 23.3 2.5 4.0 1.1 5.2 3.0 2.4 6.3 3.2 5.9 4.9 32.8 102.4 15.9 7.4 0.0 0.2 3.1 12.7 50.9 31.8 0.0 0.0 2.7 0.0 15.1 0.0 4.5 10.2 23.3 19.1 36.8 4.8 9.8 70.9 1.5 47.0 0.0 4.7 26.4 83.8 1.0 6.1 50.6 0.0 2.8 34.7 2.3 17.9 21.0 4.6 0.7 1.2 25.8 17.2 0.5 5.7 0.0 6.6 152.3 31.8 14.1 ADORA2B ENSG00000170425 "Adenosine A2b receptor" P29275 17 15944917-15975746 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.4;Suprabasal keratinocytes: 56.2;Urothelial cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8;myeloid DC: 8.4" "Group enriched" "Detected in many" 86 "dendritic cells: 8.4;granulocytes: 12.8;monocytes: 4.5" "Cell line enhanced" "Detected in many" "GAMG: 50.2;HMC-1: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073747 Uncertain Cytosol NA NA Cytosol "HPA073747: " "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (4.68e-1)" "unprognostic (7.88e-3)" "unprognostic (2.64e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "unprognostic (1.38e-1)" "unprognostic (1.66e-9)" "unprognostic (2.07e-1)" "unprognostic (3.49e-1)" "unprognostic (1.50e-2)" "unprognostic (2.84e-1)" 1.5 1.5 7.6 4.5 9.1 1.6 1.8 7.3 8.7 2.9 15.3 2.4 0.0 0.8 1.7 1.5 11.1 2.2 3.8 1.2 6.6 3.0 0.6 0.7 4.1 1.0 1.9 5.4 0.6 2.8 0.4 1.9 9.0 5.2 1.7 12.8 10.5 1.9 0.7 0.7 10.4 1.6 2.8 3.9 0.7 2.6 0.7 2.6 0.1 0.6 4.4 4.5 6.8 5.6 0.0 8.4 12.8 4.5 0.0 0.0 1.5 10.0 5.5 0.1 0.2 1.8 3.5 0.2 1.9 8.7 5.7 7.1 2.6 10.5 1.3 2.4 1.7 50.2 15.8 2.4 14.5 7.6 2.8 5.5 9.7 1.8 3.8 7.1 0.0 50.7 2.0 6.2 8.1 18.9 9.8 2.8 1.5 0.4 0.0 5.6 2.6 0.6 1.9 0.6 21.6 7.8 0.0 0.1 0.0 5.8 2.7 0.2 0.3 4.3 1.0 2.6 4.3 0.0 1.5 2.4 2.0 5.4 5.6 9.0 0.8 0.0 0.0 8.1 0.0 2.8 12.8 4.0 2.6 0.0 4.5 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.4 0.0 2.3 0.1 0.0 1.5 7.6 9.1 7.3 8.7 6.6 3.0 1.9 5.4 5.2 2.6 3.0 3.4 0.0 12.7 65.4 0.0 1.2 2.5 8.1 7.9 0.0 0.0 10.1 0.0 6.2 0.3 0.6 4.9 0.0 0.8 2.8 6.1 11.9 0.0 0.0 4.6 0.0 2.4 0.0 2.7 0.0 0.0 5.1 6.8 0.0 1.4 7.4 0.8 4.8 0.0 0.0 0.5 0.0 1.9 0.5 1.2 56.2 5.1 0.0 3.7 26.7 ADRB2 "ADRB2R, ADRBR, B2AR, BAR" ENSG00000169252 "Adrenoceptor beta 2" P07550 5 148825245-148828687 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.6" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 104.2;Basal keratinocytes: 344.2;granulocytes: 116.5;Suprabasal keratinocytes: 214.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 24.5;hTERT-HME1: 25.4;PC-3: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003431, HPA075322" Uncertain Uncertain Cytosol NA NA Cytosol "HPA003431: AB_1845333, HPA075322: " "unprognostic (2.28e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (9.35e-3)" "unprognostic (5.54e-2)" "unprognostic (2.34e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (3.15e-9)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" 11.7 0.2 0.7 0.9 0.4 4.6 13.8 0.0 0.3 6.1 0.9 0.3 0.9 0.2 6.4 1.4 1.1 2.8 0.7 0.3 0.2 6.0 8.5 1.1 0.9 0.0 0.0 0.5 0.0 4.0 3.8 0.7 3.3 0.1 4.4 15.9 1.3 1.2 1.0 3.7 2.9 0.0 0.5 2.0 2.3 5.4 4.8 6.1 14.0 10.8 7.3 34.6 9.6 7.6 0.0 0.0 0.0 0.3 0.0 0.0 1.5 4.4 2.0 2.3 0.0 3.3 0.0 2.1 0.4 7.4 6.8 0.0 9.2 2.3 0.0 0.2 0.0 1.6 0.0 0.2 0.0 3.8 0.0 24.5 0.6 25.4 1.7 0.9 0.0 0.0 2.9 5.3 0.0 0.0 4.2 0.1 0.0 10.5 2.2 1.4 4.3 1.1 1.9 0.0 0.0 1.8 0.2 0.6 0.9 0.0 2.3 4.1 0.0 1.8 2.5 1.1 0.7 0.0 0.1 0.0 5.0 0.8 3.5 4.7 14.0 34.6 7.8 25.7 4.8 8.2 20.9 5.3 3.0 1.4 12.9 7.6 7.3 10.8 6.1 0.4 9.6 104.2 33.5 11.1 31.2 344.2 0.2 12.4 0.0 8.1 33.0 0.0 0.0 0.3 0.0 1.4 0.2 17.5 0.0 0.0 0.2 0.2 6.1 16.2 116.5 11.9 14.7 0.0 2.9 6.7 12.7 0.4 0.0 16.5 28.7 1.0 1.4 3.5 5.3 0.0 0.0 0.0 4.8 0.0 3.6 0.0 0.0 214.5 0.5 35.5 0.8 48.5 ADSL ENSG00000239900 "Adenylosuccinate lyase" P30566 22 40346500-40390463 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Purine biosynthesis" Lyase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000525, CAB019285" Enhanced Enhanced Cytosol NA NA 180000 Cytosol "CAB019285: , HPA000525: AB_1078106" "unprognostic (2.80e-1)" "unprognostic (2.12e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.64e-1)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" "prognostic unfavorable (5.81e-8)" "unprognostic (1.35e-1)" "unprognostic (1.25e-1)" "unprognostic (3.99e-1)" "unprognostic (6.28e-2)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (8.43e-2)" "unprognostic (2.70e-1)" "unprognostic (4.06e-1)" "unprognostic (1.44e-2)" 9.3 11.6 5.0 13.7 8.5 11.2 9.0 6.8 10.1 7.9 9.5 7.3 4.4 6.0 10.8 9.4 9.7 9.0 6.9 14.6 4.5 4.7 12.0 17.3 6.8 17.6 4.9 4.9 10.5 21.8 5.4 9.1 9.5 5.1 7.1 9.7 9.2 14.7 6.4 79.0 6.2 9.4 10.7 4.9 14.5 9.6 10.9 4.4 18.8 8.4 23.6 15.5 9.5 7.4 15.3 28.8 11.0 22.7 19.8 34.0 24.6 21.4 25.3 21.8 31.1 14.7 20.8 25.3 19.6 19.4 42.6 32.5 41.8 12.6 62.4 16.7 22.7 19.4 16.2 48.6 31.6 43.8 16.6 45.7 28.3 28.6 38.5 30.9 92.1 23.8 22.3 17.9 37.4 39.7 21.1 31.4 28.2 33.4 27.4 31.8 24.0 28.4 32.9 35.5 25.9 27.0 43.3 45.8 44.3 27.4 17.0 14.1 13.9 23.4 13.0 37.2 20.0 17.9 29.1 20.8 22.8 42.2 20.1 37.5 26.0 45.4 47.8 19.0 34.2 22.2 11.0 19.3 7.8 16.2 22.7 22.8 15.3 34.0 21.7 28.8 14.9 27.0 20.8 1.9 19.8 20.2 14.9 34.0 24.6 5.0 8.5 6.8 10.1 4.5 4.7 4.9 4.9 5.1 4.4 11.9 9.6 11.9 15.4 16.1 15.9 25.7 20.4 5.3 7.9 3.5 35.3 78.9 6.6 48.2 34.1 17.1 14.2 0.0 38.1 60.7 23.3 13.9 36.8 21.3 54.2 6.4 13.3 33.2 40.2 16.1 23.0 24.7 11.8 41.5 20.7 43.1 33.8 7.0 13.4 13.5 17.0 25.8 17.6 39.7 73.9 13.2 27.7 27.4 37.6 9.3 AGBL3 "CCP3, MGC32955" ENSG00000146856 "ATP/GTP binding protein like 3" Q8NEM8 7 134986508-135147963 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 40.4;Spermatocytes: 19.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020397, HPA024150" Uncertain Approved Cytosol NA No Cytosol "HPA020397: AB_2242453, HPA024150: AB_1844639" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (4.72e-2)" "unprognostic (2.18e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-3)" "unprognostic (3.32e-3)" "unprognostic (4.18e-2)" "unprognostic (7.15e-4)" "unprognostic (5.00e-3)" "unprognostic (6.10e-4)" "unprognostic (3.16e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.18e-2)" "unprognostic (2.14e-1)" "unprognostic (8.13e-2)" "unprognostic (1.11e-3)" 3.2 2.7 4.2 4.1 8.4 3.8 4.6 8.7 4.5 4.3 2.4 4.4 4.5 1.6 5.5 15.4 2.2 3.6 3.1 2.4 5.0 3.4 5.3 2.6 3.6 4.0 2.7 4.5 6.8 4.5 0.6 9.2 1.9 3.3 3.8 3.0 3.1 4.9 4.3 4.2 4.7 3.7 3.3 2.9 6.5 4.4 18.7 3.7 2.7 5.4 0.8 2.8 3.3 2.5 2.2 1.7 0.5 0.2 2.2 5.0 1.7 2.6 1.4 3.6 0.8 1.0 1.4 2.2 0.7 0.0 0.5 0.8 4.7 3.0 4.3 1.3 0.0 1.4 2.8 1.3 0.5 0.0 3.4 8.8 3.6 5.3 4.6 0.0 1.6 0.0 0.2 0.0 2.1 0.0 0.0 1.6 4.7 2.6 2.5 0.6 2.5 0.9 1.5 3.1 0.4 0.3 2.5 0.2 1.2 2.6 0.5 2.1 2.4 0.5 0.0 0.3 0.1 1.9 3.5 0.0 0.4 0.9 0.5 1.6 5.3 1.6 1.9 1.8 4.3 4.4 0.0 0.2 0.4 2.4 0.0 1.8 2.1 1.2 2.5 0.5 2.2 2.0 5.0 0.5 2.2 0.1 1.7 1.7 1.7 4.2 8.4 8.7 4.5 5.0 3.4 2.7 4.5 3.3 3.7 3.0 1.1 1.3 1.0 1.1 4.9 1.6 5.1 5.3 2.3 8.7 2.0 0.2 6.6 3.1 40.4 3.8 0.3 0.0 2.5 0.3 1.4 1.5 1.1 1.6 0.4 3.2 2.9 5.5 1.6 8.5 3.1 0.3 5.0 11.8 0.3 2.7 1.6 0.0 2.1 5.1 2.9 0.0 2.3 19.5 3.6 0.3 0.1 1.0 0.0 0.8 AHCY SAHH ENSG00000101444 Adenosylhomocysteinase P23526 20 34280268-34311802 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 192.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041225, HPA044675" Approved Supported Cytosol NA NA 3900000 Cytosol "HPA041225: AB_2677371, HPA044675: AB_2679041" "unprognostic (3.35e-1)" "unprognostic (2.17e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-2)" "unprognostic (7.74e-2)" "unprognostic (3.15e-2)" "unprognostic (7.34e-3)" "unprognostic (1.10e-1)" "unprognostic (8.88e-2)" "unprognostic (2.61e-1)" "unprognostic (4.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.27e-2)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.88e-1)" "unprognostic (2.93e-3)" 15.3 18.6 11.7 15.4 15.0 17.0 24.3 6.3 16.4 25.1 30.0 14.7 18.4 24.6 20.2 23.9 43.4 26.6 22.4 26.0 12.0 12.8 52.2 99.8 19.1 18.1 16.0 10.6 39.1 72.0 15.7 15.0 44.5 13.2 26.9 20.2 14.4 32.4 18.3 48.2 14.8 20.4 18.8 15.7 17.9 22.2 33.3 13.4 25.0 52.8 31.0 29.2 18.2 20.5 9.1 24.1 2.3 26.0 4.6 7.4 11.4 37.4 49.1 20.8 36.7 24.3 26.2 23.9 15.4 22.1 34.3 27.3 132.5 32.4 58.3 27.5 19.7 22.2 43.0 48.9 86.4 22.1 7.7 29.7 70.3 24.4 85.2 26.2 32.8 23.1 54.2 39.4 21.3 34.3 18.4 23.4 21.7 34.2 14.8 18.2 39.6 42.8 31.0 26.7 48.0 47.9 32.2 53.0 41.0 30.7 26.6 36.1 24.0 30.7 36.5 51.0 17.2 54.8 30.6 14.8 29.9 31.9 15.1 29.0 22.1 32.3 35.1 22.0 20.3 15.9 2.3 13.7 0.4 4.1 26.0 6.7 9.1 6.0 5.3 21.1 7.8 6.6 7.4 1.1 4.6 16.5 24.1 6.7 11.4 11.7 15.0 6.3 16.4 12.0 12.8 16.0 10.6 13.2 13.4 38.7 21.0 33.5 72.2 32.5 11.9 44.7 25.5 17.4 29.6 26.2 0.0 93.3 49.7 60.3 58.3 23.6 33.8 0.0 70.9 130.4 41.1 68.4 20.7 56.7 103.0 11.1 20.2 16.5 33.2 135.4 39.4 28.0 25.3 26.2 64.7 41.2 59.2 24.6 38.2 192.2 10.2 12.9 38.1 20.7 47.5 34.5 76.9 18.5 111.0 66.8 AHCYL1 "IRBIT, PPP1R78, XPVKONA" ENSG00000168710 "Adenosylhomocysteinase like 1" O43865 1 109984686-110023741 "Predicted intracellular proteins" "One-carbon metabolism" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042589 Approved Supported Cytosol NA NA Cytosol "HPA042589: AB_10793885" "unprognostic (8.72e-2)" "unprognostic (2.34e-1)" "prognostic favorable (7.00e-4)" "unprognostic (1.83e-3)" "unprognostic (5.01e-2)" "unprognostic (1.81e-1)" "unprognostic (2.72e-2)" "unprognostic (3.09e-2)" "unprognostic (1.32e-1)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.68e-1)" "unprognostic (2.38e-2)" "unprognostic (3.79e-2)" "unprognostic (2.89e-1)" "unprognostic (8.87e-2)" "unprognostic (4.84e-3)" 24.0 25.7 61.7 11.7 71.2 4.8 19.7 33.2 61.4 26.7 26.3 47.7 17.7 46.5 21.0 36.0 18.3 28.0 24.7 13.9 51.6 57.2 38.6 25.4 16.5 10.5 72.3 49.9 17.6 27.1 53.0 16.3 20.6 55.7 17.3 19.7 9.7 17.9 25.8 27.1 14.2 22.9 21.8 48.8 12.1 19.6 10.2 47.5 6.8 28.6 8.6 13.4 16.7 15.3 8.0 6.2 8.7 9.3 3.9 8.2 3.7 22.7 19.4 18.3 18.9 44.3 26.1 30.2 18.1 20.5 17.2 17.0 15.0 13.2 9.7 15.5 26.7 13.1 14.7 16.2 20.7 22.8 81.2 14.0 16.0 25.2 15.8 46.0 13.7 11.3 26.6 13.1 21.4 31.4 42.0 21.6 16.5 11.5 19.7 17.7 18.1 11.4 6.8 21.6 32.2 15.0 12.4 38.1 10.7 37.6 23.1 17.9 11.6 28.1 33.7 37.7 29.2 18.0 13.8 18.6 16.6 16.3 19.5 16.0 16.3 6.7 8.3 34.1 15.1 33.8 5.0 8.8 7.7 4.3 9.3 4.4 6.8 4.4 5.7 6.2 8.0 4.6 4.4 8.7 3.9 6.3 5.7 8.2 3.7 61.7 71.2 33.2 51.5 51.6 57.2 72.3 49.9 55.7 47.5 32.8 64.0 27.3 82.1 79.2 59.7 41.9 107.0 33.5 34.2 111.7 210.1 72.2 106.1 110.2 22.2 52.0 80.5 23.3 97.7 41.1 77.1 89.9 31.1 135.4 38.2 60.4 82.1 64.4 67.4 22.3 86.6 50.2 59.1 34.3 66.6 96.8 88.6 38.6 76.7 118.7 100.2 45.3 90.1 25.8 13.5 94.7 83.9 28.0 71.2 97.0 AHSA1 "Aha1, C14orf3, hAha1, p38" ENSG00000100591 "Activator of HSP90 ATPase activity 1" O95433 14 77457870-77469474 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000903, CAB006244" Supported Supported Cytosol NA NA 28000 Cytosol "CAB006244: AB_425858, HPA000903: AB_1078112" "unprognostic (3.91e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (3.48e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (5.04e-6)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.88e-1)" "unprognostic (2.63e-2)" "unprognostic (2.16e-2)" "unprognostic (1.33e-1)" "unprognostic (3.06e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-1)" 23.7 39.3 37.8 26.9 44.4 20.7 58.9 33.1 52.1 25.7 27.9 22.6 28.9 21.0 31.7 34.9 27.2 56.4 18.6 47.8 38.2 38.2 31.5 28.4 21.9 29.4 61.8 29.7 30.3 25.4 32.0 37.0 34.9 50.1 32.0 34.9 11.5 24.7 35.3 48.5 20.8 20.7 40.0 42.5 21.5 22.8 40.5 54.3 26.0 37.6 24.5 40.3 24.8 177.1 44.3 36.6 34.5 45.1 42.3 42.3 26.9 33.8 66.9 18.3 23.9 28.4 20.5 32.2 25.2 20.0 39.6 29.7 50.1 29.3 63.0 19.8 24.6 45.9 38.7 66.0 32.3 44.2 25.0 39.3 29.7 33.3 60.4 20.9 18.7 42.9 18.1 43.2 26.6 13.0 23.7 37.4 41.0 36.7 20.3 24.7 93.0 46.0 35.7 31.8 57.6 70.4 37.1 21.7 31.4 31.2 35.2 28.2 31.1 23.4 52.3 21.6 29.8 31.9 25.9 19.4 21.5 30.5 24.1 35.8 20.5 41.2 48.4 31.2 37.6 23.6 32.6 28.2 34.5 37.8 39.0 42.3 44.3 34.8 38.7 36.6 34.3 40.0 40.1 20.2 42.3 45.1 34.1 40.0 26.9 37.8 44.4 33.1 52.1 38.2 38.2 61.8 29.7 50.1 54.3 32.8 22.9 72.8 138.0 138.5 35.7 79.2 35.7 115.1 37.5 26.2 80.5 132.6 63.0 69.8 30.4 41.4 51.9 0.0 42.8 89.9 69.9 112.4 76.0 37.3 81.2 17.5 75.1 23.4 22.5 25.2 62.7 50.6 86.0 82.0 41.3 42.4 57.3 50.1 62.6 59.7 52.4 97.0 101.1 80.9 45.1 122.5 114.3 44.9 57.2 106.3 AIF1 "AIF-1, Em:AF129756.17, IBA1, IRT-1" ENSG00000204472 "Allograft inflammatory factor 1" P55008 6 31615184-31617021 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 119.2;lymphoid tissue: 99.3" "Group enriched" "Detected in many" 19 "Hofbauer cells: 1482.8;Kupffer cells: 1886.5;Macrophages: 1383.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "classical monocyte: 67.4;intermediate monocyte: 104.8;myeloid DC: 35.9;neutrophil: 51.7;non-classical monocyte: 119.2" "Group enriched" "Detected in many" 33 "dendritic cells: 35.9;granulocytes: 51.7;monocytes: 119.2" "Cell line enhanced" "Detected in some" "HEL: 25.8;HMC-1: 37.2;JURKAT: 15.1;NB-4: 59.1;THP-1: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049234, HPA062949" Enhanced Uncertain Cytosol NA NA Cytosol "HPA049234: AB_2680685, HPA062949: AB_2732694" "unprognostic (3.20e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-2)" "unprognostic (2.33e-2)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (6.98e-2)" "unprognostic (4.83e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.29e-1)" "unprognostic (1.02e-2)" "unprognostic (9.59e-2)" "unprognostic (4.89e-2)" 13.5 9.5 13.0 27.7 23.8 39.8 7.8 1.8 10.0 5.2 8.0 17.0 0.1 6.1 3.2 8.3 3.6 5.6 9.8 5.8 10.2 10.2 15.4 12.6 19.9 40.5 16.9 3.1 4.9 3.4 2.0 4.9 17.0 12.8 6.1 9.7 4.6 5.7 4.3 3.5 2.9 10.8 11.1 28.5 99.3 4.8 2.6 16.2 71.7 3.6 1.7 9.8 11.2 3.5 0.7 35.9 51.7 119.2 0.3 2.1 59.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 1.7 37.2 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.1 0.0 0.0 0.0 0.2 59.1 0.1 0.0 0.0 9.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.3 0.0 0.5 67.4 3.2 0.2 104.8 0.2 0.7 0.3 0.3 35.9 0.1 2.1 1.7 51.7 0.3 119.2 3.3 0.1 59.6 13.0 23.8 1.8 10.0 10.2 10.2 16.9 3.1 12.8 16.2 23.8 84.5 70.4 0.6 28.8 0.0 5.5 25.5 18.7 35.2 40.1 0.0 9.9 0.0 0.0 1.1 13.5 0.4 0.0 0.4 10.9 24.2 0.3 64.9 8.9 1482.8 0.0 1.2 43.0 1886.5 1.5 6.9 1383.0 37.1 40.5 0.0 0.0 0.1 5.8 0.7 3.1 0.0 51.8 17.6 0.3 1.5 24.7 19.0 27.4 0.4 0.0 AIMP1 "EMAP-2, EMAPII, p43, SCYE1" ENSG00000164022 "Aminoacyl tRNA synthetase complex interacting multifunctional protein 1" Q12904 4 106315544-106349226 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis" "Cytokine, RNA-binding, tRNA-binding" Leukodystrophy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017618, HPA018476" Supported Enhanced Cytosol "Secreted to blood" NA NA 6500000 Cytosol "CAB017618: AB_2285445, HPA018476: AB_1848137" "unprognostic (1.17e-3)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.36e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.29e-3)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "unprognostic (1.23e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (7.13e-2)" "unprognostic (1.73e-1)" "unprognostic (2.27e-2)" 30.7 26.6 20.2 25.7 24.5 42.2 30.3 22.5 22.9 29.9 33.7 17.0 33.6 27.7 29.3 28.4 35.0 25.6 23.7 23.6 21.2 18.4 40.4 35.3 23.4 24.6 29.8 21.8 35.9 27.2 24.1 44.0 27.3 26.5 29.8 28.4 14.1 25.6 32.1 67.8 22.6 39.1 32.8 30.1 26.9 25.2 15.9 29.4 31.3 35.9 40.6 25.8 41.2 25.9 28.2 35.9 24.6 32.7 23.7 33.4 16.6 22.9 14.7 15.5 21.9 18.6 27.9 26.0 30.7 23.6 24.0 28.8 25.3 33.9 40.7 23.2 25.5 18.9 23.0 23.6 29.1 34.4 22.6 14.8 24.0 19.0 40.2 35.7 47.5 27.8 21.5 33.6 25.5 41.4 17.9 20.8 22.4 41.0 22.0 26.5 16.6 32.0 22.6 17.6 31.7 14.7 26.3 31.4 36.6 29.7 20.0 24.9 18.5 19.6 54.2 27.6 22.8 25.9 33.4 17.7 31.7 29.0 23.5 35.7 25.0 35.0 41.6 26.4 37.2 34.0 22.4 26.9 24.6 21.8 29.0 26.0 27.7 27.3 21.8 27.6 28.2 28.5 25.9 3.7 23.7 32.7 35.9 33.4 16.6 20.2 24.5 22.5 22.9 21.2 18.4 29.8 21.8 26.5 29.4 65.5 48.1 80.4 112.4 44.6 44.9 91.2 84.1 77.6 91.0 62.8 33.4 105.8 132.6 104.1 59.3 50.6 74.9 23.3 110.5 122.1 61.9 108.3 78.4 110.0 97.3 23.8 70.9 63.3 84.2 9.9 91.7 82.1 30.4 91.0 106.7 52.5 101.3 87.7 80.2 119.0 35.9 58.2 70.0 117.4 69.1 43.8 126.2 64.5 109.4 153.1 AIMP2 "JTV-1, JTV1, p38, PRO0992" ENSG00000106305 "Aminoacyl tRNA synthetase complex interacting multifunctional protein 2" Q13155 7 6009245-6023834 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Protein biosynthesis" "Developmental protein" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.1" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019098, HPA020057" Supported Approved Cytosol NA NA 8200 Cytosol "HPA019098: AB_1852040, HPA020057: AB_1852042" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (7.30e-2)" "unprognostic (2.77e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (9.29e-2)" "unprognostic (3.41e-2)" "unprognostic (8.75e-2)" "unprognostic (1.11e-1)" "unprognostic (5.13e-2)" "unprognostic (3.96e-1)" "prognostic favorable (1.38e-5)" "unprognostic (7.44e-2)" "unprognostic (8.97e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (3.09e-4)" 10.2 11.2 6.3 6.9 7.3 5.3 11.2 5.3 11.0 5.6 14.9 10.2 7.1 22.8 8.9 10.8 11.2 7.7 8.7 17.7 6.5 5.8 18.6 30.7 6.8 15.1 6.8 8.2 7.5 9.6 12.3 4.5 9.0 7.6 6.1 12.2 6.6 13.6 9.0 66.1 10.3 21.0 9.8 7.2 9.4 7.5 20.4 5.1 9.3 12.9 28.4 9.1 8.2 6.6 19.0 37.3 13.8 30.0 17.8 17.7 16.1 26.1 29.7 10.1 14.4 10.7 11.7 34.4 14.9 10.0 24.4 18.2 32.4 17.4 32.2 14.0 15.2 27.9 29.2 34.1 22.3 15.2 10.4 25.8 17.8 17.5 24.2 33.1 25.0 16.1 18.0 33.0 22.0 36.1 4.1 18.2 13.6 24.9 10.7 17.8 41.5 10.8 45.5 41.0 13.0 21.6 24.3 22.4 27.2 35.7 12.2 20.2 19.1 15.0 30.3 20.3 13.4 28.3 20.4 15.2 14.0 34.9 23.2 32.4 13.7 20.7 27.8 11.7 35.8 22.6 13.8 25.0 7.6 17.7 30.0 15.0 19.0 12.2 14.0 37.3 13.3 12.2 12.8 2.5 17.8 22.1 23.9 13.0 16.1 6.3 7.3 5.3 11.0 6.5 5.8 6.8 8.2 7.6 5.1 8.9 9.3 13.7 15.6 9.6 9.6 1.7 28.1 25.4 17.0 12.2 5.9 42.3 59.7 47.3 99.1 15.8 18.7 0.0 49.8 47.9 11.5 12.2 11.6 30.6 44.3 6.4 6.4 13.5 19.2 61.8 18.4 16.6 18.6 50.5 15.4 16.4 34.2 10.5 17.0 54.2 9.1 12.9 15.1 55.6 21.1 10.2 33.1 10.2 35.9 16.5 AIP "ARA9, FKBP16, XAP2" ENSG00000110711 "Aryl hydrocarbon receptor interacting protein" O00170 11 67483041-67491103 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cushing syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033674, HPA050217, CAB069477" Approved Supported Cytosol NA NA Cytosol "CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: AB_2681055" "unprognostic (2.59e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (8.15e-2)" "unprognostic (9.54e-2)" "unprognostic (4.02e-2)" "unprognostic (2.17e-2)" "unprognostic (1.14e-1)" "unprognostic (6.19e-3)" "unprognostic (2.18e-1)" "unprognostic (9.75e-2)" "unprognostic (1.16e-1)" "unprognostic (5.28e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (9.45e-2)" 23.1 30.5 30.7 31.1 32.6 25.1 29.0 30.3 34.2 27.8 38.5 26.6 24.2 23.7 30.6 24.2 30.8 25.0 28.6 34.7 28.0 25.4 28.0 20.7 24.7 55.2 34.2 24.6 45.5 23.0 18.2 22.0 23.6 27.1 36.2 14.6 21.4 25.0 28.1 26.5 15.9 25.0 29.8 30.2 37.9 22.9 18.2 30.4 34.6 38.0 16.6 33.5 33.1 60.6 56.5 49.8 36.9 38.0 37.6 80.0 41.7 20.6 24.0 13.8 13.2 17.8 17.9 10.5 13.0 16.4 22.5 16.5 37.5 20.6 36.8 31.9 14.4 17.2 16.8 15.6 13.6 8.7 53.8 16.8 22.3 26.2 22.3 18.4 22.3 39.2 21.3 12.9 20.0 13.0 21.9 11.5 36.6 12.7 22.2 14.6 39.6 47.4 55.0 13.0 31.5 30.8 21.1 21.0 32.5 15.7 12.3 21.9 21.9 16.9 12.1 51.4 5.6 16.2 22.6 18.8 19.9 19.4 29.1 11.9 18.2 24.9 28.8 27.2 17.4 15.3 36.9 28.9 31.0 49.5 33.4 53.5 56.5 58.5 57.9 43.1 48.7 53.2 50.8 19.0 37.6 38.0 49.8 80.0 41.7 30.7 32.6 30.3 34.2 28.0 25.4 34.2 24.6 27.1 30.4 29.8 24.6 50.9 30.2 27.0 32.4 19.3 15.3 13.4 14.8 47.1 3.9 48.9 69.6 40.7 21.2 47.5 49.9 0.0 36.9 47.7 44.7 36.1 75.1 22.2 59.5 35.0 30.6 40.5 53.1 12.2 49.2 58.2 54.0 72.1 26.8 34.6 40.6 49.1 33.2 67.7 25.0 38.8 53.6 25.0 29.0 18.4 49.8 95.0 21.7 35.7 AK1 ENSG00000106992 "Adenylate kinase 1" P00568 9 127866480-127877743 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 84.5;skeletal muscle: 279.0" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 823.7;Peritubular cells: 363.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006456, CAB009893" Enhanced Supported Cytosol NA NA 32000000 Cytosol "CAB009893: AB_2225151, HPA006456: AB_1078116" "unprognostic (6.07e-3)" "unprognostic (1.44e-2)" "unprognostic (2.36e-2)" "unprognostic (1.03e-1)" "unprognostic (3.44e-1)" "unprognostic (3.09e-1)" "unprognostic (1.52e-2)" "unprognostic (3.12e-2)" "unprognostic (2.19e-1)" "unprognostic (5.74e-2)" "unprognostic (6.65e-3)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "prognostic favorable (7.31e-4)" "unprognostic (2.62e-1)" "unprognostic (8.40e-3)" "unprognostic (6.99e-3)" 7.7 9.2 19.6 3.7 18.8 6.5 3.9 9.8 17.3 10.5 8.6 18.1 12.2 5.2 3.4 17.3 9.0 84.5 12.0 60.4 17.6 18.5 6.3 10.7 18.7 2.2 16.4 15.3 12.3 4.6 5.6 7.1 2.9 17.5 5.2 10.8 7.0 13.4 15.7 279.0 3.4 2.6 6.3 11.5 5.6 5.8 9.8 11.1 0.0 10.5 61.5 4.0 4.4 4.4 1.2 3.4 2.8 0.4 1.4 1.5 1.2 15.0 6.5 8.3 11.4 20.3 41.3 7.6 10.5 10.6 18.7 11.4 4.8 9.6 0.4 11.5 21.6 12.4 21.7 0.0 11.7 7.5 2.4 7.2 2.2 18.7 8.4 11.4 0.0 0.2 31.4 22.8 13.9 10.1 10.3 25.0 0.2 8.9 0.6 21.2 14.4 0.0 0.3 3.0 37.8 20.2 0.4 8.4 3.3 12.5 1.1 13.6 8.4 27.7 16.0 8.0 4.5 12.8 9.0 20.6 13.1 5.3 46.1 10.0 1.0 0.1 0.0 16.4 0.0 9.1 0.9 0.4 0.4 1.5 0.3 1.1 0.3 0.6 1.1 0.1 1.2 0.3 1.1 2.8 1.4 0.4 3.4 0.3 1.2 19.6 18.8 9.8 17.3 17.6 18.5 16.4 15.3 17.5 11.1 38.7 148.9 3.7 16.6 23.5 48.5 42.8 30.6 46.8 19.4 7.0 15.7 6.3 14.9 97.5 229.8 49.4 94.1 93.5 54.8 37.4 51.2 15.5 1.1 69.2 46.3 46.1 102.2 47.9 3.2 823.7 209.7 11.0 79.2 2.8 66.4 290.8 46.6 58.8 363.1 6.3 55.1 25.8 50.9 14.4 15.6 24.8 11.3 7.5 73.1 20.9 AKAP13 "AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB" ENSG00000170776 "A-kinase anchoring protein 13" Q12802 15 85380571-85749358 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 334.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 57.9" "Low region specificity" "Detected in all" HPA019773 Approved Supported Cytosol NA NA Cytosol "HPA019773: AB_1844686" "unprognostic (4.61e-2)" "unprognostic (1.16e-1)" "unprognostic (3.96e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (5.33e-2)" "unprognostic (7.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (3.99e-2)" "unprognostic (3.92e-1)" "unprognostic (6.69e-2)" "unprognostic (4.88e-2)" "unprognostic (4.80e-2)" "unprognostic (1.46e-1)" "unprognostic (3.81e-3)" 35.9 11.1 7.2 32.5 9.3 23.7 17.1 1.9 7.8 24.6 13.6 8.4 23.0 7.8 57.8 24.5 16.1 16.3 22.1 40.5 8.8 6.1 10.9 14.0 54.9 40.1 9.0 5.5 20.0 26.4 8.0 40.5 22.5 12.4 16.7 10.4 17.2 17.8 26.5 35.8 17.0 21.0 37.4 13.7 42.9 17.8 15.0 7.1 36.0 26.0 18.7 38.6 24.6 18.2 19.3 27.1 61.4 19.4 27.7 35.4 11.0 4.7 10.5 7.6 2.8 11.5 12.8 4.2 3.9 8.3 3.4 3.3 4.0 3.9 21.9 5.5 6.6 8.6 9.8 8.3 3.5 3.2 16.0 4.2 28.7 7.1 3.0 6.3 5.8 57.9 9.3 9.3 4.2 14.3 3.8 9.0 7.8 1.8 10.4 5.1 2.2 8.3 4.4 4.8 7.8 4.3 5.9 7.6 8.0 5.4 9.7 4.8 8.7 10.4 2.9 5.4 8.4 2.1 4.9 10.3 4.1 2.9 2.5 3.8 16.5 10.4 17.5 2.4 19.1 3.2 61.4 17.8 46.3 35.4 14.9 19.7 19.3 23.7 26.2 10.3 19.2 20.1 22.1 29.0 27.7 19.4 27.1 18.8 11.0 7.2 9.3 1.9 7.8 8.8 6.1 9.0 5.5 12.4 7.1 116.1 334.6 137.1 78.6 67.2 14.1 192.2 61.1 66.9 83.0 38.4 39.3 28.1 5.0 64.0 191.2 85.8 74.3 0.0 61.0 23.2 98.8 69.1 266.3 40.4 69.7 12.7 61.0 62.6 122.3 118.3 71.9 149.2 94.5 132.6 46.2 47.4 80.6 56.3 59.8 8.3 17.2 84.1 70.0 22.6 29.6 69.1 19.6 196.1 44.7 144.5 AKR7A2 AFAR ENSG00000053371 "Aldo-keto reductase family 7 member A2" O43488 1 19303965-19312146 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Proximal tubular cells: 516.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032587, CAB032841, HPA064638" Enhanced Supported Cytosol NA NA 2700000 Cytosol "CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307" "unprognostic (1.06e-1)" "unprognostic (3.48e-2)" "unprognostic (7.23e-2)" "unprognostic (5.76e-2)" "unprognostic (9.92e-2)" "unprognostic (1.09e-1)" "unprognostic (1.14e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (5.11e-2)" "unprognostic (7.11e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.72e-2)" "unprognostic (8.53e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.59e-4)" 21.2 39.0 25.2 14.0 26.9 15.2 22.0 19.8 26.2 32.9 38.5 28.1 28.7 56.0 20.2 23.0 25.7 35.1 31.9 31.2 22.0 19.4 49.3 32.4 14.4 21.9 24.9 26.2 31.6 60.8 14.8 19.0 17.2 23.6 19.9 19.5 25.8 21.4 24.9 33.8 18.8 43.1 20.8 20.0 16.3 22.3 21.6 21.4 24.7 22.9 20.2 18.3 16.7 21.6 23.0 40.1 13.7 29.0 22.2 27.1 23.5 24.1 15.3 16.8 15.5 26.6 25.9 11.2 18.1 22.2 25.4 22.9 19.4 20.5 17.5 19.4 24.3 14.3 19.3 18.7 27.2 12.1 13.9 29.7 11.0 14.8 31.0 20.7 12.1 8.9 25.8 21.5 19.5 12.0 24.1 21.5 23.1 16.0 16.5 26.0 24.1 23.5 11.8 4.8 34.0 19.3 24.8 21.0 30.9 24.7 10.7 31.6 11.8 19.7 17.9 30.4 10.0 35.5 42.3 16.8 15.9 16.9 17.1 13.5 20.1 12.6 21.4 34.4 27.9 22.4 0.1 29.0 13.7 23.0 23.7 26.8 23.0 20.7 20.3 40.1 21.4 23.9 20.6 3.4 22.2 17.8 35.0 27.1 23.5 25.2 26.9 19.8 26.2 22.0 19.4 24.9 26.2 23.6 21.4 14.9 21.1 39.8 56.3 21.6 32.8 23.2 94.3 28.1 11.4 73.3 5.9 113.3 215.5 57.4 69.6 30.0 128.4 23.3 32.2 83.3 55.7 48.3 10.3 81.5 89.0 20.6 95.6 38.1 55.4 39.4 71.7 32.8 50.6 63.1 87.2 111.7 40.7 123.6 63.6 516.4 22.5 45.3 39.1 63.0 23.2 29.7 85.8 48.1 129.1 48.9 AKR7A3 ENSG00000162482 "Aldo-keto reductase family 7 member A3" O95154 1 19282558-19289250 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 48.5;liver: 27.4;pancreas: 59.0;stomach 1: 35.5" "Cell type enhanced" "Detected in many" 19 "Cholangiocytes: 178.3;Enterocytes: 187.5;Proximal tubular cells: 542.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Group enriched" "Detected in some" 4 "OE19: 11.3;SK-BR-3: 18.4" HPA064638 Approved Cytosol NA NA 1000000 Cytosol "HPA064638: AB_2685307" "unprognostic (7.78e-2)" "unprognostic (5.07e-2)" "unprognostic (6.08e-2)" "unprognostic (1.61e-1)" "unprognostic (1.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (7.70e-3)" "unprognostic (2.72e-1)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.80e-7)" "unprognostic (4.53e-2)" "unprognostic (5.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.35e-1)" 0.7 0.4 0.7 0.7 0.7 0.0 0.7 0.7 0.9 0.7 5.1 0.7 0.7 48.5 0.7 1.3 0.7 0.0 6.9 0.7 0.7 0.2 13.4 27.4 0.7 0.7 0.7 0.7 1.0 59.0 0.0 0.7 0.7 0.7 0.7 3.0 0.7 0.7 0.7 0.7 0.2 27.0 0.7 0.7 0.7 35.5 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.3 1.9 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.6 0.4 0.4 0.2 1.8 0.1 0.1 0.2 0.1 0.4 1.4 0.2 0.3 0.3 0.0 0.6 0.0 0.0 0.0 0.2 0.6 0.2 0.6 0.8 0.1 0.1 0.3 0.3 0.2 0.3 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.5 0.4 1.4 0.3 11.3 0.6 0.7 0.1 1.4 0.0 0.3 0.9 1.4 0.3 18.4 0.4 0.1 3.3 0.4 0.3 0.3 0.2 1.0 0.3 1.3 0.3 0.3 0.5 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.7 0.7 0.7 0.9 0.7 0.2 0.7 0.7 0.7 0.7 0.0 0.0 3.5 0.6 0.7 0.4 0.8 178.3 4.0 0.0 27.9 0.0 0.4 101.2 3.8 2.7 0.2 187.5 0.0 28.4 0.2 0.0 1.1 4.6 92.4 0.3 0.0 20.0 5.5 1.9 3.1 0.3 0.3 0.0 0.0 51.4 3.5 17.3 81.8 0.4 542.3 1.1 0.0 0.4 1.1 0.9 0.5 0.5 0.0 99.7 0.3 AKT1S1 "Lobe, MGC2865, PRAS40" ENSG00000204673 "AKT1 substrate 1" Q96B36 19 49869033-49878459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 108.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021903, HPA043590, HPA064427" Uncertain Supported Cytosol NA NA Cytosol "CAB021903: , HPA043590: AB_2678569, HPA064427: AB_2685261" "unprognostic (2.11e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-1)" "unprognostic (2.21e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.41e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-1)" "prognostic favorable (6.60e-4)" "unprognostic (5.48e-2)" "prognostic unfavorable (7.34e-6)" "unprognostic (3.20e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (3.65e-1)" 22.2 22.9 16.2 11.9 18.1 10.7 13.8 12.9 19.9 16.9 15.3 21.3 20.1 18.8 17.1 13.5 21.1 14.7 14.6 20.1 15.1 12.6 15.0 43.0 11.7 7.2 17.4 11.3 15.5 17.3 19.1 14.7 25.7 18.3 15.1 13.0 14.8 17.2 19.2 72.7 21.2 16.3 15.8 13.7 10.5 16.2 13.5 21.4 7.4 17.8 20.5 10.5 15.4 29.5 1.9 3.5 5.0 4.3 2.0 3.0 1.3 23.4 28.5 8.3 19.2 17.8 19.1 14.8 21.1 23.9 20.0 17.4 15.3 15.7 4.7 10.9 23.9 15.1 16.2 14.4 24.0 11.8 10.5 40.0 5.6 16.4 14.5 15.9 4.9 9.3 23.5 22.3 21.7 24.7 15.0 18.5 5.7 18.6 6.2 18.0 16.5 4.6 12.2 21.8 28.7 41.5 5.6 11.7 14.2 19.9 16.7 19.5 22.7 18.1 32.3 12.9 10.2 16.9 9.7 17.7 41.5 21.6 11.9 20.7 9.1 22.3 5.0 24.0 9.1 19.7 0.4 3.1 2.4 2.1 4.0 1.4 1.2 1.6 2.3 2.3 1.9 1.4 2.3 5.0 2.0 4.3 3.5 3.0 1.3 16.2 18.1 12.9 19.9 15.1 12.6 17.4 11.3 18.3 21.4 0.0 3.5 10.4 23.0 13.1 11.4 5.0 30.6 0.0 2.3 10.4 2.0 54.1 38.1 28.9 22.9 16.1 47.2 46.7 35.0 41.2 27.7 36.6 4.6 32.6 27.1 9.5 28.8 11.6 19.4 9.0 22.2 18.2 11.8 32.5 33.0 28.6 28.4 31.6 26.9 40.7 10.7 25.8 30.1 11.6 13.4 17.6 108.7 9.6 31.9 23.8 AKT3 "PKBG, PRKBG, RAC-gamma" ENSG00000117020 "AKT serine/threonine kinase 3" Q9Y243 1 243488233-243851079 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013090, HPA026441" Approved Supported Cytosol NA NA Cytosol "CAB013090: AB_2533692, HPA026441: AB_1844711" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (2.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.89e-1)" "unprognostic (1.75e-1)" "unprognostic (1.96e-1)" "unprognostic (3.77e-1)" "unprognostic (2.32e-1)" "unprognostic (2.28e-1)" "unprognostic (5.47e-3)" "unprognostic (1.37e-1)" "unprognostic (6.71e-2)" "unprognostic (3.64e-3)" "unprognostic (1.29e-1)" "unprognostic (8.14e-2)" "prognostic unfavorable (9.27e-4)" 15.4 17.0 16.0 7.8 15.2 2.2 11.0 39.9 33.4 16.9 16.1 12.4 17.4 4.1 19.7 12.3 10.0 11.8 12.1 9.8 15.5 13.6 12.8 4.0 11.3 7.9 14.2 15.8 29.8 4.4 15.1 14.6 17.0 18.4 19.4 6.6 8.9 4.1 23.9 4.8 4.7 8.1 20.4 12.1 9.9 8.7 10.4 14.8 2.9 17.7 5.0 6.2 17.2 18.6 1.9 0.8 1.2 0.9 3.8 3.6 0.6 23.6 2.4 15.0 0.0 11.1 12.7 8.0 13.3 12.3 8.7 7.7 0.1 9.7 0.0 0.0 17.0 7.5 0.3 8.3 5.3 11.5 6.0 6.5 0.3 0.0 0.0 5.8 0.1 2.6 6.6 0.0 10.8 9.8 18.9 17.7 3.9 0.0 0.1 3.9 0.0 5.1 1.1 6.4 0.0 3.7 2.7 9.1 0.1 2.9 0.9 19.3 25.4 0.1 0.0 24.0 9.1 0.0 8.1 13.9 15.5 11.9 0.1 11.1 1.3 0.4 2.8 11.3 1.3 12.9 1.2 0.9 0.5 2.3 0.3 3.6 1.0 2.2 2.5 0.8 1.9 1.9 1.7 0.2 3.8 0.7 0.6 0.7 0.6 16.0 15.2 39.9 22.9 15.5 13.6 14.2 15.8 18.4 14.8 3.0 2.1 8.6 11.6 2.2 41.5 5.5 5.1 0.0 4.5 26.2 31.4 9.5 0.0 10.4 71.8 31.5 0.0 0.0 1.5 6.5 7.3 18.3 4.7 0.2 2.7 39.7 0.0 44.8 8.8 51.9 25.3 9.5 6.8 10.0 0.0 20.1 1.0 0.0 33.2 4.4 33.7 19.4 22.9 12.2 11.5 1.5 10.4 13.8 0.0 7.2 ALDH1A1 "ALDH1, PUMB1, RALDH1" ENSG00000165092 "Aldehyde dehydrogenase 1 family member A1" P00352 9 72900662-73080442 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 207.2" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 583.5;Hepatocytes: 620.8;Leydig cells: 376.3" "Cancer enhanced" "Detected in all" "liver cancer: 399.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 34.2" "Lineage enriched" "Detected in many" 30 "monocytes: 34.2" "Cell line enhanced" "Detected in some" "A549: 294.7;Hep G2: 90.7;RPTEC TERT1: 52.5" "Region enriched" "Detected in all" 6 "midbrain: 171.1" "HPA002123, CAB020690" Enhanced Approved Enhanced Cytosol NA NA 62000000 Cytosol "CAB020690: , HPA002123: AB_1844722" "unprognostic (8.46e-3)" "prognostic favorable (7.77e-5)" "unprognostic (5.59e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-2)" "unprognostic (8.71e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (4.53e-2)" "unprognostic (6.83e-2)" "unprognostic (4.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.24e-3)" "unprognostic (2.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-3)" 20.0 26.9 8.8 12.3 21.4 3.9 10.8 44.8 11.7 33.6 53.6 14.5 65.3 77.1 25.5 87.1 14.5 27.8 38.3 8.9 12.5 5.9 86.7 207.2 31.4 9.4 56.4 3.6 35.8 69.7 0.7 57.5 7.9 14.0 20.0 13.1 30.2 31.8 40.3 12.1 2.7 76.5 17.1 29.1 16.3 75.5 43.0 14.9 2.0 45.8 21.0 16.8 14.1 16.0 0.3 0.5 1.1 34.2 0.0 0.1 10.5 0.0 294.7 0.0 0.0 1.7 0.0 0.1 10.2 0.0 0.0 0.0 9.9 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 90.7 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.5 0.0 1.1 0.0 11.3 0.5 0.0 0.1 0.0 0.5 0.0 0.0 3.3 0.1 52.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34.2 0.5 0.0 5.8 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 1.1 0.0 0.4 0.3 0.0 10.5 8.8 21.4 44.8 11.7 12.5 5.9 56.4 3.6 14.0 14.9 89.3 82.8 17.6 12.3 2.4 0.0 2.8 211.5 583.5 271.8 109.9 0.0 1.1 330.0 52.4 8.7 10.5 29.0 23.3 296.8 1.1 30.2 1.8 152.7 620.8 115.7 0.0 52.7 105.0 82.2 16.5 376.3 13.6 6.8 5.4 141.2 0.0 193.4 16.9 194.8 295.4 0.3 25.8 9.2 3.6 3.8 2.8 2.1 20.0 42.1 18.3 ALDH1L1 "10-fTHF, FTHFD" ENSG00000144908 "Aldehyde dehydrogenase 1 family member L1" O75891 3 126103562-126197994 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 48.1;liver: 148.7" "Group enriched" "Detected in many" 6 "Hepatocytes: 554.3;Proximal tubular cells: 175.8" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.9;Hep G2: 23.9;Karpas-707: 24.7;RPMI-8226: 12.9;RT4: 66.0;U-266/70: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036900, HPA050139" Enhanced Supported Supported Cytosol No No 640000 Cytosol "HPA036900: AB_10672273, HPA050139: AB_2681031" "unprognostic (5.93e-2)" "unprognostic (1.22e-1)" "unprognostic (9.12e-2)" "unprognostic (2.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.12e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (4.73e-2)" "unprognostic (3.05e-3)" "unprognostic (8.40e-2)" "prognostic favorable (2.42e-8)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (7.03e-3)" "unprognostic (7.93e-2)" 28.9 12.1 13.7 1.8 17.1 1.2 6.0 8.6 10.9 7.8 4.9 5.7 2.3 1.1 1.9 2.2 3.6 3.4 1.9 8.1 8.9 5.3 48.1 148.7 1.3 1.2 9.2 10.1 11.3 10.2 1.4 0.9 1.1 10.8 3.3 3.3 5.1 34.1 4.1 30.7 1.5 1.3 2.4 7.7 1.1 1.9 4.9 6.2 0.0 1.7 6.2 2.8 11.0 3.1 0.1 0.8 0.8 0.2 0.2 0.4 0.0 0.4 0.0 0.0 0.0 10.9 0.0 0.1 0.1 0.4 0.1 0.2 0.0 0.9 0.7 3.2 0.0 0.6 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 23.9 3.2 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 24.7 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 12.9 0.3 66.0 0.1 0.1 0.3 3.2 0.0 0.2 0.0 0.0 0.1 0.4 1.9 0.0 0.0 13.6 4.2 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.4 0.2 0.2 0.2 0.0 0.8 0.1 0.0 13.7 17.1 8.6 10.9 8.9 5.3 9.2 10.1 10.8 6.2 0.0 5.9 4.5 44.7 0.1 0.2 14.9 22.9 10.7 64.8 12.2 0.0 0.0 61.3 2.2 18.0 2.7 2.3 0.0 4.8 0.1 0.8 8.1 25.6 554.3 0.1 0.0 1.2 12.3 15.3 25.4 24.5 2.6 3.3 0.0 9.1 35.7 1.9 0.0 21.2 175.8 1.0 6.5 1.0 1.1 1.2 0.0 0.1 7.0 2.2 48.0 ALDH9A1 "ALDH4, ALDH7, ALDH9, E3" ENSG00000143149 "Aldehyde dehydrogenase 9 family member A1" P49189 1 165662216-165698863 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Muller glia cells: 289.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006077, HPA010873" Approved Approved Cytosol "Intracellular and membrane" NA NA 1100000 Cytosol "HPA006077: , HPA010873: AB_1078126" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (4.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.21e-2)" "unprognostic (1.25e-1)" "unprognostic (4.14e-2)" "unprognostic (4.87e-2)" "unprognostic (2.30e-1)" "unprognostic (1.83e-1)" "prognostic favorable (4.56e-4)" "unprognostic (5.51e-2)" "unprognostic (9.05e-2)" "unprognostic (1.67e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-1)" "unprognostic (2.15e-1)" 39.1 52.7 30.8 17.4 25.4 7.7 39.6 16.2 26.6 20.3 18.0 22.7 17.1 19.5 15.5 35.5 47.0 18.8 22.2 22.2 24.8 21.1 50.5 73.5 20.7 20.4 23.7 18.4 20.6 17.8 31.2 19.2 14.1 22.8 24.6 18.7 27.2 52.2 23.2 29.9 22.6 23.9 19.2 21.9 18.8 14.7 37.3 21.5 12.4 45.1 24.2 27.9 18.5 19.1 29.6 20.2 29.4 24.5 23.1 39.0 24.4 17.0 16.7 15.6 14.0 49.9 44.0 13.1 22.6 32.1 22.8 19.8 10.3 12.8 0.0 21.7 20.2 11.2 13.5 12.6 22.1 27.0 7.9 16.0 10.9 12.0 11.2 25.7 17.0 11.6 28.2 11.2 24.1 20.2 31.6 19.7 14.5 17.2 15.4 35.4 10.2 11.3 17.6 22.7 44.9 20.5 9.7 19.8 22.8 29.6 16.2 18.6 12.8 16.1 18.2 20.7 22.1 34.6 25.9 19.4 13.8 13.5 16.7 11.4 14.4 18.7 17.0 15.5 16.3 13.2 26.8 20.3 28.1 28.3 21.5 30.1 29.6 27.7 30.6 20.2 26.0 28.1 32.0 29.4 23.1 24.5 12.6 39.0 24.4 30.8 25.4 16.2 26.6 24.8 21.1 23.7 18.4 22.8 21.5 14.9 37.5 27.9 34.1 29.0 24.6 38.9 48.4 69.6 30.7 48.8 21.6 42.9 82.9 36.4 32.5 37.9 44.4 23.3 32.5 64.2 46.7 49.5 36.9 114.6 53.7 12.7 53.6 52.8 58.2 28.9 88.3 37.5 54.0 19.8 52.5 289.8 28.8 31.6 108.5 141.7 26.8 25.8 36.0 33.8 46.2 45.4 31.9 38.9 58.1 23.5 ALDOA ENSG00000149925 "Aldolase, fructose-bisphosphate A" P04075 16 30064164-30070457 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 1296.2" "Group enriched" "Detected in some" 13284 "Cardiomyocytes: 1628.0;Cytotrophoblasts: 1088.2;Extravillous trophoblasts: 1710.3;Hofbauer cells: 1077.0;Syncytiotrophoblasts: 1138.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA004177, CAB006252" Enhanced Approved Cytosol NA NA 1200000000 Cytosol "CAB006252: AB_437007, HPA004177: AB_1078128" "unprognostic (2.63e-2)" "unprognostic (3.22e-2)" "unprognostic (6.80e-2)" "unprognostic (1.33e-1)" "unprognostic (6.74e-3)" "unprognostic (4.28e-3)" "prognostic unfavorable (5.79e-5)" "prognostic unfavorable (7.32e-5)" "unprognostic (1.68e-1)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "unprognostic (1.57e-1)" "unprognostic (1.81e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.19e-3)" "unprognostic (4.48e-2)" 27.9 30.9 34.7 24.2 42.3 36.0 25.3 31.2 59.7 21.0 32.8 16.3 25.9 29.4 21.9 33.9 73.5 22.1 24.4 109.3 31.6 33.4 28.2 11.1 17.9 34.0 35.0 49.6 23.4 19.4 51.0 25.2 19.9 38.0 23.6 23.5 24.6 37.9 36.9 1296.2 28.4 21.5 30.1 22.7 17.4 24.4 9.2 18.9 18.5 26.6 189.8 29.0 36.8 27.7 61.1 142.9 165.7 166.3 50.5 93.2 217.0 138.8 104.7 31.5 101.2 48.3 55.1 100.7 84.1 87.6 85.8 107.3 74.0 107.1 94.7 137.9 84.8 47.1 106.1 63.2 183.3 63.0 41.6 83.1 77.5 84.0 163.3 75.5 112.6 83.2 75.5 64.7 96.3 64.7 141.5 63.1 44.7 66.6 62.5 90.9 198.0 68.4 93.0 78.4 54.0 88.3 102.2 50.6 211.6 106.8 79.1 63.1 44.4 52.4 221.3 78.4 41.1 94.1 76.4 75.0 126.7 50.6 69.1 90.9 123.6 84.3 86.6 235.7 109.4 100.0 106.7 164.0 130.3 70.2 156.8 79.1 61.1 76.8 72.5 142.9 55.5 73.8 70.3 165.7 50.5 166.3 53.8 93.2 217.0 34.7 42.3 31.2 59.7 31.6 33.4 35.0 49.6 38.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 1628.0 0.0 0.0 0.0 0.0 0.0 1088.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1710.3 0.0 0.0 0.0 0.0 1077.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1138.4 0.0 0.0 0.0 ALDOA ENSG00000285043 "Aldolase, fructose-bisphosphate A" P04075 16 30053090-30070420 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 1558.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA004177 Uncertain Approved Cytosol NA NA 1200000000 Cytosol "HPA004177: AB_1078128" 1.8 0.9 2.7 1.1 5.0 2.1 7.2 0.7 7.7 4.9 1.5 2.0 2.4 0.0 2.5 3.9 0.9 3.6 1.6 5.3 2.3 1.3 0.0 2.3 2.0 0.8 4.4 2.2 0.8 0.8 3.0 1.4 4.0 2.4 0.5 2.8 1.6 7.5 10.6 0.6 0.1 1.9 0.4 1.7 1.3 11.6 0.8 1.2 4.7 0.2 2.7 1.2 1.0 7.0 6.6 0.9 6.2 4.2 8.5 12.5 3.8 8.9 1.9 6.2 1.5 5.2 1.5 4.1 7.0 5.5 21.8 3.6 5.1 24.7 6.0 6.8 1.8 6.4 14.1 11.1 3.8 4.4 8.0 6.0 8.3 6.0 11.6 10.6 2.3 5.1 0.5 10.8 12.4 4.5 7.8 4.0 1.2 7.2 13.5 3.9 5.0 8.1 2.1 1.7 5.6 7.7 4.0 22.7 15.3 0.7 6.2 5.1 1.0 1.7 1.5 0.6 5.2 4.0 1.7 8.1 2.5 3.7 5.4 7.4 5.5 8.1 7.7 11.5 3.5 0.1 6.2 0.1 5.3 2.6 7.4 7.0 7.0 5.7 6.6 6.2 8.5 6.6 0.9 4.2 2.3 5.6 5.4 12.5 11.9 25.9 269.9 530.0 703.6 362.0 0.0 315.9 36.1 40.9 40.1 111.9 0.0 94.5 100.6 190.1 242.7 1558.3 46.7 66.6 0.0 38.0 448.8 200.0 94.7 0.0 692.8 311.1 289.1 683.7 930.6 352.7 289.5 877.3 70.3 597.6 553.3 106.3 971.1 380.8 45.3 219.0 478.6 664.3 23.8 81.3 598.3 0.0 258.9 731.1 912.8 ALG5 bA421P11.2 ENSG00000120697 "ALG5, dolichyl-phosphate beta-glucosyltransferase" Q9Y673 13 36949775-37000261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007989 Approved Approved Cytosol No No Cytosol "HPA007989: AB_1078132" "unprognostic (1.87e-1)" "unprognostic (1.73e-2)" "unprognostic (6.07e-2)" "unprognostic (1.05e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.57e-2)" "unprognostic (5.82e-2)" "unprognostic (5.21e-2)" "unprognostic (7.46e-2)" "unprognostic (3.51e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.40e-5)" "unprognostic (7.44e-2)" "unprognostic (1.66e-1)" "unprognostic (7.14e-3)" "unprognostic (1.86e-1)" 14.7 18.2 11.8 14.0 14.2 11.3 19.9 10.9 13.7 16.7 16.5 10.3 34.2 13.0 13.5 34.8 11.7 12.4 12.9 13.1 10.0 10.5 18.1 36.7 19.1 28.0 16.1 12.8 11.8 60.4 11.8 11.6 17.0 12.1 12.9 20.8 7.3 30.2 37.0 9.0 11.0 12.6 10.9 15.1 12.9 17.6 7.2 14.2 15.4 25.5 12.1 12.4 12.4 11.1 19.1 45.5 17.7 24.8 22.1 25.2 26.9 9.6 13.0 12.0 12.3 33.1 22.2 8.8 26.8 28.5 22.7 18.6 25.4 33.7 13.9 11.1 16.2 19.3 23.9 14.8 20.4 21.2 14.8 29.0 31.9 10.8 15.9 32.4 27.0 16.7 23.3 30.1 18.1 24.3 14.9 17.3 15.6 14.6 17.3 20.5 17.3 18.2 21.6 12.3 60.8 10.6 22.2 14.8 34.0 24.1 18.3 9.6 18.7 11.3 21.0 15.5 9.5 12.7 26.9 13.2 12.7 7.2 14.0 17.0 14.8 11.4 18.2 19.6 17.2 21.0 17.7 24.1 10.0 24.4 24.8 24.6 19.1 23.0 24.4 23.6 17.0 21.2 23.2 2.7 22.1 20.2 45.5 25.2 26.9 11.8 14.2 10.9 13.7 10.0 10.5 16.1 12.8 12.1 14.2 47.6 44.6 33.5 34.8 30.8 16.4 9.7 81.5 22.7 31.8 50.6 9.8 71.9 19.9 78.2 27.2 40.9 34.9 0.0 121.6 63.8 57.3 47.1 28.8 63.8 63.1 11.1 34.7 32.5 37.8 17.9 37.2 44.2 75.9 39.7 51.8 33.6 80.6 45.6 36.0 43.5 23.5 45.3 44.3 47.0 21.3 26.5 68.0 41.5 66.2 37.2 ALOX12B 12R-LOX ENSG00000179477 "Arachidonate 12-lipoxygenase, 12R type" O75342 17 8072636-8087703 "Disease related genes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 38.9;tongue: 55.3" "Cell type enhanced" "Detected in some" 11 "Horizontal cells: 1.6;Rod photoreceptor cells: 1.1;Suprabasal keratinocytes: 1.6" "Group enriched" "Detected in many" 9 "cervical cancer: 2.6;head and neck cancer: 11.2;melanoma: 4.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "basophil: 7.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.0" "Cell line enhanced" "Detected in some" "HEK 293: 3.2;hTCEpi: 3.6;JURKAT: 6.7;OE19: 3.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA024002 Supported Supported Cytosol NA NA Cytosol "HPA024002: AB_1844757" "unprognostic (1.27e-2)" "unprognostic (1.59e-2)" "unprognostic (4.28e-3)" "unprognostic (1.38e-2)" "unprognostic (3.94e-3)" "unprognostic (1.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-1)" "unprognostic (4.40e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.02e-1)" "unprognostic (8.01e-2)" "unprognostic (3.46e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 1.1 0.1 0.3 7.7 0.1 0.1 0.1 0.1 0.5 0.1 3.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.6 38.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 55.3 11.4 0.1 6.2 0.9 0.2 7.0 0.0 0.2 1.1 0.2 1.2 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 1.0 0.5 0.2 0.2 0.0 0.0 3.2 0.0 0.9 0.2 0.0 0.5 0.0 0.0 3.6 0.2 0.6 0.1 0.0 6.7 0.0 0.0 0.0 0.1 0.3 0.0 0.6 3.8 0.3 2.3 0.0 0.9 0.4 0.0 1.0 1.4 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 2.3 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.5 0.0 0.7 0.9 0.3 0.5 0.0 0.3 1.1 1.0 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.9 0.4 1.6 0.0 0.0 0.0 0.0 ALPK2 HAK ENSG00000198796 "Alpha kinase 2" Q86TB3 18 58481247-58628957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 79.2;Cone photoreceptor cells: 45.2;monocytes: 31.5" "Cancer enriched" "Detected in some" 6 "renal cancer: 7.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 26.6;BJ hTERT+: 16.2;fHDF/TERT166: 24.0;U-138 MG: 13.5" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected" "Not detected" "HPA027377, HPA027976, HPA028084, HPA029801" Uncertain Approved Cytosol NA NA Cytosol "HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006" "unprognostic (7.35e-2)" "unprognostic (4.91e-2)" "unprognostic (1.64e-1)" "unprognostic (4.60e-3)" "unprognostic (2.64e-1)" "unprognostic (8.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.20e-5)" "unprognostic (5.27e-3)" "unprognostic (2.50e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-2)" 0.8 0.0 0.1 2.8 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.8 0.0 0.4 35.3 0.1 0.0 5.2 2.8 0.1 3.3 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.2 0.4 0.1 35.3 0.3 0.6 0.1 0.1 0.2 1.2 0.6 0.1 5.5 0.3 12.4 7.9 0.5 0.1 0.0 0.5 0.0 1.8 0.0 0.3 0.0 0.0 7.0 0.5 0.0 0.2 1.8 0.1 26.6 16.2 11.2 9.7 1.7 0.0 0.0 2.8 24.0 1.5 0.0 0.0 0.0 11.5 5.8 0.0 0.0 2.2 0.9 1.5 0.0 0.0 1.6 0.0 3.4 0.1 0.3 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 13.5 6.0 1.8 4.5 10.9 9.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 79.2 0.0 0.0 0.0 0.0 45.2 0.0 1.7 0.4 14.2 0.0 0.0 0.0 0.6 0.0 0.7 0.1 0.0 2.4 0.5 1.6 0.0 0.6 0.0 15.3 0.3 0.9 0.0 31.5 0.0 2.9 0.3 0.2 0.0 9.8 0.5 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.0 ALPL "HOPS, TNSALP" ENSG00000162551 "Alkaline phosphatase, liver/bone/kidney" P05186 1 21509372-21578412 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Biomineralization Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 73.3;liver: 52.7;lung: 45.1" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 88.5;Hepatocytes: 25.3;Ito cells: 25.8;Proximal tubular cells: 44.8;Rod photoreceptor cells: 28.1" "Cancer enhanced" "Detected in all" "testis cancer: 199.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 91 "neutrophil: 73.3" "Lineage enriched" "Detected in single" 127 "granulocytes: 73.3" "Cell line enhanced" "Detected in some" "HSkMC: 53.1;hTEC/SVTERT24-B: 41.5;LHCN-M2: 30.2;SCLC-21H: 26.4;SuSa: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007105, HPA008765, CAB020829" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 7300000 Cytosol "CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138" "unprognostic (3.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.05e-3)" "unprognostic (6.50e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (7.08e-4)" "unprognostic (1.17e-2)" "unprognostic (2.48e-3)" "unprognostic (1.74e-1)" "unprognostic (7.28e-2)" "unprognostic (1.73e-2)" "unprognostic (2.27e-1)" "unprognostic (9.70e-3)" "unprognostic (2.58e-1)" 15.9 22.7 4.5 17.6 6.0 2.6 10.6 2.2 7.8 2.2 2.1 4.1 0.7 1.9 3.7 1.1 2.0 5.7 2.8 10.9 5.7 4.2 29.7 52.7 45.1 28.1 5.3 4.8 1.2 4.3 2.4 4.1 2.2 7.7 2.6 1.3 18.3 3.1 6.6 0.9 1.8 2.7 2.5 3.8 19.6 1.8 2.9 2.7 0.5 3.7 1.7 3.9 7.1 8.4 0.5 0.0 73.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 2.0 3.3 0.1 0.7 0.2 0.4 0.2 0.0 0.7 2.3 0.0 0.0 0.0 9.1 0.0 0.1 0.0 0.6 0.0 1.1 1.1 0.5 0.0 0.2 53.1 0.0 41.5 0.1 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 12.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 26.4 0.3 0.0 0.0 0.1 14.8 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 73.3 0.0 0.0 0.0 0.0 0.0 4.5 6.0 2.2 7.8 5.7 4.2 5.3 4.8 7.7 2.7 3.0 88.5 0.5 0.5 0.1 2.6 2.0 0.0 1.4 10.3 0.0 0.0 0.0 6.6 0.0 1.2 7.1 0.0 23.3 0.0 0.3 0.3 1.5 7.0 25.3 0.1 1.6 0.0 25.8 1.0 4.4 0.3 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 44.8 28.1 0.0 1.0 0.3 13.6 0.4 1.3 0.0 0.0 0.3 AMPD2 SPG63 ENSG00000116337 "Adenosine monophosphate deaminase 2" Q01433 1 109616104-109632051 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 64.4" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 58.9;Horizontal cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027137, HPA045760, HPA050590" Approved Enhanced Cytosol NA NA 380000 Cytosol "HPA027137: AB_2672129, HPA045760: AB_2679443, HPA050590: AB_2681184" "unprognostic (2.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-1)" "unprognostic (1.43e-3)" "unprognostic (9.01e-2)" "unprognostic (5.25e-2)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (4.02e-1)" "unprognostic (1.23e-1)" "unprognostic (8.10e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.78e-10)" "unprognostic (9.16e-2)" "unprognostic (2.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" 8.1 22.7 20.2 21.7 41.3 64.4 4.9 16.3 26.8 9.5 10.1 9.5 6.3 17.1 9.0 6.0 5.9 11.8 13.2 5.2 21.7 19.4 7.8 13.0 8.2 10.7 14.2 14.2 16.3 9.4 13.0 37.1 10.8 18.3 9.7 5.7 15.7 9.1 12.2 2.1 10.0 11.6 9.1 8.5 15.9 8.3 5.3 12.2 10.3 6.4 3.0 7.5 8.2 8.1 2.8 8.8 29.7 24.5 3.0 4.3 5.4 10.9 12.7 18.7 15.8 16.3 16.3 7.1 15.6 31.9 16.0 15.8 9.7 4.7 5.4 12.0 29.2 10.5 8.6 9.8 14.5 9.9 8.7 13.2 28.5 16.7 10.8 15.3 12.1 30.7 18.3 7.7 21.1 16.4 28.9 13.8 11.9 8.8 14.7 11.4 16.9 17.9 29.0 12.1 10.2 13.6 12.7 7.2 8.4 14.7 6.7 14.5 15.3 10.6 13.0 12.6 7.0 7.3 11.3 13.1 19.8 23.0 24.1 16.0 29.5 14.3 7.8 29.5 18.8 20.6 0.5 9.2 11.2 3.4 19.6 4.3 2.8 3.3 3.4 8.8 1.7 3.8 2.8 29.7 3.0 24.5 1.4 2.6 5.4 20.2 41.3 16.3 26.8 21.7 19.4 14.2 14.2 18.3 12.2 3.0 8.5 8.3 4.7 7.9 35.7 2.5 17.8 4.0 5.7 0.0 58.9 4.0 6.6 9.7 2.9 6.2 3.9 0.0 9.6 7.4 11.8 4.5 3.5 17.8 10.5 49.3 16.8 6.2 37.8 1.3 12.0 28.6 5.0 1.0 8.6 9.1 8.3 0.0 20.1 3.9 5.8 12.9 11.7 4.5 2.6 7.0 2.2 10.1 9.7 3.4 ANAPC16 "APC16, bA570G20.3, C10orf104, CENP-27, FLJ33728" ENSG00000166295 "Anaphase promoting complex subunit 16" Q96DE5 10 72216000-72235860 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037815 Approved Supported Cytosol NA NA Cytosol "HPA037815: AB_10672288" "unprognostic (2.87e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (7.12e-3)" "unprognostic (2.16e-1)" "unprognostic (6.20e-3)" "unprognostic (1.51e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (3.10e-2)" "unprognostic (1.90e-2)" "unprognostic (2.11e-1)" "unprognostic (2.75e-3)" "unprognostic (7.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-3)" 16.9 26.7 13.9 15.6 15.9 10.8 18.7 21.6 15.8 18.3 21.2 9.4 25.8 13.1 19.1 19.9 22.7 19.9 17.0 35.6 14.8 9.5 24.9 22.7 15.8 21.6 18.7 9.8 23.4 49.0 17.9 27.3 12.4 13.6 23.9 15.3 17.5 41.4 26.2 46.3 14.2 19.6 26.4 14.4 23.2 23.6 11.9 18.0 25.5 32.3 20.5 20.9 22.4 32.2 32.1 23.5 18.4 11.9 16.5 26.2 15.5 11.3 5.7 5.8 6.9 15.7 7.5 4.5 4.1 7.9 5.5 5.2 6.9 15.0 11.5 6.7 5.5 6.6 9.2 5.0 9.8 5.5 13.3 8.5 5.8 5.3 6.8 19.0 9.8 7.3 9.8 44.2 4.8 16.6 12.2 6.6 16.3 8.5 13.9 6.3 7.1 8.1 9.7 4.5 8.2 3.3 4.8 5.2 11.2 14.1 5.0 8.6 7.8 6.9 18.6 13.7 7.7 5.9 10.2 8.8 2.9 6.9 4.7 6.1 14.1 11.8 11.9 8.2 18.8 3.4 16.2 11.3 18.4 16.7 11.4 18.2 27.7 18.7 16.4 9.0 32.1 26.2 20.9 10.5 16.5 11.9 23.5 16.3 15.5 13.9 15.9 21.6 15.8 14.8 9.5 18.7 9.8 13.6 18.0 145.9 175.2 315.0 204.1 99.3 78.1 380.0 252.3 196.7 161.5 211.1 35.3 168.3 580.3 194.9 57.7 177.7 157.0 93.5 256.5 162.3 141.2 194.7 195.4 368.3 197.3 31.8 155.4 152.2 273.2 38.0 216.3 147.2 183.9 367.9 211.1 118.1 181.5 190.4 235.1 374.6 112.6 226.4 253.6 129.9 117.2 123.2 124.8 276.7 182.8 189.1 ANKH "ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1" ENSG00000154122 "ANKH inorganic pyrophosphate transport regulator" Q9HCJ1 5 14704800-14871785 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Phosphate transport, Transport" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 119.8;Hofbauer cells: 162.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068104 Approved Cytosol NA NA Cytosol "HPA068104: AB_2685954" "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (6.58e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.83e-2)" "unprognostic (2.11e-1)" "unprognostic (2.38e-2)" "unprognostic (2.99e-1)" "unprognostic (1.54e-3)" "unprognostic (1.76e-3)" "unprognostic (1.71e-1)" "unprognostic (8.66e-2)" "unprognostic (6.46e-2)" 8.5 9.7 15.2 8.0 17.0 5.9 9.2 29.1 25.9 4.4 10.9 19.5 3.4 14.4 6.5 4.7 6.8 7.2 8.4 27.0 15.9 14.9 7.4 18.1 6.3 9.6 19.7 17.1 14.9 13.1 19.6 19.2 7.3 15.4 29.5 10.3 16.1 11.7 8.6 31.0 17.4 14.9 7.6 22.6 6.3 6.5 2.0 15.3 9.3 9.5 12.7 11.8 6.4 6.3 2.5 0.6 0.7 1.4 0.6 7.0 0.7 3.8 2.9 3.8 0.6 7.9 18.8 1.8 3.8 7.6 1.5 1.5 2.3 5.0 9.1 8.9 5.1 3.5 2.5 2.5 4.1 1.7 3.6 6.3 0.2 27.6 6.2 2.6 2.2 0.7 5.9 7.3 4.5 5.2 5.2 3.0 6.8 1.9 19.7 4.8 5.2 3.7 7.1 1.5 5.1 3.3 5.3 1.8 8.2 0.0 1.3 9.3 2.5 18.3 3.0 4.0 3.6 0.1 0.8 3.0 3.9 4.0 6.4 6.8 5.2 4.8 7.1 13.5 8.2 16.1 0.7 0.4 0.1 2.4 0.7 4.0 2.5 5.0 3.9 0.6 2.1 5.7 2.6 0.5 0.6 1.4 0.6 7.0 0.7 15.2 17.0 29.1 25.9 15.9 14.9 19.7 17.1 15.4 15.3 23.8 15.5 11.5 72.4 22.3 53.3 63.0 2.5 9.4 14.8 7.0 119.8 58.3 5.0 1.7 1.1 23.5 47.0 93.5 10.3 3.1 22.5 50.7 17.3 31.4 162.5 19.1 40.1 9.8 59.0 1.4 4.6 30.3 10.1 0.0 31.7 18.8 6.8 28.1 29.7 9.8 47.3 0.0 13.9 2.6 5.9 9.4 35.1 19.1 30.4 13.2 ANKRD27 "DKFZp434L0718, FLJ00040, VARP" ENSG00000105186 "Ankyrin repeat domain 27" Q96NW4 19 32597007-32676597 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 53.0" "Low region specificity" "Detected in all" HPA042769 Approved Approved Cytosol NA NA Cytosol "HPA042769: AB_10796584" "unprognostic (2.16e-3)" "unprognostic (6.04e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (1.63e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.21e-5)" "unprognostic (9.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.90e-2)" "unprognostic (6.22e-3)" "unprognostic (3.74e-2)" "unprognostic (2.14e-1)" "unprognostic (4.94e-2)" "unprognostic (4.07e-1)" "unprognostic (2.26e-2)" 13.1 10.5 14.3 12.2 16.3 12.1 13.3 18.6 19.3 12.7 20.7 14.4 9.4 10.2 15.0 12.6 19.8 11.0 10.5 12.3 12.6 12.5 13.4 6.2 13.7 13.5 15.3 12.0 12.5 9.7 12.8 11.5 18.6 17.6 17.4 16.5 14.5 13.2 19.6 26.0 16.5 14.1 16.2 15.3 12.0 14.9 22.6 14.3 24.6 18.9 10.7 17.2 23.9 17.5 5.5 8.8 20.0 11.0 19.6 13.2 8.6 12.2 14.1 4.6 8.2 9.6 7.4 11.3 7.1 7.2 7.8 10.3 11.1 7.5 13.4 6.6 8.9 8.2 7.6 11.7 8.7 13.0 18.1 5.9 53.0 5.3 9.1 12.0 20.3 19.2 5.4 11.6 8.4 13.7 5.4 7.8 10.0 14.1 30.4 5.9 12.0 7.8 17.6 2.4 15.5 5.5 11.7 6.2 4.9 6.2 11.9 8.5 3.5 6.9 11.8 8.3 6.4 4.9 9.9 7.2 8.5 9.1 7.8 10.8 7.9 4.7 9.2 8.5 20.0 5.4 20.0 7.7 19.3 10.4 11.0 13.2 5.5 10.7 11.5 8.8 5.5 8.5 8.9 6.5 19.6 8.6 4.3 9.1 8.6 14.3 16.3 18.6 19.3 12.6 12.5 15.3 12.0 17.6 14.3 14.9 10.3 5.4 4.8 13.9 8.4 7.9 10.2 4.0 4.5 8.7 19.6 11.5 0.0 2.8 3.5 5.9 7.8 0.0 5.1 9.2 7.0 7.8 11.5 3.6 7.2 11.1 8.7 4.3 10.8 10.8 10.0 7.4 15.1 2.8 9.5 4.1 5.8 9.0 8.9 5.4 13.4 0.0 11.3 3.8 16.2 13.6 12.7 8.7 7.7 7.3 ANKRD34A ANKRD34 ENSG00000272031 "Ankyrin repeat domain 34A" Q69YU3 1 145959442-145964582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 18.1" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 8.1;Cardiomyocytes: 2.9;Muller glia cells: 1.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.5;T-cells: 3.5" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029642, HPA029643" Uncertain Enhanced Cytosol NA NA Cytosol "HPA029642: AB_10599277, HPA029643: AB_10601878" "unprognostic (1.98e-1)" "unprognostic (5.66e-2)" "unprognostic (1.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-2)" "unprognostic (4.36e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-1)" "unprognostic (3.19e-1)" "unprognostic (2.15e-2)" "unprognostic (6.68e-3)" "unprognostic (9.66e-8)" "unprognostic (6.36e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (9.23e-2)" 0.8 1.3 6.4 2.0 10.5 0.3 0.6 7.8 18.1 0.9 0.7 1.2 0.0 1.6 1.5 1.2 0.9 0.7 1.1 1.7 4.2 0.5 0.2 0.7 1.4 0.4 6.7 1.6 0.5 2.0 1.2 0.5 5.7 1.7 0.4 1.3 0.8 2.2 2.3 0.8 1.6 1.6 0.0 1.4 1.1 0.5 1.0 0.0 0.6 0.0 1.5 0.9 0.0 1.5 0.4 0.6 0.3 0.3 3.5 1.0 1.4 0.8 0.7 2.5 3.6 2.8 0.3 2.7 5.2 0.6 1.7 0.2 0.8 2.8 0.3 3.5 1.4 0.6 1.1 0.8 0.4 5.9 1.7 0.2 2.1 0.0 0.5 0.3 2.3 2.5 0.3 2.3 2.6 3.7 0.9 2.3 1.3 6.4 4.0 2.5 1.1 0.8 0.3 0.2 3.1 0.3 0.7 12.6 1.1 0.1 3.5 2.5 0.5 0.1 1.6 0.3 3.6 0.4 0.8 6.3 4.3 5.3 1.4 4.5 8.6 0.4 6.2 2.2 0.5 0.0 0.1 0.6 3.5 0.3 2.6 1.5 1.7 1.9 0.4 1.4 2.3 3.4 0.3 0.3 0.0 0.1 1.7 1.0 0.0 0.0 0.0 0.4 0.2 8.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.5 0.3 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.4 0.3 1.4 0.0 0.7 0.4 0.4 0.1 0.1 0.0 0.0 0.1 ANKRD46 ENSG00000186106 "Ankyrin repeat domain 46" Q86W74 8 100509752-100559784 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013758 Approved Approved Cytosol NA NA Cytosol "HPA013758: AB_10962626" "unprognostic (3.71e-3)" "unprognostic (9.01e-2)" "unprognostic (2.03e-1)" "unprognostic (2.22e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (2.63e-1)" "unprognostic (8.84e-2)" "unprognostic (4.79e-2)" "unprognostic (3.56e-1)" "unprognostic (2.98e-2)" "unprognostic (1.51e-1)" "unprognostic (8.08e-3)" "unprognostic (5.29e-2)" "unprognostic (1.82e-1)" "unprognostic (1.81e-2)" "unprognostic (6.29e-3)" 13.0 29.7 25.8 6.0 23.4 1.6 11.1 25.2 34.2 12.2 6.9 13.9 7.6 7.6 9.7 12.8 9.6 8.9 5.9 14.5 24.0 25.9 23.8 29.5 8.0 6.8 21.7 25.2 17.6 13.6 10.7 10.8 15.2 24.5 10.6 7.1 7.7 11.7 10.7 40.3 8.3 8.1 9.5 20.6 7.9 8.4 6.1 14.6 9.4 14.7 6.1 7.9 8.2 7.6 11.3 7.9 10.4 6.0 12.7 15.8 8.7 5.5 7.0 10.6 5.9 8.1 4.8 11.7 7.3 3.3 5.6 4.8 10.1 3.4 17.6 13.8 2.5 1.8 4.3 10.7 5.4 6.0 6.2 9.4 21.9 3.5 7.9 4.8 5.1 2.8 3.4 10.0 3.6 6.0 6.1 6.9 12.3 11.5 5.7 5.3 6.3 23.8 9.5 7.7 14.4 5.2 18.5 3.5 11.7 8.2 6.0 11.6 11.8 3.1 5.8 4.6 13.2 8.6 8.9 5.1 2.6 2.9 3.8 2.8 13.5 12.8 14.5 2.8 16.8 4.1 10.4 6.0 6.1 12.5 3.2 15.2 11.3 12.0 10.9 7.9 9.5 15.8 13.5 1.5 12.7 5.1 7.4 11.2 8.7 25.8 23.4 25.2 34.2 24.0 25.9 21.7 25.2 24.5 14.6 6.0 3.8 12.0 9.0 9.6 28.0 13.7 7.6 4.0 1.2 21.0 17.7 27.0 24.9 7.2 0.8 11.4 8.4 0.0 5.3 11.8 12.0 9.1 4.6 30.4 9.8 63.5 7.0 17.2 7.2 1.1 19.5 3.4 10.1 8.2 8.1 46.0 3.3 8.4 24.8 39.6 28.0 25.8 11.8 8.1 15.1 12.4 19.6 10.0 8.6 7.9 ANXA4 ANX4 ENSG00000196975 "Annexin A4" P09525 2 69644425-69827100 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 212.1;pancreas: 160.1" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 1936.3;Ductal cells: 852.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 68.0;Hep G2: 71.0;RPTEC TERT1: 99.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB005076, HPA007393, CAB017560" Enhanced Approved Cytosol NA NA 580000 Cytosol "CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168" "prognostic unfavorable (8.55e-4)" "unprognostic (3.37e-2)" "unprognostic (4.82e-2)" "unprognostic (9.03e-2)" "unprognostic (1.62e-3)" "unprognostic (1.66e-1)" "unprognostic (3.57e-1)" "unprognostic (3.21e-1)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (7.23e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.79e-1)" "unprognostic (8.85e-2)" "unprognostic (3.60e-2)" "unprognostic (3.97e-2)" 18.7 5.9 4.2 12.2 4.3 4.1 9.7 1.3 3.0 16.9 32.7 5.3 12.9 43.2 22.8 11.5 16.1 11.9 212.1 6.8 4.3 3.1 36.2 30.9 19.2 5.9 5.1 2.4 12.3 160.1 5.8 3.3 50.9 11.8 18.1 14.9 10.3 11.7 11.4 6.9 12.9 85.7 12.3 6.5 7.2 16.9 5.6 3.6 4.0 24.7 12.9 8.3 11.0 13.2 17.6 21.3 27.6 23.7 3.6 10.3 8.9 10.8 39.4 0.5 4.9 30.3 26.2 1.8 10.5 15.9 4.3 6.1 5.9 19.5 3.5 68.0 17.1 12.9 16.8 3.8 16.9 4.5 10.0 3.2 5.4 3.6 71.0 21.5 1.8 7.0 15.5 16.7 5.8 14.2 10.2 11.1 1.7 0.3 3.2 11.8 9.8 2.8 3.4 0.9 44.1 5.4 2.9 1.1 4.3 99.5 15.7 0.8 3.7 11.6 16.1 15.8 6.0 5.3 24.5 16.0 8.0 3.9 10.6 5.8 1.3 1.4 0.1 12.4 9.3 5.4 27.6 14.8 11.9 10.3 17.4 7.8 17.6 5.3 7.7 21.3 15.9 0.9 5.8 2.0 3.6 23.7 6.4 5.9 8.9 4.2 4.3 1.3 3.0 4.3 3.1 5.1 2.4 11.8 3.6 190.6 117.9 20.5 84.8 65.9 7.2 9.8 1936.3 278.4 133.1 80.3 5.9 74.2 187.3 852.8 12.6 41.2 479.2 0.0 308.4 326.2 105.4 51.9 108.6 59.2 193.0 7.9 17.9 27.0 44.2 6.5 59.8 61.9 87.7 107.4 167.5 40.5 315.1 293.7 86.7 253.0 56.9 6.5 52.0 11.5 3.6 69.5 367.6 32.5 132.9 90.2 ANXA6 ANX6 ENSG00000197043 "Annexin A6" P08133 5 151100712-151157882 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "monocytes: 703.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 106.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002462, CAB005077, HPA009650, HPA009977" Enhanced Approved Cytosol NA NA 970000 Cytosol "CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: " "unprognostic (1.74e-1)" "unprognostic (5.85e-2)" "unprognostic (1.03e-1)" "unprognostic (5.81e-2)" "unprognostic (2.44e-1)" "unprognostic (9.41e-2)" "unprognostic (1.17e-1)" "unprognostic (1.75e-1)" "unprognostic (9.63e-2)" "unprognostic (1.60e-2)" "unprognostic (1.08e-3)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.31e-5)" "unprognostic (6.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.28e-3)" "unprognostic (1.38e-3)" 78.3 38.2 22.2 44.7 38.3 28.6 109.1 22.0 70.0 37.4 50.2 13.3 34.1 12.5 52.2 34.2 27.0 39.5 39.0 53.0 28.7 37.8 22.1 54.7 33.7 66.7 38.6 30.0 54.9 27.6 8.2 41.4 47.4 62.5 39.3 24.0 36.7 19.7 60.7 85.4 16.6 30.7 82.8 16.8 41.4 31.3 16.8 7.2 44.6 25.5 34.7 50.1 53.0 51.4 36.4 22.4 15.0 15.3 47.0 58.1 50.1 0.3 3.8 24.6 36.3 106.1 48.5 6.7 49.5 58.7 37.2 51.8 13.0 1.9 3.3 17.4 63.0 30.6 0.0 19.0 23.3 37.8 13.3 6.8 1.9 7.8 24.4 35.7 12.0 12.0 60.1 0.1 31.6 5.1 55.8 47.3 23.1 2.6 46.1 87.7 11.8 22.1 18.5 6.9 0.1 11.0 14.5 76.0 3.6 5.5 0.0 1.5 6.4 5.1 35.1 21.3 40.2 60.1 22.7 41.5 35.0 10.6 2.5 12.9 25.8 35.1 0.5 19.0 56.2 5.6 13.8 15.3 15.0 58.1 10.3 38.6 35.0 43.4 52.6 22.4 36.4 30.4 36.9 3.3 47.0 4.6 5.5 34.8 50.1 22.2 38.3 22.0 70.0 28.7 37.8 38.6 30.0 62.5 7.2 14.9 22.4 101.1 11.4 9.7 15.2 49.2 7.6 6.7 0.0 22.7 5.9 54.7 21.6 5.4 35.0 27.8 0.3 23.3 15.2 28.6 64.5 7.2 54.5 119.4 69.2 14.3 20.5 73.6 41.2 35.0 114.2 32.6 52.3 703.3 0.6 42.9 18.1 0.3 198.7 35.6 109.8 226.4 105.6 2.7 1.0 7.0 148.2 109.7 1.9 1.1 AP000646.1 ENSG00000285509 11 121024125-121113108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 2.0;parathyroid gland: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.0" "HPA038593, HPA038594" Uncertain Uncertain Cytosol NA NA Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" 0.0 0.0 0.2 0.0 0.0 0.8 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.5 0.6 0.8 0.2 0.5 0.0 0.8 2.0 2.5 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.3 0.8 1.7 0.4 0.3 0.4 0.2 1.9 2.4 2.3 0.3 1.1 1.2 0.6 0.7 0.8 1.0 0.0 0.8 0.5 2.5 0.1 0.4 4.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 1.1 1.0 0.0 1.0 0.6 1.6 0.0 0.0 0.2 0.1 0.3 0.0 1.4 0.2 2.5 0.7 0.2 0.7 2.2 3.0 0.8 0.1 0.0 2.5 1.4 0.2 0.0 2.0 0.2 0.5 0.9 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP3D1 ADTD ENSG00000065000 "Adaptor related protein complex 3 delta 1 subunit" O14617 19 2100988-2164468 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074408 Approved Cytosol No No 10000 Cytosol "HPA074408: AB_2686686" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (1.12e-1)" "unprognostic (2.24e-3)" "unprognostic (1.37e-1)" "unprognostic (6.35e-2)" "prognostic unfavorable (9.23e-4)" "unprognostic (4.24e-2)" "unprognostic (8.05e-2)" "unprognostic (5.70e-2)" "unprognostic (6.68e-3)" "unprognostic (9.37e-2)" "prognostic favorable (2.61e-6)" "unprognostic (8.11e-3)" "unprognostic (1.22e-1)" "unprognostic (6.25e-2)" "unprognostic (1.73e-2)" 22.4 30.3 27.6 26.0 31.5 18.6 27.1 38.1 41.5 24.8 23.1 22.3 30.1 27.1 27.9 23.9 28.1 26.3 22.6 32.6 25.6 23.6 28.6 45.5 23.5 29.7 19.7 29.8 24.4 55.3 32.1 39.8 26.8 25.1 23.1 18.0 25.9 35.1 28.6 42.6 21.2 26.2 25.7 16.5 25.0 25.9 33.2 21.2 23.6 34.6 19.3 22.5 27.8 23.5 4.1 11.0 5.1 5.0 7.8 8.4 2.9 32.2 33.6 20.3 30.6 26.0 22.1 24.7 26.3 25.9 28.1 25.6 38.1 17.9 17.7 15.2 38.9 34.4 22.1 29.2 31.8 18.6 25.5 27.7 22.8 21.9 29.8 45.3 24.6 30.5 27.1 21.4 29.1 42.8 23.8 27.2 12.8 23.4 61.8 24.6 23.6 23.8 13.4 30.2 22.3 21.7 25.6 22.1 23.5 21.1 46.6 28.8 24.0 23.7 25.1 44.3 19.6 24.3 28.8 35.1 26.8 11.4 36.2 30.4 52.4 50.5 22.6 36.6 16.4 26.6 0.3 4.9 3.9 5.3 5.0 8.4 3.5 5.2 6.3 5.6 4.1 4.3 5.3 5.1 7.8 4.1 11.0 3.0 2.9 27.6 31.5 38.1 41.5 25.6 23.6 19.7 29.8 25.1 21.2 56.6 63.9 17.1 33.7 18.0 63.0 60.7 45.9 22.7 37.5 38.4 33.4 44.8 18.3 48.1 58.7 32.2 59.6 0.0 63.4 58.0 31.5 49.3 16.2 46.1 57.4 46.1 45.9 31.9 25.9 49.2 35.1 37.6 37.1 16.2 41.5 59.4 61.9 44.6 35.7 30.6 41.1 19.4 28.1 72.4 116.5 20.5 65.2 27.7 43.7 53.9 APEH "D3F15S2, D3S48E, DNF15S2" ENSG00000164062 "Acylaminoacyl-peptide hydrolase" P13798 3 49674002-49683963 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029700, HPA029701, HPA029702, HPA029703" Enhanced Enhanced Cytosol No No 1600000 Cytosol "HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348" "unprognostic (4.93e-2)" "unprognostic (5.42e-2)" "unprognostic (6.04e-3)" "unprognostic (2.71e-1)" "unprognostic (9.32e-2)" "unprognostic (8.20e-2)" "unprognostic (3.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.89e-2)" "unprognostic (8.03e-2)" "unprognostic (3.21e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.32e-10)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.34e-2)" "unprognostic (7.67e-2)" 12.3 31.4 14.3 16.9 18.4 17.3 13.5 14.2 28.2 13.4 23.5 14.4 25.3 24.2 14.1 19.0 23.8 17.2 19.1 23.1 14.2 14.2 33.6 36.9 15.0 23.9 13.9 20.0 13.9 22.7 33.5 26.6 18.6 16.3 16.1 26.6 19.5 19.8 19.8 55.1 16.9 21.7 14.1 9.8 19.2 21.9 22.3 11.7 22.6 26.6 26.6 20.7 19.9 13.7 20.5 26.2 30.4 27.9 21.8 29.5 28.1 25.8 21.1 23.2 30.0 20.3 13.6 30.7 16.9 21.7 23.8 25.5 34.0 28.1 33.1 19.0 19.2 21.7 24.0 25.9 39.2 18.1 15.7 10.7 35.7 35.3 27.8 20.1 38.2 55.6 15.4 29.6 13.6 28.3 23.8 21.5 23.3 22.1 16.5 23.6 23.9 26.9 19.4 13.7 37.3 19.3 10.2 19.9 43.0 47.1 61.4 11.1 19.3 19.1 46.4 21.0 17.9 30.6 20.4 9.7 14.7 25.8 23.0 22.8 18.9 13.5 19.7 25.4 27.1 21.2 30.2 25.5 30.4 28.5 27.9 22.5 20.5 23.5 26.7 26.2 17.4 24.9 24.2 8.0 21.8 26.7 21.0 29.5 28.1 14.3 18.4 14.2 28.2 14.2 14.2 13.9 20.0 16.3 11.7 38.7 22.3 16.0 19.8 7.7 7.8 42.0 33.1 9.4 20.5 26.2 11.8 72.6 36.5 39.0 4.6 8.3 73.8 23.3 30.4 54.6 12.8 15.2 23.1 65.2 45.5 7.9 25.4 14.1 36.8 8.1 14.1 18.1 20.3 22.6 44.7 21.8 35.8 28.8 12.7 64.9 9.9 12.9 14.2 30.5 28.4 8.2 51.9 25.3 51.1 21.0 AR "AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1" ENSG00000169083 "Androgen receptor" P10275 X 67544032-67730619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 49.0" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 189.5;Leydig cells: 72.2;Peritubular cells: 81.3;Sertoli cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in single" 16 "dendritic cells: 5.4" "Cell line enhanced" "Detected in some" "AF22: 11.3;BJ hTERT+: 9.8;HAP1: 14.4;LHCN-M2: 12.6;RH-30: 20.9;T-47d: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000001, HPA004733, CAB065764" Enhanced Supported Cytosol NA NA Cytosol "CAB000001: AB_2060174, CAB065764: AB_10620739, HPA004733: " "unprognostic (1.34e-1)" "unprognostic (8.10e-3)" "unprognostic (2.49e-2)" "unprognostic (5.95e-2)" "unprognostic (1.04e-2)" "unprognostic (3.35e-2)" "prognostic favorable (8.77e-4)" "unprognostic (4.99e-2)" "unprognostic (1.72e-1)" "unprognostic (7.79e-2)" "unprognostic (2.30e-1)" "unprognostic (2.29e-1)" "prognostic favorable (1.03e-8)" "unprognostic (8.23e-3)" "unprognostic (8.90e-2)" "unprognostic (4.23e-2)" "unprognostic (7.97e-2)" 10.1 1.2 0.9 1.6 0.9 0.1 10.7 0.4 1.6 34.4 1.9 2.4 25.4 0.2 20.5 20.5 2.2 17.5 4.3 5.7 0.9 1.5 6.3 49.0 1.5 0.2 1.2 0.7 14.4 1.0 0.1 2.3 0.3 1.9 28.0 0.5 3.8 1.6 36.1 8.1 3.9 1.1 7.6 1.9 0.9 1.6 9.3 1.2 5.4 3.1 2.0 1.2 6.3 13.1 0.0 5.4 0.3 0.0 0.1 0.0 0.1 0.0 4.7 11.3 0.0 0.0 0.1 0.0 6.0 9.8 0.4 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 14.4 0.0 0.1 0.0 1.9 0.0 1.1 0.0 0.7 0.0 0.0 4.6 0.0 1.7 0.0 0.0 3.5 0.1 4.1 1.9 12.6 1.2 0.0 0.0 4.5 0.0 0.0 0.0 20.9 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 3.2 8.8 5.3 0.2 0.2 2.0 0.1 3.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 5.4 0.0 0.1 0.9 0.9 0.4 1.6 0.9 1.5 1.2 0.7 1.9 1.2 0.0 5.3 0.0 18.1 8.7 0.6 31.3 12.7 6.7 19.4 3.5 0.0 1.9 1.7 7.5 0.9 4.9 0.0 0.0 0.0 0.1 9.4 31.9 1.1 189.5 0.7 0.0 0.0 14.7 1.6 1.6 72.2 2.1 10.1 2.8 0.0 0.2 1.0 0.0 81.3 22.3 0.3 64.7 12.3 0.5 1.0 14.1 0.8 0.0 0.0 15.9 ARF6 ENSG00000165527 "ADP ribosylation factor 6" P62330 14 49893092-49897054 "Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Suprabasal keratinocytes: 588.6;Urothelial cells: 680.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002778, CAB079914" Approved Supported Cytosol NA NA 130000 Cytosol "CAB002778: , CAB079914: AB_2539861" "unprognostic (1.21e-1)" "unprognostic (2.75e-3)" "unprognostic (1.80e-1)" "unprognostic (7.02e-2)" "unprognostic (2.85e-1)" "unprognostic (1.83e-1)" "unprognostic (4.12e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (3.10e-5)" "unprognostic (1.61e-1)" "unprognostic (1.67e-1)" "unprognostic (8.37e-3)" "unprognostic (1.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.49e-2)" 19.7 14.3 8.1 22.3 11.0 31.8 18.7 10.8 11.2 23.1 27.2 9.6 17.4 20.6 17.5 17.8 73.2 16.0 20.4 12.8 7.9 7.7 21.4 23.0 19.3 27.0 10.3 11.0 17.3 15.9 8.2 10.3 29.1 9.8 21.6 23.6 13.7 25.0 13.6 20.6 42.7 43.7 16.7 10.7 28.9 20.6 17.3 8.9 33.7 18.8 34.4 44.0 22.2 35.2 22.9 15.7 17.6 21.5 18.5 26.4 13.9 41.4 17.4 11.8 13.6 16.2 21.7 24.1 26.1 19.0 18.6 19.3 12.6 29.1 27.1 13.5 21.7 14.3 30.7 13.2 20.9 22.2 53.2 10.6 13.9 9.4 11.2 18.3 25.4 18.7 16.8 25.1 15.0 29.1 22.4 20.5 17.6 13.3 54.1 25.7 29.7 22.4 22.4 12.8 22.5 25.2 17.5 15.4 15.8 48.1 33.8 17.4 11.5 20.7 31.3 25.3 15.0 23.7 20.7 27.0 34.8 17.8 20.4 19.5 29.1 29.9 20.5 12.4 15.1 24.6 17.6 14.3 13.3 24.4 21.5 26.4 22.9 24.1 24.7 15.7 17.5 16.8 21.3 9.8 18.5 19.3 10.4 23.2 13.9 8.1 11.0 10.8 11.2 7.9 7.7 10.3 11.0 9.8 8.9 47.6 25.1 175.3 466.8 532.8 22.5 16.1 104.4 18.7 33.0 96.0 2.0 137.2 134.3 117.8 2.7 72.9 203.3 93.5 70.0 160.9 87.6 430.3 78.5 116.3 146.8 31.8 95.3 90.9 177.7 5.6 31.1 185.3 288.5 199.2 149.8 40.2 95.1 160.9 30.8 117.8 17.6 45.3 154.6 55.6 45.6 588.6 169.7 182.7 111.6 680.4 ARHGAP26 "GRAF, KIAA0621, OPHN1L, OPHN1L1" ENSG00000145819 "Rho GTPase activating protein 26" Q9UNA1 5 142770377-143229011 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "neutrophil: 19.6;NK-cell: 5.8" "Group enriched" "Detected in many" 4 "granulocytes: 19.6;NK-cells: 5.8" "Cell line enhanced" "Detected in many" "Karpas-707: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035106, HPA035107" Enhanced Approved Cytosol NA NA Cytosol "HPA035106: AB_2674465, HPA035107: AB_10669855" "prognostic favorable (2.05e-4)" "prognostic favorable (1.36e-4)" "prognostic favorable (6.95e-4)" "prognostic favorable (5.93e-6)" "unprognostic (1.19e-1)" "unprognostic (1.93e-2)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.22e-1)" "unprognostic (9.43e-3)" "unprognostic (7.19e-3)" "unprognostic (8.65e-2)" "unprognostic (3.21e-3)" "unprognostic (5.67e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-2)" "prognostic favorable (2.88e-6)" 13.3 5.7 18.4 18.6 22.7 33.9 13.0 29.2 23.9 15.9 14.2 7.5 9.9 13.2 9.4 10.9 7.6 18.5 16.4 17.0 12.8 10.5 8.0 7.7 20.0 8.8 12.9 15.4 4.8 5.5 4.8 15.1 22.4 11.9 8.5 14.8 8.8 14.6 11.2 14.0 8.5 12.6 11.1 12.6 18.9 17.0 16.1 12.2 10.3 10.0 5.4 13.6 9.4 10.6 0.3 2.0 19.6 2.8 5.8 3.0 1.0 6.9 14.0 3.9 3.6 5.8 6.4 6.0 0.8 1.2 3.4 5.9 19.1 15.8 1.0 6.9 2.2 10.3 3.3 1.9 6.6 4.2 14.3 2.2 0.0 1.8 12.1 3.7 10.2 1.4 2.3 11.6 6.2 14.3 2.7 5.0 4.8 0.2 39.7 1.0 1.1 5.8 4.2 1.8 10.3 3.6 2.2 5.8 16.6 9.9 10.7 1.5 2.4 1.8 1.9 3.2 3.1 1.0 3.1 9.6 1.8 2.6 0.2 3.6 1.8 5.7 0.2 4.8 9.7 2.5 2.9 2.8 1.6 3.0 1.7 1.3 0.2 0.6 1.8 2.0 0.3 0.2 0.8 19.6 5.8 1.0 0.5 0.2 1.0 18.4 22.7 29.2 23.9 12.8 10.5 12.9 15.4 11.9 12.2 14.9 22.7 2.9 13.9 6.2 9.5 33.7 25.5 12.0 12.5 0.0 7.9 1.1 0.0 15.6 62.7 31.7 30.5 0.0 18.9 0.7 11.6 26.2 25.5 4.3 21.6 71.5 3.5 30.1 49.8 105.1 6.1 31.8 10.1 6.4 26.2 6.3 16.0 21.5 13.4 4.4 54.5 45.3 12.7 1.9 11.3 4.8 1.6 22.7 21.7 31.9 ARHGAP6 rhoGAPX-1 ENSG00000047648 "Rho GTPase activating protein 6" O43182 X 11137543-11665701 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 57.3;seminal vesicle: 58.8" "Cell type enhanced" "Detected in many" 10 "Glandular cells: 77.5;granulocytes: 39.3;Sertoli cells: 45.3;Smooth muscle cells: 47.5" "Cancer enhanced" "Detected in many" "prostate cancer: 12.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 15.1;ASC TERT1: 19.6;HEL: 19.3;HMC-1: 13.6;HSkMC: 19.3;K-562: 14.0;RT4: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001798, HPA036779, HPA064390" Enhanced Supported Cytosol "Intracellular and membrane" NA NA 920000 Cytosol "HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253" "unprognostic (2.36e-1)" "unprognostic (1.68e-2)" "unprognostic (3.49e-2)" "unprognostic (7.31e-2)" "unprognostic (6.34e-2)" "unprognostic (1.69e-2)" "unprognostic (4.70e-2)" "unprognostic (2.79e-1)" "unprognostic (1.70e-1)" "unprognostic (7.46e-4)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.55e-8)" "unprognostic (1.60e-2)" "unprognostic (5.96e-2)" "unprognostic (1.28e-2)" "unprognostic (7.99e-4)" 9.4 1.2 16.7 2.6 10.0 0.7 6.3 0.6 2.9 9.5 11.7 4.1 57.3 2.0 10.2 9.0 4.1 7.6 5.4 3.6 5.6 4.3 6.0 1.1 8.7 1.2 2.3 3.6 15.1 1.9 1.1 6.6 6.2 2.7 24.8 3.7 3.2 2.5 58.8 8.0 2.3 4.2 12.1 3.1 5.0 4.1 2.2 3.3 0.0 25.9 3.1 1.4 14.3 8.0 1.3 0.2 1.0 0.9 0.0 0.1 2.7 0.0 0.0 1.3 0.0 15.1 19.6 0.3 0.1 0.3 0.8 0.5 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.5 0.0 0.7 0.0 0.2 19.3 0.0 0.0 5.5 0.0 13.6 19.3 0.0 1.4 0.0 1.7 0.3 0.0 14.0 6.5 0.8 0.0 0.0 0.0 0.3 0.1 0.2 0.0 6.4 8.1 4.6 11.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.8 0.3 3.9 0.1 0.3 0.0 0.0 0.1 0.0 2.1 1.0 0.3 0.5 0.0 0.9 0.0 1.3 0.0 0.1 0.2 0.4 0.0 0.0 1.0 0.0 0.7 0.2 0.0 2.7 16.7 10.0 0.6 2.9 5.6 4.3 2.3 3.6 2.7 3.3 0.0 1.7 0.5 15.5 1.8 1.0 2.5 0.0 9.4 4.5 31.4 0.0 0.3 21.6 0.0 0.1 5.5 0.0 0.0 0.9 0.7 8.2 77.5 39.3 0.0 3.8 0.0 1.2 9.8 3.2 0.4 15.0 12.3 5.0 3.6 0.2 5.7 0.5 0.0 9.6 6.1 0.3 45.3 47.5 0.2 0.4 1.5 0.0 0.0 0.0 16.6 ARHGDIA "GDIA1, RHOGDI" ENSG00000141522 "Rho GDP dissociation inhibitor alpha" P52565 17 81867721-81871406 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010005, HPA021407" Approved Supported Cytosol NA NA 49000000 Cytosol "CAB010005: AB_2227516, HPA021407: AB_1856267" "unprognostic (1.08e-1)" "unprognostic (2.29e-2)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" "unprognostic (5.00e-2)" "unprognostic (8.39e-3)" "unprognostic (1.39e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (5.32e-2)" "unprognostic (4.67e-2)" "unprognostic (2.67e-2)" "unprognostic (6.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-1)" "unprognostic (3.29e-1)" "unprognostic (6.88e-3)" 67.9 52.5 43.8 71.8 59.5 91.1 57.2 20.4 65.7 41.2 55.4 44.6 29.7 85.9 50.0 34.1 55.0 40.9 46.2 36.7 41.5 44.6 50.9 64.9 56.0 68.2 39.9 43.4 49.7 65.9 30.6 42.9 52.8 39.0 44.1 27.2 39.9 52.7 43.2 36.7 41.0 88.8 35.7 41.7 57.1 68.4 26.3 35.4 67.1 41.2 41.4 49.9 42.2 44.8 17.0 24.0 35.0 41.0 18.4 29.9 22.8 65.1 64.3 20.9 33.5 19.4 24.4 23.9 56.0 36.1 42.1 31.4 31.5 24.8 34.5 24.0 42.3 36.8 35.9 23.1 42.2 17.8 26.8 59.2 36.4 38.4 41.0 39.5 57.3 53.5 30.8 19.6 30.5 26.6 21.5 64.0 29.5 30.0 48.6 33.8 39.2 83.2 58.4 24.9 21.8 56.9 38.1 26.8 27.5 27.6 40.3 27.9 82.0 29.4 75.9 52.5 16.0 35.6 47.2 70.5 84.1 71.9 77.6 95.1 42.8 22.3 35.6 73.0 34.6 57.0 15.7 20.5 35.0 29.9 31.3 28.5 17.0 25.0 28.5 21.2 13.2 16.8 19.7 13.3 18.4 41.0 24.0 23.9 22.8 43.8 59.5 20.4 65.7 41.5 44.6 39.9 43.4 39.0 35.4 35.7 65.2 154.6 166.1 113.0 16.9 3.4 50.9 29.4 47.8 75.0 9.8 118.2 114.4 225.7 4.6 94.6 257.9 0.0 230.6 215.0 113.6 128.9 116.5 75.0 216.3 49.3 129.2 117.2 156.8 12.5 80.3 143.8 183.9 315.6 139.3 79.0 299.1 224.5 69.6 115.6 10.8 116.4 103.8 37.1 37.5 101.5 185.6 157.4 104.4 180.7 ARHGDIB "GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2" ENSG00000111348 "Rho GDP dissociation inhibitor beta" P52566 12 14942017-14961728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "blood: 333.1;bone marrow: 150.7;lymphoid tissue: 221.4" "Cell type enhanced" "Detected in many" 7 "granulocytes: 669.1;Hofbauer cells: 807.6;Kupffer cells: 661.4;Macrophages: 633.0;T-cells: 892.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 102.5;HL-60: 119.9;HMC-1: 135.8;JURKAT: 91.1;MOLT-4: 141.9;REH: 119.4;U-698: 109.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018584, HPA051235" Enhanced Supported Cytosol NA NA 120000000 Cytosol "CAB018584: AB_647972, HPA051235: AB_2681398" "unprognostic (2.29e-3)" "unprognostic (8.10e-2)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (9.16e-2)" "unprognostic (1.90e-2)" "unprognostic (2.44e-1)" "unprognostic (1.47e-2)" "unprognostic (3.46e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (4.42e-3)" "unprognostic (4.97e-2)" "prognostic favorable (3.42e-4)" 40.3 13.4 9.0 66.1 18.4 150.7 27.9 1.8 8.9 14.6 14.5 13.9 3.6 8.5 14.7 13.2 16.9 18.2 18.3 20.5 8.3 7.8 24.5 20.0 41.3 93.9 17.0 3.9 11.7 7.1 3.9 8.1 35.6 11.4 18.0 16.1 20.4 22.4 7.6 13.3 14.7 38.3 15.7 17.9 157.8 11.1 11.2 15.8 221.4 22.7 12.4 108.1 31.2 13.5 114.0 95.5 267.1 151.9 96.3 231.1 333.1 9.4 0.3 0.3 21.0 1.4 1.1 0.1 0.3 0.1 0.1 0.1 1.2 10.4 76.0 4.9 1.7 0.1 10.4 0.0 16.8 1.1 0.1 0.0 102.5 0.2 0.0 0.3 119.9 135.8 0.1 2.1 0.0 1.5 0.3 59.0 91.1 0.5 29.2 1.8 0.0 141.9 86.3 0.4 0.2 0.1 119.4 1.3 34.0 3.3 52.6 0.1 0.0 0.1 13.6 0.1 0.9 0.7 87.3 74.7 0.3 0.7 0.1 2.2 4.8 0.7 109.8 0.3 84.1 0.1 206.0 109.9 267.1 125.6 130.8 123.3 114.0 144.4 140.7 95.5 103.2 141.1 146.5 237.7 96.3 151.9 41.4 231.1 333.1 9.0 18.4 1.8 8.9 8.3 7.8 17.0 3.9 11.4 15.8 56.6 190.4 437.8 45.8 60.7 0.3 8.1 15.3 38.8 80.8 55.8 0.0 51.5 14.9 20.5 1.2 156.9 3.8 23.3 303.9 465.0 49.8 3.3 669.1 4.7 807.6 0.0 1.2 329.0 661.4 2.0 49.5 633.0 86.0 32.5 2.2 1.9 43.8 20.4 55.2 6.1 1.0 239.3 61.4 0.7 1.5 49.1 56.9 892.2 5.7 85.5 ARHGEF17 "KIAA0337, p164-RhoGEF, TEM4" ENSG00000110237 "Rho guanine nucleotide exchange factor 17" Q96PE2 11 73308289-73369388 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Sertoli cells: 84.1;Smooth muscle cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "myeloid DC: 1.0;plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007991 Uncertain Approved Cytosol NA NA Cytosol "HPA007991: AB_1845005" "unprognostic (2.36e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (8.27e-5)" "unprognostic (6.96e-2)" "unprognostic (1.57e-1)" "unprognostic (1.39e-1)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (1.69e-1)" "unprognostic (1.46e-3)" "unprognostic (1.15e-2)" "unprognostic (2.39e-1)" "unprognostic (1.47e-1)" "unprognostic (7.54e-3)" "unprognostic (7.12e-3)" "unprognostic (6.85e-3)" "unprognostic (3.42e-3)" 16.7 10.0 18.1 7.0 43.0 2.5 11.1 31.8 35.1 17.1 16.7 9.5 3.5 4.3 20.4 12.6 8.3 14.3 13.9 21.0 13.7 11.4 12.9 2.6 14.8 4.1 8.5 23.1 15.5 5.6 24.7 7.8 18.5 19.6 13.6 4.5 11.4 6.9 23.3 7.3 4.7 7.5 17.9 6.9 7.6 10.5 4.8 13.5 0.8 18.1 3.3 2.2 11.7 10.1 0.0 1.5 0.2 0.2 0.0 0.2 0.0 4.7 5.6 12.2 14.2 9.6 8.2 7.5 13.3 19.4 13.5 8.5 15.3 4.1 0.0 9.5 24.7 6.1 7.5 4.0 5.3 5.5 8.4 1.2 0.0 9.1 5.7 11.1 0.3 0.2 14.1 6.2 7.9 4.7 8.6 10.0 0.6 0.4 0.1 7.3 6.6 0.1 8.3 1.6 3.1 1.2 2.0 14.1 0.3 8.3 3.3 7.9 6.1 11.3 13.3 15.5 11.7 22.6 3.9 6.4 6.5 13.6 2.7 4.2 0.8 0.1 0.0 2.2 0.9 9.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 18.1 43.0 31.8 35.1 13.7 11.4 8.5 23.1 19.6 13.5 14.9 12.3 0.0 1.9 3.1 7.1 21.0 7.6 4.0 9.1 7.0 0.0 6.1 0.0 5.6 1.0 6.3 0.0 0.0 0.6 3.9 12.2 2.5 0.0 0.4 1.9 22.3 1.2 12.3 0.0 1.1 10.0 2.3 1.7 1.8 0.3 10.4 1.6 0.0 19.1 3.1 1.3 84.1 53.6 1.8 9.4 2.4 5.1 0.0 0.8 1.4 ARHGEF18 "KIAA0521, MGC15913, P114-RhoGEF" ENSG00000104880 "Rho/Rac guanine nucleotide exchange factor 18" Q6ZSZ5 19 7395113-7472477 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 2.6;Cone photoreceptor cells: 3.9;Intestinal endocrine cells: 1.7;Melanocytes: 1.7;Smooth muscle cells: 1.7;Suprabasal keratinocytes: 3.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042689, HPA071867" Approved Enhanced Cytosol NA NA Cytosol "HPA042689: AB_10794385, HPA071867: AB_2686466" "unprognostic (2.55e-1)" "unprognostic (1.31e-2)" "unprognostic (1.57e-1)" "unprognostic (6.01e-2)" "unprognostic (1.65e-2)" "prognostic favorable (4.21e-4)" "unprognostic (1.13e-1)" "unprognostic (1.52e-3)" "unprognostic (3.56e-1)" "unprognostic (2.36e-1)" "unprognostic (1.40e-1)" "unprognostic (8.26e-2)" "prognostic favorable (3.11e-5)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (3.79e-3)" 8.7 13.3 12.3 16.7 15.0 18.3 7.1 13.2 22.2 9.9 19.3 19.9 10.4 19.0 16.1 7.4 15.6 10.6 12.7 5.4 10.9 8.8 15.8 10.9 12.2 20.6 14.6 12.9 9.3 23.0 16.2 13.3 11.5 11.8 11.3 8.1 12.5 13.1 12.2 7.7 11.8 27.8 8.7 10.4 31.2 17.4 10.6 14.0 4.6 10.7 8.5 13.0 12.6 12.9 8.9 3.3 8.6 4.2 1.7 5.9 3.5 22.0 12.6 6.4 9.4 5.3 5.7 21.1 10.1 7.6 13.6 14.1 17.2 10.8 22.0 20.9 6.5 10.1 16.3 6.3 19.3 3.6 28.7 11.3 10.7 9.1 10.2 14.6 11.9 13.1 6.7 14.0 13.4 8.7 6.6 6.4 8.8 9.6 9.7 11.0 7.8 12.8 13.8 10.5 10.6 20.8 17.2 11.1 7.7 5.6 22.7 6.3 9.7 11.1 10.4 12.6 5.0 11.6 11.6 15.2 11.6 12.9 17.5 12.3 23.8 17.6 13.5 10.7 10.0 9.9 8.6 1.9 8.3 4.1 3.4 5.9 4.2 5.5 5.9 2.1 8.9 5.0 5.1 4.2 1.7 4.2 3.3 4.0 3.5 12.3 15.0 13.2 22.2 10.9 8.8 14.6 12.9 11.8 14.0 0.0 0.6 0.0 0.0 2.6 0.0 0.2 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.6 1.7 1.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 1.7 0.0 0.0 3.3 0.0 0.0 0.0 0.3 ARHGEF3 "DKFZP434F2429, GEF3, STA3, XPLN" ENSG00000163947 "Rho guanine nucleotide exchange factor 3" Q9NR81 3 56727418-57079329 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "T-cells: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 35.6;RPMI-8226: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034715, HPA064945" Uncertain Approved Cytosol NA NA Cytosol "HPA034715: AB_10600780, HPA064945: AB_2685389" "unprognostic (1.84e-2)" "unprognostic (2.22e-2)" "unprognostic (1.62e-2)" "prognostic favorable (2.17e-4)" "unprognostic (8.25e-2)" "prognostic favorable (2.61e-4)" "unprognostic (9.42e-2)" "unprognostic (3.83e-2)" "unprognostic (9.67e-2)" "unprognostic (7.44e-2)" "unprognostic (6.90e-2)" "unprognostic (4.99e-2)" "prognostic favorable (1.96e-7)" "unprognostic (8.24e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-2)" 14.5 33.0 8.3 14.2 22.8 6.4 13.5 24.0 31.1 12.8 12.9 8.8 8.2 4.8 29.6 14.4 16.2 17.8 16.6 9.3 19.0 12.0 19.5 3.9 18.1 19.5 9.3 18.4 20.6 36.9 29.8 30.4 15.5 18.3 11.6 10.5 19.9 18.6 12.3 7.7 10.8 9.1 26.1 9.7 14.9 11.3 10.2 5.8 33.4 10.9 10.2 20.4 13.9 11.2 8.4 4.4 4.9 9.3 11.9 32.7 20.8 9.6 3.4 0.5 3.2 1.1 0.9 6.9 1.0 0.9 1.1 1.4 1.6 9.2 5.0 1.0 1.9 10.7 5.0 3.0 12.7 1.2 7.3 1.4 4.1 2.2 35.6 2.8 0.0 4.6 4.2 8.4 0.9 1.4 10.0 10.5 5.4 1.1 11.3 2.4 1.4 13.7 0.5 0.9 7.8 5.3 0.0 3.8 37.0 8.3 5.3 0.6 1.6 6.2 4.6 2.7 3.7 1.2 4.3 4.8 0.5 2.6 2.2 1.6 14.5 5.6 18.4 9.1 5.0 4.4 4.9 7.1 1.1 32.7 8.0 24.5 8.4 25.2 28.5 4.4 5.6 20.7 25.2 2.7 11.9 9.3 1.9 20.7 20.8 8.3 22.8 24.0 31.1 19.0 12.0 9.3 18.4 18.3 5.8 14.9 21.9 10.7 8.2 9.8 9.6 8.7 0.0 8.1 6.8 22.7 3.9 9.4 10.0 8.6 15.7 23.0 1.1 0.0 8.7 6.3 12.2 14.3 12.8 0.0 7.2 0.0 9.2 12.3 28.4 10.9 16.4 15.8 10.1 5.4 0.7 8.9 7.8 0.0 22.6 6.9 1.1 0.0 4.2 1.7 2.7 13.0 10.0 44.8 2.6 10.7 ARHGEF37 FLJ41603 ENSG00000183111 "Rho guanine nucleotide exchange factor 37" A1IGU5 5 149551947-149634968 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 66.1;seminal vesicle: 73.8" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 9.0;neutrophil: 4.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "EFO-21: 10.1;HaCaT: 18.5;hTCEpi: 24.5" "Region enhanced" "Detected in some" "cerebellum: 9.5" "Low region specificity" "Detected in all" "HPA043885, HPA053487" Uncertain Approved Cytosol NA NA Cytosol "HPA043885: AB_2678715, HPA053487: AB_2682167" "unprognostic (3.51e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-1)" "unprognostic (3.92e-1)" "unprognostic (1.17e-1)" "unprognostic (6.87e-2)" "unprognostic (1.54e-3)" "unprognostic (1.54e-1)" "unprognostic (2.64e-1)" "unprognostic (6.93e-2)" "unprognostic (2.13e-3)" "unprognostic (1.16e-2)" "prognostic favorable (6.85e-4)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.50e-2)" "unprognostic (2.10e-1)" 2.5 2.7 10.8 1.9 13.2 3.0 16.8 6.7 7.1 4.0 10.2 17.5 66.1 4.5 4.4 9.5 7.6 7.4 4.6 6.4 12.8 9.5 4.6 1.4 4.3 1.0 19.1 5.8 2.2 7.0 29.6 5.3 3.6 12.3 16.0 5.2 12.0 23.2 73.8 11.9 29.3 4.8 7.0 31.7 1.0 11.7 4.8 15.1 0.7 2.1 4.8 3.4 6.4 5.4 0.7 1.1 9.0 1.2 0.2 0.8 0.0 3.0 1.2 0.8 3.6 0.2 0.4 2.1 0.4 0.6 0.6 0.6 0.0 4.0 0.4 10.1 0.4 1.1 18.5 0.3 1.8 1.2 0.8 0.9 0.3 1.9 0.2 0.7 0.0 0.5 0.5 24.5 1.9 2.4 2.0 3.0 1.3 0.4 0.7 0.0 0.4 0.5 0.6 0.2 7.5 2.2 0.3 0.4 0.0 4.1 1.5 1.5 3.6 2.2 0.2 0.3 0.4 5.5 0.1 2.4 0.2 0.7 0.0 0.5 0.5 1.0 0.3 0.7 0.1 2.6 9.0 0.9 0.5 0.4 1.2 0.5 0.2 0.3 0.3 0.3 0.7 0.8 0.6 4.9 0.2 0.5 1.1 0.2 0.0 10.8 13.2 6.7 7.1 12.8 9.5 19.1 5.8 12.3 15.1 0.0 5.0 3.7 8.4 6.1 4.1 14.8 15.3 6.7 6.8 8.7 3.9 4.9 0.0 3.2 4.2 6.0 12.6 0.0 4.5 1.2 2.1 9.6 6.9 2.6 2.8 4.8 10.9 6.7 2.8 1.0 1.7 3.7 3.3 4.6 6.1 40.8 4.1 8.0 9.9 1.3 7.3 6.5 4.1 13.2 5.5 8.4 3.8 4.4 7.5 4.5 ARHGEF6 "alpha-PIX, alphaPIX, Cool-2, Cool2, KIAA0006, MRX46" ENSG00000129675 "Rac/Cdc42 guanine nucleotide exchange factor 6" Q15052 X 136665547-136782088 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 54.5;granulocytes: 188.3;Kupffer cells: 44.7" "Cancer enhanced" "Detected in all" "glioma: 24.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 22.0;HL-60: 27.4;HMC-1: 104.4;JURKAT: 28.7;U-937: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003578 Approved Approved Cytosol NA NA Cytosol "HPA003578: AB_1078203" "unprognostic (9.64e-2)" "unprognostic (3.47e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-2)" "unprognostic (7.28e-2)" "unprognostic (2.06e-3)" "unprognostic (9.08e-2)" "unprognostic (7.87e-3)" "unprognostic (4.21e-1)" "unprognostic (2.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-3)" "unprognostic (5.29e-2)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-3)" 22.0 10.4 16.9 15.3 15.4 14.8 13.9 6.4 14.6 6.4 8.3 12.8 3.7 4.0 8.4 6.1 4.4 4.5 9.5 27.0 21.7 13.6 5.0 4.5 13.8 20.6 20.7 10.2 9.5 2.7 8.8 4.8 24.4 15.1 6.4 6.3 8.4 6.2 5.1 37.5 4.3 9.6 9.3 14.6 20.2 6.4 3.2 14.6 2.6 4.1 8.6 20.5 8.8 7.9 3.1 8.8 31.5 8.8 5.5 9.9 6.2 0.2 0.0 1.0 0.0 2.3 5.8 0.0 0.3 1.8 0.3 1.6 0.0 0.0 1.0 0.4 1.5 1.6 0.1 1.2 0.0 0.3 5.1 0.4 22.0 0.0 0.0 0.8 27.4 104.4 6.3 0.0 1.1 0.0 2.0 0.6 28.7 0.1 4.3 3.9 0.0 12.8 16.8 0.9 0.0 0.4 4.9 7.4 0.0 0.3 5.5 0.0 1.3 0.0 0.2 0.8 0.5 0.6 11.4 0.1 1.5 0.2 1.8 1.4 0.7 0.0 10.5 7.0 29.3 2.0 20.2 7.2 31.5 6.8 8.8 8.0 3.1 7.6 5.5 8.8 2.6 7.0 6.1 4.2 5.5 6.8 2.8 9.9 6.2 16.9 15.4 6.4 14.0 21.7 13.6 20.7 10.2 15.1 14.6 6.0 12.8 13.2 0.8 1.0 0.5 54.5 0.0 1.4 3.4 1.8 0.0 0.2 1.7 0.4 11.0 8.4 0.0 0.0 1.6 0.2 5.3 0.4 188.3 1.3 13.2 12.7 0.0 12.3 44.7 20.0 13.8 26.2 3.3 11.8 0.1 2.8 1.0 0.0 13.8 0.3 0.3 12.9 10.8 0.5 0.6 1.5 0.3 22.3 0.0 0.6 ARHGEF9 "KIAA0424, PEM-2" ENSG00000131089 "Cdc42 guanine nucleotide exchange factor 9" O43307 X 63634967-63809274 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.6" "Group enriched" "Detected in many" 6 "Bipolar cells: 169.8;Cone photoreceptor cells: 219.9;Horizontal cells: 77.9;Rod photoreceptor cells: 311.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035419, HPA055291" Approved Supported Cytosol NA NA Cytosol "HPA035419: AB_10669859, HPA055291: AB_2682774" "unprognostic (3.19e-1)" "unprognostic (6.15e-2)" "unprognostic (4.02e-2)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.66e-1)" "unprognostic (1.98e-3)" "unprognostic (1.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.08e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.02e-5)" "unprognostic (4.56e-2)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (8.98e-2)" 5.7 9.6 22.6 4.5 42.6 3.2 6.9 19.5 38.2 6.0 8.2 7.1 1.2 10.9 6.2 4.2 7.7 5.4 6.0 22.0 24.6 22.4 6.8 4.1 4.3 4.6 12.5 28.3 10.4 4.8 11.8 8.3 4.4 17.4 8.2 8.7 9.9 4.5 7.0 3.9 7.0 8.1 8.4 8.5 4.9 6.9 2.2 9.9 2.1 6.1 0.8 5.4 7.3 3.2 5.4 3.7 1.8 3.6 11.5 8.5 2.8 4.6 7.1 11.2 7.2 5.1 7.0 0.9 8.5 7.1 7.8 6.8 0.5 5.0 9.8 6.2 5.2 8.3 0.1 5.0 10.4 7.7 13.4 5.1 8.2 3.1 0.4 2.6 4.2 3.6 8.4 4.6 3.9 12.8 7.9 5.2 10.3 1.2 16.1 7.6 6.6 8.4 2.4 7.7 4.8 8.3 12.9 23.0 9.7 4.9 4.2 0.2 3.2 3.9 7.6 4.3 5.2 5.5 4.9 2.6 5.2 5.3 24.5 3.5 5.5 4.2 7.6 6.3 7.5 3.7 1.0 2.8 1.8 8.5 3.6 5.6 3.5 4.6 4.9 3.7 5.4 5.6 5.2 1.6 11.5 2.4 2.9 4.1 2.8 22.6 42.6 19.5 37.2 24.6 22.4 12.5 28.3 17.4 9.9 8.9 10.7 17.4 5.4 5.0 169.8 34.3 2.5 9.4 7.9 10.4 219.9 4.1 11.6 5.5 1.7 8.7 16.0 0.0 7.8 1.2 6.2 4.4 13.9 7.5 8.6 77.9 20.1 11.6 3.2 4.2 14.4 5.6 13.5 1.8 13.8 28.4 6.4 14.0 14.5 16.5 311.4 0.0 18.4 1.4 3.2 5.3 3.7 20.3 19.1 4.8 ARMC6 MGC19595 ENSG00000105676 "Armadillo repeat containing 6" Q6NXE6 19 19033575-19060311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 54.4" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041420, HPA041681" Supported Enhanced Cytosol NA NA Cytosol "HPA041420: AB_2677469, HPA041681: AB_10793928" "unprognostic (2.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (2.11e-2)" "unprognostic (1.65e-2)" "unprognostic (3.55e-2)" "unprognostic (2.43e-1)" "unprognostic (8.98e-2)" "unprognostic (2.36e-1)" "unprognostic (7.04e-3)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-2)" "unprognostic (1.70e-1)" "unprognostic (3.73e-2)" "unprognostic (1.40e-1)" 9.8 10.1 10.3 9.6 11.3 12.9 10.6 13.0 20.1 8.5 10.2 10.2 5.7 8.9 9.5 10.0 10.9 9.2 9.5 11.4 10.7 12.0 10.4 54.4 8.0 12.6 10.1 11.4 10.1 6.7 9.2 11.2 10.3 12.6 10.9 8.2 11.0 12.2 8.1 14.8 9.4 7.9 8.4 8.7 11.1 8.3 17.1 7.2 21.4 16.1 12.3 10.7 8.4 7.5 10.3 19.8 6.3 13.9 20.7 16.4 11.8 21.5 14.7 10.8 13.3 5.2 9.0 14.0 14.0 8.2 23.0 17.1 20.6 19.6 32.9 22.8 11.7 8.4 11.0 25.8 16.6 12.7 6.9 36.3 16.5 13.9 16.5 11.6 29.6 19.3 11.3 15.9 15.6 11.0 5.1 14.5 19.6 28.8 12.7 12.5 26.4 31.1 23.8 25.2 24.6 30.4 25.9 9.8 23.5 11.2 14.6 25.0 10.8 11.2 14.4 11.4 7.7 12.3 18.5 9.4 11.8 10.3 16.7 28.6 9.8 17.3 31.6 9.8 40.0 15.3 6.3 13.3 3.5 16.4 13.9 12.3 10.2 9.2 14.2 19.8 10.3 12.0 13.5 2.8 20.7 10.8 12.7 15.9 11.8 10.3 11.3 13.0 20.1 10.7 12.0 10.1 11.4 12.6 7.2 0.0 5.1 8.2 6.4 6.0 13.4 5.3 10.2 2.7 6.8 12.2 11.8 18.4 6.6 16.1 19.0 6.7 8.4 0.0 9.1 16.5 6.6 9.4 1.1 51.6 18.2 4.8 14.5 8.6 16.1 32.0 9.5 8.6 5.0 18.0 9.8 15.6 9.2 12.7 7.8 10.2 16.2 12.9 5.0 15.6 30.0 8.8 10.9 7.9 14.7 4.2 ARMC7 FLJ22160 ENSG00000125449 "Armadillo repeat containing 7" Q9H6L4 17 75109952-75130265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024229, HPA053076" Uncertain Supported Cytosol NA NA Cytosol "HPA024229: AB_2059152, HPA053076: AB_2682036" "unprognostic (1.35e-1)" "prognostic favorable (2.98e-4)" "unprognostic (7.73e-2)" "unprognostic (5.84e-2)" "unprognostic (4.15e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.84e-2)" "unprognostic (3.68e-1)" "unprognostic (4.28e-2)" "unprognostic (3.40e-2)" "unprognostic (4.86e-2)" "prognostic favorable (1.27e-4)" "unprognostic (1.93e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.98e-2)" 7.5 7.5 11.1 14.1 9.8 6.1 12.0 26.6 13.8 7.8 13.5 7.6 8.8 15.3 7.9 8.1 11.2 8.4 10.1 9.8 10.5 7.9 31.6 13.3 15.8 19.5 7.8 7.4 6.3 8.9 11.2 7.9 9.2 9.5 11.9 11.3 8.9 11.4 12.3 7.2 12.6 13.7 8.5 6.9 15.0 15.5 9.8 8.4 14.8 14.9 5.9 13.4 9.6 11.1 11.9 10.5 22.1 11.3 11.6 16.6 9.1 9.9 19.8 6.0 5.6 5.0 2.9 6.5 5.6 6.0 10.7 9.6 16.2 9.6 5.8 7.3 5.0 5.9 8.1 9.6 4.0 5.2 5.8 15.7 11.1 8.8 10.0 10.6 8.4 10.8 3.8 7.5 6.7 4.0 5.2 9.7 9.6 10.1 11.7 3.5 13.8 16.1 9.4 2.9 21.3 15.0 9.4 12.1 10.8 23.6 17.6 5.5 8.3 10.3 10.4 11.8 10.7 12.1 8.3 7.5 10.9 10.2 4.5 8.5 9.9 3.6 8.4 4.8 6.2 7.8 20.5 11.3 22.1 15.8 8.0 13.7 11.9 11.4 13.2 10.5 9.5 8.8 13.2 15.4 11.6 6.1 9.0 16.6 9.1 11.1 9.8 26.6 13.8 10.5 7.9 7.8 7.4 9.5 8.4 11.9 9.1 9.8 2.2 4.0 5.2 2.4 5.1 8.1 4.5 21.0 0.0 12.2 29.9 7.4 5.2 4.3 18.0 0.0 8.4 7.5 3.9 4.9 10.4 4.0 13.3 0.0 5.8 11.6 5.6 8.5 4.9 9.6 11.8 15.4 8.3 3.1 8.7 28.1 3.5 10.9 3.0 19.4 4.6 4.1 6.0 4.0 4.1 11.5 6.6 3.3 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112726 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;kidney: 11.5;skin 1: 8.3" "Cell type enhanced" "Detected in some" 31 "Distal tubular cells: 1.7;Proximal tubular cells: 4.6" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.0;U-266/70: 1.1" HPA000549 Uncertain Cytosol "Secreted in other tissues" NA NA Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 4.6 2.7 0.0 5.3 0.0 0.1 0.0 1.9 0.4 0.0 0.0 0.0 2.5 3.1 0.0 0.0 0.0 1.3 0.5 11.5 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.6 1.5 0.3 0.2 1.9 0.3 0.8 0.3 0.0 0.2 0.4 0.5 0.7 0.0 0.2 2.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.1 1.1 0.1 0.1 0.8 0.4 0.3 1.9 0.3 0.4 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.3 0.3 0.3 1.2 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 ASAP2 "CENTB3, DDEF2, KIAA0400, PAP, SHAG1" ENSG00000151693 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 2" O43150 2 9206765-9405683 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "basophil: 6.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018615 Approved Supported Cytosol NA NA 66000 Cytosol "CAB018615: AB_2242947" "unprognostic (1.19e-1)" "unprognostic (2.66e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (3.06e-2)" "unprognostic (1.08e-3)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (8.33e-2)" "unprognostic (1.58e-3)" "unprognostic (3.14e-1)" "unprognostic (3.16e-1)" "unprognostic (2.64e-2)" "unprognostic (3.24e-2)" 13.7 3.4 7.3 8.2 14.5 0.9 11.7 16.3 13.9 13.8 15.3 8.1 6.8 12.1 19.3 10.5 8.1 10.1 16.5 10.5 8.1 5.6 21.7 3.7 9.0 2.6 10.7 7.3 7.9 7.0 12.4 44.1 9.2 10.8 6.6 14.4 10.7 7.1 8.9 3.3 12.3 13.5 12.6 8.7 1.6 21.6 38.5 7.8 0.1 17.5 6.1 3.3 8.5 11.4 0.0 0.9 6.2 0.0 0.0 0.0 0.3 11.7 6.8 12.6 7.4 9.3 13.0 2.1 11.8 9.6 8.7 8.8 4.7 17.6 0.0 10.5 13.3 19.3 11.3 6.9 20.8 10.9 8.4 2.9 2.7 5.2 9.0 22.7 0.0 0.8 4.8 8.6 10.5 34.4 26.6 18.0 2.2 1.2 1.2 33.9 7.3 3.3 0.7 6.0 17.3 8.1 6.5 18.8 2.2 17.2 9.1 5.6 21.5 9.9 6.6 11.0 7.1 4.5 1.9 28.0 14.8 0.7 11.4 10.8 0.0 0.0 0.0 10.8 0.0 18.8 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 7.3 14.5 16.3 11.6 8.1 5.6 10.7 7.3 10.8 7.8 17.9 8.8 0.0 15.4 33.1 28.4 1.2 7.6 6.7 7.9 33.2 0.0 0.8 43.1 14.8 51.2 28.1 27.6 0.0 12.3 0.3 8.0 16.4 1.1 3.6 9.9 6.4 8.7 38.1 4.9 36.9 2.6 5.8 32.1 11.8 37.5 19.5 38.5 35.1 3.5 23.5 4.6 25.8 24.2 49.4 7.0 28.1 0.3 0.0 18.8 38.4 ASL ENSG00000126522 "Argininosuccinate lyase" P04424 7 66075798-66093558 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 226.8;Hepatocytes: 477.5;Paneth cells: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003696, HPA016646" Enhanced Approved Cytosol NA NA 10000000 Cytosol "CAB003696: AB_425316, HPA016646: AB_1845096" "unprognostic (2.95e-2)" "prognostic unfavorable (4.05e-6)" "unprognostic (4.83e-1)" "unprognostic (4.18e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (2.07e-1)" "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (7.25e-2)" "unprognostic (4.95e-2)" "unprognostic (2.07e-2)" "unprognostic (3.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-1)" "unprognostic (8.40e-3)" 5.6 4.8 4.0 8.0 4.3 7.3 5.9 7.2 7.4 5.5 17.2 3.7 7.8 20.8 5.0 7.1 7.7 4.9 19.5 4.3 3.7 4.3 16.0 99.5 8.1 4.5 4.4 6.2 5.9 10.4 3.3 5.8 3.3 7.2 5.4 12.4 5.8 7.1 5.7 2.4 4.1 16.6 3.4 3.2 8.6 12.6 2.1 3.5 1.2 7.1 7.9 5.9 5.2 5.9 8.6 19.3 20.7 18.4 30.4 9.2 10.7 18.2 7.5 4.1 14.8 9.5 7.3 9.0 12.8 11.2 18.3 16.7 16.9 22.6 5.6 20.5 16.8 13.3 5.0 2.6 21.7 5.3 4.6 3.4 7.4 7.3 26.1 17.7 8.4 21.7 13.7 7.9 12.8 20.5 4.6 18.0 4.0 13.1 10.7 10.1 13.0 1.7 11.6 6.2 22.8 9.7 4.5 4.3 19.3 13.3 11.0 7.1 9.7 11.7 40.8 4.4 4.4 17.8 7.6 20.4 23.2 12.0 9.2 16.5 11.7 6.1 7.3 21.9 16.0 18.7 12.1 18.1 20.7 7.7 18.4 6.5 8.6 5.2 6.1 19.3 5.6 3.7 4.0 4.0 30.4 13.8 1.2 9.2 10.7 4.0 4.3 7.2 7.4 3.7 4.3 4.4 6.2 7.2 3.5 17.9 52.0 20.8 16.7 4.8 12.5 7.1 132.5 38.8 15.9 29.6 21.6 19.3 44.7 51.9 3.5 25.6 226.8 0.0 192.3 35.3 14.5 13.1 44.9 477.5 40.4 14.3 51.9 35.6 39.6 4.9 8.6 16.1 8.5 61.3 87.3 6.5 99.6 217.5 7.8 174.9 12.2 12.9 13.9 3.0 5.8 3.8 18.7 27.5 126.5 20.6 ASMTL ENSG00000169093 "Acetylserotonin O-methyltransferase like" O95671 X 1403139-1453762 "Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 87.4;monocytes: 172.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 52.7" "Low region specificity" "Detected in all" "HPA003630, HPA021865" Supported Enhanced Cytosol NA NA Cytosol "HPA003630: AB_1078230, HPA021865: AB_1845099" "unprognostic (3.89e-2)" "unprognostic (1.14e-3)" "unprognostic (2.28e-1)" "unprognostic (1.87e-2)" "unprognostic (7.99e-2)" "unprognostic (9.05e-2)" "unprognostic (8.17e-2)" "unprognostic (5.23e-2)" "unprognostic (8.40e-2)" "unprognostic (1.24e-1)" "unprognostic (1.91e-3)" "unprognostic (7.24e-2)" "unprognostic (3.26e-3)" "unprognostic (9.70e-2)" "unprognostic (8.38e-2)" "unprognostic (2.91e-1)" "unprognostic (2.20e-1)" 10.4 11.7 28.5 8.9 42.3 9.1 33.6 24.5 38.9 46.4 10.6 3.3 3.3 6.9 52.0 9.2 8.6 11.4 8.2 50.0 29.4 11.4 35.2 15.3 7.0 11.8 25.5 55.3 47.6 13.2 9.9 31.4 27.5 36.7 12.5 4.6 3.3 16.2 16.0 10.0 11.0 8.9 7.5 31.9 11.5 9.0 4.6 25.0 3.3 12.8 3.3 7.2 9.1 31.5 19.8 23.3 34.5 16.4 27.8 16.9 12.3 5.3 9.4 11.2 8.5 6.7 10.5 15.6 6.4 8.4 7.3 9.4 8.5 6.5 9.5 3.6 8.4 7.9 2.0 2.9 3.1 4.6 14.0 9.4 8.1 6.2 10.1 15.4 3.8 52.7 13.9 5.3 5.6 5.4 8.2 8.6 7.4 4.1 7.7 5.8 20.1 16.4 15.1 13.5 5.0 5.8 13.4 10.6 23.0 5.1 2.9 0.4 5.3 8.6 11.1 7.9 8.0 2.5 5.2 11.2 6.1 6.7 11.5 2.3 9.9 3.0 24.1 7.8 5.6 1.8 20.1 14.2 34.5 16.9 16.4 14.8 13.8 15.3 15.6 12.1 19.8 13.5 10.6 20.4 27.8 11.5 23.3 16.5 12.3 28.5 42.3 24.5 38.9 29.4 11.4 25.5 55.3 36.7 25.0 11.9 6.5 18.6 21.6 16.4 16.6 16.5 2.5 10.7 6.8 14.0 3.9 28.3 23.2 11.7 0.8 17.9 15.9 0.0 14.8 22.3 23.9 19.4 54.2 24.6 17.5 87.4 13.8 14.1 11.0 1.5 24.2 15.1 11.8 172.3 16.9 15.3 11.0 17.3 40.7 25.8 9.4 32.3 24.5 2.3 7.9 13.7 55.5 20.2 17.0 16.6 ASNS ENSG00000070669 "Asparagine synthetase (glutamine-hydrolyzing)" P08243 7 97852118-97872542 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" Ligase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 68.0" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 197.3;Erythroid cells: 93.5;Late spermatids: 147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 8.6;T-cells: 13.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004924, HPA029318, HPA064737" Approved Enhanced Cytosol No No Cytosol "HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341" "unprognostic (3.93e-2)" "unprognostic (2.51e-1)" "unprognostic (6.70e-2)" "prognostic unfavorable (4.24e-4)" "unprognostic (3.64e-1)" "prognostic unfavorable (8.79e-5)" "prognostic unfavorable (9.42e-6)" "unprognostic (2.28e-2)" "unprognostic (9.08e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" "unprognostic (2.53e-3)" "prognostic unfavorable (6.21e-7)" "unprognostic (5.33e-1)" "unprognostic (2.15e-1)" "unprognostic (6.21e-2)" "unprognostic (1.33e-1)" 6.5 7.5 15.9 10.9 21.4 7.6 9.9 31.7 32.3 5.7 10.1 9.4 5.6 6.5 10.0 19.9 10.2 6.9 6.8 9.2 24.5 20.4 6.5 5.9 9.6 16.0 16.3 13.4 19.2 68.0 16.7 16.7 3.2 35.9 9.2 12.7 4.4 49.9 9.3 3.5 13.6 7.8 11.3 20.6 11.0 20.8 16.9 9.2 3.6 16.7 8.2 15.0 9.6 6.6 8.6 1.4 1.5 1.2 2.2 13.2 3.2 19.0 7.3 7.4 60.1 5.9 8.3 18.1 14.1 9.0 6.7 20.2 9.4 7.6 15.0 7.1 28.7 14.0 8.7 19.1 22.3 16.1 18.7 14.1 4.8 3.7 7.0 54.3 30.6 13.5 16.3 75.0 8.8 54.5 3.6 5.5 14.1 26.8 53.3 10.6 40.3 0.9 8.1 10.1 45.6 20.0 2.3 1.4 39.3 4.3 3.7 32.3 24.3 3.6 19.6 76.0 9.9 8.3 21.5 1.4 3.3 22.1 8.8 6.6 63.1 31.5 57.1 41.8 13.9 32.1 1.5 0.3 0.5 3.8 1.2 4.9 8.6 7.4 3.4 1.4 6.2 10.2 5.5 1.5 2.2 0.8 0.1 13.2 3.2 15.9 21.4 31.7 32.3 24.5 20.4 16.3 13.4 35.9 9.2 8.9 4.5 3.7 18.8 11.0 20.1 5.9 12.7 1.4 3.4 8.7 23.6 2.0 6.6 34.4 197.3 3.1 1.7 93.5 52.9 7.7 6.6 17.6 8.1 1.6 1.0 23.8 23.4 2.5 0.6 147.0 8.9 1.8 8.5 11.8 12.9 8.5 38.4 11.9 8.9 3.1 25.4 6.5 12.3 2.3 7.0 9.5 4.7 13.3 7.9 15.2 ASNSD1 "FLJ20752, NBLA00058, NS3TP1" ENSG00000138381 "Asparagine synthetase domain containing 1" "L0R819, Q9NWL6" 2 189661385-189670831 "Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036132, HPA036133, HPA075042" Uncertain Approved Cytosol NA NA Cytosol "HPA036132: AB_2674960, HPA036133: AB_10696650, HPA075042: AB_2686731" "unprognostic (1.32e-1)" "unprognostic (1.70e-1)" "unprognostic (4.88e-2)" "unprognostic (2.15e-3)" "prognostic favorable (4.54e-4)" "unprognostic (8.42e-2)" "prognostic unfavorable (8.66e-4)" "unprognostic (5.68e-2)" "unprognostic (1.35e-2)" "unprognostic (1.41e-3)" "unprognostic (2.09e-1)" "unprognostic (6.32e-3)" "unprognostic (8.98e-3)" "unprognostic (8.11e-2)" "unprognostic (2.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" 23.1 22.4 25.5 15.9 24.7 25.5 29.1 41.0 29.4 22.7 19.5 14.1 18.1 18.0 23.6 17.3 18.2 20.6 18.2 23.9 22.9 26.0 25.0 31.9 16.9 22.3 24.2 22.6 33.2 22.4 20.8 36.8 26.8 29.1 19.6 16.5 13.2 18.2 18.6 52.4 14.0 15.4 23.9 27.8 22.0 18.1 14.0 21.8 20.1 25.0 19.8 20.8 22.4 23.6 15.9 11.0 41.9 11.2 21.5 24.5 15.2 13.4 10.5 22.2 18.6 24.2 23.6 19.5 29.3 27.6 31.7 31.6 26.2 9.6 26.8 17.8 25.1 15.0 11.2 23.9 20.3 37.3 28.2 26.7 24.9 20.1 26.3 26.9 24.5 14.0 24.1 15.1 27.8 24.5 20.2 28.4 18.5 23.1 20.2 29.4 17.7 29.0 26.2 33.2 20.8 41.3 16.5 20.0 25.5 17.8 19.1 25.4 16.1 21.2 15.7 24.9 29.3 22.6 22.7 22.1 25.7 20.0 21.7 28.8 29.7 40.0 47.0 21.8 14.6 22.8 24.6 11.2 41.9 17.7 9.4 21.5 15.8 19.5 19.0 11.0 15.9 23.3 20.8 20.4 21.5 10.3 10.1 24.5 15.2 25.5 24.7 41.0 29.4 22.9 26.0 24.2 22.6 29.1 21.8 50.6 27.5 45.5 20.4 26.7 19.3 37.6 20.4 36.1 39.8 15.7 11.8 58.7 69.6 30.2 4.1 29.1 17.7 0.0 39.1 34.4 35.2 20.0 18.5 48.0 29.2 14.3 34.5 29.4 26.6 4.6 37.7 28.0 16.9 27.1 23.3 29.4 31.7 8.6 31.8 45.3 23.4 45.3 32.3 27.7 32.4 24.8 100.2 41.5 24.7 17.5 ASPA "ACY2, ASP" ENSG00000108381 Aspartoacylase P45381 17 3472374-3503419 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.3;kidney: 33.2" "Group enriched" "Detected in many" 4 "Collecting duct cells: 24.4;Leydig cells: 46.1;Melanocytes: 43.9;Peritubular cells: 45.3;Proximal tubular cells: 65.3" "Cancer enhanced" "Detected in some" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 8.3;ASC TERT1: 6.5;CACO-2: 5.5;HSkMC: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022142, HPA022145" Enhanced Approved Cytosol NA NA Cytosol "HPA022142: AB_1845102, HPA022145: AB_1845103" "unprognostic (4.42e-2)" "unprognostic (4.79e-2)" "unprognostic (2.02e-2)" "unprognostic (2.79e-3)" "unprognostic (4.36e-2)" "unprognostic (5.01e-1)" "unprognostic (1.08e-3)" "unprognostic (3.57e-1)" "unprognostic (4.17e-1)" "unprognostic (3.43e-1)" "unprognostic (5.27e-2)" "unprognostic (6.27e-2)" "unprognostic (1.25e-1)" "unprognostic (7.07e-4)" "unprognostic (2.77e-1)" "unprognostic (4.68e-1)" "unprognostic (1.49e-1)" 10.9 4.1 14.5 1.8 37.6 1.7 3.3 3.0 19.4 6.2 3.6 35.2 3.1 9.7 4.1 5.5 4.5 5.0 3.3 2.2 21.9 11.0 33.2 12.6 3.2 1.3 50.2 11.3 2.9 1.0 0.9 0.9 3.1 18.9 4.0 4.6 2.6 1.9 4.8 9.3 4.6 13.3 2.9 22.4 4.6 3.9 5.6 51.3 0.0 1.8 1.1 0.8 4.5 3.5 1.7 1.2 3.6 0.7 1.6 1.3 0.2 0.4 0.2 0.9 0.7 8.3 6.5 0.5 0.4 0.3 0.3 0.3 5.5 0.3 1.1 0.3 1.0 0.5 0.5 0.5 0.3 0.4 2.9 0.3 0.5 0.9 0.4 0.9 0.7 0.8 11.7 0.6 0.7 0.2 0.4 0.1 0.7 0.6 2.0 0.4 0.4 0.4 1.0 0.8 0.4 0.5 0.4 0.5 0.9 0.4 1.7 0.7 0.5 1.6 0.6 1.3 0.8 0.6 0.3 0.6 1.0 0.7 0.7 0.4 1.2 0.6 0.7 0.4 0.6 0.8 3.4 0.7 0.8 1.2 0.6 1.0 1.1 1.0 0.9 0.5 1.7 1.2 1.3 3.6 1.6 0.7 1.2 0.5 0.2 14.5 37.6 3.0 19.4 21.9 11.0 50.2 11.3 18.9 51.3 8.9 1.0 0.0 1.2 4.6 0.4 0.8 5.1 0.0 1.2 24.4 0.0 0.0 6.6 0.0 2.8 0.5 1.0 0.0 0.2 0.1 7.4 0.3 0.0 10.2 0.2 7.9 2.4 4.9 1.5 0.5 46.1 0.8 43.9 0.0 0.1 3.4 0.0 0.0 45.3 65.3 0.5 0.0 4.2 4.8 0.6 1.5 0.1 0.0 1.2 1.7 ASPRV1 "FLJ25084, SASPase, Taps" ENSG00000244617 "Aspartic peptidase retroviral like 1" Q53RT3 2 69960089-69962265 "Plasma proteins, Predicted membrane proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 75.3" "Cell type enhanced" "Detected in some" 18 "Spermatogonia: 3.0;Suprabasal keratinocytes: 9.4" "Group enriched" "Detected in many" 8 "head and neck cancer: 23.1;melanoma: 35.1" "Cell type enriched" "Detected in some" 6 "neutrophil: 11.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "REH: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034809, HPA034810" Enhanced Approved Cytosol NA NA 83000 Cytosol "HPA034809: AB_2674343, HPA034810: AB_10601456" "unprognostic (4.75e-4)" "unprognostic (1.90e-3)" "unprognostic (2.34e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (1.17e-2)" "unprognostic (1.93e-3)" "unprognostic (1.51e-1)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (4.19e-3)" "unprognostic (1.27e-1)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.84e-2)" "unprognostic (2.43e-2)" 0.2 0.2 0.5 0.1 0.6 0.0 5.5 0.8 0.4 0.3 0.0 0.3 0.3 0.6 0.0 0.4 0.1 0.1 0.6 0.7 0.2 0.0 0.1 0.1 0.7 0.9 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.2 1.0 75.3 0.2 0.2 1.0 0.4 0.1 0.4 0.0 0.1 0.0 0.6 0.1 1.2 11.2 0.1 0.3 0.9 0.5 0.1 0.7 1.8 3.5 2.3 0.9 0.5 0.4 0.7 0.5 0.3 1.2 0.1 1.3 0.3 0.3 0.4 0.5 1.6 0.2 0.4 2.4 4.7 2.8 0.4 1.2 0.9 2.3 2.0 1.1 0.7 0.4 0.8 0.7 0.4 3.1 1.0 3.6 0.4 0.5 2.0 5.2 1.8 0.4 0.4 8.9 1.0 0.5 0.1 0.1 2.0 0.5 0.2 1.4 1.4 0.4 0.1 1.0 0.3 0.1 1.8 0.1 0.3 3.9 2.4 2.7 0.2 1.6 2.0 0.0 0.1 1.9 0.7 0.1 0.7 0.0 0.3 0.6 0.1 0.1 0.2 0.6 11.2 0.3 0.1 1.2 0.9 0.5 0.0 0.0 0.0 0.1 0.3 1.1 1.2 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.1 0.3 0.4 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.2 0.9 0.0 0.0 0.0 0.6 0.7 0.2 0.0 0.7 0.7 1.4 0.0 0.0 1.1 3.0 9.4 0.3 0.0 0.0 0.1 ATG16L1 "APG16L, ATG16A, ATG16L, FLJ10035, WDR30" ENSG00000085978 "Autophagy related 16 like 1" Q676U5 2 233210051-233295674 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012577, HPA063900" Supported Approved Cytosol NA NA Cytosol "HPA012577: AB_1845155, HPA063900: AB_2685146" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (3.57e-2)" "unprognostic (2.22e-3)" "unprognostic (1.89e-1)" "unprognostic (4.49e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.51e-1)" "unprognostic (1.80e-1)" "unprognostic (1.85e-2)" "unprognostic (6.66e-3)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.93e-2)" "unprognostic (1.41e-1)" "unprognostic (2.41e-1)" "unprognostic (2.08e-1)" 7.7 8.1 7.8 15.7 16.4 28.2 11.9 25.3 22.7 9.8 12.0 13.5 7.4 11.4 12.3 14.8 11.8 8.4 9.7 11.3 9.6 9.0 10.0 15.0 8.0 11.4 10.9 9.4 9.7 12.8 11.6 6.6 8.6 12.3 13.2 13.8 9.4 11.8 10.7 19.4 16.9 11.5 10.7 9.7 12.1 13.0 16.7 9.2 13.8 12.3 10.2 14.3 11.7 12.5 3.3 2.1 4.4 6.2 6.0 7.3 3.1 10.8 11.5 4.1 6.9 10.7 7.8 13.1 9.9 7.9 8.9 8.4 8.4 7.8 2.8 3.6 8.2 11.6 5.5 9.1 4.8 7.9 5.4 7.8 6.5 7.4 13.3 8.1 5.4 8.3 4.2 8.5 10.4 8.5 5.6 8.6 3.9 6.7 2.8 7.8 8.9 5.6 10.7 17.5 10.6 12.8 4.0 9.5 2.3 7.9 7.1 8.4 5.8 6.8 8.4 5.1 6.9 5.0 5.8 10.1 5.6 4.6 8.9 8.3 6.3 3.3 5.2 9.2 5.5 8.9 0.0 2.5 4.4 7.3 2.0 6.0 3.3 5.0 6.4 2.1 3.2 5.6 5.5 1.7 6.0 6.2 1.1 5.6 3.1 7.8 16.4 25.3 22.7 9.6 9.0 10.9 9.4 12.3 9.2 6.0 8.0 7.4 4.2 8.0 5.7 3.6 2.5 14.7 11.4 5.2 3.9 4.3 5.0 6.1 0.7 5.6 8.1 0.0 6.0 5.1 4.7 5.6 9.2 8.3 4.8 1.6 8.6 7.4 5.7 1.3 3.7 3.9 10.1 6.4 4.6 7.2 12.1 7.0 3.5 4.5 15.7 6.5 6.5 9.7 15.6 11.5 3.1 13.8 7.3 4.5 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 40.6;salivary gland: 55.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 35.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA018029, HPA064555" Enhanced Uncertain Cytosol NA NA Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favorable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.1 0.0 0.5 0.0 0.3 0.0 2.2 0.1 0.4 1.7 0.0 0.3 3.1 0.0 0.3 0.5 2.7 0.0 0.0 0.0 0.4 0.3 40.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.2 1.0 0.2 0.5 0.0 0.3 55.4 1.2 0.0 6.5 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 1.8 7.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 3.1 1.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 3.0 0.1 0.0 0.0 0.0 35.9 1.2 2.0 0.1 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.1 0.4 0.4 0.3 0.3 0.0 0.2 0.1 0.0 0.6 0.0 0.8 0.0 0.0 0.3 0.0 1.4 1.2 15.7 2.0 11.7 26.6 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.3 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 4.2 0.0 0.0 1.1 ATP6V0B "ATP6F, HATPL, VMA16" ENSG00000117410 "ATPase H+ transporting V0 subunit b" Q99437 1 43974487-43978295 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 173.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 173.6" "Group enriched" "Detected in all" 4 "dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044281 Approved Cytosol NA NA Cytosol "HPA044281: " "unprognostic (1.38e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (5.69e-2)" "unprognostic (5.31e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (7.23e-2)" "prognostic favorable (3.24e-4)" "unprognostic (6.13e-2)" "prognostic favorable (3.62e-6)" "unprognostic (5.55e-2)" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (8.87e-4)" 20.4 35.7 35.4 21.8 35.3 84.2 28.5 29.1 56.4 23.3 28.3 32.2 26.7 19.2 13.9 35.6 21.9 20.0 22.0 24.8 41.2 44.7 47.6 56.3 25.8 28.5 43.6 31.5 12.9 87.0 32.5 36.3 35.0 33.9 27.0 32.0 32.4 34.8 22.2 27.9 20.1 20.2 19.1 34.8 33.2 25.2 15.3 24.8 16.3 38.7 19.5 24.7 23.2 16.5 23.7 58.0 173.6 78.0 8.8 14.2 87.6 23.7 23.2 19.3 24.2 29.7 15.7 23.6 21.4 31.8 41.6 36.0 24.9 26.0 22.1 19.8 22.6 49.4 19.7 45.0 32.2 19.6 20.7 46.9 27.6 40.1 35.8 47.1 42.9 53.7 19.3 42.5 45.8 40.6 26.7 20.0 31.0 27.5 48.5 34.0 25.1 17.7 71.5 31.8 34.5 49.6 25.1 18.5 60.2 43.3 29.3 45.5 22.5 14.4 57.1 53.6 22.8 23.4 77.2 10.1 21.5 18.3 38.7 51.4 39.3 57.7 24.5 29.2 61.2 33.5 31.9 78.0 64.2 13.2 48.1 13.0 23.7 14.2 12.7 48.1 19.1 10.8 10.9 173.6 8.8 44.0 58.0 13.7 87.6 35.4 35.3 29.1 56.4 41.2 44.7 43.6 31.5 33.9 24.8 74.5 137.9 144.5 130.3 298.3 238.3 92.4 122.3 100.4 66.0 268.7 96.2 165.0 170.8 307.8 2.7 147.4 174.0 23.3 286.0 191.3 151.0 308.8 203.1 213.0 743.7 122.3 214.8 101.3 356.6 8.6 73.1 420.3 266.6 357.1 190.7 203.9 311.9 371.7 61.5 175.0 164.2 77.6 135.2 133.6 224.9 313.3 415.2 116.5 165.6 262.4 ATP6V0C "ATP6C, ATP6L, ATPL, VATL, Vma3" ENSG00000185883 "ATPase H+ transporting V0 subunit c" P27449 16 2513870-2520218 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 11 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 58.3;Ciliated cells: 45.5;Club cells: 33.0;granulocytes: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065100 Approved Cytosol NA NA Cytosol "HPA065100: AB_2685421" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (5.96e-2)" "unprognostic (7.67e-2)" "unprognostic (2.31e-1)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" "prognostic favorable (1.07e-6)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.85e-1)" "unprognostic (5.04e-2)" 56.5 68.2 61.2 53.6 83.5 87.2 24.1 76.0 156.7 27.7 42.9 39.2 25.2 55.2 28.0 21.9 48.7 25.6 23.0 32.5 64.3 70.1 78.0 37.3 40.5 37.1 55.4 74.2 27.2 42.7 41.9 52.3 35.1 70.4 35.7 19.5 40.1 54.3 30.3 108.8 38.7 52.8 18.3 41.9 48.3 59.0 30.4 29.4 25.1 25.7 34.7 29.2 20.8 29.6 15.9 28.2 50.6 42.5 13.0 16.1 18.2 29.7 31.9 17.3 24.6 21.9 10.9 41.3 44.1 13.9 18.5 17.8 29.7 38.6 15.0 40.6 21.1 31.7 36.2 18.4 26.2 9.3 38.3 54.8 17.2 25.7 36.3 31.1 27.2 53.0 19.7 19.6 23.4 12.3 18.8 13.2 16.9 40.6 28.8 16.0 58.0 27.4 71.1 33.5 19.6 39.2 44.0 15.0 47.1 32.5 17.7 56.4 45.8 37.1 43.1 35.3 16.1 41.5 34.8 31.5 29.8 35.5 44.8 31.5 53.7 65.5 27.5 26.2 20.1 30.1 22.1 32.6 50.6 14.8 36.3 15.1 15.9 13.4 16.1 20.4 15.4 15.6 13.5 43.7 13.0 42.5 28.2 13.2 18.2 61.2 83.5 76.0 123.3 64.3 70.1 55.4 74.2 70.4 29.4 23.8 58.3 0.5 0.1 0.9 0.5 0.0 0.0 45.5 33.0 1.8 0.0 0.5 0.0 0.5 0.0 0.1 3.2 0.0 0.2 0.7 0.5 0.0 16.3 0.5 0.9 0.0 0.0 1.8 1.8 0.0 0.6 0.7 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.5 0.7 0.0 0.1 0.4 1.0 0.9 1.0 0.7 0.9 0.1 ATPAF2 "ATP12, Atp12p, LP3663, MGC29736" ENSG00000171953 "ATP synthase mitochondrial F1 complex assembly factor 2" Q8N5M1 17 17977409-18039209 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023329, HPA059422" Supported Enhanced Cytosol No No Cytosol "HPA023329: AB_1845209, HPA059422: AB_2684011" "unprognostic (3.16e-2)" "unprognostic (1.98e-2)" "unprognostic (4.40e-2)" "prognostic favorable (4.95e-4)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (2.70e-3)" "unprognostic (1.67e-2)" "prognostic favorable (6.00e-5)" "unprognostic (1.32e-1)" "unprognostic (2.53e-1)" "unprognostic (5.15e-1)" "unprognostic (2.62e-2)" 9.8 23.1 14.2 11.0 12.5 18.0 11.4 18.1 20.9 10.3 14.3 17.1 12.7 11.5 9.9 12.1 16.1 11.1 8.9 25.3 12.4 12.6 19.1 21.6 9.8 12.5 12.7 11.6 9.8 14.5 20.0 14.2 11.5 13.0 11.3 14.1 15.4 19.5 10.7 28.3 16.4 13.8 11.2 10.9 13.6 12.9 17.3 12.5 12.9 14.2 13.5 19.1 13.0 10.4 13.0 24.2 6.9 20.6 3.9 6.0 9.7 5.7 10.7 7.1 6.7 7.1 7.7 7.1 5.1 7.4 10.9 9.3 14.1 8.8 11.5 11.4 8.7 6.0 8.9 6.7 10.8 9.6 9.2 5.3 2.5 6.9 8.1 12.0 3.6 8.0 9.1 7.8 9.8 5.5 7.7 12.4 9.6 4.0 4.0 5.9 11.6 8.4 5.5 4.7 21.4 6.1 8.7 12.4 13.2 8.7 5.1 4.6 6.2 6.7 3.5 6.2 50.3 11.2 7.3 5.2 2.7 5.8 10.2 4.8 2.8 3.5 4.2 5.0 5.3 14.2 3.5 20.6 6.9 4.8 14.0 5.3 13.0 3.7 4.6 24.2 9.4 5.7 4.4 1.4 3.9 10.1 20.5 6.0 9.7 14.2 12.5 18.1 20.9 12.4 12.6 12.7 11.6 13.0 12.5 6.0 8.5 16.9 12.6 13.6 9.0 25.4 17.8 21.4 6.8 12.2 31.4 27.6 56.3 18.3 40.0 10.9 11.3 0.0 10.6 25.5 10.8 12.5 12.7 18.3 40.8 9.5 13.9 8.0 20.6 31.1 6.1 17.9 16.9 28.9 15.7 9.6 13.2 21.0 6.3 41.3 16.8 0.0 12.2 15.2 11.9 16.6 24.0 10.9 19.4 8.2 ATRN "DPPT-L, MGCA" ENSG00000088812 Attractin O75882 20 3471040-3651122 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008853 Approved Approved Cytosol "Secreted to blood" NA NA 39000000000 Cytosol "HPA008853: AB_1078248" "unprognostic (6.42e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (2.52e-1)" "unprognostic (5.27e-2)" "unprognostic (1.65e-1)" "unprognostic (3.99e-2)" "unprognostic (4.28e-1)" "unprognostic (3.40e-2)" "unprognostic (4.61e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.19e-6)" "unprognostic (3.71e-2)" "unprognostic (9.49e-2)" "unprognostic (2.77e-1)" "unprognostic (3.91e-2)" 12.1 22.8 14.9 7.4 20.7 5.7 13.0 18.4 29.3 13.5 22.8 18.3 7.4 39.9 12.2 12.2 9.3 9.2 12.4 14.8 13.6 14.7 18.4 45.2 10.6 7.1 12.8 18.9 11.5 17.7 40.3 13.4 16.5 16.1 10.1 9.5 12.2 14.0 10.7 11.7 13.6 31.1 11.3 15.2 9.7 17.1 16.2 12.3 5.4 24.1 7.5 7.1 12.0 9.8 3.6 5.7 5.7 6.5 3.0 4.8 1.9 17.9 16.9 10.1 8.4 17.9 29.3 12.9 12.0 17.1 12.7 10.8 7.2 12.3 0.0 8.1 16.8 15.6 25.2 6.8 26.2 17.0 2.0 5.8 5.6 4.7 15.6 10.8 11.9 3.8 15.6 21.3 13.4 13.0 15.9 16.4 3.9 8.8 8.8 12.3 5.1 4.8 4.5 6.7 5.9 10.2 4.0 23.4 13.4 11.6 12.8 6.0 9.3 12.0 22.4 16.4 10.3 12.0 11.4 20.1 13.5 8.0 14.2 11.8 6.2 8.7 0.0 8.3 8.0 13.5 5.7 6.5 3.6 4.8 5.6 2.3 2.8 2.7 3.0 5.7 3.6 4.4 3.7 0.0 3.0 5.7 5.3 3.4 1.9 14.9 20.7 18.4 29.3 13.6 14.7 12.8 18.9 16.1 12.3 14.9 7.2 7.3 3.8 5.7 22.1 10.4 22.9 6.7 5.7 10.4 35.3 6.4 1.7 6.4 6.3 8.4 6.1 0.0 12.5 7.2 9.3 6.1 6.9 39.5 9.6 35.0 9.2 20.9 13.9 2.5 11.5 6.3 6.8 6.4 10.2 12.7 10.7 15.3 7.4 7.9 18.2 32.3 5.2 16.7 21.7 6.4 4.2 5.0 10.5 3.1 ATXN2 "ATX2, SCA2, TNRC13" ENSG00000204842 "Ataxin 2" Q99700 12 111443485-111599676 "Disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018295, HPA020339, HPA021146" Enhanced Enhanced Cytosol NA NA Cytosol "HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132" "unprognostic (3.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (2.34e-1)" "unprognostic (2.77e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (5.28e-2)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (3.40e-2)" 21.3 23.4 25.1 24.3 26.5 15.5 34.5 32.4 32.8 21.2 20.7 32.6 20.5 17.6 24.0 20.3 17.6 26.5 20.8 25.9 24.6 26.7 19.0 20.8 30.2 15.2 29.5 25.9 30.2 16.8 33.4 23.3 25.2 26.4 22.0 17.6 21.0 16.2 24.0 28.0 15.1 15.4 26.7 28.8 16.5 16.8 30.8 30.2 18.4 23.8 14.2 13.1 22.7 24.5 9.9 8.0 11.1 10.8 10.7 10.6 4.8 18.9 22.8 20.5 21.9 21.1 18.0 17.3 25.0 14.7 17.9 15.3 13.5 14.3 15.2 8.9 25.9 14.1 15.5 27.9 10.9 22.2 13.8 24.2 23.3 12.5 22.8 28.5 15.4 12.8 17.9 12.1 22.3 24.6 28.3 16.3 12.9 29.0 9.2 21.2 14.7 12.7 13.8 20.3 10.8 14.9 12.2 12.5 12.1 17.0 24.0 18.9 16.6 25.8 29.0 13.2 16.8 17.6 9.1 25.5 21.7 13.7 19.8 14.1 15.7 21.4 15.8 12.3 12.8 14.6 10.3 6.8 11.1 8.2 6.8 10.6 9.9 9.2 9.3 8.0 6.1 8.5 7.1 7.8 10.7 10.8 4.8 4.1 4.8 25.1 26.5 32.4 32.8 24.6 26.7 29.5 25.9 26.4 30.2 74.5 67.7 20.4 26.9 31.4 99.3 31.9 25.5 52.2 48.9 34.9 127.6 26.0 3.3 21.8 8.2 36.2 18.2 0.0 22.0 22.0 34.9 31.4 23.1 32.7 21.1 62.0 39.7 69.3 34.5 6.6 60.7 30.7 30.4 14.4 27.9 39.3 26.1 17.5 44.6 12.4 87.1 32.3 34.9 72.8 69.6 30.7 39.2 21.5 30.3 38.4 ATXN2L "A2D, A2lp" ENSG00000168488 "Ataxin 2 like" Q8WWM7 16 28823035-28837237 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041506, HPA043391, HPA071955" Approved Enhanced Cytosol NA NA Cytosol "HPA041506: AB_2677521, HPA043391: AB_2678459, HPA071955: AB_2686478" "unprognostic (1.64e-2)" "unprognostic (1.72e-1)" "unprognostic (7.33e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-1)" "unprognostic (6.63e-2)" "prognostic unfavorable (9.85e-4)" "unprognostic (5.59e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (2.83e-2)" "prognostic unfavorable (7.99e-7)" "unprognostic (1.79e-1)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (2.98e-1)" 24.7 31.1 32.5 38.7 30.4 56.8 44.9 57.9 42.5 27.4 24.6 28.0 22.8 35.1 28.4 22.9 29.5 26.2 25.8 24.8 31.1 22.2 30.9 32.9 37.1 46.2 33.8 36.1 31.7 34.8 39.9 44.8 31.2 28.9 29.2 22.8 22.5 30.9 34.2 27.9 31.7 31.9 27.8 33.6 44.0 30.2 77.2 33.1 45.2 31.4 19.5 36.8 25.5 38.8 6.8 9.5 4.2 3.7 3.0 4.0 1.4 17.8 23.0 23.9 26.9 14.8 15.3 28.1 18.1 17.6 19.9 22.3 29.0 21.4 41.7 23.3 12.8 31.3 26.1 22.4 18.2 22.2 32.5 19.9 27.7 27.3 29.5 26.7 31.2 39.2 19.5 21.9 28.2 40.6 17.7 17.5 41.6 36.2 52.9 16.3 25.5 37.9 52.9 24.2 10.9 16.1 50.1 16.6 28.9 11.9 18.6 25.0 19.9 10.5 20.1 21.8 15.8 21.9 33.0 20.8 24.8 20.6 15.9 24.8 75.7 52.6 37.4 18.7 30.0 28.5 0.7 3.7 2.2 2.9 3.3 3.0 6.8 3.5 3.5 2.7 5.7 3.3 4.0 4.2 3.0 2.6 9.5 2.8 1.4 32.5 30.4 57.9 42.5 31.1 22.2 33.8 36.1 28.9 33.1 26.8 32.3 17.5 21.3 32.4 29.7 1.6 28.1 12.0 17.0 19.2 43.2 19.8 1.7 15.3 49.2 24.3 18.2 0.0 17.3 19.6 20.3 21.6 24.4 13.4 21.5 25.4 23.6 28.3 22.5 13.8 19.8 25.3 8.5 20.8 21.3 9.2 25.3 17.5 18.7 3.3 45.8 12.9 15.3 69.2 27.9 27.1 28.7 21.8 21.3 21.7 AZIN2 "ADC, KIAA1945, ODC-p, ODC1L, ODCp" ENSG00000142920 "Antizyme inhibitor 2" Q96A70 1 33081104-33120530 "Predicted intracellular proteins" "Polyamine biosynthesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1;testis: 22.9" "Group enriched" "Detected in many" 23 "Early spermatids: 190.6;Late spermatids: 686.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 17.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 17.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 14.3;SK-MEL-30: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028527 Approved Cytosol NA NA Cytosol "HPA028527: AB_10602077" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.16e-3)" "unprognostic (7.50e-2)" "unprognostic (8.28e-2)" "unprognostic (4.56e-2)" "unprognostic (1.15e-4)" "unprognostic (9.19e-3)" "unprognostic (3.89e-2)" "unprognostic (1.54e-2)" "unprognostic (1.06e-3)" "unprognostic (2.16e-1)" "unprognostic (3.18e-1)" "unprognostic (6.91e-2)" "unprognostic (2.91e-1)" "unprognostic (9.45e-2)" "unprognostic (2.41e-1)" 1.5 5.3 7.8 3.1 11.9 0.2 3.6 5.8 14.6 5.1 4.4 23.1 0.5 1.4 3.8 3.4 1.7 7.0 4.1 5.7 10.1 7.8 3.5 0.9 2.5 1.9 10.2 12.2 9.9 3.0 4.4 2.9 1.4 13.6 3.9 3.0 3.4 3.5 3.6 0.9 1.8 1.3 3.4 18.1 1.9 1.8 22.9 10.1 0.7 4.3 0.0 3.0 2.3 1.9 0.2 17.9 3.5 0.0 0.0 1.6 0.7 0.5 0.6 2.0 1.2 1.0 4.5 0.6 0.7 3.1 3.2 2.6 0.3 2.6 0.0 0.9 0.5 1.7 1.4 1.4 0.6 0.9 0.0 0.0 0.1 0.1 0.5 4.9 0.0 0.2 4.4 2.8 2.6 1.0 14.3 0.4 0.7 0.1 0.2 2.3 0.0 0.2 0.9 1.0 0.3 0.4 1.4 1.9 0.1 2.2 0.1 0.4 2.1 0.5 0.0 18.4 1.9 0.8 0.3 0.1 0.7 1.4 2.2 0.4 1.1 0.0 0.0 4.9 0.0 0.8 3.5 0.0 0.0 1.3 0.0 1.4 0.2 1.4 1.4 0.0 0.0 1.6 1.6 0.0 0.0 0.0 17.9 0.0 0.7 7.8 11.9 5.8 12.8 10.1 7.8 10.2 12.2 13.6 10.1 0.0 4.8 2.0 2.4 0.0 7.1 0.8 0.0 4.0 1.2 1.8 17.7 0.4 0.0 1.3 190.6 1.1 4.2 0.0 1.2 0.4 1.2 1.5 0.0 0.0 1.1 6.4 1.2 1.8 0.3 686.4 5.8 0.4 0.0 2.8 1.2 9.9 1.2 4.8 7.1 2.6 7.6 6.5 0.9 18.8 5.9 0.0 0.2 1.5 2.5 0.8 BABAM2 "BRCC4, BRCC45, BRE" ENSG00000158019 "BRISC and BRCA1 A complex member 2" Q9NXR7 2 27889941-28338901 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "adrenal gland: 172.1" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 71.3;monocytes: 45.1;Proximal tubular cells: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017926, HPA048867" Enhanced Supported Cytosol NA NA Cytosol "HPA017926: AB_1845443, HPA048867: " "unprognostic (1.28e-1)" "unprognostic (2.30e-1)" "unprognostic (1.53e-3)" "unprognostic (1.61e-3)" "unprognostic (1.89e-1)" "unprognostic (2.68e-3)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.03e-1)" "unprognostic (2.38e-2)" "unprognostic (8.98e-2)" "unprognostic (2.13e-1)" "unprognostic (6.52e-2)" "unprognostic (4.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.74e-2)" "unprognostic (2.91e-2)" "unprognostic (1.22e-2)" 14.5 172.1 11.7 11.4 19.3 16.9 12.3 9.6 21.3 14.3 11.2 11.3 14.2 8.8 23.2 17.1 12.0 15.5 15.6 25.2 12.5 12.7 25.0 17.1 11.5 18.9 9.9 13.8 16.7 14.5 21.8 23.5 11.6 13.4 11.8 13.1 16.3 10.3 15.6 28.7 11.5 11.1 18.2 9.1 16.7 11.6 26.3 6.7 13.9 11.9 13.6 15.7 14.2 11.8 23.5 39.7 38.6 30.2 24.8 31.7 23.6 14.6 16.1 13.1 13.7 16.9 22.7 12.9 7.4 18.8 14.1 14.6 13.7 15.1 16.6 25.1 17.9 11.3 9.8 10.6 19.4 20.7 14.0 14.0 19.9 7.0 15.2 24.5 10.3 16.2 55.4 17.0 19.6 20.4 17.7 14.9 15.7 10.1 18.3 19.5 12.3 12.0 12.6 9.9 19.3 10.6 11.1 20.8 16.0 40.5 7.7 8.6 13.7 8.7 15.5 14.8 13.9 11.0 13.7 12.0 13.4 17.9 12.3 10.1 20.8 20.2 21.8 24.9 28.4 14.0 38.6 30.2 12.3 28.5 24.0 31.7 23.5 24.2 26.8 39.7 17.9 23.1 22.0 16.0 24.8 23.3 15.8 27.8 23.6 11.7 19.3 9.6 21.3 12.5 12.7 9.9 13.8 13.4 6.7 3.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 16.0 10.3 38.4 0.0 38.1 71.3 42.4 0.0 0.0 0.0 0.0 39.2 30.4 0.0 0.0 29.1 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 45.1 0.0 0.0 21.6 0.0 0.0 70.3 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 0.0 BBC3 "JFY1, PUMA" ENSG00000105327 "BCL2 binding component 3" "Q96PG8, Q9BXH1" 19 47220822-47232766 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 104.3;Glandular cells: 98.1;Suprabasal keratinocytes: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;neutrophil: 6.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.4" "Cell line enhanced" "Detected in many" "HHSteC: 19.0;NB-4: 21.8" "CAB007752, HPA070403" Approved Approved Cytosol NA NA Cytosol "CAB007752: AB_562336, HPA070403: " "unprognostic (4.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.31e-4)" "unprognostic (2.95e-2)" "unprognostic (4.74e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (1.93e-1)" "unprognostic (8.38e-3)" "unprognostic (7.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-2)" "unprognostic (4.66e-3)" "unprognostic (5.06e-2)" "unprognostic (3.57e-1)" "prognostic favorable (2.62e-5)" 6.8 5.4 4.0 4.7 2.9 9.4 6.5 14.0 7.2 6.3 8.9 1.4 2.3 5.9 5.4 3.7 8.2 5.0 8.0 5.8 4.9 3.9 4.6 5.9 19.0 11.8 3.6 4.3 5.2 11.8 1.6 2.5 5.6 3.4 9.8 4.9 4.5 9.2 4.2 28.6 9.4 6.6 5.7 2.8 7.4 7.9 3.2 3.0 13.3 6.2 1.7 3.2 8.2 3.0 0.2 0.4 6.4 1.0 1.0 1.1 0.3 2.4 5.3 5.9 1.2 1.4 2.7 14.4 3.8 5.2 0.9 2.3 1.5 4.0 9.3 1.7 0.9 1.6 0.8 0.8 3.4 0.1 6.0 10.3 2.6 1.8 10.2 19.0 0.4 8.8 6.5 5.5 2.0 1.8 2.4 6.6 2.8 6.7 5.9 0.6 5.4 1.0 21.8 3.7 4.1 0.7 2.6 0.8 10.7 0.2 0.8 1.0 8.9 1.7 3.6 11.4 4.9 1.2 7.3 4.4 1.1 7.3 0.1 1.2 9.6 2.1 5.8 1.7 1.4 4.0 6.1 0.9 0.5 0.9 1.0 0.8 0.2 0.2 0.6 0.4 0.0 1.1 0.7 6.4 1.0 0.8 0.1 0.5 0.3 4.0 2.9 14.0 5.7 4.9 3.9 3.6 4.3 3.4 3.0 8.9 9.0 16.4 66.9 104.3 5.5 2.4 10.2 0.0 4.5 7.0 0.0 3.5 0.0 40.9 10.7 7.0 29.7 0.0 34.2 4.0 6.6 98.1 12.7 3.2 6.7 0.0 20.5 1.8 9.7 2.4 5.8 17.3 60.8 13.6 20.7 2.7 47.6 21.8 3.9 2.1 4.0 6.5 26.4 0.5 1.3 125.3 17.2 27.7 19.1 48.3 BBS4 ENSG00000140463 "Bardet-Biedl syndrome 4" Q96RK4 15 72686179-72738476 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 113.9;Rod photoreceptor cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039418 Approved Supported Cytosol NA NA Cytosol "HPA039418: AB_10672962" "unprognostic (3.47e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" "prognostic favorable (2.57e-4)" "unprognostic (3.54e-1)" "unprognostic (2.91e-1)" "unprognostic (8.76e-2)" "unprognostic (5.47e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (3.22e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.05e-1)" 8.9 15.5 11.1 8.5 16.6 7.3 12.4 10.7 17.9 14.9 10.6 17.2 9.8 5.6 14.1 18.0 8.1 19.9 10.4 11.9 11.2 13.6 17.5 13.6 11.4 8.0 12.1 14.5 14.8 11.1 16.9 31.3 8.6 23.8 23.8 8.8 29.8 7.8 11.0 17.2 10.1 8.0 12.9 13.2 7.6 10.5 25.7 10.2 13.1 18.0 6.0 8.3 12.4 9.6 6.0 3.8 4.8 4.0 13.0 7.9 3.5 3.2 8.5 18.9 8.0 9.3 11.5 5.0 6.4 13.5 6.4 8.3 4.4 11.0 5.2 13.8 5.5 4.9 4.8 4.9 5.3 5.8 5.4 6.0 6.1 7.6 4.9 7.7 5.4 4.8 10.7 7.4 9.1 7.2 9.6 4.9 9.9 13.3 4.6 10.0 5.7 5.0 5.1 26.4 6.6 3.8 3.4 9.4 6.5 10.9 8.1 9.1 10.7 11.4 8.3 16.7 7.6 11.3 6.1 6.9 7.4 5.7 34.8 3.6 9.6 9.3 11.0 8.3 8.1 9.9 4.8 2.4 3.8 6.9 4.0 6.7 5.5 5.8 7.2 2.0 6.0 6.1 7.9 2.0 13.0 2.9 3.8 6.8 3.5 11.1 16.6 10.7 17.9 11.2 13.6 12.1 14.5 23.8 10.2 17.9 19.2 5.4 6.8 2.7 38.9 17.1 5.1 65.6 25.0 12.2 113.9 7.7 5.0 12.8 13.1 4.5 3.9 0.0 9.8 4.9 9.3 9.0 12.8 6.2 6.7 20.6 4.1 7.4 6.3 4.2 14.7 6.7 5.0 4.6 7.1 36.7 7.2 6.5 19.1 7.1 86.0 0.0 10.3 48.3 54.1 2.5 4.5 8.7 4.7 1.7 BCAP29 "BAP29, DKFZp686M2086" ENSG00000075790 "B cell receptor associated protein 29" Q9UHQ4 7 107579977-107629170 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029215, HPA049694" Enhanced Approved Cytosol NA NA Cytosol "HPA029215: AB_10602331, HPA049694: AB_2680854" "unprognostic (3.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.82e-2)" "unprognostic (1.05e-2)" "unprognostic (5.42e-3)" "unprognostic (4.71e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.43e-2)" "unprognostic (7.22e-2)" "unprognostic (9.64e-2)" "unprognostic (2.31e-2)" "unprognostic (7.36e-2)" "unprognostic (8.34e-2)" "unprognostic (5.40e-2)" "unprognostic (2.78e-2)" "unprognostic (5.28e-3)" "unprognostic (1.81e-1)" 25.6 16.0 17.6 13.7 21.3 11.0 24.0 15.9 33.8 30.5 18.9 10.3 13.6 10.4 27.4 12.3 23.3 13.5 14.7 34.0 18.9 17.0 16.7 24.4 17.3 10.6 20.3 28.7 14.6 12.3 20.8 14.8 23.6 25.7 18.5 19.3 10.0 12.1 17.0 22.9 13.6 13.6 24.0 28.1 12.8 14.6 40.0 13.7 6.3 51.4 13.8 9.8 20.5 20.8 6.6 6.3 20.0 12.4 5.1 6.5 4.3 18.9 5.0 7.9 4.1 17.0 20.2 6.4 21.4 18.6 10.5 11.6 5.5 20.3 3.7 15.2 16.0 18.5 9.5 4.8 10.1 14.6 12.5 5.2 9.1 7.8 5.3 16.8 10.4 12.6 13.0 7.4 13.4 11.0 24.7 28.4 6.8 15.3 10.7 20.7 12.9 6.6 8.8 4.7 6.9 7.8 6.0 10.7 11.7 15.8 9.9 3.4 11.0 20.7 17.9 15.8 10.5 6.8 10.2 30.3 31.0 14.3 27.2 29.6 8.2 21.1 8.8 23.2 9.6 22.6 20.0 6.4 13.0 5.4 7.4 5.5 6.6 4.5 5.7 6.3 5.2 2.7 5.1 2.2 5.1 12.4 6.1 6.5 4.3 17.6 21.3 15.9 33.8 18.9 17.0 20.3 28.7 25.7 13.7 62.5 45.7 19.1 44.3 34.2 31.4 99.3 15.3 32.1 34.2 22.7 9.8 28.2 13.3 40.3 198.1 89.9 22.6 46.7 64.6 44.0 48.3 97.8 56.6 39.4 46.1 7.9 21.5 62.6 29.8 66.5 56.7 40.5 35.4 39.7 32.4 30.9 57.9 31.6 83.8 17.0 22.5 77.6 55.3 226.6 29.8 33.9 59.2 24.5 45.9 62.9 BCL2L14 "BCL-G, BCLG" ENSG00000121380 "BCL2 like 14" Q9BZR8 12 12049844-12211084 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 40.1;testis: 29.8" "Group enriched" "Detected in many" 11 "Early spermatids: 317.4;Late spermatids: 661.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Lineage enhanced" "Detected in single" "T-cells: 3.0" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.1;NTERA-2: 3.9;OE19: 5.0;RT4: 4.7;SuSa: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040665, HPA059846" Enhanced Uncertain Cytosol NA NA Cytosol "HPA040665: AB_10964282, HPA059846: " "unprognostic (3.65e-4)" "unprognostic (4.95e-3)" "unprognostic (1.68e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-1)" "unprognostic (2.70e-4)" "unprognostic (1.10e-1)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "unprognostic (4.59e-5)" "unprognostic (1.06e-2)" "unprognostic (1.06e-2)" "unprognostic (5.79e-6)" "unprognostic (3.83e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-2)" "unprognostic (1.73e-8)" 0.1 0.1 0.1 5.3 0.2 0.0 0.3 0.1 0.1 0.3 17.6 0.1 0.1 11.5 0.1 0.4 0.4 0.2 7.7 0.1 0.1 0.1 0.3 0.3 1.3 1.6 0.1 0.1 0.4 11.2 0.0 0.1 0.1 0.1 1.6 13.3 0.1 0.8 0.1 0.1 0.1 40.1 0.1 0.1 0.9 7.8 29.8 0.1 4.1 0.1 0.3 1.2 2.5 0.2 0.9 0.0 0.1 0.2 0.0 3.0 0.3 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.9 5.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 5.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.7 0.9 1.4 0.7 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 3.0 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.9 0.0 2.6 0.3 0.3 0.4 2.5 2.7 4.5 1.8 0.0 0.1 0.0 0.3 317.4 0.3 31.5 0.0 6.6 0.0 0.4 3.1 0.0 0.0 0.2 0.0 6.4 0.0 0.0 661.8 5.2 0.0 0.0 6.4 42.7 0.0 3.3 17.5 3.5 0.0 0.7 6.5 0.0 5.2 2.7 0.4 0.1 0.0 26.4 7.8 BDH2 "DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308" ENSG00000164039 "3-hydroxybutyrate dehydrogenase 2" Q9BUT1 4 103079435-103099883 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 139.1" "Cell type enhanced" "Detected in many" 16 "Distal tubular cells: 179.1;Proximal tubular cells: 617.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 41.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036028, HPA036029" Enhanced Supported Cytosol NA NA Cytosol "HPA036028: AB_10670674, HPA036029: AB_2674909" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (1.64e-1)" "prognostic favorable (5.21e-4)" "unprognostic (3.92e-1)" "unprognostic (2.28e-1)" "unprognostic (3.82e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.71e-1)" "unprognostic (2.04e-1)" "unprognostic (4.37e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.45e-13)" "unprognostic (2.54e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.75e-4)" "unprognostic (9.69e-3)" 12.4 33.1 22.6 7.7 26.0 2.8 17.6 9.6 18.5 15.7 18.9 14.8 12.3 36.7 11.6 18.8 10.4 16.6 13.5 14.9 26.6 15.4 139.1 39.3 13.8 6.0 38.2 15.6 26.2 8.3 23.5 14.8 8.1 29.0 13.0 11.2 27.0 10.2 15.2 6.9 7.9 34.8 10.2 29.7 6.7 11.8 7.2 32.4 10.4 25.1 12.0 7.6 11.0 11.8 9.5 7.5 1.4 4.1 11.6 18.5 7.5 2.6 4.5 25.9 7.8 27.1 30.1 3.7 6.2 16.0 5.9 10.0 3.6 10.3 10.7 10.9 9.5 2.4 1.2 13.4 10.0 6.8 6.3 8.1 2.0 6.6 11.8 17.4 6.2 3.1 24.0 9.4 10.1 2.3 27.0 19.9 17.7 6.5 3.4 22.7 1.4 27.8 6.1 7.8 2.4 2.1 20.1 25.0 6.3 41.3 5.0 3.5 12.5 11.0 5.8 7.0 11.4 5.2 5.1 12.2 7.0 3.7 4.4 2.4 6.5 6.5 11.0 9.3 7.5 5.8 1.4 4.1 0.2 11.9 1.8 12.8 9.5 12.1 11.3 5.8 9.0 14.2 15.3 0.3 11.6 0.3 7.5 18.5 7.5 22.6 26.0 9.6 18.5 26.6 15.4 38.2 15.6 29.0 32.4 29.8 52.6 3.4 39.4 27.0 1.3 8.5 38.2 22.7 33.0 102.9 0.0 6.7 179.1 38.9 1.1 24.3 37.4 0.0 19.3 13.9 51.4 21.0 18.5 63.8 17.7 3.2 22.0 28.3 13.2 2.1 64.7 10.3 21.9 19.8 19.9 45.8 21.4 14.1 73.2 617.5 2.2 12.9 24.2 0.7 1.7 23.3 2.9 17.3 23.0 33.1 BEX1 ENSG00000133169 "Brain expressed X-linked 1" Q9HBH7 X 103062651-103064240 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 150.2;pituitary gland: 64.3" "Group enriched" "Detected in many" 4 "Bipolar cells: 321.5;Horizontal cells: 343.2;Muller glia cells: 473.7;Rod photoreceptor cells: 119.7" "Cancer enhanced" "Detected in many" "glioma: 111.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 60.3;HBF TERT88: 67.4;HL-60: 147.5;hTERT-RPE1: 104.5;SCLC-21H: 46.2;U-937: 46.2" "HPA045384, HPA078630" Approved Approved Cytosol NA NA Cytosol "HPA045384: AB_2679305, HPA078630: " "prognostic favorable (6.43e-4)" "unprognostic (1.51e-1)" "unprognostic (8.92e-2)" "unprognostic (2.94e-2)" "unprognostic (1.66e-1)" "unprognostic (7.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-2)" "unprognostic (5.28e-3)" "unprognostic (2.09e-1)" "prognostic favorable (8.16e-8)" "unprognostic (1.14e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (7.34e-2)" 1.8 37.4 66.4 2.8 65.1 16.3 1.9 44.7 150.2 1.8 3.0 6.2 0.0 3.3 7.7 25.2 1.6 10.1 1.8 3.6 77.4 81.0 4.5 3.0 2.1 1.7 38.9 67.8 9.5 30.9 48.1 64.3 1.5 35.8 3.8 3.1 4.7 2.2 2.9 1.3 1.5 3.9 3.3 24.3 2.3 5.0 27.5 12.0 0.0 12.1 0.0 1.5 1.5 0.4 2.4 0.2 6.4 0.5 1.7 3.1 1.5 0.0 0.0 3.7 0.0 0.0 0.0 0.1 2.1 0.0 40.6 60.3 0.0 0.0 0.0 0.0 15.1 13.0 0.0 0.0 0.0 67.4 0.0 0.1 12.3 0.0 8.0 0.7 147.5 0.2 0.9 0.0 8.8 0.0 104.5 0.0 11.8 0.0 0.0 8.1 0.0 27.7 0.0 33.6 9.3 6.0 0.0 0.0 0.7 0.0 0.0 46.2 26.6 0.0 0.0 0.1 0.6 0.0 41.7 0.0 0.0 13.9 0.1 1.5 7.2 0.2 0.0 5.4 46.2 2.6 0.6 0.5 6.4 0.7 0.1 0.7 1.2 2.0 1.2 0.1 2.4 3.1 1.4 1.2 1.7 0.4 0.2 0.9 1.5 66.4 65.1 44.7 89.0 77.4 81.0 38.9 67.8 35.8 12.0 0.0 0.3 0.5 7.8 7.7 321.5 8.2 20.4 0.0 1.2 5.2 37.3 0.3 61.3 6.4 9.3 2.8 0.4 0.0 11.5 0.1 0.4 6.9 0.0 0.0 1.3 343.2 76.4 28.8 7.5 16.7 7.5 0.3 6.8 1.8 0.4 473.7 10.3 2.3 2.5 12.7 119.7 0.0 2.2 15.4 14.7 5.6 0.5 0.0 0.9 1.4 BEX2 DJ79P11.1 ENSG00000133134 "Brain expressed X-linked 2" Q9BXY8 X 103309346-103311046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 79.2;epididymis: 67.1" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 354.8;Muller glia cells: 185.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 18.0;NK-cells: 21.3;T-cells: 26.8" "Cell line enhanced" "Detected in many" "GAMG: 18.6;hTCEpi: 31.0;NTERA-2: 29.9;SCLC-21H: 44.0;SH-SY5Y: 20.0" "HPA045384, HPA078630" Uncertain Uncertain Cytosol NA NA Cytosol "HPA045384: AB_2679305, HPA078630: " "unprognostic (7.56e-2)" "unprognostic (7.08e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (8.54e-7)" "unprognostic (3.21e-1)" "unprognostic (1.65e-1)" "unprognostic (4.27e-2)" "prognostic favorable (1.52e-4)" "unprognostic (7.36e-3)" "unprognostic (6.82e-2)" "unprognostic (8.22e-3)" "unprognostic (6.63e-2)" "prognostic favorable (3.05e-13)" "unprognostic (4.14e-3)" "unprognostic (6.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" 1.7 39.6 49.1 4.1 62.6 6.8 10.9 44.9 79.2 5.8 4.7 11.5 3.0 2.7 14.7 67.1 3.0 8.9 4.8 7.3 53.4 57.6 26.4 1.4 6.6 7.3 32.5 40.3 29.0 13.5 29.6 40.1 5.0 29.6 12.4 4.1 11.5 11.1 12.8 2.5 4.2 4.2 5.7 18.7 7.9 6.5 13.2 13.6 3.1 52.8 1.3 9.2 3.7 2.2 18.0 3.5 4.0 0.1 21.3 26.8 7.1 0.0 0.8 3.8 0.0 0.0 0.0 14.8 0.1 2.0 2.6 3.7 2.6 1.2 0.0 10.4 0.0 18.6 0.6 0.0 3.0 2.2 0.0 8.0 0.4 0.4 0.1 15.2 0.0 8.2 0.9 31.0 1.2 9.5 5.8 0.1 10.7 5.3 0.2 0.3 1.3 6.2 0.0 29.9 0.0 2.6 0.0 0.0 0.0 1.2 1.1 44.0 20.0 2.0 0.4 6.6 3.7 3.6 0.0 0.0 0.0 3.0 0.1 0.6 10.1 6.4 0.0 5.0 0.0 0.4 4.0 0.1 0.3 8.5 0.1 11.8 18.0 16.8 9.8 0.5 15.0 26.8 19.2 0.5 21.3 0.0 3.5 11.3 7.1 49.1 62.6 44.9 60.5 53.4 57.6 32.5 40.3 29.6 13.6 14.9 49.0 36.6 86.3 28.0 178.0 20.2 56.0 13.4 63.7 108.2 41.2 66.0 354.8 40.3 13.3 11.7 2.0 0.0 36.9 9.9 3.3 54.5 12.7 0.8 6.1 114.4 96.4 1.8 0.0 48.7 14.7 4.7 25.3 1.8 25.1 185.5 28.0 7.0 20.8 145.1 106.4 6.5 4.5 14.0 6.0 23.3 53.3 21.7 17.2 43.8 BEX3 "Bex, DXS6984E, HGR74, NADE, NGFRAP1" ENSG00000166681 "Brain expressed X-linked 3" Q00994 X 103376340-103378077 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 492.0;Cytotrophoblasts: 1286.1;Distal tubular cells: 1231.8;Proximal tubular cells: 518.5;Syncytiotrophoblasts: 672.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 18.8;naive CD4 T-cell: 40.8;naive CD8 T-cell: 18.8;T-reg: 32.3" "Lineage enriched" "Detected in many" 6 "T-cells: 40.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018886 Approved Supported Cytosol NA NA Cytosol "HPA018886: AB_1854453" "unprognostic (7.74e-2)" "unprognostic (6.56e-2)" "unprognostic (8.15e-3)" "prognostic unfavorable (7.23e-5)" "unprognostic (2.70e-1)" "unprognostic (1.93e-3)" "unprognostic (7.15e-2)" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.10e-2)" "unprognostic (3.85e-3)" "unprognostic (2.00e-1)" "prognostic favorable (1.28e-4)" "prognostic unfavorable (3.48e-4)" "unprognostic (1.38e-1)" "unprognostic (3.32e-2)" "unprognostic (8.68e-2)" 21.1 66.1 73.2 9.4 84.2 6.7 22.2 47.1 92.1 28.9 15.2 22.7 30.8 7.7 35.4 134.6 16.0 36.8 18.8 42.9 71.3 87.4 49.8 23.0 22.0 6.7 63.7 75.8 92.7 28.4 39.7 51.5 49.3 82.6 40.8 14.4 18.5 23.4 59.1 4.7 9.0 9.8 29.8 65.2 20.0 13.3 28.1 33.5 10.6 57.0 8.9 7.3 22.7 20.0 1.2 3.5 3.7 0.9 6.4 40.8 17.1 23.6 35.6 68.9 26.0 62.3 70.3 29.3 26.9 47.3 34.9 56.0 37.2 27.7 0.0 49.7 33.3 27.1 9.9 47.5 33.4 38.0 0.1 32.1 10.8 56.4 10.4 46.4 0.1 4.4 72.2 29.9 46.4 43.5 67.1 53.9 25.4 0.0 0.1 66.0 56.5 25.1 0.3 85.7 0.0 26.2 0.0 39.9 0.0 38.5 44.6 45.0 45.0 29.6 0.4 40.0 47.5 16.6 3.7 32.0 22.3 14.5 43.1 12.2 0.2 0.1 0.1 45.6 0.0 21.6 0.0 0.9 0.2 1.0 0.2 0.6 1.2 18.8 5.0 1.5 0.3 40.8 18.8 3.7 6.4 0.1 3.5 32.3 17.1 73.2 84.2 47.1 79.7 71.3 87.4 63.7 75.8 82.6 33.5 303.7 174.8 0.0 0.0 0.0 0.0 0.0 0.0 42.8 191.1 492.0 0.0 1286.1 1231.8 145.0 0.0 0.0 0.0 0.0 62.7 356.7 0.0 0.0 15.1 0.0 151.7 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 3.6 0.0 0.0 61.4 0.0 0.0 518.5 0.0 0.0 0.0 0.0 0.0 0.0 672.6 0.0 0.0 0.0 BHMT BHMT1 ENSG00000145692 "Betaine--homocysteine S-methyltransferase" Q93088 5 79111779-79132290 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "kidney: 105.9;liver: 216.2" "Group enriched" "Detected in some" 8 "Hepatocytes: 455.1;Proximal tubular cells: 647.0" "Cancer enhanced" "Detected in some" "liver cancer: 90.6;renal cancer: 50.4" "Region enhanced" "Detected in single" "hippocampal formation: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;NTERA-2: 3.6;SCLC-21H: 2.3" "Not detected" "Not detected" "HPA038285, HPA058310" Enhanced Supported Cytosol No NA 9200000 Cytosol "HPA038285: AB_10675791, HPA058310: AB_2683675" "unprognostic (2.61e-2)" "unprognostic (4.12e-1)" "unprognostic (4.45e-1)" "unprognostic (4.14e-3)" "unprognostic (5.62e-2)" "unprognostic (4.14e-1)" "prognostic favorable (7.32e-4)" "unprognostic (5.33e-2)" "unprognostic (1.51e-1)" "unprognostic (1.13e-1)" "unprognostic (9.66e-4)" "unprognostic (6.42e-2)" "unprognostic (8.26e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.60e-2)" "unprognostic (2.30e-3)" 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.1 1.5 0.0 105.9 216.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 4.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.4 0.0 1.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.3 0.0 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.2 2.5 0.0 0.0 15.7 0.0 0.0 66.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 455.1 0.0 0.0 0.0 3.7 9.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 647.0 0.1 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.3 BID ENSG00000015475 "BH3 interacting domain death agonist" P55957 22 17734138-17774770 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 96.5;bone marrow: 55.0" "Cell type enriched" "Detected in many" 4 "monocytes: 750.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 44.3;eosinophil: 68.5;intermediate monocyte: 75.7;myeloid DC: 36.3;neutrophil: 96.5;non-classical monocyte: 92.8;plasmacytoid DC: 25.3" "Group enriched" "Detected in all" 6 "dendritic cells: 36.3;granulocytes: 96.5;monocytes: 92.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000722, CAB003771" Enhanced Supported Cytosol NA NA 2400000 Cytosol "CAB003771: AB_365478, HPA000722: AB_1078283" "unprognostic (1.59e-1)" "unprognostic (5.51e-2)" "unprognostic (5.02e-2)" "unprognostic (3.04e-2)" "unprognostic (4.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.84e-2)" "unprognostic (5.21e-3)" "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.50e-13)" "unprognostic (4.66e-3)" "unprognostic (1.59e-1)" "unprognostic (3.55e-3)" "unprognostic (2.18e-2)" 13.0 5.2 16.8 21.7 18.7 55.0 8.5 17.1 23.0 3.9 12.2 9.3 1.0 11.2 4.3 7.1 6.7 4.9 11.3 9.6 17.8 12.8 6.1 31.9 13.7 22.5 16.5 6.3 3.7 8.9 4.3 3.5 6.9 8.1 7.1 8.3 4.5 8.0 3.8 11.3 4.7 13.0 5.3 10.9 29.1 9.5 2.4 9.2 21.0 5.5 5.9 12.8 16.2 9.4 5.5 36.3 96.5 92.8 11.6 10.1 37.0 28.7 22.9 4.0 11.7 3.9 7.8 5.1 14.2 11.6 11.5 9.9 13.3 17.2 4.9 11.2 6.2 13.0 24.6 3.4 3.4 6.4 9.3 17.1 23.1 9.1 24.0 4.7 23.6 26.9 7.2 8.4 11.3 2.7 9.3 11.5 17.2 17.3 6.8 5.7 56.8 40.4 33.6 12.0 31.4 12.7 18.7 8.5 7.3 3.1 37.4 23.4 17.2 2.8 10.1 9.8 1.7 20.2 33.2 19.8 6.6 9.5 10.9 11.1 10.2 15.9 18.1 20.1 27.0 8.8 13.8 44.3 68.5 8.8 75.7 8.2 5.5 8.1 9.6 36.3 3.2 6.4 7.5 96.5 11.6 92.8 25.3 10.1 37.0 16.8 18.7 17.1 23.0 17.8 12.8 16.5 6.3 8.1 9.2 14.9 22.1 36.9 41.1 63.8 3.1 13.7 17.8 13.4 27.3 8.7 2.0 8.3 6.6 60.2 0.5 31.8 19.7 23.3 44.8 3.0 39.1 84.8 24.3 33.8 122.1 0.0 32.7 22.1 65.9 0.2 4.9 183.3 55.6 750.2 32.8 2.8 60.9 54.6 3.9 14.7 1.2 0.0 22.7 0.9 13.8 56.3 4.2 45.7 42.4 157.1 BIN1 "AMPH2, AMPHL, SH3P9" ENSG00000136717 "Bridging integrator 1" O00499 2 127048027-127107355 "Disease related genes, Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "skeletal muscle: 399.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 141.1;Proximal tubular cells: 176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 37.0;MAIT T-cell: 32.5;memory B-cell: 32.2;memory CD4 T-cell: 38.4;memory CD8 T-cell: 36.9;naive B-cell: 34.1;naive CD4 T-cell: 36.2;naive CD8 T-cell: 34.4;NK-cell: 31.2;T-reg: 45.0" "Group enriched" "Detected in many" 9 "B-cells: 34.1;NK-cells: 31.2;T-cells: 45.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001945, HPA003894, HPA005437" Enhanced Supported Cytosol NA NA 1200000 Cytosol "CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284" "unprognostic (2.20e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" "unprognostic (9.65e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.55e-1)" "unprognostic (1.02e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-3)" "unprognostic (1.26e-2)" "unprognostic (2.57e-1)" "unprognostic (2.41e-3)" "unprognostic (3.22e-3)" 9.5 12.1 21.0 6.7 26.8 3.7 4.2 10.3 24.9 6.2 5.4 36.2 3.6 5.3 5.6 7.3 8.8 7.8 6.4 3.1 24.8 15.2 10.3 4.9 4.6 9.3 26.8 15.8 6.8 5.3 7.3 4.9 6.5 17.3 9.2 4.4 7.9 4.9 7.2 399.9 2.7 5.0 11.6 22.1 10.4 6.1 3.1 26.8 0.0 4.7 30.8 7.3 9.0 7.9 34.1 4.0 1.1 0.6 31.2 45.0 22.4 15.1 8.3 10.1 11.9 30.1 24.2 3.4 4.6 10.0 11.0 7.2 32.0 9.4 0.0 14.2 8.6 6.4 2.0 4.4 7.5 2.9 1.7 1.2 4.4 13.7 2.1 27.2 0.0 0.8 22.1 1.8 23.8 4.3 14.4 14.9 1.5 0.9 0.5 13.5 0.3 1.4 12.7 7.5 33.8 9.5 3.5 11.1 1.4 38.9 0.0 6.6 18.7 16.7 6.5 5.1 11.2 0.4 2.8 17.7 12.7 12.5 16.1 15.3 0.4 0.4 0.0 18.7 0.8 5.8 0.1 0.6 0.1 37.0 0.3 32.5 32.2 38.4 36.9 2.8 34.1 36.2 34.4 1.1 31.2 0.5 4.0 45.0 22.4 21.0 26.8 10.3 24.9 24.8 15.2 26.8 15.8 17.3 26.8 8.9 10.6 66.3 7.8 16.6 141.1 4.5 33.1 0.0 4.5 14.0 117.8 1.6 31.5 12.8 13.4 15.7 11.3 0.0 26.0 3.7 58.0 22.0 2.3 15.3 125.1 28.6 44.2 12.9 18.1 43.3 72.8 30.7 21.9 1.8 25.6 20.3 17.5 21.0 28.7 176.2 129.8 12.9 30.2 1.1 7.5 7.9 2.4 89.9 41.2 8.1 BLVRA BLVR ENSG00000106605 "Biliverdin reductase A" P53004 7 43758680-43807342 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 210.4;monocytes: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019709, HPA042865, HPA054322" Approved Supported Cytosol NA NA 1600000 Cytosol "HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450" "unprognostic (2.47e-2)" "unprognostic (8.38e-3)" "unprognostic (1.79e-2)" "unprognostic (2.16e-3)" "unprognostic (6.45e-3)" "unprognostic (5.01e-2)" "unprognostic (1.63e-2)" "prognostic favorable (8.65e-4)" "unprognostic (1.42e-1)" "unprognostic (1.75e-2)" "unprognostic (2.93e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-2)" "unprognostic (5.63e-3)" "unprognostic (3.18e-1)" "unprognostic (2.13e-3)" "unprognostic (4.56e-2)" 31.7 13.1 14.5 16.2 14.7 23.8 22.5 13.3 21.9 22.7 25.9 9.1 12.6 5.2 19.3 58.7 35.8 18.7 17.5 21.7 11.9 16.2 26.8 6.0 27.7 25.1 15.8 15.4 26.4 14.8 19.3 13.1 12.2 20.5 21.8 8.8 17.2 17.9 21.1 23.0 15.1 12.2 26.4 10.6 40.9 17.7 9.3 6.7 12.1 19.0 21.3 21.5 28.5 18.9 4.9 23.2 27.5 61.6 3.4 14.0 30.7 11.3 22.0 6.4 26.7 13.7 18.3 0.3 7.7 23.9 13.2 16.2 5.2 6.8 0.0 14.9 12.2 46.9 14.9 19.6 19.5 11.3 53.1 13.7 24.4 20.3 32.2 35.0 2.7 9.2 12.4 33.1 13.9 9.3 26.7 22.4 12.3 16.1 13.5 10.0 12.2 8.4 1.4 8.7 2.5 25.4 18.8 11.1 61.4 29.3 6.3 8.3 25.6 15.8 15.8 12.8 11.8 35.5 18.3 13.6 12.2 13.5 5.3 13.1 18.3 14.4 0.0 19.9 11.0 18.9 7.8 50.5 27.5 7.0 61.6 6.6 4.9 14.0 11.7 23.2 2.4 7.5 5.8 4.5 3.4 57.7 3.4 13.6 30.7 14.5 14.7 13.3 21.9 11.9 16.2 15.8 15.4 20.5 6.7 56.6 76.2 9.0 49.2 25.8 17.0 52.9 12.7 76.3 62.6 33.2 2.0 8.3 48.0 45.9 0.6 26.4 1.3 46.7 30.3 8.7 33.7 33.1 108.6 0.9 210.4 7.9 0.0 24.5 107.5 1.3 34.2 72.6 43.9 171.3 0.0 19.3 29.9 0.0 27.3 86.5 11.5 45.3 49.2 2.6 3.8 30.1 4.3 25.0 0.4 35.9 BMPR1A "ACVRLK3, ALK3, CD292" ENSG00000107779 "Bone morphogenetic protein receptor type 1A" P36894 10 86756601-86932838 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019398 Approved Approved Cytosol NA NA Cytosol "CAB019398: " "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (3.34e-1)" "unprognostic (9.61e-2)" "unprognostic (1.05e-3)" "unprognostic (9.34e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (3.64e-1)" "unprognostic (2.38e-2)" "unprognostic (1.53e-1)" "unprognostic (9.24e-2)" "unprognostic (9.42e-2)" "unprognostic (4.32e-2)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "unprognostic (1.01e-2)" "unprognostic (1.07e-1)" 8.9 7.0 9.4 7.9 12.4 0.9 10.7 14.1 9.2 19.4 20.6 10.9 7.7 6.2 16.3 12.3 8.4 10.9 10.8 11.0 7.7 6.1 8.2 4.6 7.4 2.9 7.3 7.6 16.1 10.6 10.0 14.0 7.4 8.5 12.8 9.3 10.9 12.6 14.2 8.4 11.3 9.8 16.5 12.2 3.4 12.1 7.8 9.2 0.3 19.4 7.8 5.7 16.0 11.4 1.8 1.1 3.6 0.8 0.9 1.4 0.3 7.3 3.7 14.3 12.1 7.5 4.8 2.5 7.4 7.7 4.3 5.1 6.2 6.4 2.2 3.4 9.4 3.1 7.8 6.3 8.0 6.4 2.4 3.6 2.8 3.5 10.3 4.0 3.8 19.7 4.2 3.4 5.8 4.3 6.4 0.0 4.1 4.4 1.5 5.0 3.1 2.6 3.1 7.7 2.6 1.7 0.0 5.6 0.0 8.9 6.9 1.4 4.6 8.2 4.2 4.9 18.2 7.1 1.9 3.7 3.1 5.0 6.4 6.8 0.4 6.8 2.8 2.7 2.6 2.5 2.0 0.8 0.6 1.4 0.5 0.9 1.8 1.4 1.2 0.3 1.5 1.0 1.1 3.6 0.9 0.6 1.1 0.7 0.3 9.4 12.4 14.1 9.2 7.7 6.1 7.3 7.6 8.5 9.2 32.8 24.8 0.0 6.7 10.8 6.0 19.0 10.2 13.4 9.1 10.4 19.6 10.0 1.7 9.8 0.6 2.1 9.0 0.0 8.1 0.7 13.3 12.9 15.0 7.2 2.7 11.1 17.3 8.0 4.0 1.7 31.1 3.5 8.5 1.0 13.6 12.9 7.7 3.5 29.4 4.7 19.0 6.5 14.1 2.3 3.6 8.5 4.2 0.0 10.0 4.2 BMT2 "C7orf60, DKFZp762M126, FLJ31818" ENSG00000164603 "Base methyltransferase of 25S rRNA 2 homolog" Q1RMZ1 7 112819147-112939916 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Collecting duct cells: 12.2;Extravillous trophoblasts: 24.3;Hofbauer cells: 7.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044405, HPA050733" Uncertain Approved Cytosol NA NA Cytosol "HPA044405: AB_10959783, HPA050733: AB_2681223" "unprognostic (5.26e-2)" "unprognostic (3.95e-2)" "unprognostic (2.86e-1)" "unprognostic (2.39e-1)" "unprognostic (2.48e-1)" "unprognostic (1.11e-1)" "unprognostic (7.61e-5)" "unprognostic (1.50e-3)" "unprognostic (1.61e-2)" "unprognostic (9.82e-3)" "unprognostic (1.68e-1)" "unprognostic (2.30e-1)" "unprognostic (1.04e-1)" "unprognostic (6.94e-2)" "unprognostic (1.13e-1)" "unprognostic (8.22e-2)" "unprognostic (9.10e-2)" 9.4 7.8 15.5 8.6 14.5 8.1 11.0 27.6 17.1 11.8 11.2 5.2 11.0 5.0 13.9 8.3 13.7 8.7 9.5 22.9 13.0 12.2 10.3 4.5 8.1 9.8 9.0 7.5 11.4 7.9 11.5 18.0 12.0 10.9 11.1 8.3 6.3 9.3 15.9 7.9 9.3 6.9 13.7 11.0 11.9 6.4 14.2 9.7 13.7 10.0 5.1 10.3 14.6 11.0 3.9 5.7 12.7 5.9 5.4 7.3 2.6 4.2 3.7 9.3 8.3 12.5 14.5 2.8 4.5 20.6 8.2 12.0 2.2 3.4 1.4 5.8 8.3 9.0 2.1 4.9 6.7 13.5 4.5 5.0 7.5 2.7 2.7 5.7 2.8 7.3 10.9 5.3 6.4 5.7 10.2 6.6 2.7 2.3 2.8 9.8 3.2 6.8 8.2 2.0 3.0 3.8 3.4 12.2 4.4 6.2 5.8 3.7 9.5 8.6 3.5 4.9 9.4 1.7 2.7 4.6 10.5 2.6 6.7 3.5 3.7 3.5 2.7 11.4 4.3 6.1 8.0 5.5 9.1 4.9 5.7 6.0 3.9 4.9 5.7 5.7 3.9 6.8 5.7 12.7 5.4 5.9 3.3 7.3 2.6 15.5 14.5 27.6 17.1 13.0 12.2 9.0 7.5 10.9 9.7 6.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 3.4 12.2 0.0 5.8 0.0 2.4 0.0 0.0 0.0 0.0 2.1 24.3 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.8 0.0 0.0 3.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 BNIP3 Nip3 ENSG00000176171 "BCL2 interacting protein 3" Q12983 10 131966455-131982013 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.7" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 391.8;Proximal tubular cells: 579.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 72.0;hTERT-RPE1: 56.2;U-87 MG: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003015, CAB011676" Supported Uncertain Cytosol NA NA Cytosol "CAB011676: , HPA003015: AB_1078290" "unprognostic (1.01e-3)" "unprognostic (1.42e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-3)" "unprognostic (6.57e-3)" "unprognostic (1.12e-1)" "unprognostic (2.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.37e-3)" "unprognostic (1.04e-1)" "unprognostic (3.29e-2)" "unprognostic (2.98e-1)" 19.3 12.0 18.3 4.0 18.6 3.0 8.7 13.5 28.3 7.7 4.6 13.0 5.1 4.0 6.0 11.4 8.1 6.0 7.9 43.3 16.9 14.6 27.6 53.4 6.7 4.6 16.5 14.2 19.3 122.7 6.0 7.3 13.0 22.6 18.2 2.9 5.2 19.2 6.6 48.0 9.0 4.5 6.0 13.3 4.9 6.4 6.0 11.1 3.3 10.8 6.2 4.0 9.2 7.3 6.1 3.0 5.1 3.5 2.2 23.4 8.9 72.0 5.8 4.2 11.7 11.2 11.9 21.6 17.6 16.3 13.3 38.0 1.2 1.6 0.1 28.6 10.1 15.5 4.4 8.8 25.0 50.1 3.8 6.7 2.5 3.7 16.7 15.0 3.3 2.0 8.2 6.3 12.9 13.1 56.2 9.2 4.5 6.6 0.2 21.7 5.7 1.6 18.4 3.5 0.5 17.5 4.0 2.1 6.1 14.5 1.2 5.5 12.9 3.6 7.4 10.0 18.6 4.5 4.6 10.5 18.8 6.3 7.0 13.9 12.3 10.5 10.0 68.2 0.1 3.2 2.2 3.5 5.1 9.8 2.3 10.4 5.7 13.9 10.3 3.0 6.1 23.4 15.4 0.9 2.2 3.1 2.3 13.2 8.9 18.3 18.6 13.5 28.3 16.9 14.6 16.5 14.2 22.6 11.1 44.7 40.9 23.1 75.3 26.6 87.6 141.4 101.9 89.7 48.9 80.3 37.3 149.9 255.4 174.2 61.9 44.2 3.5 0.0 75.7 295.7 56.6 118.1 0.0 391.8 65.8 314.6 77.8 54.6 21.8 85.4 65.0 16.1 32.1 39.7 6.7 125.3 189.3 1.9 97.2 579.1 50.2 38.8 23.8 33.5 100.7 11.4 206.9 25.4 4.8 42.9 BNIPL "BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753" ENSG00000163141 "BCL2 interacting protein like" Q7Z465 1 151036570-151047600 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.5;skin 1: 68.6" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 14.9;Suprabasal keratinocytes: 49.9;Urothelial cells: 20.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "T-47d: 33.1" "Group enriched" "Detected in some" 9 "basal ganglia: 1.4;cerebellum: 2.7" "Low region specificity" "Detected in some" HPA019946 Uncertain Cytosol NA NA Cytosol "HPA019946: AB_2732424" "unprognostic (2.62e-1)" "unprognostic (7.59e-3)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.50e-4)" "unprognostic (6.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.32e-3)" "unprognostic (3.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.88e-4)" "unprognostic (1.91e-1)" "unprognostic (8.43e-11)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" "prognostic favorable (4.32e-4)" "unprognostic (6.81e-2)" 0.1 0.1 0.2 0.1 0.2 0.3 6.4 0.2 0.2 9.7 0.1 0.1 9.4 0.1 0.6 0.6 42.5 1.0 0.1 0.2 0.2 0.0 0.5 0.2 6.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 3.2 0.1 3.4 0.1 0.3 7.1 21.0 0.7 68.6 0.2 0.8 0.1 0.1 0.6 1.0 0.1 0.2 2.7 25.8 23.2 5.0 18.2 1.8 0.8 3.2 0.6 0.5 1.7 0.4 0.3 0.2 0.5 0.6 0.3 0.3 0.6 0.3 0.0 0.2 0.1 1.1 0.4 0.6 0.5 0.0 0.1 1.3 0.7 0.2 0.4 0.8 0.8 0.9 0.5 0.2 0.1 0.5 0.6 0.0 2.4 0.1 0.2 0.9 0.0 0.9 0.5 0.5 0.2 1.5 0.6 0.9 0.5 0.7 0.4 0.3 0.2 0.3 0.5 0.3 1.1 0.5 0.4 0.7 0.2 1.9 33.1 0.2 0.7 0.7 0.4 0.2 0.1 1.5 1.1 3.1 0.0 0.2 0.6 2.7 0.6 0.7 1.7 0.6 1.4 0.5 1.0 1.2 0.3 1.8 1.0 0.6 3.2 0.5 0.6 0.8 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.1 14.9 12.1 0.0 5.4 13.6 0.4 0.3 0.0 9.4 10.3 10.4 0.0 1.5 0.0 0.0 5.9 0.3 0.4 0.0 0.0 0.3 1.3 6.2 0.0 0.0 0.3 0.0 0.0 3.7 1.2 0.9 0.9 0.8 3.3 0.0 0.1 0.5 0.0 0.0 0.0 0.3 1.4 0.0 0.2 0.5 0.1 49.9 2.2 0.8 0.2 20.9 BTBD19 ENSG00000222009 "BTB domain containing 19" C9JJ37 1 44808482-44815585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 7.0;HUVEC TERT2: 6.4;TIME: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042633, HPA076404" Uncertain Uncertain Cytosol NA NA Cytosol "HPA042633: AB_2678091, HPA076404: AB_2686796" "unprognostic (4.69e-2)" "unprognostic (8.74e-3)" "unprognostic (1.82e-3)" "unprognostic (1.20e-4)" "unprognostic (5.32e-2)" "unprognostic (3.80e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.70e-1)" "unprognostic (1.53e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.18e-8)" "unprognostic (2.20e-3)" "unprognostic (2.78e-2)" "unprognostic (8.29e-2)" "unprognostic (1.70e-1)" 6.7 8.7 3.5 3.6 1.9 2.7 4.9 0.6 2.8 13.5 2.0 2.4 6.2 1.6 13.9 21.4 2.1 6.4 4.2 3.8 1.3 1.4 4.2 2.2 4.1 1.8 1.4 4.0 8.4 1.5 3.2 11.9 7.9 6.3 5.6 1.8 7.6 1.7 8.3 1.8 1.2 2.2 5.6 1.9 2.3 2.2 3.5 0.6 0.1 6.0 2.0 1.4 2.1 4.3 0.0 0.2 2.3 0.1 0.0 0.2 0.0 0.1 1.1 1.0 1.1 2.3 2.6 0.7 2.1 1.3 1.0 2.0 0.0 0.8 0.1 1.0 3.7 0.5 0.3 0.0 1.1 0.4 0.9 0.2 2.0 0.3 1.1 2.3 0.0 1.6 3.9 0.1 3.7 0.7 7.0 6.4 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.3 0.1 1.2 1.3 0.0 0.0 14.9 3.8 3.0 1.8 1.6 0.5 0.1 0.0 2.3 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 3.5 1.9 0.6 2.8 1.3 1.4 1.4 4.0 6.3 0.6 3.0 3.4 0.0 1.6 1.8 0.0 1.0 2.5 1.4 4.5 1.8 0.0 0.2 0.0 0.9 0.4 3.5 2.1 0.0 0.5 0.2 3.8 0.9 2.3 2.8 2.7 0.0 0.0 3.7 6.0 0.0 2.8 4.6 3.3 0.0 1.3 1.5 0.8 0.8 1.1 2.7 0.0 0.0 4.6 0.7 0.2 1.9 1.0 0.0 0.7 1.3 BTF3 "BTF3a, BTF3b, NACB" ENSG00000145741 "Basic transcription factor 3" P20290 5 73498408-73505635 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013007, HPA056420" Approved Supported Cytosol NA Yes 100000 Cytosol "CAB013007: , HPA056420: AB_2683125" "unprognostic (3.48e-3)" "unprognostic (2.11e-1)" "unprognostic (2.87e-3)" "unprognostic (1.86e-1)" "unprognostic (6.25e-2)" "unprognostic (1.41e-1)" "unprognostic (1.90e-3)" "unprognostic (1.78e-2)" "unprognostic (8.20e-3)" "unprognostic (5.18e-2)" "unprognostic (8.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (1.06e-1)" "unprognostic (2.87e-1)" "unprognostic (1.26e-2)" "unprognostic (2.16e-1)" 98.4 64.4 44.7 67.6 40.8 98.2 105.6 38.2 49.0 111.8 87.3 45.8 69.7 62.2 107.5 67.3 141.3 75.1 68.7 69.1 40.7 41.3 74.4 107.7 66.6 100.6 46.7 41.6 172.4 111.0 44.3 44.5 90.8 44.8 110.9 75.1 53.0 102.7 76.0 157.9 107.7 87.7 95.7 53.2 84.4 76.9 56.5 41.0 132.6 123.5 131.7 113.4 135.1 88.0 89.0 104.4 19.3 77.0 75.6 102.1 159.0 96.6 64.9 70.5 100.6 70.8 119.4 110.6 67.6 95.2 118.3 114.0 83.4 110.7 146.6 106.9 70.4 85.8 68.4 102.5 174.9 136.0 60.6 131.5 82.9 62.4 108.8 103.2 78.4 67.0 103.4 139.7 76.1 141.3 135.5 107.4 84.4 77.1 95.4 99.5 87.9 117.5 147.2 89.6 36.1 65.3 89.9 83.8 181.8 124.4 97.7 82.8 110.5 66.4 75.8 135.9 69.3 97.6 161.8 77.1 51.3 69.8 61.1 182.4 89.9 91.5 136.5 67.9 120.2 75.4 19.3 77.0 19.3 52.5 60.9 88.6 89.0 89.8 73.3 104.4 71.3 99.5 87.1 10.8 75.6 47.8 58.7 102.1 159.0 44.7 40.8 38.2 49.0 40.7 41.3 46.7 41.6 44.8 41.0 229.3 278.1 715.0 1745.8 1743.2 127.7 303.1 473.9 325.2 444.7 307.1 41.2 1161.2 771.0 802.1 569.6 816.5 667.0 303.7 1060.8 1748.3 874.0 889.8 408.6 437.5 930.1 81.0 569.4 571.5 843.2 380.0 1155.8 1046.3 750.8 1202.0 941.3 218.3 1129.2 785.5 795.5 944.8 96.9 633.8 1145.4 210.5 145.7 1707.3 1431.9 885.4 1216.6 1923.9 BUB1B "Bub1A, BUBR1, MAD3L, SSK1" ENSG00000156970 "BUB1 mitotic checkpoint serine/threonine kinase B" O60566 15 40161023-40221136 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.5;testis: 25.6" "Group enriched" "Detected in many" 7 "Spermatocytes: 66.9;Spermatogonia: 28.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.8;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA008419 Supported Cytosol Yes Yes Cytosol "HPA008419: AB_1078308" "unprognostic (4.40e-2)" "unprognostic (2.23e-1)" "unprognostic (4.65e-2)" "unprognostic (2.44e-3)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (7.43e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.69e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.75e-2)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (3.94e-2)" 1.0 0.9 0.3 18.4 0.6 11.4 1.5 0.4 0.5 1.3 4.0 0.4 0.1 3.3 1.1 0.8 6.5 0.5 1.1 0.6 0.4 0.4 0.8 0.7 1.8 8.7 0.4 0.3 0.6 0.5 0.0 0.4 3.4 0.5 0.6 4.4 0.3 1.6 0.1 0.7 2.3 2.9 1.2 0.6 5.4 1.7 25.6 0.1 49.5 0.5 3.1 10.6 1.1 2.0 2.8 2.8 0.0 0.2 0.7 0.7 0.5 21.8 11.1 35.5 14.1 0.9 2.5 11.5 20.8 11.7 22.3 19.4 16.2 8.4 19.8 11.7 7.5 20.5 24.7 33.5 11.3 24.3 17.0 18.0 28.9 28.7 15.0 0.0 26.1 15.9 0.5 0.6 13.6 12.8 4.4 16.1 22.9 24.9 21.1 22.2 7.4 20.4 15.9 24.0 18.4 12.7 21.9 29.2 15.0 6.8 11.1 23.2 14.3 12.8 12.3 4.5 16.2 14.3 13.5 9.3 17.1 18.1 17.0 18.4 11.1 18.8 32.4 9.1 29.3 22.2 0.0 0.0 0.0 0.2 0.2 0.3 2.4 0.7 0.6 0.7 2.8 0.1 0.4 0.0 0.7 0.1 2.8 0.0 0.5 0.3 0.6 0.4 0.5 0.4 0.4 0.4 0.3 0.5 0.1 3.0 1.4 0.8 0.3 0.7 0.4 0.4 0.0 0.0 3.4 0.0 0.0 1.3 0.0 0.3 2.5 0.0 0.3 0.0 0.0 5.1 0.4 0.2 0.0 0.2 4.3 0.0 0.0 1.3 0.6 2.4 1.4 1.5 0.0 0.0 1.4 0.0 0.8 0.8 0.4 0.0 0.1 6.5 0.0 66.9 28.8 0.3 0.7 0.8 1.7 0.4 C11orf45 "FLJ43646, MGC35558" ENSG00000174370 "Chromosome 11 open reading frame 45" Q8TAV5 11 128899565-128906035 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Hofbauer cells: 8.1;Kupffer cells: 4.1;Late spermatids: 5.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;monocytes: 1.8;T-cells: 1.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 12.4;U-937: 9.6" HPA039716 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA039716: AB_10672892" "unprognostic (8.32e-2)" "unprognostic (3.93e-2)" "unprognostic (5.99e-3)" "unprognostic (1.35e-3)" "unprognostic (1.01e-1)" "unprognostic (9.93e-2)" "unprognostic (4.50e-5)" "unprognostic (1.97e-2)" "unprognostic (4.78e-2)" "unprognostic (3.10e-1)" "unprognostic (2.80e-1)" "unprognostic (9.27e-2)" "unprognostic (2.55e-9)" "unprognostic (2.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.87e-2)" "unprognostic (7.22e-2)" 0.7 4.9 1.1 0.3 5.3 0.4 0.7 0.0 1.0 0.9 0.4 1.2 0.3 0.4 3.3 0.9 2.1 5.0 0.7 0.9 1.6 0.2 2.8 0.3 1.1 0.7 4.1 4.7 3.7 2.1 1.2 0.6 1.7 3.6 0.0 8.0 0.6 0.1 1.5 1.6 2.0 1.0 1.8 0.6 1.7 1.8 0.4 3.5 0.0 1.8 0.0 1.1 0.6 2.4 4.8 0.0 0.0 0.1 0.4 1.8 0.8 5.1 1.9 4.8 6.9 6.2 0.0 3.5 0.4 4.4 2.5 2.5 12.4 0.9 0.0 1.2 0.3 3.0 0.0 0.2 0.0 0.0 0.3 1.7 1.4 0.8 4.1 1.1 3.8 0.0 0.3 2.1 1.3 2.7 2.5 2.0 1.0 3.5 1.2 5.0 0.5 4.4 1.2 0.0 0.2 2.0 5.7 0.4 1.4 0.8 4.1 0.6 0.0 7.1 0.0 0.8 0.1 0.0 0.0 0.9 9.6 0.2 0.0 1.8 0.0 0.3 0.8 0.7 0.4 0.5 0.5 3.5 0.4 1.1 0.7 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.3 0.0 1.0 2.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.6 1.4 0.0 0.0 0.0 0.7 2.1 0.2 0.1 1.1 0.0 8.1 0.0 0.0 0.0 4.1 5.7 0.0 2.6 0.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.6 1.0 0.0 0.0 0.7 C12orf71 LOC728858 ENSG00000214700 "Chromosome 12 open reading frame 71" A8MTZ7 12 27081058-27082514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 4.1;bone marrow: 3.8;skin 1: 2.5;testis: 7.4" "Cell type enriched" "Detected in some" 8 "Early spermatids: 9.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "NK-cell: 4.1" "Lineage enriched" "Detected in single" 23 "NK-cells: 4.1" "Cell line enhanced" "Detected in some" "HDLM-2: 5.7;JURKAT: 2.1" "HPA038359, HPA058728" Uncertain Approved Cytosol NA NA Cytosol "HPA038359: , HPA058728: AB_2683800" "unprognostic (1.14e-1)" "unprognostic (9.86e-2)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (2.36e-1)" "unprognostic (6.78e-3)" "unprognostic (9.90e-2)" "unprognostic (3.13e-1)" "unprognostic (7.12e-3)" "unprognostic (1.02e-1)" "unprognostic (6.73e-3)" "unprognostic (1.96e-1)" "unprognostic (4.15e-8)" "unprognostic (4.85e-2)" "unprognostic (9.71e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.1 0.0 0.1 0.4 0.1 3.8 0.2 0.8 0.3 0.4 0.1 0.2 0.1 0.0 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.5 2.5 0.4 0.0 0.0 0.5 0.1 7.4 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.5 0.2 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 5.7 0.0 1.2 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.4 0.1 0.0 0.0 0.5 0.3 0.9 0.4 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.9 0.0 0.6 0.3 0.1 0.0 0.1 0.0 0.6 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 C14orf28 DRIP-1 ENSG00000179476 "Chromosome 14 open reading frame 28" Q4W4Y0 14 44897295-44907257 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 147.4;Late spermatids: 91.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059635 Approved Cytosol NA NA Cytosol "HPA059635: AB_2684091" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.23e-1)" "unprognostic (3.06e-6)" "unprognostic (1.18e-1)" "unprognostic (6.64e-3)" "unprognostic (2.37e-2)" "unprognostic (1.90e-2)" "unprognostic (2.25e-1)" "unprognostic (5.35e-2)" "unprognostic (3.13e-3)" "unprognostic (7.33e-2)" "unprognostic (3.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.30e-1)" "unprognostic (4.68e-2)" "unprognostic (2.01e-1)" 8.8 5.3 5.0 4.1 5.6 1.6 11.8 4.0 6.2 13.3 10.3 7.2 10.7 7.3 14.4 8.4 6.5 9.2 8.9 8.5 4.8 4.1 5.1 14.4 5.1 4.4 10.6 4.3 12.4 12.4 4.4 5.0 5.7 5.6 12.8 5.8 5.9 11.4 8.7 7.4 5.9 9.0 20.4 5.4 5.9 8.5 16.1 5.4 1.7 6.6 3.2 5.0 19.0 9.2 6.8 3.4 6.9 3.5 3.9 9.7 2.1 2.4 1.7 3.3 5.6 6.6 3.5 7.4 4.9 5.4 2.4 3.8 0.1 3.1 3.2 2.9 3.3 5.4 1.3 0.8 2.3 4.2 11.7 0.6 1.5 0.8 3.3 1.9 1.4 3.7 2.8 4.0 0.7 3.9 4.6 1.3 3.9 0.8 4.5 1.8 4.7 1.3 2.7 0.6 4.6 1.9 2.3 4.0 1.3 3.3 3.1 0.7 1.0 2.0 4.0 2.1 2.7 7.1 1.4 2.0 9.1 4.4 1.5 1.0 6.3 5.1 2.1 2.6 0.7 2.8 1.8 1.7 6.9 4.3 2.6 4.9 6.8 4.4 5.6 2.0 5.1 9.7 5.5 3.8 3.9 3.5 3.4 4.8 2.1 5.0 5.6 4.0 6.2 4.8 4.1 10.6 4.3 5.6 5.4 3.0 2.4 6.2 7.6 2.7 3.2 10.3 0.0 0.0 2.3 5.2 0.0 4.6 8.3 7.7 147.4 5.6 5.4 0.0 7.5 3.8 8.0 8.6 1.1 9.6 4.1 3.2 2.9 6.2 4.3 91.1 9.8 2.8 5.0 4.6 7.5 3.1 6.1 3.5 15.2 12.8 2.9 19.4 10.8 19.2 9.4 3.9 5.5 8.7 4.9 5.8 C15orf39 "DKFZP434H132, FLJ46337" ENSG00000167173 "Chromosome 15 open reading frame 39" Q6ZRI6 15 75195643-75212169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.7" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.9" "Group enriched" "Detected in many" 5 "dendritic cells: 5.7;granulocytes: 16.9;monocytes: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039961, HPA041907" Enhanced Enhanced Cytosol NA NA Cytosol "HPA039961: AB_10673024, HPA041907: AB_2677736" "unprognostic (3.53e-2)" "unprognostic (1.66e-1)" "unprognostic (4.57e-2)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (2.00e-1)" "unprognostic (2.20e-2)" "unprognostic (3.46e-2)" "prognostic favorable (7.94e-4)" "unprognostic (3.38e-2)" "unprognostic (2.74e-1)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (2.95e-1)" "unprognostic (1.14e-1)" 14.7 10.2 3.5 9.6 5.3 36.1 9.0 2.5 4.1 11.8 8.5 3.1 3.8 7.9 16.5 5.8 13.1 11.5 13.9 7.7 3.5 3.3 5.6 5.3 11.7 11.6 3.3 2.2 23.3 11.4 5.2 7.5 24.4 3.9 10.0 3.9 7.7 12.5 5.3 4.4 9.9 7.6 10.0 3.3 21.1 6.6 71.7 3.2 11.1 7.8 9.0 17.0 10.5 13.7 0.8 5.7 16.9 10.4 2.2 1.3 2.2 7.7 15.9 3.4 4.0 4.7 3.1 10.5 2.2 4.6 2.6 2.8 19.6 10.8 17.5 7.6 3.3 9.6 10.5 14.8 6.8 0.7 17.1 16.7 34.7 7.7 13.4 5.4 9.9 35.9 4.0 5.4 5.6 2.6 3.3 6.7 6.7 14.8 26.2 0.8 4.6 9.5 12.2 10.8 5.2 6.4 8.7 2.6 18.6 1.6 6.1 10.1 3.2 5.2 12.1 8.2 3.6 4.1 12.7 5.7 4.6 7.0 8.3 6.5 19.0 11.9 10.1 4.6 19.3 4.5 4.8 4.2 12.2 1.3 8.2 1.0 0.8 0.7 0.9 2.7 0.5 0.6 0.8 16.9 2.2 10.4 5.7 0.9 2.2 3.5 5.3 2.5 4.1 3.5 3.3 3.3 2.2 3.9 3.2 23.8 5.6 6.0 5.7 13.3 0.2 1.6 7.6 6.7 9.1 3.5 0.0 9.9 0.0 13.8 38.4 10.0 5.4 0.0 12.4 13.9 12.0 4.3 17.3 1.5 10.6 0.0 7.5 9.8 20.8 54.3 10.9 11.3 6.8 12.6 5.9 0.7 14.8 23.2 10.3 1.4 1.9 12.9 10.5 11.2 5.3 12.4 17.5 6.4 7.4 12.7 C19orf12 "DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43" ENSG00000131943 "Chromosome 19 open reading frame 12" Q9NSK7 19 29698886-29715789 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 57.4" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046930 Approved Supported Cytosol NA NA Cytosol "HPA046930: AB_10962836" "unprognostic (1.76e-1)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.01e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.54e-1)" "unprognostic (9.94e-3)" "unprognostic (7.93e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (3.22e-1)" "unprognostic (1.22e-3)" 57.4 14.7 11.9 7.6 11.3 2.3 33.9 10.5 14.3 7.2 7.7 5.8 5.4 10.8 7.1 7.6 7.5 6.2 8.7 14.0 9.5 11.6 11.5 36.9 5.6 11.4 10.3 10.7 7.8 9.6 7.7 6.9 7.4 11.1 6.7 5.5 10.5 9.5 7.6 27.5 8.2 9.6 7.6 6.5 7.5 6.0 4.2 5.2 8.9 5.4 9.2 7.4 7.2 11.0 3.7 4.3 2.3 2.1 5.6 14.3 6.0 10.5 20.9 10.3 12.8 25.6 15.9 15.9 12.5 12.5 12.6 16.4 10.0 4.3 8.6 13.4 15.8 11.4 4.6 8.6 5.3 8.5 22.6 15.1 9.6 6.9 17.2 14.4 7.4 12.8 18.1 11.2 7.5 6.1 10.1 11.3 5.4 7.3 11.2 13.0 7.3 5.2 5.4 6.1 9.2 5.2 10.3 10.6 6.6 9.6 10.6 6.3 13.3 7.5 9.8 19.6 11.0 4.1 8.3 11.3 26.7 20.8 10.8 11.3 15.8 14.0 6.4 15.9 4.5 11.1 0.9 2.0 1.0 14.3 2.1 8.2 3.7 8.1 10.2 1.8 3.2 8.5 10.5 2.3 5.6 2.1 4.3 9.7 6.0 11.9 11.3 10.5 14.3 9.5 11.6 10.3 10.7 11.1 5.2 11.9 13.6 13.0 9.8 11.3 15.3 26.8 2.5 8.1 7.9 8.7 5.9 25.1 13.3 15.4 1.3 9.0 12.0 0.0 20.0 23.3 16.7 9.2 16.1 57.8 13.4 4.8 3.5 12.9 11.3 1.5 26.7 10.8 10.1 27.1 6.4 10.3 17.3 10.5 27.6 30.5 8.4 6.5 10.3 3.6 4.1 6.8 18.3 17.0 8.1 7.5 C1orf158 MGC35194 ENSG00000157330 "Chromosome 1 open reading frame 158" Q8N1D5 1 12746215-12763699 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 23.5;testis: 74.6" "Group enriched" "Detected in some" 13 "Ciliated cells: 105.7;Early spermatids: 148.7;Late spermatids: 65.2" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5" "Region enhanced" "Detected in many" "pons and medulla: 9.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA028396 Uncertain Cytosol NA NA Cytosol "HPA028396: AB_10603451" "unprognostic (1.11e-2)" "unprognostic (4.94e-3)" "unprognostic (4.62e-1)" "unprognostic (8.00e-2)" "unprognostic (4.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.45e-1)" "unprognostic (3.51e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.7 0.0 2.4 0.3 0.0 0.0 0.2 0.9 0.0 6.2 0.0 0.0 0.4 4.2 0.1 23.5 0.1 0.0 1.0 1.4 0.0 0.0 2.8 0.1 0.2 0.1 4.8 0.1 0.0 0.4 0.1 9.3 0.0 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.2 0.1 0.1 74.6 0.9 0.0 0.5 0.0 0.1 0.0 0.0 0.9 0.6 2.3 0.6 1.1 0.8 0.1 0.5 1.3 1.1 0.7 0.6 0.0 1.0 0.1 0.3 0.2 0.2 1.3 0.7 1.1 0.3 0.3 0.4 0.4 0.1 0.1 0.2 0.2 0.7 1.1 1.9 0.5 0.0 0.9 1.0 0.1 0.7 0.3 0.1 0.4 0.1 0.5 0.9 1.4 0.3 0.5 0.2 0.7 1.5 0.3 0.5 0.6 0.3 0.9 0.1 0.5 1.9 0.8 0.5 0.6 0.3 1.4 0.7 0.2 0.5 0.5 0.8 0.4 0.8 0.6 0.5 1.2 1.0 1.1 0.5 1.6 0.6 0.5 0.7 0.5 0.6 0.5 0.5 0.5 0.1 0.9 0.8 0.7 2.3 1.1 0.6 0.6 0.4 0.1 0.7 2.4 0.0 0.2 1.0 1.4 0.2 0.1 9.3 0.9 3.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 105.7 7.9 0.0 0.0 0.0 0.0 0.0 148.7 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 65.2 1.7 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.0 7.9 1.3 0.0 0.0 0.0 0.0 0.1 C1orf198 "DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710" ENSG00000119280 "Chromosome 1 open reading frame 198" Q9H425 1 230837119-230869589 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 178.6;Smooth muscle cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 44.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004798 Approved Supported Cytosol "Intracellular and membrane" NA NA Cytosol "HPA004798: AB_1848722" "unprognostic (7.44e-2)" "unprognostic (1.89e-1)" "unprognostic (1.17e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.52e-1)" "unprognostic (1.65e-1)" "unprognostic (2.32e-1)" "unprognostic (3.75e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.50e-5)" "unprognostic (3.53e-2)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (3.77e-2)" 22.6 8.8 25.7 6.6 30.4 2.9 18.6 5.2 31.9 23.4 12.9 66.2 3.5 7.4 17.4 10.2 10.2 13.8 20.4 26.9 27.5 19.4 8.2 6.7 41.9 8.3 44.9 16.2 18.2 17.2 17.1 3.4 19.3 37.4 11.8 7.7 9.1 12.0 21.5 39.0 17.3 7.8 29.2 57.4 10.6 13.0 4.4 36.7 1.5 14.8 6.8 5.7 12.9 10.9 2.8 2.3 10.6 3.6 4.2 3.9 6.6 7.0 5.4 14.8 10.0 28.3 20.8 25.4 13.0 21.0 6.8 6.9 17.2 4.0 8.4 8.3 44.9 3.4 4.6 7.8 2.8 5.1 27.7 7.3 1.3 5.1 5.7 12.1 4.3 1.3 24.9 4.5 2.6 3.0 14.8 4.3 5.4 2.7 2.9 4.7 4.8 3.4 2.1 17.2 15.9 4.4 8.0 10.5 1.9 5.4 8.5 8.5 13.7 6.6 8.8 4.6 8.3 11.2 3.8 3.2 11.1 11.2 2.5 7.7 5.3 2.4 2.5 2.9 2.7 31.0 10.6 1.7 0.5 2.8 3.6 3.5 2.8 1.9 1.1 2.3 1.9 3.9 3.2 1.4 4.2 1.7 0.3 0.8 6.6 25.7 30.4 5.2 26.8 27.5 19.4 44.9 16.2 37.4 36.7 178.6 21.0 0.8 9.8 23.1 1.9 33.8 28.1 6.7 20.5 10.4 9.8 14.6 1.7 37.4 9.1 10.2 1.6 0.0 22.6 26.6 56.3 16.9 2.3 3.9 9.4 23.8 5.2 11.1 2.2 7.3 12.4 2.8 62.4 4.6 9.7 11.2 26.6 3.5 8.5 4.8 4.4 32.3 73.1 5.7 4.2 25.3 10.8 0.7 6.0 16.2 C1orf228 "MGC33556, NCRNA00082, p40" ENSG00000198520 "Chromosome 1 open reading frame 228" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.0;testis: 17.9" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 46.8;Early spermatids: 45.0;granulocytes: 81.7;Late spermatids: 39.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 8.6;MOLT-4: 7.1;NB-4: 10.1;U-937: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.9 2.2 6.3 0.7 11.2 4.3 1.5 3.2 6.8 1.7 1.0 5.6 3.9 0.7 3.1 6.8 1.3 14.0 1.5 0.6 6.5 2.4 1.4 7.0 2.0 1.5 1.4 7.5 4.5 1.4 3.0 5.4 0.8 7.7 1.8 0.9 3.3 1.6 1.4 0.5 1.7 0.8 0.9 2.4 0.8 1.4 17.9 5.4 0.2 1.3 0.0 1.0 0.8 0.8 1.4 6.2 10.4 2.7 0.5 2.3 1.8 0.2 0.3 2.0 0.1 0.7 2.6 0.5 0.0 0.3 0.5 0.3 0.5 4.3 0.3 0.3 0.9 1.0 0.5 0.0 0.0 0.0 1.1 0.2 1.0 2.6 0.6 0.2 8.6 5.1 2.0 0.3 0.8 0.0 1.5 0.2 0.3 0.1 0.8 0.2 0.1 7.1 10.1 0.1 0.6 0.1 3.7 0.2 2.4 0.9 0.0 1.4 0.9 0.0 1.4 1.1 1.4 0.4 4.5 0.0 0.3 0.3 0.4 0.0 0.3 0.3 0.2 0.3 13.7 0.4 10.4 2.7 7.5 0.3 0.8 0.1 0.7 1.5 1.0 1.3 1.4 2.2 2.3 1.2 0.5 0.1 6.2 0.1 1.8 6.3 11.2 3.2 6.8 6.5 2.4 1.4 7.5 7.7 5.4 6.0 5.0 14.5 0.4 0.7 1.1 0.0 0.0 46.8 9.1 0.0 11.8 0.3 0.0 0.0 45.0 0.0 0.3 0.0 0.0 0.1 0.7 0.4 81.7 3.2 10.7 1.6 9.8 0.0 15.0 39.8 0.3 6.1 0.0 0.0 0.6 6.1 0.0 0.0 0.7 0.0 4.3 6.5 0.3 2.3 14.3 0.6 0.1 1.0 0.6 0.1 C20orf24 "PNAS-11, RIP5" ENSG00000101084 "Chromosome 20 open reading frame 24" Q9BUV8 20 36605734-36612557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057387 Uncertain Approved Cytosol NA NA Cytosol "HPA057387: AB_2683425" "unprognostic (2.14e-1)" "unprognostic (4.75e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-3)" "unprognostic (3.88e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.56e-6)" "unprognostic (4.47e-3)" "unprognostic (3.89e-1)" "unprognostic (2.90e-1)" "unprognostic (2.37e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.98e-2)" 17.0 19.7 15.1 18.5 16.3 25.1 29.1 11.9 21.1 15.8 31.1 10.9 15.2 21.9 11.8 18.1 55.5 10.8 25.1 24.2 14.3 14.0 35.6 71.1 21.4 24.4 15.0 11.7 9.5 27.6 15.4 8.5 19.3 12.6 13.3 26.5 9.8 21.5 17.9 70.0 13.6 26.1 14.6 12.7 26.2 20.0 19.0 11.3 20.4 21.6 42.3 28.3 14.3 20.4 10.0 15.8 41.3 24.2 6.1 11.9 7.7 36.1 27.2 9.0 12.0 21.6 12.4 24.2 22.7 12.4 21.7 19.7 74.4 45.6 15.7 56.2 19.4 40.6 26.9 19.3 35.4 20.7 11.8 20.1 37.4 38.6 81.4 25.3 39.3 18.4 15.5 37.5 31.3 17.8 11.1 19.8 16.5 25.5 37.0 20.4 24.5 23.0 50.8 16.5 35.5 58.1 18.4 23.2 39.4 18.7 27.0 16.7 12.6 32.7 84.8 28.4 14.9 17.9 32.4 22.4 32.4 22.3 33.5 34.3 23.7 38.2 26.5 35.0 45.9 17.2 7.2 24.2 29.9 6.2 12.4 6.2 10.0 7.4 9.6 15.8 8.1 9.0 6.7 41.3 6.1 14.7 10.8 11.9 7.7 15.1 16.3 11.9 21.1 14.3 14.0 15.0 11.7 12.6 11.3 32.8 18.6 61.3 37.0 155.3 30.6 0.0 104.4 17.4 23.9 0.0 23.6 72.8 0.0 0.0 42.7 44.2 136.6 23.3 0.0 105.9 54.2 76.8 47.1 249.1 216.1 12.7 52.7 58.9 146.9 62.8 40.6 64.6 67.4 0.0 79.2 49.6 0.0 118.5 40.3 0.0 29.0 58.2 32.8 171.5 84.7 183.9 113.4 69.2 118.3 184.6 C3orf18 G20 ENSG00000088543 "Chromosome 3 open reading frame 18" Q9UK00 3 50558025-50571027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 26.3;Early spermatids: 47.6;Late spermatids: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 2.1;T-cells: 7.7" "Cell line enhanced" "Detected in many" "HDLM-2: 29.8" "Group enriched" "Detected in many" 4 "cerebellum: 31.6;olfactory region: 33.8" "Low region specificity" "Detected in all" HPA012105 Approved Approved Cytosol No No Cytosol "HPA012105: AB_1845717" "unprognostic (9.29e-3)" "unprognostic (1.46e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (8.19e-2)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (1.05e-2)" "unprognostic (1.64e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-3)" "unprognostic (1.29e-2)" "prognostic favorable (2.80e-9)" "unprognostic (7.65e-2)" "unprognostic (4.49e-1)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" 5.1 6.7 10.0 3.4 12.3 1.2 6.2 34.5 20.1 6.0 6.1 8.0 2.2 2.2 8.0 5.1 5.0 8.4 6.0 25.3 8.1 9.7 6.0 3.0 4.1 3.9 11.4 9.3 14.0 6.1 19.2 7.4 2.6 10.3 8.5 3.2 11.9 7.3 11.0 32.4 2.8 2.9 10.4 6.9 4.1 5.2 9.8 6.1 1.8 6.9 7.2 4.0 6.8 4.9 2.9 0.9 0.8 0.5 2.1 7.7 3.0 1.1 1.7 1.9 0.4 6.6 5.9 0.6 6.9 10.8 6.3 4.6 0.1 1.7 1.4 1.7 9.4 6.0 0.1 0.0 2.7 3.3 29.8 0.2 2.8 3.9 0.5 3.3 0.0 3.8 5.8 0.4 6.1 0.3 5.1 1.2 4.5 0.6 1.3 3.7 0.2 0.2 0.9 2.4 1.2 7.7 0.6 0.2 1.6 0.3 0.2 2.2 10.3 1.8 0.4 0.1 2.3 2.1 0.8 0.3 6.4 5.0 11.5 0.8 1.8 1.5 0.2 9.1 3.1 0.1 0.0 0.5 0.8 6.3 0.2 7.7 2.9 5.5 6.0 0.5 1.8 6.4 7.7 0.0 2.1 0.1 0.9 2.5 3.0 10.0 12.3 34.5 20.1 8.1 9.7 11.4 9.3 10.3 6.1 0.0 0.6 0.0 1.5 1.0 9.2 26.3 0.0 1.4 2.3 1.8 7.9 0.4 3.3 1.8 47.6 1.6 0.0 0.0 1.6 0.5 4.1 0.6 0.0 1.7 1.4 1.6 1.7 2.5 0.3 47.3 4.4 0.4 0.0 15.4 0.3 8.9 0.7 0.0 3.9 1.8 15.9 12.9 3.0 2.8 1.7 0.4 0.1 2.2 0.1 0.1 C3orf70 ENSG00000187068 "Chromosome 3 open reading frame 70" A6NLC5 3 185078050-185153014 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 26.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 17.4;Melanocytes: 37.1;Peritubular cells: 46.7" "Cancer enhanced" "Detected in many" "glioma: 10.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "RH-30: 4.7;SCLC-21H: 19.5;SK-BR-3: 8.4;WM-115: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041861 Uncertain Approved Cytosol NA NA Cytosol "HPA041861: AB_10804119" "unprognostic (1.45e-1)" "unprognostic (2.17e-3)" "unprognostic (3.92e-3)" "unprognostic (2.77e-1)" "unprognostic (2.31e-1)" "unprognostic (6.62e-4)" "unprognostic (5.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-1)" "unprognostic (5.98e-3)" "unprognostic (9.91e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.06e-1)" "unprognostic (8.48e-2)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" 4.6 2.3 14.4 4.7 13.8 0.9 2.0 7.9 18.2 7.2 12.1 11.1 7.9 5.3 12.1 6.1 10.1 6.8 6.1 3.3 11.1 10.2 1.6 1.3 2.4 1.3 11.4 7.1 5.9 1.1 4.0 1.4 2.9 10.5 10.2 8.2 5.2 5.5 16.4 1.5 2.9 6.5 26.6 11.1 4.2 4.4 7.5 7.0 0.0 2.4 1.0 1.7 13.2 3.3 1.2 1.2 3.4 1.6 1.7 1.1 0.5 0.0 0.1 2.3 0.0 0.0 0.1 0.1 3.0 0.1 0.5 0.0 1.4 0.0 0.0 0.0 0.3 0.1 0.1 1.0 0.0 0.2 0.0 0.8 2.5 0.1 0.7 0.0 0.4 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 1.0 2.2 0.2 0.1 4.7 0.1 0.0 0.5 19.5 0.2 0.9 8.4 0.5 0.1 0.6 2.2 0.8 0.0 2.3 0.1 1.5 0.0 0.0 0.0 0.0 0.0 10.5 3.4 1.2 1.7 0.8 1.0 1.0 1.0 0.8 0.8 0.6 1.2 1.0 1.1 3.3 1.7 1.6 1.2 0.7 0.5 14.4 13.8 7.9 9.6 11.1 10.2 11.4 7.1 10.5 7.0 0.0 0.0 1.5 0.2 3.7 17.4 1.2 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.1 1.0 2.3 4.0 0.0 0.2 0.6 2.3 0.3 0.0 0.0 3.1 3.2 1.2 4.9 0.6 1.2 3.1 0.0 37.1 1.0 8.1 1.3 0.2 0.0 46.7 0.0 6.2 6.5 15.8 7.9 12.5 1.6 0.7 0.0 5.3 0.3 C4orf48 ENSG00000243449 "Chromosome 4 open reading frame 48" Q5BLP8 4 2041993-2043970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 78.4;brain: 37.2" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 378.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 38.6;NB-4: 27.7;PC-3: 83.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052447 Uncertain Approved Cytosol "Secreted to blood" NA NA 32000 Cytosol "HPA052447: AB_2681837" "unprognostic (7.96e-2)" "unprognostic (2.57e-3)" "unprognostic (2.08e-1)" "unprognostic (3.20e-2)" "unprognostic (4.01e-2)" "unprognostic (8.26e-2)" "unprognostic (4.85e-3)" "unprognostic (2.51e-3)" "unprognostic (2.28e-3)" "unprognostic (1.80e-1)" "unprognostic (1.95e-2)" "unprognostic (5.55e-2)" "unprognostic (3.42e-2)" "unprognostic (5.38e-3)" "unprognostic (2.68e-1)" "unprognostic (5.55e-2)" "unprognostic (3.17e-3)" 11.4 7.8 25.5 9.7 22.2 5.6 4.8 7.7 37.2 3.4 19.7 18.2 3.2 6.5 4.1 3.0 1.2 3.2 3.1 3.8 26.4 26.2 5.2 2.5 4.7 8.7 24.8 15.6 2.9 16.8 5.6 19.8 5.3 14.9 3.9 3.1 4.3 5.1 4.3 3.3 3.7 16.6 2.4 30.7 9.6 9.8 13.9 15.7 1.2 2.2 0.7 2.4 2.6 2.6 29.8 49.4 67.5 78.4 4.5 31.0 28.4 7.8 6.5 1.3 6.1 0.6 0.9 8.7 7.5 1.5 1.4 1.3 4.4 4.7 1.0 7.3 0.2 2.5 2.2 0.1 0.8 0.4 4.7 38.6 2.5 3.5 2.5 1.3 5.1 17.3 0.7 1.4 0.3 0.0 0.4 1.4 4.3 8.1 0.0 0.9 4.8 5.7 27.7 3.9 0.4 83.8 13.2 2.0 2.5 1.2 2.9 10.5 14.8 3.7 0.1 10.1 0.1 2.0 2.4 6.4 3.6 7.8 2.7 8.4 5.9 5.1 0.0 3.6 3.1 5.0 11.5 78.4 67.5 21.5 50.6 22.0 29.8 27.8 23.9 44.2 22.6 16.0 16.7 59.0 4.5 44.0 49.4 31.0 28.4 25.5 22.2 7.7 37.2 26.4 26.2 24.8 15.6 14.9 15.7 0.0 3.4 61.1 5.3 19.5 14.6 6.1 17.8 6.7 3.4 190.1 0.0 7.5 59.7 304.2 76.9 29.1 185.6 23.3 194.2 111.5 25.9 12.6 109.2 8.9 199.3 17.5 225.6 114.2 260.9 247.7 17.8 117.6 310.4 64.9 97.5 43.9 199.3 378.7 26.5 6.8 11.5 12.9 12.8 61.7 167.2 8.8 11.0 64.3 73.8 9.2 C5orf42 "FLJ13231, Hug, JBTS17" ENSG00000197603 "Chromosome 5 open reading frame 42" Q9H799 5 37106228-37249428 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 59.6;Ciliated cells: 113.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036775, HPA036776" Approved Approved Cytosol NA NA Cytosol "HPA036775: AB_10669914, HPA036776: AB_2675308" "unprognostic (3.06e-1)" "unprognostic (2.00e-1)" "unprognostic (4.96e-2)" "unprognostic (4.13e-3)" "unprognostic (1.65e-1)" "unprognostic (1.44e-2)" "unprognostic (1.38e-3)" "unprognostic (5.88e-2)" "unprognostic (3.13e-2)" "unprognostic (6.20e-3)" "unprognostic (3.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.72e-2)" "unprognostic (2.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.44e-2)" "unprognostic (2.09e-1)" 7.1 8.3 9.2 6.4 12.3 3.6 9.5 14.9 12.6 8.7 7.5 7.5 9.8 2.9 10.3 11.5 6.6 10.4 8.4 6.9 9.6 9.4 10.2 4.4 8.3 6.3 9.5 9.3 14.2 7.8 17.7 19.6 8.5 9.5 11.6 5.6 6.9 8.7 10.3 6.3 6.5 4.9 9.6 9.5 5.7 6.4 11.6 9.5 12.0 17.6 5.4 4.8 8.7 9.1 3.1 2.5 0.6 0.2 1.5 1.5 0.2 4.1 2.1 6.4 4.4 7.3 7.4 2.7 3.7 3.1 4.3 3.9 3.2 5.0 1.1 2.7 3.6 8.1 1.6 1.8 2.5 5.0 2.6 1.7 2.6 14.8 2.0 3.7 0.0 1.3 5.8 3.8 4.8 2.8 6.0 4.3 2.6 0.0 0.8 8.7 0.1 3.0 3.6 1.5 0.0 1.6 2.8 11.0 0.0 4.1 1.2 3.3 2.0 34.2 0.2 2.2 4.9 1.7 2.2 6.2 7.1 4.5 2.3 3.2 1.2 0.0 1.2 1.8 0.1 2.9 0.6 0.2 0.0 1.5 0.1 1.5 0.6 0.9 0.8 0.5 3.1 0.8 1.2 0.1 1.5 0.1 2.5 0.0 0.2 9.2 12.3 14.9 12.6 9.6 9.4 9.5 9.3 9.5 9.5 59.6 16.1 1.5 7.4 3.7 36.1 0.0 10.2 113.8 52.4 0.0 27.5 5.3 0.0 0.0 20.6 6.7 2.0 0.0 0.0 4.4 12.1 7.2 12.7 4.7 5.1 23.8 6.3 19.6 4.6 16.8 25.0 4.7 13.5 0.0 3.8 21.9 0.0 0.0 32.5 0.0 32.6 19.4 9.2 33.4 14.7 4.4 3.0 4.9 4.7 5.2 C6orf10 TSBP ENSG00000204296 "Chromosome 6 open reading frame 10" Q5SRN2 6 32288526-32371912 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 28.6" "Cell type enriched" "Detected in some" 12 "Early spermatids: 313.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SuSa: 1.1;U-2197: 1.3" HPA047479 Approved Cytosol NA NA Cytosol "HPA047479: " "unprognostic (1.00e-1)" "unprognostic (2.24e-1)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (2.42e-1)" "unprognostic (8.19e-2)" "unprognostic (6.56e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 C6orf47 "D6S53E, G4" ENSG00000204439 "Chromosome 6 open reading frame 47" O95873 6 31658298-31660772 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;fHDF/TERT166: 6.4;HBEC3-KT: 9.0;HEK 293: 7.5;RT4: 8.7;U-2 OS: 6.4" "Low region specificity" "Detected in all" HPA045281 Uncertain Approved Cytosol NA NA Cytosol "HPA045281: AB_10961000" "unprognostic (5.99e-2)" "unprognostic (5.71e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (9.92e-2)" "unprognostic (6.74e-2)" "unprognostic (2.09e-1)" "unprognostic (3.24e-2)" "unprognostic (3.27e-1)" "unprognostic (5.04e-2)" "unprognostic (2.93e-2)" "unprognostic (1.15e-1)" "unprognostic (1.66e-3)" "unprognostic (6.78e-3)" "unprognostic (2.38e-1)" "unprognostic (7.73e-2)" "unprognostic (3.59e-3)" 7.3 9.1 5.4 7.7 7.1 3.4 14.0 7.7 10.2 8.1 11.7 8.3 9.8 2.6 10.8 18.4 14.2 8.9 13.9 13.6 5.1 4.9 10.3 9.2 14.3 16.0 6.1 4.8 11.7 18.7 2.7 8.0 8.7 6.0 9.0 10.0 9.7 9.2 10.5 11.8 23.3 14.8 15.4 6.3 13.0 10.2 4.0 5.3 11.5 11.3 10.9 11.8 11.5 8.3 3.5 1.5 1.7 2.1 0.0 3.0 1.1 0.0 5.8 0.0 4.3 7.3 1.0 0.0 0.5 0.4 1.8 0.5 0.0 0.8 1.9 4.6 6.4 0.0 0.0 0.0 9.0 0.2 0.1 7.5 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.9 5.0 8.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.8 6.4 0.0 0.0 4.2 0.2 0.7 2.0 0.0 2.5 0.0 0.8 1.6 3.0 2.1 0.1 3.5 1.1 0.5 0.5 0.0 2.1 1.9 1.7 0.0 0.0 1.5 2.1 1.1 5.4 7.1 7.7 10.2 5.1 4.9 6.1 4.8 6.0 5.3 6.0 10.4 11.6 21.5 22.2 16.6 1.2 17.8 0.0 5.7 12.2 7.9 15.4 21.6 19.9 0.0 10.8 34.2 0.0 25.4 12.5 13.0 20.0 11.5 7.8 16.4 6.4 6.4 12.9 13.5 0.0 15.0 15.3 8.5 18.0 18.2 14.3 22.8 25.9 20.5 18.2 12.3 32.3 15.2 0.9 8.3 23.5 19.9 20.0 22.3 44.3 C6orf62 "DKFZP564G182, FLJ12619, XTP12" ENSG00000112308 "Chromosome 6 open reading frame 62" Q9GZU0 6 24704861-24720836 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 306.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030564, HPA030566" Supported Approved Cytosol NA NA Cytosol "HPA030564: AB_10600000, HPA030566: AB_10599425" "unprognostic (2.07e-2)" "unprognostic (2.92e-1)" "unprognostic (7.10e-2)" "unprognostic (6.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (1.18e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.04e-4)" "unprognostic (4.16e-3)" "unprognostic (3.94e-2)" "unprognostic (3.08e-2)" "unprognostic (9.01e-2)" "unprognostic (4.03e-1)" "unprognostic (1.93e-2)" "prognostic favorable (3.62e-6)" 38.9 38.3 46.0 42.8 49.9 37.8 52.0 34.3 50.1 30.7 35.4 31.4 49.9 30.8 31.0 42.6 33.1 32.0 41.9 27.8 38.2 40.5 35.1 49.0 54.6 67.6 50.0 36.7 37.8 52.9 35.6 33.6 37.9 33.9 33.6 31.3 33.8 47.4 52.6 31.1 33.7 38.6 28.8 36.4 58.3 38.9 46.0 38.1 75.2 41.5 28.1 56.5 35.6 34.2 48.4 48.7 64.0 62.3 52.7 65.3 103.5 23.0 14.3 17.6 29.8 22.2 28.7 19.3 27.4 35.8 41.3 44.2 17.9 20.8 26.6 43.2 32.1 40.8 19.3 20.1 26.8 45.8 44.8 9.7 27.9 23.3 24.0 37.9 33.9 33.4 22.3 54.1 27.9 37.2 27.6 31.9 16.6 24.5 19.9 38.7 19.1 26.0 51.0 19.4 14.1 14.5 20.9 19.1 26.7 24.6 34.9 29.8 16.8 32.8 37.4 49.7 20.6 32.8 27.2 28.3 37.4 18.1 14.1 37.2 46.8 73.7 33.1 13.4 46.9 36.1 47.7 62.1 64.0 55.7 62.0 58.6 48.4 57.4 60.6 47.7 41.8 57.6 65.3 44.2 52.7 62.3 48.7 53.4 103.5 46.0 49.9 34.3 50.1 38.2 40.5 50.0 36.7 33.9 38.1 77.4 66.5 104.0 40.4 51.1 48.9 29.1 107.0 54.9 46.6 89.0 47.1 43.9 31.5 55.4 110.4 61.6 88.0 93.5 64.0 46.9 51.8 87.1 54.3 110.1 83.6 39.7 92.1 86.5 306.8 40.0 50.0 84.3 47.2 83.8 78.0 40.4 70.7 77.0 44.6 54.9 60.4 51.8 42.8 83.7 91.8 48.9 62.9 96.5 75.2 51.5 C9orf43 MGC17358 ENSG00000157653 "Chromosome 9 open reading frame 43" Q8TAL5 9 113410054-113429684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 39.4" "Group enriched" "Detected in some" 7 "Early spermatids: 78.7;Late spermatids: 167.1;Spermatocytes: 82.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA021310 Approved Cytosol NA NA Cytosol "HPA021310: AB_1845825" "unprognostic (2.91e-2)" "unprognostic (9.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.18e-1)" "unprognostic (2.63e-1)" "unprognostic (6.58e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (8.90e-2)" "unprognostic (1.97e-2)" "unprognostic (5.96e-3)" "unprognostic (1.51e-1)" "unprognostic (7.32e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-2)" "unprognostic (1.63e-1)" 0.5 1.6 1.5 0.4 2.4 1.8 1.3 2.1 2.3 0.5 0.4 1.6 0.2 0.4 0.4 1.6 0.5 0.9 0.6 0.4 1.4 0.8 1.0 1.7 0.5 0.6 0.8 1.9 1.0 3.5 1.3 3.8 0.5 1.6 0.7 0.5 1.0 0.9 0.7 0.4 0.8 0.5 0.3 1.8 0.6 0.6 39.4 1.0 0.6 1.0 0.0 0.6 0.5 0.5 1.5 1.3 2.3 1.5 1.0 2.1 0.8 1.2 1.2 0.6 1.9 1.5 0.8 0.9 0.6 1.1 1.7 1.3 1.3 1.0 3.3 1.1 0.3 3.8 2.4 0.7 1.7 0.7 2.7 0.5 2.9 2.1 0.6 1.3 0.5 0.4 1.8 2.6 2.2 2.6 1.1 1.5 3.9 1.7 3.1 0.9 2.4 1.4 0.8 0.9 1.5 3.9 0.8 0.7 1.9 1.8 0.6 3.1 0.7 3.0 1.4 1.7 1.4 4.1 0.3 0.2 2.6 0.6 1.7 2.6 2.0 3.6 5.0 1.4 1.1 0.9 0.0 0.7 0.0 1.5 1.5 0.0 1.5 0.8 2.1 0.8 0.8 1.4 2.1 2.3 1.0 0.3 1.3 0.1 0.8 1.5 2.4 2.1 2.3 1.4 0.8 0.8 1.9 1.6 1.0 0.0 0.0 0.8 0.5 0.6 1.7 0.0 0.0 10.7 2.3 0.0 0.0 0.4 1.7 0.3 78.7 0.3 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.3 167.1 2.0 0.6 0.0 1.0 0.0 2.3 1.1 0.0 1.4 0.7 2.6 0.0 0.0 82.6 16.0 0.0 0.0 0.0 0.0 0.5 CADM3 "BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1" ENSG00000162706 "Cell adhesion molecule 3" Q8N126 1 159171609-159203313 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.5;placenta: 43.1" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 103.2;Fibroblasts: 46.4;Horizontal cells: 33.4;Melanocytes: 23.6;Muller glia cells: 35.4" "Cancer enhanced" "Detected in many" "glioma: 27.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 19.8;HSkMC: 66.3;hTERT-HME1: 35.5;U-2 OS: 9.9;WM-115: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002981, CAB025746" Enhanced Supported Approved Cytosol "Intracellular and membrane" NA NA 790000 Cytosol "CAB025746: , HPA002981: AB_1078916" "unprognostic (1.74e-2)" "unprognostic (8.26e-2)" "unprognostic (1.34e-2)" "unprognostic (1.33e-2)" "unprognostic (9.32e-2)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (6.12e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (5.52e-2)" "unprognostic (2.59e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (5.75e-4)" 8.9 5.4 23.3 8.5 41.0 0.9 6.1 88.4 96.5 18.0 8.8 6.9 0.7 3.2 2.2 1.6 7.2 3.2 4.1 4.3 23.2 27.4 1.1 1.1 2.9 7.8 18.5 22.4 1.2 2.0 1.0 7.4 43.1 30.4 1.7 8.9 4.5 2.6 3.6 2.0 7.7 6.4 4.1 9.6 7.6 2.8 2.4 4.6 0.0 4.8 0.7 5.9 10.2 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 19.8 0.0 0.0 66.3 0.0 0.0 35.5 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.1 0.0 0.0 1.5 0.0 0.0 2.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 41.0 88.4 55.6 23.2 27.4 18.5 22.4 30.4 4.6 0.0 0.3 0.0 0.0 6.0 103.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.1 4.0 0.0 0.0 0.0 0.4 46.4 0.1 0.0 0.0 1.0 33.4 0.0 4.3 0.0 4.7 0.6 0.0 23.6 0.0 0.0 35.4 0.0 0.0 0.0 0.0 7.5 0.0 3.9 0.9 1.7 3.8 0.6 0.0 0.0 0.0 CALB2 CAL2 ENSG00000172137 "Calbindin 2" P22676 16 71358713-71390438 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 50.6;brain: 118.9" "Group enriched" "Detected in many" 6 "Exocrine glandular cells: 89.2;granulocytes: 237.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.2;HEL: 24.0;HMC-1: 52.2;U-2 OS: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000106, HPA007305, HPA007306" Enhanced Supported Enhanced Cytosol NA NA 6400 Cytosol "CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385" "unprognostic (1.10e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.78e-5)" "unprognostic (1.75e-3)" "unprognostic (5.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.59e-1)" "unprognostic (4.55e-3)" "unprognostic (4.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.06e-3)" "unprognostic (1.35e-2)" "unprognostic (5.54e-4)" "unprognostic (1.97e-3)" "unprognostic (6.30e-2)" "unprognostic (4.72e-2)" "unprognostic (1.04e-2)" 50.6 11.6 10.1 5.1 7.5 0.9 18.2 31.2 9.9 1.7 8.9 1.7 0.0 1.7 1.4 3.0 3.0 2.4 2.0 2.2 5.9 74.2 0.9 0.9 2.1 0.9 17.7 7.5 5.6 1.4 0.9 3.0 0.9 118.9 1.1 6.0 4.9 2.1 1.3 1.0 1.0 2.7 2.7 7.5 0.9 1.2 14.6 1.5 0.0 0.8 0.2 1.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.7 6.6 0.0 0.2 0.0 1.3 0.2 0.1 0.2 0.0 0.0 8.2 0.0 0.1 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.2 0.0 0.0 52.2 0.0 0.0 0.5 0.1 0.1 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 14.9 0.1 1.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 7.5 31.2 9.9 5.9 74.2 17.7 7.5 118.9 1.5 8.9 11.1 0.0 0.0 0.2 3.5 0.3 0.0 2.7 0.0 0.0 5.9 0.0 0.0 1.7 2.1 0.1 0.0 0.0 89.2 0.1 0.4 0.1 237.6 0.0 0.1 28.6 0.0 0.0 0.0 2.3 5.8 0.0 5.0 0.0 0.0 2.5 10.4 0.0 0.0 0.0 6.7 0.0 0.3 0.3 3.6 0.0 0.1 0.0 0.0 0.1 CAMK1 CaMKI ENSG00000134072 "Calcium/calmodulin dependent protein kinase I" Q14012 3 9757342-9769992 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Differentiation, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 60.5;blood: 59.4" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 76.7;Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 59.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 59.4" "Cell line enriched" "Detected in many" 4 "HMC-1: 94.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031904, HPA051409" Approved Approved Cytosol NA NA 550000 Cytosol "CAB031904: AB_630964, HPA051409: AB_2681473" "unprognostic (4.43e-2)" "unprognostic (3.05e-1)" "unprognostic (1.68e-1)" "unprognostic (1.29e-1)" "unprognostic (1.11e-1)" "unprognostic (3.06e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.53e-2)" "unprognostic (3.32e-1)" "unprognostic (9.74e-2)" "unprognostic (1.37e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "unprognostic (7.76e-2)" "unprognostic (1.72e-1)" "unprognostic (3.67e-2)" "unprognostic (3.01e-1)" 27.1 60.5 28.0 11.7 26.0 3.5 34.1 12.4 31.2 9.5 10.7 4.4 5.8 6.8 12.6 10.5 7.1 12.6 8.9 10.2 21.4 14.0 13.1 20.7 9.2 10.4 10.3 19.9 21.5 4.5 7.4 7.9 5.1 10.1 18.6 8.1 6.8 5.1 15.1 4.7 3.3 8.3 18.4 7.2 7.1 8.1 13.4 5.6 0.6 7.0 3.7 10.4 9.5 10.3 0.0 3.2 59.4 9.2 0.7 0.4 0.9 0.1 3.7 3.0 0.0 15.4 5.7 7.5 8.8 4.9 10.1 9.6 5.4 0.6 0.2 2.0 5.9 1.5 0.6 0.0 1.1 6.3 0.1 21.6 11.9 7.0 7.5 8.6 1.0 94.0 6.0 0.9 14.2 1.5 8.3 8.4 0.2 1.5 0.2 3.7 2.2 0.0 8.7 2.1 0.1 5.8 0.0 0.1 0.2 6.0 0.6 1.0 3.8 1.5 0.1 0.8 1.3 0.9 15.2 4.4 4.6 5.7 6.5 11.0 0.1 0.0 0.2 9.8 3.3 0.6 3.3 4.8 59.4 0.0 9.2 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.2 0.7 9.2 0.1 0.4 0.9 28.0 26.0 12.4 31.2 21.4 14.0 10.3 19.9 10.1 5.6 0.0 1.9 6.4 17.8 4.4 8.1 0.0 10.2 1.4 2.3 10.4 2.0 0.4 8.3 13.1 1.5 22.7 2.0 0.0 3.6 1.0 11.6 14.9 31.0 21.2 76.7 0.0 5.8 17.8 40.5 3.9 33.4 50.8 5.0 19.0 1.3 30.9 6.0 3.5 42.5 35.3 8.0 58.2 35.0 1.1 1.1 3.3 0.7 7.5 5.5 10.8 CAMKK1 "CAMKKA, DKFZp761M0423, MGC34095" ENSG00000004660 "Calcium/calmodulin dependent protein kinase kinase 1" Q8N5S9 17 3860315-3894891 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.9;salivary gland: 27.1" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 36.4;Rod photoreceptor cells: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 18.2;U-87 MG: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009111, HPA028062" Approved Supported Cytosol No No Cytosol "CAB009111: AB_2068406, HPA028062: AB_1845954" "unprognostic (1.39e-2)" "unprognostic (2.13e-1)" "unprognostic (8.66e-3)" "unprognostic (4.40e-3)" "unprognostic (2.94e-3)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" "unprognostic (4.47e-3)" "unprognostic (8.23e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.65e-4)" "unprognostic (1.98e-1)" "unprognostic (1.59e-1)" "unprognostic (7.19e-2)" "unprognostic (8.70e-2)" "unprognostic (8.36e-2)" "unprognostic (3.10e-1)" 4.3 10.2 15.3 5.1 21.4 3.7 4.7 23.2 38.9 4.1 3.2 2.2 4.0 3.1 7.5 5.2 4.2 3.7 3.8 5.7 13.8 6.8 1.5 1.0 4.0 2.5 5.5 16.0 6.0 7.5 5.0 10.1 2.3 11.2 3.3 3.1 2.5 27.1 11.2 2.2 7.8 3.7 6.2 2.2 4.3 2.9 6.1 5.0 1.7 7.2 2.3 2.5 5.6 4.9 0.1 1.6 5.6 4.1 0.0 1.0 1.1 4.9 8.5 0.9 4.3 3.1 5.5 0.3 3.4 3.7 3.3 1.5 3.1 1.5 3.0 3.7 6.6 3.4 14.7 2.3 4.2 2.0 0.1 7.8 3.4 18.2 1.1 3.1 0.5 2.7 4.2 3.6 6.2 2.1 2.9 1.5 4.4 2.6 0.1 1.6 1.3 4.1 1.9 1.0 7.2 8.1 2.1 3.7 3.4 3.5 3.1 5.0 2.8 1.3 10.2 2.2 0.5 3.9 1.1 2.0 5.7 7.7 7.3 2.8 0.4 0.2 0.1 20.8 2.9 0.7 0.0 1.8 3.6 0.6 3.9 1.0 0.0 0.6 0.5 1.6 0.1 0.6 0.3 5.6 0.0 4.1 0.8 0.0 1.1 15.3 21.4 23.2 38.9 13.8 6.8 5.5 16.0 11.2 5.0 6.0 15.1 8.5 1.9 3.3 36.4 5.7 0.0 1.4 5.7 1.8 15.7 0.2 0.0 0.4 0.0 4.4 0.5 0.0 1.4 0.1 4.5 1.4 16.2 0.2 3.8 7.9 4.1 3.1 1.9 0.4 1.1 3.6 8.5 0.0 1.4 3.8 0.8 0.0 1.1 0.0 24.1 0.0 2.0 0.1 1.4 4.6 0.2 0.7 2.3 0.8 CAMKK2 "CAMKK, CAMKKB, KIAA0787, MGC15254" ENSG00000110931 "Calcium/calmodulin dependent protein kinase kinase 2" Q96RR4 12 121237691-121298308 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 125.5" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 58.8;Late spermatids: 64.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 125.5" "Group enriched" "Detected in many" 5 "classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5" "Group enriched" "Detected in all" 5 "dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017389, HPA063713" Approved Supported Supported Cytosol NA NA Cytosol "HPA017389: AB_1845956, HPA063713: " "unprognostic (5.08e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-1)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (1.12e-1)" "unprognostic (2.62e-3)" "unprognostic (2.80e-2)" "unprognostic (1.93e-1)" "unprognostic (7.76e-2)" "unprognostic (5.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.75e-1)" "unprognostic (4.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" 11.7 6.5 19.7 7.8 30.2 13.8 8.8 125.5 45.5 9.0 9.5 7.1 2.6 12.8 8.6 5.3 8.3 11.8 6.3 6.9 11.2 5.1 7.1 8.9 9.6 6.9 6.2 17.3 10.5 5.8 6.4 4.1 7.5 9.1 12.2 9.7 6.2 7.5 13.2 5.1 9.1 13.2 10.3 6.2 14.1 7.6 3.6 5.8 5.2 6.1 4.5 7.2 7.2 7.4 2.2 7.2 26.1 19.4 3.6 2.2 6.3 12.5 9.4 7.0 13.5 21.1 19.7 10.7 10.4 11.0 8.5 7.8 9.8 5.4 19.4 8.7 21.0 6.0 10.4 8.6 11.2 6.7 13.3 16.9 9.6 6.3 9.6 14.3 21.9 9.2 12.7 16.6 8.0 18.2 11.5 19.9 14.8 11.1 10.5 8.2 12.1 24.3 18.0 5.1 10.5 10.7 15.8 8.2 17.2 8.2 14.0 26.9 10.8 13.6 7.3 8.6 5.9 18.2 26.8 14.5 7.0 5.7 5.9 5.7 40.3 23.9 14.7 13.1 15.4 6.9 0.7 14.2 26.1 2.1 19.4 2.2 2.2 1.7 1.9 7.2 1.2 1.5 1.7 17.2 3.6 16.5 1.6 1.3 6.3 19.7 30.2 125.5 45.5 11.2 5.1 6.2 17.3 9.1 5.8 8.9 3.5 4.1 5.1 7.0 21.6 7.0 20.4 8.1 6.8 8.7 2.0 7.4 3.3 8.7 15.7 17.5 18.2 0.0 9.0 6.7 12.5 10.8 5.8 18.3 7.1 58.8 33.0 12.9 13.9 64.8 19.0 13.7 8.5 15.4 15.9 5.1 7.5 11.5 29.7 8.4 6.4 19.4 21.3 0.7 2.4 5.3 2.9 7.1 15.6 5.8 CAMTA1 KIAA0833 ENSG00000171735 "Calmodulin binding transcription activator 1" Q9Y6Y1 1 6785324-7769706 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036342, HPA036343" Approved Supported Cytosol NA NA Cytosol "HPA036342: AB_2675072, HPA036343: AB_10671839" "unprognostic (1.11e-1)" "unprognostic (6.31e-2)" "unprognostic (5.80e-2)" "unprognostic (4.14e-3)" "unprognostic (3.10e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "prognostic favorable (4.10e-4)" "unprognostic (3.90e-3)" "unprognostic (8.84e-2)" "unprognostic (1.35e-3)" "unprognostic (2.17e-2)" "unprognostic (9.19e-3)" "unprognostic (1.42e-1)" "unprognostic (9.03e-3)" 18.4 24.3 31.6 12.2 30.7 12.1 21.7 24.4 37.1 16.5 30.2 19.9 13.2 28.3 20.0 46.7 22.7 16.8 17.7 58.1 26.4 27.6 36.7 37.2 16.5 13.3 31.2 26.5 17.1 18.6 22.0 17.6 14.3 47.5 22.2 27.1 25.0 27.1 29.6 48.0 12.9 30.4 38.4 23.9 15.7 21.5 23.0 19.4 14.7 30.8 20.5 17.5 31.3 18.7 19.8 32.3 28.3 32.4 10.3 18.1 18.9 22.0 12.4 34.6 17.5 17.9 27.4 9.7 23.9 18.4 25.8 21.9 15.0 28.0 18.3 18.8 25.0 17.3 13.7 18.0 24.7 36.9 13.7 19.6 20.6 29.4 29.2 29.1 15.6 15.0 18.3 17.2 18.6 28.7 22.3 28.7 26.1 14.4 24.9 29.7 21.3 20.7 42.9 23.9 28.1 14.6 13.9 30.8 40.5 34.8 12.9 35.8 28.9 16.9 25.2 36.8 26.0 13.6 19.6 16.7 18.4 15.6 18.9 14.8 19.0 23.5 49.2 27.5 35.2 10.3 27.5 32.4 28.3 11.5 19.4 12.5 19.8 18.0 14.2 30.6 16.2 14.7 12.8 6.6 10.3 14.7 32.3 18.1 18.9 31.6 30.7 24.4 37.1 26.4 27.6 31.2 26.5 47.5 19.4 50.6 45.6 87.6 306.4 275.2 103.9 495.7 107.0 68.3 46.6 181.5 237.6 60.6 354.8 147.0 138.1 160.0 190.4 46.7 180.4 116.8 142.3 320.6 54.3 215.1 94.9 149.4 125.6 81.6 94.6 111.6 70.8 142.3 226.0 196.6 153.7 60.0 175.4 166.1 120.9 611.1 144.7 135.8 271.7 133.0 213.0 247.2 73.7 58.9 164.9 354.7 CAP1 CAP ENSG00000131236 "Cyclase associated actin cytoskeleton regulatory protein 1" Q01518 1 40040233-40072649 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 201.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 203.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030124 Approved Approved Cytosol NA NA 270000000 Cytosol "HPA030124: AB_10600799" "unprognostic (1.80e-3)" "unprognostic (1.23e-3)" "unprognostic (5.68e-2)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (1.44e-6)" "unprognostic (5.37e-2)" "unprognostic (4.87e-1)" "unprognostic (1.98e-1)" "unprognostic (3.33e-3)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (1.39e-1)" "unprognostic (7.08e-2)" "unprognostic (1.26e-1)" "unprognostic (3.44e-1)" 70.0 31.8 33.3 68.7 41.0 74.6 42.4 16.6 37.4 40.1 58.2 42.7 25.2 37.9 69.4 28.9 60.9 44.6 36.9 27.2 28.6 26.6 56.6 52.0 58.2 63.7 37.2 26.9 44.5 22.6 29.7 22.5 74.4 39.5 42.0 57.7 31.3 39.8 39.7 20.6 37.1 58.9 62.9 42.7 79.9 44.6 39.0 30.0 62.4 40.2 32.6 83.1 53.3 40.8 27.4 70.6 201.2 106.1 37.2 57.6 115.5 44.9 19.5 24.7 14.6 35.1 32.9 36.8 79.7 48.2 45.0 45.4 28.1 47.8 35.0 32.5 65.6 30.8 28.3 29.6 58.4 62.1 46.7 17.5 54.8 21.5 22.1 32.3 33.8 156.3 33.6 30.1 68.7 38.9 50.7 37.9 20.3 20.4 23.5 67.3 13.3 26.8 18.5 40.0 33.0 21.9 20.3 32.8 21.4 47.6 47.6 11.7 24.6 33.9 39.3 54.2 51.1 18.2 203.6 67.5 38.5 35.0 20.1 67.5 19.2 37.6 32.1 50.6 37.7 50.4 95.4 60.2 201.2 57.6 88.9 45.3 27.4 41.7 55.1 70.6 26.3 35.4 47.9 128.3 37.2 106.1 27.7 55.1 115.5 33.3 41.0 16.6 37.4 28.6 26.6 37.2 26.9 39.5 30.0 113.2 90.0 165.3 126.1 99.7 40.3 13.7 86.6 73.6 78.5 108.2 25.5 179.9 94.5 335.8 422.5 137.1 167.8 0.0 239.7 381.4 126.1 105.8 219.9 66.5 383.8 39.7 73.1 171.2 376.6 351.4 81.4 395.6 94.5 634.8 120.1 147.6 544.5 150.5 166.2 105.9 41.2 161.7 157.2 125.6 45.8 116.1 198.9 232.9 110.6 183.3 CAPN1 "CANP, CANPL1, muCANP, muCL" ENSG00000014216 "Calpain 1" P07384 11 65180566-65212006 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 90.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005992 Enhanced Supported Cytosol NA NA 28000000 Cytosol "HPA005992: AB_1845924" "unprognostic (2.07e-1)" "unprognostic (2.15e-1)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (4.06e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (7.23e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.33e-1)" "prognostic favorable (7.06e-8)" "unprognostic (5.70e-3)" "unprognostic (1.51e-1)" "unprognostic (1.86e-1)" "unprognostic (2.98e-1)" 22.0 15.6 9.6 23.8 11.6 18.2 18.8 17.7 20.1 25.8 33.3 8.4 23.0 25.4 19.3 30.2 86.9 28.1 39.1 21.4 8.8 11.2 27.8 21.3 19.4 19.5 10.8 9.7 21.4 24.9 13.3 14.1 38.1 16.8 27.3 17.0 15.8 39.7 24.3 24.2 38.9 49.9 16.5 7.7 21.3 20.7 8.3 6.7 32.1 37.5 50.2 53.7 33.7 35.2 16.7 22.8 34.5 24.8 15.7 19.6 28.5 48.4 25.8 7.4 16.4 13.4 17.1 22.5 14.4 22.9 17.0 13.0 16.4 43.6 12.1 24.1 27.3 19.8 71.6 9.6 60.8 5.5 12.9 7.6 28.9 14.9 16.0 13.4 6.8 40.6 18.8 32.7 14.4 7.0 16.0 29.0 8.8 17.2 9.8 13.8 31.1 13.3 21.5 21.3 24.8 23.4 13.2 7.6 7.3 23.0 90.0 13.3 9.8 15.2 58.9 13.9 8.3 25.3 13.4 25.2 13.2 9.0 28.2 6.5 6.0 4.4 14.4 23.1 8.3 14.3 34.3 24.8 34.5 19.6 23.7 15.7 15.6 15.5 17.7 22.8 16.7 9.1 12.5 15.8 15.7 14.0 17.9 16.6 28.5 9.6 11.6 17.7 20.1 8.8 11.2 10.8 9.7 16.8 6.7 23.8 24.7 31.9 110.9 53.1 6.6 17.9 68.8 30.8 33.0 73.3 19.6 201.3 33.2 164.8 0.5 23.3 141.6 0.0 101.4 88.1 42.3 51.8 46.1 31.0 78.5 20.6 42.6 26.4 45.7 0.4 40.3 38.8 45.5 146.9 72.1 33.2 133.6 105.2 47.7 26.9 15.0 38.8 36.4 0.5 2.0 60.2 164.4 49.8 101.5 141.7 CAPN2 "CANPL2, CANPml, mCANP" ENSG00000162909 "Calpain 2" P17655 1 223701593-223776018 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 366.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024470 Approved Approved Supported Cytosol NA NA 1500000 Cytosol "HPA024470: AB_1845925" "unprognostic (2.77e-2)" "unprognostic (1.27e-3)" "unprognostic (2.03e-1)" "unprognostic (3.39e-2)" "unprognostic (2.12e-1)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (1.10e-1)" "unprognostic (2.85e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.21e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.61e-1)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (6.21e-4)" 56.2 41.0 23.8 20.7 22.2 11.1 61.1 26.1 20.9 40.3 44.8 18.3 23.3 14.5 29.1 44.5 56.3 40.1 58.9 33.0 26.5 13.1 41.6 13.3 58.6 18.2 27.4 18.2 32.4 26.8 53.7 12.7 26.4 23.8 27.2 44.4 16.5 62.5 31.9 48.1 16.5 22.7 35.7 32.3 15.9 48.2 17.2 24.7 5.0 29.9 39.7 35.9 28.3 38.8 9.0 41.6 1.7 29.1 6.0 28.7 28.2 46.1 29.6 9.5 6.3 31.7 44.0 9.1 43.7 63.5 31.8 18.1 23.4 37.2 0.0 14.4 48.5 25.0 28.9 10.2 69.1 29.6 11.8 10.6 0.8 15.1 2.9 28.5 2.4 1.5 23.5 22.4 49.5 26.5 57.1 63.0 0.0 13.3 12.4 93.6 0.9 0.1 2.1 5.2 5.7 38.7 3.9 31.0 0.7 54.8 2.7 2.0 11.0 22.5 61.5 13.6 24.0 9.3 11.1 96.9 29.8 24.7 25.6 56.0 3.7 6.9 0.1 74.6 5.2 32.7 1.7 29.1 1.7 28.7 19.5 24.5 9.0 20.0 27.7 41.6 3.6 6.4 17.4 1.5 6.0 17.5 1.9 19.9 28.2 23.8 22.2 26.1 20.9 26.5 13.1 27.4 18.2 23.8 24.7 366.3 110.0 19.7 85.8 42.0 12.0 35.9 96.8 180.7 191.1 50.6 31.4 18.1 154.2 234.2 86.1 110.2 114.4 0.0 171.9 77.1 101.6 155.1 26.6 6.0 36.6 12.7 23.6 33.2 58.4 173.5 71.7 66.7 106.3 13.6 104.2 15.8 261.3 139.7 64.7 17.0 17.0 38.8 112.7 3.0 3.2 24.1 6.9 57.7 90.7 256.2 CAPNS2 "MGC12536, MGC14804" ENSG00000256812 "Calpain small subunit 2" Q96L46 16 55566672-55567687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 56.0;skin 1: 44.1;tongue: 45.6" "Group enriched" "Detected in some" 12 "Basal keratinocytes: 78.1;Suprabasal keratinocytes: 130.6" "Group enriched" "Detected in many" 15 "cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "eosinophil: 6.9;intermediate monocyte: 2.1" "Group enriched" "Detected in many" 9 "granulocytes: 6.9;monocytes: 2.1" "Cell line enriched" "Detected in some" 10 "hTCEpi: 71.5" "Not detected" "Not detected" "HPA059749, HPA076768" Enhanced Approved Cytosol NA NA Cytosol "HPA059749: AB_2732639, HPA076768: AB_2732322" "unprognostic (3.26e-2)" "unprognostic (6.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.77e-3)" "unprognostic (4.14e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (7.21e-2)" "unprognostic (3.38e-2)" "unprognostic (3.62e-1)" "unprognostic (2.42e-2)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" 0.1 0.0 0.1 0.1 0.4 0.2 3.4 0.1 0.1 5.8 0.1 0.1 0.1 0.0 0.4 0.1 56.0 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.3 0.0 0.2 6.7 0.1 0.6 44.1 0.1 1.3 0.1 0.1 0.0 0.1 0.1 0.3 0.1 45.6 14.6 12.3 10.8 0.0 0.5 6.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 71.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 6.9 0.0 2.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 9.0 78.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 1.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 130.6 1.9 0.0 0.0 8.1 CAPRIN1 "caprin-1, GPIAP1, M11S1, RNG105" ENSG00000135387 "Cell cycle associated protein 1" Q14444 11 34051683-34101156 "Predicted intracellular proteins" Differentiation "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 388.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018126, HPA063617" Approved Enhanced Cytosol NA NA Cytosol "HPA018126: AB_1849929, HPA063617: AB_2685062" "unprognostic (3.79e-1)" "unprognostic (3.85e-2)" "unprognostic (3.51e-3)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (8.67e-8)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-3)" "unprognostic (2.90e-1)" "unprognostic (2.87e-2)" "unprognostic (2.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" 36.7 34.5 32.7 32.0 37.5 38.4 41.5 45.8 48.7 40.4 32.0 34.0 31.2 30.2 42.6 31.6 36.1 40.8 28.7 34.4 32.1 30.5 35.8 27.8 30.8 36.0 27.5 35.7 41.0 30.6 61.2 33.4 36.8 29.7 32.4 40.4 26.2 35.3 37.7 43.8 29.8 31.3 42.6 38.3 35.5 28.3 80.0 30.3 64.3 35.1 32.9 38.8 41.5 32.9 14.3 26.0 15.8 28.2 21.6 20.7 17.7 33.3 40.3 60.3 34.8 46.5 47.7 31.3 43.1 43.4 50.5 47.3 36.7 20.5 53.8 25.9 52.5 42.9 45.1 76.7 50.3 61.5 32.2 41.2 42.0 40.5 32.1 28.5 66.6 32.0 41.9 28.0 31.9 59.6 44.6 50.3 37.6 53.6 25.5 53.5 26.8 57.8 13.0 30.8 39.4 38.1 45.2 82.2 23.8 32.1 63.6 40.0 39.1 48.5 26.6 23.8 38.8 46.8 28.7 48.0 42.6 30.4 43.3 48.6 27.9 40.2 58.2 30.5 29.5 48.4 15.8 21.2 8.8 14.1 27.4 20.7 14.3 16.6 17.3 26.0 12.8 17.5 16.5 9.4 21.6 28.2 14.2 19.4 17.7 32.7 37.5 45.8 48.7 32.1 30.5 27.5 35.7 29.7 30.3 32.8 37.9 34.4 36.0 69.0 37.6 50.0 22.9 29.4 25.0 61.1 17.7 40.7 26.6 49.7 388.5 43.6 38.1 0.0 51.9 49.7 45.8 44.7 16.2 39.2 50.8 23.8 69.0 39.3 61.9 214.2 44.3 47.7 37.1 45.9 46.6 33.8 61.1 43.8 68.2 37.4 30.5 38.8 45.4 146.7 72.4 63.7 38.3 31.9 57.5 69.7 CARMIL1 "CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A" ENSG00000079691 "Capping protein regulator and myosin 1 linker 1" Q5VZK9 6 25279078-25620530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 20.9;Collecting duct cells: 33.2;Distal tubular cells: 39.7;Proximal tubular cells: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 20.9;RPTEC TERT1: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029038, HPA029039" Enhanced Supported Cytosol NA NA Cytosol "HPA029038: AB_10601668, HPA029039: AB_10611382" "unprognostic (2.34e-2)" "unprognostic (9.45e-2)" "unprognostic (2.07e-2)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" "unprognostic (2.22e-1)" "unprognostic (1.66e-3)" "unprognostic (3.82e-1)" "unprognostic (4.02e-1)" "unprognostic (7.15e-3)" "unprognostic (8.25e-3)" "unprognostic (5.86e-2)" "unprognostic (1.28e-3)" "unprognostic (3.08e-2)" "unprognostic (2.53e-1)" "unprognostic (1.07e-1)" "unprognostic (2.31e-1)" 8.1 7.2 10.1 7.1 12.3 1.2 9.3 20.0 10.3 8.2 15.3 4.5 8.0 20.8 5.2 10.7 7.7 8.2 11.7 7.5 9.0 5.5 12.8 3.3 11.3 13.7 5.8 8.3 8.3 6.4 9.8 7.0 6.6 6.5 5.2 14.2 7.1 10.0 10.7 1.4 8.3 30.5 7.9 6.2 4.3 10.3 20.8 3.5 6.7 7.7 4.8 7.6 8.7 9.6 4.1 2.6 0.0 3.1 1.5 3.0 0.5 7.5 7.6 2.1 2.7 2.0 1.0 7.4 2.6 5.8 2.8 4.9 8.2 5.7 2.6 8.5 4.1 8.2 8.3 8.2 7.3 2.0 6.5 4.3 6.3 8.9 1.0 5.6 0.2 1.0 1.1 5.0 5.3 8.2 3.4 0.1 1.0 0.2 2.1 1.7 5.9 0.4 0.0 2.9 13.4 3.2 0.9 1.3 20.9 21.6 6.9 5.5 1.2 11.5 19.8 7.5 6.5 4.8 0.2 0.1 2.1 3.6 9.7 2.6 0.3 0.1 4.2 3.2 2.3 7.6 0.0 1.1 0.0 0.0 1.3 0.2 0.7 0.4 0.2 1.1 4.1 3.0 0.5 0.0 1.5 3.1 2.6 0.0 0.5 10.1 12.3 20.0 10.3 9.0 5.5 5.8 8.3 6.5 3.5 17.9 20.9 0.0 0.0 0.0 0.0 0.0 0.0 6.7 7.9 33.2 0.0 16.5 39.7 13.8 0.0 0.0 0.0 0.0 13.6 6.5 0.0 0.0 8.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 6.4 0.0 0.0 13.5 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 CARS CARS1 ENSG00000110619 "Cysteinyl-tRNA synthetase" P49589 11 3000922-3057613 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 92.3;Early spermatids: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737" Enhanced Enhanced Cytosol NA NA 110000 Cytosol "CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033" "unprognostic (9.10e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-3)" "unprognostic (1.43e-1)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (8.00e-2)" "unprognostic (5.51e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "unprognostic (3.46e-1)" 24.9 15.9 15.8 15.8 17.7 9.0 15.9 9.5 29.1 13.4 16.3 19.1 11.1 15.9 14.0 10.7 16.0 10.8 14.2 12.5 15.3 18.7 10.7 22.1 15.1 17.2 23.3 15.9 14.5 42.5 14.9 15.9 14.0 23.0 10.8 17.6 7.4 20.3 14.8 24.6 18.8 17.8 21.0 16.1 14.8 22.8 13.4 17.3 9.8 23.0 14.5 22.7 14.4 19.4 8.3 13.3 18.0 23.9 16.4 18.1 11.6 7.4 3.8 4.9 14.8 19.3 17.8 4.4 19.1 21.8 13.2 23.9 9.3 17.9 11.6 5.6 24.1 0.0 19.2 16.2 21.7 18.2 33.8 3.7 6.5 6.5 7.1 46.3 13.5 14.4 29.3 17.1 11.4 12.7 0.0 17.4 28.8 10.9 41.0 13.0 11.3 9.5 0.0 18.5 26.5 6.8 4.6 8.2 14.5 0.0 12.5 10.6 14.1 4.7 13.4 20.9 3.8 0.0 0.0 6.0 5.4 5.1 13.5 0.2 30.5 27.8 7.4 0.0 7.1 10.7 7.7 12.0 8.8 15.2 10.5 13.0 8.3 13.6 13.6 13.3 6.0 7.5 12.1 18.0 16.4 23.9 5.2 18.1 11.6 15.8 17.7 9.5 29.1 15.3 18.7 23.3 15.9 23.0 17.3 17.9 31.5 21.7 25.4 12.8 11.7 6.7 2.5 92.3 27.3 10.4 5.9 18.8 8.3 35.4 93.7 13.7 18.6 0.0 34.2 34.8 12.6 16.1 20.7 16.8 18.9 14.3 18.3 13.5 15.1 39.9 11.5 14.7 8.5 14.4 16.9 10.8 37.5 21.0 18.0 13.4 10.0 6.5 14.1 39.5 24.2 10.5 27.0 24.2 14.3 35.5 CBL "c-Cbl, CBL2, RNF55" ENSG00000110395 "Cbl proto-oncogene" P22681 11 119206276-119313926 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004350, HPA027956" Enhanced Supported Cytosol NA NA Cytosol "CAB004350: AB_2244054, HPA027956: AB_10601094" "unprognostic (2.52e-1)" "unprognostic (1.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-2)" "unprognostic (2.92e-1)" "unprognostic (4.10e-3)" "unprognostic (9.75e-2)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.03e-2)" "unprognostic (5.23e-2)" "unprognostic (5.21e-2)" "unprognostic (5.27e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" 9.9 5.5 9.1 17.0 11.1 11.1 8.8 10.7 12.0 6.2 7.5 8.7 3.0 5.7 9.9 5.3 7.5 7.4 6.3 5.9 8.0 9.6 5.5 4.0 10.3 16.3 8.1 6.9 6.3 5.6 16.6 4.1 9.1 9.3 5.3 7.5 6.4 5.4 7.1 3.9 7.4 8.6 10.6 8.9 13.3 7.3 32.3 5.1 40.9 6.0 5.5 15.6 7.6 7.7 1.8 3.3 11.8 3.7 0.6 1.9 1.0 6.3 4.8 16.9 10.6 5.1 6.0 10.0 6.9 7.2 6.7 6.6 10.3 7.9 15.1 6.2 8.7 13.8 9.3 11.6 5.9 14.7 8.6 2.7 15.5 3.7 3.1 6.2 18.0 17.7 5.3 6.5 17.0 18.4 7.1 16.5 14.8 12.5 6.3 12.0 6.9 9.6 10.1 8.8 5.7 5.4 10.4 8.5 2.8 5.9 5.1 2.3 7.1 12.8 5.6 4.6 12.1 5.8 15.2 13.7 10.4 7.4 7.2 9.0 2.1 3.1 12.3 4.2 15.6 7.4 0.8 3.2 2.4 1.3 3.7 1.1 1.8 1.6 1.3 3.3 1.8 1.8 1.9 11.8 0.6 3.1 1.8 1.4 1.0 9.1 11.1 10.7 12.0 8.0 9.6 8.1 6.9 9.3 5.1 8.9 8.8 18.8 4.9 16.0 12.4 5.9 7.6 1.4 4.5 10.4 43.2 5.2 1.7 5.8 22.7 17.8 6.3 0.0 5.8 8.0 8.0 6.2 3.5 2.6 15.0 12.7 8.1 19.0 52.9 32.8 7.2 29.9 15.1 5.4 4.3 17.5 8.7 8.6 12.0 3.1 33.8 25.8 17.6 38.1 26.2 19.2 5.8 20.0 4.5 9.5 CCDC103 "CILD17, FLJ13094, FLJ34211, PR46b" ENSG00000167131 "Coiled-coil domain containing 103" Q8IW40 17 44899142-44905390 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 19.6;testis: 35.5" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 12.8;RPTEC TERT1: 10.0;U-87 MG: 11.3" HPA043131 Approved Cytosol NA NA Cytosol "HPA043131: AB_10796686" "unprognostic (9.40e-3)" "unprognostic (1.75e-1)" "unprognostic (5.60e-2)" "unprognostic (1.99e-2)" "unprognostic (4.50e-2)" "unprognostic (7.43e-2)" "unprognostic (2.80e-1)" "unprognostic (2.34e-1)" "unprognostic (1.27e-1)" "unprognostic (4.35e-2)" "unprognostic (4.69e-1)" "unprognostic (1.05e-1)" "unprognostic (3.60e-1)" 0.6 2.3 2.6 0.9 6.3 0.6 1.2 0.5 4.7 1.4 0.9 2.9 1.6 0.5 1.7 2.8 0.4 19.6 2.8 0.4 2.5 3.0 2.7 0.7 1.9 0.3 1.5 3.9 3.5 0.8 1.9 2.1 0.5 4.3 0.9 0.7 1.6 1.2 1.5 0.3 0.7 0.4 1.2 1.0 0.4 0.9 35.5 1.0 0.2 3.5 0.1 0.5 0.7 0.4 0.8 2.5 3.0 3.7 0.7 0.4 2.4 2.2 12.8 1.9 2.4 2.8 2.3 1.6 1.0 3.8 1.8 1.3 2.4 4.2 0.3 2.1 0.9 5.5 3.9 0.8 1.8 1.0 7.9 1.4 0.6 2.7 0.0 1.8 1.6 0.3 1.6 3.0 1.9 0.7 3.7 1.3 0.9 1.7 0.3 0.1 2.4 0.0 0.7 0.4 2.1 1.9 0.3 0.7 0.5 10.0 1.3 5.1 1.0 0.5 0.4 2.3 1.1 3.4 1.7 1.0 0.8 2.0 1.0 1.9 0.4 0.5 0.4 11.3 0.8 0.3 1.2 3.7 3.0 0.3 1.9 0.4 0.0 0.0 0.4 2.5 0.8 0.4 0.3 0.5 0.7 1.7 0.8 0.1 2.4 2.6 6.3 0.5 4.7 2.5 3.0 1.5 3.9 4.3 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CCDC153 LOC283152 ENSG00000248712 "Coiled-coil domain containing 153" Q494R4 11 119189638-119196769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0" "Cell type enriched" "Detected in many" 7 "Ciliated cells: 151.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 15.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.1" "Cell line enhanced" "Detected in many" "T-47d: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041497 Uncertain Uncertain Cytosol NA NA Cytosol "HPA041497: AB_10794378" "unprognostic (4.66e-2)" "unprognostic (1.86e-2)" "unprognostic (3.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-3)" "unprognostic (5.19e-2)" "unprognostic (9.43e-3)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (2.92e-3)" "unprognostic (1.15e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-3)" "unprognostic (1.98e-3)" 1.4 1.1 2.2 0.6 4.8 3.8 0.8 0.5 0.9 1.4 0.6 2.0 0.5 0.5 1.1 5.3 1.5 15.8 3.1 2.0 2.6 3.9 1.5 0.6 5.2 0.5 0.5 0.5 1.7 0.5 3.3 20.0 1.3 9.8 0.5 0.6 0.5 0.7 1.6 0.5 1.4 0.8 0.7 1.2 0.8 1.6 2.8 2.4 0.5 1.1 0.5 0.9 0.7 0.5 0.4 1.6 15.1 2.4 0.3 0.6 0.7 2.2 3.0 1.8 1.8 0.3 0.3 4.4 1.3 1.5 0.6 0.7 4.9 7.7 1.5 6.4 0.3 2.2 1.6 0.4 1.5 0.1 3.0 2.5 7.2 2.2 3.3 1.1 2.3 0.9 0.7 1.0 1.6 0.4 2.4 1.5 1.6 2.1 2.9 0.1 8.9 1.5 2.2 0.9 3.2 5.2 2.0 2.5 1.4 0.5 2.2 2.4 1.2 3.0 1.5 1.7 1.2 13.1 2.7 3.0 3.3 2.6 2.0 2.7 1.2 1.8 1.2 1.5 1.3 4.0 0.4 2.4 3.8 0.3 1.5 0.2 0.4 0.2 0.4 1.6 0.4 0.6 0.5 15.1 0.3 1.5 1.6 0.4 0.7 2.2 4.8 0.5 0.9 2.6 3.9 0.5 0.5 9.8 2.4 0.0 6.7 0.0 1.3 2.5 0.0 0.2 0.0 151.3 20.5 7.0 0.0 3.5 0.0 0.8 2.5 1.5 3.3 0.0 1.8 2.9 1.3 0.9 0.0 1.3 3.1 0.0 1.7 3.1 3.5 4.8 0.3 3.4 3.3 5.4 2.7 0.9 1.0 7.0 2.5 2.9 1.9 6.5 6.2 6.6 3.4 1.9 2.7 0.0 1.8 2.0 CCDC167 "C6orf129, dJ153P14.2" ENSG00000198937 "Coiled-coil domain containing 167" Q9P0B6 6 37482920-37499922 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 242.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 9 "U-698: 175.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045215 Uncertain Approved Cytosol NA NA Cytosol "HPA045215: AB_10962866" "unprognostic (1.82e-1)" "prognostic favorable (7.59e-4)" "unprognostic (6.99e-2)" "unprognostic (3.66e-1)" "unprognostic (2.86e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.73e-1)" "unprognostic (7.67e-2)" "unprognostic (3.41e-3)" "unprognostic (2.71e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (1.71e-7)" "unprognostic (1.57e-1)" "unprognostic (4.06e-1)" "unprognostic (2.44e-1)" "unprognostic (1.95e-1)" 6.4 10.3 16.1 11.6 18.9 12.7 10.2 11.3 15.5 12.6 10.5 12.8 11.4 6.3 8.7 25.2 13.6 11.5 6.2 17.3 13.8 12.1 10.2 29.5 7.0 23.0 18.1 9.1 4.6 14.9 6.9 8.4 9.6 15.8 12.2 13.0 5.0 16.2 7.7 10.5 6.5 8.2 16.7 22.8 15.1 7.5 18.8 16.9 32.1 11.5 11.2 35.5 8.7 8.7 24.8 9.9 23.6 6.0 8.6 70.0 26.4 3.1 7.2 16.6 11.5 4.5 8.0 6.1 3.7 3.0 5.8 6.5 7.6 4.7 17.1 8.5 6.3 11.3 2.4 10.7 8.7 5.9 14.2 19.7 8.1 3.1 19.1 4.8 7.9 3.2 3.7 18.0 6.2 5.7 4.1 18.0 18.0 5.0 14.9 9.9 10.3 14.8 6.5 0.9 9.0 4.6 9.2 5.9 12.6 7.9 6.2 11.3 13.3 5.6 5.5 8.7 15.2 6.0 8.2 4.5 3.9 7.6 2.1 3.8 11.0 10.7 175.0 3.7 17.0 10.9 4.8 6.0 23.6 26.1 5.9 31.1 24.8 43.5 32.8 9.9 17.0 20.1 19.4 1.8 8.6 4.9 6.3 70.0 26.4 16.1 18.9 11.3 15.5 13.8 12.1 18.1 9.1 15.8 16.9 6.0 10.1 32.8 22.2 12.6 8.6 42.5 33.1 16.0 7.9 14.0 7.9 52.7 26.6 58.7 80.7 18.0 15.3 140.2 43.7 96.5 31.5 33.2 15.0 109.5 77.5 14.3 24.2 29.4 18.3 242.2 12.0 25.9 52.3 29.7 18.8 29.8 51.7 14.4 17.7 66.3 8.5 6.5 20.8 95.7 92.0 13.2 24.8 54.9 25.8 27.3 CCDC189 "C16orf93, MGC104706" ENSG00000196118 "Coiled-coil domain containing 189" A1A4V9 16 30757423-30762710 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.7" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 91.0;Early spermatids: 152.5;Late spermatids: 229.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041806, HPA046289, HPA075094" Approved Approved Cytosol NA NA Cytosol "HPA041806: AB_2677684, HPA046289: AB_2679615, HPA075094: " "unprognostic (5.84e-2)" "unprognostic (3.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.45e-4)" "unprognostic (3.60e-2)" "unprognostic (5.41e-3)" "unprognostic (7.76e-5)" "unprognostic (1.66e-2)" "unprognostic (1.82e-2)" "unprognostic (5.11e-3)" "unprognostic (2.15e-4)" "unprognostic (1.22e-3)" "unprognostic (1.06e-7)" "unprognostic (1.75e-3)" "unprognostic (2.14e-1)" "unprognostic (6.63e-2)" "unprognostic (3.41e-2)" 1.0 4.2 4.7 3.1 5.3 11.0 4.8 0.9 6.4 3.2 2.8 2.9 5.5 2.0 2.2 15.0 1.2 15.6 4.2 0.8 5.5 6.8 4.5 0.9 5.5 1.9 7.5 3.3 3.1 3.0 4.4 10.3 1.2 7.6 3.0 3.1 2.3 3.4 5.1 0.4 1.8 1.4 1.3 1.3 1.9 2.0 23.7 2.2 2.3 6.3 1.6 3.4 1.7 0.8 1.2 13.0 6.2 3.1 1.8 1.1 0.8 7.2 5.0 1.5 5.9 1.6 1.9 0.4 2.8 1.0 3.0 2.3 0.4 5.4 0.3 4.8 2.1 1.6 9.1 0.8 4.5 1.2 0.8 11.8 1.9 10.3 3.1 0.3 3.0 2.1 0.4 0.4 5.5 4.5 4.5 2.2 2.0 2.7 1.3 2.1 3.7 3.1 6.0 2.3 2.2 2.7 3.1 1.9 5.6 6.7 0.1 5.1 1.8 3.0 8.3 1.9 1.5 8.2 3.8 1.9 1.5 1.3 2.6 2.8 3.9 2.2 2.7 8.8 7.7 0.7 1.2 1.3 6.2 0.2 1.4 1.1 1.2 0.0 0.2 1.8 0.1 0.0 0.4 0.6 1.8 3.1 13.0 0.1 0.8 4.7 5.3 0.9 6.4 5.5 6.8 7.5 3.3 7.6 2.2 0.0 1.9 0.0 3.2 0.0 0.4 0.0 0.0 91.0 6.8 7.0 3.9 2.0 5.0 3.3 152.5 1.0 0.0 46.7 2.6 0.9 1.0 5.3 1.1 0.8 4.0 0.0 2.4 0.0 1.5 229.1 6.9 2.3 0.0 4.6 2.2 3.3 1.5 0.9 4.6 6.2 11.7 0.0 0.0 45.1 9.6 0.0 2.1 1.0 1.7 3.0 CCDC43 FLJ31795 ENSG00000180329 "Coiled-coil domain containing 43" Q96MW1 17 44673069-44689779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 50.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023078, HPA023391" Enhanced Enhanced Cytosol NA NA Cytosol "HPA023078: , HPA023391: AB_1846146" "unprognostic (6.05e-2)" "unprognostic (8.91e-2)" "unprognostic (8.75e-3)" "unprognostic (3.58e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (3.42e-5)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.11e-1)" 10.4 10.4 14.3 8.5 15.6 13.8 10.0 14.9 14.7 7.9 9.3 9.8 7.2 9.1 8.2 9.0 10.7 7.6 6.1 16.3 13.8 10.4 11.2 7.5 7.5 9.6 11.9 9.2 7.3 9.4 12.3 5.8 14.2 14.4 9.8 12.0 6.9 8.9 7.6 50.6 8.8 8.8 8.6 14.4 9.8 8.5 7.3 9.6 10.9 10.8 17.1 10.9 9.1 7.8 11.5 17.5 10.7 17.9 15.8 14.7 10.0 12.3 14.8 14.1 12.4 9.6 14.3 25.9 18.9 11.2 18.6 18.3 20.0 13.3 21.6 14.7 15.3 13.3 9.7 23.2 21.8 27.1 26.3 27.0 19.3 24.4 29.4 17.3 27.0 14.6 12.8 22.2 19.3 26.4 12.8 18.0 17.8 20.3 15.1 18.8 15.3 26.3 19.2 14.5 11.7 19.1 17.1 35.5 18.6 19.0 8.1 14.2 14.0 13.8 11.1 19.1 22.2 28.4 18.4 15.5 23.1 17.0 13.7 25.0 15.4 19.4 25.0 16.9 15.8 16.4 10.5 16.0 10.7 12.9 17.9 11.9 9.3 12.2 14.3 17.5 11.5 12.0 13.0 3.3 15.8 11.7 12.4 14.7 10.0 14.3 15.6 14.9 14.7 13.8 10.4 11.9 9.2 14.4 9.6 11.9 16.0 19.3 8.6 11.7 21.9 35.1 12.7 21.4 21.6 8.7 9.8 36.1 33.2 19.2 0.6 20.0 10.5 23.3 21.3 38.6 13.5 9.4 32.3 12.4 26.9 20.6 17.2 16.5 17.8 2.7 13.0 21.6 20.3 18.0 14.4 17.4 18.5 10.5 12.0 25.8 19.2 6.5 17.6 3.5 10.4 9.8 21.2 12.1 19.9 7.1 CCDC50 "C3orf6, DFNA44, Ymer" ENSG00000152492 "Coiled-coil domain containing 50" Q8IVM0 3 191329077-191398670 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 95.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 95.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001336 Approved Supported Cytosol NA NA Cytosol "HPA001336: AB_1078421" "unprognostic (5.01e-2)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "unprognostic (8.77e-3)" "unprognostic (1.73e-2)" "unprognostic (8.29e-2)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.03e-2)" "unprognostic (2.51e-2)" "unprognostic (4.48e-2)" "unprognostic (3.17e-3)" "unprognostic (2.05e-2)" "unprognostic (7.79e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-2)" "unprognostic (7.57e-2)" "unprognostic (4.19e-1)" 35.2 17.5 15.8 23.7 15.5 5.1 41.4 11.7 14.2 19.3 21.7 17.2 21.7 14.0 23.4 21.6 20.4 21.7 29.6 22.7 14.9 11.0 25.1 38.5 22.3 22.7 15.9 9.3 28.9 31.1 17.1 14.7 20.3 14.6 20.5 15.4 16.2 21.4 20.8 19.2 14.3 22.3 37.5 14.5 32.5 21.2 18.7 14.4 11.7 25.5 14.4 23.4 30.4 23.8 20.1 95.0 0.3 3.4 3.5 3.2 2.4 18.1 6.1 23.7 6.2 21.4 18.9 8.2 33.7 33.9 24.4 24.5 12.9 7.2 3.5 41.7 19.0 18.1 20.9 18.9 15.1 36.6 26.5 9.2 2.4 8.1 14.7 31.5 8.8 9.6 15.1 20.2 19.2 43.7 21.1 37.3 0.0 8.1 19.6 21.5 6.3 0.0 5.6 8.4 1.8 25.9 13.7 13.2 17.7 26.4 7.9 5.5 8.4 11.9 13.0 23.3 18.0 9.0 8.0 38.0 24.0 20.1 17.3 43.2 30.3 13.1 0.2 12.9 0.0 19.3 0.0 3.4 0.3 0.9 3.1 0.4 20.1 1.0 0.6 6.6 10.0 0.2 0.2 0.3 3.5 1.6 95.0 3.2 2.4 15.8 15.5 11.7 14.2 14.9 11.0 15.9 9.3 14.6 14.4 23.8 43.3 93.1 45.7 41.7 25.2 41.5 25.5 26.8 37.5 48.8 25.5 23.8 26.6 123.8 150.0 131.0 36.2 23.3 67.7 32.2 50.3 53.5 2.3 68.0 68.1 23.8 21.9 146.7 48.0 71.8 64.2 56.9 50.6 136.1 27.9 30.7 134.9 31.6 71.1 48.2 14.5 58.2 61.2 66.3 24.9 28.4 28.0 20.3 30.2 52.0 CCDC6 "D10S170, H4, PTC, TPC, TST1" ENSG00000108091 "Coiled-coil domain containing 6" Q16204 10 59788763-59906656 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019049, HPA019051" Enhanced Supported Cytosol No No Cytosol "HPA019049: AB_1846163, HPA019051: AB_1846164" "unprognostic (1.88e-2)" "unprognostic (1.72e-2)" "unprognostic (4.41e-2)" "unprognostic (1.25e-3)" "unprognostic (5.98e-3)" "prognostic favorable (5.48e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.39e-2)" "unprognostic (2.45e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (4.08e-1)" "unprognostic (4.69e-2)" "unprognostic (2.23e-1)" "unprognostic (2.56e-1)" "unprognostic (9.95e-2)" "unprognostic (4.19e-2)" 13.7 13.3 22.8 11.7 41.8 12.8 20.7 13.8 27.1 23.0 23.9 11.3 10.7 20.4 28.4 16.6 33.2 23.6 16.2 11.2 17.0 18.1 19.4 10.9 15.5 18.7 13.8 17.6 19.8 22.5 16.8 13.7 13.3 14.5 18.7 18.4 9.6 25.5 14.0 18.2 26.0 20.4 28.1 11.8 14.5 16.6 12.6 12.3 10.6 19.1 14.8 20.7 21.7 23.8 7.1 7.3 0.2 3.4 1.2 2.3 1.4 16.0 14.5 7.3 16.3 11.1 16.8 14.9 7.9 10.5 7.9 9.4 28.2 31.6 13.8 12.0 13.2 4.6 23.9 14.6 14.4 11.9 20.7 7.3 11.2 11.8 17.1 13.5 12.8 10.6 12.1 19.1 13.2 32.5 11.2 11.7 7.9 8.4 8.9 10.3 21.6 5.3 7.4 11.7 15.2 9.9 7.2 12.0 8.7 13.3 13.8 7.5 6.5 10.0 42.1 8.8 9.9 26.7 6.9 11.9 7.4 13.6 11.4 13.2 4.7 5.4 6.3 11.7 24.5 4.6 0.0 2.9 0.0 1.5 3.4 1.8 6.7 2.3 2.1 7.3 7.1 2.2 1.6 0.2 1.2 1.9 1.9 2.1 1.4 22.8 41.8 13.8 27.1 17.0 18.1 13.8 17.6 14.5 12.3 92.3 20.4 12.6 42.6 84.3 14.0 14.2 28.1 20.1 47.8 24.4 39.3 32.1 24.9 42.8 25.1 15.7 40.4 0.0 56.0 14.6 20.6 38.1 27.8 19.1 20.3 15.9 25.9 19.6 29.9 60.3 22.7 22.5 15.1 11.8 37.1 11.8 47.6 17.5 18.4 30.5 42.9 19.4 21.8 2.6 20.8 70.0 22.5 13.4 39.3 38.3 CCDC9 DKFZP586M1019 ENSG00000105321 "Coiled-coil domain containing 9" Q9Y3X0 19 47255980-47273701 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 47.5;Late spermatids: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045624, HPA072007" Enhanced Approved Cytosol NA NA Cytosol "HPA045624: AB_10961402, HPA072007: AB_2686482" "unprognostic (4.53e-3)" "unprognostic (1.75e-1)" "unprognostic (3.70e-3)" "unprognostic (8.22e-2)" "unprognostic (7.47e-2)" "unprognostic (1.15e-2)" "unprognostic (8.35e-3)" "unprognostic (1.45e-1)" "unprognostic (4.99e-1)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (9.78e-2)" "unprognostic (2.58e-1)" "unprognostic (2.45e-2)" "unprognostic (1.02e-1)" "unprognostic (7.46e-3)" "unprognostic (4.02e-1)" 17.4 16.9 10.1 18.4 13.5 38.3 16.0 14.9 15.0 18.0 16.1 13.0 20.6 14.8 31.2 19.6 15.0 16.2 17.4 15.6 10.6 7.1 14.3 16.0 18.0 14.3 14.7 10.4 23.4 35.1 16.2 14.9 21.8 13.2 19.3 9.8 17.9 14.7 19.8 23.2 23.5 14.0 28.2 9.3 16.8 17.3 23.3 15.6 11.1 19.0 13.1 13.3 21.8 23.2 2.3 2.9 7.8 2.7 2.0 3.6 0.8 11.6 11.9 9.4 10.4 3.0 8.2 10.7 16.3 7.2 10.0 11.0 12.6 9.2 5.3 4.4 10.7 8.3 11.0 8.6 6.9 5.5 14.1 5.3 13.7 10.9 9.5 9.6 5.5 14.3 8.7 10.3 9.5 8.9 8.5 6.6 6.8 18.6 27.3 6.6 14.0 6.4 48.6 10.4 19.3 4.7 11.4 9.0 6.0 4.5 8.5 3.6 9.3 22.1 16.0 8.6 8.1 13.3 11.4 9.0 11.6 10.4 6.9 13.7 9.1 15.7 8.0 10.8 7.5 8.9 0.8 2.5 3.8 2.9 2.7 1.5 1.4 2.3 2.4 1.9 2.3 2.4 1.7 7.8 2.0 1.7 2.9 3.6 0.8 10.1 13.5 14.9 15.0 10.6 7.1 14.7 10.4 13.2 15.6 6.0 1.7 12.0 13.6 12.5 2.0 2.2 0.0 1.4 1.2 1.8 3.9 4.4 5.0 6.6 47.5 6.7 8.1 0.0 9.8 7.2 5.1 9.2 8.1 2.9 5.1 0.0 3.5 3.1 7.5 57.5 4.0 6.3 6.8 10.0 6.5 1.5 9.3 4.3 3.5 5.4 7.0 6.5 14.4 2.6 5.9 15.6 12.8 6.9 5.8 11.9 CCHCR1 "C6orf18, HCR" ENSG00000204536 "Coiled-coil alpha-helical rod protein 1" Q8TD31 6 31142439-31158238 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 50.1" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 64.7;Late spermatids: 110.5;Spermatocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054167 Supported Cytosol NA NA Cytosol "HPA054167: AB_2682403" "unprognostic (6.68e-2)" "unprognostic (7.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (3.11e-3)" "unprognostic (2.23e-3)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (5.36e-3)" "unprognostic (1.65e-1)" "unprognostic (2.07e-1)" "unprognostic (3.85e-3)" "unprognostic (1.06e-1)" "unprognostic (4.35e-2)" "unprognostic (3.57e-1)" "unprognostic (4.17e-2)" 2.4 2.7 5.6 2.8 6.2 1.2 3.1 5.2 6.4 3.7 4.5 2.9 9.1 9.4 6.3 5.6 3.9 8.0 2.9 2.5 4.0 2.7 4.3 2.9 3.0 5.5 4.1 5.6 5.5 7.6 1.7 2.5 1.5 4.5 5.3 3.2 3.4 3.5 6.8 10.1 7.0 5.9 3.9 2.6 3.4 6.6 50.1 3.8 4.3 6.2 3.1 4.2 3.4 4.0 2.0 3.4 1.4 2.1 2.5 4.3 2.3 22.0 1.7 6.2 0.9 3.8 4.5 5.8 1.9 0.6 0.3 0.7 8.8 0.4 2.9 10.5 4.9 13.8 0.9 0.3 8.9 0.9 3.2 14.1 10.4 7.3 6.7 2.2 0.2 6.9 5.8 1.0 4.1 0.9 4.5 4.7 16.3 4.1 6.1 2.6 1.6 3.8 11.6 0.3 0.8 0.1 7.0 8.3 5.4 5.7 2.2 17.4 2.9 7.2 0.0 1.8 3.8 2.4 5.5 0.6 9.2 2.9 0.2 5.5 14.3 8.2 11.9 1.9 2.5 0.9 0.3 2.1 1.4 2.9 0.9 2.5 1.3 2.6 4.3 1.5 2.0 4.0 4.0 0.6 2.5 1.2 3.4 4.0 2.3 5.6 6.2 5.2 6.4 4.0 2.7 4.1 5.6 4.5 3.8 3.0 3.2 4.8 12.9 8.7 8.6 6.9 7.6 8.1 9.1 3.5 0.0 2.2 10.0 8.2 64.7 4.9 32.8 0.0 9.4 6.0 6.1 6.6 0.0 5.7 5.9 14.3 28.2 1.8 4.6 110.5 9.2 3.6 6.8 12.6 26.1 5.8 8.3 10.5 11.0 7.3 1.9 6.5 4.7 80.8 16.7 5.1 1.1 4.6 28.1 6.4 CCNB1 CCNB ENSG00000134057 "Cyclin B1" P14635 5 69167010-69178245 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 71.4" "Cell type enriched" "Detected in many" 9 "Extravillous trophoblasts: 610.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB000115, CAB003804, HPA030741, HPA061448" Enhanced Enhanced Cytosol Yes Yes Cytosol "CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522" "unprognostic (4.12e-2)" "unprognostic (2.75e-2)" "unprognostic (1.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.78e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.54e-7)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.43e-2)" "unprognostic (1.63e-2)" "unprognostic (2.49e-3)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (2.44e-1)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.15e-3)" 3.2 4.6 2.7 23.9 4.8 20.5 4.6 6.5 5.6 4.4 9.9 1.6 1.6 9.3 3.5 2.8 28.8 3.3 3.5 1.9 3.5 4.2 4.6 2.9 3.4 23.6 4.0 4.2 3.7 4.0 1.6 2.6 12.1 11.5 2.6 14.2 1.7 5.3 1.7 2.0 6.4 8.7 6.4 2.5 9.1 7.1 21.7 1.3 71.4 6.3 23.3 30.1 5.3 7.5 13.2 5.1 2.4 4.1 6.5 14.7 5.5 58.6 40.6 55.8 49.6 2.9 5.0 131.7 26.0 19.5 68.6 58.1 60.0 55.4 36.1 31.7 23.9 78.7 37.0 56.1 56.8 77.0 35.4 27.7 22.9 33.9 41.4 0.9 19.9 26.2 2.2 3.6 39.3 27.4 6.3 36.6 35.4 27.6 28.7 55.8 55.9 27.2 23.7 31.0 19.5 25.8 28.7 40.2 37.0 25.1 21.7 28.4 17.9 44.7 21.1 19.2 32.8 40.3 20.9 15.3 15.3 49.7 27.6 64.9 14.4 26.6 50.4 21.2 34.9 47.0 2.4 1.8 1.2 2.8 4.1 4.0 13.2 7.6 6.7 5.1 8.6 2.5 2.4 1.0 6.5 1.9 4.2 14.7 5.5 2.7 4.8 6.5 5.6 3.5 4.2 4.0 4.2 11.5 1.3 0.0 0.3 5.2 4.8 10.2 4.2 1.5 2.5 13.4 4.5 5.2 2.0 53.5 1.7 5.3 63.8 1.8 2.9 46.7 1.2 610.8 11.3 3.6 2.3 3.0 50.4 0.0 1.2 6.2 6.0 9.4 2.8 4.4 3.3 3.6 4.6 2.8 2.5 0.0 2.5 4.3 2.9 6.5 3.1 28.8 70.2 6.4 34.7 4.4 11.5 2.7 CCT2 Cctb ENSG00000166226 "Chaperonin containing TCP1 subunit 2" P78371 12 69585334-69601570 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 1208.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003197, HPA003198" Enhanced Supported Cytosol NA NA 9100000 Cytosol "HPA003197: AB_1078425, HPA003198: AB_1078424" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (1.40e-3)" "unprognostic (1.53e-1)" "unprognostic (4.42e-2)" "prognostic unfavorable (8.38e-4)" "prognostic unfavorable (3.61e-9)" "unprognostic (5.28e-3)" "unprognostic (2.15e-2)" "unprognostic (1.08e-2)" "unprognostic (5.34e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (6.53e-3)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.63e-1)" "unprognostic (7.21e-2)" 29.4 32.1 25.7 28.3 31.4 45.8 33.8 39.2 37.0 25.0 27.0 23.1 21.0 20.7 27.8 18.0 32.1 28.0 21.9 30.8 25.0 29.9 46.0 39.7 22.5 33.6 24.7 22.2 30.7 28.6 29.1 28.2 29.5 45.3 27.5 34.8 19.6 21.6 22.1 46.6 22.6 22.2 32.8 23.1 33.3 25.1 81.7 20.3 55.7 34.8 41.2 40.5 31.4 32.0 29.7 28.2 10.3 25.3 23.2 29.5 24.5 38.8 60.4 53.9 51.4 24.9 28.3 61.6 42.4 31.1 69.7 43.1 81.2 18.9 85.4 41.1 34.2 45.1 38.4 83.9 48.3 85.3 46.9 61.5 62.1 47.3 49.8 27.9 76.2 40.3 24.7 30.9 67.2 39.6 49.2 46.0 48.5 75.4 25.6 64.1 57.3 71.1 66.5 75.2 41.8 62.7 57.4 58.6 56.6 58.2 72.8 52.1 44.3 44.0 49.1 43.4 47.1 63.5 56.9 29.6 36.7 44.7 42.9 63.5 31.1 58.5 90.1 31.8 53.6 44.6 10.3 15.4 4.4 19.1 25.3 29.5 29.7 22.4 24.9 28.2 24.2 26.6 27.9 1.5 23.2 22.0 25.8 23.8 24.5 25.7 31.4 39.2 37.0 25.0 29.9 24.7 22.2 45.3 20.3 32.8 39.6 80.5 170.6 121.3 47.6 82.2 33.1 129.8 88.7 76.8 74.6 168.3 77.9 183.9 1208.4 68.7 26.9 23.3 110.8 169.5 100.8 92.3 104.9 40.4 113.2 39.7 101.8 50.3 35.5 299.4 71.1 66.7 43.9 92.0 70.4 64.2 130.9 28.1 62.6 104.8 51.3 84.1 111.8 459.2 324.1 102.6 128.3 61.2 136.6 138.0 CCT6A "CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20" ENSG00000146731 "Chaperonin containing TCP1 subunit 6A" P40227 7 56051630-56063989 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 179.4" "HPA042996, HPA045576, HPA049949" Supported Approved Cytosol NA NA 7400000 Cytosol "HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968" "prognostic unfavorable (4.04e-4)" "unprognostic (5.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.81e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (8.45e-4)" "prognostic unfavorable (9.00e-10)" "unprognostic (1.19e-2)" "unprognostic (3.17e-1)" "unprognostic (1.67e-2)" "unprognostic (3.24e-2)" "unprognostic (4.82e-2)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.35e-1)" "unprognostic (1.20e-1)" "unprognostic (1.78e-1)" "unprognostic (9.44e-3)" 32.9 36.5 35.3 35.8 36.1 32.0 62.4 43.7 40.4 26.2 29.1 19.6 28.4 29.8 31.7 23.7 39.5 29.7 22.9 49.3 34.7 39.8 43.2 45.7 22.6 42.0 36.8 26.8 33.4 42.9 48.3 33.7 33.9 34.9 30.2 35.4 16.4 27.3 32.2 72.3 32.6 28.6 35.3 35.8 36.7 32.3 27.0 26.5 41.1 38.2 41.4 44.0 37.1 83.7 24.0 35.3 11.8 34.2 26.6 29.9 25.8 179.4 41.1 24.7 37.3 17.4 21.9 28.5 33.9 19.2 33.4 27.0 46.2 22.6 55.6 26.3 21.8 60.2 38.2 50.6 38.9 46.3 31.2 38.4 34.8 39.9 40.6 18.9 49.8 28.3 18.7 22.4 33.7 33.6 26.5 32.8 25.4 76.0 14.0 37.7 22.2 38.3 43.5 52.3 40.3 54.8 35.3 25.3 32.0 37.6 34.4 33.1 33.2 30.0 51.2 29.9 39.5 37.6 38.4 27.5 23.0 44.1 76.2 69.7 17.2 35.4 68.7 23.0 44.3 76.0 6.9 25.0 11.8 22.4 31.6 29.9 24.0 23.5 24.4 35.3 17.8 24.0 25.4 3.1 26.6 34.2 19.6 24.2 25.8 35.3 36.1 43.7 40.4 34.7 39.8 36.8 26.8 34.9 26.5 83.4 81.3 76.7 149.2 96.7 57.8 100.5 58.6 236.9 216.1 45.4 25.5 172.0 74.6 212.7 12.0 112.8 57.1 0.0 237.7 208.2 81.7 105.7 127.1 61.8 133.8 36.5 97.8 66.9 79.5 15.6 65.3 122.3 55.6 225.4 84.4 73.1 209.1 73.7 85.2 112.3 50.9 58.2 92.9 81.2 184.0 95.9 167.2 86.7 111.5 124.2 CCT6B "Cctz2, TSA303" ENSG00000132141 "Chaperonin containing TCP1 subunit 6B" Q92526 17 34927859-34981078 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "testis: 71.5" "Group enriched" "Detected in many" 21 "Early spermatids: 252.6;Late spermatids: 121.4;Spermatocytes: 273.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 14.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA042996, HPA045576, HPA049949" Uncertain Approved Cytosol NA NA Cytosol "HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968" "unprognostic (1.56e-1)" "unprognostic (1.72e-2)" "unprognostic (2.99e-3)" "unprognostic (6.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.12e-3)" "unprognostic (3.61e-2)" "unprognostic (1.75e-1)" "unprognostic (1.44e-3)" "unprognostic (9.56e-3)" "unprognostic (3.61e-2)" "unprognostic (4.82e-7)" "unprognostic (1.24e-1)" "unprognostic (4.30e-1)" "unprognostic (4.23e-4)" "unprognostic (1.49e-1)" 1.3 1.7 1.0 0.7 2.8 1.5 2.7 1.3 1.9 1.1 0.7 2.4 1.9 0.6 0.9 3.2 0.8 1.3 0.6 0.8 1.3 1.0 1.9 2.6 0.5 0.6 1.6 1.7 1.2 1.2 1.3 1.3 0.4 2.0 1.3 0.5 1.3 1.5 1.3 2.2 1.3 0.6 0.8 2.2 0.7 0.9 71.5 0.8 0.7 1.4 1.1 0.8 0.9 0.7 2.5 6.2 2.2 2.7 3.8 2.7 1.3 0.9 1.2 3.2 1.4 4.2 2.6 1.1 1.6 6.6 2.8 3.9 0.8 2.5 6.0 0.6 2.9 2.0 1.2 0.2 0.9 0.8 0.7 2.4 0.9 0.2 0.7 5.7 2.8 0.9 3.5 1.7 0.3 3.3 0.5 0.7 1.0 0.6 6.2 3.0 2.3 0.6 6.2 1.7 0.4 0.8 2.9 1.5 14.4 1.7 1.0 3.7 1.8 2.9 1.2 4.9 0.7 2.4 2.9 0.7 1.2 0.1 1.5 0.8 5.5 1.2 5.8 1.3 1.8 1.6 0.0 2.7 2.2 1.6 2.7 1.7 2.5 1.8 1.1 6.2 2.3 2.7 2.6 0.1 3.8 2.6 1.4 0.9 1.3 1.0 2.8 1.3 1.9 1.3 1.0 1.6 1.7 2.0 0.8 0.0 1.9 0.0 1.9 2.2 1.5 3.8 2.5 6.7 3.4 1.8 0.0 1.3 3.3 2.6 252.6 0.7 0.7 0.0 7.0 0.4 2.6 1.9 2.3 3.4 1.3 0.0 0.0 1.3 2.2 121.4 10.0 1.5 5.0 0.0 2.5 8.3 2.3 0.9 3.9 5.5 2.4 0.0 1.4 273.4 9.7 2.3 0.7 0.5 1.7 3.0 CCT7 "Ccth, Nip7-1" ENSG00000135624 "Chaperonin containing TCP1 subunit 7" Q99832 2 73233420-73253021 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008425 Approved Approved Cytosol NA NA 5900000 Cytosol "HPA008425: AB_1078428" "unprognostic (5.02e-3)" "unprognostic (9.51e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (4.60e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (4.37e-3)" "unprognostic (8.76e-2)" "unprognostic (3.17e-1)" "unprognostic (4.24e-2)" "unprognostic (3.78e-1)" "unprognostic (1.41e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (3.07e-3)" "unprognostic (3.12e-2)" 35.1 55.7 33.5 34.6 46.3 27.0 54.2 52.2 46.9 34.9 36.3 32.4 29.5 28.7 46.5 42.3 43.6 47.4 32.7 56.5 36.4 36.1 38.9 48.0 29.4 47.0 35.8 37.1 51.3 56.1 45.3 34.9 34.3 36.1 41.2 43.7 27.6 33.2 41.2 82.1 32.7 28.9 51.0 33.5 36.1 36.9 80.6 28.6 49.0 44.0 52.5 51.5 37.5 61.6 53.1 49.4 29.1 45.6 42.7 54.8 62.6 46.9 78.5 45.0 48.9 33.1 27.5 57.7 40.7 38.7 72.1 45.4 127.9 33.4 89.8 27.1 44.1 66.4 40.3 100.5 65.1 79.8 49.8 89.3 59.2 50.1 91.4 37.2 68.9 46.3 42.4 37.2 70.2 86.6 38.0 64.6 54.7 76.2 32.7 60.6 75.1 80.2 96.1 63.9 65.2 56.6 73.3 110.2 64.4 52.0 45.6 64.1 39.0 35.3 51.2 48.8 43.6 29.1 40.0 39.7 49.2 58.8 30.3 80.6 37.6 38.8 83.0 40.1 81.6 53.8 29.1 31.5 17.9 48.5 42.3 53.8 53.1 50.1 48.5 48.4 49.5 54.8 51.0 9.6 42.7 45.6 49.4 43.3 62.6 33.5 46.3 52.2 46.9 36.4 36.1 35.8 37.1 36.1 28.6 53.6 40.0 72.2 131.1 61.4 74.2 94.3 63.7 78.9 58.0 55.8 17.7 167.9 92.9 145.6 274.6 80.9 50.6 0.0 121.4 180.5 69.8 91.5 72.7 60.6 117.8 77.9 72.3 48.5 53.7 195.8 97.0 56.1 70.9 128.0 80.8 110.9 124.2 49.1 100.8 99.6 59.3 71.1 100.9 234.3 136.3 64.4 139.2 70.8 109.5 98.1 CD207 "CLEC4K, Langerin" ENSG00000116031 "CD207 molecule" Q9UJ71 2 70830214-70835822 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.5;skin 1: 42.3" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 3.5;Macrophages: 1.5;Melanocytes: 5.0;monocytes: 2.8;Suprabasal keratinocytes: 4.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "myeloid DC: 4.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 4.0" "Cell line enriched" "Detected in some" 4 "AN3-CA: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002222, HPA011216" Enhanced Uncertain Cytosol No NA Cytosol "CAB002222: AB_563850, HPA011216: AB_1078453" "unprognostic (1.45e-2)" "unprognostic (8.28e-3)" "unprognostic (9.34e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-3)" "unprognostic (1.05e-1)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-1)" "unprognostic (7.92e-4)" "unprognostic (2.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" 0.5 0.1 0.1 1.8 0.1 0.0 1.4 0.1 0.1 2.4 1.7 0.1 0.1 1.6 1.1 0.4 9.7 0.3 2.9 0.3 0.1 0.1 0.2 0.9 3.7 0.2 0.1 0.1 0.2 0.2 0.0 1.1 0.1 0.1 1.0 1.1 0.4 1.2 0.2 0.1 42.3 2.6 0.1 0.1 1.5 0.4 0.4 0.1 3.3 0.2 11.3 16.5 0.3 1.9 0.0 4.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 14.1 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 1.9 0.0 0.0 0.0 0.3 2.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 CD320 "8D6, 8D6A" ENSG00000167775 "CD320 molecule" Q9NPF0 19 8302127-8308356 "CD markers, Disease related genes, Predicted membrane proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 76.2;RPMI-8226: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014500, HPA073489" Approved Approved Cytosol NA NA 400000 Cytosol "HPA014500: AB_1846295, HPA073489: AB_2686609" "unprognostic (9.97e-2)" "unprognostic (2.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.54e-3)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (4.19e-2)" "unprognostic (7.13e-2)" "unprognostic (1.31e-1)" "unprognostic (9.35e-3)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.07e-1)" "unprognostic (8.92e-2)" "unprognostic (3.14e-1)" "unprognostic (9.90e-2)" 23.1 20.1 13.1 13.4 14.9 6.3 39.0 12.6 19.1 12.0 23.2 9.7 10.5 16.6 15.8 58.1 11.4 14.9 28.9 20.7 13.2 18.7 15.2 16.3 15.1 18.0 18.0 8.5 14.0 27.6 7.6 11.9 38.0 19.9 19.7 14.2 18.6 16.5 12.8 14.0 6.4 17.4 11.9 11.9 32.8 21.3 23.7 9.3 14.3 22.4 9.3 8.6 12.1 19.6 10.3 25.0 0.8 0.6 18.0 51.3 15.0 12.9 13.3 2.9 38.0 9.6 5.0 6.9 6.8 9.2 13.7 10.5 14.2 7.8 11.7 21.3 5.0 10.2 8.3 0.0 10.8 2.6 16.4 40.7 5.6 11.4 20.2 6.4 10.7 14.2 4.7 2.5 7.9 6.6 6.1 13.3 7.9 17.1 40.3 5.3 12.2 11.3 76.2 20.7 11.4 55.5 14.0 4.0 69.2 10.2 0.3 27.5 11.9 14.1 6.0 17.2 2.2 0.4 4.8 7.5 15.7 11.6 23.4 21.4 38.4 24.0 12.7 11.2 39.3 17.0 0.0 0.6 0.0 51.3 0.6 29.2 10.3 34.0 27.4 1.1 9.9 23.1 26.0 0.8 18.0 0.4 25.0 21.7 15.0 13.1 14.9 12.6 19.1 13.2 18.7 18.0 8.5 19.9 9.3 11.9 19.7 29.0 24.5 16.5 50.8 27.1 10.2 12.0 10.3 17.4 31.4 32.9 11.6 46.3 20.5 85.7 13.4 0.0 15.8 39.7 26.8 49.2 11.5 17.1 23.7 20.6 48.9 51.0 3.8 41.6 20.1 5.8 37.1 6.4 31.5 18.4 22.6 66.2 15.9 39.0 37.7 12.9 31.4 119.7 28.0 12.3 29.6 35.5 88.5 19.2 CDC37 P50CDC37 ENSG00000105401 "Cell division cycle 37" Q16543 19 10391134-10420121 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003928, CAB004214" Supported Supported Cytosol NA NA 260000 Cytosol "CAB004214: AB_627232, HPA003928: AB_1846373" "unprognostic (2.40e-1)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (2.33e-2)" "unprognostic (2.46e-3)" "unprognostic (6.21e-2)" "unprognostic (1.37e-1)" "unprognostic (7.90e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-3)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.84e-2)" "prognostic favorable (2.33e-4)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (3.02e-2)" 47.3 29.7 33.0 41.6 33.0 41.8 42.0 35.8 46.8 31.9 35.5 17.8 32.7 31.8 36.3 34.8 37.9 30.1 42.8 49.5 28.1 31.3 33.6 35.6 38.2 33.4 26.6 36.4 34.4 34.2 26.8 24.2 34.3 32.9 31.5 27.7 21.6 37.0 34.4 148.6 29.3 31.3 28.7 23.0 43.5 34.0 23.4 29.8 32.6 33.5 50.7 34.6 33.0 48.0 33.2 45.2 40.0 46.0 40.2 52.3 53.0 53.0 35.3 19.1 27.2 26.3 23.0 24.6 63.1 28.7 39.8 34.2 40.4 21.0 31.7 51.2 38.5 23.5 33.2 25.7 41.0 27.6 25.4 76.0 60.2 28.6 57.1 41.5 34.8 27.6 28.0 22.5 46.4 21.0 22.9 50.9 27.9 46.6 38.4 30.7 50.5 34.7 85.8 46.6 33.7 62.6 34.6 25.6 36.3 36.4 34.7 22.3 32.5 29.6 31.3 27.0 15.3 21.4 37.7 56.6 46.7 26.8 63.8 50.3 52.4 51.4 39.3 36.6 56.7 37.6 29.2 46.0 40.0 52.3 45.8 47.3 33.2 42.3 46.9 45.2 29.1 33.0 38.1 26.6 40.2 44.1 38.4 44.0 53.0 33.0 33.0 35.8 46.8 28.1 31.3 26.6 36.4 32.9 29.8 50.6 99.5 87.5 97.4 132.0 73.1 60.9 76.5 69.6 87.6 61.1 37.3 164.7 86.2 190.3 86.2 167.5 121.6 0.0 172.9 359.8 113.1 81.0 130.6 39.4 190.0 84.2 78.0 142.4 66.8 195.7 98.4 192.0 131.6 208.2 93.0 57.2 218.0 128.9 97.2 64.3 78.6 77.6 140.1 60.9 70.4 116.9 202.8 124.6 108.6 144.2 CDC37L1 "CDC37B, FLJ20639, HARC" ENSG00000106993 "Cell division cycle 37 like 1" Q7L3B6 9 4679559-4708398 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HDLM-2: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021175 Approved Supported Cytosol NA NA Cytosol "HPA021175: AB_10959752" "unprognostic (1.18e-2)" "unprognostic (8.52e-2)" "unprognostic (2.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (2.38e-2)" "unprognostic (3.66e-3)" "unprognostic (2.71e-2)" "unprognostic (9.89e-2)" "unprognostic (7.82e-3)" "unprognostic (2.78e-2)" "unprognostic (7.97e-2)" "prognostic favorable (2.66e-7)" "unprognostic (8.54e-2)" "unprognostic (1.91e-1)" "unprognostic (2.91e-2)" "unprognostic (4.28e-2)" 14.9 12.6 10.4 7.1 15.4 5.6 10.5 12.4 14.9 12.2 10.0 7.1 11.2 7.8 10.9 12.0 15.8 10.1 11.6 28.6 11.2 12.6 13.4 42.0 8.4 9.0 10.0 9.9 12.4 15.1 9.3 13.7 7.5 17.3 13.0 6.5 6.2 9.4 11.1 58.8 8.1 8.0 17.9 8.8 6.3 9.5 10.8 8.9 7.0 12.2 14.0 7.2 18.0 16.1 10.7 6.2 14.8 6.8 8.1 20.7 7.9 7.2 6.6 3.5 5.6 12.7 9.4 5.4 8.6 5.9 5.2 6.0 2.1 4.5 4.6 2.4 6.2 3.5 3.2 3.9 5.2 5.1 54.0 3.3 12.3 7.2 5.7 7.6 4.9 5.1 6.0 6.8 3.9 6.2 5.8 3.7 4.2 1.4 7.2 5.8 3.5 3.8 10.2 8.9 4.8 2.3 3.1 4.3 2.6 7.4 3.0 10.1 5.0 6.3 5.2 4.2 4.7 4.2 4.7 4.0 7.9 3.7 4.4 5.6 5.6 8.8 3.4 7.0 3.5 2.5 14.8 5.7 11.0 13.3 5.3 13.1 10.7 13.4 14.0 5.4 10.5 20.7 18.5 6.8 8.1 6.8 6.2 12.1 7.9 10.4 15.4 12.4 14.9 11.2 12.6 10.0 9.9 17.3 8.9 26.8 16.5 11.2 38.4 58.5 28.6 62.3 20.4 17.4 17.0 15.7 31.4 15.6 41.4 28.4 8.6 17.6 12.9 0.0 36.2 13.7 33.8 56.3 23.1 91.2 10.4 19.1 17.1 15.4 11.2 3.9 33.4 16.0 38.8 13.6 14.9 28.6 23.9 11.5 34.3 49.1 21.9 32.3 48.6 69.4 49.7 50.2 28.3 26.1 10.7 43.1 CDC42BPG "DMPK2, HSMDPKIN, kappa-200, MRCKgamma" ENSG00000171219 "CDC42 binding protein kinase gamma" Q6DT37 11 64823387-64844569 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Club cells: 12.5;Enterocytes: 10.6;Paneth cells: 14.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 9 "cerebellum: 19.4" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 19.5;HaCaT: 14.6;MCF7: 19.7;RT4: 12.0;SK-BR-3: 12.1;T-47d: 11.9" "Region enriched" "Detected in single" 4 "cerebellum: 5.9" "Low region specificity" "Detected in single" "HPA027382, HPA061836" Enhanced Supported Cytosol NA NA Cytosol "HPA027382: AB_1846378, HPA061836: AB_2684622" "unprognostic (3.26e-2)" "unprognostic (1.58e-1)" "unprognostic (6.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.21e-1)" "unprognostic (2.50e-1)" "unprognostic (4.68e-1)" "unprognostic (5.27e-2)" "unprognostic (3.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.26e-1)" "unprognostic (1.81e-1)" "prognostic favorable (5.99e-13)" "unprognostic (2.60e-2)" "unprognostic (1.55e-1)" "unprognostic (2.14e-2)" "unprognostic (3.99e-3)" 0.5 2.7 0.8 2.1 0.5 1.1 3.5 19.4 0.8 2.9 9.1 0.8 6.3 8.2 1.0 8.0 14.3 2.9 10.5 0.5 0.7 0.0 3.5 0.5 4.2 0.7 0.5 0.5 1.5 7.9 7.0 6.5 13.0 2.0 4.4 3.4 1.0 14.3 7.6 0.5 22.4 19.7 1.6 0.8 0.8 8.5 2.5 0.7 1.8 3.9 8.1 7.7 5.4 6.3 0.4 0.0 0.0 0.0 0.2 1.0 0.1 5.6 0.8 0.5 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 7.6 4.8 0.1 2.8 0.0 0.2 14.6 0.9 5.7 0.0 0.2 2.2 0.4 3.1 2.4 0.0 0.1 1.4 0.0 7.2 0.1 0.1 0.0 0.0 2.3 3.8 0.0 0.0 19.7 0.1 1.0 1.8 5.3 0.8 0.8 0.3 2.7 3.4 12.0 10.4 0.5 1.8 12.1 0.3 2.9 11.9 0.2 0.0 0.0 2.1 0.0 0.0 1.4 1.3 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.2 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.8 0.5 19.4 0.8 0.7 0.0 0.5 0.5 2.0 0.7 8.9 6.4 0.0 2.3 5.8 0.0 1.6 2.5 6.7 12.5 1.8 0.0 4.8 0.0 1.7 0.5 0.0 10.6 0.0 5.3 4.1 0.6 2.1 1.1 0.0 0.9 0.0 3.5 0.0 0.0 0.4 0.0 0.2 0.0 1.8 3.3 0.9 2.8 14.0 0.0 0.3 0.0 0.0 0.5 1.7 1.1 7.0 5.6 0.0 3.8 2.0 CDCA3 "GRCC8, TOME-1" ENSG00000111665 "Cell division cycle associated 3" Q99618 12 6844793-6852066 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.6;lymphoid tissue: 51.0" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 53.0;Erythroid cells: 46.7;Extravillous trophoblasts: 60.9;Spermatocytes: 57.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.8" "Cell type enhanced" "Detected in many" "T-reg: 7.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA026587 Approved Cytosol NA Yes Cytosol "HPA026587: AB_1846386" "unprognostic (3.05e-1)" "unprognostic (1.32e-1)" "unprognostic (9.85e-2)" "unprognostic (1.63e-2)" "unprognostic (2.42e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.51e-5)" "prognostic unfavorable (9.77e-5)" "unprognostic (3.88e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-3)" "unprognostic (8.81e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.11e-1)" "unprognostic (4.94e-2)" 1.6 1.9 1.0 19.2 1.8 9.9 1.9 8.8 2.2 2.0 17.3 1.2 1.2 15.5 2.3 2.0 6.9 1.0 2.9 2.2 1.1 1.6 1.3 0.9 1.9 10.8 1.3 0.7 3.7 0.6 0.3 6.9 4.7 1.2 2.2 5.3 0.7 2.4 0.4 0.7 4.3 34.6 2.0 1.4 5.2 2.4 18.2 1.1 51.0 1.3 8.5 15.1 1.6 2.8 1.6 2.3 0.5 0.6 0.8 7.7 0.9 30.1 21.8 22.3 13.5 1.3 2.0 25.9 19.9 12.2 32.8 22.9 32.3 26.0 16.7 2.5 15.0 23.8 20.8 14.3 13.7 32.6 25.1 15.9 15.0 14.6 21.0 0.2 11.1 14.3 0.9 1.1 17.6 9.6 8.0 13.9 11.8 12.4 10.9 31.2 23.6 16.2 12.9 26.1 20.3 16.9 16.4 19.4 9.4 10.9 8.5 3.4 6.7 18.0 16.8 6.2 24.9 6.6 10.8 6.1 16.0 20.7 10.4 33.4 5.6 5.6 26.1 7.5 13.9 28.1 0.0 0.6 0.0 0.5 0.3 0.8 1.6 1.3 1.9 0.7 0.8 0.6 1.2 0.5 0.8 0.5 2.3 7.7 0.9 1.0 1.8 8.8 2.2 1.1 1.6 1.3 0.7 1.2 1.1 0.0 0.3 0.8 1.2 2.6 10.5 1.0 0.0 0.0 0.0 0.0 53.0 3.3 0.0 0.9 5.9 0.4 9.5 46.7 0.3 60.9 2.6 1.0 4.6 0.8 15.7 6.4 1.2 3.1 3.5 5.4 1.7 2.7 0.0 1.8 5.7 1.4 0.3 0.8 0.4 0.7 18.0 6.5 0.4 57.5 14.9 1.6 7.1 0.8 10.9 0.6 CDK3 ENSG00000250506 "Cyclin dependent kinase 3" Q00526 17 76000906-76005999 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 2.4;Distal tubular cells: 1.7;Ductal cells: 1.4;Exocrine glandular cells: 2.0;Melanocytes: 3.3;Pancreatic endocrine cells: 2.0;Suprabasal keratinocytes: 2.4" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA007420 Uncertain Approved Cytosol NA NA Cytosol "HPA007420: AB_1078490" "unprognostic (6.77e-2)" "unprognostic (1.26e-1)" "unprognostic (3.69e-2)" "unprognostic (1.87e-3)" "unprognostic (6.41e-2)" "unprognostic (1.10e-3)" "unprognostic (1.61e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-3)" "unprognostic (1.34e-1)" "unprognostic (9.80e-5)" "unprognostic (1.19e-2)" "unprognostic (6.75e-7)" "unprognostic (4.25e-2)" "unprognostic (1.63e-2)" "unprognostic (4.68e-1)" "unprognostic (4.47e-4)" 4.1 3.7 2.7 4.7 2.4 5.5 4.7 4.2 2.4 4.9 4.8 6.5 5.6 5.7 4.0 5.0 4.8 2.6 2.8 3.0 5.9 13.0 5.3 5.5 3.0 6.7 5.9 4.2 8.3 5.0 10.3 5.3 5.2 4.5 0.9 14.7 9.1 4.1 3.9 8.8 5.2 5.6 8.2 5.4 3.8 5.1 1.2 1.8 1.5 1.5 1.7 2.7 1.6 4.2 7.8 11.6 6.1 6.8 8.1 24.2 5.3 3.4 5.9 5.5 6.1 8.9 6.4 4.7 4.6 4.8 9.9 9.3 3.9 3.9 3.3 14.9 13.3 15.5 6.0 5.7 4.6 13.6 7.3 8.6 5.2 4.3 10.6 6.5 4.0 5.9 4.6 3.8 10.9 5.4 20.7 5.8 3.7 8.5 10.0 5.1 5.9 5.5 14.1 8.4 22.6 3.5 11.4 2.6 12.2 15.7 9.5 5.5 16.1 9.5 6.8 5.6 9.6 7.2 6.0 4.9 4.7 3.9 0.0 1.5 0.0 2.1 1.0 0.2 1.2 1.6 1.2 1.8 0.3 2.7 0.5 1.5 1.7 0.6 1.6 2.7 1.6 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.3 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 CDKN3 "CDI1, KAP" ENSG00000100526 "Cyclin dependent kinase inhibitor 3" Q16667 14 54396849-54420218 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 80.3" "Cell type enriched" "Detected in many" 4 "Early spermatids: 2056.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 16.1" "Group enriched" "Detected in all" 5 "NK-cells: 5.8;T-cells: 16.1" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005285, HPA039311, HPA058874" Enhanced Cytosol NA Yes Cytosol "CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842" "unprognostic (3.46e-2)" "unprognostic (9.95e-2)" "unprognostic (5.79e-2)" "unprognostic (6.78e-3)" "unprognostic (2.73e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-3)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.50e-3)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.46e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.71e-1)" "unprognostic (7.30e-2)" "unprognostic (7.92e-2)" "unprognostic (4.31e-2)" 2.4 1.0 1.6 6.5 1.7 12.8 1.5 1.5 2.5 1.0 4.5 0.2 0.2 3.8 0.9 1.1 4.4 0.7 0.9 3.0 1.4 1.9 1.0 1.1 1.1 8.8 1.7 1.9 0.9 0.7 0.0 1.0 2.3 2.8 0.9 5.8 0.9 1.7 0.1 3.9 1.8 4.0 2.2 1.0 2.3 1.8 80.3 0.3 18.3 1.1 6.4 9.5 2.1 1.8 2.0 1.6 1.1 1.4 5.8 16.1 2.9 55.2 21.2 16.3 16.3 2.7 3.3 9.4 13.2 19.5 28.2 31.2 16.0 27.6 27.2 9.7 20.6 29.7 40.7 24.7 16.0 52.7 32.6 11.9 13.8 15.3 26.4 2.0 17.2 9.8 1.2 1.0 17.6 30.7 9.9 17.9 26.4 6.9 34.8 33.8 39.3 23.8 14.0 5.7 54.1 46.0 14.8 14.4 5.9 14.9 12.1 6.7 8.5 24.2 14.3 10.5 12.8 29.6 14.7 6.5 12.5 42.9 19.7 31.2 8.4 9.7 18.7 20.9 24.9 22.8 0.0 1.3 1.1 1.2 1.4 0.6 2.0 5.2 4.3 1.6 0.9 2.7 2.2 0.9 5.8 0.9 1.2 16.1 2.9 1.6 1.7 1.5 2.5 1.4 1.9 1.7 1.9 2.8 0.3 0.0 0.0 0.8 3.1 8.2 1.4 9.3 0.0 0.0 1.2 1.8 2.0 9.8 0.0 2.8 2056.4 2.0 2.9 256.9 2.1 27.0 6.6 2.2 6.9 1.8 31.5 4.8 7.5 4.9 7.5 483.1 19.8 5.7 1.7 3.6 6.2 1.2 2.0 6.2 9.9 1.7 2.3 0.0 2.1 159.2 36.4 5.6 3.4 7.0 12.8 1.4 CDR2L HUMPPA ENSG00000109089 "Cerebellar degeneration related protein 2 like" Q86X02 17 74987632-75005800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.0" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 21.1;Pancreatic endocrine cells: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 27.4;U-138 MG: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022015 Enhanced Approved Cytosol NA NA Cytosol "HPA022015: AB_1846462" "unprognostic (4.60e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-2)" "unprognostic (3.85e-2)" "unprognostic (2.17e-1)" "unprognostic (7.36e-3)" "unprognostic (9.22e-2)" "unprognostic (1.78e-2)" "unprognostic (9.11e-2)" "unprognostic (2.11e-1)" "unprognostic (4.21e-2)" "unprognostic (1.84e-1)" "unprognostic (5.89e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" 9.5 6.1 7.0 4.2 18.7 0.8 20.1 40.0 14.3 6.8 9.9 19.1 4.2 31.0 14.3 2.1 4.3 6.8 12.9 8.3 11.7 8.3 6.9 2.3 8.9 1.8 22.0 6.9 2.4 6.3 4.3 4.1 10.2 21.9 5.4 2.7 2.7 10.2 8.3 3.2 3.1 15.8 8.3 25.1 2.2 17.7 5.6 14.0 0.0 3.2 1.0 1.7 7.0 10.1 0.3 0.1 0.0 0.4 0.0 0.1 1.5 6.3 18.2 4.0 8.5 7.2 6.3 1.8 9.3 4.1 5.4 6.9 10.8 5.9 0.0 9.8 16.1 4.9 17.0 4.8 2.2 3.6 0.1 8.2 0.0 11.3 6.9 4.1 0.7 0.3 3.7 3.6 12.9 1.3 3.9 11.6 1.4 2.7 0.9 5.7 5.7 0.8 0.6 5.3 15.1 9.0 2.9 6.2 2.7 14.3 4.0 7.0 23.8 11.7 27.4 0.8 2.5 7.5 1.2 8.2 28.1 6.0 17.6 5.8 0.9 0.5 0.0 7.8 2.2 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.0 1.5 7.0 18.7 40.0 14.3 11.7 8.3 22.0 6.9 21.9 14.0 14.9 0.0 0.0 1.9 5.4 2.4 3.6 15.3 2.7 2.3 5.2 0.0 2.2 13.3 10.7 5.4 10.0 0.7 0.0 6.2 0.4 7.5 5.2 0.0 0.0 1.2 0.0 4.7 4.9 0.3 21.1 2.6 1.0 1.7 1.0 3.2 0.8 19.1 0.0 2.5 1.8 2.5 0.0 7.3 2.1 1.9 2.0 1.9 0.0 0.6 11.5 CELA3A "ELA3, ELA3A" ENSG00000142789 "Chymotrypsin like elastase family member 3A" P09093 1 22001656-22012539 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2051 "pancreas: 2541.2" "Cell type enriched" "Detected in some" 31 "Exocrine glandular cells: 30160.2" "Cancer enriched" "Detected in some" 2497 "pancreatic cancer: 1481.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "MOLT-4: 21.6" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (1.27e-1)" "unprognostic (2.71e-1)" "unprognostic (1.79e-1)" "unprognostic (6.32e-2)" "unprognostic (2.67e-1)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 2541.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 29.3 0.0 0.0 0.0 30160.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.8 0.3 0.0 0.0 164.1 0.0 0.0 964.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CELA3B "CBPP, ELA3B" ENSG00000219073 "Chymotrypsin like elastase family member 3B" P08861 1 21977021-21998642 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 196 "pancreas: 1614.4" "Cell type enriched" "Detected in some" 24 "Exocrine glandular cells: 12399.8" "Cancer enriched" "Detected in single" 1218 "pancreatic cancer: 408.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (2.89e-1)" "unprognostic (4.01e-3)" "unprognostic (6.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (6.40e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 1614.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 5.9 5.3 8.2 3.0 2.3 3.2 0.9 0.6 5.0 1.7 1.3 2.5 1.5 2.2 1.2 1.8 1.8 1.7 5.4 2.7 5.5 2.7 1.5 2.2 1.6 1.0 0.5 0.0 2.5 4.1 2.4 4.9 4.0 1.3 1.9 3.2 2.3 2.4 1.5 0.0 2.7 2.5 3.6 2.5 5.6 0.4 2.6 2.2 1.5 1.4 0.9 3.5 3.6 0.9 4.3 0.0 3.6 3.2 1.8 3.5 0.8 0.3 3.7 2.6 2.8 3.7 2.9 1.6 2.3 1.0 4.9 4.8 2.5 1.9 4.8 0.6 5.1 2.5 1.8 3.1 3.0 2.0 3.7 2.2 2.8 1.4 5.9 3.2 3.0 8.2 2.3 1.7 5.3 2.9 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 65.6 0.0 4.9 0.0 12399.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.0 0.9 0.0 0.0 105.6 0.0 0.0 510.5 7.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 CELSR2 "ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3" ENSG00000143126 "Cadherin EGF LAG seven-pass G-type receptor 2" Q9HCU4 1 109250019-109275750 "G-protein coupled receptors, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.7;skin 1: 27.8" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 92.2;Muller glia cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 25.2;HaCaT: 24.9;MCF7: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013952 Uncertain Approved Cytosol NA NA Cytosol "HPA013952: AB_1846518" "unprognostic (4.46e-3)" "unprognostic (1.07e-2)" "unprognostic (3.00e-2)" "unprognostic (4.71e-2)" "unprognostic (2.19e-1)" "unprognostic (5.30e-2)" "unprognostic (3.51e-2)" "unprognostic (2.98e-1)" "unprognostic (1.33e-1)" "unprognostic (1.59e-2)" "unprognostic (1.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.94e-2)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-2)" "unprognostic (5.16e-2)" 1.5 2.3 12.6 1.1 16.0 0.9 5.4 9.2 31.7 6.9 1.8 13.7 3.4 1.4 3.1 4.3 10.9 18.8 1.8 5.3 17.1 8.1 5.6 1.2 1.8 1.3 10.0 15.4 1.2 4.8 7.8 2.3 1.6 8.3 3.5 1.4 5.4 6.4 10.4 9.3 27.8 1.5 2.4 14.1 1.0 2.0 11.0 8.6 0.5 10.9 2.7 3.2 2.3 6.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 7.0 6.6 25.2 4.6 0.0 0.0 6.8 0.8 0.6 1.5 0.4 1.0 0.2 1.2 5.7 0.5 1.2 24.9 6.5 4.0 0.8 0.1 2.7 0.5 6.0 1.4 0.5 0.3 3.2 0.1 9.8 0.6 0.4 5.7 0.3 4.0 4.1 0.3 0.0 28.7 0.7 0.3 8.1 0.8 1.2 6.4 2.3 0.3 5.5 2.4 10.2 4.8 3.8 8.5 5.4 6.2 8.0 1.6 0.0 0.0 4.6 0.4 6.2 1.6 0.4 0.3 1.4 0.5 2.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 16.0 9.2 31.7 17.1 8.1 10.0 15.4 8.3 8.6 8.9 5.3 0.0 4.8 14.0 7.2 9.4 5.1 2.7 4.5 17.4 3.9 1.9 1.7 2.2 4.9 0.8 0.5 0.0 0.4 1.0 1.0 2.1 1.1 5.9 0.9 92.2 1.7 0.0 0.0 5.3 3.1 0.5 10.1 0.0 0.3 32.3 1.7 0.0 18.0 2.7 5.2 6.5 2.0 0.9 3.4 19.9 0.5 0.0 1.2 5.7 CENPM "C22orf18, CENP-M, MGC861, Pane1" ENSG00000100162 "Centromere protein M" Q9NSP4 22 41938721-41947164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;lymphoid tissue: 41.5" "Cell type enhanced" "Detected in many" 11 "B-cells: 48.5;Ciliated cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 19.5;T-reg: 23.3" "Group enriched" "Detected in many" 7 "B-cells: 19.5;T-cells: 23.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042404, HPA056500" Enhanced Enhanced Cytosol NA NA Cytosol "HPA042404: AB_2677981, HPA056500: AB_2683156" "unprognostic (3.78e-2)" "prognostic favorable (3.40e-5)" "unprognostic (7.15e-3)" "unprognostic (2.65e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.50e-5)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (5.99e-7)" "unprognostic (9.54e-3)" "unprognostic (2.44e-1)" "unprognostic (8.73e-2)" "unprognostic (5.61e-2)" 1.6 1.4 1.1 31.9 0.9 18.2 3.8 1.9 1.2 1.7 6.9 1.1 0.4 6.0 1.4 2.2 8.9 9.6 4.3 3.2 1.0 0.8 2.1 1.4 4.2 17.0 1.0 0.4 1.4 0.6 0.0 0.4 3.4 0.8 1.2 3.7 1.1 3.3 0.9 0.5 6.3 7.2 1.1 0.9 9.7 4.5 13.5 0.4 41.5 0.9 5.5 18.8 3.2 3.3 19.5 0.3 0.8 0.1 2.9 23.3 4.0 22.2 22.9 12.8 8.4 1.0 0.9 5.5 11.0 5.7 19.3 19.7 26.5 11.9 28.9 8.3 5.7 12.5 8.6 9.6 11.2 4.8 8.3 40.1 13.5 24.5 18.4 1.0 25.6 15.4 0.8 0.8 12.4 5.8 2.0 7.2 26.8 10.2 28.0 11.2 34.4 25.5 26.8 6.9 13.5 17.0 24.6 12.8 30.1 7.8 13.3 14.7 2.8 16.9 10.1 5.8 2.2 9.6 16.7 3.6 18.8 28.1 12.4 18.2 15.0 10.4 26.7 6.5 21.4 20.5 0.8 0.1 0.0 3.2 0.0 4.3 13.1 9.4 4.1 0.3 19.5 1.8 2.4 0.5 2.9 0.0 0.2 23.3 4.0 1.1 0.9 1.9 1.2 1.0 0.8 1.0 0.4 0.8 0.4 0.0 4.3 48.5 2.2 1.8 2.1 0.4 0.0 109.7 1.2 0.0 0.0 14.1 14.9 1.9 2.9 0.3 4.9 23.3 0.6 28.0 3.1 1.8 2.3 0.8 35.5 3.2 7.5 4.3 3.1 4.0 1.1 6.5 6.8 2.8 35.1 0.1 1.4 8.6 0.4 0.2 0.5 0.0 0.0 37.0 36.7 0.9 7.3 17.3 19.2 3.8 CES4A "CES8, FLJ37464" ENSG00000172824 "Carboxylesterase 4A" Q5XG92 16 66988589-67009758 "Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 32.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 49.5;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 19.8" "Not detected" "Not detected" HPA035701 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA035701: AB_10696357" "unprognostic (6.34e-2)" "unprognostic (2.09e-1)" "unprognostic (3.18e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-1)" "unprognostic (6.20e-2)" "unprognostic (2.12e-2)" "unprognostic (2.04e-2)" "unprognostic (5.78e-3)" "unprognostic (3.93e-2)" "unprognostic (2.02e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.20e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-3)" 3.2 3.6 12.9 2.4 11.8 2.2 3.6 8.7 13.8 2.6 1.7 8.5 3.5 2.3 1.6 13.0 2.2 32.3 2.0 3.2 9.1 2.6 3.9 11.7 3.1 1.4 5.8 13.7 2.1 3.0 3.3 10.0 2.2 7.2 2.1 1.7 2.1 4.2 3.5 5.8 13.9 2.3 1.4 2.4 1.5 2.3 2.0 9.9 0.0 5.0 1.0 2.0 2.4 1.6 0.9 1.6 0.0 5.0 0.0 1.6 1.3 0.3 1.2 0.1 0.0 1.0 0.9 0.0 0.1 0.4 0.1 0.0 0.0 1.5 0.0 0.1 1.5 0.0 0.7 0.0 0.2 0.0 19.8 0.0 0.0 0.9 0.0 0.1 0.0 4.7 1.6 3.3 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 3.5 0.2 0.0 1.2 0.0 0.2 0.9 0.9 4.3 2.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 4.6 1.3 0.0 1.8 0.0 0.0 0.0 2.1 0.0 0.7 3.3 0.9 0.9 1.6 1.1 1.6 0.0 1.2 0.2 0.0 0.0 5.0 1.5 0.4 1.3 12.9 11.8 8.7 13.8 9.1 2.6 5.8 13.7 7.2 9.9 0.0 10.7 2.7 3.8 4.7 21.1 2.7 7.6 49.5 6.8 5.2 13.7 3.5 1.7 0.9 1.4 0.4 4.0 0.0 1.4 0.4 4.1 3.9 9.2 19.7 4.5 0.0 8.6 1.3 3.8 0.8 12.7 2.9 0.0 6.4 1.7 12.1 0.9 5.8 12.0 1.0 16.1 0.0 1.0 27.7 4.8 4.5 3.8 2.9 2.6 4.8 CFAP57 "FLJ32000, WDR65" ENSG00000243710 "Cilia and flagella associated protein 57" Q96MR6 1 43172149-43254358 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.6;testis: 29.2" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 156.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 12.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 6.9;HDLM-2: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002736, HPA028623" Enhanced Approved Cytosol NA NA Cytosol "HPA002736: AB_2272982, HPA028623: AB_10603234" "unprognostic (1.15e-2)" "unprognostic (2.29e-3)" "unprognostic (2.16e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.50e-2)" "unprognostic (3.71e-1)" "unprognostic (2.42e-2)" "unprognostic (1.02e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (2.05e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-2)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-2)" "unprognostic (7.78e-2)" 0.4 0.4 1.6 0.3 6.7 0.2 0.6 0.1 1.8 1.6 0.3 4.2 0.0 0.3 1.0 9.1 0.4 25.6 0.5 0.4 3.6 2.7 1.5 2.7 4.7 0.2 0.3 1.4 7.1 0.9 0.4 5.9 0.5 12.7 0.7 0.3 0.3 0.5 0.5 0.4 0.9 0.3 0.3 0.4 0.2 0.4 29.2 0.4 0.0 1.9 0.0 0.3 0.5 0.2 3.2 2.4 0.7 4.8 1.2 1.5 1.4 2.9 1.0 0.8 0.6 0.2 0.2 0.9 1.1 1.8 1.4 1.4 0.9 1.2 0.3 1.3 2.4 0.8 6.9 0.4 0.9 2.6 4.5 0.2 0.4 0.6 0.6 0.5 0.0 0.3 0.2 1.2 1.1 0.4 1.9 2.0 0.4 0.2 0.1 0.2 0.1 0.3 0.3 1.4 0.2 0.1 0.4 1.0 0.2 3.0 0.5 1.2 0.5 1.4 0.2 1.1 0.8 1.7 0.5 3.9 0.2 1.5 0.7 0.8 0.4 0.6 0.3 0.3 0.8 0.9 0.5 1.1 0.7 1.4 2.0 1.4 2.2 1.4 1.2 2.4 3.2 1.3 1.3 0.0 1.2 4.8 1.9 1.5 1.4 1.6 6.7 0.1 1.8 3.6 2.7 0.3 1.4 12.7 0.4 6.0 0.3 0.0 0.1 0.0 0.4 0.4 0.0 156.6 10.3 0.0 5.9 0.8 0.0 0.3 22.1 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.1 1.6 0.0 0.6 0.0 21.6 0.9 0.0 0.0 3.6 0.0 0.5 0.2 0.0 0.7 1.4 0.8 0.0 0.0 18.7 3.3 0.0 0.0 0.0 0.0 0.1 CFAP77 "C9orf171, FLJ46082" ENSG00000188523 "Cilia and flagella associated protein 77" Q6ZQR2 9 132410043-132573317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 30.9;testis: 22.0" "Group enriched" "Detected in some" 6 "Ciliated cells: 66.9;Early spermatids: 92.0;Late spermatids: 37.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.8;SH-SY5Y: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021329, HPA024647, HPA061069" Enhanced Approved Cytosol NA NA Cytosol "HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657" "unprognostic (7.28e-4)" "unprognostic (5.68e-2)" "unprognostic (5.25e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.70e-2)" "unprognostic (1.74e-1)" "unprognostic (3.01e-1)" "unprognostic (2.31e-2)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (1.77e-1)" "unprognostic (2.41e-3)" "unprognostic (2.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" 0.2 0.2 1.6 0.2 4.5 0.2 0.2 1.6 0.3 1.6 0.2 8.4 0.0 0.2 0.7 8.8 0.2 30.9 0.2 4.2 2.5 2.5 0.2 0.2 5.5 0.2 0.1 0.0 9.7 0.3 0.2 1.7 0.2 8.9 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 22.0 1.6 0.0 0.3 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.4 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.8 0.0 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.2 1.8 6.6 0.0 0.0 0.0 0.5 0.3 0.0 0.6 1.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.5 1.6 0.1 2.5 2.5 0.1 0.0 8.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.9 5.7 0.0 0.0 0.0 0.0 0.0 92.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.5 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 2.4 0.0 0.0 10.7 2.3 0.0 0.1 0.0 0.0 0.0 CFL1 CFL ENSG00000172757 "Cofilin 1" P23528 11 65823022-65862026 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 3975.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013086, CAB033687, CAB037077, HPA053761" Approved Supported Cytosol NA NA 470000000 Cytosol "CAB013086: AB_2533565, CAB033687: AB_1121774, CAB037077: AB_1078547, HPA053761: AB_2682251" "unprognostic (1.14e-1)" "unprognostic (2.37e-2)" "unprognostic (7.69e-3)" "unprognostic (4.32e-3)" "unprognostic (3.14e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.59e-3)" "unprognostic (2.52e-1)" "unprognostic (5.88e-3)" "unprognostic (6.57e-3)" "unprognostic (2.09e-1)" "unprognostic (6.19e-3)" "unprognostic (1.72e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.06e-1)" 95.5 58.2 107.4 126.1 98.4 164.2 64.2 88.0 157.9 60.6 162.4 100.1 42.3 167.5 95.9 54.2 89.3 63.7 90.1 60.0 112.0 88.7 98.3 136.6 86.3 128.0 93.3 66.0 57.0 35.0 49.5 47.2 86.0 94.3 56.6 146.0 54.6 60.7 73.0 37.3 63.1 194.0 119.7 104.7 148.2 90.3 43.7 66.6 185.1 54.1 70.8 150.2 78.9 59.0 93.6 199.7 167.7 182.9 108.6 160.6 310.0 149.1 120.9 137.2 106.8 84.6 87.4 72.8 154.1 141.6 181.6 108.9 68.9 128.8 110.5 122.2 204.5 124.0 115.1 99.3 147.5 136.1 115.3 45.7 143.0 93.3 77.3 90.0 123.6 205.5 96.2 104.0 154.0 80.2 106.6 193.3 70.6 63.3 117.3 191.3 141.8 185.5 203.3 146.7 139.5 92.7 137.9 63.5 148.8 135.4 97.6 65.2 145.2 82.1 124.4 116.1 80.3 148.5 98.7 155.1 150.6 115.2 190.2 146.3 84.7 130.1 149.6 155.6 78.6 140.7 85.0 154.1 165.2 160.6 172.7 125.1 93.6 128.8 144.9 199.7 88.9 96.6 126.1 167.7 108.6 182.9 152.3 155.9 310.0 107.4 98.4 88.0 157.9 112.0 88.7 93.3 66.0 94.3 66.6 229.3 264.2 803.2 1036.2 1198.6 195.6 68.1 463.7 159.3 188.8 493.7 55.0 1193.4 756.0 1960.0 391.6 649.3 1740.8 140.2 1718.7 2033.8 752.0 677.1 583.2 411.8 2593.2 192.3 748.0 687.5 1170.3 280.2 326.2 1493.8 934.6 3975.7 1283.0 362.3 2224.1 1460.5 472.7 935.3 92.2 413.9 796.3 147.3 358.7 1107.9 1448.8 1231.5 1117.5 1121.8 CGB1 ENSG00000267631 "Chorionic gonadotropin beta subunit 1" A6NKQ9 19 49035610-49036895 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "pancreas: 8.4" "Cell type enriched" "Detected in single" 125 "Syncytiotrophoblasts: 58.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HMC-1: 20.5" "HPA038925, HPA038934" Uncertain Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.9 0.0 0.1 0.1 0.0 0.0 0.5 0.3 4.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.5 0.0 0.0 0.0 CGB2 ENSG00000104818 "Chorionic gonadotropin beta subunit 2" 19 49031912-49033238 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.1;testis: 4.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 33.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 25.4;U-266/70: 10.2;U-266/84: 12.3" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.05e-2)" 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 1.1 1.0 0.9 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.1 1.4 0.4 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.3 4.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 3.4 0.0 0.4 0.0 0.0 0.1 0.0 25.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 3.0 10.2 12.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 6.5 0.0 0.5 1.1 0.0 33.4 0.0 0.0 0.0 CGB3 CGB ENSG00000104827 "Chorionic gonadotropin beta subunit 3" P0DN86 19 49022869-49024333 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 6.7;placenta: 15.0" "Cell type enriched" "Detected in some" 38 "Syncytiotrophoblasts: 724.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9;testis cancer: 4.2" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Cell line enriched" "Detected in some" 20 "BEWO: 39.7" "CAB000042, CAB010884, HPA038925, HPA038934" Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.39e-1)" "unprognostic (7.88e-2)" "unprognostic (6.92e-2)" "unprognostic (1.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 6.7 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 1.3 0.5 0.0 0.0 0.1 0.2 0.0 1.9 0.7 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 724.1 0.0 0.0 0.0 CGB5 HCG ENSG00000189052 "Chorionic gonadotropin beta subunit 5" P0DN86 19 49043884-49045311 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 105.2" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 16.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "BEWO: 46.9;U-251 MG: 21.3" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.38e-1)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "prognostic unfavorable (1.18e-5)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.47e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 12.7 105.2 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.2 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.0 21.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 CGB7 CG-beta-a ENSG00000196337 "Chorionic gonadotropin beta subunit 7" P0DN87 19 49054275-49058860 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 8.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;HaCaT: 5.7;HBEC3-KT: 4.8;hTCEpi: 6.9;U-251 MG: 10.4" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (9.53e-2)" "unprognostic (1.99e-1)" "unprognostic (1.87e-1)" "unprognostic (3.53e-1)" "unprognostic (4.60e-5)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (8.37e-2)" "unprognostic (2.88e-2)" "unprognostic (4.80e-2)" "unprognostic (8.83e-4)" "unprognostic (1.54e-1)" "unprognostic (3.89e-8)" "unprognostic (1.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.05e-1)" "unprognostic (9.28e-2)" 0.3 0.2 0.3 0.3 0.3 0.0 0.8 0.3 1.5 1.7 0.3 0.3 3.7 0.3 1.2 0.5 4.0 1.0 2.0 2.0 0.4 0.2 1.0 0.3 0.8 0.3 0.3 0.3 0.9 2.5 0.0 2.7 3.7 1.3 4.6 0.0 0.8 1.3 3.9 6.4 8.1 0.3 0.3 0.3 0.3 0.0 1.5 0.3 0.3 0.9 2.2 0.3 2.4 2.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.8 0.2 1.5 0.0 0.2 7.1 0.6 0.0 1.4 1.2 1.2 2.6 0.0 0.1 1.3 2.1 5.7 0.2 4.8 0.5 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.4 6.9 0.4 0.7 1.6 0.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.0 0.1 0.1 1.4 0.1 0.1 1.7 1.0 0.2 0.2 2.3 2.3 0.0 10.4 0.3 0.4 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.3 1.5 0.4 0.2 0.3 0.3 1.3 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 49.1 0.0 0.0 0.0 CGB8 ENSG00000213030 "Chorionic gonadotropin beta subunit 8" P0DN86 19 49047638-49049106 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 85 "pituitary gland: 7.0;placenta: 22.2" "Cell type enriched" "Detected in some" 15 "Syncytiotrophoblasts: 37.1" "Cancer enhanced" "Detected in some" "testis cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 61.9;U-251 MG: 21.5" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.35e-2)" "unprognostic (1.72e-1)" "unprognostic (7.44e-3)" "unprognostic (4.70e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 22.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.3 1.4 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.9 0.0 0.2 0.0 1.2 2.6 0.2 21.5 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 CHAC2 GCG1 ENSG00000143942 "ChaC cation transport regulator homolog 2" Q8WUX2 2 53767792-53775196 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049235 Approved Approved Cytosol NA NA Cytosol "HPA049235: AB_2680686" "unprognostic (2.22e-1)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (3.91e-3)" "unprognostic (1.61e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (3.80e-7)" "unprognostic (5.52e-2)" "unprognostic (1.74e-2)" "unprognostic (1.30e-2)" "unprognostic (1.36e-2)" "unprognostic (3.09e-2)" "unprognostic (4.28e-6)" "unprognostic (1.52e-1)" "unprognostic (1.79e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" 7.2 8.6 6.5 7.1 6.2 9.3 3.6 4.3 4.4 2.6 6.8 2.1 7.7 11.4 2.4 4.4 8.4 1.8 5.3 10.3 6.2 6.1 8.3 9.8 3.4 9.6 5.0 4.2 1.8 4.8 1.5 6.7 1.7 6.9 2.8 6.1 2.8 4.1 4.6 9.8 2.0 9.0 3.5 4.8 10.2 7.0 16.4 3.7 9.5 3.7 4.2 9.8 5.7 5.1 6.6 2.5 1.8 0.9 1.4 6.7 3.0 19.1 6.4 6.8 6.0 3.4 1.7 1.4 8.8 1.8 6.3 7.5 4.4 4.9 16.3 12.9 3.8 9.5 6.9 15.4 10.5 11.1 34.3 13.4 12.9 8.6 7.2 5.2 15.2 5.9 2.1 3.1 11.7 8.9 1.7 12.3 11.3 13.2 9.6 8.3 6.2 18.0 12.7 8.8 8.3 11.5 13.8 14.5 16.5 8.7 5.2 8.5 2.4 10.2 7.6 4.0 4.3 4.6 6.0 5.4 3.7 13.3 14.2 14.2 9.6 12.3 13.9 5.0 19.2 5.1 1.8 0.5 1.1 5.2 0.9 5.5 6.6 5.7 5.8 1.1 5.4 6.7 6.1 1.4 1.4 0.7 2.5 5.1 3.0 6.5 6.2 4.3 4.4 6.2 6.1 5.0 4.2 6.9 3.7 0.0 1.4 11.5 2.8 3.1 0.8 2.8 5.1 1.4 2.3 1.8 0.0 1.7 10.0 5.8 5.3 3.7 2.6 0.0 7.1 0.7 1.6 2.9 1.1 7.5 6.6 1.6 0.0 2.5 1.0 1.7 2.6 2.8 3.3 8.2 3.4 3.3 6.4 0.0 3.9 5.6 5.5 0.0 3.4 26.1 5.1 3.0 0.3 6.9 9.2 3.9 CHKB "CHETK, CHKL" ENSG00000100288 "Choline kinase beta" Q9Y259 22 50578949-50601455 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Congenital muscular dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 14.7" HPA018797 Approved Approved Cytosol NA NA Cytosol "HPA018797: AB_1846666" "unprognostic (6.03e-4)" "prognostic favorable (4.66e-4)" "unprognostic (4.31e-2)" "unprognostic (2.63e-2)" "unprognostic (2.14e-1)" "unprognostic (1.42e-2)" "unprognostic (3.25e-3)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (7.84e-2)" "unprognostic (5.23e-3)" "unprognostic (5.43e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (1.33e-1)" "unprognostic (9.54e-2)" "unprognostic (1.30e-2)" "unprognostic (2.18e-3)" 14.1 13.6 12.7 18.9 14.4 14.8 13.0 21.3 13.4 12.9 15.1 13.8 10.4 9.8 10.1 12.5 10.7 16.2 13.6 10.6 10.7 6.8 14.3 9.3 12.6 8.7 14.7 6.1 9.1 8.4 21.9 19.2 12.3 12.7 11.7 6.9 12.8 13.4 12.5 7.8 10.5 16.9 8.0 9.5 18.5 14.8 19.9 15.8 8.5 14.5 6.6 16.5 12.1 10.9 13.6 21.2 15.0 23.9 20.6 18.6 19.5 3.7 1.0 3.0 1.1 3.2 2.1 10.4 4.4 8.8 1.8 2.5 0.0 1.4 1.8 3.4 0.0 1.6 1.7 1.6 0.9 0.3 1.5 4.3 2.4 2.2 0.8 14.7 3.0 6.2 1.0 5.4 0.7 3.7 3.6 9.2 3.9 1.2 4.8 4.9 3.4 2.6 8.4 0.5 2.5 0.6 3.4 0.4 10.4 4.0 2.5 1.5 4.3 3.5 3.4 3.1 2.2 1.2 1.8 2.8 1.7 3.7 1.6 1.3 7.9 0.7 2.3 3.0 2.3 1.8 5.7 23.9 15.0 16.3 21.9 15.5 12.9 15.2 17.3 21.2 13.6 14.4 13.3 5.7 20.6 14.2 19.5 18.6 19.5 12.7 14.4 21.3 13.4 10.7 6.8 14.7 6.1 12.7 15.8 6.0 23.3 12.0 2.2 4.2 5.1 5.9 17.8 10.7 14.8 7.0 3.9 7.5 3.3 26.9 9.1 6.3 18.0 0.0 20.9 12.0 5.8 1.9 18.5 5.5 12.8 7.9 15.1 10.4 20.2 21.1 2.3 8.8 3.3 73.9 16.6 2.8 23.5 23.0 2.8 4.3 4.8 6.5 8.2 11.1 8.7 5.5 7.1 16.0 15.6 1.8 CHMP2B "CHMP2.5, DKFZP564O123, VPS2B" ENSG00000083937 "Charged multivesicular body protein 2B" Q9UQN3 3 87227271-87255548 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 108.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035069, HPA052754" Uncertain Approved Cytosol NA NA Cytosol "HPA035069: AB_10602798, HPA052754: AB_2681936" "unprognostic (7.83e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (2.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "unprognostic (9.78e-2)" "unprognostic (8.69e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (5.76e-2)" "prognostic favorable (1.74e-6)" "unprognostic (6.52e-2)" "unprognostic (2.29e-1)" "unprognostic (6.41e-3)" "unprognostic (1.21e-1)" 21.8 21.5 20.1 17.6 23.5 36.5 22.1 12.5 35.9 23.6 32.4 21.4 19.2 30.1 28.2 20.5 30.9 20.1 23.4 26.2 20.8 22.0 30.9 36.1 21.5 17.7 29.5 21.0 22.9 23.5 14.7 41.7 45.1 30.7 29.2 30.5 14.7 22.7 25.4 30.1 22.9 45.8 24.8 52.6 22.3 24.3 13.3 25.6 14.5 35.5 26.3 16.4 30.7 25.3 21.2 22.4 53.4 24.8 11.4 20.0 14.3 16.8 18.3 6.2 3.9 11.4 9.2 8.0 13.3 16.9 11.0 14.2 14.3 27.6 6.0 9.4 14.3 10.1 8.6 8.1 9.2 13.3 10.6 8.5 7.4 6.6 5.8 10.0 9.9 10.3 7.0 15.6 10.9 14.8 10.6 8.4 7.4 4.4 9.1 11.8 12.1 9.6 4.1 8.1 20.3 16.4 5.1 7.7 5.8 8.3 17.3 2.4 2.5 13.0 10.6 20.2 7.5 9.5 3.0 7.6 10.2 9.4 108.6 9.0 9.2 13.6 10.3 11.2 5.7 7.3 42.8 20.8 53.4 11.9 24.8 16.0 20.0 14.9 14.6 22.4 21.2 14.1 13.7 40.3 11.4 24.7 12.8 20.0 14.3 20.1 23.5 12.5 35.9 20.8 22.0 29.5 21.0 30.7 25.6 77.4 53.5 37.2 193.5 117.3 17.0 65.5 58.6 95.0 73.9 47.1 3.9 64.1 117.7 128.3 5.1 42.3 109.6 46.7 227.8 159.4 64.8 193.3 71.7 54.0 75.6 35.0 44.9 35.6 51.1 4.0 61.2 79.5 38.8 48.7 61.4 189.8 186.7 138.6 90.5 117.0 14.1 71.1 49.5 56.6 68.8 127.2 151.3 45.3 63.1 267.1 CHN1 "ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2" ENSG00000128656 "Chimerin 1" P15882 2 174799363-175005369 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 145.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 88.1;Horizontal cells: 73.1;Muller glia cells: 49.1" "Cancer enhanced" "Detected in all" "glioma: 18.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 9.0;memory CD8 T-cell: 2.9;T-reg: 10.0" "Lineage enriched" "Detected in single" 35 "T-cells: 10.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 60.2;BJ hTERT+ SV40 Large T+ RasG12V: 30.4" "Low region specificity" "Detected in all" HPA036111 Approved Cytosol NA NA Cytosol "HPA036111: AB_10671241" "unprognostic (3.18e-3)" "unprognostic (4.19e-2)" "unprognostic (9.69e-2)" "unprognostic (3.42e-3)" "unprognostic (1.92e-1)" "unprognostic (2.65e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "unprognostic (3.71e-2)" "unprognostic (1.34e-2)" "unprognostic (5.29e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (7.31e-3)" "unprognostic (4.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.46e-2)" 3.8 5.2 63.4 3.4 60.8 1.0 2.4 9.1 145.3 4.7 2.5 4.4 0.2 1.7 3.9 15.1 3.2 2.9 4.7 5.2 74.0 21.4 2.1 1.4 7.1 7.4 21.4 51.7 2.8 1.9 31.7 5.2 14.4 23.0 7.2 2.6 3.1 1.4 4.6 1.2 1.9 1.8 5.5 5.1 2.7 2.1 7.5 9.1 0.0 4.0 0.0 7.2 4.5 1.2 0.2 0.2 0.0 0.0 0.1 10.0 1.1 0.0 3.3 14.9 4.2 4.6 21.2 0.1 14.4 60.2 20.7 30.4 0.1 1.9 0.1 0.4 21.7 10.4 0.5 19.0 0.4 8.3 0.2 8.3 2.6 4.9 1.4 10.2 1.4 0.3 18.8 0.5 10.0 3.2 4.6 7.6 7.1 0.1 0.6 15.2 2.8 6.8 0.6 17.6 0.5 5.1 2.2 21.0 0.1 0.2 0.1 18.4 19.9 11.4 0.1 1.7 9.7 0.7 0.3 2.3 8.8 1.3 2.8 5.2 1.7 8.0 0.2 1.9 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.7 0.2 9.0 2.9 0.0 0.0 1.3 0.3 0.0 0.1 0.0 0.2 10.0 1.1 63.4 60.8 9.1 135.3 74.0 21.4 21.4 51.7 23.0 9.1 3.0 3.4 1.9 0.3 3.9 88.1 6.1 0.0 1.4 4.5 3.5 25.5 1.1 0.0 0.2 17.1 14.0 0.0 0.0 0.5 1.0 16.0 0.7 0.0 0.6 2.4 73.1 2.4 6.2 0.0 18.2 2.8 1.0 6.8 0.0 0.0 49.1 0.6 0.0 4.9 0.0 13.5 12.9 26.9 17.0 14.5 3.1 1.7 4.4 0.0 0.3 CHORDC1 "CHP-1, CHP1" ENSG00000110172 "Cysteine and histidine rich domain containing 1" Q9UHD1 11 90201160-90223364 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 100.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041040 Approved Approved Cytosol NA NA 51000 Cytosol "HPA041040: AB_10794185" "unprognostic (2.29e-3)" "unprognostic (3.08e-1)" "unprognostic (5.26e-2)" "unprognostic (3.10e-2)" "unprognostic (3.27e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (4.93e-7)" "unprognostic (1.84e-1)" "unprognostic (1.04e-3)" "unprognostic (5.27e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (4.23e-2)" "unprognostic (2.63e-1)" "unprognostic (2.59e-1)" "unprognostic (1.52e-1)" 13.9 17.8 24.9 18.1 31.9 17.8 22.2 29.9 30.7 12.5 10.9 9.0 10.6 10.6 13.8 17.3 13.1 13.2 12.4 17.1 23.6 24.6 11.0 16.2 12.4 21.3 37.8 12.9 19.8 9.5 14.1 47.6 21.3 33.7 14.8 13.2 6.1 9.6 13.0 12.9 12.4 9.0 12.8 39.8 15.3 12.1 13.1 40.2 14.2 16.8 8.7 23.3 14.9 100.9 12.6 11.9 7.9 12.5 14.5 15.5 9.3 9.4 27.3 9.1 6.0 8.8 4.9 13.8 11.8 3.9 11.3 10.0 38.9 7.5 16.7 19.8 5.0 22.5 12.9 26.6 6.2 14.0 14.8 13.5 16.4 15.9 18.5 6.9 11.7 11.0 1.8 7.2 10.7 12.5 6.6 8.9 10.2 24.0 7.4 13.4 4.8 10.9 16.0 10.7 32.8 22.7 16.4 5.7 9.2 9.4 4.3 8.7 3.7 13.0 10.5 4.7 11.5 17.4 5.5 8.5 8.4 18.6 12.7 13.9 3.4 26.7 13.3 2.6 17.3 7.6 6.8 7.7 7.9 12.0 12.5 12.9 12.6 13.1 12.5 11.9 10.8 14.0 13.3 2.3 14.5 8.0 9.2 15.5 9.3 24.9 31.9 29.9 30.7 23.6 24.6 37.8 12.9 33.7 40.2 17.9 24.3 33.4 113.0 62.8 44.2 28.5 2.5 52.2 37.5 10.4 127.6 34.0 10.0 19.8 71.4 32.2 10.7 0.0 14.1 67.3 45.9 65.4 86.4 13.9 34.7 62.0 65.9 11.6 17.8 51.1 30.2 35.8 27.0 28.9 14.1 20.9 20.9 17.5 29.4 18.8 54.7 12.9 42.6 80.0 39.0 71.5 42.6 45.9 12.5 68.6 CHST10 HNK-1ST ENSG00000115526 "Carbohydrate sulfotransferase 10" O43529 2 100391860-100417656 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 14.9;Bipolar cells: 11.4;Muller glia cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "B-cells: 2.3;dendritic cells: 3.1;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012884, HPA051545" Approved Approved Cytosol "Intracellular and membrane" NA NA 290000 Cytosol "HPA012884: AB_1846710, HPA051545: AB_2681529" "unprognostic (5.40e-3)" "unprognostic (3.62e-2)" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (3.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.89e-2)" "unprognostic (1.44e-1)" "unprognostic (1.78e-1)" "unprognostic (4.54e-2)" "prognostic favorable (4.05e-4)" "unprognostic (8.02e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-2)" "unprognostic (3.73e-2)" "unprognostic (3.06e-2)" "unprognostic (3.27e-1)" 4.1 6.7 14.6 3.9 18.7 2.6 5.0 12.6 28.2 6.2 4.1 12.1 2.4 2.2 11.4 13.5 4.1 9.7 5.3 10.1 12.4 9.5 4.4 1.2 7.8 4.0 9.8 12.2 12.9 5.3 8.8 8.6 7.8 9.3 8.1 2.4 7.3 5.5 5.4 5.1 1.6 2.5 11.7 8.9 3.7 3.4 5.8 7.6 3.1 9.8 1.6 5.1 5.8 4.9 2.3 3.1 0.0 0.0 0.1 3.5 1.0 0.1 7.7 15.3 7.8 4.7 6.6 7.7 8.8 6.3 12.1 7.8 0.1 4.5 10.6 7.7 5.3 21.5 0.0 10.7 1.1 7.8 15.0 11.3 5.4 4.2 11.9 5.6 10.9 14.3 4.8 1.5 5.7 1.0 5.8 9.5 10.3 15.7 0.0 5.1 2.4 9.7 8.7 22.5 0.1 9.4 7.0 9.4 0.1 3.3 3.4 16.5 13.5 0.6 0.0 12.2 11.3 4.1 15.1 8.6 8.4 13.4 6.3 8.1 0.0 0.0 10.9 10.3 9.8 9.9 0.0 0.0 0.0 3.5 0.0 1.3 2.3 0.6 2.9 0.6 1.8 0.8 2.3 0.0 0.1 0.0 3.1 0.0 1.0 14.6 18.7 12.6 24.8 12.4 9.5 9.8 12.2 9.3 7.6 14.9 1.9 0.8 1.0 0.8 11.4 4.7 0.0 1.4 7.9 1.8 0.0 4.2 3.3 3.0 0.4 3.3 0.0 0.0 2.5 8.4 3.1 1.0 0.0 0.0 4.8 6.4 1.7 0.0 1.2 0.0 2.0 1.1 0.0 5.4 0.0 17.6 1.9 0.0 4.9 1.0 4.3 0.0 2.5 1.1 4.5 0.5 1.1 2.5 0.0 0.1 CHURC1 "C14orf52, FLJ33064, My015" ENSG00000258289 "Churchill domain containing 1" Q8WUH1 14 64914361-64944591 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040072 Approved Approved Cytosol NA NA Cytosol "HPA040072: AB_10963788" "unprognostic (2.94e-1)" "unprognostic (2.42e-1)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.80e-1)" "unprognostic (2.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.64e-2)" "unprognostic (4.64e-1)" "unprognostic (6.78e-3)" "unprognostic (2.12e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-2)" "unprognostic (6.67e-2)" "unprognostic (3.04e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" 31.8 32.7 25.9 25.5 31.8 25.5 27.6 15.7 36.6 31.1 30.0 31.4 25.8 20.8 28.5 27.3 28.5 22.5 22.7 45.5 23.9 23.2 29.3 36.5 21.0 30.0 29.2 23.7 32.1 27.1 25.5 34.8 24.6 35.4 26.7 25.5 21.5 20.8 28.7 53.4 22.5 28.3 34.8 36.9 33.0 27.4 19.5 26.8 40.7 25.0 29.6 28.6 32.8 23.6 41.6 41.8 80.6 37.1 31.3 62.3 35.3 39.3 21.0 20.1 15.6 26.0 27.9 24.0 29.4 25.9 16.5 18.9 11.6 25.9 24.2 20.1 25.1 26.0 29.1 17.7 23.8 18.2 26.2 8.8 23.0 16.8 26.1 23.8 12.9 23.0 33.2 18.1 14.9 29.0 27.7 17.8 36.3 10.1 21.2 20.3 32.9 24.1 21.5 11.1 47.0 34.8 21.4 22.2 14.3 23.4 28.4 10.6 12.7 20.2 22.2 28.8 19.5 35.9 27.3 22.7 15.2 30.0 16.6 18.7 18.0 15.7 53.4 16.7 15.3 18.2 41.4 37.1 38.2 32.6 36.6 37.1 41.6 49.3 38.4 28.8 36.6 49.5 41.1 80.6 31.3 35.2 41.8 62.3 35.3 25.9 31.8 15.7 36.6 23.9 23.2 29.2 23.7 35.4 26.8 95.3 71.3 115.0 55.3 52.0 67.3 50.2 86.6 136.5 67.1 94.2 41.2 80.9 111.0 137.5 37.7 93.1 93.8 70.0 194.1 73.0 73.0 53.0 92.5 165.4 79.3 50.9 86.2 108.1 188.2 17.2 96.4 111.9 79.2 226.4 95.1 142.7 189.7 95.1 114.2 134.8 70.2 129.4 127.4 95.6 74.2 57.6 75.1 104.4 111.3 60.7 CIT "CITK, CRIK, KIAA0949, STK21" ENSG00000122966 "Citron rho-interacting serine/threonine kinase" O14578 12 119685790-119877291 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3;brain: 35.0" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 82.5;Early spermatids: 63.4;Late spermatids: 28.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019082, HPA048812, HPA075506" Uncertain Approved Cytosol NA NA Cytosol "HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752" "unprognostic (5.64e-2)" "unprognostic (5.00e-2)" "unprognostic (8.16e-2)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (3.55e-2)" "unprognostic (3.61e-6)" "unprognostic (6.02e-2)" "unprognostic (7.78e-2)" "unprognostic (4.42e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-2)" "unprognostic (2.55e-3)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (1.70e-1)" "unprognostic (3.30e-1)" 1.4 4.4 14.7 3.3 14.0 15.3 1.6 12.7 35.0 1.6 4.6 2.9 0.0 4.0 1.3 1.5 3.2 0.9 1.6 1.0 9.8 5.7 5.7 1.4 3.0 3.4 3.2 21.9 0.7 0.7 1.2 2.9 2.6 7.4 1.0 5.3 0.6 1.3 1.0 1.3 5.1 3.5 2.6 5.0 5.6 3.5 8.3 9.5 5.9 1.5 0.1 4.9 1.7 1.7 0.4 0.0 0.0 0.1 0.0 1.2 0.8 15.1 13.7 12.0 11.3 1.1 3.3 7.1 11.7 9.7 12.2 9.2 8.7 6.3 11.0 6.3 9.0 6.0 9.5 8.2 6.8 16.9 7.8 6.0 13.9 8.8 5.4 0.1 7.3 12.8 0.7 0.8 14.6 9.0 4.4 9.3 12.2 8.8 9.3 11.5 7.6 13.2 11.1 6.5 5.7 9.3 12.1 21.9 3.6 2.4 6.7 8.6 4.7 19.4 3.8 9.2 6.3 13.7 5.3 7.1 15.3 14.1 10.4 12.7 6.3 7.1 7.5 10.1 8.1 23.6 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 14.7 14.0 12.7 35.0 9.8 5.7 3.2 21.9 7.4 9.5 6.0 8.8 0.8 0.6 3.0 7.4 1.6 0.0 1.4 9.1 8.7 82.5 0.9 0.0 0.2 63.4 1.1 0.4 0.0 0.7 4.0 1.1 0.3 1.1 0.8 2.9 0.0 1.7 1.3 1.9 28.5 1.1 1.0 3.3 0.0 1.1 15.4 0.1 0.0 1.1 5.7 15.0 0.0 0.4 11.5 3.5 1.1 0.8 2.5 1.6 1.0 CKB CKBB ENSG00000166165 "Creatine kinase B" P12277 14 103519659-103523111 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 158.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 2313.9;Horizontal cells: 4762.4;Muller glia cells: 3352.8;Rod photoreceptor cells: 2841.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "non-classical monocyte: 50.0" "Lineage enriched" "Detected in many" 17 "monocytes: 50.0" "Cell line enhanced" "Detected in many" "CACO-2: 54.3;HEK 293: 138.1;SCLC-21H: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001254, CAB047313" Enhanced Supported Cytosol No No 50000000 Cytosol "CAB047313: , HPA001254: AB_1078528" "unprognostic (9.97e-2)" "unprognostic (1.33e-3)" "unprognostic (4.25e-3)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (3.62e-2)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (4.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.68e-3)" "unprognostic (9.89e-3)" "prognostic favorable (4.02e-8)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-2)" "unprognostic (2.13e-1)" 32.4 27.3 75.4 10.4 114.6 3.1 5.3 94.3 158.5 29.1 121.5 51.4 23.8 17.6 37.3 8.9 28.6 35.7 17.8 36.4 60.7 43.2 26.7 3.4 12.8 3.6 63.4 93.3 15.8 10.2 20.3 9.7 3.7 63.3 107.5 55.0 43.9 18.3 92.1 19.1 14.4 17.5 53.2 31.9 3.6 66.7 22.1 50.9 0.0 19.8 7.8 3.9 43.0 13.0 0.0 2.9 1.4 50.0 0.0 0.1 0.9 0.3 6.8 27.5 1.4 0.2 0.2 0.5 2.9 0.0 0.3 0.1 54.3 0.8 0.0 3.3 2.1 1.1 6.0 7.9 0.1 0.0 1.2 138.1 10.2 30.3 18.6 1.2 0.0 8.4 1.1 0.0 0.2 0.1 0.4 0.0 0.6 17.8 0.4 0.4 2.3 0.2 0.3 10.7 4.6 21.4 1.8 0.5 28.2 5.0 0.2 78.6 32.3 5.8 1.0 2.1 2.0 2.5 4.2 0.1 0.1 5.3 0.5 12.9 1.3 0.3 0.9 0.7 0.2 1.0 0.3 0.1 1.4 0.0 5.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.1 0.0 50.0 0.0 0.1 0.9 75.4 114.6 94.3 152.7 60.7 43.2 63.4 93.3 63.3 50.9 181.7 96.3 15.9 251.5 136.6 2313.9 490.2 117.2 301.2 83.0 108.2 1798.5 3.2 1933.1 99.3 397.5 36.5 717.3 0.0 37.5 9.9 100.2 316.9 28.8 6.8 6.9 4762.4 449.5 67.5 3.0 120.4 281.6 32.2 172.1 122.6 614.3 3352.8 99.2 2059.7 1024.0 69.5 2841.9 58.2 193.9 161.4 92.5 153.2 34.8 12.1 562.9 194.5 CLCN2 "ClC-2, CLC2, EJM6" ENSG00000114859 "Chloride voltage-gated channel 2" P51788 3 184346185-184361651 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 21.0;intestine: 20.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 10.2;Enterocytes: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009397, HPA014545, HPA024108" Approved Approved Cytosol NA NA Cytosol "CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883" "unprognostic (1.13e-1)" "unprognostic (4.01e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (4.67e-8)" "unprognostic (1.72e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.19e-1)" "unprognostic (4.40e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (1.35e-1)" 1.6 5.4 4.9 2.6 8.3 1.3 1.6 8.8 6.3 2.8 20.2 16.9 5.1 11.6 4.5 5.0 1.7 2.8 21.0 1.5 6.3 3.1 3.7 1.8 1.3 1.0 15.3 4.1 6.1 5.9 4.4 4.0 1.5 8.9 2.6 14.0 15.6 3.7 9.0 1.2 2.2 11.8 2.4 10.8 1.6 2.7 11.9 9.8 0.1 3.2 1.3 1.3 2.2 2.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 8.0 2.8 2.3 6.2 2.1 1.8 5.4 2.9 1.6 2.9 1.8 15.1 2.7 2.8 8.0 1.4 7.5 14.0 3.3 3.1 0.9 2.5 4.0 2.5 5.8 6.4 1.3 1.0 2.5 3.4 2.5 2.5 2.9 1.3 2.7 3.0 1.0 1.4 1.0 4.4 0.8 1.3 3.5 6.7 4.4 5.0 2.2 9.6 3.5 6.1 3.9 2.3 3.0 10.5 4.7 1.6 8.5 1.1 1.3 1.5 4.4 7.1 7.0 3.8 4.8 1.7 2.6 4.8 6.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 8.3 8.8 6.3 6.3 3.1 15.3 4.1 8.9 9.8 3.0 2.6 0.0 0.7 0.9 2.2 1.1 10.2 4.0 1.2 0.0 0.0 0.9 0.0 3.5 2.4 0.5 30.8 0.0 1.8 0.4 1.0 0.6 1.1 0.4 0.5 1.6 2.9 1.8 0.0 1.3 4.9 0.4 0.0 1.0 3.6 1.8 1.8 7.8 4.6 2.2 2.6 0.0 0.8 3.3 1.6 0.4 1.3 0.0 6.5 0.3 CLEC4E "CLECSF9, mincle" ENSG00000166523 "C-type lectin domain family 4 member E" Q9ULY5 12 8533305-8540963 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2" "Group enriched" "Detected in some" 8 "Kupffer cells: 144.8;Macrophages: 65.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 22.8;neutrophil: 81.7" "Group enriched" "Detected in many" 17 "granulocytes: 81.7;monocytes: 22.8" "Group enriched" "Detected in some" 4 "NB-4: 5.8;RPTEC TERT1: 16.3" "Not detected" "Not detected" HPA004935 Uncertain Uncertain Cytosol NA NA Cytosol "HPA004935: AB_2667299" "unprognostic (3.05e-2)" "unprognostic (2.01e-2)" "unprognostic (8.91e-2)" "unprognostic (3.76e-1)" "unprognostic (1.76e-1)" "unprognostic (9.71e-3)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.62e-1)" "unprognostic (1.51e-1)" "unprognostic (8.44e-2)" "unprognostic (2.29e-1)" 8.4 3.0 1.1 20.9 2.4 37.7 17.5 1.2 2.2 3.4 1.4 0.0 1.1 0.1 1.2 1.6 1.7 4.2 6.7 5.9 1.3 1.2 6.2 3.5 25.6 41.2 2.8 0.6 1.0 3.3 0.0 1.7 1.7 9.0 1.6 0.5 1.1 1.2 0.6 2.7 0.7 1.9 3.2 5.3 34.2 1.8 3.3 0.8 0.7 12.8 0.9 1.1 2.2 2.2 0.0 2.9 81.7 22.8 0.0 0.0 4.5 0.1 0.6 0.4 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.1 0.2 2.6 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.3 0.3 0.0 0.7 0.1 0.0 1.7 0.1 0.6 0.7 0.1 0.2 0.1 0.0 0.1 0.0 5.8 0.5 0.0 0.1 0.1 0.2 0.1 16.3 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.0 0.5 1.3 0.6 0.1 1.1 0.1 0.2 0.1 0.1 1.6 0.5 0.1 0.0 22.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 81.7 0.0 0.1 0.1 0.0 4.5 1.1 2.4 1.2 2.2 1.3 1.2 2.8 0.6 9.0 0.8 0.0 6.6 1.4 0.0 0.0 0.0 0.3 7.6 1.4 3.4 1.8 0.0 0.0 0.0 4.5 0.3 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 5.8 0.0 0.0 11.6 144.8 1.1 0.9 65.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 12.9 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 CLIC1 "G6, NCC27, p64CLCP" ENSG00000213719 "Chloride intracellular channel 1" O00299 6 31730581-31739763 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020825, CAB040557" Enhanced Supported Cytosol NA NA 78000000 Cytosol "CAB020825: , CAB040557: " "unprognostic (7.26e-2)" "unprognostic (9.32e-2)" "unprognostic (2.78e-3)" "unprognostic (7.29e-2)" "unprognostic (6.93e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (8.90e-7)" "unprognostic (2.58e-2)" "unprognostic (8.51e-2)" "unprognostic (8.71e-3)" "unprognostic (1.19e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (8.11e-5)" "unprognostic (4.51e-2)" "unprognostic (2.89e-1)" "unprognostic (1.35e-2)" "unprognostic (7.31e-2)" 64.5 22.9 7.4 33.7 11.3 35.3 41.1 2.5 8.3 38.7 50.3 9.0 27.1 24.5 30.0 29.2 59.0 26.3 60.8 35.5 7.9 7.7 70.8 28.3 58.6 59.6 13.9 3.7 34.8 30.3 11.1 17.0 72.3 12.1 42.2 43.5 20.0 37.7 33.6 18.3 45.0 54.9 31.5 13.6 79.9 34.8 16.7 9.2 52.9 46.1 37.4 58.5 49.2 40.0 39.0 30.5 70.9 39.4 33.5 37.2 67.9 27.2 12.6 20.8 10.8 13.8 29.2 10.3 12.1 24.9 22.2 18.7 29.0 20.5 11.2 17.7 43.2 28.1 16.4 15.5 36.3 30.1 8.9 8.1 21.3 10.8 25.0 17.9 37.2 30.2 18.1 19.2 37.5 35.9 24.5 37.2 10.5 24.6 35.5 42.7 18.1 17.3 48.5 1.8 29.7 18.5 3.0 11.3 26.3 50.0 17.0 3.9 4.6 10.0 11.6 16.9 15.1 8.0 52.7 24.6 31.0 21.9 9.6 38.3 11.6 21.7 15.0 15.0 28.1 31.9 45.8 36.5 48.1 37.2 39.4 30.3 39.0 22.5 34.5 30.5 30.4 7.0 21.9 70.9 33.5 33.8 17.2 31.0 67.9 7.4 11.3 2.5 8.3 7.9 7.7 13.9 3.7 12.1 9.2 65.5 61.3 354.7 452.1 853.4 0.0 16.5 257.4 207.5 94.4 225.1 0.0 468.2 510.6 945.1 18.6 330.4 596.8 70.0 880.9 648.8 394.1 631.9 536.3 52.1 938.8 0.0 366.1 247.4 525.8 10.3 216.6 766.3 497.7 307.4 477.4 70.1 1089.0 792.5 176.8 468.7 6.7 200.5 405.4 19.4 13.4 811.1 479.0 498.6 571.6 861.7 CLIC4 "CLIC4L, DKFZP566G223, H1, huH1, P64H1" ENSG00000169504 "Chloride intracellular channel 4" Q9Y696 1 24745357-24844324 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 262.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 13.0;naive B-cell: 11.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008019, HPA060804" Enhanced Supported Cytosol NA NA 20000000 Cytosol "HPA008019: AB_1846946, HPA060804: AB_2684370" "unprognostic (7.35e-3)" "prognostic unfavorable (8.31e-4)" "unprognostic (5.54e-2)" "unprognostic (7.60e-2)" "unprognostic (2.92e-2)" "unprognostic (9.48e-2)" "unprognostic (6.78e-3)" "unprognostic (1.63e-2)" "unprognostic (5.50e-2)" "unprognostic (4.03e-3)" "unprognostic (1.98e-2)" "unprognostic (7.01e-2)" "prognostic favorable (1.48e-5)" "unprognostic (2.75e-3)" "unprognostic (2.17e-1)" "unprognostic (1.22e-2)" "unprognostic (3.82e-3)" 45.3 16.9 20.6 26.3 26.7 7.6 35.4 4.5 20.0 52.1 46.4 41.6 23.2 8.9 68.0 27.4 42.0 34.7 29.7 77.4 23.5 16.5 71.2 19.9 40.8 12.9 28.2 13.0 37.6 13.5 10.8 6.1 53.7 22.3 51.9 19.1 29.1 18.2 45.2 20.9 12.6 19.3 87.2 33.6 15.1 33.4 20.9 26.4 7.1 17.7 11.2 15.0 106.7 42.3 13.0 5.3 2.2 5.1 0.0 0.3 3.3 26.4 3.0 26.7 21.2 36.4 79.4 15.4 71.8 67.3 30.4 36.9 5.9 13.9 17.3 41.8 92.7 9.1 9.6 18.2 17.7 76.7 4.3 8.6 6.6 8.2 10.1 51.0 2.2 0.8 36.6 30.7 43.4 44.0 50.2 50.3 9.4 5.1 16.8 87.1 4.4 4.1 3.3 26.1 5.7 13.7 10.4 31.5 6.3 31.1 6.8 5.0 12.8 18.9 8.1 52.4 28.5 7.2 13.4 78.4 56.0 21.4 24.7 27.4 10.2 14.0 14.1 41.2 18.6 16.9 0.7 5.1 2.2 0.3 4.1 0.0 13.0 0.3 0.2 5.3 11.9 0.2 0.2 1.1 0.0 3.3 1.6 0.0 3.3 20.6 26.7 4.5 15.8 23.5 16.5 28.2 13.0 22.3 26.4 14.9 26.2 47.7 48.0 54.7 3.4 162.6 25.5 2.7 13.6 14.0 9.8 55.0 34.9 32.8 34.8 119.6 4.5 0.0 36.5 153.1 125.4 76.4 39.3 31.1 35.9 1.6 9.2 88.4 26.6 20.0 26.4 47.9 123.2 68.5 15.5 9.3 48.8 8.0 82.4 262.2 21.6 45.3 178.4 35.6 29.6 45.5 148.1 6.9 2.9 26.7 CNEP1R1 "C16orf69, FLJ38101, NEP1-R1, TMEM188" ENSG00000205423 "CTD nuclear envelope phosphatase 1 regulatory subunit 1" Q8N9A8 16 50024410-50037088 "Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042815, HPA077906" Uncertain Supported Cytosol NA NA Cytosol "HPA042815: AB_10794765, HPA077906: AB_2686868" "unprognostic (4.11e-2)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.43e-3)" "unprognostic (1.80e-1)" "unprognostic (3.42e-2)" "unprognostic (8.53e-2)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (3.37e-3)" "unprognostic (5.09e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" 15.4 12.7 14.5 16.3 15.0 25.1 17.0 19.1 17.2 10.6 11.3 12.2 4.0 10.9 13.0 17.1 17.2 10.9 13.5 14.3 12.8 12.6 12.5 12.9 14.1 19.7 17.7 11.9 12.9 13.6 11.7 17.3 18.5 14.0 10.6 16.7 14.9 12.2 10.7 10.5 13.9 12.9 13.9 12.9 21.4 11.9 22.4 14.1 12.4 8.4 10.3 18.6 12.8 12.6 5.5 9.6 28.7 18.7 6.3 9.6 7.2 7.6 7.3 8.6 9.2 17.4 16.8 12.9 15.6 11.9 15.1 9.1 7.6 11.0 8.8 11.7 12.8 10.2 12.2 7.1 7.7 19.2 6.3 8.4 4.1 4.4 12.0 11.9 5.5 12.8 12.5 13.0 9.8 7.8 11.8 10.3 11.1 5.0 5.1 19.1 2.2 10.5 13.9 6.5 3.3 9.9 13.3 11.6 8.8 10.1 5.2 6.9 8.0 14.6 6.0 5.5 7.9 5.2 6.7 13.4 14.7 11.7 13.8 5.5 8.3 7.4 10.4 8.2 5.6 11.9 7.4 12.2 8.6 9.6 15.7 8.9 5.5 7.6 7.0 9.6 4.9 7.6 8.9 28.7 6.3 18.7 3.8 7.4 7.2 14.5 15.0 19.1 17.2 12.8 12.6 17.7 11.9 14.0 14.1 3.0 8.5 0.9 3.2 9.4 5.2 9.8 2.5 4.0 7.9 7.0 3.9 15.7 3.3 4.7 1.3 8.7 5.2 0.0 4.7 22.0 11.6 2.4 12.7 5.6 13.1 6.4 4.6 6.7 19.2 2.2 5.5 13.5 15.1 10.0 3.9 10.8 4.5 5.8 7.4 5.0 9.4 6.5 10.3 23.3 17.0 8.5 12.0 10.9 5.2 3.3 CNKSR1 "CNK, CNK1, KSR" ENSG00000142675 "Connector enhancer of kinase suppressor of Ras 1" Q969H4 1 26177403-26189886 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 2.1;memory CD4 T-cell: 2.4;naive CD4 T-cell: 1.4;T-reg: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 2.1;T-cells: 2.6" "Cell line enhanced" "Detected in many" "A-431: 11.6;BEWO: 10.1;CAPAN-2: 18.0;HaCaT: 13.3;hTCEpi: 11.5;OE19: 10.1;SK-BR-3: 11.6;T-47d: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA030847 Uncertain Approved Cytosol NA NA Cytosol "HPA030847: AB_10601100" "unprognostic (2.73e-3)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (5.07e-2)" "unprognostic (1.03e-1)" "unprognostic (3.15e-1)" "unprognostic (1.61e-2)" "unprognostic (5.26e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-1)" "unprognostic (2.49e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-2)" "unprognostic (3.27e-2)" "unprognostic (2.91e-1)" "prognostic favorable (5.91e-4)" 0.7 0.0 1.0 3.5 1.4 0.0 4.5 5.4 1.1 4.4 19.1 0.8 12.8 8.6 1.9 11.9 15.4 6.1 13.3 0.7 1.4 1.2 10.0 2.9 10.2 0.7 0.9 0.7 2.5 27.6 10.2 12.6 32.4 1.2 10.3 5.4 0.7 15.7 18.9 17.7 11.9 22.6 1.0 1.3 1.3 7.3 1.5 0.7 1.9 20.6 11.9 15.9 6.1 5.3 2.1 0.0 0.0 0.0 0.2 2.6 0.5 11.6 0.0 0.2 0.1 0.2 0.0 10.1 0.3 0.0 0.4 0.0 1.8 18.0 1.9 6.0 0.0 0.1 13.3 0.3 8.5 0.3 0.4 0.6 0.3 4.3 5.0 0.1 0.1 0.2 0.0 11.5 0.0 3.3 0.0 0.0 0.4 1.5 0.1 0.0 5.4 0.1 0.6 5.2 10.1 1.1 0.1 0.1 0.0 1.1 6.8 2.5 0.6 0.0 11.6 0.2 4.6 11.0 0.0 0.0 0.0 1.8 0.7 0.1 4.1 0.7 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 0.3 1.4 0.1 0.0 0.2 0.0 0.0 2.6 0.5 1.0 1.4 5.4 1.1 1.4 1.2 0.9 0.7 1.2 0.7 14.9 4.5 0.8 13.0 13.1 2.6 0.8 12.7 14.7 6.8 33.2 2.0 27.4 1.7 10.6 0.4 0.7 23.3 0.0 10.9 12.0 1.3 14.9 0.0 0.0 2.3 0.0 17.9 1.3 0.0 0.4 1.1 0.7 1.7 1.8 17.9 1.1 17.6 24.6 0.7 0.3 3.0 0.0 1.9 2.3 4.0 9.9 27.1 0.0 18.3 22.5 CNNM3 ACDP3 ENSG00000168763 "Cyclin and CBS domain divalent metal cation transport mediator 3" Q8NE01 2 96816245-96833911 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016711 Supported Approved Cytosol NA NA Cytosol "HPA016711: AB_1847394" "unprognostic (1.50e-2)" "unprognostic (6.96e-2)" "unprognostic (2.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (3.03e-1)" "unprognostic (1.59e-1)" "unprognostic (8.32e-3)" "unprognostic (3.64e-1)" "unprognostic (5.31e-3)" "unprognostic (7.35e-2)" "unprognostic (3.36e-1)" "unprognostic (1.06e-1)" "unprognostic (4.48e-2)" 8.1 10.7 8.6 6.4 11.5 5.2 8.6 25.0 11.2 8.9 13.3 16.9 7.4 17.4 10.7 5.3 7.5 12.0 15.0 5.9 10.0 5.2 8.6 20.7 8.8 7.2 14.5 9.7 11.6 27.9 28.9 15.7 10.3 11.4 8.9 8.3 13.1 11.4 9.9 9.9 7.7 15.1 10.7 7.0 9.5 12.3 11.4 15.9 13.8 10.0 2.4 10.2 9.9 8.2 3.0 1.8 5.5 3.3 2.1 5.4 1.3 6.9 7.3 6.0 9.8 7.5 3.6 18.3 4.9 4.2 4.7 4.7 18.8 11.7 7.8 17.0 3.8 5.3 8.1 9.1 6.4 3.0 7.7 22.0 10.6 9.2 19.0 6.6 9.1 7.8 3.6 7.8 6.3 5.6 5.7 5.7 6.4 9.6 12.5 1.8 9.2 8.5 8.9 8.3 10.2 8.5 10.5 8.4 9.7 7.6 9.5 19.3 11.7 6.3 9.6 5.3 8.6 9.7 6.7 2.7 4.2 11.9 6.1 6.8 12.5 12.1 5.7 2.4 8.7 4.2 2.7 1.4 5.5 5.4 0.6 2.9 3.0 2.8 4.4 0.4 2.8 2.5 2.7 3.0 2.1 3.3 1.8 4.6 1.3 8.6 11.5 25.0 11.2 10.0 5.2 14.5 9.7 11.4 15.9 8.9 3.7 4.2 2.8 1.1 17.9 14.3 10.2 4.0 3.4 0.0 7.9 4.3 0.0 3.6 6.3 2.3 4.9 0.0 3.6 2.0 2.4 5.7 0.0 12.9 2.2 31.8 4.1 4.3 2.6 1.1 2.3 0.8 3.3 1.0 6.4 8.9 2.9 0.0 3.9 1.6 12.9 12.9 3.3 3.4 7.5 1.4 1.4 2.5 6.9 2.2 CNOT1 "AD-005, CDC39, KIAA1007, NOT1, NOT1H" ENSG00000125107 "CCR4-NOT transcription complex subunit 1" A5YKK6 16 58519951-58629886 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046577, HPA049664" Approved Supported Cytosol NA NA 210000 Cytosol "HPA046577: AB_2679706, HPA049664: AB_2680844" "unprognostic (1.30e-2)" "unprognostic (6.86e-2)" "unprognostic (9.25e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-2)" "unprognostic (7.11e-2)" "unprognostic (3.58e-2)" "unprognostic (2.19e-1)" "unprognostic (6.43e-2)" "unprognostic (6.99e-2)" "unprognostic (1.83e-2)" "unprognostic (6.63e-2)" "unprognostic (1.33e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (5.53e-2)" "unprognostic (1.52e-1)" 20.4 26.5 14.9 31.5 16.5 18.2 18.8 24.2 16.8 21.3 26.6 16.7 26.6 24.3 22.2 19.1 45.6 19.0 15.4 15.5 14.2 9.0 18.8 20.9 19.6 24.1 19.0 12.3 22.6 21.8 39.6 25.4 23.2 16.1 15.9 26.6 17.3 28.3 27.2 32.6 27.4 31.4 20.0 13.6 25.8 22.7 53.9 18.1 45.1 20.2 22.6 32.6 26.9 26.0 15.4 14.6 18.8 20.9 14.6 19.2 10.6 26.4 31.1 23.8 19.0 11.5 14.7 27.3 20.9 18.3 24.1 18.0 35.2 16.0 40.3 10.1 16.0 14.0 26.1 38.0 21.4 32.7 15.0 20.8 31.3 25.7 40.2 15.7 48.2 35.2 14.2 14.7 28.0 33.0 14.6 18.7 22.8 36.6 11.8 16.2 10.7 37.3 12.6 24.6 17.7 27.1 47.5 41.0 25.6 13.6 37.3 19.7 12.7 71.2 24.1 11.9 22.8 14.5 25.3 21.0 17.7 17.6 13.3 18.3 27.0 27.2 81.8 18.8 20.6 16.4 18.3 11.6 13.0 14.6 15.9 19.2 15.4 14.1 14.6 14.6 14.2 12.6 13.5 18.8 14.6 20.9 7.4 14.8 10.6 14.9 16.5 24.2 16.8 14.2 9.0 19.0 12.3 16.1 18.1 14.9 40.5 34.1 27.4 42.1 27.5 15.5 43.3 46.8 39.8 22.7 27.5 30.8 8.3 26.3 70.8 29.5 51.6 46.7 40.6 26.0 23.4 33.4 30.2 35.2 31.0 38.1 34.7 27.0 46.6 26.6 23.0 34.4 18.6 27.9 57.2 18.1 34.7 23.0 30.4 19.2 22.3 32.3 23.9 105.1 59.6 41.0 31.7 34.6 59.2 59.6 CNOT3 "KIAA0691, LENG2, NOT3, NOT3H" ENSG00000088038 "CCR4-NOT transcription complex subunit 3" O75175 19 54137717-54155708 "Cancer-related genes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 72.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006408 Approved Approved Cytosol NA NA Cytosol "HPA006408: AB_1078543" "unprognostic (1.23e-1)" "unprognostic (2.54e-1)" "unprognostic (1.75e-2)" "unprognostic (1.40e-1)" "unprognostic (4.86e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (9.06e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-2)" "unprognostic (9.30e-3)" "unprognostic (4.08e-3)" "prognostic unfavorable (2.77e-4)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" "unprognostic (2.66e-2)" 18.1 25.2 25.5 23.6 26.4 21.4 20.2 46.8 27.9 22.1 20.7 24.5 27.7 21.3 25.0 26.5 22.1 23.6 19.7 16.2 21.9 15.6 21.3 20.2 17.9 23.9 25.5 20.8 28.0 22.7 27.6 30.2 24.2 20.3 23.3 17.5 20.7 22.4 31.4 20.2 25.2 21.4 22.0 16.7 26.3 21.9 34.4 26.9 33.6 26.3 14.3 23.3 23.8 29.9 3.2 6.7 8.4 3.1 1.6 3.6 2.9 13.8 22.3 23.2 13.3 8.6 8.8 16.2 13.0 22.5 17.4 15.6 14.3 12.0 17.1 8.3 15.0 14.3 14.6 25.7 12.6 18.1 17.6 72.5 26.5 14.5 12.7 15.0 15.1 18.6 11.0 12.2 15.5 26.3 12.6 13.8 13.0 19.5 16.0 12.8 17.1 18.7 8.9 14.1 28.5 17.9 18.7 17.8 11.1 11.7 28.1 15.0 12.6 25.1 18.1 8.2 18.0 10.3 16.2 12.3 14.8 17.1 7.9 17.6 15.1 16.4 23.6 12.9 11.6 15.6 1.4 3.1 5.2 3.6 2.2 2.5 2.9 2.4 3.2 2.8 3.2 2.7 2.6 8.4 1.6 2.6 6.7 2.5 2.9 25.5 26.4 46.8 27.9 21.9 15.6 25.5 20.8 20.3 26.9 11.9 9.0 17.1 14.7 8.9 17.3 1.7 12.7 12.0 11.4 7.0 15.7 23.7 8.3 12.8 7.4 10.5 14.4 0.0 12.6 22.9 13.5 16.1 3.5 7.6 14.1 15.9 13.8 12.9 7.9 5.4 15.8 7.2 5.0 16.2 15.2 11.3 13.1 20.1 8.9 8.1 17.8 6.5 11.2 44.2 39.9 8.7 41.9 12.5 11.9 14.8 CNOT6 "CCR4, Ccr4a, KIAA1194" ENSG00000113300 "CCR4-NOT transcription complex subunit 6" Q9ULM6 5 180494412-180578405 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044568 Approved Approved Cytosol NA NA Cytosol "HPA044568: AB_10797257" "unprognostic (9.41e-3)" "unprognostic (1.40e-1)" "unprognostic (2.03e-3)" "unprognostic (2.55e-1)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (1.79e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-1)" "unprognostic (4.03e-2)" "unprognostic (3.57e-2)" 10.2 10.1 19.2 15.4 20.2 14.4 13.3 43.9 18.7 12.0 16.4 11.7 9.7 16.2 13.1 12.4 19.6 13.3 12.7 13.0 15.9 11.1 14.1 8.6 13.0 14.3 12.3 14.0 14.8 10.3 13.4 12.7 17.6 12.9 13.9 16.2 14.3 13.4 10.9 8.3 14.4 20.6 13.4 12.3 17.0 13.7 17.6 14.9 25.1 12.6 10.0 18.4 16.9 24.5 2.2 2.5 3.4 5.8 2.1 4.5 1.7 11.1 13.4 27.6 22.0 4.6 5.3 28.5 8.1 5.5 10.9 13.0 16.3 16.4 11.8 12.5 5.3 15.1 11.7 23.0 27.2 12.8 34.5 11.5 12.8 18.1 10.5 6.8 14.9 9.4 4.4 13.2 8.0 17.0 10.2 13.2 13.9 13.6 11.4 10.0 22.9 18.9 9.0 8.1 11.2 6.4 17.5 13.9 8.4 12.0 22.1 20.2 17.1 13.8 18.5 11.8 14.1 23.1 15.1 14.3 11.6 13.4 8.4 14.4 7.4 13.3 12.5 11.0 20.5 9.5 1.5 2.6 3.4 3.8 4.1 4.0 2.0 3.3 2.3 2.4 2.2 4.5 4.4 2.2 2.1 5.8 2.5 2.3 1.7 19.2 20.2 43.9 18.7 15.9 11.1 12.3 14.0 12.9 14.9 26.8 12.0 6.7 5.5 19.3 18.0 9.6 10.2 8.1 6.8 10.4 21.6 7.9 1.7 10.2 5.2 11.9 11.1 0.0 7.8 9.9 10.4 14.0 2.3 5.7 10.6 17.5 13.9 14.7 16.7 7.5 12.0 13.1 10.1 8.2 14.3 13.1 12.9 5.8 17.7 11.8 15.3 25.8 7.3 39.4 56.2 19.4 9.6 12.9 15.1 12.9 CNOT6L "Ccr4b, DKFZp434K098" ENSG00000138767 "CCR4-NOT transcription complex subunit 6 like" Q96LI5 4 77713387-77819615 "Enzymes, Predicted intracellular proteins" "mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 51.3" "Cell type enhanced" "Detected in many" 5 "T-cells: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042688 Uncertain Supported Cytosol NA NA Cytosol "HPA042688: AB_10794384" "unprognostic (3.91e-1)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.10e-2)" "unprognostic (2.56e-1)" "unprognostic (3.72e-2)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (5.06e-2)" "unprognostic (6.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (4.51e-2)" "unprognostic (7.95e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-3)" 13.6 7.8 8.6 21.5 8.2 15.3 11.0 11.1 9.2 7.8 7.3 7.0 4.6 7.5 11.4 6.3 10.2 7.1 8.3 7.5 6.0 5.7 7.7 10.8 12.7 19.2 7.6 7.3 8.8 10.8 14.6 10.0 12.3 6.7 8.4 8.9 10.3 9.9 7.4 9.1 12.2 11.5 8.4 6.9 23.4 7.9 7.3 5.6 51.3 9.1 6.2 21.1 10.7 10.3 7.5 6.1 20.2 9.3 7.4 10.0 4.4 8.8 5.7 7.2 4.8 8.5 7.4 7.1 7.0 9.3 6.3 8.6 2.2 9.9 15.3 8.9 9.8 5.0 5.7 9.3 9.7 8.5 15.3 5.2 14.3 7.9 6.4 5.4 14.2 12.6 4.8 12.6 7.1 13.0 6.0 20.0 11.1 11.9 20.5 7.3 6.0 26.2 7.2 3.3 7.0 1.8 6.5 20.4 10.9 7.2 10.0 8.9 4.3 12.1 11.1 4.9 8.8 3.5 7.3 21.7 6.1 6.8 11.5 3.8 26.3 11.2 19.0 6.6 6.2 4.5 20.2 4.7 10.2 10.0 7.0 10.0 5.3 7.5 7.8 4.5 7.5 7.3 8.5 6.7 7.4 9.3 6.1 6.0 4.4 8.6 8.2 11.1 9.2 6.0 5.7 7.6 7.3 6.7 5.6 20.8 16.0 29.6 11.9 51.4 38.1 14.5 22.9 14.7 28.4 34.9 37.3 22.8 51.4 5.9 3.4 42.7 16.9 0.0 10.5 7.4 21.1 30.3 36.9 27.0 14.9 30.2 25.2 41.7 40.3 2.8 17.3 33.5 23.6 14.4 31.3 20.1 8.9 14.0 12.0 17.0 40.7 32.3 31.7 19.1 30.9 57.7 20.4 121.5 23.0 16.3 CNPY2 "Cnpy2, HP10390, TMEM4, ZSIG9" ENSG00000257727 "Canopy FGF signaling regulator 2" Q9Y2B0 12 56309842-56316336 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 396.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038465, HPA038466" Supported Supported Cytosol "Intracellular and membrane" NA NA 62000 Cytosol "HPA038465: AB_10967609, HPA038466: AB_10672646" "unprognostic (3.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.49e-1)" "unprognostic (2.46e-2)" "unprognostic (4.33e-2)" "unprognostic (2.20e-1)" "unprognostic (1.17e-3)" "unprognostic (1.46e-1)" "unprognostic (7.68e-2)" "unprognostic (2.04e-3)" "prognostic favorable (8.37e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (2.32e-8)" "unprognostic (1.91e-1)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (5.06e-2)" 17.8 31.4 19.0 16.1 23.8 14.0 27.3 17.3 24.1 29.9 23.7 23.3 40.1 23.0 21.1 46.4 19.1 26.1 19.9 16.9 19.0 20.4 26.7 53.2 17.3 14.9 21.2 21.8 25.7 59.9 19.9 39.3 39.7 21.6 23.4 24.2 18.9 46.2 33.4 10.9 12.3 26.4 16.8 22.5 20.2 23.6 13.7 20.4 13.0 38.0 15.5 16.2 19.7 17.4 33.1 35.3 22.2 36.4 30.1 38.7 33.7 16.2 29.3 21.0 19.3 57.3 22.4 42.5 18.5 36.9 34.5 24.6 39.0 29.1 15.1 32.0 39.9 18.0 23.7 26.2 20.7 20.1 18.3 24.5 14.5 30.9 34.3 28.5 27.3 22.3 26.0 31.5 28.4 32.0 49.5 27.9 21.2 23.2 39.1 23.7 26.7 16.7 32.3 21.5 33.0 41.8 19.7 17.2 32.0 26.8 12.5 22.6 13.3 27.2 27.2 27.2 28.3 25.7 60.1 15.0 15.1 11.5 16.4 22.1 19.2 25.5 11.4 28.0 26.7 24.1 22.2 36.4 18.3 33.4 26.1 38.7 33.1 37.2 35.2 35.3 27.6 37.9 34.3 5.2 30.1 15.9 34.3 31.2 33.7 19.0 23.8 17.3 24.1 19.0 20.4 21.2 21.8 21.6 20.4 44.7 80.8 67.3 61.3 48.7 74.0 8.5 150.3 68.3 56.9 96.0 60.9 216.3 44.7 170.3 31.1 66.5 86.5 23.3 146.9 396.1 82.6 106.0 90.0 177.6 129.7 55.6 136.3 84.7 56.3 11.1 96.1 63.5 116.4 114.6 123.9 72.9 148.7 108.7 94.0 116.9 81.3 25.8 72.2 66.7 41.7 47.0 197.7 84.1 139.6 60.7 CNRIP1 "C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924" ENSG00000119865 "Cannabinoid receptor interacting protein 1" Q96F85 2 68284171-68320051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 71.9;granulocytes: 120.1" "Cancer enhanced" "Detected in all" "glioma: 14.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 79 "basophil: 11.1" "Lineage enriched" "Detected in single" 79 "granulocytes: 11.1" "Cell line enhanced" "Detected in many" "HEL: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035337 Approved Cytosol NA NA 50000 Cytosol "HPA035337: AB_10601359" "unprognostic (1.23e-1)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.20e-1)" "unprognostic (6.51e-2)" "unprognostic (3.52e-2)" "unprognostic (2.86e-2)" "unprognostic (4.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.04e-2)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (3.38e-3)" 26.6 8.6 26.9 7.1 21.9 6.4 11.8 28.3 42.2 15.3 7.3 7.5 2.0 4.9 15.7 8.0 6.3 9.3 10.3 8.8 26.9 22.4 5.0 3.8 10.0 5.7 16.0 22.9 24.5 2.6 2.7 7.2 14.7 12.7 10.1 6.3 10.9 3.3 11.6 7.8 3.6 7.0 11.8 10.8 10.8 5.7 4.0 6.5 0.1 4.1 3.0 4.1 9.3 13.6 0.1 0.0 11.1 0.1 0.0 0.1 0.1 0.0 0.3 3.0 0.0 11.5 8.5 0.0 11.5 8.9 10.4 7.5 0.0 0.0 0.0 0.4 11.0 7.9 0.0 0.2 0.1 11.0 0.0 2.8 53.5 0.8 0.0 12.1 0.0 7.6 7.9 0.0 6.9 4.0 6.4 16.0 0.0 0.0 0.0 7.5 0.0 0.0 0.1 5.2 0.0 5.3 0.0 4.7 0.0 0.0 0.0 15.8 16.0 0.8 0.0 8.8 0.0 0.0 0.5 17.0 7.3 4.7 6.4 16.7 0.0 0.0 0.0 5.8 0.0 5.3 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 26.9 21.9 28.3 31.9 26.9 22.4 16.0 22.9 12.7 6.5 0.0 7.0 0.0 0.4 11.4 71.9 1.9 0.0 0.0 1.2 0.0 21.6 1.3 0.0 0.3 0.6 60.8 0.0 23.3 0.2 8.9 42.3 0.7 120.1 0.5 43.9 27.0 0.0 30.1 16.8 1.5 42.0 12.4 35.4 3.6 0.0 23.6 0.9 0.0 40.0 0.0 41.8 45.3 56.7 0.4 0.2 9.4 1.7 2.2 0.0 0.9 COL21A1 ENSG00000124749 "Collagen type XXI alpha 1 chain" Q96P44 6 56056590-56394094 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 36.4;Ciliated cells: 58.9;Extravillous trophoblasts: 52.2;Fibroblasts: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2;SuSa: 9.3" HPA031212 Supported Cytosol "Secreted to extracellular matrix" NA NA 180000 Cytosol "HPA031212: AB_10599941" "unprognostic (1.69e-1)" "unprognostic (4.53e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-1)" "unprognostic (1.21e-1)" "unprognostic (9.32e-3)" "unprognostic (6.84e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-3)" "unprognostic (2.17e-1)" "unprognostic (5.29e-2)" "unprognostic (3.10e-1)" "unprognostic (1.26e-3)" "unprognostic (3.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-3)" 3.9 1.6 6.6 2.1 2.3 0.3 3.0 5.1 3.6 25.8 11.3 5.2 7.9 0.8 20.0 7.0 3.3 7.6 3.9 4.5 8.5 2.5 1.4 1.5 7.4 0.7 3.6 4.6 3.9 2.1 0.8 3.6 26.4 6.9 5.4 2.2 5.9 4.4 10.9 2.3 6.3 2.6 24.2 5.3 0.7 5.7 3.8 5.8 0.0 2.1 4.1 0.8 10.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.1 0.0 1.0 18.9 6.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.6 0.1 0.0 19.2 0.7 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.6 2.3 5.1 3.6 8.5 2.5 3.6 4.6 6.9 5.8 0.0 1.0 0.0 2.3 5.3 0.0 36.4 0.0 58.9 12.5 0.0 0.0 17.6 0.0 0.0 3.5 3.4 0.0 0.0 0.0 52.2 33.7 0.1 0.0 0.0 5.4 0.0 0.0 4.3 0.8 1.1 14.1 1.0 5.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 6.6 0.2 0.6 3.6 19.5 0.0 0.0 1.5 COL6A1 ENSG00000142156 "Collagen type VI alpha 1 chain" P12109 21 45981737-46005050 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 779.8;Leydig cells: 326.8;Peritubular cells: 236.2;Smooth muscle cells: 211.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.0;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 94.0;ASC TERT1: 191.4;BJ: 71.8;HHSteC: 83.5;HSkMC: 139.9;U-138 MG: 104.8" "Low region specificity" "Detected in all" "HPA019142, HPA029401" Enhanced Approved Cytosol "Secreted to extracellular matrix" NA NA 250000000 Cytosol "HPA019142: AB_1847093, HPA029401: AB_10601361" "unprognostic (3.45e-1)" "unprognostic (4.09e-2)" "unprognostic (8.71e-2)" "unprognostic (1.72e-1)" "unprognostic (5.79e-3)" "unprognostic (2.12e-1)" "unprognostic (6.27e-2)" "unprognostic (1.09e-2)" "unprognostic (4.47e-2)" "unprognostic (3.69e-2)" "unprognostic (6.06e-3)" "unprognostic (3.86e-1)" "prognostic unfavorable (1.07e-8)" "unprognostic (5.16e-2)" "unprognostic (7.39e-2)" "unprognostic (3.53e-3)" "prognostic unfavorable (4.54e-4)" 73.4 10.8 6.8 45.5 7.1 0.1 85.4 31.9 9.1 100.7 111.6 5.1 34.7 17.1 98.8 75.0 54.5 64.7 89.7 39.7 6.0 5.6 10.2 9.9 21.6 24.7 4.8 5.4 83.0 13.5 6.2 19.8 65.7 9.2 59.6 9.9 18.6 23.1 36.4 20.0 28.2 33.8 147.8 4.7 15.9 40.9 20.2 5.5 9.4 15.9 23.4 12.8 86.9 49.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 1.5 2.4 7.8 94.0 191.4 0.3 71.8 46.4 18.5 6.5 1.2 4.9 0.0 5.9 40.4 14.6 0.3 1.0 0.1 1.5 0.0 1.1 0.0 0.2 0.4 83.5 0.0 0.1 139.9 0.0 46.0 0.6 1.6 0.4 0.0 0.0 0.0 4.7 0.1 0.0 0.2 1.7 1.0 20.2 0.0 1.5 0.3 0.1 0.8 0.0 3.1 6.6 0.0 1.3 0.8 0.3 0.3 0.0 104.8 7.0 28.7 27.4 0.0 0.0 0.0 37.4 0.5 9.1 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.3 1.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 7.1 31.9 9.1 6.0 5.6 4.8 5.4 9.2 5.5 0.0 8.0 0.0 9.3 108.5 14.9 33.6 2.5 1.4 7.9 8.7 0.0 9.8 3.3 23.9 4.1 30.5 0.9 0.0 2.7 15.4 779.8 4.8 1.1 11.4 20.9 14.3 1.7 138.1 4.8 7.9 326.8 5.6 140.0 3.6 0.0 22.6 7.8 0.3 236.2 11.6 2.3 181.1 211.6 2.6 4.7 78.5 17.4 2.5 0.6 2.4 COPB2 "beta'-COP, betaprime-COP" ENSG00000184432 "Coatomer protein complex subunit beta 2" P35606 3 139355600-139389732 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036867, HPA058180" Approved Approved Cytosol NA NA 1000000 Cytosol "HPA036867: AB_10672271, HPA058180: AB_2683630" "unprognostic (3.37e-2)" "unprognostic (2.04e-1)" "unprognostic (9.38e-2)" "unprognostic (6.93e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.41e-7)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (8.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.44e-2)" "unprognostic (1.14e-1)" "unprognostic (6.05e-2)" "unprognostic (4.95e-2)" 28.7 40.8 21.9 22.3 26.2 12.1 28.7 31.7 29.0 39.5 32.4 22.6 40.3 26.1 33.0 44.7 35.9 28.9 26.2 31.4 21.6 18.9 42.1 67.5 29.1 20.1 26.0 16.6 36.0 65.5 41.2 72.2 51.7 28.7 35.5 33.8 20.5 46.5 28.6 20.6 23.5 37.1 30.0 21.1 31.3 29.9 21.1 25.7 33.1 40.4 27.4 31.2 30.0 26.5 22.6 36.4 35.9 34.4 27.4 23.5 22.6 53.5 21.5 31.6 28.5 63.6 58.6 27.7 64.2 61.0 41.5 51.3 40.2 20.4 21.7 59.4 68.0 37.6 28.5 35.9 34.3 52.1 37.4 24.6 32.6 34.1 38.4 38.1 29.0 37.4 41.0 31.2 32.6 33.8 48.2 40.0 19.6 21.3 26.3 49.1 32.4 14.5 17.8 28.7 53.3 23.7 19.6 25.6 37.3 38.1 38.8 22.4 20.6 63.1 57.2 35.4 44.7 45.6 31.3 46.6 23.3 18.8 34.4 22.5 41.1 24.5 38.3 39.0 16.5 36.0 35.9 28.4 30.1 22.9 34.4 23.2 22.6 20.4 23.5 36.4 16.3 15.9 20.0 26.9 27.4 32.3 17.0 21.9 22.6 21.9 26.2 31.7 29.0 21.6 18.9 26.0 16.6 28.7 25.7 53.6 34.0 32.0 34.0 17.4 34.8 47.2 33.1 93.7 52.4 19.2 29.5 71.4 34.9 71.2 24.9 41.9 41.4 0.0 72.1 64.7 71.0 57.8 43.9 43.3 46.9 39.7 61.3 37.4 38.0 5.8 50.6 31.5 20.3 57.7 71.8 55.4 68.4 28.8 47.0 37.2 44.9 19.4 46.7 47.7 43.0 13.0 111.3 34.9 36.6 37.8 COQ10B FLJ13448 ENSG00000115520 "Coenzyme Q10B" Q9H8M1 2 197453423-197475308 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046057 Approved Approved Cytosol NA NA Cytosol "HPA046057: AB_2679518" "unprognostic (9.17e-2)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.82e-3)" "unprognostic (8.28e-3)" "unprognostic (5.76e-3)" "unprognostic (4.55e-1)" "unprognostic (2.93e-1)" "unprognostic (7.18e-2)" "unprognostic (6.00e-2)" "unprognostic (4.13e-2)" "unprognostic (3.99e-1)" "unprognostic (2.87e-3)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (3.13e-3)" 24.5 34.0 19.3 14.5 18.2 34.0 21.8 13.3 23.2 15.1 16.8 16.6 13.0 13.9 19.2 14.6 16.7 14.9 23.2 28.7 18.7 18.8 30.1 34.3 17.3 15.3 18.3 14.1 15.2 25.0 20.4 23.0 33.1 20.6 16.1 18.2 17.6 17.4 16.3 16.0 13.3 22.3 25.5 17.3 17.7 17.8 9.1 12.6 11.5 18.7 16.2 16.4 21.1 14.1 14.8 11.7 40.6 17.8 13.9 24.1 16.0 6.9 6.7 4.9 8.6 23.5 16.8 11.4 18.2 26.3 19.6 21.9 13.4 8.4 6.5 15.6 14.6 24.5 6.4 7.0 9.7 22.4 12.8 6.0 9.3 9.6 15.7 19.7 7.5 21.7 18.7 15.1 18.6 13.3 10.7 10.6 9.5 7.8 17.5 18.7 9.1 8.1 11.7 7.5 8.2 13.7 6.2 7.2 8.5 21.1 18.9 3.1 6.1 8.3 11.0 22.6 18.1 7.8 10.6 11.1 19.4 6.7 21.6 13.0 16.7 23.6 7.3 24.2 7.3 14.9 27.3 13.6 24.4 20.7 15.6 23.3 14.8 20.0 20.5 11.7 11.5 21.1 21.4 40.6 13.9 17.8 7.4 24.1 16.0 19.3 18.2 13.3 23.2 18.7 18.8 18.3 14.1 20.6 12.6 17.9 14.5 31.9 92.5 93.8 29.4 27.1 22.9 29.4 15.9 38.4 39.3 28.2 109.5 35.0 38.1 42.3 36.8 46.7 40.9 38.0 47.3 53.4 59.9 32.1 27.7 60.4 25.8 20.9 18.3 14.4 19.0 38.3 67.4 32.5 31.3 50.9 41.3 28.1 28.7 58.7 32.0 45.3 69.0 19.3 34.7 93.2 145.4 45.8 12.3 83.8 COQ2 "CL640, FLJ26072" ENSG00000173085 "Coenzyme Q2, polyprenyltransferase" Q96H96 4 83261536-83284914 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease mutation, Neurodegeneration, Parkinsonism, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 45.2;Kupffer cells: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056599, HPA068727" Approved Approved Cytosol NA NA Cytosol "HPA056599: AB_2683184, HPA068727: AB_2686022" "unprognostic (8.26e-2)" "unprognostic (7.40e-3)" "unprognostic (3.95e-3)" "unprognostic (1.55e-1)" "unprognostic (9.22e-2)" "unprognostic (5.59e-2)" "unprognostic (1.26e-2)" "unprognostic (1.52e-1)" "unprognostic (4.09e-1)" "unprognostic (4.16e-2)" "unprognostic (2.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.56e-2)" "unprognostic (3.73e-1)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (2.46e-1)" 6.6 25.5 4.9 8.4 7.0 8.9 9.9 1.9 6.0 7.4 12.1 5.8 8.4 7.8 8.0 10.2 13.1 5.4 7.4 17.5 4.3 4.1 8.0 14.9 9.8 9.0 6.5 3.4 8.0 5.9 6.7 12.3 7.2 5.0 6.6 12.5 5.2 12.7 8.5 21.8 13.8 8.2 5.8 6.7 14.1 4.8 6.6 6.7 2.9 10.1 23.9 9.2 6.2 7.4 3.6 11.8 6.0 17.4 3.7 2.0 6.8 11.7 6.9 6.8 12.9 5.3 5.4 4.8 7.6 12.6 14.5 17.0 4.8 17.0 7.9 5.6 13.5 11.5 9.1 11.5 12.4 18.3 8.1 7.3 7.1 9.0 6.7 5.8 14.4 34.2 8.0 7.9 7.0 12.1 4.3 14.4 4.5 4.6 9.5 13.4 12.1 3.8 9.7 5.0 13.9 9.7 6.6 5.3 10.2 21.1 5.7 4.8 3.1 8.7 11.1 3.9 3.2 7.1 7.9 10.0 6.8 7.1 5.1 10.6 2.8 2.3 4.7 13.3 16.9 9.3 1.1 16.3 2.3 1.6 14.4 1.2 3.6 1.8 1.5 11.8 3.5 1.3 2.0 6.0 3.7 17.4 6.2 2.0 6.8 4.9 7.0 1.9 6.0 4.3 4.1 6.5 3.4 5.0 6.7 0.0 3.4 11.8 9.6 6.0 5.2 17.1 5.1 2.7 6.8 8.7 0.0 20.5 26.6 5.8 0.6 3.6 9.6 0.0 9.5 25.6 5.4 9.8 0.0 11.4 45.2 1.6 4.6 12.9 48.6 0.6 3.4 26.3 6.8 1.0 15.2 12.9 4.7 14.0 4.6 8.2 4.2 0.0 4.7 4.3 14.5 11.0 10.4 10.0 23.9 8.9 CORO1A "coronin-1, HCORO1, p57" ENSG00000102879 "Coronin 1A" P31146 16 30182827-30189076 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 204.4;bone marrow: 94.9;lymphoid tissue: 99.8" "Group enriched" "Detected in many" 5 "B-cells: 445.3;Hofbauer cells: 429.4;Kupffer cells: 429.2;Macrophages: 313.3;monocytes: 310.2;T-cells: 809.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 86.3;HL-60: 60.2;HMC-1: 104.2;JURKAT: 54.9;MOLT-4: 58.2;NB-4: 68.9;RPMI-8226: 90.9;U-698: 56.3;U-937: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046473, HPA051132" Enhanced Approved Cytosol NA NA 130000000 Cytosol "CAB046473: AB_10602363, HPA051132: AB_2681355" "unprognostic (4.17e-3)" "unprognostic (3.64e-3)" "unprognostic (3.86e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.41e-1)" "prognostic favorable (4.42e-4)" "unprognostic (1.99e-2)" "unprognostic (8.27e-3)" "unprognostic (8.26e-3)" "unprognostic (4.30e-1)" "unprognostic (1.54e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.74e-7)" "unprognostic (2.55e-1)" "unprognostic (2.37e-2)" "unprognostic (7.16e-2)" "unprognostic (2.01e-1)" 6.4 4.9 12.7 58.9 10.8 94.9 4.4 7.8 13.6 2.9 5.0 6.0 0.2 8.3 3.0 3.0 4.7 5.9 8.6 4.8 10.4 7.8 4.9 3.8 13.7 99.8 9.6 8.2 2.2 2.7 0.6 3.0 4.8 7.3 3.3 2.9 2.2 12.3 1.6 1.3 3.4 28.7 4.1 9.0 92.0 8.5 1.1 7.5 86.0 3.6 3.2 64.8 15.8 3.1 41.6 67.7 204.4 67.5 39.1 66.4 101.2 0.2 0.3 1.0 2.1 0.0 0.0 0.5 0.2 0.0 0.5 0.2 0.0 0.6 86.3 0.5 0.0 0.1 0.4 0.4 1.0 0.1 27.6 0.2 9.1 0.0 1.3 0.1 60.2 104.2 0.3 0.0 0.4 0.0 0.0 0.1 54.9 0.1 44.4 0.3 7.3 58.2 68.9 0.4 0.2 0.6 31.7 1.6 90.9 0.1 0.4 1.6 1.2 0.2 10.4 0.2 0.0 0.1 35.0 0.1 0.4 0.8 0.2 0.2 34.5 45.5 56.3 0.3 76.3 0.6 52.5 58.3 204.4 53.7 67.5 50.5 41.6 48.4 52.2 67.7 41.6 46.6 48.1 105.8 39.1 66.3 38.2 66.4 101.2 12.7 10.8 7.8 13.6 10.4 7.8 9.6 8.2 7.3 7.5 20.8 52.4 445.3 1.0 10.1 1.2 1.2 17.8 5.3 7.9 1.8 0.0 4.1 0.0 3.5 0.4 3.6 1.1 0.0 0.8 13.9 9.4 0.7 83.0 2.1 429.4 0.0 5.8 20.9 429.2 0.4 0.6 313.3 30.4 310.2 1.7 0.8 6.6 28.8 0.0 3.7 0.7 6.5 7.2 0.0 0.9 8.0 4.1 809.5 1.3 1.0 COTL1 CLP ENSG00000103187 "Coactosin like F-actin binding protein 1" Q14019 16 84565594-84618077 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Chaperone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 206.6;lymphoid tissue: 103.0" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 1310.7;Hofbauer cells: 547.8;Kupffer cells: 920.9;Macrophages: 713.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 110.8;eosinophil: 160.2;intermediate monocyte: 190.1;myeloid DC: 117.3;neutrophil: 86.8;non-classical monocyte: 206.6" "Group enriched" "Detected in all" 5 "dendritic cells: 117.3;granulocytes: 160.2;monocytes: 206.6" "Cell line enhanced" "Detected in many" "WM-115: 130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008918, CAB062328" Enhanced Supported Cytosol NA NA 28000000 Cytosol "CAB062328: AB_2084785, HPA008918: AB_2668176" "unprognostic (2.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (3.21e-3)" "unprognostic (8.95e-2)" "unprognostic (2.43e-1)" "unprognostic (1.14e-1)" "unprognostic (7.70e-2)" "unprognostic (5.99e-2)" "unprognostic (5.43e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (5.48e-2)" "unprognostic (7.73e-2)" "unprognostic (3.35e-3)" 28.6 9.9 20.4 68.1 19.5 57.7 13.7 12.4 18.1 7.6 16.5 25.3 2.4 22.0 13.2 8.4 8.2 13.2 18.7 7.2 19.6 24.9 34.3 12.4 26.6 103.0 28.9 8.1 10.8 7.5 5.1 13.1 29.4 23.2 11.8 16.7 30.8 7.7 7.6 5.1 5.1 26.1 16.2 27.8 92.3 29.6 8.0 13.4 33.0 10.1 5.2 62.0 29.3 7.6 28.5 117.3 160.2 206.6 30.8 32.5 108.3 53.9 45.1 103.2 108.9 11.8 32.7 31.1 47.0 30.4 37.1 14.4 61.2 83.8 15.0 14.4 35.3 22.1 27.2 6.3 37.0 37.4 0.1 7.9 28.1 9.5 16.1 33.5 31.5 111.6 26.1 5.9 35.7 32.0 23.3 17.6 33.3 2.6 6.2 22.0 8.7 9.7 19.0 12.7 17.8 46.1 1.0 3.5 0.9 54.4 23.0 16.3 0.8 43.8 10.5 23.4 12.7 7.9 25.7 45.3 53.5 30.4 17.1 34.2 1.2 5.6 12.2 41.8 15.4 130.2 29.6 110.8 160.2 3.6 190.1 4.8 28.5 23.0 21.7 117.3 13.2 10.3 12.1 86.8 30.8 206.6 6.0 32.5 108.3 20.4 19.5 12.4 18.1 19.6 24.9 28.9 8.1 23.2 13.4 3.0 13.5 259.5 72.9 56.3 9.5 4.4 17.8 2.7 6.8 73.3 229.7 114.0 33.2 49.7 5.6 83.4 40.6 0.0 29.3 1310.7 47.3 43.2 143.7 4.2 547.8 23.8 139.8 242.5 920.9 6.9 7.5 713.2 91.1 125.4 65.3 16.9 70.8 14.4 15.2 238.6 41.0 6.5 62.8 2.9 18.1 33.4 144.5 177.7 122.8 153.6 COX19 MGC104475 ENSG00000240230 "COX19, cytochrome c oxidase assembly factor" Q49B96 7 898778-975599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021226 Approved Supported Cytosol NA NA Cytosol "HPA021226: AB_1847176" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (1.05e-2)" "unprognostic (3.76e-2)" "unprognostic (5.22e-2)" "unprognostic (1.05e-1)" "unprognostic (2.13e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-1)" "unprognostic (5.60e-2)" "unprognostic (4.79e-2)" "unprognostic (3.36e-2)" "unprognostic (2.37e-3)" "unprognostic (2.49e-2)" "unprognostic (1.64e-1)" "unprognostic (2.74e-1)" "unprognostic (9.14e-3)" 8.1 22.1 11.9 9.4 15.8 16.6 9.6 25.4 13.3 8.6 10.2 14.5 10.8 15.7 9.2 8.5 10.2 15.0 8.3 9.5 11.3 9.7 10.6 9.9 8.8 11.4 18.5 10.4 12.7 16.4 13.9 13.7 8.4 14.1 10.8 10.5 8.0 13.3 9.0 18.9 16.5 13.3 8.7 12.6 13.6 13.4 11.2 15.3 8.5 10.5 12.4 11.6 9.2 9.9 12.5 15.0 15.1 9.9 10.1 15.2 7.6 14.3 3.6 4.3 5.4 3.1 4.6 8.3 6.3 4.6 5.8 4.8 9.7 8.1 7.0 2.2 3.8 8.7 9.7 4.5 4.7 4.7 2.2 7.3 3.1 4.4 7.5 9.9 7.3 6.8 5.4 9.9 4.5 10.4 5.7 3.6 7.1 8.9 6.0 3.6 8.7 3.3 7.9 11.1 16.3 9.6 7.6 0.8 3.5 4.8 6.2 5.6 5.6 3.7 14.9 11.5 7.2 7.8 17.5 4.3 5.6 7.9 6.3 9.8 7.3 5.2 7.2 5.1 10.3 9.5 15.1 9.9 13.9 11.2 9.7 11.8 12.5 12.1 10.1 8.4 12.2 15.2 14.3 9.5 10.1 9.9 15.0 11.1 7.6 11.9 15.8 25.4 13.3 11.3 9.7 18.5 10.4 14.1 15.3 11.9 18.4 21.7 30.1 21.9 18.7 12.3 33.1 26.8 14.8 29.6 11.8 23.3 13.3 32.2 5.2 19.6 27.7 0.0 30.0 34.1 18.9 24.5 34.6 25.1 23.5 14.3 43.0 24.5 18.6 1.7 18.1 28.2 20.3 40.5 28.9 29.4 36.3 31.7 13.4 17.4 25.8 6.5 21.1 17.2 30.6 22.5 35.0 42.4 28.2 37.2 CPEB2 ENSG00000137449 "Cytoplasmic polyadenylation element binding protein 2" Q7Z5Q1 4 15002674-15070153 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 76.2;Suprabasal keratinocytes: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072513 Approved Cytosol Yes No Cytosol "HPA072513: AB_2686529" "unprognostic (6.59e-2)" "unprognostic (4.21e-3)" "unprognostic (4.75e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-2)" "unprognostic (2.36e-2)" "unprognostic (5.67e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-1)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (8.62e-2)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" 10.0 7.5 18.5 6.0 21.5 23.0 13.6 11.5 21.0 8.8 11.5 28.7 13.2 9.6 8.2 9.4 13.6 7.1 10.7 7.8 17.4 16.2 13.5 18.9 9.5 6.4 27.2 17.4 7.9 5.4 23.8 6.4 7.4 16.4 10.2 10.7 20.7 8.9 21.9 7.1 23.0 9.5 10.8 21.7 6.6 10.8 37.4 27.6 3.6 6.1 7.8 7.2 8.3 12.6 0.4 0.7 2.4 0.4 1.3 1.6 0.3 1.3 8.3 0.8 0.3 6.2 11.4 1.4 4.6 3.1 2.9 2.1 0.2 1.6 0.8 0.9 4.2 5.4 1.5 1.8 1.0 1.8 2.3 0.6 0.2 6.4 1.4 2.9 0.3 1.1 5.6 5.5 7.0 6.8 3.6 2.6 0.1 0.1 6.0 11.8 0.6 0.1 1.8 0.8 2.4 1.2 0.1 0.6 0.3 25.2 1.1 0.7 4.6 1.5 1.0 4.7 3.9 0.6 5.3 5.1 10.4 0.9 6.5 2.5 3.9 0.5 0.4 8.5 4.7 3.8 0.0 0.4 1.7 0.5 0.4 1.6 0.1 0.8 0.5 0.7 0.4 0.9 0.3 2.4 1.3 0.2 0.3 0.2 0.3 18.5 21.5 11.5 21.0 17.4 16.2 27.2 17.4 16.4 27.6 29.8 13.9 5.8 9.4 76.2 7.6 18.3 15.3 1.4 6.8 29.6 25.5 1.1 1.7 3.5 47.6 11.4 23.2 0.0 4.2 1.2 11.0 8.7 10.4 21.2 9.1 14.3 9.8 12.9 15.4 15.5 5.8 12.2 50.6 2.8 10.9 6.1 5.9 11.9 7.8 10.3 19.0 0.0 13.4 14.7 3.1 113.2 1.1 6.4 6.6 14.4 CPNE5 "COPN5, CPN5, KIAA1599" ENSG00000124772 "Copine 5" Q9HCH3 6 36740775-36840002 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.1;brain: 50.3;heart muscle: 28.6" "Cell type enhanced" "Detected in many" 16 "B-cells: 43.6;Cardiomyocytes: 20.4;granulocytes: 11.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 50.3" "Group enriched" "Detected in some" 82 "memory B-cell: 27.1;naive B-cell: 12.9" "Lineage enriched" "Detected in single" 111 "B-cells: 27.1" "Group enriched" "Detected in some" 4 "Daudi: 33.0;HUVEC TERT2: 13.6;U-266/70: 11.4;U-266/84: 9.1;U-698: 15.5" "Region enhanced" "Detected in many" "basal ganglia: 100.1" "Region enhanced" "Detected in many" "basal ganglia: 166.9" HPA031369 Enhanced Approved Cytosol NA NA Cytosol "HPA031369: AB_10601801" "unprognostic (5.71e-3)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.73e-2)" "unprognostic (1.04e-1)" "prognostic favorable (2.87e-5)" "unprognostic (1.07e-1)" "unprognostic (3.07e-2)" "unprognostic (9.57e-2)" "unprognostic (1.21e-3)" "unprognostic (2.45e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.68e-2)" "unprognostic (3.80e-1)" "unprognostic (2.00e-1)" "unprognostic (3.57e-1)" 1.8 1.1 8.1 12.5 50.3 1.1 1.7 1.9 49.4 1.8 4.2 1.3 0.0 3.9 3.7 1.0 1.8 11.3 1.7 28.6 3.7 4.9 1.3 0.5 1.5 14.3 3.6 12.8 2.3 1.0 0.8 3.6 1.3 3.3 2.9 3.6 4.1 2.0 2.2 0.5 1.0 2.9 3.6 3.0 7.1 3.4 11.8 6.2 0.1 1.4 0.0 20.3 5.5 1.9 27.1 0.1 0.2 0.1 0.0 0.1 2.2 0.5 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.1 33.0 0.3 0.4 1.6 0.3 0.1 0.2 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 2.4 13.6 0.1 0.1 0.9 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.6 0.1 0.0 0.5 3.1 0.2 0.4 0.0 1.3 11.4 9.1 15.5 0.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 27.1 0.1 0.0 0.0 12.9 0.0 0.0 0.2 0.0 0.1 0.1 0.0 2.2 8.1 50.3 1.9 20.4 3.7 4.9 3.6 12.8 3.3 6.2 0.0 5.1 43.6 0.1 0.6 9.8 20.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.9 2.8 5.1 0.0 0.2 0.0 0.6 0.2 11.6 0.4 0.4 0.0 4.1 3.7 1.5 3.5 0.0 0.2 3.3 0.0 0.8 1.0 0.2 10.5 0.4 0.0 1.1 0.0 0.3 0.6 1.4 0.1 0.0 0.5 1.5 0.1 CPTP "GLTPD1, MGC10334" ENSG00000224051 "Ceramide-1-phosphate transfer protein" Q5TA50 1 1324756-1328897 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056832 Approved Approved Cytosol NA NA Cytosol "HPA056832: AB_2683251" "unprognostic (9.00e-2)" "unprognostic (2.19e-1)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.94e-2)" "unprognostic (1.37e-1)" "unprognostic (1.90e-1)" "unprognostic (3.35e-1)" "unprognostic (1.52e-2)" "unprognostic (1.32e-2)" "unprognostic (2.79e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.27e-1)" "unprognostic (3.21e-2)" "unprognostic (1.25e-2)" "unprognostic (5.27e-2)" 9.8 8.7 8.0 9.2 7.6 3.7 8.1 7.2 13.8 10.7 14.9 6.0 12.0 21.4 7.0 21.9 20.5 6.1 9.6 43.1 9.3 5.8 19.1 38.9 6.8 9.0 8.1 7.2 6.4 14.5 9.0 3.7 10.4 9.2 8.4 6.2 5.3 46.4 15.0 51.7 13.9 21.1 4.3 5.7 13.4 15.7 28.2 4.8 12.0 8.8 18.4 13.7 6.6 10.2 4.9 1.8 8.6 1.9 1.8 7.6 1.9 18.8 6.8 3.3 6.0 3.2 2.7 5.4 10.0 5.3 9.4 6.2 9.2 10.6 7.5 11.6 4.5 6.2 14.1 2.6 5.8 3.5 8.9 9.1 5.6 7.3 9.2 8.1 5.3 5.7 5.2 4.6 9.9 2.8 4.7 5.0 4.9 8.2 4.5 3.1 6.9 5.9 6.3 3.0 4.9 30.3 7.4 5.5 21.6 7.6 5.0 7.8 8.2 8.0 25.3 17.0 1.8 9.0 3.7 8.4 10.1 7.1 11.0 8.1 10.0 7.6 7.8 9.7 8.0 3.0 2.9 1.9 8.6 2.6 1.0 1.5 4.9 3.2 2.5 1.3 1.9 1.9 1.5 2.7 1.8 1.8 1.8 7.6 1.9 8.0 7.6 7.2 13.8 9.3 5.8 8.1 7.2 9.2 4.8 0.0 2.7 4.5 8.0 0.0 9.0 20.5 5.1 0.0 2.3 7.0 0.0 16.1 33.2 22.4 50.8 7.5 50.3 0.0 21.2 17.4 2.9 9.5 0.0 25.1 14.5 22.3 5.8 12.3 5.7 124.6 11.2 3.0 0.0 19.8 18.5 16.0 34.5 10.5 9.2 13.5 6.2 12.9 2.0 9.4 5.3 0.0 16.4 6.9 21.5 7.5 CREB3 "Luman, LZIP, sLZIP" ENSG00000107175 "CAMP responsive element binding protein 3" O43889 9 35732335-35737004 "Predicted membrane proteins, Transcription factors" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 350.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030978 Supported Cytosol NA NA Cytosol "HPA030978: AB_2673683" "unprognostic (1.73e-3)" "unprognostic (9.72e-2)" "unprognostic (9.32e-2)" "unprognostic (5.62e-3)" "unprognostic (3.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (4.29e-2)" "unprognostic (4.63e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.13e-1)" "unprognostic (1.65e-1)" "prognostic favorable (3.77e-5)" "unprognostic (1.48e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" 15.7 25.1 23.7 12.0 27.6 5.6 19.4 18.5 30.2 25.4 20.3 17.6 28.2 12.8 20.9 22.5 15.0 23.9 25.2 16.3 19.4 21.3 21.3 42.3 15.9 15.3 23.1 17.1 20.2 26.3 22.1 23.1 19.5 17.3 32.9 16.7 17.4 31.7 37.6 12.6 9.9 14.6 26.0 19.6 13.0 20.5 23.0 14.0 9.1 24.4 9.4 14.9 22.0 17.6 17.7 19.4 14.8 16.9 15.9 21.8 15.7 12.3 11.5 12.1 9.1 25.6 16.7 8.0 22.5 36.1 24.1 25.0 12.8 6.0 4.4 9.9 32.9 26.7 4.8 7.8 18.6 15.9 16.5 6.5 3.4 10.2 5.8 32.6 5.7 6.8 14.6 15.3 23.4 22.9 19.7 14.7 8.5 4.9 7.5 24.7 6.1 5.8 2.0 7.6 9.0 15.1 6.5 5.3 5.6 19.4 6.0 5.7 7.8 9.0 8.0 5.3 10.3 12.2 2.4 15.7 16.0 9.0 11.5 13.8 4.3 5.3 5.3 16.7 2.0 17.3 14.8 16.9 6.3 19.2 16.0 20.7 17.7 16.8 21.8 17.9 12.3 13.7 13.4 7.7 15.9 12.8 19.4 18.5 15.7 23.7 27.6 18.5 30.2 19.4 21.3 23.1 17.1 17.3 14.0 26.8 16.2 9.0 41.3 31.8 28.3 10.1 38.2 41.5 27.3 15.7 11.8 41.9 28.2 83.0 124.3 32.4 52.9 0.0 61.5 45.7 42.8 65.2 31.2 20.3 32.9 4.8 25.3 19.0 14.8 350.3 27.9 22.7 47.2 58.7 42.1 33.3 62.6 30.3 39.6 55.4 13.8 32.3 53.6 60.7 24.6 19.8 51.0 26.6 24.2 39.6 CRYGS CRYG8 ENSG00000213139 "Crystallin gamma S" P22914 3 186538441-186546702 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 15.1;cervix, uterine: 21.8" "Cell type enhanced" "Detected in some" 5 "Rod photoreceptor cells: 3.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035103, HPA063539" Supported Uncertain Cytosol NA NA Cytosol "HPA035103: AB_10696367, HPA063539: " "unprognostic (5.52e-4)" "unprognostic (1.29e-3)" "unprognostic (1.44e-2)" "unprognostic (5.45e-2)" "unprognostic (4.90e-2)" "unprognostic (5.85e-2)" "unprognostic (4.79e-2)" "unprognostic (1.73e-2)" "unprognostic (4.76e-2)" "unprognostic (1.12e-1)" "unprognostic (5.84e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.72e-9)" "unprognostic (1.10e-1)" "unprognostic (9.53e-2)" "unprognostic (3.67e-1)" "prognostic favorable (2.73e-4)" 1.6 1.9 3.6 1.8 2.7 4.0 3.4 15.1 3.3 21.8 1.8 3.5 1.6 1.7 2.7 3.8 1.6 1.3 1.6 1.6 4.1 4.1 2.2 1.8 2.6 4.2 4.2 1.6 2.2 1.8 1.9 1.6 1.6 3.0 1.6 3.7 5.8 1.8 2.9 1.6 3.0 1.8 2.3 3.2 3.6 2.4 1.8 1.6 6.0 1.6 3.2 3.3 1.6 1.6 0.3 0.6 0.2 0.2 0.0 2.1 0.1 1.0 2.0 3.7 3.1 3.6 5.6 0.5 0.5 1.2 1.3 2.5 0.4 1.5 3.8 4.1 2.7 1.6 3.2 1.7 2.8 5.5 3.2 4.9 5.0 1.4 1.9 1.4 2.9 3.4 5.9 3.8 1.2 2.1 5.4 4.2 4.2 1.0 2.2 3.0 1.2 2.6 1.5 0.2 1.7 1.6 4.3 0.8 1.8 1.5 2.3 1.7 1.6 2.6 2.5 1.0 3.0 2.0 1.7 4.5 1.4 1.1 1.6 2.7 4.6 2.3 5.3 1.9 1.9 2.7 0.0 0.2 0.0 1.4 0.0 2.1 0.3 1.9 0.8 0.4 0.1 0.2 0.4 0.2 0.0 0.0 0.6 0.2 0.1 3.6 2.7 15.1 3.3 4.1 4.1 4.2 1.6 3.0 1.6 0.0 1.7 0.5 0.2 0.2 1.0 2.2 2.5 0.0 1.2 0.0 2.0 0.1 0.0 0.4 0.1 0.7 0.4 0.0 0.2 0.1 0.5 0.2 1.1 1.1 0.3 1.6 0.0 1.8 0.0 1.0 0.3 1.6 0.0 0.0 0.9 0.5 0.3 0.0 0.7 0.0 3.0 0.0 0.6 1.4 0.7 0.1 0.2 1.3 1.0 0.1 CRYM DFNA40 ENSG00000103316 "Crystallin mu" Q14894 16 21238874-21303083 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.7;brain: 61.3;heart muscle: 45.9" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 521.3" "Cancer enhanced" "Detected in many" "prostate cancer: 14.6" "Region enhanced" "Detected in many" "basal ganglia: 61.3" "Cell type enriched" "Detected in single" 26 "plasmacytoid DC: 23.7" "Lineage enriched" "Detected in single" 26 "dendritic cells: 23.7" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 31.2" "Group enriched" "Detected in many" 12 "amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0" "Low region specificity" "Detected in all" "HPA019086, HPA030619" Enhanced Supported Cytosol NA NA 110000 Cytosol "HPA019086: AB_1847260, HPA030619: AB_2673551" "unprognostic (1.32e-1)" "unprognostic (2.93e-3)" "unprognostic (8.96e-2)" "unprognostic (1.44e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.88e-1)" "unprognostic (5.75e-3)" "unprognostic (2.81e-1)" "unprognostic (7.37e-2)" "unprognostic (2.05e-2)" "unprognostic (5.95e-2)" "unprognostic (2.11e-3)" "unprognostic (7.79e-3)" "unprognostic (2.49e-2)" "unprognostic (1.87e-3)" "unprognostic (1.31e-1)" 1.4 0.5 7.6 0.5 61.3 0.5 1.0 15.6 21.2 1.8 2.2 0.0 0.0 0.7 0.8 0.3 2.3 0.5 2.3 45.9 6.5 2.1 17.8 4.2 2.7 0.5 1.0 15.5 0.5 0.8 0.6 3.3 0.3 0.1 10.5 2.6 1.0 4.8 0.3 4.0 1.4 1.0 2.0 0.9 0.5 0.6 1.6 1.2 0.0 0.5 0.0 1.5 8.3 0.8 0.9 23.7 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.6 0.2 1.6 0.0 0.0 0.0 0.4 7.2 0.0 0.7 0.0 0.0 0.7 0.3 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.3 3.2 0.5 0.1 0.0 0.0 0.2 31.2 0.0 1.2 1.7 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.2 0.2 2.7 0.0 0.0 0.0 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.3 7.6 61.3 15.6 20.7 6.5 2.1 1.0 15.5 0.1 1.2 0.0 15.3 1.5 24.8 2.1 5.8 124.1 5.1 20.1 22.7 14.0 3.9 0.0 14.9 0.1 17.0 1.0 5.3 0.0 0.0 0.0 2.2 17.1 1.1 6.0 0.1 1.6 12.6 0.6 0.0 9.6 0.0 0.9 32.1 1.0 19.3 521.3 0.2 0.0 0.0 111.6 17.7 0.0 1.0 4.4 6.3 1.1 0.1 0.0 7.9 58.9 CRYZ ENSG00000116791 "Crystallin zeta" Q08257 1 74705482-74733408 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 100.0;liver: 79.8" "Cell type enhanced" "Detected in many" 12 "Collecting duct cells: 151.8;Distal tubular cells: 192.3;Hepatocytes: 184.9;Proximal tubular cells: 384.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 98.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021921, HPA023290" Approved Supported Cytosol NA NA 7200000 Cytosol "HPA021921: AB_1847262, HPA023290: AB_1847263" "unprognostic (3.64e-2)" "unprognostic (3.38e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.32e-3)" "unprognostic (5.79e-2)" "unprognostic (6.29e-2)" "unprognostic (1.04e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-1)" "unprognostic (6.38e-3)" "unprognostic (2.19e-1)" "unprognostic (1.35e-3)" "unprognostic (3.12e-1)" "unprognostic (7.50e-2)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" 6.0 13.4 7.5 4.6 5.4 0.2 8.8 4.2 5.9 19.8 12.6 3.9 27.1 11.3 11.9 29.1 9.7 11.5 15.7 10.4 6.0 9.0 100.0 79.8 7.1 4.8 6.5 3.5 9.4 26.1 13.2 17.2 3.7 11.1 13.8 4.9 9.4 5.9 21.9 5.6 5.6 19.8 14.1 6.8 5.4 9.5 4.9 5.9 7.1 17.1 7.9 5.8 14.8 15.8 18.2 8.9 4.7 8.6 14.4 21.7 9.0 2.5 24.8 12.8 3.6 14.8 16.2 8.7 8.0 12.7 11.6 13.1 19.4 10.3 13.9 14.1 15.5 20.4 6.9 10.4 10.1 19.0 16.0 4.2 5.8 7.7 38.8 7.8 4.9 11.9 7.5 9.0 18.6 3.4 10.9 9.7 7.7 18.2 5.0 24.2 5.8 8.9 8.3 9.6 20.2 16.2 5.7 12.1 5.1 98.3 7.9 3.5 6.3 1.8 13.5 8.7 15.0 12.1 1.6 4.7 2.8 7.0 8.7 12.0 3.6 6.9 6.8 22.8 1.9 7.9 4.7 5.2 0.9 18.2 7.7 14.7 18.2 17.9 16.7 8.9 13.7 15.7 16.7 0.8 14.4 8.6 7.5 21.7 9.0 7.5 5.4 4.2 5.9 6.0 9.0 6.5 3.5 11.1 5.9 26.8 16.9 14.3 23.5 15.9 2.5 25.7 89.2 16.0 12.5 151.8 2.0 12.7 192.3 42.4 0.3 8.0 12.3 0.0 28.1 14.2 21.7 10.3 13.9 184.9 15.3 0.0 6.4 11.6 12.5 1.1 19.2 10.6 10.1 10.0 13.2 6.8 30.1 9.1 19.4 384.2 2.6 0.0 15.9 1.4 6.8 18.4 6.1 15.2 13.3 12.7 CSNK1A1 "CK1, CK1a, CK1alpha, CKIa, CKIalpha" ENSG00000113712 "Casein kinase 1 alpha 1" P48729 5 149492197-149551552 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 741.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016680, HPA051334" Uncertain Approved Cytosol NA NA Cytosol "CAB016680: AB_1614518, HPA051334: AB_2681446" "unprognostic (4.27e-3)" "unprognostic (5.85e-3)" "prognostic favorable (1.15e-4)" "unprognostic (7.39e-2)" "unprognostic (2.66e-1)" "unprognostic (3.14e-1)" "unprognostic (1.27e-2)" "unprognostic (5.56e-2)" "unprognostic (4.38e-1)" "unprognostic (8.31e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (5.47e-2)" "unprognostic (1.56e-1)" "unprognostic (7.92e-2)" "unprognostic (4.41e-2)" "unprognostic (6.28e-3)" "unprognostic (6.92e-2)" 33.5 35.8 26.0 26.9 35.2 71.0 40.2 32.0 39.3 33.8 38.2 28.2 40.5 23.2 41.0 29.4 66.1 31.8 36.0 45.7 24.4 26.1 24.0 30.1 37.5 27.3 28.0 29.8 31.7 23.9 46.9 30.9 28.7 38.0 38.1 31.4 25.5 38.5 39.3 51.4 48.4 31.8 45.8 33.9 23.6 34.2 28.6 24.1 38.6 32.0 53.1 41.1 45.0 40.0 28.6 40.6 47.4 39.6 34.2 41.9 40.8 36.9 24.7 41.6 39.4 43.0 52.7 44.5 52.8 50.2 41.2 43.4 48.1 50.1 19.7 58.5 56.1 44.2 37.8 29.3 71.1 63.0 28.5 17.7 26.7 28.6 22.1 38.7 41.8 43.0 43.1 73.8 46.2 74.5 45.6 47.4 35.6 22.5 29.7 46.4 23.2 38.3 16.9 21.8 40.9 60.2 28.7 33.0 22.4 28.7 64.4 32.1 28.9 39.2 52.6 64.3 38.5 49.3 36.4 47.0 48.5 25.5 32.1 50.3 27.6 35.4 30.4 45.3 30.4 58.6 47.4 36.6 35.4 29.0 38.7 33.1 28.6 36.7 32.9 40.6 23.4 39.9 34.0 31.1 34.2 39.6 24.2 41.9 40.8 26.0 35.2 32.0 39.3 24.4 26.1 28.0 29.8 38.0 24.1 137.0 158.5 75.9 513.8 608.0 132.0 46.4 73.9 278.4 290.0 109.9 60.9 146.8 77.9 135.8 55.7 139.6 98.3 23.3 160.7 185.9 198.0 381.5 112.3 94.7 120.9 143.0 124.9 225.9 143.6 66.9 96.4 139.7 145.1 118.2 136.8 145.0 155.3 98.2 105.0 78.9 100.0 155.2 201.9 125.6 93.5 741.0 293.5 102.2 111.1 404.2 CSNK1A1L MGC33182 ENSG00000180138 "Casein kinase 1 alpha 1 like" Q8N752 13 37103259-37105664 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 10.5;testis: 9.0" "Group enriched" "Detected in some" 8 "Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 40 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 42 "granulocytes: 10.5" "Not detected" "Not detected" HPA051334 Uncertain Cytosol NA NA Cytosol "HPA051334: AB_2681446" "unprognostic (1.23e-2)" "unprognostic (1.59e-1)" "unprognostic (3.19e-2)" "unprognostic (3.54e-2)" "unprognostic (2.40e-2)" "unprognostic (5.40e-2)" "unprognostic (8.90e-2)" "unprognostic (3.47e-1)" "unprognostic (1.47e-3)" "unprognostic (4.50e-1)" "unprognostic (2.02e-1)" "unprognostic (2.28e-3)" "unprognostic (3.45e-1)" "unprognostic (2.38e-1)" 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.0 0.0 0.0 0.0 0.0 0.1 0.2 10.5 0.2 0.1 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 10.5 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 1.5 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.1 0.5 0.0 0.0 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 1.8 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.4 1.1 2.4 0.2 0.0 0.0 1.0 CSNK1G1 CK1gamma1 ENSG00000169118 "Casein kinase 1 gamma 1" Q9HCP0 15 64165517-64356259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 121.0;Late spermatids: 209.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018209 Supported Cytosol NA NA Cytosol "HPA018209: AB_1847278" "unprognostic (9.10e-2)" "unprognostic (8.09e-2)" "unprognostic (1.20e-1)" "unprognostic (2.65e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.02e-1)" "unprognostic (8.63e-2)" "unprognostic (3.75e-2)" "unprognostic (7.51e-2)" "unprognostic (8.16e-3)" "unprognostic (1.31e-1)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" 7.2 7.8 10.2 11.9 15.1 11.6 8.7 12.2 10.6 8.7 7.4 7.6 11.6 7.0 11.1 9.9 15.7 10.8 7.8 5.6 8.9 7.6 8.6 6.0 8.4 9.6 6.6 4.7 8.5 8.8 10.4 16.1 7.2 7.2 6.8 7.9 10.1 8.2 14.5 6.5 10.4 6.8 11.1 5.3 8.2 6.8 41.3 7.3 11.8 11.5 5.6 11.2 8.3 10.6 4.1 4.1 8.8 5.1 5.3 8.0 2.4 5.1 10.9 7.9 10.2 6.8 9.3 7.2 6.4 6.6 10.9 9.8 8.7 10.1 8.1 3.5 10.1 11.4 11.9 20.6 12.9 12.8 15.4 5.3 7.6 8.7 5.8 7.8 14.0 9.0 8.2 17.2 11.1 15.9 9.5 11.9 8.4 9.2 8.5 9.8 7.1 7.1 4.4 7.4 6.8 5.7 12.0 9.9 6.5 8.8 20.8 12.8 7.8 8.4 5.1 7.4 13.6 8.9 5.5 12.8 9.9 11.9 7.9 7.9 9.8 18.9 6.9 9.2 10.3 6.1 0.9 3.6 5.6 5.7 5.1 8.0 3.6 5.1 4.1 2.7 4.1 5.1 4.7 8.8 5.3 4.3 4.1 3.9 2.4 10.2 15.1 12.2 10.6 8.9 7.6 6.6 4.7 7.2 7.3 26.8 9.9 7.1 8.7 10.3 44.6 6.5 5.1 16.0 13.6 5.2 64.8 5.8 1.7 8.2 121.0 8.4 8.4 0.0 6.1 7.4 8.9 7.9 3.5 4.0 9.4 9.5 21.9 9.2 9.7 209.9 5.8 10.3 6.8 10.0 10.0 6.9 9.1 7.0 9.6 8.7 29.5 6.5 8.5 27.2 18.4 13.7 3.4 7.7 10.3 10.1 CTBP2 ribeye ENSG00000175029 "C-terminal binding protein 2" P56545 10 124984317-125161170 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023559, HPA023564, CAB031916, HPA044971, CAB079018" Approved Approved Approved Cytosol NA NA Cytosol "CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: AB_2679161" "unprognostic (8.69e-2)" "unprognostic (1.27e-2)" "unprognostic (4.14e-2)" "unprognostic (1.41e-2)" "unprognostic (6.84e-3)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (5.60e-3)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (3.24e-2)" "unprognostic (3.99e-3)" "prognostic favorable (1.70e-4)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.62e-1)" 13.9 13.1 14.5 9.6 16.3 9.0 29.8 23.5 11.8 31.1 20.9 22.5 17.8 19.8 29.0 21.2 16.3 23.3 17.4 10.9 16.1 12.3 15.4 3.1 17.3 6.5 19.2 11.8 24.1 24.5 12.9 13.6 14.9 15.6 22.9 17.9 28.6 19.9 18.5 11.4 8.6 19.4 23.7 15.1 12.1 19.9 14.5 16.8 3.1 43.3 11.6 6.1 16.7 23.8 0.3 6.5 15.4 11.6 19.7 5.3 2.6 25.2 28.7 25.4 21.1 13.6 13.5 14.0 19.8 23.1 18.7 21.3 17.8 29.9 0.0 10.2 19.8 11.8 20.0 25.2 31.7 14.1 0.1 19.1 18.6 18.9 0.4 28.6 7.8 14.9 11.5 25.2 19.3 38.6 24.8 23.7 1.5 0.7 0.1 11.6 28.1 0.8 8.0 19.1 26.4 18.4 22.5 10.6 0.2 22.0 11.5 7.8 22.3 19.2 16.9 25.4 20.6 11.9 13.0 19.1 11.3 14.3 16.1 16.9 0.4 1.5 0.0 14.1 0.1 11.1 15.4 5.1 9.2 5.3 5.0 0.6 0.3 0.2 1.4 6.5 0.2 0.3 2.3 8.5 19.7 11.6 5.5 0.1 2.6 14.5 16.3 23.5 11.8 16.1 12.3 19.2 11.8 15.6 16.8 29.8 25.6 10.4 75.3 41.9 161.2 28.5 48.4 85.6 56.9 36.6 149.2 17.7 58.0 61.2 23.4 58.3 50.5 0.0 53.0 54.5 41.8 75.6 16.3 1.0 26.4 101.7 52.8 64.4 53.8 28.9 55.8 44.0 55.6 46.9 71.1 60.5 66.1 43.2 73.2 31.8 100.9 58.2 65.1 9.1 33.4 34.8 16.1 21.8 82.1 78.5 CTBS CTB ENSG00000117151 Chitobiase Q01459 1 84549606-84574480 "Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 6 "basal ganglia: 7.6" "CAB017043, HPA023594, HPA048810" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 380000000 Cytosol "CAB017043: , HPA023594: AB_1847311, HPA048810: " "unprognostic (7.76e-2)" "unprognostic (1.28e-2)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (9.36e-2)" "unprognostic (3.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.76e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (9.23e-2)" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.08e-2)" "unprognostic (4.89e-2)" "unprognostic (3.12e-1)" "unprognostic (4.04e-2)" 6.4 6.9 4.0 8.8 4.4 9.7 15.3 4.4 3.5 5.3 5.8 3.3 8.1 3.7 6.2 16.4 4.8 5.2 8.0 13.1 4.5 4.4 10.4 22.3 15.6 28.1 5.8 2.3 5.1 15.0 6.5 10.4 6.9 8.1 8.1 5.1 4.7 18.5 12.5 4.3 8.4 7.2 6.7 10.0 12.6 6.1 3.5 4.4 5.5 5.9 4.9 5.1 5.5 5.2 0.8 0.4 3.2 1.6 0.7 0.6 0.2 1.8 0.6 0.4 0.4 5.6 6.7 1.4 1.3 4.5 0.6 1.7 0.2 2.2 2.4 0.5 2.8 0.7 0.8 0.1 1.7 1.9 2.2 0.6 1.5 0.3 0.3 3.4 1.6 0.8 4.9 3.3 1.6 2.5 4.0 1.9 1.0 1.4 4.4 1.3 0.1 1.0 1.8 0.4 0.4 0.6 0.5 0.7 1.6 4.0 0.9 0.3 0.8 0.5 1.8 2.1 1.1 1.0 1.7 2.9 2.3 0.2 3.1 1.4 1.3 0.4 0.7 1.6 2.2 1.6 1.8 0.8 1.5 0.2 0.9 0.4 0.5 0.4 0.3 0.4 0.8 0.3 0.6 3.2 0.7 1.6 0.4 0.4 0.2 4.0 4.4 4.4 3.5 4.5 4.4 5.8 2.3 8.1 4.4 8.9 16.0 29.6 25.9 27.0 5.8 5.1 30.6 26.8 20.5 22.7 39.3 20.5 36.5 15.7 2.6 28.2 17.1 0.0 16.9 19.2 19.6 41.9 43.8 58.7 42.5 3.2 22.2 45.4 70.4 3.0 19.5 43.1 6.8 23.4 21.5 19.9 17.2 21.0 23.0 38.3 40.1 12.9 14.4 7.5 9.8 21.7 21.4 17.5 16.9 25.3 CTIF KIAA0427 ENSG00000134030 "Cap binding complex dependent translation initiation factor" O43310 18 48539046-48863217 "Predicted intracellular proteins, Transporters" "Nonsense-mediated mRNA decay, Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 32.8;Bipolar cells: 29.8;Peritubular cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016865, HPA024801" Uncertain Supported Cytosol NA NA Cytosol "HPA016865: AB_1852311, HPA024801: AB_1852312" "unprognostic (5.84e-2)" "unprognostic (5.86e-2)" "unprognostic (2.27e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" "unprognostic (8.86e-2)" "unprognostic (1.95e-3)" "unprognostic (2.77e-3)" "unprognostic (1.35e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-1)" "unprognostic (2.34e-3)" "unprognostic (7.33e-3)" 40.7 15.7 17.3 8.0 21.9 5.2 18.2 28.8 34.5 10.3 12.8 12.4 6.2 6.6 12.3 7.2 19.2 8.5 16.7 18.1 17.2 23.4 9.1 12.7 12.8 4.1 19.7 24.5 29.8 9.2 9.6 12.1 10.1 22.7 9.5 5.0 10.0 11.9 13.4 16.0 7.2 7.5 15.6 23.1 7.1 11.0 8.0 16.3 0.9 9.9 4.7 3.7 12.7 13.0 0.1 0.8 0.8 0.7 0.0 1.4 0.1 2.3 2.5 3.4 4.4 8.8 4.7 1.9 11.9 10.0 9.5 8.6 2.6 1.4 0.0 2.7 16.3 3.9 5.0 2.5 6.7 4.1 0.0 2.0 1.0 5.6 6.1 16.8 1.8 3.4 6.5 11.1 5.9 10.6 6.8 6.7 3.0 2.8 7.4 6.0 1.2 0.6 1.4 1.7 2.5 2.1 1.2 3.9 3.0 2.8 3.2 7.3 7.4 4.2 4.5 3.4 3.0 2.8 2.3 13.4 8.8 8.2 2.6 2.1 2.5 2.9 0.0 7.7 1.2 3.8 0.8 0.7 0.7 1.4 0.4 0.3 0.1 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.1 17.3 21.9 28.8 34.5 17.2 23.4 19.7 24.5 22.7 16.3 32.8 3.0 2.9 1.8 3.0 29.8 14.1 5.1 4.0 5.7 7.0 15.7 1.2 6.6 4.8 10.1 6.2 4.6 0.0 4.2 2.0 8.0 2.3 4.6 17.3 3.8 11.1 3.4 6.7 6.2 13.8 23.3 3.3 3.3 1.0 2.6 3.3 5.9 3.5 47.7 5.4 6.5 6.5 6.4 1.8 1.0 1.9 1.0 0.0 2.9 2.8 CUL9 "H7AP1, KIAA0708, PARC" ENSG00000112659 "Cullin 9" Q8IWT3 6 43182175-43224587 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 68 "Early spermatids: 532.1;Late spermatids: 1222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016434, HPA052004" Approved Approved Cytosol No No Cytosol "HPA016434: AB_1848125, HPA052004: AB_2681690" "prognostic favorable (5.28e-4)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.20e-3)" "unprognostic (1.56e-1)" "prognostic favorable (2.37e-5)" "unprognostic (3.05e-3)" "unprognostic (1.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.29e-1)" "prognostic favorable (8.07e-4)" "unprognostic (8.22e-3)" "unprognostic (2.03e-1)" "unprognostic (2.68e-1)" "unprognostic (2.31e-1)" "unprognostic (9.94e-2)" "prognostic favorable (4.87e-4)" 6.2 9.2 11.7 9.5 13.9 12.8 6.9 12.5 13.8 7.4 8.5 12.9 7.3 8.2 11.2 6.5 11.5 10.7 8.5 5.5 10.0 6.4 7.7 5.6 7.5 11.7 10.0 9.8 9.5 8.6 13.2 15.9 5.0 9.2 8.3 5.1 11.2 8.7 9.3 6.0 16.1 10.2 7.7 6.9 10.1 8.7 12.5 10.4 10.8 10.9 4.9 10.8 12.0 7.0 1.1 1.1 0.5 0.9 0.3 2.6 1.0 7.5 5.6 3.1 7.4 8.8 5.2 4.2 3.0 5.4 4.9 4.6 1.8 3.2 6.3 5.9 4.8 4.4 5.5 2.6 6.4 2.3 7.6 2.4 6.9 6.0 2.8 5.7 4.3 11.4 7.1 13.5 4.0 3.6 4.3 7.1 11.1 3.6 8.4 4.3 7.0 8.7 6.3 0.5 14.7 3.6 12.9 2.1 6.2 3.7 7.9 5.3 7.6 4.0 4.9 6.8 2.8 8.3 9.8 6.5 12.3 8.5 3.6 5.7 8.0 7.5 5.1 3.1 7.7 5.5 0.0 0.9 0.3 1.2 0.5 1.3 1.1 0.7 2.6 1.1 0.8 0.6 1.4 0.5 0.3 0.4 0.9 2.5 1.0 11.7 13.9 12.5 13.8 10.0 6.4 10.0 9.8 9.2 10.4 0.0 8.0 4.4 2.2 5.7 9.5 4.4 12.7 4.0 4.5 3.5 11.8 2.7 3.3 3.1 532.1 5.8 7.4 0.0 5.4 1.5 2.8 1.9 2.3 5.5 10.6 11.1 5.8 9.2 5.7 1222.3 10.3 4.6 3.3 4.6 6.5 9.5 4.8 0.0 7.8 4.6 10.0 12.9 3.9 9.3 9.7 4.8 2.2 4.9 6.2 2.4 CYP26B1 P450RAI-2 ENSG00000003137 "Cytochrome P450 family 26 subfamily B member 1" Q9NR63 2 72129238-72148038 "Disease related genes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4" "Group enriched" "Detected in many" 8 "Leydig cells: 70.2;Peritubular cells: 216.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 8.2;HaCaT: 12.1;RH-30: 15.6;U-2 OS: 17.3;U-2197: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012567 Uncertain Approved Cytosol "Intracellular and membrane" No No Cytosol "HPA012567: AB_1847429" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (2.19e-4)" "unprognostic (3.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.17e-4)" "unprognostic (8.41e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (7.55e-3)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.55e-1)" "unprognostic (9.44e-3)" "unprognostic (2.04e-2)" 16.6 2.6 8.3 2.1 7.8 0.1 7.7 25.0 23.9 5.8 2.4 1.2 1.6 3.6 1.5 1.6 3.4 2.7 1.2 6.0 2.5 1.5 4.2 0.7 2.7 4.4 3.4 10.0 4.9 0.2 0.9 5.2 3.2 35.4 1.3 1.2 1.2 5.1 7.5 7.6 20.5 2.4 1.5 0.6 1.9 0.5 13.8 1.1 4.9 9.2 2.2 2.8 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.9 0.0 0.1 8.2 3.1 4.9 0.7 0.1 0.2 0.2 1.5 0.4 0.0 0.4 0.6 2.4 12.1 6.9 0.0 0.1 0.0 2.2 0.0 4.9 0.6 0.1 0.0 0.2 0.0 0.4 0.0 0.2 2.5 0.9 3.3 0.4 0.1 0.7 2.3 0.0 0.1 0.0 0.1 0.8 0.0 15.6 0.0 0.0 1.2 0.5 0.1 2.7 0.0 2.9 1.0 0.2 0.7 0.0 1.3 17.3 7.6 2.6 0.0 0.9 0.0 5.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 7.8 25.0 23.9 2.5 1.5 3.4 10.0 35.4 1.1 0.0 0.0 2.9 1.1 13.1 0.1 1.1 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.1 1.6 0.0 0.0 0.0 0.7 3.7 0.3 0.0 0.2 0.1 0.0 1.7 17.2 4.5 4.9 70.2 0.0 6.8 0.0 0.0 5.4 0.2 0.0 216.0 0.0 0.0 0.0 5.6 1.4 3.0 8.4 0.1 0.0 0.0 0.1 DAD1 OST2 ENSG00000129562 "Defender against cell death 1" P61803 14 22564905-22589269 "Cancer-related genes, Predicted membrane proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028882 Uncertain Approved Cytosol NA NA 14000 Cytosol "HPA028882: AB_10602214" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (2.02e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (9.43e-3)" "unprognostic (3.06e-2)" "unprognostic (6.09e-2)" "unprognostic (1.99e-2)" "unprognostic (9.64e-2)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (3.08e-1)" "unprognostic (1.93e-1)" "unprognostic (1.37e-3)" 48.1 64.7 47.9 36.4 49.4 26.4 61.2 19.3 39.5 59.0 46.7 55.9 93.6 39.7 49.8 118.7 61.2 56.5 54.9 55.2 45.9 43.1 85.1 123.6 48.4 54.6 51.5 25.1 55.4 114.1 35.6 57.0 54.6 51.9 48.3 51.5 43.5 81.9 100.1 39.7 35.6 73.4 49.6 65.3 57.4 48.0 56.7 33.6 84.6 107.0 50.7 52.2 49.3 43.4 80.2 121.1 75.3 65.9 61.5 95.6 122.5 47.9 45.1 37.1 50.3 101.4 72.9 32.1 51.4 62.3 45.6 64.6 28.3 69.1 30.3 33.0 59.0 51.9 44.0 38.4 49.3 73.2 41.1 35.1 29.6 26.4 112.8 70.7 41.3 43.0 54.1 66.3 47.7 61.5 52.1 66.5 29.4 22.3 71.7 67.1 58.8 19.6 50.5 22.8 106.4 73.8 27.5 31.4 39.5 67.1 39.7 28.5 35.7 39.0 55.9 56.6 46.6 33.7 42.2 50.3 39.8 31.9 48.3 32.3 53.7 62.2 39.1 36.0 29.0 57.4 66.0 65.9 68.1 86.7 56.2 85.1 80.2 90.9 81.7 62.0 71.2 95.6 83.8 75.3 61.5 47.8 121.1 83.5 122.5 47.9 49.4 19.3 39.5 45.9 43.1 51.5 25.1 51.9 33.6 148.9 165.4 142.8 161.3 176.2 21.8 136.5 170.7 219.5 109.2 242.5 25.5 222.0 182.4 458.8 135.7 237.6 168.9 23.3 362.6 309.7 253.7 161.4 292.5 226.5 313.4 20.6 130.4 183.0 140.5 70.6 198.5 173.2 313.8 230.0 162.7 174.4 363.0 131.9 187.0 354.4 32.8 148.8 195.7 167.4 132.2 188.6 241.7 163.9 144.2 147.6 DARS ENSG00000115866 "Aspartyl-tRNA synthetase" P14868 2 135906677-135986100 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020451, HPA029804, HPA029805" Enhanced Enhanced Cytosol NA NA 160000 Cytosol "HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994" "unprognostic (6.13e-2)" "unprognostic (8.16e-3)" "unprognostic (5.54e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (2.39e-6)" "unprognostic (2.98e-3)" "prognostic unfavorable (7.57e-4)" "unprognostic (6.00e-3)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.24e-5)" "unprognostic (1.04e-1)" "unprognostic (9.12e-2)" "unprognostic (3.94e-3)" "unprognostic (2.00e-1)" 30.3 29.7 35.0 27.6 35.5 19.7 34.9 18.0 28.3 27.6 25.4 25.6 26.9 14.8 30.1 26.7 44.4 26.9 19.6 29.8 29.0 28.8 34.6 35.5 19.7 32.3 32.1 25.6 34.0 27.0 26.4 24.5 31.7 23.8 31.0 20.3 20.6 26.6 28.3 45.1 30.6 21.4 42.4 33.8 29.8 23.6 12.8 25.0 42.0 33.0 33.1 36.7 45.3 30.2 48.6 30.5 11.2 18.8 36.6 42.7 30.6 47.9 19.7 16.8 17.8 18.8 23.6 38.6 24.0 26.9 26.3 25.8 42.5 20.9 56.0 37.6 19.7 19.2 27.7 25.8 31.0 47.8 25.6 23.1 34.1 19.5 44.1 24.3 45.5 22.7 22.7 25.1 29.3 26.5 33.6 14.5 26.3 36.5 17.9 21.8 22.5 34.9 39.2 19.8 19.5 18.8 42.6 36.6 39.1 31.6 18.7 12.0 22.8 18.4 16.7 18.7 18.0 18.3 32.5 10.8 23.0 23.0 16.9 23.8 49.3 26.8 60.2 36.2 34.7 14.2 6.0 18.8 11.2 27.5 18.3 41.2 48.6 41.3 36.0 30.5 43.8 42.7 37.0 7.3 36.6 14.0 29.2 36.9 30.6 35.0 35.5 18.0 23.8 29.0 28.8 32.1 25.6 23.8 25.0 56.6 49.0 70.0 90.1 67.0 59.0 74.7 38.2 48.2 51.2 43.6 31.4 98.6 77.9 93.1 1.7 54.2 20.6 23.3 71.9 123.6 68.6 66.4 31.2 58.6 82.4 50.9 37.0 53.4 79.2 4.0 64.2 52.3 59.1 111.0 39.3 83.6 78.4 23.0 72.2 75.2 23.7 51.8 71.3 25.1 45.4 63.2 114.1 63.3 53.4 76.3 DCAF12L1 "KIAA1892L, WDR40B" ENSG00000198889 "DDB1 and CUL4 associated factor 12 like 1" Q5VU92 X 126549383-126552851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 22.6;testis: 30.9" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 15.4;Late spermatids: 30.6;Spermatogonia: 12.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "EFO-21: 17.6;U-2 OS: 9.8" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (2.62e-5)" "unprognostic (2.88e-1)" "unprognostic (1.19e-1)" "unprognostic (3.40e-1)" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (1.74e-1)" 0.2 0.1 0.2 0.0 0.1 0.0 0.7 0.1 0.1 0.5 0.1 0.0 6.2 0.0 0.6 22.6 0.1 4.3 4.3 0.1 0.1 0.4 3.3 0.1 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.6 0.0 0.3 1.0 0.0 0.5 0.1 3.9 0.1 0.1 0.1 2.5 0.1 1.5 1.6 30.9 0.0 0.3 0.9 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.8 0.0 0.0 0.0 3.4 12.5 0.0 0.0 0.0 0.0 0.0 DCAF12L2 WDR40C ENSG00000198354 "DDB1 and CUL4 associated factor 12 like 2" Q5VW00 X 126163499-126166097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 15.7;epididymis: 53.6;testis: 15.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HAP1: 5.9;NTERA-2: 4.9;U-2 OS: 8.1" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (1.16e-4)" "unprognostic (8.83e-3)" "unprognostic (2.93e-1)" "unprognostic (2.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-1)" "unprognostic (3.34e-3)" "unprognostic (1.16e-1)" "unprognostic (8.47e-4)" "unprognostic (1.56e-2)" "unprognostic (4.05e-2)" "unprognostic (3.86e-2)" "unprognostic (2.51e-1)" 1.1 1.2 1.1 0.1 1.9 0.1 2.3 0.5 2.1 1.9 0.9 0.0 15.7 0.1 2.4 53.6 0.5 3.0 0.2 0.4 1.0 3.9 0.4 0.1 0.2 0.2 1.0 1.7 1.9 0.2 2.4 1.3 0.1 1.3 2.0 0.2 0.2 0.6 5.6 0.4 0.5 0.5 2.0 0.8 0.2 0.7 15.8 0.1 0.0 0.4 0.0 0.3 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.5 2.1 1.0 3.9 1.0 1.7 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCBLD1 "dJ94G16.1, MGC46341" ENSG00000164465 "Discoidin, CUB and LCCL domain containing 1" Q8N8Z6 6 117453817-117569858 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA059667 Approved Approved Cytosol NA NA 11000000 Cytosol "HPA059667: AB_2684099" "unprognostic (1.00e-1)" "prognostic unfavorable (6.44e-5)" "unprognostic (1.08e-1)" "unprognostic (3.23e-3)" "unprognostic (2.47e-1)" "unprognostic (2.29e-3)" "unprognostic (1.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.74e-2)" "unprognostic (8.99e-2)" "unprognostic (5.69e-3)" "unprognostic (6.33e-2)" "prognostic unfavorable (8.57e-8)" "unprognostic (6.99e-2)" "unprognostic (4.72e-2)" "unprognostic (7.44e-2)" "unprognostic (1.36e-1)" 15.5 5.2 6.6 7.9 5.6 0.7 12.2 5.1 8.9 12.9 10.6 4.2 10.4 9.0 7.9 6.2 7.9 3.9 12.8 8.2 4.8 3.7 6.1 13.2 15.6 6.3 4.7 3.2 3.2 13.1 12.2 12.6 12.1 7.0 7.6 8.7 4.5 7.1 9.6 17.8 4.3 12.7 7.1 10.2 5.8 10.5 7.6 3.2 1.2 8.8 7.0 5.1 10.5 12.2 0.0 1.2 0.0 0.7 1.0 3.5 1.2 3.1 7.3 2.6 2.9 4.6 5.8 7.4 18.2 24.0 15.5 11.8 15.3 6.9 0.0 9.1 7.8 19.3 7.3 5.0 8.1 16.4 1.4 3.8 2.7 7.6 24.9 20.0 3.9 2.3 6.6 19.0 14.0 13.3 17.9 21.5 2.7 5.8 2.8 20.2 2.5 0.0 2.6 1.9 8.6 3.0 0.0 0.5 1.8 3.4 3.8 7.9 0.1 13.4 1.5 2.1 3.9 1.9 5.2 15.9 0.0 18.8 5.2 7.9 7.8 2.1 2.1 7.8 3.9 6.8 0.0 0.5 0.0 1.7 0.7 0.3 0.0 2.4 3.5 0.6 0.0 3.0 3.5 0.0 1.0 0.3 1.2 2.2 1.2 6.6 5.6 5.1 8.9 4.8 3.7 4.7 3.2 7.0 3.2 14.9 13.1 5.2 2.9 4.6 5.6 3.2 12.7 5.3 15.9 5.2 5.9 23.0 1.7 5.2 22.6 7.8 9.7 0.0 4.2 4.8 5.1 3.1 1.1 7.9 5.0 4.8 4.1 13.5 5.1 7.0 0.9 6.3 8.5 1.0 7.1 1.2 7.9 7.8 0.4 2.1 3.0 12.9 17.6 1.5 13.6 5.3 15.2 6.1 9.3 5.3 DCX "DBCN, DC, LISX, SCLH, XLIS" ENSG00000077279 Doublecortin O43602 X 111293779-111412429 "Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.1;testis: 6.4" "Cell type enriched" "Detected in some" 12 "Rod photoreceptor cells: 22.7" "Cancer enriched" "Detected in some" 5 "glioma: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 34.6;SH-SY5Y: 14.2" "Region enriched" "Detected in many" 9 "olfactory region: 90.9" "Region enriched" "Detected in all" 5 "olfactory region: 130.1" HPA036121 Enhanced Supported Approved Cytosol NA NA Cytosol "HPA036121: AB_2674950" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (7.36e-2)" "unprognostic (4.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.00e-2)" "unprognostic (7.18e-2)" "unprognostic (3.24e-2)" "unprognostic (2.33e-3)" "unprognostic (3.67e-1)" "unprognostic (4.90e-4)" "unprognostic (5.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" 0.8 1.1 7.0 0.7 9.2 0.7 3.2 0.7 17.1 0.7 0.6 0.9 0.0 0.7 4.1 3.6 0.6 0.6 0.8 0.7 4.2 5.4 0.5 0.5 0.6 0.7 2.5 6.7 0.6 0.8 0.5 1.0 0.6 3.7 0.5 0.8 0.0 2.2 0.6 0.5 0.7 0.7 0.6 3.0 0.6 1.2 6.4 2.3 0.0 0.6 0.0 0.5 0.6 0.3 0.3 0.4 0.6 0.2 0.7 0.4 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 34.6 14.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.1 0.4 0.3 0.3 0.2 0.1 0.3 0.3 0.3 0.6 0.7 0.0 0.4 0.1 0.0 7.0 9.2 0.7 10.8 4.2 5.4 2.5 6.7 3.7 2.3 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.2 0.0 1.4 0.0 22.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DDIT4 "Dig2, FLJ20500, REDD-1, REDD1, RTP801" ENSG00000168209 "DNA damage inducible transcript 4" Q9NX09 10 72273920-72276036 "Predicted intracellular proteins" "Antiviral defense, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 159.3" "Cell type enhanced" "Detected in all" 5 "Muller glia cells: 589.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 66.5;hTCEpi: 225.6;hTERT-HME1: 82.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034507, HPA034508" Approved Supported Cytosol NA NA Cytosol "HPA034507: AB_2674199, HPA034508: AB_10601206" "unprognostic (2.84e-3)" "unprognostic (1.05e-3)" "unprognostic (1.06e-1)" "unprognostic (2.59e-1)" "unprognostic (7.91e-3)" "prognostic unfavorable (5.42e-4)" "unprognostic (7.65e-2)" "unprognostic (1.62e-3)" "unprognostic (2.90e-1)" "unprognostic (4.96e-3)" "prognostic unfavorable (2.78e-4)" "unprognostic (9.72e-2)" "prognostic unfavorable (2.54e-6)" "unprognostic (8.52e-2)" "unprognostic (1.12e-1)" "unprognostic (5.92e-2)" "unprognostic (1.66e-1)" 29.0 43.9 27.3 28.0 28.0 35.5 88.2 23.1 27.1 38.7 18.7 6.4 14.4 7.5 16.3 13.5 37.0 14.5 21.7 23.0 28.2 8.4 13.6 27.5 33.7 26.5 45.5 11.6 73.4 159.3 5.4 16.4 16.2 34.4 15.8 5.1 10.2 41.2 29.2 29.5 21.0 13.0 11.7 22.8 17.5 19.6 8.1 34.9 30.8 13.4 11.1 34.5 37.8 47.7 25.9 40.5 9.7 2.5 70.6 57.1 40.9 12.8 9.3 1.9 17.3 12.5 7.2 5.6 3.9 4.3 1.4 5.8 1.0 27.8 1.4 11.8 0.6 1.8 15.1 2.6 66.5 3.2 20.8 3.4 1.5 21.0 6.9 49.5 4.3 6.3 30.4 225.6 6.0 82.9 13.2 5.5 3.3 12.4 34.6 5.0 5.3 2.6 6.0 0.4 6.2 2.1 1.5 2.1 24.6 11.9 3.0 3.4 4.8 9.2 14.6 52.1 4.5 2.0 9.7 11.4 0.4 3.7 0.8 2.1 24.6 13.6 3.8 24.8 9.8 2.9 9.2 1.6 9.7 50.4 2.5 48.6 17.9 32.8 27.8 7.2 25.9 57.1 42.9 5.3 70.6 2.0 40.5 24.0 40.9 27.3 28.0 23.1 27.1 28.2 8.4 45.5 11.6 34.4 34.9 11.9 40.9 153.5 238.2 203.1 78.2 12.9 58.6 36.1 63.7 57.6 74.6 7.9 51.4 226.4 2.3 154.0 50.8 23.3 146.9 35.2 109.4 154.5 397.0 55.0 80.1 28.6 71.9 166.3 61.3 4.7 81.7 238.1 376.2 53.3 48.9 589.5 133.5 28.1 120.6 9.0 131.0 71.1 402.1 1.9 4.3 219.8 15.9 277.0 34.0 244.9 DDO ENSG00000203797 "D-aspartate oxidase" Q99489 6 110391771-110415562 "Enzymes, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 14.1;Muller glia cells: 9.1;Proximal tubular cells: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.9;myeloid DC: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 10.9;RPMI-8226: 14.2;U-937: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037525, HPA037526" Enhanced Enhanced Cytosol NA NA Cytosol "HPA037525: AB_2675523, HPA037526: AB_10672352" "unprognostic (1.37e-1)" "unprognostic (1.54e-1)" "unprognostic (6.51e-2)" "unprognostic (1.30e-2)" "unprognostic (2.00e-1)" "unprognostic (3.28e-2)" "unprognostic (3.71e-2)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (2.91e-1)" "unprognostic (6.97e-2)" "unprognostic (1.43e-1)" "prognostic favorable (8.69e-5)" "unprognostic (3.51e-4)" "unprognostic (3.36e-3)" "unprognostic (1.27e-3)" "unprognostic (9.06e-2)" 3.7 11.0 5.2 1.1 12.1 1.6 3.3 1.9 5.5 2.7 3.6 10.8 4.9 8.6 2.7 5.4 1.2 6.1 3.9 21.0 6.9 3.4 12.3 12.8 3.9 1.3 8.0 6.1 1.2 5.5 18.6 1.9 2.1 8.0 2.9 3.9 2.3 4.9 3.2 11.3 0.8 7.9 5.6 7.7 2.6 1.9 0.4 8.2 0.0 3.3 5.7 0.5 3.6 1.6 0.0 7.3 0.1 4.9 1.7 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.1 5.0 1.2 0.8 0.0 0.0 0.0 0.7 0.7 10.9 0.0 0.0 0.0 2.2 4.5 0.0 4.6 0.0 3.9 1.6 0.0 0.0 0.1 0.0 2.5 0.1 2.2 0.0 0.0 0.0 1.8 4.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.8 14.2 0.0 4.5 0.1 0.1 0.0 0.4 0.6 0.0 0.7 1.0 0.8 1.0 0.1 0.0 2.3 0.1 0.3 0.0 1.9 15.8 0.0 0.1 4.6 0.0 0.0 4.9 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 1.7 1.6 0.0 0.0 1.5 5.2 12.1 1.9 5.5 6.9 3.4 8.0 6.1 8.0 8.2 0.0 0.0 0.0 0.8 0.0 0.0 14.1 0.0 1.4 0.0 0.0 2.0 0.1 3.3 2.8 0.0 0.3 2.7 0.0 1.9 0.1 0.3 0.3 0.0 4.4 1.8 0.0 4.1 2.5 4.0 0.0 0.3 1.1 0.0 1.0 5.9 9.1 1.2 6.0 0.0 9.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.3 DENR "DRP, DRP1, SMAP-3" ENSG00000139726 "Density regulated re-initiation and release factor" O43583 12 122752774-122771064 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021783 Approved Approved Cytosol NA NA 120000 Cytosol "HPA021783: AB_2670820" "unprognostic (3.65e-2)" "unprognostic (7.00e-2)" "unprognostic (5.69e-2)" "unprognostic (7.33e-3)" "unprognostic (6.62e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (2.23e-3)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (3.75e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (8.57e-6)" "unprognostic (1.32e-1)" "unprognostic (1.26e-1)" "unprognostic (2.65e-1)" "unprognostic (1.35e-1)" 19.5 23.2 23.3 28.3 23.8 19.3 27.1 21.7 36.8 19.1 20.8 12.0 24.8 20.9 20.8 23.6 33.6 17.8 23.1 20.1 22.5 26.1 22.4 26.2 16.8 28.6 24.9 30.3 19.2 21.6 56.5 23.7 27.9 23.2 23.6 21.2 13.2 24.5 24.9 42.5 23.1 21.8 30.4 16.4 24.5 19.0 11.7 14.8 35.5 24.0 28.4 26.9 22.6 22.2 15.5 15.5 57.7 20.8 14.8 17.7 13.7 34.6 19.6 25.0 25.3 15.7 23.4 21.6 31.6 17.5 27.7 19.3 27.1 12.9 31.0 33.6 22.2 21.5 26.6 29.2 27.6 37.6 28.0 21.0 37.9 11.6 19.3 20.5 42.5 31.5 20.3 27.5 25.5 34.3 26.2 26.8 34.7 39.4 11.5 29.6 22.8 41.8 40.5 50.5 20.7 40.2 37.3 29.3 19.7 26.9 30.7 28.6 20.6 43.9 13.0 32.1 26.2 41.3 23.8 26.0 26.2 31.3 29.5 31.5 18.9 43.7 50.1 24.9 30.9 28.9 57.7 11.7 18.5 13.8 17.2 16.0 15.5 15.0 13.8 15.5 14.0 17.7 15.5 13.9 14.8 20.8 13.8 15.7 13.7 23.3 23.8 21.7 36.8 22.5 26.1 24.9 30.3 23.2 14.8 65.5 34.4 63.8 54.7 63.8 36.1 60.9 28.1 57.6 48.9 45.4 39.3 61.7 54.7 64.0 15.8 42.7 36.0 0.0 53.2 110.1 42.8 48.2 41.6 44.5 50.4 52.4 81.4 37.4 44.5 7.7 46.6 50.8 25.3 55.1 49.0 36.6 67.8 45.6 43.2 53.7 34.1 19.4 47.3 51.6 143.1 56.8 50.7 52.4 54.2 44.1 DGKD "DGKdelta, KIAA0145" ENSG00000077044 "Diacylglycerol kinase delta" Q16760 2 233354507-233472104 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 22.3;U-698: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027530, HPA049101" Approved Supported Cytosol NA NA Cytosol "HPA027530: AB_2672320, HPA049101: AB_2680630" "unprognostic (1.84e-1)" "unprognostic (2.19e-2)" "unprognostic (7.76e-3)" "unprognostic (1.92e-2)" "unprognostic (5.69e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (1.69e-5)" "unprognostic (2.25e-1)" "unprognostic (1.17e-3)" "unprognostic (6.03e-2)" "unprognostic (5.76e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.07e-8)" "unprognostic (1.78e-1)" "unprognostic (7.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.94e-3)" 5.9 3.6 10.0 10.9 12.4 26.3 5.3 34.3 7.9 3.7 7.8 8.9 12.4 8.1 5.8 12.6 2.7 5.5 8.0 6.4 9.6 4.3 3.1 3.3 9.3 14.0 11.7 4.3 8.6 3.0 2.3 3.7 8.9 7.2 6.0 8.4 6.2 4.9 8.0 25.4 2.9 10.9 7.3 11.1 10.3 19.4 17.4 8.3 4.5 7.6 1.3 13.5 5.6 10.1 6.6 1.0 5.9 2.0 1.8 3.4 2.5 3.2 8.1 4.7 3.0 2.2 2.2 7.3 1.9 1.7 1.8 1.9 14.0 3.2 5.9 1.0 3.1 12.6 3.3 5.2 2.3 3.0 8.8 4.9 8.2 22.3 4.7 2.8 7.1 8.9 3.1 5.0 2.3 4.5 3.4 2.0 5.7 5.8 1.3 2.0 3.1 5.7 7.4 2.5 6.0 4.6 11.6 8.8 4.7 1.5 3.8 7.3 5.3 6.6 3.6 3.4 3.8 1.5 12.6 1.9 3.9 7.2 2.4 5.9 4.7 3.0 22.6 3.4 11.0 3.1 1.7 2.0 5.9 3.3 0.8 1.6 6.3 1.0 2.9 1.0 6.6 2.3 3.4 2.0 1.8 1.4 0.6 0.5 2.5 10.0 12.4 34.3 7.9 9.6 4.3 11.7 4.3 7.2 8.3 29.8 37.4 31.8 6.6 7.9 25.6 18.6 0.0 6.7 18.2 0.0 58.9 13.3 0.0 3.3 11.9 19.6 32.0 0.0 4.0 0.6 5.8 15.0 5.7 5.4 5.7 7.9 2.4 4.9 15.7 31.1 6.1 9.8 8.5 2.8 25.7 12.8 16.0 12.4 4.2 2.0 45.5 19.4 18.6 14.0 24.0 3.1 2.1 19.2 17.3 7.8 DGLUCY "C14orf159, FLJ39975" ENSG00000133943 "D-glutamate cyclase" Q7Z3D6 14 91060333-91225632 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.9" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 26.8;Collecting duct cells: 27.9;Cytotrophoblasts: 25.8;Hofbauer cells: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 57.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041423, HPA052932" Approved Supported Cytosol NA NA Cytosol "HPA041423: AB_10795540, HPA052932: AB_2681991" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (4.28e-4)" "unprognostic (1.28e-1)" "unprognostic (2.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (9.48e-5)" "unprognostic (3.56e-1)" "prognostic favorable (7.28e-4)" "unprognostic (2.30e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.77e-15)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.75e-2)" "unprognostic (2.57e-3)" 12.5 18.7 23.4 15.9 23.1 10.7 9.3 27.3 22.6 14.6 16.7 18.1 16.0 13.8 16.8 13.1 16.0 21.9 12.5 63.9 18.8 16.6 20.1 13.1 13.7 11.2 20.1 19.2 13.4 9.3 29.3 14.2 9.2 19.0 13.3 17.0 11.3 17.4 22.3 82.9 13.9 12.3 20.0 18.5 17.3 18.9 12.2 21.6 11.2 16.8 29.1 14.1 19.4 11.4 9.4 19.8 57.9 19.3 5.6 12.0 7.0 2.7 7.5 3.8 9.2 15.7 14.9 10.0 2.9 8.1 9.0 9.3 4.8 21.6 18.7 21.7 8.6 11.8 8.3 10.5 11.4 3.7 10.3 4.4 12.5 3.8 6.2 23.0 12.8 18.3 22.9 4.9 4.9 1.9 11.9 16.0 10.5 6.2 25.5 8.5 0.7 10.0 12.1 7.7 0.3 0.7 17.2 7.4 13.6 15.3 11.8 10.6 5.4 4.8 8.4 3.5 4.1 14.9 10.8 11.4 2.7 2.4 8.0 2.7 14.7 10.4 6.3 14.0 16.7 1.8 13.7 13.6 8.1 8.8 19.3 9.0 9.4 5.9 7.2 19.8 7.0 4.9 6.0 57.9 5.6 15.5 6.2 12.0 7.0 23.4 23.1 27.3 22.6 18.8 16.6 20.1 19.2 19.0 21.6 26.8 16.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 10.3 27.9 0.0 25.8 18.3 11.9 0.0 0.0 0.0 0.0 5.1 13.7 0.0 0.0 7.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 12.6 0.0 0.0 7.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 DHX29 DDX29 ENSG00000067248 "DExH-box helicase 29" Q7Z478 5 55256245-55307722 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Helicase, Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038317, HPA038318" Approved Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA038317: AB_10673169, HPA038318: AB_10672589" "unprognostic (3.43e-2)" "unprognostic (5.09e-1)" "unprognostic (2.21e-2)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.80e-1)" "unprognostic (2.37e-3)" "unprognostic (1.72e-1)" "unprognostic (6.66e-2)" "unprognostic (1.76e-2)" "unprognostic (3.79e-2)" "unprognostic (1.30e-1)" "unprognostic (4.57e-3)" "unprognostic (4.01e-1)" "unprognostic (3.85e-1)" "unprognostic (4.78e-3)" "unprognostic (9.40e-2)" 14.6 16.2 15.1 12.2 16.6 9.8 16.3 22.0 16.9 17.3 18.4 9.2 20.2 11.3 17.4 12.8 18.5 13.6 11.7 22.1 12.8 9.6 22.4 20.6 15.2 11.8 13.7 11.9 13.8 15.3 30.3 30.7 17.7 16.3 18.9 13.3 7.8 15.2 24.3 31.8 15.9 14.7 18.5 13.1 14.3 14.8 10.2 16.6 15.6 20.9 12.0 11.9 19.9 14.4 18.5 25.9 32.4 19.6 16.0 18.8 6.3 22.1 15.6 13.0 17.2 21.5 18.0 16.0 23.7 18.7 17.4 18.1 12.7 14.5 13.0 21.6 26.5 22.8 16.4 20.5 23.0 25.0 5.2 11.6 11.9 14.5 8.9 12.3 7.9 12.7 15.8 14.2 18.6 11.2 12.2 22.9 10.6 14.5 9.9 20.8 15.3 13.9 8.0 11.1 6.4 17.5 6.8 20.5 21.4 15.1 15.3 12.1 8.3 23.4 12.9 11.7 13.7 18.3 14.7 20.0 16.0 13.5 14.3 17.2 9.5 14.3 17.6 19.7 13.8 18.0 32.4 16.3 15.9 13.5 16.4 15.1 18.5 16.9 15.0 12.1 17.6 18.8 15.8 15.2 16.0 19.6 25.9 13.9 6.3 15.1 16.6 22.0 16.9 12.8 9.6 13.7 11.9 16.3 16.6 65.5 35.2 25.3 32.1 33.4 77.9 67.4 48.4 33.5 66.0 61.1 39.3 58.7 46.4 45.2 32.2 35.9 31.5 93.5 53.9 43.6 42.1 40.8 30.1 40.5 36.0 39.7 36.9 21.5 25.0 13.6 43.1 37.1 27.0 36.1 33.2 34.7 50.0 25.9 49.8 84.5 77.5 51.8 44.2 87.3 127.3 41.5 68.0 27.7 35.1 33.6 DICER1 "Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1" ENSG00000100697 "Dicer 1, ribonuclease III" Q9UPY3 14 95086228-95158010 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "RNA-mediated gene silencing" "Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000694, CAB068185" Approved Supported Cytosol NA NA Cytosol "CAB068185: AB_2665650, HPA000694: AB_1078661" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (6.75e-2)" "unprognostic (9.62e-2)" "unprognostic (1.96e-2)" "unprognostic (7.73e-2)" "unprognostic (1.21e-1)" "unprognostic (8.52e-3)" "unprognostic (5.73e-2)" "unprognostic (9.22e-2)" "unprognostic (4.22e-2)" "unprognostic (9.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.04e-3)" "unprognostic (3.74e-2)" 23.2 12.5 18.4 22.4 33.3 20.5 23.2 28.5 29.9 19.0 18.1 31.4 22.4 13.0 20.8 20.6 23.4 18.5 16.2 15.3 22.0 14.1 19.5 23.6 22.4 20.3 29.7 19.6 23.8 19.8 26.9 30.9 29.9 23.2 20.3 19.7 14.5 19.5 18.9 28.0 20.7 17.3 19.0 26.8 20.7 17.1 20.6 32.0 17.0 23.8 14.7 20.3 20.7 24.1 2.5 1.8 10.7 7.2 1.2 3.3 1.0 12.9 13.6 25.4 9.4 6.6 9.9 20.1 10.7 6.5 6.8 8.3 17.2 10.0 14.7 11.6 10.0 7.1 15.3 20.1 10.1 14.4 22.7 9.0 22.2 7.4 12.4 6.6 13.6 13.6 9.2 8.3 9.2 14.1 5.9 10.2 11.6 9.3 13.1 11.5 18.2 15.2 9.0 7.2 9.1 6.7 12.1 20.8 8.1 9.1 20.7 21.1 11.9 10.8 11.1 12.2 14.1 12.6 10.0 10.1 5.3 10.5 10.2 12.0 14.9 21.3 20.8 5.5 11.0 9.4 3.1 3.0 1.2 1.6 3.1 3.3 1.9 1.5 1.2 1.8 2.5 1.5 1.3 10.7 1.2 7.2 1.6 1.6 1.0 18.4 33.3 28.5 29.9 22.0 14.1 29.7 19.6 23.2 32.0 50.6 47.2 32.6 39.2 24.4 99.7 34.3 38.2 32.1 51.2 43.6 53.0 39.4 5.0 30.3 19.8 39.1 29.6 23.3 19.9 20.7 34.6 55.9 11.5 50.5 41.7 101.7 44.3 41.1 94.2 12.0 50.3 46.8 21.9 19.0 30.6 35.0 28.4 23.0 49.5 22.6 68.5 32.3 35.0 34.9 52.5 24.1 21.5 23.0 31.6 49.7 DIXDC1 "Dixin, KIAA1735" ENSG00000150764 "DIX domain containing 1" Q155Q3 11 111927144-112022584 "Predicted intracellular proteins" "Wnt signaling pathway" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.2" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 98.2;Horizontal cells: 114.4;Spermatocytes: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "eosinophil: 8.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 23.4;TIME: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039658 Supported Cytosol NA NA Cytosol "HPA039658: AB_2676611" "unprognostic (1.93e-1)" "unprognostic (2.90e-2)" "unprognostic (8.93e-3)" "unprognostic (2.84e-1)" "unprognostic (2.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-1)" "unprognostic (1.41e-1)" "unprognostic (7.23e-2)" "unprognostic (1.59e-1)" "unprognostic (7.85e-2)" "unprognostic (5.11e-2)" "prognostic favorable (6.89e-5)" "unprognostic (4.10e-2)" "unprognostic (2.11e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (4.19e-5)" 9.7 10.4 8.8 4.5 16.1 0.0 8.6 52.2 15.7 11.5 7.4 20.2 4.9 2.9 14.3 11.0 8.4 12.3 7.0 12.7 8.7 9.9 6.4 4.7 5.1 1.0 16.1 10.2 9.5 3.9 10.2 8.9 5.9 10.8 14.1 5.7 6.8 4.7 22.0 6.6 4.2 3.9 24.9 9.2 3.1 4.8 10.1 16.2 0.0 6.5 1.7 1.0 17.4 18.0 0.1 0.1 8.6 0.2 0.1 0.9 0.2 0.4 2.0 5.3 10.0 16.7 9.7 1.1 4.1 2.8 1.6 2.8 0.3 1.1 0.8 1.1 11.3 1.8 0.5 2.3 1.2 1.6 3.2 2.0 0.4 3.0 5.3 2.5 2.7 0.3 7.9 10.5 3.4 23.4 11.7 16.3 2.1 2.6 0.3 6.4 0.4 1.7 2.4 3.2 0.4 3.6 0.8 1.5 3.2 6.6 0.1 4.4 9.1 3.0 2.5 1.4 2.4 3.7 1.0 26.5 7.2 3.1 1.3 6.7 0.6 2.8 0.4 3.9 7.0 2.5 0.0 0.2 8.6 0.6 0.0 0.1 0.1 0.5 0.6 0.0 0.1 0.9 0.8 0.7 0.1 0.1 0.1 0.0 0.2 8.8 16.1 52.2 12.4 8.7 9.9 16.1 10.2 10.8 16.2 14.9 10.1 0.0 13.7 5.7 18.5 26.9 10.2 25.4 13.6 17.4 98.2 1.3 13.3 5.7 16.4 14.3 2.3 0.0 6.7 4.7 25.2 9.8 1.1 19.4 1.7 114.4 2.4 56.4 3.4 12.0 36.8 2.6 11.8 1.8 13.3 32.0 6.9 6.6 34.6 10.7 68.4 12.9 30.8 82.9 14.2 3.6 1.1 0.9 4.8 2.7 DLEC1 "CFAP81, DLC1" ENSG00000008226 "Deleted in lung and esophageal cancer 1" Q9Y238 3 38039205-38124025 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.1;fallopian tube: 23.2;testis: 28.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 68.3;Club cells: 21.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019077 Enhanced Supported Cytosol NA NA Cytosol "HPA019077: AB_1847724" "unprognostic (1.24e-4)" "unprognostic (3.60e-3)" "unprognostic (2.11e-1)" "unprognostic (1.09e-3)" "unprognostic (2.32e-1)" "unprognostic (1.76e-3)" "unprognostic (2.50e-3)" "unprognostic (8.54e-3)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (9.53e-2)" "unprognostic (7.62e-2)" "unprognostic (8.70e-4)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.94e-4)" 0.8 0.3 1.3 0.7 8.3 1.1 0.5 0.0 0.6 3.3 0.6 6.1 3.5 0.7 1.1 21.1 0.3 23.2 1.3 0.3 1.7 2.5 0.3 0.3 10.0 1.7 0.5 0.2 6.3 0.2 0.6 14.2 0.3 9.8 0.8 0.6 0.8 0.6 1.8 0.2 0.7 0.7 0.3 0.6 0.7 0.6 28.9 1.7 0.0 0.8 0.0 0.6 0.4 0.1 0.2 0.1 0.9 0.4 0.1 1.1 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.2 0.2 0.5 0.0 0.2 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.3 0.0 0.4 0.2 0.1 3.4 0.5 0.0 0.0 0.0 0.2 0.1 2.8 0.5 0.2 0.3 1.7 0.5 0.2 0.1 0.3 0.0 0.0 0.5 0.3 0.0 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.8 0.2 0.4 0.2 1.1 0.0 0.1 0.1 0.2 0.0 0.9 0.1 0.1 0.1 0.2 0.1 1.3 8.3 0.0 0.6 1.7 2.5 0.5 0.2 9.8 1.7 3.0 4.8 0.0 0.6 0.5 1.1 0.6 0.0 68.3 21.6 0.0 0.0 0.1 0.0 0.1 2.7 0.3 0.7 0.0 0.2 0.1 0.6 0.5 2.3 0.2 0.4 0.0 1.2 0.0 0.0 4.3 0.9 0.9 0.0 1.0 0.4 0.1 0.1 0.8 0.0 0.0 0.5 0.0 0.2 8.4 1.0 0.3 0.1 0.5 0.0 0.4 DNAAF2 "C14orf104, CILD10, FLJ10563, KTU, PF13" ENSG00000165506 "Dynein axonemal assembly factor 2" Q9NVR5 14 49625174-49635230 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002894, HPA004113" Enhanced Supported Cytosol NA NA Cytosol "HPA002894: AB_1078316, HPA004113: AB_1078315" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (7.57e-2)" "unprognostic (5.85e-2)" "unprognostic (1.19e-2)" "unprognostic (1.65e-1)" "unprognostic (9.50e-2)" "unprognostic (1.75e-2)" "unprognostic (2.53e-2)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "unprognostic (2.25e-2)" "prognostic favorable (6.74e-7)" "unprognostic (6.72e-2)" "unprognostic (2.54e-1)" "unprognostic (5.04e-2)" "unprognostic (3.44e-2)" 3.4 5.7 4.3 3.9 9.1 2.5 5.8 5.9 4.9 4.6 7.1 4.8 2.3 7.6 4.2 13.8 5.3 9.2 6.1 4.1 5.5 5.2 7.0 9.5 9.7 4.9 4.0 3.8 14.6 7.0 3.6 7.3 3.7 10.7 4.0 4.7 2.9 5.3 3.0 5.4 2.9 6.8 3.0 3.8 3.9 4.8 48.1 3.2 4.8 5.4 8.5 4.3 4.3 3.5 12.6 6.2 7.2 5.8 13.7 11.5 5.3 10.3 6.2 13.7 10.6 6.7 7.8 13.0 5.6 6.2 6.2 6.9 6.0 10.0 15.2 8.9 3.7 5.1 11.4 11.2 7.8 7.8 10.5 6.7 7.7 4.6 10.3 5.2 12.4 6.5 5.1 8.5 5.3 7.3 6.4 6.4 8.4 11.5 10.4 6.1 12.8 8.1 12.9 14.9 10.8 11.3 10.2 10.6 5.1 8.8 8.7 20.9 15.6 8.3 9.1 9.9 9.0 10.3 5.0 5.2 5.9 16.6 6.0 6.9 20.9 13.0 12.5 2.2 7.7 6.4 6.7 5.5 7.2 8.7 4.7 10.4 12.6 9.8 11.5 6.2 9.7 9.5 9.3 2.1 13.7 5.8 5.6 9.1 5.3 4.3 9.1 5.9 4.9 5.5 5.2 4.0 3.8 10.7 3.2 3.0 3.5 17.3 19.1 36.5 7.1 7.3 5.1 22.7 2.3 12.2 0.0 18.3 26.6 23.9 17.8 15.2 14.4 0.0 21.0 26.5 18.1 14.8 11.5 20.2 12.2 3.2 9.2 20.3 9.1 5.0 17.0 10.4 18.6 9.0 15.1 8.0 21.7 14.0 15.6 29.9 11.8 6.5 13.8 17.7 14.3 38.5 10.4 17.3 20.2 14.2 DNAH7 KIAA0944 ENSG00000118997 "Dynein axonemal heavy chain 7" Q8WXX0 2 195737703-196068812 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7;fallopian tube: 19.4;pituitary gland: 25.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 127.2;Cone photoreceptor cells: 66.8;Early spermatids: 40.0;Rod photoreceptor cells: 42.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "neutrophil: 2.0;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.0;granulocytes: 2.0" "Cell line enhanced" "Detected in some" "PC-3: 10.6;RPTEC TERT1: 5.0" "Low region specificity" "Detected in many" "HPA034724, HPA044070" Enhanced Supported Cytosol NA NA Cytosol "HPA034724: AB_10670977, HPA044070: AB_2678798" "unprognostic (1.71e-1)" "unprognostic (2.81e-2)" "unprognostic (2.65e-2)" "unprognostic (1.04e-2)" "unprognostic (3.56e-1)" "unprognostic (1.58e-2)" "unprognostic (6.74e-3)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.24e-1)" "unprognostic (7.76e-2)" "unprognostic (2.52e-3)" "unprognostic (3.98e-2)" 1.0 2.6 6.8 1.4 9.9 0.7 1.9 0.6 6.4 3.3 1.9 4.6 4.3 0.9 2.2 12.9 1.1 19.4 1.9 1.4 7.1 5.8 4.5 1.2 9.5 0.9 3.4 3.5 3.9 4.2 3.6 25.2 0.9 21.7 1.9 1.6 1.8 1.8 2.5 0.6 0.9 1.9 1.2 2.1 0.8 1.5 18.3 2.3 0.0 5.9 0.0 1.0 1.3 0.5 0.3 2.0 2.0 0.0 0.1 0.2 0.2 0.6 2.4 0.5 0.2 1.4 0.9 0.2 0.2 1.4 0.5 0.6 0.5 1.7 0.0 0.7 0.5 1.8 0.1 0.0 0.3 0.4 0.0 1.4 0.0 3.0 0.7 0.2 0.1 0.2 0.3 0.4 2.1 0.4 3.2 0.0 0.0 0.6 3.3 0.9 2.4 0.0 0.1 0.5 1.2 10.6 0.1 0.6 0.8 5.0 0.3 1.1 1.9 0.6 0.4 0.2 0.2 1.0 0.2 0.0 1.3 0.4 2.1 0.6 2.6 2.4 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.1 2.0 0.1 0.0 2.0 0.0 0.2 6.8 9.9 0.6 6.4 7.1 5.8 3.4 3.5 21.7 2.3 0.0 6.7 0.0 1.1 0.8 1.7 1.2 0.0 127.2 17.0 1.8 66.8 0.0 0.0 1.9 40.0 0.7 2.1 0.0 0.6 0.0 0.9 2.2 0.0 0.0 0.1 1.6 0.0 0.6 0.0 20.2 0.6 0.5 1.7 0.0 0.6 2.7 0.8 0.0 1.4 2.2 42.3 0.0 0.5 26.9 4.3 1.1 0.1 0.0 0.4 0.6 DNAJC2 "MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin" ENSG00000105821 "DnaJ heat shock protein family (Hsp40) member C2" Q99543 7 103312474-103344873 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chaperone, Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 178.0;Spermatocytes: 193.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020454 Approved Supported Cytosol NA NA Cytosol "HPA020454: AB_1859492" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (5.53e-2)" "unprognostic (2.20e-2)" "unprognostic (1.11e-1)" "unprognostic (7.71e-2)" "unprognostic (2.13e-3)" "unprognostic (2.13e-3)" "unprognostic (1.63e-2)" "unprognostic (5.35e-2)" "unprognostic (2.21e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (1.11e-1)" "unprognostic (2.30e-1)" "unprognostic (3.51e-1)" "unprognostic (3.28e-1)" 12.8 12.5 12.8 21.5 14.2 37.0 13.6 12.9 16.8 13.3 15.0 5.1 10.7 14.3 13.4 12.5 13.6 11.8 11.5 13.6 11.4 11.0 16.2 25.2 10.7 15.5 13.3 12.7 16.4 13.2 12.2 28.5 13.8 16.1 12.0 13.0 5.6 12.6 9.1 29.4 12.7 18.6 13.1 12.2 19.7 12.8 30.6 15.7 17.6 13.0 12.0 13.6 16.6 16.5 9.1 7.1 28.6 9.1 10.0 8.8 3.7 17.6 12.7 7.3 14.0 5.9 8.2 15.0 12.2 8.8 13.6 10.1 19.0 13.0 24.9 19.5 8.3 19.5 12.0 19.8 8.8 20.8 13.3 16.3 18.5 12.1 16.1 10.6 32.5 14.7 7.1 7.7 15.8 14.2 5.6 8.8 9.4 42.7 16.3 11.0 29.5 30.9 33.6 26.2 19.3 19.8 19.9 15.1 23.2 8.0 8.4 14.4 13.4 16.4 22.9 12.6 14.6 9.7 16.5 10.5 13.5 21.6 29.1 23.7 17.4 22.8 50.0 9.6 33.8 16.8 28.6 6.0 5.5 7.6 6.5 8.4 7.8 7.6 7.9 5.9 9.1 8.8 8.8 2.4 10.0 9.1 7.1 8.1 3.7 12.8 14.2 12.9 16.8 11.4 11.0 13.3 12.7 16.1 15.7 23.8 46.0 38.8 57.0 57.5 25.3 25.8 25.5 49.5 63.7 21.0 39.3 37.3 29.9 31.3 178.0 30.7 27.2 0.0 40.1 63.7 36.8 49.2 51.0 26.6 35.1 20.6 33.9 14.7 21.3 21.3 36.5 37.8 18.6 32.5 34.3 18.6 41.4 28.1 29.4 26.7 27.3 38.8 35.8 193.5 136.9 54.3 46.3 33.1 42.7 70.8 DNAJC24 "DPH4, JJJ3, ZCSL3" ENSG00000170946 "DnaJ heat shock protein family (Hsp40) member C24" 11 31369840-31431849 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 159.5;Late spermatids: 169.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020025, HPA025237" Approved Approved Cytosol NA NA Cytosol "HPA020025: AB_1847801, HPA025237: AB_1847802" "unprognostic (2.07e-1)" "unprognostic (3.73e-2)" "unprognostic (2.27e-2)" "unprognostic (9.74e-2)" "unprognostic (3.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (2.21e-2)" "unprognostic (1.49e-1)" "unprognostic (3.50e-1)" "unprognostic (1.28e-1)" "unprognostic (3.56e-1)" "unprognostic (2.74e-1)" "unprognostic (9.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-1)" 10.4 10.7 13.0 8.8 21.6 3.7 10.2 16.4 17.4 9.1 8.9 9.4 7.4 7.2 10.7 9.9 10.7 6.8 9.2 20.2 12.7 13.4 10.5 9.8 7.6 10.6 12.3 11.1 8.4 13.3 9.7 21.8 8.4 14.7 9.9 7.7 8.9 9.0 10.1 25.6 14.1 8.1 11.9 13.5 9.0 8.7 8.2 12.8 7.1 11.8 9.5 9.5 11.2 7.0 5.1 4.3 7.5 4.5 3.5 8.1 3.2 4.2 5.5 9.8 7.0 7.3 9.7 4.8 11.0 6.9 6.3 6.0 4.4 4.5 5.3 5.9 7.3 9.5 5.3 6.1 7.2 10.3 13.6 10.6 6.3 9.5 4.3 9.0 11.9 9.4 8.8 8.5 3.9 12.1 8.5 8.4 9.3 12.0 9.8 12.0 4.7 8.9 5.7 4.6 6.0 6.4 5.8 18.2 5.5 7.5 4.3 4.5 6.5 10.6 7.1 7.9 5.4 9.8 7.2 9.9 12.1 8.3 14.0 13.4 11.4 9.8 7.3 17.9 6.0 12.8 7.5 2.9 2.1 6.1 4.5 8.1 4.2 5.6 5.2 2.1 5.1 7.3 7.4 2.3 3.5 2.6 4.3 3.9 3.2 13.0 21.6 16.4 17.4 12.7 13.4 12.3 11.1 14.7 12.8 3.0 6.1 11.7 6.2 10.8 10.4 16.5 2.5 2.7 9.1 3.5 9.8 7.7 3.3 7.3 159.5 6.3 4.4 0.0 7.9 8.5 8.6 7.0 4.7 9.7 7.1 22.3 6.9 7.4 6.5 169.1 8.3 9.6 11.8 4.6 3.4 30.3 8.5 7.0 8.9 7.8 13.6 0.0 8.5 14.4 18.1 7.2 5.3 15.0 4.9 7.1 DNAJC27 "RabJS, RBJ" ENSG00000115137 "DnaJ heat shock protein family (Hsp40) member C27" Q9NZQ0 2 24943636-24972094 "Predicted intracellular proteins" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 30.4" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 74.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036815, HPA036816" Uncertain Approved Cytosol NA NA Cytosol "HPA036815: , HPA036816: AB_10673506" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (4.53e-2)" "unprognostic (3.09e-1)" "unprognostic (5.17e-3)" "unprognostic (5.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.13e-1)" "unprognostic (4.60e-2)" "unprognostic (7.44e-4)" "unprognostic (8.84e-2)" "prognostic favorable (8.48e-5)" "unprognostic (3.35e-1)" "unprognostic (3.66e-1)" "unprognostic (3.05e-2)" "unprognostic (1.78e-3)" 6.0 5.6 6.7 3.4 13.8 5.3 5.9 9.4 15.7 5.6 4.1 6.8 1.9 3.2 6.6 8.1 3.7 5.7 4.8 7.3 6.7 8.0 6.1 3.1 4.4 4.1 9.5 6.5 10.9 3.6 7.6 10.2 4.6 19.0 5.5 4.6 4.9 3.2 5.2 6.5 4.5 3.3 5.0 8.3 4.1 3.7 30.4 8.2 3.6 5.3 2.4 3.9 4.1 6.1 1.4 0.8 2.9 1.2 4.5 1.9 0.9 4.6 2.0 4.3 4.4 6.2 5.2 3.3 3.6 5.3 3.8 3.3 2.1 2.1 4.3 0.8 2.5 3.2 3.7 3.3 2.2 3.9 1.9 2.6 2.7 2.4 1.9 3.9 2.4 3.8 3.9 3.8 3.0 5.9 4.3 1.5 5.2 1.8 4.0 4.1 1.7 4.3 4.2 2.8 1.6 1.8 2.7 8.7 2.4 3.6 2.5 1.6 5.6 3.3 2.6 4.9 4.8 2.3 1.8 1.4 5.0 3.6 2.6 3.2 10.4 3.7 5.2 2.5 4.0 2.1 0.0 0.8 2.9 1.0 0.5 1.9 1.4 1.2 0.8 0.8 1.1 1.6 1.8 0.2 4.5 1.2 0.4 1.1 0.9 6.7 13.8 9.4 15.7 6.7 8.0 9.5 6.5 19.0 8.2 8.9 7.7 4.2 5.9 1.8 22.7 19.8 5.1 22.7 2.3 7.0 35.3 3.3 3.3 2.4 37.0 4.1 3.2 0.0 2.2 1.6 4.0 4.1 10.4 2.5 2.9 35.0 14.9 5.5 2.4 25.8 8.1 4.3 1.7 3.6 4.6 11.7 1.3 0.0 6.0 2.2 22.5 0.0 12.8 74.8 19.0 2.9 3.5 5.7 4.3 3.0 DNPEP "ASPEP, DAP" ENSG00000123992 "Aspartyl aminopeptidase" Q9ULA0 2 219373527-219400022 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 334.9;Late spermatids: 344.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036398, HPA044860" Enhanced Supported Cytosol NA NA 6200000 Cytosol "HPA036398: AB_10970915, HPA044860: AB_10961275" "unprognostic (3.71e-1)" "unprognostic (6.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.75e-1)" "unprognostic (2.54e-3)" "unprognostic (3.34e-2)" "unprognostic (2.44e-1)" "unprognostic (3.49e-2)" "unprognostic (1.61e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-1)" "unprognostic (5.63e-3)" "unprognostic (3.49e-1)" "unprognostic (2.50e-1)" "unprognostic (1.85e-3)" 20.1 12.3 8.8 15.5 10.4 7.2 20.0 7.2 9.3 16.5 30.4 8.6 13.8 27.9 15.1 13.3 16.9 15.3 16.6 22.9 10.4 6.8 21.2 33.5 15.5 11.7 10.5 7.2 19.4 19.0 9.7 11.0 28.5 9.4 21.0 15.8 15.9 18.7 14.7 36.6 14.6 50.3 12.9 6.8 17.5 15.2 33.7 9.3 11.3 15.0 20.0 17.4 20.7 13.1 11.6 16.1 5.8 15.0 15.7 15.7 10.9 16.2 8.9 5.5 16.2 14.5 12.0 43.5 8.1 16.4 21.1 22.4 24.6 21.4 10.0 17.5 16.8 27.1 15.9 6.5 18.5 7.6 19.4 4.7 16.0 9.1 26.7 38.6 13.3 11.5 19.5 19.7 21.7 18.2 13.6 14.4 13.4 18.0 15.9 10.8 35.3 20.2 14.8 9.0 23.2 5.6 26.3 12.5 13.1 11.8 25.3 6.9 9.3 9.4 31.1 11.4 10.0 9.1 14.7 8.0 20.3 16.8 10.6 11.6 17.9 10.5 7.0 28.9 12.7 8.6 5.8 13.2 5.4 13.6 15.0 15.4 10.2 11.0 15.0 16.1 11.6 12.0 15.7 1.0 15.7 12.2 5.8 12.6 10.9 8.8 10.4 7.2 9.3 10.4 6.8 10.5 7.2 9.4 9.3 11.9 15.6 23.5 61.6 34.3 15.9 28.8 33.1 8.1 11.4 24.4 31.4 76.5 41.4 49.0 334.9 40.7 74.6 0.0 57.6 79.5 42.3 44.7 24.2 41.8 45.2 9.5 46.1 28.8 28.6 344.5 48.6 32.0 30.4 58.7 90.9 28.2 48.4 66.2 38.5 58.6 36.0 25.8 49.1 17.0 16.6 39.1 55.5 30.8 58.7 65.4 DOCK3 "KIAA0299, MOCA, PBP" ENSG00000088538 "Dedicator of cytokinesis 3" Q8IZD9 3 50675241-51384198 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 20.8;Early spermatids: 10.4;Horizontal cells: 31.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 7.6;GAMG: 7.5;HMC-1: 6.1;JURKAT: 7.2;U-87 MG: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037543, HPA037544" Enhanced Supported Enhanced Cytosol NA NA Cytosol "HPA037543: AB_10672495, HPA037544: AB_10670383" "unprognostic (1.02e-1)" "unprognostic (1.11e-1)" "unprognostic (1.78e-3)" "unprognostic (6.35e-8)" "unprognostic (2.63e-1)" "unprognostic (3.02e-2)" "unprognostic (4.64e-2)" "unprognostic (3.67e-1)" "unprognostic (1.91e-1)" "unprognostic (7.99e-2)" "unprognostic (2.36e-3)" "unprognostic (1.34e-2)" "unprognostic (1.45e-2)" "unprognostic (5.83e-5)" "unprognostic (7.96e-2)" "unprognostic (6.19e-2)" "unprognostic (1.24e-1)" 1.6 5.5 15.3 1.7 19.8 1.6 1.7 24.2 38.9 1.7 2.3 11.6 1.9 1.7 2.1 2.7 4.2 2.2 1.9 4.6 11.5 9.8 1.9 1.3 1.8 1.8 9.1 17.6 1.7 2.0 15.8 9.2 1.5 13.1 3.8 1.9 1.8 3.2 5.0 4.3 4.0 1.7 3.1 8.5 1.8 1.7 9.0 10.7 0.0 17.4 0.0 1.9 2.0 0.7 0.7 0.7 0.2 2.0 0.6 1.3 0.0 0.1 0.2 0.2 7.6 0.0 0.0 3.3 0.1 0.2 0.4 0.3 0.2 0.5 0.0 0.6 2.4 7.5 0.5 5.1 0.0 0.1 4.3 5.3 0.1 1.3 0.1 0.1 0.2 6.1 0.1 0.1 0.2 0.0 0.4 0.0 7.2 0.0 0.1 0.6 0.2 0.0 0.0 2.5 0.3 2.4 0.0 0.7 0.0 0.4 0.7 4.7 0.0 0.3 4.3 0.1 5.5 0.1 0.0 0.5 0.2 2.1 0.2 2.7 0.3 0.0 0.0 10.1 1.0 0.1 0.0 0.1 0.2 0.5 0.4 0.5 0.4 0.4 0.2 0.1 0.7 1.3 0.5 0.2 0.6 2.0 0.7 0.1 0.0 15.3 19.8 24.2 25.3 11.5 9.8 9.1 17.6 13.1 10.7 0.0 1.1 0.0 0.1 0.0 20.8 6.7 0.0 0.0 1.2 0.0 2.0 0.0 1.7 0.0 10.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 31.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 4.9 0.0 1.4 3.5 2.9 0.1 0.0 0.0 0.0 0.0 DOCK5 FLJ21034 ENSG00000147459 "Dedicator of cytokinesis 5" Q9H7D0 8 25184723-25418082 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 87.6;Melanocytes: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 22.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017719, HPA056837" Approved Enhanced Cytosol No No Cytosol "HPA017719: AB_1847820, HPA056837: AB_2683253" "unprognostic (2.16e-1)" "unprognostic (3.55e-3)" "unprognostic (1.25e-2)" "prognostic favorable (1.91e-4)" "unprognostic (8.44e-2)" "unprognostic (1.24e-1)" "unprognostic (2.61e-2)" "unprognostic (2.88e-2)" "unprognostic (1.69e-2)" "unprognostic (4.21e-2)" "unprognostic (4.18e-3)" "unprognostic (3.00e-1)" "prognostic unfavorable (1.18e-6)" "unprognostic (2.81e-1)" "unprognostic (3.07e-1)" "unprognostic (1.30e-2)" "unprognostic (2.25e-1)" 5.5 4.3 12.1 10.4 30.3 26.2 7.2 3.3 18.2 6.3 11.5 38.8 12.1 14.9 6.3 7.8 4.3 7.6 9.6 8.0 15.1 7.6 4.8 16.2 10.7 4.7 35.0 9.4 10.4 5.7 6.3 10.8 15.6 18.8 9.4 13.4 10.8 7.9 14.3 3.3 7.1 17.0 5.3 17.0 21.9 9.2 7.8 33.8 0.6 18.5 2.3 2.7 5.6 5.8 0.0 1.6 22.0 4.6 0.3 0.3 0.2 10.4 21.8 2.1 0.2 5.1 5.5 7.9 25.3 12.9 6.2 4.9 3.1 7.5 0.3 2.3 19.6 6.9 18.2 2.4 16.0 9.9 3.4 3.2 10.5 18.8 7.7 5.9 2.4 11.6 3.7 6.5 6.9 10.2 6.8 5.3 0.5 0.1 0.5 6.0 6.0 0.3 4.7 2.2 11.6 6.9 0.1 4.9 0.2 4.5 6.1 1.6 0.7 13.3 7.3 2.4 1.9 2.3 2.3 15.9 10.7 7.5 13.2 9.1 0.5 0.1 0.2 13.8 5.5 13.4 7.6 1.9 2.6 0.3 3.8 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.2 22.0 0.3 4.6 0.2 0.0 0.2 12.1 30.3 3.3 18.2 15.1 7.6 35.0 9.4 18.8 33.8 41.7 40.4 5.2 9.8 16.5 8.1 12.0 30.6 24.1 28.4 14.0 2.0 22.6 0.0 10.3 0.8 6.8 50.5 0.0 10.5 87.6 24.9 31.8 30.1 25.8 13.1 1.6 16.8 10.4 55.4 2.6 26.7 42.6 81.0 2.8 23.5 26.2 31.4 24.6 45.3 2.7 1.6 12.9 7.6 0.7 5.5 6.4 17.2 6.4 19.8 11.1 DOCK6 "KIAA1395, ZIR1" ENSG00000130158 "Dedicator of cytokinesis 6" Q96HP0 19 11199295-11262481 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 124.5;Ito cells: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 33.2;TIME: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049423, HPA049424" Approved Supported Cytosol NA NA Cytosol "HPA049423: AB_2680760, HPA049424: AB_2680761" "unprognostic (2.69e-2)" "unprognostic (2.27e-1)" "unprognostic (9.51e-2)" "unprognostic (3.35e-2)" "unprognostic (4.72e-3)" "prognostic favorable (9.09e-4)" "unprognostic (2.54e-2)" "unprognostic (4.91e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (2.57e-1)" "unprognostic (7.89e-2)" "unprognostic (1.25e-3)" "unprognostic (2.76e-1)" "unprognostic (1.51e-1)" "unprognostic (5.41e-2)" "unprognostic (2.95e-1)" 17.8 4.9 6.4 5.1 7.9 0.0 12.8 3.3 8.5 7.1 12.6 6.7 6.5 10.3 11.0 8.6 9.3 4.9 8.8 10.5 6.1 2.3 12.2 7.3 19.7 3.6 8.1 2.0 5.8 8.1 3.7 6.2 11.1 6.7 7.1 4.5 10.2 7.4 5.8 9.8 18.2 11.7 13.4 5.5 7.1 10.3 5.4 5.3 1.3 14.5 8.6 7.6 7.3 22.9 1.5 0.0 0.0 0.5 0.0 0.3 0.2 6.8 4.2 4.9 3.9 3.6 5.3 7.8 2.0 3.3 2.0 3.1 8.0 5.4 0.4 12.5 3.4 1.9 4.0 2.1 10.7 1.2 5.8 3.3 1.3 0.9 6.0 5.9 2.0 6.7 4.0 6.4 3.6 8.4 3.9 33.2 0.1 7.2 0.0 4.4 15.4 0.0 6.8 6.1 6.2 8.0 0.4 3.3 6.5 3.3 9.5 0.2 8.7 2.0 2.0 3.7 3.4 2.4 3.6 32.9 3.7 3.9 8.4 3.6 0.6 0.1 6.6 3.1 1.5 3.2 0.0 0.3 0.0 0.3 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 6.4 7.9 3.3 8.5 6.1 2.3 8.1 2.0 6.7 5.3 3.0 15.9 0.8 4.8 5.8 1.2 124.5 5.1 5.3 11.4 24.4 0.0 0.2 1.7 4.8 3.0 37.9 11.2 0.0 5.9 1.1 7.8 7.5 4.7 5.8 3.6 0.0 11.6 55.3 4.4 0.9 20.8 1.4 3.3 0.0 12.5 3.7 8.0 11.4 8.9 1.9 2.3 19.4 10.8 1.7 3.9 10.0 0.5 0.7 9.0 8.2 DOK1 p62dok ENSG00000115325 "Docking protein 1" Q99704 2 74549026-74557554 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 36.8;Hofbauer cells: 43.1;Macrophages: 32.0;monocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004224, HPA048561" Approved Supported Cytosol NA NA 74000 Cytosol "CAB004224: AB_627447, HPA048561: AB_2680443" "unprognostic (2.40e-2)" "unprognostic (2.07e-2)" "unprognostic (2.60e-1)" "prognostic favorable (8.42e-4)" "unprognostic (9.86e-3)" "unprognostic (1.28e-1)" "unprognostic (7.10e-2)" "prognostic favorable (4.64e-4)" "unprognostic (7.57e-2)" "unprognostic (1.85e-2)" "unprognostic (1.89e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (3.16e-6)" "unprognostic (8.65e-2)" "unprognostic (2.40e-2)" "unprognostic (1.37e-1)" "unprognostic (1.20e-2)" 13.2 4.9 4.7 11.2 6.0 15.7 13.3 1.3 3.3 6.2 5.9 5.3 2.6 4.3 7.0 3.6 3.4 5.5 8.0 5.0 4.9 4.2 4.7 2.3 8.0 9.5 6.9 2.8 6.7 10.9 5.5 3.1 5.0 5.4 5.6 5.1 3.1 4.1 5.0 2.0 2.2 7.2 4.7 6.7 15.5 6.6 4.5 5.2 14.5 8.8 1.3 10.8 5.0 7.7 6.9 13.9 17.9 16.1 7.4 5.6 9.9 2.1 0.7 2.0 1.6 4.4 4.8 1.9 4.3 2.7 1.3 2.1 0.7 2.3 1.0 6.9 4.2 3.4 0.3 2.9 1.2 0.8 31.8 3.0 13.6 1.9 0.1 3.7 7.8 14.6 4.6 0.0 10.9 5.0 6.8 1.8 5.1 4.2 2.9 3.2 2.3 6.2 17.0 4.2 3.3 0.9 5.0 4.0 1.6 1.0 1.9 0.9 3.8 1.4 0.2 3.4 0.9 1.5 11.4 3.5 10.7 6.2 5.8 1.0 4.5 3.3 0.0 10.3 11.1 1.8 10.8 15.1 11.3 4.9 14.3 4.1 6.7 3.9 4.2 13.9 6.9 3.6 3.6 17.9 7.4 16.1 2.9 5.6 9.9 4.7 6.0 1.3 2.8 4.9 4.2 6.9 2.8 5.4 5.2 8.9 12.0 9.9 0.9 1.8 0.2 1.7 7.6 1.4 2.3 5.2 0.0 1.8 0.0 10.7 0.2 6.2 5.4 0.0 7.9 3.7 7.3 2.8 36.8 0.5 43.1 1.6 2.9 12.9 28.1 0.0 4.6 32.0 3.3 47.7 5.6 9.1 8.8 7.2 5.6 3.4 0.5 6.5 6.2 0.5 1.7 1.4 1.9 15.2 6.9 1.4 DOK4 FLJ10488 ENSG00000125170 "Docking protein 4" Q8TEW6 16 57471922-57487327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 96.4;Paneth cells: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "gdT-cell: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 5 "granulocytes: 4.3;T-cells: 1.4" "Cell line enhanced" "Detected in many" "A549: 26.0;CACO-2: 29.5;SH-SY5Y: 67.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008348, HPA055849" Supported Approved Cytosol NA No Cytosol "HPA008348: , HPA055849: AB_2682942" "unprognostic (3.44e-2)" "unprognostic (2.04e-2)" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (3.66e-1)" "unprognostic (9.71e-2)" "unprognostic (5.35e-2)" "unprognostic (1.39e-1)" "unprognostic (1.13e-2)" "unprognostic (3.00e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-1)" "unprognostic (2.58e-3)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "unprognostic (4.42e-3)" "unprognostic (1.18e-3)" 5.0 4.6 7.8 9.5 4.5 0.7 13.6 15.6 6.9 14.2 29.2 2.0 17.7 24.4 9.9 11.8 15.5 8.1 21.0 7.3 5.0 6.9 27.1 25.8 12.3 1.9 3.4 4.7 12.8 14.8 7.2 10.1 6.6 5.2 12.9 16.9 8.4 7.5 15.0 3.1 22.7 51.5 9.6 2.1 5.1 19.9 8.4 2.9 1.9 8.6 12.9 6.3 8.8 14.1 0.5 0.1 4.3 0.0 0.1 1.4 0.2 2.7 26.0 4.2 7.5 5.9 6.5 4.7 4.9 6.5 3.5 1.0 29.5 14.7 0.2 21.4 10.2 2.0 5.8 2.5 1.3 1.5 0.7 1.9 6.0 7.6 17.0 8.4 0.0 0.6 4.5 4.0 4.6 0.5 7.8 5.3 1.0 1.9 1.2 4.1 2.6 0.3 1.1 2.6 12.5 1.1 2.4 2.2 0.3 18.2 1.0 20.8 67.9 4.0 1.7 1.2 19.6 1.5 1.1 5.6 0.6 4.4 1.7 0.2 0.8 1.0 0.2 1.9 1.3 2.6 0.0 0.0 0.0 1.4 0.0 0.6 0.1 0.3 0.2 0.1 0.5 0.4 0.3 4.3 0.1 0.0 0.0 0.1 0.2 7.8 4.5 15.6 6.9 5.0 6.9 3.4 4.7 5.2 2.9 11.9 12.3 0.5 6.3 7.0 16.3 2.7 28.1 0.0 2.3 14.0 0.0 0.6 5.0 12.9 1.1 5.7 96.4 0.0 20.6 6.2 7.5 4.9 0.0 16.1 0.8 7.9 3.5 5.5 0.6 1.1 12.4 0.7 3.3 1.0 23.3 2.5 22.2 60.2 11.3 38.2 0.8 6.5 4.7 0.2 2.3 15.7 0.5 1.0 23.3 5.2 DPP3 ENSG00000254986 "Dipeptidyl peptidase 3" Q9NY33 11 66480013-66509657 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035780, HPA035781" Approved Supported Cytosol NA NA 2600000 Cytosol "HPA035780: AB_2674778, HPA035781: AB_10669529" "unprognostic (5.74e-2)" "unprognostic (1.16e-3)" "unprognostic (2.62e-3)" "unprognostic (4.77e-2)" "unprognostic (1.99e-1)" "unprognostic (5.44e-3)" "unprognostic (1.67e-3)" "unprognostic (1.25e-3)" "unprognostic (1.73e-2)" "unprognostic (9.87e-2)" "unprognostic (1.02e-2)" "unprognostic (3.87e-1)" "unprognostic (5.85e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.81e-2)" "unprognostic (3.43e-1)" "unprognostic (5.66e-2)" 10.4 13.0 5.2 16.8 12.1 10.9 16.9 13.7 11.5 7.3 18.5 9.1 10.3 15.3 10.5 6.8 15.6 7.1 15.7 8.4 9.3 5.9 18.4 31.1 9.8 20.0 9.5 10.6 5.1 11.6 11.2 6.9 10.9 7.4 10.3 16.9 5.7 17.6 8.5 15.8 9.4 15.5 10.0 10.6 12.5 11.8 15.5 6.7 16.1 10.5 10.8 14.0 11.4 8.6 7.5 19.7 12.2 24.4 18.2 17.9 9.9 28.7 25.1 11.6 12.9 9.7 10.5 18.1 16.3 22.0 22.1 14.8 31.5 24.2 16.8 55.7 18.4 18.9 26.0 18.5 20.0 14.3 31.8 8.4 21.8 11.7 18.5 15.0 26.4 36.4 14.8 19.6 16.6 8.2 9.6 16.9 17.7 15.2 10.0 20.1 32.7 30.7 26.9 19.7 28.3 15.3 21.7 11.7 27.5 19.0 24.8 22.0 18.9 13.9 16.3 21.8 11.4 25.2 15.4 17.5 13.3 14.4 14.5 15.9 8.4 15.2 19.1 17.6 12.6 16.2 9.6 11.3 12.2 13.7 24.4 8.4 7.5 10.3 11.4 19.7 7.2 6.3 9.2 2.0 18.2 16.0 13.7 17.9 9.9 5.2 12.1 13.7 11.5 9.3 5.9 9.5 10.6 7.4 6.7 14.9 10.4 20.5 13.8 5.4 10.0 2.8 15.3 9.4 4.5 22.7 9.8 41.2 11.6 43.1 21.0 5.5 31.6 0.0 53.9 28.6 7.1 11.6 1.1 12.4 33.3 6.4 17.9 4.3 7.9 5.3 2.0 12.8 15.1 46.9 17.1 16.1 36.9 21.5 4.9 22.4 61.1 12.9 4.6 7.5 22.2 5.3 30.1 14.9 23.0 17.3 DPP8 "DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141" ENSG00000074603 "Dipeptidyl peptidase 8" Q6V1X1 15 65442463-65517704 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008706 Approved Supported Cytosol NA NA Cytosol "HPA008706: AB_1078665" "unprognostic (3.65e-1)" "unprognostic (2.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-2)" "unprognostic (2.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (4.09e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (7.58e-2)" "unprognostic (8.56e-2)" "unprognostic (2.59e-1)" 15.6 16.1 16.4 14.9 18.8 16.2 13.9 22.9 24.9 15.5 14.5 15.0 12.7 18.0 15.9 13.9 13.1 11.1 12.4 18.8 15.1 14.6 16.0 9.9 13.3 16.0 15.4 11.8 16.2 11.7 22.2 14.5 15.9 21.7 13.5 15.8 13.9 15.6 20.8 30.5 14.2 16.5 16.2 17.5 17.2 13.2 29.9 15.8 22.5 17.4 12.5 16.0 16.2 13.2 10.7 8.1 20.0 10.8 6.1 10.3 5.3 9.6 15.6 10.3 10.3 11.6 16.6 8.8 15.5 18.4 13.9 13.4 6.7 8.3 17.0 12.2 19.4 9.5 17.9 19.8 11.2 17.1 14.3 12.3 16.3 12.0 6.4 12.1 21.0 16.1 12.4 10.7 11.3 10.7 11.7 15.2 13.2 11.1 15.8 17.1 7.8 11.2 7.7 7.0 9.8 8.0 14.9 19.0 16.5 11.4 21.0 7.3 12.9 10.1 10.2 15.6 10.6 9.4 12.6 19.2 18.7 13.0 8.8 16.5 20.5 26.8 17.2 14.1 21.2 13.4 20.0 9.1 11.1 9.9 9.2 10.3 9.2 8.6 9.5 8.1 10.7 8.6 9.2 18.3 6.1 10.8 7.5 8.9 5.3 16.4 18.8 22.9 24.4 15.1 14.6 15.4 11.8 21.7 15.8 32.8 24.7 23.1 12.5 11.8 24.3 36.8 25.5 22.7 27.3 14.0 35.3 16.6 19.9 19.2 44.1 27.4 20.3 0.0 26.0 12.3 17.3 17.3 25.6 14.7 18.7 27.0 24.9 43.0 34.3 48.6 27.0 25.3 21.9 30.7 28.3 29.5 29.2 21.0 27.6 24.1 27.0 19.4 17.5 62.7 22.3 17.7 14.8 26.2 24.3 20.9 DPP9 ENSG00000142002 "Dipeptidyl peptidase 9" Q86TI2 19 4675224-4724673 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 64.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036059 Approved Supported Cytosol NA NA Cytosol "HPA036059: AB_10671240" "prognostic favorable (4.96e-4)" "unprognostic (4.16e-2)" "unprognostic (2.03e-1)" "prognostic favorable (6.21e-5)" "unprognostic (5.67e-2)" "unprognostic (8.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.23e-1)" "unprognostic (8.85e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (3.38e-8)" "prognostic favorable (7.72e-5)" "unprognostic (1.55e-1)" "unprognostic (4.22e-1)" "unprognostic (1.80e-1)" 18.1 11.9 11.7 24.3 14.0 25.8 13.7 13.0 12.5 12.6 16.3 14.2 15.8 18.3 15.3 10.5 17.4 11.6 13.5 19.7 11.0 7.2 13.5 38.6 19.3 20.7 14.7 7.1 13.5 15.5 9.5 9.8 15.2 11.7 14.0 13.1 14.2 13.1 12.9 46.4 21.5 18.9 14.2 9.3 21.0 14.7 7.1 13.9 24.3 14.6 16.3 17.0 16.0 21.7 10.3 9.0 10.0 10.5 13.4 13.8 8.0 23.8 19.0 5.6 8.8 8.6 12.1 10.2 14.0 18.7 23.6 15.4 17.1 18.5 11.3 10.6 18.1 15.9 16.3 11.4 64.4 14.5 14.5 11.1 8.3 10.4 14.6 13.2 14.4 18.0 9.2 15.0 36.9 21.9 20.2 21.3 7.9 11.3 25.3 20.4 6.5 16.7 9.3 11.5 9.4 28.3 10.5 12.0 13.2 12.3 16.4 8.0 7.2 12.0 21.9 9.2 6.1 6.0 12.0 17.1 21.2 9.2 32.8 27.9 17.6 18.3 11.3 20.7 16.7 17.7 10.0 8.8 9.4 13.8 10.5 10.5 10.3 6.4 11.2 9.0 6.8 6.3 9.9 4.7 13.4 7.8 4.3 11.3 8.0 11.7 14.0 13.0 12.5 11.0 7.2 14.7 7.1 11.7 13.9 26.8 29.1 13.7 11.9 7.0 17.1 12.0 10.2 10.7 11.4 3.5 35.3 10.0 3.3 10.7 1.5 13.5 25.1 0.0 10.9 15.2 7.6 11.0 16.2 35.9 17.2 22.3 12.0 16.5 14.6 2.5 9.2 20.7 5.0 59.5 15.3 8.4 19.7 21.0 8.9 4.5 30.0 19.4 8.1 7.6 6.9 4.8 13.0 18.7 13.7 11.9 DPYSL3 "CRMP4, DRP-3, ULIP" ENSG00000113657 "Dihydropyrimidinase like 3" Q14195 5 147390811-147510056 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 91.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 312.2;Peritubular cells: 193.4;Rod photoreceptor cells: 109.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 119.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010948 Approved Approved Cytosol NA NA 170000 Cytosol "HPA010948: AB_1847245" "unprognostic (3.92e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-3)" "unprognostic (1.39e-1)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (5.99e-2)" "unprognostic (6.92e-2)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.87e-9)" "unprognostic (1.14e-2)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.23e-4)" 21.7 7.2 22.9 18.9 20.4 0.5 14.1 6.7 31.0 26.8 39.7 20.9 31.4 6.8 38.8 28.0 28.8 20.1 33.9 18.5 23.7 24.7 2.5 1.8 16.2 6.1 16.7 15.2 33.0 2.2 1.0 4.2 7.1 27.0 40.0 14.3 32.3 7.1 61.4 22.1 7.3 12.9 91.4 24.7 9.1 15.0 12.1 15.9 0.3 7.2 15.5 9.6 45.6 18.9 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 6.1 11.0 0.0 0.4 11.3 0.2 5.8 27.8 12.4 16.5 19.1 0.5 0.0 1.6 16.8 6.5 0.6 2.2 0.2 13.8 2.6 5.0 0.0 5.3 0.0 11.2 0.0 0.0 2.1 0.1 26.6 10.5 31.2 35.3 0.0 0.0 0.2 7.0 0.0 0.0 0.1 23.4 0.0 9.1 0.0 23.4 0.0 10.9 2.4 8.2 119.4 0.0 0.0 1.9 15.9 0.1 0.1 15.4 9.0 6.8 22.0 21.3 19.8 3.5 0.0 8.3 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 22.9 20.4 6.7 12.5 23.7 24.7 16.7 15.2 27.0 15.9 0.0 3.2 0.0 2.8 8.4 12.5 5.2 2.5 4.0 5.7 0.0 312.2 0.1 0.0 3.6 14.1 50.5 0.0 0.0 7.4 0.2 38.0 9.9 1.1 0.2 1.5 4.8 6.3 29.4 0.6 13.2 39.7 1.1 18.6 0.0 0.0 22.9 10.7 0.0 193.4 0.0 109.3 0.0 35.1 1.4 2.6 7.2 0.3 0.0 0.0 3.4 DRAP1 NC2-alpha ENSG00000175550 "DR1 associated protein 1" Q14919 11 65919257-65921561 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 722.4;Suprabasal keratinocytes: 887.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006790 Uncertain Approved Cytosol NA NA Cytosol "HPA006790: AB_1078702" "unprognostic (1.69e-2)" "unprognostic (1.02e-2)" "unprognostic (1.01e-1)" "unprognostic (3.01e-2)" "unprognostic (1.84e-2)" "unprognostic (4.06e-2)" "unprognostic (4.89e-3)" "unprognostic (5.58e-2)" "unprognostic (8.47e-2)" "unprognostic (4.23e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.96e-5)" "unprognostic (1.62e-1)" 39.1 41.0 45.9 39.7 43.2 41.8 22.4 43.1 53.5 22.0 27.2 28.4 17.1 30.2 27.2 19.4 32.3 20.2 27.2 41.0 40.5 36.6 23.9 27.7 24.7 34.0 37.1 40.6 24.3 39.1 21.6 25.2 24.6 33.3 25.9 12.7 18.9 27.7 28.4 84.4 31.2 26.6 28.4 32.7 38.5 25.1 46.9 30.8 40.2 40.3 42.0 25.8 25.2 23.8 21.6 30.9 45.7 84.6 31.2 24.6 16.7 59.3 23.1 13.1 25.6 12.9 25.3 7.8 69.1 34.6 43.4 28.6 8.5 34.5 15.3 31.4 53.1 51.3 25.5 5.1 34.3 18.9 22.2 7.6 18.6 9.4 8.2 23.1 15.4 25.2 15.7 14.2 46.6 31.6 25.9 16.2 16.1 7.9 29.2 47.6 29.7 27.8 26.8 19.1 9.1 63.2 25.1 11.2 32.9 14.0 7.5 14.2 15.5 16.4 17.7 35.3 6.8 22.2 12.9 46.9 56.3 51.9 108.4 63.7 24.0 20.1 15.9 55.5 9.9 77.5 21.5 20.6 45.7 23.5 50.3 21.5 21.6 21.5 24.6 30.9 19.8 21.3 22.9 27.3 31.2 84.6 22.6 24.4 16.7 45.9 43.2 43.1 51.1 40.5 36.6 37.1 40.6 33.3 30.8 6.0 32.8 129.7 134.1 722.4 51.3 29.0 56.0 14.7 29.6 123.9 33.4 120.9 240.4 172.6 96.4 114.7 101.6 140.2 148.1 133.9 210.1 153.2 236.3 90.4 270.5 60.4 145.8 80.4 126.4 50.8 166.0 269.4 234.5 261.5 87.1 51.3 208.3 108.7 162.6 190.4 38.5 90.5 180.3 150.9 179.1 887.9 145.9 174.4 99.6 356.0 DUS2 "DUS2L, FLJ20399, SMM1" ENSG00000167264 "Dihydrouridine synthase 2" Q9NX74 16 67987746-68079320 "Predicted intracellular proteins" "tRNA processing" "Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 82.3;Late spermatids: 66.4;Spermatocytes: 44.7;Syncytiotrophoblasts: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042560, HPA043528" Enhanced Enhanced Cytosol NA NA Cytosol "HPA042560: AB_10965170, HPA043528: AB_10959753" "unprognostic (2.21e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (1.23e-2)" "unprognostic (8.12e-2)" "unprognostic (1.63e-2)" "unprognostic (1.23e-2)" "unprognostic (9.84e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-1)" "unprognostic (1.53e-1)" "unprognostic (3.18e-1)" "prognostic favorable (3.50e-5)" "unprognostic (1.44e-2)" "unprognostic (8.05e-2)" "unprognostic (1.58e-1)" "unprognostic (1.81e-1)" 6.9 8.2 7.0 12.5 11.3 8.6 6.7 7.6 15.0 6.4 9.2 12.8 5.1 6.1 10.1 5.4 13.6 6.1 5.8 5.9 7.0 6.2 7.0 10.3 7.6 18.3 9.2 10.5 6.0 5.1 11.1 6.6 10.3 9.5 6.2 9.1 9.9 7.2 5.7 10.3 11.6 11.2 8.5 7.9 18.4 7.1 32.2 10.8 6.9 6.3 8.8 21.0 8.5 8.1 23.9 8.7 34.2 13.7 7.9 5.1 6.1 9.6 15.4 6.4 10.2 5.3 10.3 11.8 9.4 9.1 20.1 13.7 16.0 17.6 23.3 8.8 10.0 6.3 14.0 16.2 16.6 16.3 3.5 9.8 8.1 9.3 12.5 9.0 8.5 10.4 9.3 12.2 17.0 16.4 8.7 13.2 18.2 9.1 4.1 9.8 15.1 9.4 12.1 7.0 9.8 8.6 15.8 8.0 15.8 10.4 6.8 7.9 7.2 18.8 6.5 4.1 9.1 15.1 4.2 8.2 9.2 8.6 7.9 7.8 10.9 14.4 21.6 6.3 12.0 5.2 4.9 11.8 34.2 4.0 10.3 3.9 23.9 2.7 4.3 8.7 17.3 4.0 3.6 11.1 7.9 13.7 3.3 5.1 6.1 7.0 11.3 7.6 15.0 7.0 6.2 9.2 10.5 9.5 10.8 8.9 2.9 6.7 1.9 2.4 3.7 1.8 2.5 2.7 0.0 7.0 7.9 25.0 5.0 8.8 82.3 4.2 4.0 0.0 4.8 14.7 4.1 1.5 6.9 8.5 12.4 14.3 4.1 8.0 11.8 66.4 3.4 5.6 3.3 10.8 5.1 4.5 7.9 3.5 7.4 7.9 2.7 6.5 4.0 44.7 11.1 2.3 51.4 5.0 6.3 1.7 DUS4L "DUS4, PP35" ENSG00000105865 "Dihydrouridine synthase 4 like" O95620 7 107563484-107578464 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044301 Approved Approved Cytosol NA NA Cytosol "HPA044301: AB_10967460" "unprognostic (7.95e-2)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (5.66e-2)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (2.56e-3)" "unprognostic (2.29e-2)" "unprognostic (9.21e-3)" "unprognostic (7.74e-3)" "unprognostic (6.72e-3)" 4.5 6.2 9.4 7.0 10.4 2.9 7.8 5.0 8.2 5.5 5.7 7.5 6.2 4.8 5.7 10.4 5.5 6.0 4.7 10.1 8.0 7.7 9.9 9.0 3.9 5.0 10.3 6.2 7.8 5.4 8.0 5.1 4.8 7.6 7.8 5.7 5.7 5.1 4.8 7.1 7.1 5.2 5.3 11.0 4.3 5.4 7.7 6.6 6.6 8.5 5.9 5.7 6.2 4.5 1.5 1.3 0.5 1.3 1.2 2.4 0.7 6.5 3.0 3.0 1.8 1.2 2.0 3.9 1.9 2.6 2.8 2.7 3.4 5.4 7.0 3.6 1.5 7.4 2.0 3.1 4.0 4.3 2.1 2.6 2.5 1.6 3.7 3.0 4.8 0.4 2.0 5.4 2.7 9.2 3.2 4.1 6.6 8.7 2.6 4.3 4.8 6.6 8.4 4.3 5.2 5.4 3.6 2.7 7.9 5.4 3.4 2.7 6.8 3.1 6.4 5.4 3.9 3.1 3.8 2.9 4.0 3.2 3.0 4.4 4.9 6.0 7.9 4.3 6.8 4.8 0.0 1.2 0.1 1.4 1.3 1.6 1.5 2.3 1.2 1.3 0.7 1.9 2.4 0.5 1.2 0.7 1.1 1.7 0.7 9.4 10.4 5.0 8.2 8.0 7.7 10.3 6.2 7.6 6.6 6.0 4.6 5.6 7.5 4.5 8.8 8.0 2.5 22.7 6.8 10.4 3.9 7.9 6.6 8.7 20.0 2.7 3.8 0.0 13.9 7.4 4.2 5.5 13.8 8.9 6.1 3.2 9.2 4.9 4.6 17.7 4.0 4.9 3.3 5.4 4.5 13.0 11.5 5.3 3.5 13.2 9.1 12.9 4.2 11.2 10.9 3.4 3.1 3.8 5.5 6.4 DUSP8 "C11orf81, FLJ42958, HB5, HVH-5" ENSG00000184545 "Dual specificity phosphatase 8" Q13202 11 1554044-1571920 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 101.5;Cone photoreceptor cells: 45.2;Horizontal cells: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;MCF7: 6.2;SH-SY5Y: 5.5;U-251 MG: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020071 Approved Approved Cytosol NA NA Cytosol "HPA020071: AB_1847903" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (4.00e-2)" "unprognostic (1.35e-1)" "unprognostic (7.58e-3)" "unprognostic (6.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (4.04e-3)" "unprognostic (1.82e-1)" "prognostic favorable (2.75e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (8.65e-2)" "unprognostic (6.30e-2)" 6.3 2.2 18.8 3.2 18.8 7.5 3.5 20.0 30.2 1.9 4.3 4.2 1.4 1.7 5.9 4.8 3.5 4.0 5.4 5.7 16.6 9.3 2.6 3.7 3.6 3.5 5.5 11.2 2.2 12.7 1.7 10.8 2.8 5.1 3.0 4.1 2.7 5.1 2.7 6.1 3.2 6.3 9.3 3.6 6.3 4.3 2.4 5.1 0.0 2.6 2.2 2.3 2.7 1.6 0.1 0.1 0.0 0.0 0.0 0.7 0.0 1.8 0.8 1.0 0.1 0.0 0.1 2.2 0.1 1.2 0.4 1.2 0.0 0.0 0.1 0.0 0.3 0.0 1.2 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.4 0.0 0.1 0.1 0.0 1.8 0.0 6.2 0.0 0.4 0.0 0.0 1.9 0.1 0.1 0.7 0.0 0.2 0.0 5.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.0 2.3 0.0 0.1 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 18.8 18.8 20.0 30.2 16.6 9.3 5.5 11.2 5.1 5.1 3.0 0.6 0.0 5.6 8.8 101.5 5.2 5.1 0.0 0.0 12.2 45.2 0.1 1.7 6.9 0.2 2.2 22.7 0.0 9.6 0.4 4.5 12.8 0.0 0.4 0.4 85.8 40.5 1.3 0.0 0.0 0.6 0.3 5.0 1.8 20.2 16.0 9.8 17.5 0.4 1.1 36.7 6.5 5.1 0.2 0.4 4.3 4.9 1.3 16.8 9.8 DYNC2LI1 "CGI-60, D2LIC, DKFZP564A033, LIC3" ENSG00000138036 "Dynein cytoplasmic 2 light intermediate chain 1" Q8TCX1 2 43774039-43810010 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 111.1;Early spermatids: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062905 Approved Approved Cytosol NA NA Cytosol "HPA062905: AB_2684899" "unprognostic (3.46e-1)" "unprognostic (3.25e-1)" "unprognostic (1.75e-1)" "unprognostic (2.49e-2)" "unprognostic (2.89e-2)" "unprognostic (4.05e-2)" "unprognostic (1.84e-3)" "unprognostic (9.85e-2)" "unprognostic (2.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (2.73e-5)" "unprognostic (1.06e-1)" "unprognostic (1.48e-2)" "unprognostic (4.32e-2)" "unprognostic (4.60e-2)" 11.2 18.2 16.9 8.9 32.2 4.4 23.3 8.1 25.3 24.2 10.7 9.8 22.7 13.1 25.1 34.0 8.5 38.1 14.7 11.5 17.2 18.0 35.2 9.3 16.4 6.5 13.9 24.8 29.2 11.8 25.5 39.8 9.6 28.7 15.3 13.0 13.2 11.5 22.4 12.0 11.0 11.2 14.3 19.0 7.5 11.9 29.0 13.0 5.9 24.3 9.0 6.8 11.4 10.4 5.1 4.0 13.3 5.1 3.2 3.9 2.2 8.7 4.9 8.8 5.6 14.4 28.9 7.6 4.9 10.6 5.8 5.4 1.7 6.1 5.0 10.8 6.4 7.4 5.8 4.2 7.0 6.7 6.4 9.0 3.9 2.4 6.3 13.9 7.4 6.4 17.0 10.1 11.5 5.3 17.7 7.9 6.0 11.8 2.4 8.0 4.5 3.7 8.5 4.0 11.4 5.1 5.1 8.2 1.5 47.7 7.6 6.1 10.9 5.5 3.0 6.1 8.8 8.5 7.0 5.5 5.1 4.6 6.2 4.0 9.1 5.0 1.2 11.3 1.9 5.4 13.3 3.0 2.8 2.5 5.1 2.6 5.1 3.1 3.4 4.0 3.2 3.9 3.4 1.3 3.2 3.8 2.5 1.9 2.2 16.9 32.2 8.1 25.3 17.2 18.0 13.9 24.8 28.7 13.0 17.9 12.6 6.4 15.0 8.7 18.8 11.9 17.8 111.1 18.2 50.6 27.5 16.5 76.3 18.8 99.7 8.3 10.3 0.0 19.5 7.9 24.6 13.1 17.3 6.4 10.7 15.9 12.2 14.7 3.9 21.2 30.8 6.0 21.9 1.0 18.6 27.4 13.8 21.2 31.8 69.2 36.0 19.4 7.1 86.9 14.7 8.0 7.8 2.5 13.0 12.4 EDN2 ET2 ENSG00000127129 "Endothelin 2" P20800 1 41478775-41484673 "Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.8" "Cell type enhanced" "Detected in many" 18 "Basal glandular cells: 145.6;Collecting duct cells: 66.3;Glandular cells: 63.5" "Cancer enhanced" "Detected in many" "cervical cancer: 24.0" "Region enriched" "Detected in single" 12 "pons and medulla: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.6;EFO-21: 21.7;HeLa: 7.3;SCLC-21H: 10.4;SK-BR-3: 25.8;U-2 OS: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA028459 Uncertain Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA028459: AB_10602490" "unprognostic (2.71e-2)" "unprognostic (5.64e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" "unprognostic (5.44e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.81e-4)" "unprognostic (5.59e-2)" "unprognostic (1.28e-2)" "unprognostic (8.47e-2)" "unprognostic (1.76e-1)" "unprognostic (6.14e-2)" "unprognostic (3.85e-1)" 0.5 0.2 0.0 0.9 0.2 0.3 2.2 0.0 0.1 15.1 13.6 0.4 1.4 4.5 1.8 6.3 17.4 2.3 0.4 1.9 0.0 0.0 4.0 0.8 18.4 0.1 0.0 0.0 0.8 3.2 0.1 1.1 0.4 2.6 9.7 1.3 1.4 4.3 1.0 0.9 8.9 27.8 0.2 0.0 0.1 0.9 0.7 0.1 0.0 1.3 4.0 13.7 1.2 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 8.6 0.0 21.7 0.0 0.0 1.1 0.0 0.1 0.0 2.4 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.2 0.0 0.0 0.8 5.1 5.8 0.4 10.4 0.0 0.2 25.8 0.0 0.5 0.5 0.0 0.0 0.0 10.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.1 6.0 1.0 0.0 145.6 27.0 0.0 0.4 5.1 1.4 0.0 66.3 0.0 0.0 0.0 6.2 0.0 0.0 10.9 0.0 0.9 0.0 0.5 63.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.5 6.7 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.5 0.0 0.0 3.3 23.3 EEF1A1 "EE1A1, EEF1A, EF1A, LENG7" ENSG00000156508 "Eukaryotic translation elongation factor 1 alpha 1" P68104 6 73515750-73523797 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "Elongation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051759, HPA053862, HPA056990" Supported Supported Cytosol NA NA Cytosol "HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302" "unprognostic (6.47e-2)" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (9.64e-2)" "unprognostic (1.39e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (3.13e-1)" "unprognostic (1.61e-1)" "unprognostic (2.77e-1)" "unprognostic (1.41e-1)" "unprognostic (3.47e-1)" "unprognostic (8.61e-2)" "unprognostic (1.65e-1)" "unprognostic (8.00e-2)" "unprognostic (2.04e-1)" "unprognostic (7.73e-2)" 134.1 124.1 80.2 136.0 75.6 140.9 182.0 103.3 106.2 149.6 133.3 94.9 93.7 81.7 152.0 127.3 136.4 143.1 102.4 88.2 71.5 58.0 130.9 123.1 169.6 135.6 74.3 93.2 240.8 227.6 106.3 111.2 89.1 79.7 115.0 114.7 105.0 133.3 123.6 51.3 139.8 101.6 121.6 108.6 111.3 121.5 129.9 71.6 125.1 132.4 143.1 169.7 151.1 134.8 258.9 209.7 54.6 187.6 184.6 366.8 517.5 112.5 142.8 202.7 276.8 415.8 687.9 161.3 168.6 435.4 216.3 207.7 221.5 155.8 459.7 225.6 285.0 151.5 119.5 247.5 322.3 208.6 80.2 154.9 171.6 116.4 246.7 361.0 318.9 187.4 594.2 548.2 159.2 537.5 445.1 292.9 213.7 317.1 145.4 261.3 150.1 136.5 334.3 216.8 150.1 99.2 272.1 341.5 515.3 277.9 238.6 166.4 184.6 84.5 198.8 333.7 240.5 135.1 515.5 243.4 92.4 131.6 68.4 191.4 163.4 145.2 108.0 95.9 264.6 145.2 54.6 187.6 20.8 198.7 165.4 366.8 258.9 288.8 250.9 209.7 199.5 323.8 277.8 17.0 184.6 169.0 161.7 202.9 517.5 80.2 75.6 103.3 106.2 71.5 58.0 74.3 93.2 79.7 71.6 2945.0 5104.7 7686.4 9440.3 8731.8 946.3 163.3 4537.5 2577.7 4487.2 2501.9 514.4 8108.2 8765.4 4837.4 1096.2 6221.3 1773.7 1425.0 9007.6 10117.9 6235.0 8187.7 3506.7 2998.1 5660.8 467.2 3719.4 4654.6 6431.4 1730.5 8270.0 6531.1 4848.6 19235.8 6485.3 1457.9 7817.3 5029.0 6780.9 10371.8 951.6 3479.5 5699.9 1275.5 709.3 8789.4 9271.7 8651.4 9249.6 10618.3 EFHD2 MGC4342 ENSG00000142634 "EF-hand domain family member D2" Q96C19 1 15409895-15430343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Pancreatic endocrine cells: 329.7;Urothelial cells: 408.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 45.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 79.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048961 Enhanced Approved Cytosol No No 35000 Cytosol "HPA048961: AB_2680572" "unprognostic (1.37e-3)" "unprognostic (3.69e-1)" "unprognostic (7.83e-2)" "unprognostic (4.44e-2)" "unprognostic (2.35e-1)" "unprognostic (3.82e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (9.11e-2)" "unprognostic (9.61e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (6.31e-9)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "prognostic favorable (2.70e-4)" "prognostic favorable (3.60e-5)" 12.9 21.8 16.1 35.4 15.4 69.3 8.7 13.3 41.2 9.3 24.8 7.0 7.5 39.5 11.8 6.2 18.4 10.3 21.2 7.2 19.6 15.3 7.4 10.4 19.2 31.8 14.2 22.0 9.2 26.8 4.0 10.1 16.4 56.5 14.6 14.8 6.8 11.1 10.3 3.3 10.8 45.0 8.7 8.2 48.9 42.8 28.5 7.1 17.1 14.7 7.5 27.2 20.6 12.9 1.4 9.7 45.0 11.9 9.4 15.6 4.9 79.3 20.2 2.0 5.3 3.2 7.0 10.6 10.1 9.7 9.6 9.2 7.8 21.9 17.3 32.2 7.0 12.4 19.4 5.4 17.9 6.2 21.5 10.6 4.1 4.7 12.3 5.2 21.0 36.2 5.5 6.1 19.6 5.0 4.5 12.4 7.9 9.8 8.4 5.9 7.9 10.8 40.6 2.6 10.9 25.2 14.5 18.5 13.7 5.6 16.7 4.5 3.5 8.9 7.7 16.5 1.6 3.3 22.8 23.2 14.3 15.2 44.3 16.3 5.7 13.4 7.4 19.9 41.9 19.3 4.7 11.9 16.3 15.6 11.1 4.5 1.3 3.6 7.2 9.7 1.4 1.7 6.7 45.0 9.4 9.3 3.4 2.3 4.9 16.1 15.4 13.3 41.2 19.6 15.3 14.2 22.0 56.5 7.1 3.0 16.4 40.3 77.9 58.7 1.0 5.9 28.1 9.4 11.4 21.0 9.8 17.6 16.6 55.1 72.9 39.4 263.4 0.0 225.6 181.1 21.9 96.0 44.9 17.8 193.0 0.0 59.2 29.4 182.4 177.9 9.2 155.3 21.9 97.4 131.4 3.2 329.7 122.8 6.3 27.0 4.2 45.3 23.7 5.9 4.9 59.8 44.6 86.3 90.1 408.3 EFL1 "EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1" ENSG00000140598 "Elongation factor like GTPase 1" Q7Z2Z2 15 82130230-82262763 "Predicted intracellular proteins" "Protein biosynthesis, Ribosome biogenesis" "Elongation factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 13.4;Club cells: 7.9;Pancreatic endocrine cells: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039654, HPA047110, HPA052345" Uncertain Approved Cytosol NA NA Cytosol "HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794" "unprognostic (2.53e-1)" "unprognostic (2.04e-1)" "unprognostic (9.92e-3)" "unprognostic (8.99e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" "unprognostic (2.64e-3)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (4.75e-3)" "unprognostic (3.56e-2)" "unprognostic (3.14e-1)" "prognostic favorable (1.50e-6)" "unprognostic (8.58e-2)" "unprognostic (2.96e-1)" "unprognostic (2.60e-1)" "unprognostic (7.05e-2)" 16.3 14.0 7.0 17.3 9.9 8.9 11.8 10.2 9.4 9.5 17.2 11.0 6.8 13.2 9.2 12.2 14.1 9.1 8.0 10.7 8.8 7.9 11.9 15.4 9.0 10.0 9.5 4.5 9.8 12.5 17.9 15.0 12.8 13.3 12.7 19.6 7.4 12.1 8.5 18.5 14.6 25.7 10.8 10.1 10.1 9.7 13.9 9.9 26.9 9.8 11.3 14.9 10.8 11.7 10.7 6.8 15.8 9.0 5.8 9.0 4.5 4.9 12.3 9.2 7.9 6.2 8.5 5.9 14.4 17.0 10.4 14.0 6.1 8.7 12.1 5.9 10.7 13.1 12.9 24.4 9.5 16.6 10.7 11.9 13.3 11.8 4.6 9.8 8.5 9.5 4.2 14.9 10.5 24.2 12.3 13.7 15.6 9.9 5.5 12.0 6.9 11.1 7.7 8.3 8.8 6.4 11.9 13.7 6.5 7.3 14.9 8.4 9.0 9.0 10.6 11.0 16.7 7.9 7.6 11.5 14.8 10.0 36.9 14.2 7.1 26.3 10.2 13.5 16.0 5.4 15.8 5.6 13.7 9.0 8.1 7.2 8.9 8.4 7.6 6.8 10.7 7.3 6.3 1.0 5.8 9.0 3.3 7.6 4.5 7.0 9.9 10.2 9.4 8.8 7.9 9.5 4.5 13.3 9.9 3.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 13.4 7.9 0.0 0.0 6.1 3.3 6.0 0.0 0.0 0.0 0.0 5.3 3.1 0.0 0.0 4.7 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.6 0.0 0.0 7.4 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 EGLN3 "HIFPH3, PHD3" ENSG00000129521 "Egl-9 family hypoxia inducible factor 3" Q9H6Z9 14 33924231-34462774 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 49.6;skin 1: 44.1" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 189.9;Cardiomyocytes: 91.5;Suprabasal keratinocytes: 202.4;Syncytiotrophoblasts: 86.2" "Cancer enhanced" "Detected in all" "renal cancer: 50.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 19.0" "Lineage enriched" "Detected in many" 16 "dendritic cells: 19.0" "Cell line enhanced" "Detected in many" "RH-30: 18.1;RPTEC TERT1: 15.5;RT4: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064895 Supported Cytosol NA NA Cytosol "HPA064895: AB_2685384" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" "unprognostic (1.75e-1)" "unprognostic (8.87e-2)" "unprognostic (6.88e-2)" "unprognostic (1.38e-2)" "prognostic unfavorable (2.14e-5)" "unprognostic (1.39e-3)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" "unprognostic (2.93e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.37e-1)" "unprognostic (5.21e-2)" "unprognostic (4.71e-2)" "unprognostic (6.30e-2)" 6.3 0.8 12.9 4.8 10.6 0.4 6.0 3.0 11.9 7.3 14.3 13.4 4.9 19.3 5.9 2.8 10.4 5.4 7.8 49.6 10.9 7.3 6.1 2.4 3.0 3.0 10.7 8.1 2.5 6.5 0.4 1.5 19.6 9.9 9.9 11.3 3.5 4.2 11.3 9.7 44.1 21.7 11.7 9.7 2.8 19.9 1.0 12.5 3.4 1.2 1.3 5.3 25.6 16.1 0.0 19.0 1.2 0.0 0.8 1.0 0.6 12.0 3.1 0.3 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.3 0.0 4.1 0.0 0.3 0.3 6.0 11.7 0.0 1.2 3.2 3.2 8.9 0.4 0.0 0.0 0.1 1.6 5.9 0.0 0.0 0.0 0.0 0.9 6.4 0.0 0.1 1.0 0.2 0.0 9.8 10.4 1.1 0.0 18.1 4.3 15.5 48.6 2.5 2.8 0.8 4.7 1.3 7.7 4.8 0.0 0.0 0.1 1.3 0.0 0.7 0.1 2.6 0.0 2.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.8 1.9 0.0 0.1 0.0 0.1 0.8 0.0 19.0 0.0 0.6 12.9 10.6 3.0 9.8 10.9 7.3 10.7 8.1 9.9 12.5 0.0 1.1 0.5 43.6 189.9 4.5 91.5 5.1 22.7 1.2 8.7 2.0 4.2 8.3 14.2 1.1 18.4 46.6 0.0 6.0 63.3 14.3 12.5 1.1 0.0 2.7 1.6 15.5 12.9 1.0 4.7 2.3 3.8 38.8 1.0 24.2 10.5 32.3 25.2 0.7 14.0 2.0 0.0 7.2 0.5 0.3 202.4 86.2 1.5 10.0 11.9 EIF1AX "eIF-1A, eIF-4C, EIF1A, EIF4C" ENSG00000173674 "Eukaryotic translation initiation factor 1A, X-linked" P47813 X 20124518-20141844 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002561 Uncertain Supported Approved Cytosol NA NA Cytosol "HPA002561: AB_1078724" "unprognostic (1.91e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-2)" "unprognostic (9.69e-2)" "unprognostic (1.43e-2)" "unprognostic (1.26e-3)" "unprognostic (7.13e-3)" "unprognostic (2.22e-1)" "unprognostic (8.28e-2)" "unprognostic (1.02e-3)" "unprognostic (2.82e-2)" "unprognostic (4.73e-2)" "unprognostic (8.66e-2)" "unprognostic (2.23e-3)" "unprognostic (7.81e-2)" "unprognostic (1.61e-1)" "unprognostic (1.52e-1)" 30.9 23.2 22.0 23.7 28.8 28.3 53.4 35.4 57.3 26.1 23.6 14.5 23.9 22.7 33.8 18.7 32.6 24.7 18.4 29.2 21.4 19.5 31.0 32.0 22.1 20.9 23.5 23.5 37.0 33.0 28.7 19.8 24.7 29.0 19.5 16.9 12.0 25.2 25.0 61.5 22.5 18.9 32.5 34.1 16.5 22.7 18.0 23.7 14.8 25.7 24.6 17.2 29.3 33.9 31.1 30.2 12.6 19.9 27.2 30.9 23.8 46.2 26.2 20.2 26.8 19.7 26.9 16.4 41.4 15.2 22.7 17.9 37.6 22.2 43.4 27.8 27.3 21.2 19.9 35.5 35.9 35.4 17.7 58.7 19.2 32.9 32.0 13.8 51.0 27.1 12.6 22.1 34.9 54.9 15.0 31.5 14.1 49.6 24.4 22.2 22.6 31.4 32.0 52.4 19.6 43.5 25.9 46.4 46.3 17.8 25.9 23.4 26.2 43.9 34.3 27.2 30.4 27.9 21.7 18.0 27.6 17.1 89.8 30.9 16.7 31.5 51.4 18.8 23.4 20.8 12.6 19.1 11.5 23.1 19.9 30.2 31.1 26.5 27.1 18.3 27.7 30.9 25.8 4.7 27.2 19.2 30.2 20.3 23.8 22.0 28.8 35.4 57.3 21.4 19.5 23.5 23.5 29.0 23.7 98.3 94.3 135.4 291.6 421.9 162.4 89.0 132.5 107.1 166.1 109.9 88.4 168.6 159.2 183.9 401.5 152.7 92.4 46.7 198.9 430.4 186.0 298.0 159.4 317.5 176.9 96.9 160.6 121.5 132.4 74.9 133.5 136.3 146.8 92.0 191.7 167.0 198.1 98.2 136.5 205.2 118.8 142.3 222.6 52.6 114.6 498.3 189.8 92.0 263.5 304.6 EIF1AY ENSG00000198692 "Eukaryotic translation initiation factor 1A, Y-linked" O14602 Y 20575725-20593154 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 78.3;skeletal muscle: 124.6" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 345.1;Erythroid cells: 467.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.9;HEL: 46.5;U-266/84: 32.9;U-698: 74.6" HPA002561 Uncertain Supported Approved Cytosol NA NA Cytosol "HPA002561: AB_1078724" "unprognostic (4.31e-2)" "unprognostic (3.74e-1)" "unprognostic (2.14e-3)" "unprognostic (2.68e-2)" "unprognostic (1.12e-2)" "unprognostic (2.89e-2)" "unprognostic (4.18e-2)" "unprognostic (2.17e-2)" "unprognostic (4.10e-2)" "unprognostic (8.53e-3)" "unprognostic (2.89e-1)" "unprognostic (6.03e-2)" 5.9 8.3 7.0 18.6 8.3 29.2 5.0 4.5 10.9 0.0 12.6 10.0 22.2 9.0 0.1 20.2 9.9 0.0 10.5 78.3 6.5 10.4 9.1 23.0 13.3 22.8 8.2 0.0 0.1 15.0 0.2 11.4 10.3 13.4 17.4 16.1 8.8 13.1 22.9 124.6 4.2 17.9 28.2 9.2 45.8 6.5 13.1 0.0 28.7 6.2 48.9 15.9 8.9 0.0 22.1 23.0 44.5 8.0 7.8 11.9 5.0 0.1 5.5 0.0 0.0 0.0 0.0 11.6 12.3 8.3 8.6 8.5 0.0 0.0 37.9 0.0 6.5 0.0 0.0 0.0 0.0 11.8 20.4 0.0 46.5 0.0 13.8 8.5 0.0 0.0 4.6 9.4 0.0 0.0 0.0 0.0 12.8 0.0 0.0 13.7 0.0 30.0 0.0 8.2 0.0 0.0 0.0 15.5 15.1 12.0 14.4 11.0 0.0 0.0 0.0 8.4 16.5 0.0 6.5 12.2 6.6 0.1 0.0 13.3 22.9 32.9 74.6 2.5 0.0 0.0 10.0 6.7 9.3 5.2 7.7 7.3 19.2 9.5 6.1 5.7 22.1 11.9 9.0 44.5 7.8 8.0 23.0 10.9 5.0 7.0 8.3 4.5 10.9 6.5 10.4 8.2 0.0 13.4 0.0 29.8 47.1 119.4 60.3 48.5 15.1 345.1 22.9 49.5 51.2 50.6 9.8 109.0 74.6 30.4 26.6 37.2 2.6 467.2 0.3 42.0 36.5 59.3 86.9 0.9 30.7 6.4 17.0 39.3 60.3 8.8 39.7 51.5 64.1 79.4 12.1 66.9 34.6 8.6 41.1 80.0 20.6 38.8 56.6 53.4 88.1 44.3 77.6 62.3 1.0 56.7 EIF2AK2 "EIF2AK1, PKR, PPP1R83, PRKR" ENSG00000055332 "Eukaryotic translation initiation factor 2 alpha kinase 2" P19525 2 37099210-37157065 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003845, HPA019795, HPA063893" Approved Enhanced Cytosol NA NA Cytosol "CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144" "unprognostic (1.70e-2)" "unprognostic (2.26e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.77e-3)" "unprognostic (8.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.19e-1)" "unprognostic (3.15e-3)" "unprognostic (3.33e-1)" "unprognostic (1.74e-1)" "unprognostic (4.65e-2)" "unprognostic (5.32e-2)" 25.5 14.2 15.9 16.3 15.5 36.4 13.9 16.4 19.0 14.7 13.7 9.9 9.3 14.5 17.2 21.5 12.1 12.8 15.4 10.7 13.7 19.2 12.2 11.5 13.7 10.7 14.3 15.0 18.7 11.7 19.2 21.1 18.2 17.3 15.0 12.8 10.2 23.0 17.8 7.1 6.7 15.2 16.2 14.0 15.5 14.3 5.1 12.8 14.1 13.6 8.1 10.6 14.8 15.5 8.8 6.9 27.6 10.8 8.6 9.9 3.3 23.3 12.0 7.4 9.3 8.1 11.2 14.6 12.3 17.7 39.0 37.6 13.7 13.9 12.5 16.1 13.5 46.4 13.9 12.7 12.5 17.5 27.4 6.7 13.7 9.1 8.9 8.0 13.0 0.1 9.1 4.9 15.6 11.3 6.8 9.7 5.5 9.5 12.6 8.8 10.4 16.7 6.7 7.7 3.9 8.6 16.9 18.1 6.2 7.3 9.0 8.3 8.8 15.1 11.0 23.7 6.5 5.6 3.7 12.5 15.8 16.8 6.8 19.8 9.3 15.3 0.2 7.6 8.9 13.8 17.1 8.2 11.1 8.9 10.6 9.0 8.8 7.5 8.1 6.9 7.0 6.1 7.5 27.6 8.6 10.8 4.7 9.9 3.3 15.9 15.5 16.4 19.0 13.7 19.2 14.3 15.0 17.3 12.8 62.5 27.7 15.7 36.6 17.3 37.2 25.3 33.1 53.5 58.0 21.0 13.7 40.9 18.3 31.1 1.7 56.2 26.2 0.0 42.4 72.4 35.3 31.0 39.4 15.8 34.3 44.5 14.5 29.4 21.6 2.1 52.9 24.7 20.3 23.4 22.2 48.9 41.0 24.6 79.2 28.5 24.1 38.8 34.2 2.6 3.4 8.8 34.1 30.2 26.2 36.3 EIF2AK4 "GCN2, KIAA1338" ENSG00000128829 "Eukaryotic translation initiation factor 2 alpha kinase 4" Q9P2K8 15 39934146-40035591 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation" "Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.9" "Group enriched" "Detected in all" 4 "dendritic cells: 32.9;monocytes: 9.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011811 Approved Approved Cytosol NA NA Cytosol "HPA011811: AB_2668543" "unprognostic (3.10e-1)" "unprognostic (4.78e-3)" "unprognostic (5.97e-2)" "unprognostic (7.18e-2)" "unprognostic (1.05e-2)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-2)" "unprognostic (6.47e-2)" "unprognostic (2.31e-2)" "unprognostic (5.11e-3)" 20.7 16.5 20.2 19.4 27.3 20.2 36.0 22.4 27.3 16.8 16.3 13.6 17.1 12.2 35.7 17.9 17.8 18.1 19.4 18.2 19.5 20.5 15.4 22.7 22.5 16.6 18.6 14.2 20.1 21.5 20.3 34.7 20.5 17.6 22.0 14.6 17.9 16.7 20.3 20.4 20.7 12.2 24.3 14.6 16.1 16.4 11.5 15.1 17.7 24.1 10.6 15.9 27.0 14.4 5.0 32.9 4.2 9.3 3.8 4.5 2.4 14.0 6.8 12.1 18.2 19.9 33.6 11.5 19.8 22.8 16.3 16.1 9.6 6.1 7.5 10.4 26.9 21.8 15.0 16.1 24.0 22.7 35.3 8.1 15.9 12.5 11.6 17.1 9.6 11.0 26.5 16.5 15.5 27.9 23.0 22.6 15.8 11.7 7.1 32.0 4.7 8.0 13.2 7.4 12.5 15.1 9.7 16.8 12.3 20.2 9.6 6.3 9.7 14.2 8.6 12.3 12.3 12.1 16.6 24.0 21.7 16.5 10.8 12.8 9.8 17.7 2.3 15.2 13.2 30.3 4.2 5.8 4.0 3.6 6.7 3.1 3.5 4.0 4.1 8.4 5.0 4.5 4.2 1.7 3.8 9.3 32.9 2.7 2.4 20.2 27.3 22.4 27.3 19.5 20.5 18.6 14.2 17.6 15.1 14.9 23.6 17.2 22.6 10.6 28.5 28.8 22.9 13.4 26.1 15.7 11.8 29.7 11.6 22.9 1.0 27.0 7.3 0.0 22.0 29.4 26.2 25.6 23.1 20.8 27.4 27.0 13.8 23.4 28.6 2.4 39.1 46.9 30.4 32.5 20.8 31.3 33.9 10.5 37.4 15.1 22.8 45.3 18.6 9.8 29.6 12.7 12.7 15.8 27.6 17.2 EIF2B1 "EIF-2B, EIF-2Balpha, EIF2B, EIF2BA" ENSG00000111361 "Eukaryotic translation initiation factor 2B subunit alpha" Q14232 12 123620406-123633766 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034258, HPA049509" Approved Approved Cytosol NA NA 8500 Cytosol "CAB034258: AB_2095995, HPA049509: AB_2680797" "unprognostic (2.14e-2)" "unprognostic (4.18e-2)" "unprognostic (2.78e-1)" "unprognostic (7.50e-2)" "unprognostic (1.22e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (6.75e-7)" "unprognostic (5.65e-2)" "unprognostic (7.24e-3)" "unprognostic (1.53e-1)" "unprognostic (7.27e-2)" "unprognostic (1.94e-2)" "prognostic unfavorable (1.78e-9)" "unprognostic (2.46e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.40e-2)" 27.9 29.5 24.0 27.8 29.0 27.5 27.6 35.6 33.4 24.1 26.4 25.7 24.6 24.3 32.3 27.3 30.2 27.3 27.2 21.1 22.6 20.3 22.8 30.2 21.3 32.7 29.9 28.0 32.7 29.2 22.0 29.0 29.8 26.8 25.8 28.0 21.7 25.6 28.0 34.9 44.3 27.6 33.8 24.3 30.1 24.9 29.1 26.9 33.3 25.2 30.5 36.6 28.0 27.3 23.2 35.6 42.3 38.2 22.6 26.6 32.6 19.0 16.8 17.9 18.8 16.5 16.6 18.7 23.5 13.2 22.8 16.5 21.2 12.0 36.1 28.1 17.3 10.2 19.2 27.5 17.9 23.9 29.4 30.0 25.9 23.9 18.8 15.5 36.4 32.6 15.0 22.2 19.5 13.8 19.3 20.8 23.4 46.1 12.1 20.8 16.9 29.2 37.6 29.4 20.5 22.0 30.8 21.8 27.3 15.0 16.0 22.3 25.3 17.3 17.4 21.6 17.4 31.5 21.9 19.9 15.8 19.2 22.6 21.8 32.9 34.5 53.3 23.1 24.7 22.6 32.5 32.7 42.3 22.5 38.2 20.4 23.2 22.9 23.1 35.6 20.3 23.7 21.8 3.6 22.6 34.5 22.4 26.6 32.6 24.0 29.0 35.6 33.4 22.6 20.3 29.9 28.0 26.8 26.9 14.9 18.7 29.4 15.7 18.1 18.6 17.5 30.6 17.4 15.9 17.4 7.9 60.3 24.9 22.5 6.1 24.3 18.4 0.0 35.1 48.7 19.2 11.7 40.4 10.4 33.0 15.9 20.8 18.4 17.5 3.6 23.3 21.9 18.6 28.9 13.7 33.2 25.6 18.7 15.6 17.7 20.4 32.3 23.7 42.2 41.1 17.9 43.1 21.0 20.2 14.3 EIF2B5 "EIF-2B, EIF2Bepsilon" ENSG00000145191 "Eukaryotic translation initiation factor 2B subunit epsilon" Q13144 3 184135038-184145311 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015412, HPA064370, HPA069303" Uncertain Enhanced Cytosol NA NA Cytosol "CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114" "unprognostic (3.28e-1)" "unprognostic (1.14e-2)" "unprognostic (9.05e-3)" "unprognostic (3.33e-2)" "unprognostic (1.15e-2)" "unprognostic (9.33e-2)" "prognostic unfavorable (3.38e-8)" "unprognostic (8.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.21e-2)" "unprognostic (3.80e-1)" "unprognostic (1.32e-2)" "unprognostic (9.97e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (5.32e-2)" 15.2 20.1 15.3 15.4 20.2 10.6 21.5 24.5 25.8 15.1 18.8 17.8 24.3 17.3 16.3 14.9 24.3 15.4 14.0 21.5 13.0 16.1 17.5 27.5 15.6 20.1 20.8 15.1 16.0 19.1 27.0 21.2 20.6 17.7 20.4 23.7 15.3 23.2 21.0 47.2 22.8 18.2 17.5 14.7 21.1 19.6 11.9 17.3 20.9 17.4 16.9 26.9 19.1 18.3 12.7 10.3 10.9 8.4 11.2 17.2 6.5 24.4 11.2 13.8 15.0 13.9 11.4 14.9 14.6 15.6 21.4 18.2 18.4 12.3 22.2 16.9 14.3 28.0 18.9 24.7 17.0 21.9 19.9 20.3 36.3 11.4 16.1 10.8 27.4 19.3 9.5 15.4 12.9 13.4 11.0 15.3 22.3 19.6 19.4 15.1 20.5 20.0 19.1 18.6 29.8 20.8 21.7 16.6 25.0 19.5 21.6 14.9 16.5 12.5 39.7 16.2 11.5 36.7 27.2 14.2 13.0 15.2 12.3 28.0 16.7 23.1 28.3 15.5 29.4 16.2 7.2 8.4 10.9 7.6 7.4 10.5 12.0 11.9 12.7 10.3 12.7 17.2 10.7 1.6 11.2 7.7 5.0 9.5 6.5 15.3 20.2 24.5 25.8 13.0 16.1 20.8 15.1 17.7 17.3 23.8 20.7 22.3 31.6 27.4 19.3 21.5 10.2 18.7 30.7 34.9 7.9 33.4 44.7 20.0 2.6 22.5 23.8 23.3 31.3 23.2 16.4 34.3 16.1 23.6 22.0 33.4 44.0 16.0 16.5 2.1 17.0 20.5 18.6 34.3 24.5 13.3 21.9 14.4 13.8 25.8 15.0 12.9 21.7 13.4 13.0 25.3 32.3 23.6 26.5 37.1 EIF2S1 "EIF-2alpha, EIF2, EIF2A" ENSG00000134001 "Eukaryotic translation initiation factor 2 subunit alpha" P05198 14 67359997-67386516 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 211.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011663, HPA064885" Supported Enhanced Cytosol NA NA 52000 Cytosol "CAB011663: AB_2096478, HPA064885: AB_2685382" "unprognostic (1.86e-2)" "unprognostic (8.33e-2)" "unprognostic (4.31e-2)" "unprognostic (2.46e-2)" "unprognostic (3.78e-2)" "unprognostic (1.78e-3)" "prognostic unfavorable (4.73e-7)" "unprognostic (4.14e-3)" "unprognostic (4.49e-1)" "unprognostic (1.68e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (2.95e-1)" "unprognostic (1.21e-2)" "unprognostic (1.73e-1)" "unprognostic (4.65e-1)" "unprognostic (1.59e-2)" "prognostic unfavorable (7.11e-4)" 35.5 26.2 18.7 24.8 26.3 18.9 22.5 18.9 30.6 17.8 25.7 16.3 16.1 18.5 22.9 18.0 34.8 18.4 19.1 27.9 21.9 17.0 23.8 45.0 21.1 24.1 19.9 20.8 22.9 27.8 21.3 16.3 28.0 24.1 24.4 24.2 12.6 19.9 21.0 52.0 23.8 18.4 30.9 18.9 22.8 22.9 29.1 15.1 27.3 29.0 29.9 28.0 31.1 23.1 26.6 32.9 17.3 32.7 25.7 29.2 30.2 67.4 22.5 15.9 24.4 15.4 17.4 34.1 30.2 18.0 34.1 29.9 26.3 24.2 30.5 15.3 22.7 23.0 26.2 36.6 28.8 52.1 22.2 13.7 19.7 22.0 18.0 16.2 20.9 19.3 14.1 16.8 30.4 46.6 13.4 27.7 19.3 33.4 23.7 33.6 33.5 28.5 16.4 16.2 40.6 37.8 21.9 26.4 21.7 20.9 31.1 23.0 16.2 21.7 25.6 23.3 14.7 43.6 18.2 21.1 45.2 48.8 21.8 32.0 20.6 22.4 46.1 26.2 37.5 29.0 17.3 24.2 14.8 23.9 32.7 29.1 26.6 27.9 25.7 32.9 21.3 26.0 26.5 3.3 25.7 27.4 22.5 29.2 30.2 18.7 26.3 18.9 30.6 21.9 17.0 19.9 20.8 24.1 15.1 26.8 38.1 35.0 67.4 126.8 22.8 84.7 33.1 26.8 44.3 21.0 11.8 70.2 59.7 77.0 64.0 51.3 22.3 0.0 54.6 82.1 48.2 40.6 34.6 38.0 62.8 35.0 12.5 23.9 39.6 23.3 28.7 43.9 49.0 66.7 24.0 20.9 60.9 11.5 38.2 53.2 26.2 25.8 78.5 211.8 73.9 114.0 78.1 41.7 33.8 65.0 EIF3C "eIF3-p110, eIF3c, EIF3S8" ENSG00000184110 "Eukaryotic translation initiation factor 3 subunit C" Q99613 16 28688558-28735730 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 85.6;Cardiomyocytes: 136.5;Ciliated cells: 303.8;Club cells: 163.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB034045, HPA047097, HPA049495, HPA050112" Supported Supported Cytosol NA NA Cytosol "CAB034045: AB_1122487, HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020" "unprognostic (2.42e-1)" "unprognostic (2.69e-2)" "unprognostic (2.07e-1)" "unprognostic (2.18e-1)" "unprognostic (5.84e-2)" "unprognostic (1.23e-1)" "unprognostic (1.85e-2)" "unprognostic (5.75e-2)" "unprognostic (7.23e-2)" "unprognostic (1.40e-1)" "unprognostic (3.90e-2)" "unprognostic (6.54e-3)" "unprognostic (3.53e-3)" "unprognostic (2.25e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "unprognostic (1.10e-3)" 30.0 24.4 22.2 20.9 33.5 21.2 30.2 24.3 34.8 24.4 31.8 18.1 14.5 23.6 41.5 26.5 30.1 31.0 32.0 32.3 35.9 20.8 30.1 51.7 22.8 21.8 20.9 33.4 42.3 38.1 63.8 21.4 20.0 26.9 20.3 29.3 18.8 54.7 27.9 114.0 32.3 25.0 33.3 19.8 20.7 25.4 47.2 17.5 25.6 32.8 46.4 29.3 24.9 23.6 28.5 50.5 20.6 49.1 37.9 36.1 52.5 25.9 41.1 57.1 69.0 51.0 62.5 88.0 65.8 49.2 78.0 56.0 82.0 49.2 61.1 86.5 42.1 52.4 32.0 48.1 81.1 88.1 26.6 48.6 70.1 66.9 106.2 63.3 108.3 54.1 71.8 49.1 49.6 79.9 34.2 89.1 64.3 75.8 58.0 41.9 95.5 86.4 31.5 95.3 40.8 64.3 88.0 87.6 60.2 41.3 57.1 53.9 82.6 55.6 77.2 63.8 37.3 77.0 44.6 79.0 55.4 55.0 26.1 42.9 50.3 38.3 123.1 58.7 42.8 56.6 10.7 44.9 20.6 31.1 47.8 36.1 28.5 32.9 33.0 50.5 27.4 33.3 30.3 3.8 37.9 49.1 23.7 34.0 52.5 22.2 33.5 24.3 34.8 35.9 20.8 20.9 33.4 26.9 17.5 62.5 85.6 6.9 7.9 10.5 7.0 136.5 7.6 303.8 163.8 5.2 39.3 3.1 1.7 2.6 2.4 5.3 5.1 0.0 2.9 2.5 4.2 4.2 36.0 3.9 2.8 0.0 5.8 6.7 4.9 1.3 6.1 4.8 5.0 1.8 3.5 2.4 3.5 4.9 4.9 3.7 15.5 0.0 6.2 3.0 3.4 12.0 4.7 6.2 5.8 6.5 EIF3CL ENSG00000205609 "Eukaryotic translation initiation factor 3 subunit C like" B5ME19 16 28379579-28403879 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 32.4;Cardiomyocytes: 31.6;Ciliated cells: 69.6;Club cells: 69.4" "Group enriched" "Detected in some" 5 "glioma: 0.8;ovarian cancer: 0.5;stomach cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 33.0;REH: 26.1" "HPA047097, HPA049495, HPA050112" Supported Approved Cytosol NA NA Cytosol "HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020" "unprognostic (1.22e-1)" "unprognostic (4.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.48e-3)" "unprognostic (1.98e-1)" "unprognostic (4.59e-2)" "unprognostic (1.75e-5)" "unprognostic (6.56e-2)" "unprognostic (1.64e-1)" "unprognostic (7.58e-2)" "unprognostic (1.48e-1)" "unprognostic (1.18e-3)" "unprognostic (3.59e-2)" "unprognostic (9.52e-2)" "unprognostic (1.41e-1)" "unprognostic (9.00e-3)" "unprognostic (3.58e-2)" 6.9 4.6 5.2 2.5 5.5 5.5 6.0 3.0 4.9 4.7 8.9 8.9 4.1 10.2 5.8 7.9 2.5 5.5 5.0 4.6 5.9 5.5 3.6 3.7 4.6 7.3 10.4 4.3 4.2 3.6 4.1 1.2 9.3 13.7 13.2 18.0 9.1 4.0 3.3 4.0 7.3 3.4 5.5 10.6 4.2 4.1 7.7 10.5 4.6 15.9 10.8 11.5 5.1 2.5 4.4 5.5 3.4 2.3 3.4 3.1 3.1 7.5 9.3 11.7 4.9 1.8 1.5 10.5 2.9 6.2 3.1 3.9 7.5 6.0 1.1 2.1 2.1 5.7 7.1 2.5 4.0 7.4 2.8 6.1 2.7 2.2 3.9 6.0 3.8 2.9 2.7 2.1 5.5 9.4 33.0 6.2 4.8 2.2 26.1 5.6 5.9 7.3 3.0 8.2 10.4 1.6 8.2 12.6 0.7 4.2 7.0 2.7 2.7 8.7 2.9 3.2 7.9 2.1 4.9 3.0 6.4 1.8 4.6 6.9 4.3 6.5 15.9 5.5 6.2 11.3 8.1 10.5 7.7 10.2 11.5 0.6 10.8 9.6 6.2 7.7 5.1 20.8 32.4 0.0 1.0 1.1 0.0 31.6 0.0 69.6 69.4 0.0 0.0 0.7 0.0 0.6 0.0 1.1 0.7 0.0 1.1 0.4 0.6 0.8 9.3 0.0 0.4 0.0 0.0 2.5 1.0 0.7 0.3 1.8 0.0 0.0 0.7 0.0 1.0 1.1 0.4 1.4 0.0 0.0 0.9 0.3 0.4 1.4 0.7 1.3 1.0 0.7 EIF3D "eIF3-p66, eIF3-zeta, eIF3d, EIF3S7" ENSG00000100353 "Eukaryotic translation initiation factor 3 subunit D" O15371 22 36510850-36529436 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045882, HPA063330, HPA066216" Approved Supported Cytosol NA NA Cytosol "HPA045882: AB_2679482, HPA063330: AB_2684988, HPA066216: AB_2685637" "unprognostic (4.98e-2)" "unprognostic (2.22e-1)" "unprognostic (8.74e-3)" "unprognostic (6.50e-3)" "unprognostic (1.39e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.10e-5)" "unprognostic (1.47e-1)" "unprognostic (2.58e-1)" "unprognostic (9.98e-2)" "unprognostic (5.54e-3)" "unprognostic (3.93e-2)" "unprognostic (5.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-1)" "unprognostic (5.22e-2)" "unprognostic (9.78e-2)" 49.5 28.2 15.7 30.2 21.3 38.1 47.9 22.6 23.6 51.6 43.1 25.7 27.6 27.0 46.1 32.7 57.8 42.1 30.1 27.2 15.0 13.4 35.3 36.6 29.8 55.0 19.6 17.6 60.7 87.2 32.7 20.9 42.3 18.0 50.3 35.7 27.7 40.7 28.8 55.5 49.1 41.1 46.7 19.8 51.3 39.7 28.9 20.7 65.9 55.4 41.2 61.9 52.7 38.6 70.5 72.2 19.2 51.5 51.6 82.8 93.2 50.5 29.0 31.1 34.0 41.6 81.7 48.7 39.1 53.1 54.9 53.4 45.1 28.7 66.3 29.1 45.1 34.6 39.2 54.1 63.3 57.6 35.7 51.9 36.9 27.2 34.4 74.0 85.6 37.5 73.0 73.8 60.8 87.4 62.8 59.3 22.5 39.9 33.3 62.6 31.2 29.5 44.0 33.2 83.0 23.0 53.6 50.4 50.4 55.2 36.9 24.9 33.5 26.6 53.9 53.9 33.5 34.5 77.1 40.9 44.0 38.6 33.2 54.7 41.7 28.1 54.8 43.9 53.4 41.5 19.2 51.5 18.7 46.8 47.2 74.9 70.5 67.3 55.4 72.2 68.4 82.8 66.9 13.5 51.6 44.5 41.6 79.7 93.2 15.7 21.3 22.6 23.6 15.0 13.4 19.6 17.6 18.0 20.7 56.6 72.4 159.2 243.6 189.1 35.2 57.4 81.5 107.1 114.9 43.6 29.5 181.1 127.6 151.9 94.7 143.3 79.9 46.7 180.3 210.5 124.8 153.0 180.4 35.5 189.4 23.8 108.3 93.3 173.2 31.0 128.3 141.8 123.2 322.8 135.0 62.3 176.5 133.3 101.8 105.6 36.1 71.1 168.5 83.0 82.7 188.6 205.8 184.9 189.3 250.4 EIF3E "eIF3-p48, eIF3e, EIF3S6, INT6" ENSG00000104408 "Eukaryotic translation initiation factor 3 subunit E" P60228 8 108201216-108435333 "Cancer-related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023973 Approved Supported Cytosol NA NA Cytosol "HPA023973: AB_1848083" "unprognostic (8.18e-2)" "unprognostic (4.28e-2)" "unprognostic (6.26e-2)" "unprognostic (1.51e-1)" "unprognostic (3.52e-3)" "unprognostic (6.93e-3)" "unprognostic (2.29e-2)" "unprognostic (2.57e-2)" "unprognostic (3.47e-1)" "unprognostic (1.96e-1)" "unprognostic (1.67e-3)" "unprognostic (3.63e-1)" "prognostic unfavorable (3.06e-7)" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.77e-2)" 88.2 44.0 27.6 49.2 38.2 57.8 75.1 41.5 25.2 101.6 73.6 14.6 47.2 34.4 55.5 47.6 111.2 45.4 41.0 39.5 23.9 22.4 51.8 63.6 60.3 75.3 33.0 19.5 127.6 90.2 29.2 72.5 54.6 28.9 100.1 40.3 22.8 56.9 45.5 100.4 46.7 56.3 73.7 38.4 63.9 49.7 52.7 31.5 100.5 93.8 70.8 50.7 121.7 69.2 49.0 51.7 14.0 39.5 38.7 78.1 59.4 61.5 30.3 40.7 50.3 69.5 146.9 27.8 32.2 50.3 47.9 50.1 38.0 62.1 106.1 42.3 36.2 25.9 38.4 53.7 63.1 63.8 41.7 54.6 84.7 32.2 54.3 55.6 50.4 39.8 110.9 93.4 36.1 100.3 95.8 72.8 68.0 71.3 44.1 53.9 60.9 65.4 95.7 40.6 101.8 48.5 60.8 50.4 82.6 62.5 37.1 46.1 42.0 18.1 15.3 71.7 49.3 65.1 73.2 46.2 28.0 48.4 29.0 40.4 33.3 24.9 60.8 34.6 88.2 31.2 14.0 39.5 7.4 26.6 36.2 52.0 49.0 52.6 37.7 51.7 40.4 78.1 56.1 3.7 38.7 33.6 27.3 45.2 59.4 27.6 38.2 41.5 25.2 23.9 22.4 33.0 19.5 28.9 31.5 125.0 164.2 521.1 900.1 920.2 60.0 77.3 196.1 124.5 205.9 150.1 51.1 533.6 514.0 289.5 296.8 388.9 107.5 70.0 306.5 673.2 507.3 554.3 369.5 167.4 375.7 55.6 285.6 304.5 609.8 52.5 420.5 585.5 490.9 376.1 360.5 84.2 309.4 241.9 308.0 535.0 54.4 187.5 536.7 231.2 100.5 976.5 518.8 456.1 516.4 811.5 EIF3G "eIF3-delta, eIF3-p44, eIF3g, EIF3S4" ENSG00000130811 "Eukaryotic translation initiation factor 3 subunit G" O75821 19 10115017-10119918 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 1028.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 177.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041997 Approved Enhanced Cytosol NA NA 12000 Cytosol "HPA041997: AB_10804123" "unprognostic (1.80e-2)" "unprognostic (2.16e-2)" "unprognostic (9.00e-2)" "unprognostic (3.33e-2)" "unprognostic (2.22e-2)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.49e-1)" "unprognostic (1.73e-1)" "prognostic favorable (3.94e-4)" "unprognostic (4.90e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-1)" "unprognostic (2.40e-2)" "unprognostic (7.63e-2)" "unprognostic (1.91e-1)" "unprognostic (2.43e-1)" 41.6 29.0 20.2 34.2 21.5 34.1 36.1 18.1 28.4 41.1 41.2 27.0 30.3 29.8 40.2 34.6 37.7 34.1 47.0 52.3 19.0 18.4 30.5 45.0 28.2 40.1 22.6 18.5 63.6 88.6 30.9 24.8 34.9 19.3 41.9 17.6 25.6 57.1 35.5 141.1 40.2 30.1 39.1 24.3 36.7 38.9 51.0 23.4 46.4 42.3 49.7 40.3 46.2 48.7 47.1 58.4 31.4 60.6 80.3 70.8 74.7 25.5 21.7 16.7 22.0 22.2 28.5 21.4 21.9 30.7 34.5 32.1 35.5 13.8 26.3 31.4 26.1 15.7 19.7 20.2 32.9 14.3 23.7 61.5 46.6 21.9 35.5 37.0 36.6 24.6 34.1 24.3 24.3 23.4 22.3 24.6 33.1 41.8 31.3 20.7 34.3 39.8 177.9 40.8 16.3 46.8 32.2 16.4 34.7 21.9 22.4 21.6 42.0 14.5 19.1 34.3 9.9 16.8 32.4 24.2 29.9 16.9 32.4 41.5 92.6 67.3 29.3 22.5 40.2 28.5 31.4 60.6 25.3 54.6 44.4 70.8 46.7 59.0 59.1 58.4 47.1 60.3 54.1 11.7 80.3 35.6 45.9 64.9 74.7 20.2 21.5 18.1 28.4 19.0 18.4 22.6 18.5 19.3 23.4 41.7 79.8 229.1 225.9 202.7 38.3 40.8 122.3 78.9 77.3 102.9 17.7 402.8 159.2 159.9 356.5 161.9 178.9 23.3 266.1 265.8 177.6 154.0 126.9 95.5 198.8 20.6 124.7 129.5 241.3 1028.3 220.4 229.7 138.3 284.1 165.6 56.1 195.2 164.9 166.6 222.1 38.4 161.7 224.0 181.2 151.2 208.6 440.9 257.6 191.5 210.8 EIF3H "eIF3-gamma, eIF3-p40, eIF3h, EIF3S3" ENSG00000147677 "Eukaryotic translation initiation factor 3 subunit H" O15372 8 116642130-116766925 "Cancer-related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 200.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023117, HPA023553" Approved Approved Cytosol NA NA 3300000 Cytosol "HPA023117: AB_1848076, HPA023553: AB_1848077" "prognostic unfavorable (5.26e-4)" "prognostic unfavorable (8.07e-4)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (6.69e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (8.34e-4)" "unprognostic (3.63e-2)" "unprognostic (1.37e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-3)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.36e-2)" "unprognostic (1.48e-1)" "unprognostic (9.19e-2)" "unprognostic (1.11e-1)" 63.1 41.3 39.4 41.3 47.6 65.8 56.8 39.5 39.9 69.2 52.8 35.1 30.8 38.8 53.1 43.6 80.9 49.7 36.4 52.9 33.2 33.0 53.4 55.6 44.2 58.0 38.6 26.7 96.0 65.4 37.6 52.6 52.0 40.1 77.1 47.0 34.9 51.5 38.5 94.6 44.8 56.2 68.3 45.4 56.0 46.3 44.9 31.6 90.0 72.3 59.3 74.7 83.7 57.6 69.1 73.6 21.6 55.3 47.1 88.5 76.7 48.2 27.9 33.7 29.3 44.6 78.2 33.6 32.0 41.3 35.4 34.6 28.8 57.3 77.3 32.5 33.3 25.8 31.1 36.9 48.6 44.7 50.0 30.0 68.2 25.0 42.8 55.8 29.4 36.5 71.9 67.8 32.0 74.4 60.4 38.4 61.0 57.6 41.0 39.8 35.8 81.8 41.3 34.3 107.1 44.6 47.4 22.5 54.8 53.2 35.6 38.3 46.3 16.7 200.9 53.2 34.6 59.6 59.4 35.1 22.8 42.4 33.6 41.7 66.2 59.7 63.8 31.6 52.1 31.0 21.6 55.3 19.8 36.7 54.8 60.3 69.1 66.5 53.1 73.6 59.1 88.5 71.9 12.0 47.1 53.3 41.1 73.2 76.7 39.4 47.6 39.5 39.9 33.2 33.0 38.6 26.7 40.1 31.6 169.7 173.8 354.3 365.2 299.8 59.1 142.4 173.3 99.0 193.3 89.0 11.8 379.0 379.7 249.7 301.7 214.9 114.6 116.8 331.0 435.7 226.0 279.9 187.3 94.3 292.1 25.4 193.0 149.8 325.6 209.1 306.9 322.8 199.1 375.1 270.1 77.5 285.4 199.9 206.8 338.0 52.1 194.1 271.9 179.4 126.9 311.5 482.6 284.1 291.2 372.2 EIF3I "eIF3-beta, eIF3-p36, eIF3i, EIF3S2, TRIP-1" ENSG00000084623 "Eukaryotic translation initiation factor 3 subunit I" Q13347 1 32221928-32231604 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029939, HPA029940" Enhanced Approved Cytosol NA NA 16000 Cytosol "HPA029939: AB_10611109, HPA029940: AB_10600878" "unprognostic (4.48e-2)" "unprognostic (1.01e-1)" "unprognostic (7.82e-2)" "prognostic favorable (2.14e-4)" "unprognostic (3.86e-2)" "unprognostic (2.32e-2)" "prognostic unfavorable (4.21e-4)" "unprognostic (9.26e-2)" "unprognostic (1.28e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (4.81e-6)" "unprognostic (1.80e-1)" "unprognostic (2.93e-2)" "unprognostic (1.60e-1)" "unprognostic (8.47e-2)" 46.3 45.9 26.1 28.9 27.6 32.2 44.8 21.2 28.7 36.6 39.1 25.3 41.0 24.5 33.5 50.4 61.0 37.9 42.7 44.4 25.2 25.0 47.6 89.7 33.9 42.7 27.1 21.9 50.5 72.0 27.0 25.0 45.4 22.8 38.7 45.5 26.5 59.6 40.6 79.1 35.0 39.5 38.5 25.9 36.1 34.8 31.3 17.0 55.8 67.9 75.4 46.6 43.3 34.5 44.4 56.6 23.8 50.3 42.4 52.9 61.6 49.6 39.2 31.8 59.0 48.2 60.7 30.5 39.5 73.8 76.2 60.4 45.7 55.0 75.5 40.1 70.0 52.8 35.0 68.2 77.6 93.5 27.8 64.6 45.9 35.1 50.7 54.8 75.9 39.0 58.4 69.7 73.6 83.2 59.1 66.2 52.6 88.2 30.3 68.9 39.0 56.7 59.4 83.3 68.9 61.6 41.3 53.0 64.0 75.2 34.9 42.8 47.6 43.1 46.5 77.0 63.1 35.7 38.3 40.7 44.0 46.4 67.4 82.8 51.1 55.1 63.8 49.6 61.8 57.4 23.8 47.3 21.7 42.1 50.3 47.7 44.4 45.1 41.9 56.6 39.7 40.2 38.3 6.1 42.4 36.8 43.5 52.9 61.6 26.1 27.6 21.2 28.7 25.2 25.0 27.1 21.9 22.8 17.0 47.6 67.3 128.8 178.4 121.3 38.5 37.7 81.5 91.0 78.5 48.8 9.8 263.3 112.7 251.4 51.4 121.5 96.3 0.0 237.9 288.5 128.5 125.4 112.0 70.0 199.5 12.7 132.9 70.0 89.1 20.4 159.6 124.5 136.7 223.6 124.0 53.3 233.6 105.2 130.8 144.9 32.3 90.5 209.4 67.7 73.9 123.6 286.3 137.0 158.7 187.7 EIF3J "eIF3-alpha, eIF3-p35, eIF3j, EIF3S1" ENSG00000104131 "Eukaryotic translation initiation factor 3 subunit J" O75822 15 44537057-44563029 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 134.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050977 Approved Approved Cytosol NA NA 8600 Cytosol "HPA050977: AB_2681297" "unprognostic (4.47e-2)" "unprognostic (1.28e-1)" "unprognostic (7.68e-2)" "unprognostic (3.76e-2)" "unprognostic (1.72e-3)" "unprognostic (1.47e-3)" "unprognostic (2.33e-2)" "unprognostic (1.41e-2)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "unprognostic (3.43e-3)" "unprognostic (1.39e-2)" "unprognostic (1.97e-1)" "unprognostic (4.76e-1)" "prognostic unfavorable (4.96e-5)" 23.7 17.8 24.7 21.0 21.9 16.4 22.8 16.6 23.1 15.6 18.4 13.2 20.5 17.7 15.8 17.2 28.0 11.9 14.8 36.8 22.8 23.7 23.3 46.3 14.7 18.3 26.3 19.2 15.0 35.1 17.3 22.9 22.9 31.6 17.1 20.0 6.9 27.0 25.4 134.3 18.9 16.6 18.6 29.0 20.9 18.4 14.7 20.9 17.0 19.2 27.3 24.9 23.0 20.6 26.7 33.2 22.6 19.2 28.2 23.9 6.4 22.5 12.0 19.7 12.3 14.1 14.2 24.2 35.8 10.6 24.9 17.0 38.1 13.8 20.9 42.2 15.0 23.7 42.8 31.6 22.8 30.6 23.4 16.0 47.6 29.7 24.1 26.4 51.0 21.2 12.6 30.6 17.2 33.7 15.3 26.8 23.7 61.8 27.5 22.3 15.9 25.6 34.8 12.0 42.9 19.7 29.9 33.9 31.1 28.4 27.0 26.7 16.4 33.0 31.4 19.8 17.3 26.3 42.3 31.6 27.1 32.2 29.1 48.0 32.8 61.7 52.8 18.9 55.7 25.6 22.6 19.2 16.8 17.4 18.3 21.0 26.7 23.2 22.3 22.2 24.7 22.8 23.9 7.7 28.2 16.3 33.2 23.6 6.4 24.7 21.9 16.6 23.1 22.8 23.7 26.3 19.2 31.6 20.9 56.6 49.9 94.2 75.5 155.6 53.4 84.7 117.2 50.9 87.6 137.9 19.6 122.2 164.2 124.7 123.5 94.8 95.5 23.3 127.9 138.5 81.8 61.2 124.7 370.0 99.0 41.3 112.5 102.5 88.2 85.7 84.3 75.4 57.3 96.4 107.9 41.1 136.6 97.1 66.8 158.9 63.2 45.3 85.9 219.1 126.3 150.4 206.6 73.5 113.9 75.3 EIF3K "ARG134, eIF3k, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001" ENSG00000178982 "Eukaryotic translation initiation factor 3 subunit K" Q9UBQ5 19 38619082-38636955 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045446, HPA054590" Uncertain Supported Cytosol No No Cytosol "HPA045446: AB_10962716, HPA054590: AB_2682534" "unprognostic (7.07e-3)" "prognostic favorable (1.31e-4)" "unprognostic (3.04e-2)" "unprognostic (2.10e-3)" "unprognostic (1.67e-2)" "unprognostic (3.16e-1)" "unprognostic (2.25e-2)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (7.06e-3)" "unprognostic (2.92e-2)" "unprognostic (4.26e-2)" "prognostic favorable (5.43e-4)" "unprognostic (1.82e-1)" "unprognostic (1.00e-1)" "unprognostic (6.49e-2)" "unprognostic (3.69e-2)" 37.7 30.1 33.1 39.0 32.8 47.1 43.3 23.9 48.6 34.0 53.7 29.5 36.8 46.1 34.0 37.2 48.2 39.9 39.0 84.0 29.4 28.0 58.2 45.6 28.1 47.5 34.1 25.0 43.2 57.2 36.3 31.0 27.4 32.5 37.8 54.0 43.7 50.8 38.6 111.4 45.2 57.1 43.4 26.6 39.5 42.8 17.5 19.4 50.6 42.1 92.9 55.7 42.9 36.6 52.1 72.7 26.3 57.7 37.7 58.7 74.9 24.6 76.7 20.7 33.2 34.5 35.6 25.1 18.2 31.2 39.9 37.1 49.8 21.7 50.6 21.3 30.8 24.0 22.3 40.2 47.3 31.2 24.4 34.5 34.4 26.4 34.7 37.4 55.4 31.7 38.3 41.5 27.5 47.5 21.5 38.8 27.8 37.0 45.9 33.8 37.9 30.2 28.6 19.6 83.0 39.0 39.9 33.8 40.3 38.9 55.4 26.2 26.3 20.0 69.7 30.3 22.1 26.7 46.8 21.8 25.3 25.5 15.6 33.8 45.6 46.2 44.4 21.3 55.7 28.3 25.6 52.5 26.3 39.4 57.7 49.7 52.1 48.4 45.8 72.7 44.1 50.5 44.7 14.5 37.7 56.6 42.4 58.7 74.9 33.1 32.8 23.9 48.6 29.4 28.0 34.1 25.0 32.5 19.4 86.4 153.5 393.0 459.7 351.5 72.9 408.5 364.3 158.0 194.5 205.9 62.8 355.0 930.1 261.1 129.6 308.0 619.8 163.5 393.6 405.5 280.9 347.2 240.4 220.9 579.7 22.3 313.1 267.7 590.9 197.6 245.7 507.4 442.1 347.2 471.6 167.1 301.0 457.7 187.7 700.5 126.0 200.5 353.3 115.5 75.1 399.5 379.8 422.7 593.8 537.0 EIF3M "eIF3m, FLJ29030, GA17, hfl-B5, PCID1, TANGO7" ENSG00000149100 "Eukaryotic translation initiation factor 3 subunit M" Q7L2H7 11 32583798-32606262 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031063 Approved Approved Cytosol NA NA 48000 Cytosol "HPA031063: AB_10602128" "unprognostic (4.40e-2)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (7.16e-2)" "unprognostic (3.18e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.28e-9)" "unprognostic (5.79e-3)" "unprognostic (2.27e-2)" "unprognostic (1.83e-2)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (5.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-2)" "unprognostic (6.42e-2)" 44.3 46.1 25.4 36.8 30.9 41.0 47.1 19.3 32.2 49.0 35.1 17.3 26.5 26.2 40.2 38.9 48.7 52.0 29.1 34.3 23.3 23.0 50.0 54.5 30.8 47.7 23.4 21.9 80.9 60.6 34.0 33.1 44.7 28.3 44.3 35.0 18.8 32.5 30.3 48.8 35.1 37.8 39.2 26.4 45.0 37.1 43.5 19.6 84.1 55.1 54.7 48.1 59.8 34.6 36.5 64.0 15.4 53.2 33.3 38.5 39.4 29.0 37.6 30.0 38.1 40.1 57.8 44.3 30.3 42.1 46.7 45.5 48.4 21.5 75.5 20.9 34.5 40.1 37.1 52.2 55.0 58.5 25.4 64.7 34.0 30.6 51.1 58.1 78.9 48.9 51.7 62.5 31.4 77.3 39.3 52.3 40.6 67.0 26.4 51.1 34.2 39.3 83.0 32.9 39.1 58.2 32.3 75.8 35.2 50.9 55.0 23.2 35.9 21.5 40.8 46.4 34.5 45.2 47.3 24.4 29.3 33.4 62.0 91.1 32.4 40.7 55.1 26.3 48.1 28.7 14.3 53.2 15.4 26.5 45.8 36.3 36.5 36.6 33.4 64.0 29.2 38.5 34.8 6.3 33.3 33.3 38.4 37.9 39.4 25.4 30.9 19.3 32.2 23.3 23.0 23.4 21.9 28.3 19.6 77.4 57.3 141.1 205.6 189.1 44.1 38.3 56.0 54.9 75.1 57.6 19.6 216.5 111.0 149.6 121.1 121.7 46.7 46.7 216.8 238.7 136.9 115.7 153.7 66.1 176.7 9.5 69.5 81.6 264.9 43.2 124.0 180.6 104.6 164.1 128.3 52.2 174.4 87.7 113.1 160.4 36.8 71.1 155.2 89.9 83.3 196.7 203.2 160.3 148.5 209.0 EIF4A1 "DDX2A, EIF-4A, EIF4A" ENSG00000161960 "Eukaryotic translation initiation factor 4A1" P60842 17 7572706-7579005 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Helicase, Hydrolase, Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 1192.5;Suprabasal keratinocytes: 1078.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011689, HPA068286" Uncertain Approved Cytosol NA NA 2300000 Cytosol "CAB011689: AB_732122, HPA068286: AB_2685968" "unprognostic (1.49e-2)" "unprognostic (2.41e-1)" "unprognostic (8.00e-2)" "unprognostic (2.17e-1)" "unprognostic (2.49e-1)" "unprognostic (2.12e-3)" "unprognostic (7.25e-2)" "unprognostic (2.89e-2)" "unprognostic (2.72e-2)" "unprognostic (2.11e-2)" "unprognostic (2.65e-2)" "unprognostic (5.19e-3)" "prognostic unfavorable (1.76e-8)" "unprognostic (1.91e-1)" "unprognostic (5.96e-2)" "unprognostic (1.16e-1)" "unprognostic (1.13e-2)" 56.5 49.0 19.3 41.4 19.8 51.4 80.2 13.6 26.6 40.4 45.6 28.5 26.4 28.7 45.9 30.2 76.4 43.4 39.2 33.5 18.5 17.1 34.2 58.0 46.3 135.7 27.7 12.9 55.2 77.0 19.8 28.8 45.2 21.8 36.2 44.0 33.0 65.8 30.7 36.5 48.4 30.9 46.5 33.4 46.8 42.2 31.6 21.8 91.5 34.7 73.8 67.7 42.5 40.8 35.1 143.6 29.1 115.7 47.1 60.3 170.1 85.9 117.9 79.1 71.6 71.2 83.3 73.8 83.0 94.4 154.0 119.1 119.0 39.0 117.7 64.0 87.0 67.6 77.2 167.7 127.8 166.0 38.1 124.3 66.3 76.7 132.2 109.0 67.7 67.1 110.3 66.1 129.3 132.3 92.1 115.5 66.8 67.6 24.4 110.8 90.4 70.3 58.2 67.8 89.0 81.7 66.4 59.7 56.5 107.6 79.1 41.8 81.2 74.8 50.4 104.0 61.8 55.9 52.1 82.5 81.4 56.8 52.0 166.9 24.0 33.4 77.1 87.5 83.4 89.2 19.6 115.7 29.1 37.0 102.6 60.3 35.1 40.0 39.5 143.6 28.9 39.4 39.6 12.1 47.1 75.7 54.8 49.2 170.1 19.3 19.8 13.6 26.6 18.5 17.1 27.7 12.9 21.8 21.8 107.2 246.6 70.7 485.7 1192.5 106.4 4.8 71.4 168.6 257.0 69.8 110.0 292.0 129.3 287.6 27.4 250.8 114.3 0.0 199.9 314.2 406.1 269.6 140.3 57.2 188.0 100.1 111.9 143.1 130.1 33.1 149.0 241.8 688.4 127.2 116.0 108.1 249.6 126.3 102.6 131.4 109.7 148.8 550.1 57.5 86.6 1078.3 532.6 174.8 147.8 417.5 EIF4A2 "BM-010, DDX2B, EIF4A, EIF4F" ENSG00000156976 "Eukaryotic translation initiation factor 4A2" Q14240 3 186783205-186789900 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Helicase, Hydrolase, Initiation factor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB011690, HPA068286" Uncertain Approved Cytosol NA NA 1000000 Cytosol "CAB011690: AB_732123, HPA068286: AB_2685968" "unprognostic (1.49e-1)" "unprognostic (9.62e-2)" "unprognostic (3.78e-2)" "unprognostic (9.50e-3)" "unprognostic (2.82e-2)" "unprognostic (1.10e-2)" "unprognostic (4.46e-2)" "unprognostic (6.27e-2)" "unprognostic (4.32e-3)" "unprognostic (1.00e-1)" "unprognostic (6.39e-2)" "unprognostic (3.99e-2)" "unprognostic (6.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.03e-1)" "unprognostic (4.67e-2)" "unprognostic (2.62e-2)" 34.6 66.1 61.2 27.7 79.9 1.9 53.5 121.1 111.5 65.1 52.1 26.5 30.1 30.3 73.1 45.5 44.5 73.9 45.1 83.7 58.4 71.9 63.9 43.5 33.7 36.1 48.9 61.7 142.0 59.0 30.9 84.1 47.3 69.6 57.9 40.1 31.8 43.7 62.8 126.7 19.8 35.6 57.1 41.9 32.5 39.0 32.9 39.5 23.9 67.8 36.4 35.4 61.1 51.7 55.1 19.3 39.4 24.8 33.0 63.4 51.3 10.1 5.1 21.4 3.5 82.7 78.0 6.6 18.3 16.5 19.4 25.6 18.9 3.7 22.7 102.5 26.2 35.9 17.1 31.5 7.7 34.3 21.2 16.6 36.6 6.8 25.3 32.4 7.7 25.7 52.2 37.0 5.6 46.7 98.7 34.4 19.2 12.3 38.3 63.1 1.7 12.2 3.8 21.3 41.0 24.6 15.7 15.2 13.8 38.5 12.4 42.2 8.5 29.7 20.5 38.9 56.7 32.0 28.2 25.1 15.4 7.7 14.8 11.2 30.5 43.2 10.4 10.6 8.1 7.2 39.4 16.0 18.5 28.5 18.2 45.3 55.1 41.9 34.8 19.3 46.1 63.4 50.2 11.0 33.0 24.8 17.4 38.6 51.3 61.2 79.9 121.1 111.5 58.4 71.9 48.9 61.7 69.6 39.5 110.2 187.7 337.3 695.6 613.2 269.9 244.1 206.4 220.8 192.2 247.7 60.9 410.2 560.3 199.1 25.8 233.7 293.3 23.3 81.4 227.6 351.3 637.4 309.0 119.2 199.9 368.7 391.5 183.0 192.6 37.8 357.2 230.1 327.3 376.9 296.7 294.3 160.6 364.6 444.5 452.5 161.0 232.8 455.3 100.9 174.0 540.1 514.8 331.3 287.0 611.0 EIF4B ENSG00000063046 "Eukaryotic translation initiation factor 4B" P23588 12 53006158-53042209 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039072, HPA046164" Approved Enhanced Cytosol NA NA 50000 Cytosol "HPA039072: AB_2676333, HPA046164: AB_2679567" "unprognostic (1.91e-2)" "unprognostic (2.63e-2)" "unprognostic (4.50e-1)" "unprognostic (2.47e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" "unprognostic (2.68e-1)" "unprognostic (1.55e-2)" "unprognostic (2.83e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-1)" "unprognostic (1.55e-3)" "unprognostic (3.44e-1)" "unprognostic (3.57e-1)" "unprognostic (4.69e-1)" "unprognostic (8.20e-3)" 35.6 36.9 20.1 21.5 25.4 26.4 34.5 29.5 30.2 41.0 27.9 35.4 26.8 26.7 35.8 18.8 30.9 40.1 33.6 25.0 21.6 15.2 27.8 29.4 22.5 28.7 23.1 27.9 94.9 55.8 31.0 37.2 22.2 24.3 25.9 24.5 27.0 39.1 21.0 76.9 31.9 24.4 37.9 25.7 27.5 31.1 31.9 29.5 27.2 32.9 33.6 39.0 35.7 33.5 27.2 26.0 10.5 24.0 25.4 46.3 33.9 24.2 39.6 27.0 35.1 49.2 91.6 35.8 23.7 56.0 21.7 20.0 40.6 39.6 148.3 35.6 34.9 19.2 27.2 48.1 53.3 27.3 29.1 28.7 57.4 54.4 43.7 36.9 82.0 33.6 92.5 53.9 25.8 79.5 133.0 42.6 44.9 62.6 61.0 35.5 53.3 49.5 51.0 49.8 26.4 20.7 50.8 38.4 61.7 29.7 40.2 28.7 38.4 24.9 54.1 47.2 36.8 61.8 52.9 39.1 15.2 33.2 16.6 20.8 53.5 59.3 37.8 25.5 35.4 21.1 9.1 20.0 10.5 30.0 20.8 43.1 27.2 36.3 33.1 26.0 19.6 46.3 42.6 5.4 25.4 24.0 16.3 29.3 33.9 20.1 25.4 29.5 30.2 21.6 15.2 23.1 27.9 24.3 29.5 137.0 177.4 171.7 216.0 184.7 81.9 129.3 163.1 127.2 185.4 89.0 29.5 123.9 154.2 105.8 197.8 119.6 131.6 23.3 149.6 203.6 128.6 182.1 226.7 168.6 97.0 60.4 178.9 163.9 258.4 403.4 187.3 156.0 133.3 138.9 167.7 83.8 157.4 73.7 183.9 205.7 79.6 109.9 160.6 65.8 44.3 206.1 149.4 183.0 188.6 203.0 EIF4G1 "EIF4F, EIF4G, p220, PARK18" ENSG00000114867 "Eukaryotic translation initiation factor 4 gamma 1" Q04637 3 184314495-184335358 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding, Translational shunt" "Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014774, HPA028487, HPA043866" Approved Enhanced Cytosol NA NA 17000 Cytosol "CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705" "unprognostic (4.14e-3)" "unprognostic (2.10e-2)" "unprognostic (6.01e-2)" "unprognostic (3.01e-2)" "unprognostic (2.25e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (4.27e-3)" "unprognostic (2.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.55e-3)" "unprognostic (7.06e-3)" "unprognostic (2.42e-1)" "unprognostic (7.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.33e-3)" 30.2 33.1 18.3 26.4 18.9 26.3 30.3 18.0 23.2 24.1 25.2 19.6 33.6 21.9 24.5 30.5 45.2 20.9 31.1 33.0 16.9 16.9 40.6 108.0 26.0 21.0 19.4 15.9 29.3 46.4 47.5 21.9 34.6 18.3 24.0 21.8 19.9 31.4 34.1 103.7 39.0 31.6 26.8 15.7 33.1 27.1 30.8 18.0 25.8 30.0 46.2 34.3 28.6 27.6 8.8 15.9 5.5 17.0 8.1 11.4 9.1 90.3 37.9 31.9 36.2 35.6 35.1 55.1 49.9 35.3 55.5 42.3 80.4 29.5 57.8 66.5 61.8 66.5 48.9 54.9 61.2 43.2 61.1 57.8 52.2 38.8 35.6 30.9 52.3 36.6 35.4 35.6 50.5 48.2 28.9 48.4 22.1 37.9 45.8 36.6 67.1 35.4 18.8 62.7 44.3 30.7 36.5 31.4 46.4 29.4 55.1 33.4 29.7 42.5 70.5 33.9 28.5 75.1 37.4 60.4 39.4 39.9 51.6 93.4 35.7 43.1 107.0 44.3 45.9 43.0 4.8 13.6 5.5 11.4 13.9 11.0 7.6 7.7 9.2 12.2 8.8 7.1 7.0 5.1 8.1 17.0 15.9 5.4 9.1 18.3 18.9 18.0 23.2 16.9 16.9 19.4 15.9 18.3 18.0 71.5 58.2 39.7 51.5 52.5 25.1 95.4 50.9 40.2 67.1 59.3 13.7 53.1 11.6 92.9 153.5 57.6 100.2 23.3 116.3 63.6 52.3 82.5 45.2 130.2 58.2 20.6 53.5 43.6 38.3 140.5 67.6 40.6 32.1 49.5 68.5 21.9 122.3 58.5 52.6 40.9 22.0 77.6 66.8 27.0 39.1 80.3 66.6 33.8 68.7 78.7 EIF4G2 "DAP5, NAT1, p97" ENSG00000110321 "Eukaryotic translation initiation factor 4 gamma 2" P78344 11 10797050-10809110 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005163, HPA006773, HPA016965" Approved Enhanced Cytosol NA NA 25000 Cytosol "CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100" "unprognostic (1.10e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (9.92e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (6.18e-5)" "unprognostic (1.25e-1)" "unprognostic (7.84e-3)" "unprognostic (5.42e-2)" "unprognostic (7.07e-2)" "unprognostic (2.63e-1)" "prognostic favorable (1.67e-4)" "unprognostic (1.02e-2)" "unprognostic (2.08e-1)" "unprognostic (6.16e-2)" "unprognostic (2.74e-1)" 86.2 86.5 81.0 73.8 78.4 124.4 122.8 76.8 84.8 94.3 102.2 64.5 70.2 57.5 108.8 85.3 125.4 83.5 82.4 199.1 83.8 85.7 121.2 115.8 84.6 71.3 92.0 66.4 81.3 76.1 117.7 118.9 187.1 96.8 90.8 90.2 69.5 84.4 97.1 162.7 84.2 102.0 113.1 104.8 120.0 83.9 60.5 65.5 110.6 110.0 81.9 96.5 107.8 98.9 48.4 57.5 87.4 72.2 44.5 52.7 114.7 106.7 87.3 118.2 64.3 80.4 89.6 80.0 99.1 106.8 93.1 62.3 92.0 127.2 61.3 59.6 123.0 67.6 64.0 129.0 92.6 121.2 99.6 54.2 78.1 55.3 67.3 68.8 119.3 67.1 72.1 69.6 55.1 70.3 78.4 99.8 57.5 60.3 69.0 111.1 53.0 88.9 40.9 82.5 71.2 85.3 82.1 69.0 39.2 73.2 161.4 44.1 71.1 115.9 77.4 59.8 79.6 68.1 52.0 96.3 112.8 74.0 95.5 83.0 33.3 101.6 94.0 65.3 68.6 119.5 50.2 60.0 87.4 42.3 70.9 52.7 48.4 45.7 47.8 57.5 40.6 40.4 41.6 42.9 44.5 72.2 28.5 50.3 114.7 81.0 78.4 76.8 84.8 83.8 85.7 92.0 66.4 96.8 65.5 300.7 242.9 205.7 326.9 562.6 127.4 347.3 186.0 165.9 205.9 139.6 115.8 281.4 207.2 310.1 126.1 303.6 306.8 46.7 318.9 312.1 251.4 276.0 194.1 191.7 247.1 155.7 237.7 196.4 207.0 110.8 193.3 240.5 237.8 222.8 201.5 149.9 422.5 243.1 226.3 255.2 114.5 129.4 327.4 202.8 214.2 550.8 883.2 197.1 182.5 470.4 EIF4G3 eIF4GII ENSG00000075151 "Eukaryotic translation initiation factor 4 gamma 3" O43432 1 20806292-21176888 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 138.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025031, HPA025039, HPA025041" Enhanced Approved Cytosol NA NA Cytosol "HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104" "unprognostic (1.29e-1)" "unprognostic (8.38e-2)" "unprognostic (4.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (9.60e-7)" "unprognostic (1.02e-1)" "unprognostic (6.95e-3)" "unprognostic (8.36e-2)" "unprognostic (4.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.78e-2)" "unprognostic (9.37e-2)" "unprognostic (3.21e-2)" "unprognostic (5.07e-2)" "unprognostic (1.14e-1)" 17.8 19.2 24.8 19.0 28.6 24.1 14.3 24.8 33.8 17.2 17.9 24.5 18.6 12.2 19.7 17.5 16.8 17.1 17.0 16.6 25.9 24.8 14.8 13.6 12.9 14.8 23.1 24.8 15.7 10.6 44.5 30.3 13.8 36.3 16.1 21.0 17.4 11.3 18.5 29.1 17.7 14.0 23.8 25.0 16.1 14.2 67.1 23.1 13.9 30.5 9.7 16.1 18.0 15.7 3.6 5.6 4.2 2.6 1.4 3.7 1.5 11.2 9.2 30.5 12.1 31.9 31.7 6.3 24.5 26.5 17.2 17.8 10.0 12.4 22.7 15.9 26.6 16.2 12.7 18.8 19.9 24.4 19.7 17.7 11.3 18.2 7.0 16.1 18.6 21.0 33.1 16.2 18.1 23.5 27.5 22.2 8.6 8.5 15.9 25.5 10.0 5.8 9.7 8.6 14.1 8.3 11.2 11.2 7.5 19.0 6.1 17.3 13.4 25.5 11.1 14.9 18.6 8.0 21.6 22.6 19.5 7.3 27.7 11.1 7.3 7.8 0.1 25.0 29.7 18.1 2.0 2.6 3.0 3.7 0.5 1.6 2.6 1.5 1.8 3.4 3.6 1.0 2.8 4.2 1.4 1.0 5.6 1.7 1.5 24.8 28.6 24.8 33.8 25.9 24.8 23.1 24.8 36.3 23.1 17.9 26.2 21.5 15.0 18.3 47.5 39.2 10.2 58.9 35.2 15.7 62.8 4.2 0.0 18.6 138.6 31.0 42.3 0.0 16.8 7.4 18.3 16.8 25.5 12.7 20.1 47.7 15.6 39.3 33.2 92.8 41.4 24.3 13.5 2.8 21.4 20.0 22.0 28.8 42.1 8.8 39.4 32.3 21.7 100.5 49.8 23.1 2.9 13.8 23.3 23.7 ELMO2 "CED-12, CED12, ELMO-2, FLJ11656, KIAA1834" ENSG00000062598 "Engulfment and cell motility 2" Q96JJ3 20 46366049-46432985 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018811 Approved Supported Cytosol NA NA Cytosol "HPA018811: AB_1848126" "unprognostic (1.19e-2)" "unprognostic (4.24e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (3.71e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (8.81e-2)" "unprognostic (3.06e-2)" "unprognostic (1.92e-1)" "prognostic favorable (6.10e-4)" "unprognostic (4.53e-1)" "unprognostic (4.42e-2)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "unprognostic (3.99e-2)" "unprognostic (1.20e-2)" 12.6 14.9 23.8 11.9 30.0 28.1 10.6 39.8 32.6 14.8 9.9 34.8 5.2 7.8 12.7 17.5 18.0 13.5 9.4 13.1 25.4 17.1 12.6 8.5 13.7 15.5 21.5 16.8 11.6 17.5 30.1 13.9 13.2 20.6 18.1 9.3 13.8 11.6 22.8 16.8 18.6 9.3 19.5 20.4 17.5 9.1 18.5 22.6 12.3 13.0 7.0 16.3 11.4 13.8 5.3 13.4 38.3 27.6 21.9 22.3 15.6 4.8 14.3 17.0 14.0 29.9 19.3 8.7 11.2 15.5 15.8 15.5 19.3 5.5 6.0 18.1 18.8 26.8 11.5 14.4 16.8 12.3 9.9 6.4 9.8 9.3 14.1 22.6 5.4 20.9 18.9 15.0 16.8 12.0 10.9 12.7 14.8 9.7 20.1 14.7 12.7 10.7 14.0 6.5 9.1 14.0 9.1 16.6 12.0 15.5 11.2 10.3 9.3 16.2 14.4 21.8 16.9 11.1 21.8 14.7 32.8 18.6 13.3 7.3 8.1 12.1 6.2 13.5 8.8 9.9 38.3 10.1 16.3 18.4 19.3 22.3 4.3 16.5 17.4 9.6 5.3 10.7 12.0 11.1 21.9 27.6 13.4 10.8 15.6 23.8 30.0 39.8 32.6 25.4 17.1 21.5 16.8 20.6 22.6 3.0 15.1 5.1 4.6 4.2 7.9 8.6 7.6 0.0 3.4 1.8 27.5 4.8 0.0 4.0 3.0 6.2 2.6 0.0 2.9 4.4 5.8 7.4 8.1 2.4 11.7 11.1 7.9 4.3 5.1 4.9 10.3 5.0 6.8 9.0 2.4 15.4 4.5 3.1 12.0 3.3 8.3 25.8 7.1 6.7 13.9 5.8 3.4 13.8 2.1 3.4 ELOF1 "ELF1, MGC4549" ENSG00000130165 "Elongation factor 1 homolog" P60002 19 11551147-11559236 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 392.9;Late spermatids: 1089.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045606 Uncertain Approved Cytosol NA NA Cytosol "HPA045606: AB_10965133" "unprognostic (4.32e-2)" "prognostic favorable (1.83e-4)" "unprognostic (4.38e-3)" "unprognostic (3.39e-1)" "unprognostic (1.26e-1)" "unprognostic (3.29e-1)" "unprognostic (2.22e-2)" "unprognostic (2.65e-2)" "unprognostic (5.35e-2)" "unprognostic (4.90e-3)" "unprognostic (4.62e-2)" "unprognostic (1.26e-1)" "unprognostic (5.85e-2)" "unprognostic (2.93e-3)" "unprognostic (1.76e-2)" "unprognostic (7.09e-2)" "unprognostic (1.12e-2)" 19.0 23.4 25.5 20.4 23.9 33.0 20.9 32.8 29.0 24.5 19.8 19.8 19.5 19.2 27.4 28.6 21.2 29.2 20.6 21.2 25.1 27.6 24.8 45.2 18.9 24.9 25.0 22.4 28.1 39.3 19.7 29.6 19.4 21.2 25.4 15.9 21.0 34.2 30.6 24.9 22.7 20.8 22.1 20.5 22.5 23.2 69.0 20.8 33.1 29.3 24.3 23.2 22.5 22.6 63.1 60.4 44.2 43.2 32.4 47.1 41.4 39.7 27.8 19.2 26.3 24.0 24.4 9.9 25.7 21.8 35.4 35.9 27.6 11.0 25.6 25.4 23.2 23.2 18.8 23.3 35.8 24.8 20.2 23.8 32.0 18.2 26.0 27.1 20.7 22.1 23.6 26.6 31.2 22.8 25.5 17.2 24.6 44.4 33.6 21.1 51.4 30.7 24.3 49.8 20.3 51.4 22.9 16.4 26.9 29.1 18.6 24.2 30.7 20.7 25.0 24.1 18.4 21.0 16.7 11.9 36.7 13.9 38.4 38.6 39.1 52.4 21.7 34.2 29.3 18.4 25.0 42.4 44.2 34.3 40.1 31.7 63.1 36.0 31.8 36.8 46.9 32.6 29.1 28.8 32.4 43.2 60.4 47.1 41.4 25.5 23.9 32.8 29.0 25.1 27.6 25.0 22.4 21.2 20.8 14.9 19.2 58.8 46.7 75.4 23.1 27.8 48.4 37.5 17.0 31.4 7.9 72.7 89.5 71.8 392.9 30.6 56.1 70.0 89.2 67.4 55.4 39.7 21.9 32.1 67.5 14.3 57.8 36.8 48.9 1089.7 68.4 55.3 65.8 68.5 40.1 38.1 80.9 45.2 67.1 73.2 12.4 25.8 57.7 100.8 69.2 71.0 60.8 54.3 43.4 34.6 ELP3 "FLJ10422, KAT9" ENSG00000134014 "Elongator acetyltransferase complex subunit 3" Q9H9T3 8 28089673-28191156 "Enzymes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation, tRNA processing" "Acyltransferase, RNA-binding, Transferase, tRNA-binding" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025297, HPA025812" Uncertain Enhanced Cytosol NA NA Cytosol "HPA025297: , HPA025812: AB_10601369" "unprognostic (1.29e-2)" "unprognostic (1.26e-2)" "prognostic favorable (9.25e-4)" "unprognostic (3.49e-3)" "unprognostic (5.73e-2)" "unprognostic (1.10e-1)" "unprognostic (6.95e-2)" "unprognostic (2.07e-2)" "unprognostic (7.66e-2)" "unprognostic (1.22e-2)" "unprognostic (3.89e-1)" "unprognostic (3.46e-2)" "prognostic favorable (1.31e-5)" "unprognostic (2.29e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" 14.8 15.3 18.7 11.5 23.4 6.7 19.4 20.0 27.4 33.4 14.8 21.8 35.2 10.8 27.3 14.4 12.8 18.6 17.5 16.0 17.7 19.0 19.1 22.8 13.6 15.4 17.6 13.6 18.9 12.6 14.3 17.4 12.7 23.3 15.9 18.0 13.9 11.1 36.1 28.8 13.4 12.3 16.0 15.8 16.1 12.1 15.0 15.5 16.0 19.9 13.8 20.3 14.7 12.0 16.2 12.2 11.6 18.2 15.8 20.8 11.0 14.5 15.2 11.6 11.1 17.2 15.1 8.3 7.5 13.6 17.7 15.8 12.6 6.2 27.4 11.8 14.4 15.7 9.9 12.8 17.8 20.9 4.9 5.3 18.4 10.1 20.9 15.4 9.9 13.7 15.9 27.6 12.1 18.7 12.8 16.5 21.3 20.7 17.0 18.0 9.0 21.1 16.9 13.1 14.0 5.3 16.0 11.3 10.5 17.6 12.0 7.0 12.2 8.5 7.3 14.3 11.1 13.9 11.5 11.6 12.1 15.9 12.6 10.8 7.2 11.5 21.0 12.0 11.2 12.3 11.6 10.1 8.2 19.4 14.4 20.8 12.5 16.6 18.3 11.8 16.2 15.0 17.0 2.8 15.8 18.2 12.2 15.6 11.0 18.7 23.4 20.0 27.4 17.7 19.0 17.6 13.6 23.3 15.5 3.0 10.1 10.4 6.7 2.4 6.7 14.6 7.6 13.4 12.5 7.0 21.6 12.5 6.6 10.5 5.9 8.7 7.7 0.0 8.6 12.1 6.4 6.2 8.1 14.7 13.2 14.3 1.2 9.8 11.5 2.7 7.8 7.2 1.7 7.2 8.1 8.7 8.4 8.6 9.6 11.1 11.1 0.0 6.6 11.4 16.1 2.0 8.7 11.5 9.9 5.1 EMC8 "C16orf2, C16orf4, COX4NB, FAM158B, NOC4" ENSG00000131148 "ER membrane protein complex subunit 8" O43402 16 85771758-85799608 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 178.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049476 Approved Supported Cytosol NA NA Cytosol "HPA049476: AB_2680784" "unprognostic (2.69e-1)" "unprognostic (2.62e-2)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.88e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.49e-4)" "unprognostic (1.30e-1)" "unprognostic (2.41e-1)" "unprognostic (2.67e-3)" "unprognostic (1.03e-1)" "unprognostic (6.91e-3)" "prognostic favorable (6.39e-4)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" 16.8 17.4 18.8 17.1 19.8 26.9 39.3 12.4 21.0 14.5 16.6 16.3 14.1 18.9 18.2 14.4 17.3 14.0 16.8 23.0 17.7 15.5 19.1 22.5 14.2 16.2 18.0 12.4 16.2 16.2 20.5 14.6 20.9 14.0 14.5 16.2 13.4 16.6 17.0 25.6 13.3 16.3 17.0 17.3 17.9 15.5 15.5 13.3 24.3 19.5 18.2 16.5 14.8 12.3 12.8 20.9 21.2 15.8 16.3 13.9 9.5 13.0 15.2 9.7 8.8 10.6 10.2 19.0 12.9 12.8 21.6 9.6 24.2 15.1 11.3 15.0 12.9 9.7 14.9 14.5 13.5 19.3 4.7 20.6 9.2 8.4 22.0 16.1 9.4 6.3 11.1 9.2 16.3 19.2 9.3 12.2 13.9 21.0 4.3 13.2 22.1 14.8 26.8 19.4 12.1 19.6 21.9 7.9 9.6 13.6 9.2 16.5 9.8 23.7 7.8 14.3 9.1 15.4 16.8 10.6 13.0 13.2 11.4 16.4 12.2 11.7 45.1 11.1 18.2 13.6 12.5 15.2 21.2 9.9 15.8 11.7 9.6 11.0 13.5 20.9 12.8 13.9 13.2 6.6 16.3 15.7 15.5 10.2 9.5 18.8 19.8 12.4 21.0 17.7 15.5 18.0 12.4 14.0 13.3 6.0 7.5 21.6 23.5 54.5 20.7 18.1 12.7 9.4 9.1 24.4 11.8 43.2 51.4 39.7 178.6 25.3 21.3 23.3 36.8 53.9 27.0 29.2 9.2 19.2 40.7 14.3 44.7 28.3 24.3 39.4 23.0 25.5 27.0 39.7 22.0 22.1 39.4 21.0 29.7 34.3 14.9 25.8 23.5 45.4 53.2 47.7 42.7 17.8 30.2 39.3 EPHX2 ENSG00000120915 "Epoxide hydrolase 2" P34913 8 27490779-27545564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism" "Hydrolase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.9;liver: 87.6" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 152.5;Proximal tubular cells: 198.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 39.2" "Lineage enriched" "Detected in many" 24 "T-cells: 39.2" "Group enriched" "Detected in many" 4 "JURKAT: 50.5;K-562: 17.8;OE19: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023094, HPA023660" Enhanced Enhanced Cytosol NA NA 720000 Cytosol "HPA023094: AB_1848214, HPA023660: AB_1848215" "unprognostic (1.30e-1)" "prognostic favorable (2.45e-4)" "unprognostic (2.99e-2)" "unprognostic (3.62e-2)" "unprognostic (1.76e-2)" "unprognostic (3.30e-3)" "unprognostic (1.26e-3)" "unprognostic (3.31e-3)" "unprognostic (1.46e-1)" "unprognostic (3.55e-2)" "unprognostic (4.14e-3)" "unprognostic (1.98e-1)" "prognostic favorable (1.98e-10)" "unprognostic (9.82e-2)" "unprognostic (1.73e-1)" "unprognostic (8.12e-2)" "unprognostic (2.26e-1)" 4.8 25.1 4.8 14.3 6.0 0.4 8.3 5.6 3.3 7.6 56.2 6.1 21.8 29.8 10.3 15.1 15.2 11.3 9.4 7.8 4.1 4.8 44.2 87.6 4.6 5.0 5.8 3.2 11.4 25.3 11.6 14.6 2.9 10.5 17.9 15.6 13.3 18.0 22.7 8.5 11.5 83.9 13.1 4.5 3.5 6.7 5.4 3.9 45.7 7.5 13.2 11.7 7.0 7.4 1.6 0.0 0.0 0.0 1.4 39.2 7.6 5.3 3.6 2.3 2.9 0.1 0.0 1.7 0.4 0.3 0.2 0.0 2.8 3.6 0.0 2.1 1.3 1.2 3.8 0.4 0.9 0.1 0.0 1.7 7.9 0.4 8.7 1.3 0.0 1.6 3.2 3.9 0.0 0.4 0.9 0.1 50.5 17.8 0.0 0.0 1.6 5.1 0.2 3.7 36.3 6.2 0.0 0.0 0.1 3.2 0.8 1.9 5.9 4.3 5.2 5.2 1.8 7.9 1.5 0.0 0.0 1.4 0.6 0.0 4.6 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 4.0 1.6 12.5 4.5 0.0 0.9 39.2 18.0 0.0 1.4 0.0 0.0 9.4 7.6 4.8 6.0 5.6 3.3 4.1 4.8 5.8 3.2 10.5 3.9 6.0 13.4 4.7 14.5 10.5 33.3 21.0 15.3 24.1 10.3 26.2 74.6 18.1 152.5 4.7 6.3 6.0 93.2 0.0 5.7 2.6 7.2 27.0 5.7 98.6 1.8 31.8 22.4 10.4 3.5 2.4 27.6 0.8 5.0 2.8 54.7 84.9 4.3 74.7 17.7 198.6 56.3 0.0 12.0 1.5 7.0 15.9 6.9 5.7 88.0 6.7 EPRS "EARS, GLUPRORS, PARS, QARS, QPRS" ENSG00000136628 "Glutamyl-prolyl-tRNA synthetase" P07814 1 219968601-220046658 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding" "Disease mutation, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026490, HPA030052" Enhanced Enhanced Cytosol NA NA 29000 Cytosol "HPA026490: AB_1855979, HPA030052: AB_10601466" "prognostic unfavorable (7.25e-4)" "unprognostic (1.19e-2)" "unprognostic (3.94e-2)" "unprognostic (2.60e-2)" "unprognostic (7.98e-3)" "unprognostic (1.12e-2)" "unprognostic (3.41e-3)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.30e-1)" "unprognostic (7.13e-2)" "unprognostic (5.12e-2)" "unprognostic (2.32e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.62e-4)" 25.0 20.4 16.8 18.6 22.2 13.2 20.6 24.2 26.3 19.3 20.4 15.4 13.6 15.8 17.8 15.3 25.2 15.9 11.9 20.1 15.9 18.0 23.3 31.6 17.4 20.8 21.7 16.1 21.3 32.7 47.1 38.6 15.7 34.9 14.3 23.2 9.4 64.0 16.3 42.9 19.6 23.3 18.9 24.7 22.3 20.1 13.2 20.8 28.0 25.1 25.7 23.4 18.3 16.3 14.7 15.4 6.4 16.6 14.2 19.8 10.7 30.1 19.2 13.9 38.0 29.6 32.9 34.9 39.5 27.7 25.7 28.9 22.7 24.4 57.9 22.0 41.6 10.4 32.3 34.9 31.8 34.6 28.3 22.2 31.5 25.9 19.4 32.4 52.2 27.0 23.7 40.9 32.8 41.1 21.5 28.1 28.0 54.1 45.7 25.1 14.9 22.4 12.7 26.9 35.7 39.8 23.8 24.6 56.6 23.5 13.3 33.1 26.0 23.1 38.3 40.3 20.8 35.4 57.1 24.9 12.3 22.7 37.6 36.7 31.0 35.2 49.0 28.3 37.6 38.8 4.2 11.9 6.4 14.0 16.6 19.8 14.7 14.1 15.6 15.4 11.5 15.9 16.3 0.4 14.2 13.7 5.0 13.5 10.7 16.8 22.2 24.2 26.3 15.9 18.0 21.7 16.1 34.9 20.8 65.5 52.5 37.9 33.6 17.6 45.2 67.4 15.3 69.6 69.4 29.6 62.8 36.3 18.3 58.3 19.1 33.8 24.4 23.3 87.1 48.7 27.0 24.9 47.4 18.8 38.0 39.7 29.4 22.1 23.8 7.4 43.7 27.7 20.3 53.3 32.2 45.5 61.8 14.4 44.6 21.4 47.0 38.8 27.8 57.6 34.9 17.8 30.6 29.8 41.8 29.3 EPS8L1 "DRC3, FLJ20258, MGC23164, MGC4642" ENSG00000131037 "EPS8 like 1" Q8TE68 19 55072020-55087923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.9;placenta: 45.0" "Group enriched" "Detected in many" 4 "Syncytiotrophoblasts: 357.9;Urothelial cells: 188.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.3;BEWO: 32.6;SK-BR-3: 10.0;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041851, HPA043545" Uncertain Supported Cytosol NA NA Cytosol "HPA041851: AB_2677706, HPA043545: AB_2678544" "unprognostic (1.91e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (7.18e-2)" "unprognostic (9.33e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.43e-2)" "unprognostic (5.84e-3)" "unprognostic (2.65e-2)" "unprognostic (3.85e-3)" "unprognostic (5.04e-3)" "unprognostic (3.02e-1)" "unprognostic (5.41e-3)" "unprognostic (2.63e-1)" 1.2 0.0 0.2 2.1 0.3 0.0 1.7 0.3 0.4 7.6 2.1 0.2 1.5 2.0 1.3 1.8 40.9 6.2 6.9 0.2 0.2 0.0 4.1 0.2 1.8 0.2 0.2 0.2 1.6 4.0 1.1 1.1 45.0 0.3 2.9 0.5 0.3 6.6 2.5 0.4 18.7 1.5 0.7 0.2 0.4 23.2 0.9 0.2 1.0 6.2 12.1 16.9 1.9 12.1 0.1 3.5 5.1 0.4 1.7 0.8 0.5 9.3 0.4 0.3 0.2 0.0 0.0 32.6 0.9 0.0 0.0 0.0 2.9 7.7 0.1 1.9 0.0 0.0 4.7 0.2 0.5 0.0 0.2 0.9 0.7 0.3 0.2 0.1 1.5 6.5 0.0 1.5 0.0 0.0 0.0 0.0 0.7 3.5 0.0 0.0 4.3 0.5 1.5 0.5 4.8 0.0 0.1 0.0 3.1 0.7 0.7 0.1 2.3 0.6 10.0 0.4 0.3 15.8 1.8 0.7 0.0 0.4 0.0 0.0 1.4 1.7 0.9 2.0 0.5 1.2 2.6 0.4 5.1 0.8 0.1 0.7 0.0 0.4 0.8 0.0 0.1 0.1 0.0 0.0 1.7 0.0 3.5 0.7 0.5 0.2 0.3 0.3 0.4 0.2 0.0 0.2 0.2 0.3 0.2 8.9 6.7 0.9 18.5 1.8 0.0 2.0 5.1 5.3 11.4 29.6 0.0 28.7 11.6 18.5 1.3 3.8 22.2 0.0 9.1 18.2 2.6 37.2 10.3 0.0 7.9 0.0 2.9 8.0 1.2 3.6 1.1 2.6 20.3 8.2 28.9 0.2 62.1 35.1 0.7 0.8 0.0 25.8 14.1 0.6 2.6 3.4 357.9 2.5 9.9 188.1 ERMARD "C6orf70, dJ266L20.3, FLJ11152" ENSG00000130023 "ER membrane associated RNA degradation" Q5T6L9 6 169751622-169781584 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 35.6;Late spermatids: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041741 Approved Approved Cytosol NA NA Cytosol "HPA041741: AB_10804116" "unprognostic (2.66e-3)" "unprognostic (2.75e-1)" "unprognostic (2.33e-1)" "unprognostic (2.28e-2)" "unprognostic (1.18e-1)" "unprognostic (3.18e-1)" "unprognostic (2.24e-2)" "unprognostic (7.41e-3)" "unprognostic (1.96e-1)" "unprognostic (8.14e-2)" "unprognostic (1.66e-3)" "unprognostic (4.74e-2)" "unprognostic (3.06e-2)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.31e-2)" 12.6 14.4 11.9 16.6 15.6 10.6 13.2 12.4 16.0 10.9 10.1 17.5 18.6 8.6 21.8 25.0 10.1 13.3 11.0 7.2 10.0 9.3 12.1 16.4 9.9 16.6 10.9 14.6 18.7 13.3 14.1 17.7 13.6 12.1 12.0 11.1 16.1 15.4 15.6 13.0 21.8 12.4 12.8 11.7 16.7 10.1 27.4 11.8 15.5 14.8 12.1 15.8 11.2 9.9 7.1 7.0 2.2 13.4 7.3 9.8 6.3 4.0 5.0 9.3 14.2 10.7 12.3 3.7 5.3 10.5 6.4 6.8 3.3 9.4 7.7 5.4 7.7 7.9 11.7 4.3 11.8 6.7 8.1 4.7 10.2 7.4 3.3 15.0 12.6 6.8 12.9 13.0 6.5 18.1 10.8 7.2 13.1 9.6 10.3 10.5 7.4 5.9 11.3 3.1 9.0 4.0 7.4 6.3 11.9 10.0 4.6 3.3 6.2 8.3 10.1 4.1 8.1 6.4 14.1 5.5 5.1 3.0 8.0 5.7 11.0 12.5 6.8 7.8 10.4 8.1 2.2 5.7 1.9 6.9 11.1 6.9 6.2 7.2 7.5 7.0 7.1 8.1 7.5 0.9 7.3 13.4 5.3 9.8 6.3 11.9 15.6 12.4 16.0 10.0 9.3 10.9 14.6 12.1 11.8 3.0 12.0 3.0 3.8 3.7 11.1 2.0 0.0 18.7 5.7 5.2 9.8 10.7 10.0 8.2 35.6 3.6 3.3 0.0 7.4 7.0 5.6 2.3 2.3 7.4 5.2 4.8 5.8 7.4 7.1 38.1 4.0 4.0 3.3 4.6 2.8 12.8 4.6 2.9 4.2 6.8 10.5 6.5 5.2 27.7 15.3 2.8 5.9 3.8 3.9 3.1 ERRFI1 "GENE-33, MIG-6, RALT" ENSG00000116285 "ERBB receptor feedback inhibitor 1" Q9UJM3 1 8004404-8026308 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 141.1;pancreas: 133.6" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 1158.6;Basal keratinocytes: 1103.5;Hepatocytes: 716.0;Suprabasal keratinocytes: 640.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.9" "Group enriched" "Detected in many" 7 "monocytes: 4.9;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HHSteC: 94.3;LHCN-M2: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076543 Supported Cytosol NA NA Cytosol "HPA076543: " "unprognostic (2.13e-3)" "unprognostic (1.01e-2)" "unprognostic (2.34e-1)" "unprognostic (1.71e-2)" "unprognostic (2.50e-3)" "unprognostic (1.66e-3)" "unprognostic (2.27e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.47e-1)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (1.19e-3)" "unprognostic (1.11e-3)" "unprognostic (1.18e-1)" "unprognostic (2.34e-1)" "unprognostic (8.03e-3)" 38.6 8.8 4.4 6.3 6.3 0.6 27.8 9.6 7.0 17.5 13.6 5.4 8.4 6.8 15.9 9.6 13.6 12.2 27.3 8.8 4.7 2.5 32.6 141.1 15.5 7.7 7.5 3.7 29.7 133.6 7.7 41.9 33.7 8.1 9.3 5.1 12.0 14.5 5.9 68.3 20.2 26.5 22.9 12.5 2.1 22.3 7.4 5.2 0.6 19.4 4.7 3.8 20.0 19.5 0.4 0.3 0.2 4.9 0.0 1.3 0.2 13.4 7.9 3.4 4.6 32.4 24.3 35.5 13.2 3.8 2.4 2.9 3.5 35.4 0.2 7.9 4.4 16.9 2.9 0.9 23.3 11.3 0.4 2.6 0.2 2.3 41.0 94.3 0.1 0.5 32.9 23.5 8.1 19.7 34.6 6.2 0.5 0.9 0.1 72.0 5.7 0.0 0.8 8.1 10.5 19.8 1.1 38.4 0.2 11.4 4.3 2.3 1.4 2.6 6.0 4.1 25.1 4.1 0.3 8.7 9.6 5.6 8.0 18.5 0.2 0.1 0.2 36.9 0.6 8.8 0.0 0.4 0.0 1.3 0.1 0.2 0.3 1.2 1.3 0.2 0.4 0.9 1.2 0.2 0.0 4.9 0.3 0.6 0.2 4.4 6.3 9.6 7.0 4.7 2.5 7.5 3.7 8.1 5.2 205.4 106.1 3.4 1158.6 1103.5 8.8 38.3 122.3 92.3 168.4 26.2 13.7 65.0 26.6 64.8 18.3 16.0 90.3 0.0 96.3 48.0 90.0 430.0 13.9 716.0 8.9 3.2 104.9 36.8 11.3 51.0 48.1 13.8 67.4 1.0 17.1 35.7 105.2 28.1 36.0 45.8 9.2 6.5 58.9 10.4 22.8 640.6 216.6 5.7 21.0 466.7 ESYT2 "CHR2SYT, FAM62B, KIAA1228" ENSG00000117868 "Extended synaptotagmin 2" A0FGR8 7 158730995-158830253 "Plasma proteins, Predicted membrane proteins, Transporters" "Endocytosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002132 Approved Uncertain Cytosol NA NA 130000 Cytosol "HPA002132: AB_1078807" "unprognostic (2.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (5.72e-2)" "unprognostic (5.43e-2)" "unprognostic (9.01e-2)" "unprognostic (9.94e-2)" "unprognostic (1.72e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.13e-1)" "unprognostic (7.54e-2)" "unprognostic (6.70e-2)" "unprognostic (4.58e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (2.81e-5)" 33.3 25.6 15.3 16.2 23.5 19.6 27.3 21.7 26.3 26.7 27.9 17.8 21.6 15.8 31.2 31.0 32.5 28.3 31.1 28.4 16.1 17.5 20.6 16.7 26.1 18.0 15.6 16.7 41.6 23.2 29.7 22.0 35.2 20.6 21.1 22.6 23.4 26.7 31.4 34.5 24.5 22.5 37.8 14.9 13.2 19.4 13.3 12.1 29.0 30.5 24.3 23.2 30.5 27.6 1.4 3.6 2.0 2.3 6.6 8.5 2.9 29.6 17.8 5.7 6.0 19.2 22.3 19.0 14.0 14.3 11.2 12.6 9.9 39.0 9.1 16.2 25.1 23.1 14.8 8.2 14.7 10.8 9.4 8.4 7.5 14.2 10.5 19.6 26.9 17.2 16.1 18.3 12.6 16.9 22.5 13.2 24.8 16.1 30.8 18.2 24.9 27.9 19.5 9.1 20.0 17.2 23.8 11.0 11.2 19.0 12.7 16.7 9.2 44.6 36.1 20.3 13.9 13.1 29.5 20.4 12.4 6.5 54.7 17.8 21.1 5.4 8.9 30.7 28.0 36.5 2.0 1.9 1.5 8.5 2.3 4.7 1.4 7.1 6.0 3.6 1.0 6.7 7.9 1.2 6.6 1.5 2.4 5.8 2.9 15.3 23.5 21.7 26.3 16.1 17.5 15.6 16.7 20.6 12.1 35.7 32.5 9.0 10.9 41.0 15.1 25.8 22.9 36.1 33.0 45.4 15.7 24.1 3.3 13.5 11.2 41.4 27.1 23.3 17.1 22.4 41.1 18.3 11.6 17.4 18.3 12.7 20.3 25.2 23.8 3.0 32.5 22.6 49.0 10.8 29.5 15.2 24.1 5.8 51.2 8.2 10.6 32.3 52.8 10.9 10.0 45.2 34.1 25.9 22.5 21.4 EVA1B "C1orf78, FAM176B, FLJ10647" ENSG00000142694 "Eva-1 homolog B" Q9NVM1 1 36322031-36324154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 229.9;Ito cells: 91.4;Syncytiotrophoblasts: 134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 20.0;NB-4: 24.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041928, HPA043537" Approved Approved Cytosol NA NA Cytosol "HPA041928: AB_2677752, HPA043537: AB_2678538" "prognostic favorable (4.58e-4)" "unprognostic (5.66e-3)" "unprognostic (1.04e-3)" "unprognostic (3.20e-2)" "unprognostic (1.22e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (4.82e-4)" "unprognostic (1.45e-1)" "unprognostic (8.33e-2)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.87e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" 7.2 5.9 3.3 5.0 2.6 3.1 10.6 1.7 3.7 9.4 4.4 2.5 4.1 8.9 9.8 3.8 4.1 5.1 4.2 7.7 2.4 1.1 10.5 2.8 6.3 8.1 3.4 1.7 8.9 1.9 1.3 2.0 23.3 3.2 7.4 0.5 2.9 7.8 4.3 3.6 6.9 8.1 6.4 3.4 10.4 3.9 5.1 2.9 2.6 9.2 1.7 2.5 5.4 8.3 0.0 1.1 5.8 2.1 3.5 2.2 0.3 2.8 1.7 1.4 2.6 5.2 14.7 7.6 20.0 13.6 3.4 3.8 2.9 2.0 0.4 6.6 5.8 0.7 4.4 0.1 0.7 0.7 2.3 4.9 2.6 1.8 2.3 11.1 0.1 1.5 13.1 0.0 4.2 0.4 5.3 5.2 0.7 0.9 1.0 2.2 3.3 0.1 24.7 1.6 0.2 7.7 1.6 0.3 4.2 2.7 0.6 1.1 3.4 2.0 2.2 7.9 2.2 0.3 1.8 8.8 5.4 0.6 7.9 2.2 1.1 0.3 0.6 3.2 1.6 4.4 5.8 2.1 0.0 0.4 0.8 1.4 0.0 0.8 1.2 1.1 0.0 0.0 0.1 3.7 3.5 0.3 0.0 2.2 0.3 3.3 2.6 1.7 3.7 2.4 1.1 3.4 1.7 3.2 2.9 0.0 0.0 6.9 16.7 14.3 0.0 1.6 2.5 0.0 1.2 7.0 0.0 44.7 1.7 17.7 5.6 44.2 0.2 0.0 12.8 229.9 52.8 37.6 4.6 0.4 40.9 0.0 0.0 91.4 28.8 20.1 46.9 15.6 11.8 6.4 0.0 10.9 23.2 0.0 45.6 6.3 0.5 25.8 41.1 9.3 2.4 10.8 134.9 9.5 0.2 17.8 EXOC8 "EXO84, Exo84p, SEC84" ENSG00000116903 "Exocyst complex component 8" Q8IYI6 1 231332753-231337852 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027438 Approved Approved Cytosol NA NA Cytosol "HPA027438: AB_1848318" "unprognostic (3.85e-2)" "unprognostic (6.52e-2)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "unprognostic (4.83e-2)" "unprognostic (5.82e-2)" "unprognostic (4.85e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-1)" "unprognostic (2.69e-1)" "unprognostic (2.09e-2)" "unprognostic (1.74e-1)" "unprognostic (8.39e-2)" "unprognostic (1.77e-1)" "unprognostic (3.79e-2)" "unprognostic (2.21e-2)" "unprognostic (1.04e-1)" 12.1 9.3 10.4 11.2 9.6 22.1 10.3 14.8 12.8 8.6 8.6 9.9 9.5 8.8 9.3 7.6 11.1 8.5 7.7 9.0 9.2 10.3 9.2 11.2 9.5 12.6 9.1 9.9 11.2 11.2 17.1 11.9 14.4 11.9 8.7 7.3 6.7 9.5 9.9 26.7 12.2 11.4 6.8 9.0 13.0 10.1 6.7 9.3 16.9 12.9 9.2 13.3 7.7 9.9 1.8 2.1 6.0 3.8 2.0 3.5 1.2 7.4 8.2 5.0 5.1 13.1 10.7 12.2 9.1 7.7 6.9 6.5 7.7 7.5 8.4 8.1 9.0 6.2 12.2 7.2 9.8 7.6 10.9 17.6 5.1 10.4 4.9 7.4 8.9 14.2 10.7 10.8 10.1 9.7 8.1 8.4 8.8 9.3 20.2 10.9 3.8 8.3 5.5 7.6 9.3 7.0 5.5 7.8 10.8 8.6 8.6 6.7 7.2 9.2 12.1 8.9 4.1 11.6 13.0 11.4 9.3 6.6 12.4 15.9 15.2 8.7 9.2 10.7 8.1 11.7 4.5 1.8 3.3 1.3 2.3 1.6 1.2 1.7 1.5 1.3 1.8 2.0 3.5 6.0 2.0 3.8 2.1 1.5 1.2 10.4 9.6 14.8 12.8 9.2 10.3 9.1 9.9 11.9 9.3 8.9 9.8 9.0 4.6 16.5 3.9 6.7 12.7 2.7 9.1 8.7 5.9 3.6 1.7 2.9 0.8 9.2 6.3 23.3 3.1 2.5 5.3 4.9 2.3 8.2 4.8 3.2 4.6 8.6 12.3 0.4 3.7 6.4 3.3 2.8 4.5 5.7 4.0 0.0 5.3 4.1 11.6 0.0 3.8 4.9 4.7 12.9 7.8 7.7 3.8 6.5 EYA2 EAB1 ENSG00000064655 "EYA transcriptional coactivator and phosphatase 2" O00167 20 46894624-47188844 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 47.4" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 40.0;Club cells: 18.2;Cytotrophoblasts: 21.2;Urothelial cells: 36.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 69.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "memory B-cell: 2.4" "Lineage enriched" "Detected in single" 16 "B-cells: 2.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 13.7;SCLC-21H: 20.9;SK-BR-3: 9.3;U-266/70: 38.9;U-266/84: 47.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027024, HPA059291" Uncertain Supported Cytosol NA NA Cytosol "HPA027024: AB_1848334, HPA059291: AB_2683967" "unprognostic (1.08e-1)" "unprognostic (5.71e-3)" "unprognostic (4.03e-1)" "prognostic favorable (4.30e-5)" "unprognostic (3.32e-2)" "unprognostic (1.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (2.54e-1)" "unprognostic (2.65e-1)" "unprognostic (7.06e-2)" "unprognostic (2.15e-1)" "unprognostic (2.78e-1)" "unprognostic (4.17e-3)" "unprognostic (1.56e-1)" 10.5 2.0 6.5 2.6 7.4 0.8 13.4 2.4 6.5 47.4 6.4 3.8 21.0 1.0 15.7 10.7 25.9 28.2 2.2 4.3 7.0 4.1 5.2 1.8 2.3 1.3 6.3 4.9 5.2 2.4 11.5 4.7 5.9 9.1 18.5 3.2 15.4 28.6 27.3 2.1 4.2 1.1 2.3 7.2 1.1 8.2 4.9 5.1 14.3 21.4 3.6 14.0 5.5 17.3 2.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.7 0.1 13.7 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 20.9 0.0 0.0 9.3 0.0 1.1 1.8 0.1 0.0 0.0 1.7 0.1 3.1 38.9 47.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.5 7.4 2.4 6.5 7.0 4.1 6.3 4.9 9.1 5.1 0.0 0.0 0.0 40.0 0.6 0.2 0.5 0.0 6.7 18.2 0.0 5.9 21.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.8 4.7 9.2 1.1 2.4 5.8 0.0 1.2 0.6 0.0 0.0 0.0 0.2 3.3 4.6 0.2 0.0 0.7 1.7 0.7 4.4 0.3 0.0 1.4 0.2 0.7 0.3 9.0 0.0 1.5 36.7 FAAH FAAH-1 ENSG00000117480 "Fatty acid amide hydrolase" O00519 1 46394265-46413848 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 68.0;Late spermatids: 88.3;Spermatocytes: 73.1" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 19.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.2;OE19: 10.7;RT4: 23.9;SK-BR-3: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007425 Approved Approved Cytosol NA NA Cytosol "HPA007425: AB_1078820" "unprognostic (6.12e-2)" "unprognostic (2.04e-1)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (1.72e-1)" "unprognostic (4.97e-2)" "unprognostic (2.00e-1)" "unprognostic (6.64e-3)" "unprognostic (2.91e-2)" "unprognostic (2.33e-1)" "unprognostic (4.39e-3)" "unprognostic (9.86e-2)" "prognostic favorable (4.25e-5)" "prognostic favorable (3.63e-5)" "unprognostic (2.66e-1)" "unprognostic (9.97e-2)" "unprognostic (5.00e-3)" 6.1 7.7 11.2 2.5 22.0 7.9 7.9 20.4 21.9 6.9 15.0 40.7 10.1 18.0 3.1 8.2 4.9 10.6 4.6 2.9 14.7 11.7 12.0 18.3 6.7 2.1 19.1 19.3 2.7 18.2 15.1 10.6 3.5 17.6 33.3 12.8 7.4 12.8 8.6 7.1 10.1 17.8 2.3 23.6 2.0 14.3 30.9 18.8 5.6 24.9 3.5 3.5 5.7 4.2 0.1 6.0 19.1 4.7 0.3 0.4 0.9 2.8 0.7 0.4 0.5 0.7 0.5 22.2 0.6 0.3 0.3 0.5 4.1 6.6 0.2 2.3 0.4 0.2 9.4 0.4 1.3 0.1 1.2 3.1 0.0 0.1 1.9 0.5 0.8 1.6 0.4 6.4 0.2 0.8 0.2 0.0 0.5 0.1 0.5 0.0 5.9 0.4 1.2 1.8 10.7 0.2 0.5 0.2 0.1 5.2 23.9 2.8 2.1 3.2 12.4 0.1 0.6 8.5 8.2 0.0 0.0 0.3 0.6 0.4 1.2 0.5 0.3 0.1 7.6 0.2 0.0 4.7 19.1 0.3 1.2 0.1 0.0 0.3 0.1 5.7 0.1 0.4 0.4 0.2 0.3 0.6 6.0 0.1 0.9 11.2 22.0 20.4 21.9 14.7 11.7 19.1 19.3 17.6 18.8 20.8 10.4 4.2 27.1 4.6 12.6 2.2 25.5 4.0 10.3 21.0 41.2 14.4 0.0 12.8 35.5 1.8 68.0 0.0 5.6 6.3 2.4 27.0 0.0 29.2 2.6 1.6 14.9 0.6 3.2 88.3 6.9 2.9 5.0 0.0 33.1 6.3 5.0 40.4 4.2 19.5 11.4 0.0 2.7 73.1 7.7 5.3 10.4 0.0 48.5 12.3 FAM102A "bA203J24.7, C9orf132, Eeig1, SYM-3A" ENSG00000167106 "Family with sequence similarity 102 member A" Q5T9C2 9 127940579-127980513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036030 Approved Cytosol NA NA Cytosol "HPA036030: AB_10670675" "unprognostic (3.27e-1)" "unprognostic (1.66e-3)" "unprognostic (1.06e-3)" "unprognostic (4.69e-3)" "unprognostic (2.32e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-2)" "unprognostic (2.97e-1)" "unprognostic (8.36e-2)" "unprognostic (1.01e-2)" "unprognostic (9.28e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (8.28e-3)" "unprognostic (6.98e-2)" 5.3 18.3 28.2 19.9 39.1 7.6 12.1 10.5 31.8 22.4 35.8 65.9 8.7 33.3 15.7 12.6 27.4 29.8 28.5 6.7 29.4 17.3 15.1 23.9 8.5 34.4 41.5 22.9 19.7 21.6 12.9 22.9 5.7 28.0 10.6 11.2 12.5 19.1 13.5 1.9 18.7 39.3 16.7 39.0 12.9 61.8 15.4 53.0 32.0 12.1 13.7 26.3 17.8 18.6 4.7 0.1 2.2 0.1 0.5 11.8 3.0 10.1 22.5 4.8 3.8 10.2 12.3 18.3 3.9 10.9 2.7 1.6 12.9 18.1 11.6 2.6 7.5 5.7 11.2 2.5 2.0 1.0 5.5 2.5 3.4 5.7 11.5 6.4 1.6 26.9 5.0 10.4 7.5 3.2 5.3 3.6 7.1 2.8 14.6 3.0 26.2 6.7 3.6 5.8 20.0 10.9 3.5 3.5 4.2 7.6 17.5 7.5 3.7 6.5 14.7 9.3 5.4 27.6 2.2 3.8 4.2 4.5 22.1 5.9 19.8 26.9 8.0 18.1 2.2 9.9 0.6 0.1 2.2 1.9 0.0 6.1 4.7 9.4 5.6 0.1 1.2 9.1 6.0 0.1 0.5 0.0 0.0 11.8 3.0 28.2 39.1 10.5 31.8 29.4 17.3 41.5 22.9 28.0 53.0 6.0 7.0 18.2 26.3 19.5 14.0 10.9 45.9 13.4 6.8 61.1 9.8 5.0 6.6 45.0 4.6 5.8 107.7 0.0 86.2 4.9 13.2 53.6 18.4 40.9 2.9 25.4 26.9 69.3 7.9 4.3 31.7 2.3 21.9 4.6 34.2 62.4 54.3 31.6 40.7 10.5 15.5 0.0 7.8 5.9 9.3 41.9 4.5 20.3 20.4 65.9 FAM120A "C9orf10, KIAA0183, OSSA" ENSG00000048828 "Family with sequence similarity 120A" Q9NZB2 9 93451722-93566107 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019734, HPA055800" Approved Enhanced Cytosol NA NA Cytosol "HPA019734: AB_1848369, HPA055800: AB_2682925" "unprognostic (5.92e-2)" "unprognostic (2.15e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.03e-4)" "unprognostic (3.36e-1)" "unprognostic (2.33e-2)" "unprognostic (8.93e-2)" "unprognostic (5.84e-2)" "unprognostic (3.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.27e-2)" "unprognostic (3.71e-3)" "prognostic favorable (1.08e-7)" "unprognostic (8.16e-2)" "unprognostic (1.60e-1)" "unprognostic (2.64e-1)" "unprognostic (1.00e-2)" 25.7 35.1 23.3 28.6 19.1 15.7 23.0 22.1 21.8 26.1 27.0 14.9 32.2 21.3 33.2 17.2 26.0 24.2 24.1 22.1 20.5 11.0 21.2 33.2 25.7 26.4 18.4 12.6 25.5 34.4 40.6 16.8 24.6 20.0 17.4 26.0 15.9 27.7 22.4 71.5 17.6 23.6 23.3 17.7 21.7 25.3 7.5 17.7 19.5 19.8 23.8 17.6 46.5 33.1 4.7 6.6 15.2 9.2 4.2 7.5 3.5 47.1 38.7 8.8 25.2 26.4 33.2 27.6 33.2 29.3 25.5 18.8 12.5 29.3 30.8 19.0 41.8 20.3 51.0 23.4 38.8 19.9 30.6 17.0 16.8 34.6 19.8 29.6 28.5 23.0 32.2 24.2 28.9 46.4 25.3 36.4 21.9 19.2 25.9 27.6 52.8 27.9 16.2 11.3 56.6 36.3 16.3 23.5 25.8 31.0 28.5 23.6 14.5 37.5 45.7 22.7 9.1 24.8 18.7 37.6 27.8 20.0 34.0 36.1 20.4 20.0 11.9 30.0 25.8 24.6 3.0 7.1 5.0 5.4 8.1 5.1 4.7 5.2 5.6 6.6 4.1 3.6 5.1 15.2 4.2 9.2 4.6 7.5 3.5 23.3 19.1 22.1 21.8 20.5 11.0 18.4 12.6 20.0 17.7 41.7 72.9 25.7 37.7 90.8 28.8 107.4 79.0 48.2 76.2 71.5 47.1 61.6 18.3 44.8 23.5 54.4 108.9 23.3 65.0 83.1 53.6 103.2 47.4 158.9 64.4 38.1 88.2 64.4 144.2 6.4 61.9 69.8 50.6 35.1 160.3 34.0 71.4 70.2 61.5 66.1 29.6 38.8 67.9 13.1 13.5 99.9 86.5 44.8 129.3 93.7 FAM151B UNQ9217 ENSG00000152380 "Family with sequence similarity 151 member B" Q6UXP7 5 80487969-80542563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 6.7;Kupffer cells: 6.8;Syncytiotrophoblasts: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.0;eosinophil: 2.2;intermediate monocyte: 1.1;myeloid DC: 3.5" "Group enriched" "Detected in many" 11 "dendritic cells: 3.5;granulocytes: 2.2;monocytes: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043805 Uncertain Approved Cytosol NA NA Cytosol "HPA043805: AB_10794287" "unprognostic (1.29e-1)" "unprognostic (7.11e-2)" "unprognostic (1.67e-3)" "unprognostic (1.28e-4)" "unprognostic (1.90e-2)" "unprognostic (4.46e-4)" "unprognostic (2.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.10e-2)" "unprognostic (9.63e-2)" "unprognostic (1.20e-1)" "unprognostic (3.44e-2)" "unprognostic (6.86e-3)" "unprognostic (1.13e-1)" "unprognostic (2.66e-1)" "unprognostic (2.50e-2)" "unprognostic (1.63e-1)" 2.8 4.6 5.2 2.4 7.7 13.1 2.5 4.5 7.2 3.1 1.8 2.2 0.2 1.7 3.3 4.8 2.5 4.4 3.2 3.0 8.5 3.6 5.5 3.7 2.9 2.9 3.1 4.8 2.5 6.8 3.0 6.9 5.6 3.2 3.0 2.3 2.5 3.4 2.1 2.6 1.7 1.4 3.1 2.9 3.0 2.0 3.2 2.0 0.0 2.8 0.3 1.6 2.7 2.4 0.0 3.5 2.2 2.0 0.1 0.2 0.5 0.1 2.8 1.2 5.1 4.3 6.4 2.0 2.2 3.2 1.7 4.0 0.2 2.2 0.0 0.5 5.7 5.8 1.4 1.8 0.5 1.5 0.5 1.0 0.7 1.0 0.8 1.9 0.7 2.8 2.9 2.0 2.2 0.1 3.5 2.8 0.6 0.1 0.8 3.0 2.2 0.4 0.5 0.1 0.5 1.0 0.6 4.2 0.7 2.0 1.0 0.5 1.4 0.8 2.1 2.2 0.4 3.1 2.3 1.3 0.3 0.3 0.0 0.8 0.2 1.3 0.0 3.0 2.3 1.9 0.0 2.0 2.2 0.0 1.1 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.5 5.2 7.7 4.5 7.2 8.5 3.6 3.1 4.8 3.2 2.0 0.0 0.0 0.0 0.6 0.2 0.7 1.6 5.1 4.0 1.2 3.5 0.0 6.7 0.0 1.2 2.7 0.5 0.1 0.0 1.8 5.3 2.3 0.8 1.1 0.0 4.5 1.6 0.0 0.6 6.8 1.5 1.1 2.5 0.0 0.0 0.7 0.8 0.4 0.0 0.4 3.4 0.4 0.0 0.7 2.8 1.0 0.9 6.6 0.0 0.2 0.5 FAM160A1 FLJ43373 ENSG00000164142 "Family with sequence similarity 160 member A1" Q05DH4 4 151409216-151663632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 33.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 10.5;Horizontal cells: 7.9;Suprabasal keratinocytes: 12.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 5.8" "Lineage enriched" "Detected in single" 13 "dendritic cells: 5.8" "Cell line enhanced" "Detected in many" "A-431: 8.3;HeLa: 10.1;hTERT-HME1: 9.5;SiHa: 9.0;SK-BR-3: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046348 Enhanced Approved Cytosol NA NA Cytosol "HPA046348: AB_10966145" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.21e-3)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.33e-2)" "unprognostic (4.55e-2)" "unprognostic (1.52e-1)" "unprognostic (7.21e-3)" "unprognostic (1.30e-3)" "unprognostic (2.39e-1)" "unprognostic (1.51e-12)" "unprognostic (2.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (1.28e-1)" 1.4 1.2 3.0 3.4 0.8 1.5 3.8 7.5 0.9 6.3 5.2 0.6 10.4 1.7 6.1 5.9 13.1 2.8 4.9 6.5 0.7 0.7 7.0 1.6 5.4 0.1 0.6 0.0 3.7 23.7 11.1 9.4 1.8 4.8 4.5 3.3 10.0 11.1 12.5 33.6 12.6 9.0 1.8 0.7 0.7 2.3 3.5 0.0 0.9 11.4 22.0 10.0 6.2 5.0 0.0 5.8 0.4 0.0 0.1 0.1 0.0 8.3 0.7 0.0 0.2 0.0 0.0 3.1 0.4 2.0 0.8 0.2 3.6 3.1 0.0 0.9 0.1 2.8 7.6 2.2 6.3 1.3 0.0 3.6 0.0 10.1 0.8 0.0 0.0 0.1 0.1 6.3 0.0 9.5 1.9 0.1 0.7 0.0 0.0 0.5 1.2 0.0 0.0 2.9 2.6 0.8 0.0 2.1 0.3 4.4 5.7 1.4 0.4 9.0 7.9 0.0 2.5 3.4 0.0 0.0 0.6 3.7 0.2 1.4 0.0 0.0 0.0 2.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 3.0 0.8 7.5 0.9 0.7 0.7 0.6 0.0 4.8 0.0 3.0 1.3 0.0 6.2 10.5 0.0 1.6 0.0 0.0 6.8 0.0 0.0 0.3 0.0 1.3 1.8 0.3 3.4 0.0 1.5 0.5 0.3 5.9 1.1 0.5 0.2 7.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.0 3.7 1.2 0.0 0.0 0.3 4.5 0.0 0.3 2.1 4.1 12.7 1.4 0.0 1.4 6.8 FAM173A "C16orf24, MGC2494" ENSG00000103254 "Family with sequence similarity 173 member A" Q9BQD7 16 720581-722601 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 314.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046262 Approved Approved Cytosol NA NA Cytosol "HPA046262: AB_10963070" "unprognostic (3.94e-2)" "unprognostic (8.78e-2)" "unprognostic (1.55e-1)" "unprognostic (2.61e-1)" "unprognostic (6.54e-2)" "prognostic favorable (8.88e-4)" "unprognostic (2.11e-1)" "unprognostic (4.49e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (4.02e-2)" "unprognostic (5.70e-2)" "prognostic favorable (4.24e-5)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (9.28e-2)" "unprognostic (3.60e-3)" 16.0 10.4 15.6 10.3 9.1 7.3 9.6 8.9 21.5 4.8 15.5 8.2 9.3 19.1 6.5 8.3 6.1 5.2 10.6 11.1 13.6 11.5 18.6 15.8 7.5 7.5 11.3 12.2 4.3 10.2 8.5 13.4 5.8 9.2 8.4 3.5 6.5 15.1 8.6 37.3 6.2 14.5 5.6 9.5 15.0 19.3 21.8 7.9 8.6 7.8 11.1 7.1 5.9 8.9 9.0 6.0 5.3 6.8 6.3 18.0 4.2 6.4 4.3 0.8 2.3 0.1 0.3 10.3 5.6 1.4 1.3 1.6 4.3 5.4 8.3 10.1 0.6 2.4 10.1 0.8 2.8 0.4 18.3 11.4 3.5 4.5 4.5 2.0 5.8 4.8 0.7 2.1 0.6 1.7 2.9 0.5 5.8 7.3 3.8 1.2 10.5 0.9 14.0 3.3 3.6 14.1 3.5 2.1 15.5 3.6 2.3 3.7 9.7 2.9 4.8 9.3 0.5 5.3 5.2 4.7 1.2 10.0 3.6 3.9 33.6 15.0 8.9 2.5 4.3 3.2 0.0 6.8 5.3 7.3 3.9 16.5 9.0 5.8 12.9 4.4 9.0 5.9 18.0 0.8 6.3 4.8 6.0 12.5 4.2 15.6 9.1 8.9 21.5 13.6 11.5 11.3 12.2 9.2 7.9 6.0 5.4 49.9 28.1 9.0 86.9 11.2 50.9 1.4 0.0 61.1 33.4 40.1 99.5 47.3 182.0 14.5 140.4 0.0 56.0 31.2 20.0 36.4 28.7 74.6 77.3 50.9 50.1 27.6 51.9 314.4 23.6 43.6 45.5 55.1 53.9 57.8 49.3 73.7 17.7 139.1 71.7 25.8 27.8 65.4 88.0 8.3 21.4 60.6 62.2 31.4 FAM185A MGC35361 ENSG00000222011 "Family with sequence similarity 185 member A" Q8N0U4 7 102748971-102809225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020470, HPA029883" Uncertain Approved Cytosol NA NA Cytosol "HPA020470: AB_1853890, HPA029883: AB_10601903" "unprognostic (8.28e-2)" "unprognostic (2.28e-1)" "unprognostic (8.19e-2)" "unprognostic (1.20e-1)" "unprognostic (3.88e-3)" "unprognostic (6.06e-2)" "unprognostic (1.63e-2)" "unprognostic (1.59e-3)" "unprognostic (3.97e-2)" "unprognostic (4.45e-2)" "unprognostic (7.11e-2)" "unprognostic (2.03e-1)" "prognostic favorable (9.36e-5)" "unprognostic (3.64e-2)" "unprognostic (2.65e-1)" "unprognostic (2.13e-3)" "unprognostic (5.25e-2)" 3.7 4.6 6.6 3.0 4.9 3.6 3.8 9.3 6.3 5.6 4.3 4.4 4.1 2.3 3.8 3.1 4.4 3.1 3.4 4.2 4.2 2.3 4.0 9.4 4.8 2.3 5.1 6.0 4.7 3.7 8.7 4.8 2.8 4.0 5.2 4.3 6.1 5.1 8.4 9.5 4.6 3.1 3.7 4.5 3.0 5.9 2.2 5.1 3.0 3.8 2.4 2.7 4.4 4.0 3.3 2.6 7.5 3.0 1.2 2.2 0.9 1.4 3.5 1.6 4.1 0.6 1.7 4.2 0.9 1.7 1.6 0.5 3.4 2.9 0.0 2.2 1.2 4.3 3.6 2.3 2.4 1.6 1.8 2.0 0.2 0.4 4.2 1.0 2.9 0.4 0.0 2.7 1.0 1.2 3.3 2.0 1.1 2.1 1.5 1.7 2.7 1.4 0.3 1.8 2.7 0.0 0.3 0.1 10.2 0.8 2.5 1.4 3.0 3.4 5.4 0.4 0.9 3.3 0.0 3.6 0.4 1.7 2.5 0.5 4.9 1.6 0.6 0.7 0.9 0.0 0.0 3.0 3.3 2.1 2.2 0.9 3.3 1.4 2.2 2.6 1.9 1.3 1.5 7.5 1.2 1.0 2.4 1.6 0.9 6.6 4.9 9.3 6.3 4.2 2.3 5.1 6.0 4.0 5.1 3.0 1.0 2.4 5.9 3.8 7.7 4.4 10.2 2.7 6.8 0.0 9.8 11.6 16.6 3.7 3.1 4.5 2.3 0.0 2.0 4.9 3.3 3.1 0.0 5.9 4.0 4.8 1.2 4.3 1.3 1.9 6.6 1.9 6.8 1.8 2.2 3.5 2.2 0.0 4.9 9.1 21.2 12.9 2.8 5.2 3.6 4.0 6.8 4.9 3.5 5.1 FAM187A ENSG00000214447 "Family with sequence similarity 187 member A" A6NFU0 17 44899712-44905390 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.2;testis: 37.0" "Cell type enriched" "Detected in single" 67 "Ciliated cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 12.4;U-87 MG: 14.1" HPA043131 Approved Cytosol NA NA Cytosol "HPA043131: AB_10796686" 0.7 1.3 5.8 0.6 8.9 0.7 1.4 1.0 5.0 2.5 0.9 3.1 1.7 0.3 1.9 2.7 0.5 21.2 3.0 0.6 5.4 6.7 3.7 0.5 2.0 0.7 5.3 4.1 3.7 1.6 2.2 2.2 0.3 4.5 1.1 1.0 1.7 1.3 1.9 0.4 0.6 0.6 1.1 4.2 0.4 0.6 37.0 1.1 0.3 4.5 0.2 0.6 0.9 0.3 0.8 1.8 1.9 2.9 0.2 0.8 2.0 1.7 8.8 2.2 1.8 2.7 3.1 1.4 0.5 4.3 2.5 3.1 2.6 4.7 0.2 1.4 1.6 5.9 5.2 0.5 2.3 1.1 5.2 2.1 0.7 3.7 0.7 1.1 1.0 0.7 0.4 3.0 4.7 1.0 4.2 1.1 1.1 1.6 0.1 0.9 1.2 0.1 1.3 0.7 3.0 1.2 0.8 0.3 0.4 12.4 0.8 5.9 1.4 0.5 0.1 0.7 1.7 6.3 1.0 0.6 1.0 2.2 1.2 1.0 0.2 0.2 0.4 14.1 0.8 1.1 0.0 2.9 1.9 0.2 0.8 0.0 0.0 0.0 0.8 1.8 0.8 0.0 0.1 0.0 0.2 0.3 0.0 0.6 2.0 5.8 8.9 1.0 5.0 5.4 6.7 5.3 4.1 4.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM221A "C7orf46, DKFZp686F0810, FLJ45875, MGC72075" ENSG00000188732 "Family with sequence similarity 221 member A" A4D161 7 23680130-23703249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 46.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 11.6;GAMG: 15.8;MOLT-4: 15.0;SCLC-21H: 14.1;SH-SY5Y: 24.0" "Low region specificity" "Detected in many" "HPA019719, HPA026748, HPA026752" Enhanced Approved Cytosol NA NA Cytosol "HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912" "unprognostic (1.28e-1)" "unprognostic (7.28e-3)" "unprognostic (6.03e-3)" "unprognostic (2.54e-1)" "unprognostic (3.33e-2)" "unprognostic (8.04e-2)" "unprognostic (8.51e-3)" "unprognostic (2.18e-3)" "unprognostic (3.10e-2)" "unprognostic (5.69e-2)" "unprognostic (3.75e-1)" "unprognostic (2.42e-2)" "unprognostic (9.30e-3)" "unprognostic (4.26e-2)" "unprognostic (1.11e-2)" "unprognostic (2.40e-1)" "unprognostic (1.81e-2)" 3.9 4.8 12.8 3.8 19.7 2.1 5.7 12.9 12.3 5.0 8.2 25.1 2.9 12.0 3.5 5.1 8.7 12.1 6.8 4.0 15.9 13.4 8.4 10.0 5.5 4.3 30.0 10.3 4.5 25.2 3.8 4.5 2.3 17.2 4.7 11.0 27.8 8.7 9.2 2.1 4.7 8.9 3.2 24.6 2.3 14.6 22.9 24.3 2.1 7.7 1.4 6.2 4.2 3.1 6.9 5.3 3.8 5.2 6.8 11.4 3.7 0.0 0.3 6.7 5.5 0.2 0.0 3.1 0.2 0.5 0.8 1.0 6.8 3.0 0.7 11.6 0.1 15.8 1.3 0.0 0.0 1.3 0.0 9.0 1.8 0.6 0.0 1.8 0.0 10.0 0.4 0.4 0.1 0.0 1.4 2.1 6.8 0.0 0.0 0.2 3.1 15.0 0.0 0.0 0.0 3.3 6.2 0.6 0.0 3.7 3.0 14.1 24.0 1.0 0.0 0.0 1.6 3.0 4.3 0.3 0.0 2.4 1.3 0.6 0.0 0.0 0.0 0.6 0.0 1.1 0.0 3.0 3.8 5.4 1.9 11.0 6.9 9.0 6.5 5.3 6.0 10.6 5.7 0.1 6.8 5.2 4.3 11.4 3.7 12.8 19.7 12.9 12.3 15.9 13.4 30.0 10.3 17.2 24.3 14.9 7.4 3.9 8.6 14.3 7.0 4.4 12.7 46.8 20.5 7.0 2.0 3.0 8.3 11.6 6.8 7.1 7.7 0.0 9.3 0.2 5.0 10.3 4.7 13.1 5.7 6.4 14.3 3.7 3.7 8.2 4.4 7.7 8.5 0.0 21.7 7.3 11.7 18.7 3.5 10.3 8.0 19.4 6.1 26.5 25.7 16.6 0.7 4.4 17.1 9.5 FAM43B FLJ44952 ENSG00000183114 "Family with sequence similarity 43 member B" Q6ZT52 1 20552439-20555010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 21.9;brain: 14.9;epididymis: 8.7" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 1.2;Distal tubular cells: 3.3" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;BJ hTERT+: 3.3;fHDF/TERT166: 6.7;Hep G2: 4.9;SCLC-21H: 6.0;SiHa: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050813 Approved Approved Cytosol NA NA Cytosol "HPA050813: AB_2681244" "unprognostic (1.51e-1)" "unprognostic (5.85e-2)" "unprognostic (2.80e-3)" "unprognostic (1.48e-1)" "unprognostic (5.97e-3)" "unprognostic (1.74e-1)" "unprognostic (8.33e-2)" "unprognostic (5.87e-4)" "unprognostic (1.86e-2)" "unprognostic (7.46e-2)" "unprognostic (8.85e-3)" "unprognostic (2.73e-1)" "unprognostic (1.78e-4)" "unprognostic (1.06e-2)" "unprognostic (6.05e-3)" "unprognostic (6.48e-2)" "unprognostic (2.12e-2)" 3.2 21.9 5.6 1.5 14.9 0.9 1.5 8.8 14.4 1.6 1.3 2.4 0.0 1.1 1.4 8.7 1.3 1.6 1.5 3.3 5.3 12.1 2.6 1.4 1.2 1.0 10.1 6.0 1.0 1.2 0.9 0.7 2.5 11.2 1.4 1.1 0.5 1.2 1.3 2.8 1.0 1.2 2.9 4.0 1.4 0.9 1.3 2.8 0.0 1.3 1.7 0.9 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 4.6 0.2 0.1 0.0 0.5 3.3 0.6 0.0 0.1 0.0 0.0 0.2 6.7 1.2 0.0 0.7 0.0 0.1 0.0 1.0 0.2 0.3 4.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.0 0.7 11.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 14.9 8.8 14.4 5.3 12.1 10.1 6.0 11.2 2.8 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.3 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 FAM53B "bA12J10.2, KIAA0140, smp" ENSG00000189319 "Family with sequence similarity 53 member B" Q14153 10 124619292-124744269 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037751, HPA037752" Approved Approved Cytosol NA NA Cytosol "HPA037751: AB_2675645, HPA037752: AB_10672285" "unprognostic (7.88e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.73e-2)" "unprognostic (2.92e-1)" "unprognostic (4.91e-1)" "prognostic favorable (1.97e-4)" "unprognostic (2.52e-2)" "unprognostic (5.03e-3)" "unprognostic (1.51e-2)" "unprognostic (4.02e-2)" "prognostic favorable (7.00e-6)" "unprognostic (1.93e-1)" "prognostic favorable (4.81e-7)" "prognostic favorable (3.26e-4)" "unprognostic (3.41e-1)" "unprognostic (2.03e-1)" "unprognostic (2.45e-2)" 12.1 14.2 13.8 20.0 20.1 20.9 8.2 15.4 20.2 9.9 10.9 32.4 11.5 14.9 17.8 5.1 11.3 11.5 8.5 11.9 17.6 10.9 8.0 3.1 11.8 28.6 21.5 12.0 17.6 5.7 14.6 9.6 7.3 12.8 6.4 7.0 12.2 14.3 8.2 36.9 11.9 14.1 12.5 19.7 16.5 8.2 10.4 30.2 37.7 14.4 7.9 23.7 8.1 5.8 9.5 2.8 4.5 3.6 1.0 10.7 4.0 5.8 6.7 5.1 14.6 6.1 3.2 14.9 2.8 3.5 3.0 2.6 3.4 3.5 21.7 5.9 3.3 2.9 11.6 6.8 8.2 1.3 25.9 7.5 9.9 3.2 8.5 4.1 8.7 6.7 3.1 8.6 2.7 4.4 3.7 4.8 11.2 7.7 9.0 2.9 10.5 10.2 11.6 3.4 4.9 6.1 18.5 1.9 9.6 2.4 10.2 7.0 6.7 2.4 9.6 31.6 2.1 3.8 11.2 2.5 3.6 3.2 3.7 5.6 1.4 2.9 13.2 2.7 7.1 1.9 1.2 3.1 2.9 10.7 3.0 5.1 4.8 4.6 5.5 2.0 9.5 1.8 3.2 4.5 1.0 3.6 2.8 5.0 4.0 13.8 20.1 15.4 20.2 17.6 10.9 21.5 12.0 12.8 30.2 8.9 13.0 7.5 5.1 3.2 4.8 13.4 2.5 8.1 5.7 3.5 9.8 3.7 1.7 2.4 13.7 6.3 18.0 0.0 3.5 4.2 4.5 2.6 4.7 3.2 11.2 1.6 14.5 21.5 23.1 4.1 5.2 5.2 8.5 7.2 15.1 2.8 2.8 13.3 9.9 3.7 22.3 0.0 2.5 7.1 6.8 5.0 0.7 13.4 12.4 4.4 FAM71F1 "FAM137A, NYD-SP18" ENSG00000135248 "Family with sequence similarity 71 member F1" Q96KD3 7 128709061-128731743 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 146 "testis: 64.8" "Group enriched" "Detected in some" 103 "Early spermatids: 1001.4;Late spermatids: 1429.0" "Cancer enriched" "Detected in single" 23 "testis cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "NTERA-2: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020636 Uncertain Cytosol No NA Cytosol "HPA020636: AB_1854739" "unprognostic (3.09e-2)" "unprognostic (3.39e-3)" "unprognostic (6.03e-2)" "unprognostic (5.25e-1)" "unprognostic (2.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-5)" "unprognostic (1.48e-1)" "unprognostic (2.18e-6)" "unprognostic (6.97e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-3)" "unprognostic (1.99e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 64.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 1.5 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1001.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1429.0 11.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.3 0.0 1.8 0.0 0.0 11.7 5.5 0.1 1.0 0.0 0.0 0.0 FAM83G "FLJ41564, PAWS1" ENSG00000188522 "Family with sequence similarity 83 member G" A6ND36 17 18968789-19004804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 36.0;skin 1: 33.8;tongue: 28.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 69.0;Suprabasal keratinocytes: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA023369, HPA023940" Enhanced Approved Cytosol NA NA Cytosol "HPA023369: AB_1848415, HPA023940: AB_1848416" "unprognostic (2.12e-2)" "unprognostic (5.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.48e-2)" "unprognostic (1.42e-3)" "unprognostic (2.04e-2)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.07e-3)" "unprognostic (1.14e-1)" "unprognostic (2.03e-2)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (5.65e-2)" "prognostic favorable (7.58e-6)" "unprognostic (9.68e-2)" "unprognostic (5.13e-2)" "unprognostic (3.74e-2)" 1.8 1.0 0.5 5.1 0.8 0.6 2.2 1.0 0.8 6.2 5.5 0.4 1.3 6.6 1.4 0.9 36.0 0.8 13.4 8.7 0.9 0.6 2.6 26.5 2.3 1.5 0.4 0.4 1.1 7.0 4.7 2.2 2.6 1.6 1.7 3.2 1.5 5.7 3.0 3.4 33.8 10.1 1.6 0.4 1.0 5.9 0.8 0.3 3.2 3.3 28.9 19.1 2.4 6.9 1.5 0.2 3.4 0.7 0.0 2.6 0.7 12.5 11.6 0.1 0.0 0.4 1.1 19.2 13.2 5.8 11.2 8.5 14.8 4.6 8.3 8.1 8.7 9.2 15.0 1.9 11.1 5.2 6.7 4.2 0.2 5.7 8.1 8.4 1.4 4.2 1.5 20.9 7.2 12.0 4.2 4.0 1.3 3.9 0.3 3.1 7.7 0.3 3.1 5.8 17.5 0.0 0.0 0.0 4.0 5.5 3.2 6.0 0.0 4.5 2.8 0.8 16.3 4.9 1.8 7.4 7.0 11.7 3.3 15.2 1.1 2.0 2.1 5.4 0.0 4.5 3.4 0.0 0.0 2.6 0.1 1.4 1.1 1.5 0.8 0.2 1.5 1.4 0.2 0.0 0.0 0.7 0.2 1.8 0.7 0.5 0.8 1.0 0.8 0.9 0.6 0.4 0.4 1.6 0.3 3.0 2.1 0.0 10.6 69.0 0.0 3.5 10.2 0.0 2.3 7.0 0.0 0.1 0.0 13.9 0.0 0.3 27.0 0.0 8.7 8.1 1.0 10.5 9.2 18.3 1.2 0.0 6.8 1.3 0.0 0.4 0.0 2.1 5.0 1.8 11.2 0.0 17.5 10.5 0.0 4.3 0.1 0.0 2.2 0.1 1.1 59.8 1.6 0.7 9.8 7.8 FAM83H FLJ46072 ENSG00000180921 "Family with sequence similarity 83 member H" Q6ZRV2 8 143723933-143733801 "Disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.2;lymphoid tissue: 30.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 19.7;MCF7: 27.0;RT4: 16.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024505, HPA024604" Enhanced Approved Cytosol NA NA Cytosol "HPA024505: AB_1848417, HPA024604: AB_1848418" "unprognostic (3.80e-2)" "unprognostic (3.75e-3)" "unprognostic (6.87e-2)" "unprognostic (1.63e-2)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.93e-1)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (3.95e-2)" "unprognostic (9.69e-3)" "prognostic favorable (4.42e-4)" "unprognostic (5.54e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" 0.8 1.9 1.2 4.1 1.0 0.2 2.9 0.2 1.6 8.8 12.5 0.9 6.1 6.3 1.1 3.0 42.2 3.0 17.7 0.3 1.1 0.4 5.0 10.4 3.9 0.5 0.3 0.6 1.3 6.7 5.9 2.8 8.9 0.9 5.6 2.7 2.6 8.3 2.9 0.1 17.7 17.9 1.8 0.7 0.7 9.1 1.3 0.2 1.1 6.9 27.9 30.7 5.1 9.5 0.3 0.2 0.5 0.3 0.1 0.2 0.0 13.8 6.5 0.0 0.0 0.0 0.0 12.2 0.9 0.0 0.4 0.1 5.9 12.5 0.0 10.1 0.2 0.0 19.7 0.8 12.1 0.2 1.0 2.2 0.3 13.0 4.1 1.0 0.3 0.9 0.7 14.3 0.0 3.6 0.2 0.0 0.9 7.3 0.0 0.0 27.0 0.2 0.0 2.5 14.3 6.0 0.0 0.0 1.3 3.9 16.2 3.8 0.0 10.9 12.7 2.1 1.8 13.7 1.8 0.0 0.0 3.9 0.9 0.0 1.9 2.0 0.0 0.0 0.0 0.6 0.3 0.3 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 1.2 1.0 0.2 1.6 1.1 0.4 0.3 0.6 0.9 0.2 29.8 16.8 0.0 12.2 20.3 1.2 3.6 22.9 9.4 12.5 27.9 2.0 10.1 3.3 18.5 1.1 1.2 29.9 0.0 22.0 15.5 1.8 19.5 0.0 21.2 4.0 9.5 13.8 0.6 1.9 0.0 0.0 1.1 1.7 3.6 23.7 6.0 31.6 21.5 0.4 6.5 2.1 0.0 1.2 1.2 1.0 23.5 12.2 0.8 22.5 29.2 FARP1 "CDEP, MGC87400, PLEKHC2, PPP1R75" ENSG00000152767 "FERM, ARH/RhoGEF and pleckstrin domain protein 1" Q9Y4F1 13 98142562-98455176 "Predicted intracellular proteins" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 146.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.0;Hep G2: 38.9;SuSa: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000760 Approved Cytosol NA NA Cytosol "HPA000760: AB_1078816" "unprognostic (4.78e-3)" "unprognostic (1.65e-1)" "unprognostic (3.07e-1)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (2.30e-1)" "unprognostic (7.73e-2)" "unprognostic (6.91e-2)" "unprognostic (1.03e-1)" "unprognostic (6.09e-2)" "unprognostic (3.13e-1)" "unprognostic (1.08e-1)" "prognostic favorable (1.39e-5)" "unprognostic (4.89e-2)" "unprognostic (2.27e-1)" "unprognostic (2.18e-2)" "unprognostic (4.18e-2)" 10.4 16.5 21.3 9.1 14.6 1.4 28.3 4.6 19.0 18.3 22.9 11.2 16.0 6.5 16.5 26.2 5.9 15.4 15.1 10.7 16.0 13.1 43.4 38.4 29.3 9.2 11.7 20.0 11.0 32.7 14.1 17.5 22.2 17.2 23.9 10.6 16.8 27.2 21.9 14.0 8.0 8.0 18.8 19.7 9.5 17.2 8.1 10.6 1.5 28.7 3.9 3.6 17.7 18.7 2.2 0.1 0.3 0.2 0.0 0.8 0.2 0.2 3.2 14.6 20.6 4.2 8.3 7.1 22.0 14.4 12.4 11.0 25.3 9.8 0.0 8.5 38.0 3.0 0.4 6.1 6.0 21.0 0.3 6.3 0.1 11.4 38.9 11.3 0.0 0.1 9.7 2.7 3.6 0.8 7.2 8.1 0.3 0.0 0.2 8.5 5.5 0.8 0.1 6.9 12.2 3.8 7.6 5.7 0.4 27.5 14.2 6.2 13.6 2.7 5.8 15.6 36.2 8.3 0.0 7.8 13.5 5.2 9.1 11.1 0.2 0.2 0.1 6.2 0.4 9.3 0.3 0.1 0.0 0.3 0.2 0.0 2.2 0.8 0.6 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 21.3 14.6 4.6 19.0 16.0 13.1 11.7 20.0 17.2 10.6 41.7 19.0 0.0 50.6 6.2 10.5 7.3 86.6 34.8 33.0 54.1 43.2 5.7 68.0 39.8 146.6 12.9 5.1 0.0 30.5 4.8 23.7 58.1 12.7 60.4 41.7 28.6 29.9 24.5 15.8 95.9 17.5 9.1 27.0 29.7 8.4 34.6 40.5 2.9 27.6 120.7 16.8 19.4 27.7 5.4 7.7 2.5 3.8 2.9 13.2 39.6 FARP2 "FIR, FRG, KIAA0793, PLEKHC3" ENSG00000006607 "FERM, ARH/RhoGEF and pleckstrin domain protein 2" O94887 2 241356243-241494841 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031226, HPA055592" Approved Approved Cytosol NA NA Cytosol "HPA031226: AB_10602808, HPA055592: AB_2682856" "unprognostic (3.07e-1)" "unprognostic (1.39e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-2)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (2.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (9.11e-2)" "unprognostic (6.31e-2)" "unprognostic (6.78e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-1)" 10.2 11.2 11.2 17.6 15.3 5.5 10.1 28.4 16.5 9.9 24.5 24.0 17.3 22.2 16.4 9.3 16.0 10.8 14.4 8.4 12.3 11.5 11.4 16.1 11.1 12.2 18.3 9.7 12.8 12.9 16.0 10.2 10.1 19.5 10.9 24.4 19.7 10.1 20.1 10.5 22.6 26.1 13.3 15.7 12.1 22.6 27.0 15.2 6.1 7.8 8.2 18.2 13.9 10.6 7.1 8.2 9.2 6.7 2.0 2.5 1.9 10.2 7.4 13.8 9.3 11.9 15.9 12.3 10.2 8.5 10.6 11.1 7.8 12.3 4.3 2.8 20.0 7.5 11.7 18.2 10.7 16.3 6.8 9.5 9.6 13.3 10.3 8.7 8.6 7.5 15.9 8.0 15.5 12.7 5.0 9.6 8.4 10.8 4.0 8.5 8.6 9.2 6.3 6.8 18.1 5.9 10.3 30.9 13.0 13.8 21.1 16.3 10.9 11.5 8.2 31.2 8.3 4.3 8.7 14.4 10.2 7.8 12.6 8.3 6.9 4.9 9.7 9.2 6.0 20.5 5.4 2.6 9.2 1.8 6.7 1.6 6.1 1.9 2.1 3.9 7.1 1.3 1.4 1.6 2.0 3.5 8.2 2.5 1.9 11.2 15.3 28.4 16.5 12.3 11.5 18.3 9.7 19.5 15.2 26.8 5.1 5.7 7.5 13.7 11.8 27.7 10.2 17.4 12.5 17.4 17.7 4.8 3.3 7.2 34.8 7.1 20.1 0.0 10.6 4.7 8.7 9.2 5.8 9.4 3.8 19.1 26.9 11.6 6.5 17.0 13.8 9.1 37.1 9.0 35.1 6.7 11.4 22.9 9.9 6.1 15.2 19.4 12.0 39.2 17.2 13.2 9.3 5.3 23.7 22.7 FARSA "CML33, FARSL, FARSLA" ENSG00000179115 "Phenylalanyl-tRNA synthetase alpha subunit" Q9Y285 19 12922479-12934037 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001911 Enhanced Approved Cytosol NA NA 11000 Cytosol "HPA001911: AB_1848427" "unprognostic (1.52e-1)" "prognostic favorable (8.23e-4)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.22e-4)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (4.93e-3)" "unprognostic (5.76e-2)" "unprognostic (2.86e-1)" "unprognostic (1.24e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-2)" "unprognostic (1.45e-3)" "prognostic favorable (8.32e-4)" "unprognostic (2.59e-1)" "unprognostic (8.25e-2)" "unprognostic (1.84e-2)" 18.0 20.7 24.8 23.6 29.5 23.5 15.4 24.6 49.2 17.7 24.0 18.3 14.9 22.1 16.1 13.1 26.6 21.2 16.3 24.9 23.9 30.1 23.0 39.6 13.4 27.6 25.6 28.1 19.1 26.7 17.8 21.0 22.9 29.1 18.5 15.0 14.8 25.1 20.4 33.3 27.8 18.8 15.3 17.2 21.2 18.9 17.1 18.6 32.7 24.4 15.2 22.0 19.5 15.2 34.7 42.2 28.9 41.2 38.3 40.2 39.7 29.1 27.6 11.1 23.9 7.7 7.3 20.0 21.0 13.6 30.1 23.7 33.8 12.4 32.3 33.8 11.8 12.2 22.4 27.0 24.0 11.0 18.9 40.7 25.3 24.3 26.7 25.0 48.8 33.4 10.0 17.7 23.2 18.7 9.9 16.3 32.9 38.2 6.8 12.6 39.2 57.9 60.7 34.6 18.1 46.9 30.0 11.5 41.4 15.8 17.2 34.8 31.9 14.1 24.4 14.9 5.4 19.2 29.7 15.6 24.5 10.8 37.2 39.0 45.2 38.5 33.6 22.2 44.1 25.3 17.3 39.2 28.9 32.5 41.2 40.2 31.9 32.0 30.2 42.2 34.7 32.9 31.2 2.5 38.3 30.4 34.1 29.4 39.7 24.8 29.5 24.6 49.2 23.9 30.1 25.6 28.1 29.1 18.6 8.9 21.3 25.9 20.3 22.6 23.5 22.1 2.5 13.4 13.6 22.7 9.8 74.5 49.7 50.2 3.9 18.0 20.6 23.3 40.4 65.4 18.4 19.3 23.1 22.9 56.1 17.5 21.9 17.2 26.9 7.5 17.5 19.2 32.1 52.3 22.0 19.4 40.6 24.6 12.4 43.4 13.0 6.5 20.6 14.6 41.5 25.7 80.9 27.7 31.6 19.5 FAT4 "CDHF14, CDHR11, FAT-J" ENSG00000196159 "FAT atypical cadherin 4" Q6V0I7 4 125316399-125492932 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Endothelial cells: 11.1;Fibroblasts: 9.3;Ito cells: 30.7" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 12 "NK-cells: 1.1" "Cell line enhanced" "Detected in many" "ASC diff: 12.3;ASC TERT1: 9.1;fHDF/TERT166: 8.9;HSkMC: 10.5;HUVEC TERT2: 11.1;TIME: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052819 Approved Approved Cytosol NA NA 7900000 Cytosol "HPA052819: AB_2681963" "unprognostic (1.18e-1)" "unprognostic (1.77e-1)" "unprognostic (7.99e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (2.81e-4)" "unprognostic (6.17e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (2.78e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.89e-4)" "unprognostic (2.38e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-3)" 3.8 0.5 0.9 0.8 0.7 0.0 3.2 0.0 0.5 4.4 7.1 0.3 2.7 0.6 1.9 2.1 4.1 5.0 1.0 0.4 2.6 2.0 5.3 0.1 0.9 5.3 0.5 6.7 0.4 2.5 3.6 1.9 1.0 2.3 1.1 1.4 2.4 3.3 0.6 2.1 2.4 0.1 3.9 0.2 3.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 6.0 0.6 12.3 9.1 0.0 2.0 2.4 1.0 1.0 0.0 0.3 0.0 2.5 8.9 1.2 0.0 2.2 2.5 0.6 0.0 1.0 1.3 2.5 0.0 4.0 0.8 0.0 10.5 1.4 0.5 5.5 7.2 11.1 0.0 0.0 1.6 5.0 0.1 0.4 0.0 0.4 0.0 0.2 0.7 1.2 0.0 0.1 0.0 0.1 1.2 0.3 0.0 0.0 0.3 0.0 0.0 17.3 6.1 1.7 2.1 0.9 0.2 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.1 1.4 1.3 5.3 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.7 0.8 11.1 0.0 0.0 0.2 0.0 9.3 0.1 0.0 6.8 0.2 0.0 0.0 30.7 2.4 0.0 5.5 0.0 3.3 0.0 0.0 1.2 0.2 0.0 4.6 0.6 0.1 0.0 3.9 0.0 0.6 0.5 0.0 0.0 0.0 0.0 FBN1 "FBN, MASS, MFS1, OCTD, SGS, WMS" ENSG00000166147 "Fibrillin 1" P35555 15 48408306-48645849 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hormone" "Aortic aneurysm, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 69.8" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 91.8;Fibroblasts: 78.5;Leydig cells: 218.7;Peritubular cells: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 36.9;ASC TERT1: 79.9;fHDF/TERT166: 68.5;HSkMC: 43.2;hTERT-RPE1: 35.7;U-138 MG: 35.1;U-2197: 51.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002670, HPA017759, HPA021057, CAB058696, CAB068188" Enhanced Approved Cytosol "Secreted to blood" NA NA 540000000 Cytosol "CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586" "unprognostic (3.97e-2)" "unprognostic (1.55e-2)" "unprognostic (2.40e-2)" "unprognostic (9.50e-2)" "unprognostic (1.51e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-2)" "unprognostic (4.79e-2)" "unprognostic (7.82e-2)" "unprognostic (1.50e-2)" "unprognostic (2.78e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (7.44e-5)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.25e-2)" "unprognostic (8.69e-3)" "prognostic unfavorable (5.11e-4)" 34.2 5.4 2.1 7.8 2.7 1.8 10.9 1.0 2.8 24.6 11.1 3.5 10.7 2.2 18.4 25.6 22.1 12.1 15.5 24.3 2.5 2.3 2.9 1.9 10.7 5.8 2.8 2.6 20.4 2.5 2.6 3.3 69.8 3.1 11.8 6.9 13.4 5.7 7.8 15.4 6.6 6.9 21.5 3.8 11.3 7.2 13.6 1.6 1.9 17.9 16.3 4.9 22.8 11.2 0.8 0.8 1.8 0.6 1.1 0.6 0.2 0.0 0.8 3.3 3.7 36.9 79.9 0.0 28.8 10.4 8.6 5.5 0.0 0.0 0.0 1.3 68.5 0.0 0.1 0.6 0.1 7.8 3.3 0.2 0.3 14.7 0.0 20.8 0.1 0.0 43.2 0.0 22.7 2.6 35.7 9.2 0.2 0.0 0.0 9.2 0.0 0.2 0.0 0.6 0.0 1.1 0.0 2.8 0.0 1.0 0.0 0.0 2.1 0.0 0.3 0.0 2.7 0.0 0.2 17.4 35.1 1.0 51.0 6.0 0.2 0.1 0.0 23.5 0.0 2.3 1.1 0.5 0.7 0.5 0.3 0.4 0.5 0.4 0.4 0.2 0.8 0.5 0.6 1.8 1.1 0.6 0.8 0.3 0.2 2.1 2.7 1.0 2.8 2.5 2.3 2.8 2.6 3.1 1.6 0.0 2.2 0.0 1.1 22.8 4.5 9.3 0.0 5.3 10.3 12.2 0.0 91.8 0.0 0.2 6.3 21.7 0.0 0.0 0.5 16.3 78.5 0.5 1.1 0.6 13.5 0.0 0.0 38.1 1.0 15.7 218.7 4.4 40.5 3.6 0.0 0.5 2.0 0.0 213.6 0.6 0.1 25.8 44.7 3.0 2.1 18.1 55.0 0.0 0.0 0.1 FBXO45 Fbx45 ENSG00000174013 "F-box protein 45" P0C2W1 3 196568611-196589059 "Predicted intracellular proteins" "Neurogenesis, Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040730 Uncertain Approved Cytosol NA NA Cytosol "HPA040730: AB_10959311" "unprognostic (7.17e-3)" "unprognostic (1.14e-1)" "unprognostic (8.37e-2)" "unprognostic (1.01e-2)" "unprognostic (8.14e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.61e-5)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.13e-2)" "unprognostic (9.48e-3)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.16e-5)" "prognostic unfavorable (4.93e-5)" "unprognostic (5.18e-2)" "unprognostic (1.66e-1)" "unprognostic (6.93e-2)" "unprognostic (1.65e-1)" 6.3 5.6 15.6 7.2 15.0 14.6 9.4 19.0 19.4 6.2 8.4 12.5 4.0 6.6 6.2 4.0 11.5 4.8 5.7 4.5 15.5 12.0 4.9 8.4 5.6 7.7 13.5 11.1 6.7 6.7 13.7 7.8 6.7 11.8 6.6 9.1 3.5 5.9 5.8 15.3 15.8 6.2 6.3 14.9 6.0 6.8 14.4 13.3 6.7 4.7 7.7 12.0 7.3 11.4 2.0 4.4 3.8 3.3 1.6 4.8 1.2 19.9 3.8 8.1 10.2 5.4 5.4 9.6 8.9 4.1 7.0 7.3 10.6 6.8 8.4 15.4 5.7 10.5 8.6 15.4 10.1 13.1 12.2 6.9 15.4 7.0 6.6 5.2 20.5 7.9 2.7 11.5 8.0 14.8 3.7 7.7 13.8 18.4 18.0 7.8 20.0 11.9 9.6 12.6 17.9 14.8 10.2 10.6 20.4 5.9 8.2 16.5 11.3 9.6 16.8 10.2 7.4 28.9 13.8 7.6 8.2 8.9 11.8 23.9 17.7 29.5 23.7 7.1 26.6 7.8 3.8 3.1 3.1 2.8 2.9 4.6 1.8 2.8 1.6 3.7 2.0 2.6 3.0 1.2 1.6 3.3 4.4 4.8 1.2 15.6 15.0 19.0 19.4 15.5 12.0 13.5 11.1 11.8 13.3 11.9 2.6 9.3 5.6 8.8 18.5 9.0 2.5 6.7 2.3 3.5 13.7 2.2 0.0 4.2 11.6 5.2 4.6 0.0 6.4 3.8 3.8 11.6 1.1 7.9 5.0 12.7 16.7 6.2 11.1 12.9 5.2 6.5 5.0 2.8 7.9 7.7 6.2 3.5 6.0 2.7 9.8 0.0 5.6 26.8 24.3 11.8 1.6 4.5 7.4 15.6 FBXW8 "FBW6, FBW8, FBX29, FBXO29" ENSG00000174989 "F-box and WD repeat domain containing 8" Q8N3Y1 12 116910956-117031148 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 45.5;Late spermatids: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038850, HPA038851" Supported Supported Cytosol NA NA Cytosol "HPA038850: AB_2676238, HPA038851: AB_10673479" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (9.03e-2)" "unprognostic (1.48e-2)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (3.35e-2)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "unprognostic (4.30e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (6.20e-2)" "unprognostic (6.34e-2)" "unprognostic (2.55e-1)" 10.5 10.6 8.5 16.2 9.5 5.6 10.4 8.2 9.5 13.1 9.0 12.3 14.7 6.2 16.4 14.1 9.5 11.5 15.5 8.9 6.8 6.6 8.1 8.8 9.2 9.3 6.8 6.2 15.5 18.4 17.3 21.5 16.7 8.2 10.4 8.9 11.7 18.4 11.8 8.6 11.3 8.7 11.0 7.5 9.0 11.1 12.4 7.3 11.3 17.4 7.9 13.8 10.6 10.3 5.3 2.2 3.9 1.9 6.8 3.0 1.5 5.9 10.8 9.4 6.8 8.9 12.8 6.1 12.7 11.5 7.9 7.9 3.5 3.9 9.4 4.5 13.8 4.4 6.3 6.5 3.8 6.6 14.8 5.6 4.6 4.5 3.3 14.2 5.7 3.7 11.9 3.6 7.4 16.3 12.3 8.9 7.9 5.9 4.0 7.5 14.2 4.2 4.0 10.9 2.7 6.9 7.1 4.4 8.0 6.0 9.7 8.7 24.8 8.3 2.6 5.1 8.1 10.5 4.9 11.6 7.0 3.4 7.8 3.6 15.4 8.9 8.5 10.9 3.7 11.5 0.3 1.6 3.9 3.0 1.6 2.7 5.3 1.6 1.9 2.2 4.4 1.1 1.9 0.2 6.8 1.9 2.2 2.4 1.5 8.5 9.5 8.2 9.5 6.8 6.6 6.8 6.2 8.2 7.3 0.0 5.4 2.2 2.5 1.6 9.2 2.6 0.0 5.3 7.9 1.8 23.6 7.9 1.7 3.6 45.5 2.9 1.0 0.0 3.9 5.0 3.0 2.5 2.3 2.4 3.7 1.6 8.7 0.6 2.2 65.4 8.6 2.6 0.0 1.0 3.9 4.7 2.3 3.5 4.9 1.6 14.0 0.0 3.1 4.4 5.6 1.3 5.6 2.2 3.7 3.0 FBXW9 "Fbw9, MGC10870" ENSG00000132004 "F-box and WD repeat domain containing 9" Q5XUX1 19 12688053-12696643 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042087 Approved Approved Cytosol NA NA Cytosol "HPA042087: AB_10794168" "unprognostic (4.46e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-2)" "unprognostic (1.65e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-3)" "unprognostic (4.69e-3)" "unprognostic (4.91e-2)" "unprognostic (2.97e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (2.71e-2)" "unprognostic (4.02e-2)" "unprognostic (6.08e-3)" "unprognostic (8.04e-2)" "unprognostic (2.61e-1)" "unprognostic (8.42e-3)" 4.0 8.3 5.6 5.1 7.7 6.2 6.8 6.3 10.8 7.1 5.7 4.2 6.5 7.6 5.4 11.0 10.3 22.6 8.6 3.4 6.0 6.6 8.3 5.4 9.4 4.8 3.7 7.2 6.3 7.4 4.6 7.0 4.5 7.0 6.8 3.3 5.4 12.0 6.7 2.5 10.2 5.3 3.2 2.5 3.8 6.1 30.4 4.9 7.3 9.0 10.6 5.9 4.8 5.6 3.3 12.0 0.4 8.2 4.6 6.1 5.3 11.2 7.7 5.1 7.4 2.2 3.8 6.2 3.7 3.8 7.9 6.5 4.2 7.0 2.8 9.7 3.3 1.9 10.3 4.9 7.0 1.4 2.0 13.0 3.3 8.7 7.0 5.1 8.4 2.0 5.1 11.3 5.5 2.7 4.8 6.2 6.6 8.0 1.9 1.8 23.5 9.0 10.9 8.6 6.0 7.3 4.8 3.5 15.8 7.0 3.4 11.8 14.0 5.5 11.7 5.1 1.7 11.6 6.3 3.0 4.7 4.4 5.7 5.8 11.7 4.9 3.0 5.8 3.1 3.0 0.0 8.2 0.0 3.2 7.8 5.3 3.3 3.5 2.4 12.0 3.2 3.3 2.3 0.4 4.6 5.1 3.4 6.1 5.3 5.6 7.7 6.3 10.8 6.0 6.6 3.7 7.2 7.0 4.9 3.0 4.8 0.0 4.5 5.4 2.2 0.8 5.1 50.9 10.3 1.8 5.9 12.6 5.0 12.5 3.9 3.6 3.6 0.0 13.9 6.5 4.7 2.7 0.0 3.2 6.1 0.0 4.6 6.7 5.0 7.4 2.3 3.3 3.3 3.6 8.1 4.7 8.9 3.5 4.2 12.4 5.7 6.5 2.2 25.0 15.7 7.2 5.4 3.5 11.1 4.3 FCRLB "FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2" ENSG00000162746 "Fc receptor like B" Q6BAA4 1 161721563-161728143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.9;lymphoid tissue: 5.0" "Cell type enhanced" "Detected in many" 8 "Ito cells: 6.7;Proximal tubular cells: 10.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 7.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "basophil: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.1;Daudi: 7.4;fHDF/TERT166: 10.9;HMC-1: 9.4;PC-3: 5.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB026139 Uncertain Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB026139: " "unprognostic (1.87e-1)" "unprognostic (1.20e-4)" "unprognostic (5.77e-3)" "unprognostic (7.49e-3)" "unprognostic (1.73e-3)" "unprognostic (2.95e-1)" "unprognostic (2.98e-2)" "unprognostic (1.18e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.27e-1)" "unprognostic (9.92e-3)" "unprognostic (3.14e-2)" 0.5 0.2 0.2 3.4 0.3 0.0 0.3 1.0 0.8 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.2 1.4 0.6 0.3 2.4 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 1.2 0.0 0.2 0.7 2.7 0.2 0.3 0.8 0.2 0.4 1.5 0.2 0.2 0.2 0.2 0.3 0.2 5.0 0.8 0.2 4.9 0.6 8.9 0.2 5.3 2.7 0.6 0.7 0.1 0.0 0.3 0.5 0.8 0.0 4.6 6.1 1.5 1.5 0.1 0.2 7.4 0.2 10.9 0.3 0.1 0.2 0.4 4.0 0.1 0.3 0.2 0.1 0.2 0.2 0.0 9.4 1.4 0.0 2.7 0.2 0.5 1.3 0.0 0.4 0.3 0.2 0.4 0.0 2.6 0.2 0.0 5.5 0.0 0.5 0.3 0.2 0.2 0.0 0.0 0.0 0.2 2.3 0.3 0.0 0.0 0.8 1.6 0.7 1.7 0.8 0.0 0.0 2.9 3.3 0.4 0.8 8.9 0.1 2.4 2.7 0.1 1.0 4.6 1.6 1.5 0.6 4.9 0.8 1.2 1.5 5.3 0.2 0.0 0.0 0.6 0.2 0.3 1.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 2.2 1.0 1.0 0.0 1.6 0.0 0.0 0.0 3.5 0.0 1.8 5.0 1.1 0.1 1.1 0.0 0.0 1.0 4.6 0.7 0.4 0.0 0.8 1.3 0.0 1.2 6.7 2.4 0.0 0.0 2.3 1.7 0.0 0.0 3.1 0.9 0.0 0.4 10.5 0.4 0.0 1.4 2.7 1.2 0.4 0.7 2.2 0.0 0.7 FER "PPP1R74, TYK3" ENSG00000151422 "FER tyrosine kinase" P16591 5 108747822-109196841 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 123.9;granulocytes: 91.4;Late spermatids: 142.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "RPMI-8226: 45.1" "Low region specificity" "Detected in all" "HPA007641, CAB022464" Approved Supported Cytosol NA NA Cytosol "CAB022464: , HPA007641: AB_1078845" "unprognostic (1.72e-1)" "unprognostic (1.66e-2)" "unprognostic (1.74e-1)" "unprognostic (2.46e-3)" "unprognostic (4.72e-2)" "unprognostic (5.65e-2)" "unprognostic (6.81e-2)" "unprognostic (7.39e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-3)" "unprognostic (7.36e-2)" "unprognostic (8.05e-2)" "prognostic favorable (5.55e-4)" "unprognostic (3.83e-3)" "unprognostic (3.22e-1)" "unprognostic (1.03e-1)" "unprognostic (3.99e-3)" 13.4 5.7 5.5 6.1 13.4 1.8 5.2 6.0 5.0 9.7 6.7 1.4 16.8 2.5 6.5 19.3 8.2 4.6 5.3 4.6 4.8 4.8 7.2 3.6 12.2 1.9 4.9 2.2 7.2 3.0 18.5 15.9 5.7 3.1 6.8 3.6 5.0 4.5 21.9 5.0 6.6 3.5 7.2 6.2 8.1 4.1 15.9 2.6 3.9 10.2 12.8 2.8 7.7 9.0 10.5 5.4 8.0 5.1 1.2 2.8 1.1 4.7 1.6 5.8 9.2 3.5 5.4 3.7 5.7 5.6 3.4 4.0 9.7 2.9 7.6 3.6 6.9 4.3 3.4 3.1 7.2 7.6 3.2 4.2 5.1 7.4 3.5 2.3 2.7 4.3 3.2 4.0 8.1 9.2 3.4 5.0 7.4 6.3 5.7 4.3 1.3 2.1 0.8 0.8 0.4 3.4 1.7 5.6 45.1 3.3 1.6 1.9 2.8 9.4 0.5 6.1 3.8 2.2 1.2 7.3 6.5 5.0 3.3 4.5 4.8 7.2 3.0 4.1 0.9 3.0 8.0 5.1 5.4 1.7 3.1 2.8 10.5 1.0 1.8 2.8 3.8 1.6 2.0 0.4 1.2 2.4 5.4 2.1 1.1 5.5 13.4 6.0 4.2 4.8 4.8 4.9 2.2 3.1 2.6 74.5 27.0 2.4 9.8 26.0 16.3 18.6 12.7 40.2 33.0 14.0 17.7 3.0 1.7 11.7 123.9 13.3 3.2 0.0 5.2 8.9 10.4 8.2 91.4 1.6 6.8 17.5 8.1 22.1 10.5 142.5 17.8 10.6 13.5 12.6 3.7 10.9 7.7 3.6 16.6 5.4 16.6 6.5 9.9 4.3 9.1 15.4 2.6 9.2 3.8 4.9 FGF13 "FGF2, FHF2" ENSG00000129682 "Fibroblast growth factor 13" Q92913 X 138614731-139222777 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.7;parathyroid gland: 44.3;skeletal muscle: 37.0" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 22.0;Leydig cells: 24.2;Muller glia cells: 40.7;Peritubular cells: 23.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 7.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.4" "Cell line enhanced" "Detected in many" "AF22: 19.8;fHDF/TERT166: 17.1;HAP1: 18.1;RPMI-8226: 15.4;U-2197: 31.9;WM-115: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002809 Supported Cytosol NA NA Cytosol "HPA002809: AB_1078855" "unprognostic (3.23e-1)" "unprognostic (3.13e-2)" "unprognostic (5.42e-2)" "unprognostic (1.42e-2)" "unprognostic (1.87e-1)" "unprognostic (2.87e-3)" "unprognostic (9.92e-3)" "unprognostic (2.97e-3)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (5.22e-3)" "unprognostic (6.79e-2)" "unprognostic (4.96e-4)" "unprognostic (4.36e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" "unprognostic (7.48e-2)" 11.1 1.9 30.0 1.9 29.5 2.7 4.2 0.9 22.9 7.9 3.1 1.5 2.4 2.7 7.0 2.8 4.4 2.6 4.1 1.3 36.7 22.3 4.9 1.4 1.7 3.1 19.7 12.9 6.0 0.9 44.3 2.4 8.4 7.8 11.6 3.3 4.8 6.5 3.5 37.0 1.1 3.1 4.5 3.3 3.8 2.9 2.7 4.1 0.0 3.6 7.9 1.6 3.5 5.7 0.5 0.9 7.4 0.5 0.2 0.3 0.1 0.0 0.2 19.8 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 17.1 0.1 1.2 18.1 0.0 0.0 0.2 5.0 0.1 0.1 0.7 0.7 0.1 0.2 0.3 0.4 0.0 0.0 0.1 0.0 1.1 0.7 5.7 2.0 0.1 0.0 0.1 2.0 0.0 6.5 2.9 1.3 15.4 2.9 0.1 0.1 0.0 0.0 0.1 12.1 10.2 0.0 0.1 0.4 0.6 0.9 31.9 8.4 7.5 4.2 0.0 7.1 5.7 17.1 2.7 0.5 1.6 0.2 0.3 0.1 0.5 0.2 0.1 0.1 0.4 0.3 0.2 7.4 0.2 0.5 0.9 0.2 0.1 30.0 29.5 0.9 22.9 36.7 22.3 19.7 12.9 7.8 4.1 0.0 0.0 0.0 3.1 0.3 3.1 1.6 12.7 2.7 4.5 7.0 0.0 0.2 14.9 3.2 0.0 1.9 0.0 0.0 4.8 0.2 2.7 15.0 0.0 0.0 22.0 0.0 2.4 1.3 2.5 0.2 24.2 0.7 1.7 1.0 0.5 40.7 5.7 5.8 23.0 2.5 4.5 32.3 11.8 0.0 1.3 0.6 0.1 0.0 0.1 0.6 FHOD1 FHOS ENSG00000135723 "Formin homology 2 domain containing 1" Q9Y613 16 67229387-67247658 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.0;skeletal muscle: 61.1" "Cell type enhanced" "Detected in many" 5 "granulocytes: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024468 Approved Supported Cytosol NA NA 2500000 Cytosol "HPA024468: AB_1848568" "unprognostic (6.53e-3)" "prognostic unfavorable (9.57e-4)" "unprognostic (5.42e-2)" "unprognostic (2.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.18e-2)" "unprognostic (1.62e-1)" "unprognostic (1.81e-1)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.27e-2)" "prognostic unfavorable (1.90e-8)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-3)" "unprognostic (4.70e-2)" 8.3 7.5 2.5 5.1 4.4 2.9 7.9 4.7 2.8 4.2 5.3 2.5 3.8 3.3 3.9 4.7 2.5 3.4 5.6 3.7 2.3 1.3 4.8 2.3 12.5 4.4 4.0 0.7 12.9 3.4 2.5 2.5 5.8 4.2 4.2 2.6 4.0 5.7 4.0 61.1 2.5 3.9 3.5 5.6 38.0 2.9 2.2 3.0 2.7 8.2 11.1 5.8 2.6 3.5 0.5 2.0 2.2 3.0 1.3 1.4 2.1 4.4 12.1 4.5 3.6 18.4 11.1 15.3 9.3 7.8 10.7 10.4 8.3 5.8 5.3 6.8 6.8 3.4 5.4 5.2 7.6 5.3 4.1 8.4 23.6 4.7 9.0 4.9 9.7 43.3 13.7 1.0 16.5 1.5 9.3 16.6 7.4 12.1 3.3 6.7 15.2 6.5 17.4 6.8 4.1 3.8 7.5 10.2 12.5 3.3 1.8 1.4 7.5 14.7 8.5 8.5 4.7 9.0 7.7 19.3 14.6 8.5 8.9 7.5 11.2 11.5 7.7 30.0 9.2 13.3 1.5 3.0 0.5 1.1 1.2 1.4 0.1 1.3 1.0 2.0 0.5 0.8 0.6 2.2 1.3 1.0 1.2 1.2 2.1 2.5 4.4 4.7 2.8 2.3 1.3 4.0 0.7 4.2 3.0 11.9 22.9 5.2 1.5 5.0 1.0 10.9 10.2 4.0 7.9 5.2 7.9 7.5 0.0 2.8 0.7 15.0 6.7 0.0 5.1 4.0 10.5 2.8 40.3 0.8 16.0 1.6 8.7 28.8 21.7 1.1 9.8 15.8 3.3 16.2 13.9 2.9 5.7 2.9 10.3 1.0 0.8 25.8 15.0 1.5 2.7 3.1 1.6 12.9 14.4 1.0 FKBP3 "FKBP-25, PPIase" ENSG00000100442 "FK506 binding protein 3" Q00688 14 45115600-45135319 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000864, CAB012232, CAB012520" Supported Supported Cytosol NA NA 980000 Cytosol "CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873" "unprognostic (7.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (9.72e-2)" "unprognostic (1.25e-1)" "unprognostic (9.82e-3)" "unprognostic (3.58e-3)" "unprognostic (2.28e-1)" "unprognostic (5.04e-3)" "unprognostic (1.22e-3)" "unprognostic (7.47e-2)" "unprognostic (6.92e-3)" "unprognostic (1.00e-1)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" 11.7 13.2 28.1 10.2 40.7 9.8 15.5 25.1 32.1 12.0 14.6 11.4 8.3 13.2 9.9 20.4 14.6 8.8 9.1 31.3 26.0 24.4 16.5 20.5 8.0 14.6 23.2 23.8 9.9 10.9 15.0 17.1 14.0 22.9 17.9 15.2 6.6 10.7 12.2 113.3 11.3 13.9 12.8 19.6 9.9 10.6 13.5 22.4 12.7 12.4 24.2 16.5 12.7 9.3 19.5 27.5 13.5 17.4 15.4 19.4 13.0 37.3 41.6 60.6 31.9 27.0 29.4 23.9 23.0 26.4 36.3 40.1 36.3 32.1 19.9 24.3 25.9 20.6 31.1 45.0 29.6 51.9 28.7 26.8 16.4 32.3 46.9 26.6 28.2 17.7 27.7 30.9 21.1 19.7 33.6 47.3 31.7 23.6 15.1 43.1 45.6 45.3 37.9 30.7 41.9 39.5 43.6 44.7 24.2 58.1 43.2 37.0 14.5 36.8 22.9 35.2 47.7 53.6 21.2 30.4 27.8 48.1 14.5 17.6 25.4 45.1 31.0 16.8 19.5 25.9 11.6 14.6 13.5 13.0 17.2 15.7 19.5 17.5 17.6 21.8 13.6 16.8 18.8 2.3 15.4 17.4 27.5 19.4 13.0 28.1 40.7 25.1 32.1 26.0 24.4 23.2 23.8 22.9 22.4 38.7 36.9 49.1 82.5 42.5 68.8 177.9 45.9 77.6 69.4 89.0 9.8 264.9 213.9 116.4 165.9 49.2 61.3 0.0 64.1 95.4 67.9 74.9 51.0 84.7 113.7 38.1 53.9 39.3 36.8 297.6 74.8 68.0 65.8 155.9 63.2 57.4 80.6 52.6 91.9 168.1 44.8 103.5 53.3 145.7 112.4 41.9 138.0 47.9 83.1 70.8 FMNL1 "C17orf1, C17orf1B, FMNL" ENSG00000184922 "Formin like 1" O95466 17 45221444-45247320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 107.4;lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 52.5;Kupffer cells: 54.4;Macrophages: 116.9;monocytes: 95.6;T-cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 50.4;MOLT-4: 34.6;U-266/70: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008129, HPA028288" Enhanced Approved Cytosol NA NA Cytosol "HPA008129: AB_1848963, HPA028288: AB_10612110" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (8.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.24e-2)" "unprognostic (2.01e-1)" "unprognostic (1.58e-1)" "unprognostic (5.44e-2)" "unprognostic (6.06e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "prognostic unfavorable (4.23e-8)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (3.46e-2)" "unprognostic (2.16e-1)" 8.6 3.8 10.7 29.7 9.6 107.4 7.5 8.1 16.1 4.6 5.2 4.2 0.8 5.8 2.6 5.8 4.5 6.1 9.1 5.8 13.4 6.0 4.2 3.6 22.2 38.1 6.1 6.4 3.1 3.6 3.6 7.4 7.4 7.2 4.3 4.1 3.3 8.4 2.3 2.5 4.2 14.9 4.3 6.2 45.9 6.6 2.7 3.3 56.6 3.9 4.1 22.8 11.3 4.6 3.5 4.3 22.3 5.6 5.4 7.6 3.5 4.2 8.3 0.0 0.4 0.0 1.9 0.4 0.5 1.1 3.1 2.3 0.4 1.9 13.1 4.3 0.1 3.3 0.7 0.0 0.1 1.0 22.9 1.1 7.6 12.3 0.6 8.9 19.7 26.8 1.4 0.3 4.1 1.8 4.3 0.0 14.6 0.6 50.4 2.3 2.7 34.6 20.4 0.4 0.5 0.2 21.9 2.9 23.4 0.8 0.5 2.6 1.2 2.5 0.4 1.0 0.7 2.4 16.1 1.0 0.2 3.0 0.5 18.5 42.1 18.5 13.4 0.3 16.1 0.6 6.8 5.1 8.2 7.0 5.6 4.7 3.5 5.5 7.6 4.3 3.3 3.6 4.8 22.3 5.4 4.2 2.5 6.0 3.5 10.7 9.6 8.1 16.1 13.4 6.0 6.1 6.4 7.2 3.3 3.0 4.8 52.5 2.8 5.5 4.0 1.9 2.5 1.4 1.2 1.8 0.0 0.4 0.0 1.1 2.0 2.9 0.0 0.0 0.8 1.0 10.7 1.9 23.0 0.5 43.3 3.2 1.2 8.6 54.4 0.7 4.9 116.9 42.2 95.6 0.1 0.9 0.4 0.0 0.0 0.6 1.2 6.5 3.8 0.5 1.7 5.4 2.1 97.0 0.2 1.4 FMR1 "FMRP, FRAXA, MGC87458, POF, POF1" ENSG00000102081 "Fragile X mental retardation 1" Q06787 X 147911951-147951125 "Disease related genes, Predicted intracellular proteins" "DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Disease mutation, Mental retardation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012444, HPA050118, HPA056084" Approved Enhanced Cytosol NA NA Cytosol "CAB012444: AB_732400, HPA050118: AB_2681023, HPA056084: AB_2683033" "unprognostic (4.11e-1)" "unprognostic (1.25e-3)" "unprognostic (1.89e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (6.45e-3)" "unprognostic (2.59e-2)" "unprognostic (1.26e-2)" "unprognostic (2.29e-2)" "unprognostic (3.30e-2)" "unprognostic (3.15e-3)" "unprognostic (6.56e-2)" "unprognostic (2.24e-1)" "unprognostic (1.55e-1)" "unprognostic (5.98e-2)" 14.9 13.3 24.8 14.9 21.1 28.3 14.3 32.6 25.7 16.0 14.5 17.7 14.4 13.3 21.2 33.2 13.9 18.3 12.3 15.0 22.2 19.0 26.5 30.3 15.3 15.7 23.3 22.8 23.4 11.5 27.8 20.5 49.9 18.9 15.4 15.0 14.0 12.7 19.6 7.8 17.7 15.9 18.3 23.1 20.1 13.2 14.5 19.2 21.7 29.0 9.8 16.1 17.1 27.3 5.3 3.4 7.3 3.5 4.9 7.4 2.4 15.0 13.5 14.1 9.5 8.7 7.0 11.3 8.2 8.6 13.1 23.8 14.9 14.3 30.1 33.9 10.1 15.3 26.1 22.5 10.1 14.7 11.8 15.7 8.5 25.2 13.9 9.0 9.3 5.3 7.6 5.8 11.1 10.4 8.0 10.9 8.3 5.2 20.0 11.7 19.6 10.5 6.9 6.3 10.5 7.7 11.8 40.5 12.7 15.3 40.5 12.5 8.1 9.4 8.6 12.1 20.4 7.6 8.5 10.4 10.7 9.2 13.1 20.4 21.5 21.4 32.4 9.7 16.1 5.6 2.8 2.7 6.6 6.0 3.5 7.4 4.7 3.9 6.6 3.4 5.3 5.0 5.8 7.3 4.9 3.2 2.8 4.7 2.4 24.8 21.1 32.6 25.7 22.2 19.0 23.3 22.8 18.9 19.2 53.6 28.2 11.2 14.2 27.8 32.9 34.1 10.2 22.7 25.0 21.0 11.8 29.8 16.6 12.9 0.8 23.7 20.0 0.0 8.5 37.5 23.5 17.7 19.6 32.7 13.8 66.7 14.3 16.5 24.3 2.3 27.9 14.5 33.7 6.4 14.6 37.0 11.3 18.1 28.0 32.1 28.8 6.5 25.5 8.4 16.8 28.2 34.1 16.0 14.2 22.9 FNBP1L "C1orf39, FLJ20275, TOCA1" ENSG00000137942 "Formin binding protein 1 like" Q5T0N5 1 93448131-93554661 "Predicted intracellular proteins" "Autophagy, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 11.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.1" "Cell line enhanced" "Detected in many" "SuSa: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065273 Approved Supported Cytosol NA NA Cytosol "HPA065273: AB_2685452" "unprognostic (1.83e-1)" "unprognostic (4.28e-2)" "unprognostic (2.57e-3)" "unprognostic (8.46e-2)" "unprognostic (7.68e-2)" "unprognostic (8.65e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (5.89e-2)" "unprognostic (1.74e-1)" "unprognostic (6.35e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic favorable (4.72e-7)" "unprognostic (3.59e-2)" "unprognostic (5.64e-2)" "unprognostic (2.74e-2)" "unprognostic (1.78e-1)" 22.8 6.8 17.8 8.3 36.0 1.7 27.0 20.3 11.3 15.7 24.3 5.4 27.3 16.5 14.2 15.9 7.6 11.4 11.9 16.3 13.0 13.7 29.9 10.9 18.0 3.3 10.5 10.3 12.2 15.0 16.0 15.6 13.7 14.0 14.5 14.5 5.6 32.2 23.2 23.4 10.3 27.5 10.3 13.9 2.6 19.0 12.0 16.1 2.5 26.3 7.1 3.3 15.2 24.2 0.9 2.2 11.1 0.1 0.1 0.4 0.2 9.9 5.5 29.1 16.2 6.3 4.6 32.5 5.0 3.4 3.8 5.3 6.9 3.1 0.0 10.4 4.8 10.2 5.1 7.0 5.7 5.4 6.4 5.2 5.3 8.1 10.0 3.1 0.9 0.1 8.2 9.5 3.5 5.2 9.9 17.9 6.3 2.0 0.0 8.9 4.6 3.8 0.4 22.1 17.0 5.6 8.4 22.2 2.6 16.6 16.0 11.7 16.5 15.6 30.6 8.7 36.1 11.6 1.3 17.7 8.9 11.3 0.2 3.4 3.1 2.5 0.1 0.8 0.1 6.0 11.1 0.1 1.1 0.0 0.0 0.1 0.6 0.4 0.0 0.5 0.9 0.0 0.4 0.1 0.1 0.0 2.2 0.4 0.2 17.8 36.0 20.3 11.3 13.0 13.7 10.5 10.3 14.0 16.1 101.3 29.0 3.7 34.3 23.6 13.4 37.0 50.9 60.2 73.9 59.3 3.9 29.1 48.0 67.0 9.4 31.9 31.6 0.0 42.3 30.4 14.6 55.7 15.1 18.3 9.5 65.2 64.3 16.0 5.6 13.7 7.5 10.6 37.1 10.8 30.8 17.3 48.1 38.4 3.5 42.3 9.3 25.8 12.2 20.7 37.1 22.5 14.3 2.6 31.4 72.9 FNTA "FPTA, PGGT1A, PTAR2" ENSG00000168522 "Farnesyltransferase, CAAX box, alpha" P49354 8 43034194-43085788 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010149, HPA018830" Approved Approved Cytosol NA NA 220000 Cytosol "CAB010149: AB_2106299, HPA018830: AB_1848992" "unprognostic (2.09e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-1)" "unprognostic (1.86e-3)" "unprognostic (2.64e-1)" "unprognostic (4.70e-3)" "unprognostic (1.83e-2)" "unprognostic (3.69e-2)" "unprognostic (1.70e-2)" "unprognostic (5.37e-2)" "unprognostic (3.25e-2)" "unprognostic (4.10e-1)" "prognostic unfavorable (2.94e-12)" "unprognostic (3.63e-2)" "unprognostic (2.33e-1)" "unprognostic (3.19e-2)" "unprognostic (1.29e-3)" 32.5 21.5 25.3 20.9 31.9 15.3 29.8 21.2 28.8 26.7 25.7 36.9 25.0 23.7 23.7 29.4 28.0 22.9 18.1 32.6 25.6 23.1 24.0 30.5 22.7 27.4 43.3 23.8 21.5 26.0 17.9 24.7 32.6 33.4 25.1 22.5 14.1 23.6 25.9 45.2 29.7 20.4 23.9 75.9 22.9 20.9 18.3 36.8 26.0 25.4 26.8 28.1 27.1 29.8 11.7 11.7 11.1 8.9 13.9 11.9 5.3 24.0 11.9 16.5 5.3 29.0 37.8 13.7 14.0 16.4 16.4 15.1 19.3 18.6 28.3 10.8 17.6 21.8 13.2 20.3 23.3 19.3 7.4 13.4 22.1 8.1 16.6 37.8 9.0 11.9 29.2 38.1 11.8 33.8 23.7 28.1 15.3 26.8 16.6 18.0 2.8 21.6 13.8 28.5 20.4 8.7 18.9 26.2 15.2 22.5 17.9 9.8 15.2 18.2 15.1 24.0 19.5 19.2 17.1 22.6 5.5 7.2 22.3 14.9 15.6 13.1 27.6 14.5 17.5 12.9 3.0 6.6 11.1 8.7 8.9 10.3 11.7 9.1 11.7 11.7 11.6 11.9 11.9 1.6 13.9 6.7 11.0 11.5 5.3 25.3 31.9 21.2 28.8 25.6 23.1 43.3 23.8 33.4 36.8 53.6 16.9 34.6 70.9 78.0 21.6 35.9 28.1 41.5 27.3 31.4 35.3 121.1 59.7 61.9 33.1 51.7 30.3 23.3 61.0 105.3 62.9 62.6 32.3 25.4 71.6 19.1 30.9 49.1 38.3 40.9 44.5 50.7 89.4 75.7 36.2 36.3 57.6 42.1 56.6 40.2 53.7 51.8 48.7 59.3 32.4 83.6 173.5 55.4 39.1 62.6 FREM2 DKFZp686J0811 ENSG00000150893 "FRAS1 related extracellular matrix protein 2" Q5SZK8 13 38687129-38887131 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 13.9;lung: 11.2;thyroid gland: 12.2" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 19.8;Cholangiocytes: 7.6;Proximal tubular cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.2;HAP1: 8.2;MCF7: 5.9;RT4: 5.5;SK-BR-3: 5.0;SuSa: 24.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028831 Uncertain Approved Cytosol NA NA 170000 Cytosol "HPA028831: AB_10603668" "unprognostic (1.71e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-1)" "unprognostic (6.24e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.25e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.23e-7)" "unprognostic (7.21e-2)" "unprognostic (1.40e-1)" "unprognostic (9.92e-2)" "unprognostic (3.14e-1)" 0.6 0.4 1.3 0.1 1.7 0.1 0.5 1.5 6.4 0.7 1.3 1.2 1.1 0.4 1.1 0.5 0.2 0.9 1.5 0.2 2.8 0.4 13.9 3.4 11.2 0.1 0.4 0.8 1.8 5.2 0.1 1.1 2.6 0.8 3.5 0.4 2.9 0.4 1.5 6.3 0.6 0.7 0.7 0.4 0.3 2.2 1.8 1.5 0.1 12.2 4.1 0.1 1.5 0.3 0.3 0.3 0.9 0.2 0.2 0.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.8 0.0 0.1 0.0 1.1 0.1 1.8 5.5 0.1 0.1 0.0 5.0 0.2 24.6 0.9 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.6 0.9 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.2 0.7 0.2 0.2 0.3 0.1 0.0 1.3 1.7 1.5 6.4 2.8 0.4 0.4 0.8 0.8 1.5 0.0 19.8 0.0 0.1 0.6 0.1 2.0 7.6 5.3 2.3 1.8 0.0 5.1 5.0 1.7 0.6 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.3 0.0 0.0 22.4 0.2 0.0 0.0 0.1 0.4 0.1 1.6 0.0 0.0 0.0 FSD2 "RP11-127F21, SPRYD1" ENSG00000186628 "Fibronectin type III and SPRY domain containing 2" A1L4K1 15 82755362-82806070 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 70.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 8.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA046263 Approved Cytosol NA NA Cytosol "HPA046263: AB_2679604" "unprognostic (2.80e-1)" "unprognostic (3.54e-1)" "unprognostic (6.63e-2)" "unprognostic (6.30e-2)" "unprognostic (7.71e-2)" "unprognostic (1.83e-1)" "unprognostic (5.97e-2)" "unprognostic (7.66e-2)" "unprognostic (1.07e-1)" "unprognostic (9.37e-2)" "unprognostic (3.05e-2)" "unprognostic (2.21e-1)" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-2)" "unprognostic (1.59e-2)" 1.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.6 0.7 0.1 0.0 20.8 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.4 1.0 0.0 54.0 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 18.1 1.4 0.0 0.1 1.4 0.8 2.3 0.9 0.8 2.2 0.5 1.3 1.3 2.0 2.4 0.0 0.0 1.2 1.3 0.0 0.0 0.0 1.1 2.1 4.1 0.9 0.0 1.1 5.0 0.0 0.0 0.4 0.7 5.4 2.3 5.7 1.8 0.0 1.4 0.9 0.1 0.2 0.0 0.6 1.4 0.0 1.7 2.0 3.7 0.0 1.2 0.7 2.4 1.9 0.8 1.1 1.3 1.5 1.0 0.2 2.3 1.9 1.7 1.0 1.0 1.5 1.0 1.7 1.8 0.8 3.0 1.6 1.1 1.8 8.5 3.6 1.4 1.8 4.9 0.7 2.3 0.8 0.8 1.0 0.7 0.8 1.4 1.1 0.9 0.8 1.1 2.2 1.1 1.1 0.8 0.9 0.8 1.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 1.0 0.3 2.6 70.6 2.5 0.0 1.2 0.0 5.9 0.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.1 0.2 0.3 1.1 0.0 0.2 11.1 1.2 0.0 0.8 1.8 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 3.6 0.0 0.3 0.7 0.2 0.5 0.2 0.0 0.0 0.3 FTL "MGC71996, NBIA3" ENSG00000087086 "Ferritin light chain" P02792 19 48965301-48966878 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Iron storage" "Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 1149.4" "Cell type enhanced" "Detected in all" 10 "Hofbauer cells: 67925.7;Kupffer cells: 48067.7;Proximal tubular cells: 39652.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "granulocytes: 1149.4;monocytes: 890.5" "Cell line enhanced" "Detected in all" "HHSteC: 575.7;HSkMC: 481.6" "CAB020769, HPA041602" Enhanced Approved Cytosol NA NA 240000000 Cytosol "CAB020769: , HPA041602: AB_2677575" "unprognostic (2.95e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-1)" "unprognostic (1.56e-3)" "unprognostic (7.48e-2)" "unprognostic (5.28e-2)" "unprognostic (2.16e-3)" "unprognostic (6.17e-3)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" 326.0 111.3 147.1 113.6 130.9 179.8 321.8 25.8 101.3 105.7 107.5 134.7 58.2 120.5 54.9 85.4 85.0 71.3 214.6 140.8 111.7 88.2 295.2 526.9 391.6 444.6 139.4 49.6 126.8 108.0 27.0 63.6 166.3 89.0 108.0 92.3 114.4 59.4 75.4 75.6 48.3 159.4 149.2 194.5 317.9 105.2 53.9 74.5 45.1 130.0 57.5 67.5 159.8 172.1 147.8 231.2 1149.4 890.5 41.5 86.1 674.1 18.7 285.4 21.4 32.7 370.5 384.5 38.3 48.6 286.4 70.1 158.0 62.5 76.1 14.3 93.6 290.5 153.7 11.2 17.5 28.8 63.3 192.3 11.3 37.8 74.5 408.6 575.7 88.8 127.3 481.6 39.1 119.3 52.5 104.8 101.5 17.2 69.9 29.9 138.3 4.5 24.5 51.9 38.8 330.4 29.2 20.5 14.5 147.1 44.5 11.9 27.4 15.9 127.8 7.0 26.6 121.4 4.1 185.8 75.9 76.8 40.4 98.5 66.5 129.3 285.0 13.3 81.5 93.7 134.3 488.0 642.5 675.8 63.9 890.5 72.6 147.8 71.3 68.3 231.2 132.2 86.1 74.8 1149.4 41.5 768.3 97.2 83.8 674.1 147.1 130.9 25.8 101.3 111.7 88.2 139.4 49.6 89.0 74.5 1045.2 3325.0 4263.9 4805.4 2481.8 468.5 679.4 4145.2 769.6 1043.0 1917.5 166.9 816.1 9070.4 3524.4 247.8 2245.5 2735.4 2149.2 5208.6 1016.5 4146.4 6478.0 2236.8 16333.4 67925.7 503.7 1551.5 4087.4 48067.7 879.3 3866.6 17106.8 4823.4 23991.6 2116.7 1184.6 7872.5 3673.3 1890.2 39652.4 496.5 1319.4 4074.7 56.3 327.7 1946.3 1256.7 2296.9 2288.6 7488.3 FTSJ1 "CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7" ENSG00000068438 "FtsJ RNA methyltransferase homolog 1" Q9UET6 X 48476021-48486364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002718 Approved Approved Cytosol NA NA Cytosol "HPA002718: AB_1078914" "unprognostic (2.56e-2)" "unprognostic (1.24e-2)" "unprognostic (1.44e-1)" "unprognostic (3.37e-1)" "unprognostic (2.13e-1)" "unprognostic (6.77e-2)" "prognostic unfavorable (1.74e-5)" "unprognostic (1.95e-2)" "unprognostic (2.39e-1)" "unprognostic (3.96e-3)" "unprognostic (2.06e-3)" "unprognostic (7.82e-2)" "prognostic unfavorable (5.24e-10)" "unprognostic (2.61e-1)" "unprognostic (1.49e-1)" "unprognostic (1.56e-2)" "unprognostic (1.23e-1)" 17.6 19.4 12.3 18.2 21.6 18.4 17.1 18.7 21.2 23.3 11.7 13.6 20.8 10.7 18.5 12.6 19.0 15.9 12.8 15.0 9.9 10.3 15.9 21.3 16.9 22.9 13.6 9.2 17.4 36.6 13.9 16.2 11.3 14.9 13.3 10.6 12.4 20.8 18.6 17.3 18.0 12.0 16.6 11.0 19.6 17.8 14.6 15.2 17.2 20.0 24.8 18.6 17.3 17.2 17.1 16.8 10.7 16.1 15.9 26.9 15.1 25.8 17.9 6.9 27.3 9.9 10.4 11.3 12.7 12.3 18.7 14.8 10.7 36.4 15.1 9.6 19.4 11.8 17.6 13.7 44.9 8.4 11.5 12.9 9.6 22.7 12.0 28.1 13.2 24.4 9.6 22.8 23.4 23.1 10.4 13.0 17.4 8.1 12.6 24.1 14.7 17.0 9.4 15.5 11.1 30.8 13.9 22.6 31.3 17.5 8.8 9.3 9.2 20.2 11.2 9.3 8.4 12.8 7.6 12.7 14.8 20.1 30.7 15.5 17.1 13.3 10.9 32.7 24.8 15.4 9.2 14.1 10.7 21.9 16.1 26.9 17.1 18.9 22.1 16.8 16.9 17.3 21.9 2.0 15.9 15.1 11.6 17.5 15.1 12.3 21.6 18.7 21.2 9.9 10.3 13.6 9.2 14.9 15.2 6.0 11.2 14.1 9.5 11.3 4.5 5.6 7.6 17.4 14.8 7.0 2.0 4.8 14.9 20.1 37.9 9.9 5.4 0.0 16.0 22.0 10.8 7.7 8.1 4.4 15.8 3.2 5.2 6.2 10.2 56.9 10.0 11.0 5.0 8.2 8.9 5.2 41.1 0.0 8.1 7.3 5.5 12.9 13.5 6.8 10.1 9.5 4.8 10.0 8.1 16.2 FUZ "FLJ22688, Fy" ENSG00000010361 "Fuzzy planar cell polarity protein" Q9BT04 19 49806869-49817376 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 116.2" "Group enriched" "Detected in many" 24 "Early spermatids: 1102.3;Late spermatids: 1611.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041779, HPA042196" Approved Approved Cytosol No NA Cytosol "HPA041779: AB_10793974, HPA042196: AB_10797383" "unprognostic (2.40e-3)" "unprognostic (1.31e-1)" "unprognostic (7.73e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-2)" "unprognostic (4.36e-3)" "unprognostic (9.67e-2)" "unprognostic (1.47e-1)" "unprognostic (1.97e-2)" "unprognostic (1.06e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.50e-5)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.70e-1)" 5.6 7.8 7.4 2.1 8.4 4.7 4.1 5.4 9.0 6.5 3.8 11.3 3.5 3.7 6.1 6.6 3.4 17.8 4.7 4.5 7.7 5.8 9.0 3.0 4.4 4.1 7.8 5.6 9.8 7.0 5.6 5.2 3.6 6.8 4.5 1.7 4.8 6.2 7.1 15.1 2.0 3.2 3.8 7.9 3.6 4.6 116.2 8.1 5.4 6.8 3.4 3.2 3.5 3.0 5.7 12.3 14.9 4.0 3.0 4.6 2.4 0.0 6.6 6.1 8.0 5.4 6.3 1.7 3.0 3.4 5.3 7.1 0.5 10.8 1.9 6.4 2.9 1.5 2.8 1.5 5.8 2.3 6.2 12.6 7.5 4.4 0.0 6.6 4.5 4.3 6.6 3.9 10.2 2.4 4.0 4.4 11.7 1.8 5.4 2.5 0.4 8.9 9.6 10.3 4.7 3.5 15.4 4.5 4.3 5.9 1.4 17.4 20.1 0.6 6.6 10.7 2.5 3.8 2.9 2.3 4.4 3.9 1.1 1.1 15.5 15.4 4.9 4.9 0.1 5.4 5.4 4.0 14.9 4.6 1.9 3.6 4.6 2.8 3.7 3.2 5.7 3.5 4.0 8.9 3.0 1.3 12.3 3.2 2.4 7.4 8.4 5.4 9.0 7.7 5.8 7.8 5.6 6.8 8.1 0.0 3.2 10.4 15.2 3.4 7.2 3.4 10.2 10.7 2.3 7.0 3.9 13.8 56.3 10.8 1102.3 4.4 2.0 0.0 4.5 9.6 10.8 10.5 10.3 5.1 11.5 9.5 2.4 9.2 6.0 1611.7 25.6 6.7 0.0 11.8 3.2 23.6 4.8 3.1 16.6 53.1 10.1 0.0 7.1 46.0 10.9 3.6 10.1 7.2 3.9 13.1 FXR1 ENSG00000114416 "FMR1 autosomal homolog 1" P51114 3 180868141-180982753 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 215.4" "Group enriched" "Detected in all" 4 "Early spermatids: 827.9;Late spermatids: 1326.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018246, HPA055475" Approved Enhanced Cytosol NA NA Cytosol "HPA018246: AB_1849204, HPA055475: AB_2682828" "unprognostic (1.38e-1)" "unprognostic (1.59e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (1.04e-2)" "unprognostic (1.90e-3)" "prognostic unfavorable (2.70e-4)" "unprognostic (7.77e-3)" "unprognostic (9.20e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (7.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.02e-1)" "unprognostic (2.84e-2)" 12.4 13.8 13.0 7.6 16.1 13.7 11.7 14.8 15.0 11.5 14.3 10.5 11.4 7.5 14.7 10.1 13.4 11.7 8.9 36.1 13.7 14.3 10.1 11.3 8.5 9.4 19.4 9.6 16.9 11.4 11.4 17.3 12.7 18.1 13.1 7.4 6.5 10.2 11.8 215.4 7.7 7.9 12.3 23.4 9.1 10.5 39.1 19.4 17.2 16.2 22.7 10.0 15.6 28.8 13.8 14.9 11.4 14.0 11.0 21.8 9.4 36.1 16.8 36.4 28.2 28.0 32.0 16.5 28.8 29.5 32.4 32.1 24.7 18.3 18.5 47.6 19.8 51.2 17.5 29.3 17.6 45.4 24.4 19.7 18.8 22.2 28.2 29.9 11.6 15.5 33.7 20.2 16.3 39.1 48.6 32.6 18.2 15.0 22.5 40.7 13.0 22.1 19.6 41.0 22.4 18.5 15.4 46.5 19.7 24.9 11.3 15.4 19.7 24.9 29.0 37.2 53.4 40.3 22.4 25.9 24.4 27.3 15.2 56.5 21.0 26.3 22.0 25.5 16.8 31.1 8.9 12.9 10.0 12.9 14.0 13.6 13.8 13.8 11.7 14.9 9.5 17.6 14.4 11.4 11.0 10.2 10.5 21.8 9.4 13.0 16.1 14.8 15.0 13.7 14.3 19.4 9.6 18.1 19.4 59.6 64.8 54.7 82.6 69.6 69.6 196.5 38.2 131.2 89.9 33.2 53.0 80.5 49.7 73.6 827.9 71.9 29.3 93.5 65.6 84.4 66.3 54.2 121.5 58.7 58.6 82.6 51.6 52.2 63.0 1326.2 77.9 61.8 47.2 139.7 33.0 89.6 70.5 35.1 71.5 67.7 82.8 32.3 61.4 245.3 103.5 61.7 51.1 57.5 38.5 60.3 FXR2 FMR1L2 ENSG00000129245 "FMR1 autosomal homolog 2" P51116 17 7591230-7614871 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 55.0" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011205, HPA022997" Supported Supported Cytosol NA NA Cytosol "CAB011205: AB_476964, HPA022997: AB_1849208" "unprognostic (9.57e-2)" "unprognostic (1.23e-1)" "unprognostic (5.15e-3)" "unprognostic (2.61e-1)" "unprognostic (1.62e-1)" "unprognostic (7.56e-3)" "unprognostic (1.96e-1)" "unprognostic (3.50e-3)" "unprognostic (2.15e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.49e-6)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (2.46e-1)" "unprognostic (2.64e-1)" "unprognostic (7.79e-2)" "unprognostic (7.67e-2)" 10.4 13.6 15.9 7.4 22.5 5.8 7.5 21.2 25.2 9.6 9.5 14.5 11.2 9.2 9.7 8.3 11.1 9.0 7.4 31.9 16.1 18.1 11.1 9.6 10.5 8.5 18.8 18.5 10.2 11.2 19.2 13.9 10.6 22.4 11.8 8.0 13.5 10.9 13.2 55.0 9.1 8.5 11.7 15.1 8.4 7.8 13.5 18.2 8.3 9.4 9.5 9.8 8.9 8.3 2.4 3.1 6.0 2.2 2.1 4.6 1.9 15.6 20.7 19.2 20.0 16.5 11.3 14.8 23.5 19.6 34.0 23.7 11.5 5.1 14.6 15.7 15.9 15.0 17.2 25.2 10.6 22.9 16.4 27.1 8.2 18.1 6.6 16.1 0.1 17.7 10.5 15.7 25.8 25.1 19.2 11.7 11.6 14.6 5.0 16.8 7.8 11.2 8.0 11.5 8.0 11.2 16.4 11.6 8.9 12.5 5.5 11.5 21.3 15.9 10.7 15.9 19.0 11.0 6.1 10.9 15.9 10.1 10.4 27.7 8.4 7.5 6.5 18.3 6.7 20.9 6.0 2.0 5.8 2.4 2.2 3.2 1.1 3.8 4.6 3.1 2.4 3.1 3.3 5.1 2.1 1.4 2.1 3.8 1.9 15.9 22.5 21.2 25.2 16.1 18.1 18.8 18.5 22.4 18.2 29.8 14.1 7.3 9.7 10.2 43.8 35.9 5.1 6.7 10.3 15.7 29.5 13.4 1.7 9.2 1.4 9.7 12.2 0.0 8.0 9.8 8.1 11.6 2.3 9.7 7.8 60.4 9.2 14.1 7.8 2.0 8.9 6.9 0.0 7.2 10.3 21.1 13.8 11.0 14.5 6.6 51.7 6.5 9.2 14.4 22.4 12.5 14.3 6.1 8.0 8.3 G3BP1 "G3BP, HDH-VIII" ENSG00000145907 "G3BP stress granule assembly factor 1" Q13283 5 151771045-151812785 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity, Transport" "DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004052, CAB037068" Supported Supported Cytosol NA NA 150000 Cytosol "CAB037068: AB_1840864, HPA004052: AB_1849348" "unprognostic (1.31e-1)" "unprognostic (3.94e-2)" "unprognostic (1.19e-3)" "unprognostic (1.28e-2)" "unprognostic (1.05e-1)" "unprognostic (3.09e-2)" "unprognostic (1.03e-3)" "unprognostic (1.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.36e-1)" "unprognostic (2.06e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.33e-4)" "unprognostic (1.97e-1)" "unprognostic (1.33e-1)" "unprognostic (2.11e-2)" "unprognostic (3.88e-2)" 36.7 27.5 21.1 29.1 23.7 12.2 29.7 24.3 21.4 28.5 23.4 27.7 19.6 18.1 29.9 19.3 40.7 26.5 20.7 24.8 21.7 21.2 30.7 44.1 25.9 36.8 31.8 16.7 38.2 30.6 29.9 29.9 27.9 24.9 24.5 27.2 22.6 24.1 19.7 66.4 25.3 22.8 27.0 27.4 28.9 20.6 27.4 25.8 57.1 28.9 37.0 42.3 27.7 34.8 25.6 19.9 19.5 19.1 29.4 40.0 32.1 37.7 29.5 36.4 15.9 46.4 25.2 42.0 37.5 34.0 48.4 57.5 54.2 49.0 70.5 55.2 34.8 42.3 35.9 54.9 72.8 63.5 19.5 26.4 43.6 27.3 36.3 26.5 54.5 28.8 25.1 39.8 42.1 41.7 19.8 39.9 28.5 34.1 34.8 47.4 20.3 45.9 24.2 40.6 27.5 30.3 42.2 46.0 33.6 31.8 37.6 34.4 24.9 35.5 51.7 54.3 35.9 41.3 30.3 43.4 35.0 40.8 33.1 68.1 21.7 29.9 55.5 26.3 42.0 63.1 19.5 13.9 13.0 25.7 19.1 40.0 25.6 34.4 28.7 18.0 21.9 33.0 32.9 6.1 29.4 16.8 19.9 34.0 32.1 21.1 23.7 24.3 21.4 21.7 21.2 31.8 16.7 24.9 25.8 17.9 30.0 62.3 74.5 212.8 33.8 51.5 48.4 65.6 61.4 61.1 15.7 86.5 66.3 65.2 35.3 78.7 31.9 23.3 45.9 73.7 92.5 76.9 72.7 138.2 69.1 54.0 48.1 74.9 78.1 21.9 60.1 59.1 82.7 88.4 55.3 50.3 51.8 38.6 53.7 64.9 35.6 38.8 106.6 46.3 99.0 224.2 56.3 61.0 68.9 82.6 G3BP2 KIAA0660 ENSG00000138757 "G3BP stress granule assembly factor 2" Q9UN86 4 75642782-75724525 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018304, HPA018425" Enhanced Enhanced Cytosol NA NA Cytosol "HPA018304: AB_1849350, HPA018425: AB_1849352" "unprognostic (2.42e-2)" "unprognostic (5.79e-2)" "unprognostic (8.70e-3)" "unprognostic (2.23e-1)" "unprognostic (6.98e-2)" "unprognostic (5.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.04e-1)" "unprognostic (6.83e-2)" "unprognostic (3.79e-1)" "unprognostic (7.38e-2)" "unprognostic (7.88e-2)" "prognostic favorable (6.65e-5)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (1.27e-2)" "unprognostic (6.99e-2)" 22.7 24.7 28.2 21.9 48.4 31.6 23.9 52.2 55.6 24.3 28.6 21.5 18.7 24.5 25.1 18.7 24.5 26.9 23.3 23.0 29.3 46.3 32.3 33.7 21.3 24.8 31.3 30.0 20.4 18.8 31.0 27.6 17.7 57.9 37.7 27.3 16.3 22.0 24.2 69.7 15.3 27.8 25.9 35.2 22.9 22.0 27.4 19.6 29.9 35.4 28.1 26.6 26.9 17.9 18.8 20.4 32.5 28.2 31.9 41.4 24.7 27.6 28.8 47.0 38.7 40.6 41.5 15.6 42.6 40.8 27.3 29.1 37.2 38.8 53.2 38.2 34.0 25.1 18.7 48.4 49.7 40.0 31.6 20.0 55.2 28.7 41.9 35.8 50.6 41.2 32.8 42.6 33.1 34.4 36.7 49.3 34.0 40.5 40.6 43.5 17.8 58.8 18.2 49.2 38.9 13.3 44.6 58.0 27.8 32.3 34.0 38.6 41.4 31.3 45.1 55.3 50.3 21.7 25.6 49.9 27.8 22.6 31.1 23.7 39.6 37.7 54.6 39.8 34.7 36.0 32.5 17.0 30.7 26.8 23.1 41.4 18.8 26.1 28.8 20.4 14.6 26.3 28.4 16.6 31.9 28.2 9.9 22.1 24.7 28.2 48.4 52.2 55.6 29.3 46.3 31.3 30.0 57.9 19.6 50.6 115.9 82.1 60.0 79.0 59.4 66.9 22.9 78.9 92.1 50.6 47.1 31.6 34.9 45.0 180.8 63.3 78.6 46.7 59.3 41.8 54.5 74.8 101.8 66.8 40.5 66.7 130.0 49.7 73.0 184.9 24.5 67.6 57.3 90.2 97.3 31.7 70.8 56.1 37.4 71.9 60.6 19.4 46.4 56.0 66.1 68.0 34.6 94.8 60.7 90.4 GALNS "GALNAC6S, GAS" ENSG00000141012 "Galactosamine (N-acetyl)-6-sulfatase" P34059 16 88813734-88856970 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Dwarfism, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026404, HPA042433, HPA074225" Supported Approved Cytosol "Intracellular and membrane" NA NA 2400000 Cytosol "CAB026404: , HPA042433: AB_2732499, HPA074225: " "unprognostic (3.16e-1)" "unprognostic (9.98e-2)" "unprognostic (4.03e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (3.66e-4)" "unprognostic (4.15e-3)" "unprognostic (1.32e-1)" "unprognostic (4.84e-3)" "unprognostic (2.00e-1)" "unprognostic (3.53e-2)" "unprognostic (4.12e-3)" "unprognostic (4.24e-2)" "unprognostic (5.54e-2)" "unprognostic (3.59e-2)" "unprognostic (6.84e-2)" 11.9 14.9 9.3 11.2 11.1 25.0 14.8 12.9 15.4 11.1 15.5 11.5 8.8 13.3 9.0 19.9 10.2 14.8 12.7 12.5 11.2 13.9 13.7 17.8 14.7 10.6 11.8 5.2 11.9 7.3 9.9 13.2 15.6 11.6 10.5 8.3 7.1 10.6 9.0 7.1 10.0 17.2 9.4 9.4 10.4 9.5 27.4 8.8 7.9 14.5 6.1 9.0 11.1 13.0 2.1 7.1 19.3 11.2 2.4 3.1 4.7 2.5 19.6 2.8 20.1 22.7 10.9 19.7 8.2 12.8 9.0 7.0 10.2 17.0 3.2 17.4 13.4 13.6 15.1 4.1 6.5 5.5 2.1 6.5 2.0 8.0 5.8 15.3 1.5 13.3 15.2 12.7 10.1 2.8 12.9 7.7 3.5 4.4 1.9 5.3 15.0 4.1 6.5 6.6 6.5 9.1 8.7 2.5 5.4 5.6 6.0 7.4 5.7 19.5 1.8 9.7 7.2 12.7 14.4 14.4 19.8 15.1 20.2 4.5 2.0 1.9 5.5 21.5 13.3 11.7 0.9 11.2 19.3 3.1 8.0 2.6 2.1 1.8 2.7 7.1 0.9 1.7 2.1 14.2 2.4 5.6 3.0 3.0 4.7 9.3 11.1 12.9 15.4 11.2 13.9 11.8 5.2 11.6 8.8 14.9 4.5 1.9 6.4 5.8 3.9 6.7 2.5 26.8 7.9 3.5 5.9 7.9 3.3 5.3 14.3 4.9 12.3 0.0 3.0 11.4 10.2 5.7 1.1 5.7 17.8 23.8 11.5 7.4 13.9 28.0 6.6 8.0 6.8 20.8 6.9 8.5 5.4 12.4 6.3 4.5 9.7 6.5 9.2 49.5 33.7 5.0 13.3 5.7 8.6 5.1 GALT ENSG00000213930 "Galactose-1-phosphate uridylyltransferase" P07902 9 34638133-34651035 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Nucleotidyltransferase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004868, HPA005729" Enhanced Approved Cytosol NA NA 120000 Cytosol "HPA004868: AB_1079130, HPA005729: AB_1079131" "unprognostic (2.38e-1)" "unprognostic (8.92e-2)" "unprognostic (1.45e-3)" "unprognostic (1.54e-1)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.13e-1)" "unprognostic (3.97e-2)" "unprognostic (1.13e-2)" "prognostic favorable (3.11e-5)" "unprognostic (9.68e-2)" "prognostic favorable (6.25e-6)" "unprognostic (7.90e-2)" "unprognostic (2.74e-1)" "unprognostic (3.56e-1)" "unprognostic (7.75e-2)" 6.3 16.1 8.0 13.8 12.5 7.4 6.6 9.3 7.3 8.5 19.4 5.8 12.4 18.1 7.2 8.4 7.7 6.5 10.5 10.9 6.7 8.6 11.8 47.0 6.8 10.8 9.0 6.0 8.7 7.6 12.1 10.3 21.7 7.5 7.2 6.8 11.0 12.5 13.4 9.5 14.4 26.1 5.9 5.0 9.4 8.1 2.6 7.1 11.3 8.5 7.2 10.6 7.0 6.5 16.3 15.9 10.9 17.5 20.5 21.1 13.1 5.0 6.7 6.1 2.5 8.4 8.5 7.1 3.7 10.7 3.9 4.5 8.3 4.7 5.6 3.9 4.5 1.5 2.7 1.1 10.4 0.7 8.4 4.5 2.3 13.4 8.4 8.2 1.3 3.0 12.3 6.6 2.5 3.1 8.3 9.5 7.4 1.9 6.2 6.3 4.4 4.8 9.5 2.1 5.8 1.2 7.4 5.6 3.0 10.8 7.0 1.4 5.4 4.7 9.4 5.1 4.6 8.4 7.3 1.4 1.8 3.3 3.3 0.0 3.5 2.0 1.2 4.1 4.0 9.9 10.9 17.5 8.3 12.1 15.0 16.7 16.3 19.8 16.3 15.9 9.3 12.2 12.0 3.3 20.5 14.1 13.3 21.1 13.1 8.0 12.5 9.3 7.3 6.7 8.6 9.0 6.0 7.5 7.1 6.0 23.4 12.3 13.7 19.3 40.6 20.7 15.3 6.7 10.3 15.7 45.2 59.8 24.9 16.7 6.9 12.0 18.0 0.0 6.5 29.6 13.1 4.5 19.7 52.9 21.0 44.5 15.6 20.3 11.9 31.3 17.0 13.3 20.3 14.4 15.1 18.9 8.5 21.8 13.1 29.4 37.0 6.5 10.1 4.2 4.7 17.7 49.4 23.3 19.8 7.8 GANC ENSG00000214013 "Glucosidase alpha, neutral C" Q8TET4 15 42273233-42356935 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016949, HPA051522" Approved Approved Cytosol NA NA Cytosol "HPA016949: AB_1849465, HPA051522: " "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (2.24e-1)" "unprognostic (3.04e-3)" "unprognostic (2.51e-2)" "unprognostic (9.85e-2)" "unprognostic (2.49e-2)" "prognostic favorable (9.76e-4)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (1.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (3.14e-1)" "unprognostic (1.55e-2)" "unprognostic (3.74e-2)" 13.3 14.0 12.5 17.3 20.7 17.6 14.4 16.6 14.2 15.8 14.3 25.6 15.4 11.7 17.9 26.0 20.7 12.9 13.0 12.4 13.4 10.4 13.5 18.0 30.5 13.8 25.0 13.7 18.8 13.1 17.4 20.5 10.8 19.8 13.1 17.8 18.3 20.4 13.7 23.9 13.9 15.4 15.9 25.1 15.5 13.1 24.5 22.6 17.4 16.8 12.3 18.3 16.2 16.3 17.6 12.2 9.3 10.1 4.0 7.4 4.7 6.2 3.2 7.9 8.6 9.6 13.6 5.0 13.7 14.8 15.1 12.7 4.7 4.4 3.4 7.5 13.8 10.5 13.0 9.5 14.6 10.5 8.5 4.4 8.5 8.6 9.2 8.1 8.2 7.4 9.2 8.7 6.1 10.5 8.5 10.2 8.7 8.8 9.6 11.9 1.3 5.5 9.1 4.9 2.7 4.2 10.6 9.3 11.8 11.4 5.8 6.0 8.5 7.7 6.7 4.8 4.5 2.5 19.4 9.2 15.9 4.2 13.1 8.2 10.4 13.7 6.9 7.5 15.1 8.7 9.3 9.3 7.4 3.7 10.1 5.0 16.2 5.7 6.9 12.2 17.6 7.4 4.4 5.0 4.0 8.1 9.6 5.5 4.7 12.5 20.7 16.6 14.2 13.4 10.4 25.0 13.7 19.8 22.6 17.9 36.3 8.3 15.1 9.3 5.1 6.9 2.5 12.0 10.3 1.8 9.8 4.4 5.0 4.3 9.0 4.0 8.4 0.0 3.3 4.2 4.5 6.5 10.4 9.0 6.0 3.2 4.1 7.4 11.6 3.0 6.6 10.3 13.5 11.8 5.5 10.4 5.0 16.5 6.0 6.3 6.5 12.9 5.2 14.2 14.4 4.5 2.4 5.0 7.5 21.3 GAREM2 "FAM59B, FLJ00375, GAREML, KIAA2038" ENSG00000157833 "GRB2 associated regulator of MAPK1 subtype 2" Q75VX8 2 26173091-26189663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.2;parathyroid gland: 17.0" "Group enriched" "Detected in many" 5 "Distal tubular cells: 39.7;Muller glia cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 15.4;SH-SY5Y: 9.5;U-2 OS: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071575 Approved Cytosol NA NA Cytosol "HPA071575: AB_2686420" "unprognostic (1.70e-2)" "unprognostic (5.62e-2)" "unprognostic (7.61e-4)" "unprognostic (1.56e-2)" "unprognostic (8.27e-2)" "unprognostic (2.19e-1)" "unprognostic (2.90e-2)" "unprognostic (1.99e-1)" "unprognostic (2.12e-2)" "unprognostic (2.65e-1)" "unprognostic (1.33e-1)" "unprognostic (3.94e-2)" "unprognostic (1.15e-3)" "unprognostic (1.35e-1)" "unprognostic (3.22e-1)" "unprognostic (1.46e-2)" "unprognostic (1.04e-1)" 3.2 1.6 19.9 1.8 13.9 0.9 1.5 8.2 21.2 2.5 3.0 11.7 0.7 1.2 3.0 1.7 2.6 2.4 2.8 2.0 17.9 11.0 1.8 0.5 1.1 2.2 13.1 8.9 4.1 4.4 17.0 1.4 1.5 16.5 1.7 2.9 0.9 1.8 3.5 3.7 2.4 1.1 3.6 15.9 1.6 1.5 2.6 13.9 0.0 2.6 0.0 2.0 2.1 1.2 0.8 2.5 1.6 0.6 0.4 1.9 0.3 2.6 4.0 4.9 0.4 0.8 1.8 0.4 1.5 0.0 0.4 0.4 7.7 0.9 0.0 2.0 3.1 4.9 0.1 15.4 0.0 0.7 1.7 5.7 1.3 1.3 0.5 6.0 0.1 0.3 2.3 0.7 2.3 0.2 0.3 1.8 3.8 7.1 0.2 2.8 0.0 0.4 0.5 5.2 0.4 1.1 1.6 0.0 0.0 2.5 0.9 1.0 9.5 3.4 0.3 2.9 1.5 0.2 8.0 0.8 2.1 13.1 3.8 0.1 0.3 0.0 1.6 0.1 0.0 2.8 0.4 0.6 0.2 1.2 0.2 0.5 0.5 1.9 1.4 0.5 0.8 1.5 0.5 1.6 0.4 0.5 2.5 0.4 0.3 19.9 13.9 8.2 14.1 17.9 11.0 13.1 8.9 16.5 13.9 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 3.5 2.0 0.3 39.7 1.7 3.4 0.4 0.0 0.0 1.3 2.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.6 0.3 5.2 2.0 0.0 0.0 1.0 0.5 20.6 1.5 0.0 3.2 2.0 1.2 6.5 0.0 1.4 5.4 0.0 0.2 0.0 0.6 0.3 GARS "CMT2D, DSMAV, GlyRS, SMAD1" ENSG00000106105 "Glycyl-tRNA synthetase" P41250 7 30594681-30634033 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017896, HPA019097" Enhanced Supported Cytosol "Intracellular and membrane" NA NA 660000 Cytosol "HPA017896: AB_1849478, HPA019097: AB_1849480" "prognostic unfavorable (1.02e-4)" "unprognostic (2.46e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (2.04e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (8.95e-5)" "unprognostic (7.31e-3)" "unprognostic (4.76e-1)" "unprognostic (4.00e-3)" "unprognostic (1.77e-1)" "unprognostic (4.45e-2)" "prognostic unfavorable (1.70e-5)" "unprognostic (3.92e-1)" "unprognostic (3.40e-2)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.04e-5)" 25.8 27.3 24.5 26.2 28.5 24.6 32.4 31.1 44.7 21.5 23.7 17.0 11.5 17.2 24.1 23.3 43.7 18.6 18.4 25.7 21.1 26.8 27.6 57.2 27.9 28.0 22.9 28.4 35.4 49.4 44.4 33.3 24.3 37.6 17.2 30.2 14.1 28.7 21.6 35.6 33.2 18.1 30.1 17.6 23.5 30.5 29.7 14.9 28.6 31.4 33.9 38.4 22.8 25.7 22.5 26.4 21.2 27.2 15.3 27.6 21.2 33.5 16.6 14.8 52.3 27.6 41.5 28.0 50.2 45.5 25.9 52.5 22.1 16.8 56.5 15.2 61.1 40.7 26.6 36.8 31.9 45.6 13.5 17.2 26.1 13.6 18.6 87.7 38.4 23.1 39.5 56.0 37.1 44.1 18.4 33.2 52.5 51.7 65.9 41.1 20.7 33.4 26.6 39.8 31.0 31.8 16.9 13.0 43.9 29.7 15.2 17.8 29.9 13.4 37.6 71.4 27.6 33.5 58.9 30.4 12.3 41.3 24.7 31.7 65.2 54.6 66.5 43.0 58.2 57.8 21.2 19.0 17.7 23.2 25.8 23.7 22.5 23.7 25.1 26.4 19.3 25.5 27.6 5.6 15.3 27.2 18.0 25.9 21.2 24.5 28.5 31.1 44.7 21.1 26.8 22.9 28.4 37.6 14.9 38.7 27.4 35.6 34.3 29.9 23.3 30.7 25.5 14.7 27.3 19.2 21.6 41.1 28.2 79.9 48.1 24.6 13.9 0.0 131.2 61.8 33.2 32.2 40.3 27.0 39.9 17.5 25.2 31.9 25.5 44.0 21.6 32.4 32.1 57.7 36.9 20.2 111.3 7.0 21.5 31.8 15.7 12.9 30.0 71.9 80.1 24.1 33.3 25.4 22.3 44.7 GBE1 ENSG00000114480 "1,4-alpha-glucan branching enzyme 1" Q04446 3 81489699-81762161 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 61.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038073, HPA038074, HPA038075" Enhanced Approved Cytosol NA NA 5900000 Cytosol "HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545" "unprognostic (3.10e-1)" "unprognostic (1.02e-3)" "unprognostic (6.76e-2)" "unprognostic (1.05e-2)" "unprognostic (3.48e-2)" "unprognostic (1.89e-1)" "unprognostic (9.01e-3)" "unprognostic (1.17e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (2.19e-2)" "unprognostic (5.68e-2)" "unprognostic (1.46e-1)" "unprognostic (5.36e-2)" "unprognostic (4.42e-1)" "unprognostic (2.83e-3)" "unprognostic (3.78e-3)" 23.1 22.4 2.2 7.8 4.2 5.6 19.2 4.2 4.6 6.4 7.7 5.2 5.2 4.1 8.4 4.9 7.5 4.9 11.5 19.7 3.6 4.3 14.0 36.3 11.3 7.5 7.9 3.4 8.2 5.7 8.2 11.6 11.4 8.4 5.7 4.5 9.9 8.0 10.1 56.9 5.9 6.3 7.2 6.1 8.0 4.5 4.6 4.1 5.4 6.5 11.2 4.5 9.6 10.0 11.6 13.6 14.5 11.4 13.0 7.2 6.1 12.1 7.3 2.4 34.9 61.4 46.7 4.4 20.2 28.8 12.1 20.6 1.4 3.2 13.6 8.9 24.8 7.2 1.4 2.0 9.3 28.6 6.4 1.1 4.2 15.2 4.5 42.3 14.3 3.7 34.4 6.9 19.5 20.1 30.5 26.9 1.6 3.3 7.9 39.4 3.5 2.4 17.0 2.4 3.4 11.2 4.5 11.1 16.0 8.6 4.1 1.2 1.6 13.2 3.8 4.1 3.7 2.7 11.8 37.3 25.1 5.9 17.6 18.6 36.1 4.1 5.0 40.9 9.6 10.2 6.3 11.4 14.5 5.6 10.4 5.4 11.0 6.0 5.9 13.6 11.6 7.0 7.2 11.0 13.0 10.8 4.5 5.0 6.1 2.2 4.2 4.2 4.6 3.6 4.3 7.9 3.4 8.4 4.1 14.9 11.3 7.2 17.9 27.2 15.9 51.9 15.3 13.4 10.3 29.6 0.0 25.8 34.9 29.0 29.2 28.5 9.6 0.0 21.8 58.4 22.2 15.3 42.7 67.1 23.2 28.6 21.2 14.1 14.5 11.6 16.1 15.1 23.6 12.6 6.9 9.6 34.4 6.8 12.4 46.6 16.8 32.3 41.6 6.5 5.1 18.6 45.9 10.0 7.3 12.4 GCN1 "GCN1L, GCN1L1, KIAA0219" ENSG00000089154 "GCN1, eIF2 alpha kinase activator homolog" Q92616 12 120127203-120194710 "Plasma proteins, Predicted intracellular proteins" "Stress response, Translation regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018799, HPA019648, HPA024367" Enhanced Enhanced Cytosol NA NA 40000 Cytosol "HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569" "unprognostic (7.36e-2)" "unprognostic (2.10e-3)" "unprognostic (3.17e-1)" "unprognostic (2.60e-1)" "unprognostic (1.26e-1)" "unprognostic (3.14e-2)" "prognostic unfavorable (1.87e-8)" "unprognostic (5.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.20e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (6.35e-2)" "unprognostic (1.21e-1)" "unprognostic (2.34e-1)" "unprognostic (7.09e-3)" "unprognostic (1.43e-1)" 23.1 14.6 7.9 14.3 14.4 15.7 14.4 18.3 20.6 15.3 15.2 22.3 9.7 11.5 31.2 10.2 20.2 14.8 11.3 12.6 7.7 7.8 14.7 19.1 14.0 16.0 11.5 6.8 18.9 19.9 23.8 21.4 24.4 14.9 15.1 12.2 16.8 33.3 13.2 36.0 20.9 15.5 14.4 9.7 18.3 17.2 16.0 10.3 22.2 20.6 14.3 27.4 15.9 15.1 4.3 4.9 2.2 6.5 3.1 7.8 3.1 16.9 33.5 12.1 13.6 19.2 11.7 42.5 15.2 13.3 15.9 13.0 28.7 11.8 22.6 17.3 21.8 10.1 16.8 28.1 21.5 10.0 15.0 22.9 27.9 21.9 19.8 12.5 25.7 17.9 14.3 12.6 18.8 17.8 14.0 14.5 10.3 32.7 5.8 13.3 17.1 16.2 19.5 21.4 16.3 20.5 19.8 12.4 22.3 10.9 58.3 19.9 20.0 25.0 10.9 9.0 12.0 23.2 14.6 19.8 13.0 14.5 8.5 15.7 23.0 21.1 22.9 12.5 13.6 13.0 1.2 3.1 2.2 6.4 3.2 7.8 3.9 5.0 5.3 4.1 4.3 3.8 4.0 0.1 3.1 6.5 4.9 4.6 3.1 7.9 14.4 18.3 20.6 7.7 7.8 11.5 6.8 14.9 10.3 8.9 19.9 2.2 5.4 0.0 12.7 0.0 10.2 5.3 17.0 21.0 9.8 12.3 1.7 13.2 1.1 8.0 6.3 0.0 13.7 32.8 8.2 11.2 4.7 20.2 10.0 15.9 3.5 12.3 9.5 2.7 13.3 3.2 0.0 10.0 14.2 9.3 16.6 10.5 12.0 7.8 11.5 6.5 0.0 7.7 21.6 0.0 12.2 6.9 15.1 11.2 GCSAML "C1orf150, FLJ44728" ENSG00000169224 "Germinal center associated signaling and motility like" Q5JQS6 1 247507058-247577690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 48.3;brain: 17.6" "Cell type enriched" "Detected in some" 27 "granulocytes: 214.1" "Cancer enriched" "Detected in single" 13 "prostate cancer: 1.9" "Region enriched" "Detected in some" 10 "cerebellum: 17.6" "Cell type enriched" "Detected in single" 439 "basophil: 48.3" "Lineage enriched" "Detected in single" 439 "granulocytes: 48.3" "Group enriched" "Detected in some" 73 "HEL: 28.5;HMC-1: 113.3" "Low region specificity" "Detected in single" "HPA027507, HPA027510" Uncertain Approved Cytosol NA NA Cytosol "HPA027507: AB_10600756, HPA027510: AB_2672309" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (4.07e-3)" "unprognostic (3.48e-2)" "unprognostic (1.72e-1)" "unprognostic (2.76e-4)" "unprognostic (3.21e-1)" "unprognostic (6.14e-2)" "unprognostic (5.42e-2)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.81e-1)" "unprognostic (9.51e-3)" "unprognostic (3.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" 3.7 0.3 0.4 1.1 0.4 2.4 1.6 17.6 0.4 3.8 2.1 0.2 0.0 2.2 2.4 2.2 1.9 0.6 2.7 1.3 0.4 0.5 0.5 0.4 5.6 1.1 0.5 0.0 0.3 0.5 0.1 0.4 0.3 1.7 9.5 2.4 0.4 1.0 0.9 0.5 1.2 2.5 6.6 0.9 0.5 1.4 5.3 0.0 1.4 0.4 2.4 1.5 3.4 9.4 0.1 0.0 48.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 113.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 48.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 17.6 0.4 0.4 0.5 0.5 0.0 1.7 0.0 0.0 7.9 0.0 0.0 0.6 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 6.7 0.1 0.0 0.0 0.0 0.0 0.3 1.3 214.1 0.0 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 6.9 1.6 0.5 0.0 0.0 0.0 0.0 GDPGP1 C15orf58 ENSG00000183208 "GDP-D-glucose phosphorylase 1" Q6ZNW5 15 90233808-90245811 "Enzymes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA048189, HPA059841" Approved Approved Cytosol NA NA Cytosol "HPA048189: AB_2680307, HPA059841: AB_2684138" "prognostic favorable (6.32e-4)" "unprognostic (1.85e-1)" "unprognostic (2.17e-1)" "unprognostic (2.42e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (3.68e-2)" "unprognostic (4.46e-3)" "unprognostic (1.53e-1)" "unprognostic (3.00e-1)" "unprognostic (1.82e-2)" "unprognostic (2.93e-3)" "unprognostic (8.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.02e-3)" 3.9 9.2 9.8 5.7 9.8 5.1 4.8 9.9 12.4 4.4 10.7 8.0 7.2 10.1 5.0 7.5 6.2 9.4 6.0 10.8 12.9 7.1 7.7 12.2 5.8 6.1 5.9 11.6 6.1 9.1 11.9 10.2 2.1 8.8 7.5 14.8 7.2 9.9 10.0 12.5 4.5 9.4 5.8 5.1 8.2 6.9 9.5 8.4 8.5 7.6 3.1 7.8 7.2 3.9 8.3 4.6 7.4 5.2 6.7 7.8 2.9 3.3 13.0 1.6 4.8 5.0 1.0 4.4 3.0 1.9 4.0 3.8 3.8 12.9 8.1 5.9 2.3 2.9 5.5 5.1 3.4 1.6 7.2 8.7 7.2 7.5 5.5 5.3 3.9 4.8 1.3 2.4 2.8 1.5 4.5 4.6 4.8 2.6 3.2 2.3 7.4 2.9 1.9 2.0 9.9 5.4 5.1 1.2 4.1 4.6 6.4 5.1 2.3 4.8 7.4 5.0 3.1 8.5 4.0 4.6 2.1 2.3 3.0 2.9 6.6 7.6 3.6 4.6 3.3 3.8 6.8 4.6 2.2 6.6 5.2 5.6 4.8 6.2 7.8 4.1 8.3 6.7 6.2 7.4 6.7 4.1 4.6 7.5 2.9 9.8 9.8 9.9 12.4 12.9 7.1 5.9 11.6 8.8 8.4 0.0 2.7 1.4 1.9 0.0 3.8 6.0 12.7 4.0 1.2 7.0 5.9 2.1 3.3 3.5 1.8 0.7 4.0 0.0 5.3 1.0 1.0 1.9 3.5 4.4 3.7 1.6 5.2 1.8 2.8 1.9 2.6 3.4 0.0 1.8 3.8 3.3 3.8 5.7 2.1 4.4 3.5 0.0 0.5 2.7 2.7 0.3 0.3 2.2 3.7 1.6 GID4 "C17orf39, VID24" ENSG00000141034 "GID complex subunit 4 homolog" Q8IVV7 17 18039292-18068404 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.2" "Group enriched" "Detected in many" 17 "Early spermatids: 643.1;Late spermatids: 883.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044348 Uncertain Approved Cytosol NA NA Cytosol "HPA044348: AB_10959602" "unprognostic (1.52e-1)" "unprognostic (4.19e-2)" "unprognostic (4.65e-1)" "unprognostic (4.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.38e-1)" "unprognostic (3.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (8.99e-2)" "unprognostic (2.39e-2)" "unprognostic (1.28e-1)" "unprognostic (3.64e-3)" "unprognostic (2.11e-1)" "unprognostic (8.68e-2)" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" 10.9 5.7 9.6 4.7 9.4 5.6 7.5 13.4 9.3 9.0 9.4 6.9 7.3 4.5 7.9 7.2 13.0 6.7 5.5 10.1 8.8 5.3 6.2 6.2 5.6 5.3 9.5 5.8 8.6 7.8 10.8 3.9 6.7 7.0 9.5 5.1 4.6 7.7 9.3 24.7 11.6 5.1 9.5 7.0 6.3 6.4 55.2 10.2 8.0 7.1 5.8 6.2 13.3 10.8 4.4 3.2 6.8 2.4 3.8 3.6 1.0 6.4 6.7 3.8 6.2 10.0 9.8 6.6 5.4 8.7 6.0 6.8 5.8 2.6 8.2 4.6 6.3 5.6 7.3 5.5 6.0 7.8 4.4 11.0 3.6 5.7 4.2 8.7 2.2 6.4 7.3 10.5 6.0 9.4 8.1 6.7 11.9 3.2 2.4 4.8 1.7 6.9 4.6 3.3 8.1 5.0 5.9 13.5 8.0 4.0 2.6 2.9 4.3 3.6 3.2 3.8 39.5 2.1 2.7 5.5 3.9 2.2 8.9 2.7 4.1 3.6 1.8 5.5 3.7 4.9 6.8 2.4 6.6 2.6 1.3 2.9 4.4 2.4 2.5 1.9 4.4 2.9 2.9 6.3 3.8 1.5 3.2 3.6 1.0 9.6 9.4 13.4 9.3 8.8 5.3 9.5 5.8 7.0 10.2 0.0 0.6 3.4 6.6 9.8 5.2 10.6 2.5 2.7 1.2 1.8 3.9 6.6 8.3 5.0 643.1 7.1 2.6 0.0 4.9 10.6 5.3 7.6 5.7 6.4 6.4 15.9 1.2 7.4 6.3 883.9 11.8 5.3 6.8 5.4 7.2 4.2 8.2 0.0 14.9 9.6 3.7 12.9 5.1 45.4 22.8 15.8 12.9 5.2 5.0 6.5 GIGYF2 "GYF2, KIAA0642, PARK11, PERQ2, PERQ3, TNRC15" ENSG00000204120 "GRB10 interacting GYF protein 2" Q6Y7W6 2 232697299-232860575 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 342.4;Late spermatids: 441.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050899, HPA054612, HPA059918, HPA065064" Approved Enhanced Cytosol NA NA Cytosol "HPA050899: AB_2681267, HPA054612: AB_2682542, HPA059918: AB_2684160, HPA065064: AB_2685417" "unprognostic (7.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (1.52e-2)" "unprognostic (1.92e-2)" "unprognostic (8.61e-2)" "unprognostic (8.39e-3)" "unprognostic (2.99e-1)" "unprognostic (6.28e-2)" "unprognostic (1.27e-2)" "unprognostic (7.40e-3)" "unprognostic (8.01e-2)" "prognostic favorable (6.97e-5)" "unprognostic (7.53e-2)" "unprognostic (1.78e-1)" "unprognostic (1.20e-2)" "unprognostic (1.66e-1)" 22.8 22.1 20.7 16.5 19.4 15.2 19.7 33.0 21.7 17.9 17.5 25.0 21.2 15.9 23.7 15.0 18.6 17.8 13.7 21.3 19.2 15.7 23.1 13.7 15.7 15.4 21.4 15.6 24.6 26.5 47.5 38.1 18.1 21.5 19.4 16.9 18.1 21.4 21.7 41.5 23.4 17.2 22.3 27.5 18.9 18.2 53.4 22.0 19.2 22.4 17.7 17.3 20.8 20.5 10.1 9.8 21.5 14.6 9.8 9.9 5.2 16.1 15.6 18.2 18.9 24.8 23.9 20.4 20.4 17.5 14.9 16.1 14.5 13.5 9.7 5.4 15.2 24.3 17.1 21.7 16.4 18.4 22.6 16.2 35.7 16.1 22.0 15.6 28.9 22.8 15.0 16.9 18.0 25.7 15.9 16.7 13.5 33.3 10.8 17.1 17.1 18.9 10.3 18.5 13.3 11.5 19.3 36.0 13.2 14.0 24.7 16.2 13.5 20.5 15.0 15.8 14.5 14.5 20.2 24.2 15.9 13.5 17.8 15.7 21.9 14.6 19.1 14.4 17.0 15.4 21.5 8.6 10.8 7.9 6.7 9.9 5.6 6.5 7.2 9.8 10.1 7.8 5.9 11.2 9.8 14.6 7.6 9.6 5.2 20.7 19.4 33.0 21.7 19.2 15.7 21.4 15.6 21.5 22.0 53.6 54.8 27.6 28.8 14.0 49.5 79.9 15.3 61.6 68.2 34.9 56.9 27.8 21.6 26.2 342.4 38.3 25.7 23.3 23.5 17.9 19.7 31.1 16.3 26.2 24.4 46.1 18.4 16.5 31.6 441.2 34.8 21.3 25.3 20.8 23.6 40.9 25.2 10.5 34.6 14.6 38.4 25.8 20.2 92.6 88.6 16.8 61.2 19.8 26.2 38.2 GLOD4 "C17orf25, CGI-150, HC71" ENSG00000167699 "Glyoxalase domain containing 4" Q9HC38 17 757097-783390 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021623, HPA023246, HPA023248" Enhanced Approved Cytosol NA NA 3800000 Cytosol "HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (1.99e-1)" "unprognostic (2.11e-1)" "unprognostic (2.88e-1)" "unprognostic (3.35e-1)" "unprognostic (3.13e-2)" "unprognostic (6.27e-2)" "unprognostic (4.86e-2)" "unprognostic (1.96e-2)" "prognostic favorable (2.18e-6)" "unprognostic (6.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" 21.7 29.5 31.3 16.7 35.6 10.2 19.1 26.0 36.2 17.8 37.1 21.5 16.5 43.0 22.3 23.3 23.6 24.9 20.9 19.7 26.1 38.5 41.6 40.4 16.8 22.8 23.0 34.8 22.9 32.3 13.9 19.4 28.1 28.6 21.1 26.6 21.9 29.2 20.9 21.4 27.5 42.5 24.7 18.2 23.8 43.4 17.9 18.2 22.7 26.0 19.2 24.0 25.2 17.5 27.5 17.9 17.8 24.6 22.8 36.7 26.0 40.2 36.5 42.2 23.3 18.5 18.5 25.8 32.3 19.9 26.2 20.0 29.6 28.9 48.1 35.3 14.5 24.5 29.2 36.7 20.5 27.5 35.2 31.4 23.2 20.3 38.6 18.4 23.8 30.7 12.9 28.6 26.3 23.2 16.8 24.2 40.1 37.8 31.4 27.6 24.9 40.9 18.4 30.8 40.0 12.5 41.0 17.1 22.0 25.9 27.6 19.2 32.3 25.6 18.6 41.4 27.7 23.1 25.4 31.4 25.1 20.1 35.0 40.4 17.7 32.1 29.6 29.8 26.9 26.1 9.2 19.8 17.8 27.7 24.2 30.2 27.0 33.6 33.3 17.5 27.5 28.7 31.3 2.7 22.8 24.6 17.9 36.7 26.0 31.3 35.6 26.0 36.2 26.1 38.5 23.0 34.8 28.6 18.2 53.6 32.8 19.4 36.9 42.6 36.9 27.0 50.9 66.9 60.3 96.0 27.5 93.5 150.9 67.8 30.1 37.6 47.9 0.0 50.6 68.7 47.3 35.9 38.3 57.2 70.9 12.7 27.7 25.8 28.8 47.7 35.9 49.1 64.1 76.7 46.8 36.9 50.1 59.6 43.9 135.3 35.1 45.3 41.9 16.9 26.8 47.9 57.8 47.3 57.4 35.3 GLT1D1 FLJ31978 ENSG00000151948 "Glycosyltransferase 1 domain containing 1" Q96MS3 12 128853427-128984968 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.1;bone marrow: 25.4;liver: 24.7" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 11.5;Hepatocytes: 7.9;Kupffer cells: 11.4;Late spermatids: 34.0;Muller glia cells: 9.8" "Group enriched" "Detected in some" 6 "liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 23.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 23.1" "Group enriched" "Detected in some" 6 "MOLT-4: 12.4;NTERA-2: 18.0;SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039051, HPA039052" Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA039051: AB_10673299, HPA039052: AB_10672839" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (3.60e-2)" "unprognostic (3.47e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-1)" "unprognostic (4.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (2.20e-1)" "unprognostic (1.55e-3)" "unprognostic (2.41e-1)" 3.0 0.6 7.0 7.0 12.4 25.4 0.6 7.1 15.5 1.8 0.6 1.2 0.2 0.5 4.1 1.4 0.9 2.1 2.1 1.2 6.3 10.5 1.2 24.7 2.2 4.5 5.8 6.4 0.6 1.2 0.4 1.0 1.0 7.6 1.3 0.7 2.6 0.4 1.9 8.2 1.3 0.6 3.6 1.6 9.2 0.6 14.7 1.3 0.1 2.0 0.0 0.8 1.7 0.6 0.0 1.4 23.1 3.8 0.0 0.3 0.8 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.3 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.1 0.0 1.1 1.4 0.0 0.8 7.0 12.4 7.1 15.5 6.3 10.5 5.8 6.4 7.6 1.3 0.0 0.0 0.5 0.0 0.8 0.4 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.5 0.0 0.0 1.8 11.4 34.0 0.3 1.7 1.7 0.0 0.0 9.8 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.6 0.2 0.3 0.1 0.0 0.0 0.0 GLTP ENSG00000139433 "Glycolipid transfer protein" Q9NZD2 12 109850943-109880488 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.0;lymphoid tissue: 78.0;skin 1: 84.3" "Cell type enhanced" "Detected in many" 8 "Suprabasal keratinocytes: 418.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056461, HPA065503" Approved Supported Cytosol NA NA 280000 Cytosol "HPA056461: AB_2683138, HPA065503: " "unprognostic (1.18e-1)" "prognostic favorable (2.01e-5)" "unprognostic (7.46e-2)" "unprognostic (6.22e-3)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (6.63e-2)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (2.47e-1)" "unprognostic (3.03e-1)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (2.20e-1)" "prognostic favorable (4.17e-6)" "unprognostic (3.28e-2)" 7.0 5.8 11.4 6.1 16.4 6.6 10.5 4.7 19.3 21.8 13.2 31.3 6.6 5.4 5.4 13.4 82.0 4.9 5.4 6.4 15.9 9.7 13.7 4.5 9.2 7.0 22.4 8.9 5.9 7.7 5.7 3.4 7.9 14.8 8.0 11.8 4.0 21.2 8.0 6.1 84.3 8.2 7.1 48.7 7.4 7.6 4.0 24.7 6.2 8.9 60.6 78.0 10.8 38.5 11.8 23.2 16.7 32.3 21.2 26.7 17.2 14.2 10.2 5.9 6.3 14.1 16.3 4.3 17.7 22.0 13.7 11.6 4.0 5.5 12.6 9.5 21.7 6.7 17.6 9.1 20.8 19.6 12.8 8.1 8.2 6.2 6.1 12.4 8.8 9.7 12.0 26.2 24.5 17.4 20.8 23.0 13.1 3.7 8.7 20.1 19.7 11.9 7.2 10.6 11.8 13.8 10.7 14.0 13.2 7.7 42.9 7.5 7.5 11.1 29.0 9.4 5.7 13.5 3.1 31.4 15.7 8.5 23.1 13.3 11.5 9.6 8.6 31.7 9.2 9.7 16.7 32.3 16.5 26.7 30.8 16.2 11.8 16.1 23.3 23.2 11.4 10.5 18.8 15.8 21.2 24.8 3.7 17.6 17.2 11.4 16.4 4.7 19.3 15.9 9.7 22.4 8.9 14.8 24.7 23.8 58.2 25.4 91.0 129.1 11.8 13.3 20.4 29.4 52.4 41.8 13.7 64.4 169.1 34.4 12.2 35.0 79.9 0.0 49.6 16.3 33.4 71.1 19.7 11.9 31.9 12.7 31.2 28.3 40.0 9.7 21.3 47.5 57.3 45.9 41.0 15.1 42.3 35.1 17.0 25.6 11.6 38.8 41.8 17.0 22.0 418.8 176.1 43.3 42.2 95.9 GMPS GATD7 ENSG00000163655 "Guanine monophosphate synthase" P49915 3 155870536-155944026 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" Ligase Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 191.9;Late spermatids: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046630 Approved Cytosol No No Cytosol "HPA046630: AB_2679727" "unprognostic (3.89e-2)" "unprognostic (2.02e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (5.54e-5)" "unprognostic (2.30e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (8.73e-7)" "unprognostic (1.71e-2)" "unprognostic (3.52e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.58e-2)" "unprognostic (2.79e-2)" "unprognostic (2.89e-2)" "unprognostic (3.78e-1)" "unprognostic (3.55e-3)" "unprognostic (8.79e-2)" 15.9 18.3 10.4 19.7 14.0 24.6 22.4 22.1 24.9 16.1 13.9 9.8 15.3 10.3 17.5 15.4 19.5 14.0 10.8 15.3 9.2 7.7 11.0 14.7 15.8 19.5 9.3 12.1 15.7 23.5 19.1 14.1 13.5 14.8 13.0 15.3 9.0 21.6 18.6 16.6 21.0 12.6 16.1 8.9 14.6 15.4 60.9 10.5 28.3 13.6 12.5 18.4 15.9 18.5 11.1 17.2 10.9 18.1 19.0 20.7 10.8 56.8 22.5 30.6 25.0 12.5 19.8 29.5 24.3 22.5 32.1 32.5 41.0 38.4 41.1 29.0 18.7 24.6 28.0 26.0 25.5 44.2 23.8 20.0 43.8 16.5 22.2 14.3 44.5 17.1 14.6 15.7 24.8 38.0 17.1 19.6 22.4 30.8 15.8 23.8 38.2 36.1 23.6 29.3 31.3 16.7 35.5 36.3 49.6 16.5 25.1 18.3 17.0 27.0 38.7 24.2 22.0 40.5 29.4 13.8 21.3 17.3 30.0 48.9 22.1 13.6 70.3 21.4 33.2 18.9 10.9 10.4 7.2 17.3 13.1 20.7 11.1 16.8 15.7 17.2 8.8 16.8 15.8 1.4 19.0 18.1 9.5 17.6 10.8 10.4 14.0 22.1 24.9 9.2 7.7 9.3 12.1 14.8 10.5 17.9 19.8 20.4 39.9 35.4 21.9 14.1 15.3 13.4 22.7 7.0 2.0 33.4 21.6 24.9 191.9 28.5 8.4 23.3 25.9 43.0 27.2 23.6 28.8 11.1 26.5 20.6 6.9 14.7 18.3 149.6 21.3 24.7 21.9 29.7 17.8 17.3 20.4 10.5 23.3 22.3 7.7 19.4 31.6 80.1 54.5 33.4 25.7 24.9 24.7 34.5 GNA12 gep ENSG00000146535 "G protein subunit alpha 12" Q03113 7 2728112-2844324 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 50.1;Syncytiotrophoblasts: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010046 Approved Supported Cytosol NA NA Cytosol "CAB010046: AB_2263416" "unprognostic (1.21e-1)" "unprognostic (1.19e-2)" "unprognostic (9.28e-2)" "unprognostic (1.54e-1)" "unprognostic (2.14e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (1.20e-6)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "unprognostic (4.45e-3)" "unprognostic (7.90e-2)" "prognostic unfavorable (4.71e-5)" "unprognostic (1.22e-2)" "unprognostic (2.52e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.27e-4)" 19.4 15.0 26.5 12.3 22.8 10.5 11.9 12.9 22.5 13.7 11.9 19.4 5.2 5.9 13.8 5.9 9.2 12.1 11.0 17.6 22.9 19.3 7.6 7.3 10.4 14.2 25.2 11.4 21.9 13.4 9.5 13.8 27.2 22.1 11.4 7.4 7.4 8.8 14.2 5.4 4.4 8.5 16.8 24.4 11.7 9.1 11.5 18.2 4.6 7.7 3.9 11.4 13.3 12.8 4.7 4.3 2.5 3.1 0.2 1.8 0.9 15.1 8.4 8.7 13.0 14.0 11.2 24.1 12.8 15.0 14.0 16.1 8.0 10.8 3.2 8.8 15.1 29.4 6.9 5.9 13.2 9.5 38.7 6.0 6.6 4.5 8.4 16.4 1.0 5.9 10.8 7.2 16.3 11.1 14.4 14.8 4.7 7.3 10.2 12.5 7.2 1.7 6.0 12.2 3.9 14.6 11.5 10.0 6.5 5.1 10.4 6.9 10.0 7.2 10.9 5.4 13.0 6.0 9.1 17.4 15.3 18.3 14.9 21.0 7.3 8.5 2.9 16.4 9.8 14.9 2.5 1.3 0.2 0.6 3.1 0.9 2.7 1.5 0.8 1.1 4.7 1.4 0.2 0.3 0.2 0.8 4.3 1.8 0.9 26.5 22.8 12.9 19.7 22.9 19.3 25.2 11.4 22.1 18.2 6.0 13.2 10.9 3.2 6.3 5.3 11.6 7.6 5.3 6.8 1.8 11.8 50.1 3.3 6.5 11.9 12.1 4.0 23.3 8.8 13.6 14.6 7.1 0.0 12.7 23.5 7.9 7.5 21.5 21.9 9.8 15.8 10.8 20.3 23.4 5.3 11.2 10.7 4.2 17.7 7.7 10.8 0.0 15.5 8.6 7.8 3.1 144.9 5.3 4.7 2.4 GNA13 "G13, MGC46138" ENSG00000120063 "G protein subunit alpha 13" Q14344 17 65010715-65056839 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010087 Approved Supported Cytosol NA NA 4000000 Cytosol "HPA010087: AB_10601478" "unprognostic (2.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.33e-3)" "unprognostic (1.23e-3)" "unprognostic (8.21e-2)" "unprognostic (7.05e-2)" "unprognostic (4.22e-3)" "unprognostic (1.09e-1)" "unprognostic (7.77e-2)" "unprognostic (4.66e-1)" "unprognostic (1.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (1.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" 28.2 17.4 16.4 25.3 17.5 75.6 15.1 15.1 15.0 14.2 19.1 23.0 13.0 14.0 12.9 12.1 13.2 12.1 17.7 15.4 16.8 13.3 12.4 17.4 27.6 27.5 18.5 9.4 16.3 10.0 12.1 10.0 25.0 14.8 16.8 17.3 10.7 10.5 13.9 35.0 11.4 17.5 15.9 32.1 22.5 13.6 11.3 20.4 34.9 11.9 9.0 27.5 28.3 26.0 5.7 5.5 15.8 13.4 7.8 11.2 4.4 11.8 13.4 12.4 8.3 12.8 11.6 12.8 9.2 10.8 12.7 14.5 7.5 8.0 48.4 6.1 9.9 15.6 8.2 13.1 11.3 19.6 12.5 7.6 25.2 8.2 14.7 18.6 18.8 16.8 9.8 17.3 12.3 16.9 11.5 19.1 13.1 10.2 30.2 14.7 11.2 28.9 6.8 7.6 11.5 10.0 16.7 24.7 17.6 12.8 19.5 9.1 19.1 6.7 14.1 15.8 25.0 14.5 18.4 13.7 21.2 18.6 9.1 12.1 22.4 26.6 55.0 7.7 12.3 11.2 7.1 6.4 8.5 7.2 13.4 7.3 5.7 8.9 8.5 5.5 4.8 5.2 5.7 15.8 7.8 8.3 2.5 11.2 4.4 16.4 17.5 15.1 15.0 16.8 13.3 18.5 9.4 14.8 20.4 11.9 15.4 28.6 22.0 60.2 5.4 10.3 15.3 9.4 5.7 8.7 3.9 13.6 6.6 10.8 3.2 27.0 28.1 23.3 9.9 12.6 19.5 23.8 29.0 13.7 52.3 6.4 16.1 31.9 52.2 6.3 10.6 56.9 65.8 36.9 12.7 31.7 11.8 16.1 22.6 12.2 5.9 32.3 25.0 5.4 15.6 57.6 11.7 39.9 12.9 27.4 GNB1L "GY2, WDR14" ENSG00000185838 "G protein subunit beta 1 like" Q9BYB4 22 19783224-19854939 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034627, HPA034628" Approved Approved Cytosol NA NA Cytosol "HPA034627: AB_10600662, HPA034628: AB_10600440" "unprognostic (2.14e-1)" "unprognostic (5.56e-3)" "unprognostic (4.54e-3)" "unprognostic (2.58e-1)" "unprognostic (3.03e-1)" "unprognostic (3.34e-2)" "unprognostic (8.68e-4)" "unprognostic (1.09e-1)" "unprognostic (1.19e-1)" "unprognostic (4.26e-1)" "unprognostic (2.46e-1)" "unprognostic (2.99e-2)" "unprognostic (3.64e-5)" "unprognostic (9.80e-3)" "unprognostic (8.04e-2)" "unprognostic (2.88e-1)" "unprognostic (9.86e-2)" 6.1 6.4 6.9 12.4 10.3 7.7 8.7 11.6 16.1 7.4 7.2 5.7 8.2 18.6 8.9 7.1 9.8 8.0 5.7 5.8 6.9 5.7 5.2 5.4 6.2 9.9 6.1 9.9 7.6 12.8 3.1 6.0 11.3 5.4 7.7 2.8 4.6 9.4 7.5 13.9 12.6 10.0 4.3 5.5 13.2 8.9 6.1 4.9 30.3 8.3 4.6 8.6 7.9 8.2 11.6 12.8 14.5 7.3 10.9 16.1 7.6 7.0 5.4 1.6 4.8 0.5 1.0 4.4 4.8 1.4 2.4 2.3 9.7 2.8 9.6 3.2 1.1 1.1 13.6 1.1 2.3 0.3 6.1 18.3 5.7 6.7 4.7 1.5 6.5 1.6 0.8 1.1 2.1 0.8 0.5 0.9 4.4 34.4 3.7 0.4 10.0 14.5 9.4 2.7 2.0 9.2 7.6 4.4 2.1 0.2 2.9 3.2 3.5 1.9 4.7 8.2 0.3 1.2 1.7 2.2 5.4 6.6 8.8 4.9 4.8 4.0 5.0 5.9 5.9 1.8 5.5 5.9 14.5 13.7 7.3 13.2 9.6 13.3 10.4 9.5 11.6 13.0 11.7 5.9 10.9 5.5 12.8 16.1 7.6 6.9 10.3 11.6 16.1 6.9 5.7 6.1 9.9 5.4 4.9 3.0 4.1 5.2 5.4 19.6 7.7 1.2 0.0 0.0 3.4 0.0 11.8 12.9 3.3 4.4 25.3 3.6 4.4 0.0 2.9 11.0 6.9 3.8 12.7 2.6 9.4 0.0 0.0 1.8 4.7 4.7 3.1 7.4 13.5 6.4 2.9 2.5 4.9 3.5 4.6 4.1 4.1 6.5 6.2 4.1 11.4 14.2 3.9 10.2 4.5 3.9 GNE "IBM2, Uae1" ENSG00000159921 "Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase" Q9Y223 9 36214441-36277056 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.0;salivary gland: 45.3" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 95.4;Mucus-secreting cells: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007045, HPA027258" Approved Supported Cytosol NA NA Cytosol "HPA007045: AB_1079003, HPA027258: AB_1849873" "unprognostic (7.54e-2)" "unprognostic (1.61e-2)" "unprognostic (1.07e-3)" "unprognostic (7.28e-2)" "unprognostic (7.00e-2)" "unprognostic (1.85e-2)" "unprognostic (2.78e-3)" "unprognostic (5.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.88e-3)" "unprognostic (4.20e-2)" "prognostic favorable (9.28e-11)" "unprognostic (2.90e-1)" "unprognostic (8.28e-2)" "unprognostic (2.95e-1)" "unprognostic (1.72e-2)" 7.7 6.7 6.0 6.5 8.3 8.3 16.6 11.1 12.1 7.9 20.7 7.0 4.6 2.9 8.0 3.9 7.6 6.7 5.2 7.6 7.8 6.8 6.8 55.0 5.5 6.0 6.0 7.8 9.8 8.4 4.1 7.0 20.2 10.2 10.1 30.1 4.8 45.3 5.0 10.5 3.7 7.2 11.7 10.9 4.5 4.9 3.4 5.3 3.2 4.6 4.2 7.9 8.6 7.9 3.9 2.2 1.2 2.7 2.4 4.2 1.8 4.4 19.9 8.9 7.6 10.1 10.1 12.9 6.2 7.9 8.6 11.1 4.8 14.2 5.8 6.6 10.3 22.4 1.7 6.7 2.0 9.6 10.9 0.6 5.0 11.7 6.6 6.9 0.1 14.3 6.6 2.0 14.3 13.5 6.3 3.6 9.0 6.3 12.1 8.3 0.7 8.1 2.6 5.1 2.8 11.2 6.7 7.5 1.6 47.6 8.2 7.6 6.9 6.6 2.3 5.7 3.3 2.1 5.1 5.2 5.7 5.9 6.8 5.4 5.3 11.3 3.2 7.8 4.3 8.1 0.7 1.7 0.9 2.7 2.2 1.8 2.4 3.4 2.9 1.4 3.9 4.0 4.2 1.2 2.4 2.7 2.2 1.5 1.8 6.0 8.3 11.1 12.1 7.8 6.8 6.0 7.8 10.2 5.3 8.9 10.6 4.5 2.8 1.6 7.9 5.9 10.2 18.7 14.8 8.7 5.9 7.5 1.7 9.3 2.8 4.5 18.3 0.0 5.2 7.3 5.1 7.6 9.3 95.4 2.7 11.1 11.1 8.0 5.0 2.3 10.0 4.3 1.7 6.4 67.2 2.0 4.2 23.0 6.0 1.7 6.2 12.9 4.1 1.1 2.7 1.4 16.6 5.0 21.2 5.6 GNMT ENSG00000124713 "Glycine N-methyltransferase" Q14749 6 42960758-42963880 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 83.9;pancreas: 100.1" "Cell type enriched" "Detected in many" 34 "Hepatocytes: 729.0" "Group enriched" "Detected in many" 20 "liver cancer: 69.6;prostate cancer: 49.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 10.5;SCLC-21H: 12.4;T-47d: 7.9" "Region enriched" "Detected in some" 4 "cerebellum: 17.7" "Not detected" "Not detected" HPA027501 Enhanced Approved Cytosol NA NA 150000 Cytosol "HPA027501: AB_1849879" "unprognostic (1.53e-2)" "unprognostic (8.02e-4)" "unprognostic (3.11e-2)" "unprognostic (4.24e-3)" "unprognostic (3.91e-2)" "unprognostic (6.40e-4)" "prognostic favorable (1.86e-4)" "unprognostic (4.08e-6)" "unprognostic (1.01e-1)" "unprognostic (2.67e-2)" "unprognostic (1.63e-3)" "unprognostic (2.52e-1)" "unprognostic (3.50e-3)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (2.49e-2)" "unprognostic (4.92e-2)" 0.3 0.1 0.2 0.2 0.2 0.7 1.8 0.5 0.5 0.3 0.5 0.2 1.3 0.0 0.2 0.9 0.3 0.1 0.2 1.3 0.2 0.2 0.3 83.9 1.3 0.1 0.1 0.2 0.4 100.1 0.0 2.5 0.1 0.4 5.2 0.0 0.9 8.2 0.9 0.6 0.1 0.2 0.4 0.1 0.3 6.5 0.6 0.1 0.2 0.9 0.3 0.4 0.2 0.1 0.7 3.2 2.0 0.9 0.0 1.2 0.3 0.5 0.4 1.8 5.1 0.6 0.2 0.3 0.4 2.0 0.8 1.2 0.1 0.1 1.7 0.2 0.4 0.9 0.6 0.3 0.3 0.2 2.0 1.6 1.3 1.0 10.5 0.0 1.1 2.4 0.4 0.0 0.4 0.2 1.2 0.0 3.8 1.5 1.9 0.3 2.3 2.0 3.7 0.2 0.5 0.5 1.7 1.6 1.0 0.9 0.2 12.4 1.7 0.1 1.7 0.6 0.5 7.9 3.6 0.4 0.9 0.9 0.5 1.0 1.3 1.2 1.5 0.2 2.1 1.0 0.0 0.8 0.1 0.2 0.9 0.1 0.7 0.3 0.3 0.9 0.1 0.6 1.2 2.0 0.0 0.1 3.2 0.3 0.3 0.2 0.2 0.5 0.5 0.2 0.2 0.1 0.2 0.4 0.1 0.0 2.1 3.4 4.2 0.2 1.2 4.5 15.3 5.3 0.0 1.8 0.0 0.1 3.3 0.4 0.2 0.1 0.0 0.0 0.7 0.1 0.2 16.1 0.0 729.0 0.5 1.6 0.0 16.5 21.5 0.0 0.9 0.3 0.0 0.0 0.0 0.3 0.9 0.0 2.5 2.2 0.3 0.0 0.7 0.5 0.6 0.1 0.1 0.0 0.0 1.6 GP5 CD42d ENSG00000178732 "Glycoprotein V platelet" P40197 3 194394821-194398354 "CD markers, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;T-cells: 2.2" "Cell line enriched" "Detected in some" 9 "HEL: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA072646 Approved Cytosol NA NA 400000000 Cytosol "HPA072646: " "unprognostic (3.74e-2)" "unprognostic (3.40e-1)" "unprognostic (5.22e-2)" "unprognostic (2.96e-2)" "unprognostic (1.74e-2)" "unprognostic (1.35e-3)" "unprognostic (1.69e-3)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" "unprognostic (2.80e-2)" "unprognostic (1.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (4.18e-2)" "unprognostic (3.14e-1)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" 0.3 0.0 0.4 2.1 0.5 1.6 0.3 0.3 0.3 0.6 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.5 0.3 0.3 0.4 0.6 0.3 0.6 0.9 3.7 0.3 0.3 0.8 0.3 0.0 0.4 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 0.9 0.3 0.3 1.7 0.2 0.3 0.3 0.3 1.0 0.3 1.9 0.3 0.5 0.1 1.1 0.2 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.4 0.1 0.1 2.0 2.2 0.1 0.0 0.0 1.1 0.0 0.4 0.4 0.5 0.3 0.3 0.4 0.6 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRASP1 "GASP, GASP1" ENSG00000198932 "G protein-coupled receptor associated sorting protein 1" Q5JY77 X 102651366-102659083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.0" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 41.0;Cardiomyocytes: 21.2;Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.2" "Group enriched" "Detected in many" 5 "B-cells: 1.4;T-cells: 5.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 6.8;REH: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000161, HPA031061" Approved Supported Cytosol NA NA Cytosol "HPA000161: AB_2247872, HPA031061: AB_2673718" "unprognostic (3.92e-3)" "unprognostic (1.10e-1)" "unprognostic (2.07e-4)" "unprognostic (1.42e-1)" "unprognostic (3.32e-2)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (2.33e-2)" "unprognostic (1.58e-1)" "unprognostic (2.82e-1)" "prognostic favorable (1.77e-5)" "unprognostic (3.34e-1)" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.23e-2)" 3.5 16.6 19.0 3.7 34.3 2.5 4.0 28.2 37.0 8.9 7.2 4.3 1.6 1.9 18.2 8.1 3.3 8.7 5.5 10.6 19.9 18.3 5.2 1.4 3.8 6.2 7.9 30.3 29.9 3.0 22.4 16.1 2.2 20.6 12.0 3.5 4.0 5.1 13.4 4.0 2.2 4.1 11.7 6.6 6.8 3.5 2.9 5.6 0.9 11.9 0.8 5.4 6.3 6.3 1.4 0.6 0.0 0.0 0.3 5.2 1.0 0.4 0.8 2.6 1.6 2.6 2.7 1.5 2.7 0.2 4.1 6.8 0.3 0.5 0.0 0.6 5.6 0.4 0.7 0.8 0.1 5.9 0.0 0.3 0.2 0.7 0.7 2.1 0.3 0.4 3.5 1.1 5.0 0.4 0.7 0.4 2.6 0.5 0.2 6.4 0.6 5.3 0.2 1.8 0.4 0.9 8.1 2.6 0.0 0.4 0.6 2.6 4.1 0.9 0.4 0.7 2.2 0.4 1.3 0.8 1.3 1.6 0.8 0.4 0.4 0.7 0.0 0.6 0.4 1.7 0.0 0.0 0.0 1.3 0.0 2.9 0.6 2.4 1.0 0.0 1.4 5.2 4.8 0.0 0.3 0.0 0.6 1.8 1.0 19.0 34.3 28.2 37.0 19.9 18.3 7.9 30.3 20.6 5.6 0.0 2.2 0.8 4.4 3.2 41.0 21.2 0.0 0.0 5.7 5.2 35.3 0.3 0.0 0.2 0.3 4.5 0.1 0.0 0.2 0.1 3.8 5.1 2.3 0.6 0.3 6.4 5.8 7.4 0.0 0.5 14.1 1.2 1.7 0.0 0.0 14.1 0.4 0.0 14.5 1.1 18.4 6.5 8.1 1.2 0.8 0.6 0.1 4.1 0.6 1.4 GPSM2 "DFNB82, LGN, Pins" ENSG00000121957 "G protein signaling modulator 2" P81274 1 108875350-108934545 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 35.6" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 125.7;Syncytiotrophoblasts: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007327, HPA008408, CAB018962" Uncertain Supported Cytosol NA Yes Cytosol "CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939" "unprognostic (1.97e-1)" "unprognostic (6.80e-2)" "prognostic favorable (7.86e-5)" "unprognostic (1.37e-3)" "unprognostic (3.18e-2)" "unprognostic (1.97e-2)" "unprognostic (8.57e-6)" "unprognostic (7.12e-2)" "unprognostic (2.76e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.55e-3)" "prognostic unfavorable (3.02e-4)" "unprognostic (6.27e-3)" "unprognostic (1.00e-1)" "unprognostic (5.14e-3)" "unprognostic (6.00e-2)" 3.8 4.0 16.6 4.4 17.9 13.9 8.5 10.1 20.6 7.5 13.6 17.9 2.5 8.0 6.9 4.3 30.4 2.9 3.1 3.0 15.2 14.1 2.6 1.9 6.6 5.8 19.7 9.0 2.4 2.4 4.0 2.1 7.6 19.6 6.3 15.4 1.3 7.0 5.7 8.0 35.6 10.1 10.6 25.1 2.0 5.3 11.4 18.8 14.1 2.3 23.5 12.1 6.5 10.6 1.8 1.6 8.6 1.2 0.7 4.4 0.4 41.3 5.9 13.6 10.7 13.7 8.2 10.2 8.3 21.1 10.3 15.9 6.4 10.6 9.5 2.3 11.6 7.9 9.1 8.8 21.8 13.3 9.8 5.9 7.0 11.6 7.0 1.8 9.3 6.4 1.5 44.6 11.2 44.5 3.8 11.0 7.4 5.3 14.3 22.1 12.8 7.5 4.7 3.5 18.0 10.1 6.6 22.0 2.5 8.9 6.5 10.4 9.0 11.4 23.2 8.8 3.7 9.1 9.0 6.8 7.9 12.4 21.1 15.7 6.4 5.9 9.4 12.7 15.5 36.7 0.1 1.2 8.6 0.8 0.9 0.5 0.7 0.6 1.1 1.6 1.8 1.1 0.8 1.6 0.7 0.4 0.7 4.4 0.4 16.6 17.9 10.1 13.6 15.2 14.1 19.7 9.0 19.6 18.8 14.9 3.5 5.2 16.6 55.6 46.3 2.1 0.0 6.7 14.8 7.0 125.7 42.8 10.0 2.2 39.6 3.8 8.0 0.0 1.6 37.2 12.8 3.8 2.3 0.5 7.7 41.3 8.7 1.8 5.2 16.4 17.3 4.6 25.3 6.4 12.1 7.1 3.2 7.0 4.9 0.3 43.8 0.0 5.3 15.2 25.1 35.5 74.6 7.7 11.8 13.3 GRIP2 KIAA1719 ENSG00000144596 "Glutamate receptor interacting protein 2" 3 14489111-14556075 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 10.3;skeletal muscle: 25.7" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 9.4;Cardiomyocytes: 7.3;Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 21.1;Sertoli cells: 19.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.2;BJ hTERT+ SV40 Large T+ RasG12V: 3.3;NTERA-2: 3.6;PC-3: 10.2;SCLC-21H: 5.7;U-2 OS: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035673 Approved Cytosol NA NA Cytosol "HPA035673: AB_10669776" "unprognostic (1.48e-1)" "unprognostic (6.26e-3)" "unprognostic (2.43e-2)" "unprognostic (3.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.14e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-2)" "unprognostic (9.14e-2)" "unprognostic (2.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (5.82e-1)" "unprognostic (4.01e-1)" 0.5 0.8 3.2 0.4 2.6 0.0 0.5 0.7 6.0 0.4 0.4 1.2 1.9 0.1 1.3 0.5 1.7 0.3 1.0 10.3 3.2 1.5 0.1 0.2 0.1 0.0 3.3 2.0 0.2 0.1 0.1 3.0 1.1 0.4 0.7 0.6 0.4 0.2 25.7 1.4 0.4 0.6 0.0 1.0 2.7 0.4 1.0 0.0 0.0 4.6 0.4 0.5 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.5 0.3 0.0 0.5 5.2 0.6 3.3 2.0 0.0 0.0 1.3 0.3 0.9 0.3 1.2 0.0 0.0 0.0 0.4 0.0 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 2.4 10.2 0.0 0.1 0.0 0.0 0.0 5.7 1.1 0.5 0.0 1.8 1.9 0.0 0.0 0.0 0.3 3.9 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 9.4 7.3 0.0 0.0 1.2 0.0 13.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.1 0.0 4.1 0.6 0.0 3.4 3.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.1 21.1 19.4 0.5 0.0 0.8 0.0 0.1 0.0 0.0 0.0 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.8;parathyroid gland: 11.3" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 22.5;Early spermatids: 24.2;Late spermatids: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol NA NA Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.9 5.3 8.1 0.6 10.5 0.6 0.9 1.6 15.8 2.9 0.8 2.1 0.0 0.9 3.1 0.5 0.6 1.0 0.7 0.6 11.1 9.3 0.5 0.7 0.8 0.5 2.3 10.1 0.8 0.7 11.3 0.6 0.9 4.3 1.2 0.8 0.8 2.1 1.4 0.5 0.6 0.6 5.9 2.8 0.8 0.6 2.8 4.1 0.0 0.7 0.0 0.7 1.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 10.5 1.6 15.8 11.1 9.3 2.3 10.1 4.3 4.1 0.0 0.0 0.0 0.9 0.1 22.5 1.1 7.6 6.7 1.2 0.0 7.9 0.0 1.7 0.0 24.2 0.1 0.0 0.0 0.0 0.1 0.7 1.1 1.1 0.0 0.1 1.6 0.0 0.0 0.0 29.9 0.3 0.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.2 6.5 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.6 GSDME "DFNA5, ICERE-1" ENSG00000105928 "Gasdermin E" O60443 7 24698351-24758113 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Necrosis "Deafness, Non-syndromic deafness, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 151.1;Distal tubular cells: 34.9;Hofbauer cells: 35.4;Syncytiotrophoblasts: 87.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 8.7;myeloid DC: 6.9;naive B-cell: 8.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011326, CAB019306" Approved Enhanced Cytosol NA NA Cytosol "CAB019306: , HPA011326: AB_1847629" "unprognostic (1.08e-1)" "unprognostic (1.77e-2)" "unprognostic (6.29e-2)" "unprognostic (6.36e-3)" "unprognostic (6.70e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.35e-2)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-3)" "unprognostic (1.48e-3)" "unprognostic (6.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.90e-2)" 8.1 6.5 7.7 2.2 10.3 0.5 6.1 5.9 12.1 12.0 14.5 7.8 0.5 6.1 18.4 12.8 4.2 9.9 6.7 7.4 7.5 8.8 10.7 3.6 4.0 4.0 9.3 4.5 14.1 2.3 2.2 4.5 27.1 10.1 5.9 2.1 9.0 2.0 17.7 5.1 1.8 31.3 12.2 25.4 1.5 2.7 9.9 5.0 0.8 11.7 4.0 2.9 9.5 7.0 8.7 6.9 0.0 2.1 0.0 0.1 0.7 9.7 7.2 3.1 13.3 17.0 9.6 5.3 7.6 20.4 8.0 11.3 7.4 0.3 0.1 6.8 21.0 26.7 6.6 1.8 33.5 14.0 0.0 0.7 0.2 12.6 15.0 14.3 0.0 0.5 10.5 24.5 14.1 33.8 23.9 13.5 4.4 0.9 1.6 17.8 0.1 0.6 0.2 3.3 0.0 5.1 0.0 10.9 0.0 24.1 6.9 0.1 19.6 12.0 0.2 13.3 8.3 0.7 0.8 9.1 7.6 13.3 10.2 9.1 0.8 0.2 4.7 22.9 0.0 1.9 0.0 2.1 0.0 0.0 0.2 0.0 8.7 0.1 0.0 6.9 8.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 7.7 10.3 5.9 9.5 7.5 8.8 9.3 4.5 10.1 5.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 5.2 0.0 151.1 34.9 1.5 0.0 0.0 0.0 0.0 0.8 19.3 0.0 0.0 0.0 0.0 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 14.4 0.0 0.0 1.3 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 87.5 0.0 0.0 0.0 GSK3A ENSG00000105723 "Glycogen synthase kinase 3 alpha" P49840 19 42230186-42242625 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase" "Alzheimer disease, Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004422, HPA028423" Approved Approved Cytosol NA NA Cytosol "CAB004422: AB_627680, HPA028423: AB_10612116" "unprognostic (5.46e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (3.80e-3)" "unprognostic (2.27e-1)" "unprognostic (2.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.36e-1)" "unprognostic (2.69e-1)" "unprognostic (2.77e-2)" "unprognostic (4.49e-2)" "unprognostic (7.22e-2)" "unprognostic (8.22e-3)" 15.3 19.8 31.0 16.8 38.0 14.4 12.0 31.4 62.2 15.9 16.8 24.3 11.4 28.6 16.9 18.0 17.3 16.7 11.8 21.3 31.3 23.6 17.5 13.1 14.2 15.0 21.8 26.3 20.0 19.3 16.1 14.2 14.7 31.7 15.8 16.1 15.5 18.1 20.3 41.0 25.1 27.0 18.5 18.0 14.5 14.7 19.1 17.7 16.6 15.8 11.9 15.8 15.8 15.5 1.6 2.2 4.0 1.9 1.7 2.0 1.0 23.4 41.6 23.8 22.1 14.3 12.8 10.1 16.5 15.8 21.9 19.8 15.6 14.9 17.0 17.1 12.9 20.6 10.8 19.6 19.2 15.4 13.7 31.4 17.7 13.3 15.4 18.8 20.0 21.6 12.5 20.4 17.9 20.5 19.0 19.8 12.7 29.6 25.3 18.7 28.4 25.9 17.7 17.6 36.7 17.2 23.7 13.8 13.0 20.2 24.6 27.8 28.1 22.6 29.7 15.0 17.1 17.2 26.5 17.6 22.6 17.0 13.1 29.2 25.9 29.7 13.2 26.2 20.2 24.7 2.5 1.5 1.6 2.0 1.9 1.4 1.2 1.2 1.3 1.4 1.6 0.7 1.5 4.0 1.7 1.1 2.2 1.0 1.0 31.0 38.0 31.4 62.2 31.3 23.6 21.8 26.3 31.7 17.7 6.0 21.0 14.9 15.9 21.9 42.9 10.9 10.2 1.4 6.8 15.7 58.9 20.8 3.3 12.4 6.3 20.2 39.2 0.0 14.9 21.1 14.6 22.2 2.3 12.4 17.7 57.2 22.4 16.5 18.9 8.8 16.4 16.9 15.1 6.4 28.2 37.9 18.9 22.9 15.6 13.1 40.2 6.5 16.5 10.2 16.6 24.6 36.8 12.8 23.8 23.5 GSPT2 "eRF3b, FLJ10441" ENSG00000189369 "G1 to S phase transition 2" Q8IYD1 X 51743431-51746232 "Predicted intracellular proteins" "Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 75.1;Late spermatids: 136.6;Muller glia cells: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 24.4;PC-3: 27.4;SuSa: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044769, HPA074588" Approved Enhanced Cytosol NA NA Cytosol "HPA044769: AB_10963577, HPA074588: " "unprognostic (8.55e-3)" "unprognostic (1.76e-1)" "unprognostic (2.81e-1)" "unprognostic (2.71e-3)" "unprognostic (3.39e-1)" "unprognostic (4.12e-2)" "unprognostic (1.54e-2)" "unprognostic (3.43e-1)" "unprognostic (1.39e-1)" "unprognostic (1.83e-1)" "unprognostic (1.21e-1)" "unprognostic (3.01e-1)" "unprognostic (1.72e-1)" "unprognostic (2.08e-2)" "unprognostic (1.54e-2)" "unprognostic (9.76e-3)" "unprognostic (1.07e-1)" 8.6 11.1 11.6 8.6 17.6 3.6 9.3 14.1 18.3 8.2 7.3 6.5 3.4 4.8 8.3 11.5 4.2 8.8 7.6 9.8 11.5 19.5 9.6 16.0 7.9 12.0 9.2 13.0 15.3 7.3 7.1 14.9 3.6 8.8 10.5 5.5 6.7 8.9 9.7 7.8 4.0 7.6 8.0 6.7 9.0 6.5 18.4 8.8 18.4 9.1 3.8 12.1 7.7 4.1 9.5 9.7 2.7 4.1 7.2 8.3 4.2 0.0 4.9 10.1 0.0 7.2 6.2 0.0 5.7 1.0 4.1 5.2 3.1 5.1 14.5 0.0 4.8 12.7 1.6 0.0 2.6 4.7 0.0 6.4 0.2 0.0 0.0 5.3 0.0 6.3 8.2 1.3 3.6 3.6 7.0 5.9 6.8 3.8 1.1 7.2 0.0 1.2 0.9 24.4 0.0 27.4 6.9 9.5 0.0 7.4 5.3 0.0 8.5 0.0 0.0 4.9 21.0 0.0 4.7 3.7 4.1 8.4 3.8 3.7 0.0 8.3 0.0 5.4 0.9 4.5 2.7 2.9 1.8 5.7 4.1 5.7 9.5 5.1 5.3 9.7 9.5 8.3 7.1 0.3 7.2 3.1 8.2 6.4 4.2 11.6 17.6 14.1 18.3 11.5 19.5 9.2 13.0 8.8 8.8 11.9 10.2 4.7 5.0 1.5 16.1 14.9 17.8 13.4 7.9 14.0 7.9 8.5 5.0 11.5 75.1 5.3 1.1 0.0 7.6 4.2 6.0 5.3 10.4 15.3 5.5 11.1 2.9 8.6 7.0 136.6 11.8 6.3 3.3 11.8 3.1 56.0 5.5 4.8 17.7 9.8 9.4 25.8 4.7 11.8 7.3 1.3 2.9 7.2 3.2 3.1 GSR ENSG00000104687 "Glutathione-disulfide reductase" P00390 8 30678061-30727999 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001538, CAB008632, HPA064806" Approved Supported Cytosol NA NA 110000000 Cytosol "CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: " "unprognostic (1.23e-1)" "prognostic favorable (3.37e-4)" "prognostic favorable (4.08e-5)" "unprognostic (2.89e-3)" "unprognostic (1.62e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (4.15e-2)" "unprognostic (2.83e-2)" "unprognostic (6.92e-3)" "prognostic favorable (1.80e-4)" "unprognostic (2.31e-3)" "unprognostic (2.26e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" 8.9 14.4 6.8 10.7 9.1 7.9 6.2 9.1 11.8 18.6 18.7 7.1 18.4 20.4 13.2 12.0 19.4 8.8 17.3 11.9 5.0 5.7 27.9 17.8 10.8 9.7 4.9 6.0 11.8 17.6 22.9 7.2 8.9 6.8 16.4 17.2 10.9 12.0 17.4 14.7 6.5 31.8 9.3 4.5 13.6 17.7 7.9 4.2 17.0 9.2 11.8 12.0 23.9 14.5 2.5 4.7 19.0 5.7 2.6 7.3 2.1 11.6 49.4 8.0 6.2 8.6 9.7 7.7 5.2 11.5 7.4 10.0 14.5 6.2 22.8 25.8 6.7 22.0 13.1 12.1 11.3 8.2 5.9 11.2 23.0 17.1 48.5 23.2 7.0 37.0 16.1 7.1 11.1 4.5 8.1 10.5 14.5 19.0 10.1 16.7 10.6 24.7 8.2 14.2 48.3 8.8 9.4 9.2 11.0 14.8 29.6 6.1 7.8 7.2 16.8 12.5 11.2 7.2 8.0 14.3 3.1 8.6 7.3 7.7 5.6 6.2 14.7 9.9 9.9 10.1 19.0 4.6 11.5 4.2 4.2 7.3 2.5 3.8 4.6 4.7 2.0 2.4 3.1 6.5 2.6 5.7 2.9 3.2 2.1 6.8 9.1 9.1 11.8 5.0 5.7 4.9 6.0 6.8 4.2 3.0 21.0 15.2 10.5 3.8 6.1 21.4 30.6 9.4 14.8 12.2 15.7 11.8 8.3 9.6 6.9 8.0 61.3 0.0 17.1 5.3 5.4 23.6 5.8 37.6 15.4 3.2 32.7 15.4 38.4 14.1 6.6 12.8 8.5 5.4 52.8 11.8 14.3 34.0 10.3 14.4 7.5 6.5 6.2 1.2 4.4 4.6 5.4 11.3 38.8 23.0 GSTA1 ENSG00000243955 "Glutathione S-transferase alpha 1" P08263 6 52791664-52803910 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Oxidoreductase, Peroxidase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 614.0;Ciliated cells: 837.9;Exocrine glandular cells: 1419.6;Hepatocytes: 628.5;Pancreatic endocrine cells: 1010.1;Proximal tubular cells: 2005.4" "Group enriched" "Detected in many" 6 "liver cancer: 555.4;renal cancer: 135.0" "Region enriched" "Detected in single" 6 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "Hep G2: 89.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA 27800000 Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (4.84e-3)" "unprognostic (2.40e-2)" "unprognostic (3.40e-1)" "unprognostic (4.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-1)" "unprognostic (1.00e-2)" "prognostic favorable (8.66e-4)" "unprognostic (5.75e-2)" "unprognostic (6.90e-3)" "unprognostic (3.00e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.21e-1)" "unprognostic (4.26e-3)" "unprognostic (1.02e-1)" "unprognostic (2.16e-2)" 0.6 119.4 0.6 0.7 4.2 0.0 0.6 0.6 0.7 0.8 64.3 4.3 0.6 59.9 0.6 1.2 0.7 6.9 16.4 0.6 0.6 0.0 79.7 214.4 7.1 0.6 0.6 0.6 8.5 16.9 0.0 0.7 0.9 0.7 1.8 0.2 1.0 2.6 0.8 0.6 0.1 202.4 0.6 0.6 0.6 10.7 78.2 0.6 0.7 0.6 2.1 4.4 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 89.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.7 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 4.2 0.6 0.7 0.6 0.0 0.6 0.6 0.7 0.6 6.0 7.7 0.0 2.8 0.0 0.0 0.0 614.0 837.9 106.9 69.8 0.0 0.1 454.3 72.7 8.0 0.0 11.8 46.7 1419.6 0.0 0.0 51.4 2.3 628.5 0.1 0.0 2.9 23.4 22.6 21.8 60.7 4.4 0.0 22.6 33.3 0.0 1010.1 6.0 4.2 2005.4 0.0 0.0 0.0 5.6 3.4 0.0 0.5 4.3 29.3 42.0 GSTA2 GST2 ENSG00000244067 "Glutathione S-transferase alpha 2" P09210 6 52750089-52763569 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 63.4;liver: 192.2;pancreas: 54.1" "Cell type enhanced" "Detected in many" 15 "Cholangiocytes: 338.8;Ciliated cells: 780.3;Pancreatic endocrine cells: 549.6;Proximal tubular cells: 368.8" "Group enriched" "Detected in many" 16 "liver cancer: 124.6;renal cancer: 48.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 20.7;Hep G2: 15.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (6.43e-3)" "unprognostic (2.41e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (4.34e-2)" "unprognostic (1.91e-1)" "unprognostic (6.54e-2)" 0.2 1.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 6.4 0.2 0.2 13.4 0.2 0.3 0.2 0.0 9.9 0.2 0.2 0.0 63.4 192.2 5.3 0.2 0.2 0.2 0.3 54.1 0.0 0.2 0.3 0.2 0.7 0.0 0.2 0.3 0.2 0.2 0.0 27.6 0.2 0.2 0.2 1.5 14.1 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 20.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 15.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.5 0.3 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 5.9 0.5 0.1 0.0 0.0 0.0 338.8 780.3 46.6 15.7 0.0 0.0 180.8 6.3 4.5 0.0 0.0 0.0 201.6 0.1 0.0 5.3 0.0 50.4 0.1 0.0 0.0 1.3 1.6 6.5 1.1 1.3 0.0 9.0 0.4 0.0 549.6 0.0 0.4 368.8 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.1 1.0 GSTA3 ENSG00000174156 "Glutathione S-transferase alpha 3" Q16772 6 52896639-52909685 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9" "Group enriched" "Detected in some" 8 "Cytotrophoblasts: 121.8;Syncytiotrophoblasts: 430.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "pons and medulla: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;CACO-2: 1.2;HAP1: 2.3;HEK 293: 1.2;SK-BR-3: 2.1;SuSa: 5.2" "HPA004342, HPA048934, HPA053817" Approved Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (7.51e-2)" "unprognostic (7.06e-3)" "unprognostic (3.10e-1)" "unprognostic (5.53e-2)" "unprognostic (4.38e-3)" "unprognostic (2.86e-3)" "unprognostic (1.81e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (9.35e-2)" 0.2 36.5 0.2 0.2 0.6 0.0 0.7 0.3 0.2 0.9 0.2 1.0 0.2 0.0 0.3 6.6 0.2 32.4 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 0.2 0.2 3.8 0.2 1.1 0.2 51.9 2.1 0.2 0.0 0.5 0.6 0.2 0.2 12.5 0.2 0.2 0.2 0.2 1.0 6.4 0.3 0.2 0.2 0.9 0.2 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.2 0.2 0.2 0.2 0.2 2.1 0.3 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 33.5 10.3 0.0 0.0 121.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.4 0.2 0.0 1.1 0.2 13.5 0.0 0.0 0.0 0.0 1.3 1.4 0.0 23.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 8.5 430.9 0.0 0.0 0.0 GSTA5 ENSG00000182793 "Glutathione S-transferase alpha 5" Q7RTV2 6 52831655-52846095 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.3" "Cell type enriched" "Detected in single" 5 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004342, HPA048934, HPA053817" Uncertain Approved Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.97e-2)" "unprognostic (2.83e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 GSTM3 GST5 ENSG00000134202 "Glutathione S-transferase mu 3" P21266 1 109733932-109741038 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 115.3;testis: 96.0" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 1724.2;Late spermatids: 2908.0;Spermatocytes: 818.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.1" "Group enriched" "Detected in many" 7 "granulocytes: 4.1;T-cells: 11.1" "Cell line enhanced" "Detected in many" "SK-BR-3: 45.7;T-47d: 96.9;WM-115: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017130, HPA035190, CAB040583, HPA055972" Enhanced Approved Cytosol NA NA 560000 Cytosol "CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992" "unprognostic (2.13e-2)" "unprognostic (2.76e-2)" "unprognostic (1.95e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.28e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.89e-4)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (2.30e-1)" "unprognostic (6.16e-3)" "unprognostic (1.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.90e-2)" "unprognostic (3.48e-2)" 7.5 11.3 21.4 2.9 27.8 0.9 23.1 8.5 18.4 15.4 11.7 9.9 51.0 12.6 9.0 67.2 11.1 8.8 12.3 27.6 14.0 14.4 54.0 5.3 5.2 2.4 9.6 22.0 32.3 26.5 7.3 9.4 5.8 30.7 13.6 5.6 13.4 4.5 115.3 15.5 15.0 7.5 15.9 13.3 3.3 14.2 96.0 6.4 0.1 15.8 15.6 3.3 17.4 12.0 0.6 0.8 4.1 0.3 1.0 11.1 1.4 0.0 1.3 9.9 0.0 13.5 8.3 1.7 10.7 1.8 11.8 11.5 4.3 0.3 0.0 6.2 5.4 8.2 0.5 2.0 4.4 16.4 0.0 2.9 10.0 32.5 6.4 14.4 0.0 23.3 8.3 5.4 17.7 0.0 13.1 14.5 12.4 0.9 0.1 5.3 5.8 2.7 0.2 1.1 0.0 18.6 0.0 6.4 0.4 3.3 23.0 17.5 9.4 22.4 45.7 2.1 3.0 96.9 14.6 11.4 0.1 4.3 12.0 7.0 1.5 2.4 0.0 0.1 0.0 37.6 0.8 0.3 4.1 4.2 0.1 1.2 0.6 5.3 3.1 0.1 0.6 11.1 5.5 2.0 1.0 0.2 0.8 2.3 1.4 21.4 27.8 8.5 18.4 14.0 14.4 9.6 22.0 30.7 6.4 6.0 11.5 8.1 96.3 127.5 19.3 82.7 40.8 1.4 17.0 211.1 5.9 13.4 679.8 74.2 1724.2 31.5 27.6 0.0 131.2 7.7 152.1 47.5 9.2 2.5 8.6 14.3 48.5 54.0 6.6 2908.0 356.9 16.6 57.3 5.4 23.4 255.3 110.8 25.9 259.6 35.7 14.3 187.5 89.7 818.6 48.1 93.8 8.6 7.9 40.9 29.8 GTDC1 "FLJ11753, Hmat-Xa" ENSG00000121964 "Glycosyltransferase like domain containing 1" Q4AE62 2 143938068-144332568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036694 Approved Cytosol NA NA Cytosol "HPA036694: AB_10671709" "unprognostic (1.44e-1)" "unprognostic (1.22e-1)" "unprognostic (9.00e-3)" "unprognostic (3.36e-2)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.81e-7)" "unprognostic (8.01e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-1)" "unprognostic (6.22e-3)" "unprognostic (6.96e-2)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.44e-1)" "unprognostic (8.23e-2)" "unprognostic (6.31e-3)" "unprognostic (1.89e-1)" 14.5 12.9 22.1 7.1 17.3 12.3 8.9 7.3 26.7 12.9 6.9 15.3 1.6 4.0 6.8 9.8 7.5 6.0 10.1 15.2 21.4 14.1 9.4 6.4 8.0 9.8 18.2 14.9 12.6 7.0 10.9 10.7 9.3 14.1 6.4 6.7 7.0 5.9 6.0 8.8 5.3 4.8 7.1 24.0 12.6 4.8 11.7 11.6 6.1 10.6 3.1 11.2 8.9 6.3 4.3 2.0 10.8 2.5 8.0 12.3 3.4 4.7 2.0 14.2 2.6 14.6 13.5 4.3 3.3 8.3 7.3 10.1 2.2 4.4 10.2 2.3 5.9 4.7 1.3 2.8 4.9 15.7 13.0 3.3 15.7 1.7 2.2 6.0 6.3 8.6 9.3 12.2 7.9 11.6 5.0 10.4 4.2 2.8 11.9 16.7 2.2 1.6 7.0 4.0 3.6 3.2 4.7 7.3 2.7 8.1 9.7 7.1 5.7 6.4 5.5 6.5 9.3 3.6 7.2 6.4 8.1 6.0 3.6 4.1 7.6 0.0 5.7 4.8 4.2 10.9 2.1 2.5 7.3 5.7 2.2 12.3 4.3 3.8 9.5 2.0 3.4 0.8 6.3 10.8 8.0 2.4 0.7 4.7 3.4 22.1 17.3 7.3 26.7 21.4 14.1 18.2 14.9 14.1 11.6 8.9 30.5 7.5 3.9 6.4 19.2 15.9 0.0 18.7 17.0 5.2 3.9 3.4 5.0 3.7 8.5 11.3 3.5 0.0 9.0 3.8 16.5 3.7 16.3 3.0 9.0 17.5 4.1 23.9 16.9 3.6 11.8 12.1 5.0 10.8 2.6 11.0 7.4 3.5 13.1 5.7 3.5 12.9 17.3 3.7 19.6 4.1 3.5 16.0 3.5 7.8 GUCY1B1 "GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3" ENSG00000061918 "Guanylate cyclase 1 soluble subunit beta 1" Q02153 4 155758992-155807591 "Enzymes, Plasma proteins, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 71.6" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 6.0;Collecting duct cells: 8.7;Ductal cells: 14.1;Proximal tubular cells: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "intermediate monocyte: 5.6;non-classical monocyte: 17.8" "Lineage enriched" "Detected in many" 12 "monocytes: 17.8" "Cell line enhanced" "Detected in many" "HEL: 25.3;Karpas-707: 13.4;MOLT-4: 16.0;RPTEC TERT1: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010890, HPA020870" Approved Approved Cytosol NA NA 5200 Cytosol "CAB010890: AB_259911, HPA020870: AB_1850444" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (3.55e-2)" "unprognostic (9.10e-3)" "unprognostic (4.69e-2)" "unprognostic (1.41e-2)" "unprognostic (6.88e-2)" "unprognostic (6.69e-3)" "unprognostic (3.03e-3)" "unprognostic (1.47e-1)" "unprognostic (8.37e-2)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (7.35e-3)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.14e-1)" "unprognostic (6.36e-3)" 8.8 5.4 18.7 9.8 42.0 1.8 5.5 12.2 36.8 8.1 14.9 5.7 0.4 4.2 11.3 4.7 5.9 9.5 9.2 12.2 16.1 25.0 9.2 5.4 9.4 6.6 14.5 23.2 3.7 7.4 71.6 3.8 28.0 20.6 9.8 6.2 5.8 3.2 8.7 3.8 2.2 5.9 16.3 6.7 7.2 8.9 2.1 5.5 2.6 4.6 2.4 5.1 8.0 6.8 0.2 1.4 1.1 17.8 0.9 0.0 4.8 0.0 0.2 3.6 0.0 1.2 6.8 0.0 1.1 2.0 0.1 0.0 0.0 0.0 0.0 1.7 0.6 2.9 0.0 7.4 0.1 0.4 0.0 2.7 25.3 0.0 0.0 0.7 0.0 0.0 3.0 0.2 0.0 0.1 2.5 0.0 5.7 0.0 13.4 1.8 1.1 16.0 0.0 0.2 0.0 1.9 1.8 0.5 0.4 25.7 2.4 0.4 4.5 0.0 0.1 0.0 3.7 0.0 0.0 0.0 4.2 0.9 7.2 5.3 0.1 0.0 0.0 9.2 0.0 0.0 1.1 0.4 0.3 0.0 5.6 0.0 0.1 0.0 0.0 1.4 0.2 0.0 0.0 0.4 0.9 17.8 1.2 0.0 4.8 18.7 42.0 12.2 36.8 16.1 25.0 14.5 23.2 20.6 5.5 6.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.5 5.0 14.1 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.1 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 H6PD GDH ENSG00000049239 "Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase" O95479 1 9234775-9271337 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 116.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 29.2;ASC TERT1: 33.5;HSkMC: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004824, HPA005440" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 91000000 Cytosol "HPA004824: AB_1079037, HPA005440: AB_1079036" "unprognostic (4.83e-3)" "unprognostic (3.91e-2)" "unprognostic (1.18e-1)" "unprognostic (3.49e-1)" "unprognostic (5.53e-3)" "unprognostic (2.86e-2)" "unprognostic (8.35e-2)" "unprognostic (5.18e-2)" "unprognostic (9.73e-2)" "unprognostic (1.26e-3)" "unprognostic (2.16e-2)" "unprognostic (7.35e-3)" "unprognostic (8.20e-2)" "unprognostic (3.61e-1)" "unprognostic (1.30e-1)" "unprognostic (8.65e-2)" "unprognostic (1.95e-1)" 18.3 16.1 4.1 10.7 5.5 4.8 12.2 4.1 6.3 16.6 11.9 10.5 8.2 6.3 22.0 18.0 11.1 15.6 11.9 11.9 3.7 3.0 7.0 116.9 12.2 11.1 6.8 2.6 38.3 10.6 8.0 8.7 14.9 6.0 11.6 5.3 11.8 29.8 8.1 24.7 20.7 10.4 10.2 6.6 10.7 9.9 12.4 5.5 16.2 12.6 12.9 14.1 12.2 10.1 4.5 3.7 4.1 6.3 3.1 4.7 3.0 3.9 3.2 2.8 10.5 29.2 33.5 2.7 3.9 9.8 2.9 4.6 0.6 8.1 4.3 4.6 6.1 3.7 4.1 0.7 1.9 4.3 12.9 0.9 0.0 1.0 2.6 16.3 1.4 1.7 32.9 3.8 7.0 4.6 6.5 13.4 2.4 1.1 7.5 5.7 2.3 1.5 3.2 1.5 2.9 1.9 0.5 0.3 3.6 3.8 1.6 0.9 5.0 5.2 4.1 4.9 2.0 3.1 7.0 13.3 10.1 1.7 2.5 1.1 10.0 2.9 1.0 16.9 6.3 6.4 3.5 6.2 0.9 4.7 6.3 3.7 3.5 3.5 4.1 2.8 4.5 3.4 3.2 4.1 3.1 5.8 3.7 2.8 3.0 4.1 5.5 4.1 6.3 3.7 3.0 6.8 2.6 6.0 5.5 23.8 29.3 11.2 11.1 12.7 18.1 13.0 58.6 10.7 12.5 19.2 25.5 9.0 0.0 15.8 0.8 14.7 15.1 0.0 18.5 6.5 24.0 16.2 3.5 132.8 11.5 15.9 7.5 17.8 18.0 1.5 44.5 10.3 11.8 64.9 15.2 11.2 20.1 17.5 34.6 8.2 11.5 0.0 9.2 4.7 4.6 11.2 4.9 13.8 24.1 11.4 HAL HIS ENSG00000084110 "Histidine ammonia-lyase" P42357 12 95972662-95996365 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 29.5;liver: 96.8;skin 1: 26.9" "Group enriched" "Detected in some" 13 "Erythroid cells: 46.7;Hepatocytes: 134.4" "Cancer enriched" "Detected in some" 11 "liver cancer: 23.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 20.1;neutrophil: 29.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 29.5" "Cell line enhanced" "Detected in some" "BEWO: 3.2;NB-4: 4.0;THP-1: 15.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038547, HPA038548" Enhanced Approved Cytosol NA NA 67000 Cytosol "HPA038547: AB_10669541, HPA038548: AB_10673175" "unprognostic (3.39e-1)" "unprognostic (4.46e-2)" "unprognostic (1.53e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (5.05e-2)" "unprognostic (2.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.33e-2)" "unprognostic (9.41e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-3)" "unprognostic (1.89e-2)" "unprognostic (3.74e-1)" "unprognostic (4.03e-2)" "unprognostic (2.87e-2)" 0.5 0.0 0.1 1.1 0.3 4.4 0.9 0.1 0.3 0.3 0.2 0.1 0.1 0.1 1.1 0.3 0.5 0.2 0.3 0.2 0.1 0.0 0.2 96.8 1.7 2.3 0.5 0.1 0.3 0.5 0.0 7.4 0.4 0.2 0.2 0.0 0.1 0.2 0.1 0.2 26.9 0.2 0.2 0.3 2.7 0.1 0.2 0.2 0.1 0.2 0.9 1.3 0.2 0.5 0.0 1.4 29.5 6.3 0.3 0.1 1.6 0.6 0.0 0.2 0.1 0.0 0.0 3.2 0.0 0.2 0.1 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.2 0.5 0.4 0.2 0.0 0.0 0.6 0.7 0.0 0.9 0.4 0.4 0.1 0.3 0.4 0.0 0.2 0.1 0.0 0.2 4.0 1.3 0.1 0.7 0.3 0.1 0.1 0.1 0.8 0.2 0.4 0.5 0.1 0.0 0.1 0.0 15.5 0.2 0.1 0.2 0.2 0.2 0.7 0.7 0.2 0.0 2.4 0.0 20.1 6.3 0.9 0.0 2.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 29.5 0.3 5.1 0.1 0.1 1.6 0.1 0.3 0.1 0.3 0.1 0.0 0.5 0.1 0.2 0.2 0.0 1.4 0.0 0.1 0.1 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 46.7 0.2 0.2 0.0 0.1 0.0 134.4 0.3 0.0 0.0 1.8 6.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.1 HARS USH3B ENSG00000170445 "Histidyl-tRNA synthetase" P12081 5 140673904-140691862 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036539 Approved Enhanced Cytosol NA NA 52000 Cytosol "HPA036539: AB_10669796" "unprognostic (9.35e-2)" "unprognostic (9.95e-2)" "unprognostic (1.62e-3)" "unprognostic (1.65e-2)" "unprognostic (2.33e-1)" "unprognostic (8.57e-2)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.50e-2)" "unprognostic (1.46e-1)" "unprognostic (3.82e-2)" "unprognostic (1.28e-2)" "unprognostic (2.40e-1)" "unprognostic (3.46e-2)" "unprognostic (2.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.26e-2)" "unprognostic (1.36e-1)" 22.4 24.5 28.5 21.1 35.5 18.1 21.0 41.1 46.3 20.6 22.7 20.0 23.6 17.4 21.6 23.5 26.9 23.7 17.5 25.1 29.5 35.9 20.6 34.2 16.7 22.4 36.9 33.0 24.7 25.2 29.5 38.7 15.0 38.2 21.7 24.8 13.6 22.1 27.9 27.1 33.9 16.4 28.0 21.0 18.3 18.8 16.6 23.5 17.6 19.4 20.3 28.5 19.9 20.9 16.8 22.1 10.7 22.9 25.2 29.4 23.4 20.6 30.2 18.2 39.7 23.2 25.3 19.2 33.3 24.0 38.5 36.0 54.9 17.5 27.5 29.3 37.3 31.1 21.7 27.6 53.5 36.3 23.3 34.1 19.8 39.2 34.8 28.8 31.1 17.0 26.7 16.8 41.9 23.9 23.0 38.6 17.1 17.3 22.9 40.0 35.5 22.1 29.0 14.3 16.7 19.9 20.5 26.4 22.4 30.9 26.4 28.6 27.7 27.6 40.2 26.2 18.3 29.6 17.5 32.2 36.1 13.9 20.3 44.8 23.1 27.4 27.8 27.4 26.1 24.7 6.7 14.1 10.7 29.4 20.8 26.3 16.8 25.8 27.3 22.1 14.8 28.2 26.9 4.3 25.2 22.9 15.6 22.1 23.4 28.5 35.5 41.1 46.3 29.5 35.9 36.9 33.0 38.2 23.5 14.9 19.4 29.8 29.5 27.2 27.3 7.7 20.4 14.7 15.9 26.2 13.7 35.0 38.1 46.0 30.2 30.6 23.2 0.0 37.0 41.1 27.2 20.1 15.1 76.4 31.4 28.6 24.8 26.4 17.5 15.9 23.3 22.3 35.4 61.3 22.2 20.7 37.7 23.0 32.5 33.8 20.0 45.3 41.8 29.6 30.4 28.4 30.1 30.2 25.5 25.7 HARS2 "HARSL, HARSR, HO3" ENSG00000112855 "Histidyl-tRNA synthetase 2, mitochondrial" P49590 5 140691426-140699318 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035941 Approved Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA035941: AB_10671237" "prognostic unfavorable (6.49e-4)" "unprognostic (3.15e-2)" "prognostic favorable (6.19e-4)" "unprognostic (1.79e-2)" "unprognostic (1.78e-1)" "unprognostic (8.30e-3)" "prognostic unfavorable (2.92e-4)" "unprognostic (7.77e-2)" "unprognostic (1.88e-1)" "unprognostic (5.26e-2)" "unprognostic (1.58e-1)" "unprognostic (2.68e-2)" "unprognostic (1.85e-1)" "unprognostic (5.40e-2)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (1.31e-2)" 17.1 23.8 14.2 22.9 19.4 13.4 25.0 24.7 19.0 15.0 21.6 16.6 19.7 17.7 20.2 16.9 16.7 14.9 16.7 25.2 15.7 12.6 19.6 14.5 21.4 25.2 15.5 11.2 17.4 13.6 22.9 21.1 15.8 14.4 14.3 24.4 16.4 16.4 15.4 32.7 18.3 17.2 15.6 12.9 18.5 17.9 15.1 15.6 16.5 15.8 13.9 18.8 20.6 18.4 13.7 12.0 22.9 15.0 22.8 17.6 9.7 10.9 24.7 10.7 27.5 12.2 16.2 17.7 14.1 16.1 19.9 17.4 22.6 13.8 13.9 22.8 15.6 19.6 13.9 14.8 26.5 18.4 13.9 12.2 10.1 23.7 14.9 11.8 13.5 14.9 15.2 18.1 19.4 22.0 16.1 14.3 14.7 9.3 13.1 19.2 13.9 13.2 16.8 12.3 8.3 15.6 13.5 10.9 14.0 18.6 25.6 14.9 21.4 20.5 33.3 27.9 16.3 29.4 13.5 17.4 17.9 9.9 9.9 18.6 13.0 18.9 13.4 14.1 15.6 17.8 22.9 10.5 21.3 16.2 15.0 17.5 13.7 15.6 16.2 12.0 12.5 16.4 17.6 12.1 22.8 11.4 9.5 15.3 9.7 14.2 19.4 24.7 19.0 15.7 12.6 15.5 11.2 14.4 15.6 3.0 4.3 10.4 3.8 3.1 4.8 16.5 2.5 9.4 6.8 5.2 0.0 16.4 11.6 11.9 0.9 7.1 6.7 0.0 14.0 15.3 6.3 3.7 2.3 5.9 8.8 0.0 7.5 6.7 7.8 1.7 8.6 8.3 3.3 12.6 7.2 7.7 13.2 10.5 9.9 6.7 5.2 0.0 7.2 6.4 14.1 3.4 12.0 7.5 11.2 3.9 HDAC7 "DKFZP586J0917, HDAC7A" ENSG00000061273 "Histone deacetylase 7" Q8WUI4 12 47782722-47833132 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 85.8" "Cell type enhanced" "Detected in many" 4 "Ito cells: 87.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 10.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004775 Supported Cytosol NA NA Cytosol "HPA004775: AB_1850548" "unprognostic (3.83e-1)" "unprognostic (9.49e-3)" "unprognostic (1.37e-2)" "unprognostic (4.46e-2)" "unprognostic (6.56e-3)" "unprognostic (2.22e-2)" "unprognostic (2.50e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.28e-1)" "unprognostic (2.07e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (6.24e-2)" "unprognostic (4.38e-2)" "unprognostic (9.69e-2)" "prognostic favorable (4.65e-4)" 26.0 21.6 8.2 22.7 10.8 17.3 24.4 8.4 10.7 28.2 20.7 8.7 15.4 8.0 27.9 21.5 19.2 25.2 22.1 16.5 10.3 4.3 17.7 5.1 27.6 21.1 8.2 8.0 25.4 8.9 23.7 11.5 17.5 10.0 20.1 4.1 17.6 16.3 18.9 12.5 19.7 13.9 24.9 10.3 23.1 14.9 9.5 11.5 85.8 20.9 12.9 21.0 24.8 25.0 1.4 0.6 10.5 1.9 1.7 1.5 1.8 14.2 9.7 10.1 16.5 7.9 22.1 9.1 14.0 10.9 10.2 6.7 12.9 13.5 28.6 46.8 12.7 5.0 13.2 2.3 10.9 3.7 13.4 4.8 9.8 9.5 3.0 8.6 3.0 0.4 14.4 3.8 10.1 5.5 18.4 21.0 16.4 10.3 11.7 6.4 6.2 28.1 7.5 14.1 3.1 10.8 21.7 5.4 10.3 4.3 9.3 2.9 6.9 10.7 5.0 5.1 6.8 4.7 4.1 23.8 20.9 22.7 17.0 9.9 26.5 19.2 22.7 8.6 14.5 6.8 0.0 1.9 0.0 1.5 0.8 1.5 1.4 1.3 1.1 0.6 1.1 1.5 1.0 10.5 1.7 0.7 0.5 0.6 1.8 8.2 10.8 8.4 10.7 10.3 4.3 8.2 8.0 10.0 11.5 38.7 36.7 31.8 21.0 12.2 18.0 11.5 30.6 5.3 22.7 34.9 0.0 3.9 1.7 29.4 13.4 71.6 1.1 0.0 19.7 2.5 28.8 40.0 8.1 0.4 13.7 27.0 7.0 87.8 29.5 4.9 50.9 11.5 13.5 12.6 9.7 13.6 47.3 9.7 31.1 2.9 3.2 25.8 20.6 0.9 3.1 18.9 2.4 26.6 7.6 38.2 HDLBP "HBP, VGL" ENSG00000115677 "High density lipoprotein binding protein" Q00341 2 241227264-241317061 "Plasma proteins, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 210.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004189, CAB026457" Enhanced Supported Cytosol NA NA Cytosol "CAB026457: , HPA004189: AB_1079044" "unprognostic (2.57e-2)" "unprognostic (1.13e-2)" "unprognostic (2.13e-2)" "unprognostic (1.51e-1)" "unprognostic (4.46e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (1.70e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-2)" "unprognostic (4.39e-3)" "unprognostic (3.92e-2)" "unprognostic (9.48e-3)" "unprognostic (2.47e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (6.39e-5)" "prognostic unfavorable (4.12e-4)" 38.2 38.7 18.1 18.1 27.7 15.9 37.4 18.1 27.0 39.6 30.4 24.7 38.2 22.5 34.8 43.2 35.3 38.7 30.9 37.5 17.9 15.9 33.9 92.0 29.9 20.9 19.8 16.6 40.1 210.4 40.5 40.0 44.4 22.5 35.9 29.4 26.1 105.2 34.3 80.2 27.6 36.1 29.9 18.5 23.0 39.2 39.6 19.3 20.8 39.0 45.7 34.7 31.9 31.0 10.9 22.4 11.6 28.8 10.1 12.3 12.4 34.4 27.7 29.0 46.2 74.2 91.1 41.3 86.0 88.3 39.1 56.0 24.8 35.3 10.5 10.4 124.4 39.5 27.6 43.2 56.3 64.2 16.7 26.7 33.5 35.0 60.5 72.7 23.9 29.2 67.3 45.8 56.8 64.0 61.5 53.3 16.9 31.8 14.1 61.0 35.9 13.7 12.5 28.1 33.9 18.4 12.8 56.4 20.9 31.9 41.1 24.2 27.7 37.5 39.5 33.5 37.7 31.2 23.4 66.9 47.9 30.5 66.1 36.0 16.7 13.7 18.6 60.7 17.8 43.8 11.6 20.0 9.1 9.3 21.9 12.3 10.9 10.6 11.1 22.4 7.4 9.6 8.9 11.5 10.1 28.8 14.7 9.8 12.4 18.1 27.7 18.1 27.0 17.9 15.9 19.8 16.6 22.5 19.3 71.5 78.3 34.3 93.1 62.4 40.0 194.7 68.8 192.7 135.4 71.5 41.2 101.3 114.4 97.3 89.3 67.6 127.8 23.3 105.3 136.3 141.1 173.9 65.9 177.0 82.5 65.2 92.7 87.8 59.9 303.9 137.8 58.4 54.0 82.0 181.5 47.2 115.6 122.0 164.4 96.7 35.3 64.7 111.0 124.2 118.4 67.9 180.2 35.2 119.7 133.4 HDX "CXorf43, FLJ30678" ENSG00000165259 "Highly divergent homeobox" Q7Z353 X 84317874-84502479 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 19.1;Urothelial cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047189 Uncertain Approved Cytosol NA NA Cytosol "HPA047189: AB_10965463" "unprognostic (7.26e-2)" "unprognostic (3.53e-2)" "unprognostic (1.64e-2)" "unprognostic (1.51e-5)" "unprognostic (3.23e-4)" "unprognostic (5.52e-2)" "unprognostic (1.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (6.40e-6)" "unprognostic (1.14e-1)" "unprognostic (7.20e-2)" "unprognostic (3.86e-3)" "unprognostic (2.34e-1)" "unprognostic (1.30e-2)" "unprognostic (3.66e-2)" 5.1 7.4 8.3 3.3 7.9 0.6 6.4 23.1 10.2 8.2 4.6 2.6 3.5 1.8 7.4 5.3 4.2 6.3 5.5 4.8 5.5 4.6 4.3 4.5 4.4 2.3 6.5 7.0 8.0 2.2 5.5 16.4 1.4 6.6 6.0 4.5 2.0 4.5 6.2 1.7 1.9 2.9 6.6 5.7 4.2 3.2 4.0 7.1 0.4 5.7 2.7 2.7 5.2 8.3 2.7 6.1 0.0 6.9 1.4 1.4 1.1 0.0 2.2 9.0 0.0 5.4 4.7 0.0 2.9 3.9 6.9 7.8 0.4 1.2 0.0 0.6 3.0 8.8 0.5 0.1 1.1 5.4 0.0 0.6 0.0 1.7 0.0 5.0 0.0 0.0 3.2 0.1 4.4 2.9 3.9 6.9 0.0 0.0 0.0 6.8 0.1 0.0 0.0 6.6 0.0 3.0 0.0 7.6 0.1 3.2 1.5 0.3 5.1 0.0 0.2 0.0 3.8 0.4 0.0 7.3 3.8 2.6 1.2 2.7 0.2 0.0 0.0 1.8 0.0 1.6 0.0 4.3 0.0 1.4 6.9 0.2 2.7 0.4 0.3 6.1 1.0 1.2 0.7 0.0 1.4 5.9 0.6 0.2 1.1 8.3 7.9 23.1 10.2 5.5 4.6 6.5 7.0 6.6 7.1 0.0 2.4 1.3 19.1 2.3 8.5 1.6 2.5 1.4 4.5 5.2 11.8 0.0 0.0 5.2 3.8 7.1 0.7 0.0 1.6 0.0 5.1 11.0 1.1 0.2 0.9 6.4 6.8 1.8 1.6 1.0 3.7 2.6 0.0 3.6 1.3 3.3 2.8 2.0 3.2 1.7 5.0 0.0 3.3 0.5 0.0 1.5 0.1 1.3 0.9 18.0 HECA "dJ225E12.1, HDC, HDCL, hHDC" ENSG00000112406 "Hdc homolog, cell cycle regulator" Q9UBI9 6 139135112-139180802 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 111.7;Suprabasal keratinocytes: 124.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012581, HPA042313" Uncertain Approved Cytosol NA NA Cytosol "HPA012581: , HPA042313: AB_10796903" "unprognostic (2.98e-2)" "unprognostic (2.39e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-1)" "unprognostic (7.31e-2)" "unprognostic (3.38e-3)" "unprognostic (4.29e-2)" "unprognostic (3.27e-1)" "unprognostic (7.39e-2)" "unprognostic (2.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.09e-4)" "unprognostic (3.47e-1)" "unprognostic (2.59e-1)" "unprognostic (4.72e-3)" "unprognostic (5.77e-2)" 17.2 8.9 11.7 19.3 12.6 31.5 38.5 10.8 18.7 12.1 17.7 9.2 9.3 15.7 15.5 8.8 21.0 12.0 12.8 26.5 16.6 10.6 7.5 10.3 20.4 34.2 14.1 13.3 19.3 9.6 10.7 8.3 10.4 14.6 10.8 12.3 5.7 16.4 9.7 22.1 24.8 18.8 14.7 14.7 25.2 11.5 9.0 13.3 34.1 11.4 10.8 23.9 16.1 38.3 3.0 1.7 7.5 7.3 2.2 6.9 2.2 3.0 0.6 6.0 6.9 13.9 12.8 4.4 5.5 9.3 2.5 5.8 1.2 3.5 13.2 8.1 11.4 6.0 5.1 3.6 5.0 4.6 20.6 7.7 6.6 3.1 0.2 4.4 11.5 6.0 14.6 12.3 5.5 6.7 6.9 8.4 8.9 2.8 17.9 4.6 3.1 5.6 9.5 1.1 2.6 1.1 8.8 6.1 6.6 2.2 9.7 5.8 1.7 4.5 12.5 3.4 7.0 2.8 15.4 10.5 4.4 4.2 10.0 4.7 10.8 8.0 12.1 1.6 6.8 2.5 6.9 2.0 2.8 4.4 2.6 5.6 2.4 6.9 6.0 1.5 3.0 6.6 6.5 7.5 2.2 7.3 1.7 5.8 2.2 11.7 12.6 10.8 18.7 16.6 10.6 14.1 13.3 14.6 13.3 6.0 15.2 20.0 18.9 111.7 1.4 33.9 7.6 1.4 5.7 10.4 2.0 5.9 0.0 6.7 9.4 34.3 31.1 23.3 8.5 4.8 30.1 27.6 12.7 10.5 16.9 1.6 12.6 37.4 76.3 9.1 14.4 36.1 42.2 3.6 21.1 6.0 12.4 25.2 18.4 2.3 2.5 51.8 34.8 11.1 4.1 124.3 14.5 39.9 15.7 35.1 HECW1 "KIAA0322, NEDL1" ENSG00000002746 "HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1" Q76N89 7 43112599-43566001 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0;kidney: 15.4" "Group enriched" "Detected in some" 4 "Early spermatids: 118.3;Horizontal cells: 42.9;Late spermatids: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 5.5;GAMG: 4.9;U-266/70: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007203, HPA007593, HPA007609" Approved Supported Cytosol NA NA Cytosol "HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518" "unprognostic (1.40e-1)" "unprognostic (2.85e-3)" "unprognostic (2.57e-1)" "unprognostic (4.39e-1)" "unprognostic (2.43e-2)" "unprognostic (2.80e-2)" "unprognostic (8.65e-4)" "unprognostic (6.93e-2)" "unprognostic (7.30e-2)" "unprognostic (7.31e-2)" "unprognostic (3.43e-2)" "unprognostic (2.67e-2)" "unprognostic (1.43e-3)" "unprognostic (1.64e-2)" "unprognostic (5.23e-3)" "unprognostic (1.89e-2)" "unprognostic (2.42e-2)" 0.7 0.5 10.3 0.8 12.1 1.4 0.8 13.6 24.0 0.6 0.8 1.1 0.0 0.4 0.8 1.7 2.6 0.5 4.0 0.4 3.9 4.1 15.4 0.6 0.6 1.3 3.8 15.5 1.0 0.4 1.7 0.4 0.6 10.2 3.2 0.5 0.6 1.0 0.8 1.8 2.1 0.6 0.7 1.4 0.6 1.0 3.7 1.6 0.0 1.5 0.0 0.8 1.2 0.6 2.4 1.6 7.0 1.7 1.6 0.7 0.1 0.1 5.5 0.6 0.8 0.0 0.0 0.0 1.6 2.8 0.1 0.7 0.0 0.0 0.2 3.1 2.7 4.9 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.4 0.2 0.2 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.0 0.0 0.0 0.0 0.0 2.4 0.1 0.9 0.5 0.0 0.0 0.0 0.1 0.2 0.7 0.5 0.1 0.0 0.3 0.4 0.0 0.0 0.8 1.1 1.3 0.4 15.7 0.5 0.0 3.5 0.4 0.0 6.4 1.7 1.1 0.7 1.0 0.5 1.0 0.7 0.3 0.2 2.4 0.6 0.7 7.0 1.6 0.9 1.6 0.2 0.1 10.3 12.1 13.6 24.0 3.9 4.1 3.8 15.5 10.2 1.6 0.0 0.0 0.0 0.3 0.3 13.6 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 118.3 0.3 2.0 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 42.9 0.0 0.6 0.0 44.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.6 0.4 15.9 1.8 0.0 0.8 2.1 2.5 0.3 0.0 0.5 0.4 0.3 HERC3 KIAA0032 ENSG00000138641 "HECT and RLD domain containing E3 ubiquitin protein ligase 3" Q15034 4 88592423-88708542 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.6;hTERT-HME1: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039170 Approved Approved Cytosol NA NA Cytosol "HPA039170: AB_10673414" "unprognostic (2.21e-2)" "unprognostic (1.65e-2)" "unprognostic (9.28e-3)" "unprognostic (3.24e-1)" "unprognostic (6.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.30e-2)" "unprognostic (1.85e-2)" "unprognostic (9.77e-2)" "unprognostic (6.51e-3)" "unprognostic (3.48e-3)" "unprognostic (2.58e-2)" "prognostic favorable (5.65e-7)" "unprognostic (1.83e-1)" "unprognostic (3.21e-2)" "unprognostic (1.67e-1)" "unprognostic (1.16e-2)" 12.7 13.3 16.9 13.0 27.1 21.0 15.3 37.8 20.1 14.4 12.0 17.9 11.6 11.2 12.0 10.5 16.8 10.7 12.1 22.0 15.2 13.7 15.8 13.0 15.0 15.3 21.9 15.0 12.7 9.7 33.8 16.1 10.0 21.1 22.0 13.4 22.0 14.0 14.0 17.3 19.1 12.8 13.8 16.3 15.7 12.9 3.6 21.5 16.6 15.7 12.6 16.4 13.3 16.7 5.2 7.0 18.2 9.7 3.1 9.0 3.9 7.3 1.1 1.4 2.4 7.9 16.7 4.7 8.3 15.4 8.7 5.8 1.9 8.6 7.8 4.0 27.6 4.0 2.6 2.0 7.6 8.3 3.4 2.3 5.4 3.3 1.2 4.5 13.4 9.8 7.9 9.4 8.3 37.6 4.9 9.6 4.1 3.9 3.4 17.7 2.2 9.2 3.2 0.4 4.8 2.0 10.4 9.7 3.2 5.6 1.4 1.9 1.9 9.6 6.1 3.2 2.4 1.0 6.0 15.0 9.9 5.4 9.3 6.2 6.5 1.6 4.5 6.2 6.1 4.1 5.7 5.7 7.7 4.7 6.2 5.5 5.2 5.5 4.7 7.0 4.9 8.2 5.8 18.2 3.1 9.7 2.4 9.0 3.9 16.9 27.1 37.8 20.1 15.2 13.7 21.9 15.0 21.1 21.5 6.0 5.8 8.8 7.9 31.9 24.1 18.5 7.6 4.0 2.3 8.7 104.1 5.8 1.7 3.6 2.6 9.3 9.2 23.3 7.9 13.2 7.3 12.5 15.1 11.0 8.3 30.2 26.5 8.6 27.9 2.7 7.8 17.3 13.5 2.8 10.1 9.2 7.4 8.6 12.4 5.0 59.1 6.5 11.3 3.0 7.0 44.4 6.2 13.1 5.2 10.4 HLCS HCS ENSG00000159267 "Holocarboxylase synthetase" P50747 21 36750888-36990236 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ligase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017379 Approved Approved Cytosol NA NA Cytosol "HPA017379: AB_1850768" "prognostic unfavorable (7.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.93e-2)" "unprognostic (2.05e-1)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (5.08e-2)" "unprognostic (2.67e-1)" "unprognostic (1.54e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.44e-2)" "unprognostic (2.43e-1)" "unprognostic (2.55e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-3)" "unprognostic (3.02e-1)" 6.3 9.6 7.1 9.8 10.3 2.9 10.6 12.2 8.5 7.7 7.2 10.3 12.1 5.7 6.4 9.4 7.1 8.1 9.9 5.3 8.4 8.0 9.1 16.4 6.7 5.8 10.2 6.0 5.5 15.6 23.3 23.9 9.9 9.4 12.8 6.4 11.7 9.9 11.6 13.5 4.3 8.1 7.3 10.6 4.5 7.6 7.7 5.1 4.9 14.3 6.1 8.0 9.2 4.9 3.9 5.3 3.2 10.0 8.5 7.8 2.9 18.0 6.7 10.1 7.3 12.1 11.0 9.9 11.0 10.6 5.0 5.6 7.2 8.5 9.8 5.3 15.9 10.4 6.2 5.1 8.4 4.5 19.5 10.5 14.5 6.6 4.6 14.4 7.8 7.5 8.7 13.0 7.6 20.3 9.6 6.3 9.6 15.6 25.1 12.7 10.9 3.5 3.6 15.8 12.4 9.4 6.1 5.8 7.9 7.8 18.2 7.1 7.4 14.5 6.7 11.1 8.3 11.8 8.0 8.5 7.3 2.2 6.6 6.0 24.3 14.9 6.1 10.5 9.8 8.4 3.2 2.1 1.6 7.8 4.0 6.1 2.6 4.5 5.2 2.0 3.9 5.4 5.5 2.7 8.5 10.0 5.3 2.7 2.9 7.1 10.3 12.2 8.5 8.4 8.0 10.2 6.0 9.4 5.1 8.9 12.2 0.5 8.0 3.0 12.5 3.2 15.3 6.7 9.1 12.2 21.6 6.8 6.6 6.7 4.4 2.2 4.0 0.0 6.9 4.9 3.0 9.1 5.7 14.9 3.9 17.5 5.8 4.3 3.1 2.9 4.0 3.4 0.0 3.6 6.5 6.3 7.2 2.9 6.7 5.6 13.6 0.0 6.4 4.4 8.7 3.4 4.2 2.5 5.2 5.4 HOMER1 "HOMER-1B, SYN47, Ves-1" ENSG00000152413 "Homer scaffolding protein 1" Q86YM7 5 79372636-79514217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9;skeletal muscle: 28.0" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 87.3;Syncytiotrophoblasts: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004437, HPA036521, HPA036522" Enhanced Supported Approved Cytosol No No Cytosol "CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171" "unprognostic (2.80e-1)" "unprognostic (5.30e-2)" "unprognostic (4.00e-2)" "unprognostic (5.79e-2)" "unprognostic (8.83e-2)" "unprognostic (6.40e-2)" "unprognostic (2.00e-3)" "unprognostic (2.41e-3)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (3.07e-3)" "unprognostic (3.98e-1)" "unprognostic (7.35e-2)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (2.83e-2)" "unprognostic (2.86e-3)" 3.0 1.6 11.3 2.4 19.7 0.6 2.7 8.4 28.9 4.4 1.6 1.2 0.0 1.0 6.8 4.5 4.7 2.5 6.9 19.1 8.5 4.2 5.9 2.0 5.1 1.3 2.9 13.3 4.7 2.4 4.5 3.6 5.3 5.3 2.0 1.3 2.1 1.9 2.1 28.0 2.6 1.2 4.7 2.2 1.1 2.1 5.1 3.5 1.7 14.4 4.8 1.7 5.0 2.2 2.0 0.6 0.2 0.0 0.4 2.3 0.5 8.4 5.9 8.9 14.0 3.4 2.2 20.5 5.4 4.3 5.5 5.9 9.2 6.0 0.1 16.5 4.6 10.0 4.6 10.9 14.6 9.5 1.2 8.6 10.2 2.5 9.1 5.5 4.8 3.3 3.6 9.5 4.9 13.8 2.2 2.5 15.9 12.4 5.6 7.1 11.9 20.0 3.3 14.9 3.0 5.0 13.1 14.5 12.9 5.8 13.2 9.0 5.4 10.2 7.3 5.4 10.3 10.0 4.2 0.4 4.1 10.3 4.9 9.5 2.7 6.1 5.0 11.6 1.9 7.8 0.0 0.0 0.1 2.3 0.0 1.3 2.0 0.9 0.7 0.0 1.6 0.5 1.7 0.2 0.4 0.0 0.6 0.0 0.5 11.3 19.7 8.4 18.8 8.5 4.2 2.9 13.3 5.3 3.5 47.6 11.1 9.8 25.1 57.1 25.5 87.3 10.2 13.4 13.6 15.7 25.5 45.8 10.0 3.7 3.6 4.7 2.6 0.0 3.7 37.8 15.1 20.5 5.7 7.3 10.1 49.3 10.9 3.7 9.0 3.9 5.2 10.5 20.3 1.8 5.0 3.3 4.6 2.9 8.1 5.3 9.1 12.9 15.1 3.3 8.3 47.9 70.6 4.9 2.5 18.0 HOMER2 "CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2" ENSG00000103942 "Homer scaffolding protein 2" Q9NSB8 15 82836946-82986153 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 80.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 186.0;Exocrine glandular cells: 66.4;Glandular cells: 96.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 21.5;Karpas-707: 38.1;SCLC-21H: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040134, CAB079014" Uncertain Supported Supported Cytosol NA NA Cytosol "CAB079014: , HPA040134: AB_10795272" "unprognostic (7.34e-2)" "unprognostic (3.58e-2)" "unprognostic (5.75e-4)" "unprognostic (3.31e-3)" "unprognostic (4.85e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-2)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (2.75e-1)" "unprognostic (8.16e-4)" "unprognostic (2.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.26e-1)" "unprognostic (4.45e-3)" 0.7 2.9 3.9 0.5 3.8 1.6 9.9 5.1 6.5 8.9 1.4 4.6 2.7 3.2 3.4 13.0 8.0 9.6 12.9 12.5 5.0 3.1 2.8 19.4 2.5 1.0 2.5 4.2 1.7 80.9 2.7 4.5 0.4 13.2 21.8 0.6 12.7 34.5 2.0 36.0 15.9 0.6 0.7 5.4 2.3 17.8 2.3 2.0 0.2 13.4 14.2 5.0 0.8 4.3 1.4 4.1 1.6 0.6 0.4 1.1 1.0 6.5 2.8 3.0 7.7 0.0 0.0 0.5 0.4 0.0 0.7 0.2 0.5 4.7 0.0 3.6 3.4 3.4 3.7 21.5 10.1 0.5 17.8 13.7 4.2 0.1 3.3 0.3 0.1 13.6 0.7 15.5 0.2 0.9 0.8 0.0 8.4 0.1 38.1 2.8 19.2 1.2 0.4 4.7 0.6 2.1 0.8 4.7 2.2 10.4 8.1 21.1 5.4 7.5 5.8 7.0 2.2 7.0 1.4 0.1 7.2 13.3 0.5 6.0 4.9 2.3 0.7 12.1 0.1 2.6 0.3 0.6 1.5 0.4 0.5 0.3 0.7 0.8 0.2 4.1 1.4 0.6 0.4 1.6 0.4 0.3 1.8 1.1 1.0 3.9 3.8 5.1 6.5 5.0 3.1 2.5 4.2 13.2 2.0 14.9 8.5 2.4 45.7 4.0 9.9 19.3 186.0 1.4 19.4 10.4 17.7 0.8 6.6 25.6 1.4 2.8 0.3 0.0 66.4 0.4 2.5 96.8 0.0 53.3 14.1 19.1 2.9 0.6 2.5 1.8 1.7 5.0 35.4 10.0 0.2 15.8 25.6 0.0 0.7 5.9 4.8 0.0 4.6 4.3 11.4 5.3 0.6 0.9 0.4 25.6 HPCAL4 "DKFZp761G122, HLP4" ENSG00000116983 "Hippocalcin like 4" Q9UM19 1 39678648-39691689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 80.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 36.4;Distal tubular cells: 10.0" "Group enriched" "Detected in some" 11 "glioma: 5.4;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 5.6;naive CD4 T-cell: 5.0" "Lineage enriched" "Detected in single" 33 "T-cells: 5.6" "Cell line enhanced" "Detected in some" "Karpas-707: 4.0;SH-SY5Y: 13.4;SK-MEL-30: 4.2;U-2 OS: 2.8;U-266/70: 3.5;U-266/84: 4.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 336.7;basal ganglia: 201.9;cerebral cortex: 348.1;hippocampal formation: 324.0;olfactory region: 266.4" HPA053808 Approved Cytosol NA NA Cytosol "HPA053808: AB_2682270" "unprognostic (2.62e-1)" "unprognostic (2.37e-1)" "unprognostic (2.13e-2)" "unprognostic (8.56e-4)" "unprognostic (4.73e-3)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (4.89e-3)" "unprognostic (1.27e-1)" "unprognostic (3.18e-2)" "unprognostic (4.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.62e-3)" "unprognostic (3.78e-3)" "unprognostic (2.77e-2)" "unprognostic (3.97e-2)" "unprognostic (2.63e-1)" 1.2 10.2 35.8 1.8 46.0 1.5 1.2 31.1 80.4 1.2 1.2 3.7 0.0 1.3 1.2 1.5 5.5 1.2 1.3 1.4 28.3 17.0 3.5 1.2 1.7 1.9 7.5 32.7 3.7 4.7 1.2 0.4 1.2 6.8 1.4 1.3 0.0 1.2 1.3 2.1 1.2 1.3 1.2 4.4 1.4 1.3 4.1 3.0 0.0 1.2 0.0 1.8 1.3 0.0 0.0 0.1 0.0 0.0 0.0 5.6 1.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 2.1 0.3 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.6 0.0 1.2 13.4 0.4 0.0 4.2 0.3 0.0 0.1 0.0 0.0 2.8 0.0 0.0 3.5 4.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.4 0.0 5.6 1.0 0.1 0.0 5.0 1.8 0.0 0.0 0.0 0.0 3.8 1.8 35.8 46.0 31.1 40.4 28.3 17.0 7.5 32.7 6.8 3.0 0.0 0.0 0.0 0.1 0.0 36.4 0.8 0.0 0.0 1.2 1.8 0.0 0.0 10.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 5.0 0.1 0.0 1.4 0.0 1.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 HPRT1 "HGPRT, HPRT" ENSG00000165704 "Hypoxanthine phosphoribosyltransferase 1" P00492 X 134460153-134520513 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease mutation, FDA approved drug targets, Gout" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 192.3;monocytes: 181.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006360, CAB012200" Enhanced Supported Cytosol NA NA 15000000 Cytosol "CAB012200: AB_297217, HPA006360: AB_1079082" "unprognostic (2.02e-1)" "unprognostic (2.18e-1)" "unprognostic (1.46e-1)" "unprognostic (2.32e-3)" "unprognostic (8.55e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (1.58e-2)" "unprognostic (4.77e-3)" "unprognostic (4.93e-2)" "unprognostic (2.02e-2)" "unprognostic (7.05e-2)" "unprognostic (1.38e-3)" "unprognostic (6.00e-2)" "unprognostic (2.12e-1)" "unprognostic (2.04e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" 7.9 14.9 31.0 12.6 30.2 25.3 11.3 24.2 49.8 7.5 13.7 5.8 9.8 11.0 7.9 36.2 10.3 9.4 8.1 12.8 27.6 37.3 18.4 24.7 7.3 15.9 23.5 28.9 9.8 20.2 9.9 18.6 8.8 34.4 8.8 13.2 9.7 7.1 9.5 10.7 8.0 14.2 9.5 9.8 8.7 17.1 39.7 4.9 13.7 12.3 8.6 15.9 10.8 7.5 13.5 19.7 10.1 18.5 19.9 29.3 12.6 31.4 15.1 4.3 8.8 9.6 13.9 13.0 16.8 16.2 21.5 28.4 13.6 20.2 35.6 38.3 10.9 25.7 19.3 27.7 23.0 37.2 29.5 51.9 19.3 21.5 13.8 9.5 41.5 17.8 10.2 8.7 19.2 30.6 11.9 24.8 21.2 14.8 0.9 16.8 32.1 32.0 36.0 8.8 37.1 40.8 19.2 21.8 36.5 25.9 15.3 27.2 14.8 12.1 9.9 11.4 12.2 8.4 17.4 12.2 14.6 11.0 41.9 41.7 13.6 23.5 0.2 18.0 46.1 8.0 2.2 11.6 10.1 11.6 18.5 16.7 12.3 17.3 15.3 19.7 13.5 14.3 15.1 2.9 19.9 17.2 8.2 29.3 12.6 31.0 30.2 24.2 49.8 27.6 37.3 23.5 28.9 34.4 4.9 17.9 8.0 31.0 44.7 35.1 39.0 20.7 33.1 24.1 15.9 54.1 3.9 12.2 192.3 35.3 6.9 29.4 17.7 0.0 28.2 23.6 24.0 37.5 34.6 18.1 62.7 23.8 26.4 15.4 61.4 18.0 37.7 64.9 52.3 181.3 22.6 23.4 31.4 22.6 25.1 21.6 59.2 51.8 47.2 74.7 143.7 33.9 5.0 61.0 37.4 39.6 HPS5 "AIBP63, BLOC2S2, RU2" ENSG00000110756 "HPS5, biogenesis of lysosomal organelles complex 2 subunit 2" Q9UPZ3 11 18278668-18322198 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Albinism, Disease mutation, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 89.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077851 Approved Supported Cytosol NA NA Cytosol "HPA077851: " "unprognostic (2.25e-2)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "unprognostic (2.59e-1)" "unprognostic (9.85e-3)" "unprognostic (5.89e-1)" "unprognostic (1.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.61e-1)" "unprognostic (5.20e-2)" "unprognostic (1.51e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.06e-1)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (2.72e-1)" 7.1 9.0 6.7 8.4 7.7 4.5 15.2 6.9 6.1 6.0 8.6 8.0 3.2 8.7 5.5 4.2 7.5 5.5 5.7 6.2 6.5 6.0 8.9 35.7 12.5 11.9 8.1 4.3 7.7 9.9 8.1 18.0 13.5 7.9 5.1 4.8 15.9 20.7 7.1 5.5 6.1 18.6 5.9 11.6 15.1 4.8 17.5 7.8 9.2 7.7 4.3 15.3 6.2 5.5 10.0 14.7 15.7 9.8 4.5 5.0 4.2 6.2 9.3 9.9 10.0 13.4 7.5 10.8 16.5 13.7 10.9 11.6 5.7 2.0 15.2 6.5 14.3 13.8 9.0 11.5 10.9 13.5 12.7 8.4 7.3 7.7 7.0 12.7 16.0 13.7 12.0 11.1 6.7 14.4 11.2 8.7 9.8 9.6 8.9 17.6 5.1 8.4 11.6 5.0 7.2 10.3 12.5 14.2 6.4 10.6 5.7 3.3 6.5 20.8 7.5 24.6 10.3 5.6 9.3 6.5 12.6 6.8 16.3 7.6 3.8 12.4 17.5 7.0 8.3 35.4 15.7 6.2 4.9 4.1 9.6 5.0 10.0 5.0 4.1 14.7 8.6 5.0 4.9 1.8 4.5 9.8 5.7 4.4 4.2 6.7 7.7 6.9 6.1 6.5 6.0 8.1 4.3 7.9 7.8 89.3 10.5 10.0 12.5 13.9 18.0 15.3 15.3 10.7 7.9 7.0 29.5 17.6 5.0 4.5 40.4 9.7 6.7 0.0 7.3 9.4 9.7 13.5 13.9 34.8 16.2 9.5 10.3 9.8 18.6 12.8 7.8 23.5 27.0 37.9 4.6 14.6 5.9 6.0 12.4 5.7 25.2 6.5 9.2 15.0 11.7 13.4 14.5 8.7 5.0 20.3 HSD17B1 "EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1" ENSG00000108786 "Hydroxysteroid 17-beta dehydrogenase 1" P14061 17 42549214-42555213 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 217.6" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 1251.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "BEWO: 89.7" "Low region specificity" "Detected in single" "HPA021032, HPA065296" Enhanced Supported Cytosol NA NA Cytosol "HPA021032: AB_1844345, HPA065296: AB_2685457" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (1.68e-2)" "unprognostic (9.25e-2)" "unprognostic (1.73e-1)" "unprognostic (3.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (9.35e-2)" "unprognostic (6.04e-2)" "unprognostic (2.88e-5)" "unprognostic (2.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.60e-2)" "unprognostic (5.09e-1)" "unprognostic (4.98e-1)" "unprognostic (1.32e-2)" 2.8 1.5 2.0 1.7 2.1 1.1 1.8 2.7 3.1 1.3 1.3 1.3 1.3 1.9 1.5 1.3 4.3 1.4 1.3 1.4 2.4 1.4 1.4 1.3 1.3 1.6 2.4 1.3 5.8 2.6 0.2 1.4 217.6 1.3 1.5 0.2 1.3 2.9 1.3 3.5 4.1 1.9 1.3 1.9 2.1 2.0 2.3 1.3 1.3 1.8 1.3 1.3 1.3 1.8 6.0 5.5 7.5 8.6 6.1 5.4 5.5 1.6 1.8 0.9 4.6 0.6 0.1 89.7 1.2 0.0 0.0 0.0 1.0 0.9 0.0 1.2 0.0 1.0 2.6 0.1 0.7 0.0 2.4 2.8 1.2 1.1 1.5 0.2 1.0 1.4 0.2 2.6 0.1 0.5 1.5 0.0 1.3 1.7 0.4 0.0 1.6 1.3 1.1 0.4 0.6 0.8 1.3 1.1 0.8 0.1 1.4 1.3 1.8 0.7 9.1 1.4 1.0 11.0 0.8 1.4 1.4 1.8 1.0 0.8 2.6 1.5 0.6 0.6 0.9 1.1 3.6 7.6 7.5 4.9 8.6 5.3 5.6 5.4 5.1 5.5 6.0 5.1 4.4 7.2 6.1 5.3 4.3 3.7 5.5 2.0 2.1 2.7 1.5 2.4 1.4 2.4 1.3 1.3 1.3 0.0 2.1 0.5 6.3 2.7 8.7 2.4 2.5 4.0 2.3 5.2 11.8 250.4 19.9 1.5 1.0 4.1 3.2 0.0 4.9 23.6 3.4 13.0 2.3 5.6 26.4 9.5 4.1 4.9 0.8 1.7 1.7 0.5 1.7 1.0 2.4 9.0 2.0 2.5 3.2 10.5 8.2 0.0 2.8 0.7 2.6 6.5 1251.0 1.3 1.9 8.4 HSP90AA1 "FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA" ENSG00000080824 "Heat shock protein 90 alpha family class A member 1" P07900 14 102080738-102139699 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 519.3" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 6915.7;Urothelial cells: 5558.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002058 Approved Supported Cytosol NA NA 94000000 Cytosol "CAB002058: " "prognostic unfavorable (5.59e-4)" "unprognostic (3.77e-2)" "unprognostic (1.78e-2)" "unprognostic (9.25e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (7.79e-3)" "unprognostic (5.71e-2)" "unprognostic (7.81e-3)" "unprognostic (3.68e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.18e-5)" "unprognostic (1.04e-1)" "unprognostic (2.54e-1)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" 50.8 75.3 96.1 46.7 106.8 64.1 118.6 81.3 113.4 51.0 47.3 50.7 43.0 31.0 40.7 55.5 40.9 94.7 61.0 70.9 99.6 113.3 75.6 62.5 51.7 48.1 134.4 58.6 53.4 40.1 94.9 121.6 67.2 143.6 63.2 53.3 23.4 57.0 57.0 65.2 35.6 38.9 51.0 139.7 35.7 41.3 84.6 132.7 53.5 91.5 34.3 59.5 54.2 519.3 30.7 46.9 31.8 29.9 57.7 63.1 21.9 86.8 118.8 75.9 52.3 46.1 39.0 100.8 96.7 46.5 118.6 66.9 72.1 81.6 106.8 91.1 62.1 77.8 96.5 217.7 94.5 216.3 80.8 71.7 82.4 67.9 92.0 22.8 122.7 63.6 36.6 40.2 75.8 27.9 74.2 65.4 115.4 113.8 54.9 107.3 117.4 131.1 56.4 78.8 160.2 112.4 126.5 103.1 46.1 68.8 112.3 100.0 72.2 122.2 92.0 53.9 132.9 118.3 49.0 46.2 83.0 53.7 123.3 183.5 52.0 162.1 158.0 78.5 75.9 99.9 31.8 19.9 24.0 47.8 29.9 63.1 29.6 40.5 49.0 23.9 30.7 30.1 43.5 13.5 57.7 27.5 46.9 39.2 21.9 96.1 106.8 81.3 102.7 99.6 113.3 134.4 58.6 143.6 132.7 1057.1 642.7 718.4 6915.7 1191.0 1040.4 2043.0 677.7 2973.9 1019.1 486.8 1981.1 1152.8 290.1 998.3 319.6 818.5 645.6 934.5 749.7 1610.0 1217.1 2796.5 903.1 527.2 1188.6 683.3 908.6 338.8 568.8 289.5 677.7 1578.9 1233.2 998.3 507.2 1211.6 739.1 659.3 679.6 610.3 3287.9 608.0 1393.6 3574.3 1881.8 973.5 1714.6 761.4 693.9 5558.4 HSP90AB1 "HSPC2, HSPCB" ENSG00000096384 "Heat shock protein 90 alpha family class B member 1" P08238 6 44246166-44253888 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 3438.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005230, HPA055729, HPA072606, HPA074351" Enhanced Supported Cytosol "Intracellular and membrane" NA Yes 62000000 Cytosol "CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252" "unprognostic (6.12e-3)" "unprognostic (2.96e-3)" "unprognostic (4.72e-2)" "unprognostic (9.24e-2)" "unprognostic (4.20e-1)" "unprognostic (1.15e-3)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "unprognostic (7.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (3.02e-1)" "unprognostic (9.53e-2)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" 79.9 116.1 88.0 65.9 105.0 74.6 107.8 92.1 118.2 92.3 60.4 61.7 80.9 40.6 113.3 107.6 71.6 138.4 63.8 115.0 89.0 110.5 72.0 70.7 76.2 73.8 109.7 94.4 238.4 113.9 151.6 95.3 83.6 133.7 93.5 76.4 52.7 64.8 100.3 197.1 67.9 49.0 102.1 93.9 57.5 77.3 45.9 100.2 58.3 133.8 89.8 102.5 86.2 223.4 75.9 50.5 7.2 45.7 55.7 82.5 74.9 135.6 87.0 77.3 95.0 53.1 55.6 81.0 61.3 60.1 113.6 80.0 130.1 41.6 173.8 66.5 63.8 115.6 79.1 188.1 91.3 140.6 57.5 76.1 135.2 49.3 170.0 38.5 135.0 93.7 51.4 61.8 89.2 77.1 99.7 108.6 89.9 180.5 64.9 77.2 137.0 112.4 81.4 90.2 251.8 66.7 108.5 79.1 95.4 76.8 82.5 113.3 69.2 47.6 69.1 86.0 109.7 89.8 67.6 68.1 67.8 113.5 55.4 140.0 75.2 117.8 313.9 73.7 99.3 77.2 7.2 30.2 6.8 49.3 45.7 82.5 75.9 55.2 56.4 50.5 63.2 75.2 71.3 3.7 55.7 43.3 31.4 42.6 74.9 88.0 105.0 92.1 118.2 89.0 110.5 109.7 94.4 133.7 100.2 833.7 606.4 539.1 3438.1 940.9 289.3 1217.7 456.0 1493.6 1074.9 347.2 214.0 960.1 618.4 836.0 145.7 761.3 375.2 163.5 596.7 897.4 930.6 1319.6 967.8 307.7 711.8 321.0 544.1 275.6 256.9 156.5 635.1 727.9 698.5 738.6 374.5 296.6 721.4 313.4 574.6 560.9 223.5 342.8 894.3 197.9 740.6 807.2 939.3 460.3 567.6 2341.3 HSPA5 "BiP, GRP78" ENSG00000044574 "Heat shock protein family A (Hsp70) member 5" P11021 9 125234853-125241330 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal glandular cells: 1106.3;Syncytiotrophoblasts: 1110.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 200.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005221, HPA038845, HPA038846" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 1000000000 Cytosol "CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478" "unprognostic (3.98e-2)" "unprognostic (2.50e-3)" "unprognostic (6.64e-2)" "unprognostic (9.60e-3)" "unprognostic (1.54e-3)" "unprognostic (6.02e-3)" "unprognostic (9.08e-3)" "unprognostic (9.11e-3)" "unprognostic (4.50e-2)" "unprognostic (7.45e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (7.28e-2)" "unprognostic (3.66e-2)" 44.2 40.3 26.3 40.8 38.4 125.0 58.8 19.5 26.9 37.7 29.3 19.8 47.0 25.5 31.6 75.3 34.1 31.1 25.5 72.7 23.3 28.6 60.4 147.6 43.6 32.7 34.3 14.3 36.2 110.3 41.1 47.6 62.6 43.5 34.3 33.0 16.5 84.9 40.7 23.9 32.3 38.3 33.8 28.2 33.8 35.1 33.0 41.5 23.2 219.3 21.7 29.8 50.4 75.1 33.3 53.8 57.4 55.3 51.9 63.0 90.0 35.5 24.0 31.7 41.8 37.9 43.9 74.7 64.1 50.9 47.7 56.0 37.2 71.1 41.1 40.0 46.7 103.4 45.5 28.3 57.2 51.3 23.8 14.3 24.6 30.1 67.1 200.5 33.5 46.6 27.0 112.4 38.2 167.8 50.6 74.0 8.7 18.2 57.5 34.6 26.3 14.7 23.7 35.8 87.0 24.2 14.0 32.3 66.6 46.2 23.5 16.4 29.2 40.7 43.7 65.3 51.1 45.0 24.5 49.6 29.1 28.3 29.7 29.7 60.2 57.4 34.8 70.6 28.3 43.8 57.4 55.3 44.3 61.9 54.8 63.0 33.3 45.7 57.7 48.6 24.9 37.6 46.6 44.3 51.9 35.5 53.8 31.2 90.0 26.3 38.4 19.5 26.9 23.3 28.6 34.3 14.3 43.5 41.5 172.7 228.8 134.1 1106.3 260.1 93.3 493.6 73.9 190.1 253.6 106.4 331.8 423.2 38.1 330.8 34.2 189.6 316.5 46.7 227.7 576.5 389.6 402.8 329.8 324.2 392.1 60.4 487.5 159.0 114.8 42.9 162.3 280.8 172.1 141.5 125.9 124.7 293.4 101.7 164.1 109.1 122.6 116.4 222.8 360.8 228.7 206.6 1110.2 140.9 109.4 772.3 HTATIP2 "CC3, FLJ26963, SDR44U1, TIP30" ENSG00000109854 "HIV-1 Tat interactive protein 2" Q9BUP3 11 20363685-20383783 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Differentiation, Host-virus interaction" "Developmental protein, Oxidoreductase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006417, HPA024321" Approved Supported Cytosol NA NA Cytosol "HPA006417: AB_1079091, HPA024321: AB_1851288" "unprognostic (8.05e-3)" "unprognostic (2.13e-1)" "unprognostic (9.31e-2)" "unprognostic (3.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.79e-3)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.20e-3)" "unprognostic (1.05e-1)" "unprognostic (4.93e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.75e-1)" "prognostic unfavorable (8.01e-4)" "unprognostic (1.20e-1)" "unprognostic (9.42e-2)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" 16.3 28.1 8.5 11.9 16.3 6.3 26.3 3.2 10.6 9.4 50.4 16.2 10.8 52.2 6.8 13.0 23.1 5.7 17.6 9.5 10.8 9.9 21.5 41.8 19.5 16.2 24.3 8.0 6.8 11.9 17.9 27.4 22.9 12.4 13.9 32.2 3.3 16.5 9.2 19.4 14.8 74.6 12.1 15.0 19.6 29.4 10.6 14.6 6.6 23.9 17.2 12.1 17.8 26.7 16.4 17.4 69.4 30.6 13.5 30.6 23.8 23.1 38.5 0.8 0.0 11.8 9.0 8.6 10.1 10.0 7.8 9.4 22.2 20.4 5.3 20.8 12.6 30.4 32.6 0.0 6.1 7.6 60.3 4.7 6.5 38.0 0.0 28.5 2.4 31.1 12.9 43.5 6.3 9.9 0.0 22.3 0.0 16.0 7.0 14.5 21.7 0.0 1.5 12.5 40.7 19.2 4.9 0.0 19.0 10.6 12.9 10.5 0.1 32.8 13.0 15.4 4.2 27.2 12.2 27.1 5.6 12.3 11.3 0.2 7.5 9.2 0.1 0.0 16.5 24.1 43.7 30.6 37.3 15.5 27.5 17.5 14.9 18.0 16.5 17.4 16.4 15.8 15.5 69.4 13.5 28.3 5.1 30.6 23.8 8.5 16.3 3.2 10.6 10.8 9.9 24.3 8.0 12.4 14.6 23.8 8.1 24.1 49.8 32.3 0.3 9.7 117.2 8.1 10.3 45.4 0.0 50.0 26.6 84.2 36.1 22.9 185.2 0.0 63.6 102.1 14.2 53.7 23.0 69.2 75.1 3.2 23.2 28.8 55.0 45.4 18.4 40.5 42.2 143.3 93.7 9.4 88.6 161.4 8.9 60.3 1.7 12.9 29.5 27.3 17.2 36.8 51.5 35.8 83.1 52.5 IDO2 INDOL1 ENSG00000188676 "Indoleamine 2,3-dioxygenase 2" Q6ZQW0 8 39934614-40016391 "Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "liver: 9.7;placenta: 21.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 16.8;Late spermatids: 5.3;monocytes: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;U-266/70: 1.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA054911 Approved Cytosol NA NA Cytosol "HPA054911: " "unprognostic (2.00e-3)" "unprognostic (2.34e-5)" "unprognostic (2.22e-3)" "unprognostic (4.41e-3)" "unprognostic (5.37e-2)" "unprognostic (3.69e-5)" "unprognostic (1.19e-1)" "unprognostic (4.73e-3)" "unprognostic (1.20e-2)" "unprognostic (2.78e-1)" "unprognostic (4.11e-3)" "unprognostic (2.25e-1)" "unprognostic (6.47e-7)" "unprognostic (3.25e-2)" "unprognostic (1.96e-3)" "unprognostic (3.35e-2)" "unprognostic (3.08e-3)" 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 9.7 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 IFIT1 "G10P1, GARG-16, IFI56, IFNAI1" ENSG00000185745 "Interferon induced protein with tetratricopeptide repeats 1" P09914 10 89392546-89406486 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 54.7;Muller glia cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 47.8" "Group enriched" "Detected in all" 7 "granulocytes: 47.8;monocytes: 13.5" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 115.4;BJ hTERT+ SV40 Large T+ RasG12V: 113.9" "CAB045980, HPA053890, HPA055380" Approved Enhanced Cytosol NA NA Cytosol "CAB045980: AB_11125836, HPA053890: , HPA055380: AB_2682800" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.80e-1)" "unprognostic (7.96e-3)" "unprognostic (1.35e-3)" "unprognostic (2.02e-2)" "unprognostic (6.45e-2)" "unprognostic (3.66e-1)" "unprognostic (3.34e-1)" "unprognostic (8.65e-3)" "unprognostic (1.82e-2)" "unprognostic (7.68e-2)" "unprognostic (2.21e-2)" "unprognostic (2.03e-2)" "unprognostic (5.95e-2)" "unprognostic (9.75e-3)" "unprognostic (6.40e-3)" 17.4 25.1 21.8 4.6 18.4 10.5 8.7 38.8 29.8 9.2 8.1 9.9 3.5 4.1 8.0 13.7 7.6 10.3 17.5 15.6 16.5 24.0 23.7 28.7 16.8 3.4 20.1 22.6 10.3 6.8 19.5 13.5 12.4 28.8 9.6 6.4 10.6 46.4 8.2 18.3 3.3 4.7 10.1 24.9 20.8 4.5 5.2 18.3 5.0 7.9 7.7 2.9 9.6 6.2 2.2 2.7 47.8 13.5 1.3 4.5 5.2 3.2 0.3 0.7 5.6 2.9 6.0 0.0 3.8 24.1 115.4 113.9 0.3 3.4 0.2 1.3 4.9 21.9 2.5 0.3 0.3 5.6 0.1 0.3 0.4 2.7 0.2 3.3 0.4 0.3 4.8 0.0 2.1 0.0 2.1 0.1 0.5 0.0 2.5 1.2 0.0 0.7 2.1 0.0 0.0 2.1 0.9 0.2 0.6 2.7 0.3 0.0 0.1 0.9 0.4 22.5 0.8 0.2 0.4 0.1 0.5 0.6 0.7 0.4 0.2 0.3 0.1 0.7 0.7 0.1 6.8 8.9 10.6 1.2 11.0 2.1 2.2 3.2 2.2 2.7 2.2 4.5 2.7 47.8 1.3 13.5 0.1 3.4 5.2 21.8 18.4 38.8 29.8 16.5 24.0 20.1 22.6 28.8 18.3 32.8 7.2 0.9 3.2 2.6 26.7 16.5 2.5 25.4 6.8 8.7 17.7 2.9 54.7 11.5 0.4 34.0 0.5 0.0 4.5 14.2 8.7 1.0 2.3 9.8 30.9 30.2 0.0 8.6 10.5 2.1 17.8 7.3 1.7 2.8 0.3 73.1 2.3 5.8 41.1 21.7 12.7 38.8 4.2 0.0 0.4 1.5 1.1 1.3 0.1 0.4 IFNLR1 "CRF2/12, IFNLR, IL-28R1, IL28RA" ENSG00000185436 "Interferon lambda receptor 1" Q8IU57 1 24154157-24187959 "Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 13.9;Urothelial cells: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 6.8;dendritic cells: 11.9" "Cell line enhanced" "Detected in many" "U-266/70: 30.2;U-266/84: 10.5;U-698: 22.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA017319 Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA017319: AB_1851708" "prognostic favorable (5.12e-4)" "unprognostic (7.16e-2)" "unprognostic (8.61e-3)" "unprognostic (8.48e-2)" "unprognostic (8.09e-2)" "unprognostic (1.22e-2)" "unprognostic (7.28e-3)" "unprognostic (2.33e-1)" "unprognostic (5.10e-2)" "unprognostic (1.93e-1)" "unprognostic (5.51e-2)" "unprognostic (4.50e-1)" "unprognostic (3.66e-3)" "unprognostic (5.15e-2)" "unprognostic (1.69e-1)" "unprognostic (2.69e-1)" "unprognostic (1.10e-1)" 3.0 3.0 1.1 9.5 1.9 0.4 2.9 10.2 2.1 2.1 9.9 3.8 3.6 6.5 0.8 6.7 4.7 2.0 2.9 6.4 0.9 2.1 4.3 10.1 9.2 8.2 2.0 1.9 1.5 7.8 5.7 8.2 2.5 2.9 4.1 4.6 1.6 9.3 5.7 3.5 8.3 19.2 0.2 5.3 4.4 3.1 1.2 1.1 1.2 5.3 3.1 10.7 2.0 2.7 6.8 11.9 0.0 0.0 0.0 2.0 0.5 3.7 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.7 0.5 6.3 1.1 8.1 8.8 0.0 3.1 2.8 3.8 6.6 0.5 1.6 2.0 0.0 1.3 1.9 0.0 0.0 0.0 0.0 2.2 0.2 2.0 1.4 0.0 1.6 0.1 0.0 0.0 0.8 0.1 0.2 8.1 0.3 2.4 0.0 0.0 0.6 1.5 1.6 1.2 0.7 2.0 1.1 0.8 1.4 1.5 0.0 0.0 0.0 1.6 0.0 0.0 30.2 10.5 22.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 5.1 0.3 1.5 0.0 6.8 0.6 1.6 0.0 0.0 0.0 11.9 0.3 0.5 1.1 1.9 10.2 2.1 0.9 2.1 2.0 1.9 2.9 1.1 0.0 4.5 2.2 6.8 9.8 2.1 2.9 2.5 5.3 1.2 1.8 0.0 0.3 3.3 2.2 2.0 0.2 13.9 0.0 2.1 1.0 0.4 4.3 0.0 7.8 2.4 0.0 0.0 0.0 0.3 3.4 0.3 2.7 0.0 9.0 3.0 3.3 1.7 4.8 0.0 1.8 2.6 0.0 0.5 0.0 0.6 11.0 0.2 1.3 2.9 12.7 IFT52 "C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5" ENSG00000101052 "Intraflagellar transport 52" Q9Y366 20 43590931-43647296 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063367, HPA067423" Enhanced Approved Cytosol NA NA Cytosol "HPA063367: , HPA067423: AB_2685837" "unprognostic (2.88e-1)" "unprognostic (2.44e-2)" "unprognostic (6.82e-2)" "unprognostic (5.18e-3)" "unprognostic (7.39e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.30e-6)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" "unprognostic (2.00e-1)" "unprognostic (2.98e-2)" "unprognostic (2.28e-2)" "unprognostic (3.43e-2)" "unprognostic (7.51e-2)" "prognostic favorable (3.33e-4)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 20.1 13.6 14.2 12.7 13.9 18.6 20.3 14.2 24.9 24.1 12.8 13.4 14.5 7.0 22.2 25.9 11.6 29.8 16.8 16.5 13.1 14.2 16.0 7.1 16.3 20.2 12.1 13.9 31.6 16.2 10.8 15.8 13.1 13.8 14.1 13.9 15.0 11.6 19.4 5.1 13.7 9.5 21.7 13.2 11.3 11.2 36.8 10.8 16.3 24.3 12.1 13.8 14.7 16.8 14.6 23.1 12.8 19.2 13.0 15.9 13.2 15.1 11.6 23.6 16.6 20.1 22.4 11.2 9.5 21.3 25.2 24.5 32.0 15.5 8.5 15.5 19.4 20.5 12.7 9.8 17.1 27.8 7.0 9.2 11.1 8.0 29.6 24.7 14.8 7.7 18.1 18.9 16.3 12.8 18.4 19.7 19.1 9.4 12.2 18.5 15.2 20.4 23.0 13.2 10.0 11.5 21.8 26.9 12.4 19.4 15.0 18.3 21.3 29.2 21.8 22.7 12.5 10.1 20.4 12.3 22.4 16.7 12.3 14.0 11.9 11.8 14.9 26.9 10.9 16.1 6.6 18.0 12.8 15.9 16.4 12.9 14.6 12.9 15.0 23.1 12.2 13.8 14.3 5.2 13.0 19.2 17.5 14.2 13.2 14.2 13.9 14.2 24.9 13.1 14.2 12.1 13.9 13.8 10.8 6.0 13.3 6.0 10.4 11.6 9.9 2.4 5.1 52.2 9.1 7.0 0.0 17.0 16.6 21.9 57.0 17.6 5.6 23.3 19.6 16.8 25.7 6.5 13.9 2.0 16.8 7.9 9.1 19.0 18.3 12.1 26.4 12.2 16.9 15.4 10.7 12.4 14.6 10.5 36.0 14.1 9.7 12.9 18.8 42.1 17.6 13.0 8.0 14.4 10.1 5.8 IGF2BP1 IMP-1 ENSG00000159217 "Insulin like growth factor 2 mRNA binding protein 1" Q9NZI8 17 48997412-49055650 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 17.6;testis: 17.8" "Cell type enhanced" "Detected in some" 15 "Extravillous trophoblasts: 31.6;Spermatocytes: 17.9;Spermatogonia: 21.1" "Cancer enriched" "Detected in many" 16 "testis cancer: 28.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 36.1;CACO-2: 56.9;Hep G2: 26.7;K-562: 28.8;NTERA-2: 28.9;REH: 33.0;SuSa: 28.8" "Not detected" "Not detected" "HPA021367, HPA062273" Enhanced Supported Cytosol NA NA Cytosol "HPA021367: AB_1851480, HPA062273: AB_2684733" "unprognostic (6.79e-4)" "unprognostic (2.76e-1)" "unprognostic (4.86e-3)" "unprognostic (2.30e-6)" "unprognostic (1.95e-2)" "unprognostic (9.11e-3)" "unprognostic (1.80e-2)" "unprognostic (1.01e-2)" "unprognostic (9.55e-3)" "unprognostic (2.58e-1)" "unprognostic (2.86e-2)" "unprognostic (5.91e-2)" "unprognostic (2.80e-6)" "unprognostic (2.58e-2)" "unprognostic (1.55e-1)" "unprognostic (2.32e-3)" "unprognostic (1.47e-1)" 0.1 0.1 0.0 0.9 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.1 0.3 0.5 0.1 0.3 0.1 0.1 0.0 0.1 17.6 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 17.8 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 36.1 0.0 1.3 1.9 25.9 2.0 0.0 2.9 5.0 56.9 0.9 2.9 0.2 0.2 0.8 0.0 22.2 0.0 5.2 0.0 13.1 21.6 7.7 26.7 1.7 11.3 5.8 2.6 0.0 0.7 0.0 1.0 6.0 4.0 28.8 0.0 4.0 0.2 0.0 9.5 28.9 0.0 0.0 33.0 11.9 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 28.8 0.0 3.2 0.1 0.0 0.3 3.0 0.0 0.0 0.0 19.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 6.0 0.6 0.0 0.3 0.1 0.0 3.6 0.0 1.4 1.2 0.0 0.0 2.1 0.0 0.0 3.5 0.3 0.0 0.0 0.0 31.6 1.2 0.2 1.1 0.0 5.4 0.0 0.0 0.0 0.0 3.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 17.9 21.1 0.1 2.4 0.0 0.0 0.3 IGF2BP2 IMP-2 ENSG00000073792 "Insulin like growth factor 2 mRNA binding protein 2" Q9Y6M1 3 185643739-185825056 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 43.0" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 118.2;Rod photoreceptor cells: 160.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 60.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017126, HPA035145" Enhanced Enhanced Cytosol NA NA Cytosol "CAB017126: , HPA035145: AB_2674491" "unprognostic (7.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.12e-5)" "unprognostic (2.46e-3)" "unprognostic (8.25e-3)" "unprognostic (4.17e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (7.37e-5)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (9.45e-2)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.94e-3)" 7.9 8.9 1.0 6.4 1.9 7.6 4.9 8.6 1.6 6.5 16.4 1.6 1.5 11.3 7.6 4.8 3.7 8.3 8.1 9.9 1.7 1.4 8.0 2.6 14.0 4.0 2.8 0.7 6.7 11.3 7.6 2.9 43.0 4.5 4.9 11.6 16.9 9.0 1.6 3.2 4.3 21.4 3.3 3.7 5.8 9.9 5.1 1.5 2.4 8.6 3.2 3.3 6.2 12.5 0.0 5.5 0.9 3.3 1.3 0.0 1.2 28.3 2.4 27.8 5.2 15.2 24.0 17.0 15.0 21.2 23.3 28.0 20.4 8.0 0.0 22.3 12.6 29.9 12.9 13.0 21.8 37.9 0.0 13.4 8.1 0.1 14.1 32.5 0.2 0.0 17.5 11.6 15.5 60.3 12.2 21.4 2.1 7.9 0.0 17.0 0.2 0.0 6.8 20.3 4.8 10.3 2.9 11.0 8.5 15.1 0.1 1.7 0.2 1.1 0.0 26.7 28.8 2.2 18.9 32.4 8.1 17.7 10.1 17.2 0.1 0.0 0.0 8.0 0.0 11.3 0.9 3.0 0.5 0.0 2.8 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.2 1.3 3.3 1.0 0.0 1.2 1.0 1.9 8.6 1.6 1.7 1.4 2.8 0.7 4.5 1.5 11.9 12.3 0.0 21.8 17.5 3.2 13.6 28.1 48.2 35.2 24.4 15.7 1.7 3.3 33.9 118.2 12.2 59.3 23.3 22.6 14.2 28.3 47.6 2.3 0.0 13.3 1.6 34.2 44.2 10.5 64.7 4.9 7.4 13.5 4.6 42.1 30.6 38.8 84.6 0.4 7.6 160.2 0.0 8.6 2.8 7.0 12.8 5.3 0.0 34.5 53.7 IGF2BP3 "CT98, IMP-3, IMP3" ENSG00000136231 "Insulin like growth factor 2 mRNA binding protein 3" O00425 7 23310209-23470467 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "placenta: 74.0" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 68.4;Extravillous trophoblasts: 72.8;Hofbauer cells: 30.1;Syncytiotrophoblasts: 65.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 49.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA002037, HPA076951" Enhanced Supported Cytosol NA NA Cytosol "HPA002037: AB_1851483, HPA076951: " "unprognostic (5.72e-2)" "unprognostic (3.12e-1)" "unprognostic (7.25e-2)" "unprognostic (3.56e-3)" "unprognostic (1.45e-1)" "unprognostic (3.00e-2)" "unprognostic (2.64e-3)" "unprognostic (3.18e-2)" "unprognostic (2.60e-3)" "unprognostic (3.67e-1)" "unprognostic (1.02e-5)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (1.43e-1)" "unprognostic (7.95e-2)" "unprognostic (2.87e-4)" "unprognostic (7.51e-3)" 0.4 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.3 0.4 0.3 0.4 0.1 0.0 0.2 1.3 4.8 0.7 0.1 0.5 0.3 0.2 0.2 0.3 1.2 3.4 0.2 0.0 0.2 1.5 0.0 0.2 74.0 0.7 0.2 0.0 0.3 0.7 0.1 0.2 0.2 0.3 0.0 1.2 1.0 0.2 6.5 0.0 11.4 0.6 0.2 6.0 0.2 0.6 1.2 0.4 1.5 1.5 0.0 0.2 3.0 13.8 4.1 31.1 9.2 4.9 13.2 19.0 2.3 10.5 5.8 7.3 13.1 11.0 10.4 12.6 6.1 26.0 9.1 13.4 10.2 10.3 1.6 5.3 5.5 11.1 10.9 15.3 10.0 3.9 13.4 7.2 4.4 1.9 34.8 49.8 5.9 25.2 0.0 14.1 0.0 6.1 6.7 24.8 10.6 12.8 9.5 10.4 13.4 11.5 1.2 8.2 17.9 1.4 0.0 11.6 37.1 0.0 1.9 20.0 5.6 0.3 12.1 6.0 0.0 4.4 16.5 22.4 11.2 21.5 0.0 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.0 0.4 0.9 0.2 0.0 1.5 0.0 0.0 0.0 0.0 3.0 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.0 0.7 0.0 0.0 0.0 1.7 0.6 0.2 0.5 0.3 0.0 4.0 0.0 0.0 0.0 68.4 0.0 1.1 21.3 0.1 0.0 0.0 0.2 72.8 0.5 0.2 3.5 0.0 30.1 1.6 0.0 1.3 0.0 16.9 2.0 1.3 3.3 0.0 0.0 0.3 0.8 0.0 0.0 0.0 1.7 0.0 0.4 1.9 1.5 0.4 65.7 0.0 0.0 0.5 IGFL4 ENSG00000204869 "IGF like family member 4" Q6B9Z1 19 46039748-46077118 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.5;skin 1: 13.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 40.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 6.6;HaCaT: 5.9;OE19: 10.3" HPA047655 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA047655: AB_2680113" "unprognostic (1.22e-2)" "unprognostic (3.37e-2)" "unprognostic (2.57e-1)" "unprognostic (7.96e-2)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.39e-1)" "unprognostic (8.25e-2)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (1.09e-2)" "unprognostic (3.59e-4)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" 0.1 0.8 4.4 0.3 4.4 0.2 0.3 3.9 8.5 0.2 0.3 0.0 0.0 0.9 1.0 2.9 1.9 0.4 1.1 1.9 2.8 2.8 0.3 0.4 0.7 0.9 1.2 6.0 2.0 0.2 3.3 4.5 0.2 2.1 0.9 0.5 4.6 1.1 0.0 0.5 13.9 0.7 0.1 1.6 0.5 0.7 0.8 0.5 0.0 1.5 0.6 0.2 1.2 0.2 0.3 1.6 1.3 0.7 0.2 0.5 0.1 0.1 6.6 0.2 0.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 1.4 0.3 0.9 0.1 0.1 0.9 5.9 0.0 0.0 0.0 0.7 1.1 0.0 0.8 1.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.7 0.0 0.7 0.1 0.5 0.3 10.3 0.3 0.1 2.9 1.4 0.0 0.3 0.4 0.4 0.0 0.1 1.7 0.8 0.4 1.2 0.6 0.8 1.4 0.4 0.4 0.8 0.4 0.2 0.1 0.9 1.8 1.3 0.7 0.7 0.5 0.3 0.3 0.3 0.2 0.1 0.1 0.3 0.1 0.4 0.9 0.2 0.1 1.6 0.4 0.1 4.4 4.4 3.9 8.5 2.8 2.8 1.2 6.0 2.1 0.5 0.0 0.0 0.0 0.0 0.9 5.1 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.4 1.3 1.0 0.0 0.0 0.0 0.0 IGSF1 "IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2" ENSG00000147255 "Immunoglobulin superfamily member 1" Q8N6C5 X 131273506-131578899 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 138.7" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 3.0;Bipolar cells: 11.5;Horizontal cells: 3.2;Melanocytes: 3.3" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 65.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 23.5;SH-SY5Y: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012732, HPA035582" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 430000 Cytosol "HPA012732: AB_2732404, HPA035582: AB_2674687" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (4.25e-8)" "unprognostic (1.01e-1)" "unprognostic (2.40e-2)" "unprognostic (1.90e-3)" "unprognostic (2.52e-3)" "unprognostic (8.03e-3)" "unprognostic (9.36e-2)" "unprognostic (5.65e-2)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (5.96e-2)" "unprognostic (1.66e-1)" "unprognostic (2.35e-1)" "unprognostic (5.13e-2)" 0.8 11.9 1.4 0.4 5.3 0.0 2.7 0.6 6.2 2.7 0.5 3.3 1.2 0.2 1.1 1.5 1.3 1.6 0.8 5.6 3.3 15.4 0.5 1.5 0.2 0.0 3.8 1.9 1.0 1.7 0.0 138.7 0.6 4.7 3.9 0.2 2.2 2.0 6.4 0.3 0.6 0.4 3.2 2.7 0.2 0.5 11.8 1.9 0.2 5.3 0.8 0.5 0.6 0.5 0.6 0.4 1.5 0.3 0.3 0.3 0.2 0.3 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.2 0.0 0.0 0.0 1.3 0.0 0.0 4.1 0.3 0.0 1.7 23.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.7 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 21.2 0.0 0.2 0.0 3.2 0.4 0.0 0.0 0.3 0.6 0.0 2.4 0.7 0.3 0.0 0.0 0.0 0.0 1.5 0.3 0.2 0.2 0.1 0.2 0.3 0.3 0.3 0.1 0.6 0.3 0.2 1.2 0.3 0.1 0.4 0.3 0.2 1.4 5.3 0.6 2.3 3.3 15.4 3.8 1.9 4.7 1.9 3.0 1.1 0.0 0.2 0.0 11.5 2.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.8 0.2 0.0 0.4 0.0 3.2 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.5 0.0 0.4 0.6 0.5 0.0 0.3 0.0 0.4 0.4 0.2 0.0 0.0 0.1 IGSF9B KIAA1030 ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133908564-133956985 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 3.1;Bipolar cells: 2.2;Cardiomyocytes: 2.6;Distal tubular cells: 1.7;Muller glia cells: 2.0;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 39.7" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "OE19: 8.2;SCLC-21H: 17.7;SH-SY5Y: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010744, HPA010802" Uncertain Approved Cytosol NA NA Cytosol "HPA010744: AB_2668357, HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 2.2 2.1 4.9 3.7 6.8 0.7 1.2 39.7 12.4 7.4 6.8 2.4 4.6 1.1 7.7 4.3 5.9 7.6 4.9 13.4 2.9 3.1 1.1 0.5 1.8 1.6 2.1 4.0 2.4 2.1 1.5 6.2 1.3 3.8 4.2 2.4 6.1 2.1 6.4 5.0 2.4 2.4 12.8 1.6 1.8 3.7 5.0 2.3 0.0 4.9 2.6 1.2 5.2 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.3 1.2 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 2.6 1.6 0.8 0.5 0.4 3.1 2.6 0.0 0.1 2.8 2.4 0.0 0.0 0.0 0.2 0.7 3.8 0.0 0.0 0.0 0.5 0.2 0.0 3.3 0.0 0.0 0.0 1.8 0.3 0.3 1.9 8.2 0.1 0.0 0.0 0.0 0.3 0.0 17.7 9.0 0.1 0.2 0.0 2.9 1.8 0.0 0.0 1.3 1.4 1.1 0.8 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 4.9 6.8 39.7 9.7 2.9 3.1 2.1 4.0 3.8 2.3 0.0 0.0 0.0 0.1 3.1 2.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.4 0.0 0.7 0.0 1.0 0.0 0.1 4.3 0.0 0.0 0.1 0.0 IKBKB "IKK-beta, IKK2, IKKB, NFKBIKB" ENSG00000104365 "Inhibitor of nuclear factor kappa B kinase subunit beta" O14920 8 42271302-42332653 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 127.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001249, CAB004447" Enhanced Supported Cytosol NA NA Cytosol "CAB004447: AB_627785, HPA001249: AB_1079126" "unprognostic (1.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (1.73e-3)" "unprognostic (1.26e-1)" "unprognostic (1.27e-3)" "unprognostic (1.95e-1)" "unprognostic (1.25e-3)" "unprognostic (1.75e-1)" "unprognostic (1.55e-1)" "unprognostic (3.27e-1)" "unprognostic (1.73e-1)" "unprognostic (1.20e-2)" "unprognostic (1.89e-2)" "unprognostic (9.20e-2)" "unprognostic (3.02e-1)" "prognostic favorable (1.46e-6)" 9.1 10.8 10.9 17.0 16.7 9.3 10.0 26.1 16.9 10.3 10.3 12.4 11.4 4.7 15.3 13.2 17.9 16.4 14.9 7.9 13.1 6.9 12.4 9.9 14.9 12.2 20.3 7.9 9.6 13.3 18.0 13.6 11.2 11.9 14.0 10.9 10.5 11.4 9.7 17.6 22.2 9.8 16.4 10.5 18.7 10.8 8.3 18.6 12.9 14.3 8.4 17.1 18.1 12.8 12.6 14.8 14.1 9.6 11.9 11.2 5.8 3.6 12.9 3.7 6.3 14.3 12.4 4.7 3.2 11.3 9.5 8.4 2.9 6.7 7.1 5.5 8.8 9.0 4.1 5.0 12.7 12.3 6.9 5.7 9.9 6.0 2.3 10.9 1.9 10.4 8.2 9.7 9.1 14.2 18.7 14.0 4.7 8.4 3.5 20.8 4.1 6.9 3.1 3.6 11.8 4.1 7.1 6.3 4.1 10.7 3.3 1.1 2.1 2.0 3.6 5.2 6.9 4.8 8.3 7.2 6.7 3.5 5.2 2.3 2.1 2.1 5.0 7.9 4.7 7.6 14.1 9.6 10.4 10.1 7.6 10.3 9.4 10.5 11.2 8.9 12.6 10.2 10.4 11.4 11.9 9.0 14.8 9.9 5.8 10.9 16.7 26.1 16.9 13.1 6.9 20.3 7.9 11.9 18.6 11.9 24.0 17.7 29.3 21.6 11.3 4.5 15.3 14.7 13.6 15.7 127.6 8.6 1.7 11.4 2.0 27.7 11.8 0.0 11.8 4.6 9.8 23.2 36.9 10.2 15.8 17.5 10.9 15.4 26.9 3.0 15.3 17.7 18.6 13.6 15.1 11.6 13.3 14.4 12.0 4.8 52.3 6.5 6.4 2.6 6.4 25.5 12.7 20.3 13.6 25.7 IKBKE "IKK-i, IKKE, KIAA0151" ENSG00000263528 "Inhibitor of nuclear factor kappa B kinase subunit epsilon" Q14164 1 206470476-206496889 "Enzymes, Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.8;lymphoid tissue: 19.5" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 20.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 25.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015788, CAB025983" Approved Supported Cytosol NA NA Cytosol "CAB025983: , HPA015788: AB_1851566" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.76e-2)" "unprognostic (7.78e-3)" "unprognostic (7.37e-3)" "unprognostic (1.99e-3)" "unprognostic (2.82e-1)" "unprognostic (5.09e-3)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.34e-7)" "unprognostic (1.48e-2)" "unprognostic (5.77e-2)" "unprognostic (2.84e-3)" "unprognostic (2.84e-2)" 2.1 0.9 1.0 17.3 3.4 4.3 1.4 1.1 1.7 2.2 4.8 1.5 1.7 3.9 2.0 3.9 6.1 1.2 3.6 1.1 2.9 1.5 0.6 3.7 13.6 2.1 0.7 1.0 1.5 0.0 0.8 2.5 1.9 1.8 4.3 1.5 8.3 2.9 0.1 8.9 4.2 1.0 2.9 12.8 4.0 0.0 2.4 18.8 2.6 4.4 19.5 4.4 0.4 12.9 4.6 4.2 15.9 10.8 24.8 12.3 9.0 7.1 2.0 0.2 3.6 5.2 2.1 3.6 11.5 5.0 5.6 5.6 14.7 17.9 9.9 7.3 6.0 12.2 0.0 9.3 1.0 2.9 1.7 2.5 4.2 3.9 4.7 15.2 8.1 6.6 1.6 4.1 0.8 5.8 7.2 4.9 1.2 5.5 5.2 1.8 9.7 25.6 2.9 2.1 5.5 5.2 2.1 14.2 5.9 15.4 0.0 0.0 1.6 12.3 2.2 2.6 7.3 10.8 14.0 5.0 3.1 3.6 4.1 1.9 0.9 11.6 9.4 12.8 2.0 4.2 15.9 0.3 10.5 11.2 7.5 12.9 16.7 15.2 4.6 7.4 13.3 13.6 1.1 10.8 6.4 1.5 24.8 12.3 0.0 5.0 8.9 3.6 1.6 0.0 0.8 0.0 2.7 0.0 0.0 0.0 3.5 0.0 10.6 2.7 0.6 10.5 0.0 10.9 3.6 2.4 2.6 4.7 0.8 12.5 0.0 3.5 1.3 11.9 5.2 0.9 5.3 6.8 1.8 6.8 0.0 12.0 20.1 0.7 2.0 0.0 0.0 0.5 0.2 0.5 4.3 1.3 14.4 8.0 9.6 IKBKG "FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9" ENSG00000269335 "Inhibitor of nuclear factor kappa B kinase subunit gamma" Q9Y6K9 X 154541199-154565046 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "DNA damage, Host-virus interaction, Transcription, Transcription regulation" "Disease mutation, Ectodermal dysplasia, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 28.8" "Cell type enhanced" "Detected in many" 5 "monocytes: 63.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000426, CAB010373" Uncertain Enhanced Cytosol NA NA Cytosol "CAB010373: AB_2124846, HPA000426: AB_1851572" "unprognostic (7.53e-2)" "unprognostic (2.76e-3)" "unprognostic (1.09e-1)" "unprognostic (3.37e-3)" "unprognostic (9.77e-2)" "unprognostic (3.68e-1)" "unprognostic (9.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (9.87e-2)" "unprognostic (3.57e-2)" "unprognostic (4.41e-2)" "unprognostic (2.78e-1)" "unprognostic (7.07e-2)" "unprognostic (1.36e-2)" 6.5 5.8 5.2 10.2 6.1 15.1 5.0 5.4 9.2 5.2 4.5 9.1 5.9 7.5 5.2 6.2 6.3 4.5 7.7 5.1 4.9 3.9 16.3 6.5 10.4 6.9 5.1 5.1 6.1 3.5 2.0 6.8 6.7 5.0 3.9 5.6 5.7 3.9 4.6 11.4 6.6 8.1 3.7 10.8 7.4 4.2 6.2 6.9 5.0 6.9 9.9 4.9 6.2 11.3 13.7 28.8 21.8 13.8 17.9 13.5 15.6 16.1 3.9 12.8 8.9 7.5 10.8 10.5 13.7 11.2 16.2 11.4 9.4 12.6 26.6 11.8 32.1 14.7 5.7 9.6 4.8 15.0 8.0 10.3 23.3 21.3 13.8 10.1 36.1 8.9 8.1 15.7 6.3 7.5 13.3 12.6 5.7 12.6 9.0 15.2 10.4 16.9 3.6 12.2 26.8 11.5 6.2 13.4 11.1 10.0 7.0 7.0 13.0 12.2 7.5 3.5 7.1 11.3 13.6 10.4 12.1 27.8 25.1 24.7 17.5 23.6 15.5 18.3 15.2 10.5 15.4 28.8 17.9 20.5 12.3 11.3 11.4 13.0 13.7 10.1 9.5 11.3 25.4 13.8 21.8 12.2 13.0 13.5 3.0 11.0 14.9 10.9 11.0 5.1 6.1 15.3 5.3 7.9 12.2 9.8 20.4 1.7 16.8 0.7 11.9 11.2 23.3 14.9 14.8 12.4 9.6 28.8 28.0 25.4 23.8 4.7 9.2 21.2 1.6 13.3 18.6 11.8 63.1 6.7 11.4 17.2 11.5 13.1 6.5 9.8 6.5 12.5 3.4 13.6 9.3 31.8 22.4 7.6 12.2 IL10RB "CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2" ENSG00000243646 "Interleukin 10 receptor subunit beta" Q08334 21 33266358-33310187 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 170.3;Syncytiotrophoblasts: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB020670, HPA047550" Approved Approved Cytosol NA NA 1300000 Cytosol "CAB020670: , HPA047550: AB_2680086" "unprognostic (8.43e-2)" "unprognostic (6.50e-2)" "unprognostic (5.88e-2)" "unprognostic (1.77e-1)" "unprognostic (1.48e-2)" "unprognostic (7.78e-2)" "unprognostic (1.97e-3)" "unprognostic (1.26e-1)" "unprognostic (5.69e-3)" "unprognostic (1.31e-1)" "unprognostic (1.19e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.62e-9)" "unprognostic (3.09e-1)" "unprognostic (2.76e-1)" "unprognostic (1.29e-2)" "unprognostic (1.05e-1)" 17.6 11.0 5.4 19.6 7.3 8.9 21.5 3.6 4.4 15.2 29.2 10.3 10.6 19.6 17.5 9.6 22.7 13.2 14.8 12.3 5.6 5.4 11.6 27.5 19.3 36.1 6.6 3.1 18.2 23.2 5.5 9.7 47.4 9.3 17.7 20.8 11.7 26.0 9.7 12.4 13.8 53.6 12.2 8.0 31.7 17.6 8.4 7.3 34.0 14.3 15.3 26.2 15.1 22.6 13.8 19.4 57.9 34.7 14.0 19.5 20.4 10.3 8.0 1.5 6.4 32.4 23.8 11.4 7.9 22.5 8.8 12.6 7.5 12.8 2.9 9.1 13.8 17.9 12.9 4.3 5.4 5.8 9.6 5.9 8.0 6.0 5.7 22.6 10.2 19.5 23.9 10.2 15.3 9.0 13.8 11.6 8.6 7.2 24.2 12.1 10.7 6.8 9.9 1.1 21.0 4.3 6.4 3.6 12.2 7.9 6.1 2.1 2.9 16.3 12.1 13.8 3.6 8.0 38.7 10.5 8.8 8.6 14.9 4.3 12.8 14.3 1.7 15.5 14.7 5.6 22.3 30.1 24.8 8.8 34.4 9.6 13.6 11.1 10.6 17.8 13.8 10.5 10.4 57.9 14.0 34.7 19.4 19.5 20.4 5.4 7.3 3.6 4.4 5.6 5.4 6.6 3.1 9.3 7.3 32.8 21.5 27.9 30.6 12.9 6.2 10.4 22.9 5.3 6.8 3.5 13.7 170.3 0.0 16.0 0.7 24.6 75.7 46.7 26.6 126.8 31.9 37.4 35.7 19.5 105.9 7.9 9.8 35.6 102.1 0.7 29.4 27.9 13.5 55.1 53.6 5.6 21.9 73.7 22.3 0.8 5.5 19.4 14.2 2.2 4.7 12.8 264.0 21.8 41.1 53.1 IL20RA "IL-20R1, ZCYTOR7" ENSG00000016402 "Interleukin 20 receptor subunit alpha" Q9UHF4 6 136999971-137045180 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 28.9" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 33.5;Muller glia cells: 36.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;HaCaT: 6.8;OE19: 9.7;RT4: 11.3;SH-SY5Y: 10.9;T-47d: 10.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB024990, HPA042281" Approved Approved Cytosol NA NA Cytosol "CAB024990: , HPA042281: AB_10806235" "unprognostic (3.75e-2)" "unprognostic (8.23e-2)" "unprognostic (1.96e-2)" "prognostic favorable (1.43e-6)" "unprognostic (1.57e-2)" "prognostic favorable (2.29e-5)" "unprognostic (9.87e-3)" "unprognostic (1.64e-1)" "unprognostic (2.43e-1)" "unprognostic (3.78e-1)" "unprognostic (8.03e-3)" "unprognostic (2.18e-1)" "unprognostic (1.85e-6)" "unprognostic (9.38e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-3)" "unprognostic (1.64e-3)" 0.6 7.0 2.0 1.6 5.9 0.1 21.2 4.4 2.8 13.9 3.5 4.3 0.6 2.4 5.5 3.7 6.4 13.6 7.9 5.9 3.6 3.0 0.4 0.8 4.7 0.1 3.7 2.3 5.4 16.3 0.2 1.8 0.4 4.6 7.3 3.7 3.5 11.8 7.8 0.5 28.9 1.3 2.9 5.5 0.0 4.9 2.9 3.3 1.0 2.2 3.7 5.6 5.6 9.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 9.4 0.0 0.1 1.4 0.1 6.8 1.2 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 9.7 1.4 0.0 0.4 0.0 0.0 11.3 0.7 10.9 0.5 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 4.4 2.8 3.6 3.0 3.7 2.3 4.6 3.3 3.0 18.4 0.0 11.2 19.5 1.7 3.9 25.5 33.5 14.8 3.5 0.0 2.4 0.0 11.1 0.2 0.6 5.2 0.0 0.6 6.6 2.4 18.3 2.3 0.0 0.4 0.0 7.0 0.6 0.0 0.5 8.1 1.7 13.5 0.0 18.4 36.8 8.0 2.9 14.2 0.6 0.7 0.0 1.2 0.2 3.4 15.7 6.9 0.0 13.3 17.1 IL23A "IL-23, IL-23A, IL23P19, P19, SGRF" ENSG00000110944 "Interleukin 23 subunit alpha" Q9NPF7 12 56334174-56340410 "FDA approved drug targets, Predicted secreted proteins" "Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling" Cytokine "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.0;lymphoid tissue: 15.2;testis: 12.1" "Cell type enhanced" "Detected in many" 10 "Ductal cells: 26.3;monocytes: 58.7;Pancreatic endocrine cells: 46.8;Spermatocytes: 41.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "MAIT T-cell: 8.4;memory B-cell: 10.6;memory CD4 T-cell: 15.5;memory CD8 T-cell: 7.4;naive B-cell: 10.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 10.6;T-reg: 8.4" "Group enriched" "Detected in many" 14 "B-cells: 10.6;T-cells: 17.0" "Cell line enhanced" "Detected in some" "A-431: 9.4;CAPAN-2: 16.5;U-266/70: 27.6;U-266/84: 12.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA001554 Approved Approved Cytosol "Secreted to blood" NA NA 11000 Cytosol "HPA001554: AB_1079135" "unprognostic (2.34e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.06e-1)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (4.40e-1)" "unprognostic (1.43e-3)" "unprognostic (1.30e-1)" "unprognostic (6.79e-2)" "unprognostic (3.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-10)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.83e-1)" "unprognostic (4.50e-3)" 0.7 0.5 0.4 3.9 0.5 3.6 0.4 0.3 0.3 0.5 0.6 0.3 0.3 0.0 1.3 0.8 6.0 0.5 2.0 0.3 0.4 0.5 1.3 1.4 1.2 7.5 0.4 0.3 0.3 1.1 0.0 1.1 0.6 0.3 1.0 0.2 0.3 1.8 0.3 0.3 0.8 2.5 1.0 0.4 2.8 0.7 12.1 0.3 12.9 0.6 10.4 15.2 7.4 0.6 10.6 0.5 0.1 0.2 1.0 17.0 5.9 9.4 0.2 0.3 0.3 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.4 16.5 0.5 4.9 0.0 0.5 0.9 0.0 1.6 0.0 0.6 0.3 0.3 0.1 0.7 0.0 0.2 0.6 0.1 0.0 0.0 0.4 2.1 0.0 2.2 0.4 4.1 0.0 0.4 0.3 0.5 1.4 0.2 0.3 0.2 0.1 0.4 5.7 4.7 0.3 0.4 0.2 0.2 0.8 1.4 0.1 4.4 0.3 0.3 0.3 0.3 1.1 27.6 12.4 1.2 0.3 2.4 0.2 0.0 0.2 0.0 1.7 0.0 8.4 10.6 15.5 7.4 0.5 10.6 17.0 10.6 0.1 1.0 0.0 0.0 8.4 5.9 0.4 0.5 0.3 0.3 0.4 0.5 0.4 0.3 0.3 0.3 3.0 2.1 14.5 10.2 3.2 0.0 0.3 0.0 2.7 5.7 1.8 0.0 0.3 1.7 26.3 4.7 0.6 0.3 0.0 6.4 0.3 1.4 5.0 0.0 0.6 2.4 0.0 0.0 0.0 0.0 3.2 0.3 8.1 8.5 58.7 0.0 0.1 46.8 0.0 0.7 0.5 0.1 0.0 1.9 41.1 5.3 3.4 0.0 10.2 0.0 13.9 INPP5B ENSG00000204084 "Inositol polyphosphate-5-phosphatase B" P32019 1 37860697-37947057 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028803 Approved Supported Cytosol NA NA Cytosol "HPA028803: AB_10612121" "unprognostic (2.28e-2)" "unprognostic (8.91e-3)" "unprognostic (7.67e-2)" "unprognostic (2.27e-1)" "unprognostic (4.30e-2)" "prognostic favorable (1.11e-4)" "unprognostic (1.67e-2)" "unprognostic (1.52e-2)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "prognostic favorable (5.33e-4)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.11e-5)" "unprognostic (1.03e-1)" "unprognostic (2.00e-1)" "unprognostic (2.51e-1)" "unprognostic (1.28e-1)" 14.5 10.2 11.7 15.9 18.2 22.3 12.8 25.4 16.1 15.3 18.3 21.0 9.4 9.3 19.5 13.7 9.9 15.0 13.7 14.3 12.2 9.0 11.7 16.2 18.7 21.1 23.2 11.4 28.7 11.4 13.1 14.4 14.3 15.9 12.0 13.7 18.9 9.4 16.0 9.7 12.0 13.9 17.5 18.5 19.0 14.7 8.6 21.8 17.4 13.8 4.7 22.3 17.4 13.2 6.7 5.3 19.1 4.7 5.3 9.1 3.8 3.7 2.8 6.7 10.7 8.4 10.8 11.8 4.7 8.3 6.0 8.6 4.4 5.7 14.0 2.2 8.6 3.0 5.2 8.8 3.4 7.8 9.0 3.8 21.3 9.2 2.9 12.2 11.3 31.1 12.6 2.1 6.2 4.0 6.2 7.1 9.4 7.3 18.3 8.1 3.2 9.1 12.0 9.4 5.7 2.2 11.1 13.2 6.6 3.5 3.5 2.6 4.5 5.0 2.4 12.2 9.9 3.0 10.0 7.1 6.0 5.6 5.6 4.3 14.9 7.2 11.3 7.1 10.6 5.1 19.1 2.5 13.2 6.3 2.0 9.1 6.5 4.5 6.1 5.3 6.7 5.8 5.3 3.4 5.3 4.7 4.8 5.6 3.8 11.7 18.2 25.4 16.1 12.2 9.0 23.2 11.4 15.9 21.8 26.8 22.9 10.2 5.0 1.9 15.6 2.4 0.0 5.3 9.1 1.8 23.6 3.4 0.0 1.9 8.1 4.3 3.1 0.0 3.7 12.1 4.3 3.5 8.1 6.4 4.3 22.3 3.4 6.2 6.5 12.4 7.8 6.7 6.8 10.0 4.1 4.5 2.4 3.7 8.5 2.2 20.1 6.5 5.3 4.1 7.5 2.9 3.9 10.7 4.3 3.4 INPP5D "hp51CN, SHIP, SHIP1" ENSG00000168918 "Inositol polyphosphate-5-phosphatase D" Q92835 2 233059967-233207903 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 9 "B-cells: 58.1;Kupffer cells: 48.3;T-cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.4;HEL: 31.9;HMC-1: 33.5;hTCEpi: 30.7;NB-4: 29.9;THP-1: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016300, HPA070455" Enhanced Approved Cytosol No No Cytosol "CAB016300: AB_628250, HPA070455: AB_2686267" "unprognostic (5.29e-2)" "unprognostic (2.05e-3)" "unprognostic (1.99e-2)" "unprognostic (6.71e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "unprognostic (2.29e-2)" "unprognostic (3.74e-1)" "unprognostic (2.56e-1)" "unprognostic (1.23e-1)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (6.54e-2)" 7.1 3.1 7.2 33.0 10.7 24.6 4.7 1.7 6.9 3.6 3.7 12.5 0.7 3.5 4.1 2.9 3.3 3.3 6.7 3.2 6.6 9.1 5.1 3.3 8.0 26.1 8.8 2.6 1.9 2.1 1.6 3.4 7.4 7.6 4.5 4.5 3.3 18.8 3.0 1.9 3.4 15.8 3.4 17.6 40.9 4.1 2.4 9.5 16.7 3.1 3.4 32.3 6.2 3.5 14.5 12.0 10.5 18.2 11.9 16.7 14.0 0.0 0.0 0.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.4 6.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 5.1 0.0 31.9 0.0 3.0 0.2 9.6 33.5 0.6 30.7 0.1 3.4 0.1 4.4 0.9 0.1 2.8 0.1 0.0 4.4 29.9 1.0 0.0 0.0 9.3 0.0 2.2 0.0 1.8 0.0 0.0 0.0 0.6 0.0 4.1 0.0 21.4 3.6 0.0 0.5 0.0 0.0 0.0 1.7 9.2 0.0 12.4 0.0 9.8 9.8 10.5 16.7 15.8 11.4 14.5 7.5 12.3 12.0 13.9 6.3 8.8 9.9 11.9 18.2 6.0 10.2 14.0 7.2 10.7 1.7 6.9 6.6 9.1 8.8 2.6 7.6 9.5 3.0 25.7 58.1 1.2 1.4 0.1 3.2 2.5 4.0 4.5 3.5 0.0 0.4 0.0 0.3 12.8 17.5 0.0 0.0 0.4 0.6 1.0 0.4 14.0 1.3 24.6 0.0 0.0 13.5 48.3 10.6 0.0 20.7 0.0 13.6 0.2 0.0 0.2 0.9 1.1 0.3 0.0 0.0 1.2 0.4 0.7 1.0 0.9 51.0 0.4 1.0 INTU "KIAA1284, PDZD6, PDZK6" ENSG00000164066 "Inturned planar cell polarity protein" Q9ULD6 4 127623271-127726737 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 112.4;Cone photoreceptor cells: 129.6;Rod photoreceptor cells: 185.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036714, HPA036715, HPA061467" Approved Uncertain Cytosol NA NA Cytosol "HPA036714: AB_10670238, HPA036715: AB_2675267, HPA061467: " "unprognostic (1.09e-1)" "unprognostic (2.89e-1)" "unprognostic (4.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-1)" "unprognostic (2.88e-3)" "unprognostic (4.30e-2)" "unprognostic (2.91e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (1.22e-1)" "unprognostic (9.49e-2)" "unprognostic (3.28e-1)" "unprognostic (2.36e-1)" "unprognostic (5.33e-2)" 4.4 4.8 8.3 3.7 23.0 7.3 8.1 5.6 12.6 7.7 4.0 11.9 5.6 5.9 10.2 14.6 4.0 8.1 4.7 3.2 12.0 8.0 5.7 2.4 4.9 3.4 7.2 8.1 9.9 4.1 4.7 25.8 3.3 12.3 5.2 4.8 9.1 5.2 4.2 3.3 10.6 3.1 4.4 9.1 3.8 6.1 6.9 8.0 0.5 7.9 2.8 2.3 4.6 5.0 1.4 1.5 4.7 0.9 1.0 0.9 0.1 3.3 2.3 12.6 4.7 1.8 4.4 1.0 2.0 1.0 1.3 2.6 1.7 3.1 2.8 3.3 2.0 3.9 2.0 10.0 1.9 3.9 1.2 3.0 3.5 4.0 4.2 1.7 3.1 1.8 1.8 2.1 4.2 1.0 3.9 3.8 1.3 4.2 2.9 1.9 1.6 1.1 1.8 5.9 1.2 2.3 1.2 3.1 0.8 2.6 2.6 5.9 4.2 4.3 2.3 1.5 6.7 2.7 1.9 3.2 3.6 2.9 3.5 2.8 1.9 2.8 0.9 3.0 1.6 2.2 2.8 0.8 0.5 0.9 0.6 0.8 0.7 0.7 0.6 0.4 1.4 0.7 0.8 4.7 1.0 0.9 1.5 0.4 0.1 8.3 23.0 5.6 12.6 12.0 8.0 7.2 8.1 12.3 8.0 20.8 12.5 0.5 9.8 5.4 58.4 12.7 7.6 112.4 25.0 3.5 129.6 6.8 6.6 6.2 9.1 5.6 0.9 0.0 4.4 5.1 5.9 7.3 4.7 2.4 2.6 35.0 11.1 7.4 1.5 8.4 13.0 7.4 6.8 0.0 5.5 15.8 2.9 0.0 11.0 6.2 185.9 0.0 7.6 7.7 20.9 5.4 1.6 2.2 6.3 6.2 INVS NPHP2 ENSG00000119509 Inversin Q9Y283 9 100099256-100301000 "Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Calmodulin-binding, Developmental protein" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 20.2;Late spermatids: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049994 Approved Cytosol NA NA Cytosol "HPA049994: " "unprognostic (3.84e-3)" "unprognostic (3.11e-2)" "unprognostic (1.74e-1)" "unprognostic (2.86e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.53e-3)" "unprognostic (2.93e-3)" "unprognostic (1.99e-1)" "unprognostic (6.46e-2)" "unprognostic (1.15e-1)" "unprognostic (3.56e-2)" "unprognostic (1.34e-3)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (6.37e-2)" "unprognostic (1.83e-1)" 11.9 13.4 9.5 10.7 15.8 7.9 10.1 18.6 15.7 13.4 11.3 14.6 12.4 7.6 16.5 12.3 9.2 10.3 10.4 9.7 10.4 7.1 16.4 17.1 10.2 10.2 15.8 8.5 19.2 9.7 20.9 26.0 11.1 12.1 12.0 9.1 12.8 8.2 10.4 7.2 7.0 9.4 11.9 15.3 10.1 9.1 12.0 15.5 16.9 12.5 4.6 10.7 10.4 15.4 6.0 3.5 3.9 3.8 4.7 5.3 2.6 6.7 12.4 10.3 11.0 13.3 11.0 8.6 7.9 8.6 7.2 5.8 6.5 4.2 15.6 4.7 9.4 13.1 10.5 8.2 10.4 6.0 12.2 5.5 11.8 10.8 6.7 9.8 11.8 9.8 11.1 13.0 7.7 15.3 9.9 12.9 10.8 10.2 9.6 7.5 6.0 9.3 4.7 6.1 12.2 7.5 8.5 18.2 3.7 6.7 6.3 9.6 7.6 9.0 5.6 9.0 8.8 3.9 6.5 9.6 8.4 6.0 8.4 5.9 9.9 11.7 3.2 8.7 5.1 4.4 0.0 2.5 3.9 4.9 1.7 4.3 5.3 4.1 2.6 3.5 6.0 5.3 5.1 0.2 4.7 3.8 3.5 2.6 2.6 9.5 15.8 18.6 15.7 10.4 7.1 15.8 8.5 12.1 15.5 3.0 2.6 0.9 5.7 1.5 4.1 2.5 10.2 0.0 3.4 0.0 7.9 3.2 3.3 2.0 20.2 3.7 1.6 0.0 1.0 3.2 2.2 2.2 1.1 3.2 3.1 6.4 1.2 0.6 3.4 22.0 4.4 1.9 0.0 3.6 1.4 2.5 1.7 2.0 3.2 5.7 5.7 0.0 3.0 8.6 4.3 1.4 2.9 4.3 1.7 3.4 IPO4 "FLJ23338, Imp4" ENSG00000196497 "Importin 4" Q8TEX9 14 24180219-24188964 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.5" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 59.5;Late spermatids: 85.2;Spermatocytes: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039043, HPA064572" Uncertain Approved Cytosol NA NA Cytosol "HPA039043: AB_10673233, HPA064572: AB_2685291" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (9.45e-2)" "unprognostic (2.60e-1)" "unprognostic (5.13e-2)" "unprognostic (6.75e-2)" "unprognostic (9.28e-2)" "prognostic unfavorable (3.20e-4)" "unprognostic (8.59e-4)" "unprognostic (5.45e-2)" "unprognostic (2.18e-1)" "unprognostic (2.15e-2)" 5.3 8.1 1.2 5.2 2.2 6.9 6.1 1.7 3.3 6.5 5.8 2.8 5.5 7.5 5.4 6.5 8.8 6.3 4.4 3.6 2.2 1.6 18.0 29.0 4.4 10.8 1.8 1.2 9.8 27.0 2.2 6.4 4.4 4.1 5.0 2.3 3.0 8.7 7.9 17.2 8.5 4.7 5.3 2.4 8.8 6.9 49.5 1.4 8.8 6.5 11.0 7.4 5.7 4.0 3.5 5.3 0.3 3.0 3.6 5.4 2.2 7.8 10.4 0.9 6.2 0.8 1.2 10.7 4.8 0.2 2.3 0.7 8.9 3.9 11.3 7.8 1.7 2.7 8.8 3.7 6.9 0.3 5.4 15.6 7.0 3.3 20.1 0.8 8.5 5.1 1.6 2.2 2.1 0.7 0.5 2.3 6.2 13.1 0.9 2.4 17.4 5.5 7.6 9.5 5.4 22.9 7.5 4.4 6.1 2.2 5.5 8.1 8.7 8.0 3.8 4.1 0.6 6.9 2.0 4.0 4.8 11.6 5.2 7.0 8.0 12.0 10.0 3.2 4.6 7.9 0.0 1.9 0.3 4.8 2.6 5.4 2.8 4.6 4.4 3.1 3.5 3.6 5.0 0.0 3.6 3.0 5.3 2.2 2.2 1.2 2.2 1.7 2.8 2.2 1.6 1.8 1.2 4.1 1.4 0.0 6.4 4.7 3.4 5.3 0.6 1.8 10.2 9.4 11.4 5.2 3.9 10.1 0.0 11.4 59.5 3.5 0.7 0.0 9.4 8.5 4.2 2.5 0.0 5.1 7.2 1.6 4.1 1.3 1.9 85.2 4.6 1.4 0.0 1.0 5.6 1.3 7.2 0.0 5.3 9.8 2.7 6.5 4.4 44.5 17.3 5.5 4.9 1.3 8.3 2.6 IPPK "C9orf12, FLJ13163, INSP5K2, IP5K, IPK1" ENSG00000127080 "Inositol-pentakisphosphate 2-kinase" Q9H8X2 9 92613184-92670265 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020603 Uncertain Approved Cytosol NA NA Cytosol "HPA020603: AB_1851853" "unprognostic (3.51e-2)" "unprognostic (4.66e-2)" "unprognostic (6.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.63e-2)" "unprognostic (2.08e-1)" "unprognostic (4.88e-2)" "unprognostic (3.13e-2)" "unprognostic (4.40e-2)" "unprognostic (1.10e-1)" "unprognostic (2.68e-1)" "unprognostic (1.98e-1)" "unprognostic (6.26e-9)" "unprognostic (1.28e-2)" "unprognostic (4.23e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.28e-4)" 5.0 7.5 7.6 5.2 12.3 8.3 7.5 13.4 14.1 7.9 4.7 9.7 6.8 3.7 6.0 5.9 29.7 6.4 5.3 8.1 7.9 5.9 5.2 5.8 4.9 6.0 7.1 5.7 6.5 4.2 11.3 11.0 7.1 10.0 5.1 5.3 6.0 10.8 4.3 6.9 31.5 4.6 6.3 6.4 5.8 4.8 12.0 7.7 5.7 5.5 17.8 16.1 4.9 13.7 4.2 3.9 5.8 3.2 1.4 7.5 3.1 11.9 6.4 5.9 5.1 7.3 5.5 19.7 8.6 5.3 8.8 5.0 4.0 4.7 7.5 4.3 11.9 7.8 17.2 10.4 11.9 7.4 9.2 6.7 6.1 13.6 6.1 5.2 10.3 7.2 5.4 11.8 10.5 8.2 8.0 6.5 6.2 8.2 9.1 8.6 16.3 5.9 4.8 10.1 13.2 9.5 5.2 6.4 3.0 5.2 7.3 12.4 7.3 6.9 28.7 5.0 6.1 6.8 2.6 12.6 6.5 7.4 18.3 8.9 8.4 9.7 4.2 8.5 4.7 6.3 0.0 2.3 5.8 6.4 3.1 7.3 4.1 5.6 5.7 3.6 4.2 4.4 4.8 3.6 1.4 3.2 3.9 7.5 3.1 7.6 12.3 13.4 14.1 7.9 5.9 7.1 5.7 10.0 7.7 3.0 4.3 1.5 5.2 22.6 8.3 0.3 0.0 0.0 3.4 1.8 5.9 7.8 5.0 5.2 8.3 5.8 3.3 0.0 6.9 11.0 4.3 5.0 0.0 2.6 4.4 14.3 6.4 10.4 5.9 26.7 2.8 3.9 3.3 1.8 3.4 4.5 6.5 0.0 2.8 3.1 4.1 6.5 2.7 15.7 16.8 25.7 19.1 4.4 3.3 9.0 IQCH FLJ12476 ENSG00000103599 "IQ motif containing H" Q86VS3 15 67254800-67502260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.5;testis: 20.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 30.8;Early spermatids: 45.3;Late spermatids: 30.4;Spermatocytes: 43.6;Spermatogonia: 18.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040845 Uncertain Approved Cytosol NA NA Cytosol "HPA040845: AB_10672898" "unprognostic (2.69e-1)" "unprognostic (2.94e-3)" "unprognostic (3.11e-2)" "unprognostic (5.89e-5)" "unprognostic (2.48e-1)" "unprognostic (9.83e-2)" "unprognostic (2.57e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (3.25e-1)" "unprognostic (5.37e-2)" "unprognostic (1.70e-1)" "unprognostic (1.51e-3)" "unprognostic (2.81e-1)" "unprognostic (3.81e-2)" "unprognostic (6.16e-3)" "unprognostic (6.42e-2)" 0.9 1.8 1.3 0.4 2.9 0.2 2.5 0.9 2.8 1.4 0.8 2.9 4.1 0.3 1.3 6.4 0.9 10.0 2.1 1.3 1.6 2.1 3.3 1.5 2.4 0.5 1.2 1.8 2.7 1.4 6.5 14.5 0.5 2.6 1.2 1.1 3.5 1.0 1.4 0.9 1.0 0.8 0.6 1.4 0.8 1.6 20.9 1.4 0.6 6.1 0.7 0.4 1.3 1.0 1.0 1.2 0.1 0.3 0.2 2.1 0.3 2.8 3.0 1.3 2.2 2.0 4.6 1.0 1.5 1.2 2.4 1.6 0.3 3.1 1.8 1.4 2.5 2.6 4.8 4.4 1.8 4.0 0.3 2.1 0.6 3.0 0.4 3.5 0.9 0.6 3.1 1.8 5.0 4.8 2.1 0.9 5.2 4.2 2.0 1.7 3.0 0.7 0.8 1.6 1.8 1.9 0.6 2.1 2.1 2.7 1.2 4.6 1.2 2.0 2.8 7.9 2.9 7.2 0.5 2.0 2.6 1.3 4.1 1.8 4.1 5.4 0.5 5.3 2.2 2.7 0.0 0.3 0.1 1.2 0.0 2.1 0.4 1.0 1.1 1.1 1.0 0.9 0.8 0.0 0.2 0.1 1.2 0.8 0.3 1.3 2.9 0.9 2.8 1.6 2.1 1.2 1.8 2.6 1.4 3.0 0.6 0.0 0.9 1.1 1.4 0.8 0.0 30.8 3.4 1.8 7.9 0.2 0.0 0.8 45.3 0.7 0.0 0.0 0.7 0.3 0.5 0.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 30.4 0.9 0.0 0.0 1.8 0.5 1.4 0.7 0.0 0.7 1.7 6.0 0.0 0.5 43.6 18.5 0.4 0.2 0.0 0.0 0.9 IQCJ-SCHIP1 ENSG00000283154 "IQCJ-SCHIP1 readthrough" B3KU38 3 158962235-159897366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Basal glandular cells: 6.9;Bipolar cells: 12.0;Cone photoreceptor cells: 5.9" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA003243, HPA003445" Approved Approved Cytosol NA NA Cytosol "HPA003243: AB_1079877, HPA003445: AB_1079875" 5.3 2.1 11.1 4.1 12.4 0.5 2.4 1.5 30.0 1.9 3.8 17.8 0.3 1.7 5.6 2.8 7.3 1.4 5.8 16.4 7.7 7.6 6.3 6.8 0.6 18.8 10.6 0.8 0.9 0.2 1.3 10.9 13.1 6.3 3.0 0.4 0.6 10.0 1.8 0.8 1.7 11.8 7.3 1.2 1.0 1.7 15.1 0.0 0.6 0.1 0.4 5.9 0.9 0.0 1.0 0.1 0.0 0.9 0.2 0.2 28.8 5.0 9.9 11.8 2.3 2.2 8.7 24.9 5.9 20.6 14.1 18.6 7.1 1.4 16.1 8.2 7.8 11.7 3.8 8.4 17.0 24.0 9.4 0.0 11.0 0.9 2.7 1.3 0.1 2.3 7.2 9.1 10.9 17.1 15.2 1.6 0.0 0.1 9.4 1.2 0.1 0.0 8.3 2.3 10.9 3.4 20.1 0.0 19.8 1.6 2.0 9.4 13.4 5.7 7.1 11.9 3.3 0.2 12.6 11.9 16.5 7.9 33.7 0.1 0.1 0.1 6.6 4.1 31.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.9 0.0 1.0 0.0 0.2 6.0 0.0 0.0 6.9 1.3 12.0 0.4 0.0 4.0 2.3 1.8 5.9 0.0 0.0 0.6 1.2 0.2 0.0 0.0 0.5 0.0 0.5 0.4 2.3 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.3 0.8 0.0 1.0 0.1 0.4 0.8 0.0 1.1 2.7 0.5 0.0 3.4 0.0 0.4 0.6 0.0 0.0 0.2 1.4 IRF3 ENSG00000126456 "Interferon regulatory factor 3" Q14653 19 49659569-49665875 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004895, CAB013018" Approved Supported Cytosol NA NA Cytosol "CAB013018: AB_2533904, HPA004895: AB_1851887" "unprognostic (5.75e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-3)" "unprognostic (1.59e-1)" "unprognostic (9.17e-2)" "unprognostic (9.60e-2)" "unprognostic (7.85e-3)" "unprognostic (7.91e-2)" "unprognostic (6.98e-2)" "unprognostic (5.52e-2)" "unprognostic (5.02e-2)" "unprognostic (3.85e-3)" "prognostic unfavorable (1.56e-7)" "unprognostic (1.61e-2)" "unprognostic (4.98e-1)" "unprognostic (3.47e-2)" "prognostic favorable (3.61e-4)" 14.8 17.0 13.4 33.2 22.1 21.8 17.1 16.9 20.1 23.4 18.9 14.1 30.1 18.3 20.0 16.3 18.7 18.9 22.0 15.9 17.7 11.2 20.5 21.3 19.4 36.3 22.2 10.9 23.5 18.5 13.4 22.3 21.2 18.7 23.1 11.7 18.1 26.3 37.7 8.6 19.9 25.4 20.0 17.4 37.3 21.4 7.6 20.0 23.7 22.6 11.8 31.0 19.0 20.6 17.8 13.4 21.8 14.7 20.3 35.4 17.4 29.3 32.3 11.3 16.8 8.6 13.7 25.6 13.0 19.6 22.5 29.7 22.8 34.7 17.4 14.9 12.0 18.9 24.1 12.0 33.3 10.0 23.5 21.4 16.3 12.5 20.8 9.8 11.9 16.5 13.0 23.9 29.7 9.0 11.6 17.7 22.2 17.9 18.9 11.9 28.7 18.6 34.0 13.3 29.9 30.0 21.5 11.3 30.0 16.4 25.2 6.3 8.0 23.7 25.9 12.8 11.6 11.2 23.5 12.3 13.4 12.6 10.1 16.6 26.0 26.6 16.7 15.2 27.8 13.3 8.8 12.6 21.8 28.5 12.7 25.4 17.8 27.9 26.6 9.8 16.2 24.9 22.5 16.1 20.3 14.7 13.4 35.4 17.4 13.4 22.1 16.9 20.1 17.7 11.2 22.2 10.9 18.7 20.0 23.8 33.4 41.2 30.3 48.1 29.0 4.2 35.7 22.7 48.9 38.4 27.5 71.1 16.6 33.7 3.0 27.5 70.7 46.7 40.8 77.5 30.6 26.3 76.1 23.1 34.6 15.9 43.1 33.2 31.0 6.4 38.0 33.4 28.7 72.1 44.3 38.1 38.6 45.6 33.6 18.9 47.3 32.3 28.3 5.4 10.1 39.9 41.2 70.4 43.2 29.4 IRF9 ISGF3G ENSG00000213928 "Interferon regulatory factor 9" Q00978 14 24161053-24166565 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 34.1;BJ hTERT+ SV40 Large T+ RasG12V: 26.5;GAMG: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001862 Approved Supported Cytosol NA NA Cytosol "HPA001862: AB_1079153" "unprognostic (4.96e-3)" "unprognostic (4.91e-2)" "unprognostic (6.84e-3)" "unprognostic (8.17e-3)" "unprognostic (5.32e-2)" "unprognostic (2.51e-2)" "unprognostic (2.00e-1)" "unprognostic (1.77e-2)" "unprognostic (4.50e-1)" "unprognostic (9.10e-2)" "unprognostic (4.08e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (7.58e-8)" "unprognostic (1.56e-1)" "unprognostic (4.44e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.92e-4)" 34.4 20.9 23.4 35.0 25.3 21.5 15.8 10.1 19.5 19.1 19.1 22.5 15.1 19.2 23.5 31.3 18.6 22.6 27.4 13.5 17.7 24.6 27.4 26.8 23.8 22.7 22.1 18.4 26.5 13.6 13.9 17.5 25.4 22.1 21.7 11.8 17.8 36.0 16.2 8.1 14.7 20.3 20.4 23.8 37.0 22.4 9.3 20.1 26.4 29.2 12.0 28.3 30.1 21.9 28.4 21.4 57.8 30.9 19.5 29.0 25.4 1.6 1.5 1.5 0.6 7.6 8.0 0.9 3.0 16.4 34.1 26.5 2.8 9.4 2.2 3.4 8.2 22.1 2.9 1.0 0.7 8.6 10.0 0.3 4.7 1.5 2.8 11.6 0.5 6.4 7.6 2.5 4.3 1.0 6.7 3.7 0.6 0.8 12.4 4.4 2.3 1.0 1.8 0.5 1.3 3.0 0.7 1.1 1.2 7.8 1.7 0.4 1.4 2.9 1.9 16.2 2.6 0.7 4.3 6.9 3.5 2.6 2.2 0.9 13.2 10.3 2.1 4.1 0.8 3.2 45.6 24.3 30.8 21.5 30.9 18.4 28.4 22.7 19.3 19.4 25.5 20.1 18.1 57.8 19.5 29.2 21.4 29.0 25.4 23.4 25.3 10.1 18.5 17.7 24.6 22.1 18.4 22.1 20.1 23.8 13.7 11.2 7.5 2.1 5.9 0.2 12.7 49.5 12.5 5.2 7.9 1.0 0.0 4.2 0.1 13.5 7.7 23.3 4.8 21.0 5.8 7.1 23.2 1.7 6.4 7.9 1.7 11.6 4.9 0.2 11.8 15.1 5.0 3.6 2.6 14.7 4.2 5.8 6.3 1.2 4.0 12.9 8.2 1.1 1.5 2.4 1.4 16.0 2.5 9.4 ISCU "hnifU, IscU, ISU2, NIFUN" ENSG00000136003 "Iron-sulfur cluster assembly enzyme" Q9H1K1 12 108562582-108569384 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 1212.0;Proximal tubular cells: 986.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006329, HPA038602, HPA057592" Approved Supported Cytosol NA NA Cytosol "CAB006329: AB_425907, HPA038602: AB_2676109, HPA057592: AB_2683478" "unprognostic (1.72e-1)" "prognostic favorable (4.90e-7)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (2.43e-1)" "unprognostic (3.15e-2)" "unprognostic (1.33e-1)" "unprognostic (6.69e-3)" "unprognostic (1.14e-1)" "unprognostic (1.84e-1)" "unprognostic (1.28e-3)" "unprognostic (2.49e-2)" "prognostic favorable (2.73e-7)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-3)" "prognostic favorable (6.12e-4)" 37.3 91.2 44.7 25.2 62.2 23.6 44.5 27.4 61.6 37.4 39.7 20.1 32.7 25.2 36.5 44.7 25.2 32.5 34.6 121.6 37.5 56.1 86.7 33.1 29.6 34.1 54.9 58.9 48.5 28.3 41.7 48.5 31.4 65.8 36.6 33.1 34.7 33.9 59.6 87.3 21.4 27.2 50.5 27.4 33.6 32.9 29.9 21.9 30.3 53.2 39.1 37.6 36.3 42.1 86.6 34.7 85.9 34.3 29.6 61.9 53.8 10.0 24.8 17.6 10.4 63.3 48.7 42.9 20.3 33.5 15.6 14.8 18.4 14.5 10.2 17.5 27.8 16.7 14.8 16.7 23.3 14.1 31.3 18.0 11.1 13.5 40.6 36.9 26.3 13.2 47.1 52.3 16.8 33.7 39.8 23.7 22.1 20.6 33.1 32.5 22.0 20.6 48.0 17.0 15.2 36.5 13.7 11.7 43.8 45.3 29.2 15.1 14.0 14.8 8.8 22.2 23.0 22.6 21.4 20.1 15.9 13.3 12.6 10.2 39.4 43.0 31.4 24.7 19.7 15.9 62.3 29.4 84.0 37.2 30.2 44.0 86.6 49.1 48.0 19.9 73.7 61.9 51.7 85.9 29.6 34.3 34.7 49.7 53.8 44.7 62.2 27.4 61.6 37.5 56.1 54.9 58.9 65.8 21.9 71.5 123.4 189.5 128.2 87.1 45.3 660.9 137.6 139.2 104.6 221.6 9.8 370.6 1212.0 123.9 320.9 129.9 119.8 116.8 131.2 128.3 150.8 145.6 112.2 101.8 236.5 42.9 72.1 89.6 118.6 637.7 187.0 156.7 236.2 742.2 114.5 106.7 122.1 101.7 290.0 986.8 36.7 219.9 156.6 289.5 270.8 81.3 397.4 149.5 146.6 136.2 ITGB1BP2 CHORDC3 ENSG00000147166 "Integrin subunit beta 1 binding protein 2" Q9UKP3 X 71301734-71305371 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 69.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040721 Approved Cytosol NA NA Cytosol "HPA040721: AB_10805827" "unprognostic (1.87e-1)" "unprognostic (2.65e-2)" "unprognostic (6.91e-5)" "unprognostic (1.95e-2)" "unprognostic (7.92e-2)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (9.02e-2)" "unprognostic (4.69e-2)" "unprognostic (2.15e-2)" "unprognostic (4.85e-2)" "unprognostic (3.17e-1)" "unprognostic (3.08e-11)" "unprognostic (4.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-1)" 0.7 0.3 0.2 1.0 0.3 0.6 0.3 0.6 0.2 2.7 2.8 0.0 2.3 0.4 12.8 3.4 4.0 1.8 4.8 43.0 0.2 0.2 0.4 0.6 0.5 0.5 0.3 0.0 2.4 0.3 0.0 0.3 0.2 0.2 3.2 0.9 3.5 0.7 5.8 21.3 0.3 1.0 18.6 0.3 0.6 1.1 1.6 0.1 0.0 0.4 19.6 0.7 5.6 0.8 0.2 0.2 1.5 0.2 0.0 0.5 0.0 0.7 2.1 3.2 2.8 0.1 0.1 0.7 1.0 1.4 0.7 0.9 1.6 1.6 3.1 0.4 1.6 0.8 1.5 2.9 0.8 1.8 1.0 1.3 1.9 1.9 0.6 0.4 0.7 14.0 1.7 1.3 0.5 0.5 0.7 1.2 3.4 1.4 0.8 1.6 0.9 1.2 3.5 4.7 2.1 1.3 2.1 2.5 1.2 1.6 2.0 1.5 0.5 0.7 0.1 0.8 2.2 0.9 0.4 0.0 1.4 2.8 0.3 0.6 2.9 3.8 4.8 0.4 2.4 0.6 0.0 0.2 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 1.5 69.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.1 0.3 0.9 0.0 1.7 0.3 0.3 0.3 0.0 0.0 0.3 0.0 IVNS1ABP "HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP" ENSG00000116679 "Influenza virus NS1A binding protein" Q9Y6Y0 1 185296388-185317329 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 171.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 72.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003405 Approved Supported Cytosol NA NA Cytosol "HPA003405: AB_1079141" "unprognostic (4.11e-3)" "unprognostic (9.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.03e-2)" "unprognostic (4.42e-2)" "unprognostic (4.31e-3)" "unprognostic (4.18e-1)" "unprognostic (7.04e-2)" "unprognostic (5.13e-2)" "unprognostic (4.28e-1)" "unprognostic (5.42e-3)" "unprognostic (1.85e-3)" "unprognostic (3.73e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-2)" "unprognostic (4.13e-2)" 23.7 8.7 9.9 19.8 35.8 171.2 29.0 9.9 13.8 12.5 17.0 19.2 28.5 16.2 10.2 12.9 17.1 9.0 15.9 19.3 10.9 8.6 38.7 10.2 26.5 29.9 23.0 7.8 12.7 17.1 11.6 11.9 15.8 16.8 12.6 21.5 9.2 36.2 38.8 13.5 19.5 14.3 7.9 19.3 12.8 18.3 9.0 20.8 13.1 17.3 16.0 16.3 11.5 22.5 4.6 9.1 24.5 8.1 7.4 7.9 8.1 6.8 7.6 22.2 8.9 7.9 2.6 21.0 13.5 4.2 8.5 7.8 8.0 11.0 11.0 11.2 6.6 3.8 9.6 8.1 8.9 9.2 8.1 7.8 10.4 11.4 6.4 3.1 7.2 4.1 1.9 10.1 6.5 21.0 19.1 11.0 10.8 6.8 6.2 15.4 5.2 11.9 5.0 14.0 16.6 1.7 7.0 5.9 5.9 72.8 9.2 15.6 13.3 12.0 10.0 8.1 30.6 4.5 3.5 7.5 12.0 7.3 3.0 9.6 8.9 7.1 6.5 8.8 7.4 5.3 5.1 8.1 7.7 7.9 5.9 7.0 4.6 6.0 5.7 9.1 3.3 6.7 6.3 24.5 7.4 7.2 2.5 6.1 8.1 9.9 35.8 9.9 13.8 10.9 8.6 23.0 7.8 16.8 20.8 41.7 67.3 23.9 76.0 167.8 12.2 45.1 25.5 46.8 72.8 122.1 49.1 11.2 139.3 33.5 33.7 62.5 117.0 23.3 36.8 54.3 54.5 48.7 39.4 20.2 32.0 20.6 58.0 23.4 104.1 26.3 5.5 105.9 96.2 13.6 93.0 11.3 26.3 37.4 2.5 68.4 31.5 6.5 42.2 28.1 16.2 158.7 15.3 55.8 81.7 88.9 JMJD7 ENSG00000243789 "Jumonji domain containing 7" P0C870 15 41828085-41837581 "Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.9;Ciliated cells: 1.4;Club cells: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 19.5;RT4: 27.5" "Low region specificity" "Detected in all" HPA005726 Approved Approved Cytosol NA NA Cytosol "HPA005726: AB_1852017" "unprognostic (2.92e-1)" "unprognostic (7.99e-2)" "unprognostic (1.47e-2)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (1.78e-2)" "unprognostic (2.11e-2)" "unprognostic (1.77e-1)" "unprognostic (2.42e-1)" "unprognostic (8.74e-3)" "unprognostic (3.13e-1)" "unprognostic (7.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" 5.8 7.3 9.8 10.7 10.2 9.3 8.1 39.2 10.8 8.9 6.3 12.3 11.2 6.4 5.5 7.4 26.1 8.8 8.6 14.1 10.2 9.6 6.1 7.1 11.2 8.5 10.8 7.8 11.9 19.1 8.0 9.1 4.3 11.2 11.5 4.4 10.9 26.7 15.1 7.1 29.2 6.1 7.6 13.9 6.4 8.5 5.9 10.7 4.9 13.1 11.9 13.9 11.0 13.6 7.9 8.7 8.3 12.6 9.8 17.7 10.0 4.8 4.6 6.0 1.7 1.6 1.1 3.7 1.9 4.2 3.2 2.6 6.5 3.8 0.6 4.1 1.2 3.4 12.3 2.8 9.7 1.0 4.8 2.9 6.5 6.2 3.9 2.7 3.2 7.0 0.7 8.8 2.2 4.7 3.1 3.7 6.3 4.3 4.0 2.3 6.6 3.9 3.0 2.5 19.5 3.1 1.8 4.0 4.8 7.3 27.5 6.4 2.2 1.7 8.7 2.7 1.8 16.8 3.3 3.4 2.4 5.4 5.1 3.8 6.6 2.2 1.9 3.2 7.7 3.6 5.1 12.4 8.3 12.3 12.6 12.9 5.8 13.9 16.2 8.7 7.9 17.7 14.0 3.3 9.8 11.9 5.4 13.3 10.0 9.8 10.2 39.2 10.8 10.2 9.6 10.8 7.8 11.2 10.7 3.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 JMJD7-PLA2G4B ENSG00000168970 "JMJD7-PLA2G4B readthrough" 15 41828095-41848155 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.5;Club cells: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 5.6" HPA005726 Approved Approved Cytosol NA NA Cytosol "HPA005726: AB_1852017" "unprognostic (9.87e-3)" "unprognostic (5.65e-2)" "unprognostic (1.27e-2)" "unprognostic (6.86e-3)" "unprognostic (1.04e-1)" "unprognostic (1.84e-3)" "unprognostic (1.47e-1)" "unprognostic (7.21e-3)" "unprognostic (4.52e-2)" "unprognostic (4.92e-2)" "unprognostic (1.53e-2)" "unprognostic (1.02e-3)" "unprognostic (1.02e-3)" "unprognostic (3.98e-1)" "unprognostic (1.33e-1)" "unprognostic (2.15e-1)" "unprognostic (4.75e-3)" 6.6 2.8 4.7 5.2 4.9 6.8 4.5 21.4 5.3 6.0 4.3 6.1 5.5 2.7 4.9 3.5 8.7 6.5 3.8 3.9 4.9 2.2 2.9 3.0 6.7 3.8 5.3 3.6 5.5 5.8 2.7 4.3 1.9 5.5 4.3 2.5 5.3 9.0 7.7 4.9 12.0 4.4 4.2 3.7 3.6 4.0 2.6 5.2 1.9 4.6 5.9 7.0 6.4 6.3 0.7 1.3 0.0 1.5 0.7 4.0 1.0 0.8 0.5 1.2 4.2 1.1 3.1 1.9 0.9 2.2 1.4 2.0 2.0 0.1 0.4 1.8 1.1 0.1 4.3 0.4 3.4 0.3 0.0 0.4 0.6 0.9 0.6 4.7 0.0 2.5 1.6 2.3 0.5 1.1 0.0 0.5 1.7 0.0 0.6 0.4 0.7 0.9 0.1 0.1 1.1 0.2 0.6 0.0 1.5 1.1 5.6 1.5 1.8 3.8 0.0 0.5 0.2 0.9 4.4 0.7 0.7 0.6 4.8 1.7 1.2 0.4 0.0 2.2 0.6 0.4 0.0 1.1 0.0 4.0 1.5 1.9 0.7 0.4 0.6 1.3 0.1 0.7 0.0 0.0 0.7 1.0 0.0 0.1 1.0 4.7 4.9 21.4 5.3 4.9 2.2 5.3 3.6 5.5 5.2 8.9 4.5 0.0 0.1 0.1 0.6 0.4 0.0 1.4 4.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.8 0.0 0.4 0.1 0.2 0.1 1.1 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.9 0.1 0.0 0.9 0.0 KANSL1L "C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2" ENSG00000144445 "KAT8 regulatory NSL complex subunit 1 like" A0AUZ9 2 210021423-210171383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 178.9" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 44.2;Spermatocytes: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043102, HPA046790" Uncertain Approved Cytosol NA NA Cytosol "HPA043102: AB_2678316, HPA046790: AB_2679808" "unprognostic (3.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-3)" "unprognostic (1.45e-2)" "unprognostic (2.55e-3)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (5.99e-3)" "unprognostic (4.65e-2)" "unprognostic (5.89e-3)" "unprognostic (5.75e-2)" "unprognostic (5.95e-3)" "unprognostic (7.44e-2)" "unprognostic (4.60e-2)" "unprognostic (3.21e-2)" "unprognostic (1.30e-3)" 8.4 5.6 8.3 6.0 12.9 3.8 8.8 12.7 10.9 10.4 6.9 7.5 11.1 4.4 11.3 9.9 5.9 8.9 8.9 7.9 8.8 5.7 12.3 5.8 9.8 4.3 12.1 5.5 16.2 10.0 178.9 14.4 5.3 9.5 14.3 4.7 6.2 7.6 9.9 8.8 7.7 4.9 9.8 13.0 4.5 7.2 12.4 13.6 21.6 14.2 4.4 3.8 11.1 33.0 2.1 2.1 2.7 2.2 3.1 1.7 0.5 2.4 1.3 12.7 5.4 10.3 7.8 3.7 3.6 4.6 2.3 6.5 2.5 9.5 6.7 4.9 2.3 5.7 3.5 2.9 1.2 3.7 2.9 2.4 5.5 4.9 4.3 6.4 6.4 4.0 4.9 5.6 2.3 1.7 10.2 5.2 6.2 4.1 6.2 3.5 2.3 7.1 16.5 7.7 4.2 1.8 5.2 3.6 5.2 14.0 3.7 8.0 7.6 3.3 2.2 2.6 13.3 2.2 13.7 4.5 5.1 4.1 1.7 2.7 4.4 1.9 6.6 6.2 3.2 6.1 1.1 1.4 2.7 1.2 2.2 1.1 0.9 1.0 1.4 2.1 2.1 1.7 1.7 2.4 3.1 0.9 1.4 0.8 0.5 8.3 12.9 12.7 10.9 8.8 5.7 12.1 5.5 9.5 13.6 26.8 15.3 2.0 7.6 6.5 9.3 7.6 7.6 44.2 7.9 29.6 13.7 1.3 3.3 8.2 20.3 7.8 1.8 0.0 4.8 0.8 9.3 6.6 10.4 5.5 2.3 4.8 5.8 5.5 2.6 17.2 13.6 6.0 6.8 1.8 2.8 9.7 7.7 2.5 28.3 10.2 8.9 12.9 9.2 38.9 6.4 9.7 1.6 3.2 2.4 3.0 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Predicted membrane proteins" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5" "Cell type enriched" "Detected in some" 5 "monocytes: 16.2" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 5.6" "Group enriched" "Detected in many" 4 "dendritic cells: 5.6;monocytes: 1.7" "Cell line enhanced" "Detected in some" "HMC-1: 4.2;hTEC/SVTERT24-B: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042316 Uncertain Cytosol NA NA Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 4.8 1.1 6.4 1.3 11.3 6.8 1.2 6.0 6.6 1.0 0.6 8.2 0.0 0.7 0.8 1.3 1.2 0.5 2.4 2.2 8.9 8.1 0.7 0.7 0.8 0.8 14.3 1.6 1.7 0.4 0.4 0.2 2.5 29.5 1.9 0.5 0.1 0.6 2.3 3.2 1.1 0.8 0.9 7.3 1.4 0.6 1.2 0.3 8.5 0.6 2.6 0.8 0.8 0.2 0.0 5.6 0.0 1.7 0.1 0.8 0.3 1.0 0.0 0.2 0.4 0.1 0.1 0.1 1.9 0.5 0.7 0.7 0.1 0.4 0.4 0.0 0.4 0.8 0.8 0.0 2.2 0.9 0.2 0.4 2.7 2.6 1.8 0.1 0.0 4.2 0.6 1.5 5.5 1.3 0.5 0.4 0.4 0.0 0.1 0.5 0.0 0.8 3.4 0.0 0.0 0.1 0.2 0.1 0.1 0.8 0.1 0.2 0.4 1.3 0.0 1.1 1.5 0.0 2.5 1.2 1.8 1.0 1.0 2.4 0.5 0.6 0.3 1.2 1.2 0.5 0.0 0.7 0.0 0.8 1.7 0.0 0.0 0.1 0.1 5.6 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.3 6.4 11.3 6.0 6.5 8.9 8.1 14.3 1.6 29.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 1.3 3.0 0.0 1.1 0.2 0.0 16.2 0.0 2.9 0.2 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 KCNMB4 ENSG00000135643 "Potassium calcium-activated channel subfamily M regulatory beta subunit 4" Q86W47 12 70366276-70434292 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 24.4;brain: 37.7" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 16.9;Collecting duct cells: 22.7;Ito cells: 24.5;Peritubular cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 8.9;RH-30: 9.5;RT4: 10.4;SuSa: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072287 Enhanced Approved Approved Cytosol NA NA Cytosol "HPA072287: AB_2686507" "unprognostic (3.90e-1)" "unprognostic (1.72e-2)" "unprognostic (2.69e-2)" "unprognostic (2.62e-2)" "unprognostic (6.98e-2)" "unprognostic (1.13e-3)" "unprognostic (1.85e-1)" "unprognostic (2.48e-2)" "unprognostic (3.50e-1)" "unprognostic (2.95e-2)" "unprognostic (3.75e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.05e-2)" 4.4 24.4 19.8 2.6 24.6 1.3 2.6 13.8 37.7 3.5 5.0 28.4 1.0 2.5 3.2 2.8 2.6 3.3 3.2 5.9 25.9 10.4 5.8 1.8 4.6 2.8 28.6 19.3 5.4 1.5 1.3 1.4 4.9 11.6 2.9 2.9 2.0 3.8 4.5 4.2 4.9 3.0 2.8 15.2 2.8 1.8 3.8 26.0 0.8 3.3 0.0 2.6 2.4 2.1 1.7 0.6 0.3 0.3 0.2 2.8 0.5 0.0 0.3 5.6 3.1 0.3 0.3 0.6 0.6 1.0 0.3 0.9 0.2 2.1 2.7 0.3 0.0 1.2 0.1 6.0 0.9 0.2 1.3 3.5 1.4 1.3 3.2 0.0 0.1 0.1 1.6 0.1 0.0 0.0 0.6 0.2 4.0 0.0 0.0 1.1 0.7 1.9 0.4 8.9 0.1 6.4 2.8 9.5 0.2 0.2 10.4 2.7 3.4 0.8 1.1 0.1 8.9 3.1 0.1 0.1 0.4 1.5 0.1 0.3 2.0 0.0 2.8 0.5 0.0 0.9 0.3 0.3 0.0 0.3 0.3 0.3 0.6 0.6 0.6 0.6 1.7 2.2 2.8 0.3 0.2 0.1 0.2 0.6 0.5 19.8 24.6 13.8 19.1 25.9 10.4 28.6 19.3 11.6 26.0 0.0 1.1 0.0 0.1 2.9 16.9 3.1 0.0 0.0 0.0 22.7 0.0 0.2 0.0 0.0 0.9 6.0 0.0 0.0 0.0 0.2 2.2 0.4 0.0 0.2 1.1 0.0 0.0 24.5 9.5 1.8 6.1 2.0 1.7 0.0 0.0 0.4 0.0 0.0 17.0 7.8 2.7 0.0 1.7 1.5 4.9 4.8 0.2 0.5 0.0 0.0 KCTD21 KCASH2 ENSG00000188997 "Potassium channel tetramerization domain containing 21" Q4G0X4 11 78171249-78188822 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041964 Uncertain Approved Cytosol NA NA Cytosol "HPA041964: AB_10795647" "unprognostic (1.17e-1)" "unprognostic (5.45e-2)" "unprognostic (3.74e-3)" "unprognostic (6.40e-3)" "unprognostic (8.06e-2)" "unprognostic (2.48e-2)" "unprognostic (1.52e-1)" "unprognostic (6.82e-2)" "unprognostic (8.85e-2)" "unprognostic (1.37e-3)" "unprognostic (2.49e-1)" "unprognostic (1.31e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "unprognostic (4.70e-1)" "prognostic favorable (9.57e-5)" "unprognostic (3.43e-2)" 8.6 18.1 13.2 7.3 12.5 4.0 15.8 8.4 14.0 7.7 7.7 9.7 7.5 6.2 6.5 11.8 12.1 8.2 9.8 12.4 10.3 12.2 6.8 18.9 8.2 6.1 15.2 9.7 17.9 9.0 11.3 8.4 9.5 10.0 5.9 6.1 6.2 6.7 6.8 9.3 6.0 5.5 11.9 12.3 5.4 5.5 5.6 8.4 7.2 13.8 5.3 7.4 10.1 7.4 2.0 4.3 9.5 7.1 1.9 2.1 2.3 3.7 8.8 4.9 3.7 17.5 12.7 3.1 7.4 7.1 5.2 5.2 8.1 5.7 3.6 7.4 8.0 7.0 7.6 4.6 6.1 5.3 4.9 2.9 2.6 10.1 7.2 9.8 1.7 3.5 12.1 11.1 11.6 6.6 11.1 7.9 4.4 5.6 3.3 7.0 5.1 2.7 5.2 2.3 13.3 6.5 3.7 3.7 2.2 6.1 6.8 3.5 5.2 4.7 3.3 3.4 9.3 8.0 1.9 9.7 8.3 8.3 22.5 2.8 6.4 6.4 3.5 4.4 2.8 4.7 2.1 6.5 8.3 1.2 7.1 1.7 0.8 1.8 2.1 4.3 2.0 1.8 1.3 9.5 1.9 5.6 1.0 1.4 2.3 13.2 12.5 8.4 13.3 10.3 12.2 15.2 9.7 10.0 8.4 0.0 2.4 0.8 1.0 1.5 1.0 3.0 5.1 0.0 1.2 0.0 0.0 1.0 1.7 1.4 0.3 1.7 1.8 0.0 1.8 1.0 2.6 1.6 5.7 6.4 1.9 6.4 0.0 2.5 3.4 0.2 4.0 0.6 1.7 1.0 1.7 1.0 2.0 1.4 8.5 2.2 0.9 0.0 2.3 1.4 1.2 1.3 1.6 1.0 1.5 1.7 KCTD3 NY-REN-45 ENSG00000136636 "Potassium channel tetramerization domain containing 3" Q9Y597 1 215567392-215621807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 70.8" "Low region specificity" "Detected in all" HPA015142 Approved Approved Cytosol NA NA Cytosol "HPA015142: AB_1852174" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (5.46e-3)" "unprognostic (3.91e-2)" "unprognostic (3.67e-2)" "unprognostic (6.00e-2)" "unprognostic (3.39e-1)" "unprognostic (1.20e-2)" "unprognostic (5.60e-3)" "unprognostic (9.27e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.49e-1)" "prognostic unfavorable (8.94e-6)" "unprognostic (2.30e-2)" "unprognostic (2.55e-1)" "unprognostic (4.27e-1)" "unprognostic (3.31e-3)" 18.4 47.6 17.3 7.3 16.6 7.7 37.5 23.6 16.9 19.8 35.1 24.1 20.3 25.1 22.6 18.4 25.8 12.1 15.7 10.3 17.4 14.4 16.3 39.6 10.9 4.4 18.7 13.1 13.8 18.2 24.5 12.4 18.1 19.5 22.7 16.4 13.9 24.5 17.9 10.0 10.6 35.1 17.1 26.6 7.5 16.6 13.3 15.0 5.3 15.8 11.0 9.2 18.1 21.9 2.6 2.6 3.3 2.1 2.5 1.3 0.6 15.7 11.4 12.9 7.5 11.0 18.6 17.9 13.0 12.2 11.6 12.2 10.0 26.4 4.4 7.3 13.5 3.5 15.5 13.5 13.3 13.4 2.4 14.1 7.9 22.0 14.0 9.1 8.0 1.5 17.1 9.3 14.8 11.3 14.7 10.5 5.9 15.3 4.3 12.7 13.7 3.4 4.2 21.7 22.9 14.6 5.3 18.3 17.1 13.6 10.7 15.3 17.1 20.2 29.6 11.0 17.0 70.8 10.4 9.4 11.7 11.6 14.3 14.8 3.9 5.3 1.5 9.1 4.2 8.8 1.8 2.1 1.0 1.0 1.1 0.8 1.6 1.1 1.0 2.0 2.6 1.2 1.3 3.3 2.5 1.0 2.6 0.6 0.6 17.3 16.6 23.6 16.2 17.4 14.4 18.7 13.1 19.5 15.0 8.9 12.3 5.1 20.2 16.0 27.6 12.2 20.4 16.0 21.6 10.4 17.7 22.5 19.9 19.6 1.1 12.1 16.9 0.0 18.1 13.1 21.6 24.9 4.7 56.2 6.9 17.5 38.1 19.0 10.5 2.0 25.6 5.8 15.1 4.6 38.5 19.2 13.9 22.0 21.2 23.7 22.3 25.8 16.5 6.7 16.1 15.4 14.6 1.7 24.8 37.9 KHK ENSG00000138030 Ketohexokinase P50053 2 27086747-27100772 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 60.2;kidney: 38.4;liver: 67.0" "Group enriched" "Detected in many" 6 "Hepatocytes: 359.6;Proximal tubular cells: 948.1" "Group enriched" "Detected in all" 7 "liver cancer: 62.2;renal cancer: 32.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.6;Hep G2: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007040 Enhanced Approved Cytosol NA NA 320000 Cytosol "HPA007040: AB_1079185" "unprognostic (8.44e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.62e-8)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "unprognostic (3.08e-2)" "unprognostic (3.13e-2)" "unprognostic (1.67e-2)" "unprognostic (2.50e-2)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (1.68e-2)" "unprognostic (2.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.44e-1)" "unprognostic (1.02e-2)" 0.9 1.9 2.1 1.2 2.7 0.7 1.9 5.2 3.9 1.1 22.3 1.9 0.2 40.0 1.5 0.9 1.1 1.6 0.6 0.6 2.2 2.2 38.4 67.0 0.7 0.8 3.5 1.9 1.8 4.2 0.6 0.7 0.4 3.0 0.9 0.6 0.6 1.7 0.7 1.4 1.0 60.2 0.9 1.8 0.8 1.0 1.6 3.6 0.0 0.5 1.2 0.6 0.7 0.9 5.1 7.3 0.6 6.6 5.4 8.8 6.0 14.0 10.7 1.7 6.4 1.2 0.3 1.4 1.0 0.6 1.3 0.8 5.1 3.1 2.1 3.4 0.0 1.5 6.2 5.5 1.8 0.4 5.0 10.1 18.6 2.8 27.1 0.6 2.5 2.2 0.1 0.8 1.6 0.1 0.7 1.2 3.0 3.3 3.6 0.1 9.1 3.0 2.0 2.3 12.7 4.2 10.7 0.8 11.8 1.6 1.7 6.0 9.4 2.1 3.6 4.0 0.6 1.6 1.1 1.1 0.4 2.1 0.9 3.7 4.4 7.9 3.6 1.8 6.1 1.0 0.0 6.6 0.4 5.4 3.8 7.4 5.1 8.8 7.8 6.1 5.1 6.4 7.8 0.6 5.4 1.6 7.3 5.5 6.0 2.1 2.7 5.2 3.9 2.2 2.2 3.5 1.9 3.0 3.6 3.0 5.9 9.6 2.3 3.2 3.6 1.9 15.3 0.0 1.2 38.4 2.0 2.6 109.5 3.1 0.8 5.8 12.3 0.0 2.6 3.6 1.9 0.9 4.6 359.6 7.5 6.4 5.8 6.7 13.2 3.6 1.7 5.8 8.5 1.0 5.9 8.5 2.7 1.7 1.4 948.1 5.2 0.0 4.5 0.9 6.8 5.9 7.9 4.6 14.3 1.0 KIAA0232 ENSG00000170871 KIAA0232 Q92628 4 6781375-6884170 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 13.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036891, HPA036892, HPA061498" Approved Approved Cytosol NA NA Cytosol "HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541" "unprognostic (6.88e-3)" "unprognostic (2.74e-1)" "unprognostic (8.98e-2)" "unprognostic (4.87e-2)" "unprognostic (2.43e-1)" "unprognostic (4.13e-2)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (1.85e-1)" "unprognostic (3.16e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-1)" "prognostic favorable (3.91e-10)" "unprognostic (1.21e-1)" "unprognostic (8.57e-2)" "unprognostic (2.04e-1)" "unprognostic (3.18e-2)" 12.5 12.7 18.7 8.1 22.2 14.0 13.8 22.8 25.5 13.3 13.8 20.5 12.4 8.5 15.8 13.4 21.1 15.9 12.7 32.2 19.8 18.8 19.5 15.0 12.0 7.0 20.7 17.5 13.9 10.6 25.4 22.2 25.8 25.4 15.5 12.7 11.5 10.6 15.7 32.4 7.7 18.8 13.5 19.8 12.3 11.0 13.5 17.9 10.0 15.5 13.3 8.5 12.1 13.2 1.6 2.4 13.1 2.5 2.1 3.8 0.9 9.0 8.7 18.3 11.4 13.3 14.4 9.7 11.8 12.3 8.3 7.0 5.5 7.6 5.9 4.0 13.2 12.8 4.7 9.3 5.2 10.8 3.3 3.8 17.6 7.5 7.2 7.0 7.6 23.3 9.6 12.3 9.2 5.1 10.7 8.5 6.0 13.3 5.2 10.5 4.4 14.5 7.7 9.7 6.8 9.7 10.4 18.8 2.7 14.0 8.6 14.0 9.0 8.7 7.8 8.1 13.2 9.9 14.0 10.8 7.6 9.1 6.8 10.0 9.0 9.0 4.8 9.4 8.2 20.6 1.9 2.4 6.3 2.8 1.6 3.8 1.6 2.1 3.1 1.6 1.6 2.0 2.0 13.1 2.1 2.5 2.4 1.9 0.9 18.7 22.2 22.8 25.5 19.8 18.8 20.7 17.5 25.4 17.9 29.8 31.7 8.3 22.9 11.3 72.9 121.5 7.6 66.9 34.2 12.2 35.3 11.7 34.9 20.0 36.5 15.7 31.1 46.7 10.2 5.9 11.8 25.5 11.6 36.0 9.6 93.8 24.1 16.0 24.8 44.7 23.0 17.7 6.8 16.2 16.6 51.2 15.7 24.6 31.1 21.7 41.3 25.8 13.1 27.2 17.9 9.7 18.8 12.8 13.7 24.3 KLHDC1 MST025 ENSG00000197776 "Kelch domain containing 1" Q8N7A1 14 49693105-49753152 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 8.9;ASC TERT1: 8.5;HSkMC: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020461 Approved Supported Cytosol No No Cytosol "HPA020461: AB_1852556" "unprognostic (2.97e-2)" "unprognostic (6.30e-2)" "unprognostic (8.49e-3)" "unprognostic (1.26e-2)" "unprognostic (5.46e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (1.95e-2)" "unprognostic (1.01e-1)" "unprognostic (2.53e-1)" "prognostic favorable (1.94e-4)" "unprognostic (3.42e-1)" "unprognostic (5.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" 8.6 9.7 8.5 8.0 14.5 3.3 11.0 13.4 15.2 10.9 8.7 15.4 8.6 4.5 13.3 13.3 5.3 8.9 7.2 9.9 9.2 10.0 7.2 5.9 6.6 7.5 12.0 12.2 18.2 6.7 11.0 13.2 6.0 10.7 10.2 5.6 12.4 7.1 14.2 14.1 11.3 6.5 11.0 12.9 7.9 6.5 11.7 11.7 2.9 12.5 4.4 6.0 7.1 8.5 3.0 3.7 2.5 2.2 1.6 4.8 1.7 1.0 0.5 1.0 0.7 8.9 8.5 0.0 2.4 3.2 0.7 0.6 0.0 2.8 0.5 0.6 0.9 0.8 0.7 0.3 0.0 0.7 2.3 0.8 0.4 0.2 0.0 4.6 0.2 1.0 7.1 0.4 0.3 0.3 4.5 1.8 1.6 0.4 0.0 3.5 0.3 0.7 1.1 0.0 0.3 0.4 0.6 0.7 0.0 1.7 0.2 0.3 2.4 0.4 0.0 0.9 1.1 1.0 1.8 2.6 2.0 2.2 0.7 0.2 0.8 0.1 0.6 2.0 0.3 1.1 1.4 1.0 2.5 2.1 2.2 4.2 3.0 2.8 2.4 1.1 2.1 4.8 4.0 0.1 1.6 1.1 3.7 0.9 1.7 8.5 14.5 13.4 15.2 9.2 10.0 12.0 12.2 10.7 11.7 20.8 6.2 0.8 3.8 3.2 9.9 7.0 5.1 2.7 9.1 0.0 3.9 0.9 8.3 0.7 1.7 5.8 2.2 0.0 0.7 0.6 3.9 1.9 1.1 2.0 2.2 12.7 1.7 5.5 1.3 2.1 16.7 2.6 5.0 1.0 2.2 16.0 0.4 2.9 9.6 1.1 13.1 0.0 6.6 17.9 5.6 2.9 0.2 2.9 1.3 1.3 KLHDC8B MGC35097 ENSG00000185909 "Kelch domain containing 8B" Q8IXV7 3 49171611-49176486 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.4" "Group enriched" "Detected in many" 9 "granulocytes: 19.4;monocytes: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008463, HPA014467" Approved Enhanced Cytosol NA NA Cytosol "HPA008463: AB_1852563, HPA014467: AB_1852565" "unprognostic (1.66e-2)" "unprognostic (1.42e-1)" "unprognostic (5.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.66e-1)" "unprognostic (5.03e-3)" "unprognostic (1.71e-3)" "prognostic favorable (1.47e-4)" "unprognostic (6.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" "unprognostic (4.30e-2)" "unprognostic (1.02e-3)" "unprognostic (4.78e-2)" "unprognostic (5.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" 15.0 44.0 5.6 4.7 5.8 3.2 12.6 4.5 8.8 12.8 19.3 6.2 10.5 4.6 15.9 12.2 22.6 11.6 13.6 30.5 3.7 8.5 5.6 8.8 6.6 6.3 4.9 5.4 29.6 6.2 5.2 4.2 7.9 5.2 15.2 2.5 21.8 8.4 9.5 15.8 9.8 5.4 18.0 2.4 6.7 6.7 10.0 3.0 2.0 17.1 10.7 6.6 20.0 8.8 0.1 0.6 19.4 5.7 0.0 1.4 1.6 1.5 3.4 14.3 7.2 8.8 5.2 4.4 5.2 3.0 5.2 4.2 2.2 4.6 0.0 3.0 8.7 1.5 0.0 3.5 3.2 1.3 2.8 0.9 9.2 9.3 5.8 16.8 0.0 5.4 8.7 15.3 6.8 0.5 11.8 13.4 3.3 14.3 0.1 3.9 0.4 0.9 10.2 4.7 0.8 8.2 1.4 1.4 0.4 3.9 0.8 0.6 16.2 4.2 0.1 10.4 3.1 4.3 4.5 5.8 4.0 11.3 7.1 1.6 1.3 0.4 0.2 2.9 0.0 1.9 0.0 3.8 19.4 0.8 5.7 0.3 0.0 0.4 0.6 0.3 0.1 1.4 0.8 6.7 0.0 5.0 0.6 0.1 1.6 5.6 5.8 4.5 8.8 3.7 8.5 4.9 5.4 5.2 3.0 8.9 10.4 0.5 10.9 6.8 1.2 36.6 7.6 0.0 5.7 7.0 2.0 6.9 14.9 13.0 6.0 17.8 0.7 0.0 5.2 7.0 14.6 6.8 1.1 5.8 37.1 0.0 6.4 33.7 5.4 5.8 14.1 6.3 11.8 0.0 2.0 19.8 8.8 1.4 13.4 11.3 2.6 97.0 26.4 3.7 4.1 8.5 41.6 2.1 1.5 6.2 KLHL13 "BKLHD2, FLJ10262, KIAA1309" ENSG00000003096 "Kelch like family member 13" Q9P2N7 X 117897813-118117340 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 35.6" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 25.4;Distal tubular cells: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 3.2;eosinophil: 9.3;plasmacytoid DC: 5.6" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;granulocytes: 9.3" "Cell line enhanced" "Detected in many" "HAP1: 12.8;HeLa: 22.7;RH-30: 14.3;RPTEC TERT1: 40.8;SH-SY5Y: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046039, HPA059901" Approved Approved Cytosol NA NA Cytosol "HPA046039: AB_2679514, HPA059901: AB_2684155" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.09e-2)" "unprognostic (1.07e-2)" "unprognostic (9.54e-2)" "unprognostic (7.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (6.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.09e-3)" "unprognostic (1.24e-2)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (2.31e-1)" 2.4 5.5 3.4 3.9 11.9 0.2 19.0 2.5 3.7 24.9 5.3 3.1 6.6 2.2 35.6 5.6 5.4 8.1 10.1 9.0 2.3 4.0 15.4 3.3 1.4 0.4 4.7 2.1 7.7 3.3 3.5 5.0 1.7 6.6 7.3 3.0 5.6 2.6 9.7 2.3 1.5 4.9 22.2 3.5 1.1 3.5 2.8 4.9 3.6 1.4 3.1 1.2 8.2 5.0 0.0 5.6 9.3 0.1 1.4 0.9 0.4 0.4 0.1 2.6 5.5 0.0 0.0 0.1 0.2 0.0 0.1 0.0 3.4 0.0 0.0 6.3 0.0 0.2 6.3 12.8 2.1 0.0 0.0 4.9 0.1 22.7 0.0 0.3 0.4 0.8 0.7 0.9 0.0 0.2 2.7 9.7 0.0 0.0 0.0 0.0 0.5 2.1 0.5 5.1 0.0 3.6 0.0 14.3 0.0 40.8 1.5 0.0 36.4 0.1 0.4 0.3 1.1 7.9 0.0 0.2 0.9 1.1 0.7 3.2 0.1 0.0 0.0 3.9 0.0 1.5 3.2 0.1 9.3 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.9 0.8 0.0 1.4 0.0 5.6 0.4 0.4 3.4 11.9 2.5 3.5 2.3 4.0 4.7 2.1 6.6 4.9 0.0 0.0 0.0 5.5 0.7 3.9 5.8 0.0 25.4 5.7 1.8 0.0 0.1 24.9 1.1 0.3 0.7 1.6 0.0 2.9 0.1 2.6 1.5 0.0 1.0 0.5 0.0 1.2 4.3 0.0 0.7 5.8 0.0 1.7 0.0 2.0 8.4 1.2 3.5 1.8 8.5 1.1 6.5 3.2 1.2 12.0 0.4 0.0 0.0 2.3 1.7 KLHL28 "BTBD5, FLJ20081" ENSG00000179454 "Kelch like family member 28" Q9NXS3 14 44924319-45042322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000988 Approved Cytosol NA NA Cytosol "HPA000988: AB_1845480" "unprognostic (8.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (7.84e-3)" "unprognostic (9.20e-2)" "unprognostic (4.36e-3)" "unprognostic (4.92e-2)" "unprognostic (2.66e-1)" "unprognostic (2.14e-1)" "unprognostic (1.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.68e-2)" "unprognostic (7.55e-2)" "unprognostic (4.34e-1)" "unprognostic (1.75e-2)" "unprognostic (6.53e-2)" 10.9 9.0 8.8 11.6 12.7 39.2 10.4 22.9 15.5 12.1 9.9 11.1 10.5 9.1 12.6 9.4 12.8 11.2 9.9 8.9 10.3 10.4 8.6 11.2 10.1 13.5 11.2 9.4 14.4 10.6 9.8 18.1 9.9 16.7 10.2 10.8 12.2 12.6 9.0 13.8 11.5 11.0 10.5 12.8 11.5 8.8 14.2 10.9 27.9 13.6 8.6 12.7 11.3 10.8 10.2 6.0 17.7 7.0 13.0 23.1 4.5 4.5 6.9 9.2 6.0 8.4 7.6 7.0 6.1 6.8 9.1 7.7 3.0 7.2 6.8 6.7 10.6 2.4 8.0 8.2 6.5 10.0 12.6 4.4 5.9 7.1 3.5 7.5 9.4 12.9 5.8 9.1 5.8 9.3 5.2 7.2 10.7 5.2 17.0 5.2 6.6 7.4 4.8 5.7 5.2 6.6 6.5 10.3 3.7 5.2 8.3 10.6 6.5 7.9 5.3 8.4 6.2 10.0 4.0 9.1 8.1 9.5 5.7 3.4 10.1 11.0 9.4 2.8 4.2 4.9 17.7 5.0 11.9 12.4 6.9 23.1 10.2 12.4 13.0 4.4 9.6 14.9 12.6 11.6 13.0 7.0 6.0 9.3 4.5 8.8 12.7 22.9 15.5 10.3 10.4 11.2 9.4 16.7 10.9 14.9 6.5 22.3 14.8 21.8 23.0 10.7 7.6 18.7 11.4 17.4 33.4 6.0 6.6 8.4 28.5 11.7 10.5 23.3 4.9 6.4 12.6 10.9 18.5 10.5 8.1 14.3 13.4 14.7 16.2 34.2 20.1 15.3 21.9 12.6 11.1 27.6 9.0 11.6 16.6 6.3 20.9 12.9 16.0 9.9 4.2 26.3 11.8 25.5 10.0 13.6 KLHL36 "C16orf44, FLJ12543" ENSG00000135686 "Kelch like family member 36" Q8N4N3 16 84648525-84667686 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023423 Approved Approved Cytosol NA NA Cytosol "HPA023423: AB_10962985" "unprognostic (6.50e-2)" "unprognostic (2.41e-2)" "unprognostic (2.35e-1)" "unprognostic (5.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (2.90e-1)" "unprognostic (5.25e-2)" "unprognostic (2.59e-2)" "prognostic favorable (9.81e-5)" "unprognostic (3.79e-3)" "prognostic favorable (5.52e-10)" "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (8.47e-2)" "unprognostic (1.67e-3)" 14.6 10.3 13.7 10.8 14.8 26.3 12.2 12.1 11.7 8.9 9.7 7.5 13.0 13.7 11.1 11.1 13.8 10.4 10.1 12.6 10.8 6.0 11.6 16.2 12.7 12.3 10.2 8.6 14.7 21.9 12.7 10.1 9.2 8.7 12.1 5.6 8.8 13.5 12.4 7.8 11.9 14.9 12.0 6.7 16.8 13.1 21.3 10.5 8.4 13.9 7.2 14.0 15.1 22.6 5.9 5.4 8.8 3.7 3.1 10.4 3.2 12.4 13.4 2.5 6.7 2.6 4.8 13.2 8.7 4.8 3.9 2.1 11.8 8.9 8.6 12.8 5.3 3.9 13.3 2.7 7.2 1.8 5.6 5.4 3.0 4.4 6.5 3.5 3.7 8.6 4.6 5.4 5.1 4.0 4.2 4.7 2.6 9.6 1.5 2.8 19.6 0.5 5.3 4.9 4.1 5.9 11.8 3.3 4.2 5.4 11.6 3.8 2.8 11.0 2.8 5.4 3.2 12.0 8.7 10.6 5.0 9.3 5.5 5.8 5.1 6.4 14.8 6.8 4.5 14.9 5.3 3.7 8.8 4.9 2.5 4.1 5.9 8.7 7.1 5.4 5.7 10.4 7.2 4.8 3.1 2.6 4.9 4.0 3.2 13.7 14.8 12.1 11.7 10.8 6.0 10.2 8.6 8.7 10.5 17.9 14.4 23.8 31.2 14.2 21.2 22.4 40.8 10.7 7.9 21.0 33.4 19.3 5.0 22.4 31.8 16.8 29.1 0.0 12.6 9.5 14.3 40.6 6.9 17.9 16.8 25.4 17.9 18.4 15.8 11.8 21.6 15.6 20.3 19.8 20.4 8.6 17.7 24.6 23.7 23.0 22.3 32.3 21.7 14.8 4.7 15.4 16.1 20.8 18.6 36.1 KLHL9 "FLJ13568, KIAA1354" ENSG00000198642 "Kelch like family member 9" Q9P2J3 9 21329671-21335380 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046039, HPA059901" Approved Approved Cytosol NA NA Cytosol "HPA046039: AB_2679514, HPA059901: AB_2684155" "unprognostic (7.82e-2)" "unprognostic (4.36e-1)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.89e-1)" "unprognostic (1.87e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-2)" "unprognostic (8.23e-2)" "unprognostic (2.95e-1)" "unprognostic (4.52e-2)" "unprognostic (9.06e-2)" "prognostic favorable (9.43e-10)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (2.91e-1)" "unprognostic (3.33e-3)" 17.8 15.1 16.4 12.4 15.6 9.3 20.8 18.0 19.5 19.7 14.4 19.4 12.7 8.7 19.5 18.7 14.8 16.8 12.6 13.6 15.8 19.9 17.8 15.1 13.6 13.2 16.9 11.9 25.3 20.4 18.1 16.9 22.6 15.7 20.0 15.1 15.3 16.2 14.8 9.3 10.1 15.6 17.6 16.9 17.3 16.1 9.9 13.2 23.0 19.9 11.6 13.5 15.7 16.5 3.4 5.0 16.7 7.2 6.0 8.3 4.5 6.0 7.3 16.7 9.0 21.6 21.5 3.6 11.3 11.5 8.6 9.7 2.7 4.8 2.7 7.3 16.5 8.6 3.3 9.7 11.0 10.7 15.0 7.0 0.0 13.8 7.1 15.1 4.7 3.3 21.1 11.9 6.7 10.9 14.1 13.0 0.0 0.0 3.6 19.6 3.8 9.8 16.6 6.8 6.2 6.3 0.0 7.3 3.2 10.6 7.5 5.3 10.1 6.5 5.9 6.9 16.1 10.7 0.0 15.6 0.0 6.1 4.8 6.5 3.9 5.3 2.9 0.0 5.0 5.8 7.5 6.2 16.7 5.5 6.9 6.2 3.4 6.7 5.0 5.0 2.6 8.3 5.6 2.0 6.0 7.2 3.7 4.6 4.5 16.4 15.6 18.0 19.5 15.8 19.9 16.9 11.9 15.7 13.2 23.8 15.6 6.9 27.6 9.2 23.8 16.3 17.8 16.0 29.6 15.7 17.7 13.6 10.0 13.1 0.6 16.1 14.7 0.0 13.1 6.3 14.6 21.4 11.5 19.5 12.9 17.5 26.5 43.6 22.7 0.9 19.8 10.3 16.9 6.4 23.0 18.7 11.5 17.5 22.6 20.3 16.7 12.9 10.3 12.5 9.5 9.2 8.4 14.9 14.5 18.0 KPNA5 "IPOA6, SRP6" ENSG00000196911 "Karyopherin subunit alpha 5" O15131 6 116681187-116741866 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 211.4;Alveolar cells type 2: 181.5;Ciliated cells: 240.9;Club cells: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026464, HPA054037" Enhanced Supported Cytosol NA NA Cytosol "CAB026464: , HPA054037: AB_2682351" "unprognostic (9.64e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-2)" "unprognostic (3.56e-1)" "unprognostic (6.60e-3)" "unprognostic (6.98e-2)" "unprognostic (1.75e-3)" "unprognostic (5.19e-2)" "unprognostic (1.10e-1)" "unprognostic (6.12e-2)" "unprognostic (1.51e-3)" "unprognostic (3.02e-1)" "unprognostic (6.12e-2)" "unprognostic (8.00e-2)" "unprognostic (4.79e-1)" "unprognostic (7.89e-2)" "unprognostic (1.43e-1)" 5.7 6.5 11.9 5.9 12.8 7.5 7.6 24.1 21.2 8.6 6.0 4.3 3.4 4.0 11.2 5.3 6.1 9.8 6.5 5.8 11.0 8.1 6.6 3.6 7.2 10.7 9.0 13.5 22.3 4.4 9.5 19.7 5.6 14.1 8.4 4.5 5.7 4.7 7.1 14.0 4.7 5.6 8.5 12.0 7.4 4.8 46.6 8.2 10.9 12.2 3.9 7.3 6.4 7.4 18.0 10.5 11.9 4.0 6.3 16.6 2.9 2.5 1.5 11.0 6.8 4.2 7.9 4.5 3.8 10.6 6.7 9.5 7.1 2.6 9.2 5.0 4.1 7.6 4.2 5.8 3.4 8.7 5.8 15.8 8.8 4.6 4.0 5.2 6.8 5.5 7.0 2.1 8.2 4.8 7.9 7.6 9.3 12.9 4.0 7.4 3.4 10.5 4.7 4.9 1.7 4.1 8.7 3.6 2.6 5.1 5.0 11.5 11.0 2.9 2.3 3.6 7.5 4.6 6.7 6.0 2.8 5.7 2.9 6.6 10.4 11.3 10.7 3.1 4.8 5.8 11.9 3.1 3.7 8.8 3.2 10.9 14.9 10.0 10.3 1.6 18.0 16.6 12.1 0.8 6.3 4.0 10.5 7.3 2.9 11.9 12.8 24.1 21.2 11.0 8.1 9.0 13.5 14.1 8.2 211.4 181.5 19.3 7.0 12.0 45.3 13.6 10.2 240.9 211.5 8.7 27.5 3.3 8.3 5.3 34.2 15.8 1.4 0.0 4.7 1.5 10.8 7.1 119.7 4.2 3.8 44.5 32.4 16.0 5.4 5.9 16.4 10.4 10.1 4.6 6.8 34.6 4.2 0.0 15.6 4.2 36.7 12.9 7.2 60.3 9.8 7.9 2.7 12.5 3.5 2.6 KRT18 ENSG00000111057 "Keratin 18" P05783 12 52948871-52952901 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 268.7" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 6515.6;Exocrine glandular cells: 4232.0;Extravillous trophoblasts: 4401.0;Pancreatic endocrine cells: 4358.9;Syncytiotrophoblasts: 6392.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 10.0" "Cell type enriched" "Detected in many" 5 "basophil: 28.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 28.6" "Cell line enhanced" "Detected in many" "A549: 228.6;BEWO: 144.3;CACO-2: 251.4;CAPAN-2: 182.6;MCF7: 334.7;SK-BR-3: 185.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000008, CAB000030, HPA001605" Enhanced Supported Cytosol NA NA 140000000 Cytosol "CAB000008: , CAB000030: , HPA001605: AB_2666381" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.25e-1)" "unprognostic (7.26e-3)" "unprognostic (4.09e-3)" "prognostic unfavorable (5.06e-4)" "unprognostic (8.81e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (3.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.19e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" 23.3 4.8 1.0 31.0 1.1 0.0 24.1 2.9 1.2 28.6 45.4 1.3 66.3 35.0 6.6 55.3 22.4 21.7 147.4 6.8 1.1 2.5 61.9 181.0 39.6 2.8 1.2 1.0 13.7 162.9 8.2 39.8 268.7 10.0 29.3 57.0 14.1 121.1 49.9 1.3 6.5 83.6 3.9 1.4 4.4 36.0 9.5 0.8 4.2 83.4 10.8 20.9 21.5 10.8 4.1 1.0 28.6 0.1 1.0 5.9 1.6 76.6 228.6 0.0 0.3 0.0 0.0 144.3 11.6 14.2 15.1 4.3 251.4 182.6 0.0 32.5 12.6 7.9 18.8 3.2 88.6 9.1 0.0 5.4 0.7 37.4 69.1 39.1 0.0 0.0 0.5 8.3 13.2 18.2 43.2 16.1 0.1 18.5 0.0 0.0 334.7 0.1 1.4 18.6 107.6 17.3 0.1 0.0 8.7 73.6 46.3 2.6 0.1 18.9 185.1 0.7 116.4 97.7 0.2 5.1 0.2 17.6 0.2 2.6 0.0 0.2 0.1 0.0 0.0 1.4 28.6 0.1 1.1 0.2 0.1 1.1 2.1 2.3 0.6 1.0 4.1 5.9 2.1 1.5 1.0 0.0 0.0 0.2 1.6 1.0 1.1 2.9 1.2 1.1 2.5 1.2 1.0 10.0 0.8 801.0 239.7 47.5 1382.6 13.2 0.0 4.9 1332.4 459.0 466.3 591.5 0.0 2872.9 233.8 6515.6 0.9 56.4 1517.2 0.0 4232.0 4401.0 68.2 910.9 48.4 492.5 270.7 1.6 616.3 87.8 9.9 2.3 9.8 37.0 197.4 71.3 2268.9 5.8 4358.9 1644.8 0.0 407.9 0.5 0.0 45.3 1.6 5.9 5.8 6392.2 10.7 1202.1 1262.3 KRT20 "CK20, K20, MGC35423" ENSG00000171431 "Keratin 20" P35900 17 40875941-40885227 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 232.0" "Cell type enhanced" "Detected in some" 29 "Enterocytes: 974.5;Mucus-secreting cells: 369.1;Paneth cells: 1841.1" "Group enriched" "Detected in many" 6 "colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.4;BEWO: 2.7;NB-4: 2.4;RPMI-8226: 2.8;RT4: 7.4;SH-SY5Y: 2.3" "Region enhanced" "Detected in single" "basal ganglia: 0.7" "Not detected" "Not detected" "CAB000032, HPA024309, HPA024684, HPA027236" Enhanced Supported Cytosol NA NA 34000000 Cytosol "CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224" "unprognostic (3.49e-1)" "unprognostic (3.13e-1)" "unprognostic (1.71e-1)" "unprognostic (6.38e-3)" "unprognostic (5.12e-2)" "unprognostic (2.66e-3)" "prognostic unfavorable (7.05e-4)" "unprognostic (2.63e-2)" "unprognostic (4.87e-3)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.71e-2)" "unprognostic (6.30e-2)" "unprognostic (7.27e-2)" 0.2 0.1 0.2 38.0 0.2 0.0 0.2 0.2 0.2 0.2 75.5 0.2 0.2 40.4 0.2 0.2 0.3 0.3 3.9 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.3 45.0 0.2 0.3 0.2 0.2 0.2 232.0 2.7 0.2 0.2 13.6 0.2 0.2 0.2 0.2 0.3 0.2 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.2 0.1 0.0 0.0 2.8 0.0 7.4 0.4 2.3 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 974.5 0.0 0.0 0.0 0.0 1.4 13.8 0.0 0.1 0.0 42.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 369.1 0.0 0.0 1841.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 43.8 1.7 KRT86 "Hb6, KRTHB6, MNX" ENSG00000170442 "Keratin 86" O43790 12 52249300-52309163 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 31.5;skin 1: 60.4;testis: 23.0" "Group enriched" "Detected in some" 5 "Early spermatids: 21.8;Late spermatids: 19.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "basophil: 31.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 31.5" "Cell line enhanced" "Detected in some" "A-431: 13.9;A549: 14.7;hTERT-RPE1: 7.5;MCF7: 28.9;RPMI-8226: 18.2;U-251 MG: 8.1" "HPA039798, HPA049778" Supported Approved Cytosol NA NA 240000000 Cytosol "HPA039798: AB_10674986, HPA049778: AB_2680877" "unprognostic (4.52e-2)" "unprognostic (6.83e-2)" "unprognostic (3.16e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (2.61e-2)" "unprognostic (6.49e-2)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.22e-2)" 0.8 0.3 0.2 0.1 0.2 3.5 0.9 0.5 1.1 0.4 0.3 0.1 1.0 0.6 0.6 2.4 0.3 1.1 1.0 0.1 0.2 0.3 3.8 0.2 1.0 0.1 0.3 0.1 0.6 7.9 0.0 0.2 0.6 0.3 0.5 0.0 0.3 6.3 0.4 1.5 60.4 0.2 0.1 0.7 0.1 0.2 23.0 0.1 0.1 7.6 0.1 0.3 1.2 0.2 0.0 0.0 31.5 0.0 3.8 0.0 0.2 13.9 14.7 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.2 0.0 0.1 0.7 0.0 0.6 0.0 0.3 0.9 0.0 2.6 0.0 6.1 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 7.5 0.0 0.0 0.0 1.0 0.0 28.9 0.0 1.6 0.0 0.1 3.5 0.0 0.0 18.2 0.2 1.8 1.7 0.0 2.6 1.1 1.1 0.0 0.8 0.0 0.4 0.0 0.7 0.0 8.1 0.0 0.0 0.0 0.0 3.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.5 0.2 0.3 0.3 0.1 0.3 0.1 0.0 1.1 0.0 3.2 0.6 0.2 0.4 2.5 0.0 1.2 0.0 0.0 0.1 0.0 2.0 21.8 0.0 0.0 0.0 4.2 1.4 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.3 0.0 1.7 0.0 0.0 0.2 2.9 0.0 0.0 0.5 0.1 0.0 0.3 0.7 0.3 0.1 1.0 3.2 0.0 3.1 KYAT1 "CCBL1, GTK, KATI" ENSG00000171097 "Kynurenine aminotransferase 1" Q16773 9 128832942-128882494 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 5.3;Cytotrophoblasts: 3.4;Distal tubular cells: 3.3;Proximal tubular cells: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021176, HPA021177, HPA027736" Approved Supported Cytosol NA NA 21000 Cytosol "HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818" "unprognostic (6.51e-2)" "unprognostic (8.67e-3)" "unprognostic (1.05e-2)" "unprognostic (5.98e-3)" "unprognostic (2.15e-2)" "unprognostic (5.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-2)" "unprognostic (2.47e-1)" "unprognostic (8.60e-3)" "unprognostic (1.43e-1)" "unprognostic (3.65e-2)" "unprognostic (3.10e-2)" "unprognostic (5.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" 4.4 5.2 12.2 5.1 18.9 3.9 7.0 17.8 17.6 4.7 3.8 14.2 5.5 4.1 5.5 5.4 4.6 8.5 4.8 13.5 12.1 9.3 8.1 12.0 4.1 7.3 18.4 12.1 7.1 5.0 8.9 8.1 4.5 12.2 8.9 2.7 5.8 7.0 8.4 17.0 12.2 4.8 5.8 10.2 5.8 4.0 6.9 17.2 3.7 7.5 2.8 7.4 8.1 8.1 12.1 7.6 3.5 5.1 4.6 9.6 4.9 3.8 8.7 8.0 7.9 7.2 9.1 4.1 5.2 6.1 5.2 7.8 4.8 7.1 7.3 2.6 3.9 6.5 12.4 11.8 10.2 6.7 8.2 8.2 4.8 21.2 8.7 6.5 4.6 2.0 4.0 6.5 6.8 6.5 17.5 9.1 18.5 7.3 6.4 6.8 2.5 10.6 3.1 14.0 15.0 6.8 12.7 6.9 13.7 7.1 1.6 8.5 7.3 8.4 2.1 4.8 10.3 5.1 1.7 6.0 3.9 6.8 5.9 4.6 11.9 10.1 9.1 7.5 7.2 3.1 0.1 3.1 3.3 7.8 2.2 6.2 12.1 8.1 8.1 7.6 5.8 8.6 9.6 3.5 4.6 5.1 4.8 8.7 4.9 12.2 18.9 17.8 17.6 12.1 9.3 18.4 12.1 12.2 17.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.2 0.0 0.0 3.4 3.3 1.5 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 LAMC2 "BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa" ENSG00000058085 "Laminin subunit gamma 2" Q13753 1 183186238-183244900 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Pancreatic endocrine cells: 902.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 231.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 49.4;CAPAN-2: 44.7;HBEC3-KT: 221.9;hTERT-HME1: 137.0;RPTEC TERT1: 53.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004257, HPA024638, CAB078165" Enhanced Approved Cytosol "Secreted to extracellular matrix" No No Cytosol "CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689" "unprognostic (7.27e-3)" "unprognostic (7.21e-3)" "unprognostic (3.24e-1)" "unprognostic (6.20e-3)" "unprognostic (9.43e-2)" "unprognostic (4.94e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.25e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (7.11e-5)" "unprognostic (2.77e-1)" "unprognostic (7.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" 2.6 0.0 1.0 20.6 4.1 0.0 11.4 3.6 1.2 8.7 8.4 0.9 2.4 0.9 6.6 2.9 6.5 19.0 12.8 1.8 0.7 0.1 10.5 0.8 18.3 3.3 1.6 1.1 1.9 2.9 0.0 7.0 21.2 1.5 3.7 6.8 0.9 11.2 3.2 1.3 12.8 14.3 1.8 0.7 0.7 7.6 1.9 0.9 3.5 9.8 10.0 15.6 3.4 4.8 0.9 0.8 1.7 0.5 0.4 0.6 0.1 49.4 2.2 0.0 0.0 0.4 1.1 3.6 0.3 0.4 0.1 0.0 3.6 44.7 0.0 19.0 0.1 1.4 22.3 0.0 221.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 17.2 0.5 137.0 0.2 2.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 18.1 3.1 0.0 0.1 0.0 53.2 12.9 2.7 0.0 1.3 0.0 0.0 1.4 0.1 0.2 0.3 0.2 2.7 1.3 0.6 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.4 0.6 0.4 0.3 0.4 0.5 0.4 0.4 0.1 0.9 0.5 0.6 1.7 0.4 0.5 0.8 0.3 0.1 1.0 4.1 3.6 1.2 0.7 0.1 1.6 1.1 1.5 0.9 202.5 19.1 0.0 163.7 76.6 0.0 1.1 15.3 66.9 51.2 22.7 0.0 26.6 0.0 197.8 16.4 0.5 28.1 0.0 81.6 9.8 7.8 209.4 0.0 0.0 2.2 0.0 8.6 0.0 0.0 8.3 3.1 2.9 8.5 4.6 13.0 0.0 902.6 26.0 0.4 0.0 0.0 0.0 2.3 3.7 1.0 26.0 69.7 0.7 7.1 119.2 LAMTOR5 "HBXIP, MGC71071, XIP" ENSG00000134248 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5" O43504 1 110401249-110407942 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Proximal tubular cells: 1943.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006812 Approved Supported Cytosol NA NA 270000 Cytosol "HPA006812: AB_1079040" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (3.54e-3)" "unprognostic (2.75e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (9.97e-2)" "unprognostic (7.58e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.80e-1)" "unprognostic (2.93e-1)" "unprognostic (1.65e-2)" "unprognostic (3.77e-2)" "unprognostic (3.80e-3)" "prognostic favorable (5.52e-4)" "unprognostic (6.66e-2)" 29.0 32.1 38.9 21.0 35.2 60.9 30.1 25.2 35.8 23.6 29.8 24.4 28.9 23.7 21.6 47.3 30.4 26.7 31.0 63.8 33.2 34.8 118.7 54.3 26.7 28.1 41.5 28.5 29.7 34.8 28.9 35.2 46.3 35.8 28.0 31.6 31.0 32.9 29.6 64.0 21.5 34.2 22.9 36.4 30.7 28.6 24.0 29.5 22.6 37.8 56.7 32.3 27.8 24.7 62.0 59.0 86.1 42.6 25.4 32.4 42.1 47.1 39.5 35.9 21.4 60.2 45.9 35.8 40.2 31.7 34.0 32.4 34.4 23.3 37.6 42.9 38.8 41.8 19.2 36.3 33.5 42.0 40.3 40.8 27.5 47.6 69.5 46.0 39.4 34.3 40.0 52.0 35.1 22.4 43.3 40.7 28.1 32.4 35.5 49.3 76.8 35.7 47.7 25.4 26.6 65.8 24.8 64.8 28.5 78.4 53.1 26.5 34.6 35.6 52.1 86.8 32.4 20.1 56.0 38.6 25.8 33.5 64.8 37.6 37.4 41.7 47.9 84.5 39.5 59.2 47.1 42.6 86.1 25.2 41.2 22.1 62.0 29.5 27.0 34.7 54.6 25.9 27.3 65.6 25.4 39.0 59.0 32.4 42.1 38.9 35.2 25.2 35.8 33.2 34.8 41.5 28.5 35.8 29.5 148.9 152.7 204.3 232.1 273.4 108.4 553.2 219.1 164.6 125.1 422.2 23.6 369.9 943.3 353.9 46.9 202.1 225.2 116.8 288.3 319.7 236.7 264.3 143.1 274.5 366.0 84.2 213.4 124.6 149.1 80.3 245.1 172.6 332.3 321.0 240.5 175.3 354.9 273.5 224.9 1943.6 111.9 168.1 174.7 196.9 336.9 281.9 418.5 125.0 192.7 332.5 LAPTM5 ENSG00000162511 "Lysosomal protein transmembrane 5" Q13571 1 30732469-30757820 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5" "Group enriched" "Detected in many" 5 "B-cells: 749.7;granulocytes: 621.6;Hofbauer cells: 1099.3;Kupffer cells: 831.6;Macrophages: 787.9;T-cells: 409.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 47.1;HEL: 89.3;HL-60: 56.6;HMC-1: 211.5;REH: 66.3;U-698: 76.8;U-937: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051293 Approved Approved Cytosol NA NA Cytosol "HPA051293: AB_2681424" "unprognostic (3.12e-2)" "prognostic favorable (3.40e-4)" "unprognostic (6.86e-2)" "unprognostic (4.05e-3)" "unprognostic (1.63e-1)" "unprognostic (8.45e-2)" "unprognostic (1.43e-1)" "unprognostic (3.76e-1)" "unprognostic (1.22e-3)" "unprognostic (2.30e-1)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (9.47e-2)" "unprognostic (8.18e-3)" "unprognostic (5.98e-2)" "unprognostic (3.94e-2)" 56.0 15.5 11.5 59.1 17.8 157.5 15.0 2.2 10.4 8.2 11.2 20.7 1.8 9.5 7.5 6.8 8.3 13.7 19.9 9.2 11.2 12.7 14.0 18.2 60.8 144.5 19.0 3.3 7.7 6.3 2.0 6.8 20.1 14.6 8.2 13.2 7.4 11.7 4.7 4.0 5.5 37.1 12.9 33.8 130.9 9.5 6.7 15.8 75.2 10.1 5.2 91.2 21.4 6.4 98.2 69.1 145.1 109.3 26.0 55.4 166.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.1 4.9 0.1 0.1 0.1 0.0 0.0 0.0 5.2 0.0 89.3 0.0 0.1 0.0 56.6 211.5 0.0 0.1 0.0 0.3 0.0 10.8 6.1 1.1 2.9 0.7 0.0 9.7 11.9 0.0 0.0 0.0 66.3 8.7 32.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 36.0 12.5 0.0 0.2 0.0 0.2 0.2 0.0 76.8 0.2 46.2 0.1 73.5 109.3 115.3 47.7 87.9 55.4 70.2 43.7 44.6 69.1 98.2 44.2 43.1 145.1 26.0 83.9 33.2 53.7 166.6 11.5 17.8 2.2 10.1 11.2 12.7 19.0 3.3 14.6 15.8 23.8 148.6 749.7 1.1 21.2 0.0 5.6 10.2 18.7 25.0 3.5 0.0 5.6 0.0 0.4 1.5 31.3 0.7 0.0 0.6 5.1 16.6 0.8 621.6 4.2 1099.3 0.0 1.2 36.2 831.6 1.7 1.4 787.9 47.2 70.3 0.6 0.2 0.9 0.0 0.4 2.2 1.3 0.0 6.8 0.3 0.3 17.6 7.4 409.7 0.3 1.6 LARP1B "DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2" ENSG00000138709 "La ribonucleoprotein domain family member 1B" Q659C4 4 128061268-128222931 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 378.6;Late spermatids: 340.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036280 Approved Approved Cytosol NA NA Cytosol "HPA036280: AB_10673126" "unprognostic (1.84e-1)" "unprognostic (7.55e-2)" "unprognostic (9.39e-3)" "unprognostic (4.87e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.79e-1)" "unprognostic (2.63e-1)" "unprognostic (6.39e-2)" "unprognostic (3.36e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-1)" "prognostic favorable (5.13e-5)" "unprognostic (8.46e-2)" "unprognostic (5.94e-2)" "unprognostic (2.08e-1)" "unprognostic (7.50e-2)" 9.3 7.1 8.1 6.5 9.8 10.1 9.8 11.7 11.4 11.2 12.6 6.2 21.4 11.7 8.9 20.3 10.3 8.1 8.2 8.7 7.8 9.0 14.8 39.9 9.1 5.1 8.5 10.3 10.1 37.9 12.3 21.4 17.2 9.4 9.3 13.5 4.8 17.0 17.2 26.2 9.7 13.9 9.6 8.4 6.4 12.1 41.9 7.1 5.3 11.3 8.8 7.4 13.2 9.2 3.1 8.5 2.3 3.9 4.6 6.2 1.5 10.7 3.8 6.9 8.9 7.3 8.4 14.4 9.3 10.3 9.0 5.7 8.6 8.6 13.4 13.0 9.1 6.7 4.3 17.3 10.5 10.7 12.6 10.9 10.6 6.5 21.1 16.0 20.2 4.3 4.4 15.2 7.2 26.3 8.5 10.3 10.0 18.6 22.4 5.0 12.6 17.6 11.7 8.0 16.7 6.3 9.7 10.7 15.1 10.1 8.4 20.9 8.2 8.1 18.9 8.4 9.7 5.5 8.9 8.3 5.7 6.3 9.2 9.2 29.5 11.2 15.5 7.4 15.9 6.0 0.3 3.9 2.3 3.4 2.8 6.2 3.1 3.8 4.3 4.4 3.0 3.1 3.3 1.0 4.6 3.0 8.5 3.0 1.5 8.1 9.8 11.7 11.4 7.8 9.0 8.5 10.3 9.4 7.1 32.8 25.7 18.2 21.4 24.6 34.4 27.1 35.7 42.8 48.9 19.2 49.1 27.6 11.6 20.2 378.6 17.5 36.5 46.7 25.7 20.4 16.4 36.2 19.7 143.6 10.9 22.3 32.6 16.5 12.9 340.9 33.6 15.7 16.9 10.8 61.0 15.5 27.3 34.5 18.7 37.6 67.1 19.4 26.9 140.5 12.9 30.4 43.0 12.8 44.7 23.4 LARP4B "KIAA0217, LARP5" ENSG00000107929 "La ribonucleoprotein domain family member 4B" Q92615 10 806914-931705 "Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036566, HPA042738" Approved Enhanced Cytosol NA NA Cytosol "HPA036566: AB_10673624, HPA042738: AB_2678137" "unprognostic (3.02e-3)" "unprognostic (1.43e-1)" "unprognostic (9.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.00e-2)" "unprognostic (3.13e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (8.95e-2)" "unprognostic (2.74e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (8.10e-3)" "unprognostic (1.62e-1)" "unprognostic (6.47e-2)" "unprognostic (2.54e-2)" 17.5 23.1 16.5 27.7 20.7 17.9 17.3 23.8 23.8 15.0 19.7 21.2 20.9 21.7 19.1 23.6 30.9 17.0 19.4 22.0 15.8 13.0 17.6 17.0 25.4 23.0 16.0 16.7 18.2 21.0 22.3 18.6 27.1 18.3 20.0 18.4 18.9 22.1 28.1 37.1 25.1 21.7 16.0 14.4 25.2 25.3 22.9 15.9 29.5 25.8 16.8 21.8 18.3 20.0 8.3 12.2 13.5 13.6 7.7 9.8 5.2 21.4 18.3 9.5 10.6 8.7 8.9 13.9 14.7 6.8 15.8 15.5 24.7 24.4 26.4 5.8 14.4 4.7 22.9 16.9 12.2 13.9 17.7 12.3 21.6 12.5 14.4 14.2 16.2 19.5 9.7 14.2 16.0 9.3 9.1 10.8 12.4 28.7 17.2 12.8 21.4 23.1 14.3 10.3 21.2 8.5 16.8 8.3 17.7 12.8 16.5 9.4 13.4 14.2 27.5 10.9 9.7 25.8 15.3 15.1 12.2 3.3 38.7 14.5 19.7 23.5 26.1 13.6 13.1 7.7 12.9 12.6 13.5 8.7 13.6 9.0 6.7 9.5 9.8 10.8 8.3 9.2 9.8 12.0 7.7 11.1 12.2 8.6 5.2 16.5 20.7 23.8 23.8 15.8 13.0 16.0 16.7 18.3 15.9 47.6 50.2 9.7 12.4 27.0 18.8 39.5 33.1 28.1 34.2 22.7 25.5 13.9 5.0 14.8 12.1 17.9 31.3 23.3 14.0 11.0 17.2 22.4 7.0 15.6 19.0 22.3 13.2 14.7 29.6 4.7 16.1 24.5 16.9 19.0 36.3 23.2 24.6 23.0 22.6 14.6 23.9 25.8 12.2 23.8 21.2 37.3 38.7 14.1 31.0 33.3 LAYN "FLJ30977, FLJ31092" ENSG00000204381 Layilin Q6UX15 11 111540280-111561745 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 43.8;Endothelial cells: 33.1;Peritubular cells: 51.9;Sertoli cells: 32.3;Urothelial cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "myeloid DC: 10.3;T-reg: 11.8" "Group enriched" "Detected in many" 111 "dendritic cells: 10.3;T-cells: 11.8" "Cell line enhanced" "Detected in many" "BJ: 39.7;BJ hTERT+: 43.3;BJ hTERT+ SV40 Large T+ RasG12V: 27.6;fHDF/TERT166: 25.7;HSkMC: 25.5;hTERT-RPE1: 25.7;U-138 MG: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040087 Approved Approved Cytosol NA NA Cytosol "HPA040087: AB_10793927" "unprognostic (2.27e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-3)" "unprognostic (1.96e-1)" "unprognostic (3.90e-2)" "unprognostic (1.83e-2)" "unprognostic (5.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-1)" "unprognostic (7.75e-3)" "unprognostic (4.47e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (1.65e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-2)" 7.7 2.3 9.3 5.9 12.8 1.3 8.0 1.7 12.5 11.3 21.2 28.9 3.0 4.0 15.1 10.5 5.3 12.8 17.0 5.6 12.6 7.5 4.1 1.4 9.6 12.4 20.6 5.9 39.5 2.3 1.6 5.4 13.1 12.3 13.2 3.8 10.9 4.4 17.9 4.8 2.1 8.2 21.7 10.1 7.5 12.1 4.6 13.1 4.6 26.9 4.8 5.0 11.3 10.1 0.0 10.3 0.0 0.0 0.0 11.8 0.4 0.1 1.0 0.2 0.0 7.1 13.7 1.9 39.7 43.3 20.1 27.6 0.0 0.0 0.0 0.3 25.7 5.0 0.8 2.5 0.2 20.8 0.0 0.1 0.2 0.0 0.0 12.1 0.0 0.0 25.5 0.0 8.3 0.0 25.7 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 1.3 4.8 0.1 0.0 0.1 9.9 0.0 0.1 0.1 29.8 22.0 0.2 19.3 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 10.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 11.8 0.4 9.3 12.8 1.7 12.5 12.6 7.5 20.6 5.9 12.3 13.1 17.9 3.2 0.0 43.8 1.9 0.2 1.4 5.1 18.7 13.6 0.0 0.0 1.1 0.0 5.9 2.2 33.1 0.0 0.0 0.2 1.2 6.5 13.4 1.1 0.0 0.7 0.0 0.0 4.3 1.2 1.3 21.0 1.3 0.0 0.0 0.0 0.2 0.7 0.0 51.9 0.0 0.1 32.3 10.8 0.0 0.7 1.9 0.5 2.2 0.0 40.4 LDHB ENSG00000111716 "Lactate dehydrogenase B" P07195 12 21635342-21757857 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 255.8;kidney: 233.1" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 2212.6;Distal tubular cells: 2801.9;Proximal tubular cells: 2766.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "T-cells: 145.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 316.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004641, HPA019007" Enhanced Supported Cytosol No No 780000000 Cytosol "CAB004641: AB_425525, HPA019007: AB_2670008" "unprognostic (2.93e-1)" "unprognostic (9.20e-3)" "unprognostic (6.10e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-3)" "unprognostic (1.36e-3)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (5.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.91e-1)" "unprognostic (6.41e-2)" "prognostic favorable (2.51e-4)" "unprognostic (1.31e-1)" "unprognostic (1.71e-1)" "unprognostic (2.55e-1)" "unprognostic (9.32e-2)" 70.9 60.2 79.5 33.3 79.6 40.8 33.4 52.4 80.1 24.9 31.8 30.6 13.2 11.8 38.7 27.3 25.6 34.4 32.3 255.8 58.8 69.9 233.1 9.8 27.7 52.3 91.6 62.3 68.0 54.8 41.8 19.4 40.1 84.9 34.9 39.4 26.8 21.8 42.2 29.7 8.6 18.0 42.9 52.9 23.8 47.5 16.4 47.6 59.1 48.5 56.3 58.7 49.7 21.8 28.1 32.9 33.0 15.3 33.7 145.1 93.2 32.6 87.5 77.0 50.6 55.2 61.5 89.5 45.6 45.6 63.8 63.2 138.5 0.1 115.5 29.9 30.7 62.2 16.4 105.9 84.5 81.3 29.6 73.7 118.8 83.7 0.1 52.8 110.9 51.4 70.3 30.3 55.9 76.1 75.5 72.7 83.7 64.9 17.4 70.1 0.1 94.2 134.3 222.1 53.5 38.0 85.1 107.5 93.1 316.6 145.6 24.8 57.4 20.9 32.5 78.6 213.4 0.2 87.0 28.3 43.0 56.4 30.5 85.8 15.4 20.8 151.7 47.6 53.2 51.0 33.0 15.3 1.8 28.5 9.4 47.5 28.1 110.7 59.4 28.3 17.7 145.1 92.2 2.5 33.7 6.7 32.9 105.4 93.2 79.5 79.6 52.4 80.1 58.8 69.9 91.6 62.3 84.9 47.6 131.0 259.8 264.1 356.5 64.9 144.4 2212.6 252.3 329.2 235.4 450.1 64.8 1548.4 2801.9 8.8 8.2 201.1 10.6 163.5 278.5 675.2 313.9 183.2 261.1 6.8 514.5 133.5 88.8 124.0 155.9 19.6 254.3 185.3 170.4 154.1 114.8 173.5 149.2 14.4 390.3 2766.7 85.3 232.8 418.6 17.7 95.7 56.1 1371.1 274.1 316.8 307.0 LDHD ENSG00000166816 "Lactate dehydrogenase D" Q86WU2 16 75111860-75116771 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.3;skeletal muscle: 39.7" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 33.6;Enterocytes: 38.8;Hepatocytes: 81.8;Proximal tubular cells: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 8.9;classical monocyte: 2.7;intermediate monocyte: 4.6;non-classical monocyte: 5.7" "Group enriched" "Detected in many" 31 "granulocytes: 8.9;monocytes: 5.7" "Cell line enhanced" "Detected in many" "Hep G2: 8.7;HMC-1: 12.0;T-47d: 23.5;U-266/70: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041766, HPA048639, HPA066148" Enhanced Approved Cytosol No NA Cytosol "HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626" "unprognostic (8.75e-2)" "unprognostic (3.68e-3)" "unprognostic (1.27e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (1.53e-1)" "prognostic favorable (5.61e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.74e-1)" "unprognostic (4.01e-1)" "prognostic favorable (2.95e-14)" "unprognostic (4.10e-3)" "unprognostic (4.49e-2)" "unprognostic (7.00e-2)" "unprognostic (2.20e-1)" 15.3 5.5 6.8 1.6 6.7 0.8 3.7 4.9 11.7 4.1 12.5 7.6 4.5 6.1 1.5 3.0 3.8 2.1 3.6 25.3 6.6 5.8 21.5 44.3 2.8 0.9 8.1 9.7 7.9 7.7 8.5 4.4 2.1 9.9 4.4 6.8 5.1 14.2 4.5 39.7 1.8 2.5 1.2 4.5 0.7 11.2 1.0 4.0 0.0 4.3 14.4 2.7 1.1 1.2 0.0 0.2 8.9 5.7 0.1 0.1 0.9 0.6 1.6 0.0 0.3 1.3 1.1 5.1 0.1 0.1 0.1 0.2 2.1 2.2 0.0 1.8 0.7 0.8 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.5 8.7 2.1 0.0 12.0 1.6 0.3 0.0 0.0 0.4 0.1 0.3 0.6 1.9 0.0 4.0 0.0 0.6 1.1 2.1 1.0 0.0 0.0 6.0 1.1 0.1 0.0 0.0 0.0 4.1 0.3 0.6 23.5 2.6 0.0 0.0 0.2 0.0 0.0 9.3 0.5 0.0 1.6 0.0 0.0 8.9 2.7 0.8 0.0 4.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.9 6.8 6.7 4.9 11.7 6.6 5.8 8.1 9.7 9.9 4.0 0.0 7.9 2.2 2.1 0.6 0.0 33.6 10.2 1.4 1.2 10.4 0.0 1.6 31.5 1.3 0.3 0.6 38.8 0.0 5.5 1.1 0.5 1.6 10.3 81.8 6.2 1.6 2.9 4.3 5.3 0.2 0.0 1.6 5.0 1.0 9.4 11.0 3.7 19.9 0.0 75.5 1.0 0.0 0.4 0.0 0.3 0.3 2.6 1.3 11.0 1.7 LGALS12 GRIP1 ENSG00000133317 "Galectin 12" Q96DT0 11 63506084-63516774 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 45.1;blood: 90.2;breast: 28.6" "Cell type enriched" "Detected in some" 8 "granulocytes: 18.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enriched" "Detected in some" 19 "eosinophil: 90.2" "Lineage enriched" "Detected in many" 19 "granulocytes: 90.2" "Group enriched" "Detected in some" 14 "ASC diff: 11.8;HL-60: 20.4;NB-4: 40.2;U-937: 43.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA021124 Approved Cytosol NA NA Cytosol "HPA021124: " "unprognostic (3.89e-2)" "unprognostic (4.40e-2)" "unprognostic (5.17e-2)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.31e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-3)" "unprognostic (4.69e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (4.60e-7)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (6.22e-2)" "unprognostic (8.60e-2)" 45.1 0.5 0.1 5.8 1.1 10.1 28.6 0.0 0.1 0.1 10.6 0.0 0.0 0.3 0.2 1.1 0.1 0.7 7.7 2.2 0.1 0.1 0.4 0.2 1.4 5.3 0.1 0.0 0.5 0.5 0.0 0.1 0.1 0.2 0.7 0.4 0.1 5.9 1.6 1.6 0.6 1.4 0.6 0.2 0.8 0.4 0.1 0.0 0.1 0.5 2.4 0.2 0.9 0.2 0.0 1.2 90.2 4.7 0.0 0.0 2.8 0.0 0.0 0.0 0.0 11.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 20.4 1.3 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 43.1 0.0 1.8 4.7 90.2 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 2.8 0.1 1.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LGALS9 LGALS9A ENSG00000168961 "Galectin 9" O00182 17 27629798-27649560 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 273.5;Kupffer cells: 189.6;Paneth cells: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 11.4;HMC-1: 29.7;MOLT-4: 14.7;REH: 10.4;THP-1: 26.6;U-937: 22.8" "HPA046876, HPA047218" Approved Approved Cytosol "Secreted to blood" NA NA 448000 Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (2.62e-2)" "prognostic favorable (2.35e-5)" "unprognostic (1.16e-2)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (2.46e-3)" "unprognostic (1.58e-2)" "unprognostic (8.60e-2)" "unprognostic (4.79e-1)" "unprognostic (1.80e-1)" "unprognostic (8.13e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (4.76e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (2.24e-3)" 25.7 3.9 6.4 15.6 11.2 22.2 6.1 2.0 5.3 5.7 26.9 12.6 0.2 8.6 4.3 6.1 6.0 8.5 13.9 4.6 5.6 3.4 5.0 9.0 14.7 29.6 9.7 2.7 5.9 6.0 0.5 2.9 8.5 8.7 4.2 26.0 10.9 5.7 2.1 2.5 3.7 15.0 5.1 13.2 48.9 20.2 2.2 7.9 22.1 3.8 2.0 17.1 14.8 3.6 6.6 28.7 12.0 35.2 4.2 7.0 10.9 0.4 0.3 0.2 0.1 0.0 0.1 0.5 0.2 0.4 3.4 11.4 0.0 2.3 0.4 2.5 0.5 0.3 1.2 0.1 0.0 0.2 3.4 0.4 3.6 0.4 0.0 0.1 7.5 29.7 0.1 0.0 0.2 0.0 0.1 4.0 2.1 0.2 0.2 0.0 0.0 14.7 3.6 0.1 5.3 0.0 10.4 0.0 0.3 1.6 0.3 0.1 0.3 0.0 1.0 0.0 0.2 0.1 26.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 22.8 0.1 5.6 16.4 12.0 1.0 35.2 0.6 4.5 2.6 1.3 28.7 6.6 1.5 0.7 7.2 4.2 31.2 4.5 7.0 10.9 6.4 11.2 2.0 5.3 5.6 3.4 9.7 2.7 8.7 7.9 8.9 7.5 29.3 6.0 2.9 0.1 0.8 25.5 10.7 12.5 7.0 0.0 2.0 3.3 99.7 1.1 23.3 125.2 0.0 111.9 2.5 6.8 2.9 31.1 0.8 273.5 0.0 38.8 18.4 189.6 1.5 4.0 133.7 1.7 127.2 146.3 0.4 119.4 182.0 2.8 0.4 0.5 19.4 3.1 0.1 0.7 1.5 3.1 24.5 106.1 25.8 LGALS9B ENSG00000170298 "Galectin 9B" Q3B8N2 17 20449395-20467539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.4;esophagus: 13.6;stomach 1: 23.2" "Cell type enhanced" "Detected in some" 26 "Enterocytes: 7.8;Mucus-secreting cells: 17.2;Paneth cells: 43.5" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 15 "NK-cell: 13.4" "Lineage enriched" "Detected in single" 15 "NK-cells: 13.4" "Group enriched" "Detected in some" 7 "CAPAN-2: 13.6;U-937: 4.5" "HPA046876, HPA047218" Approved Uncertain Cytosol NA NA Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.69e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.05e-1)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (3.93e-3)" "unprognostic (2.72e-1)" "unprognostic (2.26e-2)" "unprognostic (6.85e-2)" "unprognostic (1.32e-2)" "unprognostic (3.20e-1)" "unprognostic (3.79e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (5.27e-2)" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 1.2 5.7 2.3 0.0 0.0 13.6 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.4 1.8 0.0 0.0 0.3 2.6 0.0 0.0 0.4 23.2 0.0 0.0 1.0 0.0 3.4 0.3 0.4 0.2 0.3 13.4 0.9 1.7 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.2 0.2 0.0 0.4 0.3 0.2 0.4 0.2 13.4 0.3 0.2 0.0 1.7 0.0 1.1 0.0 0.1 2.1 0.0 0.0 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.5 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.1 0.1 LGALS9C ENSG00000171916 "Galectin 9C" Q6DKI2 17 18476737-18494945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.9;esophagus: 15.8;intestine: 8.3;lymphoid tissue: 8.5;stomach 1: 15.4" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 16.8;Mucus-secreting cells: 22.5;Paneth cells: 54.7;Undifferentiated cells: 11.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "neutrophil: 3.2;NK-cell: 8.9" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 8.9" "Cell line enhanced" "Detected in some" "A-431: 1.1;CAPAN-2: 2.9;Daudi: 1.0;Karpas-707: 2.8;RPMI-8226: 1.6;U-937: 2.9" "HPA046876, HPA047218" Approved Approved Cytosol NA NA Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.47e-2)" "unprognostic (1.43e-3)" "unprognostic (3.17e-2)" "unprognostic (4.30e-2)" "unprognostic (5.92e-1)" "unprognostic (3.02e-2)" "unprognostic (2.52e-1)" "unprognostic (5.16e-2)" "unprognostic (1.63e-1)" "unprognostic (2.56e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.04e-2)" "unprognostic (5.85e-2)" "unprognostic (4.27e-3)" "unprognostic (9.84e-2)" 0.1 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 2.1 8.3 0.2 0.0 1.6 0.0 0.0 15.8 0.0 4.7 1.0 0.0 0.0 0.0 0.8 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.9 0.0 1.6 1.0 0.0 0.2 5.1 0.1 0.0 1.5 15.4 0.0 0.0 0.4 0.0 3.0 7.5 0.0 2.1 0.0 0.4 3.2 1.2 8.9 0.6 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.9 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.5 0.5 0.6 1.2 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.2 3.2 8.9 1.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 7.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.3 54.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 11.0 0.1 LGI3 ENSG00000168481 "Leucine rich repeat LGI family member 3" Q8N145 8 22146825-22157084 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 20.3;Melanocytes: 38.8" "Cancer enhanced" "Detected in many" "melanoma: 14.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.2;GAMG: 2.1;SCLC-21H: 4.6;SK-MEL-30: 4.6;U-2 OS: 2.6;WM-115: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024826 Approved Cytosol "Secreted in brain" NA NA Cytosol "HPA024826: AB_10601131" "unprognostic (4.41e-2)" "unprognostic (1.78e-1)" "unprognostic (3.28e-1)" "unprognostic (8.11e-3)" "unprognostic (1.14e-1)" "unprognostic (7.45e-2)" "unprognostic (3.38e-1)" "unprognostic (2.43e-2)" "unprognostic (9.64e-2)" "unprognostic (1.64e-2)" "unprognostic (6.25e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-5)" "unprognostic (1.36e-2)" "unprognostic (9.41e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 1.2 4.8 13.1 1.1 26.4 1.1 1.2 7.7 52.2 2.6 1.2 35.5 0.0 1.4 1.5 1.3 6.1 2.0 1.1 1.5 20.7 15.7 1.1 1.0 17.7 1.0 24.2 10.4 1.1 1.5 0.9 0.7 1.0 24.9 2.3 1.1 4.6 1.2 4.2 1.0 16.3 1.4 1.7 29.8 1.1 1.3 1.4 14.8 0.0 14.9 0.0 1.3 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.0 2.1 1.1 0.8 0.3 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.3 0.0 4.6 0.6 0.0 0.0 4.6 0.0 0.5 0.0 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 26.4 7.7 32.1 20.7 15.7 24.2 10.4 24.9 14.8 0.0 20.3 0.0 0.0 2.1 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 38.8 0.0 0.0 1.0 0.1 0.0 6.7 0.0 2.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 LHB "CGB4, hLHB, LSH-B" ENSG00000104826 "Luteinizing hormone beta polypeptide" P01229 19 49015980-49017081 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "pituitary gland: 301.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 2.3;Late spermatids: 3.3;Pancreatic endocrine cells: 4.8;Syncytiotrophoblasts: 8.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.8;T-reg: 1.3" "Lineage enriched" "Detected in single" 12 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "A549: 6.6;U-266/84: 7.1" "CAB022241, CAB022707, HPA038925" Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "CAB022241: , CAB022707: , HPA038925: AB_2676272" "unprognostic (8.12e-2)" "unprognostic (3.59e-1)" "unprognostic (2.34e-3)" "unprognostic (1.41e-2)" "unprognostic (8.89e-2)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (5.69e-2)" "unprognostic (7.04e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (2.47e-2)" "unprognostic (1.68e-3)" "unprognostic (1.38e-1)" "unprognostic (4.46e-1)" "unprognostic (9.52e-2)" "unprognostic (4.86e-2)" 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.1 23.1 0.0 301.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.5 0.1 0.1 0.1 0.5 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 1.8 0.1 1.3 6.6 0.3 1.3 0.0 0.0 1.8 0.5 0.0 1.0 0.5 5.4 1.9 1.8 0.1 0.0 0.3 0.5 0.0 0.4 0.0 1.7 5.2 0.3 1.7 2.5 0.3 0.4 1.8 0.0 0.0 0.3 0.0 0.0 0.3 1.1 4.8 2.9 0.3 0.4 0.1 0.6 0.7 0.3 0.5 2.8 1.2 1.3 0.0 1.4 3.0 1.2 2.0 0.4 2.2 0.0 2.0 0.0 0.0 2.7 2.8 0.3 3.3 2.5 7.1 1.8 1.4 3.1 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.3 0.0 0.0 0.0 0.7 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.5 0.0 8.6 0.0 0.0 0.1 LIF "CDF, DIA, HILDA" ENSG00000128342 "LIF, interleukin 6 family cytokine" P15018 22 30240447-30246851 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 58.9;granulocytes: 63.7;Smooth muscle cells: 39.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 11.7" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.2" "Cell line enhanced" "Detected in many" "GAMG: 27.0;hTEC/SVTERT24-B: 34.3;hTERT-RPE1: 31.7;U-138 MG: 38.2;U-251 MG: 27.6;U-87 MG: 30.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA018844, CAB025985" Uncertain Supported Cytosol "Secreted in other tissues" NA NA Cytosol "CAB025985: , HPA018844: AB_1852814" "unprognostic (1.28e-2)" "prognostic unfavorable (9.01e-4)" "unprognostic (8.79e-2)" "unprognostic (4.61e-2)" "unprognostic (7.36e-3)" "unprognostic (4.18e-3)" "unprognostic (1.17e-2)" "unprognostic (1.41e-2)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (8.10e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (6.78e-8)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (8.99e-2)" "unprognostic (4.71e-3)" 20.3 1.7 1.4 21.6 3.3 0.6 5.2 0.9 4.3 4.4 3.9 1.8 1.6 3.7 6.9 2.6 2.0 7.3 28.7 14.2 1.2 0.6 5.7 3.4 17.4 3.8 2.2 0.5 7.9 7.5 0.2 7.3 1.3 11.7 8.6 4.7 3.5 3.2 1.2 1.9 6.0 5.2 4.6 4.3 1.6 4.1 2.0 1.8 0.9 3.4 2.2 5.4 20.8 1.7 0.0 0.0 0.0 0.0 1.2 0.2 0.1 8.4 14.2 0.4 3.1 0.0 1.2 5.2 1.2 5.1 1.5 3.7 2.3 13.8 0.0 3.1 0.0 27.0 2.1 0.3 3.8 2.1 2.0 0.6 1.0 4.8 3.1 1.4 0.0 11.1 1.3 0.7 34.3 1.0 31.7 0.0 0.0 0.2 0.0 6.6 6.3 0.1 0.0 0.5 7.7 8.8 0.2 4.8 0.0 12.2 3.2 0.0 0.1 1.4 0.1 2.5 1.6 0.3 0.1 0.1 38.2 14.1 14.4 27.6 0.0 0.0 0.0 30.2 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 1.4 3.3 0.9 4.3 1.2 0.6 2.2 0.5 11.7 1.8 20.8 58.9 0.0 12.0 3.1 0.0 0.2 17.8 4.0 13.6 5.2 0.0 0.1 0.0 27.7 0.1 0.5 3.5 0.0 3.0 0.4 11.3 13.8 63.7 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 2.9 1.2 24.9 0.0 0.0 0.6 0.1 0.0 39.8 0.0 0.2 2.5 0.2 0.5 5.5 18.0 LIN54 "CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1" ENSG00000189308 "Lin-54 DREAM MuvB core complex component" Q6MZP7 4 82909973-83012926 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 27.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 52.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056606 Approved Approved Cytosol NA NA Cytosol "HPA056606: AB_2683187" "unprognostic (2.01e-2)" "unprognostic (1.47e-2)" "unprognostic (2.52e-2)" "unprognostic (7.11e-2)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (3.56e-3)" "unprognostic (6.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.06e-1)" "unprognostic (3.03e-1)" "unprognostic (2.60e-2)" "prognostic favorable (1.06e-4)" "unprognostic (3.02e-2)" "unprognostic (1.51e-1)" "unprognostic (9.17e-2)" "unprognostic (1.81e-2)" 6.9 6.2 9.0 6.7 13.7 16.5 7.1 13.3 12.4 8.4 8.4 12.2 2.0 7.6 6.5 6.1 15.4 5.5 5.6 6.0 10.2 8.6 10.9 11.6 6.1 8.5 15.7 7.5 7.6 4.6 9.8 8.5 8.8 10.5 5.9 10.2 6.7 8.1 6.7 10.6 7.7 6.0 6.5 15.2 7.8 6.4 9.5 12.7 27.2 14.9 8.5 11.9 7.5 8.2 3.4 2.2 8.1 8.8 6.9 7.6 3.6 7.1 4.2 6.7 7.6 3.5 3.4 5.0 11.6 8.1 8.8 8.5 5.0 8.3 7.8 6.4 11.9 5.8 5.6 9.1 3.7 10.8 8.4 4.0 7.1 6.7 5.6 3.1 8.7 52.6 2.9 2.2 9.7 4.7 2.7 5.3 7.4 7.7 15.7 8.5 5.0 18.5 3.6 2.8 8.8 2.8 10.1 7.4 5.5 4.2 6.2 7.0 3.7 7.0 11.3 4.6 4.4 4.9 5.7 4.1 10.6 7.9 9.8 5.2 7.8 5.8 13.3 5.9 5.5 8.3 5.3 3.8 7.7 6.1 3.0 6.9 2.7 6.1 6.6 2.2 3.4 7.6 6.4 8.1 6.9 8.8 1.7 6.8 3.6 9.0 13.7 13.3 12.4 10.2 8.6 15.7 7.5 10.5 12.7 6.0 5.6 7.0 3.2 10.8 8.6 5.1 5.1 4.0 3.4 5.2 2.0 2.9 0.0 2.7 27.1 4.3 4.9 23.3 3.1 4.0 4.3 4.1 2.3 6.2 5.5 4.8 4.1 5.5 4.9 11.6 2.3 5.9 8.5 1.0 3.8 6.3 3.1 2.9 4.6 5.4 8.0 12.9 4.4 2.2 2.8 10.9 2.9 5.1 4.6 6.8 LIPE HSL ENSG00000079435 "Lipase E, hormone sensitive type" Q05469 19 42401507-42427426 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism" Hydrolase "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 207.4;breast: 65.1" "Group enriched" "Detected in many" 6 "Early spermatids: 123.5;Late spermatids: 188.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "ASC diff: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA006567, CAB017700" Enhanced Supported Cytosol NA NA Cytosol "CAB017700: AB_2135504, HPA006567: AB_2667618" "unprognostic (4.24e-2)" "unprognostic (2.46e-2)" "unprognostic (8.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.77e-1)" "unprognostic (3.38e-3)" "unprognostic (5.68e-2)" "unprognostic (2.84e-1)" "unprognostic (3.11e-1)" "unprognostic (9.44e-2)" "prognostic favorable (1.15e-4)" "unprognostic (1.52e-1)" "unprognostic (3.63e-10)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (3.76e-2)" "unprognostic (2.34e-3)" 207.4 6.0 3.2 2.9 9.4 2.1 65.1 2.0 6.8 1.2 6.7 19.6 0.8 2.4 1.7 1.3 2.2 1.6 3.6 4.8 6.2 4.2 1.5 1.1 1.4 2.7 18.0 2.3 1.5 2.2 2.2 0.8 1.7 9.9 1.7 1.3 3.7 5.4 1.7 3.7 2.9 3.4 1.7 19.2 3.1 1.6 9.0 10.8 1.7 1.5 1.8 1.9 2.0 3.7 6.1 4.8 10.8 12.1 4.1 5.2 4.0 4.9 3.8 2.5 0.9 57.3 0.5 0.0 2.3 1.3 3.7 3.5 0.9 1.9 8.2 2.6 0.7 1.8 2.2 1.5 4.6 0.4 1.5 2.4 2.3 1.8 0.1 1.1 0.0 5.6 0.5 4.4 0.6 0.8 0.5 1.0 3.4 1.0 5.2 0.5 0.0 5.7 0.2 0.3 3.8 1.1 4.7 0.4 2.7 1.0 5.2 3.5 3.6 2.0 2.3 2.1 0.1 0.6 3.0 1.9 1.0 3.2 0.4 2.1 3.9 3.2 6.1 2.6 0.2 3.5 10.8 12.1 4.7 3.6 6.0 3.3 4.8 4.6 5.2 4.8 6.1 4.1 3.7 2.0 4.1 3.3 3.9 3.9 4.0 3.2 9.4 2.0 6.8 6.2 4.2 18.0 2.3 9.9 10.8 0.0 3.5 1.3 10.1 3.7 8.1 2.2 0.0 0.0 0.0 1.8 9.8 0.0 1.7 6.4 123.5 4.5 3.2 23.3 2.4 0.1 1.7 5.2 0.0 0.0 0.6 7.9 0.0 17.8 1.8 188.1 2.8 1.2 5.0 0.0 1.1 3.3 1.4 0.0 1.4 1.1 12.3 0.0 1.0 26.8 12.4 2.0 0.0 6.9 2.7 9.0 LIX1L MGC46719 ENSG00000271601 "Limb and CNS expressed 1 like" Q8IVB5 1 145933423-145958001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 53.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063598 Approved Cytosol NA NA Cytosol "HPA063598: AB_2685055" "unprognostic (5.21e-2)" "unprognostic (4.09e-1)" "unprognostic (6.84e-3)" "unprognostic (2.85e-2)" "unprognostic (3.71e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (9.81e-2)" "unprognostic (3.46e-1)" "unprognostic (3.87e-2)" "unprognostic (1.84e-3)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.10e-3)" "unprognostic (4.95e-1)" "unprognostic (1.25e-2)" "prognostic unfavorable (5.27e-4)" 13.8 8.9 4.6 6.5 4.4 2.1 6.0 4.1 5.9 14.4 8.0 7.1 3.2 2.7 15.9 7.6 5.8 6.3 10.6 10.0 4.3 4.2 5.4 6.4 9.2 5.7 4.0 19.6 1.7 4.4 9.4 7.5 4.0 11.6 4.2 11.4 3.3 10.7 10.5 2.4 4.0 12.7 4.2 9.4 2.6 7.4 5.8 11.1 4.6 4.5 9.5 11.8 8.4 4.3 4.2 5.1 4.4 4.8 11.1 3.1 3.2 4.6 14.2 15.7 29.7 25.2 0.2 7.3 13.3 11.4 8.4 0.3 3.0 8.6 8.1 14.7 4.3 0.1 6.5 6.1 10.8 7.9 2.1 4.8 5.2 4.6 9.8 11.3 11.4 15.4 2.8 9.3 13.5 18.4 22.0 11.6 7.0 13.9 18.0 0.1 14.9 9.5 4.1 0.0 6.0 10.1 7.1 14.2 11.7 0.0 5.1 14.5 15.0 0.0 10.8 6.1 0.5 9.0 16.9 19.4 5.3 12.6 12.2 11.2 7.9 8.9 13.7 9.5 9.3 4.8 2.9 4.6 8.0 2.7 9.7 4.0 9.2 8.0 2.7 4.3 8.6 11.1 5.1 4.8 4.4 4.2 6.7 3.1 0.0 7.2 19.0 10.3 10.1 15.1 14.6 12.7 1.4 3.4 10.4 7.9 1.3 3.3 8.4 5.7 31.4 0.0 23.3 8.5 3.8 21.4 7.3 4.7 17.3 18.5 12.7 12.1 35.6 19.6 3.2 33.1 14.0 27.0 21.6 2.2 22.7 8.5 0.0 53.0 5.7 12.0 25.8 37.6 13.6 3.4 6.8 0.7 21.9 1.8 3.8 LMAN1 "ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60" ENSG00000074695 "Lectin, mannose binding 1" P49257 18 59327823-59359962 "Disease related genes, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 369.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002320, CAB037163" Supported Uncertain Cytosol NA NA 13000000 Cytosol "CAB037163: AB_532237, HPA002320: AB_1079256" "unprognostic (5.64e-2)" "unprognostic (8.96e-3)" "unprognostic (4.20e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (1.65e-1)" "unprognostic (5.40e-3)" "unprognostic (1.16e-1)" "unprognostic (2.03e-1)" "unprognostic (2.40e-2)" "unprognostic (1.06e-1)" "unprognostic (5.79e-2)" "unprognostic (4.28e-2)" "unprognostic (5.37e-3)" "unprognostic (7.05e-2)" "unprognostic (3.71e-3)" 6.2 7.7 2.6 4.5 3.0 1.6 5.7 4.6 1.8 9.8 3.9 5.7 6.7 7.4 6.6 6.5 3.8 8.0 2.7 3.0 9.1 26.2 7.0 2.7 2.8 8.1 15.3 12.7 9.7 7.1 8.2 5.0 8.4 6.1 6.9 3.4 6.1 4.6 3.5 4.8 7.5 2.1 12.3 3.9 4.7 5.6 6.9 8.2 4.0 3.4 9.0 9.8 3.8 18.7 11.1 11.9 9.9 27.9 48.3 24.1 34.0 48.8 23.0 30.9 11.0 18.2 3.3 24.2 40.3 16.5 23.1 16.9 19.2 42.0 12.7 10.8 10.9 14.9 22.8 33.2 37.8 16.8 32.1 23.2 22.2 45.7 43.4 23.1 11.6 18.3 37.4 22.3 5.0 10.9 7.8 8.2 9.5 13.8 12.4 21.7 36.3 12.8 14.2 8.2 8.9 17.1 16.8 19.2 17.5 12.4 14.8 19.0 37.5 13.1 11.9 19.7 28.6 14.2 16.2 39.3 20.2 30.5 4.0 2.3 0.6 7.2 3.4 9.8 6.9 7.9 7.5 3.1 4.7 7.6 7.5 0.3 9.0 1.9 8.2 8.7 3.8 95.3 75.6 40.2 99.5 62.0 36.5 107.3 68.8 120.5 94.4 76.8 100.1 135.4 18.3 109.7 19.1 71.9 34.5 0.0 73.5 233.6 149.7 186.9 32.4 369.6 72.2 55.6 49.5 84.1 33.9 6.3 102.4 44.4 64.1 62.3 110.0 95.5 79.1 59.6 80.2 62.0 60.8 64.7 72.9 37.1 59.8 49.8 193.4 52.2 80.9 90.2 LMBR1 "ACHP, C7orf2, FLJ11665, ZRS" ENSG00000105983 "Limb development membrane protein 1" Q8WVP7 7 156668946-156893230 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016592 Approved Approved Cytosol NA NA Cytosol "HPA016592: AB_1852943" "unprognostic (8.81e-3)" "unprognostic (1.73e-2)" "unprognostic (9.49e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-3)" "unprognostic (6.90e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-1)" "unprognostic (1.21e-2)" "unprognostic (1.12e-2)" "unprognostic (1.69e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.44e-6)" "unprognostic (3.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.48e-1)" "unprognostic (7.10e-2)" 15.8 30.5 15.2 12.4 23.7 7.1 12.9 20.4 25.5 16.3 10.1 13.4 12.8 9.1 19.0 19.4 12.1 16.9 12.8 12.9 15.9 17.4 17.5 15.9 11.5 11.3 17.8 11.5 18.9 12.0 38.2 22.7 11.6 24.4 14.1 12.2 11.3 10.6 13.1 14.8 11.2 10.9 15.1 14.4 9.4 12.7 20.3 13.2 14.7 20.9 8.7 12.8 13.9 12.3 2.3 3.6 4.2 2.0 0.9 4.1 1.5 12.5 11.0 12.5 15.4 10.1 12.2 8.5 7.3 9.2 6.6 7.3 7.9 20.5 12.3 14.0 9.4 12.4 10.1 13.1 13.6 14.0 8.8 13.3 9.1 6.1 9.5 7.0 11.2 6.3 9.2 12.3 9.6 12.6 10.5 14.2 10.5 17.4 11.3 13.4 11.8 11.2 9.0 14.5 13.3 9.9 6.1 8.9 15.0 10.4 12.5 13.3 24.8 9.6 13.1 7.0 8.4 9.2 6.2 19.9 11.9 4.6 40.9 9.2 13.7 10.7 12.2 20.2 14.3 7.3 4.2 2.0 2.7 1.7 1.0 4.1 1.3 3.6 2.6 3.6 2.3 4.0 2.5 1.5 0.9 1.7 2.2 2.2 1.5 15.2 23.7 20.4 25.5 15.9 17.4 17.8 11.5 24.4 13.2 3.0 7.2 6.4 11.5 9.3 11.2 15.4 12.7 5.3 4.5 12.2 2.0 12.6 5.0 9.4 6.0 20.0 8.4 0.0 8.9 4.8 11.6 16.2 5.7 18.1 8.5 7.9 7.9 8.6 8.6 8.0 9.8 6.1 6.8 4.6 9.7 6.5 10.3 7.0 8.1 9.4 10.6 0.0 6.0 9.6 27.4 11.2 19.3 5.7 11.0 13.3 LMOD1 "1D, 64kD, D1" ENSG00000163431 "Leiomodin 1" P29536 1 201896452-201946588 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 199.7;urinary bladder: 165.5" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 127.6;Leydig cells: 116.2;Peritubular cells: 258.9;Rod photoreceptor cells: 66.8;Sertoli cells: 194.1;Smooth muscle cells: 158.8" "Cancer enhanced" "Detected in all" "prostate cancer: 43.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 9.2;BJ: 11.9;BJ hTERT+: 19.3;fHDF/TERT166: 9.6;HSkMC: 8.5;hTERT-RPE1: 31.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028325, HPA028435, HPA030097" Enhanced Approved Cytosol No No Cytosol "HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223" "unprognostic (3.84e-2)" "unprognostic (5.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.27e-1)" "unprognostic (5.64e-1)" "unprognostic (6.35e-2)" "prognostic favorable (2.52e-5)" "unprognostic (1.27e-1)" "unprognostic (6.10e-2)" "unprognostic (1.73e-2)" "unprognostic (3.51e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.30e-2)" "unprognostic (2.72e-1)" "unprognostic (4.44e-3)" "unprognostic (1.15e-2)" 27.4 12.7 1.9 26.7 6.2 0.0 20.5 2.2 1.9 65.6 83.5 1.8 42.7 6.0 84.9 29.0 94.6 33.2 80.7 8.3 1.6 1.6 5.3 1.0 11.0 5.5 2.3 3.2 38.1 1.6 7.4 1.3 10.2 4.1 77.1 12.0 28.9 6.8 63.8 29.5 7.4 20.9 199.7 1.8 6.3 47.0 23.3 0.7 0.0 7.9 12.3 2.7 165.5 39.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 9.2 1.1 0.7 11.9 19.3 0.7 0.9 0.0 0.1 0.0 0.4 9.6 0.1 0.2 0.3 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 8.5 0.0 0.5 0.0 31.2 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.2 5.6 0.4 0.0 0.0 0.1 0.4 0.1 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.9 6.2 2.2 1.9 1.6 1.6 2.3 3.2 4.1 0.7 0.0 1.4 0.0 0.7 1.1 4.9 22.4 0.0 1.4 0.0 0.0 127.6 1.1 0.0 0.0 1.9 2.1 0.0 0.0 0.5 0.2 13.9 0.6 0.0 0.0 0.8 3.2 0.0 13.5 0.0 3.6 116.2 0.0 3.3 0.0 0.0 4.5 0.0 0.0 258.9 0.0 66.8 194.1 158.8 1.4 0.2 1.9 1.0 0.0 0.0 0.3 LPIN3 "LIPN3L, SMP2" ENSG00000132793 "Lipin 3" Q9BQK8 20 41340920-41360582 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 49.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 49.9;Late spermatids: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 6.3" "Group enriched" "Detected in many" 4 "granulocytes: 1.8;NK-cells: 6.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA051466, HPA052667, HPA070640" Approved Supported Cytosol NA NA Cytosol "HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288" "unprognostic (2.31e-1)" "unprognostic (4.73e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (6.91e-3)" "unprognostic (4.26e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.74e-4)" "unprognostic (4.29e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (5.60e-3)" "unprognostic (2.02e-1)" "unprognostic (1.35e-1)" "unprognostic (3.37e-3)" 11.6 3.7 3.0 8.1 5.2 0.1 23.4 1.5 3.0 10.9 29.2 2.8 13.5 26.8 12.8 21.6 16.3 7.5 11.2 8.8 3.6 0.7 28.2 14.4 4.5 1.6 2.8 3.7 7.9 7.4 8.1 6.7 4.4 4.2 10.1 8.8 8.7 11.0 15.1 1.8 26.1 49.1 5.5 2.4 2.7 7.4 2.5 1.5 1.2 14.2 10.6 9.0 8.0 12.5 0.9 0.7 1.8 0.9 6.3 0.8 0.2 6.9 6.8 0.4 4.1 11.2 17.5 5.3 4.3 6.0 5.3 7.2 12.7 6.2 0.3 5.4 9.4 5.6 17.7 2.1 11.2 3.3 0.1 4.0 0.3 9.6 6.4 1.8 0.0 4.8 12.6 14.3 8.9 3.5 6.2 1.3 0.1 1.8 0.2 6.6 14.9 0.0 0.1 0.6 4.3 7.1 0.0 0.1 0.5 18.4 8.8 0.5 0.1 5.7 7.4 3.6 3.5 8.6 3.5 0.4 0.3 1.7 5.9 0.0 3.4 1.8 0.0 0.1 0.1 0.3 1.8 0.5 0.7 0.5 0.5 0.8 0.6 0.7 0.4 0.3 0.9 0.7 0.6 1.8 6.3 0.9 0.7 0.5 0.2 3.0 5.2 1.5 3.0 3.6 0.7 2.8 3.7 4.2 1.5 6.0 10.5 0.8 8.2 12.8 0.0 0.6 10.2 1.4 4.5 10.4 0.0 2.3 5.0 7.4 10.4 2.1 49.9 0.0 3.3 2.2 7.7 3.5 1.1 33.7 2.7 0.0 14.3 4.3 1.3 82.8 2.8 1.5 10.1 0.0 16.6 7.5 5.5 21.6 2.5 5.9 0.3 32.3 6.4 0.9 2.1 11.0 2.2 1.3 16.2 3.9 LRCH3 MGC4126 ENSG00000186001 "Leucine rich repeats and calponin homology domain containing 3" Q96II8 3 197791226-197888436 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012380, HPA017299" Uncertain Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA012380: AB_1853260, HPA017299: AB_2669576" "unprognostic (1.25e-1)" "unprognostic (4.92e-1)" "unprognostic (1.43e-1)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (8.26e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.29e-1)" "unprognostic (4.13e-1)" "unprognostic (9.85e-2)" "unprognostic (1.64e-1)" "unprognostic (2.06e-2)" "unprognostic (1.79e-3)" "unprognostic (3.29e-2)" "unprognostic (2.67e-1)" "unprognostic (5.59e-2)" "unprognostic (1.32e-1)" 16.4 14.0 19.3 23.4 19.1 11.0 18.0 37.5 19.1 21.9 19.0 28.2 15.6 11.0 24.7 14.8 15.6 18.3 16.7 18.2 15.9 14.5 12.6 14.2 14.8 23.4 19.7 13.1 27.5 12.9 23.7 26.0 15.2 15.4 20.4 16.7 23.6 15.6 22.4 23.0 15.7 15.9 28.3 15.9 18.7 15.0 20.2 20.4 27.0 13.5 9.5 26.0 20.3 18.0 6.9 2.8 22.6 4.8 4.9 6.0 3.3 18.1 6.5 17.5 10.8 21.2 24.1 6.8 13.2 16.0 16.1 18.9 15.3 9.6 9.9 20.7 16.2 22.9 11.9 14.6 12.8 21.7 7.9 9.1 16.5 9.7 13.0 14.5 12.6 13.0 16.5 7.8 15.3 19.6 15.6 19.0 8.8 10.4 16.5 15.2 15.4 9.5 5.5 12.0 9.3 13.6 10.0 10.9 7.1 8.5 10.7 8.7 9.4 16.0 12.1 12.7 16.8 21.2 11.1 18.5 13.4 7.7 16.2 13.2 15.3 13.7 9.0 12.7 18.0 12.6 22.6 3.4 7.0 5.9 4.8 4.5 6.9 4.6 5.0 2.8 5.7 4.3 6.0 2.3 4.9 4.6 2.6 4.4 3.3 19.3 19.1 37.5 19.1 15.9 14.5 19.7 13.1 15.4 20.4 29.8 24.8 15.9 14.0 9.4 55.4 14.2 17.8 16.0 19.4 8.7 53.0 7.0 1.7 10.1 9.5 20.2 6.8 0.0 8.4 5.5 19.9 12.7 10.5 13.0 7.6 36.5 5.8 41.7 13.0 7.1 23.3 15.3 16.9 28.9 8.2 26.6 11.3 7.0 26.9 4.2 44.4 19.4 17.0 16.3 16.6 9.3 5.0 14.0 9.2 13.1 LRIG1 "DKFZP586O1624, LIG-1, LIG1" ENSG00000144749 "Leucine rich repeats and immunoglobulin like domains 1" Q96JA1 3 66378797-66501263 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 64.0" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 48.2;Muller glia cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" "Cell line enhanced" "Detected in many" "Daudi: 23.8;hTEC/SVTERT24-B: 18.7;U-698: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011846 Approved Approved Cytosol NA NA 21000 Cytosol "HPA011846: AB_2668545" "unprognostic (6.41e-2)" "unprognostic (4.18e-2)" "unprognostic (4.35e-3)" "unprognostic (4.58e-2)" "unprognostic (2.12e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.01e-5)" "unprognostic (5.12e-1)" "unprognostic (7.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.18e-1)" "unprognostic (2.12e-1)" "unprognostic (8.79e-2)" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.50e-4)" 12.6 1.7 22.3 8.1 21.1 2.4 13.4 9.6 31.8 15.5 24.6 20.3 0.7 8.2 12.7 2.6 6.9 13.3 13.8 16.8 24.6 7.1 2.5 15.8 8.6 4.1 19.8 12.4 8.8 64.0 4.2 6.7 2.8 18.9 12.2 7.6 4.8 9.4 4.3 16.6 6.6 7.5 14.5 10.9 2.4 21.2 6.4 19.8 0.2 8.1 5.0 5.0 5.1 5.4 0.3 0.0 0.7 0.0 0.0 2.7 0.4 0.4 0.4 9.5 0.1 2.6 1.7 0.8 1.5 8.9 1.5 4.8 7.4 0.0 23.8 4.1 0.7 2.1 0.0 1.8 3.2 3.4 0.0 4.9 0.0 1.4 0.6 0.6 0.2 5.4 2.1 1.8 18.7 3.1 6.5 8.2 0.1 0.0 0.0 0.3 1.1 0.0 0.0 7.1 0.7 0.0 4.3 2.8 1.2 1.8 0.0 1.2 0.3 1.4 1.4 0.0 1.7 8.5 2.1 2.5 4.7 2.0 9.2 3.9 1.9 0.9 18.2 8.3 0.0 1.6 0.0 0.0 0.7 0.4 0.0 1.4 0.3 1.1 1.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 2.7 0.4 22.3 21.1 9.6 20.2 24.6 7.1 19.8 12.4 18.9 19.8 35.7 42.0 2.7 7.5 10.1 1.7 28.8 7.6 48.2 30.7 0.0 7.9 0.2 1.7 5.5 1.5 9.8 7.1 0.0 14.9 0.1 9.4 18.3 1.1 17.4 1.5 7.9 25.4 4.3 1.0 1.3 10.6 3.1 10.1 1.8 24.4 47.3 6.2 7.0 16.3 1.0 6.5 0.0 9.2 1.5 18.1 10.0 0.1 9.6 19.5 3.7 LRIG3 "FLJ90440, KIAA3016" ENSG00000139263 "Leucine rich repeats and immunoglobulin like domains 3" Q6UXM1 12 58872149-58920522 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010773 Approved Approved Cytosol NA NA Cytosol "HPA010773: AB_1853275" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-2)" "unprognostic (3.88e-2)" "unprognostic (2.53e-1)" "unprognostic (3.46e-2)" "unprognostic (1.83e-2)" "unprognostic (1.34e-3)" "unprognostic (1.21e-1)" "unprognostic (1.92e-1)" "unprognostic (3.04e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-3)" "unprognostic (2.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.46e-2)" 15.8 1.7 3.6 11.8 4.1 0.0 16.4 1.0 3.7 18.7 14.8 7.8 12.1 8.4 14.2 13.8 17.1 9.9 17.8 4.7 4.6 1.8 6.5 6.1 9.6 5.0 3.6 2.6 14.7 15.3 4.8 10.3 6.8 5.8 15.5 16.0 13.5 24.9 11.6 5.0 25.9 10.0 21.6 3.0 7.2 13.5 6.4 6.6 5.4 37.6 15.0 12.8 15.7 20.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 2.0 1.9 7.4 0.5 13.6 15.9 1.7 4.9 14.3 4.8 5.1 5.8 2.7 1.9 10.0 5.4 5.8 9.6 2.7 12.6 3.5 14.6 9.6 0.5 3.3 2.8 2.6 0.8 0.2 15.7 27.4 5.1 11.0 9.4 13.1 2.2 0.1 2.4 3.2 0.9 2.3 0.0 7.9 2.4 2.9 0.0 6.3 4.8 3.7 10.6 7.5 0.0 4.3 2.7 4.5 11.0 5.0 0.1 5.6 6.5 4.5 3.9 6.4 1.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 4.1 1.0 3.7 4.6 1.8 3.6 2.6 5.8 6.6 14.9 17.4 0.0 7.5 19.9 2.6 4.1 33.1 13.4 23.9 1.8 0.0 0.7 0.0 9.0 0.3 11.4 10.7 0.0 15.8 0.4 8.2 2.6 0.0 6.8 1.9 3.2 11.1 4.3 0.3 0.0 25.0 0.2 3.3 0.0 11.8 2.8 7.5 14.0 27.3 4.2 0.1 6.5 11.3 0.4 1.5 19.6 0.2 0.0 25.9 2.7 LRRC1 "dJ523E19.1, FLJ10775, FLJ11834, LANO" ENSG00000137269 "Leucine rich repeat containing 1" Q9BTT6 6 53794497-53924121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 81.7;Syncytiotrophoblasts: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031603, HPA031604" Enhanced Supported Cytosol NA NA Cytosol "HPA031603: AB_10601753, HPA031604: AB_10601224" "unprognostic (2.90e-1)" "unprognostic (8.01e-2)" "unprognostic (9.59e-3)" "unprognostic (2.46e-2)" "unprognostic (7.04e-3)" "unprognostic (1.55e-2)" "unprognostic (2.19e-3)" "unprognostic (6.37e-2)" "unprognostic (7.02e-2)" "unprognostic (7.12e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.97e-1)" "prognostic favorable (2.21e-7)" "unprognostic (1.74e-1)" "unprognostic (2.31e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-3)" 13.1 2.3 8.6 7.6 17.0 2.5 12.4 4.0 13.4 12.1 22.6 17.5 7.3 15.3 5.3 8.9 17.2 7.9 12.0 3.8 9.4 6.1 7.3 1.1 7.0 2.4 21.8 6.1 5.7 8.3 24.8 8.0 26.1 11.2 8.3 23.2 7.8 14.9 7.0 1.9 20.2 20.7 6.1 11.9 1.8 13.2 12.3 20.6 8.3 16.3 8.4 9.3 12.3 16.1 1.8 1.4 0.4 0.2 3.3 1.1 0.1 20.1 2.6 2.8 5.0 0.7 0.4 20.1 2.8 5.7 2.4 3.3 22.4 10.0 2.9 2.3 1.7 4.5 10.0 22.1 8.9 3.1 3.5 6.4 1.7 2.0 15.0 7.3 2.2 1.3 0.7 7.4 0.2 5.4 3.8 4.3 10.6 0.4 2.7 1.3 8.8 14.7 0.3 2.2 15.1 2.0 3.0 4.7 1.5 6.5 26.1 7.4 0.7 3.3 14.7 4.3 7.4 9.6 2.2 2.0 1.8 6.0 0.1 2.5 2.7 2.1 2.0 2.1 3.0 2.2 0.0 0.2 0.4 1.0 0.0 0.4 0.3 0.9 1.1 1.4 1.8 0.8 0.6 0.0 3.3 0.0 1.2 0.1 0.1 8.6 17.0 4.0 13.4 9.4 6.1 21.8 6.1 11.2 20.6 38.7 3.8 2.7 22.4 46.8 33.1 3.3 5.1 9.4 20.5 15.7 3.9 42.9 6.6 17.3 75.0 17.5 33.2 0.0 13.8 43.0 5.2 14.6 5.7 0.0 4.5 7.9 17.2 7.4 0.3 81.7 8.6 1.5 10.1 3.6 22.1 38.2 21.5 36.6 9.6 10.1 2.7 6.5 2.5 6.1 6.9 46.0 89.7 3.8 18.4 26.7 LRRC37B ENSG00000185158 "Leucine rich repeat containing 37B" Q96QE4 17 32007872-32053504 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 71.2;Spermatocytes: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9" "Low cell line specificity" "Detected in all" HPA015135 Approved Approved Cytosol NA NA Cytosol "HPA015135: AB_1853309" "unprognostic (5.46e-3)" "unprognostic (2.56e-2)" "unprognostic (5.08e-2)" "unprognostic (5.30e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-1)" "unprognostic (3.60e-2)" "unprognostic (9.65e-3)" "unprognostic (5.06e-2)" "unprognostic (3.19e-2)" "unprognostic (1.72e-4)" "unprognostic (6.99e-2)" "unprognostic (5.72e-3)" "unprognostic (6.94e-2)" "unprognostic (3.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.36e-3)" 4.7 5.0 13.7 4.8 15.0 28.5 6.4 35.5 14.4 5.9 5.2 7.2 5.0 4.5 8.3 6.5 4.6 8.2 4.8 2.7 10.7 8.5 3.7 3.0 6.7 5.5 8.6 10.2 12.1 4.3 7.4 13.8 4.6 8.9 5.3 6.4 6.1 6.5 4.2 3.5 11.7 6.3 7.2 8.5 7.6 6.6 24.5 10.3 8.3 4.4 1.8 5.8 5.3 10.2 0.8 1.1 2.8 0.5 6.4 4.9 0.5 2.1 3.9 12.5 7.1 3.2 4.0 3.9 1.9 7.1 5.5 7.1 5.4 2.1 5.6 4.0 4.3 6.9 2.8 7.4 1.5 4.4 1.6 6.3 2.6 5.8 2.0 4.7 10.1 4.8 4.2 4.7 5.0 12.8 5.3 4.6 9.6 6.1 5.4 2.1 1.9 17.6 15.6 3.8 1.9 2.7 12.4 2.9 4.5 3.1 5.2 2.4 4.0 4.8 3.1 6.5 4.3 8.2 16.3 3.9 3.9 2.7 8.6 4.6 5.4 7.7 5.6 2.8 10.2 2.8 0.0 0.4 2.8 1.1 0.5 2.1 0.2 2.2 3.0 0.8 0.8 3.0 0.8 1.1 6.4 0.2 1.1 4.9 0.5 13.7 15.0 35.5 14.4 10.7 8.5 8.6 10.2 8.9 10.3 6.0 7.8 2.7 6.4 3.7 7.8 4.4 10.2 8.1 10.3 1.8 0.0 1.8 8.3 8.5 71.2 5.0 2.9 23.3 9.0 1.9 5.0 8.3 3.5 2.9 8.3 3.2 1.7 7.4 7.9 11.8 6.4 8.3 8.5 7.2 5.5 9.2 8.3 0.0 6.7 6.9 8.7 0.0 9.6 37.1 10.6 4.4 1.8 10.1 5.4 6.5 LRRC46 MGC16309 ENSG00000141294 "Leucine rich repeat containing 46" Q96FV0 17 47831627-47837713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 51.2;testis: 94.4" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 239.6;Early spermatids: 97.9;Late spermatids: 46.8;Spermatocytes: 76.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.4" "Region enriched" "Detected in many" 4 "pons and medulla: 14.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 6.4;T-47d: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021882, HPA074893" Enhanced Approved Cytosol NA NA Cytosol "HPA021882: AB_1853320, HPA074893: AB_2732271" "unprognostic (1.06e-1)" "unprognostic (6.01e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.40e-1)" "unprognostic (2.81e-2)" "unprognostic (4.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-1)" "unprognostic (3.06e-1)" "unprognostic (2.21e-3)" "unprognostic (3.63e-2)" "unprognostic (2.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-1)" 0.3 0.4 1.8 0.3 3.3 0.6 0.5 0.4 0.5 2.3 0.3 5.2 1.6 0.4 1.5 13.8 0.4 51.2 0.5 0.5 2.0 2.4 0.7 0.4 11.8 0.5 0.3 0.1 8.8 0.5 0.3 4.2 0.4 14.0 0.5 0.3 1.8 0.4 1.3 0.3 0.3 0.3 0.3 0.6 0.5 0.3 94.4 1.1 1.2 1.4 0.0 0.4 0.3 0.1 0.6 2.5 4.4 1.6 2.4 1.0 0.5 1.5 6.4 0.8 3.2 0.5 1.4 1.8 0.2 1.7 1.7 3.3 3.0 1.4 0.7 4.1 0.8 1.7 1.4 0.8 1.1 2.6 2.8 2.8 1.3 1.8 1.0 0.3 0.1 1.5 0.0 1.0 3.5 1.3 0.5 0.3 1.1 1.2 0.8 2.3 2.4 2.1 0.3 0.2 0.5 1.3 2.0 0.2 1.3 2.8 1.1 2.7 2.0 0.7 0.0 0.9 0.3 7.6 0.2 0.5 3.5 1.3 0.6 0.4 1.4 1.3 1.3 2.4 0.5 0.3 4.4 1.3 2.0 0.2 1.6 0.0 0.6 0.1 1.0 2.5 0.4 0.7 0.0 1.6 2.4 1.5 1.3 0.2 0.5 1.8 3.3 0.4 0.5 2.0 2.4 0.3 0.1 14.0 1.1 0.0 2.9 0.0 0.3 0.0 0.6 0.3 0.0 239.6 27.3 5.2 2.0 0.1 0.0 0.3 97.9 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 46.8 2.6 0.7 0.0 1.0 0.1 0.9 0.5 0.0 1.8 1.0 5.4 0.0 0.1 76.7 4.0 0.0 0.1 0.0 0.0 0.1 LRRC4C "KIAA1580, NGL-1" ENSG00000148948 "Leucine rich repeat containing 4C" Q9HCJ2 11 40114203-41459773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 31.5" "Group enriched" "Detected in some" 12 "Muller glia cells: 106.3;Rod photoreceptor cells: 97.7" "Cancer enhanced" "Detected in some" "glioma: 3.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "Group enriched" "Detected in some" 6 "AF22: 17.3;U-2 OS: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054800, HPA075816" Supported Approved Cytosol NA NA Cytosol "HPA054800: AB_2682603, HPA075816: " "unprognostic (4.86e-3)" "unprognostic (3.43e-2)" "unprognostic (7.62e-3)" "unprognostic (4.87e-3)" "unprognostic (6.48e-2)" "unprognostic (1.42e-1)" "unprognostic (2.84e-1)" "unprognostic (4.64e-2)" "unprognostic (1.93e-1)" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (4.90e-13)" "unprognostic (5.05e-4)" "unprognostic (5.21e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-3)" 1.6 5.7 20.2 1.6 23.7 0.5 2.6 3.6 31.5 5.3 1.9 3.3 0.0 1.1 2.3 1.0 1.2 1.3 1.8 2.6 16.7 8.7 0.9 2.1 1.6 1.4 7.5 10.3 1.6 1.0 4.3 3.2 0.5 8.7 1.5 1.6 1.3 1.4 3.0 0.7 0.7 1.3 2.4 6.0 1.3 0.9 0.9 7.9 0.0 4.0 0.0 1.6 1.1 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 19.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 23.7 3.6 16.4 16.7 8.7 7.5 10.3 8.7 7.9 0.0 2.2 0.0 0.0 0.1 8.7 1.0 0.0 0.0 1.2 0.0 5.9 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.1 7.9 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 0.0 106.3 0.2 0.0 1.4 0.6 97.7 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 LRRC73 "C6orf154, dJ337H4.2" ENSG00000204052 "Leucine rich repeat containing 73" Q5JTD7 6 43506969-43510686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5;testis: 31.6" "Cell type enriched" "Detected in many" 7 "Early spermatids: 299.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 5.7;MCF7: 5.7;OE19: 8.0;T-47d: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046698 Enhanced Approved Cytosol NA NA Cytosol "HPA046698: AB_10959526" "unprognostic (3.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (4.42e-3)" "unprognostic (1.04e-2)" "unprognostic (3.52e-1)" "unprognostic (6.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.25e-1)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-1)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-3)" "unprognostic (1.89e-2)" 1.2 6.1 10.4 0.9 19.4 0.8 1.1 2.3 23.5 1.4 1.3 2.3 0.9 2.1 1.4 1.5 1.0 11.3 1.8 1.8 8.9 5.2 3.0 1.2 1.6 0.9 3.1 12.1 2.0 2.8 7.5 4.1 1.2 6.2 1.9 1.1 0.6 1.4 2.1 1.0 1.1 1.2 1.5 1.1 1.2 1.8 31.6 1.8 0.0 1.6 0.0 0.9 1.4 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.8 5.7 0.9 2.9 0.2 0.2 1.6 0.5 0.3 0.0 0.3 0.2 0.1 1.0 0.8 2.2 0.7 0.7 0.0 0.1 0.9 0.0 0.4 0.2 0.9 0.0 0.1 0.5 1.1 1.8 0.3 2.8 0.1 0.3 0.3 0.5 1.0 5.7 0.0 0.0 0.1 8.0 0.7 0.0 0.0 0.1 1.5 0.0 2.1 2.5 0.5 0.4 0.2 0.0 5.8 0.0 0.2 0.4 0.6 2.1 0.2 0.5 0.3 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 19.4 2.3 23.5 8.9 5.2 3.1 12.1 6.2 1.8 0.0 0.0 0.0 2.4 0.3 4.9 0.8 0.0 8.1 2.3 3.5 0.0 0.1 6.6 0.6 299.6 0.1 1.3 0.0 0.7 0.1 0.6 2.3 0.0 0.4 0.1 27.0 5.2 0.0 0.0 27.3 4.0 0.0 1.7 0.0 2.0 8.3 0.2 0.0 3.9 5.1 6.6 6.5 1.1 41.7 9.7 0.0 0.2 0.0 0.6 0.6 LRRFIP1 "FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP" ENSG00000124831 "LRR binding FLII interacting protein 1" Q32MZ4 2 237627576-237813682 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 74.5" HPA006979 Approved Supported Cytosol NA NA 120000 Cytosol "HPA006979: AB_1079282" "unprognostic (2.07e-1)" "unprognostic (2.99e-2)" "unprognostic (4.09e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.09e-1)" "unprognostic (6.50e-2)" "unprognostic (9.68e-3)" "unprognostic (3.08e-2)" "unprognostic (3.99e-3)" "unprognostic (8.90e-2)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (2.69e-2)" "unprognostic (8.07e-2)" "unprognostic (7.64e-2)" 27.2 9.9 11.2 28.6 9.4 28.5 31.3 8.8 14.5 28.0 30.9 5.4 16.4 13.7 36.3 24.1 30.1 18.5 23.3 30.7 11.1 12.0 32.1 27.6 29.9 25.5 7.7 10.0 18.0 10.4 31.3 14.2 16.8 12.2 27.5 16.3 8.2 20.2 14.4 52.7 12.6 19.8 56.8 7.4 27.9 21.5 7.3 5.8 27.6 19.0 23.1 19.4 49.3 39.5 12.8 17.6 71.6 33.1 9.3 19.9 10.6 22.7 11.8 5.6 11.3 8.0 16.0 18.9 17.1 16.5 9.3 9.3 4.5 15.3 1.9 6.9 26.3 20.1 19.1 12.8 23.7 19.9 74.5 8.3 18.1 13.4 12.7 16.2 23.8 17.2 7.2 49.8 21.6 53.1 13.9 18.8 12.8 13.3 18.7 19.9 11.0 13.7 18.2 7.4 17.0 10.9 20.5 33.0 18.5 29.8 33.3 11.5 7.7 7.9 18.3 21.7 10.6 10.3 30.1 32.9 11.3 10.9 12.1 18.0 3.8 3.2 12.7 16.4 24.1 12.3 14.3 22.8 49.4 16.5 19.7 12.4 11.0 19.9 17.1 17.6 12.8 10.6 11.8 71.6 9.3 33.1 15.5 15.3 10.6 11.2 9.4 8.8 14.5 11.1 12.0 7.7 10.0 12.2 5.8 452.6 296.6 160.3 309.8 272.8 47.5 137.7 124.9 346.6 384.5 164.0 35.3 90.2 44.7 209.5 8.0 199.3 165.6 0.0 289.9 289.9 102.6 382.8 229.3 128.8 162.7 20.6 182.9 86.5 247.2 5.6 27.6 484.3 158.6 206.4 114.8 21.5 281.3 91.1 21.9 38.3 5.6 77.6 225.8 8.8 35.9 212.4 21.2 230.4 94.7 523.2 LRSAM1 "CMT2P, FLJ31641" ENSG00000148356 "Leucine rich repeat and sterile alpha motif containing 1" Q6UWE0 9 127451486-127503501 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021403, HPA021844, CAB037304" Supported Approved Cytosol NA NA Cytosol "CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368" "unprognostic (8.83e-2)" "unprognostic (3.13e-1)" "unprognostic (7.48e-3)" "unprognostic (4.15e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (1.64e-1)" "unprognostic (5.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.72e-2)" "prognostic favorable (6.78e-6)" "unprognostic (1.27e-1)" "prognostic favorable (5.72e-4)" "unprognostic (1.94e-2)" "unprognostic (3.26e-1)" "unprognostic (9.07e-2)" "unprognostic (3.33e-2)" 9.5 13.6 15.6 10.1 17.2 15.3 9.2 24.2 22.6 10.7 18.0 15.3 10.9 10.8 12.6 17.6 12.3 11.0 11.9 18.7 13.3 17.3 11.2 15.6 11.7 11.5 13.5 22.7 16.0 9.6 17.6 11.8 9.2 17.9 13.6 8.6 10.2 11.9 13.7 20.4 28.3 11.1 16.0 18.7 12.6 12.2 6.1 13.9 5.5 11.6 9.6 11.5 17.2 12.9 4.1 5.4 17.4 6.6 1.3 4.8 3.2 5.7 8.8 5.3 10.2 9.0 8.9 8.4 5.4 6.8 8.4 6.2 10.1 5.6 9.9 5.6 7.5 4.3 19.1 6.5 11.4 3.3 10.4 4.9 5.4 11.4 8.8 7.2 5.9 11.4 5.1 9.4 5.7 11.0 10.8 9.0 8.2 4.7 10.3 3.7 14.6 4.1 5.1 5.0 13.4 8.9 6.7 4.8 15.4 9.1 5.0 9.8 8.1 3.5 12.1 7.1 5.3 24.9 3.2 10.5 5.6 5.7 7.0 3.7 11.4 8.5 1.6 9.3 5.5 2.9 14.6 4.9 17.4 4.4 6.6 4.8 4.1 3.0 3.7 5.4 3.1 1.5 2.0 5.7 1.3 5.5 4.6 2.4 3.2 15.6 17.2 24.2 22.6 13.3 17.3 13.5 22.7 17.9 13.9 8.9 4.6 2.7 2.8 1.0 5.6 18.3 5.1 6.7 10.3 0.0 5.9 4.1 5.0 5.4 0.6 3.6 5.6 0.0 1.2 1.7 2.4 3.6 9.2 5.9 5.4 11.1 1.2 4.3 6.6 0.2 2.6 4.5 3.3 10.8 5.2 5.7 4.2 4.3 4.9 5.0 4.8 0.0 4.1 4.6 3.0 2.4 5.8 5.0 4.9 3.0 LRTM2 ENSG00000166159 "Leucine rich repeats and transmembrane domains 2" Q8N967 12 1820267-1836752 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "brain: 18.7" "Cell type enhanced" "Detected in some" 29 "Bipolar cells: 3.7;Cone photoreceptor cells: 2.0;Horizontal cells: 11.1;Rod photoreceptor cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 9.2;SCLC-21H: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055094, HPA062745" Uncertain Approved Cytosol NA NA Cytosol "HPA055094: AB_2682693, HPA062745: " "unprognostic (1.84e-3)" "unprognostic (4.83e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (5.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.34e-3)" "unprognostic (2.25e-1)" "unprognostic (1.24e-1)" "unprognostic (6.20e-4)" "unprognostic (2.21e-1)" "unprognostic (8.02e-2)" 0.7 0.7 5.1 0.7 12.3 0.7 0.7 0.8 18.7 0.7 0.7 1.7 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 3.3 5.0 0.7 0.7 0.7 0.7 1.7 10.5 0.7 0.7 0.7 0.1 0.7 4.7 0.7 0.7 0.1 0.7 0.8 0.7 0.7 0.7 0.7 1.7 0.7 0.8 0.9 4.3 0.0 0.7 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.3 0.8 18.7 3.3 5.0 1.7 10.5 4.7 4.3 0.0 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LSAMP "IGLON3, LAMP" ENSG00000185565 "Limbic system-associated membrane protein" Q13449 3 115802363-117139389 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.4" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 208.2;Leydig cells: 116.8;Muller glia cells: 166.8;Peritubular cells: 86.3" "Cancer enhanced" "Detected in many" "glioma: 13.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.0;SH-SY5Y: 14.2;WM-115: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054051, HPA076122" Enhanced Cytosol NA NA 200000000 Cytosol "HPA054051: AB_2682358, HPA076122: AB_2686779" "unprognostic (4.18e-2)" "unprognostic (2.54e-1)" "unprognostic (9.97e-3)" "unprognostic (6.03e-2)" "unprognostic (9.63e-2)" "unprognostic (4.15e-3)" "unprognostic (6.81e-2)" "unprognostic (2.70e-2)" "unprognostic (5.71e-2)" "unprognostic (6.82e-3)" "unprognostic (1.26e-1)" "unprognostic (6.03e-2)" "unprognostic (1.92e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (5.23e-5)" "unprognostic (1.31e-2)" 2.3 12.7 21.9 4.3 23.7 1.1 1.6 43.4 48.4 17.8 5.5 16.6 0.0 1.9 4.4 2.8 3.4 2.9 11.3 2.1 23.7 18.8 2.5 1.0 8.5 4.0 17.6 21.5 4.8 11.1 0.6 3.1 1.2 18.3 21.1 3.5 1.2 1.7 6.2 0.7 4.6 1.9 3.3 13.1 1.7 3.2 3.9 21.3 0.0 4.2 0.0 5.2 7.3 3.4 1.6 0.4 3.0 0.8 0.3 1.0 0.3 0.2 2.2 7.0 0.2 0.7 2.2 0.7 0.6 0.3 0.2 0.7 0.2 0.4 0.5 0.2 3.6 0.2 0.1 0.1 0.1 0.3 0.5 0.1 0.2 0.8 0.3 0.1 0.5 0.4 1.7 0.0 0.8 0.1 0.2 0.0 0.9 0.3 2.3 0.0 0.2 0.8 0.6 2.7 0.3 0.8 0.2 0.1 0.1 1.7 1.6 1.6 14.2 0.0 0.1 2.2 3.2 0.2 0.8 0.1 1.5 1.3 1.7 0.4 1.5 1.9 0.2 0.5 0.2 34.6 3.0 0.8 1.4 0.9 0.5 1.0 0.7 0.6 0.5 0.2 1.6 1.0 0.7 2.8 0.3 0.6 0.4 0.5 0.3 21.9 23.7 43.4 23.7 23.7 18.8 17.6 21.5 18.3 21.3 0.0 0.6 0.5 0.2 6.8 47.9 18.9 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 15.9 2.5 0.0 0.0 3.0 0.0 16.0 17.5 0.0 0.0 0.3 208.2 0.0 1.8 0.0 18.1 116.8 1.8 54.0 0.0 0.0 166.8 0.6 0.0 86.3 0.0 9.7 0.0 1.3 0.9 0.2 4.4 0.0 0.0 0.0 0.5 LSM12 FLJ30656 ENSG00000161654 "LSM12 homolog" Q3MHD2 17 44034635-44067619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 220.5;Late spermatids: 409.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051934 Approved Approved Cytosol NA NA Cytosol "HPA051934: AB_2681666" "unprognostic (3.42e-2)" "unprognostic (1.01e-2)" "unprognostic (1.64e-1)" "unprognostic (5.98e-2)" "unprognostic (8.04e-2)" "unprognostic (3.87e-3)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.79e-2)" "unprognostic (1.17e-1)" "unprognostic (4.30e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (3.76e-1)" "prognostic unfavorable (1.18e-7)" "unprognostic (8.91e-3)" "unprognostic (2.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.18e-2)" 26.7 26.6 26.9 19.8 22.1 30.1 35.1 22.5 30.0 19.5 23.8 23.0 20.7 20.8 22.6 31.5 32.8 18.8 23.8 42.7 24.6 28.9 24.8 44.8 20.4 26.8 25.5 21.2 24.5 36.8 27.4 23.7 30.5 20.4 20.7 30.0 21.7 21.8 26.6 40.8 19.6 19.6 29.2 23.6 23.4 23.4 37.5 18.6 27.7 24.2 17.4 29.1 30.5 19.8 25.4 36.3 16.8 40.1 22.8 29.4 27.0 20.4 22.9 16.1 25.3 21.4 23.3 29.1 23.4 23.0 29.7 30.1 26.3 22.6 34.3 17.0 26.3 23.6 16.9 33.9 30.2 45.2 25.4 35.4 23.8 17.7 31.7 19.7 41.1 25.5 20.7 24.4 27.9 40.6 19.6 25.7 22.4 34.4 25.5 20.2 20.2 39.0 22.5 23.7 20.4 32.4 24.9 31.8 33.1 27.7 30.5 22.6 14.9 18.8 20.5 24.4 35.4 42.6 27.4 22.7 38.0 22.5 20.4 37.8 20.2 20.6 37.5 32.4 29.5 28.6 16.7 32.6 13.6 26.3 40.1 29.4 25.4 29.3 27.9 36.0 23.0 26.3 25.8 16.8 22.8 36.8 36.3 28.7 27.0 26.9 22.1 22.5 30.0 24.6 28.9 25.5 21.2 20.4 18.6 14.9 13.7 22.0 33.6 44.8 40.9 15.7 28.1 14.7 14.8 15.7 82.5 42.0 36.5 47.6 220.5 35.1 29.2 0.0 88.6 80.1 36.6 58.3 7.0 41.9 39.3 33.4 38.2 25.2 29.8 409.2 32.5 34.3 32.1 43.3 44.1 22.7 71.0 35.1 29.7 46.8 61.7 25.8 33.3 54.9 61.7 42.8 70.0 21.8 38.8 70.1 LSS OSC ENSG00000160285 "Lanosterol synthase" P48449 21 46188141-46228824 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Isomerase "Cataract, Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032060, HPA032062, CAB034116" Supported Approved Cytosol NA NA Cytosol "CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: AB_2674134" "unprognostic (2.78e-3)" "unprognostic (8.53e-3)" "unprognostic (6.95e-2)" "unprognostic (2.07e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (2.74e-2)" "unprognostic (1.33e-2)" "unprognostic (1.72e-1)" "unprognostic (1.58e-2)" "unprognostic (1.68e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-2)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.92e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.07e-4)" 21.1 22.9 17.9 9.9 38.8 5.0 14.7 22.5 33.9 11.2 16.9 37.7 5.8 26.4 16.6 12.5 23.4 11.0 12.1 17.8 19.0 17.3 8.4 33.8 19.7 8.3 49.5 14.9 25.7 15.8 10.4 22.7 10.3 42.7 24.0 10.7 13.2 11.0 13.2 24.5 26.2 10.3 12.2 33.3 7.1 14.1 13.8 46.9 6.0 7.5 9.8 8.3 12.3 11.8 4.8 8.0 5.2 3.3 2.7 8.3 5.0 18.1 5.9 19.2 8.2 26.1 25.1 5.4 7.0 49.9 8.7 17.1 19.4 14.5 3.9 6.0 13.6 63.9 8.6 16.9 29.4 3.5 3.8 9.1 9.7 9.7 12.5 23.8 3.5 6.8 24.7 11.2 16.2 7.0 6.0 7.2 19.3 9.4 23.5 7.4 6.1 7.6 5.0 31.2 2.9 5.3 9.0 5.9 23.7 22.6 10.0 11.2 9.9 8.3 6.4 7.2 8.6 10.2 8.8 10.7 10.3 8.4 9.1 5.4 8.6 7.3 7.9 10.8 15.6 4.4 5.2 3.3 3.5 6.9 3.0 4.7 4.8 5.0 8.3 3.8 3.0 4.2 6.2 0.0 2.7 2.5 8.0 2.3 5.0 17.9 38.8 22.5 33.9 19.0 17.3 49.5 14.9 42.7 46.9 11.9 33.7 11.5 3.8 32.7 12.9 13.4 12.7 8.1 7.9 10.4 3.9 3.4 0.0 9.7 4.2 9.8 5.3 23.3 15.0 5.1 25.7 14.9 3.5 23.8 8.1 22.3 18.9 9.8 7.8 5.3 19.5 5.0 20.3 19.0 10.0 8.7 10.9 0.0 12.7 3.8 15.2 0.0 10.0 13.6 9.4 47.2 5.3 5.0 10.0 4.1 LTBP1 ENSG00000049323 "Latent transforming growth factor beta binding protein 1" Q14766 2 32946972-33399509 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 79.5;Fibroblasts: 97.9;Leydig cells: 83.7;Peritubular cells: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.3" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 106.2;HSkMC: 34.2;HUVEC TERT2: 34.7;U-87 MG: 46.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005707, CAB025428" Approved Approved Cytosol "Secreted to extracellular matrix" NA NA 200000000 Cytosol "CAB025428: , HPA005707: AB_1853394" "unprognostic (1.02e-2)" "unprognostic (1.12e-1)" "unprognostic (5.29e-2)" "unprognostic (6.23e-2)" "unprognostic (3.11e-3)" "unprognostic (1.83e-1)" "unprognostic (1.06e-3)" "unprognostic (5.67e-2)" "unprognostic (7.48e-2)" "unprognostic (1.14e-1)" "unprognostic (9.96e-3)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.79e-6)" "unprognostic (4.61e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.62e-4)" 10.4 4.9 4.5 16.3 5.4 3.4 9.2 1.3 3.9 66.7 15.6 9.5 10.2 3.6 28.5 22.9 22.9 21.7 64.9 45.6 5.7 2.9 10.6 6.5 15.5 3.4 3.5 4.9 23.4 3.1 0.6 7.0 28.7 11.7 29.6 6.1 10.0 10.6 27.6 8.0 6.6 8.6 38.9 10.9 3.7 22.7 16.2 4.7 2.1 4.4 16.4 10.0 37.4 18.1 0.1 0.3 4.3 0.1 0.0 0.1 8.1 0.0 2.2 5.7 0.0 4.8 106.2 2.4 8.2 17.1 1.1 1.7 4.4 0.8 7.2 0.1 1.0 1.6 0.4 0.1 0.2 4.0 0.1 2.7 23.7 2.8 0.7 22.0 0.0 2.8 34.2 0.8 25.5 1.2 11.2 34.7 1.1 1.5 0.0 9.1 3.4 0.9 0.0 4.0 0.1 7.0 0.8 11.9 0.1 0.0 3.9 1.1 0.6 1.6 13.0 0.1 9.3 5.0 0.0 22.2 1.1 4.8 32.6 6.5 13.6 13.6 10.4 46.7 0.9 1.9 4.3 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 8.1 4.5 5.4 1.3 3.9 5.7 2.9 3.5 4.9 11.7 4.7 0.0 1.1 0.0 4.2 11.9 0.0 79.5 5.1 5.3 1.2 1.8 0.0 38.5 0.0 5.5 5.3 26.2 5.3 23.3 5.7 19.4 97.9 11.5 0.0 9.5 6.8 0.0 1.2 26.4 0.3 4.5 83.7 0.9 18.6 0.0 2.1 0.0 18.1 3.1 151.4 0.0 0.1 58.2 59.0 0.5 7.2 8.5 36.4 0.0 3.4 18.7 LTN1 "C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294" ENSG00000198862 "Listerin E3 ubiquitin protein ligase 1" O94822 21 28928144-28992956 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 218.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029143, CAB034164, HPA055604" Uncertain Enhanced Cytosol NA NA Cytosol "CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859" "unprognostic (3.67e-2)" "unprognostic (7.07e-2)" "unprognostic (7.78e-2)" "unprognostic (3.99e-1)" "unprognostic (1.42e-2)" "unprognostic (3.66e-3)" "unprognostic (5.38e-2)" "unprognostic (5.40e-2)" "unprognostic (9.98e-2)" "unprognostic (4.45e-2)" "unprognostic (2.85e-2)" "unprognostic (1.13e-1)" "unprognostic (9.87e-2)" "unprognostic (1.72e-1)" "unprognostic (8.22e-2)" "unprognostic (4.57e-2)" "unprognostic (1.52e-1)" 17.9 15.1 10.3 12.4 19.8 21.2 17.9 19.9 23.2 16.6 14.7 17.8 12.1 12.4 16.5 15.4 15.2 14.5 10.8 13.1 12.0 10.6 14.1 19.3 12.0 15.7 19.6 14.2 16.4 23.7 18.4 22.6 29.0 28.7 19.0 15.6 9.7 16.1 12.6 22.5 14.8 17.1 13.4 17.4 16.7 15.4 20.7 15.8 23.0 17.6 14.6 14.9 16.6 14.7 7.8 6.2 12.2 11.9 8.6 8.4 3.3 12.8 5.5 11.5 5.2 9.9 13.6 11.7 10.9 8.9 9.4 13.0 7.7 10.7 8.5 5.3 9.7 8.1 6.6 12.2 8.9 17.1 9.9 8.5 25.3 7.6 6.1 7.4 8.4 9.9 9.4 8.1 13.3 11.1 9.3 9.9 6.2 20.6 20.4 10.7 4.0 5.3 8.1 16.5 10.7 6.6 7.2 23.1 17.7 10.6 11.1 6.3 13.1 12.5 9.6 10.9 11.3 9.7 11.8 13.0 8.3 15.4 11.1 9.1 16.6 15.6 12.0 12.9 18.2 9.8 12.2 6.4 9.5 8.4 9.8 7.0 7.8 5.8 5.6 6.2 7.1 6.2 4.7 11.3 8.6 11.9 3.9 6.1 3.3 10.3 19.8 19.9 23.2 12.0 10.6 19.6 14.2 28.7 15.8 14.9 19.9 19.0 22.3 26.9 24.3 23.8 7.6 21.4 19.4 10.4 31.4 15.4 1.7 12.5 218.4 21.5 16.6 0.0 12.2 16.4 19.2 28.0 26.6 18.4 11.3 39.7 21.8 15.4 24.1 45.8 24.7 18.9 11.8 19.0 17.8 44.4 16.5 17.3 19.8 15.7 29.4 12.9 19.5 36.9 19.0 28.0 24.9 27.3 17.8 29.8 LYPD6 MGC52057 ENSG00000187123 "LY6/PLAUR domain containing 6" Q86Y78 2 149329985-149474148 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 17.7;placenta: 22.7" "Group enriched" "Detected in many" 33 "Early spermatids: 54.3;Late spermatids: 174.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 18.6;fHDF/TERT166: 23.9;HBF TERT88: 13.1;LHCN-M2: 23.7;RT4: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042805 Enhanced Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA042805: AB_10794159" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (7.23e-3)" "unprognostic (1.64e-2)" "unprognostic (3.25e-1)" "unprognostic (6.49e-3)" "unprognostic (6.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.73e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.14e-3)" "unprognostic (6.75e-2)" "unprognostic (7.33e-4)" "unprognostic (1.39e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.72e-4)" 2.6 1.0 8.7 1.8 7.9 0.4 14.6 3.3 8.2 2.0 4.4 4.3 1.1 2.8 4.0 1.0 1.2 2.9 17.7 1.4 6.2 11.5 3.4 0.8 1.3 0.8 6.2 5.3 1.4 3.2 2.6 0.9 22.7 7.2 2.5 4.1 2.8 0.8 2.6 0.7 1.4 5.6 4.7 5.1 1.3 6.2 4.5 2.6 0.0 0.6 0.0 2.3 4.4 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 18.6 0.0 0.0 0.2 7.6 3.3 9.6 6.1 0.1 1.5 0.0 0.4 23.9 4.7 1.9 2.7 0.0 13.1 0.0 0.9 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.8 0.1 0.1 0.0 0.0 0.0 23.7 3.0 0.0 1.7 2.7 1.6 2.2 0.0 10.3 0.0 1.2 19.5 0.7 3.4 5.1 5.8 0.6 6.3 0.7 0.3 0.0 0.2 3.0 0.2 4.1 0.0 0.0 0.0 1.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 8.7 7.9 3.3 8.2 6.2 11.5 6.2 5.3 7.2 2.6 0.0 0.0 0.0 0.5 0.1 1.9 0.3 2.5 1.4 3.4 0.0 0.0 0.0 3.3 2.2 54.3 0.2 1.0 0.0 0.7 0.2 0.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 174.5 2.8 0.0 0.0 0.0 2.5 3.5 3.3 0.0 0.4 0.0 3.2 0.0 0.1 0.7 1.1 0.0 0.2 0.0 1.9 1.1 LYPLAL1 Q96AV0 ENSG00000143353 "Lysophospholipase like 1" Q5VWZ2 1 219173844-219212865 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 177.4;Proximal tubular cells: 276.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045806 Approved Supported Cytosol NA NA Cytosol "HPA045806: AB_10966647" "unprognostic (1.27e-2)" "unprognostic (1.29e-1)" "unprognostic (3.98e-2)" "unprognostic (8.64e-2)" "unprognostic (2.41e-1)" "unprognostic (1.49e-1)" "unprognostic (2.01e-1)" "unprognostic (3.73e-2)" "unprognostic (4.08e-2)" "unprognostic (2.05e-1)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.68e-1)" "unprognostic (5.87e-2)" "unprognostic (1.73e-1)" "unprognostic (4.65e-2)" 10.7 22.3 19.0 9.4 17.4 2.1 12.4 15.2 13.2 10.6 7.2 14.4 4.4 10.7 19.4 5.9 10.0 7.1 10.5 39.7 17.9 15.4 46.6 29.9 8.9 9.5 19.5 12.3 12.5 12.9 14.6 25.0 9.9 14.9 16.3 7.7 16.1 9.9 8.6 12.0 11.5 9.2 15.6 28.2 6.5 7.7 10.6 17.0 7.3 19.3 9.9 10.3 9.0 12.9 12.8 6.8 8.9 9.6 4.0 7.3 5.3 6.7 6.8 3.0 0.0 6.1 12.2 7.8 3.8 4.4 3.6 4.0 3.1 9.1 7.3 11.4 3.4 3.7 3.6 6.1 8.7 5.2 10.2 7.1 4.1 3.6 6.9 24.7 8.8 3.1 14.2 7.9 3.7 8.9 8.4 10.4 7.2 12.3 7.2 8.0 4.4 4.1 7.5 5.9 6.3 11.0 2.4 7.8 12.2 14.1 5.0 7.3 4.8 4.5 12.0 13.5 10.2 11.3 11.3 6.3 2.9 2.0 5.9 4.7 6.6 3.8 5.3 9.6 7.2 6.4 2.4 8.6 4.7 3.6 6.3 5.7 12.8 4.9 4.2 6.8 7.6 7.3 5.7 8.9 4.0 9.6 6.0 4.8 5.3 19.0 17.4 15.2 12.9 17.9 15.4 19.5 12.3 14.9 17.0 23.8 28.6 20.5 17.9 19.7 28.4 100.7 30.6 32.1 15.9 48.8 7.9 74.1 177.4 41.0 24.6 15.0 13.8 0.0 46.1 29.2 23.4 15.9 16.2 42.9 57.6 17.5 17.9 30.7 27.1 5.9 25.0 31.3 40.5 14.4 18.4 92.9 39.4 14.4 29.0 276.5 27.0 12.9 20.6 24.2 22.3 25.6 52.3 9.2 11.4 10.6 LYRM2 DJ122O8.2 ENSG00000083099 "LYR motif containing 2" Q9NU23 6 89568144-89638753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063932 Uncertain Approved Cytosol NA NA Cytosol "HPA063932: AB_2685155" "unprognostic (3.23e-2)" "unprognostic (1.47e-1)" "unprognostic (8.52e-3)" "unprognostic (8.49e-2)" "unprognostic (4.27e-2)" "unprognostic (6.26e-2)" "prognostic unfavorable (2.58e-8)" "unprognostic (1.46e-1)" "unprognostic (1.18e-1)" "unprognostic (3.29e-3)" "unprognostic (8.07e-3)" "unprognostic (3.63e-2)" "unprognostic (7.98e-2)" "unprognostic (3.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.23e-2)" "unprognostic (5.64e-2)" 11.2 17.5 21.6 9.8 22.0 12.5 14.5 11.9 22.5 10.3 13.6 15.2 15.1 8.6 13.4 15.4 12.8 14.1 10.7 17.3 19.2 19.6 18.2 13.8 10.2 11.8 22.2 23.0 11.3 10.3 24.9 34.0 16.1 19.0 14.1 16.8 9.0 10.9 10.2 20.9 7.0 10.0 12.5 19.8 9.4 12.9 11.0 22.2 9.8 26.2 13.2 10.8 12.0 8.9 21.9 17.5 9.2 21.0 16.6 20.2 9.6 9.5 5.1 17.5 10.4 8.9 13.5 7.2 16.7 11.9 13.0 13.2 4.5 5.1 13.2 16.1 15.7 19.5 8.8 11.1 15.7 17.0 16.6 19.3 20.7 5.5 3.8 13.3 22.0 16.2 16.5 15.4 14.8 20.0 10.7 10.1 14.4 21.2 17.1 15.0 8.6 5.0 7.8 4.0 7.8 6.4 10.5 21.7 9.8 14.7 9.5 19.5 13.2 9.6 6.1 16.7 8.5 8.5 22.6 16.0 8.2 7.3 14.9 23.0 12.3 17.7 6.8 17.3 15.9 15.5 8.7 14.4 9.2 15.3 16.2 16.3 21.9 17.4 20.2 13.1 20.3 19.8 18.2 4.1 16.6 21.0 17.5 15.7 9.6 21.6 22.0 11.9 22.5 19.2 19.6 22.2 23.0 19.0 22.2 38.7 39.9 36.7 24.6 10.5 26.7 79.5 28.1 89.7 54.6 26.2 15.7 71.6 79.6 33.6 48.2 24.8 26.1 23.3 42.9 26.6 24.6 23.5 31.3 25.1 48.9 23.8 39.0 19.6 27.2 11.4 28.4 37.5 28.7 34.3 38.2 89.1 34.2 35.1 25.5 53.0 48.0 51.8 25.8 46.4 37.1 14.2 60.5 28.7 37.7 23.5 LYSMD3 FLJ13542 ENSG00000176018 "LysM domain containing 3" Q7Z3D4 5 90515611-90529584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018024 Approved Approved Cytosol NA NA Cytosol "HPA018024: AB_2138525" "unprognostic (4.50e-2)" "unprognostic (1.85e-2)" "prognostic favorable (3.83e-4)" "unprognostic (5.59e-2)" "unprognostic (5.61e-2)" "unprognostic (9.80e-3)" "unprognostic (3.99e-2)" "unprognostic (4.66e-2)" "unprognostic (6.23e-2)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (2.02e-1)" "prognostic favorable (9.25e-4)" "unprognostic (1.81e-1)" "unprognostic (8.48e-2)" "unprognostic (4.97e-3)" "unprognostic (9.46e-2)" 12.7 14.0 8.9 11.1 10.5 9.3 11.1 16.0 11.2 15.8 14.1 4.7 16.2 11.8 13.1 9.3 12.0 11.2 12.8 15.7 10.2 8.9 21.1 33.6 15.6 12.9 11.9 6.1 19.1 13.1 24.5 31.1 19.0 12.2 12.9 10.8 7.3 13.3 21.2 16.6 6.4 17.4 10.5 12.1 14.6 9.5 6.6 12.7 18.5 18.8 9.0 11.4 15.4 12.5 6.4 7.3 27.7 9.4 11.9 10.4 7.4 10.3 6.9 8.9 9.4 14.0 14.3 8.8 16.6 18.1 11.6 19.1 5.9 10.7 12.8 7.2 14.5 18.1 5.3 13.7 16.2 22.7 9.4 8.6 9.7 8.6 9.6 14.5 8.1 16.5 10.5 11.4 10.6 17.8 12.4 16.5 8.4 9.3 19.6 12.9 9.1 9.3 4.7 4.4 2.6 11.8 8.8 15.1 18.4 12.7 7.1 2.7 5.5 9.8 7.5 13.5 7.4 8.5 7.7 20.5 7.0 9.9 15.3 11.9 22.4 14.2 10.9 11.9 13.9 10.9 27.7 7.7 11.6 6.5 9.4 10.4 6.4 7.5 7.9 7.3 5.4 10.3 8.8 11.5 11.9 9.3 3.5 8.1 7.4 8.9 10.5 16.0 11.2 10.2 8.9 11.9 6.1 12.2 12.7 32.8 21.9 13.7 9.3 12.7 10.2 22.1 7.6 14.7 21.6 12.2 3.9 8.4 1.7 6.4 0.8 15.5 13.7 23.3 7.0 8.2 18.2 18.7 25.4 28.8 7.7 19.1 20.7 16.0 14.0 1.3 15.5 14.4 6.8 6.4 11.1 18.9 5.9 8.6 12.4 10.1 12.8 19.4 17.8 7.0 4.1 14.4 11.7 15.4 9.0 8.0 LZTFL1 BBS17 ENSG00000163818 "Leucine zipper transcription factor like 1" Q9NQ48 3 45823316-45916042 "Disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.7" "Cell type enhanced" "Detected in all" 11 "Ciliated cells: 188.7;Spermatocytes: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043466, HPA048447" Enhanced Supported Cytosol NA NA Cytosol "HPA043466: AB_2678491, HPA048447: AB_2680398" "unprognostic (1.64e-2)" "unprognostic (1.34e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-2)" "unprognostic (2.65e-2)" "unprognostic (5.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.26e-2)" "unprognostic (4.20e-2)" "unprognostic (2.94e-2)" "unprognostic (7.83e-2)" "unprognostic (5.32e-2)" "unprognostic (1.30e-3)" "unprognostic (6.27e-3)" "unprognostic (8.31e-2)" "unprognostic (4.27e-3)" "unprognostic (4.19e-1)" 5.8 7.2 12.3 5.0 14.9 4.8 13.6 9.3 21.6 14.5 6.9 4.4 10.4 6.0 14.4 16.6 6.1 20.8 7.3 5.3 10.2 11.6 12.9 10.1 9.7 4.4 6.9 13.4 12.8 8.6 14.6 30.7 6.2 10.1 9.0 6.8 5.6 7.5 10.4 3.6 6.4 6.8 8.7 6.1 5.8 6.3 27.7 5.6 55.7 20.4 4.3 5.7 7.3 6.4 7.2 4.6 1.9 2.5 2.3 4.0 2.7 6.8 3.5 5.5 3.6 5.2 12.7 2.6 3.7 6.1 7.6 9.9 1.0 5.2 2.1 2.2 4.6 9.8 3.2 6.0 6.1 10.6 0.0 4.2 1.3 4.9 2.9 6.9 6.7 2.0 6.8 21.1 9.5 6.2 5.6 4.3 10.8 6.3 4.4 4.1 1.1 18.3 6.4 5.8 4.5 3.0 2.5 0.5 7.2 10.5 2.6 3.8 7.8 4.5 4.1 8.9 6.3 5.0 11.7 6.9 3.2 2.2 8.6 4.7 12.4 6.5 0.0 10.2 7.9 2.6 0.0 1.9 0.7 2.8 2.5 3.9 7.2 2.5 2.4 4.6 3.7 4.0 3.3 1.9 2.3 1.6 4.5 3.5 2.7 12.3 14.9 9.3 21.6 10.2 11.6 6.9 13.4 10.1 5.6 26.8 18.5 8.8 8.3 11.9 7.7 6.9 10.2 188.7 33.0 14.0 13.7 2.5 13.3 10.7 53.9 7.3 2.6 23.3 6.1 4.3 11.0 7.6 8.1 11.6 5.9 22.3 10.9 8.6 3.7 8.6 9.2 5.8 8.5 13.6 11.3 15.2 5.6 3.5 12.7 16.7 14.1 12.9 6.1 140.9 20.0 8.7 1.7 15.3 8.8 4.1 MACO1 "FLJ10747, TMEM57" ENSG00000204178 "Macoilin 1" Q8N5G2 1 25430858-25500209 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 25.4;Ductal cells: 30.7;Exocrine glandular cells: 53.7;Pancreatic endocrine cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019680 Approved Cytosol NA NA Cytosol "HPA019680: AB_1858125" "unprognostic (2.42e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.83e-2)" "unprognostic (2.16e-1)" "unprognostic (1.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.69e-2)" "unprognostic (6.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (7.02e-2)" "prognostic favorable (7.13e-4)" "unprognostic (2.54e-2)" "unprognostic (4.22e-2)" "unprognostic (5.22e-2)" "unprognostic (5.35e-3)" 9.8 16.5 12.1 6.9 11.3 26.5 8.9 27.8 13.2 9.2 8.9 11.3 12.7 9.5 9.7 11.9 17.2 7.9 8.8 8.8 8.7 9.4 11.9 33.0 9.4 7.8 12.9 11.5 17.2 28.1 11.4 12.8 8.1 11.3 12.9 9.2 10.4 20.7 13.5 31.2 10.7 9.7 8.5 10.1 9.6 11.5 15.6 13.8 17.9 13.2 12.5 11.1 10.5 10.2 2.6 4.0 6.8 2.5 1.5 3.0 0.7 10.2 3.4 10.5 18.9 12.7 9.7 5.6 11.0 11.5 9.9 10.9 3.1 13.7 20.7 12.8 12.1 6.3 10.6 8.9 10.4 10.4 10.7 8.7 25.7 5.8 8.5 9.0 9.1 18.9 9.6 12.8 14.5 9.7 8.9 11.2 12.7 16.9 7.5 9.7 6.2 22.0 11.8 12.4 9.4 5.6 13.5 11.1 16.3 10.9 5.2 17.8 19.3 8.3 21.1 13.2 9.3 7.7 11.2 13.1 11.8 7.6 14.7 7.1 13.4 8.7 12.0 12.9 12.6 9.2 6.8 1.1 6.2 2.1 0.9 3.0 1.6 2.4 2.7 1.4 2.6 2.5 3.0 0.5 1.5 2.5 4.0 1.4 0.7 12.1 11.3 27.8 13.2 8.7 9.4 12.9 11.5 11.3 13.8 17.9 20.5 0.0 0.0 0.0 0.0 0.0 0.0 25.4 20.5 7.0 0.0 11.1 5.0 30.7 0.0 0.0 0.0 0.0 53.7 16.7 0.0 0.0 9.3 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 12.6 0.0 0.0 38.1 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 MAGEA1 "CT1.1, MAGE1, MGC9326" ENSG00000198681 "MAGE family member A1" P43355 X 153179285-153183880 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 13.5" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 29.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 17.8;HMC-1: 31.0;RPMI-8226: 15.3;U-2 OS: 29.6;U-266/70: 44.3;U-266/84: 70.5" CAB002620 Enhanced Supported Cytosol NA NA Cytosol "CAB002620: " "unprognostic (8.65e-2)" "unprognostic (1.33e-1)" "unprognostic (6.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (2.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 17.8 3.2 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.1 0.0 0.0 29.6 0.1 0.1 44.3 70.5 0.0 2.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 29.0 0.0 0.0 0.0 0.0 0.0 MAGEB2 "CT3.2, DAM6, MAGE-XP-2, MGC26438" ENSG00000099399 "MAGE family member B2" O15479 X 30215560-30220089 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 35.8" "Group enriched" "Detected in some" 11 "Sertoli cells: 12.9;Spermatocytes: 16.1;Spermatogonia: 45.1" "Cancer enriched" "Detected in many" 7 "testis cancer: 33.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 26.1;K-562: 18.8;Karpas-707: 22.8;U-2 OS: 27.2;U-266/70: 44.8;U-266/84: 46.8" "HPA065224, HPA074544, HPA075519" Enhanced Approved Cytosol NA Yes Cytosol "HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294" "unprognostic (4.52e-1)" "unprognostic (2.55e-2)" "unprognostic (6.39e-2)" "unprognostic (5.02e-1)" "unprognostic (6.57e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 27.2 0.0 0.0 44.8 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 16.1 45.1 0.0 0.0 0.0 0.0 0.0 MAGED1 "DLXIN-1, NRAGE" ENSG00000179222 "MAGE family member D1" Q9Y5V3 X 51803007-51902357 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 308.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 83.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043645 Approved Cytosol NA NA Cytosol "HPA043645: AB_2678597" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (1.39e-2)" "unprognostic (3.92e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-3)" "unprognostic (2.04e-2)" "unprognostic (3.92e-1)" "unprognostic (1.77e-1)" "unprognostic (3.15e-3)" "unprognostic (1.42e-1)" "unprognostic (6.10e-3)" "unprognostic (2.14e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.71e-3)" 15.4 57.6 35.3 16.8 52.9 6.9 18.6 34.6 61.8 50.9 18.8 25.9 38.9 15.2 27.6 67.4 13.1 31.6 28.1 32.4 42.2 58.4 22.5 48.6 17.5 13.6 32.2 38.0 30.7 37.2 42.9 69.6 53.5 39.4 35.1 19.3 34.7 38.1 45.5 19.6 12.7 13.4 36.3 25.7 15.9 25.8 33.8 16.1 24.6 35.4 12.5 17.9 23.9 15.8 10.1 28.8 1.5 3.2 7.7 11.6 6.9 3.2 11.9 38.3 33.0 30.3 54.7 20.6 44.2 56.9 24.6 39.0 24.4 11.2 4.6 8.6 83.5 8.8 2.4 34.1 15.7 18.5 4.9 13.2 3.1 0.0 31.6 23.2 11.6 5.8 51.4 5.6 20.7 4.7 43.3 29.3 12.2 4.8 9.2 49.2 29.9 13.2 3.9 30.1 10.7 24.6 13.6 24.8 0.6 25.3 5.9 9.9 55.0 0.0 13.0 6.5 39.2 23.2 2.9 29.1 10.7 27.6 37.6 4.9 6.1 8.9 9.5 41.9 1.0 27.8 0.7 2.2 1.5 11.6 3.2 10.3 9.3 7.6 10.0 6.8 10.1 9.6 11.3 0.7 7.7 2.8 28.8 10.5 6.9 35.3 52.9 34.6 61.8 42.2 58.4 32.2 38.0 39.4 16.1 71.5 28.0 32.1 16.5 10.2 30.8 38.2 40.8 45.5 42.1 33.2 7.9 308.7 24.9 39.2 2.2 19.4 15.3 0.0 43.5 143.1 55.9 27.2 17.3 57.0 89.9 42.9 54.9 52.2 9.4 6.0 40.0 6.3 23.6 4.6 76.3 37.5 33.2 10.5 54.1 29.1 10.5 12.9 17.6 5.6 6.3 7.2 155.3 11.4 21.8 13.6 MAP1A MAP1L ENSG00000166963 "Microtubule associated protein 1A" P78559 15 43510958-43531620 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 103.6" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 71.0;Horizontal cells: 282.9;Peritubular cells: 71.8" "Cancer enhanced" "Detected in many" "glioma: 18.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 74 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in single" 74 "dendritic cells: 12.3" "Cell line enhanced" "Detected in many" "ASC diff: 21.8;BJ hTERT+: 21.4;fHDF/TERT166: 32.0;hTEC/SVTERT24-B: 20.4;U-87 MG: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039063, HPA039064, HPA066488" Enhanced Approved Cytosol No No Cytosol "HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-2)" "unprognostic (5.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.65e-2)" "unprognostic (1.13e-3)" "unprognostic (8.36e-3)" "unprognostic (3.45e-3)" "prognostic unfavorable (6.59e-5)" "unprognostic (5.83e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (1.09e-5)" "prognostic unfavorable (1.66e-5)" 5.2 7.9 43.6 5.4 42.8 2.5 4.3 24.5 103.6 10.5 5.4 18.3 1.0 3.0 5.6 4.3 4.8 9.1 5.9 14.8 40.9 30.2 2.8 1.9 3.4 2.7 34.7 31.3 7.1 2.7 4.1 4.4 4.4 56.2 6.7 5.3 3.1 2.5 9.6 4.5 3.1 3.2 14.5 21.4 2.6 2.7 5.4 12.6 6.5 3.7 0.1 2.7 6.3 2.8 0.0 12.3 0.0 0.0 0.0 0.1 0.2 0.1 0.8 3.9 2.2 21.8 15.0 0.0 12.5 21.4 3.7 3.6 1.5 0.0 0.0 5.4 32.0 1.1 0.1 5.2 0.0 2.1 1.8 0.5 4.8 1.2 0.1 2.1 0.1 2.0 11.2 0.0 20.4 0.1 5.6 2.7 14.2 7.9 0.1 14.8 0.1 8.7 0.2 2.8 0.0 0.3 2.4 11.3 0.0 0.0 0.0 12.2 3.7 0.4 0.0 0.1 5.4 0.8 0.2 0.5 11.9 4.0 3.9 0.1 0.0 0.5 1.7 43.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.1 0.2 43.6 42.8 24.5 63.1 40.9 30.2 34.7 31.3 56.2 12.6 3.0 0.6 0.0 1.1 4.8 35.3 48.5 0.0 71.0 12.5 3.5 23.6 0.3 0.0 0.4 10.6 4.3 0.0 0.0 0.0 0.6 30.1 0.7 6.9 0.0 1.9 282.9 10.9 4.9 0.8 5.2 47.2 1.4 8.5 0.0 0.0 15.3 1.2 0.0 71.8 0.3 20.6 32.3 49.5 9.2 27.3 3.6 0.9 0.7 0.0 0.5 MAP1B "MAP5, PPP1R102" ENSG00000131711 "Microtubule associated protein 1B" P46821 5 72107234-72209570 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 102.5" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 675.4;Horizontal cells: 611.8;Muller glia cells: 420.2;Rod photoreceptor cells: 440.1;Sertoli cells: 756.7;Smooth muscle cells: 465.8" "Cancer enriched" "Detected in all" 5 "glioma: 48.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 64.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009792, HPA022275" Enhanced Supported Enhanced Cytosol NA NA 140000 Cytosol "CAB009792: AB_2137420, HPA022275: AB_1853944" "unprognostic (9.96e-2)" "unprognostic (3.97e-2)" "unprognostic (1.57e-2)" "unprognostic (3.70e-1)" "unprognostic (4.67e-3)" "unprognostic (2.98e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (7.00e-2)" "unprognostic (4.78e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-2)" "unprognostic (1.13e-2)" "unprognostic (1.90e-1)" "unprognostic (1.75e-2)" "prognostic unfavorable (8.22e-5)" 20.3 18.1 27.5 10.2 39.6 1.6 9.3 52.3 101.9 15.3 6.1 21.6 3.5 3.2 9.2 9.8 12.8 7.7 10.7 17.1 37.6 40.7 4.4 3.3 3.7 3.2 42.4 42.5 7.8 4.5 3.0 7.0 9.5 102.5 19.0 6.2 9.4 7.6 24.0 3.6 10.2 3.9 22.9 45.7 2.4 7.2 11.0 11.3 0.0 5.7 0.1 2.6 13.4 5.9 0.2 0.4 0.6 0.0 0.0 0.3 2.1 0.3 12.2 30.7 11.1 19.1 33.5 0.0 6.6 5.1 6.7 8.0 0.1 0.4 0.0 15.8 24.3 20.2 0.1 16.7 0.6 10.1 0.0 2.4 1.3 4.3 4.0 10.2 0.0 1.0 33.6 2.1 26.8 9.9 6.0 20.7 0.0 1.9 0.0 11.3 0.1 0.0 0.0 8.3 0.0 3.9 0.1 3.6 0.0 0.6 0.0 19.9 13.8 6.5 0.0 3.4 26.6 0.0 1.3 64.6 21.2 10.0 15.4 29.6 1.4 0.0 0.0 22.9 0.0 16.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.2 0.6 0.0 0.0 0.4 0.2 2.1 27.5 39.6 52.3 59.1 37.6 40.7 42.4 42.5 102.5 11.3 0.0 1.3 1.7 41.3 28.0 193.6 258.0 2.5 68.3 19.4 8.7 675.4 1.8 0.0 9.0 10.7 79.8 0.0 0.0 2.9 1.2 236.1 19.8 1.1 0.8 5.2 611.8 74.5 53.4 2.2 10.5 286.8 2.8 75.9 0.0 0.2 420.2 9.6 0.0 361.7 0.8 440.1 756.7 465.8 7.7 4.4 44.3 3.3 0.0 0.0 9.8 MAP2K2 "MEK2, PRKMK2" ENSG00000126934 "Mitogen-activated protein kinase kinase 2" P36507 19 4090321-4124129 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 596.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003835, HPA051993" Supported Supported Cytosol NA NA Cytosol "CAB003835: AB_562312, HPA051993: AB_2681685" "unprognostic (4.39e-1)" "prognostic favorable (3.72e-4)" "unprognostic (4.24e-1)" "unprognostic (1.26e-3)" "unprognostic (2.58e-1)" "prognostic favorable (7.98e-4)" "unprognostic (2.08e-3)" "unprognostic (2.11e-1)" "unprognostic (2.65e-1)" "unprognostic (1.06e-1)" "unprognostic (7.45e-3)" "unprognostic (4.95e-2)" "unprognostic (1.32e-1)" "prognostic favorable (5.43e-5)" "unprognostic (2.91e-2)" "unprognostic (2.25e-1)" "unprognostic (4.90e-2)" 23.9 33.0 35.6 27.6 36.1 46.7 30.2 31.2 43.4 22.6 38.8 24.6 27.0 70.9 21.8 23.2 32.8 21.7 27.9 41.4 33.1 31.0 22.7 42.0 24.1 44.5 34.4 29.2 30.8 46.0 18.9 29.7 21.3 26.1 25.7 24.3 21.7 41.5 24.0 134.9 27.4 56.7 19.0 25.2 25.9 28.3 42.0 20.9 44.1 26.2 42.2 29.1 20.0 26.9 11.4 10.7 28.3 10.6 11.3 12.1 4.5 36.8 40.7 22.3 31.3 30.9 37.3 22.3 24.3 32.6 33.3 30.2 35.2 20.0 31.6 23.0 27.7 26.8 26.6 17.4 26.0 25.8 26.8 21.2 11.5 22.2 38.9 47.3 21.1 24.3 41.1 25.3 23.4 31.2 44.6 29.4 28.8 22.0 62.4 28.0 46.3 41.8 29.7 25.5 27.2 29.6 32.0 14.7 36.1 29.1 23.7 30.3 30.2 22.3 30.9 75.8 26.9 23.8 36.4 25.9 27.3 23.8 69.8 37.4 62.8 38.0 22.1 42.4 38.2 46.8 15.2 9.1 28.3 11.9 10.6 9.7 8.9 9.7 12.1 10.7 11.4 8.9 11.6 14.4 11.3 8.7 6.0 9.2 4.5 35.6 36.1 31.2 43.4 33.1 31.0 34.4 29.2 26.1 20.9 8.9 38.8 57.0 73.8 31.5 79.0 54.9 17.8 10.7 19.4 38.4 39.3 23.7 124.3 17.7 223.1 33.7 242.0 0.0 38.5 28.5 33.0 88.2 19.6 43.1 46.2 114.4 60.6 34.4 35.6 596.7 33.1 29.7 40.5 12.6 77.6 82.3 41.7 90.9 21.5 75.0 82.4 25.8 32.5 25.9 14.5 55.8 29.7 45.4 69.4 97.8 MAP3K1 "MAPKKK1, MEKK, MEKK1" ENSG00000095015 "Mitogen-activated protein kinase kinase kinase 1" Q13233 5 56815574-56896152 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 27.5;THP-1: 25.7" "Region enriched" "Detected in many" 6 "olfactory region: 22.5" "Low region specificity" "Detected in all" "CAB004500, HPA046509" Approved Approved Cytosol NA NA Cytosol "CAB004500: AB_627926, HPA046509: AB_2679678" "unprognostic (1.77e-1)" "unprognostic (1.71e-2)" "unprognostic (4.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.48e-2)" "unprognostic (5.39e-3)" "unprognostic (5.20e-3)" "unprognostic (2.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (6.73e-2)" "unprognostic (1.97e-3)" "unprognostic (2.18e-2)" "unprognostic (1.58e-1)" "unprognostic (9.92e-3)" "unprognostic (1.11e-1)" 6.7 4.9 5.4 14.6 4.8 15.2 14.9 8.0 4.5 7.6 6.7 5.4 7.3 4.3 7.1 9.4 12.7 7.2 5.9 4.3 3.7 3.2 9.5 4.4 8.8 21.4 6.4 3.1 8.4 9.2 6.3 7.9 8.1 4.5 8.3 4.5 12.6 15.4 9.7 3.5 21.8 11.2 4.0 3.8 21.3 5.5 8.5 5.1 11.7 19.2 6.6 18.2 6.0 11.7 6.6 2.8 6.7 7.2 2.7 5.8 2.3 6.6 4.0 6.3 4.2 1.0 0.8 10.6 1.3 1.7 4.0 5.6 18.7 5.0 5.9 0.4 1.5 3.4 3.4 5.2 2.3 5.6 2.0 2.3 3.3 1.8 8.8 2.5 5.2 9.2 1.0 2.5 1.2 2.0 1.1 1.7 2.0 2.8 10.7 1.0 2.9 3.6 7.1 2.9 3.4 0.5 5.7 4.4 20.3 7.0 6.9 2.6 27.5 3.9 4.9 11.2 5.8 13.4 25.7 5.0 0.4 3.4 1.5 2.4 7.8 4.0 11.3 0.6 3.1 6.8 6.7 4.5 1.0 1.2 6.8 1.2 6.6 3.8 1.8 2.8 5.1 2.5 0.9 2.6 2.7 7.2 1.5 5.8 2.3 5.4 4.8 8.0 4.5 3.7 3.2 6.4 3.1 4.5 5.1 6.0 9.8 47.7 14.5 46.5 15.2 2.7 50.9 4.0 12.5 34.9 45.2 12.9 6.6 14.2 1.6 13.5 6.6 0.0 12.8 7.7 11.3 11.9 7.0 12.1 26.3 27.0 9.8 17.2 81.7 1.9 4.9 40.3 35.4 45.9 10.1 10.6 13.0 7.0 1.8 20.1 34.7 6.5 5.2 10.0 15.0 47.8 5.6 16.6 8.9 10.0 MAP3K19 "FLJ23074, RCK, YSK4" ENSG00000176601 "Mitogen-activated protein kinase kinase kinase 19" Q56UN5 2 134964491-135047468 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.3;fallopian tube: 23.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 151.3;Early spermatids: 55.2;Late spermatids: 74.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8" "Region enhanced" "Detected in many" "pons and medulla: 18.3" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.5" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.1;U-266/70: 2.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 20.2" HPA011388 Uncertain Cytosol NA NA Cytosol "HPA011388: AB_1848822" "unprognostic (7.12e-3)" "unprognostic (6.55e-3)" "unprognostic (6.96e-2)" "unprognostic (3.90e-3)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (1.96e-1)" "unprognostic (9.38e-2)" "unprognostic (1.09e-1)" "unprognostic (4.33e-1)" "unprognostic (2.02e-2)" "unprognostic (1.32e-1)" "unprognostic (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (2.83e-4)" 0.1 0.2 1.7 0.2 6.2 0.1 0.1 0.0 0.5 1.1 0.2 7.3 0.0 0.2 1.0 6.7 0.2 23.9 0.1 0.1 2.9 3.8 0.2 0.2 5.6 0.2 0.5 1.5 7.3 0.1 0.1 1.0 0.1 18.3 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.2 7.6 3.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 4.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.7 6.2 0.0 0.5 2.9 3.8 0.5 1.5 18.3 3.1 0.0 0.6 0.0 0.0 0.0 0.2 0.4 0.0 151.3 17.0 0.0 9.8 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 74.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.1 0.0 0.0 0.0 0.0 0.1 MAP3K20 "MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK" ENSG00000091436 "Mitogen-activated protein kinase kinase kinase 20" Q9NYL2 2 173075435-173268010 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 35.7;Alveolar cells type 2: 51.9;Cytotrophoblasts: 48.5;Ductal cells: 34.2;Pancreatic endocrine cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 13.7" "Group enriched" "Detected in many" 5 "dendritic cells: 13.7;monocytes: 8.0" "Cell line enhanced" "Detected in many" "hTERT-HME1: 44.9;U-138 MG: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017205 Approved Supported Cytosol NA NA Cytosol "HPA017205: AB_1858933" "unprognostic (2.90e-2)" "unprognostic (9.99e-3)" "unprognostic (4.63e-3)" "unprognostic (1.98e-1)" "unprognostic (7.63e-2)" "unprognostic (5.02e-2)" "unprognostic (2.34e-2)" "unprognostic (3.89e-3)" "unprognostic (2.83e-2)" "unprognostic (9.27e-2)" "unprognostic (4.54e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.41e-6)" "unprognostic (2.34e-1)" "unprognostic (1.86e-1)" "unprognostic (2.23e-1)" "unprognostic (1.19e-2)" 21.7 5.0 2.9 7.4 3.3 0.8 9.2 2.8 3.1 25.7 24.8 2.1 10.7 3.1 30.2 15.4 26.2 13.1 14.9 52.5 3.5 3.0 2.4 8.5 7.5 2.5 4.5 3.0 21.7 4.4 22.6 3.1 6.9 4.2 25.6 5.4 11.5 6.7 15.8 96.1 5.8 8.0 68.4 4.7 3.7 15.8 6.6 3.5 2.8 6.7 38.0 4.9 46.7 24.0 2.1 13.7 2.3 8.0 0.4 1.6 2.7 8.9 7.5 5.9 7.8 17.3 25.8 3.7 32.3 25.3 15.1 16.3 5.1 5.9 6.9 8.5 32.3 13.3 6.1 8.8 17.1 34.1 13.4 5.9 11.2 8.5 1.0 6.9 10.0 11.9 20.7 7.4 28.4 44.9 12.6 10.0 7.6 5.0 1.3 9.9 3.8 6.3 5.0 3.3 7.5 4.3 9.3 12.1 0.0 3.7 5.1 3.5 3.4 12.4 3.0 5.3 10.1 3.4 5.4 10.0 48.3 19.8 14.3 7.3 0.0 0.0 1.4 34.7 2.7 5.0 0.1 8.0 0.0 0.9 7.5 0.9 1.5 0.8 1.6 13.7 2.1 0.0 0.8 2.3 0.4 6.6 0.3 0.7 2.7 2.9 3.3 2.8 3.1 3.5 3.0 4.5 3.0 4.2 3.5 35.7 51.9 0.0 0.0 0.0 0.0 0.0 0.0 24.1 13.6 10.4 0.0 48.5 1.7 34.2 0.0 0.0 0.0 0.0 23.2 22.4 0.0 0.0 4.7 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 27.1 0.0 0.0 31.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 MAP3K4 "KIAA0213, MAPKKK4, MEKK4, MTK1" ENSG00000085511 "Mitogen-activated protein kinase kinase kinase 4" Q9Y6R4 6 160991727-161117385 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007625 Uncertain Approved Cytosol NA NA Cytosol "HPA007625: AB_1853770" "unprognostic (3.05e-3)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (2.06e-1)" "unprognostic (7.65e-2)" "unprognostic (1.35e-3)" "unprognostic (6.38e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-3)" "unprognostic (2.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.16e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.93e-1)" "unprognostic (6.84e-2)" 12.0 8.0 13.1 17.7 12.6 9.1 14.6 23.1 14.0 16.4 13.9 9.3 12.2 9.5 22.2 11.9 21.4 14.1 11.4 12.4 11.9 7.8 9.4 8.2 15.9 14.4 12.8 8.9 17.4 12.1 15.8 16.2 12.4 9.2 14.2 9.8 9.4 15.0 15.4 24.4 15.1 13.3 13.9 7.7 10.6 11.1 13.5 12.4 16.2 10.6 13.0 16.8 15.8 23.9 8.8 5.4 17.5 3.8 3.5 8.9 2.2 4.7 5.4 10.3 8.8 6.4 7.5 6.7 5.4 4.8 6.2 6.6 7.7 3.5 9.8 3.9 13.7 8.9 11.9 10.5 10.8 7.6 7.1 8.6 12.8 5.0 7.5 4.9 13.2 6.2 4.7 12.6 6.5 5.9 9.7 8.1 7.4 32.2 11.3 6.6 4.9 8.9 6.7 6.3 3.4 8.3 9.8 9.5 7.8 5.7 3.5 5.9 5.3 10.1 10.8 0.9 9.4 4.4 16.2 7.5 7.6 9.8 7.1 25.5 6.6 5.3 9.0 9.0 13.7 8.0 17.5 3.8 2.3 5.0 3.0 8.9 6.2 7.1 4.5 4.3 8.8 5.0 4.9 0.2 3.5 1.7 5.4 4.8 2.2 13.1 12.6 23.1 14.0 11.9 7.8 12.8 8.9 9.2 12.4 17.9 12.6 14.2 8.2 8.8 15.7 17.9 10.2 8.1 19.4 14.0 21.6 16.7 3.3 8.0 2.6 11.3 5.9 0.0 6.5 9.4 7.8 10.8 3.5 7.3 6.4 22.3 14.8 4.3 7.0 2.5 10.6 9.0 0.0 18.0 9.4 18.9 9.7 7.0 11.7 5.9 28.6 6.5 8.0 13.5 29.6 10.3 27.7 12.1 10.9 12.9 MAP3K5 "ASK1, MAPKKK5, MEKK5" ENSG00000197442 "Mitogen-activated protein kinase kinase kinase 5" Q99683 6 136557047-136792518 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 55.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007824, HPA063245" Supported Supported Cytosol NA NA Cytosol "CAB007824: AB_598175, HPA063245: AB_2684969" "unprognostic (1.37e-1)" "unprognostic (3.21e-2)" "unprognostic (2.85e-2)" "unprognostic (1.38e-1)" "unprognostic (3.19e-1)" "prognostic favorable (6.08e-4)" "unprognostic (8.76e-2)" "unprognostic (1.41e-2)" "unprognostic (2.84e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.91e-4)" "unprognostic (3.97e-1)" "unprognostic (3.75e-2)" "unprognostic (1.37e-1)" "unprognostic (2.72e-1)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 7.7 55.6 13.0 7.5 17.6 7.6 5.5 12.9 12.7 4.0 5.4 6.9 3.6 4.6 7.2 5.1 6.4 6.1 4.9 7.3 11.8 6.8 6.8 5.5 7.7 8.8 8.2 6.4 32.4 28.2 1.5 9.9 3.4 7.9 11.6 6.2 5.8 4.2 4.9 3.7 5.0 4.6 4.3 7.5 9.8 8.7 7.3 8.6 2.0 10.0 3.4 9.0 10.8 18.9 2.5 2.5 8.5 3.0 4.1 7.0 1.4 2.9 1.8 0.0 0.0 4.2 11.3 1.0 4.2 22.7 2.2 2.1 0.1 3.0 1.7 6.2 5.8 1.6 4.0 7.2 2.1 5.7 2.3 5.7 15.0 4.0 0.0 20.1 6.9 0.0 14.8 2.8 3.4 9.8 8.4 7.3 2.1 3.7 16.8 15.3 5.6 0.1 5.9 0.7 5.7 2.4 3.9 4.8 6.8 8.8 18.6 5.3 3.5 3.5 3.4 0.9 0.8 0.7 6.2 6.3 3.6 1.1 0.2 3.9 13.7 9.1 0.0 2.8 9.8 3.2 5.7 3.0 3.3 2.7 2.3 4.9 2.0 4.3 3.7 2.5 2.5 0.4 1.4 8.5 4.1 2.1 2.4 7.0 1.4 13.0 17.6 12.9 9.4 11.8 6.8 8.2 6.4 7.9 8.6 6.0 22.4 10.4 17.9 4.4 17.5 21.8 2.5 16.0 34.2 10.4 5.9 0.7 3.3 2.1 4.9 3.8 7.7 0.0 19.7 0.9 5.1 22.3 5.7 9.6 7.1 0.0 33.5 9.8 22.1 2.3 21.9 18.4 0.0 1.0 12.1 42.4 18.9 5.8 13.4 6.8 2.5 12.9 8.0 1.4 15.0 8.8 2.3 6.9 10.0 19.3 MAP3K8 "c-COT, COT, EST, ESTF, MEKK8, Tpl-2" ENSG00000107968 "Mitogen-activated protein kinase kinase kinase 8" P41279 10 30433937-30461833 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 104.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 133.3;Urothelial cells: 168.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005120, HPA017962" Supported Supported Cytosol NA NA Cytosol "CAB005120: AB_2140669, HPA017962: AB_1853776" "unprognostic (1.91e-2)" "unprognostic (2.94e-1)" "unprognostic (3.07e-1)" "unprognostic (9.29e-2)" "unprognostic (6.73e-2)" "unprognostic (1.00e-2)" "unprognostic (1.44e-1)" "unprognostic (3.36e-2)" "unprognostic (1.41e-2)" "unprognostic (8.04e-3)" "unprognostic (8.23e-2)" "unprognostic (2.96e-1)" "prognostic unfavorable (8.76e-7)" "unprognostic (1.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.63e-2)" "unprognostic (5.98e-3)" 28.0 7.6 3.6 15.6 4.1 104.6 26.1 1.5 2.6 8.2 8.4 2.7 11.3 3.4 11.5 16.5 13.8 19.5 15.3 20.1 4.3 2.9 6.3 7.6 29.0 33.7 4.3 2.0 9.8 3.6 2.8 4.1 27.5 8.3 7.9 6.8 9.4 6.1 18.4 8.6 15.3 9.6 23.4 9.7 25.6 10.7 6.7 3.6 2.4 7.0 13.2 17.2 13.2 15.6 19.6 13.8 23.7 16.8 12.4 7.8 4.0 8.0 7.2 2.0 4.2 10.5 8.8 9.3 2.0 12.1 4.5 5.4 5.0 18.8 5.3 5.2 4.3 4.4 15.2 4.5 1.9 1.6 12.3 2.3 9.9 12.3 16.0 8.9 3.1 24.4 11.0 1.1 4.5 0.9 4.5 2.0 0.1 4.4 8.0 0.7 4.6 0.1 11.8 0.7 4.3 2.6 0.6 1.6 3.0 4.4 16.4 0.2 0.8 7.2 6.2 0.9 5.7 2.1 6.6 0.1 2.8 2.4 9.9 0.3 12.1 11.3 1.6 4.0 13.4 0.1 17.9 7.0 23.7 7.8 12.0 4.3 9.6 1.7 4.9 6.6 19.6 0.1 3.0 16.7 12.4 16.8 13.8 0.4 4.0 3.6 4.1 1.5 2.6 4.3 2.9 4.3 2.0 8.3 3.6 35.7 41.7 14.7 46.9 103.8 13.9 7.1 5.1 25.4 13.6 3.5 0.0 23.9 1.7 25.2 0.4 36.9 5.2 0.0 9.8 71.1 77.1 32.5 71.4 3.0 109.0 0.0 11.5 14.1 86.6 0.0 7.8 94.5 40.5 78.5 5.3 5.0 17.6 17.5 3.9 2.4 1.1 6.5 75.4 0.0 0.7 74.2 133.3 52.3 5.8 168.4 MAP6D1 "FLJ12748, SL21" ENSG00000180834 "MAP6 domain containing 1" Q9H9H5 3 183815876-183825594 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 48.1;skeletal muscle: 33.5" "Cell type enhanced" "Detected in some" 5 "Early spermatids: 2.4;Glandular cells: 2.6;Intestinal endocrine cells: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 5 "T-cells: 2.7" "Cell line enriched" "Detected in many" 5 "T-47d: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037991 Enhanced Supported Approved Cytosol NA NA Cytosol "HPA037991: AB_10672503" "unprognostic (9.23e-3)" "unprognostic (2.70e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-1)" "unprognostic (1.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (8.81e-12)" "unprognostic (1.08e-1)" "unprognostic (2.96e-3)" "unprognostic (1.86e-1)" "unprognostic (5.72e-2)" 1.1 1.2 11.8 1.5 16.0 1.1 2.0 30.9 32.1 1.5 1.4 48.1 0.0 1.9 1.4 2.0 1.1 1.5 1.3 1.9 18.8 9.2 1.2 1.3 1.4 1.7 24.7 8.7 1.7 6.0 1.8 0.5 1.3 18.4 2.7 1.4 0.0 1.6 2.0 33.5 4.6 1.5 1.4 37.7 1.5 1.2 1.3 20.4 2.2 1.1 0.0 1.4 1.1 0.2 0.5 0.3 0.2 0.2 0.0 2.7 0.3 1.9 1.4 2.2 0.4 0.5 0.7 1.7 2.4 0.4 4.6 3.1 1.8 0.1 0.2 3.1 3.6 2.3 1.4 4.5 1.2 3.1 1.3 6.8 0.2 0.0 0.0 1.3 2.4 0.8 0.3 0.3 1.1 0.4 0.6 0.9 3.6 0.3 0.0 0.6 8.4 5.9 3.4 2.0 1.1 3.9 2.9 3.4 0.0 0.2 0.0 7.2 1.3 1.8 1.3 2.5 1.6 39.9 2.4 0.4 1.1 1.6 1.6 3.5 1.5 0.9 1.1 0.3 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.5 2.7 0.3 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.3 11.8 16.0 30.9 19.9 18.8 9.2 24.7 8.7 18.4 20.4 0.0 0.0 0.0 0.5 1.0 2.2 1.3 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.4 0.5 2.6 0.0 0.0 0.8 1.6 2.4 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.4 1.7 1.3 0.6 0.0 0.3 0.6 MAPK6 "ERK3, HsT17250, p97MAPK, PRKM6" ENSG00000069956 "Mitogen-activated protein kinase 6" Q16659 15 51952106-52067372 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005184, HPA030262, HPA047825" Approved Supported Supported Cytosol NA NA Cytosol "CAB005184: AB_2140298, HPA030262: AB_10601868, HPA047825: " "unprognostic (6.61e-2)" "unprognostic (1.75e-2)" "unprognostic (5.05e-2)" "unprognostic (3.40e-3)" "unprognostic (2.72e-1)" "unprognostic (5.52e-2)" "unprognostic (6.13e-2)" "unprognostic (2.32e-3)" "unprognostic (3.99e-2)" "unprognostic (8.54e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-2)" "unprognostic (3.27e-3)" "unprognostic (2.03e-1)" "unprognostic (1.72e-1)" "unprognostic (3.07e-2)" "unprognostic (2.31e-2)" 11.8 7.4 14.4 10.9 23.2 25.6 13.7 33.0 24.5 16.3 18.7 12.5 9.3 16.3 15.9 13.3 32.3 8.2 17.0 9.1 13.3 15.9 14.4 32.6 12.6 9.4 13.1 16.8 11.5 8.5 12.2 15.3 13.9 23.8 10.5 18.1 9.5 17.9 11.4 27.1 24.0 26.2 17.8 14.2 9.2 15.7 25.7 13.0 11.7 13.4 22.7 12.4 18.9 22.4 4.9 4.2 3.0 4.5 6.5 7.9 3.6 8.7 11.8 23.3 8.9 7.2 11.9 17.1 12.6 12.7 11.6 13.7 14.1 5.3 12.6 8.8 16.1 17.0 12.4 17.9 23.9 15.9 7.7 5.6 18.8 7.0 22.4 17.5 14.0 40.2 12.7 44.0 14.0 36.5 12.4 10.9 8.7 24.3 21.6 14.8 19.8 9.8 11.1 8.3 10.9 5.7 8.6 15.0 20.3 11.1 36.9 11.5 10.8 10.1 8.3 18.3 33.7 7.5 20.9 10.8 13.9 15.0 9.0 16.7 11.2 32.9 15.7 17.2 20.6 17.0 3.0 4.5 1.2 3.8 4.3 4.7 4.9 5.6 4.3 4.2 2.6 5.4 3.8 0.6 6.5 2.8 1.9 7.9 3.6 14.4 23.2 33.0 24.3 13.3 15.9 13.1 16.8 23.8 13.0 26.8 29.8 23.8 84.4 99.5 34.6 20.2 22.9 24.1 29.6 15.7 15.7 14.3 14.9 31.8 133.3 22.8 95.4 0.0 43.1 33.7 40.4 80.6 139.2 47.8 25.7 31.8 29.7 16.5 30.7 167.7 21.0 26.7 28.7 11.8 32.2 25.1 52.1 31.6 22.3 30.5 21.1 19.4 21.7 56.4 75.8 96.7 27.7 17.0 19.8 153.6 MARK4 "FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D" ENSG00000007047 "Microtubule affinity regulating kinase 4" Q96L34 19 45079288-45305283 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039186 Approved Supported Cytosol NA NA Cytosol "HPA039186: AB_10796223" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (8.31e-8)" "unprognostic (2.02e-1)" "prognostic unfavorable (3.05e-5)" "unprognostic (1.90e-1)" "unprognostic (2.16e-2)" "unprognostic (6.26e-2)" "unprognostic (5.64e-3)" "unprognostic (1.24e-3)" "unprognostic (7.50e-2)" "unprognostic (3.80e-2)" "unprognostic (6.89e-2)" "unprognostic (7.23e-2)" "unprognostic (4.65e-2)" "unprognostic (3.02e-2)" 11.8 13.0 19.4 10.3 26.0 8.4 15.2 21.9 28.6 11.4 10.2 9.0 12.9 6.6 14.0 17.5 13.5 12.9 13.4 14.7 22.2 15.7 8.7 13.5 11.7 10.5 14.3 21.6 21.0 16.8 13.7 12.9 12.1 15.0 12.2 6.3 14.1 12.1 14.2 40.7 20.6 7.5 14.1 10.8 12.4 10.3 32.1 12.3 11.2 10.5 11.5 9.4 13.7 17.9 1.0 2.8 3.5 2.9 1.8 4.3 1.2 8.9 3.8 15.1 11.0 10.8 17.2 4.2 6.6 10.4 9.9 9.3 2.3 5.1 4.3 5.7 12.1 8.2 6.1 10.7 9.7 5.6 7.9 8.8 8.6 4.7 8.2 19.9 2.1 7.5 21.4 13.8 8.3 9.6 17.5 13.2 9.6 10.9 10.8 10.7 7.5 7.6 6.7 6.5 7.4 3.3 29.6 4.9 2.8 9.3 7.2 28.4 12.5 9.8 8.7 5.1 15.3 4.1 12.5 10.7 8.9 6.8 6.0 4.3 12.1 9.6 4.9 9.5 4.0 7.1 3.5 2.9 0.7 3.4 2.2 0.7 0.9 1.2 4.3 0.8 1.0 2.3 2.6 2.9 1.8 2.0 2.8 2.4 1.2 19.4 26.0 21.9 22.7 22.2 15.7 14.3 21.6 15.0 12.3 11.9 1.9 3.0 9.5 22.1 20.9 7.3 10.2 0.0 2.3 8.7 23.6 3.3 10.0 7.8 2.1 10.5 3.3 0.0 5.3 1.1 7.5 8.5 2.3 10.9 5.8 112.8 5.8 18.4 8.4 4.1 15.0 6.1 3.3 2.8 6.0 13.2 7.3 3.2 13.1 5.6 14.6 0.0 7.3 0.5 6.1 21.1 9.6 6.9 3.4 14.0 MARS "CMT2U, MetRS, SPG70" ENSG00000166986 "Methionyl-tRNA synthetase" P56192 12 57475445-57517569 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 118.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004125, CAB017097" Supported Approved Enhanced Cytosol NA NA 21000 Cytosol "CAB017097: , HPA004125: AB_1079312" "prognostic unfavorable (1.73e-4)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.57e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (4.55e-7)" "unprognostic (8.47e-2)" "unprognostic (1.73e-1)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.13e-2)" "unprognostic (1.96e-1)" "unprognostic (1.13e-1)" "unprognostic (2.06e-2)" 23.8 26.7 35.1 27.3 29.1 23.0 19.8 25.1 36.0 17.4 23.9 23.1 23.9 17.3 23.3 36.3 29.5 17.9 16.1 25.0 28.0 29.5 20.5 45.9 24.3 25.1 40.1 25.5 25.8 48.3 35.7 34.0 22.2 30.9 25.6 24.7 19.8 26.0 30.0 24.5 18.4 20.1 33.7 30.7 30.7 31.3 29.6 30.9 21.4 26.9 22.3 34.3 24.3 27.9 12.9 29.3 19.0 27.0 14.1 18.9 15.5 16.8 23.4 15.7 27.1 17.6 10.7 28.9 24.1 28.2 25.5 27.3 25.1 18.7 29.6 16.0 29.2 15.9 19.2 35.7 31.1 26.8 25.6 15.5 20.9 8.7 14.1 39.2 31.4 24.0 15.5 48.4 29.2 75.7 12.2 18.2 37.8 32.3 63.4 17.7 23.3 28.1 23.7 29.6 27.0 25.8 24.4 118.3 30.6 19.2 13.2 20.9 21.3 12.5 19.3 33.4 18.4 25.4 41.2 13.5 9.2 27.3 13.3 14.3 58.2 58.8 35.7 22.7 23.9 31.5 12.1 14.6 19.0 18.9 27.0 17.2 12.9 12.9 17.1 29.3 7.7 11.1 15.2 7.2 14.1 21.8 28.4 13.1 15.5 35.1 29.1 25.1 36.0 28.0 29.5 40.1 25.5 30.9 30.9 35.7 22.7 29.8 15.6 16.6 14.8 10.1 12.7 28.1 29.6 17.4 31.4 24.6 5.0 32.2 19.0 13.7 11.1 0.0 39.9 18.6 15.5 18.1 26.7 11.3 17.0 6.4 14.5 8.0 12.0 6.6 12.0 22.6 3.3 32.5 10.3 11.5 33.5 14.0 14.2 9.8 28.8 12.9 17.9 33.4 34.1 14.1 31.8 20.3 9.7 23.1 MAST2 "KIAA0807, MAST205" ENSG00000086015 "Microtubule associated serine/threonine kinase 2" Q6P0Q8 1 45786987-46036124 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.3" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 43.3;Cone photoreceptor cells: 51.1;Enterocytes: 45.1;Late spermatids: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039722, HPA040155" Approved Approved Cytosol NA NA Cytosol "HPA039722: AB_10795294, HPA040155: AB_10793957" "unprognostic (7.80e-2)" "unprognostic (3.02e-2)" "unprognostic (5.77e-2)" "unprognostic (1.52e-1)" "unprognostic (3.82e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (4.31e-8)" "unprognostic (8.86e-2)" "unprognostic (2.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (6.85e-13)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (9.73e-2)" "unprognostic (4.90e-1)" 8.9 4.3 7.0 9.9 8.1 3.7 7.1 7.1 11.8 13.6 15.2 8.4 6.6 11.2 16.7 7.7 8.8 9.5 9.9 25.5 5.0 7.6 4.8 6.1 5.9 4.4 8.9 7.3 19.8 3.6 9.1 10.5 5.5 10.1 13.9 13.9 7.2 8.3 8.6 83.3 5.5 21.3 14.9 5.8 2.5 9.0 24.8 4.8 3.5 5.7 27.4 7.5 16.3 10.6 0.5 1.9 1.4 4.3 1.4 1.4 0.5 14.9 12.1 12.3 9.4 16.1 23.1 13.6 16.0 11.6 14.8 16.5 13.9 4.9 23.4 7.5 19.5 30.0 7.4 14.8 9.1 15.7 11.2 8.0 10.6 13.7 12.7 14.0 5.6 13.6 17.7 11.8 24.8 19.8 18.6 13.8 6.1 8.1 7.2 17.6 10.2 8.2 5.8 10.1 10.1 13.9 12.2 20.6 4.4 7.7 8.1 17.1 10.1 18.8 24.6 8.0 14.1 11.2 5.6 13.4 28.7 18.5 14.9 15.8 9.7 8.7 8.5 19.1 7.7 11.8 0.0 1.1 1.4 1.4 0.6 1.4 0.2 0.7 1.4 1.9 0.5 0.5 1.0 0.0 1.4 4.3 0.1 0.0 0.5 7.0 8.1 7.1 11.8 5.0 7.6 8.9 7.3 10.1 4.8 0.0 1.3 0.0 4.2 3.8 14.9 43.3 2.5 1.4 7.9 3.5 51.1 4.4 1.7 4.2 27.6 5.3 45.1 0.0 5.4 4.0 6.6 7.8 0.0 5.6 5.5 4.8 11.6 3.1 1.6 44.9 8.3 6.4 6.8 1.0 18.3 3.0 6.7 26.6 9.6 4.2 12.7 6.5 6.1 28.4 11.7 2.4 4.6 1.9 18.1 6.0 MB21D2 C3orf59 ENSG00000180611 "Mab-21 domain containing 2" Q8IYB1 3 192796815-192918161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 34.9" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 55.7;Syncytiotrophoblasts: 92.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 6.6;T-reg: 5.5" "Lineage enriched" "Detected in single" 10 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "HDLM-2: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044026 Approved Approved Cytosol NA NA Cytosol "HPA044026: AB_10962840" "unprognostic (3.52e-2)" "unprognostic (1.02e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (3.74e-5)" "unprognostic (2.42e-2)" "prognostic unfavorable (9.94e-4)" "unprognostic (2.76e-2)" "unprognostic (3.50e-2)" "unprognostic (1.53e-1)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-3)" "unprognostic (5.94e-3)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (3.28e-2)" 5.7 6.0 4.4 4.4 6.9 1.6 5.1 11.1 10.9 5.8 6.9 5.6 2.7 12.0 7.3 2.9 3.2 5.3 10.1 7.6 3.9 5.0 5.8 2.3 5.9 3.1 4.4 3.5 6.5 2.8 5.6 8.6 34.9 4.6 4.9 4.3 4.0 3.1 3.9 4.9 8.6 15.7 7.8 3.5 3.0 5.1 11.4 3.3 1.2 3.3 2.5 2.5 8.7 5.0 0.3 0.6 0.0 0.6 0.0 6.6 1.8 9.9 1.4 2.4 7.3 1.5 2.3 4.4 7.2 6.7 13.0 7.8 6.4 1.6 0.0 4.3 17.6 5.4 4.4 5.6 1.8 14.2 43.0 3.1 1.2 0.7 0.7 2.9 0.1 0.6 3.0 2.8 3.6 2.2 1.0 2.5 1.2 0.0 0.6 2.2 7.3 0.1 0.0 5.1 5.4 17.8 0.2 4.0 2.0 3.0 5.7 3.8 1.9 1.5 4.9 0.7 5.2 7.7 0.1 0.8 2.4 7.3 4.3 13.7 19.1 15.1 0.0 1.7 1.5 3.3 0.0 0.3 0.0 0.3 0.6 2.9 0.3 6.6 1.7 0.6 0.0 4.2 1.2 0.0 0.0 0.0 0.0 5.5 1.8 4.4 6.9 11.1 10.9 3.9 5.0 4.4 3.5 4.6 3.3 6.0 0.3 0.9 0.8 8.1 10.6 1.0 0.0 1.4 1.2 0.0 2.0 55.7 0.0 5.2 0.1 4.8 2.9 0.0 0.2 7.2 7.6 0.7 0.0 0.0 5.0 7.9 9.8 9.8 4.3 1.3 2.8 10.7 13.5 22.6 2.4 1.0 1.6 5.8 5.6 8.4 0.7 12.9 4.7 2.1 19.4 7.5 92.3 1.3 2.5 0.9 MBOAT7 "BB1, hMBOA-7, LENG4, LPIAT" ENSG00000125505 "Membrane bound O-acyltransferase domain containing 7" Q96N66 19 54173412-54189882 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0" "Lineage enriched" "Detected in many" 10 "granulocytes: 30.6" "Cell line enhanced" "Detected in many" "HMC-1: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055967 Approved Approved Cytosol NA NA Cytosol "HPA055967: AB_2682990" "unprognostic (1.89e-2)" "unprognostic (2.60e-2)" "unprognostic (2.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.54e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (5.55e-6)" "prognostic unfavorable (5.13e-4)" "unprognostic (5.36e-2)" "unprognostic (2.31e-2)" "unprognostic (1.08e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (6.62e-5)" "unprognostic (1.31e-1)" "unprognostic (4.75e-2)" "unprognostic (3.95e-1)" "prognostic favorable (4.31e-4)" 10.7 63.1 16.8 14.8 24.2 15.9 7.9 11.3 37.8 10.3 17.7 9.2 15.6 30.3 10.5 8.0 10.5 11.5 14.3 6.9 18.5 23.4 10.5 11.6 11.5 14.7 10.0 18.8 15.1 24.4 23.8 12.4 11.9 21.6 11.4 6.1 8.1 10.8 28.8 7.9 10.0 28.5 6.5 9.2 14.4 16.4 30.8 6.8 7.6 12.7 5.0 6.3 22.6 17.5 0.3 2.9 30.6 2.1 0.9 0.5 0.8 14.2 8.5 1.3 14.0 4.6 3.6 12.3 25.0 8.9 5.8 11.5 4.8 16.2 3.7 11.2 5.4 2.5 29.2 0.0 5.1 1.1 5.1 16.6 3.9 9.2 3.1 4.5 9.0 57.3 6.7 3.4 2.8 2.0 4.6 10.4 2.7 14.7 11.8 2.0 8.6 2.6 3.2 5.9 2.5 18.2 8.4 2.4 7.5 5.8 17.3 0.5 3.7 16.7 10.2 5.1 0.1 10.3 0.8 20.7 12.3 4.4 3.6 9.9 5.4 9.3 1.5 17.7 6.4 8.1 15.7 2.1 30.6 0.2 1.5 0.5 0.2 0.2 0.2 2.9 0.3 0.1 0.2 30.0 0.9 0.8 0.8 0.2 0.8 16.8 24.2 11.3 37.8 18.5 23.4 10.0 18.8 21.6 6.8 11.9 26.6 12.2 44.1 12.4 15.8 6.5 30.6 13.4 14.8 41.8 5.9 38.6 5.0 45.1 1.1 16.6 88.9 0.0 28.7 43.8 12.7 39.8 76.1 13.9 28.4 28.6 40.8 14.7 36.9 1.9 17.8 32.1 8.5 19.8 45.8 22.4 34.4 40.3 14.5 12.2 6.8 38.8 23.4 3.9 14.5 18.9 43.1 11.4 38.5 48.0 MCRIP1 "FAM195B, GRAN2, MCRIP" ENSG00000225663 "MAPK regulated corepressor interacting protein 1" C9JLW8 17 81822361-81833302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 209.6;Extravillous trophoblasts: 120.1;Hofbauer cells: 139.9;Pancreatic endocrine cells: 110.1;Proximal tubular cells: 118.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045542 Approved Approved Cytosol NA NA Cytosol "HPA045542: AB_2679363" "unprognostic (3.11e-3)" "unprognostic (3.82e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-3)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" "unprognostic (3.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (9.08e-3)" "prognostic favorable (2.26e-4)" "unprognostic (2.53e-2)" "unprognostic (3.65e-2)" "unprognostic (4.84e-2)" "unprognostic (1.64e-1)" "unprognostic (2.87e-1)" "unprognostic (1.86e-1)" 34.8 29.8 43.1 23.9 29.9 32.2 19.7 27.4 47.8 20.9 29.4 23.3 13.9 12.9 26.3 19.6 20.2 28.2 25.9 46.0 36.4 32.8 21.9 17.9 21.3 28.6 37.0 34.6 28.5 36.3 11.9 22.8 25.4 34.3 24.1 5.6 18.3 33.6 24.7 25.4 11.1 14.2 22.5 32.4 24.3 16.8 35.9 27.4 33.3 29.0 14.2 11.2 28.0 19.9 33.2 37.4 49.8 40.7 23.6 38.2 33.7 13.1 20.7 23.1 24.3 15.0 17.5 18.2 15.7 11.4 19.3 21.2 5.4 13.2 8.2 9.2 13.2 7.1 3.0 2.7 9.4 4.6 8.8 29.4 14.4 3.5 20.8 15.2 9.4 13.4 19.0 9.4 10.9 4.7 10.4 34.3 19.1 11.5 7.1 12.8 8.7 30.3 22.7 14.3 5.4 12.0 12.0 14.8 3.7 6.5 11.9 19.7 61.6 7.7 10.2 47.7 9.4 9.1 13.0 20.8 27.4 29.2 29.9 28.4 3.7 1.1 5.3 25.5 8.7 21.6 49.8 30.5 40.1 38.2 39.1 29.0 23.3 29.9 33.9 27.4 33.2 24.5 28.0 23.5 23.6 40.7 37.4 35.0 33.7 43.1 29.9 27.4 47.8 36.4 32.8 37.0 34.6 34.3 27.4 17.9 37.8 0.0 0.0 0.0 0.0 0.0 0.0 25.4 20.5 36.6 0.0 100.3 63.0 86.4 0.0 0.0 0.0 0.0 209.6 120.1 0.0 0.0 18.6 0.0 139.9 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 85.6 0.0 0.0 110.1 0.0 0.0 118.3 0.0 0.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 METTL13 "CGI-01, KIAA0859" ENSG00000010165 "Methyltransferase like 13" Q8N6R0 1 171781664-171814023 "Predicted intracellular proteins" "Methyltransferase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044498, HPA053705" Approved Approved Cytosol NA NA Cytosol "HPA044498: AB_10960884, HPA053705: AB_2682235" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" "unprognostic (8.30e-2)" "unprognostic (2.76e-1)" "unprognostic (3.78e-1)" "unprognostic (4.40e-1)" "prognostic unfavorable (5.68e-4)" "unprognostic (1.86e-1)" "unprognostic (3.12e-1)" "unprognostic (8.83e-2)" "unprognostic (1.16e-1)" "unprognostic (3.65e-1)" "unprognostic (4.12e-1)" "unprognostic (6.86e-3)" "unprognostic (7.49e-2)" "unprognostic (3.01e-1)" "unprognostic (1.13e-1)" 13.0 20.7 18.3 13.3 17.8 9.0 14.7 19.0 21.8 14.6 13.6 14.7 13.6 15.1 16.5 24.8 14.9 16.2 11.2 11.7 14.1 10.9 13.2 16.9 15.1 15.9 16.3 17.9 15.3 16.0 14.0 11.0 11.4 14.7 12.6 15.1 11.7 19.2 14.5 18.4 14.2 14.0 15.4 11.4 16.8 14.7 18.9 16.2 16.3 13.1 9.4 17.7 13.7 12.6 10.2 10.0 3.2 8.7 11.5 12.0 7.8 11.8 28.2 7.4 7.8 10.8 9.9 20.5 15.0 11.8 18.2 14.2 21.2 12.3 21.9 18.0 10.4 11.9 12.2 23.1 12.0 14.3 14.0 13.2 15.1 14.6 9.3 8.0 19.8 15.4 8.6 11.2 18.9 8.3 8.3 10.8 11.9 30.2 7.5 13.8 9.0 15.8 13.6 29.0 23.9 38.2 14.6 10.0 20.0 10.5 12.2 12.5 17.1 11.1 25.8 13.7 19.5 18.8 17.6 8.9 12.3 11.3 12.4 17.6 19.5 21.8 25.2 9.3 13.8 10.9 1.8 8.7 3.2 9.9 8.5 11.5 10.2 9.9 8.4 8.6 8.0 9.1 12.0 2.6 11.5 7.4 10.0 7.4 7.8 18.3 17.8 19.0 21.8 14.1 10.9 16.3 17.9 14.7 16.2 8.9 3.2 7.7 6.4 7.6 7.2 7.5 20.4 6.7 5.7 3.5 5.9 14.0 10.0 17.2 33.4 10.5 9.8 0.0 13.4 20.0 7.6 8.6 9.2 11.6 15.1 4.8 10.4 11.6 14.9 8.4 9.2 8.5 3.3 12.6 11.5 8.1 16.0 7.0 7.4 10.9 6.9 12.9 7.2 4.7 14.5 7.9 8.0 7.2 11.1 7.5 METTL8 "FLJ13984, TIP" ENSG00000123600 "Methyltransferase like 8" Q9H825 2 171317405-171434802 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035421 Uncertain Approved Cytosol NA NA Cytosol "HPA035421: AB_10670116" "unprognostic (3.13e-1)" "unprognostic (2.72e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.76e-1)" "unprognostic (3.76e-1)" "unprognostic (1.43e-4)" "unprognostic (2.94e-3)" "unprognostic (7.29e-2)" "unprognostic (6.52e-3)" "unprognostic (4.83e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (6.75e-4)" "unprognostic (1.45e-1)" "unprognostic (2.04e-1)" "unprognostic (2.10e-3)" "unprognostic (2.59e-3)" 10.8 8.0 7.4 8.4 9.6 6.8 8.8 6.2 8.5 9.4 12.6 10.4 9.2 4.6 8.4 6.3 21.0 5.9 7.2 6.7 8.7 6.4 8.6 8.6 5.5 6.0 13.2 4.5 6.4 8.1 6.1 5.0 7.8 10.9 10.9 14.1 5.2 6.2 11.6 6.9 15.1 8.2 20.5 12.5 7.8 6.3 11.2 10.1 4.0 4.7 13.5 8.9 13.7 10.3 6.6 10.1 1.2 4.4 7.0 7.5 3.6 8.4 6.4 3.1 9.5 10.4 12.4 17.2 10.5 8.0 9.9 12.4 14.0 11.8 17.5 8.4 5.0 8.5 8.6 11.2 17.1 12.5 9.2 5.8 9.7 5.7 19.7 8.4 14.8 7.5 12.2 18.9 15.7 24.7 2.5 19.5 9.3 17.9 4.0 13.5 9.2 10.4 3.6 13.1 7.4 5.8 5.5 12.2 19.0 7.4 8.3 11.5 4.5 11.1 8.5 7.7 5.4 6.1 5.6 9.6 8.7 6.8 6.1 5.8 2.1 9.3 10.6 6.9 10.5 9.0 0.8 3.0 0.9 5.4 4.4 7.5 4.3 6.3 5.0 4.0 6.6 2.9 3.3 1.2 7.0 2.1 10.1 6.3 3.6 7.4 9.6 6.2 8.5 8.7 6.4 13.2 4.5 10.9 10.1 6.0 6.7 33.5 8.2 22.7 7.5 7.5 17.8 8.1 17.0 3.5 2.0 14.4 10.0 7.3 11.1 8.1 7.4 23.3 5.3 17.3 10.8 7.0 5.8 8.6 10.6 11.1 6.4 5.5 9.4 2.9 13.0 11.6 10.1 7.2 4.2 7.7 7.5 2.9 15.2 14.4 9.6 6.5 10.5 6.1 18.1 23.3 10.8 12.5 12.5 8.1 MEX3A "RKHD4, RNF162" ENSG00000254726 "Mex-3 RNA binding family member A" A1L020 1 156072013-156081998 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 7.2;ovary: 10.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8;Ductal cells: 9.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 13 "B-cells: 1.4" "Cell line enhanced" "Detected in many" "AF22: 25.4;NTERA-2: 23.1;SCLC-21H: 24.1;SH-SY5Y: 43.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062703 Supported Cytosol NA NA Cytosol "HPA062703: AB_2684840" "unprognostic (8.63e-2)" "unprognostic (2.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.55e-3)" "unprognostic (6.18e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.23e-8)" "unprognostic (4.25e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.96e-1)" "unprognostic (1.08e-3)" "unprognostic (4.73e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" "unprognostic (4.96e-2)" 0.4 0.2 1.8 1.0 1.8 0.8 2.5 3.3 5.1 2.5 1.3 1.4 0.2 0.7 7.2 0.7 1.4 1.7 1.1 0.2 3.5 1.0 1.1 1.8 0.6 3.4 1.9 2.1 10.1 0.6 0.4 0.4 0.8 2.2 1.7 1.0 1.0 2.0 0.6 0.2 0.7 0.6 1.7 1.0 1.4 0.5 3.1 2.0 3.6 1.5 0.2 1.1 1.9 1.4 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 25.4 6.3 0.3 0.4 3.0 0.6 0.1 1.0 0.9 1.4 0.3 0.8 3.0 0.3 0.6 0.5 11.0 0.4 1.2 1.2 3.0 0.6 1.1 2.5 0.5 0.3 0.5 0.7 0.8 0.5 0.4 2.6 4.8 5.8 5.7 0.0 1.4 1.6 2.9 0.4 23.1 1.0 3.3 9.3 2.0 0.1 0.8 1.1 24.1 43.9 0.7 2.8 1.5 11.1 4.9 1.9 1.6 1.6 3.9 0.4 1.4 0.6 0.4 1.3 0.1 0.7 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.8 3.3 2.0 3.5 1.0 1.9 2.1 2.2 2.0 0.0 0.3 0.0 2.6 3.5 1.6 0.8 0.0 2.7 0.0 0.0 9.8 0.6 1.7 9.9 0.1 6.0 0.0 0.0 1.3 1.8 2.8 2.1 0.0 5.6 1.7 3.2 5.8 7.4 1.5 0.0 4.6 0.0 5.0 0.0 0.5 1.4 4.2 0.0 1.1 7.5 2.7 0.0 2.7 0.0 2.7 3.0 0.2 0.0 2.2 1.1 MFGE8 "BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10" ENSG00000140545 "Milk fat globule-EGF factor 8 protein" Q08431 15 88898683-88913411 "Cancer-related genes, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Fertilization" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 363.2;Rod photoreceptor cells: 972.8;Sertoli cells: 1067.2;Smooth muscle cells: 475.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 13.3" "Group enriched" "Detected in many" 6 "granulocytes: 3.6;NK-cells: 6.3;T-cells: 13.3" "Cell line enhanced" "Detected in many" "ASC diff: 181.9;ASC TERT1: 94.5;fHDF/TERT166: 64.0;HSkMC: 95.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002753, HPA002807" Enhanced Approved Cytosol "Secreted to blood" NA NA 2830000 1100000 Cytosol "CAB002753: , HPA002807: AB_1078072" "unprognostic (1.28e-1)" "unprognostic (1.23e-1)" "unprognostic (1.63e-2)" "unprognostic (7.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.11e-3)" "unprognostic (6.27e-2)" "unprognostic (8.49e-2)" "unprognostic (3.99e-1)" "prognostic unfavorable (6.06e-9)" "prognostic unfavorable (3.08e-4)" "unprognostic (4.85e-2)" "unprognostic (7.36e-3)" "unprognostic (2.41e-3)" 34.2 23.2 5.4 14.5 11.2 0.9 73.4 5.7 14.8 43.4 15.8 9.6 11.3 5.2 73.2 38.6 32.8 56.2 30.2 115.4 5.6 4.1 12.4 3.9 20.8 14.9 6.0 8.3 49.8 6.6 2.9 8.1 23.1 10.8 29.5 7.3 59.5 15.6 50.7 57.8 18.3 15.4 39.6 8.8 6.5 22.2 23.6 4.4 8.5 21.7 21.1 12.6 32.8 68.3 1.2 0.0 3.6 0.2 6.3 13.3 2.0 1.8 7.1 7.8 9.5 181.9 94.5 0.6 46.9 14.0 9.4 11.2 6.2 2.2 0.0 14.5 64.0 14.1 0.9 2.7 9.3 3.1 7.5 4.7 13.6 0.4 0.6 47.9 0.0 4.8 95.7 25.0 7.4 12.4 20.5 3.6 3.4 2.1 4.1 18.2 0.1 2.1 0.3 39.9 0.7 2.5 2.1 7.4 2.4 3.3 0.6 0.8 4.1 2.5 0.2 21.2 17.1 0.2 1.0 3.9 23.4 12.6 6.0 3.4 14.4 2.8 1.4 3.1 1.1 9.0 3.6 0.2 0.4 1.2 0.0 4.2 1.2 4.2 3.0 0.0 0.8 4.4 3.1 0.0 6.3 0.1 0.0 13.3 2.0 5.4 11.2 5.7 14.8 5.6 4.1 6.0 8.3 10.8 4.4 11.9 4.8 1.9 27.2 43.3 16.8 80.8 12.7 0.0 2.3 3.5 363.2 4.3 0.0 12.8 9.7 36.0 0.8 0.0 3.6 16.7 111.8 11.6 4.7 7.4 7.1 15.9 42.9 28.3 35.4 22.8 173.2 16.6 113.1 2.8 5.4 69.0 18.8 0.0 102.6 0.0 972.8 1067.2 475.7 2.7 8.6 31.5 4.5 12.2 1.2 7.4 MGEA5 "MEA5, NCOAT, OGA" ENSG00000198408 "Meningioma expressed antigen 5 (hyaluronidase)" O60502 10 101784443-101818465 "Enzymes, Predicted intracellular proteins" "Host-virus interaction" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036141, HPA076501" Approved Supported Cytosol NA NA Cytosol "HPA036141: AB_10672079, HPA076501: AB_2686802" "unprognostic (4.34e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.69e-5)" "unprognostic (4.63e-1)" "unprognostic (2.06e-1)" "unprognostic (2.57e-2)" "unprognostic (2.65e-1)" "unprognostic (1.79e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-3)" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "unprognostic (1.68e-1)" "unprognostic (3.01e-1)" "unprognostic (3.21e-2)" "unprognostic (1.90e-1)" "unprognostic (9.23e-3)" 29.5 17.5 51.9 27.4 54.4 49.3 35.5 58.9 51.4 24.5 27.0 29.0 20.9 17.6 29.9 36.8 26.0 23.3 19.1 27.4 46.0 29.8 27.7 28.6 24.0 40.1 30.7 43.6 33.8 20.9 53.3 22.1 25.5 42.6 31.6 26.5 30.7 24.4 26.3 25.4 36.6 28.5 37.4 29.5 35.2 23.9 21.9 35.4 32.9 25.9 11.8 39.5 34.3 26.7 8.1 3.3 14.7 5.6 6.8 7.1 1.4 30.8 15.7 23.0 44.6 14.8 36.0 16.0 21.7 22.0 10.1 17.5 11.5 19.8 20.7 15.9 25.9 17.5 22.3 21.5 27.4 21.6 30.2 14.7 20.6 21.9 9.0 16.0 15.2 11.7 34.7 30.8 17.4 41.5 29.1 18.8 18.9 14.5 38.4 17.2 15.7 16.0 15.9 12.7 6.7 16.0 22.3 25.4 15.1 17.0 28.0 10.0 17.7 19.5 10.5 27.1 22.0 27.8 16.6 28.4 15.7 15.2 22.7 24.8 19.2 30.5 16.5 19.7 26.2 8.5 10.5 2.1 6.8 7.1 2.0 5.6 6.4 4.9 6.1 1.3 8.1 6.8 5.7 14.7 6.8 5.6 3.3 4.5 1.4 51.9 54.4 58.9 51.4 46.0 29.8 30.7 43.6 42.6 35.4 107.2 86.7 52.8 42.9 64.5 144.1 0.0 63.7 61.6 70.5 0.0 265.1 31.5 0.0 0.0 86.9 51.4 61.9 23.3 0.0 23.6 49.2 69.4 73.0 70.0 33.8 74.7 86.1 95.8 62.6 94.2 73.4 62.1 62.4 0.0 53.3 63.6 0.0 48.9 59.4 0.0 132.6 25.8 55.6 20.2 36.6 81.8 42.6 117.6 48.7 51.0 MIPOL1 CCDC193 ENSG00000151338 "Mirror-image polydactyly 1" Q8TD10 14 37197913-37552361 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 99.0;Club cells: 96.7;Early spermatids: 128.1;Late spermatids: 106.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.2" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002893, HPA050179" Enhanced Approved Cytosol NA NA Cytosol "HPA002893: AB_1079386, HPA050179: AB_2681043" "unprognostic (3.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.26e-1)" "unprognostic (4.30e-2)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "unprognostic (4.61e-4)" "unprognostic (2.37e-2)" "unprognostic (2.84e-2)" "unprognostic (2.39e-2)" "unprognostic (3.54e-2)" "unprognostic (8.73e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-1)" "unprognostic (9.78e-3)" "unprognostic (3.41e-3)" "unprognostic (1.85e-2)" 5.8 6.1 8.8 4.5 8.4 1.5 8.6 2.1 11.1 14.0 5.7 1.4 7.8 3.0 9.3 5.1 7.4 7.6 7.0 7.0 8.1 3.9 8.9 4.2 5.3 1.1 4.6 8.4 13.2 8.7 12.6 24.4 3.2 6.6 13.7 4.7 4.6 8.0 9.1 10.1 4.2 3.2 13.7 7.6 2.7 7.5 14.7 8.0 0.0 11.2 5.4 1.7 8.7 15.8 0.8 0.8 4.2 0.3 0.5 0.5 0.3 3.9 1.7 0.6 5.7 4.2 7.0 0.0 3.7 2.4 3.2 4.7 2.2 2.4 0.0 3.6 3.1 1.3 4.7 0.0 5.0 4.3 0.0 6.0 0.0 2.9 9.7 2.7 0.0 0.1 4.5 5.3 0.8 10.2 3.9 19.6 0.0 7.7 0.1 4.7 4.0 0.0 0.0 2.4 2.6 12.7 0.0 0.6 0.0 4.6 4.5 4.9 0.0 4.7 4.1 4.3 4.4 5.1 0.0 10.2 0.0 3.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 7.3 1.1 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.2 0.1 0.8 0.4 0.3 4.2 0.5 0.3 0.8 0.4 0.3 8.8 8.4 2.1 11.1 8.1 3.9 4.6 8.4 6.6 8.0 71.5 49.9 0.9 13.5 3.8 14.5 12.3 12.7 99.0 96.7 8.7 49.1 0.0 8.3 3.6 128.1 5.3 0.9 0.0 6.1 0.1 5.3 14.0 43.0 2.1 0.1 11.1 8.7 4.3 1.0 106.6 7.8 1.8 6.8 0.0 2.1 5.8 9.4 0.0 8.5 3.6 25.3 0.0 5.2 29.2 13.6 5.5 0.0 2.2 2.7 7.6 MLC1 "KIAA0027, LVM, MLC, VL" ENSG00000100427 "Megalencephalic leukoencephalopathy with subcortical cysts 1" Q15049 22 50059391-50085902 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.0;brain: 95.3" "Cell type enhanced" "Detected in some" 23 "Hofbauer cells: 2.6;Muller glia cells: 12.6;T-cells: 4.5" "Cancer enriched" "Detected in some" 69 "glioma: 122.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 46.8;NB-4: 43.3;THP-1: 82.0;U-266/70: 28.7;U-266/84: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003040 Enhanced Supported Cytosol NA NA Cytosol "HPA003040: AB_1079387" "unprognostic (2.68e-2)" "unprognostic (5.46e-6)" "unprognostic (5.41e-3)" "unprognostic (1.51e-1)" "unprognostic (1.47e-1)" "unprognostic (2.42e-3)" "unprognostic (9.54e-3)" "unprognostic (7.21e-2)" "unprognostic (2.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.31e-1)" "unprognostic (1.51e-3)" "unprognostic (8.39e-4)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (3.66e-2)" "unprognostic (2.92e-1)" 1.6 1.4 42.3 1.9 45.4 27.0 1.4 17.6 95.3 2.5 1.5 25.9 0.0 1.8 1.5 2.3 1.4 2.8 2.1 1.6 30.9 19.6 1.4 1.6 2.3 1.6 22.5 28.9 1.4 1.4 1.4 0.1 3.2 18.4 2.9 1.4 0.0 1.5 2.6 1.4 2.2 1.5 1.6 18.9 2.8 1.5 2.8 17.3 0.0 1.4 0.0 1.8 1.8 2.6 0.1 0.7 0.1 7.1 15.8 3.3 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 46.8 15.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 43.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 82.0 0.0 0.0 0.0 0.0 0.0 28.7 24.5 0.0 0.0 7.2 0.4 0.0 0.7 0.0 3.3 5.7 0.1 0.1 0.2 1.4 0.7 0.0 0.1 1.6 0.1 15.8 7.1 0.1 0.1 2.7 42.3 45.4 17.6 29.8 30.9 19.6 22.5 28.9 18.4 17.3 0.0 0.3 0.0 0.0 0.2 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 2.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.2 4.5 0.0 0.0 MMAA cblA ENSG00000151611 "Methylmalonic aciduria (cobalamin deficiency) cblA type" Q8IVH4 4 145618263-145660035 "Disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 14.7" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 28.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037361, HPA058187" Supported Approved Cytosol No No Cytosol "HPA037361: AB_10672107, HPA058187: " "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "prognostic favorable (3.38e-4)" "unprognostic (1.97e-3)" "unprognostic (1.44e-1)" "unprognostic (4.83e-3)" "unprognostic (1.31e-3)" "unprognostic (3.98e-1)" "unprognostic (7.03e-2)" "unprognostic (7.26e-2)" "unprognostic (3.19e-3)" "unprognostic (1.46e-1)" "prognostic favorable (2.23e-5)" "unprognostic (3.40e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.21e-4)" 1.7 3.3 1.4 1.4 1.7 0.5 2.6 2.3 1.5 1.5 3.1 4.2 1.4 2.6 2.3 1.5 2.0 1.8 1.2 1.5 4.3 14.7 1.7 1.3 1.4 1.3 2.5 1.4 0.9 1.1 1.3 3.5 2.0 1.3 5.2 2.3 3.4 1.2 1.2 1.6 1.9 2.0 2.2 1.7 1.6 1.6 4.2 4.2 4.1 10.0 5.8 7.8 2.9 2.3 1.3 4.3 2.2 10.4 10.4 0.9 5.9 4.7 2.4 1.4 1.8 4.7 7.9 2.0 3.9 1.2 1.9 2.1 4.5 1.6 5.5 1.0 3.5 0.9 1.4 7.5 4.2 3.2 6.5 6.4 2.5 6.6 4.1 7.4 9.5 1.0 5.4 5.1 2.9 7.6 1.6 1.6 6.1 2.2 3.6 1.5 1.5 14.1 1.8 2.1 1.7 3.4 7.2 3.2 2.2 3.7 2.0 6.1 3.8 1.6 4.6 1.5 3.0 1.9 3.6 4.0 4.2 3.4 4.1 3.8 3.2 6.3 8.4 5.8 4.2 7.8 6.4 3.6 3.3 5.9 7.8 0.0 5.8 10.0 4.2 6.1 2.9 11.9 3.5 2.2 7.3 2.6 2.9 7.0 12.7 4.0 15.9 10.4 2.0 6.9 13.3 8.5 7.0 3.3 8.8 0.0 10.8 2.8 3.8 5.2 8.1 28.6 4.5 0.0 2.4 7.4 2.7 4.7 4.4 2.6 1.7 3.6 4.9 2.2 7.8 7.0 2.8 15.3 1.5 0.0 3.1 6.7 4.9 1.0 6.4 1.7 5.9 9.5 MMP9 CLG4B ENSG00000100985 "Matrix metallopeptidase 9" P14780 20 46008908-46016561 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1" "Cell type enhanced" "Detected in many" 25 "Hofbauer cells: 273.8;Macrophages: 115.1;Melanocytes: 54.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 141 "neutrophil: 63.2" "Lineage enriched" "Detected in single" 339 "granulocytes: 63.2" "Cell line enriched" "Detected in some" 12 "NB-4: 89.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201" Enhanced Approved Cytosol "Secreted to blood" NA NA 43300000 57000000 Cytosol "CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150" "unprognostic (4.62e-2)" "unprognostic (1.64e-1)" "unprognostic (2.85e-2)" "prognostic favorable (2.55e-4)" "unprognostic (6.65e-3)" "unprognostic (2.82e-1)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.54e-1)" "unprognostic (8.57e-2)" "unprognostic (3.21e-2)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.05e-5)" "unprognostic (4.65e-1)" "unprognostic (9.85e-3)" "unprognostic (2.48e-2)" "unprognostic (2.17e-3)" 64.0 0.5 0.6 38.6 0.7 89.4 4.3 0.4 0.6 0.8 1.2 0.1 0.0 2.8 0.6 0.2 0.9 1.5 0.6 4.0 0.5 0.6 1.4 2.0 13.3 80.1 0.6 0.0 2.7 1.4 0.0 0.8 2.6 0.5 0.6 0.8 0.5 12.5 0.0 1.3 1.3 4.2 0.3 0.5 53.7 2.5 2.7 0.0 23.6 1.3 2.3 44.5 4.5 2.9 0.0 0.0 63.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 7.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 89.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 1.0 0.0 0.3 0.0 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.2 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.4 0.6 0.5 0.6 0.6 0.0 0.5 0.0 0.0 8.5 0.0 0.0 30.5 1.6 0.4 0.0 0.0 0.0 0.0 7.9 0.9 0.0 0.8 0.6 0.5 0.0 0.0 1.5 2.0 1.7 0.1 1.1 0.0 273.8 3.2 0.0 0.0 1.9 0.0 0.0 115.1 54.0 3.6 0.0 0.5 1.6 0.0 0.0 0.3 4.3 0.0 12.3 5.4 5.5 24.6 1.6 0.0 0.0 0.0 MOCS1 MOCOD ENSG00000124615 "Molybdenum cofactor synthesis 1" Q9NZB8 6 39899578-39934551 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 23.5;Hepatocytes: 33.6;Sertoli cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5" "Group enriched" "Detected in many" 9 "NK-cells: 1.5;T-cells: 2.9" "Cell line enhanced" "Detected in many" "CACO-2: 23.6;JURKAT: 30.1" "Low region specificity" "Detected in all" "HPA045783, HPA058177, HPA075505" Uncertain Enhanced Cytosol NA NA Cytosol "HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751" "unprognostic (1.22e-1)" "prognostic unfavorable (1.07e-5)" "unprognostic (3.26e-2)" "unprognostic (1.44e-1)" "unprognostic (9.03e-2)" "unprognostic (1.99e-1)" "unprognostic (2.61e-2)" "unprognostic (4.85e-2)" "unprognostic (3.14e-2)" "unprognostic (1.08e-1)" "prognostic favorable (6.07e-5)" "unprognostic (5.34e-3)" "unprognostic (1.21e-1)" "unprognostic (3.97e-3)" "unprognostic (2.78e-1)" "unprognostic (2.93e-1)" "unprognostic (6.21e-2)" 26.6 9.6 4.6 5.3 7.9 0.2 27.1 5.9 8.7 6.4 17.5 10.5 5.0 15.4 10.1 8.7 6.9 7.9 8.0 18.0 6.2 2.3 17.5 34.9 19.6 9.2 9.5 6.2 9.0 10.9 4.5 6.3 30.2 7.0 6.7 5.2 11.2 5.9 7.6 19.9 7.1 13.1 8.9 7.1 3.5 6.5 4.0 7.6 0.2 15.4 5.9 3.1 9.7 7.7 0.0 0.1 0.0 0.2 1.5 2.9 0.8 0.0 1.2 4.4 7.1 12.1 4.6 9.0 4.9 8.9 7.0 6.4 23.6 0.1 0.0 5.1 4.8 4.5 0.3 5.3 5.9 5.4 0.0 4.9 0.0 0.0 7.5 7.7 0.0 1.9 8.1 2.2 4.9 2.6 4.3 6.0 30.1 4.8 0.4 7.1 3.0 9.2 0.0 4.1 0.0 2.6 0.0 3.4 0.7 4.3 4.6 3.6 4.7 0.0 2.9 4.1 3.7 3.1 0.8 9.3 7.0 6.1 4.6 2.5 0.0 0.9 0.0 0.8 0.0 2.5 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.6 0.5 0.1 0.0 2.9 2.5 0.0 1.5 0.2 0.0 0.0 0.8 4.6 7.9 5.9 8.7 6.2 2.3 9.5 6.2 7.0 7.6 6.0 1.0 0.0 0.5 0.6 0.8 10.1 7.6 0.0 0.0 8.7 11.8 23.5 5.0 3.4 0.6 2.8 6.4 0.0 3.7 1.2 2.9 0.2 1.1 33.6 2.5 3.2 0.0 2.5 2.8 0.6 3.4 0.0 1.7 0.0 2.9 4.2 1.1 4.8 2.8 12.2 2.2 77.6 15.6 1.4 1.5 1.0 5.1 0.0 4.1 0.3 MON1A "MGC13272, SAND1" ENSG00000164077 "MON1 homolog A, secretory trafficking associated" Q86VX9 3 49907160-49930173 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3;Late spermatids: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053752, HPA058032" Uncertain Approved Cytosol NA NA Cytosol "HPA053752: AB_2682250, HPA058032: AB_2683584" "unprognostic (1.81e-2)" "unprognostic (6.34e-2)" "unprognostic (1.48e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-2)" "unprognostic (3.51e-2)" "unprognostic (3.29e-2)" "unprognostic (2.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-2)" "prognostic favorable (3.30e-4)" "unprognostic (5.23e-2)" "unprognostic (2.07e-1)" "unprognostic (1.46e-1)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" "unprognostic (1.55e-1)" 7.1 6.5 11.7 6.1 10.4 4.1 4.6 5.2 17.8 5.9 9.3 7.6 3.8 27.9 5.6 3.2 5.6 5.1 6.3 5.4 10.8 10.3 6.0 11.0 4.9 5.2 10.3 8.8 4.7 10.9 5.8 7.4 4.9 8.9 5.0 4.0 5.6 6.0 6.7 15.2 6.9 17.6 5.9 9.7 4.6 5.8 12.6 6.6 6.6 6.3 4.1 4.5 4.6 4.4 8.8 7.8 3.3 6.4 13.6 13.5 7.8 4.6 3.9 2.4 7.5 7.7 4.6 3.4 6.7 3.3 6.5 7.3 5.8 3.1 14.2 6.1 6.2 5.6 5.9 5.2 8.4 2.7 11.8 13.1 6.2 4.6 7.4 9.7 7.2 9.0 6.3 9.1 12.6 4.4 3.3 9.4 6.1 9.6 5.0 4.9 7.7 8.2 10.6 5.4 10.1 20.1 5.1 2.7 10.9 4.6 3.4 7.0 4.2 2.8 5.6 6.7 1.7 4.3 4.9 7.4 4.3 5.1 11.9 10.6 10.5 10.3 8.8 6.6 11.2 6.4 0.1 6.4 3.3 11.9 4.9 13.5 8.8 10.0 11.9 7.8 4.8 12.4 10.0 1.9 13.6 3.9 3.9 10.1 7.8 11.7 10.4 5.2 17.8 10.8 10.3 10.3 8.8 8.9 6.6 3.0 4.8 4.3 1.7 13.3 2.8 5.3 0.0 4.0 3.4 1.8 3.9 3.7 1.7 4.2 11.9 3.8 9.3 23.3 5.8 2.6 3.5 3.7 4.6 12.9 4.7 0.0 6.4 4.3 3.8 25.2 3.1 2.5 5.0 1.8 4.0 4.6 9.6 5.8 5.3 10.5 2.2 0.0 6.2 14.0 5.7 8.0 3.3 4.9 4.9 1.8 MON1B "HSRG1, KIAA0872, SAND2" ENSG00000103111 "MON1 homolog B, secretory trafficking associated" Q7L1V2 16 77190835-77202405 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046285 Approved Approved Cytosol NA NA Cytosol "HPA046285: AB_10959467" "unprognostic (1.73e-2)" "unprognostic (9.99e-2)" "unprognostic (9.97e-2)" "prognostic favorable (6.90e-4)" "unprognostic (1.94e-1)" "unprognostic (7.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-2)" "unprognostic (9.78e-2)" "unprognostic (2.42e-2)" "unprognostic (1.76e-1)" "unprognostic (1.19e-1)" "prognostic favorable (9.42e-5)" "unprognostic (2.21e-2)" "unprognostic (3.62e-2)" "unprognostic (8.34e-3)" "unprognostic (1.75e-1)" 15.7 12.3 21.8 19.1 22.5 16.5 12.4 17.5 22.9 14.7 19.1 25.3 18.5 17.1 14.6 14.4 16.7 13.6 16.1 12.5 21.7 19.4 17.4 26.9 14.9 19.3 26.8 17.9 11.5 17.7 25.1 13.0 11.8 19.9 23.7 15.7 15.2 22.9 13.3 11.5 15.9 23.1 11.6 28.0 18.0 16.9 10.8 24.0 23.5 23.2 11.2 17.7 15.1 12.0 5.7 7.2 19.8 14.5 9.2 8.6 6.7 8.2 19.7 7.5 8.4 8.3 8.2 10.6 7.0 9.1 7.2 7.1 11.2 12.6 13.3 13.9 5.5 12.1 15.2 7.8 7.5 5.9 10.5 8.0 9.3 6.9 11.0 11.5 9.8 28.7 8.6 14.5 10.4 8.7 7.0 12.9 12.8 13.2 4.7 5.8 15.5 14.9 11.8 7.9 9.5 4.9 18.6 5.2 14.2 7.4 5.8 11.6 9.6 13.5 5.2 8.9 5.6 13.3 14.9 13.3 8.6 10.4 10.3 7.1 17.0 10.8 37.7 14.3 10.9 11.0 10.4 8.3 14.1 8.6 14.5 8.6 5.7 6.8 8.4 7.2 5.4 5.2 6.6 19.8 9.2 8.7 3.9 8.4 6.7 21.8 22.5 17.5 22.1 21.7 19.4 26.8 17.9 19.9 24.0 35.7 33.3 8.0 9.8 6.6 14.8 9.6 10.2 9.4 20.5 14.0 17.7 8.8 3.3 11.7 15.0 19.4 25.6 0.0 17.0 10.5 7.8 20.2 12.7 25.2 11.7 7.9 23.1 20.9 26.4 11.3 8.3 13.6 8.5 16.2 23.9 20.3 15.9 17.5 9.6 9.9 21.2 19.4 7.2 10.4 4.9 8.3 14.1 20.2 19.5 16.9 MOV10 "fSAP113, gb110, MGC2948" ENSG00000155363 "Mov10 RISC complex RNA helicase" Q9HCE1 1 112673141-112700746 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031627 Approved Cytosol NA NA Cytosol "HPA031627: AB_2673966" "unprognostic (1.44e-2)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" "unprognostic (6.82e-3)" "unprognostic (1.91e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.44e-4)" "unprognostic (9.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.58e-3)" "unprognostic (2.85e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.48e-11)" "unprognostic (4.01e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-3)" "unprognostic (1.21e-3)" 12.5 17.0 6.2 12.6 6.9 3.5 15.0 1.9 6.3 11.4 23.1 9.3 12.3 18.8 16.4 12.6 15.8 12.2 15.3 5.8 8.6 5.1 13.3 19.4 9.7 7.7 5.9 5.1 14.5 12.9 13.1 14.1 20.2 8.2 14.0 9.3 13.8 13.5 16.5 3.1 23.2 33.8 9.4 6.3 12.9 10.4 17.7 6.0 14.5 12.1 6.9 10.9 11.0 12.5 1.9 5.6 0.9 9.5 9.9 10.8 5.9 12.0 7.4 4.4 17.0 3.6 10.4 16.8 8.3 19.7 24.4 35.0 13.7 13.3 0.0 5.7 11.4 9.1 12.8 16.8 19.9 8.5 13.2 10.2 8.3 10.8 15.4 15.5 3.4 8.3 17.5 6.1 14.8 4.7 16.1 20.7 17.2 11.0 4.2 7.5 22.3 13.1 2.7 9.9 5.0 7.6 23.7 11.2 0.5 11.3 13.2 1.9 6.4 17.1 11.6 13.4 9.1 9.0 8.0 12.3 7.6 13.7 5.3 7.3 4.8 1.3 0.0 15.1 7.2 21.7 0.7 2.8 0.5 10.7 8.4 10.8 1.9 9.7 9.7 5.6 1.4 9.4 7.1 0.9 9.9 9.5 0.9 8.2 5.9 6.2 6.9 1.9 6.3 8.6 5.1 5.9 5.1 8.2 6.0 8.9 10.9 5.4 9.8 7.8 2.1 2.5 7.6 6.7 10.3 15.7 0.0 42.2 3.3 13.7 4.2 14.7 31.4 0.0 13.3 16.6 5.1 9.2 1.1 14.0 13.8 4.8 14.5 17.8 9.4 4.9 8.6 7.1 3.3 18.0 15.3 20.4 13.7 28.1 7.1 11.2 0.8 12.9 6.2 2.6 2.6 6.0 31.9 5.7 11.5 9.5 MOXD1 "dJ248E1.1, DKFZP564G202, MOX" ENSG00000079931 "Monooxygenase DBH like 1" Q6UVY6 6 132296055-132401545 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 57.2;smooth muscle: 41.1" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 24.8;Early spermatids: 36.8;Muller glia cells: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 47 "memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8" "Group enriched" "Detected in many" 58 "B-cells: 4.9;dendritic cells: 7.8" "Cell line enhanced" "Detected in many" "ASC diff: 38.5;ASC TERT1: 31.0;BJ: 23.4;fHDF/TERT166: 43.5;HBF TERT88: 28.1;U-2197: 69.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035740 Approved Approved Cytosol NA NA Cytosol "HPA035740: AB_10610141" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (8.05e-2)" "unprognostic (9.87e-3)" "unprognostic (5.62e-2)" "prognostic favorable (7.09e-5)" "unprognostic (5.77e-2)" "unprognostic (2.48e-1)" "unprognostic (6.55e-2)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (3.72e-4)" "unprognostic (2.92e-2)" "unprognostic (6.24e-2)" "unprognostic (1.73e-2)" 1.9 19.5 13.4 3.8 12.5 0.2 1.4 0.3 16.0 17.2 7.7 6.7 7.3 2.7 57.2 7.8 17.4 1.9 15.1 3.2 9.8 1.1 21.4 1.2 15.3 2.9 1.0 6.4 2.4 1.7 0.1 4.3 3.3 0.2 17.6 4.9 0.9 10.6 21.5 0.4 7.4 4.5 41.1 0.8 3.2 3.1 3.1 4.6 0.8 1.5 7.7 7.7 9.4 8.6 4.9 7.8 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.9 0.0 38.5 31.0 0.0 23.4 15.9 8.6 15.1 0.0 0.2 0.1 0.0 43.5 7.1 0.0 0.3 0.1 28.1 0.0 4.3 0.0 0.0 0.0 0.3 0.0 0.0 7.3 0.0 17.3 0.5 10.7 0.0 0.0 0.0 1.7 5.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.1 0.0 10.5 0.0 0.6 0.0 0.0 0.1 0.5 2.3 0.0 1.3 0.1 3.9 3.7 69.7 12.2 0.9 0.0 0.0 10.0 0.0 11.5 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.3 13.4 12.5 0.3 16.0 9.8 1.1 1.0 6.4 0.2 4.6 0.0 2.2 3.4 0.4 24.8 0.2 0.6 0.0 0.0 4.5 1.8 0.0 0.6 0.0 0.4 36.8 0.0 0.0 0.0 0.0 1.0 9.6 0.2 3.5 0.0 0.4 0.0 0.0 0.0 0.0 6.8 0.3 0.6 6.8 0.0 0.0 14.0 0.4 0.0 0.4 0.0 0.8 0.0 0.4 0.5 0.4 5.9 0.0 0.0 0.0 0.0 MROH2A HEATR7B1 ENSG00000185038 "Maestro heat like repeat family member 2A" A6NES4 2 233775679-233833423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 1.8;testis: 5.0;thyroid gland: 5.1" "Cell type enhanced" "Detected in single" 13 "Spermatocytes: 1.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RT4: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA052107 Uncertain Uncertain Cytosol NA NA Cytosol "HPA052107: AB_2681729" "unprognostic (7.00e-2)" "unprognostic (3.37e-3)" "unprognostic (4.77e-1)" "unprognostic (1.65e-2)" "unprognostic (4.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.41e-2)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (4.32e-2)" "unprognostic (5.05e-2)" "unprognostic (4.06e-9)" "unprognostic (5.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 5.0 5.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 11.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.0 0.0 0.0 0.1 MSI2 ENSG00000153944 "Musashi RNA binding protein 2" Q96DH6 17 57255851-57684685 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Cone photoreceptor cells: 710.8;Rod photoreceptor cells: 517.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022300, HPA068990" Approved Supported Cytosol NA NA Cytosol "CAB022300: , HPA068990: " "unprognostic (4.73e-2)" "unprognostic (2.28e-1)" "unprognostic (3.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.12e-1)" "unprognostic (1.08e-1)" "unprognostic (4.20e-2)" "unprognostic (2.20e-2)" "unprognostic (4.89e-2)" "unprognostic (2.96e-1)" "unprognostic (4.17e-2)" "unprognostic (1.18e-1)" "prognostic favorable (9.22e-8)" "prognostic favorable (2.00e-4)" "unprognostic (4.87e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-3)" 3.4 34.7 20.0 22.4 21.5 8.4 8.8 18.0 25.3 9.7 14.4 7.7 14.2 5.0 6.7 36.3 4.6 11.1 23.5 28.5 13.9 16.9 18.0 3.6 6.9 9.6 21.0 6.4 22.8 6.1 41.4 23.1 10.7 19.7 10.5 7.4 14.6 9.8 48.5 25.6 3.6 5.4 4.6 14.8 8.7 7.7 7.5 9.5 23.7 12.4 8.4 8.6 11.6 5.0 1.9 3.0 4.8 1.5 1.9 4.1 0.5 3.4 5.9 20.4 7.9 2.3 2.2 16.1 3.9 4.5 5.1 3.1 7.0 5.9 16.1 13.7 2.4 4.1 3.4 13.0 5.2 9.5 22.4 9.1 7.0 13.1 16.1 5.1 7.7 7.2 2.8 6.8 0.6 8.3 6.4 5.2 12.9 15.3 12.1 17.9 8.1 34.8 2.1 7.4 17.5 9.5 48.9 30.6 12.7 12.4 22.6 22.7 42.3 6.3 6.0 18.1 9.8 10.8 6.0 6.6 3.2 8.5 2.8 6.6 16.9 14.2 19.6 8.5 4.7 19.6 4.4 0.4 4.8 2.0 0.3 1.5 1.9 1.9 1.8 0.6 1.1 1.8 1.7 0.4 1.9 1.5 3.0 4.1 0.5 20.0 21.5 18.0 25.3 13.9 16.9 21.0 6.4 19.7 9.5 6.0 26.6 60.1 59.4 21.3 190.2 86.4 56.0 93.7 29.6 71.5 710.8 98.4 104.5 41.8 12.8 24.4 15.3 23.3 12.7 17.2 28.6 73.1 40.5 25.1 17.3 278.1 94.3 28.8 11.1 19.3 59.8 13.2 37.1 1.8 48.0 265.7 11.1 17.5 72.9 43.4 517.0 12.9 27.8 3.9 4.5 14.1 124.8 44.8 33.3 79.0 MST1R "CD136, CDw136, PTK8, RON" ENSG00000164078 "Macrophage stimulating 1 receptor" Q04912 3 49887002-49903873 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 34.3;skin 1: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 23.8;Enterocytes: 29.1;Mucus-secreting cells: 21.5;Pancreatic endocrine cells: 19.7;Paneth cells: 20.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 35.9;HaCaT: 19.8;HBEC3-KT: 21.6;hTCEpi: 30.3;RT4: 23.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007657, HPA008180, CAB008972" Enhanced Approved Cytosol NA NA Cytosol "CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291" "unprognostic (3.84e-3)" "unprognostic (3.86e-1)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.82e-2)" "unprognostic (2.32e-1)" "unprognostic (8.07e-3)" "unprognostic (1.54e-2)" "unprognostic (4.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.24e-3)" "unprognostic (2.28e-1)" "unprognostic (8.08e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-1)" "unprognostic (8.00e-3)" "prognostic favorable (2.33e-5)" 1.7 0.1 0.4 7.5 0.6 0.0 2.4 0.5 0.7 1.8 20.5 0.7 2.0 11.2 1.2 1.3 6.1 0.6 27.7 0.9 0.5 0.1 1.4 0.4 5.0 1.1 0.4 0.6 0.5 4.1 0.0 1.3 0.8 0.9 1.7 9.7 2.5 2.1 0.4 0.5 28.7 34.3 0.7 0.4 0.6 19.1 1.9 0.4 7.7 1.3 6.0 4.5 4.3 3.5 0.2 0.0 0.0 0.0 0.6 2.1 0.0 12.9 5.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.2 35.9 0.5 3.1 0.2 0.0 19.8 0.0 21.6 0.0 0.3 0.3 0.0 8.5 0.3 0.3 0.0 0.4 0.1 30.3 0.1 4.3 0.1 0.0 0.0 0.2 0.1 0.0 1.8 0.0 0.0 0.1 11.6 10.5 0.9 0.0 0.3 13.3 23.1 0.3 0.0 3.6 8.4 0.0 0.0 6.6 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.4 0.6 0.5 0.7 0.5 0.1 0.4 0.6 0.9 0.4 23.8 10.1 0.0 2.2 7.8 0.0 1.2 0.0 2.7 9.1 0.0 0.0 0.1 0.0 5.2 13.7 0.0 29.1 0.0 8.7 0.4 0.4 1.7 0.0 0.0 0.1 0.0 4.1 0.0 0.0 7.9 0.3 0.0 0.0 1.0 21.5 0.0 19.7 20.4 0.0 0.0 0.0 0.0 0.4 1.6 0.8 4.1 0.0 0.0 12.4 4.6 MSTO1 "FLJ10504, LST005, misato, MST" ENSG00000125459 "Misato 1, mitochondrial distribution and morphology regulator" Q9BUK6 1 155610205-155614967 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 30 "Early spermatids: 324.7;Late spermatids: 974.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005899, HPA005914" Approved Supported Cytosol NA NA Cytosol "HPA005899: AB_2667460, HPA005914: AB_2667466" "unprognostic (1.80e-2)" "unprognostic (3.43e-1)" "unprognostic (6.49e-2)" "unprognostic (2.65e-1)" "unprognostic (1.15e-1)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.63e-2)" "unprognostic (1.26e-1)" "unprognostic (5.28e-2)" "unprognostic (3.73e-2)" "unprognostic (3.67e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (5.35e-2)" "unprognostic (1.28e-1)" 9.5 5.8 3.5 5.0 3.8 3.0 6.9 5.3 4.2 5.1 3.9 4.6 6.8 10.6 4.8 6.3 3.5 4.6 4.4 4.3 5.7 11.5 4.6 5.6 4.3 6.9 8.3 9.6 8.9 4.3 7.4 4.8 4.8 9.3 1.6 4.5 4.9 6.6 2.9 7.5 4.6 7.1 7.9 5.2 3.8 4.0 7.6 8.3 3.1 8.0 8.8 10.9 6.3 12.2 15.8 15.0 22.8 12.9 10.1 17.6 15.0 13.4 19.3 15.2 16.7 7.9 20.3 14.9 13.6 11.9 13.6 21.5 20.7 13.7 8.3 18.2 18.4 15.2 9.7 20.2 19.6 15.3 10.8 11.0 21.5 31.9 9.0 16.1 15.4 14.6 9.7 16.0 20.0 12.4 13.7 19.1 20.6 21.9 11.5 13.7 19.2 16.2 12.4 12.5 15.0 11.3 33.1 14.0 17.7 18.8 25.7 10.7 12.9 13.7 13.2 23.5 20.8 17.0 15.5 14.2 18.6 16.2 3.1 5.7 0.2 10.4 8.0 10.9 7.6 9.7 9.7 8.0 5.5 10.6 6.3 0.5 8.8 5.0 8.3 6.8 6.3 6.0 5.9 7.5 4.2 2.4 9.1 8.7 5.1 13.4 5.7 7.0 21.6 6.7 3.3 7.9 324.7 6.4 2.1 0.0 11.6 19.0 5.5 4.0 13.9 6.2 7.6 11.1 5.2 1.8 2.7 974.9 8.3 6.0 3.3 10.0 3.4 3.7 6.8 0.0 10.6 6.9 9.8 0.0 4.7 18.6 13.2 1.3 5.5 5.0 3.7 2.5 MT-ND3 "MTND3, NAD3, ND3" ENSG00000198840 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3" P03897 MT 10059-10404 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 357.8" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 33020.6;Erythroid cells: 20674.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 644.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063296 Enhanced Uncertain Cytosol NA NA Cytosol "HPA063296: AB_2684978" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (8.10e-2)" "unprognostic (3.07e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "prognostic favorable (4.63e-5)" "unprognostic (2.45e-2)" "unprognostic (7.13e-2)" "unprognostic (8.85e-2)" "unprognostic (1.76e-3)" "unprognostic (1.74e-1)" "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-1)" "unprognostic (5.65e-3)" 102.1 73.9 117.3 17.6 137.2 17.9 59.3 33.7 70.5 31.2 76.3 64.0 25.9 49.2 21.7 24.7 19.7 256.8 110.3 81.7 138.1 145.8 19.7 17.4 92.0 27.5 77.8 14.6 22.2 34.6 39.1 59.1 67.6 50.7 357.8 42.2 48.9 28.4 66.8 19.1 60.6 21.0 25.0 20.3 24.2 15.9 84.8 32.6 159.6 48.5 48.6 75.3 24.4 85.5 139.7 93.3 91.5 644.7 129.2 77.7 72.1 42.4 39.1 44.3 210.2 133.3 89.1 111.9 92.5 70.8 178.3 40.1 157.5 67.3 127.7 192.1 87.6 465.1 346.0 100.6 129.0 132.7 223.4 292.0 65.5 73.9 233.9 60.8 102.4 69.0 104.2 73.7 279.5 67.7 172.2 47.9 245.4 129.3 58.7 91.7 82.0 237.9 236.2 38.5 83.7 34.8 69.8 142.5 254.3 161.5 208.4 103.2 60.5 91.9 105.1 77.0 40.5 53.1 192.1 49.1 78.4 34.2 159.6 48.5 36.6 36.7 36.4 49.8 73.1 42.6 44.8 32.6 84.8 63.1 75.3 100.7 48.6 32.7 32.3 27.6 24.4 652.1 738.1 6543.7 1904.3 1765.5 0.0 33020.6 8848.3 2785.1 1856.3 4782.3 0.0 0.0 986.5 1173.3 880.9 872.1 11850.5 20674.5 2500.6 0.0 790.1 1401.0 1375.6 14769.6 0.0 0.0 2746.0 8921.3 11655.5 4356.4 8457.2 1642.1 1763.0 2463.5 12873.7 0.0 1918.1 9893.1 4573.5 7467.5 0.0 6887.9 1962.1 6063.0 3539.9 1651.0 0.0 4305.8 10869.3 1952.0 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" P11586 14 64388031-64463457 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis" "Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 121.6" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol NA Yes 250000 Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998" "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favorable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 18.9 9.0 8.1 8.4 18.1 9.7 12.2 5.7 15.9 7.1 9.3 9.0 4.0 7.5 8.5 6.9 12.0 6.7 6.4 10.6 8.4 6.5 20.5 121.6 6.8 9.2 8.0 10.4 10.1 13.4 13.1 5.6 5.6 10.0 5.5 11.4 9.3 11.6 5.6 26.5 7.6 7.3 8.8 6.9 8.3 7.9 2.3 7.4 15.6 8.6 14.0 12.5 8.7 7.3 21.1 12.8 0.5 13.2 12.8 14.9 8.4 72.5 41.3 15.7 34.2 16.9 13.8 25.5 28.5 19.6 37.0 36.7 40.1 33.4 30.5 13.5 16.9 18.6 35.7 48.4 28.3 43.3 30.3 31.9 37.8 41.4 30.4 12.5 29.0 20.6 10.7 9.2 33.0 17.9 15.3 23.0 30.9 28.1 25.1 28.0 60.2 46.7 17.0 28.7 46.2 43.8 37.3 54.6 27.6 27.8 42.5 34.0 13.2 47.6 25.9 14.3 15.3 40.3 14.7 14.1 27.9 48.4 25.7 34.1 16.8 20.6 53.8 25.6 33.5 31.6 0.2 8.2 0.1 8.1 13.2 10.9 21.1 9.0 9.9 12.8 11.6 7.6 10.1 0.5 12.8 10.3 3.2 14.9 8.4 8.1 18.1 5.7 15.9 8.4 6.5 8.0 10.4 10.0 7.4 17.9 26.3 11.5 9.9 12.2 0.0 38.1 17.8 12.0 20.5 15.7 0.0 20.0 34.9 15.4 0.9 9.9 5.2 0.0 9.0 24.2 10.6 8.3 49.7 125.3 21.6 0.0 2.9 7.4 11.3 0.9 12.0 10.9 13.5 14.4 11.9 0.0 10.8 2.9 12.4 49.9 0.0 19.4 18.6 0.9 7.5 9.4 8.2 20.0 21.3 9.9 MTHFS HsT19268 ENSG00000136371 "Methenyltetrahydrofolate synthetase" P49914 15 79833585-79897379 "Enzymes, Predicted intracellular proteins" Ligase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.7;liver: 120.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 163.6;monocytes: 231.8;Proximal tubular cells: 140.3;Syncytiotrophoblasts: 212.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 88.7" "Group enriched" "Detected in all" 5 "granulocytes: 88.7;monocytes: 25.4" "Low cell line specificity" "Detected in many" "HPA008067, HPA054177" Approved Supported Cytosol NA NA Cytosol "HPA008067: AB_1078882, HPA054177: AB_2682405" "unprognostic (4.57e-2)" "unprognostic (9.76e-2)" "unprognostic (6.11e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (9.13e-3)" "prognostic favorable (1.29e-6)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "unprognostic (6.18e-3)" "unprognostic (2.91e-2)" "unprognostic (2.76e-1)" "prognostic favorable (2.04e-4)" "unprognostic (1.36e-1)" "unprognostic (2.85e-1)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" 10.0 6.6 4.5 7.6 4.4 2.5 5.7 3.9 2.8 4.4 12.4 3.7 6.8 8.3 4.3 6.2 4.5 4.0 7.9 5.2 4.1 5.0 27.9 120.9 6.4 5.4 5.5 1.7 3.3 18.8 11.4 9.4 13.9 3.9 8.6 3.7 6.5 10.6 7.6 6.0 1.9 18.3 4.4 6.1 7.6 6.3 5.9 3.3 5.3 12.0 3.1 5.7 4.0 9.9 9.7 9.3 88.7 25.4 12.4 12.6 13.8 10.9 27.7 2.5 1.4 9.8 8.3 11.2 7.7 10.1 13.5 10.3 21.5 21.6 13.8 23.4 9.5 12.1 17.7 23.6 7.5 10.3 14.3 15.7 11.8 16.1 25.5 17.0 5.5 0.4 12.5 22.1 5.6 14.1 12.6 5.0 12.2 26.1 11.3 10.7 23.6 8.5 23.0 11.8 34.2 10.4 9.3 13.6 20.9 24.6 20.6 6.8 3.2 21.4 12.8 28.2 12.5 16.4 10.2 3.3 5.2 11.0 2.4 5.1 5.7 18.4 13.9 2.6 21.8 4.0 9.8 16.6 43.5 7.7 19.0 9.9 9.7 10.8 9.0 9.3 8.7 12.6 9.7 88.7 12.4 25.4 7.0 11.2 13.8 4.5 4.4 3.9 2.8 4.1 5.0 5.5 1.7 3.9 3.3 17.9 35.3 18.8 8.6 9.5 0.0 0.6 40.8 25.4 18.2 21.0 0.0 57.2 54.7 50.9 1.1 8.4 11.9 0.0 65.9 31.6 13.1 11.4 8.1 163.6 41.2 0.0 16.9 16.5 21.5 1.7 12.7 29.7 20.3 231.8 22.7 0.0 65.8 29.8 14.9 140.3 0.0 12.9 5.1 7.5 7.3 7.0 212.2 35.2 30.5 7.4 MTR cblG ENSG00000116984 "5-methyltetrahydrofolate-homocysteine methyltransferase" Q99707 1 236795281-236903981 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Methyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 84.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044474, HPA054915" Approved Supported Cytosol NA NA Cytosol "HPA044474: AB_10966696, HPA054915: AB_2732589" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (6.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (4.87e-1)" "unprognostic (1.02e-1)" "unprognostic (2.48e-2)" "unprognostic (3.34e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (1.67e-2)" "unprognostic (8.84e-3)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (8.10e-2)" 14.5 11.4 9.9 13.2 13.5 7.6 13.6 14.8 14.4 16.9 16.4 16.2 16.0 7.5 18.1 27.3 10.4 18.4 16.3 21.9 9.4 9.8 21.2 9.5 11.7 14.3 12.6 12.8 24.7 20.8 27.4 12.4 17.5 13.0 14.0 8.9 17.7 11.1 17.3 27.0 15.4 11.7 23.3 12.1 13.9 14.9 20.1 12.1 20.8 22.4 11.1 13.2 18.4 14.4 3.3 1.6 3.0 2.0 2.3 5.8 2.1 9.9 6.7 8.3 6.8 15.4 14.2 9.8 8.8 7.8 9.7 10.1 6.4 7.7 22.3 8.1 9.8 5.2 6.9 10.7 7.8 11.6 10.3 9.2 13.1 9.0 11.7 10.3 20.7 8.2 20.2 4.9 12.8 12.3 7.6 12.8 12.1 18.8 10.5 8.1 6.9 10.8 6.7 11.1 8.2 3.6 11.8 14.7 14.3 7.0 11.6 6.8 18.9 9.9 7.2 8.8 6.1 10.3 8.5 16.6 16.0 6.1 12.2 11.3 22.7 7.0 13.0 10.4 13.1 15.8 2.7 1.6 3.0 3.2 2.0 5.8 2.7 4.2 4.5 1.5 3.3 5.0 4.0 0.1 2.3 1.5 1.6 2.9 2.1 9.9 13.5 14.8 14.4 9.4 9.8 12.6 12.8 13.0 12.1 53.6 31.2 20.1 6.8 7.2 0.0 84.0 20.4 20.1 13.6 38.4 0.0 19.3 1.7 11.9 5.3 12.8 6.3 0.0 12.8 7.8 17.5 8.3 29.0 9.6 12.6 0.0 8.1 15.4 16.5 4.2 22.2 10.4 10.1 10.8 7.3 0.0 11.7 10.5 31.1 5.7 0.0 6.5 15.5 14.9 19.7 4.4 18.9 11.7 12.1 4.8 MTTP "ABL, MTP" ENSG00000138823 "Microsomal triglyceride transfer protein" P55157 4 99563761-99623999 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Lipid transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 49 "intestine: 211.4;liver: 60.8" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 201.1" "Cancer enriched" "Detected in many" 13 "liver cancer: 28.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Group enriched" "Detected in some" 6 "AF22: 12.8;Hep G2: 14.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA051170, HPA054862" Uncertain Uncertain Cytosol "Intracellular and membrane" NA NA 450000 Cytosol "HPA051170: , HPA054862: AB_2682628" "unprognostic (1.66e-2)" "unprognostic (1.14e-1)" "unprognostic (5.64e-2)" "unprognostic (5.33e-2)" "unprognostic (3.49e-3)" "unprognostic (7.38e-2)" "unprognostic (1.05e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (3.66e-2)" "unprognostic (1.00e-2)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (2.02e-2)" "unprognostic (3.64e-1)" "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" 0.1 0.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.0 53.2 0.2 0.1 53.4 0.0 0.0 0.2 0.2 0.4 0.4 0.3 0.4 2.7 60.8 0.1 0.0 0.4 0.1 1.1 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 211.4 0.7 0.4 0.1 0.2 1.8 0.2 0.1 0.1 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.8 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.3 0.5 0.0 0.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.2 0.3 0.1 14.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.7 0.6 0.0 0.3 0.3 0.2 1.3 0.0 0.0 0.8 1.0 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.3 0.4 0.4 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.6 0.0 0.0 1.8 0.0 0.1 0.0 0.0 25.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 201.1 0.1 0.0 0.0 5.5 3.3 7.9 0.9 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.4 18.6 0.0 6.5 0.0 21.9 1.5 0.0 0.0 0.0 0.0 0.0 MTURN "C7orf41, Ells1, FLJ25903" ENSG00000180354 "Maturin, neural progenitor differentiation regulator homolog" Q8N3F0 7 30134810-30162762 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 189.2" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 9.9" "Group enriched" "Detected in many" 4 "granulocytes: 9.9;NK-cells: 3.0" "Cell line enhanced" "Detected in many" "ASC diff: 23.1;HEL: 40.2;SCLC-21H: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029507 Enhanced Approved Cytosol NA NA Cytosol "HPA029507: AB_10601149" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (3.70e-1)" "unprognostic (7.14e-2)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-3)" "unprognostic (9.80e-2)" "unprognostic (1.94e-1)" "unprognostic (1.11e-3)" "unprognostic (8.11e-3)" "prognostic favorable (7.64e-13)" "unprognostic (9.50e-2)" "unprognostic (7.64e-2)" "unprognostic (4.64e-1)" "unprognostic (3.26e-1)" 35.9 5.7 113.5 4.8 86.7 9.3 14.2 21.7 100.8 12.9 5.2 97.0 3.3 3.0 7.9 45.6 9.6 8.2 5.3 11.2 122.8 79.5 24.7 2.3 10.1 2.8 162.4 26.2 16.5 6.2 9.7 2.7 4.0 54.2 9.2 5.3 2.9 14.9 12.0 14.3 7.8 3.4 8.5 189.2 4.1 10.0 4.5 49.4 0.0 6.7 2.4 3.0 6.0 6.5 0.7 1.4 9.9 0.4 3.0 0.8 2.4 5.1 0.9 3.0 3.2 23.1 15.8 2.7 2.5 2.9 0.8 1.2 0.4 2.1 0.3 2.1 5.5 4.8 1.0 6.8 9.8 2.8 2.2 5.5 40.2 6.4 2.8 1.8 2.0 13.3 7.8 4.6 2.6 4.7 3.7 1.3 5.5 2.5 2.1 5.8 1.9 2.3 0.9 2.1 4.8 3.2 0.2 7.1 8.6 10.3 2.1 29.7 7.9 1.6 8.1 8.1 3.0 5.7 3.0 6.5 3.4 3.7 7.1 3.5 3.6 5.1 0.4 4.5 4.3 1.7 9.9 0.4 4.8 0.5 0.2 0.1 0.7 0.3 0.2 0.6 0.5 0.2 0.5 3.1 3.0 0.0 1.4 0.8 2.4 113.5 86.7 21.7 51.7 122.8 79.5 162.4 26.2 54.2 49.4 14.9 18.3 2.9 13.7 33.3 0.0 22.0 17.8 22.7 9.1 41.8 0.0 1.8 132.6 7.5 10.1 17.9 0.4 0.0 7.6 5.5 12.8 24.6 5.8 4.4 4.8 0.0 52.0 18.4 18.2 26.7 15.8 6.5 52.3 10.8 9.2 0.0 8.6 5.7 11.7 9.1 0.0 6.5 31.2 1.4 3.4 32.1 1.8 6.9 3.0 16.5 MVP "LRP, VAULT1" ENSG00000013364 "Major vault protein" Q14764 16 29820394-29848039 "Cancer-related genes, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" Ribonucleoprotein "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Enterocytes: 450.3;monocytes: 338.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 69.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002321, CAB002752, CAB022717, HPA064740" Enhanced Supported Cytosol NA NA 38000 Cytosol "CAB002752: , CAB022717: , HPA002321: AB_1079277, HPA064740: AB_2685342" "prognostic favorable (4.51e-4)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "unprognostic (1.80e-1)" "unprognostic (8.17e-2)" "unprognostic (3.03e-2)" "unprognostic (1.11e-2)" "unprognostic (2.22e-2)" "unprognostic (6.03e-3)" "unprognostic (2.19e-1)" "unprognostic (6.85e-3)" "unprognostic (2.86e-1)" "prognostic favorable (5.49e-5)" "unprognostic (2.22e-1)" "unprognostic (5.19e-2)" "unprognostic (5.69e-3)" "unprognostic (2.65e-2)" 32.4 55.4 6.8 37.8 17.9 13.9 20.7 5.4 11.4 20.5 49.5 12.0 11.7 48.7 29.5 29.0 28.6 21.0 46.6 27.8 6.6 6.0 58.9 43.6 57.9 59.4 20.4 4.9 42.7 37.2 8.9 14.6 22.8 13.2 18.3 32.6 14.5 23.3 14.8 16.9 17.6 81.5 24.4 14.6 38.8 34.2 27.4 13.5 17.4 27.1 23.5 23.3 25.4 21.6 10.1 28.7 41.1 53.1 17.6 22.4 33.3 10.6 31.5 0.9 1.0 37.5 49.2 4.6 27.0 44.5 16.5 21.4 4.7 36.1 2.0 22.0 39.5 19.2 13.7 1.5 23.6 8.0 25.7 1.6 0.6 13.6 14.1 33.9 1.0 11.5 64.2 18.6 36.6 10.8 30.6 47.8 2.6 0.7 15.4 29.1 5.3 0.5 2.7 1.0 15.8 3.9 2.4 1.6 6.7 39.7 18.2 3.7 2.1 7.7 10.0 5.6 2.0 2.3 3.8 69.8 21.5 10.7 20.6 10.8 12.1 8.6 1.1 50.1 1.9 4.5 9.7 33.8 13.4 19.3 53.1 15.1 10.1 21.8 19.8 28.7 7.1 16.8 14.9 41.1 17.6 47.5 17.5 22.4 33.3 6.8 17.9 5.4 11.4 6.6 6.0 20.4 4.9 13.2 13.5 44.7 98.7 34.8 31.6 17.4 4.2 10.1 86.6 40.2 47.8 66.3 2.0 102.0 38.1 233.0 4.4 35.9 450.3 23.3 272.7 63.2 42.2 19.8 33.4 21.2 72.1 7.9 54.3 39.9 45.7 14.1 53.2 49.6 30.4 338.2 134.2 3.3 221.7 280.5 44.9 146.5 4.3 19.4 32.8 1.7 1.3 19.2 221.2 37.1 139.8 52.1 MXD4 "bHLHc12, MAD4, MST149, MSTP149" ENSG00000123933 "MAX dimerization protein 4" Q14582 4 2247432-2262294 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053363 Supported Cytosol NA NA Cytosol "HPA053363: AB_2682128" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-2)" "unprognostic (2.84e-2)" "unprognostic (3.54e-2)" "prognostic favorable (2.21e-5)" "unprognostic (1.64e-1)" "unprognostic (5.94e-2)" "unprognostic (8.37e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.39e-5)" "unprognostic (5.65e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.12e-2)" 31.9 21.6 20.1 11.8 17.1 23.3 26.2 63.2 23.3 16.5 17.6 15.1 29.8 17.4 19.7 19.7 13.6 24.4 19.2 19.8 16.0 13.1 23.3 12.1 20.0 19.9 13.5 12.4 12.6 18.7 11.4 32.7 24.5 14.4 17.6 7.3 18.3 32.7 26.3 19.3 24.3 16.8 13.8 11.4 29.8 15.1 11.8 11.3 34.8 17.6 8.0 16.1 16.2 21.3 3.5 10.6 8.1 4.3 2.7 5.6 1.9 1.0 3.6 5.7 6.8 20.2 15.0 1.3 7.2 7.4 5.4 5.5 0.8 3.1 3.0 16.2 10.8 2.8 4.9 1.6 5.7 1.4 2.7 17.4 0.5 12.2 10.0 14.9 2.3 6.5 23.4 10.2 1.7 2.7 11.9 12.8 4.5 4.1 5.1 5.0 6.9 5.3 13.4 2.3 4.1 16.1 3.6 1.9 6.3 6.3 5.6 9.3 17.4 6.7 3.3 5.1 7.4 15.6 14.9 30.0 6.0 2.4 4.4 1.6 7.8 5.5 1.1 8.2 2.1 1.7 8.1 4.2 4.8 5.3 4.3 4.3 3.4 4.7 5.0 3.6 3.5 2.4 2.5 1.7 2.7 4.1 10.6 5.6 1.9 20.1 17.1 63.2 23.3 16.0 13.1 13.5 12.4 14.4 11.3 17.9 14.5 26.4 14.2 16.9 79.3 15.7 15.3 5.3 14.8 57.6 82.5 34.2 13.3 14.4 8.0 36.0 42.9 23.3 15.5 42.1 33.4 28.8 24.2 29.8 42.0 62.0 32.2 108.1 54.1 22.1 30.8 25.9 21.9 4.6 47.2 66.8 16.1 28.8 53.0 18.4 95.5 25.8 30.2 4.9 21.1 23.1 27.3 29.9 29.8 10.8 MYO15B MYO15BP ENSG00000266714 "Myosin XVB" 17 75588058-75626501 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 10 "intestine: 155.3" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 148.8;Paneth cells: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 26.0;HEL: 10.9;HMC-1: 14.9;THP-1: 21.5" "Not detected" "Not detected" "HPA022857, HPA023105" Approved Cytosol No No Cytosol "HPA022857: AB_1848813, HPA023105: AB_1859526" "prognostic favorable (9.34e-4)" "unprognostic (7.55e-2)" "unprognostic (6.99e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (5.59e-4)" "unprognostic (7.29e-3)" "unprognostic (1.48e-1)" "unprognostic (4.97e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-3)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "unprognostic (3.35e-1)" "prognostic favorable (6.90e-5)" 7.5 2.8 4.2 7.3 5.3 13.8 8.9 1.6 4.3 8.0 58.9 8.1 5.4 48.9 13.6 4.5 2.8 10.8 13.5 5.8 4.5 1.7 13.0 2.0 10.7 5.0 6.5 5.5 14.9 3.6 1.8 3.7 4.0 5.1 7.1 5.9 6.5 5.2 4.5 3.1 3.9 155.3 5.9 4.0 13.2 4.8 3.1 5.9 5.5 14.0 2.3 4.0 4.9 7.2 2.8 2.0 6.2 1.5 1.9 1.4 1.1 0.3 26.0 0.3 1.0 0.2 0.4 0.4 0.1 0.0 0.0 0.0 3.4 7.4 0.4 1.0 0.0 0.3 0.4 0.0 0.0 0.0 0.3 2.0 10.9 5.0 6.4 0.7 0.0 14.9 0.7 0.5 0.0 0.0 0.5 0.1 4.6 0.6 2.9 0.0 3.5 0.2 4.3 0.5 7.2 6.5 6.8 0.2 1.1 0.1 0.5 1.0 2.0 0.2 0.4 0.8 0.9 2.3 21.5 0.5 0.1 1.1 0.1 0.1 1.4 0.8 0.1 0.6 5.3 0.4 2.4 1.5 1.2 1.4 1.4 0.9 1.5 0.7 0.5 0.8 2.8 0.5 1.0 6.2 1.9 1.5 2.0 0.2 1.1 4.2 5.3 1.6 4.3 4.5 1.7 6.5 5.5 5.1 5.9 0.0 3.5 8.0 2.1 2.2 3.8 5.6 10.2 6.7 2.3 8.7 15.7 0.1 1.7 1.5 0.5 9.8 148.8 0.0 1.4 0.1 5.1 1.7 13.9 1.6 4.7 1.6 30.4 25.2 9.1 0.4 5.2 10.2 3.3 1.8 31.9 6.1 5.2 56.1 4.6 12.7 14.2 6.5 3.8 3.5 3.6 2.6 0.1 4.3 11.1 1.6 MYO1D "KIAA0727, myr4, PPP1R108" ENSG00000176658 "Myosin ID" O94832 17 32492522-32877177 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 110.8;Enterocytes: 119.8;Mucus-secreting cells: 86.3;Paneth cells: 95.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 2.6" "Group enriched" "Detected in many" 5 "B-cells: 1.7;T-cells: 2.6" "Cell line enhanced" "Detected in many" "ASC diff: 34.4;CACO-2: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054744 Uncertain Approved Cytosol NA NA Cytosol "HPA054744: AB_2682589" "unprognostic (3.83e-3)" "unprognostic (1.53e-1)" "unprognostic (9.70e-3)" "unprognostic (3.95e-2)" "unprognostic (6.68e-2)" "unprognostic (1.89e-1)" "unprognostic (1.84e-1)" "unprognostic (2.04e-1)" "unprognostic (8.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" "prognostic favorable (5.01e-6)" "unprognostic (1.73e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.53e-6)" 20.3 16.9 4.4 21.6 14.4 1.8 13.9 8.8 9.7 12.8 53.1 26.2 4.8 40.5 12.5 11.8 19.8 9.2 26.9 7.4 6.4 3.7 15.7 8.1 17.7 6.9 18.4 6.8 14.7 15.2 19.6 7.4 8.4 11.6 11.3 45.6 10.2 18.7 7.1 3.8 22.0 46.5 9.4 20.9 5.9 13.1 6.4 15.7 2.5 21.9 10.6 13.4 12.7 13.9 1.7 0.2 0.3 0.0 0.4 2.6 0.5 9.7 0.4 0.3 0.1 34.4 19.9 0.4 5.8 11.5 1.1 6.8 45.7 15.7 5.5 1.2 26.0 0.2 9.2 1.2 14.7 1.7 0.7 11.8 5.0 0.0 3.2 2.2 0.0 2.7 5.7 9.3 8.5 7.8 0.1 14.4 3.0 8.3 9.2 5.2 11.8 0.0 0.1 1.8 11.1 8.8 0.0 6.7 6.3 4.7 19.3 11.5 1.9 1.9 3.6 29.1 3.0 15.9 0.0 17.8 5.2 2.6 0.2 0.1 11.1 12.7 0.0 7.0 0.0 1.5 0.0 0.0 0.0 1.1 0.0 2.6 1.7 1.2 1.4 0.2 0.3 0.3 0.4 0.3 0.4 0.0 0.0 1.1 0.5 4.4 14.4 8.8 9.7 6.4 3.7 18.4 6.8 11.6 15.7 20.8 12.5 9.3 7.7 7.1 0.6 3.4 25.5 14.7 9.1 22.7 17.7 15.0 5.0 18.0 110.8 9.4 119.8 0.0 20.4 3.3 8.0 13.6 1.1 10.5 7.3 0.0 25.5 4.9 1.0 24.7 5.5 2.8 15.1 0.0 86.3 0.9 36.4 95.1 17.3 1.8 0.8 6.5 15.5 14.6 6.8 9.8 10.4 1.9 66.0 16.9 MYO1F ENSG00000142347 "Myosin IF" O00160 19 8520790-8577577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 69.4;Kupffer cells: 191.9;Macrophages: 117.9;T-cells: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 15.5;HL-60: 15.3;HMC-1: 27.2;NB-4: 60.4;THP-1: 45.0;U-937: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055242, HPA056036" Enhanced Enhanced Cytosol NA NA 8800 Cytosol "HPA055242: AB_2682754, HPA056036: " "unprognostic (4.86e-2)" "unprognostic (5.86e-3)" "unprognostic (1.39e-2)" "unprognostic (1.04e-3)" "unprognostic (1.76e-2)" "unprognostic (2.12e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (7.47e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.57e-1)" "unprognostic (9.35e-2)" 7.6 3.7 4.8 22.9 9.1 50.6 3.6 1.0 4.6 2.2 4.3 7.5 0.4 4.6 2.1 4.7 2.7 5.4 6.5 4.0 5.2 3.1 3.7 6.2 17.1 24.8 9.0 1.7 2.5 2.3 0.6 2.3 4.8 6.9 3.3 2.3 3.5 3.3 1.3 1.2 1.8 8.5 3.9 9.9 56.1 3.9 1.3 7.0 4.2 2.7 1.8 11.1 6.8 2.5 1.5 15.4 64.9 23.7 7.5 14.9 18.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 15.5 0.0 11.2 0.0 0.0 0.0 15.3 27.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 60.4 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 45.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 24.8 0.0 14.4 23.7 24.5 14.9 19.6 11.6 1.5 5.9 10.2 15.4 0.7 0.4 4.6 64.9 7.5 22.4 1.9 8.1 18.6 4.8 9.1 1.0 4.6 5.2 3.1 9.0 1.7 6.9 7.0 3.0 20.1 25.2 1.9 3.0 0.7 2.1 7.6 0.0 4.5 1.8 2.0 4.1 1.7 1.2 5.2 2.7 2.1 23.3 0.8 6.0 3.1 1.2 30.1 5.6 69.4 6.4 1.2 14.1 191.9 3.6 2.3 117.9 6.8 53.3 1.7 1.4 1.7 1.9 1.1 2.1 0.3 0.0 2.8 2.7 2.1 4.6 4.2 142.2 2.4 1.4 MYO7A "DFNA11, DFNB2, NSRD2, USH1B" ENSG00000137474 "Myosin VIIA" Q13402 11 77128264-77215241 "Disease related genes, Predicted intracellular proteins" Hearing "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.3;retina: 30.9" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 45.2;Cytotrophoblasts: 34.1;Hofbauer cells: 24.3;Ito cells: 21.5;Kupffer cells: 20.9;Rod photoreceptor cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 5.6;intermediate monocyte: 4.0;NK-cell: 1.4" "Group enriched" "Detected in many" 10 "monocytes: 5.6;NK-cells: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 11.6;CACO-2: 7.1;RH-30: 15.9;RPMI-8226: 10.4;SK-BR-3: 8.7;U-937: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA028918, CAB034059" Uncertain Approved Cytosol NA NA Cytosol "CAB034059: AB_2148626, HPA028918: AB_10603022" "unprognostic (1.14e-3)" "unprognostic (2.58e-2)" "unprognostic (2.94e-2)" "unprognostic (1.61e-1)" "unprognostic (9.66e-2)" "unprognostic (4.02e-3)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (3.65e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (3.03e-2)" 5.8 26.3 3.6 3.7 5.6 1.1 5.0 0.7 3.0 1.3 1.7 3.5 0.9 2.2 1.3 2.9 1.2 2.3 2.8 1.7 4.0 3.8 5.3 14.8 1.6 4.5 5.2 1.7 4.4 3.8 1.2 25.1 16.9 7.2 13.6 1.4 30.9 1.1 0.9 1.0 0.6 2.4 2.4 3.9 11.2 2.0 22.9 4.7 0.5 1.5 0.3 1.1 1.9 4.4 0.0 0.3 0.0 5.6 1.4 0.1 1.8 0.0 1.1 0.1 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 7.1 2.0 0.0 1.6 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.7 0.0 0.3 4.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.3 0.0 15.9 10.4 0.0 0.2 2.5 0.8 0.1 8.7 0.1 1.9 1.2 1.1 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 5.6 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 1.8 3.6 5.6 0.7 3.0 4.0 3.8 5.2 1.7 7.2 4.7 0.0 0.0 0.0 0.2 0.2 7.3 3.6 7.6 0.0 0.0 0.0 45.2 34.1 0.0 0.6 1.5 0.7 0.0 0.0 1.5 7.0 0.8 0.1 0.0 12.4 24.3 0.0 1.2 21.5 20.9 3.7 2.8 1.1 0.0 0.0 0.5 15.1 1.0 0.0 0.4 2.2 31.8 0.0 0.3 0.3 0.4 0.3 13.5 0.0 0.4 0.1 MYO9B CELIAC4 ENSG00000099331 "Myosin IXB" Q13459 19 17075781-17214537 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, GTPase activation, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 192.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037190, HPA042043" Approved Supported Cytosol NA NA Cytosol "CAB037190: AB_477214, HPA042043: AB_10796897" "unprognostic (1.92e-1)" "unprognostic (1.79e-3)" "unprognostic (4.35e-2)" "unprognostic (6.63e-2)" "unprognostic (1.70e-1)" "unprognostic (1.18e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (5.66e-6)" "unprognostic (1.97e-1)" "unprognostic (1.50e-1)" "unprognostic (2.36e-2)" "unprognostic (5.53e-2)" 17.4 14.3 14.3 34.7 30.2 59.3 16.0 16.2 25.0 12.7 15.3 40.1 10.6 12.5 16.2 12.8 11.0 10.0 14.9 11.2 16.0 11.8 9.4 12.9 25.0 37.4 38.8 10.7 8.2 9.0 6.7 9.2 15.2 18.8 15.6 11.1 14.7 12.3 10.7 4.8 13.5 20.3 17.2 27.8 55.9 15.2 21.8 28.2 17.4 9.2 5.4 24.8 17.2 16.2 3.3 4.4 14.4 4.7 2.9 3.9 1.9 19.1 8.9 11.9 13.9 8.7 9.2 34.6 18.2 9.4 11.5 10.1 7.1 9.8 17.9 10.2 15.9 10.3 12.0 5.1 8.9 8.7 31.9 10.5 21.5 10.5 6.8 11.2 16.8 34.8 8.4 4.7 15.9 6.2 7.1 12.0 8.0 8.8 12.2 7.9 8.0 22.8 31.3 9.0 6.2 19.8 25.0 8.9 5.1 4.5 16.3 4.1 9.1 11.3 9.0 23.5 6.7 8.9 17.7 23.2 21.5 9.6 33.1 15.3 17.6 11.1 11.5 21.2 22.1 26.7 4.2 3.8 6.6 3.4 4.7 2.1 3.3 2.5 2.7 2.2 3.0 1.6 2.4 14.4 2.9 2.8 4.4 3.9 1.9 14.3 30.2 16.2 25.0 16.0 11.8 38.8 10.7 18.8 28.2 8.9 32.6 32.1 45.6 17.4 8.0 8.7 12.7 6.7 11.4 5.2 192.4 14.3 1.7 7.0 4.2 25.9 19.2 0.0 6.6 21.0 16.9 41.3 20.9 13.5 66.4 7.9 6.9 26.4 56.8 7.6 11.5 84.1 42.2 45.1 12.6 9.3 9.7 12.7 15.9 2.2 97.0 6.5 29.9 8.0 13.2 15.7 12.0 35.7 13.3 33.8 NAA16 "FLJ22054, MGC40612, NARG1L, PRO2435" ENSG00000172766 "N(alpha)-acetyltransferase 16, NatA auxiliary subunit" Q6N069 13 41311205-41377030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039761, HPA040157" Approved Enhanced Cytosol NA NA Cytosol "HPA039761: AB_10795112, HPA040157: AB_10793917" "unprognostic (2.09e-2)" "unprognostic (2.86e-2)" "unprognostic (2.95e-1)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "unprognostic (4.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.47e-3)" "unprognostic (1.09e-2)" "unprognostic (2.90e-1)" "unprognostic (3.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.36e-2)" "unprognostic (7.94e-2)" "unprognostic (5.81e-2)" "unprognostic (1.58e-1)" "unprognostic (3.34e-2)" 7.2 6.3 8.4 6.1 9.6 25.5 6.7 20.0 13.2 7.7 6.0 5.1 5.3 5.6 10.0 4.3 7.9 9.0 5.0 5.3 7.5 3.7 4.4 4.0 6.3 9.0 8.5 5.8 8.0 25.7 5.1 9.6 5.0 6.6 6.5 4.4 4.5 7.0 8.3 8.3 7.9 6.5 10.0 7.9 5.5 6.7 9.2 9.7 8.3 5.7 4.0 5.1 8.7 21.1 3.0 2.7 4.8 2.4 5.4 8.2 2.2 6.5 5.4 13.6 10.0 4.8 6.2 5.3 8.1 6.8 8.1 7.1 6.5 5.2 11.0 3.9 6.4 3.3 9.2 7.0 5.2 9.9 6.7 14.3 13.4 5.3 6.4 5.2 15.0 9.1 4.3 3.8 3.3 6.3 5.3 7.9 10.8 6.0 6.1 5.1 5.3 15.5 4.2 11.7 9.1 7.5 11.5 5.7 9.0 6.3 6.0 4.7 10.8 7.3 7.2 2.8 8.3 4.4 8.2 5.8 5.6 4.6 8.8 6.2 4.3 4.8 12.8 7.1 6.4 6.5 4.3 2.4 4.8 3.9 1.3 3.8 1.6 4.5 4.1 1.3 3.0 8.2 8.2 1.3 5.4 1.8 2.7 3.3 2.2 8.4 9.6 20.0 13.2 7.5 3.7 8.5 5.8 6.6 9.7 8.9 11.8 13.7 18.6 15.8 26.3 8.9 7.6 21.4 14.8 8.7 13.7 7.0 1.7 10.1 15.7 15.9 5.1 0.0 17.9 6.4 12.5 16.7 3.5 8.3 15.8 36.5 7.5 13.5 8.7 15.8 27.9 12.3 13.5 5.4 4.4 14.0 13.0 5.8 18.7 6.3 35.1 19.4 13.2 29.7 27.4 12.8 2.4 20.3 8.7 16.6 NAA20 "dJ1002M8.1, NAT3, NAT5" ENSG00000173418 "N(alpha)-acetyltransferase 20, NatB catalytic subunit" P61599 20 20017116-20033655 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063344 Supported Cytosol NA NA Cytosol "HPA063344: AB_2684991" "unprognostic (2.94e-2)" "unprognostic (1.14e-1)" "unprognostic (7.14e-2)" "unprognostic (2.59e-1)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.00e-2)" "unprognostic (1.11e-2)" "unprognostic (2.40e-1)" "unprognostic (6.18e-2)" "unprognostic (9.30e-2)" "unprognostic (3.85e-1)" "unprognostic (2.93e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.32e-1)" 15.9 20.0 14.2 10.0 21.4 17.4 23.2 15.5 34.1 17.3 12.7 12.0 22.7 9.7 20.5 17.7 58.4 15.8 12.3 24.1 14.7 14.1 24.6 25.0 15.7 19.0 13.1 18.3 12.9 43.2 24.8 20.0 18.5 19.4 14.4 12.2 11.2 22.0 20.6 35.2 15.6 11.0 17.3 13.1 11.0 14.5 43.7 10.2 9.5 23.6 37.5 22.1 14.0 23.7 18.6 28.3 20.4 27.5 17.7 25.8 26.4 40.5 24.6 8.9 13.9 18.8 19.8 13.4 30.0 20.5 27.0 25.3 12.6 29.4 22.0 16.3 20.2 21.8 32.2 15.2 48.1 22.0 9.9 16.5 16.5 6.5 18.8 27.0 17.4 12.2 22.5 31.7 27.4 27.7 15.6 23.2 15.8 26.7 22.8 23.5 31.7 24.5 18.2 6.9 28.1 40.3 13.5 35.1 29.2 26.6 9.4 16.9 11.5 18.1 51.2 25.0 6.1 31.6 28.1 25.2 22.5 13.2 27.0 27.5 24.8 30.9 23.8 13.6 15.3 16.0 8.0 27.5 20.4 17.6 27.5 25.8 18.6 20.5 20.2 28.3 16.5 19.9 22.0 3.6 17.7 23.2 22.9 20.8 26.4 14.2 21.4 15.5 34.1 14.7 14.1 13.1 18.3 19.4 10.2 62.5 35.6 41.7 83.1 96.6 54.1 70.6 71.4 99.0 55.7 99.5 23.6 98.0 195.6 180.5 209.7 76.7 31.4 0.0 145.5 94.1 66.4 74.5 49.7 69.9 213.0 65.2 39.6 52.2 51.1 27.3 64.7 64.9 67.4 121.8 44.4 78.6 191.0 35.1 70.4 177.4 48.7 38.8 66.9 234.3 53.9 103.8 71.5 45.7 56.2 118.5 NAA30 "C14orf35, FLJ35355, MAK3, Mak3p, NAT12" ENSG00000139977 "N(alpha)-acetyltransferase 30, NatC catalytic subunit" Q147X3 14 57390544-57415917 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057824 Uncertain Supported Cytosol NA NA Cytosol "HPA057824: AB_2683539" "unprognostic (5.13e-2)" "unprognostic (7.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (6.31e-2)" "unprognostic (1.84e-2)" "unprognostic (5.44e-2)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.25e-8)" "unprognostic (1.77e-1)" "unprognostic (1.67e-1)" "unprognostic (5.75e-3)" "unprognostic (1.63e-1)" 10.7 10.3 15.8 10.7 18.3 15.0 16.4 18.1 18.9 9.9 15.0 9.2 8.6 11.4 12.1 8.8 13.5 9.1 12.5 18.8 13.9 15.6 14.7 19.1 8.2 9.6 12.9 16.4 18.1 10.5 16.2 13.4 15.4 12.0 12.3 9.6 9.6 10.8 12.8 34.9 10.5 13.5 13.0 9.9 9.8 8.6 21.4 10.1 15.0 12.6 13.6 10.3 12.8 13.7 2.6 1.5 1.7 5.3 5.5 4.2 0.8 14.1 13.6 7.8 12.7 13.2 17.3 13.2 16.6 16.1 12.7 11.6 12.2 10.5 10.4 14.7 13.7 9.7 15.0 14.0 10.7 21.3 18.0 7.2 8.4 7.8 10.6 13.8 16.8 9.8 11.7 16.0 11.5 19.3 14.2 19.5 13.0 8.2 10.4 16.8 16.3 14.0 9.8 8.3 13.1 15.2 11.2 22.5 8.1 13.1 12.9 16.8 8.8 14.0 13.9 16.8 14.6 17.8 8.8 17.0 20.0 21.0 10.9 10.5 7.7 9.3 12.7 13.2 8.5 14.1 1.7 0.9 0.5 2.9 2.1 3.0 2.3 2.8 4.2 0.8 2.6 3.0 2.8 0.4 5.5 5.3 1.5 3.7 0.8 15.8 18.3 18.1 18.9 13.9 15.6 12.9 16.4 12.0 10.1 8.9 7.5 12.0 10.0 36.5 12.8 36.4 15.3 6.7 5.7 3.5 17.7 14.5 8.3 11.2 72.4 16.1 8.5 0.0 10.2 13.2 13.2 14.3 6.9 21.2 8.7 9.5 20.2 11.6 10.7 23.6 12.7 6.9 21.9 8.2 14.6 12.3 11.8 11.9 12.7 13.7 13.4 19.4 12.3 44.7 16.9 36.0 18.5 14.6 10.9 12.4 NAALADL1 ENSG00000168060 "N-acetylated alpha-linked acidic dipeptidase like 1" Q9UQQ1 11 65044818-65058549 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "blood: 49.5;intestine: 123.4" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 39.3;monocytes: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 49.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.4;fHDF/TERT166: 6.8;HHSteC: 19.0;HSkMC: 12.5;SCLC-21H: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047123 Enhanced Uncertain Cytosol NA NA Cytosol "HPA047123: AB_2679942" "unprognostic (2.98e-2)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "unprognostic (8.76e-2)" "unprognostic (1.70e-1)" "unprognostic (1.28e-3)" "unprognostic (1.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.75e-4)" "unprognostic (2.10e-3)" "unprognostic (3.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.80e-2)" 4.1 0.9 1.4 3.3 1.6 7.0 4.1 1.9 1.4 6.0 54.3 1.2 2.6 7.8 7.2 1.8 2.7 4.4 3.4 3.5 1.3 0.6 2.3 1.2 3.4 5.2 1.5 1.5 6.2 1.0 0.9 2.0 1.5 1.6 4.6 2.6 3.1 2.3 4.8 2.0 1.6 123.4 4.3 1.4 5.0 2.8 1.8 1.2 1.8 1.8 2.3 2.9 3.1 5.4 8.8 4.9 49.5 6.3 22.2 12.9 7.0 0.0 0.0 0.1 0.2 0.5 5.4 0.9 2.0 0.0 2.5 1.1 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.1 3.1 19.0 0.0 0.0 12.5 0.0 2.5 0.0 0.0 3.2 0.1 0.0 0.2 0.0 0.2 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.0 9.8 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.7 0.0 0.1 0.1 49.5 6.3 10.3 9.5 4.3 4.9 8.0 7.6 4.8 4.9 8.8 8.8 4.9 1.1 22.2 2.5 0.2 12.9 7.0 1.4 1.6 1.9 1.4 1.3 0.6 1.5 1.5 1.6 1.2 0.0 0.0 8.2 3.2 3.2 1.1 1.1 2.5 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.6 9.0 39.3 0.0 0.7 0.2 5.7 0.5 19.6 0.0 2.8 9.5 1.2 16.5 7.6 1.7 10.9 6.4 15.1 22.6 0.7 10.8 0.3 14.4 17.0 0.0 0.9 0.0 13.7 1.6 2.6 2.9 0.3 11.7 0.4 0.3 NACA NACA1 ENSG00000196531 "Nascent polypeptide-associated complex alpha subunit" "E9PAV3, Q13765" 12 56712428-56731628 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Activator, Chaperone, DNA-binding" Allergen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA073152, HPA073648" Approved Cytosol NA Yes Cytosol "HPA073152: AB_2686575, HPA073648: AB_2686621" "unprognostic (3.35e-2)" "unprognostic (9.98e-3)" "unprognostic (1.56e-1)" "unprognostic (2.30e-3)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.24e-3)" "unprognostic (1.55e-1)" "unprognostic (3.92e-2)" "unprognostic (2.95e-2)" "unprognostic (5.64e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (4.58e-11)" "unprognostic (9.47e-2)" "unprognostic (6.28e-2)" "unprognostic (7.00e-2)" "unprognostic (9.79e-2)" 106.9 85.3 72.2 77.6 63.0 120.7 149.8 71.7 65.5 115.5 89.1 40.5 76.7 57.3 83.3 107.7 142.6 95.2 69.2 111.5 58.9 52.7 79.8 130.1 68.5 148.3 63.7 51.3 213.8 119.9 58.1 61.3 80.8 63.7 112.3 79.7 45.9 95.5 72.9 241.6 124.5 71.2 115.1 74.1 81.9 72.3 53.2 53.8 97.8 109.0 149.1 125.1 144.8 139.1 91.8 101.6 45.4 160.0 66.3 97.4 146.6 78.5 91.5 109.0 86.1 130.5 223.6 108.3 78.8 113.8 107.4 74.8 110.2 87.3 141.4 88.3 73.9 44.3 69.2 96.5 126.6 114.5 69.2 150.1 102.6 64.1 109.6 122.4 144.6 66.2 176.7 162.8 87.2 178.1 193.1 118.5 83.8 127.1 184.9 104.9 76.4 93.4 178.8 111.2 76.1 102.2 106.3 91.9 150.0 149.2 79.8 80.9 87.4 58.5 139.6 121.0 79.5 152.0 166.3 76.7 56.8 69.7 60.3 79.1 88.6 98.6 125.9 83.3 99.2 72.2 33.2 88.1 45.4 58.5 124.6 85.6 91.8 83.4 72.5 94.4 74.6 97.4 83.9 33.2 66.3 160.0 101.6 85.9 146.6 72.2 63.0 71.7 65.5 58.9 52.7 63.7 51.3 63.7 53.8 413.9 563.5 1474.2 1870.1 1800.9 294.5 578.3 937.6 440.3 720.0 375.1 62.8 1562.4 1507.1 1062.8 561.3 1209.8 673.8 420.4 1761.3 2399.9 1079.6 1341.5 713.0 646.1 1391.2 173.2 622.3 710.2 1196.9 484.6 2231.3 1465.0 1175.9 1424.7 1175.0 458.5 1465.8 1052.1 1345.3 1857.7 337.7 789.0 1297.8 499.0 489.8 1950.7 1943.0 1208.8 1657.0 2037.8 NACA2 "MGC71999, NACAL" ENSG00000253506 "Nascent polypeptide associated complex alpha subunit 2" Q9H009 17 61590426-61591202 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 76.7" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 120.7;Early spermatids: 304.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 7.7;SK-MEL-30: 4.4" "HPA073152, HPA073648" Approved Cytosol NA NA Cytosol "HPA073152: AB_2686575, HPA073648: AB_2686621" "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (9.59e-2)" "unprognostic (5.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.45e-1)" "unprognostic (8.14e-3)" "unprognostic (4.91e-2)" "unprognostic (3.51e-2)" "unprognostic (1.18e-2)" "unprognostic (7.80e-2)" "unprognostic (2.08e-1)" "unprognostic (1.80e-2)" "unprognostic (6.88e-2)" "unprognostic (7.53e-3)" "unprognostic (5.45e-3)" "unprognostic (3.09e-3)" 2.5 2.5 2.4 2.7 2.8 2.2 5.6 2.2 2.8 6.6 2.4 1.0 0.8 2.2 2.1 2.6 5.0 2.2 1.9 3.7 2.2 2.0 4.7 5.5 3.3 6.5 2.2 2.1 9.5 14.3 2.3 2.1 3.6 1.3 3.3 2.1 1.3 2.2 2.0 7.2 2.8 4.1 5.4 2.9 4.2 2.2 76.7 2.8 4.8 4.1 3.2 2.7 6.3 2.4 2.1 1.9 0.7 3.2 1.7 2.0 2.9 0.8 0.0 0.8 0.8 0.3 0.6 2.3 0.2 0.8 0.3 0.5 0.7 0.4 0.0 1.3 0.0 0.3 0.2 0.2 0.2 0.6 0.6 0.2 0.2 0.8 0.8 0.2 0.3 0.8 0.0 0.9 0.0 0.0 0.3 0.4 0.1 0.2 2.6 0.2 0.2 1.1 7.7 1.9 0.1 0.2 1.0 0.5 2.5 0.3 0.1 1.0 1.9 0.5 1.2 4.4 0.0 2.0 2.8 0.0 0.4 1.0 1.5 0.8 0.9 0.7 0.8 1.0 0.5 0.7 0.4 1.4 0.7 1.2 3.2 1.4 2.1 1.6 1.6 1.9 1.8 2.0 1.8 0.4 1.7 3.0 1.8 1.9 2.9 2.4 2.8 2.2 2.8 2.2 2.0 2.2 2.1 1.3 2.8 0.0 0.0 26.2 34.9 61.6 0.7 120.7 33.1 0.0 0.0 1.8 0.0 16.5 72.9 0.3 304.8 29.2 2.8 0.0 0.7 19.1 22.7 38.5 0.0 16.2 12.6 0.0 3.5 22.7 59.5 103.0 31.4 21.0 43.9 0.0 6.5 1.2 0.5 10.5 10.6 5.1 0.8 12.9 44.3 61.4 10.7 69.4 20.1 27.7 11.9 38.7 NAPA ENSG00000105402 "NSF attachment protein alpha" P54920 19 47487637-47515240 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010100, HPA046149, HPA050196" Approved Uncertain Cytosol NA NA 5400000 Cytosol "CAB010100: AB_628263, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (9.83e-2)" "unprognostic (9.43e-3)" "unprognostic (1.12e-2)" "unprognostic (1.76e-3)" "unprognostic (9.72e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (5.61e-2)" "unprognostic (2.42e-3)" "unprognostic (1.09e-3)" "prognostic favorable (4.26e-9)" "unprognostic (4.04e-2)" "unprognostic (4.17e-2)" "unprognostic (8.55e-2)" "unprognostic (2.90e-2)" 28.1 52.4 35.5 24.5 49.1 43.6 29.3 70.2 86.9 30.9 29.9 34.8 31.0 26.5 37.6 29.0 56.0 29.1 33.4 47.3 41.8 29.6 35.8 73.8 30.3 24.6 28.1 39.4 28.8 41.2 40.4 35.4 30.3 52.6 49.0 21.7 35.5 52.3 45.5 56.9 45.6 27.4 31.8 25.1 24.8 28.8 38.5 20.8 44.8 36.4 39.0 28.4 31.4 29.1 15.7 44.5 68.2 41.1 24.1 23.5 40.6 17.3 22.9 11.2 19.3 23.5 20.2 8.2 19.7 23.8 43.9 55.4 17.2 10.0 13.1 10.3 25.7 29.1 13.0 18.1 22.9 17.5 21.2 19.6 16.9 22.7 21.0 61.8 19.1 30.0 30.1 15.8 18.3 11.4 9.2 21.3 17.3 14.0 34.8 28.9 14.5 26.1 51.2 9.3 25.9 17.6 17.2 10.6 18.4 34.1 33.4 40.6 15.4 25.1 29.5 17.3 11.2 24.2 30.1 22.8 22.5 11.9 19.1 21.1 22.3 32.4 18.7 42.3 20.1 23.2 35.6 35.6 68.2 22.7 41.1 18.8 15.7 19.3 22.0 30.1 15.2 20.5 20.0 39.6 24.1 41.0 44.5 23.5 40.6 35.5 49.1 70.2 86.9 41.8 29.6 28.1 39.4 52.6 20.8 11.9 40.4 29.8 78.5 56.2 53.9 2.8 68.8 9.4 20.5 48.8 25.5 90.7 150.9 96.2 24.5 35.3 77.2 46.7 87.3 57.2 49.8 66.0 64.5 77.8 115.3 33.4 80.2 40.5 54.8 27.9 39.7 56.4 92.8 101.0 48.5 71.6 84.3 49.1 43.5 81.6 37.2 90.5 59.0 82.1 70.7 60.0 191.4 49.8 39.9 62.1 NAPB "SNAP-BETA, SNAPB" ENSG00000125814 "NSF attachment protein beta" Q9H115 20 23374519-23421519 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 110.9" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 176.7;Cone photoreceptor cells: 62.8;Horizontal cells: 63.5;Rod photoreceptor cells: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 24.5;U-937: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037225, CAB037227, HPA046149, HPA050196" Supported Uncertain Cytosol NA NA Cytosol "CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (3.89e-1)" "unprognostic (2.71e-1)" "unprognostic (5.95e-2)" "unprognostic (1.05e-1)" "unprognostic (2.54e-2)" "unprognostic (3.92e-2)" "unprognostic (1.32e-3)" "unprognostic (1.25e-1)" "unprognostic (4.71e-2)" "unprognostic (6.37e-2)" "unprognostic (4.46e-3)" "unprognostic (7.52e-3)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" 3.2 15.5 32.7 3.8 32.7 6.0 4.4 46.0 110.9 4.0 4.0 4.4 2.6 3.8 4.7 6.3 3.7 4.6 3.8 3.7 30.5 32.0 4.4 3.8 3.9 4.0 26.1 40.1 6.4 3.4 6.1 4.6 5.9 50.2 4.0 5.0 6.1 4.0 4.6 3.4 5.0 5.5 4.5 9.7 4.5 4.3 5.3 4.0 0.7 5.1 0.1 3.4 3.6 2.3 2.4 1.9 6.0 2.1 1.5 5.1 2.1 4.3 2.8 4.6 4.8 5.2 4.8 6.5 5.6 3.0 4.5 4.0 3.3 3.8 6.3 6.7 3.3 3.3 5.5 5.9 3.8 5.5 2.0 4.4 6.9 3.7 7.7 6.1 5.1 4.1 4.8 5.0 3.2 4.0 4.1 3.3 6.5 5.8 8.4 7.2 2.9 5.2 4.7 2.0 3.5 5.1 3.5 3.7 4.7 5.9 4.7 24.5 7.8 3.2 3.1 5.2 7.0 3.2 3.2 3.9 4.3 3.2 4.8 3.9 6.2 4.8 2.9 2.2 24.4 4.3 6.0 1.2 0.0 5.1 1.3 1.5 1.7 2.0 2.4 1.9 2.4 2.0 3.3 1.5 1.5 2.1 1.5 2.5 2.1 32.7 32.7 46.0 57.7 30.5 32.0 26.1 40.1 50.2 4.0 11.9 6.2 5.1 4.4 7.7 176.7 4.9 7.6 2.7 6.8 14.0 62.8 5.6 0.0 2.9 39.1 7.7 3.5 0.0 1.2 4.4 8.4 3.3 10.5 4.9 4.4 63.5 9.8 10.4 7.2 45.5 8.3 3.6 10.1 4.6 2.3 15.7 2.7 0.0 8.5 2.2 78.5 6.5 6.2 9.7 9.8 7.3 5.1 5.7 4.5 3.3 NAPEPLD "C7orf18, FMP30, NAPE-PLD" ENSG00000161048 "N-acyl phosphatidylethanolamine phospholipase D" Q6IQ20 7 103099776-103149560 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 74.1;Early spermatids: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019832, HPA024338" Approved Approved Cytosol NA NA Cytosol "HPA019832: AB_1844422, HPA024338: AB_2671533" "unprognostic (3.62e-1)" "unprognostic (1.86e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-1)" "unprognostic (7.58e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" "unprognostic (6.39e-3)" "unprognostic (2.70e-2)" "unprognostic (1.20e-1)" "unprognostic (2.81e-2)" "unprognostic (3.21e-1)" "prognostic favorable (7.32e-6)" "unprognostic (8.83e-2)" "unprognostic (1.19e-1)" "unprognostic (1.42e-1)" "unprognostic (2.41e-2)" 3.8 5.3 8.6 3.8 14.0 3.1 3.9 13.9 18.5 5.1 8.8 17.2 3.7 15.9 4.9 3.5 2.6 6.5 6.1 4.2 6.4 5.5 15.1 7.4 4.3 3.8 15.0 11.6 9.7 4.1 8.5 6.2 2.9 10.3 5.4 10.1 5.0 4.2 4.1 5.0 5.7 10.8 4.5 9.7 6.6 11.2 11.1 16.7 5.3 8.8 0.9 3.8 6.9 4.6 7.9 3.7 5.7 4.6 2.9 7.6 2.5 4.6 6.2 4.0 3.6 3.6 3.9 0.6 3.0 2.8 2.1 3.4 2.7 6.2 4.2 5.1 2.3 4.7 4.3 2.8 1.0 2.5 6.5 3.9 1.7 3.7 1.2 0.9 3.7 1.8 2.2 1.2 1.9 0.0 7.8 3.4 3.0 2.0 4.5 4.0 1.7 4.4 2.0 3.7 7.3 7.3 2.8 1.8 2.2 7.6 2.1 2.9 3.9 8.2 2.6 1.8 2.2 1.7 2.1 3.0 5.9 4.2 12.0 3.7 5.6 6.1 3.6 4.2 2.7 11.3 0.2 3.1 5.7 4.9 4.6 4.4 7.4 5.3 5.8 3.7 7.9 7.6 5.6 0.3 2.9 3.0 2.7 4.7 2.5 8.6 14.0 13.9 18.5 6.4 5.5 15.0 11.6 10.3 16.7 17.9 7.7 9.8 4.8 6.0 74.1 10.2 20.4 1.4 6.8 50.6 49.1 7.3 8.3 4.4 112.3 2.9 30.7 0.0 2.3 3.1 4.6 8.5 4.6 18.4 3.5 47.7 13.3 4.9 3.5 31.4 29.4 2.7 13.5 4.6 26.3 21.0 3.7 28.6 31.5 26.7 34.0 6.5 2.3 14.6 10.9 2.5 2.4 4.3 23.0 5.5 NARS NARS1 ENSG00000134440 "Asparaginyl-tRNA synthetase" O43776 18 57600656-57622213 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034257, HPA040017" Enhanced Supported Cytosol NA NA Cytosol "CAB034257: AB_2151043, HPA040017: AB_2676801" "unprognostic (9.85e-2)" "unprognostic (1.88e-1)" "unprognostic (3.86e-3)" "unprognostic (1.68e-1)" "unprognostic (2.61e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.23e-7)" "unprognostic (1.78e-1)" "unprognostic (1.48e-1)" "unprognostic (1.62e-2)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.73e-7)" "unprognostic (1.24e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-1)" "unprognostic (1.51e-1)" 30.9 36.9 35.0 28.8 42.6 19.5 31.6 47.1 51.4 28.1 49.7 24.8 31.1 42.5 30.8 31.6 40.2 27.4 26.8 40.6 40.5 36.5 66.0 41.9 26.0 23.0 39.5 39.2 29.4 29.4 52.0 35.7 25.6 49.5 33.1 46.1 18.5 33.7 30.9 76.6 26.9 35.2 29.9 40.6 25.7 36.0 14.9 36.3 25.0 44.5 31.9 29.2 34.6 35.3 20.0 26.6 15.6 40.8 15.8 23.4 23.7 36.6 24.2 22.8 33.3 29.3 22.5 35.6 51.3 26.8 30.3 37.5 17.4 17.2 46.2 24.6 35.5 30.5 41.8 35.8 31.7 44.4 22.4 12.4 35.3 18.6 27.4 49.6 73.2 36.5 23.9 55.5 41.5 39.7 23.8 25.1 28.4 43.3 34.5 34.0 13.6 28.3 17.8 33.5 23.3 19.5 22.5 26.9 39.0 56.6 41.3 25.1 27.5 24.9 32.1 53.8 25.1 17.9 40.7 27.4 33.8 22.6 14.2 37.9 77.5 95.9 44.9 31.1 48.1 39.3 15.6 40.8 14.2 16.4 35.1 20.2 20.0 17.3 17.4 26.6 18.8 23.4 21.2 12.7 15.8 26.6 25.1 17.2 23.7 35.0 42.6 47.1 51.4 40.5 36.5 39.5 39.2 49.5 36.3 71.5 60.9 52.8 56.5 68.6 83.3 195.9 79.0 170.0 72.8 66.3 33.4 91.5 286.8 103.2 11.5 56.6 105.3 93.5 78.8 68.1 57.5 71.7 91.6 94.8 102.8 90.6 60.9 38.1 67.5 12.5 65.3 70.5 74.2 75.7 75.6 85.4 101.4 49.1 73.2 181.5 68.2 71.1 59.4 41.1 41.9 66.1 132.6 49.0 92.8 67.0 NCDN "NCDN-1, NCDN-2" ENSG00000020129 Neurochondrin Q9UBB6 1 35557473-35567274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 144.3" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 21.4;Club cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023676 Enhanced Supported Supported Cytosol NA NA Cytosol "HPA023676: AB_1854325" "unprognostic (1.15e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (4.66e-2)" "unprognostic (1.41e-1)" "unprognostic (4.36e-2)" "prognostic favorable (3.73e-4)" "unprognostic (5.91e-3)" "unprognostic (5.34e-3)" "unprognostic (5.88e-3)" "unprognostic (2.87e-1)" "unprognostic (3.24e-2)" "unprognostic (2.23e-2)" 5.2 11.3 33.4 6.0 144.3 3.4 3.6 28.7 104.9 9.9 3.5 8.7 1.2 3.9 6.2 4.8 4.5 8.1 6.5 12.0 45.4 25.0 4.0 2.5 4.5 5.9 15.8 32.3 9.2 6.1 6.2 5.5 4.7 26.4 7.1 2.9 3.6 6.7 8.0 5.3 5.6 3.2 6.5 10.7 5.0 4.7 5.8 15.6 0.8 6.5 0.6 4.6 6.0 2.4 5.9 2.7 0.8 4.5 3.0 6.5 5.5 8.8 10.7 9.0 14.1 13.1 16.2 6.2 11.7 12.2 12.3 9.9 10.7 13.1 10.1 11.4 10.8 8.9 13.6 8.8 14.2 4.5 9.8 18.2 12.5 15.7 5.5 18.1 11.3 14.5 15.5 12.0 21.8 8.8 10.2 6.5 6.1 13.5 16.2 10.0 15.9 10.3 7.3 40.3 9.8 18.9 8.5 5.0 13.0 8.3 9.9 11.2 16.1 13.3 12.3 16.5 7.5 11.8 7.4 8.9 15.8 11.3 11.5 16.0 22.8 16.1 7.5 19.6 18.2 14.3 0.0 4.5 0.8 3.1 2.6 3.8 5.9 4.8 4.8 2.7 2.7 6.5 5.3 0.7 3.0 4.2 1.6 2.7 5.5 33.4 144.3 28.7 61.4 45.4 25.0 15.8 32.3 26.4 15.6 3.0 11.8 0.8 0.5 3.1 3.4 12.0 5.1 21.4 15.9 7.0 0.0 5.0 1.7 3.2 2.2 2.8 1.0 0.0 3.7 2.2 5.0 0.4 3.5 3.6 3.3 6.4 3.5 3.1 7.0 0.7 6.1 1.9 5.0 1.0 2.8 1.6 3.5 2.8 3.9 3.0 2.4 0.0 4.1 3.2 2.2 2.6 4.7 3.2 2.1 0.4 NCF2 "NOXA2, p67phox" ENSG00000116701 "Neutrophil cytosolic factor 2" P19878 1 183555563-183590876 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4" "Group enriched" "Detected in many" 6 "Ductal cells: 59.6;Hofbauer cells: 199.3;Kupffer cells: 138.6;Macrophages: 192.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 125.2;neutrophil: 80.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 13.4;HMC-1: 11.7;hTERT-HME1: 28.0;U-2 OS: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002327, HPA006040, CAB022160" Enhanced Supported Cytosol NA NA Cytosol "CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906" "unprognostic (4.97e-2)" "unprognostic (3.48e-2)" "unprognostic (2.40e-2)" "unprognostic (1.22e-3)" "unprognostic (5.83e-3)" "unprognostic (4.04e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.29e-1)" "unprognostic (2.45e-1)" "unprognostic (2.33e-1)" "unprognostic (5.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-2)" "unprognostic (8.24e-2)" "unprognostic (2.36e-2)" 15.3 3.1 2.0 23.0 4.5 53.0 3.9 0.7 2.8 2.9 2.8 3.7 0.2 2.3 1.8 6.1 4.1 5.2 7.2 6.4 2.0 1.8 2.9 5.4 39.5 42.7 6.8 0.4 3.5 4.2 0.6 1.9 11.5 3.8 3.4 3.7 4.2 4.4 0.8 3.5 7.1 3.8 5.8 5.5 45.4 2.6 3.9 3.2 4.2 2.0 5.6 5.5 7.3 3.5 1.4 24.3 125.2 45.7 0.2 1.0 22.7 13.4 0.4 0.0 0.0 0.0 0.0 0.1 1.0 1.2 1.8 0.8 0.1 0.4 1.6 2.3 0.4 0.3 7.6 0.0 9.9 1.6 8.4 0.0 0.0 3.4 3.1 0.0 1.0 11.7 0.0 2.2 1.8 28.0 1.1 0.0 0.0 0.0 3.0 3.1 0.1 0.1 0.5 0.2 0.8 0.8 3.6 1.2 10.1 0.4 0.1 0.0 0.0 0.1 0.0 0.4 1.0 1.5 4.7 0.6 0.0 27.2 0.0 2.5 0.5 0.7 0.3 0.2 5.4 0.0 15.5 45.7 125.2 0.1 34.4 0.1 1.4 0.4 0.1 24.3 0.8 0.2 0.1 80.6 0.2 29.7 1.3 1.0 22.7 2.0 4.5 0.7 2.8 2.0 1.8 6.8 0.4 3.8 3.2 8.9 17.8 4.8 0.1 4.8 0.4 1.1 10.2 26.8 13.6 0.0 0.0 0.8 3.3 59.6 1.0 0.7 0.0 0.0 3.3 0.8 2.1 0.3 7.0 0.4 199.3 0.0 0.0 4.3 138.6 2.1 0.6 192.4 6.8 20.8 0.0 0.0 18.4 1.1 0.0 0.1 0.6 12.9 3.4 0.0 0.2 3.8 1.6 1.3 0.0 0.8 NCF4 "p40phox, SH3PXD4" ENSG00000100365 "Neutrophil cytosolic factor 4" Q15080 22 36860988-36878015 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0" "Cell type enhanced" "Detected in many" 14 "B-cells: 49.2;granulocytes: 71.7;Hofbauer cells: 162.7;Kupffer cells: 83.9;Macrophages: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 130.3" "Cell line enhanced" "Detected in some" "HEL: 18.6;HMC-1: 88.9;NB-4: 31.5;REH: 16.2;RPMI-8226: 31.3;THP-1: 29.6;U-937: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010146, HPA036156, HPA057975" Enhanced Enhanced Cytosol NA NA Cytosol "CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568" "unprognostic (3.27e-2)" "unprognostic (1.55e-2)" "unprognostic (2.68e-2)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (2.78e-3)" "unprognostic (4.20e-2)" "unprognostic (3.69e-2)" "unprognostic (4.03e-2)" "unprognostic (2.70e-1)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (7.06e-8)" "unprognostic (3.60e-1)" "unprognostic (2.23e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-1)" 10.4 5.8 4.4 24.8 5.6 69.0 5.6 0.7 2.8 3.4 7.4 2.5 1.2 5.0 2.2 8.1 4.4 5.9 7.2 8.0 3.9 2.2 4.4 4.2 17.5 21.2 8.0 1.0 3.3 2.1 0.6 2.6 10.3 4.6 5.1 5.3 4.2 6.5 2.2 2.6 2.3 16.0 4.3 7.7 66.0 3.9 3.0 5.4 5.0 3.5 2.8 22.2 9.0 7.1 12.6 10.0 130.3 19.5 0.4 10.8 10.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 18.6 0.0 0.0 0.0 2.7 88.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 31.5 0.0 0.0 0.0 16.2 0.0 31.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 16.5 0.0 58.0 19.5 76.4 0.2 9.6 1.1 12.6 3.9 0.8 9.1 8.9 0.2 0.2 130.3 0.4 6.4 10.0 10.8 10.2 4.4 5.6 0.7 2.8 3.9 2.2 8.0 1.0 4.6 5.4 3.0 28.4 49.2 2.2 2.5 0.0 0.8 0.0 1.4 9.1 1.8 0.0 2.5 0.0 0.6 0.3 1.4 0.4 0.0 2.7 14.2 2.5 0.3 71.7 0.6 162.7 0.0 0.0 0.6 83.9 1.0 0.6 82.4 13.5 17.2 0.3 0.0 1.2 17.3 0.0 0.2 0.2 0.0 0.4 0.0 0.2 1.9 10.9 17.0 1.2 3.8 NCKAP1 "HEM2, Nap1, NAP125" ENSG00000061676 "NCK associated protein 1" Q9Y2A7 2 182909115-183038858 "Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020449 Enhanced Approved Cytosol NA NA 210000 Cytosol "HPA020449: AB_1854327" "unprognostic (7.92e-3)" "unprognostic (1.24e-2)" "unprognostic (3.35e-2)" "unprognostic (8.10e-2)" "unprognostic (1.31e-1)" "unprognostic (1.24e-1)" "unprognostic (2.12e-3)" "prognostic unfavorable (9.71e-4)" "unprognostic (5.06e-2)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (3.48e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-2)" "unprognostic (2.41e-1)" "unprognostic (1.36e-1)" "unprognostic (3.61e-2)" 25.2 23.7 35.8 12.6 49.7 0.6 25.5 32.9 47.2 30.8 29.1 12.9 17.8 28.2 27.9 28.6 42.6 22.6 22.0 46.1 34.0 26.8 37.0 20.8 20.5 4.9 25.8 36.4 24.5 21.9 47.9 26.2 29.4 25.5 30.0 25.6 16.9 24.2 35.9 45.4 26.2 28.5 38.2 20.0 10.2 28.4 16.0 20.4 4.3 44.3 21.0 12.2 33.3 40.9 0.2 0.2 2.8 0.2 0.5 0.9 0.3 23.3 14.7 22.6 14.4 32.0 31.2 25.2 30.6 27.8 20.8 26.3 22.7 20.1 0.1 20.6 36.3 31.3 22.3 19.1 28.8 34.8 5.6 14.9 5.2 16.6 18.8 33.0 0.0 4.5 23.3 35.7 30.1 49.5 28.5 33.0 1.4 12.6 0.0 39.2 15.0 0.4 0.1 23.2 18.9 25.5 1.5 24.7 0.1 29.3 31.6 16.7 15.9 27.7 22.1 28.6 37.5 11.8 0.1 35.7 35.5 20.0 19.9 18.7 3.0 5.6 0.1 27.4 0.0 17.9 2.1 0.2 2.8 0.8 0.1 0.7 0.1 0.6 0.6 0.2 0.2 0.2 0.8 0.9 0.5 0.2 0.2 0.9 0.3 35.8 49.7 32.9 42.3 34.0 26.8 25.8 36.4 25.5 20.4 44.7 40.1 0.9 54.6 77.4 82.1 92.1 56.0 17.4 39.8 76.8 66.8 26.6 23.2 49.3 3.9 76.4 44.4 0.0 53.6 42.5 61.5 90.7 13.9 36.6 4.6 116.0 48.5 68.7 7.0 6.0 72.8 6.1 52.3 1.0 58.2 92.2 72.3 65.1 99.0 50.0 60.1 58.2 79.6 45.9 29.8 98.2 43.6 7.5 47.8 94.9 NCSTN "APH2, KIAA0253" ENSG00000162736 Nicastrin Q92542 1 160343272-160358952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021982, HPA054846, HPA070642" Approved Approved Cytosol NA NA 120000 Cytosol "CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289" "unprognostic (1.08e-1)" "unprognostic (5.22e-3)" "unprognostic (1.51e-1)" "unprognostic (2.89e-2)" "unprognostic (1.19e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-3)" "unprognostic (2.89e-1)" "unprognostic (3.30e-2)" "unprognostic (3.62e-2)" "unprognostic (8.21e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.75e-9)" "unprognostic (1.36e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-2)" "unprognostic (4.89e-2)" 25.6 23.8 12.7 15.3 20.9 12.8 23.3 15.8 24.3 21.8 24.1 39.0 16.5 31.7 24.1 23.3 23.3 19.9 19.5 23.7 13.8 13.9 25.3 37.8 24.7 19.8 28.2 14.2 29.5 41.3 38.9 21.8 63.3 21.5 18.5 24.6 25.1 49.2 19.6 24.2 20.2 38.5 20.7 25.4 25.8 21.4 22.4 22.8 20.3 25.9 13.6 20.6 26.1 20.1 12.5 28.8 27.0 30.5 13.1 11.1 16.8 10.4 12.9 22.2 18.1 68.0 34.4 24.5 21.5 39.4 20.9 24.6 10.0 30.8 7.7 44.8 44.0 14.5 17.8 10.0 20.5 17.7 12.3 8.8 7.3 16.0 15.0 27.0 15.8 33.7 35.0 20.4 19.9 20.8 45.9 30.6 11.9 13.6 22.2 29.8 7.3 5.6 8.3 18.1 27.3 7.2 7.7 13.7 21.7 29.2 14.6 7.4 16.7 23.2 26.5 15.7 37.0 23.7 39.5 24.6 15.7 10.3 10.9 16.3 28.8 40.7 7.7 24.5 10.0 28.6 17.8 29.9 25.0 11.1 30.5 10.4 12.5 9.5 9.5 28.8 11.2 9.9 9.4 27.0 13.1 27.9 16.9 10.0 16.8 12.7 20.9 15.8 24.3 13.8 13.9 28.2 14.2 21.5 22.8 6.0 9.4 20.1 21.7 9.3 17.2 15.2 35.7 12.0 12.5 50.6 49.1 93.6 6.6 34.8 2.1 17.5 49.8 0.0 23.7 84.3 24.4 16.5 12.7 26.8 52.0 17.5 19.4 28.3 43.7 3.1 25.0 26.3 16.9 14.4 31.1 35.8 29.7 28.1 19.8 21.9 19.7 25.8 15.0 43.2 41.7 9.9 123.2 16.0 27.7 17.4 NDST2 "HSST2, NST2" ENSG00000166507 "N-deacetylase and N-sulfotransferase 2" P52849 10 73801911-73811798 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 50.8" HPA051515 Approved Approved Cytosol NA NA 72000 Cytosol "HPA051515: AB_2681517" "unprognostic (8.84e-2)" "unprognostic (7.57e-2)" "unprognostic (2.53e-2)" "unprognostic (9.43e-3)" "unprognostic (5.69e-1)" "unprognostic (1.07e-2)" "unprognostic (5.83e-3)" "unprognostic (2.16e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-2)" "unprognostic (2.23e-5)" "unprognostic (1.49e-2)" "unprognostic (4.08e-7)" "unprognostic (3.71e-2)" "unprognostic (3.69e-2)" "unprognostic (5.93e-2)" "unprognostic (9.06e-2)" 12.6 14.6 7.9 19.2 11.3 37.5 11.8 30.2 12.2 16.6 10.7 13.8 13.4 8.9 18.4 14.8 14.4 12.8 15.5 9.3 9.6 8.4 11.0 9.4 14.7 21.9 7.3 8.8 15.1 12.3 17.3 26.5 14.1 9.2 13.6 10.5 14.7 20.1 17.2 16.4 15.1 14.4 13.4 7.5 31.8 11.8 13.5 9.2 35.3 12.2 8.2 19.3 12.3 13.3 3.1 6.8 5.8 5.3 2.2 7.1 3.2 4.3 3.6 7.5 11.5 9.3 10.8 3.9 5.1 10.9 5.9 6.1 1.9 5.3 3.9 3.1 9.7 6.0 5.0 3.7 5.4 4.8 10.4 3.6 3.9 2.7 3.0 16.4 5.0 50.8 10.2 6.6 10.2 10.5 18.4 7.7 7.9 3.7 15.1 7.4 3.3 5.8 5.5 2.1 2.7 15.3 3.6 3.7 2.4 5.0 3.0 2.5 4.2 4.5 10.7 3.5 5.2 8.2 7.7 12.3 3.0 3.5 3.9 3.6 7.5 3.3 5.2 3.5 7.7 2.3 1.4 5.3 2.1 5.5 3.7 6.5 2.5 4.7 4.8 4.0 3.1 5.6 7.1 5.8 2.2 3.5 6.8 3.1 3.2 7.9 11.3 30.2 12.2 9.6 8.4 7.3 8.8 9.2 9.2 0.0 4.8 3.7 0.3 1.1 0.6 1.4 0.0 4.0 2.3 0.0 0.0 1.2 0.0 4.4 5.7 0.5 3.5 0.0 8.4 1.4 1.0 1.5 13.9 3.8 4.5 1.6 2.4 0.0 6.7 6.8 0.0 3.5 1.7 4.6 2.3 0.7 5.5 2.6 0.0 5.6 0.7 0.0 1.0 2.4 1.4 1.4 5.1 3.2 1.7 2.1 NEDD4 "KIAA0093, MGC176705, NEDD4-1, RPF1" ENSG00000069869 "Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase" P46934 15 55826922-55993746 "Enzymes, Predicted intracellular proteins, Transporters" "Host-virus interaction, Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 57.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 86.4;Alveolar cells type 2: 87.7;Ciliated cells: 135.1;Club cells: 79.6;granulocytes: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001991, HPA039883, CAB072833" Approved Approved Cytosol NA NA Cytosol "CAB001991: , CAB072833: , HPA039883: AB_10795683" "unprognostic (1.18e-1)" "unprognostic (2.10e-2)" "unprognostic (5.66e-3)" "unprognostic (1.15e-1)" "unprognostic (6.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.18e-3)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (6.38e-3)" "unprognostic (2.98e-1)" "unprognostic (2.22e-1)" "unprognostic (2.35e-2)" 14.1 4.1 2.5 3.1 3.3 4.5 8.7 1.5 2.7 9.9 9.4 2.8 3.4 3.4 10.1 4.1 8.2 3.8 4.5 4.1 2.9 2.4 8.6 21.5 7.2 2.1 3.5 1.3 6.6 2.8 6.5 6.7 20.1 3.5 8.4 3.4 5.4 4.0 6.4 57.7 7.1 15.2 10.9 6.0 5.9 4.4 2.6 3.1 9.4 5.7 9.0 3.3 11.9 8.9 0.1 1.6 1.2 2.8 1.2 2.9 0.9 7.3 11.5 3.1 3.0 4.1 6.8 5.1 14.1 22.3 10.5 10.5 5.1 2.2 1.8 3.7 5.4 25.5 12.2 3.4 9.3 17.2 4.1 2.1 9.1 2.7 2.6 21.9 4.0 0.9 11.6 23.1 12.5 21.1 5.1 8.6 5.4 3.9 0.0 30.6 3.8 5.3 0.0 0.8 3.9 1.7 3.9 24.8 1.0 4.3 14.6 0.3 2.0 6.3 4.5 5.6 5.9 5.6 3.0 29.6 23.3 7.7 4.9 22.9 1.2 2.7 4.8 15.7 8.6 5.5 0.6 1.0 0.0 1.3 2.8 2.9 0.1 1.5 1.2 0.8 0.0 1.4 1.6 1.2 1.2 1.9 1.6 1.3 0.9 2.5 3.3 1.5 2.7 2.9 2.4 3.5 1.3 3.5 3.1 86.4 87.7 2.0 3.3 10.8 0.3 4.8 7.6 135.1 79.6 0.0 21.6 16.5 1.7 3.2 1.3 16.8 6.9 0.0 4.8 6.4 6.3 3.4 67.4 17.9 4.0 0.0 0.0 15.4 1.8 1.0 5.2 3.8 1.7 0.0 4.2 8.4 3.3 0.0 6.7 10.8 6.0 0.0 8.2 1.2 5.9 9.2 11.6 2.2 2.9 1.6 NEK4 "NRK2, pp12301, STK2" ENSG00000114904 "NIMA related kinase 4" P51957 3 52708449-52770949 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 47.7" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 58.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015750, HPA058543" Enhanced Supported Cytosol NA NA Cytosol "HPA015750: AB_1854367, HPA058543: AB_2732623" "unprognostic (1.32e-1)" "unprognostic (1.57e-1)" "prognostic favorable (2.69e-5)" "unprognostic (9.65e-3)" "unprognostic (3.42e-1)" "unprognostic (6.64e-2)" "unprognostic (8.75e-3)" "unprognostic (2.27e-1)" "unprognostic (7.85e-2)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.74e-3)" "unprognostic (5.11e-2)" "unprognostic (2.85e-1)" "unprognostic (1.51e-2)" "unprognostic (8.39e-2)" 7.2 10.7 15.5 9.1 15.7 7.3 11.0 20.2 16.1 10.6 8.4 10.6 9.6 7.6 10.3 10.7 8.1 15.8 7.5 7.4 12.5 14.2 11.6 12.4 7.7 8.8 12.7 8.6 15.8 10.2 13.4 17.6 8.7 11.9 9.4 9.7 9.1 8.5 11.3 10.8 5.3 6.6 9.5 10.7 7.9 11.0 47.7 12.4 11.1 15.5 5.0 10.4 9.3 10.7 5.1 6.4 12.4 11.8 4.6 5.2 5.5 12.9 10.1 13.9 10.9 12.7 9.2 15.1 9.2 12.5 17.3 17.5 8.8 9.7 13.3 4.3 9.0 19.1 6.1 16.9 10.9 23.2 13.3 7.1 10.4 12.3 11.2 7.9 25.4 10.5 5.6 10.1 22.1 14.8 9.2 6.4 11.7 12.9 10.9 10.9 11.1 13.7 9.3 12.0 13.7 10.0 12.0 12.1 9.8 9.8 18.7 10.3 6.1 19.4 11.9 9.1 11.2 11.1 15.3 5.9 11.6 11.8 18.5 17.0 12.2 17.7 13.1 13.3 12.0 12.5 12.4 11.8 5.8 4.6 7.3 5.2 3.6 4.0 4.8 6.4 5.1 4.9 4.2 1.8 4.6 4.8 3.2 3.1 5.5 15.5 15.7 20.2 16.1 12.5 14.2 12.7 8.6 11.9 12.4 11.9 5.1 9.5 4.6 3.7 12.7 3.5 0.0 21.4 15.9 5.2 11.8 6.1 8.3 6.4 16.2 5.3 5.1 0.0 8.4 6.8 4.6 6.5 7.0 13.4 7.2 6.4 4.6 4.9 14.9 16.1 13.6 7.0 1.7 5.4 9.6 16.2 7.8 0.0 11.7 14.6 17.4 6.5 5.9 58.3 31.9 3.6 5.6 5.3 8.2 4.1 NFKBIA "IkappaBalpha, IKBA, MAD-3, NFKBI" ENSG00000100906 "NFKB inhibitor alpha" P25963 14 35401511-35404749 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 209.1" "Cell type enhanced" "Detected in all" 8 "Basal keratinocytes: 3603.5;Suprabasal keratinocytes: 2990.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003815, HPA029207" Approved Enhanced Cytosol NA NA Cytosol "CAB003815: AB_344886, HPA029207: AB_10603122" "prognostic favorable (1.33e-5)" "unprognostic (3.39e-1)" "unprognostic (7.29e-2)" "unprognostic (7.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (2.46e-1)" "unprognostic (2.46e-1)" "unprognostic (7.19e-2)" "unprognostic (2.32e-2)" "unprognostic (3.69e-1)" "unprognostic (4.44e-2)" "unprognostic (9.74e-2)" "unprognostic (3.80e-2)" 49.0 38.5 14.9 63.7 25.7 209.1 60.8 16.1 27.8 33.8 32.8 10.3 36.7 13.5 21.3 15.6 50.4 30.5 34.3 30.9 18.8 10.5 30.6 45.1 73.0 47.7 29.7 7.8 57.4 22.1 6.5 25.3 25.5 21.8 28.7 18.6 19.5 44.2 64.6 33.1 48.2 42.3 24.9 23.0 47.4 26.1 19.6 23.9 35.0 27.8 46.2 38.1 41.8 45.2 45.3 55.0 118.2 58.3 33.2 37.3 51.7 13.1 11.7 4.4 4.0 26.1 17.4 15.8 5.5 52.8 11.9 10.6 3.6 8.0 8.0 14.7 8.7 28.0 17.4 8.4 22.8 17.1 48.5 3.2 3.9 8.4 21.5 15.6 6.2 3.3 18.9 23.0 8.1 20.7 7.9 10.7 4.0 3.3 12.9 8.4 15.5 8.2 15.0 4.1 12.8 7.2 18.6 5.1 6.6 20.4 84.8 4.0 6.9 14.6 25.7 6.1 9.6 14.6 13.3 19.9 16.4 5.9 4.7 8.8 15.8 16.0 13.6 13.7 4.7 3.3 35.8 58.3 36.6 24.2 33.4 37.3 34.0 29.3 25.4 55.0 45.3 25.6 21.7 118.2 33.2 22.1 29.7 19.5 51.7 14.9 25.7 16.1 27.8 18.8 10.5 29.7 7.8 21.8 23.9 497.3 711.4 171.6 1047.5 3603.5 25.1 132.1 298.1 131.2 346.9 59.3 11.8 146.4 165.8 692.3 3.4 543.9 448.5 23.3 344.2 134.5 404.0 1015.6 876.2 131.0 760.7 46.1 195.3 279.9 370.8 7.2 141.8 871.3 1029.1 602.3 143.8 87.6 391.8 259.6 109.3 89.7 34.8 200.5 1642.1 2.8 10.7 2990.0 552.0 370.7 198.2 907.4 NIM1K "MGC42105, NIM1" ENSG00000177453 "NIM1 serine/threonine protein kinase" Q8IY84 5 43192071-43280850 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 23.7;pituitary gland: 9.7" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 7.1;Cone photoreceptor cells: 5.9;Horizontal cells: 17.5;Muller glia cells: 8.2;Rod photoreceptor cells: 6.1" "Cancer enriched" "Detected in some" 11 "glioma: 6.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 10 "dendritic cells: 1.2;T-cells: 3.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 4.5;HDLM-2: 4.9;PC-3: 5.6;U-87 MG: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007695 Uncertain Approved Cytosol NA NA Cytosol "HPA007695: AB_2667897" "unprognostic (7.97e-2)" "unprognostic (9.79e-2)" "unprognostic (8.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (4.35e-2)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (8.84e-4)" "unprognostic (1.25e-1)" "unprognostic (1.55e-5)" "unprognostic (2.18e-1)" "unprognostic (2.66e-1)" "unprognostic (6.46e-3)" "unprognostic (4.98e-3)" 1.4 3.5 9.4 1.6 10.9 0.9 1.3 4.9 23.7 1.6 1.4 6.3 0.0 1.1 1.2 1.6 1.6 1.4 1.5 1.8 8.7 7.7 1.4 1.2 3.6 1.2 5.6 5.8 1.2 1.5 1.2 9.7 1.8 6.4 1.4 1.7 1.7 2.3 2.4 2.0 1.8 1.2 1.3 4.9 1.0 3.0 1.4 8.1 0.0 2.7 0.0 1.0 1.1 0.8 0.1 1.2 0.0 0.0 0.2 3.2 0.0 0.2 0.6 0.1 0.1 0.9 0.6 0.0 1.0 3.2 1.2 4.5 0.1 0.0 0.5 0.6 0.8 1.6 0.3 0.6 0.0 2.8 4.9 0.3 0.1 0.6 0.2 1.6 0.2 0.7 1.9 0.1 0.5 0.0 1.7 0.0 0.1 0.2 0.3 0.9 0.2 0.3 0.2 0.0 0.0 5.6 0.2 0.3 0.5 0.1 0.7 0.9 0.1 1.8 0.5 0.3 0.2 0.4 1.5 0.0 0.9 0.8 0.8 0.7 1.6 0.4 0.3 6.1 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 1.2 3.2 0.0 9.4 10.9 4.9 11.6 8.7 7.7 5.6 5.8 6.4 8.1 0.0 4.1 0.0 0.1 0.5 7.1 0.3 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.1 17.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 8.2 0.2 0.0 0.7 0.0 6.1 0.0 0.4 0.4 0.5 0.4 0.0 0.0 0.0 0.0 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123804141-124825657 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 43.2" "Group enriched" "Detected in some" 16 "Horizontal cells: 44.5;Muller glia cells: 20.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.9;HEK 293: 6.5;HEL: 8.2;Karpas-707: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol NA NA Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 2.2 1.6 12.9 1.1 12.1 1.9 1.3 17.3 43.2 1.4 1.7 24.9 0.0 1.1 1.2 1.6 1.4 1.4 1.3 2.6 17.5 8.8 1.3 1.2 1.3 1.3 18.1 10.9 1.2 1.0 1.0 1.1 1.2 18.0 1.4 1.3 0.5 1.1 1.3 4.8 1.1 1.5 1.5 42.9 1.1 1.0 1.6 16.1 0.0 1.2 0.5 1.3 1.5 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.2 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.5 0.1 0.0 0.0 0.0 13.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.1 17.3 15.3 17.5 8.8 18.1 10.9 18.0 16.1 0.0 0.0 0.0 0.0 0.1 2.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 44.5 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NKAPD1 "C11orf57, FLJ10726" ENSG00000150776 "NKAP domain containing 1" Q6ZUT1 11 112074086-112085150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 29.8;Ciliated cells: 32.1;Club cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039493, HPA039892" Approved Approved Cytosol NA NA Cytosol "HPA039493: AB_10795036, HPA039892: AB_10795372" "unprognostic (5.93e-2)" "unprognostic (3.24e-1)" "unprognostic (6.45e-3)" "unprognostic (1.80e-1)" "unprognostic (1.45e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.45e-2)" "unprognostic (8.61e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (7.05e-3)" "unprognostic (1.15e-2)" "unprognostic (2.86e-1)" "unprognostic (8.24e-2)" "unprognostic (1.41e-1)" 20.6 16.2 20.6 14.1 19.1 13.5 20.6 34.8 21.6 21.5 16.0 13.9 13.1 13.4 19.3 15.7 18.1 17.6 15.6 14.7 19.6 21.1 21.7 14.5 13.4 17.6 20.7 14.7 26.0 17.9 17.4 15.8 24.0 20.7 18.9 14.6 13.2 18.0 14.8 28.2 14.6 16.2 23.3 19.6 19.6 13.9 18.8 15.9 29.7 26.7 15.6 16.4 21.6 19.4 9.1 19.4 7.5 7.7 12.2 11.2 4.3 8.0 5.4 11.5 18.5 11.9 13.9 8.5 11.9 10.2 10.0 11.5 16.7 14.6 22.7 18.3 10.7 11.4 11.7 13.7 12.8 13.1 16.2 9.6 17.3 5.4 8.0 11.0 26.1 11.4 14.1 17.6 12.1 28.0 15.3 8.9 18.7 25.5 14.0 10.0 4.9 23.3 16.2 11.5 13.7 12.0 18.1 14.2 18.5 11.6 7.2 9.7 17.7 12.3 15.3 11.1 10.7 19.1 10.9 9.0 13.5 15.2 8.2 10.2 10.6 23.2 46.6 5.7 24.8 13.6 7.5 7.2 4.3 9.9 7.1 10.1 8.3 10.5 6.7 7.6 9.1 11.2 9.5 3.8 12.2 7.7 19.4 8.1 4.3 20.6 19.1 34.8 21.6 19.6 21.1 20.7 14.7 20.7 15.9 29.8 20.2 0.0 0.0 0.0 0.0 0.0 0.0 32.1 31.8 15.7 0.0 16.4 11.6 17.6 0.0 0.0 0.0 0.0 18.5 14.6 0.0 0.0 8.1 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 24.4 0.0 0.0 18.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 NLRP11 "CLR19.6, NALP11, NOD17, PAN10, PYPAF6" ENSG00000179873 "NLR family pyrin domain containing 11" P59045 19 55785397-55836800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6" "Cell type enhanced" "Detected in some" 26 "Collecting duct cells: 1.8;Early spermatids: 10.0;Late spermatids: 2.7;Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 39.1;RPMI-8226: 22.0;U-266/70: 38.9;U-266/84: 16.8;U-698: 28.3" "Not detected" "Not detected" "HPA046402, HPA078027" Uncertain Supported Cytosol NA NA Cytosol "HPA046402: AB_10962951, HPA078027: AB_2732369" "unprognostic (2.36e-2)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (4.36e-3)" "unprognostic (3.31e-2)" "unprognostic (7.88e-2)" "unprognostic (9.95e-3)" "unprognostic (8.04e-2)" "unprognostic (1.94e-1)" "unprognostic (2.52e-1)" "unprognostic (3.75e-2)" "unprognostic (3.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.06e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-2)" "unprognostic (7.61e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 4.0 0.1 0.3 0.2 0.1 0.1 0.0 0.7 3.3 0.1 0.6 0.1 0.1 0.9 0.4 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 1.2 0.1 0.1 0.3 0.5 3.6 0.1 0.1 0.1 0.1 4.5 0.1 0.1 1.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 39.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.7 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.7 0.0 0.0 38.9 16.8 28.3 0.7 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 2.7 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 NLRP14 "CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8" ENSG00000158077 "NLR family pyrin domain containing 14" Q86W24 11 7020446-7071308 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 2.5;testis: 3.4" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 1.7;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7;Early spermatids: 1.5;Rod photoreceptor cells: 2.9;Spermatocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HEK 293: 1.7;HL-60: 1.2;HUVEC TERT2: 4.1;U-698: 2.2" "Not detected" "Not detected" HPA039477 Approved Uncertain Cytosol NA NA Cytosol "HPA039477: AB_10794748" "unprognostic (6.46e-3)" "unprognostic (5.76e-3)" "unprognostic (1.44e-4)" "unprognostic (7.20e-4)" "unprognostic (5.57e-2)" "unprognostic (8.02e-3)" "unprognostic (6.57e-2)" "unprognostic (2.65e-1)" "unprognostic (2.68e-1)" "unprognostic (1.44e-1)" "unprognostic (2.68e-1)" "unprognostic (2.65e-2)" "unprognostic (3.17e-3)" "unprognostic (6.69e-2)" "unprognostic (3.22e-1)" "unprognostic (3.85e-2)" "unprognostic (1.25e-1)" 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.3 0.3 1.6 2.5 0.4 0.2 0.4 1.3 0.0 1.7 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.0 1.2 0.3 0.0 3.4 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.2 0.9 0.5 0.7 0.0 0.4 1.6 0.0 0.1 0.4 0.0 0.0 0.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 4.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 2.2 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.3 2.9 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.0 0.0 NME1-NME2 "NM23-LV, NMELV" ENSG00000011052 "NME1-NME2 readthrough" 17 51153590-51171744 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 41.6;Basal keratinocytes: 34.1;Ciliated cells: 25.4;Club cells: 45.5;granulocytes: 20.9;Melanocytes: 21.9;Suprabasal keratinocytes: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB002169, HPA008467, HPA041113, CAB076057" Approved Approved Cytosol NA NA Cytosol "CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305" "unprognostic (2.39e-1)" "unprognostic (5.29e-2)" "unprognostic (9.70e-2)" "unprognostic (5.13e-2)" "prognostic favorable (6.66e-4)" "unprognostic (2.46e-2)" "unprognostic (4.82e-3)" "unprognostic (8.39e-2)" "unprognostic (2.30e-2)" "unprognostic (1.53e-1)" "unprognostic (4.58e-6)" "unprognostic (1.03e-1)" "unprognostic (2.74e-6)" "unprognostic (1.84e-1)" "unprognostic (9.72e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-3)" 12.8 29.3 19.7 35.5 16.7 20.6 8.5 13.9 31.2 5.4 7.2 6.7 4.9 14.7 10.6 6.2 10.6 7.4 6.8 8.0 23.0 17.0 10.4 31.3 7.8 18.3 16.9 18.7 8.1 24.1 6.5 11.4 13.6 21.5 6.7 5.7 7.7 23.5 4.7 10.1 8.2 10.7 11.7 11.0 11.9 14.8 5.8 5.6 10.0 8.6 17.9 12.7 9.5 7.6 19.6 37.6 1.0 21.1 14.6 21.9 16.2 29.0 2.0 9.4 34.6 8.8 4.5 7.4 23.0 7.5 6.1 3.8 3.8 19.6 17.0 24.1 11.8 15.3 18.1 9.2 14.8 4.0 25.6 13.8 14.1 3.5 7.3 10.7 23.8 23.5 8.1 11.1 7.7 11.0 14.3 9.7 17.0 11.1 22.0 3.8 4.8 58.2 16.4 28.2 34.6 2.9 34.5 23.1 50.3 7.1 3.8 30.4 17.8 12.1 52.6 26.4 14.4 53.8 40.4 19.4 38.8 28.3 37.6 47.0 37.7 40.7 33.1 22.3 17.2 33.3 0.2 15.1 0.3 15.0 21.1 21.9 19.6 14.7 16.1 37.6 18.4 13.7 16.8 1.0 14.6 11.6 25.7 13.7 16.2 19.7 16.7 13.9 26.4 23.0 17.0 16.9 18.7 21.5 5.6 14.9 41.6 0.0 0.0 34.1 0.0 1.7 0.0 25.4 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 20.9 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.3 8.1 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 45.4 0.0 0.0 0.0 0.0 NMNAT2 "C1orf15, KIAA0479, PNAT2" ENSG00000157064 "Nicotinamide nucleotide adenylyltransferase 2" Q9BZQ4 1 183248237-183418602 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.9" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 30.1;Early spermatids: 50.3;Horizontal cells: 19.1;Late spermatids: 19.5;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 12.9;SCLC-21H: 37.5;SuSa: 12.3;U-2197: 21.9;U-87 MG: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015708, HPA061714" Enhanced Approved Cytosol NA NA Cytosol "HPA015708: , HPA061714: AB_2732669" "unprognostic (3.70e-1)" "unprognostic (7.98e-3)" "unprognostic (8.83e-2)" "unprognostic (4.16e-2)" "unprognostic (8.95e-2)" "unprognostic (9.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.35e-1)" "unprognostic (7.92e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.73e-3)" "unprognostic (2.90e-3)" "unprognostic (1.87e-1)" "unprognostic (7.51e-2)" "unprognostic (1.02e-1)" 9.6 7.7 26.2 1.9 34.5 1.0 2.9 53.9 53.5 3.6 2.2 2.0 0.0 1.5 2.5 2.7 1.9 3.8 4.1 19.6 20.6 15.1 1.5 1.1 1.8 1.7 8.6 28.3 1.5 2.9 1.3 17.4 2.0 15.6 1.3 2.1 0.5 1.5 4.1 1.3 1.7 2.0 2.7 4.1 1.2 2.1 8.7 6.3 0.0 7.2 0.0 1.7 1.9 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.2 2.5 0.0 1.5 6.2 2.2 1.6 4.1 0.8 0.2 1.2 2.4 0.0 6.8 0.4 0.7 1.0 0.1 0.0 1.6 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 12.9 0.5 1.0 0.2 5.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.2 4.4 0.0 2.4 0.0 0.1 0.0 2.8 2.0 37.5 2.9 0.3 0.1 0.0 12.3 0.3 0.6 1.4 1.2 0.4 21.9 1.5 0.3 0.0 0.0 17.1 0.1 0.1 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 26.2 34.5 53.9 34.7 20.6 15.1 8.6 28.3 15.6 6.3 0.0 1.0 0.0 0.2 0.7 10.7 30.1 0.0 2.7 3.4 0.0 0.0 0.6 0.0 0.1 50.3 2.9 0.0 0.0 0.0 9.6 0.4 0.1 0.0 0.0 0.5 19.1 0.0 0.0 0.6 19.5 0.0 0.5 1.7 0.0 0.0 0.3 0.5 0.0 0.0 0.0 1.6 19.4 5.0 0.5 0.2 0.3 1.1 0.0 0.0 0.0 NPEPPS "MP100, PSA" ENSG00000141279 "Aminopeptidase puromycin sensitive" P55786 17 47522942-47623276 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 253.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021453, HPA045649" Uncertain Supported Cytosol No No 2100000 Cytosol "HPA021453: AB_2670709, HPA045649: AB_2679406" "unprognostic (1.63e-1)" "unprognostic (3.15e-2)" "prognostic favorable (3.39e-5)" "unprognostic (2.66e-2)" "unprognostic (1.53e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (3.67e-5)" "unprognostic (3.84e-2)" "unprognostic (1.22e-1)" "unprognostic (1.77e-1)" "unprognostic (3.85e-2)" "unprognostic (3.63e-2)" "unprognostic (1.93e-1)" "unprognostic (8.55e-2)" "unprognostic (1.52e-1)" "unprognostic (1.23e-2)" "unprognostic (1.07e-1)" 16.0 26.0 27.2 15.9 27.7 11.1 56.1 36.5 33.8 17.1 17.7 9.8 14.6 14.6 16.9 17.1 47.7 17.2 16.3 22.2 24.0 15.6 18.8 11.1 30.3 24.1 16.0 29.7 20.8 16.8 21.2 15.3 17.6 27.2 18.6 20.0 13.3 21.8 16.5 52.3 29.6 17.3 20.4 22.8 15.7 16.2 15.3 16.1 7.0 14.5 14.8 18.1 19.0 30.5 6.9 9.0 23.2 8.6 9.3 9.2 5.4 32.7 21.6 21.8 15.3 25.1 25.4 45.9 14.5 18.8 21.9 21.4 13.9 37.7 19.6 22.4 21.1 19.9 20.0 23.9 13.3 34.2 8.7 20.6 23.5 22.3 16.1 14.5 13.3 15.3 19.4 13.2 15.9 8.4 32.0 22.5 6.8 19.8 11.4 31.1 8.8 17.6 11.9 13.3 18.5 19.6 14.3 30.6 17.3 27.4 24.0 17.4 15.0 18.6 10.9 12.9 38.4 81.1 9.3 28.8 14.7 10.6 21.8 10.1 23.4 22.5 11.9 20.7 7.0 9.6 10.2 8.6 10.7 9.1 6.6 9.2 6.8 7.3 8.5 8.7 6.9 6.5 7.6 23.2 9.3 6.8 9.0 8.4 5.4 27.2 27.7 36.5 33.8 24.0 15.6 16.0 29.7 27.2 16.1 77.4 58.6 28.2 59.7 69.1 136.0 50.0 50.9 29.4 39.8 40.1 253.3 68.9 23.2 54.3 25.4 43.7 53.1 0.0 47.2 63.0 58.6 89.0 39.4 26.9 35.7 106.5 42.6 39.3 44.0 43.4 48.9 38.9 55.6 26.2 41.6 39.6 80.1 54.0 47.0 38.3 167.1 77.6 44.8 47.1 27.9 89.6 87.5 32.0 44.8 147.8 NPR3 "ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC" ENSG00000113389 "Natriuretic peptide receptor 3" P17342 5 32689070-32791724 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.2" "Group enriched" "Detected in many" 4 "Distal tubular cells: 44.7;Proximal tubular cells: 133.6" "Cancer enhanced" "Detected in many" "renal cancer: 19.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.3;fHDF/TERT166: 10.5;HeLa: 37.5;HSkMC: 24.4;U-138 MG: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052702 Supported Approved Cytosol NA NA Cytosol "HPA052702: AB_2681922" "unprognostic (8.56e-3)" "unprognostic (1.54e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (7.64e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-2)" "unprognostic (9.28e-2)" "unprognostic (6.78e-3)" "unprognostic (1.76e-1)" "unprognostic (6.07e-2)" "unprognostic (3.46e-3)" "prognostic favorable (5.43e-6)" "unprognostic (6.00e-4)" "unprognostic (5.74e-2)" "unprognostic (2.80e-2)" "unprognostic (3.38e-2)" 26.9 3.5 0.4 0.4 1.5 1.9 2.7 0.2 0.8 4.5 5.3 0.3 1.4 0.3 4.2 3.3 6.8 2.5 3.9 16.4 0.4 0.5 54.2 7.6 24.2 0.5 0.2 0.8 1.9 0.7 0.3 0.7 5.3 3.1 8.8 0.5 7.3 1.2 18.1 9.5 3.7 1.4 1.8 0.3 4.5 1.0 1.5 0.0 1.1 11.0 13.4 1.4 5.5 4.5 1.4 0.9 7.3 0.6 1.1 1.1 0.2 0.1 1.9 0.1 0.2 1.1 17.3 0.0 4.6 0.9 0.2 0.2 0.0 0.1 0.0 0.1 10.5 0.3 0.0 2.3 0.0 0.5 0.0 0.0 0.2 37.5 0.0 3.4 0.0 0.1 24.4 0.3 1.2 3.3 1.1 0.1 0.0 0.0 0.3 1.5 0.3 0.0 0.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 6.3 0.0 0.1 0.1 0.0 0.1 10.3 0.1 0.8 0.1 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.6 0.4 0.8 0.3 0.5 0.9 0.7 0.5 0.0 1.4 0.9 1.1 7.3 1.1 0.1 0.9 0.4 0.2 0.4 1.5 0.2 0.8 0.4 0.5 0.2 0.8 3.1 0.0 14.9 8.2 0.9 0.0 4.7 3.3 20.6 0.0 6.7 2.3 8.7 0.0 0.0 44.7 0.0 1.1 3.3 0.0 0.0 0.0 0.1 1.5 2.5 3.5 1.5 0.1 3.2 0.0 4.9 0.0 2.2 10.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 12.0 133.6 1.2 6.5 2.7 0.1 0.9 1.1 0.1 0.0 0.0 0.1 NPRL3 "C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11" ENSG00000103148 "NPR3 like, GATOR1 complex subunit" Q12980 16 84271-138860 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011741 Uncertain Approved Cytosol NA NA Cytosol "HPA011741: AB_1845577" "unprognostic (1.34e-1)" "unprognostic (1.32e-1)" "unprognostic (3.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.24e-2)" "unprognostic (4.87e-2)" "unprognostic (6.18e-3)" "unprognostic (9.50e-2)" "unprognostic (7.28e-2)" "unprognostic (4.85e-2)" "unprognostic (9.07e-3)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (8.69e-2)" "unprognostic (1.65e-1)" "unprognostic (3.11e-1)" "unprognostic (2.73e-1)" 11.0 16.8 17.1 10.0 17.1 16.5 9.6 20.5 18.9 11.4 7.4 11.8 9.2 6.9 12.3 6.8 10.0 15.1 6.7 9.8 15.9 6.8 8.4 10.3 8.1 7.9 12.6 20.2 16.1 11.9 21.7 14.9 6.8 13.0 7.5 5.9 8.6 11.3 9.8 22.6 8.2 8.3 8.9 10.4 9.5 9.4 15.7 13.7 5.7 13.2 6.5 7.6 12.5 9.1 4.8 5.5 1.4 5.5 3.4 6.5 3.2 7.0 14.5 6.9 14.0 19.2 10.3 10.9 7.6 9.7 12.6 9.5 22.4 13.0 14.2 12.1 14.2 6.5 7.9 11.8 17.0 7.5 13.7 7.5 19.8 7.9 16.8 18.9 8.1 10.8 12.5 13.2 16.4 14.9 7.5 11.7 10.9 20.3 13.3 11.3 24.5 8.4 4.6 5.0 5.0 9.9 13.2 5.6 20.2 12.2 6.4 15.1 8.1 11.8 13.9 6.7 3.7 11.1 3.6 9.1 15.9 9.0 9.6 6.2 14.8 7.5 19.8 0.5 8.2 7.2 0.1 4.1 1.4 6.0 3.6 6.5 4.2 4.9 4.9 5.3 4.8 5.6 6.4 1.2 3.4 5.5 5.5 5.1 3.2 17.1 17.1 20.5 18.9 15.9 6.8 12.6 20.2 13.0 13.7 11.9 9.4 19.1 15.2 8.4 58.2 7.6 2.5 8.1 5.7 10.4 62.8 19.7 19.9 13.2 26.4 10.8 6.6 93.5 7.9 28.0 13.0 11.6 3.5 9.6 17.4 52.4 9.2 12.3 13.2 60.2 21.0 9.3 11.8 19.0 10.2 23.2 10.7 3.5 18.4 17.0 53.4 6.5 14.6 43.6 33.7 4.8 12.8 16.6 12.8 9.0 NQO1 "DHQU, DIA4, DTD, NMOR1, QR1" ENSG00000181019 "NAD(P)H quinone dehydrogenase 1" P15559 16 69706996-69726951 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 142.1" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 203.8;Ciliated cells: 259.6;monocytes: 222.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 149.4;OE19: 264.4;SiHa: 169.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007308, CAB012421" Enhanced Supported Cytosol NA NA 310000 Cytosol "CAB012421: , HPA007308: AB_1079501" "unprognostic (1.04e-2)" "unprognostic (1.95e-3)" "unprognostic (3.14e-1)" "unprognostic (3.76e-3)" "unprognostic (9.03e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.05e-3)" "unprognostic (1.97e-1)" "unprognostic (5.07e-2)" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (2.25e-1)" "unprognostic (2.41e-2)" "unprognostic (6.36e-2)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.27e-1)" 31.3 24.2 12.8 6.4 20.7 0.6 77.1 2.7 9.1 7.6 23.2 7.8 5.7 29.5 3.9 8.6 36.3 8.2 77.2 9.3 9.9 7.5 44.7 1.2 17.2 6.9 11.3 6.0 3.7 2.5 7.0 3.7 3.5 25.5 9.8 20.8 20.2 10.5 7.6 7.6 2.3 17.7 22.7 10.4 6.0 142.1 3.8 4.9 0.1 25.7 69.7 16.2 21.2 18.9 5.2 3.2 0.9 3.2 15.1 12.3 4.4 13.1 149.4 12.5 55.9 31.2 45.3 4.7 22.3 40.0 23.0 35.6 18.1 85.3 0.4 26.5 115.2 40.2 13.8 4.8 25.1 11.8 5.3 0.2 0.6 37.0 131.8 41.5 3.1 10.7 10.6 15.9 39.9 4.6 34.6 57.0 1.0 5.4 0.9 122.9 42.6 0.6 5.7 6.6 264.4 14.5 1.0 2.6 6.1 45.9 47.9 4.5 1.0 169.7 24.1 99.3 14.9 39.0 10.5 38.6 23.2 9.6 8.7 17.5 0.7 2.9 0.6 29.7 1.7 114.7 0.6 3.2 0.2 5.7 0.3 2.9 5.2 6.6 7.2 3.2 2.1 2.1 4.7 0.9 15.1 0.3 1.2 12.3 4.4 12.8 20.7 2.7 9.1 9.9 7.5 11.3 6.0 25.5 4.9 23.8 13.4 1.4 19.5 4.6 4.0 4.5 203.8 259.6 28.4 40.1 3.9 2.1 124.3 22.1 0.3 55.5 72.0 0.0 134.0 3.1 13.1 25.1 19.6 3.2 12.5 3.2 19.5 31.9 3.3 0.9 23.3 8.2 16.9 222.8 60.8 7.6 63.7 49.1 11.3 24.5 10.7 6.5 17.6 0.2 1.5 4.0 1.6 4.4 33.4 25.4 NRBP1 "BCON3, MADM, MUDPNP, NRBP" ENSG00000115216 "Nuclear receptor binding protein 1" Q9UHY1 2 27427790-27442259 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029527, CAB033078" Supported Supported Cytosol NA NA 38000 Cytosol "CAB033078: AB_2154375, HPA029527: AB_10601379" "unprognostic (4.95e-3)" "unprognostic (1.29e-1)" "unprognostic (1.09e-1)" "unprognostic (1.38e-1)" "unprognostic (3.62e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.22e-5)" "unprognostic (7.36e-2)" "unprognostic (1.44e-1)" "unprognostic (6.11e-2)" "unprognostic (3.13e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (5.84e-5)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.75e-2)" "unprognostic (3.48e-3)" 30.8 27.6 20.9 30.8 25.9 49.8 29.1 31.6 38.4 36.3 35.2 21.3 27.5 27.3 40.6 34.2 52.2 28.7 29.9 27.7 18.0 26.0 24.6 38.8 27.1 25.6 21.5 26.2 36.6 28.2 23.0 27.0 58.7 33.9 30.3 25.4 30.6 31.6 34.7 62.2 36.6 31.5 40.7 18.3 29.1 28.9 46.9 20.6 24.4 25.4 39.4 37.6 34.2 37.7 20.6 29.1 57.9 37.2 27.5 33.7 32.9 30.2 30.4 25.2 33.4 39.1 39.0 30.6 28.9 36.4 41.3 32.2 30.7 12.4 8.8 21.7 45.8 41.1 20.9 25.0 26.0 26.7 17.2 15.6 17.4 12.4 40.3 32.8 9.7 23.5 31.8 32.8 42.2 28.3 27.0 45.4 9.8 9.8 14.0 36.2 45.6 12.8 23.5 31.7 26.9 19.2 9.9 53.8 9.8 29.3 21.1 6.8 19.2 34.2 24.7 18.0 29.4 13.6 10.9 35.8 36.5 36.3 21.8 23.3 29.4 29.3 10.5 28.6 17.0 18.2 53.6 28.5 57.9 33.2 37.2 29.2 20.6 28.6 29.9 29.1 18.1 26.3 27.0 38.2 27.5 33.3 18.6 33.7 32.9 20.9 25.9 31.6 38.4 18.0 26.0 21.5 26.2 33.9 20.6 6.0 18.4 41.7 48.8 50.8 34.3 23.0 17.8 34.8 28.4 33.2 33.4 135.2 26.6 78.8 200.9 40.3 55.7 0.0 84.0 190.6 54.2 36.0 19.7 33.7 70.8 27.0 26.9 44.8 33.9 22.9 42.6 38.2 28.7 87.4 34.7 43.5 81.5 38.6 57.0 40.7 51.1 32.3 51.5 50.5 89.7 45.8 169.9 34.6 27.6 51.7 NRBP2 DKFZp434P086 ENSG00000185189 "Nuclear receptor binding protein 2" Q9NSY0 8 143833594-143840974 "Enzymes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020944, HPA029051, HPA029052" Approved Approved Cytosol NA NA Cytosol "CAB020944: , HPA029051: AB_2672886, HPA029052: AB_10602714" "unprognostic (1.84e-1)" "unprognostic (4.66e-2)" "unprognostic (2.54e-2)" "unprognostic (1.53e-3)" "unprognostic (1.01e-1)" "unprognostic (2.00e-2)" "unprognostic (4.03e-1)" "unprognostic (2.86e-1)" "unprognostic (3.97e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (2.01e-5)" "unprognostic (3.86e-2)" "unprognostic (3.98e-1)" "unprognostic (4.56e-2)" "unprognostic (2.04e-1)" 18.5 10.7 21.6 6.8 21.1 1.9 10.0 17.5 32.6 7.6 13.3 47.5 8.7 8.8 11.2 10.0 9.9 14.6 11.3 15.2 23.5 14.9 14.0 18.9 14.9 4.9 30.9 23.6 10.7 10.4 8.4 8.8 6.1 30.2 17.8 6.9 10.1 22.1 15.5 7.6 23.0 9.3 12.3 54.1 7.5 10.1 6.1 27.5 1.0 9.0 3.6 3.8 8.2 7.8 0.5 0.0 0.0 0.4 0.0 1.5 0.3 5.9 7.4 6.7 8.3 10.5 16.2 1.5 12.1 5.3 4.4 6.4 1.7 5.5 0.6 3.2 14.4 3.3 9.5 3.9 4.2 1.7 7.1 2.9 1.1 19.6 3.0 10.8 0.0 2.8 20.7 10.0 2.3 2.2 14.9 6.1 2.1 3.7 7.8 9.3 2.5 0.5 0.3 2.5 6.0 4.1 2.0 6.2 2.7 6.0 2.0 2.4 4.9 15.5 7.9 6.0 4.5 11.3 0.4 14.0 2.6 8.0 12.5 3.9 4.3 0.2 0.1 13.9 2.4 3.5 0.0 0.4 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 21.6 21.1 17.5 21.4 23.5 14.9 30.9 23.6 30.2 27.5 41.7 10.7 0.8 6.0 8.1 14.2 8.1 28.1 5.3 13.6 10.4 13.7 0.7 0.0 4.0 0.3 7.1 5.1 0.0 3.6 0.9 5.8 9.0 0.0 32.1 2.4 15.9 8.6 7.4 4.1 0.0 26.7 3.2 10.1 4.6 8.4 23.2 4.7 3.5 20.1 2.8 10.6 12.9 10.3 1.1 2.3 8.0 0.7 2.9 4.5 3.7 NRIP3 C11orf14 ENSG00000175352 "Nuclear receptor interacting protein 3" Q9NQ35 11 8980576-9004049 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 11.5;blood: 13.8;bone marrow: 12.7;brain: 28.4;testis: 30.3" "Group enriched" "Detected in many" 7 "Early spermatids: 432.1;Horizontal cells: 228.8;Late spermatids: 344.8;Spermatocytes: 110.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "basophil: 13.8" "Lineage enriched" "Detected in many" 13 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 14.4;HMC-1: 26.2;SiHa: 17.0;U-87 MG: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058827, HPA072961" Approved Approved Cytosol NA NA Cytosol "HPA058827: AB_2683829, HPA072961: " "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (8.84e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-1)" "unprognostic (2.68e-1)" "unprognostic (2.03e-4)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (3.63e-2)" "unprognostic (1.04e-2)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.13e-1)" "unprognostic (1.41e-1)" "unprognostic (5.88e-3)" "unprognostic (1.30e-1)" 2.9 11.5 10.0 2.0 19.7 12.7 4.8 27.6 24.7 1.9 1.0 3.1 0.0 1.0 3.9 3.8 1.4 2.1 2.2 1.4 28.4 9.6 1.2 0.7 1.3 1.3 10.5 6.8 0.8 0.8 2.4 0.7 1.3 11.0 1.2 1.2 3.3 1.1 1.4 0.6 0.9 1.0 2.8 4.5 1.0 1.6 30.3 0.8 0.0 1.4 0.0 1.1 1.0 0.3 0.1 0.2 13.8 0.3 0.1 1.0 0.2 0.0 0.4 0.9 0.1 0.4 1.4 0.0 10.2 4.0 8.2 8.7 1.5 0.9 0.0 1.5 2.9 4.9 0.1 2.7 0.2 14.4 0.7 4.0 1.1 0.5 0.1 0.6 12.7 26.2 1.9 0.1 8.5 0.1 8.7 6.6 2.2 2.0 0.1 7.5 0.0 0.6 4.1 3.3 0.0 0.0 0.0 1.4 0.0 0.1 0.6 2.7 0.8 17.0 0.5 2.6 0.7 1.7 1.2 8.3 12.7 6.0 0.7 0.0 0.0 0.0 0.0 24.5 1.5 6.1 13.8 0.1 2.0 0.1 0.3 0.2 0.1 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 1.0 0.2 10.0 19.7 27.6 19.6 28.4 9.6 10.5 6.8 11.0 0.8 0.0 2.2 0.0 4.8 1.9 6.7 1.2 0.0 0.0 0.0 0.0 9.8 0.4 5.0 0.4 432.1 1.4 0.0 0.0 1.0 0.4 1.2 2.6 15.1 0.0 12.7 228.8 5.1 0.0 1.5 344.8 6.4 5.2 3.3 1.0 0.0 4.1 4.8 0.0 5.3 0.0 9.8 0.0 2.1 110.3 37.3 0.9 0.8 0.0 0.0 3.4 NT5C "cdN, DNT-1, DNT1, PN-I, UMPH2" ENSG00000125458 "5', 3'-nucleotidase, cytosolic" Q8TCD5 17 75130225-75131795 "Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021581, HPA023632" Approved Supported Cytosol NA NA 600000 Cytosol "HPA021581: AB_1854663, HPA023632: AB_1854662" "unprognostic (3.83e-2)" "unprognostic (4.45e-2)" "unprognostic (2.39e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (9.21e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.26e-1)" "unprognostic (7.25e-2)" "unprognostic (8.26e-3)" "unprognostic (7.15e-2)" "unprognostic (2.22e-1)" "unprognostic (6.57e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "prognostic favorable (7.66e-4)" 14.5 16.7 10.7 32.5 10.5 14.4 15.2 16.0 13.8 16.3 27.3 18.5 16.2 25.1 18.0 18.7 21.6 15.9 21.0 16.7 9.6 11.0 21.0 13.5 19.9 30.1 12.3 11.0 19.7 28.0 10.4 9.7 11.6 10.9 17.5 14.2 18.0 17.9 17.7 27.1 16.0 30.1 16.7 13.7 20.5 24.5 11.4 12.0 17.2 22.0 30.4 24.5 20.5 17.1 30.7 16.8 46.7 15.8 22.7 14.3 9.7 21.0 33.1 10.9 11.4 3.3 6.9 15.0 12.6 11.0 12.7 8.1 12.3 24.9 14.7 9.2 8.8 2.3 14.8 7.6 15.7 7.3 6.9 23.9 16.1 25.7 20.6 16.5 15.6 7.4 10.0 7.5 9.1 25.5 5.2 14.1 11.7 15.7 7.2 13.0 21.2 11.4 15.9 11.2 18.3 22.0 10.4 14.3 20.4 16.5 11.4 12.9 26.5 12.1 15.0 17.4 6.5 21.0 11.5 8.1 11.1 27.5 4.2 16.6 14.3 2.1 16.3 10.3 9.6 17.2 46.7 10.2 15.2 13.8 15.8 9.7 30.7 9.0 11.6 12.7 29.1 7.9 11.9 4.6 22.7 15.5 16.8 14.3 9.7 10.7 10.5 16.0 13.8 9.6 11.0 12.3 11.0 10.9 12.0 29.8 21.6 121.5 83.2 42.1 67.1 15.5 94.3 9.4 11.4 55.8 19.6 58.2 66.3 80.9 1.6 21.2 215.1 0.0 106.1 86.7 57.7 61.8 46.1 34.2 66.0 39.7 61.5 16.5 50.0 3.3 55.0 59.6 55.6 144.3 82.5 46.3 97.1 133.3 44.6 119.5 63.7 32.3 67.0 20.7 54.1 38.8 26.1 67.1 96.4 63.4 NTPCR "C1orf57, HCR-NTPase, MGC13186" ENSG00000135778 "Nucleoside-triphosphatase, cancer-related" Q9BSD7 1 232950605-232983882 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028125, HPA054304" Uncertain Approved Cytosol NA NA Cytosol "HPA028125: AB_10601091, HPA054304: AB_2682443" "unprognostic (2.67e-1)" "unprognostic (2.28e-2)" "unprognostic (1.63e-2)" "unprognostic (7.59e-2)" "unprognostic (5.85e-3)" "unprognostic (1.04e-1)" "unprognostic (8.70e-3)" "unprognostic (2.12e-1)" "unprognostic (6.00e-2)" "unprognostic (5.03e-3)" "unprognostic (4.78e-2)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (2.74e-2)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (6.37e-3)" 5.4 9.8 13.2 5.8 14.9 2.5 8.7 14.5 15.9 9.9 8.0 11.1 4.1 5.1 9.6 9.5 8.0 11.3 9.6 10.3 13.3 13.1 8.4 6.1 7.4 6.5 13.7 10.8 12.9 13.4 16.9 8.0 6.3 18.5 8.8 10.3 10.8 10.1 10.0 26.8 9.9 6.8 9.9 12.6 6.3 5.8 11.2 11.0 5.7 13.6 11.1 6.5 7.1 7.4 2.4 1.5 3.3 1.8 1.6 4.3 1.3 2.5 6.2 7.1 3.5 5.3 7.0 0.1 1.7 5.5 5.3 7.2 4.4 3.0 3.9 3.8 3.4 3.0 3.4 4.7 6.3 5.8 2.9 8.9 1.2 3.9 5.6 5.5 2.1 2.4 9.3 12.3 5.1 5.2 5.3 4.3 7.5 3.4 6.1 6.2 1.8 5.5 5.6 7.0 5.1 7.4 3.6 4.6 5.7 7.8 3.1 6.2 10.3 2.4 2.1 2.5 5.6 5.2 4.8 3.2 4.4 3.6 4.8 4.7 6.9 5.6 4.5 5.2 5.2 6.3 1.1 1.6 0.8 2.1 1.8 2.5 1.6 3.0 1.3 1.5 2.4 4.3 3.5 3.3 1.6 1.6 0.6 3.5 1.3 13.2 14.9 14.5 15.9 13.3 13.1 13.7 10.8 18.5 11.0 17.9 19.7 13.4 32.1 17.2 15.2 58.9 28.1 12.0 11.4 24.4 25.5 55.1 79.6 53.6 28.3 24.0 38.0 0.0 56.9 49.7 26.7 31.6 16.1 32.1 37.9 9.5 24.8 26.4 19.2 21.4 18.7 22.0 21.9 33.3 46.4 34.1 37.9 21.0 28.7 60.8 20.0 12.9 24.7 60.2 34.9 20.8 23.5 17.5 61.5 31.6 NTRK2 TRKB ENSG00000148053 "Neurotrophic receptor tyrosine kinase 2" Q16620 9 84668551-85027070 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Epilepsy, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 133.8;thyroid gland: 63.4" "Cell type enhanced" "Detected in many" 12 "Horizontal cells: 228.8;Leydig cells: 96.4;Muller glia cells: 248.1;Sertoli cells: 122.9;Smooth muscle cells: 96.9" "Group enriched" "Detected in many" 5 "glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.7;SH-SY5Y: 13.4;SuSa: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007637, CAB010346, HPA074873" Enhanced Approved Cytosol NA NA 13000000 Cytosol "CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: " "unprognostic (2.75e-3)" "unprognostic (3.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (1.29e-2)" "unprognostic (9.16e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (4.25e-2)" "unprognostic (2.18e-2)" "unprognostic (2.66e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-3)" 19.8 2.7 66.1 2.0 56.7 1.2 33.2 15.1 133.8 6.4 4.4 27.4 0.0 1.4 3.0 3.3 5.6 3.7 18.7 5.8 61.0 30.7 12.5 2.1 6.3 2.7 32.4 41.4 6.6 18.9 1.6 3.0 2.1 34.1 3.8 3.1 2.0 8.6 11.9 2.0 7.2 1.6 3.0 22.1 6.5 1.4 2.4 34.1 0.0 63.4 2.6 3.4 3.5 3.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 11.7 0.8 0.9 13.4 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 66.1 56.7 15.1 45.6 61.0 30.7 32.4 41.4 34.1 34.1 0.0 0.3 0.0 1.0 50.4 24.4 8.7 0.0 2.7 0.0 8.7 5.9 0.0 23.2 26.5 1.5 4.5 0.0 0.0 0.6 0.1 10.6 0.9 0.0 0.0 0.2 228.8 0.0 5.5 0.0 1.7 96.4 1.2 16.9 1.0 0.0 248.1 0.5 7.2 45.3 7.9 9.1 122.9 96.9 0.7 1.1 21.5 0.0 0.0 5.4 0.8 NUBP1 "NBP1, NBP35" ENSG00000103274 "Nucleotide binding protein 1" P53384 16 10743786-10769351 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041656, HPA041799" Enhanced Supported Cytosol NA NA Cytosol "HPA041656: AB_10960278, HPA041799: AB_10960692" "unprognostic (2.51e-2)" "prognostic favorable (2.81e-5)" "unprognostic (4.01e-3)" "unprognostic (1.66e-3)" "unprognostic (2.81e-1)" "unprognostic (7.04e-2)" "unprognostic (1.33e-1)" "unprognostic (7.30e-3)" "unprognostic (8.28e-2)" "unprognostic (5.08e-2)" "unprognostic (1.61e-1)" "unprognostic (2.50e-1)" "prognostic favorable (7.61e-8)" "unprognostic (2.12e-1)" "unprognostic (1.04e-1)" "unprognostic (8.23e-2)" "unprognostic (1.69e-2)" 16.1 31.4 10.8 25.0 11.2 18.3 19.3 12.8 11.4 17.7 19.0 15.8 20.4 14.8 18.8 20.7 15.2 18.4 18.2 31.8 10.2 9.6 26.8 39.6 15.0 24.2 11.0 8.8 21.7 24.8 25.1 14.2 25.3 14.4 20.3 14.2 18.2 23.3 20.3 26.3 11.8 21.0 19.8 13.7 25.4 21.1 15.4 10.7 16.8 23.2 20.6 24.6 19.0 22.7 27.1 33.5 14.8 32.4 12.5 17.2 18.1 13.7 25.2 17.1 10.5 7.9 14.7 16.4 13.5 12.7 23.8 19.6 21.8 15.0 23.6 28.2 16.4 18.5 15.1 15.8 13.8 17.8 37.5 20.2 13.4 18.0 35.3 15.9 12.1 15.8 13.7 10.5 16.0 8.9 13.2 15.6 9.3 18.6 14.5 17.4 31.8 7.8 17.6 21.1 11.3 13.7 31.8 22.1 25.9 16.9 16.8 10.6 15.5 23.4 17.6 13.1 11.4 17.9 13.4 13.9 18.6 19.1 23.0 16.9 25.8 22.3 18.5 17.1 24.5 21.7 1.4 31.9 14.8 15.6 32.4 14.4 27.1 14.0 15.7 33.5 26.5 12.3 12.7 3.8 12.5 23.7 16.3 17.2 18.1 10.8 11.2 12.8 11.4 10.2 9.6 11.0 8.8 14.4 10.7 6.0 17.2 38.3 24.0 12.7 13.6 4.8 33.1 28.1 22.7 22.7 5.9 42.3 56.3 47.0 1.8 18.1 16.8 0.0 69.3 24.1 18.0 17.0 24.2 24.1 51.2 6.4 16.1 16.0 33.8 3.0 23.9 47.4 15.1 96.4 14.9 25.8 42.9 14.2 18.4 46.4 13.4 6.5 17.5 35.6 29.4 10.5 50.8 17.1 17.9 24.5 NUDC NudC ENSG00000090273 "Nuclear distribution C, dynein complex regulator" Q9Y266 1 26900238-26946862 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027183, HPA028105" Enhanced Enhanced Cytosol NA NA 18000 Cytosol "HPA027183: AB_10600086, HPA028105: AB_10601988" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.61e-2)" "unprognostic (6.52e-3)" "unprognostic (2.30e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-2)" "unprognostic (3.82e-1)" "unprognostic (3.26e-2)" "unprognostic (2.90e-2)" "unprognostic (1.55e-1)" "unprognostic (2.53e-1)" "unprognostic (5.10e-2)" 30.7 57.9 49.9 25.8 44.9 31.8 30.9 40.1 59.0 30.5 35.7 32.0 31.7 25.8 30.0 53.0 26.6 69.2 28.2 41.8 39.3 41.0 28.2 46.8 26.4 27.3 39.6 49.7 34.5 44.7 36.7 32.3 29.2 38.6 34.2 23.7 25.0 35.0 43.9 65.6 30.8 22.9 39.0 32.9 29.2 36.6 41.4 35.9 30.0 36.8 24.8 29.5 37.6 84.4 73.7 69.0 63.1 62.8 57.9 71.8 64.8 42.6 44.7 23.5 32.6 18.8 16.9 26.7 34.3 21.2 46.3 34.2 41.0 29.9 35.9 30.4 23.4 34.1 33.6 49.9 45.2 35.8 27.8 51.7 44.6 45.5 70.1 33.2 47.0 33.0 18.1 29.6 55.6 36.0 20.2 33.9 42.2 63.5 20.2 31.1 37.1 47.2 60.9 61.7 56.1 58.1 49.5 29.8 36.6 39.4 16.9 39.2 29.4 37.3 23.8 30.2 23.1 23.2 29.0 33.4 33.1 39.5 41.3 43.9 40.7 63.9 43.3 35.7 66.5 37.1 63.1 60.3 57.5 69.1 62.8 69.7 72.0 70.4 65.3 59.8 73.7 70.0 71.8 41.0 57.9 60.0 69.0 66.5 64.8 49.9 44.9 40.1 59.0 39.3 41.0 39.6 49.7 38.6 35.9 125.0 96.1 101.3 254.2 136.9 88.8 139.6 127.4 592.9 157.0 104.7 49.1 182.7 222.2 232.6 46.2 119.1 64.9 0.0 274.8 170.3 125.0 214.5 143.3 551.3 129.0 104.9 125.9 76.1 61.3 97.3 125.7 95.2 143.4 146.1 65.8 130.4 273.1 71.9 143.9 157.8 81.0 109.9 158.4 185.6 247.7 129.7 136.0 118.6 82.6 183.4 NUDT1 MTH1 ENSG00000106268 "Nudix hydrolase 1" P36639 7 2242222-2251146 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 59.5" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 233.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012636 Approved Supported Cytosol No No Cytosol "HPA012636: AB_1854696" "unprognostic (1.31e-1)" "unprognostic (1.19e-2)" "unprognostic (2.13e-2)" "unprognostic (2.37e-1)" "unprognostic (3.01e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (2.15e-2)" "unprognostic (4.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.81e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (3.49e-2)" "unprognostic (1.70e-1)" 8.8 3.9 7.4 12.6 13.4 37.1 10.8 5.0 10.8 5.9 9.0 8.7 2.2 9.1 8.2 9.2 13.1 6.0 8.1 11.3 8.7 4.7 4.1 2.9 7.2 18.9 8.2 7.0 4.8 4.0 0.7 1.8 5.8 7.2 7.2 6.3 4.0 5.5 4.2 12.0 18.8 9.3 10.5 11.9 11.1 5.5 26.7 5.3 30.7 4.1 14.4 17.2 6.8 8.1 18.3 59.5 11.9 21.3 10.1 20.4 13.0 21.7 35.1 19.3 25.5 7.1 9.8 14.2 9.6 8.4 13.2 15.4 18.9 16.5 23.0 7.8 10.5 26.9 26.6 14.6 14.6 7.7 10.2 25.0 17.9 29.6 16.0 1.7 13.9 18.1 6.4 3.8 19.0 6.8 4.3 7.1 33.5 14.2 25.7 14.7 55.5 25.9 54.2 41.4 10.8 21.7 36.3 28.6 19.2 7.2 12.3 19.4 26.9 9.9 29.2 4.4 14.6 19.2 37.0 6.5 12.7 48.5 29.3 22.8 19.9 15.0 23.8 12.8 34.7 45.6 9.0 17.5 11.9 12.9 21.3 10.2 18.3 15.1 13.6 26.6 18.0 15.1 13.1 4.6 10.1 17.4 59.5 20.4 13.0 7.4 13.4 5.0 10.8 8.7 4.7 8.2 7.0 7.2 5.3 6.0 6.9 41.2 21.9 35.6 10.2 15.1 12.7 8.1 7.9 10.4 3.9 30.9 16.6 20.1 42.6 10.8 14.4 233.6 32.2 67.3 28.8 13.6 61.0 5.3 76.9 0.0 7.5 4.3 37.3 78.4 20.4 69.4 43.9 36.9 26.8 18.6 17.6 17.3 17.7 11.7 6.1 32.3 28.5 80.4 63.8 32.4 19.8 39.2 33.8 16.0 NUDT10 "DIPP3a, hDIPP3alpha" ENSG00000122824 "Nudix hydrolase 10" Q8NFP7 X 51332231-51337525 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2" "Group enriched" "Detected in some" 5 "Ito cells: 54.6;Peritubular cells: 27.3" "Group enriched" "Detected in many" 6 "glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 6.2;HAP1: 11.6;HEK 293: 8.6;NTERA-2: 21.3;SH-SY5Y: 4.6;SuSa: 4.4;U-2 OS: 10.7" "HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.61e-2)" "unprognostic (1.12e-2)" "unprognostic (7.40e-3)" "unprognostic (7.84e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.51e-3)" "unprognostic (1.80e-3)" "unprognostic (1.04e-2)" "unprognostic (1.12e-2)" "unprognostic (5.04e-5)" 1.0 2.3 9.3 1.4 10.7 1.8 1.4 6.0 13.1 4.4 2.0 0.9 28.8 1.1 5.5 18.3 1.7 3.4 2.0 0.9 4.9 13.6 3.1 1.9 0.7 0.9 5.3 8.0 19.2 0.6 0.5 4.5 0.5 6.2 17.9 1.3 0.8 1.0 36.3 0.5 1.0 1.2 4.9 1.9 3.1 1.1 27.2 1.2 0.0 0.8 0.0 0.9 2.8 2.9 0.8 0.1 0.0 0.7 2.1 1.0 0.3 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.0 11.6 0.5 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 21.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.1 0.0 0.8 1.0 0.0 0.1 0.3 0.0 0.6 0.0 2.1 0.5 0.0 0.0 0.3 9.3 10.7 6.0 11.7 4.9 13.6 5.3 8.0 6.2 1.2 0.0 2.2 0.0 4.6 0.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.4 0.4 2.1 0.0 0.0 0.2 0.0 0.0 54.6 3.4 4.0 5.5 0.0 1.7 0.0 0.0 1.8 0.0 0.0 27.3 0.0 0.4 0.0 1.9 2.4 7.9 0.1 0.3 0.0 0.0 0.0 NUDT11 "DIPP3b, FLJ10628, hDIPP3beta" ENSG00000196368 "Nudix hydrolase 11" Q96G61 X 51490011-51496596 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;testis: 35.5" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 13.6;Peritubular cells: 19.4;Smooth muscle cells: 12.7;Spermatocytes: 13.4;Spermatogonia: 11.9" "Cancer enhanced" "Detected in many" "testis cancer: 17.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 3.7" "Cell line enhanced" "Detected in many" "HAP1: 33.6;NTERA-2: 21.0" "HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.01e-1)" "unprognostic (2.57e-1)" "unprognostic (8.21e-2)" "unprognostic (1.93e-3)" "unprognostic (6.61e-2)" "unprognostic (1.13e-3)" "unprognostic (5.52e-3)" "unprognostic (1.25e-1)" "unprognostic (2.25e-2)" "unprognostic (2.18e-1)" "unprognostic (8.41e-2)" "unprognostic (1.33e-1)" "unprognostic (7.80e-12)" "unprognostic (4.34e-4)" "unprognostic (1.17e-2)" "unprognostic (2.78e-1)" "unprognostic (3.94e-4)" 1.2 5.4 11.2 1.4 21.9 1.6 2.8 7.4 26.1 3.8 2.6 0.8 4.4 1.7 5.9 4.3 1.9 1.6 2.2 0.8 7.0 17.9 0.9 0.6 0.8 1.1 5.3 12.7 10.0 3.8 0.5 2.8 0.6 5.3 10.1 1.4 0.5 1.3 11.9 0.6 1.7 1.5 5.0 1.8 0.9 0.9 35.5 1.1 3.6 1.0 0.2 1.1 1.7 1.6 0.5 0.4 0.0 0.2 1.9 3.7 1.0 0.0 0.5 10.1 0.0 8.8 11.2 0.0 4.7 1.3 0.2 0.2 0.0 0.0 0.0 0.2 5.7 5.6 0.7 33.6 11.5 0.1 0.0 2.2 0.0 0.0 0.0 4.1 0.0 2.2 6.8 4.6 3.0 11.1 1.9 7.9 10.4 0.0 0.0 9.5 0.2 12.7 0.0 21.0 0.0 8.5 0.0 7.1 0.0 2.1 0.0 0.0 6.6 2.0 0.0 1.8 5.2 0.0 0.0 4.6 2.4 11.1 0.7 0.0 4.4 2.0 7.2 1.5 0.0 0.9 0.0 0.0 0.0 3.7 0.0 1.4 0.5 1.2 1.9 0.4 0.3 0.2 3.1 0.0 1.9 0.2 0.2 0.0 1.0 11.2 21.9 7.4 14.9 7.0 17.9 5.3 12.7 5.3 1.1 0.0 0.0 0.0 4.8 13.6 1.5 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 9.4 0.0 0.0 0.0 1.3 0.9 4.1 9.3 0.0 0.0 0.1 0.0 0.0 0.0 0.8 10.2 8.1 0.6 5.0 0.0 0.0 0.9 2.2 0.0 19.4 0.0 0.1 0.0 12.7 13.4 11.9 8.0 0.2 0.0 0.0 1.1 NUDT3 DIPP ENSG00000272325 "Nudix hydrolase 3" O95989 6 34279679-34392674 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047027, HPA055953" Uncertain Approved Cytosol NA NA 110000 Cytosol "HPA047027: AB_2679907, HPA055953: AB_2682984" "unprognostic (2.42e-1)" "prognostic favorable (5.29e-4)" "unprognostic (9.63e-3)" "unprognostic (4.74e-3)" "unprognostic (3.60e-2)" "unprognostic (1.84e-1)" "unprognostic (1.41e-3)" "unprognostic (4.21e-2)" "unprognostic (4.93e-3)" "unprognostic (1.08e-1)" "unprognostic (3.16e-1)" "unprognostic (4.63e-1)" "unprognostic (1.24e-2)" "unprognostic (3.28e-2)" "unprognostic (1.09e-1)" "unprognostic (1.54e-1)" "unprognostic (6.24e-2)" 10.5 11.4 38.8 9.3 28.6 8.8 12.6 33.4 40.0 15.4 11.4 16.8 10.3 7.7 11.4 25.9 10.8 15.2 8.5 16.9 33.8 30.0 15.3 10.1 11.2 10.5 29.4 25.6 17.4 9.1 27.9 9.3 8.9 26.1 11.4 9.7 11.2 9.4 15.6 50.7 11.2 8.0 11.2 20.3 13.0 8.4 7.3 21.3 5.4 21.3 8.7 12.1 8.6 9.9 4.5 6.4 12.4 5.9 2.1 3.9 2.6 5.4 4.0 10.8 21.1 7.2 12.2 4.7 4.0 6.7 4.1 3.0 4.8 3.8 19.6 5.4 7.1 2.7 4.6 6.1 10.8 7.7 7.3 7.8 21.6 5.6 10.4 7.2 20.3 11.3 11.0 10.0 5.0 9.4 5.3 11.8 10.2 21.4 7.1 6.6 5.7 14.0 23.8 6.9 16.1 4.0 12.3 8.9 20.4 9.4 11.4 15.2 17.0 8.8 12.5 15.9 3.4 12.5 14.6 12.9 8.3 3.0 7.2 8.6 6.1 14.1 14.4 5.0 20.8 12.9 1.9 5.8 12.4 3.4 5.9 3.9 3.4 3.4 3.2 6.4 4.5 3.2 3.7 4.1 2.1 5.8 3.2 2.4 2.6 38.8 28.6 33.4 40.0 33.8 30.0 29.4 25.6 26.1 21.3 14.9 22.4 43.5 59.4 53.1 115.6 43.3 63.7 46.8 14.8 40.1 111.9 28.0 11.6 15.4 3.0 55.9 18.4 0.0 24.5 26.3 42.3 39.4 12.8 52.1 67.2 160.5 47.2 84.7 91.0 4.0 34.8 58.5 50.6 22.6 24.7 115.6 20.8 19.8 59.4 19.2 125.0 58.2 46.4 44.7 78.0 52.7 16.4 20.1 25.2 59.3 NUDT4 "DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487" ENSG00000173598 "Nudix hydrolase 4" Q9NZJ9 12 93377883-93408146 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 140.7" "Cell type enhanced" "Detected in all" 5 "Muller glia cells: 411.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA017593, HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (1.44e-2)" "unprognostic (2.15e-1)" "unprognostic (4.40e-3)" "unprognostic (4.25e-1)" "unprognostic (3.08e-3)" "unprognostic (1.42e-1)" "unprognostic (8.12e-2)" "unprognostic (9.09e-3)" "unprognostic (1.88e-1)" "unprognostic (1.51e-1)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.75e-1)" "unprognostic (2.87e-1)" "unprognostic (5.01e-1)" "unprognostic (8.32e-3)" 17.2 29.7 14.1 14.7 9.5 37.4 20.4 7.0 29.0 15.2 14.7 6.7 17.5 6.5 13.6 24.8 13.7 12.8 40.0 140.7 12.4 12.4 47.9 11.2 11.3 10.9 9.4 13.7 41.9 21.1 16.1 11.9 19.2 13.9 27.1 16.9 25.1 65.2 14.8 40.3 8.1 12.7 13.8 12.6 9.2 13.1 10.6 6.3 14.6 25.5 22.4 8.9 19.6 32.9 6.0 4.1 13.6 3.6 7.6 6.6 2.5 5.8 5.0 9.1 10.2 34.0 14.1 11.5 16.3 13.0 9.4 6.9 46.9 14.6 8.2 3.6 13.0 6.1 7.4 25.5 8.2 14.4 12.5 5.4 30.7 4.4 23.9 32.7 15.9 7.4 30.5 27.5 9.6 21.6 47.1 53.1 14.8 31.1 11.5 10.7 6.0 14.8 15.2 14.4 14.4 12.0 12.4 8.2 8.8 11.2 42.3 7.4 9.5 13.2 25.9 36.5 15.3 18.8 20.8 20.1 8.0 4.7 12.0 10.3 6.5 8.1 12.1 4.2 12.6 24.4 8.2 2.8 13.6 3.9 3.6 6.6 6.0 5.8 3.9 2.6 4.7 6.2 5.8 2.4 7.6 2.9 4.1 5.2 2.5 14.1 9.5 7.0 29.0 12.4 12.4 9.4 13.7 13.9 6.3 17.9 42.6 40.8 110.6 103.7 39.3 226.3 94.3 91.0 31.8 59.3 58.9 156.3 306.7 20.9 78.9 50.0 102.5 327.1 14.7 23.0 86.0 142.6 25.3 48.9 37.7 39.7 146.0 28.8 34.5 17.0 36.2 31.8 101.3 12.6 83.5 411.5 37.2 85.6 43.9 43.1 40.3 71.1 166.9 28.7 7.7 84.6 137.0 29.9 64.3 133.5 NUDT4B NUDT4P1 ENSG00000177144 "Nudix hydrolase 4B" 1 148748894-148750099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "eosinophil: 4.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.5" "Cell line enhanced" "Detected in many" "CACO-2: 23.3;RT4: 21.1" "HPA017593, HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (1.24e-1)" "unprognostic (4.01e-2)" 0.5 1.2 0.0 5.4 0.0 0.0 0.5 0.7 0.7 0.2 0.0 2.0 1.4 5.5 6.5 2.0 0.2 0.0 1.2 4.5 3.0 2.1 1.5 1.4 1.0 5.7 0.0 0.0 0.0 0.5 0.1 0.0 0.1 1.6 1.7 0.1 5.8 0.0 0.3 4.5 0.8 0.2 0.6 0.4 1.6 2.2 0.5 2.6 3.4 3.3 5.0 1.3 3.3 2.4 2.4 23.3 8.5 1.4 0.5 1.7 2.5 2.5 2.8 1.3 1.4 4.8 1.8 3.8 1.4 2.7 3.7 2.8 0.8 5.4 4.5 3.2 2.9 2.1 8.4 1.1 6.9 9.2 2.4 1.4 1.8 0.5 3.0 1.4 2.2 3.4 0.9 5.4 2.0 21.1 1.3 2.1 1.8 3.4 14.4 0.5 6.0 6.0 4.6 3.2 2.0 5.5 3.0 0.8 2.4 1.5 1.6 4.9 9.3 0.0 0.1 4.5 0.0 0.2 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXN "FLJ12614, NRX" ENSG00000167693 Nucleoredoxin Q6DKJ4 17 799313-979770 "Enzymes, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Oxidoreductase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 74.7;Urothelial cells: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 31.7;HHSteC: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023566 Approved Approved Cytosol NA NA Cytosol "HPA023566: AB_1854737" "unprognostic (1.68e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (3.48e-2)" "unprognostic (7.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.75e-2)" "unprognostic (6.98e-2)" "unprognostic (1.65e-3)" "unprognostic (2.27e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-1)" "unprognostic (5.76e-2)" "unprognostic (3.56e-2)" "unprognostic (2.34e-1)" "unprognostic (2.68e-2)" "unprognostic (2.05e-3)" 11.9 4.9 5.8 11.5 5.9 1.0 12.8 5.0 5.0 21.7 27.1 4.7 16.9 4.0 21.5 19.2 14.0 13.8 14.5 7.6 6.0 4.2 5.1 3.8 15.8 7.2 3.9 3.1 13.9 23.1 1.1 3.2 10.0 5.6 18.9 3.6 12.3 10.9 19.0 48.9 10.6 8.1 25.8 4.4 2.9 13.0 6.4 4.3 6.0 5.7 17.4 11.8 20.8 26.3 0.9 1.2 1.5 0.2 1.8 1.6 0.3 4.4 6.6 26.1 16.8 1.7 0.3 1.4 14.0 9.3 14.9 23.8 15.6 4.6 0.1 27.0 17.9 3.4 31.7 16.8 26.2 11.8 0.2 9.8 0.0 4.1 13.7 35.0 0.1 0.7 10.6 24.3 1.9 11.7 3.0 13.3 3.6 2.2 0.0 3.9 1.8 0.8 0.3 12.5 13.1 0.4 1.9 0.6 0.1 10.5 6.4 6.7 4.4 6.6 0.0 0.3 16.9 4.7 4.0 0.0 0.3 6.3 0.1 3.9 2.4 1.5 0.1 0.1 0.5 0.2 0.8 0.2 0.1 0.2 0.1 0.1 0.9 0.4 0.2 1.2 0.3 1.6 0.2 1.5 1.8 0.1 1.2 1.4 0.3 5.8 5.9 5.0 5.0 6.0 4.2 3.9 3.1 5.6 4.3 29.8 13.2 0.8 42.2 15.5 1.8 6.3 0.0 10.7 11.4 3.5 31.4 0.4 0.0 3.1 20.4 29.2 0.0 0.0 21.1 0.6 18.8 21.1 1.1 6.7 4.8 4.8 1.7 11.6 0.3 74.7 14.4 3.8 6.8 1.0 0.0 9.6 8.6 0.0 6.7 0.3 16.7 12.9 19.8 10.6 9.1 10.8 0.3 0.0 0.0 52.9 NXNL2 "C9orf121, RdCVF2" ENSG00000130045 "Nucleoredoxin like 2" Q5VZ03 9 88535101-88584274 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 11.7" "Group enriched" "Detected in some" 5 "Early spermatids: 8.6;Proximal tubular cells: 12.2" "Group enriched" "Detected in some" 7 "breast cancer: 1.7;endometrial cancer: 4.0;ovarian cancer: 7.2;renal cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA045526 Uncertain Approved Cytosol NA NA Cytosol "HPA045526: AB_10961044" "prognostic favorable (6.53e-4)" "unprognostic (9.70e-2)" "unprognostic (4.78e-3)" "prognostic favorable (3.83e-8)" "unprognostic (2.70e-2)" "unprognostic (3.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-4)" "unprognostic (1.92e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-3)" "unprognostic (5.58e-2)" "prognostic favorable (9.60e-4)" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-2)" 7.2 0.4 1.6 1.0 1.6 4.4 3.2 0.6 1.1 6.7 0.5 2.0 0.4 0.6 6.2 9.7 0.8 6.6 0.7 0.5 1.8 2.9 4.4 5.1 0.4 0.4 1.3 1.0 11.7 0.5 0.0 0.7 3.9 1.2 0.8 0.0 2.0 1.4 3.7 1.0 1.3 0.5 0.4 1.8 0.8 0.5 2.2 0.4 0.4 1.2 0.4 0.4 1.2 1.5 1.2 1.1 4.8 1.0 1.7 2.4 0.7 2.0 4.2 1.7 1.5 0.2 1.1 1.2 3.9 1.0 0.5 0.7 0.9 1.3 1.0 1.6 0.4 1.0 2.0 0.6 0.2 1.4 0.6 1.3 1.9 4.0 1.3 0.8 1.2 1.4 0.8 0.3 0.4 0.4 0.6 0.0 1.4 1.3 4.2 1.0 1.0 1.1 1.9 2.1 0.7 0.9 0.8 0.8 1.4 15.3 1.4 1.1 0.7 2.3 1.3 0.7 1.1 1.7 1.0 1.5 1.5 2.9 2.1 0.9 1.4 1.2 1.1 1.3 1.6 1.0 4.8 1.0 2.3 2.1 0.5 2.1 0.8 1.2 2.4 0.3 1.2 2.1 2.4 2.8 1.7 0.5 1.1 2.0 0.7 1.6 1.6 0.6 1.1 1.8 2.9 1.3 1.0 1.2 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.5 8.6 0.0 0.0 0.0 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 2.1 12.2 0.7 0.0 0.8 0.3 0.4 0.1 0.9 0.0 0.0 1.8 OLA1 "GTPBP9, PTD004" ENSG00000138430 "Obg like ATPase 1" Q9NTK5 2 174072447-174248698 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035790, HPA041443" Approved Enhanced Cytosol NA NA 3600000 Cytosol "HPA035790: AB_10601977, HPA041443: AB_2677483" "unprognostic (3.30e-1)" "unprognostic (1.06e-1)" "unprognostic (2.23e-2)" "unprognostic (2.85e-3)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "prognostic unfavorable (9.73e-8)" "unprognostic (6.51e-3)" "unprognostic (7.66e-2)" "unprognostic (1.09e-2)" "unprognostic (3.50e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-3)" "unprognostic (4.32e-2)" "unprognostic (2.51e-2)" "unprognostic (2.62e-2)" "unprognostic (9.75e-2)" 28.5 23.1 39.3 18.0 40.6 23.0 29.1 39.4 52.4 18.5 23.5 14.7 12.2 24.9 17.9 20.6 29.9 19.8 20.0 27.9 35.4 34.3 28.4 33.3 14.7 26.1 28.8 27.9 17.1 31.1 19.7 23.8 20.7 45.3 21.5 27.3 15.1 18.9 18.2 50.1 25.9 24.0 18.8 27.0 18.7 19.2 23.1 16.5 36.1 31.9 27.2 25.6 21.9 18.4 12.7 24.5 9.6 16.3 16.7 16.6 13.9 40.4 19.2 31.6 52.5 16.8 37.0 57.0 32.7 33.1 45.8 35.0 45.5 24.1 55.8 32.9 26.2 34.0 32.3 38.3 37.8 54.1 25.4 32.7 52.1 18.6 47.2 32.6 58.8 21.3 32.4 47.3 48.5 51.7 42.1 40.4 20.3 56.7 19.2 39.6 26.1 53.2 61.1 37.1 43.9 63.1 40.5 51.1 38.4 57.2 43.9 51.4 29.4 22.2 33.1 46.2 35.1 23.5 50.0 29.2 30.2 38.3 30.0 47.5 17.9 44.8 42.5 29.6 40.7 26.7 9.6 16.3 4.6 11.5 16.0 16.6 12.7 13.4 14.6 24.5 11.1 15.8 15.1 1.4 16.7 12.4 15.0 16.6 13.9 39.3 40.6 39.4 52.4 35.4 34.3 28.8 27.9 45.3 16.5 32.8 27.0 45.5 62.9 55.6 45.7 65.7 33.1 36.1 45.5 29.6 33.4 127.3 87.9 131.0 196.0 41.5 47.7 0.0 92.2 85.5 49.4 49.5 40.4 23.6 86.6 31.8 67.9 20.3 55.3 68.3 37.4 50.8 30.4 66.7 72.7 43.8 98.5 38.6 48.1 106.1 29.4 25.8 61.3 77.1 35.2 56.0 88.6 58.0 102.0 66.2 OLFML2B DKFZP586L151 ENSG00000162745 "Olfactomedin like 2B" Q68BL8 1 161983192-162023854 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 56.2;Hofbauer cells: 31.7;Kupffer cells: 20.4;Leydig cells: 19.2;Peritubular cells: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 8.8;non-classical monocyte: 6.5" "Lineage enriched" "Detected in single" 10 "monocytes: 8.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 16.0;HSkMC: 45.3;RH-30: 34.6" "Region enriched" "Detected in many" 6 "hippocampal formation: 45.1" "Low region specificity" "Detected in many" "HPA054136, HPA062739" Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA054136: AB_2682397, HPA062739: AB_2684858" "unprognostic (2.97e-2)" "unprognostic (1.79e-1)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (6.01e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (5.97e-3)" "unprognostic (7.32e-2)" "unprognostic (7.68e-3)" "unprognostic (1.16e-1)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.01e-12)" "unprognostic (1.64e-3)" "unprognostic (2.11e-2)" "unprognostic (4.53e-3)" "unprognostic (1.97e-2)" 19.6 6.6 1.7 12.8 3.0 0.3 12.3 0.6 4.1 13.0 14.5 2.9 6.5 1.5 14.2 21.8 3.2 9.8 33.7 25.4 2.9 1.6 3.9 1.2 12.8 24.1 2.9 1.2 7.0 2.3 3.2 2.6 27.6 2.2 6.6 2.2 14.5 9.0 6.1 6.1 8.9 5.0 15.1 3.6 22.4 3.4 12.5 2.1 1.9 18.3 13.7 8.5 12.4 7.3 0.0 0.8 0.3 8.8 0.0 0.1 0.2 0.0 0.1 2.6 0.8 8.4 16.0 0.0 0.8 4.1 1.7 4.6 0.0 0.0 0.0 0.1 9.7 1.7 0.0 0.2 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 45.3 0.0 2.0 0.0 0.8 0.2 0.0 0.0 0.4 7.4 0.0 0.0 0.1 0.8 0.0 0.4 0.0 34.6 3.3 0.6 0.0 0.3 0.1 3.4 0.0 0.2 8.0 0.0 0.0 0.0 1.0 0.2 1.5 1.3 0.0 0.0 0.0 9.9 1.0 0.5 0.0 0.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.3 0.0 6.5 0.0 0.0 0.2 1.7 3.0 0.6 4.1 2.9 1.6 2.9 1.2 2.2 2.1 0.0 1.1 0.0 0.0 3.0 0.0 2.5 0.0 0.0 1.2 1.8 0.0 0.2 0.0 0.0 56.2 0.0 0.0 0.0 0.0 0.3 9.3 0.1 1.1 0.0 31.7 0.0 0.0 1.8 20.4 4.5 19.2 9.9 1.7 1.0 0.0 0.9 0.0 0.0 27.6 0.0 0.0 6.5 12.6 1.5 0.9 1.9 0.2 0.0 0.0 0.0 OPTN "FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP" ENSG00000123240 Optineurin Q96CV9 10 13099449-13138308 "Disease related genes, Predicted intracellular proteins" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 170.7" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 620.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003279, HPA003360, CAB019303" Approved Enhanced Cytosol NA NA Cytosol "CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528" "unprognostic (2.84e-2)" "unprognostic (3.37e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-3)" "unprognostic (5.58e-2)" "unprognostic (3.74e-2)" "unprognostic (5.15e-3)" "unprognostic (3.14e-2)" "unprognostic (2.68e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-2)" "unprognostic (6.14e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (7.62e-2)" "unprognostic (5.67e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" 19.3 21.4 16.1 8.4 15.4 9.6 17.9 17.1 20.4 9.5 11.8 9.4 5.8 14.3 9.4 6.9 14.5 7.3 10.1 32.5 11.9 13.6 16.6 16.7 12.0 9.5 16.2 18.0 22.1 8.2 8.9 9.9 13.0 21.0 9.9 13.4 5.8 10.2 10.2 170.7 17.6 16.0 10.3 16.9 12.4 12.7 16.0 12.5 4.9 6.4 24.5 8.4 11.0 19.8 6.0 1.8 11.9 1.1 16.0 34.5 9.2 18.4 5.3 3.0 4.1 40.9 42.2 3.5 22.2 25.4 16.9 28.0 9.2 24.8 0.1 8.8 30.4 26.5 17.3 3.9 21.3 12.9 42.9 2.1 3.8 7.4 4.9 41.9 0.1 14.0 22.6 16.9 16.1 16.9 41.8 14.3 5.4 4.7 28.7 22.7 3.9 1.8 0.5 1.2 5.0 2.3 0.3 5.9 1.9 20.6 13.2 0.8 3.1 19.3 5.9 14.4 12.2 12.6 2.6 39.0 13.9 6.9 18.8 6.2 14.8 5.1 0.1 20.9 3.2 2.6 11.9 0.8 0.1 19.7 0.5 15.0 6.0 24.9 22.6 0.1 3.4 10.1 12.3 0.7 16.0 1.1 1.8 34.5 9.2 16.1 15.4 17.1 20.4 11.9 13.6 16.2 18.0 21.0 12.5 62.5 31.4 21.6 40.4 66.1 34.5 210.2 58.6 71.0 84.2 29.6 17.7 73.8 28.2 124.6 229.9 71.6 159.4 93.5 100.1 33.9 80.3 54.6 67.2 28.0 27.2 85.8 40.9 41.7 11.3 620.2 88.6 13.1 86.0 59.5 91.3 27.5 138.2 161.4 97.2 125.5 92.1 109.9 116.4 72.2 7.5 68.1 63.0 86.3 38.1 54.0 ORAI1 "CRACM1, FLJ14466, TMEM142A" ENSG00000276045 "ORAI calcium release-activated calcium modulator 1" Q96D31 12 121626550-121642677 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 26.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016583, HPA061823" Approved Enhanced Cytosol NA NA Cytosol "HPA016583: AB_1848720, HPA061823: AB_2684619" "unprognostic (2.22e-2)" "unprognostic (3.78e-3)" "unprognostic (7.82e-3)" "unprognostic (8.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.99e-3)" "unprognostic (4.25e-3)" "unprognostic (1.92e-1)" "unprognostic (2.00e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "unprognostic (6.84e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" 4.3 1.3 0.0 6.2 1.1 3.7 7.1 0.0 1.3 2.1 9.8 1.7 5.0 10.6 2.3 2.2 3.4 1.7 4.8 3.5 0.4 4.9 9.6 7.5 14.1 2.5 0.6 4.8 5.9 1.4 0.0 4.6 5.6 3.3 0.1 10.6 6.8 3.0 26.0 17.0 14.0 4.4 0.9 11.4 3.9 6.8 0.9 8.1 6.5 7.0 9.1 3.8 2.3 6.9 5.6 6.3 4.3 4.9 14.4 5.1 6.1 13.1 1.4 6.0 1.5 2.0 6.7 7.4 1.2 3.4 2.2 11.3 5.0 4.4 12.3 1.4 5.1 11.3 1.1 5.1 0.0 14.8 3.1 8.0 2.2 4.9 4.2 5.0 15.0 0.6 2.1 5.1 0.2 1.9 5.5 13.3 6.4 1.0 1.0 13.6 14.3 35.2 6.2 4.5 15.6 6.5 2.3 7.1 2.5 3.4 5.4 0.8 2.8 3.8 5.5 0.1 8.7 1.9 6.5 7.8 3.5 9.2 5.6 3.8 2.5 1.8 5.2 8.8 5.8 6.3 4.2 5.7 14.1 4.3 10.9 4.4 11.5 14.4 5.6 6.9 11.2 9.8 5.2 4.9 3.7 1.4 10.0 5.1 26.8 16.0 20.4 7.7 20.0 1.9 3.7 22.9 8.1 15.9 1.8 3.9 2.0 1.7 10.9 2.7 38.3 8.6 23.3 17.0 12.5 10.4 5.4 6.9 14.3 32.8 0.0 2.4 32.5 19.7 9.7 12.4 33.8 20.3 19.8 7.1 4.5 23.1 7.0 8.9 9.0 6.5 0.0 8.2 1.2 3.2 32.6 6.5 41.5 16.4 7.5 OSBP2 "KIAA1664, ORP-4, ORP4, OSBPL1" ENSG00000184792 "Oxysterol binding protein 2" Q969R2 22 30693782-30907824 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.1;retina: 45.7" "Cell type enhanced" "Detected in many" 24 "Early spermatids: 112.6;Late spermatids: 239.9;Rod photoreceptor cells: 571.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 15.6;HeLa: 55.9;hTERT-HME1: 15.0;SiHa: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021514 Uncertain Approved Cytosol NA NA Cytosol "HPA021514: AB_1854813" "unprognostic (2.89e-1)" "unprognostic (2.04e-1)" "unprognostic (2.83e-1)" "unprognostic (6.94e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (1.38e-5)" "unprognostic (3.01e-1)" "unprognostic (2.57e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-1)" "unprognostic (2.31e-1)" "prognostic favorable (3.79e-6)" "unprognostic (9.00e-2)" "unprognostic (2.68e-1)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" 1.0 8.5 5.7 2.3 11.6 36.1 1.2 17.0 14.4 1.4 1.6 8.5 1.3 6.3 1.9 13.0 3.3 2.0 2.7 10.0 7.7 5.6 2.1 0.7 1.8 1.9 7.1 6.2 1.7 4.9 8.8 14.1 4.0 7.3 2.2 1.7 45.7 2.5 2.4 2.3 4.6 4.6 1.2 6.4 3.4 3.2 19.6 5.5 0.0 2.9 0.3 1.3 4.3 2.2 1.9 1.6 2.5 3.1 2.7 3.2 6.2 2.6 5.8 0.5 2.5 0.4 2.3 0.6 0.5 1.2 1.8 1.9 5.2 1.4 4.6 2.2 0.7 0.6 1.5 2.3 0.2 1.3 2.5 0.7 15.6 55.9 1.0 0.3 0.1 0.9 0.1 6.5 4.6 15.0 0.6 4.6 1.8 9.7 0.2 4.2 2.9 0.4 1.6 1.4 1.2 5.4 1.3 0.2 0.2 0.2 1.0 6.5 2.7 14.9 1.6 0.1 1.2 1.8 0.8 3.3 1.3 7.0 1.2 2.6 1.2 1.7 0.8 5.2 0.0 1.0 0.6 1.8 1.1 1.5 3.1 3.1 1.7 2.9 1.4 1.6 1.9 3.0 3.2 2.5 2.7 2.3 0.7 1.9 6.2 5.7 11.6 17.0 14.4 7.7 5.6 7.1 6.2 7.3 5.5 0.0 1.9 0.0 1.0 4.6 89.3 8.5 0.0 1.4 1.2 1.8 76.6 0.2 1.7 1.4 112.6 1.8 0.4 23.3 1.3 0.2 2.5 1.0 0.0 0.0 0.2 17.5 6.9 0.0 0.0 239.9 2.3 0.2 1.7 0.0 2.3 23.7 0.7 5.8 1.8 0.4 571.4 0.0 1.2 16.2 3.4 8.3 0.2 0.0 1.3 1.6 OSBPL2 "DFNA67, KIAA0772, ORP-2" ENSG00000130703 "Oxysterol binding protein like 2" Q9H1P3 20 62231922-62296213 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Transport" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 38.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 38.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041127, HPA042659" Uncertain Approved Cytosol NA NA Cytosol "HPA041127: AB_10962008, HPA042659: AB_10960683" "unprognostic (1.00e-3)" "unprognostic (7.20e-3)" "unprognostic (1.31e-1)" "unprognostic (6.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.73e-3)" "unprognostic (3.79e-2)" "unprognostic (9.60e-2)" "unprognostic (6.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.73e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.20e-5)" "unprognostic (3.86e-2)" "unprognostic (8.13e-2)" "unprognostic (4.00e-1)" "unprognostic (3.32e-2)" 12.7 12.7 17.0 13.2 22.7 25.8 17.4 41.6 28.8 15.5 21.2 23.3 16.9 20.0 14.8 16.6 35.0 14.7 20.3 22.0 16.4 16.0 15.4 14.9 13.8 11.6 17.4 15.2 15.1 34.7 26.8 21.3 19.5 24.3 17.0 20.6 15.7 27.3 18.5 16.2 35.1 19.6 20.0 19.1 19.3 24.2 15.2 17.1 14.7 20.0 13.2 19.5 19.8 22.4 6.0 4.0 38.7 4.6 6.5 6.7 4.1 11.4 8.3 9.7 9.0 9.9 9.9 9.2 7.0 13.7 23.5 16.2 29.6 11.8 5.5 18.7 13.8 21.1 20.1 9.3 20.8 13.0 6.6 8.7 14.7 10.3 15.1 9.8 5.6 13.3 9.0 30.7 10.4 11.8 11.1 9.4 14.5 9.5 10.4 6.7 9.5 8.1 9.4 3.1 21.0 7.4 7.6 11.7 7.2 12.0 23.5 12.9 8.4 12.7 24.0 11.9 13.6 15.8 10.1 6.4 11.7 8.7 12.3 8.3 12.2 17.3 8.2 13.1 4.0 7.2 6.0 3.7 13.6 5.5 4.6 5.0 6.0 4.6 5.9 4.0 4.7 4.2 5.0 38.7 6.5 4.0 2.8 6.7 4.1 17.0 22.7 41.6 28.8 16.4 16.0 17.4 15.2 24.3 17.1 14.9 19.4 16.1 18.7 17.9 18.1 54.5 12.7 37.5 22.7 10.4 5.9 12.1 26.6 18.9 17.7 14.6 28.0 23.3 17.5 13.1 10.1 31.4 10.4 10.9 10.8 17.5 15.6 16.0 10.0 12.3 16.1 8.9 8.5 17.2 26.0 18.1 29.1 26.8 12.4 11.2 14.2 12.9 10.3 21.1 13.0 24.3 31.0 15.2 21.1 53.8 OSTF1 "bA235O14.1, OSF, SH3P2" ENSG00000134996 "Osteoclast stimulating factor 1" Q92882 9 75088543-75147265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 448.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 73.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020514 Approved Supported Cytosol NA NA 190000 Cytosol "HPA020514: AB_2670461" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (7.54e-2)" "prognostic favorable (3.67e-5)" "unprognostic (1.36e-1)" "unprognostic (2.43e-1)" "unprognostic (9.73e-2)" "unprognostic (1.48e-2)" "unprognostic (2.40e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-3)" "unprognostic (3.76e-1)" "unprognostic (7.89e-2)" "unprognostic (6.36e-3)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (1.53e-1)" 25.8 18.5 19.1 29.8 22.7 24.2 30.6 12.2 25.5 18.5 19.9 16.7 9.0 18.0 11.5 19.4 62.0 11.9 20.7 21.7 19.5 14.4 20.3 30.9 32.5 36.9 21.5 18.6 10.6 14.8 33.4 12.7 41.5 21.5 14.0 22.6 12.4 24.0 13.8 7.4 31.0 24.8 13.8 22.5 52.9 19.1 9.6 17.8 21.3 16.1 17.2 38.9 26.1 30.1 18.7 25.4 84.5 40.1 27.2 30.8 40.9 16.7 4.0 1.9 2.8 11.8 10.9 20.7 17.9 11.8 6.9 6.3 2.0 12.7 17.4 9.0 14.6 8.8 27.9 3.2 12.9 19.9 73.4 4.0 9.6 6.2 10.3 9.6 17.2 36.2 7.6 12.5 8.0 5.6 6.1 22.9 14.9 3.2 40.0 16.5 8.7 25.7 10.8 3.6 39.6 7.7 4.9 13.3 15.3 14.4 24.1 1.6 0.1 13.2 18.7 8.6 15.5 24.6 19.5 21.5 14.4 5.0 27.5 7.5 7.7 12.4 6.5 17.2 20.1 11.6 50.9 30.8 75.5 29.3 33.0 30.8 18.7 20.5 24.0 25.4 16.5 11.8 20.6 84.5 27.2 40.1 19.0 27.5 40.9 19.1 22.7 12.2 25.5 19.5 14.4 21.5 18.6 21.5 17.8 20.8 26.1 58.4 52.5 73.0 2.9 6.7 30.6 18.7 21.6 31.4 5.9 102.0 64.6 43.9 8.0 51.3 60.1 0.0 46.0 197.4 51.6 40.1 135.0 27.1 196.0 9.5 26.2 79.2 180.5 4.2 22.2 143.3 72.6 448.2 31.4 5.8 47.2 91.7 14.5 51.6 7.5 19.4 35.8 4.6 15.3 100.1 112.0 179.9 33.8 77.0 OTOGL "C12orf64, FLJ90579" ENSG00000165899 "Otogelin like" Q3ZCN5 12 80099537-80380879 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 4 "amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 5.2" "HPA040364, HPA053392" Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA040364: AB_10795365, HPA053392: AB_2682135" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (2.55e-2)" "unprognostic (1.50e-1)" "unprognostic (5.99e-2)" "unprognostic (3.10e-1)" "unprognostic (3.34e-3)" "unprognostic (4.76e-2)" "unprognostic (2.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.79e-2)" "unprognostic (1.57e-1)" "unprognostic (1.95e-5)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.79e-2)" "unprognostic (2.04e-2)" 0.4 0.2 3.5 0.2 4.3 0.1 0.4 0.2 5.8 0.4 2.7 0.0 0.0 0.2 0.5 3.1 0.5 0.5 0.4 9.8 1.0 0.4 13.3 0.1 0.3 0.5 0.5 3.6 0.2 0.7 0.2 21.0 1.4 0.3 0.5 0.3 1.4 0.3 0.5 1.0 0.3 0.6 0.6 0.3 0.4 0.4 0.8 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.5 3.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.4 0.5 2.5 0.0 0.2 0.9 0.0 0.1 7.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 0.2 5.8 1.0 0.4 0.5 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OTUD4 "DUBA6, HSHIN1, KIAA1046" ENSG00000164164 "OTU deubiquitinase 4" Q01804 4 145110838-145180161 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036623 Uncertain Supported Cytosol NA NA Cytosol "HPA036623: AB_10696780" "unprognostic (1.67e-1)" "unprognostic (4.18e-2)" "unprognostic (3.41e-2)" "unprognostic (1.95e-1)" "unprognostic (2.80e-1)" "unprognostic (4.06e-2)" "unprognostic (3.42e-2)" "unprognostic (2.66e-2)" "unprognostic (1.21e-1)" "unprognostic (1.74e-2)" "unprognostic (5.21e-3)" "unprognostic (2.03e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.62e-1)" 14.3 11.8 16.6 11.6 16.7 24.7 12.0 22.7 15.9 14.0 15.3 16.0 10.1 10.0 13.9 13.3 14.8 14.9 11.2 15.6 12.0 9.2 11.1 17.7 15.5 13.1 14.1 8.4 14.3 13.4 22.4 12.2 17.9 12.7 10.6 11.2 10.6 12.7 11.0 36.2 13.6 16.2 12.4 10.1 13.5 10.8 26.8 18.8 13.1 13.4 13.6 12.3 11.5 12.8 3.3 2.8 2.8 2.8 1.6 3.5 1.0 15.2 8.7 10.5 9.6 12.4 15.1 14.0 13.3 15.1 17.3 13.8 9.4 18.9 28.1 6.1 18.7 10.6 9.3 18.0 18.7 22.7 12.0 8.6 13.4 10.6 8.5 14.5 28.2 10.2 11.8 19.1 21.1 27.7 14.6 15.2 12.4 22.2 21.1 16.9 9.1 17.4 12.3 11.6 14.8 10.0 14.4 11.5 6.6 16.7 11.2 10.1 8.3 12.3 18.7 13.3 14.4 6.2 11.6 18.3 19.5 12.4 10.0 17.7 15.6 15.3 18.6 13.5 20.1 18.8 0.0 1.7 2.8 3.5 2.1 2.6 3.3 2.7 2.8 1.6 2.4 2.7 2.4 0.5 1.6 2.8 2.8 2.0 1.0 16.6 16.7 22.7 15.9 12.0 9.2 14.1 8.4 12.7 18.8 59.6 19.7 15.9 40.5 56.1 15.3 18.5 28.1 42.8 23.9 26.2 23.6 17.2 8.3 11.1 130.8 21.8 10.5 0.0 12.7 17.3 25.9 44.8 19.7 20.2 11.8 6.4 14.6 22.1 18.0 63.1 18.7 17.9 30.4 5.4 12.1 7.5 18.4 14.0 28.3 6.6 19.1 0.0 29.9 28.8 41.0 47.6 13.4 14.6 14.3 50.2 OXSR1 "KIAA1101, OSR1" ENSG00000172939 "Oxidative stress responsive 1" O95747 3 38165089-38255488 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008237, CAB017181" Supported Enhanced Cytosol NA NA 21000000 Cytosol "CAB017181: , HPA008237: AB_1079540" "unprognostic (2.16e-1)" "unprognostic (2.36e-2)" "unprognostic (1.79e-2)" "unprognostic (4.55e-3)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (3.53e-3)" "unprognostic (4.05e-2)" "unprognostic (4.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.95e-3)" "unprognostic (1.88e-2)" "unprognostic (1.87e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.71e-1)" "unprognostic (6.99e-3)" 17.6 16.8 9.4 18.3 13.4 24.2 15.9 17.4 14.9 16.8 15.4 9.2 35.7 12.4 14.9 14.7 31.6 11.6 18.9 15.5 11.9 9.0 18.3 17.6 14.6 13.9 13.6 9.3 16.7 12.3 23.7 15.3 21.4 12.3 16.5 16.8 13.0 15.1 23.9 32.6 17.4 21.4 17.0 12.9 15.8 14.0 11.2 13.2 26.2 14.2 24.1 19.6 23.5 19.2 2.3 4.4 10.1 4.8 5.0 4.7 1.6 17.7 8.1 16.3 11.3 11.4 13.2 18.5 15.7 21.6 22.8 24.8 10.5 11.6 19.7 8.0 18.8 9.8 11.1 21.8 16.2 30.1 20.8 8.9 21.5 17.3 11.4 13.6 13.3 13.2 10.4 19.1 21.0 34.1 21.5 14.2 25.5 16.3 11.4 39.0 5.0 25.6 9.6 17.1 11.5 9.7 8.9 13.6 15.2 14.0 13.5 8.5 13.1 17.2 43.6 10.7 18.7 14.3 8.7 12.9 14.3 14.2 21.7 23.2 8.7 10.3 14.5 19.7 16.6 28.5 10.1 2.8 6.1 3.3 4.8 3.5 1.9 4.0 3.1 4.4 2.3 3.0 3.7 5.5 5.0 4.1 2.5 4.7 1.6 9.4 13.4 17.4 14.9 11.9 9.0 13.6 9.3 12.3 13.2 11.9 26.3 13.3 24.0 39.2 11.8 26.6 2.5 12.0 27.3 26.2 19.6 9.4 16.6 25.2 3.1 17.1 28.7 0.0 12.5 15.6 14.9 44.7 15.1 17.8 13.4 20.6 23.2 12.3 32.9 1.4 8.9 28.2 6.8 33.3 18.0 7.6 33.8 24.6 12.0 19.4 5.5 12.9 26.7 12.7 15.0 45.4 27.6 17.5 15.3 110.3 P2RX5 "LRH-1, P2X5" ENSG00000083454 "Purinergic receptor P2X 5" Q93086 17 3672199-3696404 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4" "Cell type enriched" "Detected in some" 7 "B-cells: 69.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 18 "memory B-cell: 28.1;naive B-cell: 30.4" "Lineage enriched" "Detected in many" 19 "B-cells: 30.4" "Cell line enhanced" "Detected in many" "Daudi: 24.5;Karpas-707: 15.9;RPMI-8226: 27.6;U-698: 22.8" "HPA021948, HPA067827" Supported Supported Cytosol NA NA Cytosol "HPA021948: AB_1854878, HPA067827: AB_2685908" "unprognostic (1.08e-3)" "unprognostic (9.16e-2)" "unprognostic (1.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.79e-1)" "unprognostic (1.06e-1)" "unprognostic (8.33e-2)" "unprognostic (4.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.14e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.99e-8)" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (3.50e-2)" "unprognostic (3.63e-2)" 0.6 0.3 2.2 32.0 4.9 4.8 0.5 4.1 5.1 0.3 1.4 0.0 0.4 0.9 0.2 0.2 2.4 0.2 0.8 4.9 1.8 3.0 0.8 0.4 1.0 39.1 1.5 2.1 0.2 0.8 0.1 1.2 0.2 1.7 0.5 1.2 0.0 5.4 0.1 11.4 0.2 12.0 0.4 0.6 29.6 1.8 0.6 0.2 9.3 0.5 1.9 27.6 2.2 0.3 30.4 0.1 0.7 0.0 0.0 1.6 1.6 3.9 3.2 0.0 0.0 0.1 0.6 0.0 4.1 1.9 0.4 1.3 2.4 4.8 24.5 2.5 1.9 1.3 2.1 8.8 0.0 0.8 0.4 1.5 1.2 8.7 2.9 0.6 1.6 2.1 1.0 0.9 0.1 5.7 3.2 0.0 5.8 0.2 15.9 8.9 0.0 11.0 3.7 2.4 1.9 9.9 0.5 0.0 27.6 0.1 3.0 2.0 0.0 3.4 1.1 1.8 0.0 1.0 1.5 0.0 0.0 2.3 0.1 0.7 5.6 11.9 22.8 0.0 2.4 0.2 0.0 0.0 0.7 1.1 0.0 1.6 28.1 1.0 0.8 0.1 30.4 0.1 0.1 0.0 0.0 0.0 0.0 0.5 1.6 2.2 4.9 4.1 5.1 1.8 3.0 1.5 2.1 1.7 0.2 0.0 1.1 69.3 0.1 0.3 0.4 2.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 0.4 0.2 0.0 0.0 0.6 1.2 2.2 1.4 0.6 3.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.7 0.0 0.0 9.6 0.0 0.0 P2RY2 P2U ENSG00000175591 "Purinergic receptor P2Y2" P41231 11 73218298-73236352 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.1;skeletal muscle: 29.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 14.0;Enterocytes: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 28.1" "Group enriched" "Detected in many" 12 "granulocytes: 28.1;monocytes: 10.4" "Cell line enhanced" "Detected in many" "HaCaT: 16.4;HL-60: 15.5;MCF7: 12.4;NB-4: 12.6;PC-3: 12.9;SK-BR-3: 14.3;THP-1: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB022642 Uncertain Uncertain Cytosol NA NA Cytosol "CAB022642: " "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (6.50e-4)" "unprognostic (2.04e-2)" "unprognostic (4.66e-3)" "unprognostic (8.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (9.69e-2)" "unprognostic (4.92e-4)" "unprognostic (1.34e-1)" "unprognostic (2.82e-1)" "unprognostic (1.05e-1)" "unprognostic (8.57e-3)" 0.4 2.3 0.9 1.4 1.2 10.8 1.3 0.3 1.1 5.5 3.1 1.1 0.3 2.2 1.3 2.3 20.0 1.2 2.8 11.7 0.6 0.3 0.9 2.6 2.9 1.5 1.2 0.6 1.7 1.7 6.1 1.1 10.3 1.0 1.7 2.4 3.3 4.0 1.6 29.5 3.4 10.8 0.4 0.4 6.6 0.6 0.7 0.6 0.6 20.2 20.6 12.8 2.1 10.9 0.0 1.6 28.1 10.4 0.0 0.0 1.2 3.6 3.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 8.4 2.8 0.0 5.6 0.2 0.0 16.4 0.4 7.7 0.0 0.0 0.3 1.2 0.2 1.5 0.0 15.5 0.0 0.0 3.6 1.2 0.2 0.0 0.7 0.0 0.7 0.0 0.0 12.4 0.0 12.6 0.2 3.3 12.9 0.0 0.0 0.5 1.2 8.8 0.0 0.0 0.2 14.3 0.0 0.1 6.6 36.3 5.3 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 2.8 0.0 0.2 3.4 28.1 0.0 10.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 1.2 0.9 1.2 0.3 1.1 0.6 0.3 1.2 0.6 1.0 0.6 3.0 0.3 0.0 6.8 3.3 0.5 5.3 7.6 0.0 4.5 0.0 0.0 14.0 1.7 5.0 5.3 0.5 12.9 0.0 5.6 0.5 0.4 1.1 0.0 4.5 2.3 0.0 0.0 0.0 2.7 6.7 0.0 0.9 0.0 0.0 2.9 5.2 11.6 10.5 0.0 0.3 0.2 0.0 0.2 0.0 0.0 6.4 9.2 0.0 2.3 11.1 PA2G4 ENSG00000170515 "Proliferation-associated 2G4" Q9UQ80 12 56104319-56113907 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation, Translation regulation" "Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB011711, CAB012428, HPA016484" Supported Approved Cytosol NA NA 1200000 Cytosol "CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912" "unprognostic (5.53e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-2)" "unprognostic (3.87e-1)" "unprognostic (6.03e-3)" "prognostic unfavorable (6.31e-7)" "unprognostic (4.25e-3)" "unprognostic (2.77e-1)" "unprognostic (3.79e-3)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (4.59e-7)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (1.32e-1)" "unprognostic (4.67e-2)" 41.1 32.1 26.6 41.4 29.8 52.5 38.5 35.1 38.8 33.7 39.2 31.0 27.1 34.4 36.1 22.4 69.4 31.2 31.9 55.6 26.6 25.5 36.1 51.6 32.6 43.3 26.7 28.0 43.3 44.3 42.8 20.5 39.0 28.2 40.3 44.2 23.6 34.6 33.4 77.3 53.0 31.7 39.4 32.3 46.7 34.4 27.9 23.9 70.8 39.7 57.2 54.0 45.5 39.6 25.5 27.1 13.5 25.1 37.4 48.9 36.0 53.5 47.6 32.7 36.0 15.1 23.0 65.7 56.8 27.2 69.9 39.0 58.2 39.9 107.3 38.2 26.8 20.6 44.2 74.5 63.3 68.3 30.4 63.9 82.4 32.5 49.6 29.6 111.8 30.5 23.2 32.4 60.5 54.7 28.9 42.4 36.7 100.0 49.9 38.2 47.5 86.9 58.4 53.6 33.4 58.5 71.6 59.1 72.7 35.3 40.2 49.1 29.7 37.4 59.1 34.7 25.3 63.8 43.5 33.9 34.1 48.2 39.2 62.6 30.7 42.0 105.1 30.9 67.3 44.2 7.8 23.0 13.5 36.6 25.1 48.9 25.5 38.9 39.4 27.1 22.2 37.6 37.3 3.7 37.4 20.0 26.3 43.3 36.0 26.6 29.8 35.1 38.8 26.6 25.5 26.7 28.0 28.2 23.9 50.6 76.2 104.2 176.7 327.3 53.9 31.3 112.1 121.8 170.6 123.9 17.7 192.6 164.2 166.6 352.5 140.6 87.8 373.8 214.0 240.3 114.2 91.6 164.3 167.1 182.5 31.8 89.5 96.3 99.0 161.4 122.3 128.8 123.2 116.4 123.0 92.6 216.5 94.7 119.2 155.9 42.6 142.3 166.0 162.3 110.4 317.1 161.8 164.1 218.3 201.6 PABPC1 "PAB1, PABP1, PABPC2, PABPL1" ENSG00000070756 "Poly(A) binding protein cytoplasmic 1" P11940 8 100685816-100722809 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011536, HPA045423, HPA067156" Supported Supported Cytosol NA NA 2700000 Cytosol "CAB011536: AB_777008, HPA045423: AB_2679320, HPA067156: AB_2685793" "unprognostic (5.00e-2)" "unprognostic (2.64e-2)" "unprognostic (3.18e-1)" "unprognostic (4.50e-1)" "prognostic favorable (2.51e-4)" "unprognostic (1.93e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (2.51e-3)" "unprognostic (5.70e-2)" "unprognostic (1.50e-2)" "unprognostic (3.21e-3)" "unprognostic (7.24e-2)" "prognostic unfavorable (5.70e-12)" "unprognostic (6.22e-2)" "unprognostic (2.55e-1)" "unprognostic (6.98e-3)" "unprognostic (1.40e-2)" 85.6 49.6 33.6 66.1 38.8 94.2 80.5 35.8 32.5 84.2 80.7 41.9 57.2 64.1 85.3 48.8 195.5 54.6 56.4 35.1 32.3 19.3 43.6 83.2 72.8 156.2 40.6 24.3 111.1 106.9 31.8 34.1 50.6 36.8 88.2 71.5 43.4 192.9 79.0 35.1 95.4 104.0 89.9 65.2 135.3 73.4 98.7 37.6 137.2 65.4 63.0 157.9 120.9 116.4 70.8 98.4 32.3 106.7 65.9 106.0 90.6 181.7 45.4 35.6 64.6 66.7 132.7 61.5 44.5 64.5 47.9 52.2 54.4 85.6 230.7 173.5 78.2 25.9 70.6 55.8 87.0 82.0 70.4 36.8 118.9 34.3 69.9 82.7 50.9 84.2 123.2 137.8 44.6 219.4 111.2 74.8 88.1 99.9 88.8 71.0 53.0 253.4 106.1 79.8 152.0 64.6 83.7 43.3 83.3 57.9 118.3 49.7 55.3 29.7 46.4 103.8 70.3 83.5 84.5 69.7 43.2 80.6 63.3 74.8 87.1 60.3 129.2 50.8 114.5 43.4 27.6 83.3 28.8 39.7 99.9 84.2 70.8 78.3 64.4 98.4 62.6 106.0 85.1 32.3 65.9 106.7 65.5 67.4 90.6 33.6 38.8 35.8 32.5 32.3 19.3 40.6 24.3 36.8 37.6 345.4 847.8 973.7 893.3 699.5 56.6 119.8 412.7 665.1 1209.1 104.7 47.1 409.0 223.8 411.2 1289.9 466.5 396.9 443.9 663.3 702.0 352.5 474.8 995.7 223.1 549.7 68.3 458.2 554.9 1326.0 159.3 462.0 1050.9 350.9 954.0 755.7 118.9 569.7 462.9 398.9 263.5 88.4 491.5 506.8 1312.8 244.0 669.1 650.6 839.7 923.8 1043.9 PABPC3 "PABP3, PABPL3, tPABP" ENSG00000151846 "Poly(A) binding protein cytoplasmic 3" Q9H361 13 25095868-25099254 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 50.9" "Group enriched" "Detected in many" 9 "Early spermatids: 131.2;Late spermatids: 106.4;Spermatocytes: 81.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 14 "U-266/84: 11.7" "HPA045423, HPA067156" Approved Approved Cytosol NA NA Cytosol "HPA045423: AB_2679320, HPA067156: AB_2685793" "unprognostic (2.17e-2)" "unprognostic (6.50e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.78e-1)" "unprognostic (2.98e-1)" "unprognostic (8.76e-3)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (8.00e-4)" "unprognostic (5.26e-4)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" "unprognostic (5.18e-2)" "unprognostic (5.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.61e-3)" 0.5 0.2 0.2 0.5 0.8 0.2 1.0 0.1 1.1 0.7 0.5 0.1 0.0 0.2 0.2 0.3 0.7 0.2 0.2 0.2 0.3 0.1 0.2 0.2 1.2 2.0 0.2 0.4 0.4 0.3 0.1 0.4 0.2 0.3 0.4 0.2 0.0 0.6 0.9 0.2 0.4 0.5 0.2 0.1 0.4 0.2 50.9 0.0 0.8 0.3 0.0 0.2 0.3 0.4 1.6 1.9 0.5 2.2 1.8 2.5 1.9 0.4 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.8 0.7 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.8 0.2 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.2 0.4 11.7 0.2 0.1 0.3 0.1 0.4 1.4 0.5 0.7 2.1 1.6 1.6 1.7 1.3 1.9 1.3 2.5 2.2 0.5 1.8 2.2 1.1 1.5 1.9 0.2 0.8 0.1 1.1 0.3 0.1 0.2 0.4 0.3 0.0 0.0 0.0 0.5 4.6 10.4 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 131.2 3.6 0.6 0.0 0.3 1.4 3.5 3.4 4.6 0.6 1.4 1.6 4.1 3.1 5.6 106.4 2.8 3.9 5.0 0.0 1.3 1.0 0.1 3.5 4.6 0.8 0.0 6.5 4.1 81.1 4.6 11.3 2.4 2.2 3.3 3.1 PABPC4 "APP-1, iPABP" ENSG00000090621 "Poly(A) binding protein cytoplasmic 4" Q13310 1 39560816-39576790 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 137.3;skeletal muscle: 117.8" "Cell type enhanced" "Detected in all" 6 "Kupffer cells: 414.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027301, HPA056496" Supported Enhanced Cytosol NA NA Cytosol "HPA027301: AB_2672208, HPA056496: AB_2683153" "unprognostic (6.81e-2)" "unprognostic (7.01e-3)" "unprognostic (2.93e-2)" "unprognostic (5.45e-2)" "unprognostic (3.63e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (1.14e-7)" "unprognostic (2.22e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (3.00e-10)" "unprognostic (1.87e-1)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.08e-1)" 30.0 19.2 9.0 23.0 7.9 20.8 19.6 7.2 9.6 19.1 26.0 14.0 22.0 12.4 22.2 21.1 20.3 13.7 20.2 32.0 8.6 7.2 12.3 28.8 24.9 38.2 8.3 7.3 28.6 137.3 9.1 8.2 16.2 8.6 20.7 11.5 15.4 16.4 22.9 117.8 12.9 21.1 22.4 16.4 27.5 28.0 29.2 6.4 21.5 18.1 51.1 21.0 25.3 20.3 13.9 13.7 6.7 21.2 8.2 21.4 5.5 57.5 15.7 16.7 27.7 41.8 83.0 54.9 34.1 23.9 26.5 19.7 31.4 30.2 49.8 33.9 42.8 12.6 30.8 31.8 38.1 34.3 25.4 26.2 41.9 17.9 31.2 41.9 27.7 28.2 71.9 45.1 32.2 49.1 37.4 33.2 39.6 44.4 27.6 42.5 22.5 28.7 35.8 51.6 19.4 18.0 22.1 53.5 37.7 25.5 56.9 15.8 24.0 23.8 22.7 51.5 31.7 24.2 82.2 29.9 25.8 35.8 62.4 43.0 71.2 78.1 38.7 38.3 28.1 14.7 6.7 13.9 3.5 9.9 18.0 10.6 13.8 16.1 10.3 13.7 13.9 21.4 15.1 1.4 8.2 21.2 13.5 11.2 5.5 9.0 7.9 7.2 9.6 8.6 7.2 8.3 7.3 8.6 6.4 17.9 49.3 108.2 65.3 49.6 24.0 117.4 112.1 8.1 54.6 45.4 76.6 73.5 34.9 38.4 37.3 38.0 79.4 70.0 78.6 128.3 61.8 38.6 51.9 117.5 95.8 31.8 56.9 82.3 414.4 19.0 63.9 76.1 54.0 32.5 56.2 26.4 58.7 46.3 43.5 34.2 89.3 6.5 60.6 30.6 120.1 36.5 89.6 43.3 61.7 91.4 PAICS "ADE2H1, AIRC, PAIS" ENSG00000128050 "Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase" P22234 4 56435741-56464579 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Decarboxylase, Ligase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 137.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035895, HPA041538" Approved Approved Cytosol Yes No 340000 Cytosol "HPA035895: AB_10669660, HPA041538: AB_2677540" "unprognostic (2.59e-3)" "unprognostic (7.90e-3)" "unprognostic (3.84e-3)" "unprognostic (2.88e-2)" "unprognostic (9.85e-2)" "unprognostic (2.82e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (8.07e-3)" "unprognostic (1.23e-2)" "prognostic favorable (8.44e-4)" "unprognostic (1.48e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (5.85e-5)" "unprognostic (7.11e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.41e-4)" "unprognostic (2.16e-1)" 15.5 27.1 21.6 20.4 17.4 21.4 29.3 15.8 20.6 17.5 22.5 18.5 18.4 17.2 19.6 12.6 29.0 19.6 11.4 13.4 16.7 22.6 26.5 63.7 11.3 25.6 26.4 19.2 23.3 27.7 26.2 17.9 24.3 29.8 17.5 30.5 13.1 15.7 16.8 23.8 20.0 16.1 19.4 23.5 19.8 12.8 18.3 15.9 44.9 17.8 26.8 33.1 18.7 18.9 13.7 12.8 3.2 6.4 10.9 14.4 6.7 34.3 25.8 53.3 33.0 11.4 25.9 45.9 29.8 21.6 42.8 42.2 40.9 40.9 79.6 34.7 19.9 23.3 21.3 84.1 43.3 73.4 15.9 29.6 43.2 39.5 45.3 21.9 76.8 19.3 21.9 31.4 45.4 34.3 23.7 35.0 45.7 74.5 29.7 36.8 22.9 88.1 38.5 61.1 66.2 32.3 71.6 22.8 52.3 40.5 24.1 57.3 34.3 29.3 41.0 18.0 45.5 27.1 24.6 18.8 33.9 44.4 33.3 60.8 21.0 18.0 83.7 35.7 56.3 37.3 3.2 3.7 0.3 4.1 6.4 11.8 13.7 11.5 7.3 11.4 8.9 14.4 12.1 0.9 10.9 4.8 12.8 8.3 6.7 21.6 17.4 15.8 20.6 16.7 22.6 26.4 19.2 29.8 15.9 20.8 19.3 31.8 57.8 50.4 26.0 20.9 56.0 21.4 31.8 31.4 5.9 117.2 31.5 30.5 45.8 21.6 14.2 46.7 22.8 137.4 35.6 28.6 20.7 68.6 45.7 27.0 23.8 11.6 15.8 6.6 27.6 17.1 16.9 22.6 34.9 13.2 23.3 7.0 21.9 41.1 22.9 0.0 17.9 39.4 47.7 44.2 45.7 16.0 65.0 44.1 PAIP2B KIAA1155 ENSG00000124374 "Poly(A) binding protein interacting protein 2B" Q9ULR5 2 71182739-71227083 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.9;pancreas: 47.8;skeletal muscle: 39.4" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 60.6;Hepatocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 13.2;SCLC-21H: 20.5" "Low region specificity" "Detected in all" "HPA046784, HPA072371" Approved Approved Cytosol NA NA Cytosol "HPA046784: AB_2679804, HPA072371: AB_2686514" "unprognostic (8.70e-2)" "unprognostic (8.20e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (8.17e-5)" "unprognostic (4.56e-2)" "unprognostic (1.34e-1)" "unprognostic (9.67e-3)" "unprognostic (1.51e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (2.76e-1)" "prognostic favorable (6.96e-12)" "unprognostic (1.63e-2)" "unprognostic (3.87e-1)" "unprognostic (1.21e-2)" "unprognostic (4.61e-2)" 2.8 2.4 36.3 2.3 28.8 1.8 4.8 11.9 15.7 3.3 4.2 50.9 5.1 4.0 3.5 2.5 6.2 7.4 1.8 17.8 39.5 25.1 9.9 16.6 3.3 2.5 47.7 9.7 11.6 47.8 6.4 2.1 1.4 21.9 5.2 4.2 2.7 29.9 5.6 39.4 15.1 3.2 3.4 44.9 2.7 6.7 2.7 24.6 0.6 11.1 3.5 4.7 2.7 2.3 5.8 4.5 1.0 0.9 1.5 4.6 1.2 2.1 0.5 0.9 3.1 0.3 0.5 3.9 0.3 0.1 0.3 0.1 0.8 0.9 2.7 0.6 0.0 2.1 1.7 5.3 3.1 1.0 1.4 4.3 2.6 0.3 0.1 1.5 0.7 0.2 0.6 2.9 0.1 3.2 0.8 0.5 6.2 4.6 2.7 0.1 2.7 0.8 1.5 2.3 4.9 2.0 0.0 9.2 13.2 1.7 1.4 20.5 1.2 2.3 1.5 0.9 5.0 6.5 0.1 0.1 0.2 1.7 1.7 0.9 5.3 4.5 3.4 0.2 1.0 0.5 1.0 0.7 1.0 2.0 0.9 2.6 4.9 2.8 2.0 0.8 5.8 4.6 4.0 0.5 1.5 0.8 4.5 1.1 1.2 36.3 28.8 11.9 15.7 39.5 25.1 47.7 9.7 21.9 24.6 3.0 5.0 3.0 6.2 6.9 10.8 60.6 15.3 12.0 0.0 7.0 5.9 3.0 18.3 4.1 33.7 3.6 1.1 0.0 35.4 5.9 2.7 8.7 1.1 52.1 1.6 6.4 39.9 4.9 2.2 18.6 4.9 2.1 13.5 3.6 5.9 7.8 16.3 3.5 4.9 43.1 39.1 0.0 3.1 9.3 7.5 17.6 5.3 3.8 7.5 4.7 PANK2 "C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN" ENSG00000125779 "Pantothenate kinase 2" Q9BZ23 20 3888839-3929882 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008440 Approved Supported Cytosol NA NA Cytosol "HPA008440: AB_1079559" "unprognostic (4.50e-2)" "unprognostic (7.96e-3)" "unprognostic (2.26e-1)" "unprognostic (1.39e-2)" "unprognostic (1.68e-1)" "unprognostic (6.00e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (2.75e-1)" "unprognostic (3.39e-1)" "unprognostic (2.52e-1)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" "unprognostic (6.01e-3)" "unprognostic (1.73e-2)" "unprognostic (2.18e-3)" "unprognostic (2.63e-1)" "unprognostic (1.81e-1)" 15.2 21.5 18.7 18.5 18.9 20.8 19.7 21.8 24.8 14.7 14.4 16.8 10.7 11.8 15.5 15.5 28.9 19.1 14.3 11.0 17.4 18.6 18.8 20.3 16.1 18.5 16.2 16.2 14.4 13.5 15.3 15.7 18.1 20.8 14.5 16.4 17.0 15.8 13.2 14.4 12.8 14.5 16.6 12.3 20.6 12.1 28.9 14.1 23.2 17.0 10.5 24.6 17.3 16.4 5.8 8.6 8.0 12.8 8.3 6.4 3.1 20.8 13.5 14.6 7.4 17.5 15.2 8.0 13.7 15.0 18.1 23.5 18.2 11.2 17.0 6.4 15.3 36.2 17.3 15.7 26.7 23.1 5.0 6.9 23.2 9.7 33.9 14.7 15.4 7.7 13.4 11.6 20.2 13.0 6.9 16.9 12.0 17.0 15.9 19.4 5.2 13.2 13.6 14.6 8.6 10.2 10.9 20.4 10.7 11.2 19.2 19.0 9.3 17.0 18.6 34.0 14.9 11.3 12.5 11.6 21.7 10.9 28.3 21.0 8.9 25.9 12.9 6.4 14.1 16.9 1.6 11.2 4.7 4.4 12.8 4.3 4.7 4.3 4.5 8.6 5.8 4.4 4.0 8.0 8.3 10.7 3.0 6.4 3.1 18.7 18.9 21.8 24.8 17.4 18.6 16.2 16.2 20.8 14.1 17.9 9.4 18.5 15.5 22.7 20.0 9.0 7.6 16.0 9.1 14.0 23.6 25.6 19.9 16.8 63.9 22.4 12.3 23.3 15.4 29.5 18.0 15.9 7.0 13.0 29.7 33.4 19.4 20.3 37.4 13.0 19.5 30.0 18.6 36.1 9.9 13.3 12.2 11.5 21.2 15.3 20.0 6.5 16.9 32.6 21.8 21.2 15.6 25.5 12.6 16.5 PANK4 FLJ10782 ENSG00000157881 "Pantothenate kinase 4" Q9NVE7 1 2508533-2526628 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.1" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 9.0;HDLM-2: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011723, HPA012036, HPA027961" Uncertain Approved Cytosol NA NA Cytosol "HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042" "unprognostic (1.23e-1)" "unprognostic (2.31e-1)" "unprognostic (3.36e-1)" "unprognostic (1.13e-1)" "unprognostic (4.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-1)" "unprognostic (6.51e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-2)" "unprognostic (3.29e-2)" "prognostic favorable (1.57e-5)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (2.25e-1)" "unprognostic (8.15e-2)" 5.3 14.4 10.7 17.8 12.6 4.2 5.4 14.9 12.4 5.5 7.1 6.8 4.9 4.2 7.0 4.2 9.8 5.6 9.2 11.8 8.0 5.2 7.2 7.0 6.7 12.5 9.0 6.8 5.7 5.8 4.2 8.3 6.7 7.4 5.8 6.1 8.9 5.6 5.3 43.1 19.0 7.6 9.1 4.4 8.1 6.3 11.0 9.7 9.4 6.8 6.8 7.2 7.2 5.7 4.5 4.8 11.7 6.9 11.4 8.9 5.3 2.5 6.7 2.3 0.0 0.0 2.7 1.6 9.0 0.0 8.2 7.7 0.0 0.0 1.1 3.1 2.5 0.0 3.9 1.9 0.0 1.8 9.4 5.7 0.0 3.9 5.6 2.6 0.0 4.7 0.0 0.0 0.0 0.0 1.2 1.9 1.3 2.5 0.0 2.2 0.0 1.3 0.3 0.0 0.8 2.8 0.0 0.0 1.8 0.0 0.0 2.0 0.0 5.1 1.9 0.0 0.9 0.0 3.4 0.0 0.0 1.9 4.7 2.2 1.3 4.6 6.1 3.0 0.9 0.0 11.7 4.9 4.5 6.2 6.6 5.1 4.5 3.9 6.4 4.8 3.0 7.4 8.0 6.4 11.4 6.9 0.9 8.9 5.3 10.7 12.6 14.9 12.4 8.0 5.2 9.0 6.8 7.4 9.7 6.0 3.2 5.6 4.9 3.7 7.2 22.5 2.5 0.0 2.3 3.5 9.8 6.5 6.6 5.2 1.1 5.2 4.9 0.0 6.0 4.2 7.0 3.2 1.1 7.6 4.6 3.2 2.9 3.7 5.9 0.4 5.5 5.9 5.0 8.2 4.0 4.5 4.7 7.0 8.5 3.6 13.0 19.4 5.9 4.8 5.2 3.9 8.1 8.5 5.0 3.1 PAPD4 "FLJ38499, GLD2, TUT2" ENSG00000164329 "Poly(A) RNA polymerase D4, non-canonical" Q6PIY7 5 79612120-79686648 "Enzymes, Predicted intracellular proteins" "mRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054468 Approved Cytosol No No Cytosol "HPA054468: AB_2682497" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.25e-3)" "unprognostic (1.91e-1)" "unprognostic (8.03e-2)" "unprognostic (2.80e-3)" "unprognostic (2.10e-2)" "unprognostic (1.10e-1)" "unprognostic (6.80e-2)" "unprognostic (1.57e-3)" "unprognostic (9.37e-2)" "unprognostic (2.21e-1)" "unprognostic (7.71e-2)" "unprognostic (2.38e-1)" "unprognostic (8.43e-3)" "unprognostic (5.84e-3)" "unprognostic (2.67e-3)" 25.4 21.1 15.8 34.4 22.1 42.1 27.9 20.9 30.3 23.8 22.6 24.7 22.7 19.2 34.4 28.1 22.0 20.7 23.3 16.5 16.5 14.6 20.0 25.3 25.6 34.7 19.4 20.2 29.6 21.4 18.0 23.1 25.7 17.2 20.6 23.3 23.8 21.4 28.3 21.0 25.5 25.4 23.1 22.2 37.4 21.0 26.0 21.2 33.8 24.9 21.3 29.3 22.6 21.9 20.2 19.5 22.3 22.1 19.3 29.9 15.7 11.6 8.1 9.1 14.3 15.9 18.5 14.6 14.1 21.7 16.6 26.5 7.2 13.9 21.8 7.4 15.6 19.6 11.2 11.6 15.7 19.0 16.2 10.6 12.4 10.1 11.2 20.7 18.3 17.2 16.3 17.1 11.7 22.0 16.2 14.0 16.0 14.1 16.1 18.2 6.3 20.8 23.6 8.4 8.9 5.8 18.7 9.1 24.3 16.0 16.7 6.0 10.9 11.2 12.3 22.1 15.0 10.5 29.0 12.8 9.0 6.1 8.7 15.6 17.0 14.1 21.6 15.8 19.3 12.5 22.3 19.1 18.6 18.2 22.1 29.9 20.2 19.9 19.9 19.5 16.2 19.3 19.8 17.3 19.3 21.7 10.7 20.2 15.7 15.8 22.1 20.9 30.3 16.5 14.6 19.4 20.2 17.2 21.2 17.9 15.6 14.7 16.3 26.1 21.3 0.0 12.7 24.1 14.8 0.0 21.6 23.1 0.0 0.0 7.5 20.4 16.9 23.3 0.0 18.7 18.8 16.8 20.9 23.2 29.3 31.8 13.8 33.2 52.9 6.6 17.8 36.5 15.1 0.0 17.6 17.1 0.0 20.9 25.1 0.0 33.2 12.9 12.5 24.2 15.0 27.5 28.1 35.0 18.4 20.3 PAQR7 "MPRA, mSR" ENSG00000182749 "Progestin and adipoQ receptor family member 7" Q86WK9 1 25861210-25871253 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 12 "Early spermatids: 346.5;Late spermatids: 1377.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.3;HaCaT: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046936 Approved Approved Cytosol NA NA Cytosol "HPA046936: AB_2679869" "unprognostic (1.12e-1)" "unprognostic (2.08e-2)" "unprognostic (8.03e-2)" "unprognostic (4.54e-3)" "unprognostic (1.32e-1)" "unprognostic (3.41e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.47e-1)" "unprognostic (4.59e-3)" "unprognostic (7.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.05e-5)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.15e-2)" "unprognostic (1.54e-2)" 1.2 9.5 1.8 0.7 2.3 1.0 1.4 1.8 1.8 2.8 1.6 6.7 4.1 10.2 6.1 6.8 2.1 0.6 1.7 2.6 11.9 1.9 1.6 0.6 2.0 13.2 1.8 3.9 2.1 6.9 2.4 0.4 1.5 8.9 0.2 10.7 5.7 2.9 1.4 3.5 2.3 16.2 1.4 1.0 6.3 4.6 3.2 5.5 10.8 11.7 2.4 1.4 0.8 11.7 2.3 2.4 7.8 2.9 6.2 8.4 7.7 6.9 7.8 7.0 3.9 30.3 0.1 5.5 7.6 2.5 24.9 1.3 13.1 4.7 4.6 1.3 10.0 3.3 4.7 4.9 0.1 1.3 6.3 17.5 5.5 4.1 6.9 2.9 1.1 1.0 0.8 5.7 2.7 0.0 0.7 3.7 1.2 4.0 0.8 0.2 1.4 15.8 9.1 1.2 4.7 12.6 16.5 5.7 3.5 4.7 1.8 3.2 1.3 4.0 4.1 2.1 0.1 0.1 0.5 5.9 0.3 2.6 3.1 5.7 10.8 1.1 10.2 1.1 3.2 0.6 0.8 5.5 1.2 1.0 1.4 2.6 2.4 11.7 0.6 0.2 0.8 0.0 1.9 1.9 4.7 16.1 1.9 1.6 17.8 10.7 6.8 73.3 0.0 36.5 18.3 4.9 346.5 4.5 1.3 0.0 12.5 10.0 7.5 1.0 6.9 4.9 9.2 3.2 4.6 10.4 7.3 1377.7 18.4 5.3 20.3 5.4 1.5 2.0 7.0 3.5 14.2 49.2 0.6 12.9 4.0 11.1 9.1 11.4 29.9 0.9 2.9 2.2 PARD6B PAR-6B ENSG00000124171 "Par-6 family cell polarity regulator beta" Q9BYG5 20 50731544-50756795 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 40.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 175.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 15.8;MCF7: 27.8;T-47d: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013376 Uncertain Supported Cytosol NA NA Cytosol "HPA013376: AB_1854972" "unprognostic (1.13e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.39e-3)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (9.33e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.27e-1)" "prognostic favorable (6.38e-5)" "unprognostic (1.84e-2)" "unprognostic (1.97e-1)" "unprognostic (4.18e-2)" "unprognostic (1.07e-2)" 3.7 2.3 1.6 3.1 2.3 2.6 7.9 3.5 2.0 2.7 13.9 1.4 11.3 4.5 2.2 12.1 5.8 5.7 6.6 2.1 2.0 1.9 40.0 8.0 15.4 1.9 1.5 1.3 3.4 9.9 7.3 3.7 24.1 2.7 4.0 3.0 12.2 3.6 17.2 4.3 3.8 17.5 1.0 1.6 2.4 8.3 6.4 0.5 2.9 14.4 1.0 5.8 3.5 5.5 3.6 3.1 3.4 1.5 3.8 6.1 1.1 2.9 3.4 1.0 2.1 0.6 0.2 4.5 0.2 0.3 0.5 0.4 15.8 7.0 1.3 3.0 0.0 2.2 2.4 1.4 2.1 0.8 0.6 0.8 0.7 1.1 6.2 0.6 0.5 0.7 0.0 1.0 0.3 0.9 1.0 0.0 1.2 1.6 0.9 0.0 27.8 1.3 1.2 1.7 4.9 1.3 0.7 0.9 1.1 7.1 3.2 0.6 0.9 2.2 5.3 1.5 4.2 27.2 0.7 0.1 0.3 1.8 0.3 0.5 1.1 0.7 1.1 0.7 0.5 0.6 2.9 0.7 3.4 3.6 0.9 4.0 2.9 3.7 3.6 0.8 3.6 6.1 3.8 2.8 3.8 1.5 3.1 2.3 1.1 1.6 2.3 3.5 2.0 2.0 1.9 1.5 1.3 2.7 0.5 175.7 50.3 4.5 51.0 55.9 12.3 3.3 28.1 25.4 33.0 85.5 51.1 28.8 34.9 22.0 3.2 1.1 39.4 0.0 21.2 12.5 2.6 39.6 1.1 17.8 3.1 4.8 14.3 2.5 0.3 2.2 1.7 2.5 15.1 1.0 18.0 10.0 40.3 18.2 0.7 63.2 52.4 6.5 2.3 11.2 9.8 59.7 40.5 4.6 12.1 85.3 PARP14 "KIAA1268, pART8" ENSG00000173193 "Poly(ADP-ribose) polymerase family member 14" Q460N5 3 122680618-122730840 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 229.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 29.6;BJ hTERT+ SV40 Large T+ RasG12V: 45.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008846, HPA012063" Supported Supported Cytosol NA NA Cytosol "HPA008846: AB_1854982, HPA012063: AB_1854981" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-1)" "unprognostic (2.50e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (1.44e-1)" "unprognostic (4.20e-2)" "unprognostic (1.74e-3)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (7.87e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-3)" "unprognostic (1.71e-2)" 21.6 10.3 5.6 15.8 7.2 11.7 9.3 2.3 6.0 11.6 13.3 5.9 6.4 11.4 10.6 12.7 11.7 7.2 10.0 6.5 5.2 4.8 13.7 21.5 26.0 16.7 7.3 5.2 10.0 6.7 7.2 6.8 17.5 6.3 12.3 6.7 7.5 8.5 5.5 5.2 5.7 22.3 11.9 6.8 29.7 7.6 4.6 4.9 18.7 20.4 6.4 18.9 12.8 12.4 15.9 4.2 20.8 10.5 7.4 7.0 2.8 5.9 5.0 3.2 3.4 4.5 10.7 0.0 2.3 15.6 29.6 45.6 2.6 11.9 0.0 9.8 5.2 16.6 4.6 4.6 4.8 6.0 9.1 0.5 5.5 2.3 4.0 10.9 2.4 2.7 6.4 2.4 5.1 2.0 7.2 12.8 4.9 2.6 8.9 1.0 3.1 9.1 1.6 0.4 0.9 4.3 12.8 3.2 1.6 7.2 6.2 0.2 0.0 6.0 1.3 6.7 0.4 2.2 4.3 8.6 1.6 3.9 0.9 2.1 3.5 0.6 1.0 4.8 5.7 2.8 8.3 8.2 4.0 6.9 10.5 6.0 10.2 3.8 4.5 4.2 15.9 3.2 3.4 20.8 7.4 9.3 0.6 7.0 2.8 5.6 7.2 2.3 6.0 5.2 4.8 7.3 5.2 6.3 4.9 229.3 87.3 41.0 15.2 14.9 1.1 10.1 30.6 52.2 84.2 24.4 3.9 12.0 3.3 28.1 0.3 61.9 21.0 0.0 35.6 24.3 19.7 23.9 30.2 29.6 32.4 0.0 10.3 67.5 50.6 0.2 25.9 50.6 15.1 94.6 14.3 18.7 33.8 17.5 16.3 7.0 0.8 12.9 18.4 1.6 1.1 9.3 4.0 27.4 11.0 21.3 PARP4 "ADPRTL1, p193, VAULT3, VPARP, VWA5C" ENSG00000102699 "Poly(ADP-ribose) polymerase family member 4" Q9UKK3 13 24420926-24512810 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Ribonucleoprotein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 83.0;granulocytes: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011739 Approved Supported Cytosol Yes No Cytosol "HPA011739: AB_1854986" "unprognostic (1.61e-1)" "unprognostic (2.34e-2)" "unprognostic (1.62e-2)" "unprognostic (4.35e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" "unprognostic (2.52e-1)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (4.12e-3)" "unprognostic (2.97e-2)" "prognostic favorable (1.21e-5)" "unprognostic (3.23e-2)" "unprognostic (1.71e-1)" "unprognostic (3.80e-2)" "unprognostic (2.84e-3)" 25.3 24.7 6.6 16.7 12.9 11.6 14.6 2.3 7.0 17.8 39.4 16.7 21.6 22.9 19.1 11.2 22.2 14.9 23.8 11.3 7.9 5.6 28.8 17.3 17.8 16.5 14.6 4.4 15.9 15.5 11.2 12.6 14.8 12.5 16.1 24.1 14.0 17.7 30.9 6.5 10.2 49.9 15.5 20.5 28.4 20.4 7.0 12.1 28.8 18.2 11.3 26.2 23.3 13.2 9.0 16.4 26.1 18.6 11.8 12.9 10.6 14.6 13.1 6.4 11.6 17.8 25.4 5.4 17.1 22.4 15.0 13.4 5.3 38.2 11.0 17.1 15.5 16.6 17.1 9.6 17.3 12.3 25.1 6.7 15.7 12.2 12.3 10.2 20.1 15.6 14.6 5.8 12.4 6.6 29.4 24.6 8.6 4.4 4.9 17.7 6.8 12.6 9.7 7.3 34.7 16.2 12.0 12.1 15.4 27.9 30.2 5.9 7.5 12.5 5.0 11.8 8.8 2.5 16.6 34.8 6.8 7.1 8.7 17.4 5.6 6.4 14.5 12.4 10.6 14.8 25.2 12.4 26.1 12.9 15.3 12.9 9.0 10.8 12.8 16.4 5.1 8.1 9.6 14.3 11.8 18.6 6.2 12.7 10.6 6.6 12.9 2.3 7.0 7.9 5.6 14.6 4.4 12.5 12.1 47.6 43.8 12.3 5.6 2.5 6.0 15.5 20.4 83.0 64.8 24.4 2.0 4.6 5.0 20.5 3.5 18.8 54.7 0.0 19.4 7.7 6.9 8.6 92.8 12.9 15.7 1.6 4.7 36.2 23.1 3.1 10.9 25.1 8.5 31.5 26.9 7.0 25.8 48.9 7.8 15.6 6.9 6.5 6.2 2.8 7.2 3.3 1.6 15.2 26.0 14.8 PARVB CGI-56 ENSG00000188677 "Parvin beta" Q9HBI1 22 43999211-44172949 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 64.5;Hofbauer cells: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 44.5;RPMI-8226: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062601, HPA072217" Enhanced Approved Cytosol NA NA 90000000 Cytosol "HPA062601: AB_2684803, HPA072217: " "unprognostic (2.41e-1)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.83e-2)" "unprognostic (2.10e-3)" "unprognostic (7.65e-3)" "unprognostic (1.28e-1)" "unprognostic (1.73e-2)" "unprognostic (2.28e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-2)" "unprognostic (6.45e-2)" "unprognostic (1.28e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-2)" "unprognostic (4.19e-2)" "unprognostic (7.05e-3)" 15.9 10.7 6.4 9.7 7.3 16.8 17.4 3.1 8.3 8.0 7.2 3.5 6.3 3.7 8.6 8.7 7.3 6.8 5.3 28.5 5.6 8.8 7.3 7.3 12.6 19.7 8.0 6.3 13.4 4.8 8.6 9.3 10.2 5.8 7.8 4.4 9.3 5.3 7.2 82.1 5.1 6.3 11.9 8.3 15.2 5.4 5.7 4.5 2.3 4.9 22.4 7.9 11.7 26.0 6.3 14.1 4.8 6.4 0.7 2.2 8.3 6.4 7.7 0.1 5.4 8.2 10.4 0.0 9.1 5.6 5.9 4.5 7.9 3.8 0.0 5.0 24.2 4.7 0.2 12.9 0.6 3.3 9.0 8.0 27.6 13.4 0.0 13.6 20.7 24.8 16.1 6.8 4.3 0.0 4.3 44.5 0.1 9.8 18.9 6.4 4.3 0.1 13.7 2.7 5.6 5.3 0.0 0.2 43.4 0.1 0.1 7.0 4.9 2.4 0.4 22.8 0.9 4.5 8.4 27.6 5.4 5.8 8.3 0.9 4.7 4.1 0.2 23.8 6.1 29.8 4.5 6.1 1.4 1.0 6.4 1.6 6.0 1.7 1.4 6.8 6.3 0.4 0.9 4.8 0.7 2.6 14.1 2.2 8.3 6.4 7.3 3.1 8.3 5.6 8.8 8.0 6.3 5.8 4.5 0.0 11.7 29.8 2.6 4.6 9.2 34.8 5.1 6.7 1.2 1.8 15.7 0.9 23.2 1.0 5.5 46.8 0.0 46.7 2.7 8.6 19.0 3.2 64.5 9.8 82.8 6.4 1.2 46.1 44.1 13.6 18.4 40.4 18.6 44.1 0.1 6.7 5.5 0.0 10.3 11.6 13.3 6.5 6.9 1.4 3.2 3.9 1.5 12.8 0.6 1.1 PASK "KIAA0135, PASKIN, STK37" ENSG00000115687 "PAS domain containing serine/threonine kinase" Q96RG2 2 241106099-241150264 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 24.1;testis: 22.0" "Cell type enhanced" "Detected in many" 6 "Ito cells: 27.0;Peritubular cells: 23.0;Rod photoreceptor cells: 17.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 24.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA016450, HPA021079" Uncertain Supported Cytosol NA NA Cytosol "HPA016450: AB_1854992, HPA021079: AB_1854993" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.84e-1)" "unprognostic (1.41e-2)" "unprognostic (1.14e-1)" "unprognostic (8.99e-6)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.60e-3)" "unprognostic (1.58e-2)" "unprognostic (1.02e-2)" "unprognostic (6.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.52e-3)" "unprognostic (1.68e-1)" "unprognostic (6.44e-2)" "unprognostic (4.38e-3)" 1.5 1.1 2.4 10.3 24.1 8.9 3.1 6.3 5.2 2.2 2.1 2.2 2.1 3.8 2.9 6.7 3.1 7.2 3.3 1.1 2.9 2.7 3.7 1.3 3.0 14.5 1.3 1.6 1.9 3.3 4.4 4.9 1.1 3.6 12.1 2.8 4.7 2.7 1.8 2.0 4.9 3.9 1.4 1.6 4.4 3.4 22.0 7.2 9.0 4.8 1.9 9.9 2.7 1.9 7.1 1.1 4.8 1.0 2.7 6.0 3.0 5.0 6.8 9.2 11.6 0.8 1.4 12.3 4.8 1.5 4.5 6.3 5.5 5.1 2.6 1.0 1.1 10.0 12.6 10.4 4.2 3.3 10.6 9.9 7.2 12.6 9.7 0.5 9.8 11.3 0.7 3.3 4.6 1.3 1.9 3.2 11.2 9.3 3.6 3.1 5.7 11.6 10.3 10.2 5.9 4.1 18.5 9.3 3.2 1.7 11.4 16.3 4.9 2.9 5.6 2.1 5.1 4.7 7.1 4.2 6.1 5.6 7.8 6.4 4.8 4.9 12.4 3.8 7.4 5.6 4.8 1.0 0.7 1.7 0.6 1.5 7.1 5.9 5.3 1.1 6.6 3.7 3.9 1.3 2.7 1.0 0.7 6.0 3.0 2.4 24.1 6.3 5.2 2.9 2.7 1.3 1.6 3.6 7.2 3.0 9.3 10.6 1.0 2.4 2.3 2.8 2.5 6.7 1.2 3.5 3.9 0.8 0.0 1.2 7.7 2.4 1.8 0.0 1.8 1.5 0.9 2.5 3.5 1.0 1.6 1.6 0.0 27.0 5.3 2.2 5.5 1.9 11.8 1.0 2.9 1.6 0.6 0.0 23.0 1.0 17.7 0.0 0.3 14.7 12.7 1.3 0.2 13.1 2.7 0.7 PBK "CT84, FLJ14385, Nori-3, SPK, TOPK" ENSG00000168078 "PDZ binding kinase" Q96KB5 8 27809620-27838095 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "lymphoid tissue: 19.4;testis: 67.9" "Group enriched" "Detected in many" 4 "Early spermatids: 218.2;Spermatocytes: 187.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.1;T-reg: 1.6" "Group enriched" "Detected in many" 10 "NK-cells: 2.1;T-cells: 1.6" "Cell line enhanced" "Detected in many" "A-431: 61.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA005753, HPA050656" Enhanced Supported Approved Cytosol NA Yes Cytosol "HPA005753: AB_1855018, HPA050656: AB_2681205" "unprognostic (7.17e-2)" "unprognostic (7.21e-3)" "unprognostic (1.04e-3)" "unprognostic (2.77e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.29e-5)" "unprognostic (3.65e-3)" "unprognostic (7.38e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.18e-12)" "unprognostic (9.61e-2)" "unprognostic (1.86e-1)" "unprognostic (8.30e-2)" "unprognostic (8.68e-2)" 0.6 0.8 0.2 7.7 0.3 3.3 1.3 0.3 0.4 1.1 3.8 0.3 0.2 3.7 0.4 0.6 6.2 0.3 0.8 3.3 0.3 0.2 0.7 0.9 1.2 5.4 0.3 0.2 0.4 0.4 0.0 0.2 2.2 0.3 0.4 4.6 0.2 1.1 0.2 0.4 1.9 3.6 0.9 0.6 1.7 1.7 67.9 0.2 19.4 0.3 4.7 5.3 0.7 1.9 0.1 0.0 0.0 0.0 2.1 1.6 0.5 61.3 20.0 19.7 12.5 1.9 3.5 8.3 28.2 13.4 29.0 24.5 6.9 11.4 32.7 10.0 10.8 32.3 16.3 18.9 9.5 31.9 8.0 10.2 7.8 14.2 10.1 0.1 5.1 11.7 0.9 7.8 13.4 7.2 5.2 14.6 16.2 11.5 22.0 34.2 6.9 19.3 6.0 3.5 16.6 17.4 12.1 27.4 8.8 10.9 9.5 7.8 12.2 10.5 12.4 15.8 5.7 13.0 7.8 8.5 19.1 46.0 24.2 29.9 3.1 8.7 15.1 11.6 9.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 1.6 0.5 0.2 0.3 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.9 7.9 0.0 0.3 5.1 0.0 2.3 0.0 0.0 3.1 0.0 0.5 218.2 0.0 1.3 46.7 0.0 40.6 2.9 0.7 0.0 1.0 4.2 0.0 0.0 7.4 1.9 37.5 7.8 0.6 0.0 0.0 4.3 0.0 0.2 0.0 2.8 0.0 0.0 6.5 0.5 187.0 31.0 2.0 5.6 0.0 5.3 0.7 PCBP4 "LIP4, MCG10" ENSG00000090097 "Poly(rC) binding protein 4" P57723 3 51957454-51974016 "Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.5" "Group enriched" "Detected in many" 7 "Bipolar cells: 389.4;Cone photoreceptor cells: 616.5;Rod photoreceptor cells: 516.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 20 "B-cells: 4.6;granulocytes: 4.6;T-cells: 10.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 49.4;SK-MEL-30: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057754 Supported Cytosol NA NA Cytosol "HPA057754: AB_2683517" "unprognostic (7.17e-2)" "unprognostic (8.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.34e-2)" "unprognostic (4.94e-3)" "unprognostic (1.94e-2)" "unprognostic (4.97e-3)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (5.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.13e-2)" "unprognostic (6.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (4.72e-2)" 19.5 16.6 27.2 9.6 21.9 3.0 10.6 86.0 56.3 12.7 16.7 36.2 16.0 15.1 15.4 12.1 14.5 10.4 18.3 36.5 29.2 29.9 21.2 38.9 13.9 17.0 28.9 13.0 16.3 22.0 22.9 15.8 7.8 16.4 20.1 8.6 47.3 20.3 19.6 97.5 13.6 29.0 14.4 44.4 10.9 13.3 10.6 19.7 11.9 17.3 11.0 15.7 13.3 9.6 4.6 0.3 4.6 0.0 0.1 10.2 2.4 10.2 3.5 14.1 20.5 6.4 11.5 2.4 23.6 11.5 14.2 9.2 13.0 3.7 0.3 3.5 18.6 12.6 2.4 13.1 8.2 6.7 16.2 2.1 1.3 11.8 13.5 10.4 1.3 10.0 15.5 15.4 9.0 4.0 17.7 7.1 6.0 0.6 4.6 22.7 4.8 0.5 1.6 6.8 6.5 9.5 7.1 6.8 1.8 5.0 7.3 27.8 49.4 6.4 3.5 41.8 3.9 6.5 5.0 14.1 15.2 28.8 4.8 12.5 3.1 1.9 2.0 17.6 2.9 22.1 4.6 0.0 3.1 10.2 0.0 7.1 4.6 9.6 9.8 0.3 2.3 4.6 3.5 0.0 0.1 0.0 0.1 10.0 2.4 27.2 21.9 86.0 24.2 29.2 29.9 28.9 13.0 16.4 19.7 3.0 2.7 2.2 13.9 7.7 389.4 6.7 2.5 1.4 4.5 8.7 616.5 1.2 14.9 28.1 52.1 11.2 7.3 0.0 20.1 1.1 16.4 16.8 1.1 3.9 1.0 39.7 59.5 12.3 0.3 76.2 20.8 1.1 21.9 1.0 8.6 56.4 34.6 14.0 15.2 7.9 516.1 6.5 15.3 0.9 2.3 10.3 0.5 6.9 4.8 9.7 PCDH19 "EFMR, EIEE9, KIAA1313" ENSG00000165194 "Protocadherin 19" Q8TAB3 X 100291644-100410273 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 27.1" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 7.1;Cholangiocytes: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027533 Approved Approved Cytosol NA NA Cytosol "HPA027533: AB_10602043" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (5.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (4.77e-2)" "unprognostic (3.64e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-1)" "unprognostic (2.79e-1)" "unprognostic (9.77e-3)" "unprognostic (2.82e-3)" "unprognostic (1.53e-1)" "unprognostic (1.80e-4)" "unprognostic (1.37e-1)" 4.9 1.1 19.8 1.3 10.5 0.7 3.7 1.0 22.5 5.5 4.0 1.9 0.0 1.2 3.8 1.3 2.9 2.2 2.0 1.6 27.1 12.8 1.4 0.9 1.0 1.3 3.7 14.2 3.6 1.1 1.2 2.1 1.0 7.3 1.4 5.5 6.4 2.1 1.6 2.4 3.3 1.8 3.1 3.7 0.8 2.0 2.3 1.0 0.0 1.1 0.7 0.9 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 3.5 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 10.5 1.0 22.5 27.1 12.8 3.7 14.2 7.3 1.0 0.0 0.3 0.0 0.0 2.7 7.1 1.4 7.6 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.7 2.8 0.0 0.0 0.0 0.1 1.8 0.4 0.0 0.0 0.1 0.0 1.7 1.3 0.0 1.9 3.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.4 0.0 1.6 0.0 0.5 0.0 0.7 1.4 0.0 0.0 0.0 0.0 PCMT1 ENSG00000120265 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase" P22061 6 149749443-149811420 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 968.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003239 Approved Supported Cytosol No No 8200000 Cytosol "HPA003239: AB_1079580" "prognostic unfavorable (4.02e-7)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.35e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.88e-4)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.91e-2)" "unprognostic (1.58e-2)" "unprognostic (9.02e-2)" "unprognostic (6.45e-2)" "unprognostic (6.77e-2)" "unprognostic (6.14e-2)" "unprognostic (4.38e-1)" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "prognostic unfavorable (6.38e-4)" 19.1 18.4 35.7 13.0 43.0 28.5 19.3 33.5 58.3 20.2 16.9 19.2 12.4 14.7 16.0 22.2 17.9 15.8 11.0 43.9 35.0 38.8 21.3 29.5 15.1 14.6 35.1 46.0 16.2 14.6 16.4 15.5 17.2 57.4 22.1 18.1 11.6 17.2 21.4 69.5 14.7 13.6 19.6 28.6 12.0 12.7 29.1 19.2 18.1 19.3 15.9 17.9 14.4 13.7 31.6 53.0 51.2 58.0 30.0 37.4 51.6 21.8 17.3 17.7 22.1 38.1 31.5 19.7 35.9 20.5 28.5 36.1 50.2 16.7 27.6 30.5 30.3 33.9 27.2 30.4 35.8 41.2 19.2 44.0 42.2 32.5 49.0 25.5 50.2 51.9 15.7 26.5 32.5 35.2 20.6 26.9 23.4 60.3 27.1 34.0 65.0 24.3 38.3 14.4 21.5 19.4 20.2 23.0 19.9 27.7 16.1 33.8 13.0 27.2 43.5 23.3 22.7 26.3 35.8 20.0 16.8 21.4 31.9 38.9 17.1 26.6 28.2 26.5 33.6 33.4 40.0 58.0 51.2 30.2 53.6 30.1 31.6 30.6 32.7 53.0 24.2 28.5 32.5 30.8 30.0 52.2 23.9 37.4 51.6 35.7 43.0 33.5 58.3 35.0 38.8 35.1 46.0 57.4 19.2 50.6 33.8 61.0 64.4 155.6 73.9 150.1 58.6 62.9 33.0 75.0 35.3 145.0 66.3 107.5 968.1 68.2 50.9 46.7 96.6 180.3 97.5 60.4 104.1 112.2 107.3 62.0 53.0 50.3 78.3 318.9 66.4 94.5 131.6 139.7 62.0 111.0 87.2 56.9 69.3 69.4 50.7 109.9 107.2 205.7 85.4 137.8 124.0 71.9 52.4 51.7 PCNX3 "FLJ22427, PCNXL3" ENSG00000197136 "Pecanex homolog 3" Q9H6A9 11 65615773-65637439 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 8.3;Collecting duct cells: 12.2;Ductal cells: 8.4;Exocrine glandular cells: 7.5;Hofbauer cells: 7.7;Pancreatic endocrine cells: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018084 Uncertain Approved Cytosol NA NA Cytosol "HPA018084: AB_1855083" "unprognostic (9.93e-2)" "unprognostic (1.33e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-2)" "unprognostic (2.54e-1)" "unprognostic (1.70e-2)" "unprognostic (3.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (7.69e-3)" "unprognostic (7.06e-2)" "unprognostic (2.44e-2)" "unprognostic (8.52e-3)" "unprognostic (6.51e-3)" "unprognostic (1.93e-1)" "unprognostic (2.32e-2)" "unprognostic (4.82e-1)" 11.0 14.0 11.6 17.0 12.5 20.4 11.8 18.1 16.8 10.3 14.4 13.5 15.6 18.4 16.4 12.6 15.4 13.9 13.6 9.0 11.9 7.1 12.4 18.8 15.1 17.6 12.6 10.6 13.1 18.1 13.9 13.9 16.1 11.7 13.0 7.8 12.1 16.9 13.3 8.2 14.5 18.8 12.1 11.1 18.0 15.3 26.6 11.7 21.6 15.3 8.8 14.2 13.7 10.9 2.6 3.3 6.0 2.5 1.7 3.6 1.3 12.0 18.2 6.7 16.5 5.2 4.1 15.2 8.6 7.5 8.4 6.2 8.7 13.8 8.9 16.7 7.6 11.5 19.9 7.1 9.9 2.5 7.5 12.5 11.6 16.9 7.1 5.9 11.3 14.3 7.7 5.0 8.3 6.6 3.8 8.2 9.5 13.3 7.6 4.9 18.0 9.5 8.8 13.6 5.2 11.7 13.5 6.0 11.6 3.7 19.6 8.3 12.4 9.1 12.1 10.2 3.1 21.2 7.8 11.6 14.7 13.9 12.1 8.6 12.5 7.4 8.0 11.7 5.5 12.8 6.0 2.5 1.5 3.6 1.2 3.0 1.5 2.0 2.1 1.3 2.6 1.5 2.1 3.5 1.7 1.7 3.3 0.8 1.3 11.6 12.5 18.1 16.8 11.9 7.1 12.6 10.6 11.7 11.7 6.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 12.2 0.0 5.6 0.0 8.4 0.0 0.0 0.0 0.0 7.5 4.6 0.0 0.0 4.7 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.6 0.0 0.0 10.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 PCNX4 "C14orf135, PCNXL4" ENSG00000126773 "Pecanex homolog 4" Q63HM2 14 60091911-60169133 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 62.9;Club cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002076, HPA003390" Uncertain Approved Cytosol NA NA Cytosol "HPA002076: AB_1078322, HPA003390: AB_2066703" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.89e-1)" "unprognostic (9.87e-2)" "unprognostic (2.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.83e-3)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (3.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.81e-1)" "prognostic favorable (6.84e-5)" "unprognostic (2.13e-1)" "unprognostic (2.08e-1)" "unprognostic (4.14e-2)" "unprognostic (8.59e-2)" 12.0 16.5 13.6 14.7 18.2 9.1 14.3 19.4 18.6 18.8 10.2 15.2 14.0 8.2 21.2 13.6 10.4 22.7 14.2 17.8 12.7 13.6 20.6 11.1 12.2 11.0 12.5 12.4 27.4 12.1 26.3 39.8 13.7 16.1 21.3 11.2 17.7 12.7 17.2 15.2 13.0 11.3 16.2 14.5 13.1 10.0 23.0 11.6 24.6 16.5 11.1 11.7 11.6 13.9 7.3 7.7 5.3 8.1 13.4 11.4 5.3 40.1 6.3 12.1 8.2 10.4 12.3 5.4 13.4 22.0 16.1 20.3 6.7 12.2 7.2 5.6 11.2 13.2 5.3 8.1 7.9 27.4 9.1 3.7 11.4 4.6 5.2 22.0 11.8 8.3 9.9 5.5 11.1 18.9 13.0 7.5 16.6 5.8 10.1 25.0 5.3 16.3 4.2 6.2 4.6 8.1 9.5 15.5 2.9 8.9 5.5 9.1 10.7 12.5 4.9 9.7 7.2 10.9 5.2 14.9 33.1 25.3 7.8 10.3 3.3 3.2 9.6 12.6 4.2 16.0 4.8 6.9 5.3 8.7 7.2 11.4 7.3 6.3 7.5 7.0 5.5 7.2 8.0 3.2 13.4 8.1 7.7 6.2 5.3 13.6 18.2 19.4 18.6 12.7 13.6 12.5 12.4 16.1 11.6 14.9 22.2 0.0 0.0 0.0 0.0 0.0 0.0 62.9 35.2 24.4 0.0 14.5 14.9 16.8 0.0 0.0 0.0 0.0 11.2 6.9 0.0 0.0 14.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 18.0 0.0 0.0 15.8 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 PDCD1LG2 "B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2" ENSG00000197646 "Programmed cell death 1 ligand 2" Q9BQ51 9 5510570-5571254 "Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 15.1;monocytes: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 25.9;BJ hTERT+: 40.8;HDLM-2: 31.1;TIME: 18.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013411 Approved Uncertain Cytosol "Secreted - unknown location" NA NA 34000000 Cytosol "HPA013411: AB_1855102" "unprognostic (3.93e-2)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (6.68e-3)" "unprognostic (7.66e-2)" "unprognostic (6.77e-2)" "unprognostic (5.72e-2)" "unprognostic (2.91e-1)" "unprognostic (1.68e-1)" "unprognostic (4.37e-3)" "unprognostic (5.79e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (5.00e-2)" "unprognostic (4.66e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-3)" 15.2 1.8 1.2 7.7 1.4 0.2 9.5 0.7 1.2 7.0 1.9 2.3 0.0 0.8 2.9 7.2 3.9 3.8 4.0 5.8 1.2 1.3 2.5 6.4 13.3 10.8 1.6 0.5 4.1 1.8 0.5 1.1 12.9 1.9 5.0 2.5 2.4 2.9 1.7 5.5 3.6 2.5 4.6 3.7 19.5 1.9 4.2 1.2 8.1 3.5 3.5 8.1 6.0 5.4 0.5 0.9 4.1 3.6 0.0 3.0 0.7 2.1 0.0 0.0 0.0 1.8 2.1 0.0 25.9 40.8 12.5 15.2 0.0 0.1 0.0 0.1 10.5 1.8 0.2 0.0 3.5 12.5 31.1 0.0 0.0 0.0 0.0 10.1 0.0 0.0 1.9 0.0 5.8 6.9 3.6 8.2 0.0 0.0 3.1 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 18.0 9.0 0.5 4.3 7.1 0.4 0.0 0.0 5.1 0.0 1.1 4.1 0.9 0.0 1.4 3.6 1.9 0.5 2.2 0.9 0.9 0.3 0.0 1.0 2.0 0.0 0.5 0.0 3.0 0.7 1.2 1.4 0.7 1.2 1.2 1.3 1.6 0.5 1.9 1.2 6.0 0.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.2 15.1 2.1 0.1 3.5 0.0 2.8 0.0 0.0 6.7 4.3 0.0 5.5 2.2 1.7 45.9 0.0 0.0 2.1 0.0 2.1 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.7 0.0 0.0 0.0 PDE2A ENSG00000186642 "Phosphodiesterase 2A" O00408 11 72576141-72674591 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0;lymphoid tissue: 65.4" "Group enriched" "Detected in some" 6 "Endothelial cells: 33.1;Intestinal endocrine cells: 33.1;Ito cells: 118.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.7;T-cells: 9.6" "Cell line enriched" "Detected in some" 8 "HeLa: 107.5" "Group enriched" "Detected in all" 5 "amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9" "CAB009752, HPA031192" Enhanced Supported Cytosol NA NA Cytosol "CAB009752: AB_2268159, HPA031192: AB_2673781" "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (4.58e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-1)" "unprognostic (2.50e-1)" "prognostic favorable (1.76e-6)" "unprognostic (3.06e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-3)" "unprognostic (3.13e-3)" "unprognostic (1.50e-2)" "unprognostic (1.77e-2)" "unprognostic (2.85e-3)" "unprognostic (6.31e-2)" "unprognostic (7.72e-2)" "unprognostic (7.96e-4)" 27.8 18.4 30.4 3.0 34.2 2.5 25.4 1.0 48.0 8.9 7.7 3.8 1.9 3.5 9.4 4.9 10.2 11.6 12.0 11.3 18.0 6.1 7.0 10.4 5.1 3.8 3.8 27.0 3.4 2.4 4.4 3.4 6.6 6.7 4.8 5.2 3.0 2.3 6.3 6.6 4.8 4.2 10.3 2.1 65.4 4.2 2.9 7.4 0.1 7.0 3.9 2.2 8.3 11.2 3.7 1.2 0.2 1.0 0.1 9.6 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.6 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 107.5 0.1 0.2 0.0 1.6 0.0 0.2 0.5 4.4 0.2 2.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 2.9 0.0 0.0 0.2 0.0 0.0 9.6 0.5 0.0 0.0 0.4 0.1 0.0 0.0 13.7 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 9.6 1.0 5.6 3.7 5.7 5.6 1.2 2.5 3.7 3.0 0.2 0.1 0.5 0.0 2.3 1.9 30.4 34.2 1.0 48.0 18.0 6.1 3.8 27.0 6.7 7.4 0.0 0.3 0.0 0.0 2.3 2.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 33.1 0.0 0.0 0.0 0.2 0.9 0.1 1.1 0.9 0.5 1.6 33.1 118.4 10.0 1.5 0.3 1.0 1.7 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.4 0.0 4.3 1.4 0.8 2.5 0.0 0.0 0.0 0.3 PDE5A ENSG00000138735 "Phosphodiesterase 5A" O76074 4 119494395-119628991 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Peritubular cells: 98.6;Smooth muscle cells: 79.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 27.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.6;HHSteC: 35.4;hTERT-RPE1: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004729, HPA012873" Approved Approved Cytosol NA NA 3100000 Cytosol "HPA004729: AB_1079588, HPA012873: AB_1855124" "unprognostic (6.95e-2)" "prognostic favorable (5.20e-4)" "unprognostic (1.28e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (7.36e-2)" "unprognostic (2.58e-2)" "unprognostic (2.29e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-2)" "unprognostic (2.54e-1)" "unprognostic (2.16e-2)" "unprognostic (1.52e-2)" "unprognostic (8.98e-2)" "unprognostic (8.71e-3)" "prognostic unfavorable (1.17e-4)" 12.3 4.9 2.0 28.2 2.3 0.4 8.1 3.0 2.3 21.3 28.0 1.7 20.1 6.5 17.3 21.4 30.7 10.7 13.3 5.3 2.0 2.8 3.8 1.2 11.4 4.1 2.4 3.4 10.0 7.8 5.1 3.4 8.9 4.4 31.8 11.7 20.2 8.5 23.7 6.8 4.2 15.6 45.6 2.0 2.1 9.1 7.6 1.2 0.9 9.1 8.1 2.2 25.9 15.9 1.5 0.5 1.4 0.4 0.6 2.1 4.2 8.1 0.4 5.7 0.6 2.0 3.0 1.0 5.5 24.6 0.2 0.5 0.5 0.7 0.8 0.2 6.8 1.5 3.0 1.8 0.8 0.7 0.2 3.7 9.1 1.4 0.4 35.4 1.9 0.9 3.3 1.7 0.6 0.0 12.9 0.7 1.9 1.0 1.5 0.8 0.4 2.4 0.3 1.2 0.9 1.4 0.3 2.9 2.1 2.1 2.5 2.2 4.6 6.3 8.0 0.6 4.4 1.4 1.0 1.2 3.2 2.8 1.7 0.7 2.1 1.0 0.7 3.1 0.5 0.4 0.0 0.3 0.0 0.6 0.1 2.1 1.5 1.3 0.4 0.2 1.0 0.6 0.9 1.4 0.6 0.4 0.5 0.4 4.2 2.0 2.3 3.0 2.3 2.0 2.8 2.4 3.4 4.4 1.2 6.0 4.6 0.0 2.3 3.1 8.1 3.5 12.7 1.4 5.7 1.8 13.7 0.2 0.0 12.0 25.6 3.3 6.3 0.0 2.5 0.2 3.8 2.4 1.1 1.0 0.2 4.8 2.4 1.3 0.0 9.4 19.2 0.7 5.0 0.0 10.1 28.4 4.2 9.1 98.6 0.5 5.9 19.4 79.9 2.9 5.5 2.0 0.2 0.0 8.6 1.6 PDE6B "CSNB3, CSNBAD2, PDEB, rd1, RP40" ENSG00000133256 "Phosphodiesterase 6B" P35913 4 625584-670782 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2;retina: 64.2" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 453.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054148, HPA059929" Enhanced Approved Cytosol NA NA Cytosol "HPA054148: AB_2682401, HPA059929: AB_2684166" "unprognostic (2.43e-2)" "unprognostic (1.33e-4)" "unprognostic (2.45e-4)" "unprognostic (7.18e-3)" "unprognostic (1.88e-2)" "unprognostic (5.04e-3)" "unprognostic (7.32e-3)" "prognostic favorable (5.34e-4)" "unprognostic (9.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.37e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" 1.6 1.9 12.1 4.6 19.1 6.7 3.8 2.3 13.2 2.3 1.3 30.2 1.5 0.8 2.5 3.9 1.4 9.6 3.2 5.2 18.1 10.2 4.6 0.7 4.2 12.0 29.6 9.8 2.6 1.4 9.1 3.2 2.6 14.5 2.5 1.0 64.2 3.5 2.9 0.7 1.8 2.2 2.1 20.2 8.7 2.5 3.6 22.4 4.3 11.4 0.2 8.3 4.1 1.1 16.5 14.1 11.2 5.8 10.2 13.1 7.1 0.0 0.2 0.8 0.4 0.2 0.3 0.2 0.0 0.0 0.5 1.4 0.0 0.1 0.2 8.0 0.2 0.7 0.1 1.7 0.4 0.0 0.1 0.0 0.6 0.2 0.0 4.1 0.1 0.3 0.5 0.1 2.4 0.0 0.5 0.7 11.8 0.1 0.6 0.0 0.2 20.5 0.2 6.5 0.4 0.2 11.1 0.2 0.4 1.4 0.9 14.0 8.2 0.0 0.3 0.1 3.3 0.4 0.0 0.2 0.1 0.8 0.1 0.3 5.4 15.2 0.2 0.2 0.2 0.1 11.2 4.2 0.6 11.5 5.8 10.5 10.0 7.7 7.9 6.6 16.5 12.2 13.1 1.1 10.2 5.6 14.1 11.4 7.1 12.1 19.1 2.3 10.0 18.1 10.2 29.6 9.8 14.5 22.4 3.0 5.3 4.5 1.2 0.3 18.2 3.7 0.0 16.0 5.7 0.0 78.5 0.1 1.7 5.1 0.4 1.8 0.0 0.0 0.6 0.2 0.8 0.9 3.5 0.0 9.2 11.1 1.7 2.5 3.9 0.0 1.4 3.4 3.3 7.2 0.2 20.9 0.7 0.0 1.4 6.7 453.5 0.0 0.2 3.9 2.7 0.3 0.2 7.0 0.1 0.6 PDLIM3 ALP ENSG00000154553 "PDZ and LIM domain 3" Q53GG5 4 185500660-185535612 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 447.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 159.2;Ductal cells: 168.1;Melanocytes: 118.1;Peritubular cells: 184.2;Smooth muscle cells: 182.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 51.1;RH-30: 12.6;U-266/70: 41.1;U-266/84: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004749 Enhanced Supported Cytosol NA NA 270000 Cytosol "HPA004749: AB_1855150" "unprognostic (2.75e-1)" "unprognostic (3.85e-2)" "unprognostic (3.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (9.46e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.97e-7)" "unprognostic (1.64e-3)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.78e-3)" 7.8 1.2 1.6 5.2 1.9 0.1 3.7 2.2 1.0 6.6 16.5 1.4 7.9 2.3 22.2 17.0 27.2 9.3 9.9 29.5 1.5 1.6 0.8 0.8 5.6 1.4 1.6 1.0 11.1 2.1 0.1 1.9 2.2 1.6 15.2 3.6 4.8 5.3 18.7 447.7 1.0 6.1 49.5 1.4 3.4 10.2 3.9 0.7 0.1 6.2 87.3 9.1 28.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.4 0.5 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.4 1.9 5.6 0.0 0.0 4.0 0.0 1.2 0.0 5.1 4.2 0.0 0.0 0.0 51.1 0.0 0.0 0.0 0.9 0.0 0.4 0.0 12.6 0.1 0.0 0.0 7.6 5.7 0.0 0.0 3.0 1.5 0.3 0.0 2.8 0.0 3.0 0.0 2.6 41.1 11.6 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.9 2.2 1.0 1.5 1.6 1.6 1.0 1.6 0.7 8.9 5.9 0.0 9.4 7.9 7.2 159.2 7.6 5.3 3.4 0.0 11.8 1.4 0.0 168.1 0.3 50.8 0.0 0.0 14.6 2.1 51.6 14.4 0.0 0.6 1.3 4.8 3.4 65.1 2.7 1.5 18.1 4.4 118.1 5.4 0.0 30.9 51.1 0.0 184.2 0.0 39.4 103.5 182.4 2.8 12.4 6.1 10.2 0.0 0.0 4.1 PDPK1 PDK1 ENSG00000140992 "3-phosphoinositide dependent protein kinase 1" O15530 16 2537964-2603188 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004272, HPA035199" Supported Supported Cytosol NA NA Cytosol "CAB004272: AB_626657, HPA035199: AB_2674514" "unprognostic (2.67e-2)" "unprognostic (1.63e-1)" "unprognostic (3.12e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (4.69e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (8.17e-2)" "unprognostic (3.70e-2)" "unprognostic (1.52e-2)" "unprognostic (3.28e-2)" "prognostic favorable (1.29e-14)" "unprognostic (2.04e-2)" "unprognostic (5.96e-2)" "unprognostic (1.95e-1)" "unprognostic (2.16e-1)" 11.1 14.9 21.0 11.6 31.9 14.2 14.2 29.6 26.4 10.5 15.6 14.5 10.4 17.2 13.0 14.0 13.8 15.3 10.8 14.8 17.2 13.5 17.6 12.6 13.4 13.5 11.3 20.6 14.8 28.2 34.5 13.9 17.1 16.7 13.6 15.3 12.8 16.5 13.2 18.2 14.1 19.1 12.9 10.9 13.7 13.4 14.2 10.1 14.1 16.1 10.6 13.9 12.3 13.3 5.1 9.1 14.7 9.4 5.4 6.0 4.5 8.5 11.0 13.8 9.1 14.2 11.9 14.6 14.3 9.2 12.8 10.8 11.0 10.3 14.1 9.8 13.8 10.9 13.6 16.4 10.3 12.2 25.1 11.1 7.5 14.5 18.2 12.4 12.3 19.7 10.8 19.0 13.8 9.2 12.4 11.7 12.9 13.9 11.5 15.0 18.1 12.4 8.7 8.7 16.0 9.8 25.4 13.7 12.8 12.4 7.7 21.7 11.2 18.5 21.3 7.7 9.2 19.7 15.5 14.3 14.0 13.9 13.6 12.3 15.3 14.6 22.1 6.7 8.6 12.1 3.9 7.9 9.0 5.1 9.3 4.8 5.1 4.7 6.0 6.7 4.5 5.3 4.9 14.7 5.4 9.4 9.1 2.3 4.5 21.0 31.9 29.6 26.4 17.2 13.5 11.3 20.6 16.7 10.1 14.9 18.4 17.1 18.3 23.7 56.0 28.1 43.3 21.4 14.8 10.4 51.1 38.1 11.6 20.5 12.0 15.5 32.9 0.0 20.5 24.1 22.4 24.3 7.0 38.5 22.9 69.9 20.7 23.9 46.7 21.8 29.4 21.5 20.3 30.7 31.7 39.4 25.3 17.5 41.8 34.2 41.5 45.3 18.6 36.7 40.5 29.7 87.5 17.5 27.9 19.6 PDSS1 "COQ1, TPRT, TPT" ENSG00000148459 "Decaprenyl diphosphate synthase subunit 1" Q5T2R2 10 26697659-26746798 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 22.4;lymphoid tissue: 31.8" "Cell type enhanced" "Detected in many" 5 "Undifferentiated cells: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038032, HPA042741" Uncertain Approved Cytosol NA NA Cytosol "HPA038032: AB_10670650, HPA042741: AB_2678139" "unprognostic (1.41e-2)" "unprognostic (3.92e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (1.66e-4)" "unprognostic (6.79e-3)" "unprognostic (5.43e-2)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.47e-2)" "unprognostic (9.43e-2)" "unprognostic (2.33e-2)" "unprognostic (2.20e-1)" "unprognostic (4.11e-2)" "unprognostic (2.99e-3)" "unprognostic (2.93e-3)" "unprognostic (8.85e-2)" "unprognostic (9.83e-2)" "unprognostic (6.36e-2)" 3.1 2.6 2.4 7.0 3.1 5.6 3.5 5.6 5.1 3.1 18.2 1.5 1.2 20.6 3.8 2.1 8.3 3.4 3.7 4.2 2.2 2.2 8.6 7.2 4.0 7.8 2.1 2.3 2.8 3.8 1.7 2.5 2.8 2.9 2.3 17.0 3.2 3.5 1.8 10.4 2.7 22.4 3.6 3.1 5.7 3.8 3.0 1.6 31.8 2.1 4.7 5.0 2.9 4.0 3.2 5.2 0.9 5.3 0.8 3.4 1.3 7.6 5.9 4.5 8.3 1.5 2.8 6.3 7.1 1.9 10.3 7.0 9.1 4.3 17.4 3.7 3.5 3.9 9.7 14.5 10.8 8.8 7.3 12.1 15.1 5.2 6.6 2.2 10.0 6.0 3.5 4.7 9.6 2.6 1.8 5.4 11.5 13.8 4.6 7.2 12.0 31.5 7.0 9.1 12.3 5.8 14.7 13.0 12.6 6.0 3.6 13.3 8.2 6.8 14.2 7.7 4.9 5.0 11.7 3.4 5.8 9.2 11.8 11.2 1.8 6.7 12.7 5.7 25.5 4.4 0.0 5.3 0.9 0.9 4.1 2.1 0.5 1.8 1.3 5.2 3.2 3.4 1.5 0.3 0.8 2.1 1.4 0.1 1.3 2.4 3.1 5.6 5.1 2.2 2.2 2.1 2.3 2.9 1.6 0.0 0.0 3.7 3.2 6.2 2.8 1.8 7.6 1.4 3.4 3.5 3.9 5.3 6.6 6.6 9.3 2.2 14.7 0.0 3.3 10.1 2.9 2.7 0.0 3.4 7.9 1.6 10.4 3.1 6.8 2.5 2.0 5.1 1.7 2.8 9.8 1.2 4.2 7.0 2.5 17.7 4.7 0.0 3.8 7.0 9.8 2.8 5.3 3.3 23.4 2.5 PDSS2 "bA59I9.3, C6orf210" ENSG00000164494 "Decaprenyl diphosphate synthase subunit 2" Q86YH6 6 107152557-107459564 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Cancer-related genes, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029685, HPA029686" Approved Supported Cytosol NA NA Cytosol "HPA029685: AB_10600219, HPA029686: AB_10602309" "prognostic unfavorable (1.34e-5)" "unprognostic (1.44e-1)" "prognostic favorable (5.74e-5)" "unprognostic (5.76e-2)" "unprognostic (1.42e-1)" "unprognostic (3.30e-2)" "unprognostic (3.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (9.38e-2)" "unprognostic (2.19e-1)" "prognostic favorable (3.75e-7)" "unprognostic (2.25e-1)" "unprognostic (2.86e-1)" "unprognostic (1.29e-1)" "unprognostic (2.11e-2)" 10.6 27.3 7.2 17.0 8.3 8.3 19.6 9.0 10.3 10.4 12.7 9.0 13.7 9.6 13.1 11.4 11.5 9.2 11.2 16.0 7.0 6.8 22.1 27.4 18.2 18.3 9.2 5.3 10.8 14.0 11.4 19.4 7.0 9.6 15.6 13.9 12.0 19.9 19.9 13.1 9.0 10.1 11.0 8.1 9.1 10.5 12.8 10.1 11.3 14.1 11.1 10.6 10.9 12.9 8.5 9.4 4.1 12.1 4.6 8.3 4.3 5.7 7.7 6.7 10.3 11.5 14.7 15.2 10.2 12.9 9.8 9.5 7.6 8.4 11.0 9.3 11.3 10.5 7.9 16.0 12.7 13.4 7.0 7.8 10.9 9.2 12.7 12.2 14.0 8.8 10.9 15.1 15.5 12.3 8.6 10.3 12.9 15.5 15.0 9.5 7.1 4.0 14.9 4.2 13.3 10.0 7.3 5.9 8.8 12.1 7.9 6.6 5.7 7.0 12.2 14.5 7.5 9.9 17.0 6.4 7.0 4.2 9.8 8.7 4.2 5.1 8.5 13.0 20.9 12.9 4.1 6.6 3.5 5.3 7.6 8.3 6.6 5.6 6.8 9.4 8.5 7.3 6.9 0.9 4.6 12.1 4.5 7.1 4.3 7.2 8.3 9.0 10.3 7.0 6.8 9.2 5.3 9.6 10.1 14.9 15.5 8.3 11.4 3.8 8.1 15.1 10.2 20.1 11.4 14.0 2.0 22.3 29.9 10.8 31.9 6.8 11.2 0.0 12.7 14.4 6.2 15.1 13.9 24.1 10.3 6.4 9.9 5.5 14.1 4.4 4.9 10.4 6.8 6.4 16.1 10.9 11.0 11.5 8.9 33.4 10.1 25.8 5.9 18.1 12.5 5.1 10.0 6.2 17.4 10.7 PEAK3 "C19orf35, FLJ45778" ENSG00000188305 "PEAK family member 3" Q6ZS72 19 2274622-2282176 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;lymphoid tissue: 19.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 1.4;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 24.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 24.5" "Cell line enriched" "Detected in some" 10 "HMC-1: 16.9" "Group enriched" "Detected in many" 5 "basal ganglia: 6.4;cerebellum: 6.0" HPA057806 Uncertain Uncertain Cytosol NA NA Cytosol "HPA057806: AB_2683534" "unprognostic (9.42e-2)" "unprognostic (3.26e-2)" "unprognostic (7.27e-2)" "unprognostic (6.23e-2)" "unprognostic (2.65e-2)" "unprognostic (8.40e-3)" "unprognostic (3.67e-1)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (2.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.19e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (3.20e-2)" "unprognostic (1.90e-1)" 1.9 1.3 1.4 4.7 3.3 8.2 0.9 0.8 2.0 1.3 1.7 2.1 0.1 1.1 0.7 1.0 0.8 1.6 0.9 2.1 2.0 0.9 3.8 2.0 4.4 14.3 3.3 0.9 1.0 0.8 0.6 1.2 0.8 2.3 1.0 1.1 0.7 0.8 0.6 1.5 1.0 2.5 0.9 4.0 19.1 1.1 0.6 1.7 0.6 0.8 0.0 2.7 0.9 1.9 0.2 1.1 24.5 3.4 2.8 1.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.1 0.2 0.6 0.1 16.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 5.3 2.7 6.6 1.0 3.4 0.1 0.1 0.1 0.1 1.1 0.2 0.0 0.2 24.5 2.8 1.1 0.1 0.0 0.5 1.4 3.3 0.8 2.0 2.0 0.9 3.3 0.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PER3 ENSG00000049246 "Period circadian regulator 3" P56645 1 7784320-7845177 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Bipolar cells: 194.4;Cone photoreceptor cells: 76.6;Horizontal cells: 117.6;Muller glia cells: 119.7;Rod photoreceptor cells: 141.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-937: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019530 Approved Supported Cytosol NA NA Cytosol "HPA019530: AB_1855201" "unprognostic (5.11e-2)" "prognostic favorable (7.14e-4)" "unprognostic (2.45e-2)" "unprognostic (2.97e-3)" "unprognostic (1.74e-1)" "prognostic favorable (1.34e-4)" "unprognostic (3.87e-1)" "unprognostic (5.53e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-2)" "prognostic favorable (2.20e-5)" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (3.46e-1)" "unprognostic (1.62e-1)" 10.2 9.1 10.9 6.0 15.6 0.5 10.4 42.4 17.5 13.5 14.5 22.5 11.2 5.0 16.2 8.9 13.9 10.8 13.5 17.2 10.1 9.4 10.4 20.5 9.6 3.3 11.2 10.7 15.7 13.3 16.0 15.2 2.1 13.4 13.0 5.5 23.2 18.8 17.7 20.4 11.1 7.4 18.5 16.2 6.7 14.0 8.7 10.9 0.9 19.0 15.6 7.1 13.2 9.5 1.3 1.8 1.1 3.3 0.9 5.1 1.6 4.2 1.2 3.8 1.1 0.7 0.3 1.1 1.8 3.3 3.4 4.7 5.1 16.9 1.9 1.0 7.4 5.8 2.0 13.5 0.8 5.2 0.1 0.7 13.5 5.0 0.7 4.3 0.4 4.7 1.9 1.5 3.7 3.8 7.1 1.2 1.0 10.9 3.6 1.4 3.4 7.4 6.0 2.0 9.5 3.6 6.5 1.3 0.1 1.9 0.8 4.9 5.2 15.9 0.0 6.8 4.0 4.1 0.5 2.5 9.3 13.6 2.8 2.4 0.5 0.3 1.6 6.5 21.5 12.9 0.9 1.6 1.1 4.2 2.0 5.1 1.3 2.0 3.8 1.8 0.8 1.7 2.1 0.2 0.9 3.3 1.4 3.1 1.6 10.9 15.6 42.4 17.5 10.1 9.4 11.2 10.7 13.4 10.9 17.9 8.9 1.5 10.8 26.8 194.4 12.3 12.7 12.0 12.5 8.7 76.6 1.4 8.3 2.2 12.3 14.6 4.5 0.0 4.0 0.2 16.4 8.7 25.4 22.2 7.6 117.6 6.3 6.2 4.5 5.0 11.5 7.2 11.8 2.8 2.7 119.7 4.4 1.4 25.8 4.4 141.4 6.5 24.4 17.6 21.8 22.3 0.5 4.4 1.2 6.1 PFDN2 ENSG00000143256 "Prefoldin subunit 2" Q9UHV9 1 161100556-161118111 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 570.2;Suprabasal keratinocytes: 561.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028700, HPA058304" Approved Enhanced Cytosol NA NA 60000 Cytosol "HPA028700: AB_10603983, HPA058304: AB_2683673" "unprognostic (2.56e-1)" "unprognostic (2.76e-2)" "unprognostic (1.01e-2)" "unprognostic (2.62e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.10e-4)" "unprognostic (9.59e-3)" "unprognostic (1.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.50e-2)" "unprognostic (8.46e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (4.39e-8)" "unprognostic (1.01e-1)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (3.66e-2)" 36.5 30.4 47.2 22.7 41.7 40.9 20.9 25.1 38.8 19.6 19.9 27.8 15.1 19.1 20.8 29.1 19.7 18.5 16.0 38.2 41.4 48.6 25.9 41.1 18.5 23.5 52.2 32.9 18.5 20.8 13.6 29.3 25.1 42.7 20.1 17.9 12.9 21.2 20.8 62.2 15.0 18.4 19.4 48.6 21.2 17.8 22.1 31.8 14.7 18.3 20.9 24.3 22.7 26.2 34.4 61.7 33.4 37.3 18.2 28.5 21.0 43.4 29.2 22.7 29.4 20.7 19.8 24.8 32.4 29.4 28.0 22.2 38.4 33.1 29.5 38.1 21.0 27.7 32.3 34.4 39.7 33.8 32.1 35.5 32.6 41.5 54.2 61.0 44.7 32.7 22.2 52.3 45.0 128.2 21.3 31.4 30.8 47.8 20.8 25.1 44.1 33.4 53.1 44.5 51.2 73.2 28.7 23.0 35.2 30.3 26.1 30.0 50.0 24.9 32.9 51.6 30.9 27.1 56.4 27.6 29.0 42.6 36.4 67.6 32.0 30.4 56.6 35.3 30.6 39.8 24.7 32.7 33.4 19.2 31.4 21.8 34.1 23.5 23.1 39.1 34.4 24.8 24.1 16.2 18.2 37.3 61.7 28.5 21.0 47.2 41.7 25.1 38.8 41.4 48.6 52.2 32.9 42.7 31.8 29.8 37.8 97.5 214.7 570.2 76.9 106.9 73.9 81.7 40.9 109.9 15.7 156.1 290.1 151.8 21.8 101.2 75.9 0.0 130.4 209.7 150.8 165.7 97.0 123.5 154.2 20.6 97.3 81.6 57.7 15.7 117.1 160.7 175.5 129.8 71.4 55.8 186.7 64.2 103.6 225.6 50.4 77.6 263.3 153.5 288.9 561.7 150.2 74.8 76.8 356.8 PFKP "PFK-C, PFKF" ENSG00000067057 "Phosphofructokinase, platelet" Q01813 10 3066333-3137712 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 368.5;Late spermatids: 396.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018257, HPA056484" Uncertain Supported Cytosol No No 4500000 Cytosol "HPA018257: AB_10960391, HPA056484: AB_2683147" "unprognostic (1.16e-1)" "unprognostic (2.41e-3)" "unprognostic (5.79e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.55e-4)" "prognostic unfavorable (8.72e-6)" "unprognostic (1.36e-3)" "unprognostic (2.38e-1)" "unprognostic (8.51e-2)" "unprognostic (2.37e-2)" "unprognostic (8.82e-2)" "unprognostic (6.02e-3)" "unprognostic (2.60e-2)" "unprognostic (9.74e-2)" "unprognostic (2.06e-1)" "unprognostic (4.54e-3)" 14.6 7.9 29.6 22.0 28.9 9.2 8.1 34.2 61.4 9.7 20.5 11.5 7.9 26.8 19.2 11.0 36.0 12.8 19.8 62.0 29.3 32.9 20.0 2.8 9.2 18.2 22.2 29.8 9.3 8.8 1.5 16.8 8.8 21.3 20.3 19.4 14.7 13.4 36.5 24.4 16.5 31.1 34.3 21.1 11.3 20.7 71.8 14.8 9.6 19.3 11.7 13.3 26.9 15.6 8.9 12.5 16.2 4.7 14.3 20.4 8.9 47.8 67.3 4.5 0.1 4.5 9.5 58.8 29.8 10.7 30.2 36.4 70.9 50.9 5.7 23.8 21.4 28.0 38.9 23.0 46.5 31.8 16.1 17.7 20.7 32.4 3.8 10.7 8.3 34.8 4.4 10.5 31.7 15.8 45.8 58.1 24.3 5.7 0.2 33.4 37.4 28.3 9.0 7.4 21.0 23.6 22.2 7.5 23.1 32.7 18.8 12.4 10.7 21.1 18.0 26.4 56.5 14.8 13.1 69.9 20.6 11.1 62.1 32.4 32.7 29.5 20.5 52.9 16.0 12.6 16.2 4.7 1.6 15.9 2.3 12.6 8.2 15.9 14.8 8.0 8.9 6.0 9.5 0.7 14.3 0.9 12.5 20.4 8.9 29.6 28.9 34.2 51.7 29.3 32.9 22.2 29.8 21.3 14.8 3.0 6.5 16.7 44.9 25.4 38.3 113.1 10.2 21.4 27.3 61.1 51.1 2.1 36.5 101.2 368.5 28.8 46.6 0.0 9.2 171.9 17.4 35.9 56.4 0.8 28.5 39.7 35.7 14.1 12.6 396.4 6.9 16.2 18.6 21.6 19.5 104.9 80.1 28.1 6.3 2.1 105.7 12.9 30.8 39.9 3.2 19.7 22.2 27.3 24.5 48.7 PFN1 ENSG00000108518 "Profilin 1" P07737 17 4945652-4949061 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 509.4" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 4080.6;monocytes: 7018.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037134, CAB037140" Enhanced Approved Cytosol NA NA 1100000000 Cytosol "CAB037134: AB_1079599, CAB037140: AB_1079598" "unprognostic (1.07e-1)" "unprognostic (3.57e-1)" "unprognostic (1.60e-1)" "unprognostic (5.45e-3)" "unprognostic (1.65e-1)" "unprognostic (7.54e-2)" "unprognostic (4.01e-3)" "unprognostic (7.83e-3)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" "unprognostic (2.17e-1)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.62e-1)" "unprognostic (8.17e-2)" "unprognostic (1.02e-2)" "unprognostic (1.28e-1)" 65.2 48.2 24.0 125.4 36.7 118.0 61.3 15.6 25.9 63.8 102.3 33.1 46.7 66.4 97.4 52.9 96.6 67.5 87.8 40.7 22.0 19.6 80.5 137.3 70.5 159.4 37.4 17.3 53.7 37.2 18.3 27.5 82.8 28.5 62.0 68.2 39.3 46.0 52.6 51.6 51.2 96.4 119.4 33.3 138.7 70.4 27.2 30.5 199.3 46.6 65.3 116.3 97.9 54.4 154.4 263.4 356.5 322.9 223.0 288.9 509.4 140.1 169.1 63.5 50.9 32.8 40.9 95.3 119.9 78.8 104.2 79.0 65.4 49.5 101.9 104.3 101.3 63.0 88.6 56.6 122.1 83.9 177.2 111.3 104.3 86.6 84.9 90.0 65.7 248.2 48.5 53.7 80.7 80.5 63.7 93.4 69.8 57.5 74.4 124.7 69.7 125.2 141.8 98.8 60.2 103.9 125.5 85.3 65.6 100.8 75.0 26.0 77.5 80.5 50.5 73.4 55.5 47.3 55.8 114.2 91.1 84.5 68.3 174.1 53.1 53.8 82.1 78.5 79.0 138.3 168.7 216.8 356.5 286.3 278.7 190.1 154.4 236.8 270.9 263.4 135.2 154.8 221.1 255.4 223.0 322.9 212.4 288.9 509.4 24.0 36.7 15.6 25.9 22.0 19.6 37.4 17.3 28.5 30.5 104.2 205.8 866.8 636.2 1604.2 21.1 131.7 501.9 111.1 149.0 703.1 0.0 1882.1 840.6 1770.0 14.2 550.7 1316.6 93.5 1422.2 4080.6 968.1 512.4 473.6 682.9 3613.7 36.5 580.1 689.9 1477.5 18.5 244.2 2021.5 828.4 7018.1 1219.5 67.9 2136.3 1369.2 352.5 1192.8 11.6 498.0 1013.7 95.6 348.1 1322.9 1407.4 2210.4 1246.9 991.4 PGGHG "ATHL1, FLJ22635" ENSG00000142102 "Protein-glucosylgalactosylhydroxylysine glucosidase" Q32M88 11 289135-296107 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "pancreas: 148.7" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 148.9;Alveolar cells type 2: 104.9;Club cells: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 54.5;U-266/70: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039383, HPA058829" Uncertain Enhanced Cytosol NA Yes Cytosol "HPA039383: AB_10796225, HPA058829: AB_2683830" "unprognostic (1.40e-3)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (1.36e-2)" "unprognostic (5.83e-2)" "unprognostic (7.95e-3)" "unprognostic (2.77e-2)" "unprognostic (2.16e-2)" "unprognostic (2.14e-2)" "unprognostic (2.71e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (2.85e-3)" "unprognostic (1.09e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.12e-4)" 5.6 1.8 6.0 16.7 9.3 6.3 10.5 2.9 7.7 12.7 5.6 3.3 10.4 21.1 6.9 14.9 5.6 8.4 8.3 4.4 6.3 1.7 14.8 17.0 15.7 24.6 7.6 2.5 3.5 148.7 2.6 3.6 3.4 8.0 8.5 3.0 7.1 8.9 21.8 5.6 2.4 23.2 5.2 10.1 24.2 4.7 2.3 7.5 6.3 18.0 6.4 15.4 7.3 8.7 2.3 2.5 4.9 4.2 6.9 8.5 2.7 2.1 2.3 4.4 4.8 1.8 1.6 3.3 1.7 1.4 1.0 0.8 2.0 6.1 0.0 2.2 2.0 2.1 1.3 0.3 0.7 0.1 5.2 1.6 1.0 1.5 2.6 2.2 0.1 9.4 5.9 0.6 0.3 0.3 3.7 3.3 54.5 4.0 6.5 0.5 3.1 8.9 4.7 3.4 0.7 0.3 8.5 0.8 3.0 2.3 0.7 0.0 1.0 0.6 3.2 2.9 2.0 2.3 1.1 3.0 2.1 2.9 0.6 0.2 14.3 0.4 2.3 0.3 1.7 2.4 1.5 0.9 1.2 8.5 4.2 7.2 2.1 1.3 4.7 0.6 2.3 3.1 6.1 4.9 6.9 3.2 2.5 0.2 2.7 6.0 9.3 2.9 7.7 6.3 1.7 7.6 2.5 8.0 7.5 148.9 104.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 58.0 31.4 0.0 0.3 0.0 4.9 0.0 0.0 0.0 0.0 7.1 2.9 0.0 0.0 5.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.0 14.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PGM1 ENSG00000079739 "Phosphoglucomutase 1" P36871 1 63593276-63660245 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 233.5" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 209.3;Hepatocytes: 186.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004666, HPA024190, HPA024637, HPA046329" Enhanced Approved Cytosol NA NA 20000000 Cytosol "CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625" "unprognostic (2.50e-1)" "unprognostic (2.26e-3)" "unprognostic (1.74e-2)" "unprognostic (5.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.28e-2)" "unprognostic (1.86e-3)" "unprognostic (2.42e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.74e-5)" "unprognostic (7.07e-2)" "unprognostic (1.55e-2)" "unprognostic (6.58e-3)" "unprognostic (1.37e-1)" "unprognostic (2.46e-1)" "unprognostic (9.74e-3)" 17.8 14.1 7.0 4.4 8.3 3.5 9.8 4.4 8.3 6.7 12.9 5.2 4.6 10.6 4.6 7.7 8.8 3.3 8.9 36.9 6.4 5.4 10.0 56.4 7.6 2.7 6.2 6.3 9.7 21.6 12.9 6.2 11.5 8.5 8.7 9.1 5.4 7.9 9.4 233.5 5.3 12.4 8.4 5.6 3.0 5.7 3.0 5.5 3.0 6.0 42.8 6.3 9.4 4.7 12.2 25.9 25.6 17.9 21.1 23.3 16.6 29.8 12.5 4.7 15.5 31.2 23.1 38.3 12.3 16.7 13.4 22.0 10.3 13.9 9.4 25.8 19.0 29.7 7.1 6.5 25.9 15.8 11.5 8.7 19.9 21.2 10.6 25.8 17.4 1.1 29.1 16.7 15.6 24.8 36.0 8.0 9.8 0.0 12.6 21.5 1.8 5.0 9.6 21.4 0.9 20.1 7.1 22.0 3.0 19.5 9.4 2.8 18.4 26.9 28.2 41.0 22.9 8.8 6.6 0.7 19.9 10.2 17.6 10.4 8.0 11.7 15.4 32.5 15.3 8.5 20.5 17.9 25.6 23.3 12.0 18.6 12.2 13.7 17.5 25.9 6.9 12.5 14.5 21.2 21.1 10.2 7.5 10.6 16.6 7.0 8.3 4.4 8.3 6.4 5.4 6.2 6.3 8.5 5.5 86.4 31.4 19.9 24.0 15.9 8.1 140.8 50.9 14.7 10.3 15.7 9.8 71.5 74.6 42.0 24.0 10.7 74.3 0.0 209.3 136.9 28.0 18.3 4.7 186.6 22.2 0.0 12.6 16.0 18.3 5.2 20.4 10.7 25.3 32.5 40.1 54.2 92.3 23.0 35.7 59.8 10.7 12.9 17.9 4.7 7.5 15.8 49.2 21.8 71.1 13.6 PGM5 PGMRP ENSG00000154330 "Phosphoglucomutase 5" Q15124 9 68328308-68531061 "Predicted intracellular proteins" "Carbohydrate metabolism, Cell adhesion, Glucose metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 123.0" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 88.7;Endothelial cells: 35.0;Ito cells: 31.9;Sertoli cells: 51.8;Smooth muscle cells: 36.4" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 89 "neutrophil: 8.9" "Lineage enriched" "Detected in single" 89 "granulocytes: 8.9" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 15.9;PC-3: 29.8;RH-30: 20.7;SK-BR-3: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB034397, HPA046329, HPA067102" Enhanced Uncertain Cytosol NA NA 380000 Cytosol "CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758" "unprognostic (3.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.98e-3)" "unprognostic (5.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-4)" "unprognostic (1.22e-3)" "unprognostic (2.79e-1)" "unprognostic (5.28e-3)" "unprognostic (4.78e-2)" "unprognostic (2.28e-2)" "prognostic favorable (1.83e-5)" "unprognostic (3.04e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-1)" "unprognostic (4.73e-2)" 5.9 13.6 0.8 7.5 1.3 0.0 4.1 2.1 1.5 25.9 52.2 1.8 26.1 2.9 36.9 10.3 22.6 20.9 11.1 31.6 1.0 0.4 2.0 1.5 2.7 5.9 0.9 1.3 9.3 1.9 0.5 1.2 1.7 1.3 37.1 7.6 4.3 2.9 51.1 8.5 2.2 15.4 123.0 1.5 1.7 16.6 4.3 0.9 0.9 2.8 4.5 1.5 57.4 24.5 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 4.2 3.4 2.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 29.8 0.0 20.7 0.9 0.9 0.0 0.0 0.1 0.0 25.9 1.4 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.8 1.3 2.1 1.5 1.0 0.4 0.9 1.3 1.3 0.9 0.0 1.7 0.0 5.1 2.1 22.3 88.7 0.0 1.4 3.4 12.2 3.9 0.0 1.7 0.1 1.2 35.0 0.0 0.0 0.0 0.1 3.3 2.7 0.0 0.0 0.1 0.0 0.0 31.9 3.2 0.0 7.5 1.9 3.3 1.8 0.0 8.4 0.1 0.0 4.6 0.6 1.1 51.8 36.4 0.1 0.2 2.0 0.0 0.0 0.0 1.3 PHKG2 ENSG00000156873 "Phosphorylase kinase catalytic subunit gamma 2" P15735 16 30748270-30761176 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 44.5;testis: 95.4" "Group enriched" "Detected in many" 6 "Early spermatids: 304.4;Late spermatids: 1171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065618, HPA068751" Supported Cytosol NA NA Cytosol "HPA065618: AB_2685520, HPA068751: AB_2686025" "unprognostic (7.63e-3)" "prognostic favorable (7.90e-4)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "prognostic favorable (1.90e-4)" "unprognostic (6.45e-2)" "unprognostic (1.25e-2)" "prognostic favorable (8.02e-4)" "unprognostic (6.15e-2)" "unprognostic (5.27e-2)" "unprognostic (1.36e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" 4.3 8.3 8.7 6.9 8.0 15.9 5.8 9.1 12.0 4.7 7.9 7.3 9.0 6.8 5.6 7.8 5.3 6.8 7.2 6.4 9.0 9.3 8.2 11.0 5.8 6.8 8.6 9.2 4.7 5.1 17.3 8.5 6.3 11.8 7.7 7.6 6.4 7.0 9.9 6.4 8.4 7.3 6.3 5.8 6.9 7.2 95.4 7.3 5.5 8.6 5.5 7.7 5.2 4.7 8.8 21.2 44.5 22.7 23.5 16.8 17.6 13.7 9.0 7.6 9.3 7.1 5.8 17.1 9.6 14.4 13.2 15.1 7.8 6.9 11.9 11.4 9.9 6.7 13.2 7.9 12.2 10.6 6.4 21.9 6.5 15.0 21.8 11.0 10.0 9.3 7.8 6.6 12.6 5.9 6.3 13.4 8.5 8.8 6.9 9.5 31.5 11.8 14.8 10.5 9.9 10.5 16.0 11.9 15.8 15.1 15.5 10.2 7.0 7.8 21.8 9.2 7.2 17.1 8.7 7.9 8.1 9.0 10.1 8.8 13.9 7.5 8.1 16.1 19.6 6.5 14.0 22.7 44.5 16.2 22.4 13.3 8.8 11.6 16.4 21.2 8.5 10.4 12.1 18.2 23.5 15.9 18.2 16.8 17.6 8.7 8.0 9.1 12.0 9.0 9.3 8.6 9.2 11.8 7.3 11.9 23.7 12.6 12.5 18.7 8.9 10.6 2.5 25.4 29.6 17.4 9.8 26.7 23.2 11.4 304.4 9.9 23.2 0.0 21.4 32.3 12.9 24.0 12.7 19.5 25.4 19.1 15.6 9.2 22.4 1171.9 16.1 24.0 11.8 42.3 15.6 9.8 16.8 15.0 21.9 32.7 8.4 0.0 12.5 127.4 23.3 20.1 63.2 26.2 19.6 12.4 PHYHIPL "Em:AC025038.1, KIAA1796" ENSG00000165443 "Phytanoyl-CoA 2-hydroxylase interacting protein like" Q96FC7 10 59176590-59247774 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 131.3;Early spermatids: 143.9;Horizontal cells: 136.7;Late spermatids: 172.3;Muller glia cells: 208.8;Spermatocytes: 91.0" "Group enriched" "Detected in many" 5 "glioma: 21.1;renal cancer: 8.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.8;Hep G2: 24.9;SCLC-21H: 4.5;SH-SY5Y: 14.9;SK-BR-3: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038746 Uncertain Approved Cytosol NA NA Cytosol "HPA038746: AB_10673293" "unprognostic (6.34e-3)" "unprognostic (2.40e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-3)" "unprognostic (7.06e-2)" "unprognostic (3.37e-1)" "unprognostic (5.63e-2)" "unprognostic (3.78e-2)" "unprognostic (1.06e-1)" "unprognostic (4.00e-3)" "unprognostic (2.67e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.60e-7)" "unprognostic (1.29e-3)" "unprognostic (1.30e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 1.9 23.1 22.2 2.0 22.4 1.6 1.8 17.6 70.3 2.1 2.1 25.4 0.4 11.2 2.5 3.8 2.0 2.5 1.8 1.7 20.8 21.4 14.8 2.7 1.7 1.6 28.0 25.0 2.5 5.6 1.6 4.4 10.6 24.8 4.4 2.0 7.6 2.2 4.9 1.6 1.6 11.5 1.7 27.4 1.6 2.2 8.9 31.0 0.0 1.6 0.0 1.6 1.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 14.9 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 22.4 17.6 32.6 20.8 21.4 28.0 25.0 24.8 31.0 0.0 0.0 0.0 11.5 0.0 131.3 0.4 0.0 0.0 0.0 3.5 11.8 0.9 11.6 0.3 143.9 0.3 0.0 0.0 5.7 0.2 0.2 3.3 0.0 2.1 0.5 136.7 0.0 1.3 0.0 172.3 12.0 0.0 1.7 0.0 0.0 208.8 2.8 0.0 0.4 46.1 49.8 0.0 0.1 91.0 13.2 0.0 41.0 0.0 0.0 3.2 PI4K2B "FLJ11105, PI4KIIB, PIK42B" ENSG00000038210 "Phosphatidylinositol 4-kinase type 2 beta" Q8TCG2 4 25233975-25279092 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 49.3" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA004099 Approved Supported Cytosol NA NA Cytosol "HPA004099: AB_1855353" "unprognostic (1.02e-1)" "unprognostic (6.34e-3)" "prognostic favorable (9.64e-5)" "unprognostic (2.75e-2)" "unprognostic (1.98e-2)" "unprognostic (2.68e-2)" "unprognostic (7.54e-2)" "unprognostic (7.75e-2)" "unprognostic (5.06e-1)" "unprognostic (6.39e-3)" "unprognostic (1.71e-1)" "unprognostic (1.32e-1)" "unprognostic (9.07e-2)" "unprognostic (9.61e-2)" "unprognostic (2.39e-2)" "unprognostic (2.02e-2)" "unprognostic (4.47e-2)" 9.2 7.1 3.4 13.6 2.9 3.9 8.0 3.2 2.3 8.7 48.4 4.1 11.3 19.4 7.4 8.0 13.5 4.9 9.5 4.2 3.1 2.7 12.9 38.6 14.3 9.4 3.5 2.3 6.9 10.5 4.2 5.7 7.7 2.9 6.4 9.8 3.3 22.6 12.0 4.4 8.6 49.3 6.9 4.5 13.8 11.3 8.0 2.7 18.6 16.2 12.9 14.1 7.8 10.3 1.4 1.8 1.5 1.0 0.4 4.1 0.4 11.5 2.1 4.9 5.2 6.6 12.3 11.9 17.4 16.4 15.2 19.5 3.7 12.4 29.9 4.0 13.1 10.6 4.8 11.1 8.7 15.1 9.1 3.9 9.5 5.2 9.2 6.3 19.2 7.5 8.2 7.9 5.7 6.0 4.6 10.3 8.5 6.3 25.1 14.8 4.4 18.5 17.2 8.5 13.8 4.7 11.2 19.2 17.4 13.4 8.2 10.2 2.2 8.8 7.0 3.6 5.5 9.9 11.1 10.5 10.8 2.8 6.6 11.2 28.8 13.8 22.8 12.7 16.3 11.0 1.5 0.4 0.0 1.3 1.0 0.9 1.4 1.5 1.2 0.3 1.0 1.4 1.3 0.2 0.4 0.9 1.8 4.1 0.4 3.4 2.9 3.2 2.3 3.1 2.7 3.5 2.3 2.9 2.7 6.0 14.4 14.1 11.2 13.4 1.9 0.0 7.6 2.7 12.5 8.7 0.0 18.1 5.0 5.1 0.6 6.4 14.2 23.3 6.2 10.1 8.3 11.3 0.0 36.0 9.1 1.6 8.1 6.7 12.4 0.9 4.0 7.0 5.0 12.6 12.8 1.1 5.0 8.6 4.2 15.6 3.0 0.0 7.2 8.0 12.7 13.7 11.3 5.0 12.7 11.9 PICK1 "dJ1039K5, MGC15204, PRKCABP" ENSG00000100151 "Protein interacting with PRKCA 1" Q9NRD5 22 38056311-38075701 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 106.4;Late spermatids: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000819, HPA072674" Approved Supported Cytosol NA NA Cytosol "HPA000819: , HPA072674: AB_2686547" "unprognostic (1.97e-2)" "unprognostic (4.61e-3)" "unprognostic (7.79e-2)" "unprognostic (9.26e-2)" "unprognostic (1.29e-2)" "unprognostic (1.81e-1)" "unprognostic (6.04e-2)" "unprognostic (1.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "unprognostic (1.68e-3)" "unprognostic (1.20e-1)" "unprognostic (8.56e-2)" "prognostic favorable (5.26e-5)" "unprognostic (1.36e-1)" "unprognostic (2.74e-1)" "unprognostic (4.61e-3)" 7.7 11.9 16.9 5.7 32.7 5.3 14.9 18.4 26.2 8.9 12.5 21.3 18.6 10.8 11.3 15.5 13.0 18.1 10.0 14.7 17.2 14.8 12.4 14.5 10.8 8.1 47.4 21.5 15.6 16.1 36.6 22.7 8.7 24.7 25.5 13.4 11.4 19.1 18.9 18.0 11.5 9.8 12.5 17.6 8.1 15.0 18.6 36.5 2.5 13.4 6.8 8.5 8.9 8.6 2.5 4.6 1.9 2.7 1.4 3.2 1.7 10.3 7.4 4.2 5.5 3.0 2.4 6.3 5.8 7.0 12.5 12.7 7.9 6.5 4.6 6.5 7.0 9.5 11.3 11.5 23.4 10.8 2.8 18.4 1.6 8.9 9.0 11.0 5.3 11.3 7.6 13.8 8.2 12.2 12.8 4.8 6.1 3.3 3.4 2.6 6.6 3.1 0.5 6.6 23.7 8.1 2.7 0.2 4.1 14.5 16.8 17.5 8.9 6.5 15.9 5.9 6.4 9.2 3.9 1.3 3.6 6.7 4.7 3.4 7.6 1.8 1.3 7.7 1.8 5.1 0.0 2.7 0.0 1.8 1.5 0.6 1.1 1.8 3.2 4.6 2.5 3.1 1.8 1.9 1.4 1.5 0.9 1.7 1.7 16.9 32.7 18.4 26.2 17.2 14.8 47.4 21.5 24.7 36.5 8.9 11.7 5.1 10.6 7.1 11.8 8.9 5.1 10.7 5.7 7.0 7.9 20.7 10.0 16.8 106.4 8.0 19.0 0.0 13.6 13.0 5.4 17.5 9.2 8.5 13.1 19.1 9.9 6.7 22.6 63.9 10.3 9.9 6.8 21.6 16.2 14.5 17.0 14.8 15.9 13.3 11.7 12.9 5.1 10.9 6.0 8.4 32.2 4.4 15.7 13.1 PIH1D1 "FLJ20643, NOP17" ENSG00000104872 "PIH1 domain containing 1" Q9NWS0 19 49446298-49453497 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047258 Approved Approved Cytosol NA NA Cytosol "HPA047258: AB_10964561" "unprognostic (2.28e-1)" "unprognostic (1.56e-1)" "unprognostic (2.14e-1)" "unprognostic (8.99e-2)" "unprognostic (7.77e-3)" "unprognostic (9.66e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-1)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (5.13e-2)" "unprognostic (1.22e-2)" "unprognostic (1.86e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" 23.1 24.3 29.5 21.1 24.4 22.3 23.7 31.1 36.9 27.3 31.9 25.8 32.9 31.9 23.2 18.1 29.0 30.6 23.0 21.1 25.2 23.2 26.7 41.6 19.2 28.4 23.4 24.7 21.4 36.9 24.4 23.2 27.6 24.8 25.8 22.4 23.0 40.8 27.3 44.7 31.4 27.3 19.9 19.2 25.8 24.9 16.8 23.7 43.6 37.2 34.0 30.6 23.8 24.2 38.6 35.9 49.7 36.4 33.0 52.5 32.6 36.3 18.7 24.1 36.8 11.8 11.0 15.4 14.8 19.5 22.8 35.4 20.0 25.0 24.5 14.0 15.8 5.7 22.3 12.5 27.1 13.4 23.4 24.0 21.9 24.9 25.2 18.3 23.7 33.1 12.8 11.5 16.9 16.0 21.6 21.2 22.3 32.2 21.7 14.3 16.4 26.4 47.0 28.7 32.6 17.9 22.6 27.0 24.6 18.5 29.9 31.2 45.2 15.1 25.8 14.5 12.3 12.3 28.7 12.6 19.2 15.1 7.6 23.1 58.9 46.0 13.4 10.5 25.7 13.4 49.7 36.4 39.3 32.4 34.9 27.4 38.6 36.3 34.4 35.9 34.2 29.5 27.4 4.2 33.0 34.6 34.2 52.5 32.6 29.5 24.4 31.1 36.9 25.2 23.2 23.4 24.7 24.8 23.7 35.7 35.8 57.4 48.9 49.6 17.7 8.7 30.6 46.8 26.1 19.2 17.7 87.9 53.0 65.4 12.8 32.1 42.6 0.0 40.6 102.6 54.6 54.9 51.9 38.6 60.9 22.3 55.2 35.6 35.3 6.2 57.8 45.4 60.8 70.3 50.2 50.7 43.4 63.3 44.2 89.8 19.3 25.8 51.8 33.4 28.1 58.6 78.6 51.7 56.6 56.2 PIK3R1 "GRB1, p85, p85-ALPHA" ENSG00000145675 "Phosphoinositide-3-kinase regulatory subunit 1" P27986 5 68215720-68301821 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Protein transport, Stress response, Transport" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 241.2;Leydig cells: 159.3;Muller glia cells: 180.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001216, CAB004268" Approved Supported Cytosol NA NA Cytosol "CAB004268: AB_628126, HPA001216: AB_1079612" "unprognostic (5.74e-2)" "unprognostic (6.58e-2)" "unprognostic (2.01e-1)" "unprognostic (1.31e-2)" "unprognostic (1.18e-1)" "unprognostic (1.33e-2)" "prognostic favorable (8.09e-4)" "unprognostic (3.78e-3)" "unprognostic (1.78e-1)" "unprognostic (2.71e-1)" "unprognostic (6.10e-2)" "unprognostic (1.32e-1)" "unprognostic (4.59e-3)" "unprognostic (5.66e-3)" "unprognostic (1.27e-1)" "unprognostic (5.92e-2)" "unprognostic (1.54e-1)" 26.2 13.4 26.0 13.0 24.3 51.6 42.3 15.3 50.3 27.1 20.3 12.8 12.8 8.1 41.3 22.1 20.8 33.0 18.1 33.9 24.0 13.4 17.9 46.5 16.3 12.0 22.0 40.8 25.8 6.8 22.3 9.4 15.0 18.2 15.2 10.8 8.7 54.6 16.2 48.9 19.1 16.1 36.3 17.6 18.8 13.1 7.6 23.6 16.2 12.8 8.5 10.8 25.2 24.4 2.2 2.1 10.6 4.1 8.2 14.8 4.0 1.1 2.1 6.4 19.1 73.1 21.4 2.8 6.1 2.8 2.3 2.5 5.3 1.9 5.6 10.5 8.4 1.1 2.6 1.8 12.4 3.0 23.5 2.3 6.7 1.8 4.3 24.6 6.9 5.4 22.6 28.2 4.3 22.9 1.1 3.1 6.6 1.0 4.3 2.1 2.9 16.7 2.7 1.8 3.8 1.1 15.8 3.0 4.4 3.1 12.6 1.2 5.8 1.0 1.6 4.0 3.9 9.2 4.9 3.7 2.8 2.8 4.6 3.8 4.8 7.1 6.5 3.0 8.6 2.0 10.6 1.2 5.9 9.2 1.7 12.7 1.2 11.5 8.4 2.1 2.2 14.8 10.8 1.5 8.2 4.1 0.9 8.5 4.0 26.0 24.3 15.3 50.3 24.0 13.4 22.0 40.8 18.2 23.6 47.6 25.6 14.3 14.9 12.8 45.1 241.2 28.1 12.0 27.3 5.2 23.6 12.3 61.3 13.7 9.4 23.1 20.0 0.0 8.1 13.0 36.6 8.2 66.0 142.1 25.9 46.1 9.2 39.9 52.0 6.8 159.3 29.5 32.1 21.6 24.8 180.6 9.7 19.3 114.9 31.6 85.9 19.4 26.7 0.9 2.6 8.9 8.4 132.3 21.7 6.0 PIM2 ENSG00000102096 "Pim-2 proto-oncogene, serine/threonine kinase" Q9P1W9 X 48913182-48919024 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 63.4;lymphoid tissue: 71.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 48.0;B-cells: 109.2;Melanocytes: 89.4;monocytes: 163.3;T-cells: 70.8" "Cancer enriched" "Detected in all" 6 "testis cancer: 171.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 60.3;Karpas-707: 74.7;RPMI-8226: 73.6;U-266/70: 136.0;U-266/84: 120.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000285 Approved Cytosol NA NA Cytosol "HPA000285: AB_1079619" "unprognostic (2.34e-3)" "prognostic favorable (4.05e-5)" "unprognostic (8.04e-2)" "unprognostic (7.30e-2)" "unprognostic (6.41e-3)" "unprognostic (2.74e-3)" "unprognostic (2.84e-1)" "unprognostic (5.23e-2)" "unprognostic (2.47e-2)" "unprognostic (4.01e-2)" "unprognostic (1.33e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.17e-11)" "unprognostic (3.36e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-1)" "unprognostic (4.38e-2)" 3.6 3.4 4.3 37.2 7.2 30.4 3.4 7.1 7.9 4.5 13.4 2.1 2.2 29.5 2.8 4.3 10.0 5.6 8.3 3.1 5.6 6.7 5.2 5.4 10.6 59.7 3.8 4.6 5.4 3.0 1.0 4.9 2.4 6.7 3.6 17.7 6.1 16.9 4.9 1.5 3.0 19.2 2.2 3.1 71.2 14.7 5.7 1.3 39.4 4.8 3.6 47.9 24.6 3.3 26.0 2.9 46.9 3.0 17.0 63.4 13.2 1.8 1.6 0.8 1.7 0.3 0.2 1.3 1.1 1.4 1.6 1.4 1.4 1.4 8.0 0.5 0.5 0.6 1.1 2.7 1.0 1.5 60.3 2.1 9.7 1.6 1.4 0.7 2.3 6.5 0.6 0.9 1.7 1.0 1.3 0.6 1.0 10.2 74.7 0.9 1.3 0.8 4.8 18.2 0.6 2.5 1.0 0.6 73.6 1.6 0.2 0.6 0.8 1.2 0.8 0.8 4.3 2.1 3.1 0.3 0.4 0.2 0.3 1.1 136.0 120.2 15.3 1.5 2.0 0.4 46.9 1.5 14.3 12.5 1.9 21.2 26.0 34.4 17.6 2.5 15.9 36.9 23.0 38.3 17.0 3.0 2.9 63.4 13.2 4.3 7.2 7.1 7.9 5.6 6.7 3.8 4.6 6.7 1.3 11.9 48.0 109.2 9.5 18.0 2.3 2.0 0.0 14.7 12.5 3.5 2.0 5.3 3.3 2.8 1.4 4.3 4.0 0.0 3.1 5.0 7.5 4.0 22.0 5.4 6.3 11.1 12.6 3.1 9.1 1.4 1.7 18.6 89.4 163.3 6.6 2.3 1.6 3.5 3.9 5.4 2.2 0.0 8.1 2.1 1.5 12.0 2.1 70.8 8.1 3.9 PIM3 ENSG00000198355 "Pim-3 proto-oncogene, serine/threonine kinase" Q86V86 22 49960513-49964080 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 46.5;SK-BR-3: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068758 Supported Cytosol NA Yes Cytosol "HPA068758: AB_2686026" "unprognostic (3.67e-2)" "unprognostic (7.69e-3)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-2)" "unprognostic (5.83e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.09e-4)" "unprognostic (5.59e-3)" "unprognostic (1.71e-1)" "unprognostic (3.92e-3)" "unprognostic (7.27e-3)" 32.5 15.5 6.8 19.9 16.7 62.4 50.5 7.6 11.9 16.4 22.6 11.3 20.9 15.9 14.4 17.6 25.0 15.9 37.8 23.6 7.5 7.9 29.1 25.7 38.3 29.4 21.1 4.9 13.9 36.4 4.8 14.9 31.4 15.1 28.4 7.6 9.7 27.6 22.7 39.9 31.3 20.9 12.2 10.1 25.4 33.6 13.0 13.5 9.7 19.1 19.9 19.0 25.6 18.3 6.1 5.7 16.9 4.0 1.2 4.5 1.9 7.3 4.9 3.3 6.2 2.6 1.9 18.9 4.6 7.5 5.6 4.0 8.1 6.3 13.2 5.9 1.2 11.3 6.3 6.3 3.5 2.0 9.9 26.2 5.4 11.7 9.8 12.2 11.7 10.5 3.7 11.7 3.4 5.8 3.0 18.0 9.0 7.4 46.5 1.6 16.5 5.9 20.9 6.9 7.7 7.9 27.7 5.5 15.6 2.9 5.6 11.8 8.2 9.0 41.3 28.9 3.2 5.4 15.6 4.7 3.5 15.0 5.7 7.5 23.9 15.2 11.2 8.7 6.6 9.4 0.0 3.1 0.1 1.9 3.2 2.3 3.4 4.4 3.8 2.5 6.1 4.1 1.7 16.9 1.2 4.0 5.7 4.5 1.9 6.8 16.7 7.6 11.9 7.5 7.9 21.1 4.9 15.1 13.5 59.6 91.3 64.7 240.2 201.8 30.4 27.9 68.8 20.1 45.5 76.8 2.0 51.0 71.3 44.7 2.1 87.2 56.5 0.0 46.7 226.7 51.4 225.9 70.2 37.5 64.3 58.8 93.7 59.5 30.8 4.1 30.0 74.6 102.9 46.9 56.5 11.1 57.1 46.3 10.6 48.8 15.3 25.8 117.4 19.9 37.3 178.9 326.1 26.6 49.6 261.0 PIP5KL1 "bA203J24.5, MGC46424" ENSG00000167103 "Phosphatidylinositol-4-phosphate 5-kinase like 1" Q5T9C9 9 127920879-127930797 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 9.4;Ciliated cells: 9.4;Early spermatids: 20.0;Late spermatids: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "intermediate monocyte: 1.2;MAIT T-cell: 1.0;memory B-cell: 1.0;myeloid DC: 1.0;naive B-cell: 2.4;plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Karpas-707: 29.6;RPMI-8226: 19.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA056240 Uncertain Supported Cytosol NA NA Cytosol "HPA056240: AB_2683075" "unprognostic (2.15e-2)" "unprognostic (3.06e-1)" "unprognostic (1.23e-3)" "unprognostic (8.51e-5)" "unprognostic (1.44e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (6.29e-2)" "unprognostic (5.20e-2)" "unprognostic (5.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.57e-3)" "unprognostic (9.95e-8)" "unprognostic (1.87e-1)" "unprognostic (7.21e-2)" "unprognostic (6.05e-2)" "unprognostic (1.59e-1)" 0.6 0.7 3.1 0.6 1.0 1.4 2.5 2.4 5.3 2.1 0.6 1.9 0.6 0.5 1.3 0.6 3.7 1.8 1.2 0.6 2.1 2.9 1.3 0.6 2.9 0.6 1.4 2.6 0.7 1.3 6.5 4.8 1.6 8.3 3.3 0.2 1.0 8.7 4.1 0.6 4.7 0.6 1.0 1.5 0.6 2.4 2.5 1.2 0.6 2.9 0.6 0.6 1.2 4.0 2.4 1.3 0.0 1.2 0.0 1.0 0.3 0.0 0.5 0.4 0.5 0.5 1.3 2.8 0.6 0.5 0.1 0.1 0.2 3.6 0.3 1.1 2.4 1.1 1.1 0.0 2.6 0.1 0.3 1.7 0.0 0.8 0.0 0.9 0.0 0.1 1.4 1.7 0.3 0.0 0.9 0.0 2.4 0.0 29.6 0.0 2.5 0.0 1.0 0.2 1.1 0.4 0.2 0.0 19.3 0.0 0.0 1.0 1.8 0.1 0.7 0.0 0.3 1.1 1.4 0.3 0.3 1.0 0.6 0.1 2.6 1.7 0.7 5.3 0.4 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.0 0.1 0.0 1.0 2.4 0.2 0.1 0.0 0.0 0.1 1.3 0.0 0.3 3.1 1.0 2.4 5.3 2.1 2.9 1.4 2.6 8.3 1.2 0.0 9.4 0.5 3.7 1.9 0.2 0.5 0.0 9.4 1.2 5.2 0.0 0.7 1.7 1.2 20.0 0.6 0.0 0.0 1.3 3.8 0.8 1.9 0.0 0.0 0.3 4.8 0.0 0.6 0.3 14.7 0.9 0.0 0.0 0.0 0.2 1.7 1.2 0.0 0.4 0.0 0.7 0.0 0.8 1.1 0.9 1.0 2.6 0.0 0.2 1.8 PIR ENSG00000087842 Pirin O00625 X 15384799-15493564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 74.0;Syncytiotrophoblasts: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 51.0;HUVEC TERT2: 117.2;SK-MEL-30: 44.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000697 Approved Supported Cytosol NA NA Cytosol "HPA000697: AB_1079621" "unprognostic (3.46e-3)" "prognostic favorable (2.78e-4)" "unprognostic (4.26e-2)" "unprognostic (5.62e-3)" "unprognostic (4.16e-3)" "unprognostic (2.09e-2)" "unprognostic (6.70e-3)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic favorable (4.94e-4)" "unprognostic (3.78e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (6.11e-7)" "unprognostic (1.99e-2)" "unprognostic (8.90e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" 20.9 16.1 14.1 5.9 16.8 5.7 26.5 8.5 13.5 8.1 7.5 14.0 21.8 7.7 11.2 18.8 20.7 16.2 13.4 14.0 11.7 12.1 13.9 23.7 18.6 8.6 20.8 9.8 13.0 2.6 5.4 9.1 12.1 15.6 12.1 8.3 25.0 7.5 18.0 9.8 13.7 6.9 24.6 26.0 15.5 13.8 7.2 14.4 1.3 12.1 19.9 9.1 26.5 11.7 0.0 0.5 1.0 0.5 0.0 2.2 0.3 2.3 12.9 7.8 11.4 4.6 5.2 2.5 0.7 4.5 1.9 4.3 3.6 20.3 0.0 25.7 2.0 51.0 16.5 9.0 3.6 0.7 0.0 1.9 1.4 14.6 10.5 5.9 0.7 5.2 1.4 12.5 7.2 2.5 3.3 117.2 0.0 1.0 3.3 1.6 4.9 0.5 0.6 8.3 10.4 8.2 0.0 1.5 6.4 3.8 22.9 3.0 8.3 6.2 3.5 44.1 14.0 7.3 4.4 7.3 1.0 1.9 4.9 1.4 1.5 6.4 0.0 5.0 2.6 10.2 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.3 14.1 16.8 8.5 13.5 11.7 12.1 20.8 9.8 15.6 14.4 0.0 2.6 1.9 20.5 7.7 2.5 5.1 10.2 24.1 4.5 1.8 0.0 74.0 8.3 3.8 0.4 25.9 4.0 0.0 2.2 8.6 8.9 8.4 0.0 21.3 18.4 19.1 10.9 17.2 6.4 0.2 34.8 2.9 38.8 20.8 2.4 26.6 4.6 1.4 26.9 7.7 4.5 12.9 8.6 0.5 2.4 11.0 71.6 0.9 3.3 43.0 PKM "OIP3, PK3, PKM2, THBP1" ENSG00000067225 "Pyruvate kinase M1/2" P14618 15 72199029-72231822 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Translation regulation" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 541.2" "Cell type enhanced" "Detected in all" 5 "monocytes: 1878.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019421, HPA029501" Uncertain Enhanced Cytosol No No 540000000 Cytosol "CAB019421: AB_2252325, HPA029501: AB_10602118" "unprognostic (8.73e-3)" "unprognostic (4.63e-3)" "unprognostic (1.68e-2)" "unprognostic (3.09e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (1.30e-4)" "prognostic unfavorable (2.74e-6)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.51e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (5.17e-5)" "unprognostic (3.16e-1)" "unprognostic (3.22e-1)" "unprognostic (7.85e-2)" "unprognostic (3.17e-2)" "unprognostic (1.44e-1)" "unprognostic (1.25e-2)" 23.2 76.8 53.8 49.8 70.4 57.5 41.6 56.6 85.9 65.7 31.2 32.1 31.5 26.4 24.7 41.8 76.4 37.9 32.9 94.8 50.1 57.1 60.9 6.1 33.3 39.4 62.5 63.6 26.2 15.6 33.3 28.3 27.1 80.5 34.8 31.9 54.4 47.1 47.5 541.2 51.8 25.1 44.7 34.9 30.7 26.7 29.0 29.4 23.5 23.8 114.4 60.6 53.1 40.9 25.1 79.6 14.9 90.6 11.6 37.4 114.9 81.9 210.9 42.5 50.3 51.2 57.5 35.1 88.9 207.7 142.9 144.6 59.3 101.0 62.4 90.0 166.4 106.4 119.5 134.4 181.0 112.0 109.5 63.5 38.2 106.1 49.1 35.6 49.5 82.5 52.2 84.3 110.0 45.2 185.5 84.1 32.1 9.5 50.1 225.2 50.9 18.5 21.3 52.6 125.8 80.5 55.0 136.1 118.9 189.6 105.5 44.2 48.3 116.0 71.6 90.9 74.7 50.2 36.1 65.4 162.8 89.0 159.0 161.3 64.4 90.9 55.0 200.4 82.0 159.4 12.6 90.6 14.9 23.5 52.6 22.8 25.1 31.3 23.2 79.6 16.1 27.3 20.2 11.8 11.6 40.2 16.2 37.4 114.9 53.8 70.4 56.6 85.9 50.1 57.1 62.5 63.6 80.5 29.4 110.2 78.1 134.8 464.1 502.3 450.3 279.7 94.3 129.8 157.0 786.9 347.5 523.8 679.8 1147.1 307.8 224.6 361.4 70.0 528.2 1096.0 273.6 329.6 203.1 2.0 698.2 1005.9 270.8 71.2 307.3 1333.1 145.6 439.7 337.4 1878.3 130.3 624.4 887.7 231.5 252.1 165.5 510.0 122.9 245.6 32.6 84.3 340.0 481.5 163.0 247.6 730.1 PLA2G4C cPLA2-gamma ENSG00000105499 "Phospholipase A2 group IVC" Q9UP65 19 48047843-48110817 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid metabolism, Phospholipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;skeletal muscle: 45.0" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 54.2;Cone photoreceptor cells: 62.8;Muller glia cells: 53.7;Rod photoreceptor cells: 133.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 8.2;HHSteC: 13.4;TIME: 18.6" "Not detected" "Not detected" HPA043083 Approved Approved Cytosol NA NA Cytosol "HPA043083: AB_10795714" "unprognostic (1.27e-1)" "unprognostic (3.88e-2)" "unprognostic (4.18e-2)" "unprognostic (2.82e-2)" "unprognostic (7.37e-2)" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (6.53e-2)" "unprognostic (8.30e-2)" "unprognostic (1.94e-1)" "unprognostic (5.11e-3)" "unprognostic (1.90e-1)" "unprognostic (4.66e-2)" "unprognostic (9.45e-2)" "unprognostic (2.28e-3)" "unprognostic (1.87e-1)" "unprognostic (9.01e-2)" 4.0 11.7 8.9 4.2 23.2 0.4 3.0 12.9 14.5 3.4 3.5 23.4 2.0 5.1 6.8 5.2 3.6 4.3 4.6 18.5 10.0 10.0 4.4 3.8 5.9 7.2 31.8 8.5 2.0 4.1 14.8 4.6 4.1 16.9 5.7 2.9 5.4 3.1 6.7 45.0 4.9 6.7 8.1 18.6 8.1 2.4 2.4 17.1 0.7 3.3 7.5 4.3 4.9 2.1 5.4 2.0 0.0 7.9 1.5 0.8 2.0 0.7 1.1 0.0 0.3 5.2 3.0 0.1 1.3 8.2 1.2 3.5 0.0 2.1 0.0 1.8 3.2 2.6 0.2 0.0 0.2 2.0 0.8 0.1 0.0 0.3 1.2 13.4 0.0 1.8 0.6 0.3 0.5 5.4 2.5 5.1 0.0 0.0 7.4 2.0 2.0 0.0 0.1 0.1 0.9 0.1 0.1 1.8 0.7 2.5 0.4 0.8 0.1 1.5 2.6 6.3 4.2 0.7 1.8 18.6 2.3 0.7 2.5 0.9 0.5 1.4 0.2 1.6 0.0 4.4 0.0 3.2 0.0 0.2 7.9 0.6 5.4 0.8 0.0 2.0 1.6 0.0 0.0 0.0 1.5 2.0 1.4 0.2 2.0 8.9 23.2 12.9 14.5 10.0 10.0 31.8 8.5 16.9 17.1 3.0 1.7 0.5 0.8 2.5 54.2 30.9 10.2 0.0 0.0 0.0 62.8 0.1 1.7 7.7 0.2 16.9 1.6 0.0 2.5 0.2 3.8 1.7 0.0 1.0 5.0 31.8 0.0 3.1 0.3 0.0 0.6 2.8 6.8 4.6 1.5 53.7 4.1 0.3 7.4 3.4 133.4 12.9 11.8 0.3 0.5 2.6 0.1 0.0 0.0 0.1 PLA2R1 "CLEC13C, PLA2-R, PLA2G1R, PLA2IR" ENSG00000153246 "Phospholipase A2 receptor 1" Q13018 2 159932006-160062610 "Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 46.1" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 31.4;Muller glia cells: 30.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 19.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 9.2;ASC TERT1: 12.5;BJ hTERT+: 9.9;hTERT-RPE1: 16.5;TIME: 28.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB068217, CAB068218" Approved Approved Cytosol "Secreted to blood" NA NA 99000 Cytosol "CAB068217: AB_2665660, CAB068218: AB_2665661" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (4.91e-3)" "unprognostic (6.01e-2)" "unprognostic (9.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.38e-3)" "unprognostic (4.30e-3)" "unprognostic (2.82e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.62e-1)" "unprognostic (6.58e-2)" "unprognostic (2.02e-1)" 4.6 2.1 0.6 2.3 1.1 0.0 9.4 19.5 1.9 11.3 7.0 1.0 2.4 2.4 17.8 4.7 4.7 4.8 6.9 2.7 0.7 1.0 15.0 0.9 2.3 1.8 0.8 0.7 8.7 0.8 14.5 2.6 6.6 3.3 3.3 2.0 7.8 46.1 2.0 0.8 9.6 9.4 5.7 2.5 3.0 1.6 1.3 0.2 0.3 27.6 6.6 5.1 4.5 9.4 0.6 0.6 2.3 0.8 1.0 0.6 0.2 0.1 1.0 0.3 0.0 9.2 12.5 0.0 4.1 9.9 0.8 1.1 0.0 2.1 0.0 0.2 4.3 0.9 2.0 0.0 3.0 0.8 0.0 0.0 0.0 6.9 0.0 0.7 0.0 0.0 5.0 3.3 1.2 1.3 16.5 5.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 7.2 1.3 0.0 1.1 1.6 0.1 28.7 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.5 0.5 0.5 0.6 0.5 0.4 0.3 0.3 0.6 0.6 0.6 2.3 1.0 0.8 0.6 0.4 0.2 0.6 1.1 19.5 1.9 0.7 1.0 0.8 0.7 3.3 0.2 6.0 3.2 0.0 2.2 8.4 0.8 3.6 5.1 6.7 2.3 31.4 0.0 4.3 0.0 0.7 0.0 3.6 2.6 0.0 1.8 1.1 6.7 2.3 1.1 0.0 0.5 15.9 1.2 8.0 0.0 0.9 15.0 0.0 6.8 0.0 6.1 30.3 3.2 5.8 15.6 1.1 1.1 6.5 2.2 0.0 0.6 4.6 1.3 0.0 6.5 2.2 PLAC8 "C15, onzin" ENSG00000145287 "Placenta specific 8" Q9NZF1 4 83090048-83137075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8" "Cell type enhanced" "Detected in many" 8 "B-cells: 305.1;Ciliated cells: 487.2;Enterocytes: 398.3;Extravillous trophoblasts: 527.8;Kupffer cells: 319.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 181.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 32.2;CAPAN-2: 93.1;HL-60: 57.7;NB-4: 28.4;RPMI-8226: 41.6;THP-1: 33.5;U-937: 26.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040465, HPA077912" Enhanced Approved Cytosol NA NA Cytosol "HPA040465: AB_10794875, HPA077912: AB_2686870" "unprognostic (6.82e-5)" "prognostic favorable (3.03e-4)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.05e-1)" "unprognostic (4.86e-2)" "unprognostic (1.14e-1)" "unprognostic (1.94e-3)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (7.44e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-7)" "unprognostic (3.89e-2)" "unprognostic (2.85e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" 2.3 1.3 1.7 47.9 5.9 62.0 1.6 0.7 4.1 6.1 44.1 0.6 0.2 14.6 1.0 0.9 34.5 3.1 7.5 2.4 1.4 1.9 1.6 12.4 23.4 51.6 2.5 0.2 1.9 1.2 0.0 1.3 32.3 3.0 2.0 31.4 1.3 9.7 1.0 0.8 0.7 66.5 3.1 5.2 74.8 21.8 0.7 2.7 18.2 1.5 1.4 53.1 3.4 2.5 41.5 181.6 7.0 47.8 77.6 32.9 36.0 32.2 0.2 0.1 0.2 0.0 0.0 5.3 0.8 0.2 2.0 2.5 0.6 93.1 5.4 0.2 9.4 3.2 3.4 0.5 0.2 7.7 0.0 0.1 0.1 6.4 2.7 0.3 57.7 0.3 0.1 0.6 0.3 0.4 0.0 0.1 2.8 0.0 0.4 5.3 0.1 10.9 28.4 0.2 2.5 0.1 1.4 1.9 41.6 0.1 0.9 4.7 0.0 0.2 5.4 0.1 1.7 0.3 33.5 0.2 0.2 6.0 0.1 0.1 0.3 0.0 14.4 0.4 26.6 0.0 2.7 11.0 7.0 32.9 47.8 24.9 41.5 15.7 18.7 10.0 38.4 19.4 22.0 2.4 77.6 25.8 181.6 1.0 36.0 1.7 5.9 0.7 4.1 1.4 1.9 2.5 0.2 3.0 2.7 181.7 50.7 305.1 1.9 0.3 0.0 0.4 2.5 487.2 61.4 0.0 0.0 7.9 0.0 0.0 0.2 1.4 398.3 0.0 3.3 527.8 0.9 0.9 25.5 1.5 20.9 1.6 83.1 171.9 319.5 0.4 0.0 79.4 6.8 1.0 179.6 1.3 57.7 270.0 0.0 0.8 0.1 6.5 0.3 0.2 0.1 0.1 11.9 261.7 36.3 8.4 PLCE1 "KIAA1516, NPHS3, PLCE" ENSG00000138193 "Phospholipase C epsilon 1" Q9P212 10 94030812-94332823 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 44.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 65.5;Enterocytes: 45.9;Muller glia cells: 98.6;Paneth cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015597, HPA015598" Enhanced Supported Cytosol NA NA Cytosol "HPA015597: AB_1855321, HPA015598: AB_1855322" "unprognostic (4.73e-2)" "unprognostic (1.16e-1)" "unprognostic (4.03e-2)" "unprognostic (3.59e-3)" "unprognostic (3.01e-1)" "unprognostic (2.96e-1)" "unprognostic (1.73e-2)" "unprognostic (4.76e-3)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-3)" "unprognostic (3.56e-1)" "unprognostic (3.92e-2)" "unprognostic (3.54e-2)" "unprognostic (4.30e-2)" 3.2 2.4 4.1 9.1 5.5 0.0 2.2 1.8 7.9 9.2 13.8 3.1 1.6 5.0 11.4 4.6 4.5 4.2 3.8 12.8 4.1 2.6 6.3 0.7 7.2 0.4 2.4 6.8 3.2 12.8 0.1 5.2 3.1 6.4 3.3 12.6 44.6 2.1 7.7 4.3 0.7 4.6 5.8 2.4 5.8 8.7 1.7 2.3 0.0 15.1 7.3 1.1 7.9 5.4 3.2 1.2 0.8 0.9 1.1 2.3 0.5 5.8 8.1 1.7 0.9 0.9 5.7 2.3 3.6 1.0 0.8 1.1 5.2 1.4 0.6 1.8 2.9 2.9 2.5 4.1 1.0 1.3 0.3 2.0 0.4 4.4 0.4 0.1 0.7 0.3 2.3 0.0 2.2 0.0 9.7 0.0 0.3 0.4 0.3 7.0 0.2 0.6 0.8 0.6 11.0 8.4 0.1 5.5 0.2 0.2 18.2 0.8 1.4 4.2 5.8 0.5 7.9 4.9 0.5 0.5 3.7 10.9 2.3 4.7 0.5 0.2 0.3 3.0 1.0 3.3 0.4 0.5 0.1 1.5 0.9 1.3 2.6 1.6 1.1 0.6 3.2 2.3 1.8 0.8 1.1 0.8 1.2 0.6 0.5 4.1 5.5 1.8 7.9 4.1 2.6 2.4 6.8 6.4 2.3 65.5 4.8 9.3 7.4 7.2 11.5 32.3 0.0 10.7 13.6 0.0 0.0 3.2 1.7 1.3 15.0 7.4 45.9 0.0 5.7 2.0 7.3 2.9 0.0 1.1 0.6 6.4 1.7 6.2 0.6 3.4 11.2 1.4 6.8 1.0 6.4 98.6 3.2 46.7 21.9 2.1 19.4 6.5 19.4 3.5 7.8 6.5 1.6 4.3 28.0 6.0 PLCG1 "NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1" ENSG00000124181 "Phospholipase C gamma 1" P19174 20 41136960-41196801 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4" "Group enriched" "Detected in many" 8 "NK-cells: 4.0;T-cells: 8.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004277, HPA036681, HPA036682" Approved Enhanced Cytosol NA NA Cytosol "CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246" "unprognostic (2.77e-1)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (4.31e-2)" "unprognostic (5.82e-2)" "unprognostic (2.09e-2)" "unprognostic (4.45e-3)" "unprognostic (1.25e-2)" "unprognostic (2.29e-2)" "unprognostic (1.16e-1)" "prognostic favorable (4.72e-4)" "unprognostic (3.32e-1)" "unprognostic (2.73e-3)" "unprognostic (1.82e-1)" "unprognostic (2.65e-1)" "unprognostic (9.27e-2)" "unprognostic (2.79e-2)" 20.2 15.1 25.1 20.9 22.1 8.3 34.9 52.6 26.8 19.9 13.9 23.4 12.5 16.5 27.6 13.9 13.5 17.0 18.7 20.9 25.4 13.6 15.3 6.8 19.3 30.7 18.5 20.5 28.7 9.1 16.9 14.2 22.2 18.7 18.4 13.2 20.0 13.2 20.6 13.4 22.3 17.1 22.2 15.4 20.1 12.4 19.9 23.9 48.1 28.5 11.9 21.9 17.1 21.1 0.7 0.0 0.0 0.0 4.0 8.0 3.3 5.4 6.9 33.2 24.3 13.3 9.3 10.6 8.9 11.5 18.0 15.3 16.6 1.8 12.1 11.0 9.7 18.9 10.1 14.4 16.0 10.5 3.4 7.7 0.8 11.5 19.5 10.1 4.7 3.3 11.9 9.0 13.3 10.4 16.3 20.0 26.0 9.0 8.0 16.2 40.4 29.2 3.7 12.3 7.0 12.7 23.3 24.2 5.9 9.9 10.0 11.8 22.5 16.0 7.5 16.0 19.4 8.7 5.6 21.6 43.1 14.0 13.7 10.8 8.9 3.9 10.0 10.2 5.2 17.8 0.0 0.0 0.0 5.9 0.0 8.0 0.3 5.2 4.9 0.0 0.7 5.7 5.4 0.0 4.0 0.0 0.0 4.4 3.3 25.1 22.1 52.6 26.8 25.4 13.6 18.5 20.5 18.7 23.9 14.9 6.5 0.8 1.8 4.9 3.7 9.2 0.0 1.4 3.4 3.5 9.8 1.3 0.0 2.7 5.1 15.8 6.4 0.0 1.4 1.6 6.1 1.9 1.1 2.5 3.2 3.2 1.7 13.5 2.2 5.3 14.1 1.7 3.3 1.0 9.8 7.2 2.8 3.7 17.3 2.4 4.6 12.9 5.1 11.6 11.5 6.0 0.7 6.9 5.1 0.9 PLCXD1 FLJ11323 ENSG00000182378 "Phosphatidylinositol specific phospholipase C X domain containing 1" Q9NUJ7 X 276322-303356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.3" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 25.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 53.8" "Low region specificity" "Detected in many" HPA007721 Approved Approved Cytosol NA Yes Cytosol "HPA007721: AB_1079630" "unprognostic (2.73e-2)" "unprognostic (5.67e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.80e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.92e-2)" "unprognostic (1.72e-2)" "unprognostic (4.80e-2)" "unprognostic (7.25e-2)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.82e-14)" "unprognostic (6.01e-2)" "unprognostic (1.95e-1)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" 7.4 1.5 6.5 5.3 42.3 18.8 8.7 24.6 19.1 8.9 3.7 2.1 2.1 5.3 9.1 2.1 11.4 3.5 5.3 2.8 7.1 4.2 3.1 5.4 3.5 10.0 4.8 3.6 19.3 4.3 2.3 5.5 12.5 29.2 3.5 3.5 2.1 7.0 2.4 4.5 11.6 5.9 2.1 22.2 10.5 17.3 3.6 6.7 2.1 5.1 2.1 5.4 4.7 7.9 5.8 2.9 6.3 11.9 1.8 4.1 2.7 8.8 33.9 8.2 12.3 1.7 1.3 6.5 8.0 0.9 4.3 4.2 13.7 9.6 11.4 5.6 3.5 6.4 2.8 2.0 5.3 2.3 6.8 15.1 53.8 11.0 18.2 5.3 5.5 21.2 7.0 0.7 15.8 1.6 2.9 3.3 18.6 14.0 6.2 3.1 2.8 16.6 8.1 17.4 2.3 6.6 9.4 4.4 16.6 1.3 4.1 8.8 4.7 8.1 4.8 7.4 5.9 9.2 7.7 2.3 5.7 9.1 6.2 8.8 2.1 5.6 26.3 3.7 14.6 6.1 4.3 3.8 6.3 2.8 8.1 3.9 2.3 2.2 3.4 2.9 5.8 2.8 2.7 4.9 1.8 11.9 2.7 4.1 2.7 6.5 42.3 24.6 19.1 7.1 4.2 4.8 3.6 29.2 6.7 8.9 25.9 6.1 8.4 6.2 8.1 2.2 7.6 0.0 2.3 0.0 2.0 8.4 0.0 5.1 0.6 3.9 11.5 0.0 1.6 9.0 3.4 4.9 3.5 6.4 4.8 7.9 2.9 6.2 6.5 0.6 2.3 6.4 0.0 1.0 7.5 2.8 12.0 8.7 3.5 1.4 6.1 12.9 4.1 7.9 18.3 7.5 22.5 4.4 7.4 7.1 PLPBP PROSC ENSG00000147471 "Pyridoxal phosphate binding protein" O94903 8 37762593-37779767 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 86.2;Exocrine glandular cells: 43.8;Hofbauer cells: 41.9;Proximal tubular cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017033, HPA023646, HPA023733" Approved Enhanced Cytosol NA NA 20000 Cytosol "CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742" "unprognostic (1.55e-2)" "unprognostic (2.17e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-2)" "unprognostic (1.34e-1)" "unprognostic (2.35e-2)" "unprognostic (2.36e-1)" "unprognostic (7.78e-3)" "unprognostic (1.80e-1)" "unprognostic (4.28e-2)" "unprognostic (2.83e-2)" "unprognostic (2.59e-2)" "unprognostic (9.41e-3)" "unprognostic (3.16e-2)" "unprognostic (3.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.85e-2)" 23.3 18.2 22.0 14.6 23.3 8.4 20.6 19.7 23.2 15.7 29.1 16.1 18.3 21.3 17.2 16.2 14.0 18.9 16.4 30.1 19.7 21.4 37.0 48.2 16.5 14.7 20.7 20.3 17.8 38.4 26.2 17.9 13.2 15.3 19.5 25.5 15.2 18.6 19.2 32.6 11.0 24.7 19.4 18.5 15.1 20.0 7.2 15.4 16.6 30.6 15.7 18.3 20.1 28.8 27.4 40.0 46.1 46.5 24.1 39.2 34.2 17.4 17.1 14.2 12.8 10.7 13.1 11.1 20.0 18.1 13.9 15.8 20.3 9.1 21.0 23.9 15.9 22.4 16.0 26.4 21.0 23.3 17.4 11.1 29.1 6.8 19.4 21.1 13.2 19.8 9.6 19.6 13.4 21.8 15.5 20.9 30.1 15.3 16.8 11.6 12.9 42.6 12.3 16.8 36.1 14.0 28.0 17.4 12.3 22.7 22.9 8.4 9.2 16.5 8.0 20.8 10.9 17.4 17.4 18.5 7.7 23.5 25.8 13.0 16.5 32.4 15.6 10.8 19.4 13.7 46.1 38.4 45.6 31.8 43.8 33.3 27.4 32.6 30.5 40.0 22.9 29.2 27.8 16.2 24.1 46.5 23.7 39.2 34.2 22.0 23.3 19.7 23.2 19.7 21.4 20.7 20.3 15.3 15.4 8.9 24.5 0.0 0.0 0.0 0.0 0.0 0.0 25.4 14.8 29.6 0.0 17.4 86.2 32.4 0.0 0.0 0.0 0.0 43.8 26.8 0.0 0.0 11.6 0.0 41.9 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 20.8 0.0 0.0 30.6 0.0 0.0 63.4 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 PMM1 Sec53 ENSG00000100417 "Phosphomannomutase 1" Q92871 22 41576894-41589890 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030712, HPA074950" Uncertain Supported Cytosol NA NA Cytosol "HPA030712: AB_10669600, HPA074950: " "unprognostic (2.66e-1)" "prognostic favorable (5.92e-4)" "unprognostic (3.25e-2)" "prognostic favorable (6.09e-6)" "unprognostic (1.25e-1)" "unprognostic (2.85e-2)" "unprognostic (1.01e-2)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "unprognostic (1.78e-1)" "prognostic favorable (2.05e-4)" "unprognostic (6.56e-3)" "unprognostic (5.76e-3)" "unprognostic (2.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.40e-2)" "unprognostic (2.70e-1)" 20.8 25.1 24.3 15.2 28.8 15.3 15.0 15.5 27.9 24.7 29.5 12.6 14.1 25.3 12.1 20.1 36.5 24.8 14.7 17.7 19.6 20.6 32.8 32.2 21.7 10.8 20.3 25.5 34.8 30.5 7.7 8.7 9.7 17.8 13.7 13.9 11.8 13.0 17.3 6.6 13.6 22.0 14.3 15.2 6.0 24.5 27.6 13.2 8.8 8.9 12.7 14.7 15.2 13.2 10.6 13.2 24.5 12.7 6.8 27.1 10.3 5.3 9.8 6.7 14.4 19.4 30.2 7.8 21.1 24.1 19.5 21.5 7.8 5.1 5.0 7.1 25.1 14.0 8.0 8.8 13.6 11.0 10.3 13.5 1.2 12.3 16.4 30.8 7.4 8.1 25.1 13.2 20.1 8.5 21.7 3.1 8.1 5.5 17.8 26.4 14.0 5.6 10.7 2.1 25.2 13.2 4.3 7.2 10.3 8.2 5.7 1.9 3.8 17.2 6.2 25.2 5.5 7.0 8.2 2.4 22.0 12.1 20.5 10.8 11.2 10.8 7.9 24.6 6.2 13.2 9.6 12.7 24.5 16.3 10.2 13.8 10.4 16.8 13.8 13.2 10.6 18.3 12.9 16.6 6.8 12.0 5.0 27.1 10.3 24.3 28.8 15.5 27.9 19.6 20.6 20.3 25.5 17.8 13.2 32.8 81.3 24.1 11.2 13.2 18.0 10.2 61.1 46.8 36.4 33.2 5.9 49.2 91.2 22.6 11.4 5.8 103.9 23.3 9.6 78.2 28.7 9.3 3.5 75.7 29.4 27.0 46.8 10.4 11.3 10.8 25.9 14.0 42.2 25.2 41.2 49.6 15.1 112.2 28.7 109.0 19.6 38.8 39.8 45.9 10.4 12.3 54.6 20.3 47.6 5.5 PNP "NP, PUNP" ENSG00000198805 "Purine nucleoside phosphorylase" P00491 14 20468954-20477094 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 153.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 276.6;Syncytiotrophoblasts: 540.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 82.7;U-937: 94.3" "Low region specificity" "Detected in all" HPA001625 Enhanced Supported Cytosol NA NA 100000000 Cytosol "HPA001625: AB_1854577" "unprognostic (1.20e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" "unprognostic (1.70e-1)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (4.94e-3)" "unprognostic (3.87e-2)" "unprognostic (7.45e-2)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "prognostic favorable (2.24e-4)" "unprognostic (1.69e-1)" "unprognostic (7.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" 24.7 7.6 9.5 15.0 14.0 69.4 15.7 13.9 11.8 9.5 19.1 6.2 25.2 29.4 5.9 153.1 34.0 7.8 15.7 12.1 11.5 8.4 49.7 24.2 18.3 13.2 13.5 3.4 3.6 11.0 8.7 8.4 45.3 17.7 6.0 16.1 3.8 9.2 7.9 3.3 10.6 32.0 9.8 16.3 18.0 17.0 4.5 12.5 7.0 7.1 21.7 19.1 7.5 14.7 13.1 20.7 4.1 12.4 15.7 33.7 12.1 13.4 18.2 3.8 8.7 4.4 3.5 11.9 13.8 6.5 11.3 11.1 10.5 12.3 36.0 16.0 7.3 13.3 14.6 20.4 26.0 15.0 11.6 17.9 30.1 15.5 17.3 4.1 82.7 15.7 2.4 9.4 34.0 15.1 6.2 48.1 22.3 14.8 22.5 14.1 12.5 24.3 48.8 11.0 34.4 30.4 20.6 5.8 14.0 40.1 12.8 16.9 3.7 26.5 33.7 2.1 5.6 12.4 14.7 38.5 7.7 10.3 17.3 23.4 10.3 17.2 40.7 6.6 94.3 0.7 4.0 12.4 4.1 18.1 11.5 33.7 11.2 20.3 20.0 20.7 13.1 12.9 16.3 1.6 15.7 10.6 11.7 6.9 12.1 9.5 14.0 13.9 11.8 11.5 8.4 13.5 3.4 17.7 12.5 0.0 26.3 18.6 51.4 75.2 4.8 3.1 28.1 8.1 17.0 78.5 13.7 276.6 33.2 38.4 1.0 60.2 56.3 93.5 44.5 26.6 19.4 21.8 56.6 23.1 63.4 15.9 44.5 19.6 22.4 0.0 0.3 46.2 28.7 1.0 31.7 70.2 85.7 56.1 0.7 91.5 17.0 0.0 33.8 0.2 0.6 55.8 540.4 19.3 34.8 70.5 PPCDC "FLJ14585, MDS018" ENSG00000138621 "Phosphopantothenoylcysteine decarboxylase" Q96CD2 15 75023555-75117462 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 19.9;granulocytes: 40.4;monocytes: 18.1" "Cell line enhanced" "Detected in all" "Karpas-707: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045667 Approved Approved Cytosol NA NA Cytosol "HPA045667: AB_2679412" "unprognostic (8.66e-2)" "unprognostic (1.07e-3)" "unprognostic (6.03e-2)" "unprognostic (2.57e-2)" "unprognostic (2.95e-2)" "unprognostic (6.53e-2)" "unprognostic (1.76e-2)" "unprognostic (8.40e-2)" "unprognostic (1.72e-1)" "unprognostic (1.53e-1)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (1.60e-2)" "unprognostic (7.67e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-1)" "unprognostic (2.13e-3)" 10.4 18.5 7.7 11.1 9.3 16.7 14.5 10.8 10.2 8.4 10.8 16.0 15.1 9.4 16.3 13.3 17.5 10.9 12.1 7.8 7.3 7.9 12.5 12.0 13.9 14.0 16.8 5.9 9.2 22.1 14.4 11.3 8.9 11.0 12.0 9.3 15.6 17.5 8.0 10.5 8.3 11.6 6.1 13.6 18.0 10.7 9.7 11.3 7.4 11.0 11.5 16.5 14.2 9.4 4.2 19.9 40.4 18.1 4.5 5.6 4.2 6.0 11.4 4.7 3.7 2.9 2.7 4.1 6.1 2.7 8.3 6.5 6.7 16.5 6.9 11.0 3.0 5.1 6.3 7.7 10.2 4.2 24.3 9.4 12.1 7.1 7.1 8.3 7.0 15.8 3.6 6.8 8.5 13.1 3.3 6.5 10.3 8.1 54.0 5.9 11.7 4.2 10.9 7.6 12.9 5.3 7.1 9.3 14.8 6.2 8.7 11.5 3.3 9.0 12.6 13.2 5.7 15.6 9.1 3.7 8.5 5.9 4.2 10.8 16.5 10.8 11.4 5.2 17.9 9.5 10.9 6.5 40.4 3.4 17.5 5.6 4.2 3.1 3.8 4.9 2.3 3.6 4.3 39.3 4.5 18.1 19.9 3.3 4.2 7.7 9.3 10.8 10.2 7.3 7.9 16.8 5.9 11.0 11.3 14.9 6.9 2.2 6.1 3.4 2.6 3.4 5.1 12.0 3.4 8.7 0.0 14.7 21.6 15.1 0.7 9.8 11.1 0.0 13.4 11.5 7.2 5.7 11.5 4.2 16.7 7.9 4.1 4.9 12.5 2.9 4.0 15.4 13.5 21.6 8.5 3.5 16.2 31.7 4.9 14.9 8.4 6.5 8.2 6.5 16.4 3.4 9.2 13.1 10.0 11.9 PPP1R13L "IASPP, RAI" ENSG00000104881 "Protein phosphatase 1 regulatory subunit 13 like" Q8WUF5 19 45379634-45406349 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 78.3" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 77.1;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.6;hTCEpi: 52.2;hTERT-HME1: 36.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB005016, HPA041231, HPA059883" Approved Enhanced Cytosol NA Yes Cytosol "CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151" "unprognostic (1.87e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (2.92e-1)" "unprognostic (3.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.31e-3)" "prognostic unfavorable (3.39e-5)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.40e-4)" "unprognostic (2.52e-3)" "unprognostic (1.92e-2)" "unprognostic (1.55e-3)" "unprognostic (1.34e-1)" "unprognostic (7.69e-2)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" 6.7 6.6 2.5 3.6 4.1 0.6 14.5 3.5 3.4 13.2 6.2 2.4 8.5 2.9 5.8 8.2 51.6 3.6 4.7 37.2 4.0 1.2 8.0 5.7 8.5 1.6 3.9 2.5 4.4 12.4 6.6 6.6 38.7 3.9 11.5 3.8 5.1 17.8 15.7 3.8 78.3 7.1 3.8 3.3 2.5 4.4 1.6 6.1 2.7 10.6 24.4 25.6 13.2 22.9 0.6 0.7 0.0 1.5 0.0 2.3 0.2 21.2 3.0 1.2 1.0 1.3 0.8 18.5 3.8 0.6 4.8 6.7 6.0 19.8 2.5 1.7 3.0 9.9 28.4 1.0 35.6 4.4 6.5 1.5 0.3 9.8 2.2 2.8 0.2 0.9 1.1 52.2 7.6 36.2 21.7 8.9 2.1 2.1 0.9 0.3 17.4 0.4 0.4 1.4 9.7 5.0 1.9 1.5 0.4 6.2 25.5 0.6 2.2 19.7 18.9 0.4 8.5 16.5 0.5 13.6 6.1 18.7 0.4 18.7 10.6 10.9 1.6 0.9 0.7 1.5 0.0 0.0 0.0 1.5 0.4 0.7 0.6 2.3 0.4 0.2 0.2 0.1 0.7 0.0 0.0 1.5 0.7 1.3 0.2 2.5 4.1 3.5 3.4 4.0 1.2 3.9 2.5 3.9 6.1 32.8 8.8 0.5 77.1 61.0 2.0 34.3 20.4 8.1 22.7 19.2 9.8 69.5 5.0 28.4 0.5 11.2 15.4 0.0 13.4 33.0 6.1 31.1 4.6 2.1 6.7 0.0 6.9 8.0 2.6 0.2 5.5 2.7 11.8 1.8 6.2 2.2 35.6 14.0 11.7 2.7 25.6 6.5 10.4 2.9 1.9 62.0 107.4 0.7 7.1 62.2 PPP1R37 LRRC68 ENSG00000104866 "Protein phosphatase 1 regulatory subunit 37" O75864 19 45091396-45148077 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "memory B-cell: 2.3" "Lineage enriched" "Detected in single" 23 "B-cells: 2.3" "Cell line enhanced" "Detected in all" "RT4: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041500 Approved Approved Cytosol NA NA Cytosol "HPA041500: AB_10795122" "unprognostic (8.45e-2)" "unprognostic (5.23e-2)" "unprognostic (8.34e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "unprognostic (1.79e-1)" "unprognostic (1.04e-3)" "unprognostic (2.16e-1)" "unprognostic (1.08e-1)" "unprognostic (2.89e-3)" "unprognostic (7.72e-3)" "unprognostic (5.44e-2)" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.40e-1)" "unprognostic (4.71e-2)" "prognostic favorable (2.04e-4)" 12.7 19.2 17.3 9.8 17.5 8.1 12.6 27.9 27.2 12.8 13.3 10.4 23.0 20.7 11.6 11.2 13.3 10.1 18.8 11.7 15.9 11.4 13.8 9.3 11.0 8.6 12.9 19.1 10.4 18.2 11.5 28.3 11.1 11.4 13.7 7.0 13.9 25.5 17.0 25.2 19.2 19.2 8.4 10.2 13.1 27.4 16.6 11.2 10.7 14.7 10.3 8.8 18.3 14.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.2 5.0 7.2 6.3 4.3 9.7 9.8 5.7 6.9 7.9 5.9 7.5 3.7 7.1 5.2 6.4 10.7 3.3 7.6 2.0 4.7 8.5 3.2 6.4 7.0 7.9 2.9 5.3 5.5 5.9 6.5 4.2 7.4 5.5 5.0 5.3 2.9 3.7 17.0 6.9 4.5 4.8 9.7 8.0 8.4 5.7 2.6 4.4 35.5 15.3 7.0 8.4 17.7 14.8 2.7 11.3 4.8 8.7 8.2 9.8 4.8 8.6 5.0 3.1 2.7 10.7 3.3 7.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 17.5 27.9 27.2 15.9 11.4 12.9 19.1 11.4 11.2 6.0 4.3 4.7 9.9 6.8 45.1 5.1 15.3 4.0 2.3 3.5 37.3 18.4 6.6 15.9 5.0 6.7 20.3 0.0 8.7 16.3 8.2 8.3 0.0 6.2 15.6 73.1 29.4 9.8 6.5 5.7 11.2 3.0 11.8 4.6 22.2 20.6 10.2 18.1 11.7 14.1 44.4 19.4 8.5 13.4 22.0 8.3 15.3 6.5 22.6 9.7 PPP1R3B "FLJ14005, GL, PPP1R4" ENSG00000173281 "Protein phosphatase 1 regulatory subunit 3B" Q86XI6 8 9136255-9151574 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 66.2;Hepatocytes: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "basophil: 18.0;eosinophil: 7.4;neutrophil: 25.3" "Lineage enriched" "Detected in many" 17 "granulocytes: 25.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 26.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA028731 Enhanced Approved Cytosol NA NA Cytosol "HPA028731: AB_10602120" "unprognostic (4.97e-3)" "unprognostic (1.45e-2)" "unprognostic (2.82e-1)" "unprognostic (3.46e-2)" "unprognostic (2.39e-1)" "unprognostic (5.81e-2)" "unprognostic (1.52e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (4.98e-2)" "prognostic unfavorable (4.08e-7)" "prognostic unfavorable (6.03e-5)" "unprognostic (3.33e-1)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" 26.6 4.3 1.2 3.2 3.4 4.4 21.4 0.8 1.7 19.7 8.3 1.5 10.3 1.9 22.8 11.0 12.8 6.5 4.3 17.3 1.5 1.4 4.7 58.5 7.8 6.9 3.3 1.0 16.2 4.1 40.7 2.4 18.7 4.7 25.3 4.0 3.3 12.9 15.5 34.8 6.7 4.5 33.7 5.1 5.4 6.3 8.6 2.8 1.6 11.5 6.8 4.5 37.0 21.7 0.8 0.8 25.3 0.7 0.9 1.5 0.6 3.6 1.4 4.1 1.4 10.3 8.8 14.9 1.3 4.4 1.6 2.0 5.5 1.7 1.3 2.2 2.7 9.1 0.6 0.7 1.0 1.7 3.9 0.6 2.2 0.6 0.0 4.6 1.1 9.7 7.2 3.3 1.4 8.3 12.5 26.3 6.5 1.6 3.1 0.6 2.2 5.9 2.0 5.9 8.2 1.2 2.4 5.2 2.2 16.0 14.8 0.0 7.7 2.4 0.1 10.3 6.9 1.9 2.2 18.2 4.8 1.6 0.9 1.7 1.7 3.9 0.0 8.4 3.4 1.4 18.0 0.7 7.4 1.1 0.6 0.9 0.8 1.0 0.6 0.4 0.7 1.5 0.7 25.3 0.9 0.3 0.8 0.7 0.6 1.2 3.4 0.8 1.7 1.5 1.4 3.3 1.0 4.7 2.8 11.9 34.6 3.0 17.9 9.5 3.4 66.2 35.7 48.2 30.7 8.7 5.9 10.1 3.3 8.3 10.4 20.6 8.4 0.0 11.2 25.5 12.1 10.8 32.4 135.4 6.1 6.4 0.0 32.5 10.8 2.7 8.9 13.6 5.0 1.0 8.9 3.5 13.2 3.5 17.0 5.3 13.5 12.9 15.5 1.9 4.7 10.7 15.3 6.4 4.7 1.6 PPP2R1A "PP2A-Aalpha, PP2AA, PR65A" ENSG00000105568 "Protein phosphatase 2 scaffold subunit Aalpha" P30153 19 52190039-52229533 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chromosome partition" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018599 Approved Cytosol NA NA 3400000 Cytosol "CAB018599: AB_628178" "unprognostic (1.78e-1)" "unprognostic (2.31e-2)" "unprognostic (4.52e-2)" "unprognostic (2.87e-1)" "unprognostic (6.67e-2)" "unprognostic (7.82e-2)" "prognostic unfavorable (1.76e-4)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.30e-2)" "unprognostic (3.06e-1)" "unprognostic (6.48e-3)" "unprognostic (8.28e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.97e-1)" "unprognostic (3.57e-2)" "unprognostic (1.70e-2)" "unprognostic (9.19e-2)" 25.3 57.3 60.7 20.5 71.0 18.0 21.4 47.5 82.1 29.6 31.2 26.6 21.5 33.4 26.4 37.9 37.7 47.0 39.9 74.7 70.2 44.8 31.0 29.3 20.0 27.5 44.0 50.9 45.8 24.3 37.8 29.5 24.6 51.0 31.0 29.8 31.0 24.3 35.6 50.6 33.5 25.3 34.5 25.2 20.5 19.8 21.7 18.1 29.0 28.9 35.9 30.6 27.3 23.1 52.8 62.8 51.9 67.2 69.8 56.3 67.8 30.9 52.6 42.0 37.3 34.2 35.8 22.1 26.1 34.2 34.9 30.6 26.4 24.5 27.1 18.8 41.5 19.2 22.4 45.0 39.4 20.3 20.0 121.9 19.9 29.0 29.7 31.3 21.5 19.0 48.0 32.6 32.7 30.1 32.8 33.1 18.2 23.1 19.1 38.7 35.8 30.0 41.0 41.5 31.2 46.5 29.5 24.4 30.3 56.1 51.0 31.7 33.9 32.0 32.0 19.5 28.6 28.9 38.0 31.4 27.7 25.1 13.5 29.8 19.8 29.0 31.8 29.8 21.8 34.9 45.0 55.3 51.9 50.4 67.2 45.8 48.4 45.1 47.1 62.8 52.8 37.7 43.0 33.7 69.8 59.8 39.0 56.3 67.8 60.7 71.0 47.5 82.1 70.2 44.8 44.0 50.9 51.0 18.1 41.7 30.7 69.2 78.9 62.5 111.3 81.8 68.8 52.2 36.4 113.4 23.6 183.6 99.5 195.0 3.8 51.7 133.3 0.0 136.1 214.1 70.0 78.9 68.0 44.8 127.2 136.7 102.6 66.9 55.1 6.8 67.0 47.0 50.6 131.7 108.9 97.9 137.7 175.6 80.2 103.3 48.5 77.6 81.4 14.8 54.1 55.3 152.2 70.3 147.4 93.1 PPP2R2A "B55A, B55alpha, PR52A, PR55A, PR55alpha" ENSG00000221914 "Protein phosphatase 2 regulatory subunit Balpha" P63151 8 26291491-26372680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042122, HPA042770, CAB079289" Approved Approved Cytosol NA NA Cytosol "CAB079289: AB_659890, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (1.17e-1)" "unprognostic (2.68e-2)" "unprognostic (4.29e-3)" "unprognostic (5.34e-2)" "unprognostic (3.44e-2)" "unprognostic (2.11e-2)" "unprognostic (4.64e-3)" "unprognostic (3.65e-1)" "unprognostic (2.48e-1)" "unprognostic (3.87e-2)" "unprognostic (2.71e-2)" "unprognostic (8.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (2.90e-1)" "unprognostic (3.44e-2)" "unprognostic (1.16e-1)" 26.1 14.8 25.1 19.1 30.3 21.2 41.7 23.7 28.0 25.2 18.2 27.9 16.0 23.4 20.5 16.0 50.3 19.1 16.8 24.6 21.2 16.2 21.5 32.0 21.7 17.6 28.9 22.3 22.5 13.3 19.3 18.3 39.4 24.8 20.6 18.4 11.3 24.3 18.3 41.6 31.7 16.2 21.1 22.6 15.9 15.3 19.2 32.1 18.3 21.6 29.1 30.4 21.8 29.9 8.0 4.8 6.5 4.8 7.9 10.1 3.6 18.9 18.4 23.8 17.0 14.9 21.3 25.4 29.6 19.0 27.8 26.7 22.6 14.1 26.2 9.0 15.8 18.3 22.8 28.7 24.0 38.1 11.5 15.1 19.8 18.4 11.9 23.5 11.4 15.4 16.9 34.0 24.0 33.4 18.2 43.2 14.8 27.0 25.5 25.3 12.1 25.9 12.7 31.4 45.1 13.0 18.6 17.8 21.8 17.4 28.7 10.0 13.1 14.2 14.3 23.1 22.9 15.1 10.3 23.2 17.4 21.6 17.7 20.7 9.3 12.1 33.9 20.7 20.8 29.3 3.1 2.3 6.1 4.3 4.4 5.4 8.0 6.0 7.6 4.3 6.8 6.1 7.9 6.5 7.9 4.8 4.8 10.1 3.6 25.1 30.3 23.7 28.0 21.2 16.2 28.9 22.3 24.8 32.1 68.5 57.4 46.7 211.9 121.3 52.2 30.0 30.6 123.1 100.1 14.0 45.2 66.8 41.4 40.1 32.5 64.2 45.3 70.0 28.2 56.0 37.8 125.3 54.3 29.2 32.0 35.0 73.7 52.2 31.3 86.3 43.4 50.2 57.3 42.3 32.7 48.8 45.2 26.2 68.9 36.8 37.6 51.8 57.7 28.9 62.2 125.0 56.0 43.7 33.3 178.5 PPP2R2B "B55beta, PR52B, PR55-BETA, SCA12" ENSG00000156475 "Protein phosphatase 2 regulatory subunit Bbeta" Q00005 5 146581146-147084784 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 73.2" "Cell type enhanced" "Detected in many" 20 "Cone photoreceptor cells: 141.4;Early spermatids: 312.5;Late spermatids: 670.1;Rod photoreceptor cells: 261.9" "Cancer enriched" "Detected in some" 8 "glioma: 7.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0" "Group enriched" "Detected in many" 33 "NK-cells: 9.5;T-cells: 16.1" "Cell line enriched" "Detected in some" 4 "HDLM-2: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038118, HPA042122, HPA042770" Approved Uncertain Cytosol NA NA Cytosol "HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (4.54e-5)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.80e-4)" "unprognostic (2.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-2)" "unprognostic (2.68e-1)" "unprognostic (3.20e-2)" "unprognostic (9.73e-4)" "unprognostic (4.51e-2)" "unprognostic (1.49e-8)" "unprognostic (2.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.48e-5)" "unprognostic (1.14e-4)" 2.0 9.7 30.8 2.5 35.2 2.9 1.8 10.2 73.2 1.6 2.7 26.0 0.0 3.0 1.7 1.8 2.9 14.5 2.9 2.9 26.4 20.9 4.7 2.4 2.5 4.3 25.5 22.4 1.6 2.9 16.0 6.4 2.6 27.5 2.7 2.8 4.6 2.0 2.9 1.5 4.9 2.3 3.5 18.6 2.9 2.2 15.7 29.3 0.0 4.2 0.0 2.4 6.8 1.1 0.0 0.0 0.3 0.0 9.5 16.1 4.1 0.4 0.4 2.4 1.0 0.1 0.1 0.2 0.5 0.2 1.1 1.6 1.3 4.8 0.2 0.1 0.0 0.0 10.2 0.8 1.0 1.1 47.5 0.2 0.6 2.8 0.5 0.2 0.0 0.2 0.1 0.7 0.0 0.2 0.7 0.1 0.4 0.6 0.5 0.7 0.3 0.0 0.0 6.3 0.0 1.1 0.7 0.1 0.1 4.2 10.9 1.9 0.2 0.3 0.0 0.2 1.7 0.4 0.1 0.3 0.2 0.7 2.5 0.4 0.4 0.2 0.0 1.7 4.3 1.4 0.2 0.0 0.0 15.1 0.0 13.8 0.0 7.1 16.1 0.0 0.0 1.3 12.0 0.3 9.5 0.0 0.0 8.0 4.1 30.8 35.2 10.2 34.1 26.4 20.9 25.5 22.4 27.5 29.3 3.0 2.6 0.0 1.1 1.8 83.2 1.2 12.7 0.0 1.2 8.7 141.4 14.1 18.3 1.3 312.5 2.1 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.0 0.8 44.5 12.5 0.0 1.2 670.1 3.1 1.7 5.0 0.0 0.0 31.8 0.8 0.0 2.1 4.0 261.9 0.0 8.6 3.7 1.6 1.3 4.5 16.7 0.0 0.7 PPP2R2C "B55gamma, IMYPNO, MGC33570, PR52, PR55G" ENSG00000074211 "Protein phosphatase 2 regulatory subunit Bgamma" Q9Y2T4 4 6320578-6563600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.4" "Group enriched" "Detected in some" 5 "Early spermatids: 52.2;Late spermatids: 144.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 14.2;A549: 21.0;CAPAN-2: 14.0;GAMG: 34.1;MCF7: 17.3;PC-3: 19.9;SCLC-21H: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042122, HPA042770, HPA060473" Approved Approved Cytosol NA NA Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291" "unprognostic (9.39e-2)" "unprognostic (7.10e-2)" "unprognostic (9.12e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (5.91e-2)" "unprognostic (2.70e-4)" "prognostic unfavorable (4.94e-4)" "unprognostic (1.77e-1)" "unprognostic (3.90e-1)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (1.36e-13)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.66e-3)" "unprognostic (9.90e-3)" 1.5 6.6 28.2 1.6 33.9 1.1 2.4 17.0 78.4 11.8 1.5 13.8 0.5 1.7 25.3 7.0 25.2 10.5 1.4 1.9 25.8 19.5 1.2 1.1 1.1 1.3 25.6 19.3 1.3 1.7 1.1 5.9 1.1 19.1 5.5 1.4 0.4 1.4 14.4 1.7 28.8 2.0 11.8 32.0 1.3 1.9 4.7 13.5 0.0 1.1 3.9 3.6 1.5 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.2 21.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 9.2 0.0 34.1 6.6 10.3 0.3 0.0 0.0 1.2 0.0 1.4 1.6 0.3 0.0 0.0 3.0 5.5 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.8 17.3 0.0 0.0 1.0 0.3 19.9 0.0 0.0 0.6 0.0 0.0 19.3 3.6 0.6 0.0 0.0 0.6 8.9 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 33.9 17.0 40.2 25.8 19.5 25.6 19.3 19.1 13.5 0.0 0.0 0.0 0.5 13.1 10.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.2 0.1 0.0 0.0 0.2 0.0 0.2 1.2 0.0 0.0 0.1 3.2 0.0 0.0 0.0 144.3 6.4 0.0 0.0 0.0 0.0 4.1 1.3 0.0 4.2 0.0 2.4 0.0 1.4 1.0 0.9 19.3 0.0 0.0 0.0 0.1 PPP2R2D "B55D, B55delta, MDS026" ENSG00000175470 "Protein phosphatase 2 regulatory subunit Bdelta" Q66LE6 10 131900644-131959834 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042122, HPA042770" Approved Approved Cytosol NA NA Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (7.75e-3)" "unprognostic (7.11e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.40e-1)" "unprognostic (3.57e-1)" "unprognostic (9.64e-3)" "unprognostic (1.83e-1)" "unprognostic (3.13e-2)" "unprognostic (1.76e-2)" "unprognostic (8.74e-2)" "unprognostic (8.46e-2)" "unprognostic (8.04e-2)" "unprognostic (4.41e-3)" "unprognostic (1.10e-1)" "unprognostic (6.57e-2)" "unprognostic (6.66e-2)" "unprognostic (1.90e-2)" 4.5 8.1 5.4 4.0 6.6 1.6 11.4 13.5 12.5 3.7 5.2 5.4 2.4 5.3 3.9 5.2 4.2 4.6 4.7 7.9 5.5 4.7 4.9 4.3 5.5 6.0 4.9 5.2 8.5 34.3 9.9 6.3 5.3 4.7 4.8 5.4 4.9 7.8 5.7 11.4 6.8 5.8 6.0 4.4 5.1 4.4 4.4 5.1 6.3 6.1 3.0 4.4 5.6 6.4 0.4 0.0 0.3 0.6 0.1 0.3 0.0 5.2 4.6 2.5 1.5 3.5 2.6 4.1 1.8 3.7 3.5 3.7 3.2 3.6 2.1 1.3 1.9 2.0 9.2 3.7 0.6 3.5 5.4 5.2 3.6 3.9 1.5 0.8 3.2 3.4 0.9 8.4 3.9 5.6 5.7 2.1 2.9 4.7 0.7 3.7 2.1 1.6 8.9 1.8 1.6 4.5 2.1 1.9 0.4 2.8 0.4 2.2 2.9 2.4 1.9 2.0 2.8 1.2 2.9 3.1 1.9 0.7 2.7 9.5 3.2 1.8 2.5 1.7 2.2 0.6 0.0 0.2 0.0 0.2 0.4 0.1 0.4 0.1 0.3 0.0 0.0 0.1 0.3 0.3 0.1 0.6 0.0 0.1 0.0 5.4 6.6 13.5 9.2 5.5 4.7 4.9 5.2 4.7 5.1 17.9 11.0 20.7 31.2 33.2 46.6 33.4 15.3 4.0 11.4 8.7 9.8 9.2 16.6 7.9 7.9 16.9 20.4 0.0 15.3 11.1 13.4 31.3 5.8 18.7 12.5 49.3 10.3 14.1 7.9 5.8 16.1 16.7 11.8 3.6 15.1 24.9 15.7 18.2 19.4 18.8 30.8 25.8 14.4 12.3 14.9 29.6 9.8 10.0 15.6 30.1 PPP2R5A "B56A, B56alpha, PR61A" ENSG00000066027 "Protein phosphatase 2 regulatory subunit B'alpha" Q15172 1 212285537-212361863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 187.3;Late spermatids: 383.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059288, HPA078841" Approved Supported Cytosol NA NA Cytosol "HPA059288: AB_2683966, HPA078841: " "unprognostic (3.56e-1)" "unprognostic (2.71e-1)" "unprognostic (8.48e-2)" "unprognostic (2.54e-1)" "unprognostic (9.21e-2)" "unprognostic (1.01e-1)" "unprognostic (5.01e-2)" "unprognostic (1.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.84e-2)" "unprognostic (3.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.40e-3)" "unprognostic (8.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" 40.9 8.4 21.9 23.2 24.1 46.6 26.5 13.7 17.6 19.5 23.9 19.6 18.9 15.9 21.2 13.4 36.7 12.9 25.7 31.9 17.5 16.6 22.4 34.0 37.9 17.1 25.6 14.2 11.8 27.5 17.0 14.4 21.5 16.4 30.6 23.2 16.5 22.2 20.0 24.3 20.0 27.6 28.5 21.1 28.6 26.4 10.0 24.4 35.2 27.6 29.2 18.3 28.8 38.8 2.1 1.6 14.5 3.0 3.1 4.9 1.4 17.6 7.3 3.7 7.6 41.5 25.4 30.7 7.8 14.9 8.7 8.3 21.9 17.8 12.4 5.9 12.1 9.1 12.6 7.1 10.8 9.1 10.7 9.4 8.0 8.1 8.0 13.4 16.3 12.4 10.6 14.8 7.9 11.6 11.0 20.9 10.9 11.4 13.1 4.8 7.6 6.4 11.2 6.4 15.5 16.0 8.4 6.0 15.4 15.6 8.0 5.5 3.7 10.6 33.3 25.2 16.6 20.7 14.8 4.4 6.1 6.3 9.6 8.3 20.8 15.9 16.1 7.4 12.7 4.5 14.5 2.0 9.4 4.6 2.2 3.1 1.4 3.6 4.1 1.3 2.1 2.1 4.2 9.9 3.1 3.0 1.6 4.9 1.4 21.9 24.1 13.7 16.1 17.5 16.6 25.6 14.2 16.4 24.4 92.3 86.7 14.7 20.8 60.9 18.6 59.8 30.6 18.7 19.4 14.0 2.0 9.1 82.9 20.6 187.3 37.9 31.9 0.0 30.1 21.8 19.8 31.9 39.3 45.7 19.2 49.3 15.5 47.3 26.0 383.1 17.8 23.5 16.9 18.0 33.3 34.4 24.1 31.6 13.4 14.6 10.7 32.3 35.6 13.5 9.5 71.0 6.9 39.8 26.7 33.1 PPP2R5E "B56E, B56epsilon" ENSG00000154001 "Protein phosphatase 2 regulatory subunit B'epsilon" Q16537 14 63371357-63543374 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 254.8;Horizontal cells: 247.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006034, CAB072342" Approved Supported Cytosol NA NA Cytosol "CAB072342: , HPA006034: AB_1079670" "unprognostic (1.58e-1)" "unprognostic (1.65e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (2.26e-1)" "unprognostic (2.91e-1)" "unprognostic (1.57e-2)" "unprognostic (1.70e-2)" "unprognostic (4.62e-2)" "prognostic favorable (4.16e-4)" "unprognostic (1.23e-1)" "unprognostic (9.51e-2)" "unprognostic (1.92e-1)" "unprognostic (8.22e-2)" 20.9 19.3 18.1 27.2 18.8 16.9 26.5 27.6 32.7 21.3 22.3 11.7 14.2 14.1 20.5 19.2 29.2 16.3 18.9 20.2 19.2 20.5 20.1 22.9 27.7 19.1 16.4 20.1 21.5 14.7 29.0 18.8 21.0 18.5 18.5 27.3 15.7 17.3 28.3 31.2 19.2 17.6 23.2 17.7 20.2 16.6 25.1 13.5 35.5 27.4 21.3 21.7 28.5 20.8 3.3 3.6 2.7 3.4 9.2 5.1 1.1 39.5 11.6 21.4 10.0 14.8 17.5 20.4 16.6 13.8 18.2 18.2 14.7 16.0 17.5 10.2 17.0 13.5 16.3 21.7 15.4 31.5 15.8 5.3 11.3 8.8 12.2 15.8 18.1 14.0 12.7 17.3 17.8 19.8 13.3 18.2 17.9 14.4 19.1 19.9 26.4 18.0 8.2 16.1 16.6 21.2 18.4 21.9 13.2 17.5 30.4 12.2 23.8 21.4 17.8 11.1 19.3 26.1 9.2 16.9 28.6 32.0 14.5 14.6 7.0 10.4 22.8 13.2 11.7 19.3 2.7 2.5 2.4 4.2 2.7 3.9 2.3 4.6 5.1 2.3 3.3 3.6 3.9 2.0 9.2 3.4 3.6 2.6 1.1 18.1 18.8 27.6 32.7 19.2 20.5 16.4 20.1 18.5 13.5 83.4 46.8 36.6 41.8 71.4 62.8 54.9 28.1 36.1 33.0 21.0 60.9 22.8 24.9 40.7 254.8 48.8 30.7 0.0 40.9 34.6 38.6 52.0 23.1 40.2 25.7 247.9 26.0 43.6 33.9 30.7 40.6 30.0 35.4 31.5 45.9 35.2 34.8 17.5 40.7 28.7 78.0 25.8 53.3 47.0 18.3 80.0 25.6 44.9 62.1 42.8 PPP4R4 "CFAP14, KIAA1622, PP4R4" ENSG00000119698 "Protein phosphatase 4 regulatory subunit 4" Q6NUP7 14 94146128-94279735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3;testis: 14.0" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 20.1;Cone photoreceptor cells: 70.7;Spermatocytes: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "RH-30: 16.6;T-47d: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041866, HPA050321" Approved Supported Cytosol NA NA Cytosol "HPA041866: AB_10804120, HPA050321: AB_2681086" "unprognostic (2.65e-3)" "unprognostic (3.06e-1)" "unprognostic (9.07e-2)" "unprognostic (9.49e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (2.45e-1)" "unprognostic (1.25e-1)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (1.72e-2)" "unprognostic (8.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.35e-2)" "unprognostic (1.77e-1)" "unprognostic (6.24e-2)" 1.0 1.7 15.2 1.3 15.5 1.1 3.5 4.9 21.3 6.9 1.0 1.9 0.1 1.0 2.1 4.0 1.4 4.0 1.5 1.1 11.1 6.9 1.3 3.0 3.1 1.2 4.7 9.8 11.5 1.6 1.1 7.1 1.7 8.0 1.4 1.1 2.3 1.2 1.8 1.0 2.0 1.0 1.3 5.2 1.0 2.1 14.0 4.1 0.0 1.3 0.0 1.8 1.2 1.3 0.3 0.0 1.1 0.0 0.0 0.3 0.0 0.7 0.0 1.8 0.9 0.4 0.0 0.5 0.2 1.6 1.0 0.4 0.1 0.5 0.9 0.0 0.0 3.6 0.0 4.1 4.2 0.4 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.3 0.0 0.4 0.0 3.9 0.0 0.0 1.2 0.0 0.1 0.4 0.5 0.0 0.1 1.1 0.0 0.9 0.1 16.6 0.0 0.2 0.9 0.2 0.1 0.0 0.0 0.1 0.8 17.6 0.0 0.0 3.2 1.7 0.1 0.1 0.8 0.1 0.3 1.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 15.2 15.5 4.9 13.2 11.1 6.9 4.7 9.8 8.0 4.1 3.0 7.4 0.0 4.2 4.2 0.6 0.4 0.0 20.1 3.4 0.0 70.7 0.0 0.0 2.1 12.4 0.1 0.0 0.0 0.3 0.1 0.0 3.0 0.0 1.0 0.1 1.6 0.0 8.6 2.6 13.6 5.5 0.0 0.0 0.0 0.0 5.7 0.3 0.0 5.3 0.0 0.6 0.0 0.1 26.5 4.9 2.3 0.0 0.0 0.0 7.3 PPP5D1 ENSG00000230510 "PPP5 tetratricopeptide repeat domain containing 1" E7EU14 19 46480796-46601200 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 19.6;Early spermatids: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 6.7" HPA073186 Uncertain Uncertain Cytosol NA NA Cytosol "HPA073186: AB_2732220" "unprognostic (2.84e-2)" "unprognostic (3.26e-1)" "unprognostic (3.50e-2)" "unprognostic (2.26e-1)" "unprognostic (7.10e-2)" "unprognostic (1.89e-1)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (2.22e-2)" "unprognostic (1.62e-2)" "unprognostic (1.00e-4)" "unprognostic (3.90e-1)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (3.62e-1)" "unprognostic (1.41e-1)" "unprognostic (1.96e-1)" 1.9 4.5 8.9 0.9 6.8 1.5 2.2 3.6 7.5 3.5 1.5 5.8 6.6 0.9 3.9 7.4 1.1 6.8 2.6 2.8 6.5 8.7 1.6 1.2 2.2 1.4 6.9 5.9 5.8 2.3 2.8 6.9 2.3 4.1 4.4 0.9 3.7 7.2 4.3 2.4 2.2 0.9 1.9 5.4 1.9 1.8 5.3 4.7 1.0 5.8 0.6 1.4 1.9 2.4 2.0 2.2 6.2 1.4 2.6 1.8 0.5 1.7 1.0 1.4 1.0 0.9 3.0 0.3 1.0 0.9 2.6 0.6 0.1 1.2 1.8 1.7 3.4 2.6 1.0 2.3 0.4 1.4 2.1 5.8 3.0 1.5 1.7 1.4 1.0 2.4 2.3 3.6 0.4 1.2 2.1 0.8 3.1 1.2 1.4 2.3 6.7 1.0 3.0 0.7 0.3 1.4 3.3 0.6 0.5 1.3 1.0 4.4 1.6 1.0 0.6 0.7 0.3 0.8 1.6 1.9 0.2 0.6 0.4 0.8 0.9 0.8 1.5 0.9 3.1 0.7 6.2 1.4 0.7 0.9 1.0 0.5 1.7 0.4 0.7 2.2 2.0 0.8 1.8 2.0 2.6 0.4 0.9 0.4 0.5 8.9 6.8 3.6 7.5 6.5 8.7 6.9 5.9 4.1 4.7 3.0 1.3 2.7 2.4 1.4 8.1 1.6 10.2 1.4 0.0 1.8 19.6 1.7 1.7 1.2 14.6 3.0 1.6 0.0 1.6 1.4 2.8 2.4 0.0 0.8 2.5 9.5 0.0 5.5 2.9 2.7 3.7 2.1 3.3 4.6 0.6 8.6 0.7 0.0 2.8 0.4 9.1 0.0 1.7 4.9 3.6 1.1 1.4 2.9 1.7 1.7 PPP6R1 "KIAA1115, SAP190, SAPS1" ENSG00000105063 "Protein phosphatase 6 regulatory subunit 1" Q9UPN7 19 55229780-55258995 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 195.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043989, HPA063681" Approved Enhanced Cytosol No No Cytosol "HPA043989: AB_10987309, HPA063681: AB_2685087" "unprognostic (1.15e-1)" "unprognostic (2.34e-1)" "unprognostic (1.20e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.82e-6)" "unprognostic (2.22e-2)" "unprognostic (5.44e-2)" "unprognostic (5.41e-2)" "unprognostic (3.35e-3)" "unprognostic (1.63e-3)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (3.65e-2)" "unprognostic (3.30e-2)" "unprognostic (2.20e-1)" 13.2 18.4 27.8 30.8 26.2 49.7 9.8 12.5 28.0 11.2 20.7 14.0 9.0 22.9 13.5 11.3 17.5 16.8 17.7 12.8 27.3 12.4 12.5 25.1 14.6 45.2 13.0 14.0 11.9 12.5 13.9 15.3 15.8 9.8 11.7 7.8 11.5 13.7 14.4 18.4 13.3 22.9 11.3 9.2 31.6 25.1 39.9 13.4 57.3 14.0 13.4 31.0 17.7 12.6 2.6 21.2 4.4 3.0 6.1 9.2 4.2 20.3 29.6 6.0 9.6 7.2 6.7 15.5 13.1 11.5 13.8 11.8 19.5 14.1 53.2 7.2 11.6 10.2 10.0 2.1 13.6 5.4 19.8 50.5 40.3 14.2 14.3 12.5 59.5 39.9 9.8 7.9 13.6 9.3 7.4 8.8 37.3 21.0 23.6 8.8 13.0 43.5 21.4 8.2 16.7 24.4 26.7 11.9 44.0 9.7 26.1 17.4 9.6 12.1 14.7 12.8 5.4 8.0 44.9 11.4 21.7 10.7 8.3 19.6 11.8 21.3 37.7 19.7 49.2 16.5 0.0 2.0 4.4 9.2 3.0 5.3 2.6 3.8 7.2 3.0 2.3 4.0 5.9 2.3 6.1 2.4 21.2 2.7 4.2 27.8 26.2 12.5 28.0 27.3 12.4 13.0 14.0 9.8 13.4 11.9 23.2 31.3 6.8 2.5 16.6 2.2 17.8 20.1 10.3 17.4 9.8 9.6 0.0 20.1 195.4 11.7 24.0 0.0 24.5 7.5 9.9 16.6 7.0 18.1 27.5 28.6 14.6 16.0 29.7 28.2 17.3 25.3 0.0 13.6 17.4 13.7 32.0 21.2 18.4 9.8 14.2 19.4 2.1 31.4 32.1 3.0 9.5 27.3 13.0 36.9 PQLC3 "C2orf22, MGC33602" ENSG00000162976 "PQ loop repeat containing 3" Q8N755 2 11155198-11178874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 30.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061607 Approved Cytosol NA NA Cytosol "HPA061607: AB_2797264" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (2.19e-1)" "unprognostic (5.55e-2)" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.09e-3)" "unprognostic (9.11e-2)" "unprognostic (3.14e-1)" "unprognostic (2.24e-1)" "unprognostic (4.93e-3)" "unprognostic (2.93e-1)" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.21e-1)" "unprognostic (2.34e-1)" "unprognostic (4.00e-2)" 26.9 21.3 5.1 16.5 6.2 4.2 16.7 2.4 6.2 22.2 14.4 11.3 8.6 5.6 19.7 27.0 18.1 15.4 19.5 14.9 5.4 5.1 20.6 9.8 21.0 26.9 7.9 5.8 20.7 33.3 5.3 5.4 15.5 7.8 18.5 10.5 15.5 14.1 11.2 14.0 9.8 16.5 19.8 13.1 26.3 12.7 12.0 5.7 12.0 17.6 13.0 15.0 15.7 14.7 11.4 36.9 37.0 46.9 14.4 18.4 33.0 3.1 10.8 2.0 6.1 30.8 21.1 7.3 6.6 8.7 3.1 3.7 2.0 12.5 1.1 5.0 12.9 13.6 4.1 3.1 3.4 3.2 20.0 1.6 3.0 1.4 1.3 12.3 1.5 9.3 15.3 11.6 2.0 4.5 6.9 7.0 7.1 2.8 7.0 8.5 14.3 2.2 3.0 4.3 11.2 3.8 2.8 3.3 3.4 11.6 5.4 0.7 3.4 5.6 17.6 12.4 9.3 15.7 5.5 9.9 4.5 1.9 4.8 1.8 12.0 8.7 0.5 11.9 7.1 8.8 15.1 37.3 37.0 18.4 45.7 16.1 11.4 18.2 18.0 36.9 7.7 10.1 13.9 2.3 14.4 46.9 7.1 18.2 33.0 5.1 6.2 2.4 6.2 5.4 5.1 7.9 5.8 7.8 5.7 23.8 6.2 18.0 19.8 22.2 1.7 2.4 20.4 12.0 14.8 50.6 15.7 16.2 8.3 32.7 0.5 17.5 10.7 0.0 56.6 70.6 37.3 19.5 12.7 10.9 53.1 1.6 6.4 38.6 87.8 0.7 43.4 62.1 55.6 84.8 10.7 4.5 41.4 3.5 55.5 11.7 0.9 58.2 38.7 2.1 18.5 20.5 9.4 45.9 11.5 16.9 PREP ENSG00000085377 "Prolyl endopeptidase" P48147 6 105277565-105403084 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025414, HPA031388, HPA031389, HPA031390" Supported Supported Cytosol NA NA 1400000 Cytosol "CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857" "unprognostic (3.05e-2)" "unprognostic (9.09e-3)" "unprognostic (2.85e-2)" "unprognostic (5.46e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.33e-4)" "unprognostic (2.63e-3)" "unprognostic (2.39e-1)" "unprognostic (6.78e-2)" "unprognostic (5.81e-2)" "unprognostic (2.66e-2)" "unprognostic (1.15e-1)" "unprognostic (4.47e-3)" "unprognostic (2.74e-2)" "unprognostic (8.98e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" 13.0 14.2 10.1 22.2 10.1 10.4 36.2 10.9 24.9 11.9 27.2 5.2 11.2 20.2 13.2 10.9 16.4 10.5 15.0 19.0 8.8 7.1 8.9 14.6 23.9 31.4 8.3 15.4 13.6 18.8 16.1 11.1 15.4 9.7 9.4 33.0 8.9 14.9 11.5 58.0 24.2 19.0 15.3 8.5 11.9 14.0 20.1 8.8 17.4 10.2 18.5 13.3 18.2 21.0 8.3 15.3 7.1 18.7 16.6 16.3 11.2 11.0 13.5 14.5 16.2 34.3 20.3 14.3 14.9 14.0 19.7 20.9 17.2 7.0 14.2 14.7 17.5 18.2 17.2 21.3 43.6 22.4 21.4 20.8 19.0 11.4 19.6 13.2 19.2 13.9 18.8 26.6 14.1 36.5 14.9 18.3 25.1 32.4 25.4 23.8 18.0 12.8 19.5 14.0 21.4 13.6 19.8 24.9 9.2 14.7 26.4 19.0 27.1 13.1 21.9 10.4 19.2 9.4 30.8 18.4 9.0 12.6 11.3 18.3 7.4 4.9 18.6 16.0 20.9 28.1 4.8 13.6 7.1 16.0 15.4 15.6 8.3 13.7 16.3 15.3 6.8 12.9 15.2 0.7 16.6 18.7 6.5 12.0 11.2 10.1 10.1 10.9 24.9 8.8 7.1 8.3 15.4 9.7 8.8 3.0 7.0 6.1 5.7 9.6 5.3 13.2 5.1 1.4 7.9 7.0 13.7 16.0 5.0 9.1 0.9 9.0 15.7 0.0 10.2 27.4 9.0 4.3 13.8 13.9 13.4 12.7 18.6 9.2 15.8 2.4 10.0 10.0 5.0 18.0 33.1 3.3 12.9 17.3 8.5 6.7 9.5 0.0 12.3 2.1 17.9 7.4 56.8 11.3 34.9 7.6 PRF1 "HPLH2, P1, PFP" ENSG00000180644 "Perforin 1" P14222 10 70597348-70602775 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Cytolysis "Cancer-related genes, Disease mutation, Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 100.3;lymphoid tissue: 38.7" "Cell type enriched" "Detected in some" 9 "T-cells: 203.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "gdT-cell: 100.3;MAIT T-cell: 70.9;memory CD8 T-cell: 54.9;naive CD8 T-cell: 36.1;NK-cell: 65.1" "Group enriched" "Detected in many" 48 "NK-cells: 65.1;T-cells: 100.3" "Cell line enriched" "Detected in some" 11 "HDLM-2: 72.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002436, HPA037940" Approved Approved Cytosol "Intracellular and membrane" NA NA 960000 Cytosol "CAB002436: AB_563955, HPA037940: AB_2675747" "unprognostic (6.11e-3)" "unprognostic (1.26e-2)" "unprognostic (1.71e-1)" "prognostic favorable (2.09e-4)" "unprognostic (1.87e-2)" "prognostic favorable (3.54e-4)" "unprognostic (6.98e-3)" "unprognostic (2.62e-1)" "unprognostic (1.44e-3)" "unprognostic (1.69e-2)" "unprognostic (5.22e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (7.38e-2)" "unprognostic (2.70e-1)" "unprognostic (7.97e-3)" "unprognostic (5.22e-3)" 8.8 1.3 0.9 5.5 1.1 15.3 2.4 0.5 0.7 1.7 3.8 0.4 0.2 1.4 4.4 2.9 2.7 1.7 5.3 4.1 0.8 0.9 1.8 6.5 19.6 11.3 2.5 0.3 2.1 1.6 0.0 1.1 3.1 1.2 3.3 0.8 3.9 2.5 3.3 2.6 0.9 5.1 1.2 1.4 38.7 3.1 1.6 0.2 12.7 2.8 1.0 10.3 3.2 1.7 0.4 0.3 1.7 0.2 65.1 100.3 46.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 0.4 0.0 2.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.2 0.0 100.3 0.1 70.9 0.4 14.6 54.9 0.2 0.2 6.2 36.1 1.7 65.1 0.2 0.3 11.1 46.7 0.9 1.1 0.5 0.7 0.8 0.9 2.5 0.3 1.2 0.2 3.0 22.3 6.5 0.0 0.3 0.0 0.8 0.0 2.7 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.1 8.1 2.1 0.1 0.0 0.0 8.6 5.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.6 0.6 203.1 0.0 0.0 PRKAR1A "CNC1, PRKAR1, TSE1" ENSG00000108946 "Protein kinase cAMP-dependent type I regulatory subunit alpha" P10644 17 68511780-68551319 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 608.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019378, HPA049979" Approved Approved Cytosol NA NA 11000000 Cytosol "CAB019378: , HPA049979: AB_2680980" "unprognostic (8.69e-2)" "unprognostic (6.97e-2)" "unprognostic (5.34e-2)" "unprognostic (2.04e-1)" "unprognostic (1.68e-1)" "unprognostic (4.39e-2)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (2.27e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-2)" "unprognostic (5.55e-2)" "unprognostic (8.56e-3)" "unprognostic (6.26e-2)" "unprognostic (6.92e-2)" "unprognostic (3.29e-2)" "unprognostic (1.11e-1)" 47.1 48.0 41.7 34.5 54.8 14.6 38.7 40.4 57.4 48.2 23.8 44.9 31.4 15.1 43.6 37.7 29.6 43.2 37.4 122.7 42.5 52.3 49.2 43.4 47.3 29.5 50.1 43.6 62.5 19.1 107.8 41.9 47.3 57.7 35.6 24.2 32.2 47.5 43.6 99.8 22.8 19.3 39.4 52.8 35.3 25.1 36.9 40.1 28.2 51.8 23.6 29.2 33.8 33.4 11.3 26.9 52.6 28.7 18.5 13.0 22.9 16.6 32.1 41.2 24.6 55.0 62.5 6.2 22.5 46.5 35.2 31.2 12.5 22.5 16.9 15.5 49.1 36.1 13.8 30.4 36.5 50.6 11.4 10.9 26.2 27.9 40.8 39.9 20.0 29.4 44.6 38.0 40.6 34.3 39.6 58.4 14.5 11.8 26.7 42.6 31.6 22.0 10.7 15.2 17.2 21.9 15.4 68.2 18.7 53.4 36.3 15.0 20.3 20.6 37.7 86.7 40.0 29.5 28.3 41.4 49.7 23.7 22.4 20.9 22.3 15.8 25.2 30.1 19.1 30.9 31.1 26.1 46.3 13.0 25.5 13.0 11.3 9.8 11.6 26.9 8.5 8.9 9.8 52.6 18.5 28.7 8.8 12.3 22.9 41.7 54.8 40.4 57.4 42.5 52.3 50.1 43.6 57.7 40.1 137.0 210.8 75.1 77.8 126.8 93.4 608.0 89.2 258.3 168.4 239.0 62.8 66.4 150.9 74.2 287.1 138.4 34.9 23.3 45.5 74.3 135.4 82.7 180.2 101.7 123.8 131.9 131.3 160.2 157.1 53.4 123.7 102.2 182.2 93.8 51.5 115.8 62.1 52.9 179.3 150.9 56.6 84.1 208.1 100.7 40.5 115.2 69.0 106.6 36.6 95.0 PRPSAP1 PAP39 ENSG00000161542 "Phosphoribosyl pyrophosphate synthetase associated protein 1" Q14558 17 76309486-76384521 "Predicted intracellular proteins" "Nucleotide biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062396 Approved Cytosol NA NA Cytosol "HPA062396: AB_2684750" "unprognostic (1.12e-1)" "unprognostic (3.37e-2)" "prognostic favorable (1.39e-5)" "unprognostic (3.31e-2)" "unprognostic (3.11e-2)" "unprognostic (8.45e-3)" "unprognostic (1.09e-1)" "unprognostic (7.19e-2)" "unprognostic (2.66e-2)" "unprognostic (2.37e-2)" "unprognostic (6.51e-2)" "unprognostic (4.10e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (8.20e-2)" "unprognostic (5.37e-2)" 18.4 20.5 19.7 14.9 21.3 15.4 27.9 25.7 24.7 16.4 17.3 22.4 16.8 12.9 17.9 22.8 26.1 16.9 14.7 15.4 19.4 22.8 21.0 52.7 23.6 12.8 32.4 20.6 16.3 18.5 27.2 17.1 16.1 27.4 16.5 20.2 22.1 49.2 22.0 11.6 16.9 14.6 18.3 21.1 11.8 16.2 28.1 23.6 12.8 38.3 16.1 19.3 15.0 25.1 16.5 13.1 19.3 15.2 16.7 22.2 11.6 13.8 17.1 20.6 10.1 14.0 12.6 8.1 12.5 17.5 21.1 17.5 12.3 12.0 16.0 6.9 18.7 16.9 8.2 18.5 14.9 21.2 6.2 16.6 11.8 14.0 54.0 17.4 10.0 9.4 13.6 12.2 15.2 13.3 20.6 41.2 16.4 14.2 15.1 13.9 14.8 18.0 9.3 5.2 23.9 15.4 14.8 26.8 11.8 16.1 16.1 11.8 19.3 13.8 14.1 27.9 24.2 22.9 11.8 15.6 24.4 17.9 14.4 15.4 10.2 6.4 11.3 10.8 9.3 10.3 14.4 15.2 19.3 16.2 13.2 17.1 16.5 16.3 15.5 13.1 11.9 14.1 13.6 5.0 16.7 12.3 13.0 22.2 11.6 19.7 21.3 25.7 24.7 19.4 22.8 32.4 20.6 27.4 23.6 0.0 13.9 15.6 34.7 11.6 29.6 15.2 15.3 30.8 13.6 14.0 33.4 41.1 41.4 49.2 21.3 39.3 19.1 0.0 25.7 56.4 18.3 21.4 19.7 33.0 26.4 57.2 15.1 17.8 11.8 20.9 27.0 18.1 30.4 92.0 25.7 119.8 32.0 17.5 43.5 20.7 38.4 58.2 24.7 96.5 84.4 12.8 25.6 24.0 30.4 16.5 PRR12 KIAA1205 ENSG00000126464 "Proline rich 12" Q9ULL5 19 49591643-49626439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011959 Approved Approved Cytosol NA NA Cytosol "HPA011959: AB_10610286" "unprognostic (8.30e-2)" "unprognostic (8.64e-2)" "unprognostic (5.20e-3)" "unprognostic (5.04e-2)" "unprognostic (2.59e-1)" "unprognostic (1.05e-2)" "unprognostic (4.40e-3)" "unprognostic (5.00e-2)" "unprognostic (1.59e-1)" "unprognostic (1.25e-2)" "unprognostic (3.52e-3)" "unprognostic (8.59e-2)" "unprognostic (6.18e-2)" "unprognostic (2.00e-2)" "unprognostic (2.76e-1)" "unprognostic (9.32e-2)" "unprognostic (9.65e-3)" 15.3 14.3 17.3 14.6 16.3 11.1 11.3 33.6 21.9 14.0 11.9 12.7 14.7 13.7 17.0 10.1 11.6 14.4 13.7 8.9 16.5 10.7 10.5 6.2 11.7 15.4 11.6 17.3 17.3 12.0 12.0 22.4 10.5 10.3 14.0 5.7 13.2 19.9 25.5 27.7 27.0 13.1 8.6 7.5 21.1 16.7 8.9 14.6 20.0 15.8 7.9 12.3 14.7 15.3 0.5 1.8 0.4 0.5 0.4 0.9 0.4 10.8 16.9 9.3 10.2 4.3 3.8 7.4 6.9 3.4 3.9 3.1 6.4 6.5 11.1 5.9 4.9 3.6 10.1 4.3 6.0 1.2 9.3 12.6 11.3 8.6 6.3 3.0 10.6 17.1 4.8 6.1 4.3 2.9 4.7 4.3 6.9 7.8 6.6 3.4 8.2 12.0 12.9 13.2 5.6 15.8 15.7 7.2 4.1 3.5 13.6 7.4 13.8 10.0 9.4 4.7 3.9 6.6 7.8 10.0 13.5 12.9 5.1 11.2 8.5 9.9 7.6 8.4 6.1 8.2 0.0 0.4 0.0 0.4 0.2 0.8 0.3 0.3 0.9 0.1 0.5 0.3 0.5 0.4 0.4 0.5 1.8 0.3 0.4 17.3 16.3 33.6 21.9 16.5 10.7 11.6 17.3 10.3 14.6 6.0 1.6 4.2 1.3 3.5 7.2 2.6 7.6 2.7 1.2 12.2 3.9 4.5 1.7 3.6 0.6 3.2 5.6 0.0 6.4 2.8 4.0 1.5 10.3 2.4 5.6 4.8 9.8 4.9 7.8 1.1 13.0 2.2 3.3 2.8 7.2 3.5 9.6 7.0 13.8 2.1 3.2 12.9 2.8 2.6 6.1 6.8 0.9 4.4 6.4 1.0 PRR15L "ATAD4, MGC11242" ENSG00000167183 "Proline rich 15 like" Q9BU68 17 47951967-47957878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 113.1;pancreas: 75.4;thyroid gland: 61.0" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 144.2;Enterocytes: 169.7;Mucus-secreting cells: 103.4;Paneth cells: 199.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.2" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "OE19: 67.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 19.0" HPA022918 Approved Approved Cytosol No NA Cytosol "HPA022918: AB_2060743" "unprognostic (9.91e-2)" "unprognostic (4.77e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-3)" "unprognostic (1.83e-1)" "unprognostic (2.31e-2)" "unprognostic (2.48e-1)" "unprognostic (5.22e-2)" "unprognostic (2.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.32e-2)" "prognostic favorable (6.29e-13)" "prognostic favorable (1.69e-5)" "unprognostic (1.36e-1)" "unprognostic (8.26e-2)" "unprognostic (3.34e-2)" 0.9 0.2 0.2 13.5 0.2 0.0 10.0 0.2 0.3 3.2 88.7 0.6 22.9 44.9 0.6 8.3 4.9 6.6 21.2 0.3 0.4 0.2 37.3 1.6 20.3 0.2 0.2 0.2 1.9 75.4 0.0 8.5 0.2 2.2 8.1 32.0 0.4 38.7 26.7 0.2 3.7 113.1 0.5 0.2 0.2 27.2 1.3 0.2 0.3 61.0 2.5 5.8 2.1 2.4 1.3 0.5 0.0 0.2 1.2 2.2 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 1.9 0.0 0.1 0.0 0.0 6.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.1 0.1 0.0 67.3 0.2 0.1 0.0 0.4 0.3 0.8 4.0 0.1 0.0 12.0 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.2 2.2 0.1 0.0 0.5 0.5 1.3 0.8 0.6 0.0 1.2 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.4 0.2 0.2 0.2 2.2 0.2 20.8 13.7 0.0 1.4 0.0 0.0 0.0 73.9 16.0 17.0 15.7 0.0 0.0 144.2 20.3 4.5 0.0 169.7 0.0 32.6 0.0 0.0 25.3 0.0 0.5 0.1 0.0 30.3 0.0 0.0 6.7 1.1 0.0 0.0 1.0 103.4 0.0 11.5 199.8 0.4 24.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 76.5 6.8 PRRC2C "BAT2D1, BAT2L2, KIAA1096, XTP2" ENSG00000117523 "Proline rich coiled-coil 2C" Q9Y520 1 171485551-171593511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025766, HPA028659" Approved Enhanced Cytosol NA NA Cytosol "HPA025766: AB_1845277, HPA028659: AB_10600786" "unprognostic (4.16e-1)" "unprognostic (2.40e-2)" "unprognostic (6.66e-3)" "unprognostic (8.71e-2)" "unprognostic (6.07e-3)" "unprognostic (1.85e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-2)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (5.56e-2)" "prognostic unfavorable (7.76e-6)" "unprognostic (7.03e-2)" "unprognostic (2.62e-1)" "unprognostic (1.82e-1)" "unprognostic (4.34e-2)" 33.1 21.2 32.9 40.1 35.7 61.2 32.6 44.3 37.0 35.1 26.0 19.8 41.4 21.2 32.9 38.8 37.3 28.5 26.3 23.5 27.4 25.4 25.5 30.2 35.2 39.8 33.8 30.2 37.3 29.6 47.2 43.7 35.9 30.6 28.7 32.4 18.2 31.4 53.9 24.5 38.5 33.2 32.9 36.7 37.3 27.6 27.3 36.9 45.3 29.5 30.3 41.1 35.3 33.8 4.8 4.4 7.5 2.9 5.8 3.0 1.0 26.6 20.7 29.0 19.1 20.6 24.0 21.5 15.4 22.0 18.1 16.6 31.6 19.1 39.3 24.3 22.5 14.7 23.9 31.4 24.5 28.0 22.1 16.7 29.9 16.0 22.0 21.4 48.3 24.4 23.1 18.9 30.6 45.8 16.4 26.3 21.6 39.3 21.8 20.5 12.7 28.8 20.5 38.3 21.4 36.0 21.8 21.6 19.2 25.6 29.9 18.8 19.3 23.4 28.0 17.8 40.1 19.0 34.0 32.7 20.6 19.0 19.9 31.9 18.3 19.5 57.8 13.1 23.9 18.4 3.4 2.9 1.5 2.9 2.7 3.0 3.7 2.8 2.8 1.2 4.8 2.6 3.0 7.5 5.8 2.8 4.4 2.1 1.0 32.9 35.7 44.3 37.0 27.4 25.4 33.8 30.2 30.6 36.9 276.9 218.4 153.4 214.3 148.4 154.9 94.9 127.4 184.7 273.0 82.0 131.6 168.2 21.6 138.0 25.6 177.6 134.0 46.7 131.7 178.0 148.4 210.4 252.2 99.5 112.3 130.3 158.3 113.5 118.5 20.7 128.9 166.9 91.1 219.2 79.1 116.7 164.6 91.2 90.5 36.1 164.3 77.6 114.7 173.0 161.2 127.5 398.8 179.9 89.0 320.3 PRSS21 "ESP-1, TEST1" ENSG00000007038 "Serine protease 21" Q9Y6M0 16 2817180-2826304 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 21.0;salivary gland: 20.9;testis: 37.5" "Cell type enhanced" "Detected in many" 17 "Late spermatids: 257.7;Spermatocytes: 426.2;Spermatogonia: 234.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 23.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 10.5;eosinophil: 21.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 21.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.4;HEL: 11.6;HeLa: 29.8;K-562: 13.7;U-698: 42.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 27 "basal ganglia: 6.7" HPA008477 Enhanced Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA008477: AB_1079697" "unprognostic (4.35e-2)" "unprognostic (3.46e-2)" "unprognostic (7.06e-2)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (2.61e-2)" "unprognostic (2.33e-1)" "unprognostic (5.21e-2)" "unprognostic (8.83e-3)" "unprognostic (1.52e-3)" "unprognostic (2.97e-2)" "unprognostic (1.14e-2)" "unprognostic (5.07e-2)" "unprognostic (7.79e-2)" "unprognostic (2.99e-1)" 0.8 0.0 0.2 0.2 0.2 5.5 1.0 0.4 0.4 1.4 0.4 0.2 1.4 0.2 0.3 0.2 0.8 2.2 2.1 0.2 0.2 0.0 0.2 0.2 2.1 3.3 0.2 0.2 0.3 0.9 1.7 0.2 0.3 0.4 1.8 0.2 0.2 20.9 0.2 0.5 0.4 0.4 0.2 0.2 0.9 0.4 37.5 0.2 0.9 0.2 1.2 1.1 0.3 0.6 0.8 1.4 21.0 2.3 1.0 3.3 1.3 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 11.6 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 5.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 10.5 2.3 21.0 2.2 1.6 3.3 0.8 1.1 1.8 0.6 0.6 1.5 2.2 0.2 1.0 0.3 1.4 0.5 1.3 0.2 0.2 0.4 0.4 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 10.2 29.2 1.0 0.0 81.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 1.1 94.4 0.0 0.2 0.0 0.3 6.3 0.2 21.6 0.0 0.0 11.5 0.0 0.0 0.0 0.0 257.7 6.1 1.8 0.0 0.0 0.9 0.0 0.8 0.0 3.5 0.0 0.0 45.3 1.1 426.2 234.2 0.5 0.1 2.5 1.6 11.1 PRUNE1 "DRES-17, H-PRUNE, HTCD37, PRUNE" ENSG00000143363 "Prune exopolyphosphatase 1" Q86TP1 1 151008420-151035713 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 7 "Alveolar cells type 2: 8.8;Collecting duct cells: 10.4;Proximal tubular cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028411 Uncertain Supported Cytosol NA NA 210000 Cytosol "HPA028411: AB_10603229" "unprognostic (6.24e-2)" "unprognostic (2.24e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (6.91e-2)" "unprognostic (2.02e-1)" "unprognostic (2.12e-3)" "unprognostic (7.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.92e-2)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (3.48e-4)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" 9.3 9.7 9.3 8.8 11.6 3.7 16.0 15.7 16.4 15.0 12.5 10.9 16.2 11.7 17.9 15.7 11.5 15.6 12.8 31.3 10.5 10.3 18.0 12.8 10.1 11.8 11.9 9.2 17.1 16.2 16.5 16.2 7.2 8.8 12.2 14.0 12.7 13.3 18.2 24.4 10.5 11.8 14.7 7.9 11.0 10.5 16.3 8.6 15.0 41.6 8.5 12.9 13.8 13.6 12.1 9.5 14.7 8.9 14.3 19.0 18.3 3.9 4.2 7.5 7.2 9.4 2.6 4.2 1.9 4.1 7.0 6.1 5.1 4.7 8.1 8.2 2.5 2.0 5.7 7.3 4.9 5.6 8.7 8.3 9.5 4.4 7.4 5.1 6.2 4.8 3.2 9.3 3.7 3.6 5.8 3.3 10.7 7.4 6.8 3.3 9.4 9.5 5.1 7.0 14.3 5.5 8.7 4.8 7.7 5.0 5.4 10.9 8.9 6.3 8.8 5.8 11.1 12.1 9.4 2.3 2.5 3.0 2.7 2.9 16.6 14.0 62.0 2.4 4.7 6.2 12.5 6.4 13.4 14.0 6.0 16.9 12.1 15.5 15.7 9.5 11.6 19.0 15.0 14.7 14.3 8.9 5.1 14.5 18.3 9.3 11.6 15.7 16.4 10.5 10.3 11.9 9.2 8.8 8.6 6.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.7 10.4 0.0 3.6 0.0 4.9 0.0 0.0 0.0 0.0 4.9 3.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 2.8 0.0 0.0 5.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 PSAPL1 ENSG00000178597 "Prosaposin like 1 (gene/pseudogene)" Q6NUJ1 4 7430294-7434973 "Predicted secreted proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skin 1: 42.2;stomach 1: 23.9;testis: 19.9" "Cell type enriched" "Detected in single" 14 "Suprabasal keratinocytes: 2.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 11.9;OE19: 23.0;RPMI-8226: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038013, HPA038482" Approved Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA038013: AB_10673652, HPA038482: AB_2676037" "unprognostic (2.64e-2)" "unprognostic (2.40e-1)" "unprognostic (9.33e-2)" "unprognostic (2.40e-1)" "unprognostic (2.61e-1)" "unprognostic (7.90e-3)" "unprognostic (2.52e-1)" "unprognostic (2.08e-2)" "unprognostic (2.75e-1)" "unprognostic (2.63e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 1.4 0.6 0.0 1.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 42.2 0.1 0.1 0.1 0.1 23.9 19.9 0.1 2.5 0.1 0.1 2.1 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 PSAT1 PSA ENSG00000135069 "Phosphoserine aminotransferase 1" Q9Y617 9 78297143-78330093 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 56.0;liver: 112.2" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 129.9;Proximal tubular cells: 244.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 13.3" "Lineage enriched" "Detected in many" 4 "T-cells: 13.3" "Cell line enhanced" "Detected in many" "hTCEpi: 147.9;SK-MEL-30: 90.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014882, CAB040567, HPA042924" Enhanced Enhanced Cytosol NA NA 1700000 Cytosol "CAB014882: , CAB040567: , HPA042924: AB_2678223" "unprognostic (8.26e-3)" "unprognostic (4.69e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (5.62e-5)" "unprognostic (4.05e-3)" "unprognostic (1.41e-1)" "unprognostic (2.21e-3)" "unprognostic (1.86e-1)" "unprognostic (9.85e-2)" "unprognostic (2.25e-2)" "unprognostic (4.53e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-7)" "unprognostic (3.87e-3)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (1.71e-1)" 3.1 25.0 44.6 3.8 33.4 1.7 3.0 8.5 50.5 2.4 3.3 44.8 0.9 3.2 2.7 28.4 9.3 16.0 1.6 1.4 33.9 22.3 56.0 112.2 1.6 4.5 42.2 24.6 3.7 54.6 4.8 2.1 2.2 21.9 5.3 3.3 8.1 26.2 2.8 1.1 24.7 2.8 2.3 29.8 2.4 7.0 5.1 35.0 2.2 13.7 4.9 5.9 4.2 2.6 3.0 0.2 0.2 0.1 0.0 13.3 3.1 26.7 18.0 15.2 26.9 4.5 5.3 35.9 22.7 16.2 11.6 21.7 4.6 5.2 17.4 10.1 51.1 10.5 26.6 25.9 25.1 17.4 17.0 9.2 5.9 8.3 35.4 41.6 33.1 10.7 16.9 147.9 15.3 41.1 2.8 10.5 68.0 6.3 44.8 9.6 10.0 11.3 5.3 34.8 50.3 19.7 5.6 9.8 20.4 15.8 6.2 6.9 16.0 6.3 10.9 90.5 10.0 5.2 41.8 2.4 2.9 9.5 10.8 18.4 30.5 28.1 0.1 34.2 26.2 13.9 0.0 0.0 0.0 4.9 0.0 5.7 3.0 4.8 6.5 0.2 1.0 7.9 7.3 0.2 0.0 0.1 0.0 13.3 3.1 44.6 33.4 8.5 24.9 33.9 22.3 42.2 24.6 21.9 35.0 0.0 0.0 16.4 6.8 37.3 0.8 0.5 0.0 2.7 0.0 10.4 0.0 25.8 53.0 14.1 1.3 2.1 0.7 46.7 41.7 10.5 2.4 14.9 0.0 129.9 4.4 4.8 3.5 3.7 3.2 1.7 4.6 1.8 18.6 6.4 2.0 22.2 28.4 0.0 1.8 244.0 1.3 0.0 1.0 1.4 2.8 44.4 7.8 4.4 3.0 11.2 PSMA5 ZETA ENSG00000143106 "Proteasome subunit alpha 5" P28066 1 109399031-109426427 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 31.2" "Low region specificity" "Detected in all" "HPA028392, HPA028398, HPA028441" Approved Supported Cytosol NA NA 22000000 Cytosol "HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003" "unprognostic (3.82e-2)" "unprognostic (3.09e-3)" "prognostic favorable (1.45e-5)" "unprognostic (1.57e-1)" "unprognostic (2.71e-1)" "unprognostic (1.52e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (5.95e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-3)" "unprognostic (4.20e-3)" "unprognostic (3.05e-1)" "unprognostic (1.07e-3)" "unprognostic (3.99e-2)" "unprognostic (2.34e-1)" "unprognostic (8.81e-3)" "unprognostic (1.05e-1)" 12.1 23.7 13.2 17.3 15.0 7.7 16.2 8.2 40.5 13.3 16.1 9.8 16.7 15.1 15.8 23.0 21.5 17.6 16.7 20.8 13.8 13.5 27.5 41.9 17.1 24.2 13.4 14.9 13.6 21.4 12.6 11.5 20.9 12.8 12.3 14.9 10.2 16.8 14.2 31.6 15.8 21.8 14.4 12.9 18.5 15.2 16.3 10.3 31.5 27.9 23.4 19.8 14.0 11.7 2.1 1.2 7.3 2.2 2.8 7.1 1.6 1.2 1.0 1.7 1.2 3.9 4.2 1.4 0.9 9.3 6.1 3.6 1.3 1.1 5.3 1.2 4.1 0.4 1.7 2.4 3.1 3.8 1.1 1.5 2.3 0.9 1.6 2.9 3.0 1.2 1.9 3.1 1.8 3.0 1.5 2.3 1.6 1.8 1.4 2.5 1.6 31.2 1.3 1.4 1.3 1.5 0.8 3.1 0.9 4.9 1.6 1.4 1.2 1.6 5.5 2.0 1.4 1.2 2.7 1.5 1.0 0.8 2.1 1.2 0.9 1.8 6.7 6.8 6.7 1.1 7.3 1.0 0.7 4.0 2.2 4.8 1.8 5.8 4.9 1.2 2.1 7.1 6.5 0.3 2.8 2.0 0.8 5.3 1.6 13.2 15.0 8.2 17.5 13.8 13.5 13.4 14.9 12.8 10.3 38.7 52.0 75.2 57.4 56.4 28.9 80.5 71.4 113.8 56.9 40.1 5.9 188.1 119.3 151.2 42.4 54.0 101.9 93.5 159.8 154.0 44.1 63.2 80.8 125.2 151.4 12.7 54.1 53.4 54.0 13.6 62.7 72.3 55.6 215.6 84.3 42.7 167.1 91.2 58.4 151.0 27.9 45.3 54.2 105.7 86.6 57.6 201.7 98.3 114.8 81.6 PSMB9 "beta1i, LMP2, PSMB6i, RING12" ENSG00000240065 "Proteasome subunit beta 9" P28065 6 32844136-32859585 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 69.1;lymphoid tissue: 54.9" "Cell type enhanced" "Detected in many" 6 "monocytes: 319.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 29.5;REH: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB015180, HPA042818, HPA053280" Enhanced Supported Cytosol NA NA 420000 Cytosol "CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098" "unprognostic (1.09e-2)" "unprognostic (1.68e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-3)" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (5.68e-2)" "unprognostic (6.67e-2)" "unprognostic (1.56e-2)" "unprognostic (6.50e-3)" "unprognostic (1.87e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.96e-3)" "unprognostic (5.99e-2)" 13.3 9.7 5.0 30.0 7.9 10.7 11.6 1.6 5.3 7.6 16.5 6.0 3.4 15.7 8.8 7.1 10.8 7.4 10.8 8.9 5.1 4.7 12.2 12.2 17.7 32.7 7.3 3.7 9.2 5.4 1.2 4.5 5.5 6.3 12.5 5.8 7.7 9.0 3.5 6.2 7.6 36.1 5.7 9.8 54.9 11.2 3.0 6.7 35.4 14.4 9.3 35.2 15.9 8.8 31.8 17.2 69.1 30.5 23.4 31.1 45.7 0.0 1.4 0.0 0.1 1.2 3.0 2.0 0.2 3.3 4.2 9.9 0.0 9.2 29.5 0.4 2.7 10.8 6.0 0.4 6.3 0.6 16.6 0.0 18.0 0.5 1.1 15.9 3.1 1.3 1.4 0.2 2.7 0.4 2.3 1.5 8.5 0.7 5.5 1.4 0.5 13.6 4.2 0.0 0.0 0.9 21.8 0.0 7.0 2.8 0.5 0.0 0.0 2.7 1.8 2.0 0.0 2.4 6.6 1.5 4.6 0.4 8.6 2.6 10.2 15.5 9.4 4.7 11.9 3.8 21.9 22.4 39.3 28.7 30.5 23.8 31.8 23.3 27.5 17.2 23.4 17.5 22.9 69.1 23.4 29.4 12.7 31.1 45.7 5.0 7.9 1.6 5.3 5.1 4.7 7.3 3.7 6.3 6.7 38.7 64.6 199.7 29.6 64.5 1.9 5.3 73.9 30.8 34.2 24.4 0.0 0.9 16.6 87.6 1.0 123.4 127.8 46.7 101.9 4.2 38.3 33.2 76.1 23.2 118.3 0.0 32.1 108.1 113.4 0.7 27.0 117.7 33.7 319.2 103.0 19.5 69.2 118.1 14.9 33.5 1.1 32.3 41.0 1.4 6.5 51.3 1.1 214.2 55.9 33.0 PSMF1 PI31 ENSG00000125818 "Proteasome inhibitor subunit 1" Q92530 20 1113263-1189415 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 19 "Early spermatids: 1123.3;Late spermatids: 3219.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041122, HPA041300" Approved Enhanced Cytosol NA NA 270000 Cytosol "HPA041122: AB_10805838, HPA041300: AB_10794370" "unprognostic (1.79e-2)" "unprognostic (8.96e-2)" "unprognostic (7.22e-2)" "unprognostic (3.88e-2)" "unprognostic (1.68e-3)" "unprognostic (1.43e-2)" "unprognostic (9.14e-3)" "unprognostic (1.56e-1)" "unprognostic (7.03e-2)" "unprognostic (4.71e-1)" "unprognostic (2.45e-1)" "unprognostic (7.41e-2)" "unprognostic (3.72e-3)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (4.18e-2)" "unprognostic (8.32e-2)" 27.3 21.5 23.4 23.9 26.4 27.3 23.0 22.9 32.7 21.8 26.5 26.9 19.8 27.2 24.6 24.1 29.3 22.5 27.4 27.7 21.6 21.2 25.1 63.7 23.7 29.9 23.2 19.8 28.2 48.3 23.7 20.4 20.5 28.2 21.2 19.3 26.2 33.6 24.0 67.2 25.3 28.4 23.9 23.4 22.8 25.7 86.2 19.2 31.9 27.7 42.1 24.5 26.2 25.7 31.4 28.7 51.5 33.9 24.1 33.6 26.2 38.6 35.2 8.5 20.2 18.2 19.3 14.8 23.6 17.9 21.4 19.2 33.1 27.2 19.7 15.9 24.4 23.0 35.1 21.8 40.0 26.9 11.5 13.1 28.1 6.3 60.1 24.5 32.9 9.5 19.3 23.2 24.2 37.5 13.2 23.0 15.7 28.0 39.6 17.4 20.6 41.9 28.8 12.6 22.2 21.7 20.2 18.0 32.3 18.9 32.8 21.6 15.3 26.0 45.6 21.4 8.4 30.6 11.9 27.4 27.5 18.8 31.8 31.8 24.6 48.2 21.1 12.2 22.8 20.9 43.2 28.6 51.5 23.0 33.9 26.5 31.4 30.8 25.0 28.7 27.6 28.4 24.7 31.1 24.1 33.2 16.4 33.6 26.2 23.4 26.4 22.9 32.7 21.6 21.2 23.2 19.8 28.2 19.2 32.8 43.6 51.3 52.3 36.6 32.7 45.6 25.5 32.1 27.3 38.4 3.9 59.1 69.6 90.2 1123.3 44.7 57.7 46.7 90.0 73.1 49.0 49.8 49.5 57.6 88.7 20.6 64.8 52.8 47.0 3219.2 71.7 56.6 49.0 82.0 52.3 45.6 80.0 65.4 83.4 64.4 26.8 116.4 64.1 69.0 63.9 42.4 61.9 53.2 59.6 60.7 PSPH PSP ENSG00000146733 "Phosphoserine phosphatase" P78330 7 56011051-56051604 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 91.2;Early spermatids: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020376, HPA029515" Approved Approved Cytosol NA NA Cytosol "HPA020376: AB_1855867, HPA029515: AB_10601492" "prognostic unfavorable (2.30e-4)" "unprognostic (7.80e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (2.75e-5)" "unprognostic (1.74e-1)" "unprognostic (2.13e-1)" "unprognostic (4.45e-2)" "prognostic favorable (3.77e-4)" "unprognostic (3.78e-2)" "unprognostic (5.74e-2)" "unprognostic (2.64e-1)" "unprognostic (3.01e-2)" "unprognostic (1.90e-3)" "unprognostic (9.05e-3)" 7.5 13.4 14.1 5.9 16.6 5.1 11.0 10.1 14.6 5.4 8.0 13.2 11.4 6.9 7.0 9.0 11.0 26.3 10.6 12.8 13.2 12.5 14.7 9.8 5.4 7.4 14.8 10.0 13.9 15.9 7.8 17.1 6.4 11.1 10.6 6.9 6.9 6.8 11.5 6.8 6.4 6.2 8.5 15.2 5.7 8.5 9.1 13.3 10.2 12.2 6.9 8.5 7.1 16.0 7.8 11.9 6.8 8.5 5.3 6.2 5.8 46.9 14.4 8.8 32.9 7.4 10.0 6.1 11.9 7.0 6.6 11.8 12.9 8.2 23.2 8.0 11.0 16.7 9.8 19.5 10.1 6.9 17.6 10.9 6.5 3.9 21.7 15.9 6.5 10.0 12.5 19.0 10.5 12.2 9.4 6.5 22.0 15.5 15.0 10.0 6.3 9.9 15.5 14.1 16.8 20.2 13.0 5.3 13.3 6.3 2.4 16.1 18.6 8.6 5.3 23.8 7.5 15.9 13.7 5.5 5.8 9.2 17.9 10.8 10.4 18.0 26.3 8.3 14.3 18.2 2.2 7.7 6.8 4.2 5.3 3.0 7.2 4.0 5.1 11.9 7.8 6.2 5.5 3.6 5.3 8.5 11.3 5.1 5.8 14.1 16.6 10.1 14.6 13.2 12.5 14.8 10.0 11.1 13.3 3.0 1.0 9.7 8.3 6.1 4.4 9.4 17.8 34.8 9.1 5.2 2.0 11.9 91.2 7.9 131.4 3.6 1.3 0.0 6.8 6.3 5.3 5.3 1.1 7.3 7.9 1.6 4.6 6.7 6.5 38.2 7.8 4.8 6.8 4.6 3.9 41.4 7.8 3.5 5.6 39.1 2.8 12.9 5.7 23.6 26.0 7.4 3.9 5.0 7.5 4.7 PTPRQ DFNB84 ENSG00000139304 "Protein tyrosine phosphatase, receptor type Q" 12 80402178-80680271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6;urinary bladder: 19.2" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 14.9;Club cells: 7.9;Early spermatids: 7.0;Late spermatids: 3.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 24 "basal ganglia: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.4;BJ: 6.2;HBF TERT88: 4.4;RH-30: 4.9;RT4: 5.4;SiHa: 3.1;U-2197: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA053245 Uncertain Approved Cytosol No NA Cytosol "HPA053245: AB_2682087" "unprognostic (9.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (1.37e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (4.47e-11)" "unprognostic (8.51e-3)" "unprognostic (1.47e-1)" "unprognostic (1.73e-2)" "unprognostic (2.66e-2)" 4.6 0.2 0.3 1.0 12.6 0.0 5.2 0.2 0.3 1.7 1.3 0.0 1.6 0.0 0.5 4.7 1.6 4.1 0.5 1.3 0.4 0.5 6.5 0.2 5.4 2.1 0.2 0.0 0.9 0.6 0.0 1.1 6.4 0.0 6.5 0.0 0.0 0.4 0.5 0.5 0.3 0.2 4.0 0.2 0.2 0.2 5.8 0.0 0.0 3.9 0.0 0.6 19.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 6.2 1.3 1.9 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.9 0.0 0.8 0.2 0.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 5.4 0.0 0.0 3.1 0.1 0.0 0.3 0.3 0.0 0.0 0.5 0.1 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.6 0.2 0.3 0.4 0.5 0.2 0.0 0.0 0.0 14.9 0.6 0.0 1.5 0.0 0.0 1.7 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 PTS PTPS ENSG00000150787 "6-pyruvoyltetrahydropterin synthase" Q03393 11 112226365-112269955 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Disease mutation, Phenylketonuria" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001481 Uncertain Approved Cytosol NA NA Cytosol "HPA001481: AB_1079716" "unprognostic (2.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.66e-3)" "unprognostic (8.38e-3)" "unprognostic (4.58e-1)" "unprognostic (3.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.81e-2)" "unprognostic (2.05e-2)" "unprognostic (8.74e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-2)" "unprognostic (3.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.97e-1)" "unprognostic (1.52e-3)" "unprognostic (1.65e-1)" 6.7 37.1 13.9 6.3 16.6 12.2 13.9 8.9 16.5 10.4 12.7 10.2 6.1 10.7 9.3 20.3 17.9 8.2 14.7 11.6 11.8 28.9 21.9 40.7 5.6 10.4 23.5 14.3 6.7 11.9 12.1 21.5 12.1 18.8 14.9 14.4 9.9 10.9 11.4 11.7 11.5 10.9 12.4 16.8 5.1 18.8 6.7 9.8 3.6 16.3 13.2 7.7 9.3 16.1 6.3 6.8 1.9 5.5 3.4 5.9 2.9 10.4 11.0 12.0 5.1 8.6 10.3 15.9 31.1 14.2 17.1 18.1 24.8 10.5 11.1 23.8 18.2 22.9 15.1 17.0 20.0 18.5 9.0 14.3 2.8 17.0 20.2 27.2 6.8 1.5 17.9 28.3 16.3 19.3 13.2 12.8 9.5 10.6 6.0 10.7 11.5 5.2 9.0 9.0 19.4 21.7 3.5 2.4 15.9 36.6 15.0 13.6 13.7 17.5 17.1 9.7 40.8 12.8 6.1 16.1 16.8 18.3 20.0 24.4 4.2 8.3 26.5 11.6 7.2 17.4 0.9 2.1 1.9 3.8 2.3 3.8 5.5 5.0 4.7 3.6 6.3 3.5 4.5 1.0 3.4 5.5 6.8 5.9 2.9 13.9 16.6 8.9 16.5 11.8 28.9 23.5 14.3 18.8 9.8 17.9 24.5 24.0 66.3 109.0 14.8 83.9 56.0 54.9 21.6 52.4 0.0 48.3 179.1 80.8 4.1 41.9 57.6 23.3 68.2 99.5 46.6 67.1 19.7 115.0 33.0 9.5 76.7 34.4 17.3 6.9 13.6 30.6 25.3 34.3 50.0 26.2 90.3 66.6 24.4 114.8 16.5 25.8 69.5 15.8 93.0 114.6 58.8 33.1 39.6 98.4 PUM2 "KIAA0235, PUMH2" ENSG00000055917 "Pumilio RNA binding family member 2" Q8TB72 2 20248691-20352234 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030316, HPA049670" Approved Enhanced Cytosol NA NA Cytosol "HPA030316: AB_10610289, HPA049670: AB_2680845" "unprognostic (2.41e-1)" "unprognostic (8.77e-2)" "unprognostic (1.97e-1)" "unprognostic (2.31e-2)" "unprognostic (9.89e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (3.86e-2)" "unprognostic (1.23e-1)" "unprognostic (4.49e-3)" "unprognostic (1.05e-2)" "unprognostic (6.87e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (2.41e-1)" "unprognostic (4.81e-2)" "unprognostic (2.87e-2)" 20.3 20.7 21.1 35.2 20.0 18.3 25.2 41.2 26.0 31.4 35.4 19.5 13.5 20.5 26.1 20.5 25.1 19.9 25.7 25.7 22.1 19.8 22.9 25.6 24.6 26.8 20.7 21.1 29.1 23.2 32.9 24.2 39.3 17.5 24.3 22.9 21.8 22.7 42.6 19.2 27.7 27.8 20.5 18.5 25.4 23.5 14.6 20.2 56.2 35.7 21.7 28.1 26.8 29.0 6.6 5.6 15.3 8.6 9.4 10.0 4.8 24.0 17.6 21.5 15.4 13.3 14.0 23.2 17.6 17.4 15.8 14.3 14.6 11.3 32.3 4.0 14.8 18.7 13.5 21.7 12.0 24.3 30.1 13.9 32.9 12.9 19.9 14.6 34.6 31.5 10.1 25.7 15.0 27.2 15.4 18.2 18.5 25.2 27.1 18.6 11.6 31.0 20.2 19.0 21.7 11.6 26.5 37.4 24.3 14.5 21.9 18.6 26.6 14.7 19.3 15.3 15.0 11.3 19.4 18.1 20.6 20.1 13.1 21.6 32.3 39.1 61.2 12.5 25.0 17.7 11.8 5.5 7.4 8.1 6.7 9.8 6.4 9.0 9.8 5.6 6.6 10.0 8.0 15.3 9.4 8.6 4.7 6.8 4.8 21.1 20.0 41.2 26.0 22.1 19.8 20.7 21.1 17.5 20.2 32.8 45.9 28.4 26.0 70.7 87.4 35.5 25.5 24.1 31.8 45.4 58.9 28.4 10.0 15.5 6.9 34.6 29.0 0.0 13.2 14.8 36.0 39.5 19.7 48.2 24.9 55.6 33.3 44.2 65.6 4.9 31.7 30.6 30.4 14.4 46.3 24.3 19.1 20.1 24.8 23.8 68.2 32.3 38.1 16.1 17.7 93.0 43.5 39.6 37.7 44.8 PYGB ENSG00000100994 "Glycogen phosphorylase B" P11216 20 25248069-25298014 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 101.9" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 93.8;Enterocytes: 83.8;Peritubular cells: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 71.7;SK-MEL-30: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031067 Approved Approved Cytosol NA NA 16000000 Cytosol "HPA031067: AB_2673722" "unprognostic (6.13e-2)" "unprognostic (5.98e-2)" "unprognostic (1.21e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.37e-4)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.23e-3)" "unprognostic (8.39e-3)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "unprognostic (3.41e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.43e-4)" 19.0 11.3 24.2 12.1 22.9 6.1 28.4 38.3 34.8 14.3 47.0 21.5 19.0 12.5 15.9 13.8 49.6 14.1 21.1 72.5 21.1 21.3 13.5 4.4 14.8 8.1 22.9 24.7 11.9 9.7 8.0 18.2 6.2 28.0 42.2 33.8 11.0 58.4 52.0 5.0 23.9 13.1 101.9 17.8 8.2 24.1 14.5 17.4 9.5 21.1 8.4 10.3 56.7 14.8 4.5 11.2 5.2 16.8 8.1 10.6 16.0 5.3 38.3 6.9 6.7 17.7 33.4 5.1 10.8 14.2 9.1 7.7 8.6 6.6 6.3 12.8 14.4 17.1 21.5 7.8 28.8 5.0 3.5 4.8 5.1 3.1 14.7 21.0 7.5 7.1 19.4 27.0 23.1 34.3 11.3 11.6 4.0 2.7 16.1 12.7 14.8 7.5 5.8 6.2 6.5 71.7 5.7 12.6 8.4 49.9 9.8 10.4 6.5 7.4 13.0 89.9 5.7 9.1 4.8 25.5 10.8 6.6 11.5 22.0 6.2 9.6 2.4 12.1 5.9 58.7 2.6 10.2 5.2 8.5 15.5 8.3 4.5 6.8 7.5 11.2 4.2 8.8 10.6 2.5 8.1 16.8 5.5 7.5 16.0 24.2 22.9 38.3 34.8 21.1 21.3 22.9 24.7 28.0 17.4 8.9 28.8 2.2 18.7 10.5 23.6 93.8 15.3 9.4 9.1 24.4 35.3 5.9 10.0 15.4 2.4 10.8 83.8 0.0 14.5 5.7 9.1 20.1 5.8 5.9 10.0 17.5 27.1 8.6 15.2 6.8 25.3 11.0 33.7 18.0 47.4 20.4 19.1 57.9 81.3 9.9 9.4 0.0 17.6 1.7 4.9 8.8 3.7 12.8 52.1 7.1 QARS ENSG00000172053 "Glutaminyl-tRNA synthetase" P47897 3 49095932-49105135 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Epilepsy, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 438.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036986, HPA036987" Enhanced Enhanced Cytosol No No 21000 Cytosol "HPA036986: AB_10672344, HPA036987: AB_2675418" "prognostic favorable (1.43e-4)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (1.10e-2)" "unprognostic (5.13e-3)" "unprognostic (6.62e-3)" "unprognostic (6.53e-3)" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-1)" "unprognostic (4.33e-1)" "unprognostic (9.14e-2)" "prognostic favorable (5.60e-6)" "unprognostic (2.73e-3)" "unprognostic (1.65e-1)" "unprognostic (2.74e-2)" "unprognostic (3.11e-1)" 20.9 16.3 9.7 19.3 10.2 18.4 22.7 15.8 13.2 17.6 27.3 13.1 27.7 17.2 12.3 19.8 35.1 16.4 20.0 22.0 9.8 9.6 27.1 26.0 15.0 33.9 12.4 7.2 21.6 33.8 20.3 13.7 25.7 9.6 16.2 29.9 15.2 31.7 28.7 33.3 26.7 31.8 16.7 11.2 21.1 16.9 30.1 11.3 36.8 16.5 34.8 33.3 19.4 18.5 20.4 40.0 8.9 32.3 21.8 24.0 19.6 18.8 19.2 32.1 45.9 41.3 44.9 33.1 21.0 48.1 41.7 41.0 24.3 24.5 58.4 13.5 34.8 23.4 24.0 45.5 34.6 30.0 16.6 36.3 46.0 30.8 42.3 21.8 37.4 28.4 47.3 30.3 32.1 27.3 44.8 45.5 34.2 20.5 26.0 30.5 10.1 26.9 33.6 27.5 38.6 30.0 17.8 27.0 43.0 28.0 28.1 11.8 32.8 18.6 47.3 28.9 33.0 39.2 43.7 26.2 19.0 27.0 31.3 23.4 22.4 38.1 32.8 19.5 33.7 12.0 8.9 23.1 8.7 13.5 32.3 18.1 20.4 16.8 14.9 40.0 15.2 15.5 15.4 2.6 21.8 26.1 16.9 24.0 19.6 9.7 10.2 15.8 13.2 9.8 9.6 12.4 7.2 9.6 11.3 20.8 57.3 55.9 52.1 59.8 10.1 50.4 40.8 22.7 35.2 38.4 9.8 160.6 58.0 67.5 150.2 50.3 110.2 23.3 94.9 127.6 48.0 47.5 38.1 41.8 85.6 19.1 62.3 50.3 98.5 438.0 54.4 55.2 45.5 120.0 127.2 20.6 67.1 71.9 34.3 63.0 13.0 45.3 43.4 18.4 46.6 75.3 156.4 69.2 176.8 57.2 QPCT "GCT, QC" ENSG00000115828 "Glutaminyl-peptide cyclotransferase" Q16769 2 37344574-37373322 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6;blood: 137.6" "Group enriched" "Detected in many" 6 "Intestinal endocrine cells: 208.4;Melanocytes: 501.0" "Cancer enhanced" "Detected in all" "melanoma: 97.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 137.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 137.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 17.9;SCLC-21H: 24.3;SK-MEL-30: 81.6;U-266/84: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008406 Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA008406: AB_1855981" "unprognostic (6.25e-3)" "unprognostic (6.69e-2)" "unprognostic (4.95e-2)" "unprognostic (1.44e-1)" "unprognostic (1.44e-2)" "unprognostic (9.32e-2)" "unprognostic (1.13e-3)" "unprognostic (9.73e-2)" "unprognostic (2.71e-3)" "unprognostic (7.86e-2)" "unprognostic (3.67e-2)" "unprognostic (1.17e-1)" "unprognostic (6.78e-2)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (9.48e-3)" "unprognostic (3.62e-3)" 3.2 77.6 4.3 5.4 5.8 17.0 6.4 1.2 11.6 9.2 11.3 2.2 1.5 2.2 6.2 43.7 2.4 1.9 5.5 2.9 6.7 17.9 12.4 1.3 6.1 7.4 3.9 5.0 1.4 5.5 9.6 31.6 7.8 5.9 3.5 4.2 21.2 14.7 2.8 4.0 14.2 2.3 3.4 3.0 8.5 3.4 2.6 0.5 2.3 1.8 4.4 4.8 7.0 2.9 0.2 10.7 137.6 29.7 0.0 0.0 12.1 0.1 8.0 0.0 0.0 1.1 2.7 0.0 1.1 17.9 1.3 2.1 0.5 1.4 0.0 0.6 6.0 15.2 0.0 0.5 0.0 2.1 0.1 15.6 3.6 0.0 1.5 0.1 0.5 0.0 1.5 0.0 9.9 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 8.8 2.2 24.3 0.0 1.3 0.0 81.6 1.6 0.1 0.6 3.8 0.0 0.0 0.0 0.1 3.1 63.8 0.0 5.5 0.0 0.0 0.6 29.7 0.2 0.0 3.4 0.0 0.2 0.0 0.0 10.7 0.1 0.0 0.0 137.6 0.0 0.3 0.2 0.0 12.1 4.3 5.8 1.2 11.6 6.7 17.9 3.9 5.0 5.9 0.5 3.0 2.9 8.2 9.7 34.7 10.9 1.1 2.5 1.4 0.0 21.0 2.0 0.5 1.7 45.4 0.4 7.3 2.0 0.0 2.1 4.3 11.0 9.5 55.3 0.2 21.3 41.3 208.4 22.7 29.2 2.2 2.8 35.6 501.0 10.8 5.8 1.2 25.4 1.9 22.3 4.7 2.9 12.9 15.5 2.1 0.6 12.7 3.9 1.9 6.9 5.5 RAB32 ENSG00000118508 "RAB32, member RAS oncogene family" Q13637 6 146543693-146554965 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.8" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 26.5" "Group enriched" "Detected in many" 40 "dendritic cells: 16.0;granulocytes: 26.5;monocytes: 17.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025731 Approved Approved Cytosol NA NA 330000 Cytosol "HPA025731: AB_1856001" "unprognostic (3.07e-1)" "unprognostic (5.32e-2)" "prognostic favorable (1.56e-4)" "prognostic unfavorable (6.51e-4)" "unprognostic (1.26e-1)" "unprognostic (2.34e-3)" "prognostic unfavorable (1.08e-7)" "unprognostic (2.64e-2)" "unprognostic (9.71e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.54e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.67e-1)" 18.4 9.0 5.2 11.0 4.9 57.8 29.9 1.1 4.4 8.4 14.6 6.6 6.3 6.7 14.8 12.8 10.2 10.2 11.2 15.3 5.2 3.0 10.7 23.0 16.5 26.4 6.2 3.5 11.0 7.4 1.5 2.8 5.9 7.4 12.5 14.9 11.3 10.1 6.9 6.3 10.2 9.0 28.2 7.5 29.4 10.6 20.8 5.5 10.4 5.8 7.0 5.6 15.6 15.2 0.0 16.0 26.5 17.3 0.5 0.0 4.9 12.0 6.4 7.5 12.5 11.4 19.4 0.0 23.5 26.1 32.2 53.6 3.9 6.0 0.0 8.6 24.7 35.8 16.0 0.4 15.1 43.5 0.0 5.8 15.3 16.1 14.1 49.6 21.1 22.7 17.1 25.4 18.4 26.2 16.9 20.8 0.0 2.9 0.0 17.5 2.8 9.6 11.5 0.9 0.0 12.4 0.0 8.0 0.1 12.6 8.4 0.0 9.9 27.5 3.3 40.5 6.9 6.4 17.2 16.6 9.8 13.4 25.7 28.5 0.0 1.7 0.0 22.5 15.9 13.2 26.5 17.3 2.9 0.0 7.7 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 6.3 0.5 5.3 0.8 0.0 4.9 5.2 4.9 1.1 4.4 5.2 3.0 6.2 3.5 7.4 5.5 44.7 6.5 5.3 93.5 47.6 1.4 1.4 48.4 2.7 9.1 10.4 3.9 1.7 21.6 146.0 64.9 29.2 39.3 0.0 90.9 5.3 38.7 32.5 57.6 67.1 193.4 0.0 57.7 31.9 182.0 123.7 22.7 98.6 160.3 72.1 30.8 9.1 140.5 43.2 24.1 61.7 1.3 19.4 20.6 31.1 12.3 16.7 2.6 5.7 62.4 55.7 RAB3C ENSG00000152932 "RAB3C, member RAS oncogene family" Q96E17 5 58582221-58859394 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 13.6;brain: 47.4;pituitary gland: 14.1" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 35.2;Early spermatids: 17.4;Intestinal endocrine cells: 55.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEL: 3.5;NB-4: 2.2;SCLC-21H: 14.6;SH-SY5Y: 5.3" "Low region specificity" "Detected in all" "HPA003160, HPA048156" Enhanced Approved Cytosol NA NA Cytosol "HPA003160: AB_1079731, HPA048156: AB_2680291" "unprognostic (1.30e-1)" "unprognostic (3.35e-2)" "unprognostic (9.94e-2)" "unprognostic (2.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (8.73e-3)" "unprognostic (3.40e-2)" "unprognostic (6.90e-2)" "unprognostic (7.58e-2)" "unprognostic (9.52e-4)" "unprognostic (1.51e-3)" "unprognostic (3.70e-5)" "unprognostic (4.70e-2)" "unprognostic (1.05e-1)" "unprognostic (9.65e-2)" "unprognostic (3.61e-3)" 2.5 13.6 19.8 2.5 36.1 1.1 1.3 7.7 47.4 1.3 1.8 2.1 0.0 3.1 2.1 1.0 1.3 1.3 1.9 1.1 22.9 23.6 1.2 1.2 1.2 1.3 14.5 23.6 1.2 3.3 1.4 14.1 1.2 25.6 1.1 2.1 0.0 1.1 1.1 1.1 1.1 3.3 2.0 3.2 1.0 2.3 1.3 4.1 0.0 1.1 0.0 1.4 1.7 0.4 0.3 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.8 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.6 5.3 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.8 36.1 7.7 32.4 22.9 23.6 14.5 23.6 25.6 4.1 0.0 1.1 0.0 0.0 0.1 35.2 0.6 0.0 0.0 0.0 0.0 3.9 0.0 3.3 0.1 17.4 3.3 0.0 0.0 8.4 0.7 0.2 0.0 2.3 0.4 0.1 3.2 55.3 6.7 0.0 7.7 0.9 0.0 1.7 0.0 0.3 1.5 6.4 0.0 0.7 0.0 6.8 12.9 0.0 2.5 1.7 0.1 0.0 0.0 0.0 0.0 RABGAP1 "GAPCenA, TBC1D11" ENSG00000011454 "RAB GTPase activating protein 1" Q9Y3P9 9 122940833-123104866 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041651, HPA064860, HPA072273" Enhanced Enhanced Cytosol NA NA Cytosol "HPA041651: AB_10794673, HPA064860: AB_2685372, HPA072273: AB_2686504" "prognostic unfavorable (8.09e-4)" "unprognostic (3.45e-1)" "unprognostic (3.85e-3)" "unprognostic (3.90e-1)" "unprognostic (4.16e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-1)" "unprognostic (3.75e-2)" "unprognostic (5.19e-2)" "unprognostic (3.52e-2)" "unprognostic (1.88e-2)" "unprognostic (2.76e-1)" "prognostic favorable (6.06e-6)" "unprognostic (1.39e-1)" "unprognostic (2.75e-1)" "unprognostic (8.72e-2)" "unprognostic (3.05e-2)" 16.9 12.6 24.2 12.5 31.0 5.1 17.1 16.9 36.3 18.8 27.6 19.5 16.4 9.5 23.6 20.9 25.5 18.2 15.2 20.0 22.4 20.8 16.2 9.0 15.0 14.0 23.9 25.0 19.6 12.6 29.1 17.7 18.5 23.9 24.1 18.6 19.4 18.1 25.4 23.7 17.3 12.8 25.6 23.0 13.5 17.8 16.4 17.5 11.4 31.2 8.6 16.2 22.9 16.4 4.1 3.9 6.1 5.5 2.1 4.5 1.4 8.9 12.0 19.0 15.7 22.0 18.0 11.7 9.4 17.0 14.6 13.7 13.9 8.8 12.4 7.5 14.6 19.5 30.5 12.1 11.8 15.8 11.5 7.3 9.7 19.4 10.5 18.9 7.8 8.4 17.3 18.1 12.5 14.2 21.1 16.5 12.4 8.3 9.5 17.5 19.9 10.2 6.2 7.0 25.8 9.3 16.9 34.7 10.5 12.2 10.0 10.7 8.3 16.8 15.2 8.6 14.9 28.9 4.3 12.6 12.4 7.4 13.6 9.4 9.3 15.1 13.0 11.7 4.0 10.8 6.1 3.6 4.3 2.6 5.5 2.0 3.0 2.7 2.3 2.8 4.1 4.5 2.9 5.6 2.1 2.4 3.9 3.1 1.4 24.2 31.0 16.9 36.3 22.4 20.8 23.9 25.0 23.9 17.5 23.8 43.2 18.2 20.2 16.0 47.9 39.5 10.2 33.5 34.2 10.4 47.1 17.8 3.3 9.1 11.8 24.1 12.7 0.0 12.8 7.4 18.2 30.8 13.9 13.7 13.6 54.0 16.3 27.0 26.4 10.7 37.7 15.9 13.5 18.0 17.1 36.5 10.0 10.5 48.4 9.0 35.9 84.1 32.0 71.1 34.5 15.2 34.8 8.7 14.4 15.5 RANBP1 HTF9A ENSG00000099901 "RAN binding protein 1" P43487 22 20115938-20127357 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 603.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 217.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065868, HPA065931" Supported Enhanced Cytosol NA NA 910000 Cytosol "HPA065868: AB_2685572, HPA065931: AB_2685580" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.35e-2)" "unprognostic (2.50e-2)" "prognostic unfavorable (1.58e-6)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (5.67e-3)" "unprognostic (1.54e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (2.40e-2)" "unprognostic (3.95e-1)" "unprognostic (4.44e-2)" "unprognostic (7.30e-2)" 26.4 28.6 27.9 34.7 28.0 57.1 26.0 32.4 46.0 23.3 33.3 25.7 17.2 30.5 29.6 15.7 38.7 26.4 23.1 18.2 25.1 28.3 22.5 41.1 21.8 50.4 28.4 34.9 26.8 37.0 16.0 22.0 26.8 28.4 20.5 25.7 18.1 24.1 21.9 22.8 23.0 27.8 30.7 24.4 30.4 24.9 58.3 26.7 58.2 22.0 27.6 40.7 22.2 25.9 37.6 37.7 24.2 33.7 29.7 37.1 31.4 39.2 20.2 45.5 24.7 7.6 9.2 38.4 36.2 15.9 47.2 34.3 36.9 14.1 61.3 16.2 14.5 21.4 36.6 42.2 31.6 25.9 26.3 100.4 51.4 20.7 38.7 11.7 82.4 28.0 10.1 15.1 37.3 13.3 10.9 21.3 28.0 217.8 24.7 21.2 30.7 59.6 56.3 51.8 50.7 35.8 60.7 64.1 15.7 16.2 21.6 45.6 33.8 33.2 18.5 20.7 21.0 12.9 34.5 16.3 32.8 63.8 24.5 40.0 24.9 33.7 97.3 17.8 37.2 27.4 6.6 32.8 24.2 25.8 33.7 28.3 37.6 37.0 32.7 37.7 33.8 37.1 28.3 3.3 29.7 29.6 35.0 36.9 31.4 27.9 28.0 32.4 46.0 25.1 28.3 28.4 34.9 28.4 26.7 32.8 33.3 117.6 133.4 243.8 42.1 38.6 86.6 38.8 30.7 85.5 5.9 311.0 235.4 167.8 320.8 110.1 58.6 93.5 98.1 603.6 164.4 101.1 64.5 166.2 238.0 35.0 113.0 81.0 79.6 149.2 134.3 122.3 168.7 160.5 134.9 84.0 127.5 115.8 128.7 162.5 29.7 97.0 178.2 431.1 339.5 257.8 162.8 117.1 220.6 182.0 RAP1GAP "KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII" ENSG00000076864 "RAP1 GTPase activating protein" P47736 1 21596215-21669363 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.3;thyroid gland: 72.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 66.1;Distal tubular cells: 61.3;Horizontal cells: 87.4;Mucus-secreting cells: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "A549: 16.5;OE19: 57.5;SCLC-21H: 19.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 286.1" "HPA001922, CAB003851" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB003851: AB_562338, HPA001922: AB_1079743" "unprognostic (1.17e-2)" "unprognostic (4.33e-2)" "unprognostic (7.84e-2)" "unprognostic (2.45e-2)" "unprognostic (4.52e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (8.33e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (3.43e-2)" "unprognostic (1.35e-2)" "prognostic favorable (1.12e-6)" "unprognostic (1.11e-1)" "unprognostic (9.85e-3)" "unprognostic (4.86e-3)" "unprognostic (3.64e-2)" 0.9 38.2 30.2 1.9 89.3 1.1 3.1 27.1 40.1 4.7 10.5 5.7 0.0 6.9 1.7 1.8 2.9 3.0 13.4 2.7 17.8 12.9 33.2 10.3 7.8 1.2 8.6 20.6 1.6 49.3 7.1 8.2 5.8 14.6 7.4 9.4 2.4 43.9 1.2 0.7 2.1 11.6 1.1 3.2 0.9 28.4 2.1 14.2 0.0 72.5 0.9 1.6 2.5 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.3 2.1 16.5 0.1 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 2.3 0.0 1.7 0.0 11.1 2.8 1.6 0.1 0.0 0.3 0.8 0.7 1.5 7.7 0.2 0.0 2.4 0.1 1.1 0.0 0.0 0.0 0.0 8.0 10.2 0.4 0.0 5.5 2.6 0.2 1.0 57.5 2.5 1.5 0.4 0.3 3.8 1.2 19.2 3.4 2.7 10.0 3.2 0.7 1.0 1.8 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 30.2 89.3 27.1 30.4 17.8 12.9 8.6 20.6 14.6 14.2 8.9 21.1 0.5 0.9 1.1 66.1 3.3 25.5 0.0 6.8 14.0 0.0 0.1 61.3 10.9 0.6 0.0 4.2 23.3 24.6 1.1 0.6 8.3 0.0 5.6 0.2 87.4 6.4 0.0 0.8 0.0 0.0 0.7 15.1 1.0 97.4 10.0 20.3 10.2 0.0 10.2 6.2 0.0 0.4 1.0 3.4 1.0 1.3 0.0 6.9 1.1 RAP1GDS1 SmgGDS ENSG00000138698 "Rap1 GTPase-GDP dissociation stimulator 1" P52306 4 98261384-98443861 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 332.5;Late spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019060 Approved Supported Cytosol NA NA 120000 Cytosol "HPA019060: AB_1856068" "unprognostic (8.12e-2)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (1.66e-1)" "unprognostic (9.11e-2)" "unprognostic (1.35e-2)" "unprognostic (1.57e-3)" "unprognostic (3.44e-1)" "unprognostic (6.31e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (4.60e-1)" "prognostic favorable (2.00e-4)" "unprognostic (7.11e-2)" "unprognostic (3.09e-1)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" 11.3 9.7 25.8 12.9 28.2 9.0 13.1 28.0 43.6 9.3 12.0 20.0 9.0 7.3 8.9 8.7 13.7 6.1 8.6 6.8 29.7 28.0 12.3 15.2 10.1 15.3 36.9 20.5 7.9 13.8 8.4 15.3 9.6 30.1 8.0 14.0 8.0 8.6 11.9 3.6 10.5 9.0 16.3 37.0 12.5 8.2 15.5 26.2 16.2 13.0 4.8 17.0 12.5 7.6 13.9 31.9 16.0 14.7 19.5 22.7 8.4 17.9 10.5 13.4 11.5 17.3 20.7 5.4 30.6 17.0 18.3 14.4 7.8 23.3 21.3 10.0 22.8 8.9 10.3 16.5 28.0 24.8 21.8 6.8 13.2 13.5 10.2 34.3 21.9 9.2 24.1 17.1 16.1 25.0 15.2 23.9 21.9 8.7 18.3 45.2 9.4 36.2 10.9 4.9 14.7 7.6 15.1 8.0 7.2 18.6 14.1 19.9 12.1 12.8 28.8 16.9 7.7 6.5 14.3 23.5 19.0 13.6 8.7 18.1 6.3 11.0 18.0 15.7 16.5 24.6 16.0 10.6 5.7 14.2 14.6 14.3 13.9 14.5 13.6 16.7 11.0 7.8 11.9 1.6 19.5 14.7 31.9 22.7 8.4 25.8 28.2 28.0 30.5 29.7 28.0 36.9 20.5 30.1 26.2 14.9 9.8 23.0 8.8 12.4 41.4 10.1 20.4 5.3 15.9 15.7 47.1 5.8 19.9 16.8 332.5 13.5 11.1 23.3 18.3 13.9 11.6 11.1 15.0 16.3 22.1 14.3 20.1 16.0 29.4 174.5 8.6 23.3 16.9 29.7 13.9 15.6 19.2 16.7 10.3 15.9 66.0 0.0 11.8 14.6 22.5 14.6 3.8 30.8 17.4 12.8 RAPGEF3 "bcm910, cAMP-GEFI, EPAC" ENSG00000079337 "Rap guanine nucleotide exchange factor 3" O95398 12 47734367-47771040 "Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Collecting duct cells: 66.3;Endothelial cells: 26.0;Proximal tubular cells: 32.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 13.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 22.3;HUVEC TERT2: 9.5;NB-4: 10.9;RPTEC TERT1: 10.7;TIME: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004386, HPA040365, HPA043518" Approved Approved Cytosol NA NA Cytosol "CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524" "unprognostic (2.12e-1)" "unprognostic (2.88e-2)" "unprognostic (2.99e-2)" "unprognostic (1.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-4)" "unprognostic (9.35e-2)" "unprognostic (1.25e-2)" "unprognostic (5.32e-3)" "unprognostic (4.67e-2)" "unprognostic (4.37e-2)" "prognostic favorable (6.67e-7)" "unprognostic (9.16e-2)" "unprognostic (2.92e-1)" "unprognostic (2.61e-3)" "unprognostic (3.38e-2)" 26.5 2.8 18.2 3.0 19.7 1.9 22.1 3.9 23.0 12.7 4.8 28.8 19.4 4.7 10.6 11.9 10.4 15.9 13.7 15.9 20.7 7.3 22.8 1.6 6.9 4.7 24.2 14.9 30.9 5.4 4.9 3.0 9.8 19.1 7.1 3.2 3.3 20.5 16.9 10.6 6.9 4.8 6.0 12.0 10.9 6.3 2.5 27.4 0.0 27.3 4.8 2.7 8.6 11.5 1.1 0.6 0.5 0.7 0.0 1.2 0.4 1.8 0.5 0.6 1.9 0.2 1.9 0.6 1.4 1.1 0.5 0.3 0.2 4.7 0.1 22.3 2.3 0.9 1.9 0.7 3.4 0.3 2.3 0.3 0.2 1.7 0.1 0.1 0.3 0.2 0.7 0.3 1.0 0.6 2.9 9.5 0.4 0.1 2.4 0.4 1.2 0.0 10.9 0.5 0.7 3.0 0.3 0.1 0.8 10.7 2.0 0.2 0.3 0.2 1.3 0.3 0.7 5.1 0.4 9.5 5.6 0.9 1.2 0.4 1.0 0.3 0.1 3.4 2.3 0.6 0.0 0.7 0.0 0.1 0.4 0.6 0.5 0.1 1.2 0.3 1.1 0.2 0.3 0.5 0.0 0.5 0.6 0.4 0.4 18.2 19.7 3.9 23.0 20.7 7.3 24.2 14.9 19.1 27.4 0.0 13.2 0.0 3.9 2.4 0.6 10.6 0.0 2.7 3.4 66.3 0.0 0.2 6.6 0.7 0.9 26.0 0.4 0.0 0.6 0.3 4.1 6.6 3.5 0.0 0.8 0.0 0.0 18.4 0.3 2.1 22.5 1.5 5.0 0.0 5.5 1.2 3.5 2.9 8.1 32.2 0.3 6.5 2.1 0.6 0.8 2.9 0.2 0.0 0.4 18.0 RBMS1 "C2orf12, DKFZp564H0764, HCC-4, MSSP-1, MSSP-2, MSSP-3, SCR2, YC1" ENSG00000153250 "RNA binding motif single stranded interacting protein 1" P29558 2 160272151-160493794 "Predicted intracellular proteins" "DNA replication" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 333.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 55.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047943, HPA061791" Enhanced Cytosol NA NA Cytosol "HPA047943: AB_2797235, HPA061791: AB_2684611" "unprognostic (2.81e-1)" "unprognostic (2.44e-2)" "unprognostic (3.78e-2)" "unprognostic (1.38e-3)" "unprognostic (2.50e-1)" "unprognostic (6.81e-3)" "prognostic unfavorable (4.45e-4)" "unprognostic (6.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.14e-1)" "unprognostic (7.16e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (1.33e-7)" "unprognostic (1.84e-3)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (2.32e-1)" 29.4 8.7 4.0 15.6 9.4 11.6 23.0 2.6 7.1 25.9 19.1 2.9 11.4 4.4 29.1 13.5 15.8 17.0 17.5 30.1 4.1 4.1 16.2 8.1 22.8 25.3 4.0 2.9 22.9 4.4 24.3 12.7 74.2 7.2 18.6 5.9 11.2 11.7 16.0 10.5 14.1 9.7 21.7 5.3 23.3 11.5 7.1 5.6 15.7 12.3 11.7 7.8 23.9 23.9 1.2 7.3 24.2 11.0 6.6 16.8 5.7 13.7 5.1 18.2 2.3 26.4 46.0 22.1 17.6 25.2 12.2 12.7 14.1 10.4 0.1 22.0 29.6 5.7 8.4 8.8 12.9 20.0 11.1 6.5 5.2 12.7 11.2 24.1 8.3 0.3 55.0 10.2 21.1 9.5 16.3 19.0 4.2 0.3 6.5 29.2 10.7 7.7 8.5 11.2 2.3 11.3 5.9 15.9 6.9 18.6 17.0 2.3 6.2 10.9 6.5 16.1 23.7 3.3 13.2 22.8 21.8 13.8 19.9 15.8 3.5 0.1 5.9 17.5 12.8 13.8 2.1 11.0 13.5 5.0 6.3 16.8 0.5 8.7 7.6 7.3 1.2 14.2 6.4 24.2 6.6 3.5 4.1 1.3 5.7 4.0 9.4 2.6 7.1 4.1 4.1 4.0 2.9 7.2 5.6 104.2 86.2 18.1 101.0 80.9 1.1 52.3 12.7 41.5 39.8 66.3 0.0 87.3 21.6 25.4 38.4 101.2 0.0 0.0 41.2 91.7 155.8 97.0 19.7 19.5 105.1 1.6 0.0 160.8 119.6 15.3 82.3 73.9 52.3 19.0 0.0 19.2 65.7 0.6 93.0 29.9 1.0 77.6 83.0 1.8 8.5 72.1 333.1 71.0 0.4 131.7 RCAN1 DSCR1 ENSG00000159200 "Regulator of calcineurin 1" P53805 21 34513142-34615142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 220.2" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 195.4;Hepatocytes: 146.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "SK-MEL-30: 156.7;WM-115: 102.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037218, HPA068436" Enhanced Approved Cytosol NA NA Cytosol "CAB037218: AB_2179743, HPA068436: " "unprognostic (3.83e-2)" "unprognostic (4.40e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (9.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.82e-3)" "unprognostic (5.27e-2)" "unprognostic (7.99e-2)" "unprognostic (4.83e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (4.07e-3)" "unprognostic (1.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-2)" "unprognostic (2.60e-3)" 21.5 7.9 22.2 15.8 25.8 2.8 20.7 14.8 19.6 29.3 12.2 27.7 3.2 10.6 10.6 7.4 10.1 4.2 18.8 18.6 22.4 22.4 27.1 77.3 15.0 7.5 27.2 11.1 5.0 20.3 220.2 11.2 30.4 18.1 8.9 13.3 12.6 6.9 5.9 10.9 9.7 13.5 15.4 41.3 5.2 13.1 3.7 19.4 19.9 19.8 12.2 6.9 19.8 6.9 1.6 5.2 8.0 3.9 0.2 1.9 0.9 5.8 1.1 6.0 3.8 3.3 2.0 3.7 21.9 22.6 9.0 9.0 6.6 5.6 0.1 1.0 12.7 17.9 0.5 4.3 4.4 12.2 3.3 2.6 1.1 2.0 3.1 12.8 1.8 3.7 5.3 4.0 10.7 7.5 2.2 2.9 4.0 2.2 5.7 5.9 2.8 17.4 1.4 3.4 5.8 2.9 6.6 4.7 2.7 2.8 10.1 2.9 1.2 16.0 10.4 156.7 5.7 14.0 3.1 3.2 30.5 3.1 5.0 5.3 5.0 3.1 1.0 10.0 5.4 102.2 0.0 2.0 8.0 1.3 3.4 1.9 1.6 1.6 1.2 2.7 1.2 0.7 1.3 1.0 0.2 3.9 5.2 1.8 0.9 22.2 25.8 14.8 19.6 22.4 22.4 27.2 11.1 18.1 19.4 89.3 64.0 6.7 17.3 84.0 14.8 21.4 22.9 16.0 17.0 195.4 25.5 6.3 18.3 67.7 38.0 57.3 62.2 0.0 16.3 10.7 35.7 12.5 8.1 146.7 46.2 3.2 3.5 25.2 24.5 9.6 6.6 30.2 54.0 38.7 22.2 10.6 25.9 38.4 9.2 96.4 6.7 0.0 82.6 11.9 2.3 69.4 9.3 5.2 8.4 34.1 REEP2 "C5orf19, SGC32445, SPG72, Yip2d" ENSG00000132563 "Receptor accessory protein 2" Q9BRK0 5 138439017-138446969 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.9" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 50.6;Cone photoreceptor cells: 66.8;Horizontal cells: 46.1;Rod photoreceptor cells: 59.8" "Cancer enriched" "Detected in many" 9 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 21 "dendritic cells: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 41.9;SCLC-21H: 17.6;SH-SY5Y: 19.8;U-87 MG: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031813, HPA076571" Enhanced Approved Cytosol NA NA Cytosol "HPA031813: AB_2674054, HPA076571: " "prognostic favorable (7.83e-5)" "unprognostic (1.11e-2)" "unprognostic (3.97e-6)" "unprognostic (3.70e-3)" "prognostic unfavorable (6.65e-4)" "unprognostic (5.43e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-1)" "prognostic favorable (9.31e-4)" "unprognostic (5.93e-2)" "unprognostic (3.70e-3)" "unprognostic (9.78e-2)" "unprognostic (6.54e-3)" "unprognostic (7.54e-2)" "unprognostic (1.47e-3)" "unprognostic (6.19e-3)" "unprognostic (1.13e-3)" 5.2 10.9 27.2 3.4 27.2 1.2 2.0 37.0 58.9 3.0 4.4 5.9 0.4 2.8 3.7 2.6 5.6 2.8 3.6 10.5 29.3 32.1 1.6 1.0 1.5 1.4 27.9 19.6 3.5 2.9 2.8 13.9 1.6 25.8 6.1 3.3 7.9 2.1 9.9 15.6 2.0 3.1 13.6 9.7 1.2 2.2 4.5 6.3 0.0 1.4 0.5 1.5 4.1 1.1 0.0 1.0 0.0 0.0 0.0 3.2 0.3 0.2 3.1 12.0 41.9 1.8 4.7 0.0 3.6 1.7 4.9 5.7 2.2 0.4 0.0 0.6 4.4 0.1 0.2 11.4 2.3 3.8 1.2 10.1 0.0 0.8 5.4 4.4 0.0 0.0 1.5 0.1 2.8 0.2 8.9 1.0 11.7 0.0 3.0 1.6 1.8 1.0 0.7 7.4 0.0 0.1 4.0 1.1 0.0 0.9 0.0 17.6 19.8 1.2 0.0 3.0 3.2 1.1 0.4 0.1 2.8 2.9 2.7 6.7 7.8 4.9 0.3 15.8 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 3.2 0.3 27.2 27.2 37.0 35.6 29.3 32.1 27.9 19.6 25.8 6.3 0.0 0.0 0.0 0.8 0.6 50.6 8.7 0.0 0.0 0.0 1.8 66.8 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.1 46.1 4.6 0.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 16.1 0.1 0.0 2.5 0.2 59.8 0.0 3.4 0.4 3.0 0.4 0.0 0.0 0.0 0.1 REEP4 "C8orf20, FLJ22246, FLJ22277, PP432, Yip2c" ENSG00000168476 "Receptor accessory protein 4" Q9H6H4 8 22138020-22141951 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 93.5;Syncytiotrophoblasts: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042683 Approved Approved Cytosol No Yes Cytosol "HPA042683: AB_2571730" "unprognostic (2.38e-1)" "unprognostic (9.96e-3)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (3.41e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (4.14e-5)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.88e-5)" "unprognostic (5.72e-2)" "unprognostic (1.06e-1)" "unprognostic (2.25e-1)" "unprognostic (6.65e-2)" 6.3 4.3 3.9 9.2 6.2 18.1 22.9 2.3 4.3 12.8 11.9 6.9 4.0 8.4 5.6 5.4 39.8 5.5 11.1 4.5 3.4 2.9 5.2 6.4 18.0 16.5 7.2 2.5 4.9 11.0 3.2 5.6 35.8 5.7 9.2 8.8 4.5 11.0 6.0 3.0 43.1 8.6 5.2 7.5 19.9 12.3 19.1 6.8 14.5 10.8 20.4 24.9 12.4 20.8 4.4 17.7 25.9 23.6 9.8 10.9 10.2 12.3 25.7 8.3 13.0 3.6 3.6 14.7 11.1 6.3 14.6 13.3 14.8 12.6 15.1 14.6 6.1 12.9 32.0 9.9 19.2 7.5 8.4 11.3 16.2 13.6 15.1 3.9 7.4 25.1 3.3 37.1 11.1 9.4 4.7 8.9 18.4 12.7 52.8 7.5 19.0 19.1 26.9 12.0 18.9 16.1 10.8 6.9 30.9 6.6 13.3 6.7 12.3 9.0 10.5 16.0 5.8 20.8 11.3 9.1 9.7 15.8 21.6 15.6 12.1 9.1 9.9 10.9 16.8 19.2 17.7 23.6 25.9 10.9 23.0 8.5 4.4 9.6 9.1 17.7 2.2 4.5 5.9 6.8 9.8 15.3 6.9 6.1 10.2 3.9 6.2 2.3 4.3 3.4 2.9 7.2 2.5 5.7 6.8 3.0 8.6 6.7 15.8 24.8 5.4 1.4 7.6 2.7 5.7 12.2 2.0 42.2 0.0 21.3 7.0 6.7 17.0 93.5 13.4 42.8 9.8 4.1 10.3 4.9 49.9 0.0 16.7 13.5 40.7 7.4 8.3 23.4 3.3 11.8 28.1 2.1 18.6 28.6 7.8 1.8 1.6 12.9 10.3 28.2 16.8 34.4 78.7 13.1 29.0 18.3 REG3A "HIP, PAP, PAP1, PBCGF, REG-III, REG3" ENSG00000172016 "Regenerating family member 3 alpha" Q06141 2 79157003-79159753 "Plasma proteins, Predicted secreted proteins, Transporters" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "intestine: 354.2;pancreas: 502.4" "Cell type enriched" "Detected in some" 5 "Pancreatic endocrine cells: 8841.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 710.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.4;EFO-21: 11.8;HDLM-2: 10.9;NB-4: 12.2;RPMI-8226: 15.7;SH-SY5Y: 10.2;U-2 OS: 19.4;U-251 MG: 7.2;U-266/84: 10.2" "HPA047894, HPA048334, HPA060705" Supported Approved Cytosol "Secreted to digestive system" NA NA 22000000 Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (2.43e-2)" "unprognostic (2.12e-1)" "unprognostic (3.62e-2)" "unprognostic (1.42e-1)" 0.2 0.4 0.2 0.4 0.2 0.0 0.2 0.2 0.2 0.2 73.1 0.2 0.2 276.3 0.2 0.2 0.2 0.0 1.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 502.4 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 354.2 0.2 0.2 0.2 6.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.1 0.2 0.0 0.0 0.0 15.7 0.0 0.0 1.2 10.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.4 3.8 7.2 0.0 10.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.8 4.3 0.0 5.2 0.0 1666.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 97.4 19.1 0.0 8841.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 REG3G "LPPM429, PAP1B, UNQ429" ENSG00000143954 "Regenerating family member 3 gamma" Q6UW15 2 79025686-79028505 "Predicted secreted proteins" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 262.6" "Group enriched" "Detected in some" 25 "Exocrine glandular cells: 161.0;Pancreatic endocrine cells: 87.4" "Cancer enriched" "Detected in many" 13 "pancreatic cancer: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.0;RPMI-8226: 1.0;SK-MEL-30: 3.1;U-2 OS: 1.6;U-266/84: 1.3" "HPA047894, HPA048334, HPA060705" Uncertain Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (8.82e-2)" "unprognostic (7.20e-3)" "unprognostic (5.64e-2)" 0.1 3.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.8 0.6 0.1 61.1 0.1 0.0 0.1 0.1 0.1 0.0 7.1 0.1 0.1 0.1 0.1 0.1 0.1 262.6 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 2.8 0.3 0.1 0.1 0.0 19.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 1.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 161.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.6 0.0 0.0 1.0 0.0 0.0 87.4 0.0 0.7 2.4 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 RELA "NFKB3, p65" ENSG00000173039 "RELA proto-oncogene, NF-kB subunit" Q04206 11 65653596-65663094 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004264, CAB005030, HPA063461" Supported Enhanced Cytosol NA NA Cytosol "CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: AB_2685016" "unprognostic (9.17e-2)" "unprognostic (1.79e-1)" "unprognostic (2.04e-1)" "unprognostic (3.22e-1)" "unprognostic (7.67e-2)" "unprognostic (5.39e-2)" "prognostic unfavorable (9.18e-4)" "unprognostic (1.30e-3)" "unprognostic (1.69e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (5.66e-4)" "unprognostic (2.78e-1)" "unprognostic (1.46e-1)" "unprognostic (9.81e-2)" "unprognostic (2.53e-1)" 36.2 23.1 21.4 27.6 32.0 50.2 37.8 21.5 28.2 35.6 32.3 22.9 23.6 23.6 36.9 26.8 36.4 32.8 33.6 28.9 21.1 12.9 28.4 38.5 37.7 30.8 35.6 13.3 51.9 29.0 27.3 19.3 27.1 22.6 31.1 19.7 23.9 32.8 39.2 46.5 35.2 26.7 33.5 29.5 38.1 31.8 20.6 30.1 34.3 26.3 30.6 36.4 54.7 38.8 15.2 13.2 18.3 14.4 21.3 23.3 12.4 26.2 27.0 12.1 16.8 19.3 18.8 12.2 20.2 24.5 23.3 18.9 12.3 26.7 19.9 33.9 28.3 27.4 23.5 13.8 24.5 16.5 23.4 19.9 21.8 20.2 17.8 21.2 16.2 31.0 21.6 24.2 25.9 30.7 22.7 28.2 15.9 21.9 23.1 18.7 35.0 29.3 13.6 7.9 16.0 23.8 24.5 11.8 29.7 19.5 23.8 9.9 22.9 17.2 27.1 26.9 9.6 31.5 10.6 38.4 25.2 21.6 38.5 19.1 35.2 32.3 21.2 28.5 11.1 24.0 10.5 11.3 15.1 20.5 14.4 23.3 15.2 18.2 20.4 13.2 13.7 17.3 18.2 18.3 21.3 12.5 13.1 17.8 12.4 21.4 32.0 21.5 28.2 21.1 12.9 35.6 13.3 22.6 30.1 29.8 26.7 18.2 42.0 42.0 8.6 20.2 15.3 14.7 21.6 10.4 7.9 20.6 24.9 37.4 3.6 38.3 20.1 0.0 39.0 20.1 24.9 50.9 42.8 17.9 21.7 14.3 18.9 33.2 23.4 5.6 26.7 20.1 30.4 41.5 22.3 13.7 49.8 20.1 24.8 13.7 9.0 12.9 37.1 9.9 17.9 37.8 36.5 29.6 19.6 63.8 RETREG2 "C2orf17, FAM134A, MAG-2, MGC3035" ENSG00000144567 "Reticulophagy regulator family member 2" Q8NC44 2 219176225-219185479 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 43.6;Ductal cells: 36.6;Exocrine glandular cells: 41.9;Extravillous trophoblasts: 32.2;Hofbauer cells: 31.4;Pancreatic endocrine cells: 35.3;Proximal tubular cells: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011170, HPA011844" Approved Approved Cytosol NA NA Cytosol "HPA011170: AB_1845713, HPA011844: AB_2668544" "unprognostic (2.63e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (7.95e-4)" "unprognostic (1.03e-1)" "unprognostic (2.88e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (1.49e-4)" "unprognostic (8.74e-2)" "unprognostic (9.61e-2)" "unprognostic (1.34e-2)" "unprognostic (4.37e-2)" "unprognostic (2.36e-1)" "unprognostic (4.29e-3)" "unprognostic (4.45e-2)" "unprognostic (4.47e-2)" "unprognostic (1.53e-2)" "unprognostic (3.70e-2)" 14.8 22.4 27.8 14.8 34.2 23.8 22.3 38.5 56.9 20.9 20.0 24.1 20.0 18.6 19.9 28.8 18.7 23.8 18.9 10.8 28.2 28.7 31.2 24.0 17.4 18.1 26.6 35.7 32.7 29.5 38.0 20.2 16.6 26.7 18.4 23.5 20.0 20.7 19.1 10.6 19.5 18.1 20.7 21.5 17.4 17.6 61.4 16.5 15.1 28.0 12.8 19.7 18.6 24.7 6.8 5.8 21.1 7.3 4.2 8.7 2.9 12.5 13.4 11.6 17.5 44.0 18.7 12.3 15.4 26.7 18.8 16.4 13.4 21.7 10.3 15.5 29.0 38.7 16.3 13.9 13.8 20.8 14.4 11.6 13.7 18.6 22.1 25.3 14.8 19.0 20.2 36.2 21.1 20.4 32.5 16.9 11.2 9.4 23.8 26.0 18.5 8.9 16.1 8.5 16.1 15.7 11.4 12.8 8.3 15.5 14.8 16.6 17.1 9.9 19.2 36.4 18.9 16.0 16.5 13.3 21.1 11.4 29.8 11.5 24.1 13.7 11.6 22.1 14.8 11.6 8.5 5.7 5.3 8.5 7.3 7.8 6.8 7.0 8.7 3.8 5.8 6.4 8.1 21.1 4.2 6.6 5.8 8.1 2.9 27.8 34.2 38.5 56.9 28.2 28.7 26.6 35.7 26.7 16.5 14.9 13.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 11.4 43.6 0.0 25.1 18.3 36.6 0.0 0.0 0.0 0.0 41.9 32.2 0.0 0.0 4.7 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 19.8 0.0 0.0 35.3 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.0 REV1 REV1L ENSG00000135945 "REV1, DNA directed polymerase" Q9UBZ9 2 99400475-99490035 "Predicted intracellular proteins" "DNA damage, DNA repair, DNA synthesis" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044534, HPA051036" Uncertain Approved Cytosol NA NA Cytosol "HPA044534: AB_2678975, HPA051036: AB_2681319" "unprognostic (3.05e-1)" "unprognostic (3.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (7.87e-3)" "unprognostic (1.30e-3)" "unprognostic (3.56e-3)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (3.17e-1)" "unprognostic (1.45e-1)" "unprognostic (4.36e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-3)" 12.0 15.5 11.0 15.8 16.9 7.8 14.5 32.5 15.6 14.1 10.4 12.2 13.4 7.6 18.3 23.1 13.7 14.8 10.3 14.4 10.1 9.1 11.3 12.4 14.1 12.2 10.5 11.3 16.5 11.1 13.7 16.7 9.1 10.8 14.9 12.1 14.1 12.1 16.2 17.8 12.9 14.3 15.4 10.5 11.2 10.1 11.8 11.1 10.1 13.3 12.8 15.7 16.0 18.2 1.6 1.1 0.4 0.6 1.3 3.3 0.6 7.0 1.8 11.3 4.3 8.9 8.8 12.3 8.0 9.7 9.1 10.5 4.0 6.7 14.3 6.4 8.1 9.6 9.8 8.4 10.3 14.3 6.6 6.8 7.4 6.5 9.1 10.0 9.2 15.3 8.5 12.6 8.1 12.0 10.2 11.6 7.3 8.5 4.9 10.0 4.5 9.6 16.8 8.2 4.5 5.9 15.4 8.6 6.1 11.2 11.9 7.5 7.9 7.2 5.8 10.1 12.8 6.0 13.4 8.8 10.9 9.2 4.5 5.1 6.6 6.8 11.6 4.4 11.9 8.3 0.0 0.6 0.2 1.3 0.6 0.8 0.4 1.8 1.6 1.1 1.6 3.3 2.8 0.4 1.3 0.5 0.6 1.1 0.6 11.0 16.9 32.5 15.6 10.1 9.1 10.5 11.3 10.8 11.1 65.5 45.7 19.7 49.2 42.8 81.5 48.1 5.1 32.1 45.5 21.0 37.3 27.9 5.0 16.0 21.1 28.7 23.3 70.0 16.0 16.9 25.3 37.2 24.3 12.9 16.6 77.9 16.8 22.7 13.8 17.5 25.0 25.0 18.6 25.2 16.6 40.2 13.4 21.0 43.5 9.8 61.1 25.8 21.2 56.7 48.5 31.0 29.4 19.7 17.7 53.5 RGN "RC, SMP30" ENSG00000130988 Regucalcin Q15493 X 47078355-47093314 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 51.0;liver: 118.8" "Cell type enhanced" "Detected in many" 13 "Distal tubular cells: 49.7;Hepatocytes: 141.5;Muller glia cells: 48.0;Peritubular cells: 65.4;Proximal tubular cells: 86.9" "Cancer enriched" "Detected in many" 6 "liver cancer: 47.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 16.5;fHDF/TERT166: 5.3;Hep G2: 24.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029102, HPA029103, HPA029104" Enhanced Approved Cytosol NA NA 47000 Cytosol "HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: " "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (5.56e-3)" "unprognostic (8.22e-3)" "unprognostic (1.32e-2)" "prognostic favorable (7.55e-4)" "unprognostic (2.60e-3)" "unprognostic (2.23e-2)" "unprognostic (8.38e-2)" "unprognostic (3.37e-2)" "unprognostic (1.14e-2)" "prognostic favorable (5.10e-10)" "unprognostic (1.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.82e-2)" "unprognostic (5.22e-2)" 2.6 51.0 6.7 0.6 6.5 0.4 1.5 8.4 6.2 2.8 1.9 6.2 2.5 4.5 2.3 6.1 1.5 1.7 2.0 4.5 6.1 4.2 17.6 118.8 4.9 0.7 5.9 4.5 7.5 12.7 6.2 2.5 4.2 5.0 4.8 1.1 8.4 7.5 6.3 3.8 0.6 4.6 4.9 4.4 1.1 2.9 1.5 5.2 0.0 6.5 1.6 0.6 2.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.3 0.6 0.0 0.0 16.5 0.0 0.0 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.6 0.8 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.7 6.5 8.4 6.2 6.1 4.2 5.9 4.5 5.0 5.2 6.0 2.2 0.0 2.9 0.5 10.2 25.8 7.6 2.7 1.2 14.0 0.0 0.1 49.7 8.4 0.4 1.8 0.0 0.0 7.9 0.1 7.5 0.9 0.0 141.5 0.1 4.8 4.6 6.2 4.0 0.6 23.0 0.0 1.7 0.0 0.0 48.0 7.8 0.0 65.4 86.9 1.9 12.9 8.0 0.2 0.2 0.3 0.2 0.0 0.3 1.1 RGS16 "A28-RGS14, RGS-r" ENSG00000143333 "Regulator of G protein signaling 16" O15492 1 182598623-182604408 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 67.5" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 519.8;Smooth muscle cells: 484.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 32.0;NB-4: 17.6;SCLC-21H: 33.4;U-266/70: 37.8;U-698: 47.2" "Region enriched" "Detected in many" 5 "thalamus: 87.4" "Group enriched" "Detected in many" 6 "midbrain: 92.1;pons and medulla: 72.2;thalamus: 126.3" "HPA053250, HPA055824" Uncertain Approved Cytosol NA NA Cytosol "HPA053250: AB_2682090, HPA055824: AB_2682934" "unprognostic (4.03e-2)" "unprognostic (6.08e-2)" "unprognostic (4.87e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (2.38e-2)" "unprognostic (3.55e-2)" "unprognostic (2.01e-2)" "unprognostic (2.10e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.93e-2)" "unprognostic (3.65e-2)" "unprognostic (9.07e-3)" "unprognostic (5.39e-2)" 17.8 7.5 4.5 18.6 9.8 3.0 5.2 3.3 9.9 2.4 6.4 20.7 7.2 2.3 2.6 3.7 4.5 8.0 10.8 3.6 7.4 12.3 6.7 6.8 13.3 10.8 12.0 1.3 2.9 4.3 6.0 28.1 7.9 16.5 3.7 4.1 9.1 3.3 40.8 5.2 3.0 3.5 8.0 25.0 6.1 5.1 1.2 10.7 0.3 67.5 16.2 4.9 6.1 4.2 5.8 11.5 2.2 0.9 3.4 5.4 1.4 0.2 0.0 1.9 0.0 0.3 0.0 14.8 0.0 0.5 0.0 0.0 0.0 0.1 32.0 0.1 0.0 0.0 0.1 3.5 0.3 0.0 3.6 2.6 3.3 0.3 0.0 0.5 5.3 2.9 0.7 5.4 0.0 0.2 0.0 0.0 1.1 0.1 5.6 0.0 3.5 0.1 17.6 10.3 0.2 1.0 0.0 10.6 7.6 0.0 1.5 33.4 3.5 0.0 2.7 0.0 2.0 1.1 4.2 0.0 0.1 0.7 0.9 1.6 37.8 1.7 47.2 0.1 3.4 1.7 2.2 0.4 0.7 0.4 0.5 0.8 5.8 5.4 0.6 0.6 2.3 2.5 0.8 1.4 3.4 0.9 11.5 3.2 1.4 4.5 9.8 3.3 9.9 7.4 12.3 12.0 1.3 16.5 10.7 125.0 148.7 13.4 6.7 73.2 519.8 16.5 0.0 4.0 31.8 8.7 17.7 6.1 0.0 1.6 0.4 67.1 1.3 23.3 2.0 125.4 54.3 12.1 72.5 1.0 15.6 30.2 48.3 25.8 3.7 0.0 0.3 13.9 77.6 20.8 3.8 129.8 2.8 0.9 0.4 0.3 30.5 64.7 484.2 0.0 1.5 55.2 28.8 5.7 1.9 9.0 RGS2 G0S8 ENSG00000116741 "Regulator of G protein signaling 2" P41220 1 192809039-192812283 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Translation regulation" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 234.2" "Cell type enhanced" "Detected in many" 16 "granulocytes: 1743.9;Macrophages: 609.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 135.8;neutrophil: 234.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 234.2" "Cell line enhanced" "Detected in many" "hTCEpi: 39.9;hTERT-HME1: 27.6;Karpas-707: 26.2;PC-3: 63.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013385 Supported Cytosol NA NA Cytosol "HPA013385: AB_2668827" "prognostic favorable (2.43e-4)" "unprognostic (9.75e-2)" "unprognostic (1.28e-3)" "unprognostic (4.43e-2)" "unprognostic (1.79e-1)" "unprognostic (1.93e-1)" "unprognostic (2.09e-3)" "unprognostic (1.29e-2)" "unprognostic (2.59e-1)" "unprognostic (2.79e-2)" "unprognostic (1.36e-1)" "unprognostic (6.49e-2)" "prognostic unfavorable (2.90e-5)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" 22.7 62.0 8.1 39.2 20.1 84.9 23.3 6.0 10.0 20.7 57.5 4.5 50.6 23.2 43.3 34.2 45.5 27.4 35.0 14.2 8.2 13.2 9.4 10.8 24.3 32.6 8.9 6.6 25.1 84.3 1.9 52.6 16.7 16.9 99.8 19.1 44.0 5.0 54.5 4.4 6.4 33.9 135.0 19.0 50.6 22.5 13.0 7.9 3.9 4.2 5.7 6.2 72.1 28.5 0.3 6.2 234.2 26.6 0.1 1.8 12.2 0.0 5.5 7.1 0.6 14.1 2.2 0.4 2.7 3.4 0.9 0.9 4.8 3.2 0.4 0.7 2.5 0.7 2.6 4.6 4.8 0.8 0.7 3.4 1.3 3.6 0.1 6.2 3.2 0.8 2.3 39.9 1.8 27.6 5.1 6.6 2.4 1.1 26.2 2.7 0.0 1.7 4.5 9.5 0.5 63.1 1.7 1.6 1.4 4.6 4.4 2.6 13.4 1.9 0.1 3.0 7.6 0.2 1.6 1.8 1.3 1.2 1.4 1.4 15.6 0.4 1.4 19.2 0.6 4.8 135.8 26.6 38.0 0.8 10.5 1.8 0.3 0.5 0.5 6.2 0.1 0.3 0.3 234.2 0.1 17.7 0.8 0.3 12.2 8.1 20.1 6.0 10.0 8.2 13.2 8.9 6.6 16.9 7.9 47.6 315.5 133.6 46.1 37.5 21.4 56.8 2.5 30.8 62.6 129.1 17.7 168.7 0.0 22.6 22.0 24.3 61.9 23.3 26.0 21.8 64.8 43.7 1743.9 2.1 326.0 20.6 335.5 23.9 383.7 13.9 15.3 609.2 84.4 77.5 43.4 36.4 13.0 20.1 59.1 2.2 35.7 0.0 69.0 5.0 9.4 27.1 103.9 144.7 17.8 7.5 RILPL2 "FLJ30380, FLJ32372, MGC7036" ENSG00000150977 "Rab interacting lysosomal protein like 2" Q969X0 12 123410683-123436717 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Macrophages: 123.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 16.5;NB-4: 35.7;THP-1: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028958 Uncertain Supported Cytosol NA NA Cytosol "HPA028958: AB_10602124" "unprognostic (1.94e-3)" "unprognostic (3.29e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.24e-7)" "unprognostic (2.62e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.69e-2)" "unprognostic (4.08e-2)" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (1.11e-1)" "unprognostic (8.57e-2)" "unprognostic (2.10e-1)" "unprognostic (4.74e-2)" 14.8 5.6 5.8 13.2 7.1 42.9 13.6 3.8 5.7 25.1 7.7 5.3 12.8 4.1 17.8 10.6 10.2 14.2 13.4 7.4 6.3 5.1 12.8 7.8 21.6 15.3 6.3 4.7 12.2 5.0 6.0 7.0 7.7 7.2 18.2 3.8 8.2 21.4 15.6 4.4 6.5 9.8 9.6 7.6 29.9 7.6 7.8 5.8 8.6 25.7 7.4 14.3 14.0 22.0 8.5 13.6 26.2 19.0 3.1 9.0 7.8 2.5 2.5 1.2 4.6 5.2 4.2 2.9 3.1 6.4 2.4 2.1 2.7 1.4 1.6 2.6 4.3 1.7 2.1 1.9 2.1 2.5 5.1 2.0 16.5 2.6 3.9 5.5 12.5 9.7 3.4 1.6 2.6 1.9 3.8 2.5 3.6 2.3 2.0 2.1 1.7 4.5 35.7 1.1 0.9 2.6 3.7 2.6 2.9 2.6 4.3 0.6 1.6 3.6 0.8 2.8 1.8 3.5 22.8 3.1 2.5 2.8 4.3 1.9 2.2 1.7 3.2 2.5 8.9 1.2 12.5 19.0 21.5 3.8 14.4 3.5 8.5 7.8 6.5 13.6 5.7 3.4 3.7 26.2 3.1 15.7 6.9 9.0 7.8 5.8 7.1 3.8 5.7 6.3 5.1 6.3 4.7 7.2 5.8 32.8 66.4 47.4 59.9 21.8 1.0 3.7 28.1 50.9 42.1 21.0 2.0 8.6 21.6 16.7 1.7 50.1 1.1 0.0 18.6 6.2 24.9 47.9 60.2 11.9 67.8 1.6 4.1 49.1 107.3 0.9 46.6 123.1 35.4 92.0 7.5 12.2 16.2 3.7 62.2 44.4 1.6 6.5 38.1 0.7 14.0 13.4 6.8 70.5 3.7 63.3 RIOK1 "AD034, bA288G3.1, FLJ30006, RRP10" ENSG00000124784 "RIO kinase 1" Q9BRS2 6 7389496-7418037 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017866, HPA051446" Enhanced Supported Cytosol NA NA Cytosol "HPA017866: AB_2669670, HPA051446: AB_2681488" "unprognostic (2.33e-2)" "unprognostic (1.24e-1)" "unprognostic (2.38e-1)" "unprognostic (1.03e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.41e-5)" "unprognostic (2.23e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (3.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.85e-5)" "unprognostic (2.33e-1)" "unprognostic (2.09e-1)" "unprognostic (6.12e-3)" "unprognostic (2.59e-2)" 13.8 10.6 7.7 13.2 13.0 17.5 13.1 12.2 13.5 12.7 11.6 7.3 4.0 7.3 15.4 6.0 15.6 12.3 8.5 11.8 8.0 8.1 8.7 11.7 10.1 14.2 11.6 9.4 13.8 15.3 7.7 17.8 13.9 13.3 10.7 9.6 7.2 10.2 10.3 18.8 12.5 9.9 15.5 9.4 14.4 10.3 21.3 9.2 19.2 10.1 14.7 16.8 10.9 12.6 15.4 14.9 7.7 11.1 18.6 15.0 8.2 7.6 4.4 7.2 16.8 11.2 9.2 11.0 9.6 6.5 9.0 7.4 12.9 3.9 19.9 17.1 7.8 7.8 7.8 18.1 7.7 11.5 13.1 19.5 10.6 7.1 13.8 9.5 30.5 13.9 6.8 10.7 9.7 20.0 4.3 7.9 15.0 27.0 4.7 8.4 10.0 20.7 14.5 15.4 14.2 10.5 15.9 9.4 21.6 5.0 7.4 24.0 11.8 8.1 4.9 14.0 19.4 7.4 10.1 7.9 9.8 7.4 6.5 14.5 6.4 12.2 29.6 3.0 15.7 15.0 7.7 8.5 5.9 11.5 11.1 13.8 15.2 11.9 12.1 14.9 15.4 13.7 15.0 1.7 18.6 9.7 12.4 11.3 8.2 7.7 13.0 12.2 13.5 8.0 8.1 11.6 9.4 13.3 9.2 6.0 26.6 22.4 26.7 46.9 9.2 20.4 2.5 25.4 45.5 7.0 9.8 29.8 3.3 13.2 34.2 23.9 5.8 0.0 10.2 28.8 22.0 11.9 32.4 8.9 20.4 4.8 6.9 17.2 6.5 6.5 18.4 16.7 16.9 11.8 10.4 5.5 10.9 5.8 18.7 9.0 10.4 19.4 26.4 55.6 78.8 56.7 23.3 22.0 15.3 20.6 RIPK2 "CARD3, CARDIAK, RICK, RIP2" ENSG00000104312 "Receptor interacting serine/threonine kinase 2" O43353 8 89757747-89791063 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Apoptosis, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015273, HPA016499" Approved Enhanced Cytosol NA NA Cytosol "HPA015273: AB_1856299, HPA016499: AB_1856300" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (2.35e-1)" "unprognostic (3.82e-2)" "unprognostic (1.67e-1)" "unprognostic (6.20e-2)" "unprognostic (1.43e-3)" "prognostic unfavorable (6.33e-5)" "unprognostic (2.06e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (5.00e-6)" "unprognostic (6.39e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.84e-2)" "unprognostic (5.08e-2)" "unprognostic (1.05e-2)" "prognostic favorable (8.05e-4)" 12.0 5.5 9.3 11.2 7.9 13.6 10.0 3.0 9.3 9.7 7.9 10.6 5.2 3.5 10.9 7.8 8.3 7.0 17.3 11.6 9.2 8.6 7.7 10.4 18.7 10.9 11.8 5.8 8.9 13.2 14.7 7.3 20.8 9.1 10.7 5.6 4.6 10.2 5.8 3.1 10.4 6.9 10.4 16.5 14.2 8.3 5.6 11.5 5.1 8.5 4.9 11.8 15.0 7.6 7.5 6.9 19.4 11.2 3.8 5.5 4.3 10.3 3.6 1.8 2.6 4.5 6.3 3.4 11.5 19.6 6.1 7.9 3.1 5.4 8.0 17.9 6.4 4.9 2.5 4.9 3.8 11.3 5.7 4.9 6.7 1.7 3.1 12.7 2.4 3.3 5.0 3.1 8.7 28.1 6.5 6.4 0.0 3.2 2.6 5.6 2.1 0.0 5.1 1.0 4.7 8.5 1.7 2.6 3.9 14.3 4.6 0.3 2.0 2.7 7.2 5.4 2.5 7.0 3.0 5.7 3.7 3.5 6.3 5.3 5.3 2.4 4.8 9.1 0.2 2.4 8.8 5.7 19.4 3.6 10.6 4.1 7.5 5.5 4.7 6.9 4.3 5.2 5.5 4.5 3.8 11.2 2.3 1.2 4.3 9.3 7.9 3.0 7.4 9.2 8.6 11.8 5.8 9.1 11.5 32.8 17.8 13.4 31.1 51.2 2.4 2.8 5.1 10.7 22.7 3.5 0.0 10.6 5.0 66.4 5.0 9.5 2.3 0.0 53.1 35.2 38.5 46.3 42.7 2.6 39.0 3.2 0.0 5.5 25.3 1.6 7.2 48.6 18.6 50.5 5.2 10.0 41.2 0.0 5.6 6.7 0.1 12.9 22.7 8.1 10.9 42.2 70.0 12.7 6.6 40.4 RNASEL "PRCA1, RNS4" ENSG00000135828 "Ribonuclease L" Q05823 1 182573634-182589256 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002633, CAB010906" Approved Supported Cytosol NA NA Cytosol "CAB010906: AB_477444, HPA002633: AB_1856314" "unprognostic (3.46e-2)" "unprognostic (9.10e-2)" "unprognostic (7.74e-2)" "unprognostic (1.13e-1)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.43e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.81e-1)" 8.1 10.8 7.4 9.5 10.9 3.7 8.3 5.7 7.7 12.5 9.3 6.7 8.5 8.0 12.4 11.9 10.0 8.8 8.0 5.8 7.0 5.3 9.9 3.9 8.4 10.1 7.7 3.3 14.0 5.3 13.5 18.0 8.5 10.1 10.5 10.8 13.3 10.5 10.3 4.1 6.3 12.2 9.6 7.4 10.5 8.8 3.5 6.7 13.3 13.3 2.8 11.0 13.9 11.0 5.0 7.2 26.9 13.5 5.0 9.2 4.9 2.3 3.3 1.4 0.5 7.7 13.4 2.6 4.5 5.7 4.7 4.3 1.9 5.2 5.1 8.0 5.1 2.1 4.3 3.4 4.7 1.8 4.1 2.8 6.0 1.2 0.2 3.9 11.1 11.9 9.5 10.8 2.5 0.7 3.0 2.0 7.6 2.1 4.0 4.0 3.4 3.2 4.6 1.1 7.6 0.9 4.8 1.1 2.6 4.9 3.1 0.7 0.2 4.1 5.0 3.9 3.8 5.1 12.4 2.6 2.4 1.9 2.6 2.5 3.5 1.2 0.6 3.8 6.8 3.5 16.8 7.2 24.6 4.9 7.6 6.4 5.0 5.8 5.2 6.0 3.8 9.2 6.7 26.9 5.0 13.5 7.2 4.6 4.9 7.4 10.9 5.7 7.7 7.0 5.3 7.7 3.3 10.1 6.7 6.0 3.4 2.4 2.7 0.9 1.9 1.2 2.5 8.1 5.7 3.5 3.9 3.4 6.6 5.6 0.0 3.6 6.3 0.0 1.6 2.6 3.7 2.7 5.7 1.5 5.5 1.6 2.4 3.1 10.0 0.0 2.6 4.6 0.0 1.0 7.1 9.1 2.6 3.5 6.0 6.1 6.3 19.4 2.1 0.1 0.9 0.9 2.2 6.9 3.0 4.2 RNF123 "FLJ12565, KPC1" ENSG00000164068 "Ring finger protein 123" Q5XPI4 3 49689499-49721529 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065983, HPA071879" Supported Approved Cytosol NA NA Cytosol "HPA065983: AB_2685592, HPA071879: AB_2686468" "unprognostic (2.68e-1)" "unprognostic (3.34e-1)" "unprognostic (2.67e-1)" "unprognostic (1.04e-1)" "unprognostic (2.21e-1)" "unprognostic (9.51e-2)" "unprognostic (2.04e-1)" "unprognostic (3.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.07e-1)" "unprognostic (7.51e-2)" "unprognostic (5.03e-3)" "prognostic favorable (1.33e-8)" "unprognostic (5.69e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-2)" "unprognostic (3.83e-1)" 5.3 8.0 7.7 8.0 10.4 17.5 5.0 13.8 13.6 5.2 6.8 6.2 7.8 12.7 6.4 8.0 7.5 6.4 7.0 12.9 8.5 6.8 8.4 21.8 5.7 6.1 7.3 6.6 5.1 7.7 8.9 8.4 7.3 6.6 7.3 4.8 7.6 6.9 6.7 81.2 7.7 12.5 6.2 6.7 7.6 6.9 8.8 7.8 8.3 6.2 12.0 9.1 6.6 4.8 11.3 12.7 11.8 10.9 7.7 11.4 5.3 6.7 9.6 11.4 11.8 17.4 10.8 12.3 8.8 11.7 11.3 12.6 10.2 11.7 16.5 8.1 12.6 10.0 8.5 8.6 13.3 7.9 10.9 11.8 13.4 18.9 22.3 17.4 13.0 14.6 13.6 13.1 10.6 12.3 11.2 11.6 16.8 14.1 14.3 9.5 10.1 13.7 21.1 6.3 8.5 15.5 6.5 7.0 17.0 15.4 11.5 7.8 15.7 12.2 10.8 13.4 6.7 11.1 23.4 12.0 9.9 12.1 8.9 10.9 19.5 19.1 6.6 14.1 16.5 14.9 11.8 10.9 7.9 11.4 9.5 6.8 9.8 7.2 6.8 8.6 11.3 8.7 8.2 6.3 7.7 9.7 12.7 5.5 5.3 7.7 10.4 13.8 13.6 8.5 6.8 7.3 6.6 6.6 7.8 8.9 4.0 4.4 2.4 2.1 8.6 1.0 20.4 1.4 4.5 3.5 3.9 5.6 5.0 4.9 10.6 3.6 13.1 0.0 4.8 3.6 4.9 4.4 6.9 23.8 4.8 6.4 6.4 9.8 9.9 12.6 6.9 3.2 3.3 4.6 5.9 3.5 6.0 7.0 5.3 8.5 8.2 0.0 4.9 8.7 9.1 2.6 7.1 2.9 6.3 3.7 RNF180 ENSG00000164197 "Ring finger protein 180" Q86T96 5 64165844-64372869 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 54.0" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 31.9;Muller glia cells: 32.9;Sertoli cells: 38.8" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006897 Approved Approved Cytosol NA NA Cytosol "HPA006897: AB_1856348" "unprognostic (7.46e-2)" "unprognostic (3.90e-3)" "unprognostic (3.19e-2)" "unprognostic (8.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.72e-1)" "unprognostic (5.57e-2)" "unprognostic (2.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (3.68e-2)" "prognostic favorable (6.81e-5)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.81e-2)" "unprognostic (9.81e-3)" 8.1 8.1 9.9 3.1 12.8 1.6 6.3 6.0 13.0 10.1 7.1 5.5 20.1 3.4 12.7 11.8 6.9 8.1 7.3 10.4 7.4 10.6 12.4 7.2 6.1 3.4 9.4 9.3 12.0 6.6 54.0 16.1 2.0 10.7 11.5 3.0 11.3 7.3 16.4 4.4 6.6 3.2 15.0 11.0 5.1 5.0 8.1 7.1 0.0 20.6 2.5 2.4 10.9 7.9 2.4 1.0 4.2 1.8 2.0 4.2 0.3 0.0 0.1 1.3 0.0 0.0 0.0 0.3 1.1 0.5 1.1 0.6 0.0 0.1 0.0 0.1 0.8 0.6 0.2 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.2 0.1 2.7 0.0 0.1 5.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.5 0.0 1.3 0.1 3.3 25.4 1.9 0.3 0.3 0.1 0.0 0.3 0.0 1.7 1.3 0.1 0.1 0.0 3.2 0.1 2.9 0.0 0.0 0.0 0.5 0.0 3.6 3.0 1.8 4.2 1.9 0.6 2.5 1.4 3.0 3.2 0.6 2.4 4.2 3.9 2.6 2.0 0.8 1.0 1.8 0.3 9.9 12.8 6.0 11.7 7.4 10.6 9.4 9.3 10.7 7.1 14.9 10.5 0.0 6.5 4.0 16.5 9.6 12.7 2.7 7.9 15.7 13.7 0.0 6.6 4.5 3.7 5.6 0.0 0.0 2.3 0.1 2.5 5.0 0.0 5.4 0.1 11.1 1.2 12.3 1.2 5.5 31.9 0.2 5.0 0.0 1.6 32.9 2.8 0.6 23.7 14.3 17.3 38.8 17.9 15.4 9.7 6.5 0.0 0.0 0.1 3.8 RNF19B "FLJ90005, IBRDC3" ENSG00000116514 "Ring finger protein 19B" Q6ZMZ0 1 32936445-32964685 "Enzymes, Predicted membrane proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 54.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 16.1" "Cell line enhanced" "Detected in all" "Daudi: 39.3;Karpas-707: 47.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049587, HPA063640" Approved Approved Cytosol NA NA Cytosol "HPA049587: AB_2680826, HPA063640: " "unprognostic (2.83e-2)" "unprognostic (1.77e-2)" "unprognostic (1.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "prognostic favorable (3.39e-4)" "prognostic unfavorable (5.41e-6)" "unprognostic (8.78e-2)" "unprognostic (5.02e-1)" "unprognostic (1.69e-1)" "unprognostic (9.85e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.39e-5)" "unprognostic (2.58e-2)" "unprognostic (4.93e-2)" "unprognostic (3.30e-1)" "unprognostic (1.23e-2)" 8.6 11.3 8.0 13.1 10.5 36.4 12.0 14.1 14.1 9.9 13.2 10.1 4.8 14.1 10.8 6.9 23.3 7.9 10.1 8.5 6.0 7.2 12.0 6.5 13.8 12.9 9.6 9.3 7.1 7.0 6.4 5.7 9.4 10.2 7.4 15.3 9.0 10.8 5.7 10.2 13.6 15.5 10.6 8.0 9.0 7.4 54.7 8.3 6.8 8.2 11.1 16.7 11.3 12.8 1.3 1.3 16.1 2.0 0.8 1.6 0.7 6.7 5.2 4.5 4.1 2.7 3.9 30.0 3.1 3.8 5.7 6.1 6.1 20.3 39.3 5.5 4.1 7.0 9.7 5.5 7.5 5.2 14.4 3.6 3.4 4.1 6.1 8.8 5.2 7.2 3.1 14.0 12.5 15.4 6.6 11.9 3.9 4.2 47.3 5.5 2.2 3.4 6.4 7.2 7.7 5.9 4.6 6.4 4.0 4.4 9.8 7.1 3.6 10.0 3.4 22.4 11.5 2.9 7.6 13.0 3.1 4.3 7.8 5.4 11.3 5.7 13.9 4.5 5.3 4.6 5.3 2.0 3.5 1.6 1.8 1.2 1.2 1.4 0.8 1.3 1.3 0.4 0.6 16.1 0.8 1.5 0.6 1.5 0.7 8.0 10.5 14.1 14.1 6.0 7.2 9.6 9.3 10.2 8.3 11.9 4.1 1.9 20.3 41.0 4.4 12.0 15.3 6.7 2.3 7.0 2.0 11.0 1.7 9.3 30.1 8.7 34.3 0.0 9.9 5.4 7.1 22.8 4.6 3.4 12.6 3.2 10.9 3.7 20.2 18.4 2.0 28.7 5.0 43.3 16.5 2.0 19.2 17.5 3.5 7.1 7.4 0.0 5.4 29.3 12.6 28.4 6.2 3.2 10.5 35.3 RNF207 "C1orf188, FLJ32096, FLJ46380" ENSG00000158286 "Ring finger protein 207" Q6ZRF8 1 6205475-6221299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 24.2" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 28.2;Urothelial cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 2.7" "Lineage enriched" "Detected in single" 8 "monocytes: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.8;HaCaT: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028378, HPA042535" Uncertain Approved Cytosol NA NA Cytosol "HPA028378: AB_10601157, HPA042535: AB_2678042" "unprognostic (5.53e-3)" "unprognostic (1.23e-1)" "unprognostic (1.62e-2)" "unprognostic (4.46e-2)" "unprognostic (4.84e-2)" "unprognostic (5.91e-3)" "unprognostic (9.48e-2)" "unprognostic (1.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.74e-2)" "unprognostic (9.93e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.76e-2)" "unprognostic (2.93e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" 1.6 2.1 0.6 6.6 1.5 0.3 1.9 5.6 1.8 5.7 5.8 0.9 13.3 2.8 3.6 3.8 4.4 4.7 6.6 24.2 0.7 2.1 5.9 4.3 2.0 2.2 0.7 0.2 3.3 5.3 3.3 4.0 9.2 0.9 7.7 2.4 10.6 6.1 16.6 2.5 1.1 8.2 7.6 1.2 1.9 3.5 1.2 0.6 1.4 6.4 2.8 8.7 5.0 5.0 0.0 0.0 0.0 2.7 0.0 0.3 0.1 2.3 4.5 0.4 3.2 0.2 0.4 2.9 1.5 1.1 0.3 0.4 2.3 17.8 0.3 1.2 1.2 0.0 7.6 0.4 1.1 0.1 2.4 1.8 0.1 5.5 2.3 1.5 1.8 0.1 1.3 0.3 0.0 0.0 4.4 0.1 0.4 0.6 3.9 0.1 1.7 0.2 0.3 0.2 0.4 4.1 0.0 0.8 3.2 2.6 4.0 0.5 1.2 2.4 1.6 1.1 0.8 2.9 0.1 0.5 0.0 0.7 0.5 0.0 3.8 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.2 0.1 0.6 1.5 5.6 1.8 0.7 2.1 0.7 0.2 0.9 0.6 8.9 3.8 0.5 28.2 0.2 3.0 14.6 12.7 4.0 15.9 17.4 2.0 11.4 0.0 13.4 0.7 0.7 6.8 0.0 8.6 5.7 3.7 17.2 0.0 3.4 1.0 3.2 3.5 1.8 0.0 0.0 0.0 1.7 0.0 3.6 9.2 6.5 12.5 2.9 1.1 1.9 18.7 6.5 5.0 0.1 2.3 0.4 4.7 0.5 6.0 32.3 RNF213 "C17orf27, KIAA1554, KIAA1618, MYMY2, NET57" ENSG00000173821 "Ring finger protein 213" Q63HN8 17 80260866-80398786 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Ubl conjugation pathway" "Hydrolase, Transferase" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003347, HPA026790" Approved Supported Cytosol NA NA Cytosol "HPA003347: AB_1079204, HPA026790: AB_10602296" "unprognostic (8.98e-2)" "unprognostic (1.60e-1)" "unprognostic (8.97e-3)" "prognostic unfavorable (4.65e-5)" "unprognostic (7.39e-2)" "unprognostic (3.99e-2)" "unprognostic (2.23e-2)" "unprognostic (1.52e-1)" "unprognostic (4.57e-2)" "unprognostic (3.85e-1)" "unprognostic (1.96e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-3)" "unprognostic (8.92e-2)" "unprognostic (1.13e-2)" "unprognostic (1.40e-1)" "unprognostic (4.56e-2)" 17.0 15.1 7.4 16.9 10.3 22.4 10.2 4.7 7.5 11.0 12.2 15.6 14.9 8.5 16.6 13.0 13.2 9.7 12.1 8.5 7.8 7.8 17.1 11.6 15.4 17.9 10.9 5.6 11.5 9.0 41.1 11.4 15.1 10.0 11.2 8.0 12.3 11.7 12.5 9.0 8.7 14.8 13.6 14.3 17.0 10.6 5.9 8.7 24.5 15.9 7.5 18.2 13.6 15.4 7.2 13.9 37.9 9.6 11.4 12.1 1.8 16.2 28.9 2.9 2.0 10.6 16.2 2.2 4.1 9.0 18.6 15.9 3.1 7.5 1.0 3.5 8.6 19.9 9.5 3.9 5.3 6.3 36.8 1.8 2.5 11.7 5.4 4.5 2.7 2.6 8.9 3.6 10.4 4.5 5.8 14.3 11.8 4.7 6.1 6.9 3.9 10.6 1.1 2.1 3.0 6.7 7.3 6.7 1.2 5.2 14.1 2.8 3.9 10.0 21.2 7.6 6.8 4.8 3.4 18.5 10.4 8.3 6.1 4.2 2.7 2.5 2.9 7.8 3.2 3.7 6.9 9.6 4.2 12.1 8.0 8.1 6.2 8.6 9.7 2.3 7.2 6.9 8.5 37.9 11.4 6.9 13.9 6.4 1.8 7.4 10.3 4.7 7.5 7.8 7.8 10.9 5.6 10.0 8.7 83.4 56.5 111.7 32.9 31.8 18.0 28.5 79.0 38.8 38.7 96.0 47.1 18.7 11.6 100.5 1.1 68.4 78.6 23.3 139.5 24.8 43.3 49.8 44.1 45.9 84.7 22.3 44.2 79.2 104.8 2.0 56.4 97.6 28.7 162.3 61.5 23.6 181.0 73.7 48.4 56.6 71.2 64.7 34.9 1.4 4.4 30.1 18.2 168.3 34.5 65.7 RNF31 "FLJ10111, FLJ23501, HOIP, Paul, ZIBRA" ENSG00000092098 "Ring finger protein 31" Q96EP0 14 24146683-24160661 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 5.8;Club cells: 5.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009063, HPA048745" Approved Approved Cytosol NA NA Cytosol "CAB009063: AB_2127706, HPA048745: AB_2680509" "unprognostic (3.58e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (9.05e-2)" "unprognostic (2.52e-1)" "unprognostic (6.24e-2)" "unprognostic (9.09e-3)" "unprognostic (1.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (6.21e-3)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" 14.4 18.5 11.7 21.5 17.4 20.0 15.1 20.0 26.4 17.7 17.3 18.4 19.9 13.4 22.4 22.3 15.4 17.4 17.2 14.5 10.7 9.8 17.2 14.8 15.3 19.3 11.0 18.0 20.6 23.6 20.0 19.2 18.7 13.4 16.4 14.1 16.9 19.6 23.1 39.5 29.1 16.1 19.7 9.1 27.3 16.5 21.8 11.0 33.6 17.4 13.1 24.9 16.3 13.5 2.4 4.6 3.8 3.7 2.5 4.8 1.3 4.5 10.6 9.9 12.2 6.7 7.0 20.1 7.9 11.7 15.6 12.5 9.6 11.5 9.0 5.0 11.3 9.2 7.8 5.6 11.3 9.3 9.4 4.2 8.4 10.8 21.0 11.1 14.1 15.0 12.8 9.7 7.1 11.1 9.7 9.9 7.5 4.9 11.9 6.9 14.1 13.3 8.3 5.3 7.9 11.6 8.9 7.3 5.7 7.9 18.8 8.8 11.0 7.3 19.3 9.6 9.0 6.8 10.4 9.7 11.0 8.4 8.0 7.4 16.0 14.1 8.8 4.1 5.6 10.2 0.0 2.1 1.5 1.9 3.7 4.8 2.4 1.9 2.1 1.8 1.1 2.3 1.3 3.8 2.5 2.1 4.6 3.0 1.3 11.7 17.4 20.0 26.4 10.7 9.8 11.0 18.0 13.4 11.0 0.0 5.8 0.5 0.2 0.6 0.7 0.2 0.0 1.4 5.7 0.0 0.0 0.4 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.3 0.4 0.2 0.0 0.6 0.3 0.0 0.0 0.6 0.8 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.7 0.0 0.1 0.7 0.4 0.6 0.5 0.8 0.0 0.3 ROCK2 ENSG00000134318 "Rho associated coiled-coil containing protein kinase 2" O75116 2 11179761-11348330 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007459, CAB008666, HPA044109" Approved Supported Cytosol NA NA 3700000 Cytosol "CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813" "unprognostic (4.55e-2)" "unprognostic (1.05e-2)" "unprognostic (4.18e-3)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "unprognostic (2.71e-1)" "unprognostic (1.39e-2)" "unprognostic (2.72e-1)" "unprognostic (3.62e-2)" "unprognostic (6.66e-2)" "unprognostic (3.83e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.57e-5)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "unprognostic (2.52e-2)" "unprognostic (3.47e-2)" 26.9 7.8 14.6 9.5 21.9 4.4 21.4 26.1 26.4 16.6 16.5 5.6 8.6 12.3 22.4 11.0 12.4 13.2 11.9 12.3 13.4 7.6 11.4 12.3 16.7 6.8 7.2 16.7 15.1 8.6 12.9 14.8 18.4 10.3 14.4 20.3 5.6 10.3 14.4 28.0 8.7 13.8 42.9 7.1 12.6 10.7 5.8 9.6 5.9 10.5 5.1 6.2 22.1 20.8 2.5 3.0 3.6 2.2 3.5 3.3 0.9 6.6 16.2 13.4 13.1 24.3 17.1 8.6 15.8 14.8 10.3 10.9 15.3 14.6 8.4 9.4 24.9 12.5 7.4 9.7 9.1 16.3 11.9 5.8 16.7 27.9 30.5 8.7 9.3 4.8 13.3 5.8 12.7 9.1 8.4 16.4 4.6 14.5 3.4 15.3 5.6 6.8 4.8 7.4 14.1 10.0 8.2 29.5 2.7 5.6 18.9 6.3 6.8 31.0 10.8 10.8 10.6 4.4 5.2 22.3 21.3 15.4 8.4 13.8 2.7 3.3 7.5 9.2 11.0 29.6 3.6 1.8 1.7 2.7 2.2 3.3 1.6 2.2 1.8 1.3 2.5 1.9 2.1 3.0 3.5 1.7 3.0 1.8 0.9 14.6 21.9 26.1 26.4 13.4 7.6 7.2 16.7 10.3 9.6 107.2 64.4 9.3 35.3 35.4 33.2 94.7 35.7 41.5 86.4 21.0 55.0 22.5 1.7 25.4 6.5 88.7 62.6 0.0 34.0 15.9 43.2 45.6 26.7 37.6 16.5 76.3 20.4 58.9 19.8 3.5 40.6 24.0 21.9 8.2 82.3 34.2 30.5 38.6 73.9 13.6 42.5 129.4 101.5 21.4 17.7 24.3 26.3 11.4 40.0 38.2 RPAP3 "FLJ21908, hSpagh, spag" ENSG00000005175 "RNA polymerase II associated protein 3" Q9H6T3 12 47661249-47706061 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038311, HPA038312" Enhanced Enhanced Cytosol NA NA Cytosol "HPA038311: AB_10671527, HPA038312: AB_10672512" "unprognostic (5.76e-2)" "unprognostic (2.25e-1)" "unprognostic (1.37e-2)" "unprognostic (4.21e-2)" "unprognostic (7.28e-2)" "unprognostic (4.47e-1)" "prognostic unfavorable (2.01e-5)" "unprognostic (9.89e-2)" "unprognostic (9.87e-3)" "unprognostic (6.34e-2)" "unprognostic (9.48e-2)" "unprognostic (1.28e-2)" "unprognostic (2.01e-2)" "unprognostic (8.35e-2)" "unprognostic (5.11e-1)" "unprognostic (3.29e-1)" "unprognostic (1.35e-2)" 12.1 13.2 20.3 17.0 19.9 10.6 15.3 23.5 23.2 13.2 16.2 6.7 14.9 13.0 15.7 14.7 16.4 15.2 11.7 15.4 18.4 14.8 12.9 16.0 10.3 25.7 18.8 18.4 23.3 12.1 15.7 24.6 12.3 20.5 14.2 12.5 5.2 14.4 12.8 47.6 11.1 12.8 15.1 22.8 18.2 12.1 14.3 19.1 21.5 13.4 14.4 26.7 16.8 13.2 15.1 10.2 22.7 16.9 9.3 11.5 6.2 16.1 15.1 18.4 12.6 9.9 14.2 15.5 16.1 16.6 20.4 17.6 20.9 18.4 35.8 22.2 14.2 14.7 16.2 15.9 9.5 23.9 19.0 14.9 24.1 10.2 10.1 8.6 25.6 16.9 6.9 11.8 23.9 8.7 16.7 12.7 14.1 26.4 11.0 18.0 11.5 21.9 18.5 19.7 14.9 13.0 17.8 22.2 17.5 16.6 14.7 13.3 9.7 18.8 15.5 16.1 20.4 15.9 15.4 9.1 14.2 18.8 15.5 17.7 8.7 16.2 25.6 13.3 56.9 8.7 2.6 7.6 22.7 7.9 14.4 8.1 15.1 8.9 8.5 10.2 14.0 11.5 10.3 14.2 9.3 16.9 7.1 10.9 6.2 20.3 19.9 23.5 23.2 18.4 14.8 18.8 18.4 20.5 19.1 11.9 14.5 15.6 11.9 11.7 16.4 28.2 15.3 29.4 21.6 10.4 7.9 19.8 19.9 15.3 6.1 10.3 7.5 0.0 17.1 13.3 13.9 7.6 11.5 14.3 15.9 11.1 12.6 8.0 16.4 5.6 20.1 18.0 6.8 52.3 10.7 12.6 11.6 15.8 19.4 20.7 13.8 6.5 15.5 43.2 33.8 8.9 14.2 11.3 13.3 8.9 RPL23 "L23, rpL17" ENSG00000125691 "Ribosomal protein L23" P62829 17 38847865-38853843 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003373 Approved Supported Cytosol NA NA 76000 Cytosol "HPA003373: AB_1856436" "unprognostic (1.02e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-2)" "unprognostic (5.31e-2)" "unprognostic (5.62e-2)" "unprognostic (2.48e-2)" "unprognostic (9.08e-3)" "unprognostic (9.95e-2)" "unprognostic (1.02e-1)" "unprognostic (7.07e-2)" "unprognostic (8.01e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (4.19e-5)" "unprognostic (1.18e-1)" "unprognostic (9.60e-2)" "unprognostic (6.46e-3)" "unprognostic (4.45e-1)" 103.1 79.0 47.1 86.5 56.3 125.2 175.1 35.2 54.6 117.2 86.6 26.4 106.1 48.7 93.4 115.8 132.6 92.1 119.4 163.9 58.9 39.5 79.6 107.5 112.3 239.3 52.1 51.0 240.1 329.6 33.8 55.3 68.4 73.2 99.9 76.1 52.5 114.5 101.3 150.0 119.8 69.5 192.7 72.8 95.5 80.1 49.2 42.6 89.3 95.2 117.3 132.0 152.4 207.2 160.0 168.4 29.0 94.3 87.5 176.7 163.2 92.0 92.6 122.4 103.6 218.9 287.8 85.9 92.5 140.2 116.7 87.8 133.5 82.3 205.2 92.2 101.6 86.6 163.0 106.0 179.3 143.2 70.9 158.4 75.3 121.5 190.0 164.6 207.5 79.4 269.7 223.7 101.2 212.4 209.8 123.4 143.8 119.1 104.1 149.7 82.5 181.9 222.3 89.4 121.5 56.5 124.0 179.6 201.3 162.9 117.3 83.4 124.0 49.6 85.9 186.2 176.6 142.0 261.1 86.2 53.9 82.7 84.0 153.3 67.4 103.6 160.7 82.5 124.7 69.2 29.0 94.3 19.6 82.3 76.6 101.9 160.0 130.7 100.1 134.8 149.7 176.7 145.4 15.2 87.5 65.5 168.4 95.4 163.2 47.1 56.3 35.2 54.6 58.9 39.5 52.1 51.0 73.2 42.6 941.0 1278.0 2023.1 1729.6 2173.4 127.8 440.2 1248.4 813.7 1579.9 448.4 64.8 1510.8 1145.6 1170.8 249.3 1286.4 637.4 560.6 1801.4 2205.2 1253.7 1567.9 1280.3 1237.0 1445.9 55.6 884.2 1308.7 2128.6 175.3 2483.5 2049.1 1051.1 2214.6 1221.7 291.3 2001.5 1052.1 1360.9 1581.2 153.2 737.3 1166.3 278.6 184.6 2766.5 1592.5 1392.4 1661.2 1922.3 RPS10 "MGC88819, S10" ENSG00000124614 "Ribosomal protein S10" P46783 6 34417454-34426125 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047268, HPA048084" Approved Approved Cytosol NA NA 170000 Cytosol "HPA047268: AB_2680007, HPA048084: AB_2680255" "unprognostic (1.92e-1)" "unprognostic (1.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.78e-1)" "unprognostic (8.92e-3)" "unprognostic (3.79e-2)" "unprognostic (9.72e-3)" "unprognostic (1.93e-2)" "unprognostic (4.30e-3)" "unprognostic (2.04e-1)" "unprognostic (3.59e-1)" "unprognostic (3.82e-1)" "prognostic unfavorable (2.57e-6)" "unprognostic (4.98e-2)" "unprognostic (7.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.45e-1)" 84.5 76.6 68.1 142.7 49.5 158.8 142.0 35.9 54.3 130.3 132.7 48.2 97.2 65.1 149.8 103.9 169.7 113.6 74.7 84.9 51.3 44.1 80.7 122.5 96.3 180.1 54.8 31.9 189.4 323.2 20.3 59.1 88.0 39.5 129.7 64.5 59.4 248.9 75.5 153.2 131.9 76.4 105.6 49.4 132.5 85.3 66.7 41.0 110.5 151.0 158.8 127.4 127.1 169.7 150.1 105.0 31.6 61.5 83.1 176.2 227.6 98.7 64.0 66.6 151.0 114.8 169.3 110.1 81.5 112.8 134.7 97.5 155.2 50.5 190.9 84.5 90.2 68.8 74.6 124.3 139.4 81.2 80.1 221.5 85.4 70.6 147.1 158.8 135.0 91.9 187.0 243.0 94.3 179.1 119.1 117.5 108.6 145.6 96.8 100.6 154.1 109.7 202.9 100.4 244.7 94.4 104.1 78.0 180.1 101.2 109.3 111.4 68.2 58.6 98.8 225.6 65.5 128.4 346.0 80.6 60.8 77.8 69.1 132.3 80.2 178.5 160.0 33.1 175.6 109.0 31.6 61.5 18.8 78.9 50.6 116.3 150.1 136.2 111.1 88.7 147.7 176.2 136.7 13.6 83.1 47.2 105.0 90.2 227.6 68.1 49.5 35.9 54.3 51.3 44.1 54.8 31.9 39.5 41.0 333.5 603.3 2152.2 474.9 1201.0 51.9 57.2 950.3 406.9 664.3 249.5 27.5 1272.5 507.3 1182.8 376.5 678.3 1089.4 654.1 2086.5 1615.5 676.8 419.9 573.0 927.7 904.0 49.3 1185.7 891.2 1556.1 890.1 786.1 881.2 600.6 1996.4 2188.6 195.4 1807.7 1595.7 444.1 950.3 80.4 258.7 675.6 285.7 224.9 1448.4 1216.1 1389.4 2844.5 431.7 RPS10-NUDT3 ENSG00000270800 "RPS10-NUDT3 readthrough" 6 34284887-34426071 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 46.7;Ciliated cells: 21.4;Club cells: 35.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 21.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 21.2" "Low cell line specificity" "Detected in all" "HPA047027, HPA047268, HPA048084, HPA055953" Uncertain Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA047268: AB_2680007, HPA048084: AB_2680255, HPA055953: AB_2682984" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.85e-2)" "unprognostic (7.54e-3)" "unprognostic (1.28e-2)" "unprognostic (6.85e-2)" "unprognostic (8.95e-2)" "unprognostic (2.67e-1)" "unprognostic (5.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.63e-1)" "unprognostic (5.17e-8)" "unprognostic (5.80e-2)" "unprognostic (9.49e-2)" "unprognostic (2.23e-1)" "unprognostic (1.42e-1)" 14.5 10.9 28.0 24.9 21.7 35.6 12.1 9.9 25.4 22.6 23.0 7.3 16.4 9.5 26.2 17.7 29.9 10.0 12.2 20.8 23.7 23.2 13.4 21.1 16.3 31.8 25.2 4.3 33.2 58.4 5.3 7.6 18.8 5.7 22.5 7.7 9.4 44.6 12.4 49.4 6.4 12.9 18.0 17.2 23.0 14.4 23.4 6.0 18.9 26.4 27.9 22.0 22.0 29.9 3.7 4.7 21.2 4.8 2.9 2.3 2.1 9.6 2.9 8.1 14.4 6.0 4.1 8.4 6.7 3.4 5.1 5.3 3.2 4.5 9.3 13.0 4.2 12.1 6.2 11.1 3.5 6.4 7.6 4.9 16.6 6.0 10.2 1.2 15.9 21.2 1.6 7.3 7.3 15.3 7.0 5.0 10.3 16.2 12.6 6.3 8.4 18.1 9.2 4.5 18.7 1.7 10.1 6.8 5.3 5.0 10.4 12.6 4.1 4.7 5.3 17.7 5.1 7.9 33.5 3.9 7.7 12.7 3.9 10.2 6.7 9.2 15.2 1.0 9.6 12.6 6.9 3.9 21.2 2.1 4.8 2.1 3.7 2.3 2.0 4.7 3.5 2.3 1.9 3.1 2.9 4.1 3.3 2.2 2.1 28.0 21.7 9.9 25.4 23.7 23.2 25.2 4.3 5.7 6.0 32.8 46.7 0.0 0.1 0.7 0.0 0.0 0.0 21.4 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 RPS18 "D6S218E, HKE3, KE-3, KE3, S18" ENSG00000231500 "Ribosomal protein S18" P62269 6 33272010-33276510 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 484.7" "Cell type enhanced" "Detected in all" 5 "Suprabasal keratinocytes: 27922.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050159, HPA055007" Approved Supported Cytosol NA NA 90000 Cytosol "HPA050159: AB_2681035, HPA055007: AB_2682668" "prognostic favorable (9.81e-4)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (7.74e-2)" "unprognostic (4.00e-2)" "unprognostic (3.95e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.67e-1)" "unprognostic (4.63e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.15e-10)" "unprognostic (7.00e-2)" "unprognostic (4.00e-2)" "unprognostic (2.85e-1)" "unprognostic (9.19e-2)" 67.0 49.1 43.4 126.4 32.2 109.6 132.5 20.9 37.7 99.8 105.5 17.8 48.6 44.6 83.1 109.2 120.3 66.7 92.9 71.5 31.2 26.1 48.1 69.1 69.1 263.7 34.5 35.4 154.5 484.7 8.9 33.0 56.3 26.6 95.9 65.2 37.0 168.4 53.7 107.6 140.4 56.9 99.6 35.8 89.9 56.8 40.2 32.3 94.1 94.3 155.9 90.6 101.6 114.8 98.8 55.7 7.8 30.3 49.6 92.4 130.1 52.1 30.2 40.1 105.2 68.8 136.2 64.6 52.3 76.2 68.8 52.1 76.1 30.5 171.9 56.4 55.4 33.0 38.4 62.9 82.8 54.1 53.8 98.9 64.1 36.0 100.1 134.2 110.7 34.2 147.1 164.0 52.5 157.0 65.0 65.2 51.3 85.1 54.0 60.6 87.3 55.8 123.3 55.2 61.5 43.6 66.8 64.8 115.1 63.3 67.6 46.1 68.0 20.4 104.8 164.4 30.3 71.8 193.0 53.9 32.4 37.8 34.4 68.4 64.8 131.5 131.7 18.1 120.7 39.4 7.8 30.3 3.9 42.7 27.4 72.8 98.8 83.0 60.9 55.7 80.2 92.4 78.5 3.1 49.6 20.2 50.6 61.4 130.1 43.4 32.2 20.9 37.7 31.2 26.1 34.5 35.4 26.6 32.3 1375.7 2198.7 12042.6 13399.3 18243.0 341.9 558.4 4063.7 1350.4 3447.5 1746.4 217.9 7435.2 4327.1 3565.1 899.4 6848.9 2783.6 2266.0 11029.6 11450.2 6671.8 8883.4 2873.3 3644.3 5551.7 151.0 2974.8 4982.4 5437.2 2221.6 9162.8 7322.1 8013.6 5403.2 6713.5 580.3 7620.3 4990.4 3813.6 4409.9 516.0 1972.6 5953.7 913.9 1583.7 27922.0 7341.1 7120.5 12043.3 13812.9 RPS28 S28 ENSG00000233927 "Ribosomal protein S28" P62857 19 8321158-8323340 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047132 Approved Approved Cytosol NA NA Cytosol "HPA047132: AB_10962147" "unprognostic (3.47e-2)" "unprognostic (7.47e-3)" "unprognostic (1.49e-1)" "prognostic favorable (2.47e-4)" "unprognostic (3.09e-2)" "unprognostic (2.84e-3)" "unprognostic (2.16e-1)" "unprognostic (6.34e-2)" "unprognostic (1.56e-1)" "unprognostic (3.61e-2)" "unprognostic (2.80e-2)" "unprognostic (2.19e-2)" "unprognostic (3.22e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-2)" "unprognostic (8.82e-2)" "unprognostic (1.81e-2)" 20.3 19.0 24.1 19.2 22.0 45.2 29.7 23.4 38.9 18.2 16.9 8.2 16.3 23.5 20.4 17.5 32.5 23.1 17.4 35.6 15.1 14.5 18.7 45.0 17.5 35.8 18.4 23.1 49.5 71.9 6.4 17.7 17.0 22.4 20.4 8.6 21.1 42.4 12.2 40.7 36.3 20.7 16.3 13.7 29.3 20.9 48.6 11.2 22.2 25.0 35.9 17.7 21.9 33.5 30.3 26.5 5.3 16.6 11.1 30.8 38.4 33.6 13.7 12.4 28.2 18.0 27.2 19.7 22.1 20.4 25.8 21.1 18.5 14.8 50.6 27.3 12.9 11.0 25.8 16.5 38.0 3.7 30.6 109.9 24.4 14.9 18.4 32.5 28.0 27.2 43.6 44.0 18.7 16.9 16.1 23.7 39.7 34.1 57.7 11.4 21.1 42.7 99.6 37.3 19.6 83.8 30.5 13.4 53.5 17.0 16.2 24.0 23.4 15.9 29.6 39.3 4.2 22.4 47.4 29.6 21.4 18.2 41.3 36.8 67.4 35.4 34.4 22.6 53.9 14.3 5.3 16.6 3.5 16.9 10.6 22.8 30.3 27.1 19.7 15.8 26.8 30.8 21.4 2.6 11.1 9.8 26.5 16.4 38.4 24.1 22.0 23.4 38.9 15.1 14.5 18.4 23.1 22.4 11.2 1354.9 2501.9 6198.1 3612.6 7018.3 462.3 334.0 2894.3 1209.9 2587.6 1271.9 278.8 3255.4 2826.8 2557.8 200.6 2505.3 1869.9 1728.7 6319.3 3886.7 2995.5 2958.6 1841.3 4636.2 3871.6 252.6 2554.9 3833.9 4924.3 397.0 3625.0 3606.8 3342.1 4294.1 4940.9 645.3 4721.1 3391.2 1546.1 3475.5 503.9 1067.2 2167.5 225.8 948.4 9504.9 3550.0 3573.0 6794.8 3480.6 RPS6KB2 "KLS, P70-BETA, p70S6Kb, STK14B" ENSG00000175634 "Ribosomal protein S6 kinase B2" Q9UBS0 11 67428460-67435408 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010010, CAB019404" Approved Supported Cytosol NA NA Cytosol "CAB019404: AB_331355, HPA010010: AB_1856469" "unprognostic (1.38e-1)" "unprognostic (2.36e-3)" "unprognostic (8.50e-2)" "unprognostic (2.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (9.01e-3)" "unprognostic (5.10e-2)" "unprognostic (1.22e-1)" "unprognostic (9.49e-3)" "unprognostic (7.66e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.03e-7)" "unprognostic (1.28e-2)" "unprognostic (1.55e-1)" "unprognostic (2.12e-1)" "unprognostic (2.66e-1)" 8.7 14.1 8.5 12.8 9.2 18.0 11.2 12.9 11.5 13.1 13.0 12.5 12.3 19.8 10.2 10.1 36.1 11.0 10.7 10.7 8.8 4.2 11.3 27.8 10.7 12.0 11.4 8.7 9.5 18.7 9.6 11.7 13.8 8.7 17.2 9.9 11.7 18.1 15.8 25.0 41.4 17.7 8.8 7.6 18.6 17.1 7.5 8.8 21.8 11.4 28.6 21.8 10.1 15.6 15.7 27.1 16.4 28.3 17.8 20.7 20.2 21.3 16.2 8.9 15.0 4.1 8.0 11.7 10.3 13.0 19.4 13.5 25.3 14.4 7.9 18.0 10.1 12.1 16.0 10.0 15.8 7.8 13.6 26.6 12.7 20.7 20.6 14.0 16.1 15.7 10.1 16.6 10.2 10.5 4.9 14.4 21.0 20.4 21.2 9.7 32.8 24.7 25.3 9.5 31.4 20.9 18.3 12.3 37.5 9.0 12.3 13.4 14.4 10.7 29.7 22.1 5.4 34.9 13.4 6.0 10.1 10.8 24.5 11.5 19.0 15.6 12.7 16.6 10.1 12.7 9.7 22.6 16.4 15.7 25.2 15.9 15.7 14.9 15.3 27.1 14.3 10.9 11.9 15.1 17.8 28.3 18.7 20.7 20.2 8.5 9.2 12.9 11.5 8.8 4.2 11.4 8.7 8.7 8.8 8.9 18.6 37.3 23.0 44.3 24.7 1.1 40.8 4.0 9.1 7.0 9.8 63.1 36.5 40.3 10.4 15.8 75.3 23.3 56.9 74.1 22.2 38.7 27.6 48.6 53.5 31.8 44.4 16.0 37.6 22.0 18.7 27.9 18.6 55.1 53.9 19.0 40.6 63.3 16.3 27.7 26.0 19.4 22.7 13.1 13.8 55.7 86.6 44.9 49.3 30.7 RRM1 ENSG00000167325 "Ribonucleotide reductase catalytic subunit M1" P23921 11 4094707-4138876 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Allosteric enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 78.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022093, HPA057265, HPA064297" Enhanced Supported Cytosol NA Yes 13000 Cytosol "CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236" "unprognostic (4.47e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-3)" "unprognostic (3.65e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.31e-2)" "unprognostic (3.43e-2)" "unprognostic (6.90e-2)" "unprognostic (1.06e-3)" "unprognostic (4.21e-2)" "unprognostic (6.88e-3)" "unprognostic (9.20e-3)" "unprognostic (6.16e-2)" "unprognostic (8.41e-2)" "unprognostic (9.93e-3)" 13.9 25.3 8.0 15.2 12.2 18.5 14.4 18.0 12.6 15.7 15.9 11.1 11.5 11.9 13.0 9.8 25.4 10.7 8.7 11.9 7.9 9.0 9.2 13.1 11.0 20.2 9.0 10.3 13.6 10.7 24.2 11.2 22.7 18.4 14.0 18.9 12.0 15.4 10.7 28.3 26.8 12.5 17.5 10.7 12.4 13.8 10.5 9.1 78.6 9.8 28.0 27.1 17.5 18.5 5.6 4.3 3.3 8.3 5.7 24.3 6.0 46.1 25.1 41.1 23.9 6.3 12.6 16.0 42.5 21.1 48.4 50.0 22.5 35.1 50.0 10.3 21.2 21.0 37.1 38.1 30.6 57.3 24.5 40.4 25.4 37.6 17.5 2.5 43.4 18.6 5.9 8.3 26.5 19.1 10.6 23.2 30.2 33.1 23.6 40.3 20.9 51.1 9.4 26.0 32.1 25.5 41.4 32.1 17.8 13.3 13.1 35.2 19.3 37.4 22.6 6.8 17.3 22.3 15.2 13.2 45.5 23.8 45.1 31.2 15.5 21.4 54.6 25.3 29.1 28.2 3.3 2.5 2.6 7.7 6.5 13.3 5.6 14.2 10.7 4.3 3.5 11.3 9.2 0.0 5.7 8.3 2.7 24.3 6.0 8.0 12.2 18.0 12.6 7.9 9.0 9.0 10.3 18.4 9.1 17.9 11.8 16.4 16.8 29.8 14.7 30.7 17.8 17.4 21.6 17.4 5.9 33.4 6.6 22.3 59.0 10.8 9.7 70.0 19.4 48.6 21.4 12.0 6.9 14.8 24.3 17.5 17.3 11.6 8.6 43.8 12.0 10.6 10.1 9.0 17.5 21.8 14.0 11.8 15.6 6.3 20.0 12.9 21.5 60.8 31.3 25.3 33.2 15.8 24.7 13.6 RRM2 ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10131419 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 120.9" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 93.5;Extravillous trophoblasts: 192.1;Spermatogonia: 44.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in many" 6 "T-cells: 10.4" "Low cell line specificity" "Detected in many" HPA056994 Enhanced Supported Cytosol Yes Yes Cytosol "HPA056994: AB_2683304" "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 4.7 2.2 0.4 32.6 0.4 29.0 4.2 0.4 0.9 3.5 9.3 0.4 0.4 5.2 2.1 1.7 21.6 0.7 5.0 3.3 0.4 0.5 2.0 3.9 5.7 16.4 0.6 0.1 0.9 2.9 0.0 0.7 5.4 0.3 1.0 10.6 0.1 2.9 0.0 0.5 2.8 11.3 3.2 0.8 19.8 5.4 8.0 0.0 120.9 0.8 22.3 33.1 3.8 5.2 1.4 0.3 0.6 0.2 1.8 10.4 2.6 29.5 17.9 25.4 17.4 2.2 4.1 25.1 48.3 24.0 34.5 37.6 29.9 14.1 27.1 6.7 15.1 35.0 14.5 41.0 24.9 42.3 60.8 15.8 52.3 17.2 26.3 0.1 38.7 25.1 1.5 0.5 42.2 3.6 5.7 27.9 21.0 21.9 80.5 42.9 22.3 42.7 20.8 20.5 30.4 21.0 32.2 55.4 18.6 17.0 22.5 25.1 20.7 39.7 28.2 4.9 11.0 15.2 6.9 9.7 26.5 38.5 19.8 67.7 52.3 41.0 55.4 18.8 32.9 38.0 0.3 0.1 0.1 3.7 0.0 0.0 1.4 2.6 2.9 0.2 0.4 0.2 1.2 0.6 1.8 0.2 0.3 10.4 2.6 0.4 0.4 0.4 0.9 0.4 0.5 0.6 0.1 0.3 0.0 3.0 1.0 2.2 1.0 9.3 0.0 1.2 2.5 5.3 1.2 0.0 0.0 5.4 1.7 0.5 3.0 0.3 2.6 93.5 0.0 192.1 3.6 1.1 5.7 1.7 40.1 0.0 0.0 5.5 5.9 5.7 0.3 3.5 0.0 0.0 7.9 0.0 0.5 0.0 0.4 1.6 0.0 0.0 0.3 5.2 44.5 1.4 40.7 7.2 13.0 2.0 RTL1 "HUR1, Mar1, MART1, PEG11, SIRH2" ENSG00000254656 "Retrotransposon Gag like 1" A6NKG5 14 100880655-100884847 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 5.0;brain: 7.6;placenta: 8.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "SH-SY5Y: 121.1" "Region enhanced" "Detected in single" "hypothalamus: 2.1" "HPA066979, HPA077601" Enhanced Approved Cytosol No NA Cytosol "HPA066979: AB_2685759, HPA077601: " "unprognostic (1.61e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-1)" "unprognostic (1.42e-3)" "unprognostic (2.10e-1)" 0.0 5.0 0.2 0.0 0.9 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 1.8 1.3 0.1 0.0 0.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RUBCNL "C13orf18, FLJ21562, KIAA0226L" ENSG00000102445 "RUN and cysteine rich domain containing beclin 1 interacting protein like" Q9H714 13 46342000-46438190 "Predicted intracellular proteins" "Autophagy, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.1;lymphoid tissue: 24.0" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 9.6;Club cells: 4.5;Hofbauer cells: 13.4" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 17.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "memory B-cell: 29.9;naive B-cell: 31.1;neutrophil: 31.1;plasmacytoid DC: 22.5" "Group enriched" "Detected in many" 17 "B-cells: 31.1;dendritic cells: 22.5;granulocytes: 31.1" "Group enriched" "Detected in some" 5 "Daudi: 40.0;U-698: 66.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026614 Approved Approved Cytosol NA NA Cytosol "HPA026614: AB_10602693" "unprognostic (3.35e-2)" "unprognostic (2.61e-1)" "unprognostic (1.94e-3)" "prognostic favorable (3.76e-5)" "unprognostic (1.09e-2)" "unprognostic (8.30e-4)" "unprognostic (7.83e-2)" "unprognostic (2.62e-3)" "unprognostic (1.07e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "unprognostic (5.95e-5)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (7.47e-2)" "unprognostic (7.00e-3)" 3.7 1.6 4.5 21.2 4.3 15.0 5.7 2.9 3.6 5.5 8.1 2.9 1.3 1.5 3.0 3.2 1.0 2.0 3.8 1.5 3.4 3.7 1.5 1.7 5.5 20.2 4.5 2.7 0.9 1.2 0.1 2.7 3.3 5.2 2.2 11.2 3.0 6.5 1.8 0.8 2.7 14.9 2.8 8.8 24.0 1.6 15.9 3.7 10.1 2.2 0.2 21.7 2.9 2.0 31.1 22.5 31.1 1.6 0.3 0.0 1.2 0.1 0.0 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 1.5 0.0 40.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.4 11.5 0.1 1.6 0.0 0.0 0.8 0.0 0.1 0.0 0.6 2.3 0.0 9.2 0.0 0.0 0.3 0.0 0.1 0.2 9.2 66.1 0.4 0.1 0.0 0.0 1.0 0.0 0.0 1.6 0.0 29.9 0.0 0.0 1.0 31.1 0.0 0.0 31.1 0.3 0.9 22.5 0.0 1.2 4.5 4.3 2.9 3.6 3.4 3.7 4.5 2.7 5.2 3.7 3.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 2.3 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RUFY3 "KIAA0871, RIPx, Singar1, ZFYVE30" ENSG00000018189 "RUN and FYVE domain containing 3" Q7L099 4 70704204-70807315 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 80.2" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022952, HPA022970" Enhanced Supported Cytosol NA NA Cytosol "HPA022952: AB_2671005, HPA022970: AB_1856307" "unprognostic (4.33e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (3.96e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.28e-4)" "prognostic unfavorable (8.95e-4)" "unprognostic (1.69e-2)" "unprognostic (2.00e-1)" "unprognostic (3.50e-2)" "prognostic favorable (8.02e-5)" "unprognostic (7.90e-3)" "unprognostic (1.31e-3)" "unprognostic (1.26e-1)" "unprognostic (1.21e-2)" "unprognostic (7.45e-3)" "unprognostic (5.41e-1)" 10.9 24.5 39.1 11.8 53.4 6.9 12.5 36.4 66.3 12.3 8.7 24.1 6.7 8.1 20.6 16.3 15.3 9.3 12.7 8.9 64.5 34.4 15.5 13.6 14.8 13.6 37.0 51.3 25.5 9.8 8.5 61.4 12.0 54.2 13.8 11.4 12.8 10.1 11.5 15.4 29.9 9.9 15.1 80.2 16.0 12.8 25.3 32.5 7.1 31.6 5.9 11.5 9.3 12.3 3.5 6.0 0.0 3.1 2.2 2.8 1.0 3.7 2.6 31.2 7.3 15.1 17.6 12.4 12.2 4.7 4.0 4.5 4.5 9.2 15.0 5.1 10.1 8.9 3.8 4.7 5.4 6.4 8.1 6.0 3.2 3.6 4.9 8.6 3.7 1.9 12.4 8.4 5.3 6.2 18.6 8.4 16.2 8.8 15.5 8.7 4.6 23.2 3.9 7.5 6.6 3.4 5.7 9.7 6.8 7.8 3.6 29.2 14.4 4.4 7.9 7.4 12.6 5.4 1.8 7.1 13.6 9.5 4.0 2.8 17.3 7.8 16.0 14.1 2.7 2.7 0.0 3.1 0.0 2.2 3.0 2.8 3.5 1.5 2.0 6.0 3.1 1.5 1.6 0.0 2.2 2.8 4.8 1.0 1.0 39.1 53.4 36.4 66.3 64.5 34.4 37.0 51.3 54.2 32.5 32.8 68.4 13.4 19.5 17.2 119.8 18.3 10.2 34.8 45.5 22.7 249.4 12.7 6.6 12.7 57.5 30.2 8.7 0.0 17.9 5.7 21.6 29.3 20.7 21.8 9.7 131.9 14.5 34.4 31.8 95.1 43.7 29.7 40.5 83.8 8.3 45.6 18.9 3.5 47.7 12.8 190.1 25.8 29.9 13.4 29.3 25.2 6.4 8.7 8.3 16.0 RUSC1 NESCA ENSG00000160753 "RUN and SH3 domain containing 1" Q9BVN2 1 155320896-155331114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028510, HPA029922, HPA029923" Approved Enhanced Cytosol NA NA Cytosol "HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288" "unprognostic (1.98e-1)" "unprognostic (2.82e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-1)" "unprognostic (5.25e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (7.78e-6)" "unprognostic (1.42e-1)" "unprognostic (1.38e-1)" "unprognostic (1.73e-1)" "unprognostic (8.29e-2)" "prognostic unfavorable (2.65e-4)" "prognostic unfavorable (9.24e-6)" "unprognostic (7.59e-2)" "unprognostic (4.25e-2)" "unprognostic (2.05e-2)" "unprognostic (1.40e-1)" 10.9 15.9 24.8 8.7 24.1 8.9 12.2 46.1 45.4 16.6 20.2 5.6 9.2 17.5 13.0 7.4 21.8 12.4 13.6 12.2 18.5 22.3 12.9 4.9 11.0 7.4 14.4 26.4 13.3 12.5 11.5 21.5 14.7 26.1 16.3 19.0 8.7 18.1 18.1 8.7 22.7 19.5 15.3 8.9 7.6 14.2 3.1 6.2 12.6 8.4 11.4 8.8 12.1 16.1 3.4 7.5 5.1 18.9 2.6 6.4 4.2 22.7 14.4 8.3 12.2 10.3 11.3 16.1 10.9 7.0 14.4 16.2 16.5 15.1 4.5 8.3 11.0 8.2 31.8 12.8 15.8 6.2 6.1 16.4 6.4 14.3 8.6 8.5 6.4 11.2 11.5 10.0 14.4 5.0 7.0 14.8 9.9 9.7 3.1 12.4 43.4 8.0 8.2 16.3 42.0 23.0 10.9 5.8 7.9 13.5 17.4 8.6 14.0 9.2 25.9 5.5 14.1 38.6 11.0 6.7 18.6 15.4 17.4 21.5 2.5 5.6 2.7 13.0 8.6 5.0 5.1 6.8 3.2 5.8 8.1 6.4 3.4 4.7 5.8 7.5 1.5 2.6 5.5 0.9 2.6 18.9 7.1 4.7 4.2 24.8 24.1 46.1 45.4 18.5 22.3 14.4 26.4 26.1 6.2 8.9 10.1 10.9 16.6 24.8 14.6 9.0 10.2 6.7 18.2 17.4 5.9 25.0 19.9 19.9 0.3 23.5 60.7 0.0 15.6 61.6 23.7 24.2 8.1 6.4 18.6 35.0 15.0 12.9 10.4 0.0 17.0 11.5 18.6 10.0 42.2 12.8 20.4 37.4 17.0 22.0 6.6 19.4 21.7 1.8 7.2 30.6 31.8 13.8 33.3 22.1 S100A7 "PSOR1, S100A7c" ENSG00000143556 "S100 calcium binding protein A7" P31151 1 153457744-153460701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 78.3;Syncytiotrophoblasts: 22.1" "Group enriched" "Detected in many" 5 "cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 7.4;SK-BR-3: 17.3" "CAB001453, HPA006997, CAB033766" Enhanced Uncertain Cytosol "Secreted in other tissues" NA NA 17000000 Cytosol "CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860" "unprognostic (3.28e-1)" "unprognostic (9.85e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-2)" "unprognostic (3.17e-1)" "unprognostic (2.94e-2)" "unprognostic (1.03e-2)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 2.2 0.1 0.1 45.2 0.1 0.1 0.1 0.0 3.7 3.9 116.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 6.2 0.1 0.1 45.7 0.1 0.2 0.1 0.1 0.0 0.3 0.1 1.2 0.1 409.9 156.7 0.2 85.3 0.0 0.4 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 7.4 0.0 2.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 0.8 17.3 0.0 1.1 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 78.3 22.1 0.0 0.0 0.4 S100A7A "S100A15, S100A7f, S100A7L1" ENSG00000184330 "S100 calcium binding protein A7A" Q86SG5 1 153416524-153423225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "tongue: 178.1" "Group enriched" "Detected in some" 6 "Early spermatids: 1.1;Late spermatids: 1.6;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SK-BR-3: 3.4" HPA006997 Supported Uncertain Cytosol NA NA Cytosol "HPA006997: AB_1079860" "unprognostic (2.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" "unprognostic (1.17e-1)" "unprognostic (4.40e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.9 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 178.1 12.5 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 S100G "CABP1, CABP9K, CALB3" ENSG00000169906 "S100 calcium binding protein G" P29377 X 16650158-16654670 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "intestine: 74.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "breast cancer: 4.7;renal cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.1;PC-3: 2.2;RPMI-8226: 7.0;SH-SY5Y: 1.3" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in many" "CAB017688, HPA028920, HPA055873" Enhanced Approved Cytosol NA NA Cytosol "CAB017688: AB_1119899, HPA028920: , HPA055873: AB_2682952" "unprognostic (2.68e-2)" "unprognostic (2.78e-1)" "unprognostic (9.88e-3)" 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 18.0 0.0 0.0 74.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.2 0.0 0.0 7.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.4 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAC3D1 "HSU79266, SHD1" ENSG00000168061 "SAC3 domain containing 1" 11 65040901-65044828 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 26.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 67.9;Late spermatids: 96.5;Spermatocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042677 Uncertain Approved Cytosol NA NA Cytosol "HPA042677: AB_10797506" "unprognostic (1.35e-1)" "unprognostic (5.45e-3)" "unprognostic (5.00e-1)" "unprognostic (8.01e-2)" "unprognostic (3.56e-1)" "unprognostic (3.53e-2)" "prognostic unfavorable (9.67e-6)" "unprognostic (4.11e-1)" "unprognostic (1.70e-1)" "unprognostic (4.45e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (5.66e-5)" "unprognostic (2.97e-3)" "unprognostic (5.71e-1)" "unprognostic (4.53e-2)" "unprognostic (2.49e-1)" 6.3 6.1 5.1 5.1 5.8 7.1 10.9 7.1 8.4 3.7 7.7 3.0 5.0 5.8 4.3 4.2 5.1 4.0 6.4 4.2 4.8 4.5 3.7 6.6 4.7 4.4 5.1 3.0 3.2 8.6 2.6 4.1 3.0 6.5 4.2 3.5 1.4 6.7 5.7 12.4 6.4 3.9 4.9 4.4 4.5 5.0 26.3 4.6 16.2 3.3 6.2 4.8 3.6 4.6 2.3 3.6 0.4 3.6 0.1 2.7 0.8 18.7 11.1 7.7 7.3 4.1 2.9 4.8 12.2 3.2 9.4 7.9 7.9 4.9 10.0 8.5 4.7 10.2 10.4 6.3 8.9 1.3 12.4 10.4 7.9 7.2 14.1 3.0 5.3 2.9 0.8 8.0 7.2 3.2 2.3 3.3 11.4 11.0 5.6 3.2 10.3 8.3 21.7 2.5 6.7 22.6 6.2 5.5 11.0 4.0 4.3 9.5 7.9 9.3 10.3 6.8 2.2 8.1 7.6 3.2 4.5 13.7 14.6 7.8 13.4 9.4 7.5 2.7 7.0 2.0 0.0 3.1 0.4 1.6 2.6 1.5 2.3 1.9 1.2 1.5 2.2 2.7 1.8 0.3 0.1 3.6 3.6 2.2 0.8 5.1 5.8 7.1 8.4 4.8 4.5 5.1 3.0 6.5 4.6 3.0 0.3 5.2 5.1 7.7 6.8 5.2 5.1 1.4 1.2 8.7 0.0 15.5 6.6 1.8 67.9 5.8 14.6 0.0 1.4 37.0 8.9 8.3 5.7 13.1 25.4 4.8 6.9 4.3 16.1 96.5 16.4 8.3 10.1 2.8 12.1 12.7 2.3 11.9 13.1 10.3 6.9 0.0 8.2 199.6 43.9 6.8 5.6 9.6 20.7 3.1 SAMD4B "FLJ10211, hSmaug2, MGC99832, SMGB" ENSG00000179134 "Sterile alpha motif domain containing 4B" Q5PRF9 19 39342396-39385710 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 157.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016800, HPA059385" Approved Enhanced Cytosol No No Cytosol "HPA016800: AB_1856552, HPA059385: AB_2684000" "unprognostic (2.56e-1)" "unprognostic (6.76e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (2.17e-6)" "unprognostic (3.41e-2)" "unprognostic (8.66e-2)" "unprognostic (6.24e-3)" "unprognostic (2.31e-2)" "unprognostic (1.15e-1)" "unprognostic (4.98e-2)" "unprognostic (2.30e-1)" "unprognostic (4.92e-2)" "unprognostic (1.34e-2)" "unprognostic (1.32e-1)" "unprognostic (9.91e-3)" "unprognostic (2.12e-1)" "unprognostic (1.89e-2)" 24.9 24.6 34.8 19.5 43.9 15.0 19.5 24.9 34.3 26.3 19.5 40.0 18.8 15.9 24.5 15.2 32.7 27.9 22.5 18.8 29.2 19.5 16.5 14.1 20.4 11.8 37.3 24.0 35.2 22.5 37.5 23.5 21.9 32.6 21.1 13.7 20.9 19.9 30.4 18.1 25.1 18.4 23.7 28.7 19.0 18.9 23.0 37.7 13.6 21.2 12.3 15.2 21.8 24.2 3.0 2.5 6.8 2.8 2.1 3.7 1.2 31.6 43.5 22.3 16.9 21.8 26.3 18.4 18.3 20.2 14.7 12.3 38.0 17.8 10.6 24.0 29.2 19.1 15.4 21.9 16.8 10.1 21.2 35.8 10.6 17.9 15.8 22.5 11.4 11.2 25.8 19.9 24.1 18.0 18.1 13.8 14.4 31.2 11.6 17.9 21.7 12.3 5.6 17.6 20.8 17.7 15.0 14.3 9.2 12.3 25.8 22.9 22.3 24.1 16.6 13.1 17.7 13.4 12.4 18.1 24.1 17.6 52.1 32.0 21.8 19.6 11.8 32.1 9.0 23.5 2.9 2.8 3.9 3.0 1.1 2.2 3.0 2.2 2.4 2.0 2.0 3.7 2.6 6.8 2.1 0.9 2.5 0.9 1.2 34.8 43.9 24.9 34.3 29.2 19.5 37.3 24.0 32.6 37.7 11.9 34.9 22.6 53.6 29.7 54.1 6.3 22.9 22.7 12.5 34.9 157.1 21.2 5.0 24.8 5.4 24.0 21.3 0.0 23.6 18.1 28.6 59.6 17.4 24.5 17.8 49.3 49.0 43.6 19.3 1.8 40.6 19.2 18.6 9.0 26.3 29.5 31.1 17.3 31.1 9.9 67.9 64.7 25.5 62.7 26.6 38.0 45.7 19.2 21.8 58.6 SAMD9L "C7orf6, FLJ39885, KIAA2005" ENSG00000177409 "Sterile alpha motif domain containing 9 like" Q8IVG5 7 93130055-93148369 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 71.3;Paneth cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 21.0;GAMG: 17.0;HDLM-2: 18.6;Karpas-707: 50.1" "Low region specificity" "Detected in all" "HPA019461, HPA019465, HPA019488" Enhanced Approved Cytosol NA NA Cytosol "HPA019461: AB_1856555, HPA019465: AB_2183384, HPA019488: AB_1856557" "unprognostic (6.93e-3)" "unprognostic (6.12e-2)" "unprognostic (5.00e-2)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (5.03e-2)" "unprognostic (7.10e-2)" "unprognostic (4.21e-2)" "unprognostic (2.32e-1)" "unprognostic (6.18e-3)" "unprognostic (1.05e-3)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.63e-5)" "unprognostic (1.36e-1)" "unprognostic (2.07e-2)" "unprognostic (1.85e-2)" "unprognostic (1.22e-1)" 25.1 6.8 6.0 16.5 7.9 5.9 7.1 5.1 5.7 10.0 6.7 3.3 3.2 7.4 5.9 11.4 8.8 7.0 9.4 5.5 5.7 3.3 9.1 3.7 14.8 17.3 4.5 5.9 11.1 3.9 1.2 6.4 11.3 7.4 8.8 7.7 4.2 8.1 4.5 3.6 2.6 13.2 5.8 6.5 28.4 9.3 3.9 6.0 26.7 11.7 5.5 10.3 9.1 7.8 11.2 4.5 21.7 9.7 5.9 10.1 2.4 2.6 0.1 0.0 0.1 3.6 7.4 0.0 2.3 9.7 13.2 21.0 0.0 6.0 1.7 2.9 6.2 17.0 1.1 0.0 0.8 2.1 18.6 0.0 1.6 0.6 0.0 2.9 3.4 2.6 2.8 0.3 2.6 0.4 2.4 5.7 2.6 0.0 50.1 5.5 0.0 5.5 3.1 0.2 0.0 0.6 2.3 0.8 4.0 0.7 0.2 0.0 0.1 0.4 0.0 3.6 0.0 0.1 1.8 13.2 3.9 0.8 11.3 1.4 13.9 4.6 0.5 4.1 3.1 3.8 14.3 4.9 11.4 10.1 9.7 8.9 11.2 5.8 7.4 4.5 7.9 3.3 5.7 21.7 5.9 8.9 3.3 8.2 2.4 6.0 7.9 5.1 5.7 5.7 3.3 4.5 5.9 7.4 6.0 32.8 9.1 23.1 2.1 2.1 0.0 1.2 5.1 17.4 7.9 10.4 0.0 0.3 8.3 10.9 0.0 20.7 2.6 0.0 5.3 0.7 7.6 2.8 33.5 0.0 23.8 0.0 1.2 23.9 18.6 0.7 8.9 22.7 6.8 71.3 8.4 16.3 9.9 51.8 11.0 3.3 0.0 6.5 5.6 0.2 0.0 1.9 0.1 28.7 2.4 7.3 SARS SERS ENSG00000031698 "Seryl-tRNA synthetase" P49591 1 109213918-109238169 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "Aminoacyl-tRNA synthetase, DNA-binding, Ligase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016939, HPA064668" Uncertain Enhanced Cytosol NA NA 100000 Cytosol "HPA016939: AB_1856585, HPA064668: AB_2685316" "unprognostic (4.92e-2)" "unprognostic (2.61e-1)" "unprognostic (5.87e-2)" "unprognostic (6.78e-2)" "prognostic favorable (9.47e-4)" "prognostic unfavorable (5.75e-4)" "prognostic unfavorable (6.13e-5)" "unprognostic (3.02e-1)" "unprognostic (1.77e-1)" "unprognostic (2.68e-2)" "unprognostic (3.23e-1)" "unprognostic (2.06e-1)" "unprognostic (1.69e-1)" "unprognostic (1.71e-1)" "unprognostic (1.56e-1)" "unprognostic (3.85e-2)" "unprognostic (3.45e-3)" 35.8 42.6 46.1 28.2 45.9 16.3 38.3 42.6 60.6 40.1 37.6 31.2 30.9 33.5 39.4 36.0 42.0 39.6 28.7 43.9 55.9 47.3 37.6 58.6 44.5 28.8 46.4 56.0 44.4 68.7 55.3 40.1 44.9 64.1 34.3 41.0 22.0 54.2 42.3 72.3 46.1 31.1 42.9 41.0 29.4 46.0 20.9 35.0 25.3 75.0 32.9 38.7 41.8 60.4 54.3 45.9 48.6 48.3 41.0 66.1 88.9 33.3 13.1 25.2 37.9 37.9 34.4 43.4 35.1 36.4 30.5 38.1 25.3 10.3 36.0 18.2 49.4 17.0 18.3 39.2 49.6 35.5 25.4 23.9 13.9 16.2 18.3 76.2 17.5 15.7 42.3 86.8 35.9 78.3 26.0 36.3 45.5 31.8 45.1 29.6 31.9 19.4 8.9 10.5 20.0 31.0 16.1 32.2 16.1 23.2 17.7 35.0 18.6 16.8 27.1 95.1 20.0 15.3 20.9 28.6 18.2 22.9 25.8 24.5 34.4 13.9 29.5 57.4 19.3 61.8 35.6 44.5 48.6 56.0 48.2 58.4 54.3 59.3 55.4 45.9 52.5 61.8 57.7 21.3 41.0 48.3 29.6 66.1 88.9 46.1 45.9 42.6 60.6 55.9 47.3 46.4 56.0 64.1 35.0 47.6 92.0 61.1 90.9 109.9 51.2 87.9 81.5 66.9 81.9 68.0 21.6 157.2 112.7 120.1 15.1 64.7 75.8 70.0 195.0 122.6 80.4 56.7 96.0 112.9 78.0 55.6 66.7 63.8 59.4 21.0 73.1 68.8 60.8 110.0 61.3 56.1 142.9 49.1 65.4 85.4 34.4 129.4 118.7 46.1 22.4 95.2 157.6 64.0 84.6 77.6 SAV1 "salvador, WW45, WWP4" ENSG00000151748 "Salvador family WW domain containing protein 1" Q9H4B6 14 50632058-50668331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001808 Approved Supported Cytosol NA NA Cytosol "HPA001808: AB_2666441" "prognostic favorable (2.92e-5)" "unprognostic (5.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.52e-2)" "unprognostic (4.38e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-3)" "unprognostic (3.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (1.41e-3)" "unprognostic (5.20e-2)" "prognostic favorable (3.83e-6)" "unprognostic (2.32e-1)" "unprognostic (2.05e-1)" "unprognostic (1.28e-2)" "unprognostic (1.90e-3)" 28.5 13.5 13.9 10.8 16.2 5.0 30.3 11.9 13.9 23.3 18.9 19.9 13.8 11.7 19.3 15.5 13.9 17.1 20.7 23.1 15.6 12.5 18.4 13.5 22.1 10.9 17.3 11.1 30.8 31.3 24.5 11.2 17.0 15.6 29.2 10.1 18.6 34.0 19.8 25.6 15.9 18.3 16.0 20.1 16.6 16.5 22.5 17.7 5.5 32.1 12.1 11.0 23.5 36.7 7.1 2.3 1.1 0.7 0.9 1.9 0.9 37.1 4.3 7.2 5.0 18.0 16.6 9.1 10.5 34.9 13.8 17.7 6.3 19.1 5.8 26.1 10.4 7.3 17.1 10.3 11.4 25.8 17.7 8.0 6.4 6.8 4.5 8.8 6.9 5.9 10.3 14.8 6.2 13.8 10.5 9.8 6.4 10.5 2.9 17.0 6.9 5.8 4.3 13.5 8.4 6.7 6.6 20.1 2.4 8.7 5.4 9.1 7.1 18.7 11.2 15.7 12.4 8.1 7.0 7.0 6.6 22.6 9.0 6.4 4.5 5.8 3.5 4.6 2.8 8.8 1.1 0.7 0.1 1.7 0.6 1.9 6.2 1.4 1.2 0.7 7.1 1.1 1.4 1.1 0.9 0.7 2.3 1.6 0.9 13.9 16.2 11.9 13.9 15.6 12.5 17.3 11.1 15.6 17.7 32.8 41.9 22.9 32.5 58.5 16.9 34.0 15.3 38.8 46.6 17.4 23.6 17.6 14.9 36.3 55.9 45.2 9.7 0.0 41.0 16.7 43.1 61.4 2.3 12.8 9.3 4.8 5.2 51.5 12.9 18.4 61.9 17.6 28.7 13.6 10.7 21.7 59.9 11.5 40.0 11.7 24.7 6.5 54.3 39.0 38.3 51.9 19.3 7.5 9.5 29.0 SCARB2 "CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII" ENSG00000138760 "Scavenger receptor class B member 2" Q14108 4 76158733-76234536 "Disease related genes, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 18.3;granulocytes: 6.2;monocytes: 15.3" "Cell line enhanced" "Detected in many" "ASC diff: 88.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015415, HPA018014" Supported Approved Cytosol NA NA Cytosol "CAB015415: AB_831511, HPA018014: AB_1852881" "prognostic unfavorable (2.82e-5)" "unprognostic (2.73e-2)" "unprognostic (4.09e-2)" "unprognostic (4.96e-2)" "unprognostic (4.17e-3)" "unprognostic (1.12e-3)" "unprognostic (2.08e-1)" "unprognostic (5.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.25e-2)" "unprognostic (4.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (6.88e-2)" "unprognostic (5.06e-2)" "unprognostic (3.89e-2)" 33.6 20.6 30.7 13.0 32.9 4.1 34.1 22.9 42.8 40.1 34.9 63.7 21.4 22.7 26.8 37.0 20.3 24.9 34.5 29.7 35.7 30.3 29.0 51.6 43.8 21.7 43.9 31.6 37.0 32.3 47.5 14.5 41.0 44.1 44.2 32.7 23.1 40.3 34.1 54.3 16.5 27.6 24.4 70.5 26.7 36.1 16.1 40.7 6.2 39.2 16.5 10.8 31.7 40.3 2.6 18.3 6.2 15.3 0.7 3.0 3.6 5.7 4.6 7.2 13.9 88.2 43.1 6.1 19.3 44.4 16.9 31.4 8.2 15.9 0.0 15.3 41.3 16.3 4.9 5.1 12.0 17.9 24.8 5.8 0.5 4.2 3.9 21.6 3.0 2.0 31.9 12.1 17.9 10.3 39.3 30.2 1.5 2.7 29.2 26.0 8.8 0.2 0.6 1.7 17.1 4.5 3.6 14.7 4.9 11.9 3.8 17.1 17.7 16.5 11.5 16.7 9.4 5.2 3.0 19.9 17.1 8.6 14.1 6.0 27.1 17.0 0.0 19.9 3.9 25.2 6.2 8.8 2.1 1.8 15.3 1.9 2.6 1.5 1.1 5.2 2.0 1.8 3.0 1.5 0.7 14.7 18.3 1.8 3.6 30.7 32.9 22.9 41.1 35.7 30.3 43.9 31.6 44.1 40.7 163.8 38.3 16.4 69.4 21.3 92.5 50.2 96.8 45.5 37.5 94.2 56.9 29.5 6.6 100.8 5.0 72.9 82.1 0.0 63.0 42.1 60.9 149.5 3.5 90.6 138.6 57.2 98.3 91.4 117.9 2.9 42.0 58.7 64.1 26.2 73.9 73.8 79.5 66.0 62.6 27.2 69.7 90.5 54.8 3.4 13.2 29.5 49.7 10.5 48.8 82.4 SCGN "CALBL, DJ501N12.8, SECRET, SEGN" ENSG00000079689 "Secretagogin, EF-hand calcium binding protein" O76038 6 25652201-25701783 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3;pancreas: 39.7;pituitary gland: 47.9" "Cell type enriched" "Detected in some" 6 "Intestinal endocrine cells: 576.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 38.2" "Group enriched" "Detected in many" 11 "cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 23.6" "Region enriched" "Detected in single" 16 "olfactory region: 100.5" "Region enriched" "Detected in some" 9 "olfactory region: 282.4" "CAB004005, HPA006641, CAB044060, CAB062563, CAB068232" Enhanced Supported Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874" "unprognostic (8.15e-2)" "unprognostic (4.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.25e-2)" "unprognostic (4.70e-1)" "unprognostic (1.78e-2)" "unprognostic (2.01e-1)" "unprognostic (5.14e-2)" "unprognostic (5.41e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-1)" 1.5 2.1 0.7 6.0 0.8 0.1 2.0 22.3 1.5 0.4 10.5 0.5 0.9 7.2 0.1 0.3 0.3 0.0 0.5 5.0 6.2 22.0 3.8 2.5 0.4 0.1 0.5 1.2 0.2 39.7 0.0 47.9 1.8 1.4 1.1 11.7 1.8 3.7 3.0 0.1 0.3 8.0 0.7 1.0 0.1 12.5 0.6 0.1 0.5 1.1 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 23.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 22.3 1.5 6.2 22.0 0.5 1.2 1.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 99.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.3 0.1 0.0 4.7 0.0 0.0 0.1 0.0 576.5 1.8 0.0 0.0 0.6 0.0 0.0 1.8 2.8 0.0 7.8 2.9 0.0 2.2 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 SCRN1 KIAA0193 ENSG00000136193 "Secernin 1" Q12765 7 29920103-29990289 "Enzymes, Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.8" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 65.2;Muller glia cells: 76.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 69.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024517 Enhanced Approved Cytosol No No 110000 Cytosol "HPA024517: AB_2184811" "prognostic unfavorable (8.32e-4)" "prognostic unfavorable (8.46e-4)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.00e-5)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (1.13e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "prognostic favorable (1.15e-5)" "unprognostic (2.57e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (2.60e-4)" 6.8 14.8 32.0 6.3 31.5 3.6 7.6 62.8 55.4 12.4 8.1 23.2 4.5 3.4 13.3 8.8 10.0 13.9 8.5 9.8 26.6 30.7 12.8 1.5 8.3 6.7 42.7 26.6 17.5 18.5 42.9 12.1 8.0 26.3 15.0 5.6 7.8 8.4 20.2 1.0 5.7 5.0 17.7 42.9 5.2 7.1 11.4 23.3 8.2 7.1 1.5 10.6 9.4 5.8 10.4 7.8 6.9 16.7 4.8 8.1 2.2 21.8 15.8 25.8 10.4 18.3 28.2 0.1 20.4 27.4 22.2 24.0 18.2 17.4 2.7 18.2 26.1 49.4 9.9 29.3 8.7 32.5 0.1 6.1 9.0 10.6 11.7 23.4 0.0 0.1 23.5 12.6 20.1 10.8 30.3 20.4 5.9 0.1 7.1 31.2 12.3 3.1 0.0 23.5 0.0 17.0 0.0 27.5 0.2 15.5 10.8 9.4 22.4 21.1 13.7 23.6 33.9 18.5 1.4 22.5 28.9 24.9 0.3 25.8 2.3 35.4 0.2 13.6 0.1 69.6 2.2 2.3 6.9 0.6 10.2 8.1 10.4 0.1 0.8 7.7 5.0 0.6 1.0 0.4 4.8 16.7 7.8 0.0 2.2 32.0 31.5 62.8 43.1 26.6 30.7 42.7 26.6 26.3 23.3 26.8 13.1 8.2 9.7 2.7 63.5 12.6 20.4 21.4 22.7 31.4 43.2 0.3 13.3 18.8 49.3 5.8 0.0 0.0 21.5 1.6 7.7 14.1 8.1 0.5 4.8 65.2 11.6 2.5 10.0 48.7 12.7 10.6 6.8 4.6 0.9 76.1 21.8 17.3 19.8 1.8 39.0 6.5 8.5 2.3 12.3 1.5 0.8 4.3 1.0 17.0 SCYL1 "GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP" ENSG00000142186 "SCY1 like pseudokinase 1" Q96KG9 11 65525077-65538704 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 115.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015015 Uncertain Supported Cytosol NA NA Cytosol "HPA015015: AB_1856643" "unprognostic (5.56e-2)" "unprognostic (1.16e-1)" "unprognostic (1.03e-1)" "unprognostic (3.99e-1)" "unprognostic (1.23e-2)" "unprognostic (7.87e-2)" "unprognostic (1.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.14e-1)" "unprognostic (7.23e-2)" "unprognostic (4.41e-1)" "unprognostic (4.29e-1)" "unprognostic (7.86e-3)" "unprognostic (6.49e-3)" "unprognostic (4.27e-1)" "unprognostic (8.29e-2)" "unprognostic (2.29e-3)" 24.1 35.5 24.1 20.2 24.4 22.8 49.4 24.6 47.3 25.0 21.6 19.0 27.8 22.5 26.9 30.0 24.1 26.7 21.4 35.8 25.1 21.1 24.1 61.4 22.4 22.9 21.7 23.9 34.1 40.7 27.0 24.3 30.7 19.6 24.7 14.3 24.9 34.0 30.3 51.2 23.6 19.8 23.0 17.1 24.7 24.4 31.4 20.6 18.0 27.3 20.2 20.2 24.9 24.1 10.7 15.5 27.9 13.7 11.1 14.7 12.1 19.9 17.2 13.9 19.2 25.5 22.3 19.0 24.8 33.8 29.7 23.3 24.8 12.1 14.4 25.2 32.2 25.3 18.3 14.6 18.7 10.4 16.9 18.7 16.9 18.9 28.4 36.3 11.1 24.5 30.8 18.5 25.5 19.0 21.0 19.4 14.9 17.6 20.4 18.4 43.5 14.8 25.6 13.3 13.5 24.1 15.1 10.8 26.4 18.3 17.9 12.9 13.6 15.3 33.9 27.0 8.9 33.6 14.1 19.1 23.6 15.9 38.2 14.6 28.3 19.7 15.0 27.4 9.3 16.5 1.9 13.7 17.6 14.7 13.2 11.8 10.0 13.8 14.6 15.5 10.7 11.2 10.5 27.9 11.1 8.5 11.3 9.5 12.1 24.1 24.4 24.6 47.3 25.1 21.1 21.7 23.9 19.6 20.6 17.9 11.8 17.1 26.0 19.5 23.4 5.6 15.3 10.7 13.6 19.2 11.8 53.7 31.5 31.7 20.6 21.5 42.3 0.0 37.5 60.7 33.0 37.9 25.3 33.7 33.9 15.9 29.3 23.4 18.4 17.2 42.3 21.4 28.7 44.1 26.8 20.3 31.3 24.6 42.8 30.5 17.4 12.9 34.2 22.4 22.6 20.3 115.9 19.1 29.9 27.8 SDK1 FLJ31425 ENSG00000146555 "Sidekick cell adhesion molecule 1" Q7Z5N4 7 3301448-4269000 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 99.7;Late spermatids: 120.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 28 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 28 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "AF22: 7.9;BEWO: 9.8;RPTEC TERT1: 8.2;RT4: 10.2;SuSa: 9.9;U-2 OS: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011392 Approved Approved Cytosol NA NA 2700000 Cytosol "HPA011392: AB_1856648" "unprognostic (2.39e-1)" "unprognostic (1.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.83e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.23e-1)" "unprognostic (9.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.16e-1)" "unprognostic (2.49e-2)" "unprognostic (7.84e-2)" "unprognostic (1.59e-1)" "unprognostic (8.44e-2)" "unprognostic (1.37e-1)" 5.8 1.1 2.2 6.1 1.7 1.4 5.8 0.9 3.1 16.6 6.2 1.4 6.8 1.8 6.1 10.9 2.9 4.5 4.8 1.9 3.4 2.2 3.9 0.7 7.0 8.7 1.6 1.4 4.3 22.4 1.5 6.3 2.9 2.1 6.9 2.4 5.6 2.6 9.4 1.8 2.9 4.2 16.5 1.9 16.3 3.6 7.7 1.9 1.8 1.5 3.6 3.4 9.5 13.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.0 1.7 7.9 0.0 0.0 0.0 9.8 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.3 0.0 3.1 0.1 0.8 0.0 0.2 0.0 4.6 0.0 0.3 0.2 3.9 0.0 0.0 1.6 0.0 0.3 0.5 0.0 0.6 0.1 0.0 0.0 3.9 2.0 0.0 0.0 2.7 0.1 0.0 5.6 5.5 0.0 8.2 10.2 4.9 7.2 0.0 0.0 0.0 9.9 0.0 2.5 0.2 0.0 12.3 0.0 3.4 0.0 0.0 0.0 0.0 1.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 2.2 1.7 0.9 3.1 3.4 2.2 1.6 1.4 2.1 1.9 0.0 4.0 0.0 0.4 1.1 10.0 20.4 2.5 9.4 7.9 5.2 0.0 2.3 0.0 1.0 99.7 0.6 0.0 0.0 4.7 0.8 4.1 0.6 0.0 0.0 0.5 1.6 4.7 1.3 0.0 120.8 1.7 0.5 5.0 0.0 0.5 0.3 3.5 0.0 5.3 1.4 0.7 6.5 2.1 6.6 5.1 0.4 1.6 0.0 0.0 0.3 SDSL "cSDH, SDS-RS1" ENSG00000139410 "Serine dehydratase like" Q96GA7 12 113422237-113438276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 118.4;Hofbauer cells: 93.1;monocytes: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 8 "dendritic cells: 13.2;monocytes: 7.1" "Cell line enhanced" "Detected in many" "HMC-1: 22.6;MCF7: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005740 Approved Approved Cytosol NA NA Cytosol "HPA005740: AB_10601486" "unprognostic (1.34e-1)" "unprognostic (8.33e-2)" "unprognostic (3.62e-2)" "unprognostic (3.54e-2)" "unprognostic (2.24e-2)" "unprognostic (6.17e-3)" "unprognostic (1.57e-1)" "unprognostic (6.46e-2)" "unprognostic (8.22e-2)" "unprognostic (2.00e-2)" "prognostic favorable (8.58e-4)" "unprognostic (2.93e-1)" "prognostic favorable (3.09e-5)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (7.33e-2)" 3.1 15.3 4.2 3.8 5.1 1.4 2.8 1.5 7.1 2.6 7.1 5.5 6.2 10.0 2.5 9.7 1.3 4.6 5.2 7.2 3.6 6.1 15.5 53.2 2.8 2.8 9.5 4.2 4.6 15.3 5.0 7.6 3.1 7.8 4.2 5.0 4.6 4.9 4.5 2.1 0.7 7.8 2.9 8.8 3.0 5.2 7.0 2.6 1.5 20.3 1.3 1.6 4.0 1.5 1.1 13.2 0.3 7.1 1.3 0.2 1.7 3.6 14.2 2.0 6.0 0.4 0.9 1.4 2.1 0.5 2.2 1.9 6.1 3.8 0.2 10.7 3.4 6.2 3.7 0.9 4.8 0.8 8.6 3.6 9.1 3.4 2.6 12.0 1.1 22.6 1.9 6.8 5.5 8.2 2.6 3.3 0.0 7.1 2.8 2.7 38.7 0.0 4.5 2.1 3.9 6.1 0.0 3.0 6.8 5.9 4.4 0.6 0.2 8.8 10.0 8.5 1.9 12.3 10.4 3.0 2.7 5.3 12.1 1.8 0.6 0.5 0.1 11.6 3.7 3.3 0.1 6.5 0.0 0.0 7.1 0.0 1.1 0.0 0.0 13.2 0.1 0.0 0.0 0.3 1.3 0.9 12.8 0.2 1.7 4.2 5.1 1.5 7.1 3.6 6.1 9.5 4.2 7.8 2.6 0.0 6.1 8.6 2.1 0.8 0.2 15.7 25.5 0.0 0.0 27.9 2.0 11.4 66.3 30.4 0.4 2.9 43.5 23.3 17.7 2.6 3.8 6.0 43.8 118.4 93.1 3.2 30.5 4.9 12.3 1.1 2.6 14.9 3.3 174.9 28.9 19.5 17.4 40.3 5.3 76.8 1.5 0.0 5.7 0.0 0.2 0.5 6.1 4.3 25.5 4.3 SELENON "MDRS1, RSMD1, RSS, SELN, SEPN1" ENSG00000162430 "Selenoprotein N" Q9NZV5 1 25800176-25818224 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Desmin-related myopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 19.2;Ductal cells: 16.8;Exocrine glandular cells: 36.9;Hofbauer cells: 25.2;Pancreatic endocrine cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA058076 Approved Uncertain Cytosol "Intracellular and membrane" NA NA Cytosol "HPA058076: AB_2683598" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.11e-1)" "prognostic favorable (2.23e-4)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (3.40e-5)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (3.32e-3)" "unprognostic (6.01e-2)" "unprognostic (3.07e-1)" "unprognostic (1.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (5.56e-3)" "unprognostic (5.89e-2)" 41.4 27.2 26.3 26.4 24.8 12.4 53.6 22.0 29.7 32.2 21.9 26.5 26.3 14.3 30.7 20.4 25.4 34.3 27.4 29.3 26.3 16.3 33.0 15.1 35.2 47.8 19.2 18.2 35.3 39.9 23.0 23.7 31.6 22.0 37.5 17.8 30.0 29.1 35.0 30.0 18.0 16.5 45.8 21.0 29.1 24.4 11.6 19.1 10.7 31.4 17.6 16.8 26.1 28.0 1.7 2.1 5.9 3.3 0.7 2.6 1.0 12.2 11.7 39.1 33.4 25.5 44.9 13.2 14.8 22.5 16.5 13.2 3.0 13.0 0.0 9.9 22.4 18.3 11.9 10.2 15.7 12.6 12.9 7.8 12.0 4.5 3.7 18.4 2.5 28.5 47.8 10.6 17.3 8.7 19.6 51.5 4.2 4.2 1.7 15.5 6.2 0.5 3.6 14.7 9.6 8.1 10.5 17.1 1.5 6.8 3.5 8.2 13.9 9.3 8.5 12.4 11.0 8.6 8.4 42.8 16.8 11.5 30.7 8.6 1.4 0.0 0.3 23.3 3.7 20.2 5.9 3.3 3.8 1.8 2.6 1.1 1.7 1.7 1.3 2.1 1.1 2.6 1.6 0.5 0.7 2.5 0.3 1.7 1.0 26.3 24.8 22.0 29.7 26.3 16.3 19.2 18.2 22.0 19.1 8.9 9.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 6.8 19.2 0.0 12.7 0.0 16.8 0.0 0.0 0.0 0.0 36.9 9.5 0.0 0.0 2.3 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 5.4 0.0 0.0 23.6 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690667-169711698 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 227.5;lymphoid tissue: 77.8" "Group enriched" "Detected in many" 6 "B-cells: 178.5;Kupffer cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 7.0;EFO-21: 6.8;JURKAT: 18.6;MOLT-4: 12.8;U-266/70: 24.1;U-698: 11.2;U-937: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002144, HPA051972" Enhanced Uncertain Cytosol NA NA 8100000000 Cytosol "CAB002144: AB_563862, HPA051972: AB_2797242" "prognostic favorable (3.76e-4)" "prognostic favorable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favorable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favorable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 6.9 0.9 2.0 25.1 4.6 30.3 1.5 1.1 2.5 0.9 1.4 1.1 0.0 0.4 1.0 1.1 4.2 3.2 5.4 4.1 2.5 2.2 2.3 2.5 11.4 77.8 5.2 0.2 0.8 1.0 10.7 7.9 3.4 2.7 1.2 1.3 3.8 12.1 0.1 0.9 0.8 8.8 2.9 5.2 67.7 1.7 1.0 2.3 43.8 1.9 1.3 64.0 8.1 6.1 40.4 40.7 227.5 49.7 130.8 69.5 90.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.2 7.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.8 0.8 0.3 0.0 0.0 0.0 0.0 1.2 18.6 0.0 0.9 0.0 0.8 12.8 0.1 0.0 0.2 0.2 4.9 0.1 0.3 3.9 0.2 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 24.1 0.0 11.2 1.3 7.0 0.1 170.8 49.7 88.6 16.5 11.2 4.5 33.8 30.7 17.0 40.7 40.4 69.5 39.6 227.5 130.8 4.5 32.8 52.7 90.1 2.0 4.6 1.1 2.5 2.5 2.2 5.2 0.2 2.7 2.3 8.9 20.2 178.5 0.3 0.3 0.0 0.3 2.5 2.7 3.4 10.4 0.0 9.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.6 0.8 0.0 9.3 0.4 5.6 0.0 0.0 1.8 97.5 0.0 0.6 7.5 1.7 0.0 0.0 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 23.8 20.3 0.0 0.5 SEM1 "C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1" ENSG00000127922 "SEM1, 26S proteasome complex subunit" "P60896, Q6ZVN7" 7 96481626-96709891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 543.9;Exocrine glandular cells: 464.8;Extravillous trophoblasts: 599.1;Syncytiotrophoblasts: 729.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020429, HPA072648" Uncertain Approved Cytosol NA NA Cytosol "HPA020429: AB_1859527, HPA072648: AB_2686543" "unprognostic (5.41e-3)" "unprognostic (6.25e-2)" "unprognostic (1.62e-2)" "unprognostic (2.14e-3)" "unprognostic (1.24e-3)" "unprognostic (6.16e-3)" "unprognostic (4.29e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "prognostic favorable (2.52e-4)" "unprognostic (4.55e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.32e-1)" "unprognostic (2.67e-2)" "unprognostic (2.64e-1)" "prognostic favorable (8.00e-5)" 44.1 58.5 33.3 38.6 48.7 23.1 29.0 25.0 36.3 29.6 48.4 16.8 44.0 41.5 33.5 44.1 45.4 24.0 29.5 69.9 34.8 27.9 34.7 91.6 24.3 28.2 31.7 31.8 45.7 43.6 14.8 51.2 63.5 32.2 32.2 27.8 22.0 43.4 34.5 109.5 34.2 39.0 42.1 43.8 25.0 40.0 52.5 28.8 28.8 28.7 61.8 28.0 31.5 34.0 50.6 94.9 36.7 65.7 42.0 79.0 48.9 63.4 37.5 52.3 54.3 22.4 19.5 28.2 51.9 25.5 21.9 27.4 33.9 52.8 41.9 129.0 25.2 67.7 32.9 43.7 35.0 31.1 48.7 33.0 50.2 55.2 52.6 20.5 74.2 37.6 24.8 27.5 32.7 33.5 34.3 29.2 50.4 65.0 51.8 22.2 80.4 83.8 105.3 70.7 64.4 34.3 32.6 67.4 49.5 31.0 63.2 43.1 54.5 96.9 81.4 52.8 83.8 23.2 56.6 60.0 43.2 75.2 79.8 64.7 32.6 87.4 121.2 47.2 65.6 59.4 36.7 61.3 15.8 45.5 65.7 43.2 50.6 59.3 53.1 86.3 45.3 46.9 47.2 4.1 42.0 55.4 94.9 79.0 48.9 33.3 48.7 25.0 36.3 34.8 27.9 31.7 31.8 32.2 28.8 160.8 197.7 0.0 0.0 0.0 0.0 0.0 0.0 274.4 190.0 232.1 0.0 543.9 349.8 309.5 0.0 0.0 0.0 0.0 464.8 599.1 0.0 0.0 94.2 0.0 339.5 0.0 0.0 0.0 0.0 0.0 0.0 130.5 0.0 421.2 0.0 0.0 446.5 0.0 0.0 414.8 0.0 0.0 0.0 0.0 0.0 0.0 729.5 0.0 0.0 0.0 SEMA5B "FLJ10372, KIAA1445, SEMAG, SemG" ENSG00000082684 "Semaphorin 5B" Q9P283 3 122909193-123028605 "Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;heart muscle: 11.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 2.5;Cardiomyocytes: 3.2;Cholangiocytes: 2.5;Ito cells: 3.1;Muller glia cells: 10.6" "Cancer enhanced" "Detected in many" "renal cancer: 18.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 42.4;NTERA-2: 8.2;SH-SY5Y: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066548 Enhanced Supported Cytosol NA NA Cytosol "HPA066548: AB_2685689" "unprognostic (7.34e-2)" "unprognostic (1.84e-3)" "unprognostic (1.92e-4)" "unprognostic (3.01e-2)" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "unprognostic (4.72e-2)" "unprognostic (1.58e-2)" "unprognostic (7.66e-3)" "unprognostic (2.87e-2)" "unprognostic (4.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (1.31e-3)" "unprognostic (5.96e-2)" "unprognostic (6.12e-2)" "unprognostic (2.12e-1)" 1.5 1.2 12.0 0.7 12.3 0.3 1.1 0.8 13.6 2.1 1.5 4.3 0.4 1.9 2.8 5.5 1.5 3.0 4.7 11.7 13.0 3.3 6.1 1.4 2.2 1.1 2.5 3.3 1.3 3.1 1.1 2.5 5.0 2.0 1.8 1.8 6.0 0.9 3.1 1.6 1.2 1.3 3.8 1.7 0.5 0.7 1.1 5.7 0.1 2.2 2.5 1.3 3.3 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 42.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 11.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.0 12.3 0.8 13.2 13.0 3.3 2.5 3.3 2.0 5.7 0.0 0.6 0.0 0.0 0.0 2.5 3.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 1.0 0.0 10.6 0.0 0.0 0.0 0.0 0.9 0.0 2.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SENP2 "AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2" ENSG00000163904 "SUMO1/sentrin/SMT3 specific peptidase 2" Q9HC62 3 185582496-185633551 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029247, HPA029248" Approved Supported Cytosol NA NA Cytosol "HPA029247: AB_10599305, HPA029248: AB_10601855" "unprognostic (4.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.80e-2)" "prognostic unfavorable (7.98e-5)" "unprognostic (7.85e-2)" "unprognostic (2.90e-2)" "unprognostic (4.41e-3)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "unprognostic (8.41e-3)" "unprognostic (5.12e-2)" "unprognostic (6.92e-2)" "unprognostic (1.60e-1)" "unprognostic (1.92e-1)" "unprognostic (1.56e-1)" 10.3 10.1 16.0 7.6 19.8 13.8 11.6 18.8 20.2 8.7 8.8 13.8 7.8 9.2 9.5 15.4 9.3 9.7 7.0 10.9 15.2 15.1 11.3 14.2 9.5 8.6 14.6 12.0 16.0 9.1 15.6 16.7 13.4 13.9 9.7 9.6 9.1 11.0 10.3 24.6 13.9 8.5 9.2 12.9 9.2 9.4 34.9 17.1 11.0 11.2 7.3 8.9 8.5 9.3 4.2 4.4 7.8 3.2 5.1 3.8 1.9 15.3 3.1 7.6 8.7 13.7 9.3 9.9 7.2 8.1 9.0 9.6 11.6 4.9 8.3 13.6 6.4 15.6 8.2 15.9 5.8 13.4 6.1 7.5 5.6 6.4 6.9 7.3 8.2 3.7 5.8 8.8 5.1 6.3 6.6 6.2 8.0 6.6 11.8 7.7 7.6 6.9 9.2 28.1 7.8 5.3 8.2 10.4 13.8 5.0 5.1 7.9 8.9 6.0 13.3 11.1 16.1 18.2 11.1 3.9 6.0 6.5 10.9 11.2 13.7 16.3 15.2 9.8 8.8 8.1 7.2 3.0 5.4 3.7 2.8 3.8 3.0 3.1 3.0 2.2 4.2 3.7 3.6 7.8 5.1 3.2 4.4 2.7 1.9 16.0 19.8 18.8 20.2 15.2 15.1 14.6 12.0 13.9 17.1 26.8 21.4 9.0 19.8 9.6 23.0 20.5 10.2 32.1 35.2 8.7 29.5 21.4 5.0 11.3 190.6 11.3 16.0 0.0 13.3 16.4 13.4 15.3 10.4 15.8 11.1 11.1 5.2 16.5 9.1 24.4 21.0 9.5 16.9 8.2 13.7 15.6 13.8 3.5 16.6 14.7 34.4 19.4 13.4 83.9 30.9 10.9 33.2 16.7 14.4 18.2 SEPT11 FLJ10849 ENSG00000138758 "Septin 11" Q9NVA2 4 76949703-77040384 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 227.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 91.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003459, HPA005665" Approved Approved Cytosol NA NA 6500000 Cytosol "HPA003459: AB_1856696, HPA005665: AB_1079910" "unprognostic (1.69e-1)" "unprognostic (2.93e-1)" "unprognostic (3.39e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.70e-5)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.58e-2)" "unprognostic (2.58e-2)" "unprognostic (5.85e-2)" "prognostic favorable (2.40e-4)" "unprognostic (5.70e-3)" "unprognostic (6.84e-2)" "unprognostic (1.55e-1)" "unprognostic (2.57e-1)" 39.9 6.4 25.0 12.1 36.6 3.2 28.0 24.8 49.7 21.1 22.8 9.9 7.8 10.1 16.7 12.2 10.9 11.1 21.8 14.6 17.2 13.7 25.5 16.0 18.8 10.3 11.4 27.1 10.2 10.4 7.8 5.7 39.1 14.3 12.3 19.5 7.9 8.5 13.1 17.4 6.7 16.2 19.2 10.5 11.6 11.5 4.5 13.9 2.7 10.1 5.9 10.3 15.9 16.8 2.7 12.0 18.2 3.8 21.2 6.9 3.7 12.9 5.3 51.0 45.2 30.5 24.4 14.7 75.7 58.5 17.2 24.3 9.6 9.6 0.3 15.8 91.1 8.1 5.5 16.8 11.2 26.8 16.9 5.6 25.5 7.1 6.9 26.7 13.7 10.9 30.9 5.3 24.9 9.3 13.7 25.8 5.2 10.5 7.2 50.6 7.5 18.0 0.4 17.1 10.6 2.7 21.2 58.0 1.5 9.7 14.2 17.5 13.1 14.7 8.4 12.0 34.2 7.6 5.5 28.0 57.8 17.3 28.3 13.9 4.4 3.5 0.1 22.0 1.5 11.6 6.6 1.4 18.2 5.1 1.2 3.1 2.0 5.8 6.9 4.5 2.7 2.2 5.9 0.4 21.2 3.8 12.0 3.2 3.7 25.0 36.6 24.8 49.7 17.2 13.7 11.4 27.1 14.3 13.9 14.9 13.2 17.5 0.0 20.4 51.2 11.2 15.3 36.1 21.6 82.0 23.6 74.7 33.2 0.0 3.4 49.3 65.6 46.7 0.0 227.1 109.2 0.0 81.0 42.3 44.8 58.8 35.2 60.8 13.0 3.1 99.5 34.0 28.7 0.0 49.9 32.4 0.0 56.1 112.8 45.9 25.0 135.8 45.3 1.4 8.1 13.4 50.6 27.4 62.6 0.0 SEPT6 "KIAA0128, MGC16619, MGC20339, SEP2, SEPT2" ENSG00000125354 "Septin 6" Q14141 X 119615724-119693370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 145.4" "Cell type enhanced" "Detected in many" 6 "B-cells: 130.4;Horizontal cells: 100.1;T-cells: 146.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 52.7;MOLT-4: 56.0;REH: 51.6;SH-SY5Y: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003459, HPA005665" Supported Approved Cytosol NA NA 10000000 Cytosol "HPA003459: AB_1856696, HPA005665: AB_1079910" "unprognostic (6.35e-3)" "unprognostic (1.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.09e-1)" "unprognostic (1.73e-1)" "unprognostic (6.23e-2)" "unprognostic (2.13e-1)" "unprognostic (7.24e-2)" "unprognostic (6.27e-2)" "unprognostic (1.46e-1)" "unprognostic (1.95e-1)" "unprognostic (2.55e-1)" "unprognostic (2.88e-1)" "unprognostic (1.92e-1)" "unprognostic (2.60e-2)" 5.1 39.1 6.9 34.0 6.5 20.6 5.6 23.6 13.1 6.1 22.5 3.8 5.6 5.4 6.7 7.2 9.5 7.3 9.9 8.8 6.7 17.2 8.2 9.8 7.0 42.9 9.5 6.9 6.0 2.2 3.4 5.5 14.1 13.3 6.5 7.3 8.4 12.4 16.7 2.3 3.8 17.6 9.3 5.4 31.8 9.5 24.7 3.3 145.4 4.3 4.5 43.8 9.8 5.3 24.3 22.6 13.0 12.9 27.5 38.5 16.8 1.2 1.9 7.5 13.4 0.7 1.5 10.6 3.6 8.1 6.2 10.8 0.6 2.8 24.9 2.9 4.6 6.5 0.7 11.7 2.3 4.3 15.2 2.7 11.0 4.0 4.4 1.8 12.4 5.8 2.8 0.5 4.9 0.1 2.6 9.0 52.7 8.1 13.4 3.6 0.9 56.0 7.0 7.9 0.3 6.0 51.6 6.2 20.1 6.6 1.3 3.3 78.6 9.5 3.5 4.0 8.4 4.7 6.4 5.6 1.7 3.5 5.4 0.9 6.7 2.6 33.0 0.1 13.2 1.2 9.8 5.6 13.0 22.3 9.4 23.3 24.3 28.4 25.6 12.0 22.9 30.5 26.0 4.4 27.5 12.9 22.6 38.5 16.8 6.9 6.5 23.6 13.1 6.7 17.2 9.5 6.9 13.3 3.3 8.9 16.2 130.4 0.0 6.4 23.2 7.3 2.5 13.4 9.1 21.0 45.2 40.1 46.4 0.0 2.3 21.7 1.2 0.0 0.0 43.9 20.5 0.0 41.6 14.7 47.3 100.1 7.5 25.8 33.0 6.5 31.1 58.0 15.1 0.0 2.6 32.6 0.0 2.9 71.8 1.1 34.4 25.8 7.4 1.4 9.8 6.0 35.9 146.6 5.3 0.0 SERBP1 "CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1" ENSG00000142864 "SERPINE1 mRNA binding protein 1" Q8NC51 1 67407810-67430415 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020559, CAB026297" Supported Enhanced Cytosol NA NA 430000 Cytosol "CAB026297: AB_425924, HPA020559: AB_1856701" "unprognostic (1.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.45e-2)" "unprognostic (6.80e-3)" "unprognostic (2.71e-3)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (1.98e-2)" "unprognostic (1.32e-3)" "unprognostic (5.97e-2)" "unprognostic (8.25e-3)" "unprognostic (3.04e-1)" "unprognostic (1.33e-2)" "unprognostic (1.40e-2)" "unprognostic (4.76e-1)" "unprognostic (6.64e-2)" "unprognostic (1.34e-3)" 38.3 30.4 22.5 35.7 30.0 33.8 36.9 25.4 27.7 35.4 32.8 25.5 28.6 30.9 36.4 35.2 68.4 25.9 39.4 32.6 22.3 19.1 30.6 48.4 27.5 47.9 29.7 18.6 33.5 56.1 52.2 21.8 28.7 25.0 34.8 27.1 23.2 41.8 28.5 87.5 50.5 29.9 42.0 26.8 31.9 31.5 35.8 28.7 48.9 42.6 54.1 41.3 36.0 40.7 34.3 35.4 16.8 30.2 46.7 44.4 33.9 59.2 36.2 38.9 38.7 34.7 31.9 57.7 62.6 24.6 43.5 36.9 69.8 26.5 114.7 46.9 33.7 40.4 45.7 61.0 58.6 47.2 51.2 73.4 105.6 68.0 61.8 30.4 85.5 40.5 32.5 39.5 55.8 51.0 28.8 47.1 37.5 117.6 40.5 34.7 41.3 64.3 51.9 135.3 39.5 47.9 74.3 85.4 57.3 33.7 49.4 65.7 46.1 48.6 52.9 56.6 33.9 28.9 52.3 49.1 40.0 48.6 57.6 84.1 37.7 48.2 102.9 32.9 81.2 44.6 9.8 27.4 16.8 35.0 30.2 44.4 34.3 35.2 35.3 35.4 33.4 41.4 37.4 9.0 46.7 27.4 32.3 41.7 33.9 22.5 30.0 25.4 27.7 22.3 19.1 29.7 18.6 25.0 28.7 232.3 185.1 214.5 341.9 609.6 146.7 119.8 186.0 238.3 320.8 111.7 86.4 217.4 205.6 253.5 407.2 294.6 134.6 186.9 310.6 429.9 231.1 212.2 213.7 301.4 265.1 135.1 220.8 148.0 205.2 164.8 204.8 212.7 182.2 266.1 277.0 146.7 292.1 133.3 262.0 212.1 123.4 135.8 315.9 477.7 288.9 629.1 191.8 235.2 341.4 442.1 SERINC1 "KIAA1253, TDE1L, TDE2, TMS-2" ENSG00000111897 "Serine incorporator 1" Q9NRX5 6 122443354-122471822 "Plasma proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035738, HPA035739" Uncertain Approved Cytosol NA NA Cytosol "HPA035738: AB_10672990, HPA035739: AB_10669536" "unprognostic (2.83e-3)" "unprognostic (2.68e-3)" "unprognostic (1.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.65e-1)" "unprognostic (2.84e-2)" "unprognostic (2.04e-1)" "unprognostic (7.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.27e-2)" "unprognostic (9.07e-3)" "unprognostic (2.84e-1)" "unprognostic (5.50e-3)" "unprognostic (1.80e-3)" "unprognostic (9.22e-2)" "unprognostic (3.58e-1)" "unprognostic (1.00e-2)" 49.0 62.0 72.0 21.6 74.5 31.4 39.6 67.3 96.4 40.4 25.1 61.5 17.0 23.9 36.7 27.8 23.8 27.0 31.6 39.1 75.5 78.4 48.7 58.1 38.9 20.6 91.6 57.7 42.7 24.4 56.4 32.9 47.0 109.2 36.0 25.2 29.7 22.5 37.8 37.4 20.5 27.2 35.4 120.6 28.4 23.1 15.6 57.5 12.9 50.8 13.0 18.7 33.2 22.8 10.0 12.6 44.1 20.4 17.7 20.7 17.4 7.4 9.2 23.3 21.3 88.4 48.6 12.4 39.2 49.2 21.5 33.4 10.7 20.2 5.0 30.9 44.1 24.7 14.9 13.7 16.9 32.3 15.9 16.3 14.1 15.7 19.5 39.6 14.1 28.2 50.4 33.3 26.7 37.0 49.6 18.5 13.2 14.0 28.5 44.4 8.5 6.3 9.4 7.5 11.7 11.7 7.8 11.5 12.0 46.2 13.1 12.2 22.1 17.3 19.3 26.5 21.6 13.3 19.9 37.7 25.9 11.3 21.2 20.3 21.6 24.1 6.6 34.3 11.5 30.2 44.1 15.0 31.4 16.8 18.8 18.1 10.0 17.6 16.2 12.6 8.7 20.7 17.9 38.9 17.7 20.4 9.9 18.6 17.4 72.0 74.5 67.3 86.9 75.5 78.4 91.6 57.7 109.2 57.5 140.0 86.4 39.7 67.4 58.7 103.2 138.9 89.2 52.2 54.6 73.3 66.8 48.9 8.3 55.1 2.4 116.4 66.3 46.7 42.2 46.7 95.4 88.7 119.2 115.6 64.9 130.3 81.1 105.6 142.0 5.6 117.3 84.8 89.4 25.2 36.8 98.4 63.7 38.6 123.4 38.5 56.5 58.2 75.4 17.9 19.6 65.5 100.1 71.3 29.3 78.2 SERPINE1 "PAI, PAI1, PLANH1" ENSG00000106366 "Serpin family E member 1" P05121 7 101127089-101139266 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 253.6" "Cell type enhanced" "Detected in many" 22 "Pancreatic endocrine cells: 138.9;Syncytiotrophoblasts: 545.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 20 "NK-cell: 10.8" "Lineage enriched" "Detected in single" 20 "NK-cells: 10.8" "Cell line enhanced" "Detected in many" "BJ: 142.8;HUVEC TERT2: 165.7;LHCN-M2: 160.0;TIME: 409.8;U-138 MG: 195.1;U-251 MG: 171.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA050039, CAB068501" Uncertain Approved Cytosol "Secreted to blood" No No 142000000 14000000 Cytosol "CAB068501: AB_1642775, HPA050039: AB_2680997" "unprognostic (5.02e-2)" "prognostic unfavorable (5.01e-4)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.10e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (2.84e-5)" "unprognostic (6.80e-3)" "prognostic unfavorable (4.41e-6)" "unprognostic (2.33e-1)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (5.88e-8)" "prognostic unfavorable (3.27e-6)" "unprognostic (1.05e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.51e-4)" 45.5 14.0 1.1 16.7 1.8 0.1 11.4 0.5 1.5 13.3 7.0 3.4 3.3 1.2 6.6 14.4 6.8 9.3 69.6 29.2 1.5 0.6 7.8 65.3 56.3 3.3 4.1 1.8 19.7 24.7 1.4 2.6 253.6 5.9 7.6 0.9 2.3 2.4 6.2 12.4 4.1 2.3 13.5 4.1 5.8 6.6 8.6 2.2 0.6 11.3 3.7 2.8 71.7 18.1 0.2 0.4 0.5 0.2 10.8 0.3 1.0 3.0 2.6 0.0 0.2 32.7 65.2 3.7 142.8 27.0 72.1 63.0 0.3 0.2 0.1 34.2 45.4 99.7 0.7 0.0 11.0 74.4 0.1 0.0 0.0 0.2 2.4 65.8 0.0 0.1 25.5 4.4 110.5 58.1 39.1 165.7 0.0 0.2 0.1 160.0 0.0 0.0 0.0 0.7 0.0 1.7 0.0 0.2 0.1 0.2 1.2 0.0 0.0 11.7 3.2 0.3 18.0 0.1 0.4 409.8 195.1 8.5 66.4 171.5 0.0 0.1 0.1 48.7 0.0 1.8 0.5 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.3 0.2 0.0 0.1 0.2 10.8 0.0 0.4 0.0 1.0 1.1 1.8 0.5 1.5 1.5 0.6 4.1 1.8 5.9 2.2 0.0 11.4 0.0 30.0 35.5 0.4 1.9 7.6 8.1 7.9 5.2 0.0 34.4 0.0 22.9 0.0 53.9 0.0 0.0 3.8 35.1 24.7 5.4 10.3 90.0 15.2 0.0 5.1 60.2 4.7 0.4 16.4 7.5 6.8 1.8 0.0 0.3 138.9 0.0 11.3 0.0 0.2 38.8 16.5 0.0 0.0 21.7 545.0 0.7 0.0 5.9 SERPINI1 "neuroserpin, PI12" ENSG00000163536 "Serpin family I member 1" Q99574 3 167735243-167825568 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 96.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 71.8;Muller glia cells: 71.6;Smooth muscle cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.9;HeLa: 16.5;Karpas-707: 18.5;U-266/84: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001565, HPA056092" Enhanced Uncertain Cytosol "Secreted in brain" NA NA 200000 Cytosol "HPA001565: AB_1079924, HPA056092: AB_2683036" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (4.09e-3)" "unprognostic (1.35e-1)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.48e-1)" "unprognostic (2.61e-1)" "unprognostic (6.07e-3)" "unprognostic (2.18e-2)" "unprognostic (1.01e-1)" "unprognostic (1.58e-3)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 5.9 8.2 31.9 2.4 27.9 1.3 6.1 3.6 96.0 4.2 2.8 7.1 0.4 1.5 4.3 4.3 3.2 3.9 3.4 6.4 35.9 35.3 14.5 2.5 3.4 2.3 36.9 35.7 4.0 16.3 3.7 10.3 3.5 22.9 5.8 2.5 2.4 9.9 3.6 1.7 2.1 2.5 3.1 51.6 4.1 3.6 7.0 15.9 0.0 5.2 0.3 3.8 3.1 1.6 15.4 4.4 1.0 0.4 6.0 16.0 3.4 0.4 2.0 3.2 0.2 6.0 1.6 0.2 1.2 1.8 0.8 1.3 0.7 3.9 15.9 6.1 0.8 2.7 0.9 2.1 2.2 0.9 5.0 4.5 5.4 16.5 6.7 0.4 0.8 0.6 2.3 0.8 0.4 0.8 1.8 0.2 6.1 10.1 18.5 0.7 1.5 0.4 1.1 2.0 2.5 2.5 1.8 0.1 2.0 6.9 0.5 1.3 8.4 2.3 4.3 5.1 7.8 6.6 2.4 0.5 3.5 0.3 0.3 5.7 13.9 17.1 11.6 2.9 4.1 2.0 1.0 0.2 0.5 6.2 0.4 4.5 12.7 6.5 6.6 0.3 15.4 4.7 5.7 0.6 6.0 0.3 4.4 16.0 3.4 31.9 27.9 3.6 78.9 35.9 35.3 36.9 35.7 22.9 15.9 6.0 1.0 8.0 12.2 3.3 71.8 7.3 0.0 13.4 7.9 5.2 13.7 5.0 6.6 1.5 0.3 9.2 0.0 0.0 15.6 4.7 5.2 9.8 2.3 0.6 2.3 4.8 4.6 3.1 0.8 1.8 3.7 1.9 6.8 1.8 0.1 71.6 4.6 0.0 2.5 31.2 31.4 25.8 68.9 1.8 13.2 1.5 4.2 5.3 0.0 1.6 SESN2 "DKFZp761M0212, HI95, SES2, SEST2" ENSG00000130766 "Sestrin 2" P58004 1 28259527-28282491 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 23.1;SK-MEL-30: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018191 Uncertain Approved Cytosol NA NA Cytosol "HPA018191: AB_1856750" "unprognostic (7.05e-2)" "unprognostic (4.95e-3)" "unprognostic (1.43e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.78e-4)" "unprognostic (8.97e-2)" "unprognostic (2.50e-3)" "unprognostic (1.41e-1)" "unprognostic (1.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (2.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" 9.2 7.7 7.0 6.8 6.7 32.0 7.6 6.1 11.1 6.1 9.6 3.5 4.6 14.3 7.2 4.0 15.2 6.2 7.6 4.3 4.5 6.1 12.5 18.4 7.7 4.1 8.4 4.5 22.4 10.4 7.5 5.4 9.3 7.6 5.2 8.3 6.9 14.5 4.6 5.8 4.9 12.6 6.2 10.9 5.8 7.2 9.2 4.3 4.8 7.0 4.2 9.7 7.3 14.9 1.9 2.8 6.2 2.7 3.9 9.6 2.5 2.6 1.4 3.5 5.8 5.7 4.5 19.2 5.1 4.7 3.1 3.7 2.0 1.9 3.0 2.1 2.3 3.5 2.6 4.1 3.6 2.2 2.7 3.8 1.2 2.0 3.4 18.8 4.5 6.8 14.3 23.1 8.4 20.1 1.4 3.4 7.1 7.1 14.5 2.9 1.5 1.6 1.2 2.8 1.2 2.9 2.5 0.9 6.6 2.1 4.5 1.2 1.3 1.4 1.2 27.9 4.0 3.2 6.4 1.9 1.6 4.9 3.6 3.1 18.8 4.7 4.7 3.7 4.6 3.5 0.0 2.3 1.9 9.6 1.9 4.7 1.9 3.4 4.6 2.4 1.4 2.1 4.3 6.2 3.9 2.7 2.8 3.9 2.5 7.0 6.7 6.1 11.1 4.5 6.1 8.4 4.5 7.6 4.3 0.0 5.3 7.3 16.1 15.0 12.1 6.1 7.6 1.4 1.2 7.0 7.9 25.1 3.3 20.3 2.0 5.8 23.8 0.0 14.6 17.0 10.4 12.6 4.6 18.8 11.7 0.0 12.6 8.0 3.3 2.7 2.3 10.9 6.8 7.2 10.7 5.8 23.7 11.5 3.2 20.7 7.4 0.0 21.9 4.7 3.3 10.9 56.0 12.8 11.5 19.1 SGCB "A3b, LGMD2E, SGC" ENSG00000163069 "Sarcoglycan beta" Q16585 4 52020706-52038482 "Disease related genes, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011422, HPA058656" Enhanced Approved Cytosol NA NA Cytosol "HPA011422: AB_1856795, HPA058656: AB_2683790" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (1.03e-1)" "unprognostic (1.60e-3)" "unprognostic (9.80e-2)" "unprognostic (3.42e-2)" "unprognostic (3.57e-3)" "unprognostic (1.86e-2)" "unprognostic (2.84e-2)" "unprognostic (6.04e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.53e-6)" "unprognostic (3.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (7.61e-4)" 17.7 13.2 17.6 5.4 19.0 0.5 8.8 18.6 20.7 14.9 18.3 17.5 3.7 7.7 17.1 7.0 13.2 11.5 11.6 32.4 16.5 14.5 20.5 6.4 9.0 3.4 20.4 12.9 12.6 4.0 29.9 17.5 13.9 17.9 15.4 9.9 7.9 7.8 17.0 54.1 4.4 8.7 21.8 24.7 6.3 9.0 9.2 20.3 0.9 7.9 10.4 2.8 13.5 11.8 4.3 1.7 0.9 2.0 0.5 6.6 2.0 3.4 4.2 8.9 3.3 34.4 26.0 3.2 19.7 25.3 11.1 11.7 1.1 4.7 0.9 3.8 25.8 17.2 1.7 6.6 7.2 11.9 5.7 2.5 0.0 4.0 2.1 14.1 2.0 1.1 28.5 5.1 9.6 5.6 29.1 14.5 3.4 0.0 0.0 23.6 1.3 4.5 0.0 3.2 1.4 6.5 0.0 4.7 0.0 9.3 1.2 5.2 9.1 12.5 0.6 4.3 10.4 1.6 1.2 14.7 16.5 5.5 7.7 17.4 4.8 6.1 1.7 12.1 0.7 18.8 0.4 2.0 0.1 3.9 0.8 3.7 4.3 4.6 4.1 0.9 3.6 3.3 4.1 0.9 0.5 0.6 1.7 6.6 2.0 17.6 19.0 18.6 17.5 16.5 14.5 20.4 12.9 17.9 20.3 29.8 12.5 7.0 23.0 11.8 22.7 71.9 20.4 18.7 12.5 12.2 5.9 4.3 1.7 23.7 46.3 25.1 15.9 0.0 46.3 44.3 51.2 9.7 2.3 14.3 2.6 27.0 15.6 35.0 2.2 132.8 35.9 5.1 25.3 1.8 2.6 22.7 35.3 3.5 85.9 54.8 13.4 45.3 63.4 9.8 15.8 9.3 5.3 7.5 11.3 12.3 SH2B2 APS ENSG00000160999 "SH2B adaptor protein 2" 7 102285091-102321711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 37.8" "Cell type enhanced" "Detected in many" 13 "B-cells: 20.7;Extravillous trophoblasts: 58.6;Syncytiotrophoblasts: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 5.2;neutrophil: 3.9" "Group enriched" "Detected in many" 5 "B-cells: 5.2;granulocytes: 3.9;monocytes: 3.3" "Cell line enhanced" "Detected in many" "Daudi: 23.5;Karpas-707: 22.9;RPMI-8226: 16.8;U-266/70: 21.3;U-266/84: 37.3;U-698: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051131 Uncertain Approved Cytosol NA NA Cytosol "HPA051131: AB_2681354" "unprognostic (2.01e-2)" "unprognostic (4.00e-1)" "unprognostic (2.43e-2)" "unprognostic (7.32e-3)" "unprognostic (4.65e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-3)" "unprognostic (2.42e-1)" "unprognostic (3.65e-1)" "unprognostic (1.29e-1)" "unprognostic (8.29e-2)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.99e-7)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "unprognostic (2.02e-3)" "unprognostic (3.42e-2)" 5.5 1.3 4.2 11.8 5.1 3.9 2.4 6.5 4.3 2.9 2.0 1.3 0.0 3.1 3.3 1.1 2.3 2.9 2.2 1.7 2.7 5.0 3.2 1.1 9.2 12.6 3.6 1.5 2.2 2.6 1.9 1.9 5.7 4.3 2.9 1.1 0.9 2.0 1.5 37.8 2.4 3.5 1.9 5.0 16.7 2.9 2.2 4.1 0.6 2.8 2.6 10.4 3.1 3.9 5.2 0.7 3.9 3.3 0.0 0.2 0.1 1.3 1.0 1.1 2.4 0.2 0.1 10.4 0.4 0.1 0.3 0.2 0.3 0.2 23.5 2.4 0.1 1.0 1.3 0.2 0.3 0.1 2.9 1.0 0.0 0.6 0.2 0.2 0.1 0.8 0.2 0.3 0.2 0.0 0.4 0.0 0.6 0.1 22.9 0.4 2.5 0.1 4.1 2.6 0.8 4.3 2.9 1.2 16.8 0.8 0.3 1.2 4.3 0.8 2.1 0.5 0.9 0.3 3.0 0.0 0.4 2.4 4.1 0.4 21.3 37.3 31.7 1.5 0.8 0.5 0.0 0.6 0.0 0.2 3.3 0.0 1.4 0.0 0.0 0.7 5.2 0.0 0.0 3.9 0.0 1.3 0.0 0.0 0.1 4.2 5.1 6.5 2.9 2.7 5.0 3.6 1.5 4.3 4.1 0.0 0.0 20.7 2.1 2.3 5.9 1.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.1 0.3 3.5 0.0 0.0 0.0 58.6 1.8 2.8 0.0 0.8 7.1 4.8 1.7 1.3 7.1 0.7 0.6 6.4 6.8 0.0 0.6 8.5 0.1 0.0 0.4 10.3 1.4 0.0 2.5 0.9 12.6 1.4 48.6 0.0 1.2 1.8 SH2D4A "FLJ20967, PPP1R38, SH2A" ENSG00000104611 "SH2 domain containing 4A" Q9H788 8 19313617-19396218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 1.4;neutrophil: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.4;granulocytes: 5.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 50.7;U-2197: 37.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001871, HPA001919" Enhanced Enhanced Cytosol NA NA Cytosol "HPA001871: AB_1079949, HPA001919: AB_1079947" "unprognostic (9.08e-2)" "unprognostic (8.40e-3)" "unprognostic (4.04e-3)" "unprognostic (2.72e-3)" "unprognostic (3.51e-2)" "unprognostic (4.07e-3)" "unprognostic (2.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.67e-1)" "unprognostic (2.70e-2)" "unprognostic (8.84e-3)" "unprognostic (2.81e-1)" "prognostic favorable (6.02e-8)" "unprognostic (1.67e-2)" "unprognostic (2.18e-1)" "unprognostic (3.51e-3)" "unprognostic (4.11e-2)" 4.1 8.5 2.1 6.8 1.8 0.0 3.3 0.7 3.2 7.4 8.9 1.7 15.2 6.3 2.5 3.7 17.5 4.6 12.8 2.9 3.7 1.3 10.0 20.0 8.8 2.2 1.8 2.0 20.5 12.8 6.1 3.6 13.5 2.2 7.6 5.5 5.1 16.3 20.1 2.6 5.9 10.6 6.5 1.4 1.8 15.6 3.2 2.4 0.6 20.7 14.6 9.9 11.9 14.1 0.7 1.4 5.3 0.0 0.4 0.6 0.1 16.5 18.8 0.0 0.0 1.9 2.3 12.9 20.8 10.3 20.3 19.8 15.4 15.1 0.0 5.0 50.7 3.2 8.6 0.7 5.6 21.3 0.0 0.2 0.0 11.8 2.3 11.2 0.4 0.0 2.2 7.0 13.9 2.5 12.3 0.1 0.0 0.0 0.0 3.3 7.4 0.0 0.1 4.5 28.2 7.2 0.0 0.0 5.3 5.5 17.4 1.1 0.0 18.6 20.1 0.0 3.1 3.8 1.4 0.3 6.6 0.0 37.4 6.2 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 1.4 0.7 0.6 0.0 5.3 0.4 0.0 0.1 0.4 0.1 2.1 1.8 0.7 3.2 3.7 1.3 1.8 2.0 2.2 2.4 59.6 26.9 2.0 13.2 1.3 1.6 1.6 30.6 52.2 18.2 43.6 25.5 71.2 36.5 42.0 23.9 4.5 17.7 0.0 58.5 63.3 6.6 11.3 1.1 34.2 28.8 1.6 2.9 3.1 6.9 38.5 5.8 3.2 0.0 1.0 19.3 2.4 70.7 7.0 10.6 6.5 34.6 19.4 2.0 0.1 1.9 2.3 25.6 0.0 21.7 24.5 SH2D5 ENSG00000189410 "SH2 domain containing 5" Q6ZV89 1 20719732-20732837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 19.5;placenta: 14.8;testis: 9.4" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 4.2;Suprabasal keratinocytes: 1.9;Syncytiotrophoblasts: 4.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 25.3;hTERT-HME1: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030182 Approved Cytosol NA NA Cytosol "HPA030182: AB_10670431" "unprognostic (2.32e-1)" "unprognostic (2.80e-2)" "unprognostic (3.85e-2)" "unprognostic (5.37e-3)" "unprognostic (1.20e-4)" "unprognostic (4.41e-2)" "unprognostic (1.80e-6)" "unprognostic (1.11e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-3)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (2.34e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-2)" 0.4 0.9 4.5 1.3 19.5 0.4 0.3 0.5 19.2 0.6 0.5 0.3 0.0 1.2 1.4 0.3 0.5 0.5 0.6 0.3 3.9 4.1 0.4 0.3 0.4 0.3 1.5 7.3 1.7 0.3 0.6 0.1 14.8 2.1 0.5 0.3 0.0 0.4 1.8 0.3 0.6 0.5 1.2 0.3 0.4 0.6 9.4 0.7 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.7 3.9 0.8 0.0 0.0 0.0 0.1 4.6 6.6 4.6 3.1 1.6 1.6 0.0 1.2 1.4 10.0 0.4 3.3 25.3 1.9 0.0 1.7 0.0 0.5 1.2 3.8 0.0 0.0 0.2 5.3 8.6 32.4 1.6 0.1 0.8 0.0 0.0 1.9 0.9 0.5 0.0 1.5 0.5 5.0 0.1 0.1 0.2 4.8 0.6 1.5 0.2 0.3 0.1 1.5 0.7 0.0 0.0 0.0 5.6 9.9 8.3 2.2 0.0 0.0 0.4 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.5 19.5 0.5 12.3 3.9 4.1 1.5 7.3 2.1 0.7 0.0 0.0 0.0 1.0 4.2 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.9 1.9 4.2 0.0 0.0 0.3 SH3BP1 ARHGAP43 ENSG00000100092 "SH3 domain binding protein 1" Q9Y3L3 22 37634654-37656119 "Predicted intracellular proteins" Phagocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "T-cells: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 20.3;HMC-1: 20.9;NB-4: 21.2" HPA000757 Supported Approved Cytosol NA NA Cytosol "HPA000757: AB_1079951" "unprognostic (7.81e-3)" "unprognostic (7.91e-3)" "unprognostic (3.42e-1)" "unprognostic (2.62e-2)" "unprognostic (5.38e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.55e-4)" "unprognostic (1.39e-1)" "unprognostic (3.08e-1)" "unprognostic (1.89e-1)" "unprognostic (2.59e-2)" "unprognostic (4.78e-1)" "prognostic unfavorable (3.48e-7)" "prognostic favorable (3.39e-4)" "unprognostic (1.74e-1)" "unprognostic (5.37e-2)" "unprognostic (8.48e-3)" 4.1 3.0 3.2 17.9 4.5 12.8 2.6 5.0 5.7 7.9 12.0 3.6 2.0 20.6 2.6 3.6 25.1 3.2 4.2 2.2 2.9 2.1 2.8 2.2 6.2 11.7 3.1 2.9 4.3 2.2 1.9 1.8 9.1 3.2 5.7 5.0 2.7 7.0 2.6 1.1 16.8 18.2 2.4 4.2 19.9 5.1 3.8 4.1 15.4 2.0 15.2 23.4 9.8 13.5 0.6 2.1 7.3 5.9 1.6 2.8 1.1 10.0 0.5 1.7 1.4 0.4 1.7 14.2 1.6 2.8 2.7 3.0 2.6 1.0 5.7 1.4 1.0 0.9 20.3 0.8 11.0 1.1 17.7 6.6 8.0 0.3 3.6 1.4 11.5 20.9 2.1 2.7 3.4 0.4 2.3 0.4 2.8 2.7 2.1 0.2 5.4 1.4 21.2 3.5 5.9 1.6 7.3 1.5 4.9 0.3 10.7 1.9 4.8 0.5 2.4 8.4 1.8 3.0 10.2 0.5 1.0 5.4 0.3 0.1 15.0 5.3 4.4 1.4 11.9 5.7 3.2 2.7 7.3 2.0 3.2 2.2 0.6 2.2 2.2 1.4 0.3 1.4 2.8 1.8 1.6 5.9 2.1 2.1 1.1 3.2 4.5 5.0 5.7 2.9 2.1 3.1 2.9 3.2 4.1 0.0 11.1 18.4 16.5 16.9 0.2 0.8 5.1 4.0 0.0 0.0 2.0 41.3 0.0 2.3 0.3 1.1 41.3 0.0 4.0 37.2 3.9 5.0 13.9 0.0 43.7 7.9 4.1 4.3 24.1 0.0 4.6 26.8 5.0 26.2 28.9 2.7 2.0 35.1 1.8 0.2 0.4 0.0 1.9 2.8 3.9 13.4 31.4 48.5 20.0 36.7 SH3GL1 "CNSA1, EEN, MGC111371, SH3D2B, SH3P8" ENSG00000141985 "SH3 domain containing GRB2 like 1, endophilin A2" Q99961 19 4360370-4400547 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Endocytosis "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021485 Approved Enhanced Cytosol NA NA Cytosol "HPA021485: AB_1856816" "unprognostic (1.32e-1)" "prognostic favorable (1.50e-4)" "unprognostic (6.85e-2)" "prognostic favorable (1.86e-4)" "unprognostic (1.84e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.36e-8)" "unprognostic (5.48e-3)" "unprognostic (2.45e-1)" "unprognostic (1.02e-3)" "unprognostic (4.10e-2)" 20.5 22.4 12.8 17.7 14.5 28.9 17.5 19.1 25.9 21.6 18.7 13.3 11.9 25.4 16.9 12.1 66.0 15.0 16.1 13.2 13.0 8.0 13.8 19.7 14.8 13.0 11.4 13.0 23.5 20.5 5.6 17.3 33.9 9.4 17.1 6.2 14.9 22.1 16.8 8.6 40.4 29.8 18.8 9.0 19.5 16.4 13.7 11.3 10.1 14.2 19.1 33.0 22.2 30.0 6.1 6.5 9.7 5.1 3.8 7.4 3.4 31.7 14.4 15.0 19.8 17.6 27.5 27.7 27.7 24.0 24.8 24.7 22.5 16.8 7.2 11.8 27.5 12.0 26.3 10.6 30.5 6.6 9.5 17.7 8.6 19.9 29.4 25.5 7.7 9.8 23.0 21.3 20.8 12.9 12.3 29.1 7.0 22.3 16.4 19.8 26.6 7.5 8.1 37.6 11.6 16.1 5.9 20.9 12.5 19.5 28.2 14.8 22.8 24.5 24.5 17.4 7.4 16.8 12.3 43.8 23.9 17.4 49.9 28.1 10.5 6.4 7.6 34.3 20.2 32.7 1.0 3.8 4.8 5.0 1.9 4.8 6.1 7.4 6.9 5.0 4.5 4.2 4.5 9.7 3.8 5.1 6.5 6.6 3.4 12.8 14.5 19.1 25.9 13.0 8.0 11.4 13.0 9.4 11.3 8.9 22.1 14.3 32.2 54.0 16.6 3.3 7.6 6.7 9.1 8.7 5.9 32.6 11.6 31.4 5.6 21.5 32.5 23.3 25.4 128.0 43.2 30.1 9.2 18.8 42.1 9.5 9.8 33.7 15.9 4.9 30.2 14.3 21.9 16.2 16.3 12.4 36.0 15.0 22.6 17.9 8.0 12.9 23.1 13.3 12.4 75.0 37.0 13.8 16.4 59.9 SH3GLB1 "Bif-1, CGI-61, KIAA0491, PPP1R70" ENSG00000097033 "SH3 domain containing GRB2 like, endophilin B1" Q9Y371 1 86704570-86748184 "Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 468.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 69.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 69.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004650, HPA015608, HPA019900" Enhanced Supported Cytosol NA NA 18000 Cytosol "CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356" "unprognostic (1.72e-2)" "unprognostic (1.76e-1)" "unprognostic (5.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (8.34e-2)" "unprognostic (1.75e-1)" "unprognostic (4.29e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (1.56e-1)" "unprognostic (4.04e-3)" "unprognostic (7.70e-2)" "unprognostic (2.65e-1)" "unprognostic (1.88e-2)" "unprognostic (1.69e-1)" 42.3 19.9 15.0 22.1 18.8 23.7 50.5 13.7 16.9 20.1 24.1 17.8 25.7 20.0 19.9 25.6 42.4 15.2 20.0 48.1 15.4 12.6 22.4 24.0 27.6 40.2 18.2 14.8 18.0 28.5 18.2 18.4 23.7 20.3 19.7 24.8 11.7 30.2 24.5 89.7 19.4 24.4 26.6 24.5 33.6 16.1 45.4 16.2 19.0 20.0 29.7 20.8 28.5 35.6 8.9 10.4 69.7 16.3 13.9 14.5 10.0 19.3 7.1 11.4 10.4 47.9 41.6 18.8 29.3 29.4 27.9 29.6 20.5 16.2 9.9 18.9 36.3 34.8 11.3 10.1 19.1 26.6 21.4 7.2 23.6 10.9 21.7 29.0 12.7 24.1 29.7 22.2 30.7 33.8 30.0 43.9 10.6 8.8 28.0 37.3 5.7 11.4 8.1 11.1 14.2 12.2 13.2 48.0 7.3 24.0 33.4 12.5 9.1 16.5 21.3 34.9 17.8 8.4 13.0 38.4 26.9 16.3 33.5 24.1 14.8 13.6 14.6 13.3 13.1 16.2 29.4 13.7 14.7 10.6 14.5 10.4 8.9 9.9 10.6 10.4 8.1 4.8 8.5 69.7 13.9 16.3 10.2 14.5 10.0 15.0 18.8 13.7 16.9 15.4 12.6 18.2 14.8 20.3 16.2 77.4 64.0 67.1 96.1 79.6 31.2 138.8 43.3 80.3 58.0 52.4 49.1 72.5 72.9 127.2 468.5 101.4 103.4 46.7 149.1 181.7 92.1 83.8 111.9 70.0 131.7 15.9 83.1 143.6 150.6 144.3 65.0 116.4 77.6 140.7 120.2 67.6 162.6 110.1 79.9 93.5 53.0 77.6 110.4 217.9 73.1 103.3 85.2 73.9 68.5 158.5 SH3KBP1 CIN85 ENSG00000147010 "SH3 domain containing kinase binding protein 1" Q96B97 X 19533975-19887601 "Predicted intracellular proteins" "Apoptosis, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 356.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003351, HPA003355, CAB021892" Enhanced Supported Cytosol NA NA Cytosol "CAB021892: , HPA003351: AB_1079956, HPA003355: AB_1079954" "unprognostic (1.17e-2)" "unprognostic (1.33e-1)" "unprognostic (9.48e-2)" "unprognostic (4.65e-3)" "unprognostic (1.62e-1)" "unprognostic (2.88e-2)" "unprognostic (6.47e-2)" "unprognostic (9.91e-2)" "unprognostic (9.75e-2)" "unprognostic (1.76e-3)" "unprognostic (5.96e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (4.00e-1)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (4.92e-2)" 25.0 6.6 17.2 31.0 23.7 32.2 25.3 3.3 18.1 10.6 19.3 23.6 2.6 7.1 6.3 6.6 4.6 6.6 11.3 14.4 17.2 20.1 7.9 8.2 16.6 32.9 30.2 11.4 5.7 3.6 13.1 10.2 17.0 22.6 5.1 19.1 6.8 12.5 4.1 6.1 14.7 12.2 7.9 28.8 22.0 9.6 3.0 27.0 19.5 11.5 5.5 34.9 10.7 17.1 13.6 35.8 51.3 24.5 17.8 51.2 39.4 12.7 13.5 2.1 4.9 10.8 21.0 11.2 11.6 16.9 5.9 9.6 9.1 26.5 23.8 12.2 16.7 17.1 1.4 4.9 4.6 9.6 7.8 3.3 5.1 3.5 7.3 7.1 32.4 41.0 12.3 4.6 12.3 36.5 16.6 8.9 16.9 1.9 28.9 15.0 5.7 19.2 32.9 3.7 15.4 17.9 11.9 20.9 2.2 6.9 2.6 1.5 1.5 10.7 1.4 16.3 14.3 1.3 38.1 28.2 10.4 9.0 13.2 12.7 42.3 28.0 21.2 22.2 26.9 46.1 10.4 24.5 39.6 46.1 18.7 36.0 13.6 45.1 47.7 31.9 12.2 37.6 37.3 51.3 17.8 21.5 35.8 51.2 39.4 17.2 23.7 3.3 18.1 17.2 20.1 30.2 11.4 22.6 27.0 14.9 61.5 58.7 3.2 10.6 5.9 69.4 15.3 21.4 26.1 8.7 15.7 19.0 1.7 7.2 0.4 20.2 105.1 0.0 16.8 31.2 53.0 3.4 90.5 13.9 50.5 7.9 48.8 30.7 83.0 0.9 48.9 91.2 32.1 356.1 29.9 0.0 30.5 103.5 36.0 28.6 2.8 58.2 51.8 3.8 12.1 9.5 18.9 108.8 44.7 7.6 SHC1 "p66, SHC, ShcA" ENSG00000160691 "SHC adaptor protein 1" P29353 1 154962298-154974395 "Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Growth regulation, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001844, CAB005374, CAB016305" Supported Enhanced Cytosol NA NA Cytosol "CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826" "unprognostic (4.12e-2)" "prognostic unfavorable (6.74e-4)" "unprognostic (1.10e-2)" "unprognostic (3.77e-2)" "unprognostic (6.40e-2)" "unprognostic (4.08e-3)" "unprognostic (2.94e-3)" "prognostic unfavorable (1.92e-4)" "unprognostic (9.13e-2)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.22e-16)" "unprognostic (7.19e-2)" "unprognostic (1.40e-1)" "unprognostic (9.21e-2)" "unprognostic (1.31e-1)" 45.1 36.4 14.6 27.8 15.9 20.4 43.6 11.8 12.6 33.9 30.5 11.1 32.9 23.1 34.8 28.1 31.4 32.5 30.5 23.4 11.7 8.5 30.1 54.7 37.5 36.5 13.9 8.7 36.1 21.5 23.0 44.7 47.3 18.9 31.9 23.7 31.5 22.4 24.9 22.1 20.3 39.5 35.4 16.0 38.6 25.8 16.2 11.1 19.9 37.7 21.1 29.8 40.4 31.2 13.9 21.8 31.9 27.0 12.7 23.7 19.8 13.8 28.7 22.1 35.5 24.2 48.6 11.6 50.5 46.0 29.4 22.4 10.2 33.4 7.4 41.4 60.7 8.4 11.9 5.8 50.0 26.5 9.1 3.2 19.1 23.6 18.0 63.4 6.1 21.7 72.2 59.4 36.6 45.6 80.2 64.3 3.2 8.4 60.2 61.4 11.3 7.0 3.7 19.3 11.3 12.2 6.4 7.3 15.4 14.1 10.5 2.8 76.9 30.2 16.9 16.5 40.4 24.7 13.0 76.3 46.4 29.0 9.8 26.4 27.2 17.4 12.6 45.3 8.3 60.0 17.0 20.8 31.9 23.7 27.0 23.5 13.9 19.0 20.9 21.8 13.3 15.6 14.1 17.0 12.7 25.7 10.0 14.1 19.8 14.6 15.9 11.8 12.6 11.7 8.5 13.9 8.7 18.9 11.1 26.8 24.2 12.3 42.7 31.7 4.8 2.0 20.4 6.7 15.9 5.2 5.9 21.8 6.6 27.1 0.6 78.8 30.8 0.0 24.3 49.6 36.6 37.1 17.3 38.1 20.4 23.8 12.1 79.2 21.7 1.5 21.3 17.3 16.9 10.8 23.3 10.0 25.1 25.1 32.5 7.7 6.8 19.4 41.2 2.8 5.0 31.9 50.9 14.1 20.4 37.3 SHC2 "SCK, SHCB, SLI" ENSG00000129946 "SHC adaptor protein 2" P98077 19 416583-460996 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 44.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 51.6;Horizontal cells: 46.1;Ito cells: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.6;HHSteC: 6.5;SCLC-21H: 14.1;SH-SY5Y: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006136 Approved Approved Cytosol NA NA Cytosol "HPA006136: AB_1856827" "unprognostic (2.54e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (4.58e-4)" "unprognostic (6.40e-2)" "unprognostic (1.64e-1)" "unprognostic (1.50e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.36e-1)" "prognostic favorable (8.53e-4)" "unprognostic (4.45e-2)" "unprognostic (5.30e-2)" "unprognostic (1.99e-2)" "unprognostic (3.37e-1)" "unprognostic (8.86e-2)" "unprognostic (4.43e-2)" 9.8 11.3 18.5 2.7 15.1 1.0 6.8 5.0 17.6 7.9 6.3 10.2 3.7 8.9 11.7 5.9 2.6 8.1 14.6 7.9 15.7 15.2 3.8 20.6 6.5 2.8 15.2 11.3 5.1 44.8 7.8 18.6 10.7 15.6 13.7 1.4 9.9 19.5 8.2 3.4 8.5 6.2 4.7 9.6 11.5 10.5 6.0 15.0 0.0 9.7 0.7 1.3 3.8 6.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.7 0.5 2.8 0.3 0.0 0.0 0.5 0.0 5.6 0.0 1.4 0.4 1.3 0.0 0.0 1.2 1.8 0.0 0.0 3.0 6.5 0.0 2.1 0.3 0.0 0.0 0.0 2.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 2.1 0.0 14.1 12.7 0.0 0.0 0.0 2.7 0.3 2.1 0.0 0.6 3.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 18.5 15.1 5.0 17.6 15.7 15.2 15.2 11.3 15.6 15.0 6.0 12.0 0.0 1.8 1.6 4.3 7.7 20.4 0.0 0.0 0.0 2.0 0.1 0.0 20.6 1.9 11.9 0.0 0.0 32.6 0.1 4.3 12.6 0.0 51.6 0.8 46.1 8.1 57.7 6.5 6.0 8.3 0.5 8.5 1.8 3.4 28.9 30.9 0.0 10.6 0.3 2.7 0.0 5.0 15.4 8.2 2.8 0.0 1.7 0.1 3.3 SHC4 "RaLP, SHCD" ENSG00000185634 "SHC adaptor protein 4" Q6S5L8 15 48823735-48963444 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;testis: 19.5" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 4.0;Ductal cells: 4.1;Melanocytes: 6.8;Spermatocytes: 6.0" "Cancer enhanced" "Detected in some" "melanoma: 9.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "eosinophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.5" "Cell line enhanced" "Detected in some" "AN3-CA: 9.6;SK-MEL-30: 17.9;WM-115: 15.3" "Low region specificity" "Detected in all" HPA074146 Approved Cytosol NA NA Cytosol "HPA074146: AB_2686667" "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" "unprognostic (6.70e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.05e-3)" "unprognostic (1.23e-2)" "unprognostic (3.47e-2)" "unprognostic (2.59e-1)" "unprognostic (2.21e-2)" "unprognostic (3.80e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-5)" "unprognostic (9.84e-3)" "unprognostic (3.26e-2)" "unprognostic (3.49e-2)" "unprognostic (1.36e-2)" 1.5 2.3 9.0 2.3 24.8 0.7 3.7 2.0 15.8 2.5 2.5 18.9 0.3 1.1 1.3 2.5 1.5 1.9 3.2 6.6 11.2 6.2 1.2 0.8 1.2 1.1 25.7 9.4 1.6 0.9 0.7 1.1 1.3 13.2 1.3 1.6 1.7 4.8 3.3 2.0 1.3 1.1 1.9 16.2 0.9 1.0 19.5 23.8 0.0 1.1 0.0 0.8 1.7 0.9 0.0 0.0 2.5 0.0 0.0 0.3 0.0 0.0 0.3 0.9 9.6 0.4 1.3 0.0 1.4 2.7 0.6 1.1 0.0 0.2 0.1 2.4 0.5 0.1 0.0 0.2 0.4 0.8 1.9 0.1 0.6 0.0 0.0 1.0 0.0 0.1 1.8 0.0 1.2 0.1 1.2 0.1 0.9 0.0 0.2 1.3 1.5 0.3 0.2 0.1 0.0 3.5 0.2 2.5 0.3 2.0 0.4 0.5 0.7 0.2 0.1 17.9 0.9 0.0 0.1 0.0 0.8 0.4 0.6 1.0 0.7 0.1 0.0 0.8 0.5 15.3 0.2 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 24.8 2.0 13.4 11.2 6.2 25.7 9.4 13.2 23.8 0.0 0.0 0.0 0.0 0.2 0.5 1.8 0.0 4.0 2.3 0.0 0.0 0.6 0.0 4.1 2.2 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 3.6 1.1 0.0 6.8 0.0 0.0 2.7 0.1 0.0 3.2 0.0 0.7 0.0 0.2 6.0 2.8 0.3 0.7 0.0 0.0 0.0 SHISA7 ENSG00000187902 "Shisa family member 7" A6NL88 19 55428740-55442863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.9" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.8;Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 9 "glioma: 2.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 6.7;HMC-1: 7.0;THP-1: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058935 Uncertain Approved Cytosol NA NA Cytosol "HPA058935: AB_2683857" "unprognostic (3.98e-2)" "unprognostic (5.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.28e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.08e-1)" "unprognostic (4.40e-1)" "unprognostic (7.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.22e-2)" "unprognostic (6.87e-7)" "unprognostic (7.53e-3)" "unprognostic (2.82e-1)" "unprognostic (3.29e-4)" "unprognostic (4.04e-1)" 0.7 1.7 11.3 0.7 16.7 2.6 0.7 4.0 24.9 0.7 0.8 7.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 11.2 8.2 0.7 0.7 0.7 0.7 8.3 3.1 0.7 0.8 0.7 2.4 0.7 5.5 0.7 0.8 0.0 0.7 0.7 0.7 0.8 0.8 0.7 4.0 0.7 0.8 2.2 14.6 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 1.2 0.6 0.0 1.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 16.7 4.0 10.9 11.2 8.2 8.3 3.1 5.5 14.6 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 SIGLEC8 "MGC59785, SAF2, SIGLEC-8, SIGLEC8L" ENSG00000105366 "Sialic acid binding Ig like lectin 8" Q9NYZ4 19 51450847-51458456 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 63.0" "Cell type enriched" "Detected in some" 4 "granulocytes: 42.8" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 42 "eosinophil: 63.0" "Lineage enriched" "Detected in single" 623 "granulocytes: 63.0" "Cell line enriched" "Detected in some" 45 "HMC-1: 58.8" HPA012556 Uncertain Uncertain Cytosol NA NA Cytosol "HPA012556: AB_1856869" "unprognostic (1.27e-1)" "unprognostic (1.88e-4)" "unprognostic (1.28e-1)" "unprognostic (6.70e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-2)" "unprognostic (2.51e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-1)" "unprognostic (1.10e-1)" "unprognostic (4.19e-1)" "unprognostic (8.62e-3)" "unprognostic (7.18e-2)" "unprognostic (6.02e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" 0.6 6.7 5.8 2.4 8.4 0.7 2.3 0.7 7.0 1.4 2.9 7.4 0.0 2.9 1.0 1.1 1.1 1.1 2.7 0.3 8.6 4.8 0.4 1.6 4.1 9.6 8.3 3.6 0.3 0.7 0.7 1.2 0.1 7.5 1.0 2.8 0.1 1.1 0.9 0.3 0.8 4.5 1.5 14.8 9.2 2.1 0.5 6.2 0.6 0.7 0.0 4.1 2.0 0.7 0.0 0.0 63.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.5 0.1 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.8 8.4 0.7 5.6 8.6 4.8 8.3 3.6 7.5 6.2 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 42.8 0.0 0.3 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SLC12A7 "DKFZP434F076, KCC4" ENSG00000113504 "Solute carrier family 12 member 7" Q9Y666 5 1050376-1112035 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 265.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 25.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041652 Approved Uncertain Cytosol NA NA Cytosol "HPA041652: AB_10793971" "unprognostic (2.22e-2)" "unprognostic (1.56e-1)" "unprognostic (8.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-2)" "unprognostic (8.72e-2)" "prognostic unfavorable (2.12e-6)" "unprognostic (1.67e-1)" "unprognostic (1.71e-3)" "unprognostic (4.40e-2)" "unprognostic (4.50e-2)" "unprognostic (3.44e-2)" "unprognostic (1.65e-3)" "unprognostic (1.17e-3)" "unprognostic (1.26e-1)" "unprognostic (3.93e-2)" "prognostic favorable (3.16e-5)" 10.1 6.4 5.7 14.1 7.3 4.3 13.0 2.4 8.3 6.5 11.5 5.6 6.6 28.0 7.2 7.6 4.7 8.9 29.4 27.9 6.1 3.8 20.4 31.3 10.0 10.3 5.8 3.2 8.5 12.4 8.2 11.5 3.8 7.9 10.2 7.0 15.5 10.9 8.7 3.2 7.9 20.3 8.2 4.9 17.9 15.2 14.5 7.4 12.2 13.3 5.5 6.9 7.1 34.5 1.4 4.2 0.5 6.9 2.5 2.7 2.2 2.1 6.0 3.3 10.4 0.5 0.5 5.2 0.1 0.7 0.5 0.0 14.3 3.8 0.0 11.8 0.2 4.1 4.4 2.7 3.6 0.0 13.0 3.6 2.8 7.5 4.9 7.6 0.0 6.3 1.1 0.5 0.0 1.1 0.2 3.3 1.3 4.0 0.1 0.0 6.9 8.4 0.0 7.2 8.4 9.6 25.3 14.4 11.8 4.0 8.7 1.8 2.3 3.2 0.0 3.6 2.1 5.8 1.6 2.8 0.0 3.4 0.0 0.0 0.2 0.0 1.4 0.0 0.4 1.7 0.5 3.4 0.0 2.5 5.4 2.6 1.1 2.4 2.7 4.2 1.4 2.5 2.5 0.0 2.5 6.9 1.8 2.4 2.2 5.7 7.3 2.4 8.3 6.1 3.8 5.8 3.2 7.9 7.4 8.9 17.5 5.4 5.2 6.3 17.7 32.1 40.8 10.7 14.8 27.9 2.0 0.2 1.7 23.0 0.3 14.9 28.8 0.0 15.7 0.3 7.3 14.6 8.1 29.2 15.8 265.4 12.7 9.2 20.4 1.3 3.4 12.2 15.1 1.8 16.5 6.6 28.0 17.5 5.3 26.1 2.9 19.4 7.2 0.7 4.5 5.9 0.2 3.3 14.2 13.2 SLC19A2 "THTR1, TRMA" ENSG00000117479 "Solute carrier family 19 member 2" O60779 1 169463909-169486003 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.7" "Cell type enhanced" "Detected in many" 12 "Suprabasal keratinocytes: 44.2;Syncytiotrophoblasts: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006119, HPA016599" Uncertain Approved Cytosol NA NA Cytosol "HPA006119: AB_1079996, HPA016599: AB_1857005" "prognostic favorable (8.41e-4)" "unprognostic (8.82e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-3)" "prognostic favorable (2.90e-4)" "unprognostic (4.45e-2)" "unprognostic (9.69e-2)" "unprognostic (1.45e-1)" "unprognostic (2.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.70e-5)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (3.60e-2)" "unprognostic (2.14e-2)" 23.1 11.1 1.9 5.3 4.4 4.8 14.2 7.4 6.1 5.9 5.4 2.8 2.7 2.1 5.0 9.0 7.5 10.0 17.5 14.8 2.7 2.1 8.6 23.4 9.2 3.1 2.8 1.7 10.3 14.4 6.8 16.3 22.1 4.7 9.4 2.8 16.4 10.4 4.6 75.7 7.5 6.6 11.3 3.7 1.8 9.4 7.3 1.8 3.6 7.9 21.6 3.9 10.4 9.8 1.4 1.9 3.0 4.6 2.6 3.3 0.7 4.5 3.2 7.3 5.7 22.8 8.4 16.2 3.6 2.7 3.0 4.2 13.1 4.8 4.0 4.2 2.4 5.5 4.9 8.8 5.4 3.3 11.5 8.2 3.8 10.4 11.9 12.4 9.6 3.8 9.9 7.9 4.8 12.3 4.2 4.4 7.1 15.4 2.6 5.0 3.0 4.9 4.3 16.6 8.8 4.9 0.0 15.8 4.6 7.9 9.7 6.4 8.6 5.0 8.7 17.8 8.7 5.5 6.3 3.7 3.6 5.0 4.4 7.1 3.6 3.3 1.3 5.3 3.7 4.7 0.0 1.7 3.0 0.9 0.7 3.3 1.4 1.1 2.1 1.9 1.2 3.1 3.0 1.1 2.6 4.6 0.7 1.0 0.7 1.9 4.4 7.4 6.1 2.7 2.1 2.8 1.7 4.7 1.8 8.9 17.1 0.9 13.6 26.3 4.7 24.0 7.6 13.4 11.4 5.2 2.0 19.6 0.0 7.1 4.4 2.3 6.3 0.0 4.6 3.0 20.6 10.4 10.3 23.1 6.2 6.4 8.6 0.6 3.7 0.4 6.4 5.7 20.3 0.0 4.4 2.6 8.2 5.7 4.6 1.8 4.7 0.0 9.4 3.4 3.4 44.2 130.8 1.5 4.7 21.3 SLC25A43 ENSG00000077713 "Solute carrier family 25 member 43" Q8WUT9 X 119399060-119454478 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035188, HPA078530" Uncertain Approved Cytosol NA NA Cytosol "HPA035188: AB_10602400, HPA078530: " "unprognostic (6.05e-3)" "unprognostic (1.48e-1)" "unprognostic (9.92e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (4.99e-3)" "unprognostic (1.59e-2)" "unprognostic (3.26e-2)" "unprognostic (2.74e-2)" "unprognostic (7.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.80e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.06e-8)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "unprognostic (1.96e-2)" "unprognostic (4.92e-2)" 12.7 3.0 4.4 11.1 3.7 1.3 11.8 5.9 3.8 8.9 12.3 4.3 5.6 12.8 8.0 7.3 23.5 5.8 6.3 6.0 5.1 3.4 11.4 11.3 10.4 9.5 3.8 2.7 7.8 15.6 4.0 3.0 7.3 5.8 8.5 14.2 7.4 12.8 4.4 6.3 14.0 13.3 7.7 8.2 9.0 7.9 4.3 4.3 1.9 5.7 9.6 16.2 8.9 12.9 4.3 6.3 0.2 10.7 6.6 3.2 1.4 13.6 10.1 0.7 4.0 14.0 21.2 5.4 7.5 9.6 6.1 5.9 5.2 6.9 1.5 4.6 21.0 18.4 10.1 7.9 7.1 5.5 11.8 2.4 4.9 3.3 7.0 8.7 4.6 5.2 8.7 12.6 10.1 8.5 8.7 7.5 2.7 0.9 7.3 7.0 24.4 0.0 6.5 4.6 7.2 15.9 1.2 0.0 2.0 10.1 4.7 0.6 0.0 10.2 21.6 12.0 3.4 3.8 4.6 10.4 10.0 2.9 10.8 11.6 0.1 5.7 3.3 10.0 7.7 8.8 0.0 3.4 0.2 1.0 5.1 1.8 4.3 2.0 3.2 6.3 3.6 1.1 1.9 0.0 6.6 10.7 1.6 1.6 1.4 4.4 3.7 5.9 3.8 5.1 3.4 3.8 2.7 5.8 4.3 6.0 8.9 6.0 5.9 6.9 0.1 1.4 0.0 1.4 6.8 3.5 0.0 8.9 8.3 3.6 0.0 7.3 16.9 0.0 7.9 6.7 9.3 3.1 8.1 4.9 9.7 0.0 7.0 6.2 6.5 0.0 7.5 9.9 10.1 11.8 10.3 0.0 12.1 8.6 5.3 7.0 0.1 0.0 13.3 0.4 2.2 12.2 5.7 7.2 10.3 5.1 SLC26A6 DKFZp586E1422 ENSG00000225697 "Solute carrier family 26 member 6" Q9BXS9 3 48625723-48635493 "Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 43.3;Mucus-secreting cells: 32.0;Paneth cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048363 Approved Uncertain Cytosol NA NA Cytosol "HPA048363: AB_2680371" "unprognostic (1.54e-1)" "unprognostic (4.94e-2)" "unprognostic (3.34e-1)" "unprognostic (3.15e-2)" "unprognostic (2.15e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.39e-1)" "unprognostic (2.35e-1)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (9.66e-3)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.58e-2)" 5.3 5.7 6.4 12.3 9.8 18.8 5.7 6.8 6.9 6.3 24.8 6.0 7.3 9.7 6.8 7.4 6.5 4.7 6.3 6.7 4.9 3.1 13.6 6.2 7.8 7.4 9.4 3.1 6.7 14.9 6.8 5.8 6.5 9.3 10.2 25.4 7.7 9.6 7.4 8.8 6.7 19.5 6.8 4.8 10.6 19.7 7.7 9.9 7.7 5.5 5.4 6.3 5.1 6.6 0.9 8.8 5.2 10.7 0.5 3.3 4.5 4.5 5.1 7.3 8.2 23.1 11.6 6.2 7.5 9.9 14.6 15.7 9.7 4.2 6.5 2.6 6.4 16.2 6.1 6.8 6.9 4.2 4.8 6.8 5.9 14.5 18.7 16.8 2.8 9.2 15.8 24.8 9.9 7.2 12.6 4.5 6.7 4.5 7.4 3.5 5.4 5.4 14.8 10.4 12.5 9.9 2.8 2.7 7.9 10.7 4.5 1.8 3.5 9.8 12.1 14.1 10.6 6.3 10.5 3.6 6.3 5.3 8.5 17.1 8.8 9.2 2.9 5.3 11.1 15.9 5.2 10.7 2.1 3.1 10.0 2.8 0.9 1.9 2.0 8.8 0.2 1.1 1.6 1.5 0.5 8.9 5.0 3.3 4.5 6.4 9.8 6.8 6.9 4.9 3.1 9.4 3.1 9.3 9.9 3.0 5.1 0.8 2.4 2.9 1.5 6.4 2.5 2.7 1.2 1.8 13.7 7.5 0.0 2.5 1.2 2.9 43.3 0.0 5.6 13.1 4.3 1.9 0.0 4.2 6.2 4.8 19.5 5.5 5.2 0.7 3.4 7.0 5.0 4.6 32.0 2.0 5.2 36.6 8.9 5.1 6.4 0.0 5.7 2.5 5.7 3.0 8.8 3.8 23.5 0.8 SLC35E4 ENSG00000100036 "Solute carrier family 35 member E4" Q6ICL7 22 30635652-30669016 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 20.2;testis: 22.5" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 93.5;Late spermatids: 68.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 15.0;U-2197: 14.5;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049558 Approved Approved Cytosol NA NA Cytosol "HPA049558: AB_2680817" "unprognostic (2.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.05e-1)" "unprognostic (1.01e-2)" "unprognostic (4.99e-2)" "unprognostic (2.04e-1)" "unprognostic (3.03e-4)" "unprognostic (5.71e-2)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (3.45e-7)" "unprognostic (2.77e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (8.05e-3)" 4.0 2.5 5.6 3.3 11.8 3.4 2.6 4.0 11.4 2.7 5.9 8.1 2.1 2.7 4.2 3.5 4.5 3.1 2.9 5.6 5.2 4.7 2.0 1.1 2.4 2.1 13.0 6.3 2.8 4.1 3.1 2.8 1.6 6.6 2.9 4.2 2.4 2.6 3.5 20.2 7.3 2.5 3.5 2.6 2.4 3.8 22.5 10.1 0.0 2.0 6.6 2.1 3.6 7.6 0.7 3.6 1.6 2.8 2.1 3.2 0.9 6.5 2.9 1.1 2.2 3.0 7.7 0.6 4.3 3.8 3.0 2.8 0.2 1.8 0.4 2.3 4.4 4.2 4.2 1.9 2.5 1.5 15.0 2.1 0.1 2.1 0.2 4.3 0.3 1.8 2.4 1.1 11.9 3.7 4.7 10.1 0.5 0.6 2.0 4.6 1.9 0.2 1.3 1.3 1.9 10.9 1.2 2.2 0.2 1.4 0.5 6.0 2.3 4.4 1.9 2.1 0.5 1.3 0.5 13.4 12.7 4.0 14.5 4.1 0.6 0.5 0.2 15.5 0.2 3.3 1.6 2.1 0.3 0.9 2.8 1.4 0.3 2.1 3.2 3.6 0.7 2.1 1.7 0.8 2.1 2.2 1.0 2.3 0.9 5.6 11.8 4.0 11.4 5.2 4.7 13.0 6.3 6.6 10.1 0.0 1.0 0.9 2.0 12.9 8.8 1.6 0.0 8.1 1.2 1.8 21.6 0.0 0.0 3.2 93.5 4.9 2.6 0.0 2.1 0.4 3.7 1.5 1.1 0.0 1.7 11.1 2.4 4.9 0.3 68.4 3.1 4.5 3.3 2.8 2.6 17.3 1.9 5.7 3.5 0.3 9.3 0.0 4.1 21.8 3.4 16.7 0.1 2.5 4.4 1.4 SLC44A5 "CTL5, MGC34032" ENSG00000137968 "Solute carrier family 44 member 5" Q8NCS7 1 75202131-75611116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.6" "Group enriched" "Detected in some" 7 "Early spermatids: 63.4;Late spermatids: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 7.2;RPTEC TERT1: 7.1;SH-SY5Y: 11.1;SuSa: 11.8;TIME: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047455, HPA051011" Uncertain Approved Cytosol NA NA Cytosol "HPA047455: AB_2680054, HPA051011: AB_2681309" "unprognostic (9.00e-2)" "unprognostic (1.91e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-3)" "unprognostic (4.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (5.78e-3)" "unprognostic (6.41e-2)" "unprognostic (9.19e-2)" "prognostic unfavorable (6.52e-4)" "unprognostic (1.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" "unprognostic (4.30e-1)" 1.0 0.4 2.4 1.0 1.5 0.0 6.3 1.0 3.6 1.0 1.8 1.0 1.0 0.9 1.0 1.0 7.7 3.7 1.0 2.2 2.8 2.8 2.0 1.0 1.0 1.0 2.3 1.0 1.0 1.8 5.6 3.7 3.8 1.0 1.0 2.9 1.0 1.6 1.0 1.5 11.3 1.0 1.0 1.0 1.0 1.3 32.6 1.0 1.0 1.0 1.0 1.8 2.2 1.9 3.2 0.3 0.6 0.3 0.5 1.1 0.3 0.2 0.2 4.5 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 0.0 0.0 2.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.5 0.6 1.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.8 0.4 2.4 2.6 0.0 0.0 1.7 0.0 4.5 2.9 0.6 0.0 0.0 2.1 7.1 4.8 1.0 11.1 0.0 4.6 0.0 11.8 0.2 0.0 13.7 0.4 1.2 0.0 1.4 2.0 1.9 3.0 0.2 0.0 0.7 0.4 0.3 0.2 0.4 0.1 0.9 3.2 0.8 1.1 0.1 2.4 0.6 0.4 0.6 0.5 0.2 0.3 0.6 0.3 2.4 1.5 1.0 3.4 2.8 2.8 2.3 1.0 1.0 1.0 0.0 0.6 0.0 0.6 1.6 3.7 0.6 0.0 2.7 1.2 0.0 0.0 6.8 0.0 0.1 63.4 0.4 0.4 0.0 0.8 3.2 0.2 0.8 0.0 0.0 1.0 0.0 2.4 3.1 0.0 27.3 0.9 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 5.8 3.2 0.0 0.2 3.1 SLFNL1 FLJ23878 ENSG00000171790 "Schlafen like 1" Q499Z3 1 41015597-41023237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 49.7" "Group enriched" "Detected in some" 83 "Early spermatids: 200.0;Late spermatids: 500.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054956 Approved Cytosol NA NA Cytosol "HPA054956: AB_2682649" "unprognostic (7.01e-3)" "unprognostic (1.62e-1)" "unprognostic (1.54e-3)" "unprognostic (4.35e-2)" "unprognostic (3.39e-1)" "unprognostic (4.11e-4)" "unprognostic (8.98e-3)" "unprognostic (1.02e-3)" "unprognostic (8.40e-3)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.71e-4)" "unprognostic (2.70e-3)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (3.26e-1)" "unprognostic (2.43e-1)" 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.3 0.2 0.4 0.2 0.2 0.2 0.5 2.6 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.8 1.9 0.2 0.2 0.2 0.6 0.3 0.1 0.3 0.2 0.2 0.6 0.0 0.2 3.4 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.1 49.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 1.3 0.0 0.0 0.7 0.0 1.0 1.6 0.7 1.1 0.0 0.3 4.9 2.1 0.1 0.0 0.1 10.2 1.0 1.8 1.8 0.1 0.3 1.8 0.1 0.0 0.0 1.3 3.0 1.3 2.4 1.3 0.7 1.9 1.2 0.2 0.2 0.1 0.0 0.5 0.2 1.5 1.1 2.2 0.1 0.9 1.1 2.0 1.9 0.2 2.6 2.5 1.3 1.1 0.0 2.8 1.3 0.6 0.4 0.9 0.8 0.9 0.6 1.2 0.8 2.0 2.4 1.0 1.5 1.1 0.6 2.3 0.3 2.2 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.4 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 3.2 0.0 0.1 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 200.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 500.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 4.2 2.4 0.1 0.0 0.0 0.0 0.0 SLX4IP "C20orf94, dJ1099D15.3" ENSG00000149346 "SLX4 interacting protein" Q5VYV7 20 10435303-10636829 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046372 Approved Approved Cytosol NA NA Cytosol "HPA046372: AB_2679641" "unprognostic (4.96e-2)" "unprognostic (2.91e-1)" "unprognostic (2.34e-1)" "unprognostic (2.66e-1)" "unprognostic (1.05e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-3)" "unprognostic (1.58e-2)" "unprognostic (2.58e-1)" "unprognostic (1.14e-1)" "unprognostic (4.56e-3)" "unprognostic (3.91e-1)" "prognostic unfavorable (9.51e-4)" "unprognostic (6.52e-2)" "unprognostic (3.42e-1)" "unprognostic (1.30e-2)" "unprognostic (1.55e-2)" 4.9 6.4 4.7 7.1 8.1 4.2 5.9 6.6 7.9 5.5 5.7 9.9 9.1 5.1 5.2 13.1 7.2 6.1 5.2 4.2 5.3 5.4 6.7 6.9 5.7 5.5 7.3 4.1 5.2 8.4 13.8 25.4 4.4 6.8 5.6 6.4 9.5 6.2 6.4 9.9 9.6 5.8 3.0 6.1 6.2 6.1 6.1 7.7 11.2 7.2 3.9 9.1 6.4 6.0 3.9 5.6 2.5 4.4 3.7 4.0 1.3 3.8 7.3 3.7 10.0 2.2 2.9 3.1 1.9 2.2 3.1 3.3 5.4 4.9 6.0 3.2 2.3 4.3 7.6 5.5 5.7 4.9 0.0 2.1 5.5 2.5 7.3 3.6 5.9 3.3 4.0 5.0 3.8 7.6 4.0 3.0 5.4 4.4 5.3 3.7 3.2 8.8 8.7 6.6 4.6 2.5 6.4 9.7 5.4 4.5 3.8 6.6 5.0 5.6 8.9 5.7 5.4 9.7 3.1 4.4 2.5 5.2 3.1 2.2 5.5 12.5 7.7 1.9 5.7 4.3 0.7 2.9 1.2 2.3 3.8 3.8 3.6 3.3 2.7 3.5 3.9 3.4 2.7 2.5 3.7 4.4 5.6 4.0 1.3 4.7 8.1 6.6 7.9 5.3 5.4 7.3 4.1 6.8 7.7 6.0 5.4 3.0 4.5 0.6 11.2 3.2 10.2 4.0 10.3 1.8 15.7 9.2 10.0 7.0 1.6 1.9 5.9 0.0 3.5 6.9 4.1 4.1 8.1 5.7 7.0 9.5 9.8 6.7 3.5 2.9 4.6 3.1 5.0 10.8 6.3 11.0 3.9 7.4 4.2 8.4 18.4 0.0 5.3 7.4 9.6 1.4 5.5 5.3 6.8 4.7 SNAP47 "C1orf142, SNAP-47, SVAP1" ENSG00000143740 "Synaptosome associated protein 47" Q5SQN1 1 227728539-227781231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028167 Supported Approved Cytosol NA NA Cytosol "HPA028167: AB_10603032" "unprognostic (3.31e-2)" "unprognostic (1.31e-1)" "unprognostic (1.93e-2)" "unprognostic (7.31e-2)" "unprognostic (4.88e-2)" "unprognostic (2.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-2)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (6.14e-2)" "unprognostic (4.81e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-1)" 7.4 23.8 21.2 10.8 27.8 6.7 16.2 21.2 29.0 12.4 10.0 10.7 6.9 8.3 21.3 13.4 10.8 15.7 9.8 30.7 21.0 15.1 11.9 14.7 10.0 13.5 12.9 17.4 29.5 17.1 20.7 15.8 16.2 11.6 11.3 8.5 12.6 14.8 10.4 20.4 11.2 8.0 16.6 8.4 9.0 9.2 25.5 11.4 11.6 15.6 9.2 11.9 11.5 9.9 15.4 14.7 20.2 15.1 18.2 29.8 14.7 17.3 24.1 15.2 14.5 18.7 14.7 19.5 11.3 18.1 18.5 15.5 15.9 16.1 12.5 20.7 18.2 14.9 19.1 19.3 21.4 15.9 24.5 34.2 10.7 17.0 10.8 11.5 15.5 9.8 16.8 17.8 24.0 12.9 16.3 15.5 15.1 19.4 12.9 19.1 11.4 15.6 14.8 24.2 22.9 35.0 17.6 17.1 19.3 13.4 15.9 30.2 17.8 17.4 24.6 17.0 16.6 29.8 15.0 11.6 17.6 21.2 16.9 27.5 16.3 11.8 15.2 16.0 12.1 22.4 10.1 13.0 20.2 19.2 12.4 18.4 15.4 21.8 22.0 14.3 13.9 18.6 17.0 4.7 18.2 15.1 14.7 29.8 14.7 21.2 27.8 21.2 29.0 21.0 15.1 12.9 17.4 11.6 11.4 6.0 12.5 22.7 14.5 11.8 28.6 10.1 12.7 9.4 11.4 14.0 25.5 21.8 29.9 17.7 39.1 9.0 8.9 0.0 15.7 23.8 13.7 11.9 5.7 11.6 14.4 39.7 15.5 9.2 6.7 71.2 23.9 6.4 11.8 23.4 7.5 28.1 14.4 0.0 19.4 14.6 31.0 12.9 10.3 24.5 23.0 13.4 23.0 22.0 9.5 8.4 SND1 "p100, TDRD11" ENSG00000197157 "Staphylococcal nuclease and tudor domain containing 1" Q7KZF4 7 127652180-128092609 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 195.0;Syncytiotrophoblasts: 223.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002529, HPA002632, CAB019323" Enhanced Enhanced Cytosol NA NA 1200000 Cytosol "CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316" "unprognostic (2.06e-1)" "unprognostic (8.27e-3)" "unprognostic (2.21e-1)" "prognostic favorable (1.95e-4)" "unprognostic (5.10e-3)" "unprognostic (6.83e-2)" "unprognostic (1.17e-2)" "unprognostic (2.91e-2)" "unprognostic (4.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.30e-1)" "unprognostic (1.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.42e-2)" "unprognostic (2.26e-3)" 21.5 29.8 25.3 25.3 19.8 22.5 45.4 28.1 28.1 33.3 20.0 13.0 57.7 21.3 36.1 38.4 24.8 26.7 25.3 28.3 20.9 16.6 17.3 39.6 38.8 64.2 20.2 19.0 39.7 130.3 22.2 30.3 33.7 27.6 24.5 20.2 13.9 37.5 66.7 20.5 21.5 19.2 41.0 40.1 24.9 30.8 37.0 18.0 22.3 26.6 13.5 24.9 26.5 24.2 28.1 34.9 16.1 30.0 21.0 30.9 28.5 28.5 25.9 19.8 35.9 30.1 31.5 27.2 33.6 39.8 30.8 34.6 33.4 24.8 37.9 17.0 41.2 26.0 24.0 27.9 36.4 30.1 20.7 23.6 20.9 30.9 32.0 54.8 32.3 20.6 46.3 40.7 26.3 44.1 35.1 38.2 15.7 23.1 38.1 30.7 21.3 35.1 24.2 22.2 29.0 32.3 24.5 17.7 84.8 24.1 20.1 25.0 27.0 24.3 113.2 38.9 31.1 14.1 23.0 37.9 25.1 16.4 45.5 26.1 47.0 17.6 39.8 50.3 27.9 45.3 16.1 30.0 5.9 26.1 28.1 30.9 28.1 19.8 21.0 32.3 16.2 14.3 15.8 2.2 21.0 22.8 34.9 15.8 28.5 25.3 19.8 28.1 28.1 20.9 16.6 20.2 19.0 27.6 18.0 14.9 43.1 29.8 20.4 17.4 11.2 26.2 38.2 14.7 20.5 27.9 19.6 195.0 14.9 60.6 12.9 28.0 32.8 23.3 83.7 91.7 29.4 34.2 34.6 43.3 73.2 28.6 70.2 26.4 48.3 40.2 42.3 43.7 32.1 80.2 55.0 15.6 63.2 31.6 38.9 25.1 32.0 32.3 19.5 19.2 29.2 24.0 223.8 27.7 53.0 21.3 SNN ENSG00000184602 Stannin O75324 16 11668414-11679159 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell type enhanced" "Detected in many" 7 "monocytes: 71.3;Muller glia cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 31.5;REH: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011055 Approved Uncertain Cytosol NA NA Cytosol "HPA011055: AB_1857326" "unprognostic (1.94e-1)" "unprognostic (7.26e-2)" "unprognostic (2.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (4.51e-2)" "unprognostic (3.45e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.83e-5)" "unprognostic (4.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.58e-1)" "unprognostic (4.72e-2)" 29.2 16.6 34.7 10.0 51.5 11.0 13.7 27.2 52.2 6.9 4.4 11.2 1.8 4.9 6.8 11.5 10.5 5.9 12.0 13.2 33.0 15.5 7.0 5.1 9.2 15.0 29.8 25.2 9.8 4.7 4.5 4.6 4.5 15.6 8.1 3.3 6.9 9.9 12.9 29.1 4.5 4.4 6.6 15.2 17.4 4.6 2.2 11.4 6.1 9.5 4.8 14.2 9.3 6.1 7.0 9.0 24.1 20.3 0.3 3.0 7.4 3.0 2.9 31.5 8.5 20.9 6.0 3.0 1.3 2.8 3.8 3.8 4.7 2.1 3.1 12.9 4.3 6.7 6.0 9.4 3.7 2.9 0.8 2.1 10.4 3.2 6.2 5.6 0.7 6.3 5.2 17.2 2.0 4.2 5.4 7.0 9.3 1.6 5.0 3.5 5.1 8.3 2.3 16.3 3.8 2.1 29.4 4.2 21.7 3.5 9.0 18.8 7.6 7.1 9.4 4.6 12.9 3.8 6.2 6.2 4.4 9.2 25.7 1.3 2.0 1.3 7.4 2.6 8.9 5.5 0.0 9.5 6.9 0.3 16.3 0.3 7.0 1.6 0.7 9.0 6.8 3.0 2.1 24.1 0.3 20.3 3.6 0.9 7.4 34.7 51.5 27.2 39.3 33.0 15.5 29.8 25.2 15.6 11.4 0.0 6.7 34.4 17.9 16.4 6.5 14.3 10.2 4.0 3.4 5.2 0.0 1.0 21.6 15.0 0.6 14.3 0.0 0.0 16.3 19.9 8.2 15.5 13.8 2.4 17.7 6.4 5.1 20.3 27.0 0.0 4.6 26.4 20.3 71.3 0.2 90.5 13.6 0.0 14.5 4.4 5.9 6.5 26.7 0.3 2.1 16.7 1.1 5.7 0.4 9.1 SNRPD2 "Sm-D2, SNRPD1" ENSG00000125743 "Small nuclear ribonucleoprotein D2 polypeptide" P62316 19 45687454-45692569 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041437 Supported Supported Cytosol NA NA Cytosol "HPA041437: AB_10795119" "unprognostic (1.48e-1)" "unprognostic (1.11e-1)" "unprognostic (2.18e-1)" "unprognostic (1.94e-2)" "unprognostic (6.63e-2)" "unprognostic (6.84e-2)" "unprognostic (1.23e-3)" "unprognostic (2.08e-1)" "unprognostic (7.71e-2)" "unprognostic (3.50e-1)" "unprognostic (4.79e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.95e-1)" "unprognostic (6.57e-3)" "unprognostic (1.53e-1)" "unprognostic (7.12e-2)" 37.2 45.7 57.1 66.4 63.2 75.8 73.2 26.0 66.6 51.9 47.1 17.7 54.3 33.3 43.4 60.2 51.2 55.7 48.8 47.5 49.7 43.6 43.2 36.3 33.9 76.7 45.2 66.7 85.3 68.6 19.9 43.8 38.6 55.1 42.8 46.2 26.6 38.6 40.9 55.7 48.5 33.4 61.5 51.1 44.7 39.7 45.0 47.1 62.3 45.6 56.5 67.7 40.4 89.0 104.7 74.4 22.0 44.8 68.8 113.4 127.2 74.5 106.3 70.4 74.6 67.4 60.9 37.8 49.3 56.0 68.9 73.2 58.4 48.5 84.3 39.9 58.7 51.6 45.0 88.4 89.3 66.3 54.0 116.9 81.4 64.2 84.9 46.4 97.9 54.5 69.8 64.2 62.0 59.5 51.4 69.6 88.0 72.8 60.2 56.7 100.5 99.6 89.9 67.1 137.6 63.7 67.7 72.2 68.4 60.8 95.5 62.9 70.6 64.5 71.8 62.6 59.3 42.4 107.3 47.8 38.2 59.6 33.1 92.8 61.0 139.1 143.3 52.8 79.5 58.3 20.1 44.8 22.0 72.7 40.3 92.0 104.7 97.5 85.6 65.9 88.7 113.4 97.5 5.4 68.8 30.9 74.4 91.3 127.2 57.1 63.2 26.0 66.6 49.7 43.6 45.2 66.7 55.1 47.1 137.0 182.8 480.0 471.5 417.9 40.3 385.3 203.8 269.0 257.0 312.3 21.6 537.3 563.7 326.3 481.8 261.5 277.1 0.0 303.0 702.6 351.2 314.1 257.7 240.3 408.0 35.0 297.9 211.1 256.7 1076.8 322.2 277.6 411.7 402.2 416.7 90.0 299.7 291.0 217.8 520.2 47.3 161.7 380.1 213.2 223.6 369.5 403.8 424.2 482.9 435.3 SNX11 ENSG00000002919 "Sorting nexin 11" Q9Y5W9 17 48103357-48123074 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044787, HPA054660" Approved Approved Cytosol NA NA Cytosol "HPA044787: AB_10795988, HPA054660: AB_2682560" "unprognostic (1.75e-1)" "unprognostic (6.86e-3)" "unprognostic (4.34e-2)" "unprognostic (4.33e-3)" "unprognostic (2.45e-1)" "unprognostic (1.54e-1)" "unprognostic (2.68e-3)" "unprognostic (2.07e-1)" "unprognostic (9.27e-2)" "unprognostic (2.15e-1)" "unprognostic (5.42e-2)" "unprognostic (2.12e-1)" "unprognostic (5.22e-3)" "unprognostic (9.02e-3)" "unprognostic (2.70e-2)" "unprognostic (9.50e-2)" "unprognostic (3.89e-2)" 16.8 12.1 15.1 18.7 23.5 21.0 11.9 12.9 19.5 8.8 13.8 20.2 11.0 9.2 11.6 16.6 19.6 10.4 10.2 12.5 16.2 15.4 16.0 14.4 12.8 21.5 17.2 15.0 9.7 12.3 12.1 13.7 14.9 13.7 12.5 14.0 13.7 15.6 11.3 12.3 11.5 12.2 17.5 18.1 25.5 12.6 11.5 17.0 15.0 21.3 12.2 28.9 14.2 11.3 9.8 11.7 39.8 21.0 6.6 8.4 9.2 12.1 15.4 12.9 12.5 11.7 5.1 14.7 12.4 9.0 17.0 18.4 22.9 10.8 13.0 16.5 14.8 9.9 10.3 12.2 12.9 17.3 29.8 15.4 17.8 9.5 11.0 12.7 20.1 13.4 8.4 14.5 15.1 14.8 10.4 14.6 12.3 11.2 12.2 11.0 11.3 12.6 15.5 7.5 13.8 13.2 7.5 22.4 14.1 10.8 12.1 9.3 17.8 8.4 6.0 22.5 16.5 12.3 15.6 11.3 17.3 10.8 11.9 15.7 20.9 30.1 14.6 12.6 9.8 11.2 11.4 14.5 13.9 8.4 18.1 6.1 9.8 4.7 5.9 11.7 9.4 4.1 6.6 39.8 6.6 21.0 5.5 4.2 9.2 15.1 23.5 12.9 19.5 16.2 15.4 17.2 15.0 13.7 17.0 6.0 1.3 10.7 4.5 5.4 8.5 4.3 0.0 1.4 2.3 15.7 2.0 9.1 5.0 10.6 1.5 5.8 9.7 0.0 13.2 9.3 5.8 5.9 2.3 6.2 16.9 14.3 14.3 4.9 17.7 1.6 4.9 8.1 5.0 50.5 7.6 11.1 13.8 3.5 6.3 6.3 9.2 12.9 4.2 7.7 23.6 4.4 13.7 5.1 6.3 5.4 SNX18 "SH3PX2, SH3PXD3B, SNAG1" ENSG00000178996 "Sorting nexin 18" Q96RF0 5 54517759-54546585 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 68.7;Kupffer cells: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037800 Approved Approved Cytosol NA NA Cytosol "HPA037800: AB_10672465" "unprognostic (2.22e-2)" "unprognostic (3.96e-3)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (4.12e-1)" "unprognostic (2.22e-1)" "unprognostic (9.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (9.13e-2)" "unprognostic (3.81e-3)" "prognostic favorable (1.58e-4)" "unprognostic (6.79e-3)" "unprognostic (7.96e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" 16.2 9.0 10.1 9.2 13.5 50.3 17.8 5.8 9.9 13.0 12.1 20.3 13.8 8.1 14.7 7.6 11.4 11.5 11.8 13.1 10.3 9.0 11.6 13.9 12.1 18.7 18.3 7.0 23.8 8.1 17.4 5.3 18.4 12.7 14.5 5.2 10.9 11.4 13.9 7.7 9.6 8.8 12.5 23.3 26.0 11.7 13.5 15.0 6.7 15.0 5.4 6.6 15.1 26.2 1.2 4.2 6.7 6.1 1.7 1.3 0.6 4.0 3.3 5.3 6.0 12.4 13.4 28.9 6.7 17.0 3.5 5.9 4.1 7.5 0.1 11.3 10.4 6.5 3.8 5.0 6.6 4.5 2.2 3.7 1.2 2.2 2.5 20.8 2.2 1.2 21.0 8.0 4.8 5.0 6.3 7.4 3.0 2.1 28.1 6.1 3.8 2.1 2.5 2.6 1.6 3.5 5.6 2.9 6.4 3.4 11.8 6.6 3.9 5.6 6.5 7.3 8.5 7.7 3.7 2.5 13.3 6.7 9.8 7.1 19.1 18.4 1.1 5.1 5.3 13.7 0.0 1.6 0.2 1.3 2.6 0.3 1.2 0.6 0.8 1.9 1.2 0.3 1.0 6.7 1.7 6.1 4.2 0.3 0.6 10.1 13.5 5.8 7.9 10.3 9.0 18.3 7.0 12.7 15.0 50.6 23.2 7.5 4.0 8.8 9.2 12.4 5.1 16.0 14.8 21.0 68.7 21.3 13.3 11.9 0.3 12.0 3.6 0.0 13.2 25.8 15.4 5.3 5.7 23.3 34.9 4.8 5.8 40.5 73.9 1.7 13.0 34.5 10.1 8.2 8.5 10.3 12.6 6.6 16.6 5.8 43.9 0.0 36.8 2.4 8.9 10.3 6.9 14.1 9.6 12.2 SOCS7 "NAP4, NCKAP4" ENSG00000274211 "Suppressor of cytokine signaling 7" O14512 17 38352228-38405593 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.9;testis: 19.7" "Group enriched" "Detected in many" 6 "Early spermatids: 232.7;Late spermatids: 410.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004475 Approved Approved Cytosol NA NA Cytosol "HPA004475: AB_2667194" "prognostic unfavorable (7.49e-4)" "unprognostic (7.93e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.87e-4)" "unprognostic (7.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.43e-3)" "unprognostic (1.23e-1)" "unprognostic (1.77e-1)" "unprognostic (4.12e-3)" "unprognostic (1.97e-3)" "unprognostic (6.62e-2)" "unprognostic (4.91e-3)" "unprognostic (1.55e-2)" "unprognostic (1.53e-1)" "unprognostic (6.65e-2)" "unprognostic (1.88e-1)" 2.4 1.9 6.1 2.5 6.7 2.1 3.2 22.9 7.8 2.6 2.3 3.5 3.3 2.2 3.6 4.2 3.5 3.2 2.3 2.7 5.1 2.4 0.9 2.6 1.8 3.3 5.1 5.1 9.1 5.1 0.9 2.2 2.9 3.1 2.7 2.9 3.6 3.2 6.0 5.2 2.1 3.6 1.4 1.7 1.4 19.7 4.3 4.7 5.2 1.8 2.8 2.4 2.4 0.8 1.0 0.2 0.9 0.7 2.6 0.3 8.9 10.1 11.3 8.8 6.4 5.4 9.4 3.9 3.4 4.8 3.9 7.9 2.7 6.1 6.0 6.2 6.8 6.0 9.6 2.8 6.1 11.4 8.6 6.5 11.4 8.2 2.2 14.2 11.2 3.3 11.3 5.0 6.9 6.0 4.0 3.2 5.3 4.2 5.9 4.9 12.2 9.4 3.7 9.8 1.6 12.2 19.0 5.6 3.2 11.0 20.0 10.9 9.7 6.3 6.9 10.0 11.7 8.0 4.0 4.8 4.3 8.6 12.0 14.7 10.2 9.0 6.4 7.2 9.7 0.2 0.9 0.1 2.1 0.5 2.6 0.8 0.7 0.3 0.4 0.7 0.4 0.6 0.2 0.7 0.5 1.0 1.1 0.3 14.9 8.5 0.8 6.0 0.7 43.1 19.2 2.5 9.4 14.8 1.8 27.5 7.8 1.7 5.2 232.7 3.6 3.6 0.0 5.6 4.0 4.3 6.6 0.0 7.8 2.8 33.4 4.7 7.4 7.0 410.0 9.8 2.2 1.7 2.8 6.1 12.0 5.6 7.0 8.5 2.2 16.6 0.0 2.6 58.3 22.2 0.6 6.8 6.9 6.3 6.8 SORD ENSG00000140263 "Sorbitol dehydrogenase" Q00796 15 45023104-45077185 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3" "Cell type enhanced" "Detected in many" 17 "Hepatocytes: 654.8;Proximal tubular cells: 226.9" "Cancer enhanced" "Detected in all" "prostate cancer: 72.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "eosinophil: 36.4" "Lineage enriched" "Detected in many" 13 "granulocytes: 36.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040260, HPA040621" Enhanced Approved Cytosol NA NA 430000 Cytosol "HPA040260: AB_10794872, HPA040621: AB_10795384" "unprognostic (8.18e-2)" "unprognostic (7.58e-2)" "unprognostic (8.19e-2)" "unprognostic (1.51e-1)" "unprognostic (5.69e-3)" "unprognostic (3.90e-2)" "prognostic favorable (6.14e-5)" "unprognostic (3.33e-3)" "unprognostic (1.67e-1)" "unprognostic (4.95e-2)" "unprognostic (7.04e-3)" "unprognostic (1.40e-1)" "unprognostic (4.26e-2)" "unprognostic (1.23e-2)" "unprognostic (8.53e-2)" "unprognostic (2.31e-2)" "unprognostic (1.56e-1)" 1.4 10.2 3.0 1.5 3.2 1.0 7.1 3.1 3.8 66.3 5.5 6.2 39.2 2.6 2.6 3.2 6.7 3.5 3.9 3.4 3.0 3.0 20.9 98.4 1.6 2.2 4.2 2.3 1.6 7.3 1.2 1.8 0.5 5.0 48.5 3.8 2.3 7.6 46.7 1.4 8.0 8.7 2.0 5.0 2.4 5.6 2.5 3.9 3.1 116.3 3.8 3.5 4.2 4.4 1.6 2.4 36.4 2.7 0.4 1.0 1.3 15.6 13.8 3.5 11.3 3.0 5.3 3.7 4.3 3.0 9.9 8.4 11.5 8.6 2.0 9.8 5.3 10.7 23.6 18.1 16.4 7.9 34.0 11.2 15.7 18.1 25.3 2.3 27.3 26.4 6.8 12.5 5.7 9.1 4.8 9.3 24.2 17.6 5.6 9.3 6.3 16.5 14.8 13.5 26.5 14.7 0.0 22.8 7.6 7.2 15.3 24.8 13.0 8.9 14.0 6.6 3.9 20.2 11.2 8.3 7.9 7.0 17.6 10.4 1.0 6.9 2.0 12.8 24.1 20.6 5.0 2.7 36.4 0.6 2.5 1.0 1.2 0.6 0.8 2.4 1.6 0.5 0.6 1.4 0.4 2.5 1.3 0.6 1.3 3.0 3.2 3.1 3.8 3.0 3.0 4.2 2.3 5.0 3.9 0.0 1.9 16.8 20.6 6.9 9.5 2.8 38.2 28.1 28.4 31.4 0.0 1.0 24.9 52.5 26.1 3.8 9.1 0.0 118.4 3.9 5.8 134.4 8.1 654.8 14.4 3.2 81.4 20.9 21.2 17.1 3.4 8.2 15.1 8.2 29.3 6.8 90.9 13.3 5.6 226.9 3.6 0.0 9.2 6.5 2.5 17.8 0.8 6.4 32.6 87.8 SOS1 "GF1, GINGF, HGF" ENSG00000115904 "SOS Ras/Rac guanine nucleotide exchange factor 1" Q07889 2 38981396-39124345 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005396 Uncertain Approved Cytosol NA NA Cytosol "CAB005396: AB_2270724" "unprognostic (6.68e-2)" "unprognostic (2.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.14e-3)" "unprognostic (4.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.74e-3)" "unprognostic (4.55e-2)" "unprognostic (1.10e-1)" "unprognostic (4.13e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-3)" "unprognostic (7.61e-2)" "unprognostic (5.59e-2)" "unprognostic (1.33e-2)" 25.9 13.2 19.2 18.8 18.1 12.0 26.1 33.3 18.6 18.6 21.9 12.1 15.3 18.3 19.1 14.6 17.4 17.0 18.1 16.4 17.9 14.1 14.6 15.2 19.9 19.9 18.2 14.0 28.1 13.0 33.5 21.7 21.5 17.8 18.4 16.8 14.6 15.9 18.1 26.2 15.0 23.1 22.3 14.6 16.2 20.1 12.7 20.1 23.1 19.4 12.9 21.8 25.1 22.0 3.2 1.4 3.2 2.0 6.2 4.6 0.9 9.9 6.1 9.6 6.8 13.0 15.5 10.0 6.3 7.8 5.0 4.8 6.6 6.0 14.5 4.3 8.2 7.8 6.0 11.2 5.7 9.4 14.5 5.0 22.4 5.3 9.1 5.3 7.1 57.0 9.5 9.2 6.8 6.7 8.6 7.9 3.3 9.5 6.8 6.4 5.4 7.6 6.6 6.0 12.3 4.4 8.6 8.6 4.2 5.3 8.1 9.3 9.3 7.5 13.5 7.8 8.3 4.3 3.8 8.8 8.4 6.8 6.6 6.2 8.1 8.2 7.6 6.7 7.1 5.0 0.0 1.2 3.2 3.2 1.8 4.6 3.2 3.3 3.3 1.0 2.4 3.7 3.4 1.4 6.2 2.0 1.4 1.9 0.9 19.2 18.1 33.3 18.6 17.9 14.1 18.2 14.0 17.8 20.1 14.9 31.1 14.3 12.7 18.4 17.6 28.1 17.8 21.4 19.4 8.7 9.8 7.5 1.7 8.3 24.4 32.8 15.5 0.0 10.3 6.5 15.3 19.0 3.5 14.8 9.1 7.9 11.5 10.4 14.6 4.9 21.0 14.4 6.8 8.2 17.7 15.7 10.1 10.5 20.5 10.0 11.2 6.5 11.2 7.6 5.3 22.1 8.7 22.3 16.4 25.8 SOWAHC "ANKRD57, C2orf26, FLJ21870" ENSG00000198142 "Sosondowah ankyrin repeat domain family member C" Q53LP3 2 109614334-109618990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 131.1;Suprabasal keratinocytes: 174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 55.9;hTCEpi: 18.6;RT4: 23.6" "Low region specificity" "Detected in all" HPA056131 Enhanced Approved Cytosol No No Cytosol "HPA056131: AB_2683047" "unprognostic (6.76e-2)" "unprognostic (6.96e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.87e-1)" "unprognostic (8.91e-3)" "unprognostic (1.63e-2)" "unprognostic (1.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (5.11e-3)" "prognostic favorable (3.56e-5)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (3.50e-1)" "unprognostic (2.54e-2)" 4.9 2.7 2.7 3.7 2.7 0.1 6.5 0.8 2.3 8.9 11.8 3.5 5.3 3.3 3.7 6.4 30.4 3.6 7.2 2.2 2.5 3.2 11.5 35.4 5.1 3.7 5.7 0.8 9.2 4.1 4.1 2.2 20.7 3.6 9.8 5.9 3.9 8.1 6.3 1.1 14.4 17.9 7.8 5.7 3.6 4.4 7.8 2.8 3.2 5.3 30.4 15.9 11.5 10.5 0.8 0.5 1.3 2.3 0.5 1.1 0.5 6.7 1.3 3.9 2.1 2.0 3.3 12.8 14.8 8.7 2.6 2.7 6.0 2.1 0.0 6.1 2.2 4.9 6.4 0.9 9.7 2.8 55.9 6.5 0.0 3.0 8.5 1.8 0.0 1.7 1.7 18.6 5.6 4.0 2.2 0.6 0.0 0.1 0.0 1.9 2.2 0.0 0.6 2.8 6.2 5.9 0.0 0.8 0.1 3.9 23.6 4.9 2.1 5.0 0.9 3.9 4.0 1.9 0.1 0.9 2.1 7.9 1.2 1.0 1.9 1.8 0.0 2.4 0.2 4.7 1.3 2.3 0.3 0.3 0.9 0.4 0.8 0.7 0.3 0.2 0.6 0.5 0.7 1.2 0.5 0.8 0.5 1.1 0.5 2.7 2.7 0.8 2.3 2.5 3.2 5.7 0.8 3.6 2.8 14.9 9.8 3.0 32.5 131.1 10.3 4.2 20.4 2.7 12.5 12.2 9.8 3.1 3.3 14.2 38.3 6.8 30.2 0.0 6.2 25.3 12.3 14.5 0.0 44.5 6.9 0.0 15.0 7.4 7.2 8.5 10.9 6.1 18.6 1.8 27.8 8.0 11.7 40.3 14.2 17.4 18.6 12.9 15.3 10.4 6.9 174.3 8.4 1.5 31.7 73.5 SPAG1 "CILD28, CT140, FLJ32920, HSD-3.8, SP75, TPIS" ENSG00000104450 "Sperm associated antigen 1" Q07617 8 100157906-100259278 "Disease related genes, Predicted intracellular proteins" Fertilization Hydrolase "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 195.4;Spermatocytes: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023748, HPA053682" Enhanced Supported Cytosol NA NA Cytosol "HPA023748: AB_2671304, HPA053682: AB_2682229" "unprognostic (9.95e-2)" "unprognostic (5.37e-2)" "unprognostic (1.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.46e-1)" "unprognostic (2.57e-1)" "unprognostic (5.86e-2)" "unprognostic (9.19e-2)" "unprognostic (1.53e-1)" "unprognostic (5.62e-2)" "unprognostic (1.57e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.87e-4)" "unprognostic (9.11e-3)" "unprognostic (8.83e-3)" "unprognostic (1.54e-1)" "prognostic favorable (2.62e-4)" 2.0 1.5 3.9 3.5 6.8 9.1 3.6 6.4 5.9 6.0 12.8 7.8 13.5 3.0 3.0 8.5 8.1 10.4 4.4 5.4 5.6 6.1 7.5 10.8 10.0 2.6 4.1 2.6 4.5 3.3 13.0 21.2 1.9 26.2 4.8 19.3 2.8 6.1 14.4 0.7 8.0 3.4 2.0 5.7 2.7 6.5 18.2 5.4 1.3 4.5 0.5 4.3 5.6 3.9 2.9 0.8 2.5 0.6 3.2 0.6 0.2 20.5 5.5 0.3 1.2 1.3 1.1 3.2 3.8 2.3 4.7 5.0 5.5 9.1 0.8 13.9 1.2 7.0 10.9 4.0 7.4 4.4 12.0 4.2 3.4 6.3 2.1 1.7 0.9 3.1 0.9 4.0 5.8 4.6 3.7 3.9 3.8 0.1 11.1 0.7 7.3 2.0 0.9 0.3 10.3 6.2 0.3 0.9 3.1 18.0 9.9 3.3 2.4 5.3 4.4 4.5 1.6 6.3 3.9 3.6 4.7 6.8 2.5 9.9 7.5 5.7 0.6 4.5 3.3 2.3 0.0 0.4 1.8 0.5 0.0 0.3 2.9 0.4 0.5 0.4 1.2 0.1 0.6 2.5 3.2 0.6 0.8 0.0 0.2 3.9 6.8 6.4 5.9 5.6 6.1 4.1 2.6 26.2 5.4 44.7 21.4 0.8 7.5 4.9 1.1 5.4 25.5 195.4 42.1 17.4 0.0 1.0 5.0 14.3 59.8 6.8 12.0 0.0 7.6 4.6 4.1 9.0 9.3 6.8 2.3 7.9 21.2 2.5 0.6 20.5 4.6 3.5 1.7 6.4 16.7 10.8 13.8 17.8 3.5 9.1 2.2 0.0 3.3 93.3 3.8 4.6 1.9 12.9 24.0 21.4 SPATA5 "AFG2, SPAF" ENSG00000145375 "Spermatogenesis associated 5" Q8NB90 4 122923074-123319450 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Chaperone, Developmental protein, Hydrolase" "Deafness, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "Early spermatids: 147.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036450, HPA036451" Approved Approved Cytosol NA NA Cytosol "HPA036450: AB_2675131, HPA036451: AB_10670107" "unprognostic (4.28e-1)" "unprognostic (7.54e-2)" "unprognostic (7.37e-3)" "unprognostic (1.26e-1)" "unprognostic (5.16e-1)" "unprognostic (1.18e-1)" "unprognostic (7.65e-4)" "unprognostic (1.95e-3)" "unprognostic (9.00e-2)" "unprognostic (2.78e-1)" "unprognostic (4.43e-3)" "unprognostic (4.62e-2)" "unprognostic (1.26e-2)" "unprognostic (1.52e-1)" "unprognostic (5.68e-1)" "unprognostic (2.63e-2)" "unprognostic (1.79e-1)" 8.2 4.7 5.8 8.5 9.3 6.0 7.8 20.7 8.0 8.3 6.1 6.4 5.6 3.8 12.8 5.5 5.7 6.0 4.4 5.3 5.5 4.6 5.9 5.2 5.3 8.0 7.1 5.2 6.4 5.1 11.2 13.5 5.9 6.9 6.0 6.1 7.4 6.1 5.3 6.4 7.4 4.8 9.1 7.4 7.3 11.6 11.3 9.0 13.6 6.7 5.0 9.3 6.2 7.0 2.9 2.8 2.3 1.9 2.5 2.8 0.7 2.9 3.2 4.0 8.0 3.1 2.1 2.6 4.2 1.8 3.2 3.1 2.1 4.3 4.4 2.8 2.6 2.3 2.7 5.2 2.8 6.3 6.2 1.3 3.8 5.9 3.4 1.4 6.5 4.8 1.5 1.5 4.5 4.2 2.0 3.1 3.0 7.4 7.8 5.5 3.2 10.9 4.5 2.3 4.8 1.6 3.8 8.4 2.4 2.6 2.1 5.9 4.2 3.9 3.4 2.4 5.5 2.4 2.5 3.8 8.5 5.6 5.4 5.0 5.1 5.2 3.1 4.4 5.9 7.3 2.3 1.2 1.1 2.7 1.9 1.6 2.0 2.2 2.3 0.9 2.9 2.4 2.8 1.8 2.5 1.1 2.8 1.1 0.7 5.8 9.3 20.7 8.0 5.5 4.6 7.1 5.2 6.9 9.0 14.9 5.3 4.4 5.1 4.5 5.1 3.4 17.8 9.4 11.4 1.8 13.7 3.9 0.0 2.3 147.3 8.0 2.0 0.0 3.1 3.5 3.7 3.0 4.7 2.1 3.0 3.2 2.4 5.5 3.7 13.2 6.6 4.8 0.0 1.0 1.6 4.9 3.4 2.6 4.2 2.7 11.6 0.0 3.6 13.3 10.0 4.6 1.8 5.3 3.7 2.6 SPATS2 "FLJ13117, SCR59, SPATA10" ENSG00000123352 "Spermatogenesis associated serine rich 2" Q86XZ4 12 49366584-49527424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 114.2;Spermatogonia: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038642, HPA038643, HPA076823" Uncertain Enhanced Cytosol NA NA Cytosol "HPA038642: AB_2676128, HPA038643: AB_10672523, HPA076823: " "unprognostic (2.87e-2)" "unprognostic (2.63e-1)" "unprognostic (2.20e-2)" "unprognostic (1.89e-1)" "unprognostic (5.56e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (9.57e-8)" "unprognostic (4.55e-2)" "unprognostic (6.32e-2)" "prognostic favorable (1.44e-4)" "unprognostic (2.64e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (2.57e-1)" "unprognostic (4.81e-1)" 7.7 8.2 10.6 19.9 12.4 5.6 9.4 25.7 18.0 13.5 12.1 4.0 7.7 11.2 19.0 8.3 9.1 6.7 11.0 7.5 11.7 8.9 9.1 5.1 8.0 14.2 9.0 11.0 9.0 12.1 30.6 24.8 8.6 15.6 10.1 11.5 9.8 19.2 9.2 9.7 15.8 10.5 11.6 6.1 11.1 12.2 24.2 4.5 8.8 13.6 5.4 19.1 13.7 13.8 7.8 10.2 1.9 1.8 1.6 2.3 1.5 7.0 15.7 13.5 15.9 7.9 12.5 4.4 8.2 11.6 14.1 11.5 14.5 15.9 17.4 19.2 7.3 9.1 8.4 11.6 15.6 18.3 13.1 6.7 15.6 12.0 11.3 14.4 4.1 9.4 10.6 7.8 22.2 21.0 46.2 32.9 7.8 8.3 16.1 14.5 12.2 8.4 6.2 14.1 11.3 16.0 12.9 22.7 20.8 13.1 8.9 15.3 13.8 17.3 11.7 19.8 8.8 20.2 4.8 29.8 6.2 15.2 5.6 5.2 21.4 24.1 14.2 8.2 7.2 8.9 1.9 1.8 0.6 2.3 0.5 2.3 7.8 1.9 1.5 5.0 4.9 1.7 1.5 1.3 1.6 0.3 10.2 1.4 1.5 10.6 12.4 25.7 18.0 11.7 8.9 9.0 11.0 15.6 4.5 17.9 20.3 22.0 45.5 51.5 37.0 8.1 20.4 6.7 14.8 34.9 21.6 8.5 5.0 23.2 64.2 40.9 8.4 23.3 24.4 9.8 35.6 26.6 10.4 4.2 7.0 39.7 35.2 25.2 7.5 27.6 29.4 17.9 18.6 19.0 17.3 21.1 32.7 7.0 31.5 9.3 4.7 51.8 25.5 114.2 132.8 52.8 4.5 14.9 27.3 22.4 SPC25 "AD024, MGC22228, SPBC25" ENSG00000152253 "SPC25, NDC80 kinetochore complex component" Q9HBM1 2 168834132-168913371 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 31.3;Hofbauer cells: 12.6;Muller glia cells: 13.2;Spermatocytes: 21.2;Spermatogonia: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.5" "Group enriched" "Detected in many" 4 "B-cells: 1.1;T-cells: 2.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047144, HPA050544" Enhanced Enhanced Cytosol NA Yes Cytosol "HPA047144: AB_2679952, HPA050544: " "unprognostic (3.52e-2)" "unprognostic (2.28e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.74e-6)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.84e-3)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.30e-2)" "unprognostic (1.11e-16)" "unprognostic (9.91e-3)" "unprognostic (1.85e-1)" "unprognostic (3.43e-1)" "unprognostic (1.57e-1)" 0.9 1.6 3.6 7.2 2.2 6.7 2.1 0.4 3.5 1.3 4.0 0.9 0.0 6.8 1.3 1.5 8.5 0.6 1.0 1.1 2.7 1.6 1.5 1.6 1.9 7.5 1.2 2.5 1.2 2.6 0.7 0.2 3.3 1.1 0.8 3.1 1.3 2.1 0.0 0.7 2.1 3.8 1.8 0.7 4.1 3.0 5.9 1.1 38.0 0.6 5.6 8.0 1.5 2.7 1.1 0.0 0.4 0.1 0.0 2.5 0.4 1.0 8.4 19.6 10.9 0.9 0.9 7.1 11.3 4.3 11.4 9.1 4.3 7.9 7.0 5.0 1.8 15.0 10.4 7.5 0.0 10.1 4.7 11.5 14.0 5.3 2.0 0.0 10.4 4.2 0.0 0.5 7.3 0.1 2.3 5.7 14.8 1.1 7.9 3.2 5.2 7.5 12.6 0.6 5.0 11.2 13.6 19.5 3.1 4.6 6.6 14.7 0.9 10.1 6.9 1.9 6.6 0.5 7.3 1.7 1.7 20.7 6.7 9.5 15.3 26.6 6.9 2.2 1.6 6.7 0.0 0.1 0.2 0.0 0.1 0.0 0.9 0.4 0.0 0.0 1.1 0.2 0.5 0.4 0.0 0.0 0.0 2.5 0.4 3.6 2.2 0.4 3.5 2.7 1.6 1.2 2.5 1.1 1.1 0.0 0.6 1.5 1.1 4.7 0.0 0.4 0.0 0.0 3.4 0.0 0.0 2.8 0.0 0.0 1.2 0.4 1.0 0.0 0.0 31.3 0.8 0.2 0.0 0.8 12.6 0.0 0.0 4.3 1.6 0.6 0.6 1.6 0.0 0.0 1.4 13.2 0.8 0.0 1.1 0.0 0.3 0.0 0.3 21.2 17.6 1.3 4.8 1.7 3.0 0.9 SPDL1 "CCDC99, FLJ20364, hSpindly" ENSG00000040275 "Spindle apparatus coiled-coil protein 1" Q96EA4 5 169583634-169604778 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 97.4;Spermatogonia: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA044700, HPA048146" Enhanced Approved Cytosol NA Yes Cytosol "HPA044700: AB_2679052, HPA048146: AB_2680284" "unprognostic (2.61e-2)" "unprognostic (1.94e-1)" "unprognostic (8.59e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (4.24e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.48e-6)" "unprognostic (2.63e-3)" "unprognostic (5.70e-3)" "unprognostic (8.27e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.81e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.93e-1)" 5.5 4.7 6.5 9.0 11.5 9.9 8.0 14.5 11.0 5.5 5.6 6.6 3.4 5.9 6.4 4.4 9.7 4.9 4.9 4.0 7.8 5.8 5.1 3.6 4.7 13.9 8.3 7.1 7.2 4.1 5.6 8.0 8.4 11.6 4.1 6.0 2.0 5.1 3.6 5.0 5.3 5.9 7.7 16.7 8.2 5.3 33.7 10.4 23.9 4.5 8.5 13.6 5.4 5.8 10.7 16.5 3.2 4.6 6.4 9.3 3.0 14.6 17.6 18.0 12.6 4.8 4.5 15.9 46.6 6.2 34.9 31.7 23.1 9.9 13.8 30.9 38.1 24.0 10.3 14.6 20.0 38.3 14.2 16.3 16.1 31.7 9.0 2.2 16.9 13.9 2.1 1.7 14.6 9.2 7.4 15.8 14.3 10.1 10.2 37.1 14.2 13.8 7.2 13.1 7.3 17.1 16.2 17.7 10.2 22.8 5.2 11.6 8.5 21.7 6.2 9.1 13.3 7.0 11.3 11.2 39.8 12.6 11.3 36.1 8.1 17.0 18.6 9.6 15.6 13.3 3.2 2.2 2.9 7.3 3.0 7.7 8.8 6.6 7.7 2.2 10.7 9.3 7.4 0.4 6.4 4.6 16.5 6.4 3.0 6.5 11.5 14.5 11.0 7.8 5.8 8.3 7.1 11.6 10.4 3.0 7.5 6.7 1.7 3.5 7.1 7.2 0.0 4.0 7.9 1.8 0.0 7.9 5.0 4.9 7.6 3.9 0.5 23.3 4.2 21.7 7.5 1.1 8.1 2.9 10.0 3.2 1.7 11.6 4.0 8.7 4.0 6.1 3.3 6.4 1.9 6.1 5.4 1.7 6.0 5.1 3.9 6.5 9.2 97.4 70.9 3.9 4.1 4.4 5.1 2.1 SPTB ENSG00000070182 "Spectrin beta, erythrocytic" P11277 14 64746283-64879907 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6" "Cell type enhanced" "Detected in some" 22 "Erythroid cells: 46.7;Horizontal cells: 15.9" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 23.5;K-562: 28.1;U-937: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003394, HPA003398, CAB015169, CAB016232" Enhanced Approved Cytosol NA NA 43000000 Cytosol "CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074" "unprognostic (2.69e-1)" "unprognostic (4.72e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-3)" "unprognostic (1.71e-1)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-3)" "unprognostic (2.66e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-3)" "unprognostic (2.11e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-2)" "unprognostic (2.97e-1)" "unprognostic (3.44e-2)" "unprognostic (2.18e-2)" 1.9 1.6 3.2 0.7 11.6 32.2 0.7 25.2 10.4 0.8 0.7 0.8 0.3 0.6 0.7 5.2 1.8 0.8 0.8 14.7 3.1 3.2 1.2 0.6 0.9 0.6 2.8 3.5 0.7 2.2 6.5 4.7 4.7 16.4 1.5 0.7 1.1 1.9 1.3 67.6 0.7 0.7 1.0 1.7 1.1 0.7 1.0 1.4 0.0 0.7 17.4 0.6 0.8 0.5 0.0 0.6 0.9 0.0 0.0 0.2 1.5 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 1.4 3.9 0.1 0.0 0.2 2.3 23.5 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.9 28.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 3.8 1.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 4.3 0.0 0.4 0.9 4.4 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.5 3.2 11.6 25.2 10.4 3.1 3.2 2.8 3.5 16.4 1.4 0.0 0.0 0.0 0.4 0.7 8.1 5.5 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 46.7 0.2 0.2 0.3 0.5 2.3 0.0 0.2 15.9 2.9 0.0 0.0 0.0 0.3 0.2 1.7 0.0 0.0 6.5 0.4 0.0 1.1 0.0 1.9 6.5 3.8 0.1 0.2 0.4 0.1 0.0 0.0 0.5 SRGAP1 "ARHGAP13, KIAA1304" ENSG00000196935 "SLIT-ROBO Rho GTPase activating protein 1" Q7Z6B7 12 63844293-64162221 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 153.7;Muller glia cells: 159.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.4;hTERT-HME1: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052416, HPA078079" Uncertain Approved Cytosol NA NA Cytosol "HPA052416: AB_2681824, HPA078079: " "unprognostic (3.05e-3)" "unprognostic (2.28e-1)" "unprognostic (1.58e-2)" "unprognostic (2.22e-3)" "unprognostic (2.24e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.45e-3)" "unprognostic (1.43e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (3.54e-3)" "unprognostic (8.56e-2)" "unprognostic (1.41e-3)" "unprognostic (8.16e-2)" "unprognostic (2.08e-1)" "unprognostic (8.31e-2)" "unprognostic (1.56e-2)" 11.4 5.4 6.6 6.2 9.6 1.2 8.2 6.6 7.7 7.4 6.1 7.1 2.0 3.2 6.2 4.7 7.0 5.3 5.8 4.2 8.6 3.8 5.5 2.5 11.2 2.2 7.0 3.1 7.5 11.3 17.7 6.1 4.2 10.4 3.8 5.9 4.1 13.4 2.4 3.4 3.1 3.9 5.5 12.1 4.9 4.2 9.4 10.9 0.0 9.4 0.3 2.3 5.2 8.9 1.2 0.8 2.9 1.4 1.2 0.8 0.2 3.0 6.4 10.4 1.0 8.0 14.1 2.2 9.5 8.5 3.5 3.1 3.3 2.5 0.0 3.9 17.4 8.8 1.9 0.9 5.4 3.6 2.4 1.0 0.1 4.5 3.4 9.9 0.0 0.1 13.0 5.2 9.9 27.9 4.9 3.2 0.2 0.0 0.1 4.6 1.8 0.0 0.1 0.8 1.6 3.7 0.0 1.9 0.0 4.4 1.6 1.7 3.1 3.7 3.9 2.6 1.7 1.1 0.1 6.7 7.3 1.3 7.7 4.3 0.1 0.0 0.0 6.2 0.7 2.9 2.1 0.9 0.5 0.6 1.4 0.7 0.7 0.7 0.4 0.4 1.2 0.8 0.8 2.9 1.2 0.8 0.8 0.4 0.2 6.6 9.6 6.6 7.7 8.6 3.8 7.0 3.1 10.4 10.9 0.0 3.5 5.9 33.4 6.9 7.1 4.8 40.8 25.4 10.3 8.7 5.9 23.0 10.0 28.5 153.7 14.7 22.3 0.0 22.6 7.9 18.5 30.6 1.1 0.9 10.4 3.2 16.0 25.2 30.1 41.5 20.4 18.1 16.9 41.5 25.0 159.6 29.4 37.4 14.9 10.2 5.0 0.0 17.0 4.7 16.6 3.3 6.1 3.2 20.1 44.2 SRGAP2B SRGAP2P2 ENSG00000196369 "SLIT-ROBO Rho GTPase activating protein 2B" P0DMP2 1 144887265-145095528 "Predicted intracellular proteins" Neurogenesis "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 9.6" "Cell type enhanced" "Detected in many" 7 "Ito cells: 54.6;Kupffer cells: 49.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA078079 Approved Cytosol NA NA Cytosol "HPA078079: " "unprognostic (1.13e-2)" "unprognostic (2.76e-1)" "unprognostic (1.48e-3)" "unprognostic (3.52e-3)" "unprognostic (1.66e-2)" "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (4.60e-2)" "unprognostic (3.13e-1)" "unprognostic (2.89e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (2.16e-5)" "unprognostic (3.12e-1)" "unprognostic (5.43e-1)" "unprognostic (8.54e-2)" "unprognostic (2.38e-1)" 2.5 3.4 1.5 1.6 0.6 2.7 1.3 0.0 0.0 1.4 0.6 1.2 1.7 1.2 0.6 2.2 0.5 2.4 0.9 2.7 0.3 4.4 3.3 0.4 0.0 0.0 0.8 1.9 6.6 0.0 1.8 3.7 0.0 0.2 0.5 0.3 1.2 1.4 4.6 5.0 9.6 0.5 1.6 1.1 6.8 14.7 32.0 6.6 15.4 13.4 10.1 7.6 6.7 6.5 7.5 4.4 12.6 3.4 10.2 4.5 11.6 11.9 8.2 4.4 8.0 3.2 8.3 5.0 10.7 6.2 10.8 4.4 6.6 9.5 6.7 16.0 14.2 9.8 13.0 3.0 2.7 12.2 3.5 7.6 1.9 5.2 5.9 3.4 5.4 5.2 6.9 5.9 5.6 3.0 4.0 5.1 10.1 3.6 16.8 8.3 7.6 11.3 23.5 14.0 14.5 12.4 8.8 5.1 6.3 2.1 5.1 6.0 19.9 1.4 5.1 0.7 0.9 6.9 0.7 1.2 1.4 1.6 3.5 1.4 1.0 1.1 5.0 0.5 9.6 4.6 1.4 1.1 23.8 7.7 8.3 3.5 0.0 11.9 3.2 0.0 14.7 4.5 8.7 2.0 4.7 0.0 5.8 1.0 24.3 0.3 23.3 2.6 14.4 12.3 3.6 1.1 4.7 10.9 0.0 2.4 54.6 49.1 1.7 14.1 15.9 0.0 23.4 0.8 6.3 4.3 0.0 9.2 0.8 2.4 6.5 9.4 2.6 6.4 0.0 2.4 10.1 1.2 3.5 SRGAP2C SRGAP2P1 ENSG00000171943 "SLIT-ROBO Rho GTPase activating protein 2C" P0DJJ0 1 121184810-121392822 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 16.5" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 50.6;Erythroid cells: 70.0;Ito cells: 64.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 39.8" HPA078079 Approved Cytosol NA NA Cytosol "HPA078079: " "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (7.65e-3)" "unprognostic (1.48e-6)" "unprognostic (2.40e-2)" "unprognostic (1.11e-1)" "unprognostic (7.18e-4)" "unprognostic (6.10e-2)" "unprognostic (7.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (2.89e-1)" "unprognostic (3.71e-7)" "unprognostic (4.90e-2)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" "unprognostic (7.66e-2)" 4.7 4.5 3.5 2.8 4.4 4.2 2.7 7.8 6.0 3.5 2.0 8.5 3.3 1.0 3.5 1.2 5.4 3.2 3.0 2.9 3.3 4.6 2.9 5.5 2.5 6.3 4.0 4.8 1.1 16.5 4.6 6.5 6.2 2.1 1.7 2.1 1.3 3.2 1.3 10.9 1.7 3.9 6.4 7.0 1.8 1.3 4.7 4.5 2.0 1.9 2.2 3.1 2.7 1.7 4.2 5.2 7.7 1.0 2.3 1.4 5.2 6.9 15.3 3.4 11.9 10.4 8.5 6.0 4.8 5.1 6.7 0.1 5.4 3.3 5.4 8.2 3.7 2.9 5.4 4.4 6.8 4.4 5.5 4.8 12.0 5.3 6.8 3.2 5.7 7.7 4.4 6.5 8.4 5.8 12.1 2.1 4.4 6.3 3.7 3.1 2.0 4.1 4.8 1.7 3.3 3.0 18.0 3.0 4.8 3.1 2.9 1.9 10.4 3.7 18.7 8.3 4.7 9.5 10.7 9.7 9.6 14.4 8.8 3.7 2.6 2.0 8.4 6.6 39.8 0.5 5.9 1.0 1.9 4.6 1.3 1.7 2.3 2.1 4.2 1.7 1.1 1.6 5.2 1.0 7.7 3.8 2.0 1.4 50.6 11.5 9.3 6.2 0.0 12.1 4.9 5.1 16.0 9.1 10.4 2.0 4.6 1.7 9.3 0.4 29.2 0.4 70.0 4.4 18.8 12.7 4.2 5.8 7.2 16.5 0.0 2.4 64.4 41.9 0.9 18.1 16.7 0.0 27.9 2.6 8.4 5.4 0.6 24.1 0.7 4.5 32.3 12.4 4.7 6.8 0.0 2.1 13.4 1.4 3.8 SRGAP3 "ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP" ENSG00000196220 "SLIT-ROBO Rho GTPase activating protein 3" O43295 3 8980591-9363053 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.9" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 228.5;Cone photoreceptor cells: 257.2;Horizontal cells: 216.1;Muller glia cells: 117.0;Rod photoreceptor cells: 104.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.7;HBEC3-KT: 8.4;hTCEpi: 8.3;RT4: 11.2;T-47d: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036959, HPA044074, HPA078079" Enhanced Approved Cytosol NA NA Cytosol "HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: " "unprognostic (3.63e-3)" "unprognostic (1.12e-3)" "unprognostic (7.61e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.70e-2)" "unprognostic (5.58e-2)" "unprognostic (1.18e-3)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "unprognostic (2.75e-2)" "unprognostic (6.39e-3)" 1.8 6.1 10.6 1.7 20.4 1.2 3.2 32.4 34.9 9.7 2.1 10.5 0.0 1.9 4.4 3.4 2.6 18.5 2.3 2.7 10.0 11.2 4.9 1.4 2.2 2.3 7.5 9.8 7.2 2.4 2.7 5.7 1.9 15.5 4.7 2.5 4.8 5.7 3.2 2.5 4.0 1.7 2.0 6.1 1.7 2.9 4.4 4.8 0.4 3.3 0.6 2.1 6.7 1.4 0.0 1.9 1.9 0.4 1.0 1.3 0.1 0.5 0.5 9.7 0.4 0.7 1.3 1.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.5 0.0 0.2 4.9 0.2 8.4 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 5.2 0.8 8.3 0.7 0.8 0.3 0.0 2.2 0.0 0.0 0.0 0.1 0.2 2.1 0.9 1.7 0.7 1.1 0.0 0.0 4.2 11.2 1.1 1.3 0.2 3.0 0.1 2.5 10.8 0.0 0.0 0.0 0.4 0.1 0.1 2.9 0.1 0.0 0.8 1.7 0.3 1.2 0.4 1.9 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.2 0.0 0.0 1.0 0.1 0.5 1.3 0.1 10.6 20.4 32.4 34.9 10.0 11.2 7.5 9.8 15.5 4.8 3.0 6.4 0.0 23.8 3.7 228.5 8.1 0.0 52.2 27.3 73.3 257.2 1.8 5.0 1.8 18.5 1.8 0.4 0.0 0.4 0.7 4.0 9.9 1.1 1.6 10.6 216.1 2.9 0.6 9.9 15.3 2.3 3.8 1.7 1.0 3.7 117.0 0.5 0.0 1.1 1.0 104.8 0.0 1.4 5.4 4.9 5.1 1.1 2.9 2.2 27.1 SRP68 ENSG00000167881 "Signal recognition particle 68" Q9UHB9 17 76038775-76072653 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023303, HPA055617" Approved Supported Cytosol NA NA Cytosol "HPA023303: AB_1857477, HPA055617: AB_2682863" "unprognostic (1.25e-1)" "unprognostic (8.97e-2)" "unprognostic (3.47e-2)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.18e-4)" "prognostic unfavorable (4.28e-5)" "unprognostic (3.31e-2)" "unprognostic (8.31e-2)" "unprognostic (1.62e-2)" "unprognostic (1.11e-1)" "unprognostic (4.10e-2)" "unprognostic (4.42e-2)" "unprognostic (8.73e-2)" "unprognostic (4.75e-2)" "prognostic favorable (2.65e-4)" "unprognostic (4.02e-3)" 23.2 23.8 39.8 20.3 41.1 17.5 22.9 35.4 44.1 25.4 28.1 16.6 26.3 18.4 25.7 34.4 37.6 26.0 16.4 25.5 32.4 24.9 24.9 28.9 21.8 22.1 23.8 32.2 32.3 43.1 33.4 29.1 32.0 34.5 24.4 25.0 16.6 27.6 25.8 71.7 35.4 19.7 30.8 30.3 22.6 25.2 18.4 32.4 20.6 32.0 20.4 34.5 25.6 27.3 17.5 20.4 20.2 16.4 26.3 24.5 10.5 38.5 34.1 21.1 22.0 30.1 24.3 38.2 28.2 20.7 33.8 26.5 28.7 21.5 30.5 14.5 28.6 28.7 26.2 39.7 29.9 50.5 12.7 44.1 28.3 27.6 42.2 35.6 33.3 22.1 21.4 33.5 29.6 26.0 25.4 39.2 19.3 40.4 28.8 28.3 23.6 32.1 20.7 19.5 38.4 36.1 27.2 56.5 31.2 28.2 34.0 26.0 25.5 25.8 41.9 31.0 37.0 37.3 30.4 25.0 36.9 28.2 17.0 37.5 28.5 12.9 34.4 26.7 24.8 27.4 3.7 16.4 20.2 15.2 15.0 16.5 17.5 21.5 23.3 20.4 14.6 24.5 18.2 2.6 26.3 14.8 15.8 18.8 10.5 39.8 41.1 35.4 44.1 32.4 24.9 23.8 32.2 34.5 32.4 26.8 19.3 22.9 42.7 27.8 22.2 22.7 17.8 24.1 18.2 12.2 35.3 74.5 31.5 33.0 12.5 26.3 16.9 70.0 35.9 53.4 23.6 31.9 16.2 20.2 33.1 35.0 13.8 18.4 16.2 13.7 22.5 16.9 23.6 38.7 16.9 28.4 35.1 14.0 26.5 20.3 21.5 0.0 28.8 30.5 24.8 27.7 135.7 22.4 20.8 41.4 SRRD "HC/HCC, SRR1L" ENSG00000100104 "SRR1 domain containing" Q9UH36 22 26483877-26494658 "Predicted intracellular proteins" "Biological rhythms, Heme biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA002945 Uncertain Approved Cytosol NA NA Cytosol "HPA002945: AB_1079265" "unprognostic (3.25e-1)" "unprognostic (3.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.47e-1)" "unprognostic (1.33e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (9.00e-2)" "unprognostic (8.51e-3)" "unprognostic (2.49e-2)" "unprognostic (4.50e-3)" "unprognostic (3.93e-2)" "unprognostic (2.63e-1)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (1.76e-3)" "unprognostic (2.96e-1)" 8.7 7.2 12.5 7.1 14.3 9.6 11.3 20.0 17.2 10.6 10.9 10.4 10.5 6.6 12.7 11.5 9.9 10.3 6.9 16.2 10.5 10.1 11.5 15.7 9.5 11.4 10.5 11.8 13.3 14.9 11.8 10.6 9.4 9.4 12.7 9.6 9.6 13.1 13.7 30.0 10.8 7.8 12.5 9.6 9.7 9.0 13.8 7.5 10.4 18.8 11.4 12.4 10.0 9.1 3.2 1.6 1.4 1.4 2.6 3.8 1.0 7.4 4.5 7.7 7.9 8.0 4.8 4.4 5.3 7.4 10.7 9.9 4.4 3.3 16.5 3.7 6.9 5.4 6.8 11.9 11.0 10.5 8.5 11.8 7.3 3.8 7.0 5.7 16.0 5.7 4.6 9.7 7.6 12.0 7.1 9.2 9.9 11.9 10.5 7.0 6.4 7.1 5.0 4.7 8.2 5.7 16.3 9.6 11.9 7.0 5.4 8.2 5.6 6.1 5.5 13.6 6.7 6.6 6.3 7.1 8.3 27.7 4.7 9.2 6.9 5.6 13.9 5.7 6.6 10.8 0.6 1.4 0.8 2.3 1.4 3.4 3.2 2.8 3.3 1.6 2.4 3.8 3.8 1.4 2.6 1.2 1.2 0.7 1.0 12.5 14.3 20.0 17.2 10.5 10.1 10.5 11.8 9.4 7.5 0.0 5.4 8.2 13.0 26.4 12.7 2.4 15.3 1.4 4.5 1.8 2.0 12.1 8.3 23.7 17.5 7.9 2.9 0.0 42.8 18.5 7.5 9.4 11.5 12.7 12.1 12.7 4.6 9.8 2.4 35.9 6.6 7.3 8.5 5.4 4.3 7.1 37.1 0.0 8.5 15.5 7.8 6.5 6.6 14.4 11.0 27.9 14.0 6.7 5.6 14.8 SSSCA1 p27 ENSG00000173465 "Sjogren syndrome/scleroderma autoantigen 1" O60232 11 65570430-65573942 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039789, HPA064670" Uncertain Approved Cytosol NA NA Cytosol "HPA039789: AB_2676680, HPA064670: AB_2732718" "unprognostic (9.32e-2)" "unprognostic (3.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.35e-3)" "unprognostic (3.03e-2)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (1.36e-2)" "unprognostic (1.20e-1)" "unprognostic (3.11e-1)" "unprognostic (5.75e-2)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (5.86e-2)" "unprognostic (9.34e-2)" 17.6 21.6 20.0 24.6 23.3 34.0 17.9 19.9 39.1 16.6 22.2 15.2 14.6 18.7 23.1 15.4 23.2 19.9 20.9 28.4 19.5 13.8 20.5 40.4 18.1 24.2 15.1 21.7 22.9 50.3 15.7 15.7 21.4 18.7 20.1 7.6 16.8 36.6 20.8 70.5 19.5 17.0 16.9 10.6 20.9 18.7 44.1 12.0 27.6 17.7 25.0 19.6 21.6 16.6 39.6 35.7 10.6 26.9 32.8 29.3 21.2 26.3 20.9 12.6 22.7 7.3 6.3 21.3 18.2 10.5 17.1 12.0 20.6 26.6 25.6 32.8 9.0 12.4 22.1 8.9 20.0 5.2 17.8 15.4 22.2 19.4 15.6 11.6 27.0 18.1 10.5 13.2 12.8 12.1 12.6 13.6 23.8 24.9 31.6 9.0 38.0 31.2 23.7 21.3 9.2 39.6 24.8 9.5 45.8 9.8 13.4 25.3 26.5 11.0 27.3 26.6 5.1 36.8 13.5 15.3 30.1 17.6 35.8 22.7 23.6 31.4 21.6 24.3 18.8 27.5 5.7 26.9 10.6 24.6 21.9 25.9 39.6 25.5 25.0 21.6 33.9 29.3 26.1 8.5 32.8 14.2 35.7 27.1 21.2 20.0 23.3 19.9 39.1 19.5 13.8 15.1 21.7 18.7 12.0 14.9 21.5 51.3 60.8 35.6 8.8 40.3 38.2 40.2 17.0 33.2 2.0 73.2 77.9 84.2 103.1 33.5 42.4 23.3 129.2 67.2 44.0 42.9 54.4 53.9 51.7 20.6 48.1 26.4 27.0 57.4 32.5 27.7 50.6 76.7 29.8 21.7 84.0 31.6 24.8 101.2 13.2 12.9 39.9 77.2 51.3 35.1 66.8 38.8 29.9 66.5 SSTR2 ENSG00000180616 "Somatostatin receptor 2" P30874 17 73165012-73176633 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 49.1;Intestinal endocrine cells: 34.5;Sertoli cells: 32.3;Smooth muscle cells: 97.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007264 Uncertain Supported Cytosol NA NA Cytosol "HPA007264: AB_1080053" "unprognostic (2.13e-3)" "unprognostic (2.61e-3)" "unprognostic (7.43e-2)" "unprognostic (9.37e-3)" "unprognostic (6.25e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-3)" "unprognostic (7.46e-2)" "unprognostic (2.96e-1)" "unprognostic (6.55e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.04e-7)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (3.71e-3)" "unprognostic (2.95e-2)" 4.5 7.4 6.1 2.3 15.8 2.5 4.2 23.1 26.6 1.4 2.2 0.5 0.6 3.3 1.9 4.1 1.5 2.3 1.8 2.2 9.3 5.3 13.6 3.3 1.4 2.7 2.6 13.1 1.5 2.0 1.4 5.7 1.0 4.9 2.8 2.7 1.1 1.8 3.6 1.7 1.9 2.5 2.2 3.3 8.3 7.2 1.4 1.9 0.3 2.3 0.0 2.9 2.0 1.9 1.4 1.0 4.7 0.9 0.9 1.0 0.3 0.3 0.5 0.6 1.2 0.2 0.2 0.7 0.2 0.3 0.5 0.5 0.5 0.5 0.7 0.3 0.1 1.4 0.5 0.1 0.1 0.2 0.6 1.0 0.6 1.1 0.5 0.1 0.4 2.3 0.2 0.1 0.2 0.1 0.3 0.0 0.7 0.7 1.2 0.2 0.6 0.4 1.3 1.6 0.2 0.6 0.7 0.9 0.4 0.4 0.6 17.2 1.5 0.3 0.3 0.2 1.0 2.2 0.3 0.3 0.4 2.2 0.6 0.3 0.8 0.4 1.6 0.3 1.8 0.4 3.8 0.9 1.2 1.0 0.7 0.8 0.8 0.8 0.8 0.3 1.4 0.8 0.9 4.7 0.9 0.8 1.0 0.5 0.3 6.1 15.8 23.1 22.1 9.3 5.3 2.6 13.1 4.9 1.9 6.0 2.4 0.0 3.0 1.0 49.1 2.6 0.0 1.4 2.3 1.8 3.9 0.4 0.0 0.0 7.0 4.0 0.0 0.0 0.0 0.3 2.2 3.0 2.3 0.8 1.1 6.4 34.5 3.7 1.0 3.0 0.9 2.6 5.0 1.8 7.2 1.7 0.6 0.0 0.7 17.4 3.9 32.3 97.1 0.7 1.9 1.0 0.8 1.5 0.4 3.1 ST13 "FAM10A1, HIP, HSPABP1, P48, SNC6" ENSG00000100380 "ST13, Hsp70 interacting protein" P50502 22 40824535-40857022 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043233, HPA046412, HPA047114, HPA047116" Enhanced Enhanced Cytosol NA NA Cytosol "HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.69e-2)" "unprognostic (7.15e-2)" "unprognostic (2.68e-2)" "prognostic unfavorable (5.23e-4)" "unprognostic (2.73e-3)" "unprognostic (1.74e-2)" "unprognostic (3.63e-1)" "unprognostic (2.50e-1)" "unprognostic (1.00e-1)" "unprognostic (9.54e-2)" "prognostic favorable (3.10e-4)" "unprognostic (8.41e-2)" "unprognostic (3.93e-2)" "unprognostic (3.04e-1)" "unprognostic (8.40e-2)" 43.0 46.0 36.8 26.2 32.0 20.9 39.9 32.2 35.3 45.0 36.4 41.3 33.0 23.9 57.1 37.9 32.9 46.5 32.7 44.0 33.8 33.6 63.2 72.0 23.7 25.0 40.8 28.8 141.6 31.8 38.6 38.1 35.9 36.6 45.1 27.6 30.4 34.8 37.8 75.3 28.3 25.9 42.4 52.0 25.6 31.9 29.3 40.5 38.7 50.3 38.5 30.2 49.4 76.7 41.3 29.4 23.3 36.6 28.2 62.1 39.0 45.8 37.0 56.0 48.8 52.1 80.9 51.0 43.5 55.7 54.0 47.3 66.5 27.5 66.2 37.7 43.5 49.0 33.6 73.6 42.6 64.3 42.2 47.0 47.5 74.3 75.3 47.5 68.6 38.5 71.9 45.2 48.7 33.1 68.2 55.6 41.5 56.7 29.0 51.5 34.4 60.1 32.7 31.8 55.9 24.5 69.4 47.8 52.1 54.8 69.6 18.6 18.9 50.3 40.5 62.2 67.4 39.2 43.4 41.8 45.2 44.1 37.9 35.2 33.5 65.9 62.1 61.9 32.2 43.5 23.3 21.4 22.5 24.9 29.3 37.8 41.3 39.1 29.6 29.4 36.6 62.1 46.7 7.4 28.2 36.6 20.7 32.7 39.0 36.8 32.0 32.2 33.8 33.8 33.6 40.8 28.8 36.6 40.5 131.0 179.9 243.5 322.7 276.8 89.2 128.6 326.1 322.5 245.7 162.3 15.7 330.2 477.5 243.9 414.3 227.7 216.0 163.5 179.4 326.2 254.0 270.9 201.1 499.1 287.6 36.5 251.4 181.1 216.6 710.5 472.6 248.9 200.8 355.3 224.0 239.1 201.5 178.5 388.6 803.1 51.8 219.9 251.3 314.7 140.1 239.9 418.9 181.1 280.9 275.1 STAB2 "DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2" ENSG00000136011 "Stabilin 2" Q8WWQ8 12 103587273-103766727 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 71.3" "Cell type enriched" "Detected in some" 10 "Ito cells: 196.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 16.1;HaCaT: 4.4;RH-30: 2.5" "Not detected" "Not detected" "HPA026871, HPA072699" Enhanced Supported Cytosol NA NA 210000 Cytosol "HPA026871: AB_1857536, HPA072699: " "unprognostic (5.66e-3)" "unprognostic (7.51e-2)" "unprognostic (3.31e-1)" "unprognostic (3.84e-2)" "unprognostic (8.47e-2)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (5.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.05e-1)" "unprognostic (9.72e-4)" "unprognostic (1.37e-2)" "unprognostic (5.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.06e-1)" 0.6 0.2 0.1 0.5 0.1 0.4 0.5 0.1 0.1 0.7 1.4 0.1 0.1 0.1 1.1 1.1 2.5 0.9 0.6 0.4 0.1 0.1 0.1 11.7 0.5 19.9 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.2 0.5 0.2 0.1 2.1 0.3 0.1 0.2 0.3 0.2 0.1 71.3 0.3 1.5 0.1 0.2 0.7 0.5 0.4 0.3 0.4 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.8 0.2 0.0 0.0 16.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 4.4 0.0 0.0 0.0 0.0 1.1 0.4 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 0.5 0.1 2.5 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.1 0.9 0.3 0.1 0.6 0.8 0.4 0.0 1.1 0.2 0.2 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.1 0.0 0.0 196.4 19.9 9.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 STARD10 "CGI-52, NY-CO-28, PCTP2, SDCCAG28" ENSG00000214530 "StAR related lipid transfer domain containing 10" Q9Y365 11 72754729-72794168 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 130.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 585.1;Late spermatids: 1716.5;Mucus-secreting cells: 590.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 75.1;OE19: 160.9;SK-BR-3: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026661 Uncertain Supported Cytosol NA NA Cytosol "HPA026661: AB_1857538" "prognostic favorable (6.92e-4)" "unprognostic (2.07e-1)" "unprognostic (8.03e-2)" "unprognostic (1.74e-3)" "unprognostic (3.71e-2)" "unprognostic (1.37e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "unprognostic (4.16e-1)" "unprognostic (4.69e-2)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (4.24e-3)" "unprognostic (8.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.12e-2)" "unprognostic (1.04e-1)" 4.5 34.0 11.3 6.8 16.0 2.0 16.0 17.6 15.9 18.6 42.8 5.5 16.6 11.5 6.5 26.2 10.9 6.2 28.7 15.5 10.3 6.8 11.1 130.6 10.0 3.1 10.6 5.4 8.2 47.3 16.4 9.5 22.6 10.1 17.6 46.0 9.1 21.7 12.1 15.0 12.7 15.0 6.7 4.4 4.6 47.4 40.0 14.8 3.3 21.3 12.0 9.3 7.8 10.2 2.9 2.0 15.8 1.8 5.6 1.3 0.6 6.1 1.9 0.9 3.6 1.2 1.2 12.4 0.6 3.2 2.2 2.2 25.9 4.5 0.5 2.1 2.3 5.3 3.9 2.9 5.8 2.5 3.4 1.1 0.7 1.3 26.4 4.5 0.1 1.1 0.8 16.1 2.4 3.4 6.0 2.2 1.2 1.4 2.7 0.4 75.1 0.5 1.3 0.4 160.9 2.5 0.5 1.6 0.4 2.9 7.5 1.6 1.2 1.0 53.7 7.6 4.3 29.6 0.7 1.6 2.2 1.4 0.7 1.2 2.7 2.2 0.9 0.5 0.7 0.7 7.9 1.8 11.4 1.2 0.9 1.0 2.9 1.1 1.3 0.8 2.3 1.1 1.3 15.8 5.6 0.4 2.0 1.2 0.6 11.3 16.0 17.6 15.9 10.3 6.8 10.6 5.4 10.1 14.8 32.8 67.8 18.8 64.0 27.9 9.3 39.6 239.5 24.1 33.0 52.4 21.6 163.2 104.5 65.2 406.8 12.9 92.8 0.0 83.1 75.5 15.7 146.3 25.3 585.1 23.0 31.8 290.1 26.4 19.3 1716.5 24.2 11.8 15.1 1.0 590.8 39.3 80.3 364.7 23.7 47.4 15.5 6.5 15.6 61.3 15.6 48.1 294.5 10.7 374.8 96.0 STAT5B ENSG00000173757 "Signal transducer and activator of transcription 5B" P51692 17 42199168-42276707 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 85.5;Late spermatids: 113.5;Peritubular cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004298, CAB005418, HPA042128, HPA049883, HPA051156" Approved Approved Cytosol NA NA 170000 Cytosol "CAB004298: AB_2197067, CAB005418: AB_632445, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366" "unprognostic (1.49e-1)" "unprognostic (3.60e-2)" "unprognostic (4.06e-2)" "prognostic favorable (9.37e-4)" "unprognostic (2.68e-1)" "unprognostic (4.29e-1)" "unprognostic (2.23e-1)" "unprognostic (1.03e-1)" "unprognostic (3.06e-2)" "unprognostic (7.98e-2)" "prognostic favorable (1.63e-4)" "unprognostic (1.36e-1)" "prognostic favorable (2.39e-5)" "unprognostic (9.19e-2)" "unprognostic (2.95e-1)" "unprognostic (1.54e-1)" "unprognostic (2.13e-1)" 25.7 24.0 13.5 19.5 16.3 21.8 26.2 32.1 15.9 21.6 21.0 13.7 16.3 8.6 31.9 12.0 11.6 24.5 18.1 12.8 11.9 20.1 12.4 13.5 15.8 24.6 16.0 13.9 34.4 12.1 12.0 22.6 55.4 17.2 20.8 10.3 16.4 12.9 21.7 38.3 12.2 14.8 33.1 10.6 22.1 14.4 13.2 15.7 21.7 15.4 9.6 19.8 21.5 33.1 2.5 2.4 18.8 2.8 3.5 8.3 3.8 5.3 8.4 12.5 3.3 15.6 7.9 6.0 5.5 9.8 7.9 6.9 3.6 4.5 17.4 8.3 6.3 15.7 6.9 7.4 4.8 6.3 43.9 8.6 17.0 15.8 5.6 8.6 7.5 27.5 9.7 7.4 5.9 7.6 6.8 12.5 11.8 30.6 3.8 3.2 5.2 35.1 19.7 3.1 12.4 0.0 15.1 7.8 6.0 5.0 8.6 9.2 5.4 10.1 12.9 7.7 2.9 9.1 8.8 9.5 11.1 3.9 5.7 7.6 7.5 3.4 8.7 4.4 7.9 5.7 8.8 2.8 4.6 5.9 2.5 6.4 2.5 8.3 6.7 2.4 2.5 5.9 5.0 18.8 3.5 2.8 1.8 6.9 3.8 13.5 16.3 32.1 15.9 11.9 20.1 16.0 13.9 17.2 15.7 6.0 17.9 3.7 4.7 7.9 18.0 17.3 10.2 5.3 9.1 3.5 19.6 5.9 5.0 7.2 85.5 23.3 6.2 23.3 10.1 5.7 10.8 8.0 15.1 10.2 8.1 9.5 9.8 16.0 14.2 113.5 43.7 11.1 10.1 10.0 7.2 8.4 10.7 7.8 70.0 8.1 13.8 38.8 22.8 4.2 4.1 8.5 10.6 24.5 7.5 5.4 STAU1 "PPP1R150, STAU" ENSG00000124214 "Staufen double-stranded RNA binding protein 1" O95793 20 49113339-49188367 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020839, HPA049892, HPA072004" Approved Enhanced Cytosol NA NA Cytosol "CAB020839: , HPA049892: AB_2680938, HPA072004: " "unprognostic (7.73e-2)" "unprognostic (1.38e-1)" "unprognostic (1.97e-1)" "unprognostic (1.01e-2)" "unprognostic (7.97e-2)" "unprognostic (9.56e-2)" "unprognostic (3.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-1)" "unprognostic (9.17e-3)" "prognostic unfavorable (4.41e-4)" "unprognostic (1.42e-2)" "unprognostic (2.73e-1)" "unprognostic (8.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-2)" 30.8 34.2 33.3 32.6 30.8 34.9 59.4 28.7 38.3 28.7 35.7 31.4 24.3 34.3 34.1 25.2 31.1 43.2 31.2 37.4 30.0 27.1 55.7 77.1 30.9 26.9 33.9 28.8 31.2 44.4 58.1 20.9 31.1 39.7 30.9 30.7 26.0 31.3 31.5 51.0 30.1 38.8 34.8 45.4 25.3 33.1 28.6 28.8 39.1 48.6 20.6 28.6 45.6 36.7 14.0 13.1 29.9 15.0 11.1 17.4 9.9 26.3 20.2 22.1 9.7 22.4 27.9 24.5 20.1 24.2 60.3 27.4 68.8 29.2 18.0 34.8 25.1 28.9 29.1 29.4 35.9 50.8 7.0 16.9 14.8 15.7 54.7 19.0 11.9 14.6 22.3 31.0 24.4 28.8 24.8 29.5 13.7 25.7 11.3 22.7 16.8 20.8 19.9 18.0 25.6 28.3 16.1 29.0 17.4 24.7 23.3 25.6 22.8 50.0 48.2 29.1 23.4 30.7 17.2 26.8 36.5 31.7 22.5 23.8 10.2 11.8 20.6 26.7 12.9 21.0 19.6 15.0 14.6 14.9 12.5 16.7 14.0 16.0 15.8 13.1 13.0 14.8 13.9 29.9 11.1 14.5 12.5 17.4 9.9 33.3 30.8 28.7 38.3 30.0 27.1 33.9 28.8 39.7 28.8 83.4 74.3 59.5 85.0 99.9 31.2 58.2 71.4 119.1 60.3 73.3 13.7 88.9 79.6 112.4 15.6 81.5 80.0 23.3 102.6 32.3 76.6 153.5 46.2 138.4 56.5 41.3 72.9 65.7 53.9 17.1 60.7 63.2 47.2 82.0 66.4 57.6 115.7 64.2 65.7 143.6 25.4 58.2 69.3 110.2 58.0 104.6 162.6 48.0 59.0 164.2 STIMATE "MGC52022, TMEM110" ENSG00000213533 "STIM activating enhancer" Q86TL2 3 52836219-52897596 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 17.4;Collecting duct cells: 7.0;Hofbauer cells: 8.1;Proximal tubular cells: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA051855 Uncertain Approved Cytosol NA NA Cytosol "HPA051855: AB_2681639" "unprognostic (1.45e-1)" "unprognostic (7.93e-3)" "unprognostic (2.19e-1)" "unprognostic (2.49e-2)" "unprognostic (2.29e-3)" "unprognostic (3.87e-2)" "unprognostic (9.31e-2)" "unprognostic (7.55e-4)" "unprognostic (3.34e-1)" "unprognostic (6.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.33e-2)" "unprognostic (1.00e-1)" "unprognostic (1.76e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" 12.0 13.0 8.9 12.0 13.9 26.4 12.8 11.6 16.1 12.5 10.7 17.8 8.8 7.8 14.4 7.9 9.2 17.7 9.6 8.3 9.5 6.7 9.9 34.7 15.2 18.1 9.9 8.1 12.2 19.2 7.7 8.9 7.8 13.0 10.2 6.7 13.0 12.8 11.5 17.9 10.5 10.1 16.5 10.2 14.9 11.2 8.4 9.5 18.0 11.8 6.8 13.2 12.5 12.5 1.7 4.0 1.7 5.8 0.7 4.6 1.4 6.8 6.0 9.2 15.9 20.9 13.3 18.5 10.1 11.3 13.7 12.6 7.3 7.2 6.7 2.0 11.5 13.1 6.5 10.8 9.8 9.6 14.9 8.3 10.9 7.6 11.4 14.0 16.4 8.4 10.5 13.6 15.3 6.9 8.6 11.1 10.9 3.8 6.7 11.4 5.6 8.9 9.2 8.3 5.6 12.3 4.9 7.1 4.5 6.4 8.9 2.0 6.8 10.2 7.0 9.5 5.4 5.9 14.3 11.2 10.9 6.4 14.3 12.0 13.1 8.4 6.3 9.5 16.5 8.3 0.0 3.3 1.7 2.2 5.8 1.8 1.7 3.5 2.4 4.0 1.5 1.9 1.4 0.3 0.7 5.5 2.3 4.6 1.4 8.9 13.9 11.6 16.1 9.5 6.7 9.9 8.1 13.0 9.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 17.4 1.2 7.0 0.0 1.5 1.7 2.1 0.0 0.0 0.0 0.0 2.5 5.3 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 2.7 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 STK36 "FU, KIAA1278" ENSG00000163482 "Serine/threonine kinase 36" Q9NRP7 2 218672026-218702716 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 20.1;Cone photoreceptor cells: 35.3;Spermatocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027409, HPA027453, HPA030058" Approved Supported Cytosol NA NA Cytosol "HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225" "unprognostic (8.11e-2)" "unprognostic (3.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (5.20e-4)" "unprognostic (1.55e-1)" "unprognostic (5.83e-3)" "unprognostic (9.04e-2)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.52e-3)" "unprognostic (1.46e-1)" "unprognostic (2.60e-2)" "unprognostic (1.77e-1)" "unprognostic (1.99e-3)" 4.8 10.0 7.5 4.7 11.4 2.0 6.4 7.9 11.1 9.1 7.4 7.0 11.9 4.1 14.4 13.3 5.0 13.9 9.8 3.3 6.3 3.5 10.1 4.4 6.9 3.9 2.3 6.6 13.6 9.7 12.3 23.2 3.9 7.6 9.5 6.3 9.3 7.3 8.3 3.3 4.6 5.8 7.8 5.5 4.9 7.9 63.2 4.2 3.5 11.4 3.7 5.0 9.3 7.1 1.8 1.6 3.2 1.9 2.2 1.6 1.7 2.5 5.8 12.8 10.9 14.0 10.9 7.9 7.0 5.6 8.9 8.4 7.6 4.2 3.4 9.8 7.3 6.0 5.2 8.8 7.3 7.9 1.4 7.3 3.3 17.6 10.5 6.8 4.6 5.6 11.7 5.5 8.7 6.2 23.8 6.7 4.5 7.6 4.3 7.4 5.9 2.7 5.8 7.7 3.2 3.7 5.1 5.5 3.4 10.9 12.9 10.4 8.9 5.4 8.9 3.6 13.9 9.0 3.8 6.3 12.4 4.6 4.7 4.7 5.5 4.2 1.8 7.7 2.2 5.1 0.0 1.9 3.2 1.5 1.2 0.9 1.8 1.1 1.3 1.6 0.6 1.1 1.6 0.2 2.2 1.4 1.3 1.0 1.7 7.5 11.4 7.9 11.1 6.3 3.5 2.3 6.6 7.6 4.2 8.9 4.6 1.7 1.0 1.0 7.7 2.8 5.1 20.1 1.2 3.5 35.3 1.4 0.0 2.9 11.3 2.1 2.0 0.0 2.2 1.3 1.8 1.3 1.1 4.9 2.3 1.6 2.4 4.3 2.8 4.1 5.5 1.2 0.0 1.0 4.4 5.6 1.9 3.7 4.6 3.3 9.8 6.5 2.1 26.8 8.2 0.9 0.7 1.5 3.8 0.4 STK38 NDR ENSG00000112079 "Serine/threonine kinase 38" Q15208 6 36493892-36547470 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004673, HPA038623, HPA051324" Uncertain Approved Cytosol NA NA Cytosol "CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442" "unprognostic (3.58e-3)" "unprognostic (1.80e-2)" "unprognostic (3.07e-2)" "unprognostic (6.76e-3)" "unprognostic (8.25e-2)" "unprognostic (1.47e-2)" "unprognostic (2.88e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (1.98e-2)" "unprognostic (3.80e-1)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (3.13e-3)" 19.1 8.4 12.4 39.8 10.0 19.4 32.8 18.8 12.7 16.0 26.3 7.8 14.9 17.0 18.8 16.4 28.1 14.6 18.3 15.3 12.1 7.0 15.0 17.3 21.7 45.9 11.9 6.4 12.3 9.5 7.8 11.0 15.4 9.0 17.0 27.1 11.3 24.8 18.7 14.9 21.8 29.1 28.1 13.1 25.1 16.4 24.4 11.0 34.3 10.6 13.4 28.5 22.4 19.8 10.6 13.1 33.2 30.5 25.8 27.6 22.4 17.8 13.2 14.0 15.1 28.3 21.6 12.2 20.0 16.2 20.8 21.0 10.1 12.3 24.1 15.5 29.7 17.3 19.2 11.6 8.3 24.6 9.8 9.9 17.2 17.2 9.1 14.0 6.5 9.5 14.2 21.9 16.1 10.4 24.0 13.0 12.3 14.0 14.1 29.6 10.7 10.5 17.0 5.8 21.3 11.8 40.8 17.0 6.4 19.7 22.5 16.4 7.8 24.3 11.2 14.0 16.4 12.0 17.2 12.5 16.9 15.0 13.5 12.9 11.8 21.0 17.0 3.8 25.4 16.3 33.2 19.8 15.0 27.6 22.6 21.5 10.6 22.9 24.1 13.1 8.1 20.5 22.3 27.1 25.8 30.5 6.6 21.4 22.4 12.4 10.0 18.8 12.7 12.1 7.0 11.9 6.4 9.0 11.0 17.9 16.5 10.8 8.5 11.9 2.5 15.1 22.9 37.5 50.0 7.0 0.0 11.8 1.7 16.1 5.8 12.4 32.4 0.0 11.2 15.4 19.9 11.5 12.7 13.6 11.7 4.8 13.8 11.1 28.5 4.1 25.0 31.7 16.9 9.0 22.9 6.1 19.6 25.9 28.3 13.6 8.5 12.9 13.7 23.6 9.6 18.4 12.8 23.6 22.1 22.5 STK38L "KIAA0965, NDR2" ENSG00000211455 "Serine/threonine kinase 38 like" Q9Y2H1 12 27243968-27325959 "Enzymes, Predicted intracellular proteins" "Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 19.3;granulocytes: 32.2;monocytes: 13.0" "Cell line enhanced" "Detected in all" "HDLM-2: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038623, HPA051324" Approved Approved Cytosol NA NA Cytosol "HPA038623: AB_10967059, HPA051324: AB_2681442" "unprognostic (2.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.94e-2)" "unprognostic (2.43e-2)" "unprognostic (2.02e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-2)" "unprognostic (4.68e-2)" "unprognostic (5.56e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (5.82e-4)" "unprognostic (1.16e-1)" "unprognostic (3.41e-2)" "unprognostic (1.09e-1)" "unprognostic (1.95e-1)" "unprognostic (5.05e-2)" "unprognostic (1.05e-2)" 21.2 8.4 11.0 14.6 10.9 10.9 27.2 9.6 14.6 13.0 26.3 5.7 9.7 8.4 23.9 18.2 16.8 14.8 18.2 30.2 10.9 7.8 8.9 8.5 10.8 7.8 11.1 11.8 9.6 8.9 30.2 15.2 10.6 11.9 15.3 15.0 6.8 14.0 10.9 9.1 10.8 14.6 52.3 17.0 7.6 15.6 7.5 10.1 10.0 8.8 10.5 9.8 21.9 22.7 4.5 19.3 32.2 13.0 4.0 4.0 5.3 4.2 5.8 15.1 6.7 6.9 4.7 11.2 2.7 4.0 1.7 2.5 7.3 3.2 9.9 6.5 2.4 5.2 7.9 6.8 4.7 2.7 57.8 5.6 6.1 7.0 3.6 5.8 15.0 7.1 5.7 4.9 6.4 8.2 11.2 13.9 12.8 7.4 7.8 3.5 3.0 9.8 16.3 17.9 11.2 8.8 3.7 17.6 7.6 2.5 8.1 2.4 8.1 12.2 7.5 4.7 15.4 3.7 5.1 5.4 6.0 5.3 8.6 7.4 2.8 2.8 10.4 3.0 7.0 2.4 6.0 13.0 22.9 4.0 11.1 2.8 4.5 3.1 3.9 19.3 3.4 3.8 3.1 32.2 4.0 8.1 8.2 4.0 5.3 11.0 10.9 9.6 14.6 10.9 7.8 11.1 11.8 11.9 10.1 17.9 14.4 9.8 27.4 31.5 11.3 44.5 10.2 9.4 20.5 8.7 2.0 10.0 8.3 41.2 13.6 21.5 19.7 0.0 35.8 7.9 16.0 21.3 16.3 13.0 27.6 9.5 18.5 18.4 33.1 2.3 6.1 48.1 20.3 45.1 27.7 7.5 51.1 31.7 11.3 10.5 6.4 19.4 50.7 6.5 12.1 28.0 23.2 12.5 20.5 39.1 STMN1 "C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN" ENSG00000117632 "Stathmin 1" P16949 1 25884181-25906991 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 143.4;lymphoid tissue: 117.1" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 782.4;Late spermatids: 1640.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 79.3" "Group enriched" "Detected in all" 5 "dendritic cells: 79.3;T-cells: 26.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010107, HPA068438" Enhanced Approved Cytosol NA NA 210000 Cytosol "CAB010107: AB_628297, HPA068438: " "unprognostic (6.30e-2)" "unprognostic (2.40e-3)" "unprognostic (5.31e-2)" "unprognostic (7.94e-2)" "unprognostic (1.89e-1)" "unprognostic (5.02e-2)" "prognostic unfavorable (9.90e-7)" "unprognostic (9.45e-2)" "unprognostic (1.39e-2)" "unprognostic (1.61e-2)" "unprognostic (1.78e-1)" "unprognostic (3.33e-3)" "unprognostic (1.02e-2)" "unprognostic (1.68e-1)" "unprognostic (4.46e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-2)" 7.3 13.2 91.7 17.5 47.4 40.7 10.9 54.1 124.8 6.2 16.7 47.0 2.5 12.7 24.7 7.8 13.0 7.3 9.4 9.5 67.9 88.4 13.2 6.4 11.0 42.8 86.5 58.0 33.6 3.5 4.6 12.1 21.7 43.4 5.2 20.7 7.7 5.3 6.3 3.8 9.5 15.9 18.8 143.4 10.9 9.7 58.2 27.1 117.1 6.1 7.2 43.1 13.0 8.1 8.6 79.3 4.0 1.5 10.1 26.2 9.3 68.4 15.4 153.8 61.4 9.2 8.9 15.6 53.4 42.4 76.4 73.9 10.6 70.4 84.3 30.0 38.9 29.9 20.9 42.6 30.9 114.9 25.5 21.1 52.2 27.3 36.8 3.7 65.7 37.4 5.4 4.5 30.8 35.1 28.6 57.4 109.3 70.5 84.1 98.9 17.8 216.1 96.6 94.3 41.6 20.7 127.9 119.9 50.0 36.9 6.1 104.3 90.5 48.5 24.3 42.6 51.3 34.9 83.8 27.6 51.3 60.9 44.4 44.5 49.6 78.7 104.6 25.3 128.5 55.2 2.0 0.7 4.0 10.4 1.5 6.3 6.4 9.3 13.1 4.2 8.6 15.3 13.7 0.3 10.1 0.7 79.3 26.2 9.3 91.7 47.4 54.1 124.8 67.9 88.4 86.5 58.0 43.4 27.1 38.7 43.0 57.6 148.3 179.2 299.1 70.0 30.6 60.2 76.2 165.7 60.9 218.8 192.3 136.4 782.4 74.2 13.5 140.2 17.6 493.5 139.8 37.1 251.1 7.8 436.3 184.3 240.7 76.1 70.3 1640.5 41.4 141.8 254.8 48.7 70.1 201.0 61.7 45.6 44.2 144.1 147.2 38.8 101.9 532.9 205.4 79.0 109.0 151.0 130.1 26.3 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978923-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol NA NA Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.1 10.2 19.2 6.2 18.8 4.2 8.1 7.8 35.3 7.7 6.9 8.3 3.1 5.9 4.6 6.0 7.0 6.2 9.1 14.4 19.0 18.0 4.5 6.1 6.9 8.7 13.4 14.3 9.0 9.9 6.8 8.5 7.9 10.2 7.0 3.7 4.0 7.7 9.7 13.2 7.3 6.5 7.7 12.3 6.3 7.9 6.7 5.9 6.2 10.4 3.6 5.6 6.2 4.4 6.1 11.0 2.2 15.5 6.8 9.4 5.3 3.6 7.0 4.2 5.8 8.6 5.5 3.6 12.0 4.7 6.5 5.5 2.0 20.6 3.7 19.0 9.7 4.9 12.4 4.0 8.4 2.0 12.4 4.4 3.8 5.9 2.3 8.5 2.5 3.1 9.7 6.6 10.3 9.8 5.4 6.1 8.6 9.2 7.2 9.4 5.6 4.7 1.8 2.0 5.7 5.6 2.8 4.3 5.6 13.9 4.1 8.1 5.2 5.4 7.2 7.6 2.8 6.0 2.8 9.3 15.1 4.9 17.2 16.0 7.3 3.5 1.9 13.9 7.8 7.6 0.7 4.0 2.2 5.3 7.0 4.4 4.3 4.4 7.0 6.2 6.1 8.9 9.4 2.0 6.8 15.5 11.0 7.4 5.3 19.2 18.8 7.8 35.3 19.0 18.0 13.4 14.3 10.2 5.9 0.0 2.6 9.5 3.4 2.9 12.3 9.3 2.5 1.4 4.5 7.0 5.9 11.2 1.7 20.5 0.6 7.1 8.0 0.0 16.7 8.1 11.2 5.0 4.6 3.9 9.0 15.9 9.8 4.9 1.8 1.8 8.3 2.3 3.3 2.8 5.7 12.2 17.8 3.6 11.0 5.3 13.7 6.5 5.8 21.9 4.1 1.8 4.7 2.9 5.0 2.0 STRAP "MAWD, pt-wd, UNRIP" ENSG00000023734 "Serine/threonine kinase receptor associated protein" Q9Y3F4 12 15882391-15903478 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027320, HPA055557, HPA073876" Approved Enhanced Cytosol NA NA 290000 Cytosol "HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639" "unprognostic (4.64e-3)" "unprognostic (2.25e-2)" "unprognostic (9.88e-2)" "unprognostic (1.42e-2)" "unprognostic (2.88e-1)" "unprognostic (4.05e-3)" "prognostic unfavorable (6.83e-6)" "unprognostic (1.69e-2)" "unprognostic (3.71e-1)" "unprognostic (2.15e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-1)" "unprognostic (3.60e-3)" "unprognostic (5.93e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (9.07e-4)" "prognostic unfavorable (5.10e-4)" 36.7 39.8 43.5 28.1 43.2 24.1 46.4 38.1 55.3 30.5 29.4 19.3 29.2 24.7 31.8 29.1 33.7 24.7 25.8 54.0 55.7 44.9 46.4 42.9 27.7 30.4 35.8 48.3 25.5 38.7 40.4 36.7 34.4 47.1 27.8 29.5 20.5 26.0 32.2 109.2 25.3 23.6 37.4 51.5 20.7 28.9 32.9 27.5 27.9 42.6 36.6 29.4 28.6 29.8 36.9 44.6 30.8 41.8 29.2 43.4 38.5 32.4 38.2 36.5 31.1 32.4 32.4 48.8 39.0 27.2 35.2 32.9 54.7 28.7 36.2 19.4 39.6 34.4 23.6 43.6 42.8 52.0 48.3 35.4 36.6 30.4 23.9 53.2 42.4 17.8 31.2 36.5 38.8 43.7 38.9 40.9 23.8 28.0 11.1 45.7 22.6 35.2 20.3 129.0 20.9 25.1 27.2 50.3 20.8 40.7 33.5 23.6 40.1 31.4 21.7 42.5 76.0 40.6 22.8 34.2 26.4 31.3 27.9 47.8 12.7 17.2 59.4 32.4 23.6 33.2 26.8 36.7 30.8 34.6 41.8 38.9 36.9 36.0 33.3 44.6 30.8 35.4 37.3 17.0 29.2 35.9 27.4 43.4 38.5 43.5 43.2 38.1 55.3 55.7 44.9 35.8 48.3 47.1 27.5 35.7 36.8 74.9 140.3 216.3 84.6 96.8 40.8 44.2 42.1 62.8 33.4 132.9 233.8 149.7 27.7 77.1 37.6 46.7 119.4 167.9 122.0 110.6 46.1 73.0 98.2 57.2 101.9 64.4 87.9 61.5 64.7 73.5 121.4 105.6 50.2 130.3 114.5 67.4 95.8 178.6 74.9 77.6 196.1 150.4 65.6 199.2 246.8 82.2 78.1 179.1 STRIP1 "FAM40A, FAR11A, FLJ14743, KIAA1761" ENSG00000143093 "Striatin interacting protein 1" Q5VSL9 1 110031577-110074641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060302, HPA060498" Approved Supported Cytosol NA NA Cytosol "HPA060302: AB_2684247, HPA060498: AB_2684293" "unprognostic (2.75e-2)" "unprognostic (3.91e-1)" "unprognostic (2.81e-2)" "unprognostic (1.63e-1)" "unprognostic (5.09e-1)" "unprognostic (2.90e-2)" "unprognostic (1.01e-2)" "unprognostic (9.08e-2)" "unprognostic (2.83e-1)" "unprognostic (6.29e-2)" "unprognostic (1.41e-3)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (1.82e-1)" "unprognostic (6.23e-2)" "unprognostic (2.23e-2)" 14.7 15.8 25.6 11.8 20.2 21.7 14.1 30.3 30.7 16.6 14.6 19.7 10.1 14.0 21.0 17.8 15.6 17.7 13.0 13.5 22.3 19.0 12.3 10.0 13.7 15.1 17.7 18.1 24.7 15.7 24.8 16.7 21.2 24.5 13.5 15.0 15.3 14.6 16.2 13.6 18.0 19.8 20.1 11.1 23.8 13.8 21.9 16.4 18.6 14.5 10.9 17.3 16.2 15.2 13.0 13.5 15.9 15.7 17.3 18.4 13.1 12.3 8.2 22.5 15.2 19.7 13.0 16.3 19.4 17.1 20.4 17.8 8.6 7.2 10.1 10.7 17.2 13.0 11.8 11.9 13.8 14.4 21.4 14.4 16.8 14.6 11.1 10.9 15.1 16.8 13.9 16.6 17.2 19.0 15.1 16.2 14.0 14.9 13.0 19.6 14.6 17.3 16.0 18.1 9.3 11.2 16.9 28.9 8.9 14.2 18.2 29.1 16.7 16.6 21.2 12.5 13.6 10.5 13.8 16.6 15.4 14.8 17.8 12.9 13.3 7.3 10.3 17.6 16.4 22.2 12.2 11.5 15.9 17.7 12.7 15.5 12.8 15.1 18.4 13.5 13.0 17.5 15.5 10.7 17.3 15.7 6.2 13.3 13.1 25.6 20.2 30.3 30.7 22.3 19.0 17.7 18.1 24.5 16.4 3.0 8.5 13.7 9.0 12.2 12.0 6.5 2.5 0.0 6.8 8.7 17.7 13.0 1.7 8.7 38.2 9.8 13.6 0.0 6.2 8.4 10.0 8.6 6.9 8.3 11.3 6.4 14.5 16.0 10.8 33.5 9.2 9.3 3.3 14.4 11.2 5.8 9.5 9.5 9.6 3.1 19.6 6.5 13.3 9.5 9.2 11.2 21.6 13.8 9.8 14.2 STRIP2 "FAM40B, FAR11B, KIAA1170" ENSG00000128578 "Striatin interacting protein 2" Q9ULQ0 7 129434433-129488399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.6;retina: 55.6;skeletal muscle: 27.4" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 37.1;Muller glia cells: 70.1;Spermatocytes: 32.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 36.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "LHCN-M2: 20.8;U-2197: 23.7;U-87 MG: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019657 Approved Approved Cytosol NA NA Cytosol "HPA019657: AB_1848399" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "unprognostic (2.11e-1)" "unprognostic (2.41e-1)" "unprognostic (4.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (6.78e-4)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (8.99e-2)" "unprognostic (1.95e-1)" "unprognostic (2.87e-6)" "prognostic favorable (5.41e-4)" "unprognostic (4.06e-2)" "unprognostic (5.34e-2)" "unprognostic (7.50e-2)" 0.7 2.4 1.9 2.0 36.6 3.7 0.8 7.0 10.0 0.4 0.8 3.0 0.0 0.8 0.8 1.6 1.1 0.4 1.2 10.3 1.5 2.1 5.6 0.6 1.0 2.7 2.2 2.9 0.7 1.3 0.4 4.7 1.3 7.6 1.6 1.4 55.6 1.7 0.5 27.4 1.5 1.0 0.8 1.2 1.5 1.0 13.5 9.4 0.2 0.8 2.1 2.1 0.9 0.3 0.6 0.7 2.5 0.6 0.4 0.9 0.4 7.7 3.4 3.1 4.9 1.2 1.1 13.6 3.2 4.1 5.4 5.3 1.8 4.4 3.3 0.4 1.3 17.7 8.8 3.3 2.9 8.3 19.0 2.8 2.5 5.6 1.9 0.8 1.6 13.3 1.3 1.0 9.2 5.8 9.0 9.3 3.0 10.8 2.1 20.8 0.4 4.1 4.0 3.0 1.7 7.0 2.7 5.8 0.7 2.0 2.9 0.7 0.7 7.4 0.6 1.6 2.5 0.9 3.9 3.3 3.1 3.1 23.7 9.2 1.9 1.2 3.9 21.1 4.1 4.4 2.5 0.6 0.6 0.9 0.4 0.3 0.3 0.6 0.3 0.2 0.6 0.5 0.4 2.0 0.4 0.5 0.7 0.9 0.4 1.9 36.6 7.0 4.8 1.5 2.1 2.2 2.9 7.6 9.4 3.0 0.6 0.0 0.2 0.2 11.0 37.1 0.0 1.4 0.0 0.0 2.0 0.4 0.0 0.8 4.7 0.5 0.0 0.0 3.3 3.4 1.0 0.1 7.0 0.0 0.7 1.6 0.0 0.6 0.0 7.9 0.6 1.3 1.7 13.6 0.0 70.1 3.8 0.0 0.7 9.6 3.5 0.0 0.5 32.7 9.6 0.1 0.2 0.0 0.4 0.6 STRN4 "PPP2R6C, ZIN" ENSG00000090372 "Striatin 4" Q9NRL3 19 46719507-46746994 "Predicted intracellular proteins, Predicted membrane proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043051, HPA043527, HPA056706" Supported Approved Cytosol NA NA 34000 Cytosol "HPA043051: AB_2678290, HPA043527: AB_10959664, HPA056706: AB_2683214" "unprognostic (3.57e-2)" "unprognostic (7.96e-2)" "unprognostic (2.13e-2)" "unprognostic (7.39e-2)" "unprognostic (1.81e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (6.06e-8)" "unprognostic (8.31e-3)" "unprognostic (5.34e-2)" "prognostic unfavorable (2.98e-4)" "unprognostic (1.56e-1)" "unprognostic (9.41e-3)" "unprognostic (4.86e-3)" "unprognostic (6.74e-2)" "unprognostic (4.06e-2)" "unprognostic (6.04e-2)" "unprognostic (1.84e-1)" 21.8 13.7 22.6 17.8 26.6 27.0 18.7 10.5 34.9 15.3 18.0 17.9 17.8 19.0 19.9 12.6 23.8 16.9 17.0 20.7 23.1 13.4 15.8 11.4 17.4 16.2 15.1 21.4 16.9 26.6 12.7 12.3 22.2 11.8 17.3 11.3 15.7 25.2 18.4 16.6 22.0 20.6 18.5 12.8 22.9 20.2 48.8 15.7 15.0 14.6 11.6 15.5 18.4 16.6 3.1 3.3 10.1 9.8 1.5 1.2 5.7 21.3 28.6 25.0 18.5 7.1 8.0 17.6 18.6 10.0 19.3 16.9 21.2 19.1 10.7 11.2 15.2 15.8 15.2 11.8 18.0 7.7 15.4 24.2 23.6 18.8 18.1 23.1 19.1 25.8 12.9 18.1 12.4 17.1 9.8 17.1 12.6 20.5 14.1 8.0 14.5 21.2 50.0 18.9 22.5 13.5 19.5 15.2 8.3 12.9 38.7 31.0 33.2 26.1 24.4 12.2 11.3 18.3 21.5 23.1 14.5 21.8 9.9 27.3 17.9 25.4 15.9 12.6 12.0 30.0 3.1 6.5 2.9 1.2 9.8 0.3 1.7 1.0 0.8 3.3 3.1 0.5 1.1 10.1 1.5 6.0 3.0 0.3 5.7 22.6 26.6 10.5 34.9 23.1 13.4 15.1 21.4 11.8 15.7 3.0 6.9 3.7 8.9 15.2 12.4 9.0 15.3 2.7 5.7 7.0 11.8 12.5 1.7 11.2 8.2 15.1 19.2 0.0 13.2 14.8 11.9 13.2 0.0 11.1 12.7 28.6 16.8 25.2 20.8 16.9 16.4 11.9 10.1 5.4 20.9 7.5 14.7 14.4 18.7 5.9 7.2 6.5 14.1 19.7 37.7 15.2 16.7 6.9 15.7 13.9 STUM "C1orf95, DKFZp761P211" ENSG00000203685 "Stum, mechanosensory transduction mediator homolog" Q69YW2 1 226548800-226609214 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 25.6" "Group enriched" "Detected in many" 5 "amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4" "Low region specificity" "Detected in many" HPA074381 Approved Cytosol NA NA Cytosol "HPA074381: AB_2732253" "unprognostic (3.23e-3)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" "unprognostic (2.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.41e-3)" "unprognostic (3.07e-1)" "unprognostic (5.15e-2)" "unprognostic (7.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.14e-2)" "unprognostic (9.04e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-3)" 2.8 2.2 30.4 2.1 16.2 0.6 3.5 2.4 32.2 3.7 8.1 6.3 0.0 2.8 3.7 3.0 8.9 3.1 1.6 2.5 21.8 7.0 5.8 0.7 1.2 0.9 6.8 15.9 2.7 1.0 1.9 4.2 1.2 18.2 6.2 3.7 1.4 2.0 2.4 5.0 3.7 3.5 8.7 3.0 1.8 1.8 2.0 7.4 0.0 0.8 0.4 1.0 5.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 4.2 0.3 25.6 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.3 0.2 0.0 3.9 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 16.2 2.4 30.0 21.8 7.0 6.8 15.9 18.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 STXBP2 "Hunc18b, UNC18B" ENSG00000076944 "Syntaxin binding protein 2" Q15833 19 7636881-7647873 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.5;lymphoid tissue: 101.5" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 332.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 25.5;classical monocyte: 58.1;eosinophil: 35.5;intermediate monocyte: 73.1;myeloid DC: 30.2;neutrophil: 45.6;non-classical monocyte: 101.5" "Group enriched" "Detected in all" 6 "dendritic cells: 30.2;granulocytes: 45.6;monocytes: 101.5" "Cell line enhanced" "Detected in many" "HMC-1: 56.3;U-937: 49.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015564, HPA063868" Approved Enhanced Cytosol No No 53000000 Cytosol "HPA015564: AB_1857626, HPA063868: AB_2685136" "unprognostic (1.20e-2)" "unprognostic (6.17e-3)" "unprognostic (2.85e-2)" "prognostic favorable (2.29e-4)" "unprognostic (2.54e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (4.65e-4)" "unprognostic (4.22e-3)" "unprognostic (2.35e-1)" "unprognostic (6.25e-2)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "unprognostic (1.51e-1)" "unprognostic (4.62e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.68e-4)" "prognostic favorable (5.13e-6)" 7.2 7.9 5.5 17.9 9.9 49.5 9.9 2.0 5.8 6.5 17.7 5.4 15.9 19.0 3.0 10.4 23.4 9.6 14.3 18.4 5.2 2.0 20.2 19.0 46.4 61.5 12.2 1.3 4.6 28.0 10.9 9.8 24.9 5.8 16.4 10.5 8.7 24.6 9.7 1.5 15.3 32.0 3.7 16.9 101.5 20.6 22.5 8.0 73.4 19.5 5.4 17.8 11.4 18.0 6.7 30.2 45.6 101.5 9.0 9.9 31.9 24.5 8.7 0.2 0.1 0.0 0.2 17.3 3.1 0.3 0.6 1.7 20.5 15.6 6.5 12.7 2.5 11.4 16.9 0.9 15.0 0.6 27.0 10.5 28.0 10.4 12.1 15.0 18.0 56.3 1.0 15.4 3.0 8.7 0.0 13.2 16.8 17.4 22.3 0.0 15.5 8.8 42.0 6.5 16.0 15.4 9.1 0.0 24.9 12.5 28.5 2.6 0.1 7.6 11.3 0.5 8.5 14.0 46.7 13.8 0.1 5.1 0.3 0.1 24.9 12.3 8.4 0.2 49.4 0.6 25.5 58.1 35.5 9.6 73.1 7.7 6.3 7.3 8.6 30.2 6.7 5.2 6.2 45.6 9.0 101.5 11.5 9.9 31.9 5.5 9.9 2.0 5.8 5.2 2.0 12.2 1.3 5.8 8.0 0.0 7.7 46.2 41.5 20.9 3.5 0.7 40.8 5.3 3.4 33.2 2.0 85.8 28.2 91.9 74.2 5.9 162.4 23.3 104.4 107.0 3.1 43.4 72.5 17.3 155.4 0.0 57.4 21.5 332.1 169.0 1.7 76.6 13.5 138.9 84.0 0.8 109.9 133.3 1.8 54.9 3.9 6.5 1.4 29.3 18.1 18.6 127.9 56.4 58.5 59.5 STXBP5 "LLGL3, tomosyn" ENSG00000164506 "Syntaxin binding protein 5" Q5T5C0 6 147204425-147390476 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 82.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 11.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "HEL: 56.6;HMC-1: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039991, HPA049727, CAB079016" Enhanced Supported Enhanced Cytosol NA NA 11000 Cytosol "CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863" "prognostic unfavorable (4.48e-4)" "unprognostic (4.60e-3)" "unprognostic (2.28e-3)" "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (1.52e-1)" "unprognostic (9.56e-4)" "unprognostic (6.01e-2)" "unprognostic (3.60e-1)" "unprognostic (2.74e-2)" "unprognostic (1.70e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (2.74e-7)" "unprognostic (8.01e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-3)" 4.4 9.1 4.3 6.6 5.9 14.0 9.0 7.8 9.0 6.7 17.6 2.0 22.1 3.9 4.6 6.5 10.2 3.8 9.2 3.5 3.6 4.3 2.0 2.4 3.8 3.5 3.3 4.7 3.0 10.9 82.7 15.5 3.1 4.3 5.7 7.8 6.5 5.7 21.0 7.0 10.9 35.1 5.3 2.7 4.7 4.0 9.6 2.3 2.2 4.2 5.6 4.6 5.3 9.1 0.9 0.5 11.2 0.6 0.5 1.7 0.3 2.8 2.5 1.3 4.6 6.7 14.1 1.5 6.7 10.0 5.0 5.6 2.1 1.9 2.1 1.5 13.3 8.6 3.5 3.9 5.9 6.1 4.5 3.0 56.6 7.5 2.4 7.7 19.3 61.9 10.2 4.2 10.0 20.4 11.9 6.4 3.3 15.2 2.6 9.8 4.2 3.0 5.0 1.1 2.4 5.9 0.4 7.1 0.8 2.7 5.0 2.9 2.1 5.2 3.7 2.3 2.5 1.1 7.6 7.3 7.2 2.6 3.5 6.1 2.2 0.0 2.5 3.9 7.1 5.1 4.7 0.3 11.2 1.2 0.5 1.3 0.5 0.7 1.4 0.5 0.9 1.2 1.7 4.0 0.5 0.6 0.4 0.3 0.3 4.3 5.9 7.8 9.0 3.6 4.3 3.3 4.7 4.3 2.3 14.9 9.1 1.5 2.0 3.2 28.1 12.9 7.6 1.4 9.1 15.7 29.5 4.0 0.0 4.4 26.8 7.9 17.0 0.0 11.2 3.2 4.5 10.0 41.7 3.4 4.0 31.8 39.6 8.6 7.8 34.7 7.2 4.1 10.1 2.8 28.2 5.0 9.8 24.6 6.7 1.4 25.2 12.9 3.4 12.3 10.7 5.8 3.2 4.9 17.4 3.0 SULT1C4 "SULT1C, SULT1C2" ENSG00000198075 "Sulfotransferase family 1C member 4" O75897 2 108377911-108388057 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Cholangiocytes: 22.9;Collecting duct cells: 8.7;Muller glia cells: 12.4" "Group enriched" "Detected in many" 6 "glioma: 7.1;renal cancer: 20.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 6.4;HUVEC TERT2: 6.8;SH-SY5Y: 29.5;SuSa: 8.2" "Low region specificity" "Detected in all" HPA034530 Approved Cytosol NA NA Cytosol "HPA034530: AB_10670170" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-1)" "unprognostic (2.89e-1)" "unprognostic (5.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-2)" "unprognostic (5.77e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-3)" "prognostic favorable (9.99e-7)" "unprognostic (1.79e-2)" "unprognostic (2.96e-2)" "unprognostic (1.85e-2)" "unprognostic (1.38e-1)" 5.2 2.2 9.5 1.1 14.5 0.7 4.5 7.8 16.3 20.6 3.2 13.0 1.8 1.6 9.9 5.4 2.5 8.4 24.8 9.5 9.2 11.4 15.8 3.2 13.9 1.7 12.7 6.8 25.0 3.1 1.0 6.8 11.3 13.6 6.1 2.2 10.6 1.7 7.7 2.7 0.9 3.1 5.1 8.3 1.4 2.2 2.3 10.0 1.1 4.4 1.1 1.4 4.0 5.6 0.3 0.3 1.4 0.2 0.7 0.4 0.2 0.0 0.1 6.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.2 0.1 0.1 0.2 0.3 0.2 0.0 0.3 0.2 0.4 1.4 0.7 0.1 0.3 0.1 0.2 9.5 14.5 7.8 7.1 9.2 11.4 12.7 6.8 13.6 10.0 0.0 0.3 0.0 0.2 0.2 1.5 0.6 22.9 0.0 0.0 8.7 0.0 0.2 0.0 0.3 4.9 5.9 0.0 0.0 0.2 0.1 1.6 0.6 0.0 0.0 0.7 1.6 0.0 4.3 0.6 0.4 1.4 0.4 0.0 0.0 0.0 12.4 0.1 0.0 4.2 2.7 0.7 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.1 SULT2A1 "DHEA-ST, STD" ENSG00000105398 "Sulfotransferase family 2A member 1" Q06520 19 47870466-47886397 "Enzymes, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 211.7" "Cell type enriched" "Detected in some" 24 "Hepatocytes: 1127.7" "Cancer enriched" "Detected in some" 52 "liver cancer: 244.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 5.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 34 "Hep G2: 26.6;RT4: 18.1" "Low region specificity" "Detected in all" "CAB018755, HPA041487, HPA063633" Enhanced Supported Cytosol NA NA 210000 Cytosol "CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066" "unprognostic (2.14e-1)" "unprognostic (6.79e-3)" "unprognostic (6.82e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-2)" 0.1 46.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 11.4 1.1 1.1 8.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 211.7 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.6 0.0 0.1 0.1 3.9 0.1 0.0 42.7 0.1 0.1 0.1 2.8 0.7 0.1 0.1 0.2 0.1 0.1 0.6 0.2 1.3 1.0 5.3 0.8 2.3 1.3 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 26.6 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.2 0.0 18.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 5.3 0.8 0.7 0.9 0.4 0.6 0.7 1.0 0.6 0.3 1.3 1.3 1.0 3.1 2.3 0.4 1.0 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 7.0 0.5 0.1 0.6 0.6 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.7 0.0 0.0 0.1 0.3 0.0 1127.7 0.0 0.0 0.0 38.6 31.7 0.0 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 SV2A "KIAA0736, SV2" ENSG00000159164 "Synaptic vesicle glycoprotein 2A" Q7L0J3 1 149903318-149917882 "FDA approved drug targets, Predicted membrane proteins" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3;parathyroid gland: 34.0" "Group enriched" "Detected in many" 6 "Bipolar cells: 95.8;Horizontal cells: 90.6;Muller glia cells: 25.1" "Cancer enriched" "Detected in many" 6 "glioma: 27.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002226, HPA007863" Enhanced Approved Cytosol NA NA Cytosol "CAB002226: AB_564144, HPA007863: AB_1080135" "unprognostic (8.05e-3)" "unprognostic (3.86e-3)" "unprognostic (2.24e-1)" "unprognostic (5.39e-2)" "unprognostic (2.66e-1)" "unprognostic (2.02e-1)" "unprognostic (6.24e-2)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (2.06e-1)" "unprognostic (9.00e-3)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.44e-2)" "unprognostic (9.86e-2)" "unprognostic (1.95e-2)" "unprognostic (4.81e-3)" 2.0 7.3 20.4 2.8 24.7 4.5 1.5 36.8 75.3 3.2 2.3 4.8 0.9 1.9 5.6 18.0 2.0 3.2 3.2 1.5 22.3 30.5 1.7 1.2 1.8 2.3 21.6 25.1 2.6 1.9 34.0 7.2 1.9 32.9 3.1 2.2 3.1 1.7 3.7 1.1 1.5 2.2 6.6 16.8 2.0 2.0 1.6 6.0 0.3 4.0 0.0 2.0 2.5 1.2 1.2 0.8 2.1 0.7 1.7 2.5 0.6 0.1 0.0 10.3 0.0 1.0 3.0 1.1 4.3 15.2 13.0 18.8 0.3 0.4 0.1 3.9 6.5 13.7 0.2 0.1 0.9 11.2 0.0 2.4 13.5 0.7 0.7 9.9 0.1 0.2 6.8 0.1 20.7 1.5 14.5 1.1 12.4 0.1 14.1 8.5 0.1 13.0 0.6 26.1 0.0 0.0 4.5 6.5 0.2 0.1 0.3 21.6 17.4 0.0 0.1 9.9 10.3 0.1 8.2 0.0 12.1 12.2 0.5 15.8 0.1 0.1 0.0 21.2 0.1 4.8 1.5 0.7 0.4 1.8 0.3 1.9 0.7 1.9 1.1 0.2 1.2 1.0 2.2 2.1 1.7 0.3 0.8 2.5 0.6 20.4 24.7 36.8 40.0 22.3 30.5 21.6 25.1 32.9 6.0 0.0 1.4 0.0 2.0 0.1 95.8 0.6 0.0 1.4 0.0 0.0 3.9 0.3 0.0 0.0 0.3 1.4 0.0 0.0 0.3 0.7 1.5 1.0 0.0 0.0 0.2 90.6 4.1 5.5 0.0 0.0 0.0 0.3 0.0 0.0 0.2 25.1 0.2 0.0 5.3 0.0 11.4 0.0 4.1 1.2 0.8 0.4 0.3 2.5 0.3 0.6 SWT1 "C1orf26, FLJ20121, HsSwt1" ENSG00000116668 "SWT1, RNA endoribonuclease homolog" Q5T5J6 1 185157080-185291765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 99.9;Late spermatids: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024214, HPA027334" Enhanced Approved Cytosol NA NA Cytosol "HPA024214: AB_1845642, HPA027334: AB_1845643" "unprognostic (2.67e-3)" "unprognostic (1.32e-1)" "unprognostic (3.65e-1)" "unprognostic (4.26e-2)" "unprognostic (3.17e-3)" "unprognostic (8.41e-3)" "unprognostic (5.71e-3)" "unprognostic (9.26e-3)" "unprognostic (7.37e-2)" "unprognostic (2.68e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.97e-1)" "unprognostic (4.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.35e-2)" 5.0 4.8 4.1 3.4 6.0 8.7 8.4 6.5 5.9 5.0 5.8 5.7 7.1 5.6 6.6 5.4 3.8 4.1 4.5 4.4 4.2 4.7 5.7 4.7 5.4 7.6 5.2 4.6 7.7 12.4 5.8 9.9 18.1 6.8 5.7 4.1 3.2 6.7 7.9 5.0 3.9 5.4 4.0 9.1 4.8 6.1 39.1 6.5 7.6 6.1 3.2 3.6 5.2 9.1 4.5 1.5 12.0 4.8 1.0 7.2 1.5 1.9 1.7 4.7 2.6 7.9 6.1 4.0 1.9 3.3 2.4 3.8 1.4 1.6 1.9 3.9 1.5 2.5 1.6 2.8 2.6 3.1 5.1 1.9 2.0 1.2 1.8 3.9 0.6 1.7 4.4 2.7 2.7 2.4 4.2 5.9 3.9 4.3 9.6 2.5 0.6 2.2 1.8 5.1 5.1 1.0 1.7 4.2 4.6 2.3 1.1 1.0 7.4 1.6 2.4 6.7 11.6 2.8 1.3 2.8 3.2 2.1 3.1 1.2 17.5 13.3 0.7 3.6 1.2 1.2 12.0 2.5 3.4 2.0 2.2 3.7 3.1 4.0 3.0 1.5 4.5 3.9 2.9 7.2 1.0 4.8 1.4 7.2 1.5 4.1 6.0 6.5 5.9 4.2 4.7 5.2 4.6 6.8 6.5 3.0 0.6 2.2 1.7 0.9 3.9 7.0 2.5 1.4 4.5 5.2 3.9 2.8 0.0 2.2 99.9 3.4 3.5 0.0 2.3 5.4 4.1 2.4 2.3 3.2 3.0 7.9 0.0 8.6 5.7 37.0 4.4 2.8 1.7 3.6 2.9 2.4 1.6 8.6 5.3 5.0 4.4 0.0 1.9 22.7 11.5 0.5 5.6 2.1 2.4 1.6 SYNGR1 ENSG00000100321 "Synaptogyrin 1" O43759 22 39349925-39385588 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.9" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 21.0;monocytes: 18.9;T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029673, CAB034277" Enhanced Supported Cytosol NA NA Cytosol "CAB034277: AB_2255766, HPA029673: AB_10670430" "unprognostic (2.68e-3)" "unprognostic (1.84e-3)" "unprognostic (5.90e-2)" "unprognostic (8.51e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-3)" "unprognostic (7.39e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.16e-1)" "prognostic favorable (4.98e-7)" "unprognostic (1.32e-3)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (1.04e-1)" 4.4 11.4 19.4 2.7 31.4 39.9 8.0 66.9 62.0 15.6 6.3 8.5 1.0 3.3 9.2 6.5 17.3 9.8 6.1 21.6 31.6 22.3 5.5 2.0 3.3 3.8 17.4 35.1 38.8 14.5 10.3 4.1 3.7 23.5 10.9 2.6 19.5 23.5 10.4 13.4 26.2 3.0 7.2 7.0 4.1 4.8 7.2 5.4 0.7 4.6 4.6 5.2 7.8 9.0 2.4 21.0 0.8 18.9 2.6 15.2 7.8 2.6 4.8 8.7 15.7 0.8 2.3 3.8 11.6 20.5 14.8 13.7 1.0 0.3 0.1 2.7 3.0 1.7 3.7 5.9 0.2 4.5 0.0 18.4 0.2 0.3 0.5 2.5 0.7 5.4 3.4 0.9 4.0 0.0 10.5 0.7 3.4 5.2 0.3 2.3 6.1 2.3 2.1 1.8 2.3 9.3 6.8 0.0 0.7 0.4 7.4 13.8 2.9 3.0 12.6 12.0 3.8 18.6 13.6 0.2 0.0 10.2 0.1 0.0 3.2 0.1 7.3 0.4 14.8 15.8 0.2 18.9 0.3 15.2 5.5 0.9 2.4 0.6 4.4 21.0 2.2 0.7 8.2 0.8 2.6 0.2 15.3 0.1 7.8 19.4 31.4 66.9 62.0 31.6 22.3 17.4 35.1 23.5 5.4 8.9 1.4 11.2 51.4 27.0 109.4 55.7 68.8 1.4 11.4 62.8 25.5 19.6 13.3 38.6 27.1 6.7 0.0 46.7 10.4 12.0 41.0 29.2 2.3 5.0 13.5 44.5 0.0 13.5 15.0 64.1 123.4 10.0 133.3 1.0 0.0 35.9 25.8 0.0 112.1 9.8 36.1 19.4 28.1 74.9 12.1 32.6 11.0 22.3 0.2 63.3 SYNRG "AP1GBP1, MGC104959, SYNG" ENSG00000275066 "Synergin gamma" Q9UMZ2 17 37514797-37609496 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023554, HPA023555" Approved Approved Cytosol NA NA Cytosol "HPA023554: AB_1844892, HPA023555: AB_2058337" "unprognostic (1.22e-1)" "unprognostic (1.24e-1)" "unprognostic (9.25e-2)" "unprognostic (1.11e-1)" "unprognostic (4.99e-2)" "unprognostic (3.44e-2)" "unprognostic (3.71e-2)" "unprognostic (1.90e-1)" "unprognostic (1.40e-1)" "unprognostic (1.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.21e-2)" "unprognostic (4.68e-3)" "unprognostic (8.76e-2)" "unprognostic (2.56e-1)" "unprognostic (2.91e-2)" "prognostic favorable (3.96e-4)" 6.3 5.9 5.4 10.3 9.4 4.8 5.2 9.4 8.6 5.5 6.0 10.4 4.3 5.4 7.4 8.7 5.4 5.0 5.8 6.2 4.8 7.0 5.6 5.7 14.2 6.9 6.3 5.8 6.4 9.6 14.5 5.9 10.8 5.8 6.8 6.2 6.2 6.2 7.3 4.6 5.7 4.8 8.5 10.4 7.5 10.9 8.2 22.7 7.0 3.8 14.2 6.5 4.0 10.4 11.4 8.0 3.4 13.8 13.8 3.2 5.2 8.4 11.4 7.3 7.1 7.8 5.5 7.8 7.9 8.9 10.7 7.5 8.5 9.4 7.4 7.1 8.8 5.2 9.9 4.3 12.5 8.7 7.0 5.1 5.3 4.4 9.2 8.2 11.8 9.1 8.9 10.8 5.6 7.6 12.7 16.7 11.0 8.5 9.4 3.9 18.8 5.0 4.7 4.8 3.5 11.8 9.6 6.2 7.4 9.2 9.7 8.2 7.7 2.4 6.1 14.1 7.0 6.3 11.3 6.2 7.9 5.2 7.1 9.9 12.3 17.2 7.7 4.5 6.3 8.0 3.4 7.2 10.4 2.6 13.8 8.9 9.1 10.5 2.9 10.4 9.4 9.2 7.0 13.8 2.5 11.4 9.2 3.2 50.6 34.2 39.9 14.5 7.6 45.9 24.3 25.5 22.7 25.0 31.4 51.1 13.7 14.9 20.9 33.0 26.1 19.7 0.0 18.8 9.3 12.5 15.8 24.4 19.2 18.3 35.0 40.9 22.1 30.1 39.2 21.0 25.7 15.1 22.6 21.5 37.1 20.1 22.9 22.6 21.6 52.7 12.9 14.4 56.2 22.3 8.2 22.2 76.7 16.5 19.3 SYT16 "CHR14SYT, Strep14, SYT14L, yt14r" ENSG00000139973 "Synaptotagmin 16" Q17RD7 14 61811974-62112550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.8;testis: 6.8" "Group enriched" "Detected in some" 5 "Early spermatids: 26.4;Late spermatids: 10.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.6;hTERT-HME1: 4.3;PC-3: 5.5;RPTEC TERT1: 6.5;RT4: 17.1;U-2 OS: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004199, HPA076871" Enhanced Approved Cytosol NA NA Cytosol "HPA004199: AB_1080156, HPA076871: AB_2732324" "unprognostic (2.55e-2)" "unprognostic (1.43e-2)" "unprognostic (4.12e-1)" "unprognostic (8.88e-4)" "unprognostic (1.41e-1)" "unprognostic (9.08e-2)" "unprognostic (9.57e-2)" "unprognostic (9.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (3.41e-2)" "unprognostic (1.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.53e-3)" "unprognostic (2.15e-1)" 0.4 1.3 7.2 0.4 17.2 0.6 0.6 0.7 20.8 0.4 0.4 0.4 0.0 0.4 1.0 2.1 0.4 0.7 0.5 0.5 3.3 3.4 0.7 0.4 0.5 0.5 1.6 12.3 0.4 4.0 0.4 1.9 1.1 1.8 4.6 0.4 0.0 0.4 0.6 0.4 0.5 0.5 0.4 0.9 0.5 2.6 6.8 0.7 0.0 0.5 0.0 0.4 0.9 0.6 0.2 0.1 0.6 0.1 0.1 0.2 0.0 10.6 0.2 0.3 0.0 0.0 0.0 0.1 0.7 1.0 1.0 0.6 0.0 0.0 0.1 0.2 0.0 0.6 0.6 0.0 1.0 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 5.5 0.0 0.0 0.0 6.5 17.1 0.3 3.0 0.5 0.7 0.0 1.1 0.0 0.0 0.0 2.9 6.9 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.6 0.1 0.1 0.1 0.0 0.0 7.2 17.2 0.7 18.9 3.3 3.4 1.6 12.3 1.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.5 2.0 0.3 0.0 0.1 26.4 0.0 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 2.1 0.0 0.1 0.0 0.0 0.1 TACC1 ENSG00000147526 "Transforming acidic coiled-coil containing protein 1" O75410 8 38728186-38853028 "Predicted intracellular proteins" "Cell cycle, Cell division" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017041, HPA024702, HPA056841" Approved Approved Cytosol NA NA Cytosol "CAB017041: , HPA024702: AB_1857723, HPA056841: " "unprognostic (1.83e-2)" "unprognostic (3.07e-1)" "unprognostic (2.18e-1)" "unprognostic (8.31e-2)" "unprognostic (6.55e-2)" "unprognostic (5.30e-2)" "unprognostic (1.79e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-1)" "unprognostic (7.85e-2)" "unprognostic (1.63e-1)" "unprognostic (5.94e-2)" "prognostic favorable (1.06e-5)" "unprognostic (1.03e-3)" "unprognostic (2.84e-2)" "unprognostic (2.15e-2)" "unprognostic (1.18e-1)" 55.9 12.8 15.0 15.3 16.7 23.3 39.4 8.2 20.4 32.1 31.9 16.8 25.7 8.3 44.9 16.1 28.7 29.9 18.9 19.9 14.6 12.4 21.3 9.1 26.6 15.0 17.5 13.1 19.5 17.4 13.6 8.1 28.8 15.2 22.8 18.0 23.9 11.8 32.0 20.5 10.4 17.5 36.6 17.4 28.0 20.2 14.2 16.5 8.1 18.5 15.5 13.3 40.0 39.6 1.6 21.2 19.0 8.0 2.3 4.1 3.1 10.7 20.8 15.3 4.7 16.5 11.5 9.9 14.0 18.3 13.5 13.8 9.6 1.7 11.0 8.6 13.8 11.7 10.3 9.1 6.3 28.1 7.8 3.4 42.9 6.4 6.2 19.4 8.5 19.9 20.9 5.9 21.8 7.0 14.1 48.3 13.4 4.4 27.8 40.6 8.0 20.1 4.9 2.1 17.7 9.8 4.5 34.4 1.9 4.5 10.6 1.0 1.2 11.4 11.8 9.5 9.5 5.4 6.6 38.6 16.4 9.9 20.9 11.3 14.5 9.4 9.9 14.9 9.9 19.8 6.4 6.9 9.0 3.8 6.2 4.1 1.3 2.6 3.1 4.5 1.6 2.2 2.4 19.0 2.3 8.0 21.2 2.0 3.1 15.0 16.7 8.2 20.4 14.6 12.4 17.5 13.1 15.2 16.5 202.5 130.7 53.4 44.9 31.3 23.8 42.5 170.7 8.1 51.2 43.6 58.9 51.0 101.2 129.7 3.5 172.1 11.9 0.0 51.9 48.9 114.7 69.5 111.1 31.0 67.2 103.3 36.2 302.0 73.2 7.9 155.9 86.0 38.8 73.1 117.5 67.6 55.5 35.1 193.7 20.3 43.1 187.5 177.2 39.4 58.6 16.6 78.6 66.3 52.4 32.8 TAGAP "ARHGAP47, FLJ32631, IDDM21" ENSG00000164691 "T cell activation RhoGTPase activating protein" Q8N103 6 159034468-159045152 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.9;bone marrow: 55.6;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 13 "B-cells: 68.1;Macrophages: 53.7;T-cells: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.4;HMC-1: 21.0;Karpas-707: 21.9;U-266/84: 9.8;U-698: 20.2;U-937: 16.1" "Low region specificity" "Detected in all" "HPA031000, HPA039982" Uncertain Approved Cytosol NA NA Cytosol "HPA031000: AB_10610560, HPA039982: " "unprognostic (9.86e-3)" "unprognostic (7.55e-2)" "unprognostic (2.41e-2)" "unprognostic (1.56e-2)" "unprognostic (6.36e-2)" "unprognostic (3.10e-3)" "unprognostic (1.04e-1)" "unprognostic (5.25e-2)" "unprognostic (3.35e-3)" "unprognostic (8.39e-2)" "unprognostic (6.19e-2)" "unprognostic (2.41e-1)" "unprognostic (1.49e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (5.24e-2)" "unprognostic (7.39e-2)" 4.4 2.3 1.5 16.9 2.1 55.6 2.5 0.9 2.0 1.9 2.5 7.9 1.3 1.7 9.7 1.8 2.7 2.1 4.1 2.0 1.9 3.7 2.2 2.4 8.4 32.7 5.0 1.1 1.9 1.0 0.4 1.4 2.8 3.9 1.9 3.6 3.2 3.2 1.8 0.8 1.4 11.8 12.2 9.2 22.1 2.7 1.7 3.0 32.6 2.2 4.0 32.1 6.8 1.9 14.9 7.8 47.9 7.7 12.0 22.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.2 0.0 0.0 0.0 7.4 21.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 21.9 0.0 0.0 1.9 3.9 5.9 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.0 3.4 0.1 0.0 0.0 0.0 0.0 2.4 9.8 20.2 0.0 16.1 0.0 38.7 7.7 23.6 16.4 5.5 18.5 13.9 22.0 19.0 7.8 14.9 17.4 12.1 47.9 12.0 7.0 2.6 15.5 14.4 1.5 2.1 0.9 2.0 1.9 3.7 5.0 1.1 3.9 3.0 3.0 10.0 68.1 0.2 2.5 0.1 0.4 0.0 1.4 1.2 0.0 0.0 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.4 3.7 0.4 18.5 0.8 23.7 0.0 0.0 1.8 19.5 0.9 1.1 53.7 27.0 0.0 0.0 0.3 0.0 0.0 21.2 0.2 0.1 0.0 0.3 0.0 0.1 2.4 0.7 89.6 0.0 0.3 TAL2 bHLHa19 ENSG00000186051 "TAL bHLH transcription factor 2" Q16559 9 105662457-105663112 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 8.8;kidney: 4.6;skeletal muscle: 17.3" "Cell type enhanced" "Detected in some" 16 "Cone photoreceptor cells: 3.9;Distal tubular cells: 6.6;Intestinal endocrine cells: 3.4;Muller glia cells: 1.8" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Group enriched" "Detected in some" 21 "memory B-cell: 8.8;naive B-cell: 7.9;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 18 "B-cells: 8.8;dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "CACO-2: 3.4;HAP1: 4.9;K-562: 12.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA030886 Uncertain Approved Cytosol NA NA Cytosol "HPA030886: AB_10601596" "unprognostic (3.89e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "unprognostic (5.54e-2)" "unprognostic (2.24e-1)" "unprognostic (9.06e-2)" "unprognostic (4.98e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-3)" "unprognostic (2.63e-1)" "unprognostic (7.00e-4)" "unprognostic (2.84e-2)" "prognostic favorable (2.69e-4)" "unprognostic (2.70e-2)" "unprognostic (1.24e-1)" "unprognostic (1.29e-1)" "unprognostic (7.39e-2)" 0.1 0.3 0.5 0.1 0.7 0.0 0.0 0.3 0.6 0.2 0.0 0.0 0.2 0.9 0.1 0.2 0.0 0.3 0.4 0.5 4.6 0.3 0.0 0.2 0.7 0.3 0.1 0.0 0.8 0.1 0.1 0.1 0.0 0.2 17.3 0.1 0.1 0.0 0.8 0.3 0.0 0.6 0.1 0.4 0.1 0.0 8.8 2.2 0.0 0.0 0.3 0.0 0.1 0.0 0.7 2.5 0.7 0.3 0.0 0.3 0.1 0.3 0.1 0.4 3.4 0.2 0.1 0.3 0.0 0.7 0.1 4.9 0.0 0.2 0.6 0.5 1.1 0.0 0.0 0.2 0.6 1.9 0.3 0.6 0.1 0.2 0.2 0.0 0.8 12.9 0.3 0.4 0.3 0.8 0.7 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 2.9 1.2 0.2 0.3 0.2 0.1 0.2 2.1 0.5 0.3 0.8 0.7 1.1 1.0 2.0 0.1 0.2 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.4 1.1 0.9 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 TAMM41 "C3orf31, DKFZp434E0519, MGC16471" ENSG00000144559 "TAM41 mitochondrial translocator assembly and maintenance homolog" Q96BW9 3 11790442-11846919 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036834, HPA044861" Uncertain Approved Cytosol NA NA Cytosol "HPA036834: AB_10672270, HPA044861: AB_2679116" "unprognostic (2.40e-2)" "unprognostic (4.41e-2)" "prognostic favorable (1.23e-4)" "unprognostic (4.45e-2)" "unprognostic (1.44e-2)" "unprognostic (5.60e-2)" "unprognostic (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.33e-3)" "unprognostic (3.78e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-1)" "unprognostic (7.34e-2)" "unprognostic (3.59e-3)" 13.9 12.9 21.8 15.9 27.5 9.1 15.7 25.6 19.8 12.5 12.2 14.2 12.5 11.5 17.7 23.7 15.2 12.4 10.0 13.8 13.9 11.5 12.4 12.0 18.7 25.0 11.3 15.3 21.7 12.9 12.5 15.4 9.9 11.4 10.7 12.0 11.2 11.7 14.2 15.2 17.3 10.4 15.0 13.7 12.3 10.1 14.1 14.8 12.7 10.8 8.4 17.4 13.8 13.8 8.7 8.9 7.7 7.1 7.1 11.3 5.0 4.2 7.9 9.7 6.7 10.5 13.3 17.9 6.5 4.7 10.0 10.0 9.5 7.0 16.2 9.6 6.8 4.4 5.2 16.2 9.8 13.0 6.0 15.3 9.6 7.6 11.0 12.3 17.6 5.1 7.6 14.6 9.4 10.6 6.6 15.4 12.9 14.1 5.0 12.8 12.2 9.9 13.2 7.7 6.6 16.9 9.9 5.5 14.2 15.3 10.4 4.5 3.9 5.7 7.4 10.8 11.4 9.6 8.0 4.0 5.2 6.0 15.6 9.2 3.9 9.5 8.3 6.3 15.0 4.8 2.2 5.3 7.7 7.2 3.6 9.2 8.7 11.3 7.0 8.9 8.0 10.4 10.6 0.2 7.1 7.1 6.6 8.7 5.0 21.8 27.5 25.6 19.8 13.9 11.5 11.3 15.3 11.4 14.8 6.0 6.5 7.3 7.8 3.8 10.6 8.1 0.0 10.7 5.7 3.5 11.8 10.3 8.3 9.7 1.6 5.8 2.8 0.0 8.0 9.1 4.6 5.4 2.3 5.7 8.1 9.5 2.9 4.9 6.5 1.1 7.2 7.2 3.3 4.6 7.3 10.8 6.6 3.5 6.0 7.9 14.0 0.0 6.2 8.4 11.9 3.6 5.8 9.5 7.6 4.6 TANC2 "DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA" ENSG00000170921 "Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2" Q9HCD6 17 63009556-63427699 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 31.6" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 43.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023274 Uncertain Approved Cytosol NA NA Cytosol "HPA023274: AB_2199727" "unprognostic (8.37e-2)" "unprognostic (4.15e-2)" "unprognostic (2.21e-2)" "unprognostic (1.57e-4)" "unprognostic (1.51e-1)" "unprognostic (4.09e-2)" "unprognostic (9.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.09e-2)" "unprognostic (5.52e-2)" "unprognostic (2.62e-1)" "unprognostic (2.69e-1)" "unprognostic (2.02e-2)" "unprognostic (5.15e-2)" "unprognostic (1.47e-1)" "unprognostic (1.57e-1)" "unprognostic (2.01e-1)" 3.4 3.9 4.4 3.1 8.5 6.2 2.7 2.1 19.5 4.5 1.5 2.8 1.5 1.0 2.7 7.0 3.4 2.5 3.1 2.0 5.2 5.4 3.1 1.5 7.9 1.5 5.2 3.5 3.0 2.3 31.6 5.1 2.8 2.7 2.6 1.1 1.9 3.5 3.4 1.5 4.8 2.0 4.1 7.5 2.7 1.8 10.9 3.4 4.6 2.1 4.4 1.9 6.4 2.9 0.8 1.6 1.1 0.1 2.9 2.2 0.1 12.2 11.6 7.2 1.2 3.7 8.9 13.9 7.8 7.8 7.8 9.7 0.6 3.6 0.0 2.4 13.4 9.9 1.7 11.6 23.1 17.7 4.7 5.3 18.0 17.1 0.6 3.2 4.8 0.0 13.6 13.5 9.1 26.3 8.6 2.4 4.7 2.2 0.0 11.1 9.4 3.1 0.8 0.8 2.2 7.6 2.5 14.4 0.9 6.9 17.0 12.2 13.4 4.4 8.3 3.4 13.1 3.8 1.3 12.5 19.1 10.0 1.2 9.6 0.0 0.0 0.0 7.0 1.3 6.8 0.0 0.1 0.0 2.2 0.1 1.7 0.1 1.2 1.7 0.1 0.8 0.5 1.1 1.1 2.9 0.0 1.6 0.0 0.1 4.4 8.5 2.1 19.5 5.2 5.4 5.2 3.5 2.7 3.4 14.9 41.2 2.0 9.1 22.2 43.0 3.6 10.2 4.0 13.6 26.2 15.7 6.7 1.7 8.8 14.2 9.5 0.5 0.0 12.1 32.1 4.6 8.9 0.0 0.8 7.2 7.9 4.1 16.0 7.8 8.0 5.2 16.1 10.1 13.6 3.9 3.7 20.4 2.9 3.2 1.4 6.8 19.4 4.1 18.0 14.6 13.9 13.7 7.5 1.5 9.6 TARSL2 FLJ25005 ENSG00000185418 "Threonyl-tRNA synthetase like 2" A2RTX5 15 101653598-101724604 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.7" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 9.7;NK-cells: 9.0;T-cells: 6.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066697 Enhanced Approved Cytosol NA NA Cytosol "HPA066697: AB_2685705" "unprognostic (9.33e-3)" "unprognostic (2.13e-2)" "unprognostic (1.88e-1)" "unprognostic (2.54e-1)" "unprognostic (8.44e-2)" "unprognostic (1.92e-1)" "unprognostic (8.45e-2)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-2)" "unprognostic (2.26e-3)" "unprognostic (9.76e-3)" "unprognostic (4.00e-2)" "unprognostic (2.23e-1)" "unprognostic (7.52e-2)" "unprognostic (6.48e-3)" "unprognostic (2.79e-2)" 7.4 6.9 15.1 6.4 20.2 4.8 7.5 15.8 16.2 7.2 7.1 20.2 5.5 6.2 6.5 6.0 6.3 6.5 5.9 21.0 16.9 13.8 8.3 5.9 6.2 6.5 20.0 11.2 11.0 9.8 12.9 10.5 3.7 15.7 9.2 6.2 4.0 7.1 9.7 47.7 4.9 6.5 6.9 19.9 6.2 8.5 5.4 18.9 3.9 9.6 8.0 7.1 7.0 7.8 9.7 2.0 1.6 1.7 9.0 6.1 1.0 2.1 4.0 6.9 3.7 7.4 5.8 3.5 7.4 4.9 5.8 3.6 5.9 1.9 2.8 2.9 8.9 4.7 6.3 12.1 4.3 5.4 3.2 19.5 6.9 2.6 4.6 3.4 3.1 1.4 4.1 4.0 2.7 3.4 6.9 4.1 6.1 6.7 6.1 5.7 3.5 1.7 6.1 8.4 10.6 2.8 3.5 10.5 7.2 4.8 2.1 11.0 6.8 10.0 3.9 4.0 13.3 2.5 6.3 5.5 2.8 6.6 5.6 2.4 8.5 9.5 3.5 7.3 5.6 5.1 0.9 1.1 1.6 3.4 1.7 3.4 4.8 6.1 5.2 0.8 9.7 5.9 3.2 0.3 9.0 0.7 2.0 1.0 1.0 15.1 20.2 15.8 16.2 16.9 13.8 20.0 11.2 15.7 18.9 0.0 5.6 26.9 18.3 16.1 51.2 37.0 5.1 12.0 11.4 5.2 41.2 2.7 16.6 7.6 13.2 12.5 18.0 0.0 10.8 4.0 18.6 13.9 24.3 14.7 4.6 30.2 23.6 8.0 8.9 5.7 21.9 8.6 10.1 9.0 13.5 34.6 17.6 9.3 17.7 17.7 78.2 19.4 16.7 27.4 21.3 10.3 3.5 31.7 12.6 7.1 TBC1D2B KIAA1055 ENSG00000167202 "TBC1 domain family member 2B" Q9UPU7 15 77984036-78077724 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041833, HPA048174, HPA052663" Approved Enhanced Cytosol NA NA Cytosol "HPA041833: AB_2732494, HPA048174: AB_2680297, HPA052663: AB_2681906" "unprognostic (3.13e-1)" "unprognostic (2.16e-1)" "unprognostic (8.25e-2)" "unprognostic (1.28e-2)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.07e-3)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (8.22e-3)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.23e-3)" "unprognostic (6.68e-2)" "unprognostic (3.07e-2)" "unprognostic (3.37e-1)" "unprognostic (3.19e-2)" 26.0 14.1 9.3 12.0 10.0 11.9 21.4 8.4 8.4 22.8 16.7 8.4 7.3 7.6 20.2 13.0 9.3 18.2 20.0 7.8 7.7 4.3 8.2 18.3 22.7 12.5 8.3 5.6 31.2 16.6 17.7 7.1 28.9 7.2 13.6 10.8 20.7 8.6 14.0 5.0 10.5 14.3 15.5 9.7 19.9 12.6 11.0 7.3 20.4 10.4 5.8 14.4 17.1 18.4 0.4 3.2 3.7 2.1 3.8 4.2 1.3 5.0 4.0 4.9 4.6 34.4 27.5 8.5 11.7 17.7 11.0 12.2 5.1 2.1 7.8 4.7 9.8 6.1 7.4 10.6 12.9 8.4 14.8 8.2 5.0 3.9 3.4 16.3 12.6 7.6 26.7 9.0 7.3 4.9 16.4 12.4 10.2 2.5 5.4 14.2 5.5 4.6 8.2 3.8 3.9 3.9 7.1 22.4 1.7 5.7 19.4 2.6 7.1 10.9 7.4 13.8 4.7 2.4 13.2 15.2 12.1 8.0 3.8 6.1 9.3 9.7 4.2 4.1 17.0 6.3 0.0 2.1 0.9 3.9 1.8 2.2 0.2 2.6 4.2 1.4 0.4 1.9 1.5 3.7 3.8 0.5 3.2 1.5 1.3 9.3 10.0 8.4 8.4 7.7 4.3 8.3 5.6 7.2 7.3 3.0 12.9 9.7 8.0 8.2 9.7 2.4 12.7 2.7 3.4 5.2 5.9 15.3 0.0 6.9 7.4 12.0 10.6 0.0 8.4 6.3 13.9 8.1 9.2 62.2 16.0 14.3 7.0 28.3 28.3 6.1 39.4 18.9 13.5 12.6 17.8 7.2 11.5 10.5 39.6 2.7 10.0 25.8 8.9 5.0 7.2 8.7 23.8 19.5 15.6 7.6 TBC1D4 "AS160, DKFZp779C0666, KIAA0603" ENSG00000136111 "TBC1 domain family member 4" O60343 13 75284665-75482114 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "GTPase activation" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 17.4" "Group enriched" "Detected in many" 5 "dendritic cells: 7.2;T-cells: 17.4" "Cell line enhanced" "Detected in many" "CACO-2: 36.9;HUVEC TERT2: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040145, HPA059885" Approved Supported Cytosol NA NA Cytosol "HPA040145: AB_2676860, HPA059885: AB_2684152" "unprognostic (5.44e-3)" "unprognostic (5.23e-1)" "unprognostic (9.85e-2)" "unprognostic (1.39e-1)" "unprognostic (2.78e-2)" "unprognostic (9.54e-3)" "unprognostic (1.25e-2)" "unprognostic (8.87e-2)" "unprognostic (2.87e-1)" "unprognostic (5.02e-2)" "unprognostic (7.53e-2)" "unprognostic (2.64e-1)" "prognostic favorable (1.07e-11)" "unprognostic (6.40e-2)" "unprognostic (3.16e-1)" "unprognostic (8.88e-2)" "unprognostic (3.45e-1)" 12.0 43.9 6.7 6.7 7.0 1.2 17.5 9.3 10.7 6.9 5.7 4.6 4.2 1.9 5.4 10.1 6.1 5.9 8.5 25.5 8.0 4.1 15.6 5.3 8.5 14.9 5.4 7.0 22.5 8.5 9.5 4.2 9.5 11.1 7.4 4.9 2.0 20.8 2.4 40.1 10.8 6.3 4.7 4.8 9.6 6.1 3.3 4.4 1.1 17.7 17.3 14.8 4.7 8.7 0.5 7.2 2.6 0.3 0.3 17.4 1.8 5.5 6.5 4.1 0.2 9.7 10.5 5.3 4.8 2.5 3.9 4.3 36.9 6.8 1.1 1.1 6.8 1.9 5.2 10.4 4.8 4.1 18.3 10.5 18.0 8.8 11.1 2.4 8.5 0.2 11.4 8.9 4.3 10.2 6.8 27.3 20.3 5.0 0.6 4.4 2.6 12.4 1.5 5.8 10.7 3.9 11.2 3.9 6.5 3.8 4.0 7.6 2.3 2.1 6.5 3.5 2.2 2.2 0.2 11.4 4.4 5.5 2.3 5.6 0.3 0.0 0.1 7.9 8.0 6.5 2.6 0.3 0.0 0.5 0.1 0.0 0.5 8.6 1.8 0.4 0.4 8.0 3.7 0.3 0.3 0.1 7.2 17.4 1.8 6.7 7.0 9.3 10.7 8.0 4.1 5.4 7.0 11.1 4.4 6.0 26.1 0.5 7.9 32.2 0.0 70.6 12.7 4.0 9.1 14.0 0.0 9.3 13.3 9.7 13.3 32.1 3.5 0.0 6.5 8.5 8.2 13.9 4.7 16.4 21.4 1.6 20.2 33.7 17.4 3.6 3.4 8.8 20.3 47.7 10.6 0.3 5.3 0.0 6.7 7.4 0.6 6.5 12.3 0.9 6.1 38.6 4.1 13.1 16.2 8.1 TBC1D8B "FLJ20298, GRAMD8B, RP11-321G1.1" ENSG00000133138 "TBC1 domain family member 8B" Q0IIM8 X 106802680-106876145 "Predicted intracellular proteins" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Alveolar cells type 1: 214.4;Alveolar cells type 2: 173.1;Ciliated cells: 192.7;Club cells: 159.3;granulocytes: 104.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023883, HPA027527" Enhanced Approved Cytosol NA NA Cytosol "HPA023883: AB_1857794, HPA027527: AB_2199395" "unprognostic (6.69e-2)" "unprognostic (1.06e-1)" "unprognostic (8.19e-2)" "unprognostic (4.69e-3)" "unprognostic (8.15e-2)" "unprognostic (6.97e-2)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (2.75e-1)" "unprognostic (4.89e-2)" "unprognostic (3.32e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-1)" "unprognostic (9.97e-2)" "unprognostic (5.16e-2)" 3.8 24.5 4.6 3.5 7.9 3.3 3.9 1.2 7.9 6.0 6.6 2.6 21.5 6.0 5.1 10.4 3.7 4.4 9.6 4.7 4.2 2.5 12.4 14.5 4.1 2.0 6.8 3.3 7.2 10.7 10.0 28.6 4.5 9.0 6.1 5.6 2.2 10.1 16.8 1.8 2.9 13.3 4.1 4.7 2.7 8.5 7.6 7.6 0.5 7.9 3.1 1.8 4.9 4.8 4.7 2.8 5.2 2.2 1.5 2.0 0.4 10.0 3.2 1.5 4.9 15.8 22.4 5.7 11.3 11.7 2.0 6.1 5.4 8.9 3.6 9.3 11.3 8.3 5.2 4.1 5.6 5.1 1.9 4.5 4.8 4.0 5.2 4.1 1.4 2.0 9.8 4.6 4.2 2.0 12.2 5.5 3.0 1.6 6.2 7.0 5.1 3.2 1.9 6.9 14.7 5.1 1.6 2.8 1.5 5.6 7.4 2.5 2.1 8.9 6.9 4.0 7.1 7.9 1.7 6.9 7.4 8.3 9.7 4.1 5.7 6.1 1.1 14.3 1.1 9.2 3.7 2.2 1.1 2.0 1.2 1.6 2.2 1.7 1.5 0.7 4.7 1.4 1.7 5.2 1.5 1.1 2.8 0.7 0.4 4.6 7.9 1.2 7.9 4.2 2.5 6.8 3.3 9.0 7.6 214.4 173.1 1.5 5.8 2.2 3.4 2.2 5.1 192.7 159.3 7.0 3.9 2.4 6.6 7.5 0.8 6.0 8.4 0.0 8.3 2.5 7.6 12.9 104.6 13.9 1.4 0.0 4.6 2.5 2.7 0.4 8.3 1.9 3.3 1.0 15.4 1.5 6.2 10.5 8.1 9.7 3.4 0.0 4.1 1.4 1.7 1.3 2.2 0.0 8.4 7.2 TBCB "CG22, CKAP1, CKAPI" ENSG00000105254 "Tubulin folding cofactor B" Q99426 19 36114289-36125947 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041428, HPA041722" Approved Supported Cytosol NA NA 340000 Cytosol "HPA041428: AB_10794517, HPA041722: AB_10804007" "unprognostic (3.88e-3)" "unprognostic (3.05e-1)" "unprognostic (8.52e-2)" "unprognostic (1.38e-2)" "unprognostic (7.94e-2)" "unprognostic (1.25e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.15e-2)" "unprognostic (5.19e-2)" "unprognostic (1.32e-1)" "prognostic favorable (3.11e-4)" "unprognostic (4.54e-2)" "unprognostic (6.34e-3)" "unprognostic (9.20e-2)" "unprognostic (6.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.02e-1)" 23.0 30.2 59.1 26.0 48.8 23.2 20.0 30.9 67.6 22.1 22.3 64.3 14.3 16.8 20.7 20.9 18.0 27.7 14.9 29.2 55.8 56.7 21.0 14.1 19.9 20.7 63.5 43.8 33.9 11.2 15.1 23.1 19.0 49.7 20.0 17.4 14.7 12.2 22.7 34.5 12.8 17.6 29.8 85.5 21.0 16.3 24.1 44.4 15.0 12.2 13.7 23.9 16.2 15.0 64.6 73.4 79.4 101.2 59.7 96.3 80.6 32.4 95.7 37.0 24.8 26.3 27.9 13.0 25.3 19.5 44.1 30.7 42.0 17.6 24.0 47.6 41.8 34.7 15.5 30.8 27.0 26.6 56.0 29.8 21.4 26.7 64.0 28.6 25.0 48.2 26.3 20.4 35.3 24.8 31.2 25.5 40.4 9.3 40.8 39.1 49.1 38.4 27.8 22.2 39.6 31.4 35.7 19.1 23.1 41.2 31.6 37.2 38.5 22.8 32.5 28.9 32.5 17.1 33.6 28.0 45.7 47.9 26.9 52.1 18.5 47.1 28.2 40.0 24.3 24.2 66.4 65.0 79.4 78.8 85.2 53.0 64.6 73.6 69.1 70.9 54.8 44.0 55.2 27.6 59.7 101.2 73.4 96.3 80.6 59.1 48.8 30.9 61.4 55.8 56.7 63.5 43.8 49.7 44.4 56.6 30.1 79.2 71.3 59.4 55.0 42.3 66.2 91.0 51.2 130.9 11.8 122.5 152.5 129.6 118.3 85.4 49.9 46.7 98.1 167.7 130.9 58.0 83.0 30.6 140.7 68.3 103.0 70.6 73.2 193.4 83.4 107.5 123.2 354.3 52.1 89.1 105.9 92.1 95.1 144.2 59.8 64.7 127.8 113.8 172.0 59.1 69.1 96.9 55.1 70.7 TBCC CFC ENSG00000124659 "Tubulin folding cofactor C" Q15814 6 42744481-42746096 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035073, HPA035074" Approved Supported Cytosol NA NA Cytosol "HPA035073: AB_10602897, HPA035074: AB_2674448" "unprognostic (7.16e-2)" "unprognostic (9.88e-2)" "unprognostic (2.17e-1)" "unprognostic (4.23e-2)" "unprognostic (8.20e-2)" "unprognostic (6.79e-2)" "unprognostic (5.80e-3)" "unprognostic (1.41e-2)" "unprognostic (2.47e-1)" "unprognostic (3.96e-3)" "unprognostic (1.84e-2)" "unprognostic (1.92e-1)" "unprognostic (2.22e-1)" "unprognostic (2.28e-1)" "unprognostic (1.29e-1)" "unprognostic (6.31e-2)" "unprognostic (3.76e-3)" 5.8 6.1 8.6 9.4 8.0 19.0 6.2 10.9 15.7 7.6 7.6 7.9 6.9 7.4 8.7 7.1 6.4 8.5 8.5 8.0 6.6 7.1 7.0 5.6 5.9 14.1 7.7 8.4 8.0 7.8 3.0 7.3 7.2 10.9 6.9 5.0 6.0 7.4 6.8 13.5 8.7 7.9 5.5 6.6 8.5 7.4 8.4 6.6 9.4 7.8 4.1 10.0 7.7 6.6 31.6 46.3 54.8 30.2 52.1 48.8 49.5 15.4 5.1 7.9 14.7 11.5 7.7 10.4 10.7 12.1 11.9 13.0 7.9 6.1 14.0 8.6 10.3 9.9 13.6 10.6 10.6 6.7 7.6 11.6 7.3 7.6 13.3 13.1 7.9 12.0 12.6 13.0 9.2 7.6 10.7 9.3 7.9 16.7 12.8 10.6 19.0 6.5 15.3 7.4 42.3 14.1 6.6 9.5 9.1 11.3 8.5 30.5 13.2 6.9 12.0 18.3 7.6 13.2 27.1 10.0 11.4 10.2 9.2 14.6 17.0 19.1 23.6 5.6 10.9 10.9 37.6 30.2 54.8 37.2 25.3 37.7 31.6 39.4 40.3 27.3 30.7 46.1 42.6 53.4 52.1 22.6 46.3 48.8 49.5 8.6 8.0 10.9 15.7 6.6 7.1 7.7 8.4 10.9 6.6 3.0 29.5 40.3 21.8 22.2 53.4 5.9 25.5 9.4 4.5 10.4 39.3 18.0 28.2 33.2 18.6 16.2 21.8 0.0 27.2 20.1 17.5 13.9 30.1 8.3 16.4 17.5 43.4 19.6 10.0 7.0 16.4 15.1 27.0 33.3 15.6 48.9 25.4 25.9 19.4 19.2 46.6 19.4 22.1 30.9 24.0 21.8 17.6 63.3 16.6 22.1 TBCEL "LRRC35, MGC10233" ENSG00000154114 "Tubulin folding cofactor E like" Q5QJ74 11 121024072-121090775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038593, HPA038594" Approved Uncertain Cytosol NA NA Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" "unprognostic (9.06e-3)" "unprognostic (3.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.29e-1)" "unprognostic (5.80e-2)" "unprognostic (3.13e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.27e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.07e-3)" "unprognostic (1.86e-1)" "unprognostic (1.66e-2)" "unprognostic (1.02e-1)" 12.4 10.8 9.2 8.3 11.9 6.6 12.2 12.5 13.8 10.8 11.4 15.6 25.8 7.3 18.4 18.3 8.1 11.5 10.8 12.8 9.6 9.1 11.7 19.6 13.7 9.1 12.5 11.1 15.3 10.8 30.8 22.8 14.3 15.8 12.8 8.3 13.2 12.9 17.7 11.0 7.6 9.6 13.1 11.8 14.1 10.2 26.1 12.3 9.5 14.6 6.1 9.6 10.5 10.2 1.1 2.1 0.8 1.4 2.8 2.2 1.0 4.4 4.3 7.4 6.4 13.6 12.9 5.7 8.6 10.6 6.6 9.7 4.4 7.2 5.6 13.3 10.6 6.5 1.2 8.1 2.8 8.9 6.6 6.0 9.6 3.3 4.4 16.9 6.8 6.7 14.1 9.7 6.4 7.0 6.8 10.8 3.2 2.8 10.8 9.2 3.2 2.7 5.6 4.3 0.2 4.2 2.4 10.9 2.5 8.9 2.8 3.9 9.2 8.4 8.9 5.7 6.9 8.5 5.8 14.0 14.7 3.3 5.9 4.7 4.2 3.0 2.9 2.1 0.0 5.5 0.0 1.1 0.5 1.5 1.4 2.1 0.5 2.1 2.1 1.3 1.1 2.2 1.4 0.8 2.8 1.0 2.1 1.0 1.0 9.2 11.9 12.5 13.8 9.6 9.1 12.5 11.1 15.8 12.3 6.0 7.0 4.5 1.7 2.6 8.5 7.0 7.6 6.7 1.2 7.0 13.7 1.3 1.7 3.7 7.6 4.9 2.0 46.7 2.1 1.5 4.2 2.6 1.1 17.9 2.7 7.9 3.5 12.3 6.3 4.2 8.6 2.4 10.1 14.4 2.5 6.0 3.3 0.0 9.2 3.6 8.5 0.0 4.7 12.7 5.5 1.5 1.1 4.4 2.2 1.0 TBL2 "DKFZP43N024, WBSCR13, WS-betaTRP" ENSG00000106638 "Transducin beta like 2" Q9Y4P3 7 73568932-73578791 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.5" "Group enriched" "Detected in many" 7 "Early spermatids: 291.7;Late spermatids: 375.4;Spermatocytes: 284.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007477, HPA051533" Supported Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA007477: AB_1080214, HPA051533: AB_2681523" "unprognostic (9.04e-2)" "unprognostic (6.61e-3)" "unprognostic (4.24e-2)" "unprognostic (1.10e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.24e-3)" "unprognostic (7.50e-2)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (1.74e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" 8.9 12.1 3.7 5.4 3.3 1.8 5.9 2.7 5.3 8.7 6.6 3.4 11.6 6.1 6.5 10.9 7.3 5.5 6.3 5.4 2.5 2.5 6.1 14.2 6.5 4.7 3.5 2.1 10.7 27.0 8.5 7.0 13.0 3.4 6.5 6.9 5.1 16.3 8.0 4.9 6.9 6.3 5.4 3.0 5.4 8.2 70.5 3.7 6.2 11.8 4.2 5.2 8.5 6.2 4.2 14.4 13.2 11.4 8.3 6.7 7.6 12.2 14.0 4.8 7.1 13.2 12.8 6.0 14.7 11.0 5.6 10.1 21.4 13.2 10.0 3.3 12.9 11.9 9.4 10.2 5.9 11.1 3.9 6.9 3.6 7.4 14.0 19.0 7.3 13.3 7.9 10.2 17.1 13.7 10.9 6.4 1.9 14.7 7.9 8.5 11.9 7.1 7.2 5.0 15.0 11.5 4.6 8.7 22.1 7.2 8.6 5.1 8.2 14.6 40.0 9.2 6.6 10.5 5.6 10.8 10.6 5.2 9.8 14.8 15.9 9.9 11.3 13.6 9.0 12.3 13.2 11.4 5.2 6.6 7.9 6.5 3.4 5.6 6.0 14.4 4.2 6.7 4.2 1.0 8.3 7.0 10.8 6.5 7.6 3.7 3.3 2.7 5.3 2.5 2.5 3.5 2.1 3.4 3.7 23.8 9.4 12.3 11.1 4.0 10.0 4.5 12.7 6.7 7.9 5.2 7.9 39.4 1.7 21.8 291.7 9.8 10.9 0.0 26.3 45.4 11.5 14.0 13.9 15.3 26.0 3.2 9.1 12.9 7.5 375.4 21.9 7.9 6.8 23.4 15.7 7.8 21.3 14.4 25.1 5.0 12.9 6.5 8.0 284.6 22.2 3.1 36.3 3.3 14.3 7.5 TCL1B TML1 ENSG00000213231 "T cell leukemia/lymphoma 1B" O95988 14 95686417-95692643 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3" "Cell type enriched" "Detected in some" 13 "Syncytiotrophoblasts: 60.8" "Cancer enriched" "Detected in single" 72 "testis cancer: 8.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "naive B-cell: 13.0;plasmacytoid DC: 5.9" "Group enriched" "Detected in many" 23 "B-cells: 13.0;dendritic cells: 5.9" "Cell line enriched" "Detected in some" 7 "U-698: 104.8" "Not detected" "Not detected" HPA053163 Uncertain Approved Cytosol NA NA Cytosol "HPA053163: AB_2682064" "unprognostic (1.55e-1)" 0.1 0.2 0.1 0.9 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 1.4 0.4 0.1 0.0 0.1 0.1 0.1 1.1 0.1 0.1 5.3 0.1 0.0 0.2 0.1 0.0 0.1 12.7 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.1 1.8 0.1 7.3 0.0 0.0 0.1 0.0 5.4 0.1 0.1 13.0 5.9 0.3 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 104.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.3 0.4 0.0 5.9 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.7 0.0 60.8 0.0 0.0 0.0 TCN2 "D22S676, D22S750, TC2" ENSG00000185339 "Transcobalamin 2" P20062 22 30606838-30627278 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 104.9;Ito cells: 111.1;Kupffer cells: 140.0;Proximal tubular cells: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 19.2;intermediate monocyte: 29.0;non-classical monocyte: 9.8" "Lineage enriched" "Detected in many" 8 "monocytes: 29.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 35.3;HUVEC TERT2: 41.4;Karpas-707: 53.8;RPTEC TERT1: 20.9;TIME: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000837 Approved Cytosol "Secreted to blood" NA NA 13000000 Cytosol "HPA000837: AB_1080235" "unprognostic (6.43e-2)" "prognostic favorable (3.47e-4)" "unprognostic (1.53e-3)" "unprognostic (3.17e-1)" "unprognostic (1.49e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.64e-4)" "unprognostic (1.52e-2)" "unprognostic (2.90e-1)" "unprognostic (1.07e-1)" "unprognostic (4.03e-2)" "unprognostic (1.59e-1)" "unprognostic (6.95e-3)" "unprognostic (4.94e-3)" "unprognostic (2.09e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" 39.8 15.2 6.5 7.2 8.1 2.2 30.0 3.4 10.9 13.1 14.8 9.2 9.6 10.9 15.0 23.9 7.0 11.2 31.7 15.8 6.6 7.3 73.2 8.7 21.7 43.3 8.6 8.5 7.8 6.3 5.7 7.9 8.7 10.7 9.6 13.5 13.5 6.8 23.0 5.4 4.5 30.4 17.6 9.0 24.8 8.4 9.7 5.1 1.9 12.8 4.8 4.6 11.6 10.9 0.0 3.4 0.6 29.0 0.0 0.3 6.5 0.0 2.6 12.1 0.0 7.2 35.3 0.4 0.8 8.8 2.2 3.7 1.2 6.1 0.1 13.4 1.7 0.2 0.4 1.0 0.6 0.7 0.0 0.6 0.0 0.3 0.5 17.3 0.1 9.9 5.8 0.7 1.7 1.5 2.5 41.4 0.0 0.2 53.8 3.6 0.0 0.0 0.9 4.7 3.3 0.3 1.3 1.7 18.1 20.9 0.3 4.2 0.5 0.0 0.1 3.5 0.8 0.1 0.5 24.2 7.8 1.0 0.9 0.3 1.4 0.3 0.0 2.7 0.4 0.1 0.0 19.2 0.0 0.0 29.0 0.3 0.0 0.3 0.2 3.4 0.0 0.1 0.2 0.6 0.0 9.8 0.6 0.1 6.5 6.5 8.1 3.4 10.9 6.6 7.3 8.6 8.5 10.7 5.1 3.0 3.8 6.0 0.8 4.6 7.3 5.0 35.7 2.7 4.5 12.2 19.6 0.4 6.6 5.9 0.8 59.1 104.9 0.0 5.2 0.7 11.2 2.0 4.6 5.0 40.3 1.6 6.4 111.1 140.0 1.0 9.8 32.3 21.9 7.2 23.3 6.0 5.6 49.1 9.2 115.0 28.1 12.9 4.7 0.7 7.8 4.5 0.3 2.1 10.0 2.4 TCP11L1 FLJ11336 ENSG00000176148 "T-complex 11 like 1" Q9NUJ3 11 33039417-33105943 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005769 Approved Approved Cytosol NA Yes Cytosol "HPA005769: AB_2202398" "unprognostic (5.22e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (3.73e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "unprognostic (6.99e-2)" "unprognostic (9.10e-2)" "unprognostic (1.42e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (9.50e-3)" 12.0 10.1 13.0 10.2 19.2 12.8 14.1 15.0 25.3 10.4 15.1 14.7 9.3 11.7 11.1 6.9 9.8 8.2 15.5 10.6 13.9 14.9 11.6 8.1 9.4 8.8 16.8 16.1 11.1 12.6 9.9 12.5 13.3 21.2 10.3 14.4 7.4 8.7 14.4 6.6 10.4 22.9 16.8 16.2 9.8 10.0 10.3 11.1 8.1 7.4 5.0 10.7 10.6 10.9 2.6 11.1 13.1 6.1 4.5 5.7 3.1 6.8 12.5 6.3 6.0 11.0 12.4 4.3 10.0 8.4 7.7 10.4 6.4 3.3 6.9 2.8 19.2 11.5 11.0 8.4 7.7 10.9 8.9 6.7 4.5 13.8 4.6 7.2 4.3 6.4 10.0 9.7 7.9 15.1 8.8 7.5 10.1 2.9 8.4 19.2 9.9 4.6 1.8 4.7 5.1 4.6 5.4 13.1 1.2 7.0 2.6 5.2 10.7 25.2 16.4 4.6 8.5 4.0 1.9 11.4 13.6 19.8 15.2 10.4 10.5 10.3 8.0 9.8 2.3 10.6 13.1 6.1 8.3 3.6 3.7 3.5 2.2 2.0 4.0 5.9 2.6 2.0 2.6 3.6 4.5 0.9 11.1 5.7 3.1 13.0 19.2 15.0 22.9 13.9 14.9 16.8 16.1 21.2 11.1 8.9 0.6 3.0 8.6 2.1 7.2 2.8 5.1 0.0 1.2 0.0 3.9 2.7 1.7 3.6 8.4 3.5 4.2 0.0 3.5 17.4 3.2 3.9 4.6 1.3 5.8 7.9 1.7 4.9 5.3 4.5 1.7 3.7 0.0 31.5 1.0 1.5 5.1 1.5 2.5 4.4 4.9 0.0 7.3 7.6 5.5 2.3 3.9 5.0 1.2 3.3 TCTA ENSG00000145022 "T cell leukemia translocation altered" P57738 3 49412206-49416475 "Disease related genes, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007342 Approved Approved Cytosol NA NA Cytosol "HPA007342: AB_2202399" "unprognostic (5.58e-2)" "unprognostic (4.33e-2)" "unprognostic (6.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.17e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "prognostic favorable (6.76e-4)" "unprognostic (3.74e-1)" "unprognostic (3.38e-3)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.00e-15)" "unprognostic (1.68e-1)" "unprognostic (1.96e-1)" "unprognostic (3.43e-1)" "unprognostic (6.41e-3)" 15.4 29.3 21.8 9.2 21.9 7.9 16.3 12.5 26.1 18.3 16.9 23.1 19.5 14.0 13.6 46.9 12.8 20.1 19.3 13.1 20.6 20.8 35.6 27.2 17.2 14.3 23.2 18.5 19.4 18.5 17.9 28.4 19.1 22.2 25.2 21.8 23.3 16.0 20.0 10.5 7.8 19.4 16.5 25.6 15.1 16.3 9.3 12.8 12.6 34.1 10.2 11.4 13.0 8.9 9.5 10.1 14.6 28.0 13.4 13.0 13.4 5.9 7.3 4.8 7.1 21.2 9.3 6.3 12.3 9.2 12.6 10.6 4.3 6.5 7.1 9.1 29.1 14.5 6.9 9.3 12.4 10.3 10.6 6.4 11.8 9.6 5.5 12.8 5.1 15.6 20.0 13.0 13.9 11.2 12.1 12.9 5.7 4.3 16.3 30.6 5.5 6.1 4.5 3.9 11.3 17.1 3.7 5.2 16.7 21.5 7.9 12.8 4.2 14.7 16.3 13.4 10.1 13.9 4.8 11.7 9.5 5.9 19.6 4.6 9.0 11.8 4.8 22.3 9.0 13.0 12.7 11.5 14.6 13.0 21.9 7.6 8.0 8.4 10.0 6.6 9.5 10.4 11.0 13.2 13.4 28.0 10.1 10.7 13.4 21.8 21.9 12.5 26.1 20.6 20.8 23.2 18.5 22.2 12.8 23.8 17.0 11.9 9.0 2.4 10.1 11.0 25.5 29.4 12.5 26.2 11.8 21.6 39.7 13.5 5.9 10.8 32.5 0.0 10.0 10.1 10.8 18.7 5.7 27.2 21.4 9.5 16.8 12.3 20.2 11.1 14.4 13.1 13.5 16.2 16.3 20.7 12.8 21.0 15.2 42.1 10.7 6.5 15.1 7.2 6.1 4.0 16.7 20.1 15.1 7.0 TCTEX1D2 MGC33212 ENSG00000213123 "Tctex1 domain containing 2" Q8WW35 3 196291219-196318299 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 37.4" "Group enriched" "Detected in many" 4 "Ciliated cells: 301.2;Distal tubular cells: 102.8;Early spermatids: 174.6;Spermatocytes: 192.1;Spermatogonia: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 16.6;dendritic cells: 10.9;T-cells: 18.3" "Cell line enhanced" "Detected in many" "T-47d: 38.9" HPA049555 Approved Cytosol NA NA Cytosol "HPA049555: AB_2680816" "unprognostic (1.16e-1)" "prognostic favorable (7.83e-4)" "unprognostic (5.34e-2)" "unprognostic (1.59e-2)" "unprognostic (1.47e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (4.61e-1)" "unprognostic (9.98e-3)" "unprognostic (3.99e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (6.23e-4)" "unprognostic (3.73e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" 4.3 7.4 20.5 5.1 21.6 5.3 7.0 15.0 18.3 5.2 5.3 7.0 7.2 4.7 8.4 10.4 10.7 37.4 6.3 6.3 15.4 18.6 11.8 2.3 9.1 9.1 12.1 15.8 8.7 6.6 6.8 18.8 4.1 10.6 6.4 4.9 6.8 7.6 6.2 3.1 9.2 3.0 5.3 8.7 4.1 5.2 24.2 8.1 6.8 11.2 5.1 6.5 4.9 5.9 16.6 10.9 1.4 2.3 2.9 18.3 5.6 13.6 10.2 15.7 10.2 4.1 8.1 2.2 5.6 3.2 6.0 6.7 3.5 16.7 8.8 10.3 4.0 2.3 14.4 6.4 5.1 5.6 7.7 5.7 3.4 10.1 1.4 4.5 2.2 0.3 4.0 13.5 4.9 6.2 10.9 3.5 17.2 4.9 4.4 11.5 33.5 11.5 11.3 11.1 12.7 19.4 14.5 3.1 3.6 12.8 5.6 19.8 16.7 12.7 6.4 11.2 6.5 38.9 6.5 7.9 5.8 2.5 2.3 6.5 7.5 14.3 18.9 17.4 4.3 9.9 0.0 2.3 1.2 9.2 0.8 5.6 16.6 11.6 7.3 6.0 9.5 7.4 7.3 1.4 2.9 0.6 10.9 18.3 5.6 20.5 21.6 15.0 18.3 15.4 18.6 12.1 15.8 10.6 8.1 8.9 6.9 10.0 18.9 14.7 17.4 5.0 30.6 301.2 39.8 34.9 9.8 24.1 102.8 23.6 174.6 10.5 4.0 0.0 9.4 7.0 11.6 10.3 8.1 3.4 13.5 28.6 24.6 14.7 3.2 30.9 16.1 6.3 18.6 19.8 9.5 29.8 9.2 3.5 29.4 35.2 18.4 12.9 7.3 192.1 110.5 15.9 5.1 11.5 11.9 14.4 TEX37 "C2orf51, FLJ25369, TSC21" ENSG00000172073 "Testis expressed 37" Q96LM6 2 88524651-88529584 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 221 "testis: 54.4" "Group enriched" "Detected in some" 176 "Early spermatids: 799.5;Late spermatids: 2063.1" "Cancer enriched" "Detected in single" 17 "testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "BEWO: 34.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043987, HPA070239" Enhanced Supported Cytosol NA NA Cytosol "HPA043987: AB_10961125, HPA070239: " "unprognostic (1.08e-3)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 34.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 799.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2063.1 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 6.5 0.0 7.7 8.1 0.0 0.2 0.0 0.0 0.0 TGFBR3 "betaglycan, BGCAN" ENSG00000069702 "Transforming growth factor beta receptor 3" Q03167 1 91680343-91906335 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 105.0;Ito cells: 311.2;Leydig cells: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 22 "NK-cells: 9.0;T-cells: 21.3" "Cell line enhanced" "Detected in many" "ASC diff: 67.2;ASC TERT1: 32.8;U-2197: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008257, CAB018971" Supported Approved Cytosol "Secreted to blood" NA NA 29000000 Cytosol "CAB018971: , HPA008257: AB_1080258" "unprognostic (7.57e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.36e-4)" "unprognostic (9.39e-3)" "prognostic favorable (4.84e-4)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (9.32e-2)" "unprognostic (1.07e-1)" "prognostic favorable (4.99e-4)" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.08e-2)" 40.1 15.9 3.2 6.8 3.1 1.6 63.5 1.8 4.4 30.1 15.2 3.5 30.0 3.4 17.6 21.0 22.2 17.6 23.3 16.3 3.9 1.9 12.5 11.9 18.4 18.1 2.6 2.0 62.4 8.9 4.4 4.4 25.1 4.5 21.7 5.6 8.8 14.7 46.5 19.2 13.4 9.8 34.4 4.1 27.1 11.1 14.0 3.0 1.1 7.5 6.5 3.1 39.2 42.1 0.0 0.6 0.6 0.6 9.0 21.3 3.9 2.7 2.7 4.1 0.7 67.2 32.8 13.0 2.0 10.2 2.4 2.9 1.2 0.4 0.0 0.5 3.7 1.9 0.4 1.0 0.3 1.8 9.5 2.2 0.0 3.4 11.3 1.4 0.1 0.0 7.9 1.3 5.2 1.2 0.3 1.2 0.0 6.5 0.2 0.7 0.0 0.0 0.0 1.7 1.2 0.9 0.1 1.4 0.5 0.9 16.4 0.1 0.0 1.0 0.0 5.7 1.7 0.3 1.0 3.6 4.0 1.0 22.8 0.4 10.1 0.9 0.0 0.8 0.5 0.5 0.6 0.0 0.0 21.3 0.1 11.6 0.0 5.4 11.4 0.0 0.0 1.7 8.0 0.3 9.0 0.6 0.6 2.4 3.9 3.2 3.1 1.8 4.4 3.9 1.9 2.6 2.0 4.5 3.0 8.9 11.9 3.0 10.4 33.4 0.2 17.3 28.1 6.7 6.8 29.6 2.0 23.5 3.3 1.7 48.3 64.2 0.7 23.3 4.2 9.3 105.0 7.3 2.3 17.8 9.7 0.0 23.1 311.2 19.6 18.5 135.4 3.8 33.7 0.0 0.5 2.2 3.5 0.0 70.0 15.9 0.2 12.9 35.4 0.7 1.7 29.7 48.5 30.5 2.3 5.4 TGS1 "NCOA6IP, PIMT" ENSG00000137574 "Trimethylguanosine synthase 1" Q96RS0 8 55773142-55825448 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025024, HPA029824" Supported Supported Cytosol NA NA Cytosol "HPA025024: AB_1854330, HPA029824: AB_2673212" "unprognostic (4.13e-2)" "unprognostic (7.46e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.70e-2)" "unprognostic (1.60e-2)" "unprognostic (4.94e-2)" "unprognostic (9.32e-2)" "unprognostic (3.15e-2)" "unprognostic (3.58e-1)" "unprognostic (2.22e-2)" "unprognostic (8.62e-2)" "unprognostic (7.23e-2)" "unprognostic (3.42e-1)" "unprognostic (2.85e-2)" 12.1 10.0 7.2 18.2 9.1 13.3 12.6 18.1 10.2 11.6 14.1 7.2 18.2 7.6 14.3 16.0 13.5 14.1 9.4 8.5 8.8 6.7 12.6 8.8 10.7 18.8 5.3 6.9 14.8 9.6 12.3 13.8 10.2 7.4 11.9 10.1 7.1 11.6 20.0 19.6 14.1 16.8 11.5 6.3 17.7 10.5 10.8 8.0 29.7 11.6 13.2 18.3 14.5 14.5 10.4 10.1 10.0 7.6 6.3 13.1 4.8 9.3 7.0 8.4 9.3 7.3 7.3 8.7 8.8 9.0 9.4 9.6 6.5 9.1 21.1 6.1 5.8 7.1 9.0 17.6 11.2 11.9 11.7 6.7 22.6 7.8 3.6 10.4 12.6 7.8 7.2 7.6 9.0 18.4 4.3 7.2 12.4 18.4 8.3 7.6 7.1 28.3 8.2 30.5 13.9 2.8 20.2 6.0 6.7 8.6 9.4 8.5 11.7 11.2 6.8 10.0 9.4 9.3 7.7 7.0 6.9 8.8 8.2 7.9 7.3 4.8 26.7 6.8 9.9 8.8 10.0 5.5 8.8 11.6 6.3 13.1 9.8 11.6 11.2 5.5 10.4 11.9 12.4 6.3 6.3 7.6 10.1 9.2 4.8 7.2 9.1 18.1 10.2 8.8 6.7 5.3 6.9 7.4 8.0 44.7 29.1 31.2 30.3 32.7 29.5 10.9 17.8 33.5 53.4 48.8 21.6 24.4 3.3 15.9 2.8 25.1 8.9 23.3 21.8 24.3 18.5 18.5 48.5 13.4 17.7 20.6 10.3 20.9 16.7 3.1 27.3 18.6 6.8 17.2 20.3 28.3 19.2 10.5 21.5 14.2 27.6 25.8 18.1 52.9 61.5 22.8 18.8 30.5 18.9 23.8 TH DYT5b ENSG00000180176 "Tyrosine hydroxylase" P07101 11 2163929-2171877 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Catecholamine biosynthesis, Neurotransmitter biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "adrenal gland: 83.5;brain: 41.4" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 1.8;Extravillous trophoblasts: 7.9;Leydig cells: 3.1;Syncytiotrophoblasts: 1.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 4.0" "Group enriched" "Detected in many" 6 "hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "PC-3: 35.9;SK-BR-3: 12.8" "Region enhanced" "Detected in many" "olfactory region: 220.1" "Region enriched" "Detected in many" 19 "midbrain: 692.0" "CAB002522, HPA013768, HPA014010, HPA061003, CAB072340" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374" "unprognostic (1.31e-1)" "unprognostic (1.30e-1)" "unprognostic (9.08e-2)" "unprognostic (1.75e-4)" "unprognostic (8.82e-3)" "unprognostic (5.88e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-3)" "unprognostic (3.83e-2)" "unprognostic (4.39e-4)" "unprognostic (4.97e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-2)" "unprognostic (2.18e-2)" 1.3 83.5 0.0 0.3 5.4 0.2 0.2 0.0 0.7 1.8 0.2 6.2 0.0 0.2 0.3 0.3 0.2 0.3 0.4 0.2 0.3 15.5 0.2 0.2 0.2 0.2 41.4 0.0 0.3 0.3 0.2 0.2 0.9 41.2 0.6 0.2 0.3 0.2 2.0 0.2 0.5 0.4 0.2 0.0 0.3 0.2 0.3 1.5 0.0 0.2 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 35.9 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.7 0.3 15.5 41.4 0.0 41.2 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.1 THADA "ARMC13, FLJ21877, GITA, KIAA1767" ENSG00000115970 "THADA, armadillo repeat containing" Q6YHU6 2 43230836-43596046 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035191, HPA035192" Uncertain Approved Cytosol NA NA Cytosol "HPA035191: AB_10670290, HPA035192: AB_2674512" "unprognostic (1.20e-1)" "unprognostic (2.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (4.26e-1)" "prognostic unfavorable (6.48e-4)" "unprognostic (8.27e-2)" "unprognostic (9.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.12e-1)" "unprognostic (3.43e-2)" "unprognostic (5.25e-2)" "unprognostic (2.14e-1)" 15.7 12.5 8.6 14.2 11.9 12.0 15.8 8.8 10.6 15.0 10.6 13.8 20.2 6.6 25.3 16.8 12.8 15.8 9.7 11.8 7.5 7.1 12.6 18.5 13.5 20.0 10.9 6.1 15.8 17.1 27.2 29.9 9.6 10.9 16.4 10.1 12.7 17.7 12.6 12.7 16.2 11.7 12.4 11.4 17.2 11.1 12.3 10.0 23.1 17.9 12.3 23.3 12.6 19.4 4.9 5.2 14.7 4.7 6.5 5.4 2.6 13.1 15.8 7.2 0.2 19.5 16.9 10.4 8.8 7.3 8.4 7.2 9.2 7.9 12.1 15.2 10.5 11.4 12.3 11.1 15.1 14.5 10.0 11.0 8.6 6.3 12.2 6.8 13.3 7.0 11.0 13.8 17.6 23.1 8.8 11.3 4.5 15.3 6.5 10.1 16.5 13.1 14.9 14.4 19.0 9.0 6.1 13.0 9.1 13.2 11.8 9.5 14.8 8.4 8.2 7.9 8.7 8.4 7.0 9.6 13.9 10.2 10.5 15.9 16.5 10.2 13.7 11.2 13.3 11.1 14.7 3.3 1.4 4.5 4.7 4.8 4.8 5.0 5.4 5.2 4.9 4.7 5.3 2.6 6.5 3.4 4.1 5.3 2.6 8.6 11.9 8.8 10.6 7.5 7.1 10.9 6.1 10.9 10.0 17.9 11.8 7.9 15.9 7.6 11.6 7.5 17.8 18.7 14.8 14.0 15.7 6.6 1.7 7.8 16.4 7.1 3.3 0.0 8.4 4.7 8.7 10.7 5.8 14.0 8.8 3.2 7.0 11.6 5.7 7.4 9.2 8.6 3.3 5.4 4.5 6.7 5.9 6.2 8.1 5.4 24.9 0.0 7.5 20.2 12.8 3.9 4.0 7.5 5.6 6.9 THOP1 ENSG00000172009 "Thimet oligopeptidase 1" P52888 19 2785460-2815807 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 167.6;Paneth cells: 149.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025497, HPA035262" Uncertain Supported Cytosol NA NA 1400000 Cytosol "CAB025497: , HPA035262: AB_2674541" "unprognostic (1.52e-2)" "unprognostic (1.73e-3)" "unprognostic (7.94e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" "unprognostic (1.19e-1)" "unprognostic (4.05e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-3)" "unprognostic (3.00e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.90e-4)" "unprognostic (1.27e-1)" "unprognostic (2.64e-1)" "unprognostic (5.37e-2)" 8.2 9.4 19.1 12.3 19.8 18.4 6.2 21.7 26.1 5.2 11.8 14.1 5.8 24.6 7.5 8.4 11.0 8.4 6.7 11.6 18.5 15.4 7.1 30.4 6.2 11.9 14.1 15.2 11.1 7.8 7.0 12.7 22.3 13.1 18.1 8.2 11.9 13.7 6.8 29.1 11.9 20.0 7.1 10.7 9.8 7.8 27.3 10.9 17.0 7.5 11.5 11.3 5.8 6.8 7.5 9.8 8.0 7.5 3.9 9.5 3.2 29.4 21.9 8.6 18.3 4.4 4.3 30.5 18.4 6.8 18.3 14.8 25.7 9.4 26.6 9.0 7.1 12.8 24.0 12.7 15.1 7.7 0.1 26.6 9.4 24.1 30.4 4.7 18.1 14.7 4.8 5.4 15.2 6.8 5.2 10.4 18.0 21.8 13.0 7.7 22.8 20.1 34.0 25.2 8.8 30.2 16.7 11.4 25.1 7.6 17.1 23.3 18.5 16.1 14.5 8.9 4.6 14.0 17.6 11.7 14.1 12.1 30.0 31.1 22.8 19.1 17.9 15.7 30.4 16.7 8.0 3.5 1.6 5.5 3.9 4.5 5.6 4.0 7.4 4.9 7.5 5.1 4.3 1.7 3.9 7.5 9.8 9.5 3.2 19.1 19.8 21.7 26.1 18.5 15.4 14.1 15.2 13.1 10.9 3.0 11.7 12.3 8.7 6.1 20.3 7.3 10.2 5.3 7.9 10.4 33.4 20.9 8.3 17.0 11.4 5.7 167.6 0.0 12.9 46.8 8.4 12.6 5.7 79.1 19.9 6.4 39.2 6.2 9.5 18.4 10.6 7.0 3.3 11.8 46.9 12.9 15.9 149.7 5.6 9.1 29.7 12.9 9.2 47.9 19.4 5.1 28.3 6.5 38.5 6.4 THRA "AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3" ENSG00000126351 "Thyroid hormone receptor, alpha" P10827 17 40058290-40093867 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009654, CAB023349" Approved Supported Cytosol NA NA Cytosol "CAB023349: AB_619577, HPA009654: AB_1854603" "unprognostic (2.75e-2)" "unprognostic (2.20e-1)" "unprognostic (6.64e-2)" "unprognostic (4.22e-2)" "unprognostic (8.78e-2)" "unprognostic (1.64e-1)" "unprognostic (3.41e-3)" "prognostic favorable (1.84e-4)" "unprognostic (1.47e-1)" "unprognostic (5.47e-2)" "unprognostic (7.85e-2)" "unprognostic (2.65e-2)" "prognostic favorable (6.05e-8)" "unprognostic (3.05e-1)" "unprognostic (1.35e-1)" "unprognostic (4.21e-1)" "unprognostic (1.88e-3)" 17.1 20.7 58.6 5.7 90.7 9.9 12.9 37.4 73.1 19.8 12.6 24.1 8.2 15.1 19.3 11.5 9.7 29.3 12.7 30.1 43.8 38.1 12.1 2.7 11.6 4.5 34.3 45.5 46.5 12.3 13.0 10.7 8.5 29.6 12.4 9.6 10.4 13.7 18.8 38.5 10.0 16.7 17.4 29.4 6.1 11.9 7.8 43.6 1.8 12.5 7.9 3.3 10.0 18.6 1.0 1.5 3.7 0.7 5.1 4.7 1.4 2.1 17.3 5.4 13.5 37.3 13.7 2.0 8.9 10.7 9.2 8.7 14.3 12.6 2.5 14.8 17.2 4.1 5.2 10.5 5.4 5.0 1.0 10.0 4.7 20.6 6.1 12.6 7.5 5.2 21.7 4.5 8.6 3.4 21.6 12.4 7.7 9.4 2.4 7.6 3.2 10.1 12.5 4.9 11.2 5.4 14.4 10.7 12.4 3.1 1.5 9.2 8.4 6.8 10.9 15.4 8.6 12.8 8.9 8.5 9.2 9.2 8.3 2.6 5.6 3.9 1.5 5.7 8.7 4.9 0.3 0.6 3.7 4.7 0.3 2.0 0.6 1.9 2.8 0.8 1.0 3.4 4.1 2.5 5.1 0.7 1.5 2.2 1.4 58.6 90.7 37.4 41.8 43.8 38.1 34.3 45.5 29.6 43.6 17.9 5.3 2.2 23.4 9.4 70.7 41.6 45.9 6.7 2.3 31.4 19.6 0.7 43.1 9.9 0.6 15.7 41.1 0.0 13.1 1.1 21.6 16.7 13.9 11.5 10.8 58.8 24.1 24.5 7.8 0.8 47.8 4.6 18.6 0.0 17.6 75.1 6.8 17.5 46.7 18.8 20.2 19.4 34.9 0.0 14.9 9.2 0.2 12.5 29.5 9.5 THSD1 TMTSP ENSG00000136114 "Thrombospondin type 1 domain containing 1" Q9NS62 13 52377167-52406494 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 26.3;Ito cells: 12.9;Spermatocytes: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 12.3;HBEC3-KT: 12.3;hTCEpi: 12.3;hTERT-HME1: 12.6;HUVEC TERT2: 25.6;LHCN-M2: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012611, CAB020796" Uncertain Supported Cytosol "Intracellular and membrane" No No 810000 Cytosol "CAB020796: , HPA012611: AB_1857990" "unprognostic (1.21e-1)" "unprognostic (7.54e-3)" "unprognostic (3.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.31e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-1)" "unprognostic (6.10e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-3)" "unprognostic (8.44e-2)" "unprognostic (1.31e-1)" "unprognostic (3.35e-2)" "unprognostic (4.90e-2)" 9.7 1.8 8.3 1.8 7.2 0.4 11.1 2.9 6.4 7.6 2.6 1.9 3.6 1.2 6.8 4.9 4.4 5.7 4.9 9.0 8.1 2.2 2.0 2.1 19.8 4.7 2.2 4.6 2.3 1.2 2.5 3.4 16.8 2.1 8.5 2.3 5.5 3.9 3.2 9.7 6.0 2.3 7.4 2.2 6.6 1.9 2.7 1.1 0.7 5.2 5.2 2.5 5.9 4.5 0.3 0.0 0.0 0.0 0.4 0.7 0.0 0.5 2.4 0.2 2.2 2.0 6.7 0.5 5.2 2.6 2.0 3.3 0.0 0.3 0.2 0.6 12.3 2.0 2.7 0.0 12.3 3.2 5.7 1.8 0.3 0.0 0.0 1.2 1.2 0.3 2.6 12.3 9.9 12.6 1.1 25.6 0.7 0.0 0.1 11.7 0.0 0.4 0.2 0.1 0.1 0.5 0.3 2.7 0.0 2.8 0.1 0.0 0.4 0.1 0.0 0.4 0.1 0.2 0.2 5.9 0.6 1.1 0.0 3.8 0.4 0.0 0.0 1.1 0.4 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.3 7.2 2.9 6.4 8.1 2.2 2.2 4.6 2.1 1.1 0.0 1.4 1.4 0.9 1.3 0.8 2.7 0.0 0.0 1.2 1.8 2.0 4.2 3.3 0.2 0.8 26.3 0.0 0.0 0.6 1.5 2.7 1.3 0.0 1.6 2.4 0.0 0.0 12.9 2.6 0.0 3.1 0.7 5.0 0.0 0.2 1.2 0.2 0.0 3.5 0.8 2.8 6.5 1.9 19.1 9.1 1.4 2.9 1.9 0.4 0.3 THUMPD1 "FLJ20274, Tan1" ENSG00000066654 "THUMP domain containing 1" Q9NXG2 16 20702816-20742084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027851 Approved Approved Cytosol NA NA Cytosol "HPA027851: AB_10670036" "unprognostic (1.67e-1)" "unprognostic (1.62e-1)" "prognostic favorable (2.99e-4)" "unprognostic (1.48e-1)" "unprognostic (3.69e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "unprognostic (4.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.73e-2)" "unprognostic (6.88e-2)" "unprognostic (2.45e-1)" "prognostic favorable (8.52e-8)" "unprognostic (1.98e-1)" "unprognostic (5.95e-2)" "unprognostic (1.09e-1)" "unprognostic (1.25e-2)" 22.0 20.1 17.5 17.6 24.2 17.8 36.7 23.6 24.7 27.2 23.6 12.4 25.9 12.8 29.1 27.2 16.7 23.3 17.7 16.5 17.6 15.8 22.8 16.6 16.0 18.3 14.2 20.7 29.2 21.9 37.1 27.6 20.3 19.2 33.1 19.2 12.9 18.5 28.7 17.3 16.6 19.7 31.9 13.3 18.6 27.0 15.9 17.2 27.6 23.3 15.0 19.9 25.5 22.0 10.0 5.9 17.8 7.3 13.4 19.6 8.5 9.9 10.9 19.1 10.9 16.2 14.1 11.5 10.0 9.9 9.2 9.0 8.4 10.5 24.7 19.0 11.1 8.5 9.3 12.1 13.1 14.3 14.1 7.2 22.8 9.8 18.3 10.6 36.1 45.7 11.9 17.4 10.0 11.5 10.8 10.5 11.0 43.7 19.0 10.2 11.1 16.9 13.1 16.1 8.6 6.6 23.2 18.3 19.1 10.2 8.6 14.9 10.2 8.4 14.6 9.5 11.8 10.5 11.9 10.7 13.6 7.8 9.0 9.5 20.1 18.6 18.4 10.4 10.0 10.8 7.1 6.0 17.8 15.4 7.0 18.8 10.0 14.7 14.4 5.9 9.5 19.6 16.8 2.8 13.4 7.3 5.0 11.3 8.5 17.5 24.2 23.6 24.7 17.6 15.8 14.2 20.7 19.2 17.2 38.7 40.3 41.6 30.4 42.9 33.8 26.9 45.9 44.2 45.5 29.6 19.6 50.2 33.2 24.4 3.6 42.8 25.2 23.3 29.7 30.3 36.0 37.9 68.3 39.9 26.5 33.4 35.1 35.0 34.5 4.5 38.0 26.5 32.1 32.5 36.4 47.9 21.7 24.6 63.6 39.6 36.3 45.3 41.9 45.3 67.7 48.4 61.1 52.5 39.6 29.8 TIGAR C12orf5 ENSG00000078237 "TP53 induced glycolysis regulatory phosphatase" Q9NQ88 12 4307763-4354593 "Enzymes, Predicted intracellular proteins" "Apoptosis, Autophagy" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 53.0;monocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 36.9;SuSa: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034010, HPA040354, HPA044111" Approved Supported Cytosol NA NA Cytosol "CAB034010: AB_1128227, HPA040354: AB_2676935, HPA044111: AB_2678814" "unprognostic (1.76e-1)" "unprognostic (6.33e-2)" "unprognostic (4.08e-1)" "unprognostic (2.60e-1)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (5.41e-2)" "unprognostic (2.11e-1)" "unprognostic (9.37e-2)" "unprognostic (1.85e-1)" "unprognostic (5.21e-2)" "unprognostic (2.03e-2)" "unprognostic (2.02e-3)" "unprognostic (2.44e-1)" "unprognostic (3.31e-1)" "unprognostic (1.05e-1)" 14.3 14.3 8.3 12.3 10.8 10.5 7.1 3.7 17.8 6.3 10.4 10.1 6.4 6.7 7.5 7.3 10.3 5.7 8.5 9.8 9.5 7.9 7.7 11.0 10.4 12.3 13.5 7.9 6.0 5.2 9.0 14.4 14.6 12.2 7.5 13.5 8.4 8.2 9.5 13.6 6.2 8.7 12.5 12.3 14.9 8.5 8.4 8.3 8.9 6.0 6.6 12.6 13.9 8.9 3.7 14.0 4.7 15.5 3.2 5.7 3.6 5.3 8.6 7.0 8.1 6.6 6.4 36.9 9.3 7.9 7.1 9.7 10.4 5.5 6.0 1.3 6.4 7.6 6.8 7.4 15.9 8.9 7.7 5.4 0.1 5.7 8.5 14.0 3.3 1.2 11.6 19.2 8.3 15.0 4.4 14.4 4.4 0.6 4.5 14.3 7.9 2.9 1.7 15.0 6.3 2.6 4.2 11.4 2.2 6.9 10.9 0.2 4.2 8.8 4.4 11.5 36.2 1.4 2.9 12.4 9.6 12.4 7.5 5.2 3.8 3.8 10.3 6.7 2.3 7.6 0.5 8.2 0.7 3.6 14.4 3.4 3.7 2.8 3.9 14.0 2.9 1.9 3.2 4.7 3.2 15.5 5.5 5.7 3.6 8.3 10.8 3.7 17.8 9.5 7.9 13.5 7.9 12.2 8.3 0.0 1.7 11.5 7.6 0.0 3.3 9.7 2.5 0.0 0.0 5.2 17.7 23.6 13.3 13.4 23.6 8.7 1.6 0.0 12.0 23.6 8.6 7.1 0.0 5.1 53.0 1.6 7.0 5.5 19.7 22.4 3.4 12.3 0.0 43.3 1.8 11.0 13.1 3.5 4.2 7.3 3.1 6.5 6.6 17.0 23.4 0.0 28.7 4.4 2.0 10.8 TKTL1 "TKR, TKT2" ENSG00000007350 "Transketolase like 1" P51854 X 154295671-154330350 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 50 "blood: 28.6;testis: 103.6" "Cell type enriched" "Detected in some" 14 "Spermatogonia: 515.6" "Cancer enriched" "Detected in many" 8 "testis cancer: 44.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "eosinophil: 28.6;gdT-cell: 12.0" "Group enriched" "Detected in many" 6 "granulocytes: 28.6;T-cells: 12.0" "Cell line enriched" "Detected in single" 157 "THP-1: 102.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000505, HPA029155, CAB032191" Enhanced Enhanced Cytosol NA NA Cytosol "CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (1.98e-1)" "unprognostic (5.80e-3)" "unprognostic (2.43e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.61e-1)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.34e-2)" "unprognostic (3.90e-2)" "unprognostic (5.04e-2)" "unprognostic (2.38e-1)" 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.6 0.1 3.3 12.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 102.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.8 0.0 28.6 12.0 0.1 1.8 0.0 1.4 1.1 0.0 0.0 3.1 2.7 0.4 3.3 0.1 0.1 1.5 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 23.8 0.0 0.0 0.0 16.9 3.7 1.3 0.0 0.0 0.0 5.3 0.0 0.0 1.8 0.0 1.1 25.8 1.4 35.6 515.6 0.1 0.0 0.5 0.0 0.0 TMC3 ENSG00000188869 "Transmembrane channel like 3" Q7Z5M5 15 81331217-81374213 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "parathyroid gland: 66.9" "Cell type enhanced" "Detected in single" 24 "Distal tubular cells: 1.7" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Region enhanced" "Detected in some" "pons and medulla: 1.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040265, HPA040510" Enhanced Supported Cytosol NA NA Cytosol "HPA040265: AB_10795379, HPA040510: AB_10796123" "unprognostic (1.17e-2)" "unprognostic (3.43e-1)" "unprognostic (3.14e-1)" "unprognostic (8.33e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (4.85e-3)" "unprognostic (2.20e-2)" "unprognostic (3.12e-2)" "unprognostic (1.77e-1)" "unprognostic (6.20e-5)" "unprognostic (2.32e-1)" "unprognostic (1.97e-7)" "unprognostic (1.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.26e-1)" "unprognostic (5.96e-2)" 0.0 0.1 0.0 1.7 0.0 0.3 0.2 0.4 1.4 1.5 1.5 0.0 0.0 0.2 0.8 4.6 0.7 0.8 0.2 0.2 0.0 0.1 0.1 1.3 0.0 0.1 0.0 0.0 0.2 0.2 66.9 1.5 0.7 1.6 1.0 0.1 0.4 0.2 2.9 0.0 0.2 0.5 1.7 1.9 0.1 0.8 3.0 0.0 0.0 1.5 0.0 0.0 1.3 3.6 1.6 0.7 0.2 0.2 0.2 1.8 0.7 0.9 1.0 0.5 2.7 0.4 0.2 1.9 0.8 0.3 0.2 0.3 0.7 1.9 2.3 0.1 0.0 2.4 0.7 0.3 0.2 0.1 1.7 1.4 1.9 1.1 0.9 0.3 1.5 1.1 0.5 0.1 0.4 0.3 1.2 0.0 2.8 0.6 2.8 0.2 0.8 1.0 1.4 1.5 0.8 0.9 0.7 1.0 4.3 0.2 0.6 1.1 2.0 0.9 1.0 2.0 0.6 2.3 1.1 0.4 1.5 1.8 1.3 0.5 4.6 1.8 1.4 1.1 2.5 0.9 0.1 0.0 0.2 0.7 0.1 0.6 1.2 0.8 0.4 0.1 1.6 1.8 1.3 0.2 0.2 0.2 0.7 0.9 0.7 0.0 0.0 0.4 1.4 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 TMCO3 "C13orf11, FLJ20623" ENSG00000150403 "Transmembrane and coiled-coil domains 3" Q6UWJ1 13 113490995-113554590 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 17.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039561, HPA048126" Uncertain Approved Cytosol NA NA Cytosol "HPA039561: AB_2676573, HPA048126: AB_2680276" "unprognostic (7.89e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (6.78e-2)" "unprognostic (7.88e-2)" "unprognostic (2.89e-1)" "unprognostic (6.01e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (2.93e-2)" "unprognostic (9.44e-2)" "unprognostic (3.08e-3)" "unprognostic (2.76e-2)" "unprognostic (8.47e-3)" "unprognostic (3.70e-3)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (6.27e-3)" "prognostic unfavorable (4.10e-4)" 16.1 20.5 15.1 11.1 14.2 40.3 14.5 38.7 14.6 21.3 15.7 18.6 16.7 13.0 23.1 15.5 13.1 17.2 23.2 17.0 14.4 13.0 18.0 15.5 13.8 9.4 17.4 9.6 16.9 46.1 18.6 18.6 23.2 21.2 16.1 14.1 17.1 25.8 14.5 10.2 7.7 17.6 18.9 20.7 14.8 27.8 11.0 11.3 7.2 7.5 13.4 11.3 13.2 23.9 2.6 5.0 17.4 8.5 4.1 1.8 2.0 27.1 9.2 13.4 9.2 27.7 41.0 7.3 29.8 28.5 13.1 13.3 10.1 12.1 6.5 7.6 32.6 17.9 11.0 7.0 10.8 20.5 13.3 7.2 5.8 14.9 10.0 26.1 9.5 12.3 33.2 25.6 9.8 20.4 34.1 21.4 4.2 8.3 9.3 22.9 4.9 4.9 5.7 6.7 13.0 14.6 6.3 8.2 4.6 21.9 3.7 11.8 9.8 9.2 20.4 9.5 19.9 12.0 18.1 33.3 14.9 15.9 10.8 12.5 11.5 6.5 4.2 49.2 5.0 7.1 2.4 6.9 6.8 1.1 4.4 1.4 2.6 1.4 1.8 5.0 1.4 1.5 1.5 17.4 4.1 8.5 1.1 1.2 2.0 15.1 14.2 38.7 14.6 14.4 13.0 17.4 9.6 21.2 11.3 11.9 13.7 13.7 30.6 8.8 15.6 16.5 25.5 33.5 21.6 24.4 13.7 17.6 5.0 37.3 11.6 32.2 18.2 0.0 32.8 48.1 26.7 79.7 26.5 8.9 17.4 20.6 32.8 31.9 30.8 28.3 33.9 20.1 16.9 30.7 58.9 26.1 43.8 28.3 44.9 12.8 17.6 6.5 32.0 17.7 13.2 6.1 10.9 12.7 15.2 27.6 TMEM110-MUSTN1 ENSG00000248592 "TMEM110-MUSTN1 readthrough" 3 52833121-52897562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.0" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 1.4;Cholangiocytes: 2.5;Club cells: 1.2;Exocrine glandular cells: 1.6;Ito cells: 1.3;Kupffer cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.3;Karpas-707: 9.1" HPA051855 Uncertain Approved Cytosol NA NA Cytosol "HPA051855: AB_2681639" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (5.95e-2)" "unprognostic (7.28e-2)" "unprognostic (5.35e-2)" "unprognostic (3.11e-4)" "unprognostic (4.73e-2)" "unprognostic (2.66e-2)" "unprognostic (1.59e-2)" "unprognostic (2.51e-2)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.01e-6)" "unprognostic (5.49e-2)" "unprognostic (7.31e-2)" "unprognostic (4.55e-2)" "unprognostic (5.09e-5)" 13.3 6.7 3.8 5.4 7.6 5.2 5.8 5.2 9.6 4.9 5.5 8.6 3.7 4.1 8.6 3.4 6.4 4.2 3.8 5.8 4.1 3.7 8.0 23.6 5.0 8.6 6.6 3.4 5.2 9.2 2.0 3.8 3.9 6.0 4.1 2.6 6.0 5.5 3.1 58.0 4.2 7.9 7.8 4.8 5.7 5.0 3.9 4.1 8.6 4.4 2.7 6.1 5.8 5.7 0.9 1.6 1.6 1.7 0.0 2.3 0.4 1.5 0.8 1.6 6.2 0.5 0.0 0.0 3.2 1.0 0.2 0.4 0.0 1.0 1.1 0.5 0.0 2.2 1.4 1.6 1.6 0.0 8.3 3.3 2.1 0.0 0.0 0.2 1.4 3.2 0.0 0.6 0.6 1.3 0.0 0.3 4.2 0.9 9.1 0.1 1.0 1.9 1.1 1.1 0.6 4.2 0.3 0.0 2.0 0.3 0.0 0.6 0.4 0.8 0.9 1.9 0.4 0.7 3.1 0.9 1.1 2.9 1.2 1.8 4.2 3.8 1.2 1.4 4.0 1.7 0.0 0.2 1.6 0.4 1.7 2.3 0.9 0.7 0.9 0.8 0.3 0.0 0.0 0.4 0.0 0.0 1.6 0.6 0.4 3.8 7.6 5.2 7.6 4.1 3.7 6.6 3.4 6.0 4.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.2 0.0 0.0 0.3 0.0 1.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526603-105530202 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 9.5;Muller glia cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1" "Cell line enhanced" "Detected in some" "EFO-21: 9.5;MCF7: 8.9;PC-3: 11.7;REH: 7.5;SCLC-21H: 6.1;WM-115: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 3.2 2.6 7.2 2.5 8.8 1.5 1.7 3.3 12.6 2.5 1.6 7.9 1.9 1.5 3.0 2.9 1.6 3.1 1.3 2.3 7.4 6.0 2.5 3.0 1.9 2.5 5.0 3.9 2.7 2.9 2.5 3.5 1.6 3.0 3.8 0.8 2.7 2.8 2.7 1.1 2.1 1.9 1.6 4.3 7.1 3.4 1.6 1.6 0.0 2.9 0.4 1.0 1.1 4.7 4.7 0.5 0.0 0.0 1.8 3.1 0.6 0.0 4.5 0.4 4.1 0.0 0.2 0.8 2.8 0.6 0.5 0.0 0.0 1.5 1.3 9.5 0.0 0.8 0.4 0.4 0.1 0.0 0.6 2.2 0.1 0.4 1.5 0.7 0.0 1.6 0.3 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.9 0.2 0.0 1.4 0.1 11.7 7.5 0.0 0.1 0.1 0.0 6.1 2.3 0.5 0.0 2.2 0.1 2.7 0.3 1.6 1.3 2.4 0.2 0.5 0.7 0.0 0.0 0.1 0.5 6.2 0.0 0.0 0.0 1.8 0.0 2.6 4.7 3.1 1.6 0.5 1.7 1.9 1.2 0.0 1.8 0.0 0.0 0.2 0.6 7.2 8.8 3.3 8.2 7.4 6.0 5.0 3.9 3.0 1.6 0.0 0.3 0.5 2.4 4.0 4.3 1.2 0.0 1.4 1.2 5.2 0.0 0.2 0.0 1.0 1.3 7.1 0.0 0.0 0.2 1.2 3.8 1.7 0.0 1.7 0.3 9.5 0.0 7.4 0.3 1.5 4.0 0.0 6.8 0.0 0.0 17.0 0.0 0.0 6.0 0.0 1.1 0.0 1.7 0.5 3.1 2.3 0.2 0.0 0.0 0.6 TMEM134 FLJ21749 ENSG00000172663 "Transmembrane protein 134" Q9H6X4 11 67461710-67469272 "Predicted membrane proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043744 Approved Supported Cytosol NA NA Cytosol "HPA043744: AB_10794773" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (4.67e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (7.22e-2)" "unprognostic (3.85e-1)" "unprognostic (1.39e-2)" "unprognostic (4.30e-2)" "unprognostic (3.48e-1)" "unprognostic (1.75e-1)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-2)" "unprognostic (4.43e-3)" 7.1 15.3 11.2 11.9 14.9 4.8 7.8 6.5 12.7 10.1 11.2 13.4 16.1 8.8 7.2 16.4 30.2 10.3 14.1 22.7 9.7 7.9 13.1 23.7 8.1 10.9 12.9 7.9 6.9 42.1 6.9 4.7 10.7 10.1 15.6 5.1 7.1 16.9 14.0 46.2 31.8 10.2 6.9 12.5 12.3 14.0 12.0 9.7 11.1 8.3 20.7 21.6 10.4 13.2 51.9 23.9 25.9 44.5 22.7 32.2 19.2 7.1 2.7 3.9 8.4 2.6 4.5 4.3 1.5 2.8 1.8 0.7 3.4 8.5 6.8 16.6 3.6 5.6 6.0 1.7 6.3 1.1 6.5 2.9 1.3 2.4 3.5 4.1 1.3 2.0 4.5 8.2 1.4 4.7 7.7 1.8 4.7 1.7 4.0 3.8 17.0 7.6 4.9 6.6 11.9 9.7 3.7 2.3 22.1 6.7 7.3 3.7 8.1 5.4 8.5 15.6 2.8 20.7 1.3 3.4 6.4 5.6 7.5 1.9 16.9 10.6 4.5 9.5 1.7 5.0 12.5 15.4 25.9 20.9 34.7 22.9 51.9 25.0 23.3 18.2 50.3 25.5 23.9 7.2 22.7 44.5 23.9 32.2 19.2 11.2 14.9 6.5 12.7 9.7 7.9 12.9 7.9 10.1 9.7 14.9 37.4 63.8 71.1 79.9 27.8 45.6 53.5 53.5 48.9 64.6 9.8 58.8 112.7 81.8 42.3 30.4 71.9 0.0 110.6 111.2 35.7 133.5 22.0 66.8 75.8 11.1 68.5 22.1 35.0 27.2 19.2 50.4 104.6 75.7 89.3 29.2 138.9 72.4 23.3 134.2 27.4 6.5 42.2 95.3 76.8 157.5 60.9 50.7 73.6 137.5 TMEM161A "FLJ20422, FLJ39645" ENSG00000064545 "Transmembrane protein 161A" Q9NX61 19 19119169-19138513 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043365 Approved Approved Cytosol NA NA Cytosol "HPA043365: AB_10796793" "unprognostic (4.31e-2)" "unprognostic (9.13e-2)" "unprognostic (2.34e-2)" "unprognostic (7.42e-3)" "unprognostic (6.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-2)" "unprognostic (3.51e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (9.42e-2)" "unprognostic (2.46e-1)" "unprognostic (9.15e-2)" "prognostic favorable (2.99e-4)" "unprognostic (4.18e-1)" "unprognostic (2.79e-1)" "unprognostic (4.89e-3)" 10.4 18.3 10.6 9.2 13.5 8.1 10.3 12.8 11.7 12.2 10.5 9.8 15.8 10.0 17.2 8.6 11.7 12.4 15.5 12.7 8.6 6.9 12.7 21.1 9.1 12.1 13.4 8.4 14.2 18.6 17.3 6.6 6.4 9.9 12.8 5.3 12.7 17.1 13.6 34.5 13.5 9.1 9.9 7.8 8.8 10.6 5.3 11.6 15.0 20.8 13.8 9.1 10.8 12.6 6.8 23.5 1.5 7.2 6.7 13.5 5.4 16.1 11.3 6.4 13.8 13.9 9.3 10.2 6.8 8.4 8.5 11.2 9.5 20.2 14.1 33.6 5.1 5.8 13.1 10.3 15.8 5.6 6.4 37.5 5.4 6.2 12.8 18.5 7.1 9.0 14.5 13.3 8.4 12.5 8.1 9.4 17.2 18.0 17.1 5.9 19.5 10.3 15.0 6.1 18.7 18.6 16.5 5.4 28.0 6.5 6.6 8.7 8.8 10.3 13.1 8.3 4.7 10.5 12.7 5.5 7.9 3.9 17.7 12.7 15.9 9.9 8.4 8.7 14.7 11.4 1.5 7.2 1.4 10.0 6.3 8.8 5.7 9.1 8.1 10.1 6.8 10.8 9.1 0.8 6.7 6.3 23.5 13.5 5.4 10.6 13.5 12.8 11.7 8.6 6.9 13.4 8.4 9.9 11.6 6.0 16.5 7.3 11.6 5.5 15.3 6.9 25.5 6.7 7.9 10.4 9.8 16.1 6.6 17.7 0.7 9.4 6.3 0.0 11.1 12.3 9.1 11.9 16.1 20.4 14.0 15.9 5.2 9.8 9.1 0.5 10.9 6.7 11.8 5.4 8.4 18.1 11.0 3.5 16.6 25.9 13.1 12.9 13.3 7.9 9.8 7.5 10.3 10.0 16.6 6.7 TMEM40 FLJ11036 ENSG00000088726 "Transmembrane protein 40" Q8WWA1 3 12733525-12769457 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5" "Cell type enhanced" "Detected in many" 24 "Cytotrophoblasts: 120.6;Suprabasal keratinocytes: 176.4;Syncytiotrophoblasts: 549.0;Urothelial cells: 120.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 73.7;hTCEpi: 16.6;hTERT-HME1: 21.0;RT4: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044165, HPA073122" Enhanced Approved Cytosol NA NA 7000000 Cytosol "HPA044165: AB_10961279, HPA073122: " "unprognostic (2.51e-3)" "unprognostic (1.96e-2)" "unprognostic (2.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.27e-1)" "unprognostic (1.92e-1)" "unprognostic (5.15e-4)" "unprognostic (5.96e-2)" "unprognostic (3.15e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-3)" "unprognostic (2.47e-1)" "unprognostic (1.20e-3)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 0.0 0.2 1.4 1.8 0.0 0.0 11.7 0.0 0.0 0.4 0.0 0.9 0.6 62.9 1.6 0.1 1.6 0.0 0.0 0.3 0.0 1.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 53.6 0.1 2.3 0.0 0.0 6.6 1.4 0.4 24.0 0.0 0.7 0.0 1.1 0.0 0.4 0.0 0.4 0.0 40.5 41.8 10.6 18.6 0.0 0.5 4.5 0.6 0.0 0.3 21.1 7.4 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.3 0.4 0.2 1.1 0.0 0.0 0.0 0.2 2.1 0.0 73.7 1.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 16.6 0.0 21.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.4 10.3 0.0 0.0 0.0 9.2 0.0 1.4 0.8 0.2 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.6 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.5 0.0 0.0 0.5 0.0 21.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 71.9 57.1 0.0 3.3 0.0 22.7 6.8 1.8 0.0 120.6 0.0 0.5 0.6 0.4 0.0 0.0 0.0 12.6 4.3 9.6 0.0 0.6 9.6 0.0 0.0 0.0 0.3 1.6 0.3 0.2 10.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.3 0.2 1.9 176.4 549.0 0.0 0.0 120.1 TMEM44 DKFZp686O18124 ENSG00000145014 "Transmembrane protein 44" Q2T9K0 3 194587673-194633689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ito cells: 50.3;Mucus-secreting cells: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 3.2;NK-cell: 11.5" "Group enriched" "Detected in many" 9 "granulocytes: 3.2;NK-cells: 11.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043718 Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA043718: AB_10794662" "unprognostic (8.94e-2)" "unprognostic (1.01e-1)" "unprognostic (8.31e-3)" "unprognostic (4.53e-2)" "unprognostic (2.78e-3)" "unprognostic (9.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (6.55e-13)" "unprognostic (1.23e-2)" "unprognostic (3.36e-1)" "unprognostic (1.65e-3)" "unprognostic (5.66e-2)" 13.2 2.8 4.8 6.2 11.8 10.6 21.2 1.9 7.3 6.6 11.8 2.4 9.2 4.6 6.8 22.9 5.1 4.9 7.9 5.9 6.1 6.3 5.6 3.6 15.1 6.3 5.2 7.8 5.1 3.3 1.3 2.3 12.0 6.7 4.8 11.9 3.3 7.0 5.8 6.7 3.4 6.0 5.6 3.7 9.0 6.7 4.1 3.3 4.1 5.3 5.5 3.7 5.0 6.7 0.3 0.6 3.2 0.4 11.5 0.8 0.0 6.3 5.1 7.8 8.3 2.9 9.8 6.9 4.9 9.2 4.1 6.5 2.8 12.6 1.1 23.3 5.7 11.8 7.4 2.6 3.7 2.7 10.4 3.7 7.1 5.3 2.1 5.3 2.2 11.3 6.3 4.1 9.2 4.1 19.4 16.6 7.0 2.0 0.3 13.2 5.9 3.3 5.6 4.1 6.2 8.4 6.3 4.9 0.2 4.2 3.6 2.2 4.7 3.5 1.1 7.2 3.4 5.3 4.7 19.6 12.3 4.6 3.8 6.3 0.9 0.7 2.2 18.4 8.6 6.1 3.2 0.3 0.3 0.5 0.2 0.1 0.2 0.2 0.8 0.0 0.3 0.1 0.3 0.8 11.5 0.4 0.6 0.0 0.0 4.8 11.8 1.9 7.3 6.1 6.3 5.2 7.8 6.7 3.3 0.0 2.9 3.7 3.0 0.5 0.8 1.1 0.0 2.7 3.4 5.2 2.0 6.6 0.0 5.1 0.6 15.2 13.4 0.0 4.3 2.8 4.8 5.1 17.3 0.8 3.0 0.0 5.8 50.3 2.2 0.0 2.8 0.8 1.7 0.0 20.6 0.6 9.6 17.5 1.8 0.1 0.3 6.5 1.2 0.5 5.9 0.5 7.3 1.5 16.2 5.1 TNK2 "ACK, ACK1, p21cdc42Hs" ENSG00000061938 "Tyrosine kinase non receptor 2" Q07912 3 195863364-195911945 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 47.1;Horizontal cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041954 Approved Approved Cytosol NA NA Cytosol "HPA041954: AB_10794164" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-3)" "prognostic unfavorable (8.96e-4)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (8.89e-3)" "unprognostic (1.13e-1)" "unprognostic (8.92e-3)" "unprognostic (4.49e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (6.82e-2)" "unprognostic (9.76e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.00e-4)" 9.2 7.6 36.3 16.2 27.6 38.9 8.5 20.7 43.7 6.0 6.3 17.6 3.8 6.6 8.0 6.6 13.0 10.7 6.5 10.6 28.4 21.8 4.1 7.2 9.3 18.1 21.6 31.8 8.6 7.8 5.1 19.3 8.4 20.0 10.8 3.9 5.3 16.8 8.2 30.5 37.1 6.9 7.6 10.3 17.0 12.1 7.7 21.8 3.4 4.6 9.8 12.8 7.7 12.3 6.1 3.1 6.3 3.2 0.9 1.9 1.2 31.9 3.1 5.2 5.5 7.2 4.6 31.1 6.2 5.9 3.7 3.4 4.9 24.7 9.3 21.6 8.4 6.3 11.4 4.5 7.6 1.1 21.9 5.7 8.4 10.4 3.5 3.2 4.3 4.2 3.4 12.2 5.1 6.1 10.6 4.7 3.5 3.4 12.9 3.4 23.5 1.8 15.7 4.9 8.5 11.5 5.4 6.2 9.4 3.3 15.5 6.3 6.4 4.0 16.2 7.9 5.2 26.5 5.4 7.6 8.6 5.0 4.4 17.1 28.2 3.0 5.8 7.7 14.0 6.3 2.0 2.4 0.9 1.9 3.2 1.1 2.7 1.8 1.0 1.1 6.1 1.4 1.3 6.3 0.9 2.8 3.1 0.2 1.2 36.3 27.6 20.7 33.3 28.4 21.8 21.6 31.8 20.0 21.8 6.0 4.8 11.8 6.8 6.2 26.5 12.8 5.1 5.3 11.4 0.0 47.1 10.6 1.7 3.5 0.8 7.5 6.9 0.0 4.5 2.6 5.3 7.2 1.1 13.5 7.2 93.8 5.8 9.8 20.5 0.8 6.1 11.4 5.0 9.0 1.4 6.6 19.1 3.5 6.0 1.4 20.9 0.0 5.5 3.9 10.0 9.3 3.5 8.9 3.3 16.3 TOB2 "APRO5, bK223H9, TOB4, TOBL, TROB2" ENSG00000183864 "Transducer of ERBB2, 2" Q14106 22 41433492-41447023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016603, HPA054112" Approved Approved Cytosol NA NA Cytosol "HPA016603: AB_2669400, HPA054112: AB_2682385" "unprognostic (1.21e-3)" "unprognostic (3.10e-2)" "unprognostic (3.41e-1)" "prognostic favorable (3.08e-5)" "unprognostic (3.89e-2)" "unprognostic (1.38e-1)" "unprognostic (1.36e-1)" "unprognostic (5.36e-2)" "unprognostic (4.94e-2)" "unprognostic (5.74e-2)" "unprognostic (3.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.18e-6)" "unprognostic (1.50e-2)" "unprognostic (7.14e-2)" "unprognostic (1.85e-1)" "unprognostic (7.13e-2)" 27.3 20.7 25.4 12.5 27.6 5.4 14.1 53.5 22.0 18.0 16.1 23.2 12.2 14.0 14.5 9.8 17.1 25.2 24.4 16.4 25.5 9.9 16.0 13.4 13.5 10.6 35.8 13.6 21.8 18.1 26.2 13.2 13.8 23.1 17.6 10.1 17.6 9.6 15.1 47.3 13.9 16.1 13.3 18.3 12.2 17.7 9.1 36.5 13.6 23.2 17.0 12.1 12.8 21.1 13.4 10.3 4.9 10.0 4.6 9.9 5.7 16.9 7.8 13.7 9.3 32.3 22.7 13.4 11.3 17.5 14.4 12.8 10.2 8.1 10.4 11.5 16.3 5.6 14.9 12.7 6.3 13.2 10.7 16.4 5.7 10.9 15.4 22.2 15.3 7.7 20.8 10.9 17.2 7.5 14.6 14.4 3.6 8.6 11.7 11.7 18.9 6.3 8.9 11.7 22.4 8.5 13.9 9.2 8.9 10.2 11.9 6.4 4.2 28.5 15.4 20.7 8.9 8.5 7.7 17.9 14.3 13.4 11.1 10.5 11.2 4.8 5.7 8.7 6.6 9.4 4.2 6.9 4.8 9.9 10.0 9.2 13.4 8.2 8.1 6.5 10.3 4.3 6.1 4.9 4.6 9.3 10.3 6.9 5.7 25.4 27.6 53.5 22.0 25.5 9.9 35.8 13.6 23.1 36.5 44.7 45.7 18.2 58.0 112.6 49.6 49.5 50.9 56.2 36.4 45.4 60.9 28.9 19.9 26.5 38.6 35.9 84.5 0.0 16.8 27.5 49.4 69.7 32.4 25.5 17.2 23.8 52.1 48.5 21.1 45.5 61.9 25.5 50.6 35.1 55.4 65.6 27.4 54.1 77.1 26.1 95.8 51.8 63.1 24.2 25.7 119.6 53.0 27.3 50.5 89.9 TP53INP1 "DKFZp434M1317, FLJ22139, P53DINP1, SIP, Teap, TP53INP1A, TP53INP1B" ENSG00000164938 "Tumor protein p53 inducible nuclear protein 1" Q96A56 8 94925972-94949411 "Predicted intracellular proteins" "Apoptosis, Autophagy, Transcription, Transcription regulation" "Activator, Antioxidant" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 81.5;Hepatocytes: 143.1;Intestinal endocrine cells: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 25.7" "Group enriched" "Detected in many" 5 "B-cells: 6.8;granulocytes: 25.7" "Cell line enhanced" "Detected in many" "Karpas-707: 32.7;U-266/70: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005856 Uncertain Supported Cytosol NA NA Cytosol "HPA005856: AB_10600832" "unprognostic (1.39e-2)" "unprognostic (4.47e-3)" "unprognostic (7.17e-2)" "unprognostic (2.70e-1)" "unprognostic (5.31e-2)" "prognostic favorable (1.11e-4)" "unprognostic (5.72e-2)" "unprognostic (1.16e-3)" "unprognostic (1.28e-1)" "unprognostic (7.54e-2)" "unprognostic (5.00e-3)" "unprognostic (1.23e-2)" "unprognostic (1.87e-2)" "unprognostic (9.83e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-2)" "prognostic favorable (5.45e-5)" 8.2 8.3 5.1 21.0 7.6 17.9 14.3 5.9 5.9 8.3 11.1 7.4 11.5 8.4 10.2 11.6 10.6 8.4 11.2 8.6 5.5 3.1 7.8 50.0 21.0 51.9 6.9 3.5 7.4 42.7 6.7 6.9 12.4 5.7 14.9 10.4 8.4 13.3 15.3 17.9 9.1 24.8 9.9 5.3 28.9 12.3 22.3 7.4 39.8 7.9 4.6 31.4 15.5 6.6 6.8 0.8 25.7 2.1 2.9 3.6 1.3 0.2 1.0 9.9 3.8 12.4 11.7 10.2 2.3 5.5 1.0 2.6 0.8 0.2 2.1 5.1 4.4 0.9 1.7 0.0 3.8 2.4 0.1 1.2 1.3 2.0 5.8 8.3 0.0 6.9 19.1 9.2 2.8 1.1 9.3 16.2 1.0 0.7 32.7 5.0 0.6 1.5 0.6 0.9 0.0 0.2 1.3 0.7 11.3 2.6 10.6 1.4 8.0 1.4 0.8 2.0 16.6 4.8 1.3 11.1 2.0 2.4 0.0 0.3 35.3 7.3 0.9 3.5 0.0 0.0 25.7 2.1 6.1 0.8 2.0 0.8 6.8 2.4 1.6 0.7 5.9 0.5 0.4 9.6 2.9 1.2 0.8 3.6 1.3 5.1 7.6 5.9 5.9 5.5 3.1 6.9 3.5 5.7 7.4 32.8 33.1 25.7 2.9 4.0 4.8 10.5 81.5 42.8 18.2 10.4 25.5 5.4 3.3 8.3 14.0 9.8 16.6 0.0 18.1 1.2 6.6 23.2 4.6 143.1 10.2 1.6 80.3 35.6 43.5 30.1 6.6 7.9 15.1 4.6 15.5 4.8 19.9 24.6 9.6 8.6 21.0 6.5 9.0 23.2 2.5 5.6 4.8 7.9 5.1 4.8 TPH1 "TPH, TPRH" ENSG00000129167 "Tryptophan hydroxylase 1" P17752 11 18017564-18042426 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3" "Cell type enriched" "Detected in many" 164 "Intestinal endocrine cells: 1412.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "cerebral cortex: 4.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 4.5" "Low region specificity" "Detected in some" "CAB010767, HPA022483" Approved Uncertain Cytosol NA NA Cytosol "CAB010767: AB_261587, HPA022483: AB_1858378" "unprognostic (2.14e-4)" "unprognostic (9.97e-2)" "unprognostic (6.92e-2)" "unprognostic (6.78e-2)" "unprognostic (1.55e-1)" "unprognostic (6.26e-5)" "unprognostic (1.73e-1)" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-2)" "unprognostic (1.19e-4)" "unprognostic (6.72e-2)" "unprognostic (5.40e-8)" "unprognostic (3.76e-2)" "unprognostic (7.42e-2)" "unprognostic (3.10e-1)" "unprognostic (2.46e-5)" 0.7 0.0 0.7 0.7 0.7 0.6 0.9 0.7 4.2 0.7 7.1 0.7 0.7 8.2 0.7 0.7 0.7 1.5 0.7 0.7 0.7 0.3 0.7 0.7 0.7 0.7 0.7 0.7 1.0 0.7 0.0 5.4 0.7 0.7 1.3 16.2 0.7 0.7 0.7 0.7 1.0 9.1 0.7 0.7 1.0 13.3 0.9 0.7 0.7 0.7 0.7 0.7 0.7 0.7 1.4 0.8 1.5 0.5 0.9 1.6 0.2 0.4 0.1 1.7 1.5 0.1 0.0 0.6 0.6 0.5 0.2 1.1 1.8 0.3 1.4 0.3 0.0 0.1 0.6 0.4 1.5 0.7 1.3 3.1 2.2 0.8 3.5 0.0 4.5 1.2 0.0 1.8 0.2 0.6 0.3 0.7 2.7 0.9 0.8 0.1 0.5 1.0 0.7 0.5 0.1 0.3 1.7 0.3 0.0 0.0 1.0 1.3 0.9 0.2 0.4 0.9 0.2 0.3 2.9 0.2 0.4 1.3 0.5 1.7 0.2 0.3 1.1 0.2 1.0 1.4 1.5 0.4 0.4 1.6 0.2 0.8 0.5 0.5 0.4 0.1 1.4 0.6 0.6 1.5 0.9 0.5 0.8 0.6 0.2 0.7 0.7 0.7 4.2 0.7 0.3 0.7 0.7 0.7 0.7 0.0 0.0 0.0 0.4 0.3 4.7 0.4 0.0 1.4 0.0 5.2 2.0 0.2 0.0 0.2 0.7 0.3 1.0 0.0 0.5 0.0 0.7 2.0 0.0 0.0 0.2 1.6 1412.4 0.0 0.0 0.4 0.9 0.9 0.0 0.0 2.8 1.5 0.4 8.6 1.1 0.2 6.0 6.5 1.0 2.7 3.4 1.3 0.0 0.5 1.7 0.0 TPRKB "CGI-121, CGI121" ENSG00000144034 "TP53RK binding protein" Q9Y3C4 2 73729104-73737400 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035712 Approved Supported Cytosol NA NA Cytosol "HPA035712: AB_10669674" "unprognostic (1.11e-1)" "unprognostic (2.41e-2)" "unprognostic (6.59e-2)" "unprognostic (2.31e-2)" "unprognostic (2.74e-1)" "unprognostic (2.67e-2)" "unprognostic (1.21e-3)" "unprognostic (4.96e-2)" "unprognostic (3.16e-3)" "unprognostic (3.01e-3)" "unprognostic (5.10e-3)" "unprognostic (6.06e-2)" "unprognostic (2.68e-3)" "unprognostic (5.66e-2)" "unprognostic (8.45e-3)" "unprognostic (1.82e-1)" "unprognostic (5.03e-2)" 15.5 13.9 13.5 9.9 16.2 30.2 23.3 24.1 17.0 18.0 16.7 11.1 21.1 19.9 16.5 19.9 22.4 29.3 10.7 24.5 15.6 12.0 24.3 23.6 14.4 17.5 17.6 12.6 22.2 19.2 8.4 21.3 14.8 18.2 16.6 18.0 8.7 20.3 13.0 36.8 13.3 24.1 20.6 16.6 15.5 15.9 25.1 15.9 21.9 14.7 30.6 16.6 14.3 17.5 20.6 22.0 24.3 21.9 19.4 22.3 14.6 23.7 18.9 18.6 20.7 6.9 9.8 14.6 14.6 9.3 18.7 13.7 28.8 15.5 15.3 12.1 8.0 34.7 15.3 14.4 17.8 29.6 9.8 20.6 31.1 12.1 21.9 6.9 37.8 17.9 6.9 11.7 18.3 20.1 9.5 19.4 27.4 28.5 24.1 19.1 15.1 33.0 32.9 24.4 34.7 25.1 19.8 51.2 22.7 17.4 22.5 16.2 20.4 12.4 20.3 26.5 17.1 14.3 20.0 8.9 14.8 24.1 29.0 43.0 17.0 22.6 40.4 14.4 29.8 17.9 14.3 17.1 24.3 14.9 21.9 19.8 20.6 20.1 18.0 19.4 17.6 22.3 21.2 13.8 19.4 17.1 22.0 18.6 14.6 13.5 16.2 24.1 17.0 15.6 12.0 17.6 12.6 18.2 15.9 29.8 38.6 44.7 60.3 47.3 13.9 56.1 40.8 53.5 47.8 21.0 3.9 65.0 74.6 70.6 93.1 68.4 61.1 70.0 161.5 88.2 43.6 39.5 46.3 40.5 77.1 7.9 32.3 90.9 47.3 15.6 54.7 59.9 32.1 54.1 64.9 20.6 92.6 71.9 49.1 126.5 18.6 51.8 35.4 189.6 92.5 46.3 38.1 41.5 73.4 42.6 TPT1 "fortilin, TCTP" ENSG00000133112 "Tumor protein, translationally-controlled 1" P13693 13 45333471-45341370 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008364, HPA039437" Approved Supported Cytosol NA NA 3000000 Cytosol "CAB008364: AB_591904, HPA039437: AB_2676508" "prognostic favorable (5.90e-5)" "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "prognostic favorable (2.35e-4)" "unprognostic (3.25e-1)" "unprognostic (3.57e-2)" "unprognostic (8.71e-3)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-3)" "unprognostic (4.56e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (2.54e-5)" "unprognostic (1.47e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.31e-5)" "unprognostic (6.51e-2)" 197.3 108.4 81.7 126.7 74.3 156.7 185.4 35.2 41.3 173.3 229.7 66.5 131.7 101.9 197.9 162.6 234.4 97.1 168.2 292.9 74.4 58.0 141.0 317.4 179.5 286.0 85.1 27.1 273.2 671.6 32.3 97.4 188.3 46.3 203.4 91.6 77.5 460.5 124.6 772.2 98.5 178.1 169.1 101.1 180.2 107.7 95.9 52.1 211.5 306.1 322.2 178.4 211.5 356.3 106.0 111.8 76.0 91.7 110.6 165.2 205.6 58.7 53.3 90.3 58.9 266.7 372.0 107.3 125.2 195.2 80.0 84.0 119.6 153.0 125.3 105.7 129.9 53.0 102.5 72.8 183.7 110.9 57.8 63.7 100.4 48.5 132.8 269.4 136.5 157.3 304.9 374.1 50.9 308.1 260.2 165.1 107.0 74.3 34.6 163.0 107.3 165.2 326.2 102.9 198.3 56.8 104.3 85.6 93.6 205.0 123.5 38.5 103.1 41.5 133.1 191.0 96.2 76.3 398.1 107.5 36.9 52.6 59.9 76.8 85.5 86.4 118.5 98.5 109.2 28.6 76.0 91.7 44.6 82.3 71.6 149.6 106.0 154.6 111.3 87.2 84.4 165.2 133.5 42.2 110.6 65.9 111.8 134.7 205.6 81.7 74.3 35.2 41.3 74.4 58.0 85.1 27.1 46.3 52.1 1479.9 2965.6 3028.0 5179.8 3104.5 333.9 2317.0 2366.8 1212.6 2306.7 724.0 151.2 3924.7 2664.3 2026.9 855.5 2800.2 4687.9 934.5 4449.5 5200.5 3170.6 5725.2 1748.2 3780.3 3821.0 201.8 1990.0 4043.9 4707.2 1251.1 6296.7 3543.0 1682.0 2041.5 6067.3 780.7 4698.0 5432.3 3638.3 7341.6 481.8 2490.0 1772.7 484.4 364.3 3041.2 4808.3 3056.2 6095.0 6368.7 TRADD Hs.89862 ENSG00000102871 "TNFRSF1A associated via death domain" Q15628 16 67154180-67160298 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "monocytes: 256.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004602, HPA071341" Enhanced Approved Cytosol NA NA Cytosol "CAB004602: AB_2209061, HPA071341: AB_2732178" "unprognostic (2.66e-1)" "unprognostic (3.11e-1)" "unprognostic (2.23e-2)" "prognostic favorable (1.40e-4)" "unprognostic (1.50e-2)" "unprognostic (1.21e-1)" "unprognostic (5.68e-2)" "unprognostic (4.96e-2)" "unprognostic (4.15e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (8.27e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (1.83e-1)" 12.2 13.3 8.7 15.9 10.5 5.6 10.1 2.1 6.9 11.9 12.3 10.8 13.0 10.2 10.4 11.1 17.4 11.6 14.5 7.3 6.5 3.1 15.0 11.8 11.6 14.4 10.5 4.4 12.8 17.9 9.7 8.4 14.9 9.5 13.7 7.4 9.0 15.4 10.5 6.6 14.8 12.1 8.7 7.2 20.3 21.8 4.4 9.8 9.7 19.5 11.0 22.4 11.7 12.0 20.8 21.4 25.6 20.0 10.5 50.5 14.3 8.8 7.5 0.1 2.9 7.0 5.9 9.7 7.0 5.1 3.3 5.2 4.7 7.2 4.7 12.0 6.0 7.0 16.2 1.2 6.1 2.7 13.5 7.0 3.1 3.4 4.6 8.6 3.9 8.0 6.1 8.9 4.5 1.7 8.7 6.3 5.0 4.5 7.5 4.9 8.1 4.6 7.8 0.1 8.6 22.7 9.2 3.7 18.5 5.6 5.8 1.5 4.5 15.4 3.5 4.4 2.9 6.1 5.5 7.2 4.5 4.8 7.3 4.9 15.0 4.8 5.6 10.9 3.5 5.2 12.0 12.3 25.6 16.7 15.3 25.1 20.8 50.5 28.9 15.2 18.5 14.8 11.9 21.6 10.5 20.0 21.4 22.2 14.3 8.7 10.5 2.1 6.9 6.5 3.1 10.5 4.4 9.5 9.8 3.0 7.5 39.0 21.6 15.3 1.0 3.3 22.9 6.7 4.5 5.2 0.0 29.2 26.6 55.2 1.2 18.8 23.1 0.0 33.5 37.2 28.6 34.8 9.2 18.7 41.8 0.0 18.5 12.3 34.6 1.5 27.9 29.1 54.0 256.1 25.5 4.7 54.2 28.3 28.7 65.5 2.1 25.8 22.1 1.8 7.9 22.5 25.5 30.6 21.7 32.5 TRAF2 "RNF117, TRAP3" ENSG00000127191 "TNF receptor associated factor 2" Q12933 9 136881912-136926607 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004603, HPA009972, HPA010634" Uncertain Enhanced Cytosol NA NA Cytosol "CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347" "unprognostic (7.77e-2)" "unprognostic (4.54e-3)" "prognostic unfavorable (9.32e-4)" "unprognostic (1.15e-1)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (4.91e-2)" "unprognostic (7.23e-2)" "unprognostic (4.28e-2)" "unprognostic (7.39e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.80e-3)" "unprognostic (5.52e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-2)" 7.3 6.6 8.7 20.3 10.4 15.9 8.6 16.0 10.0 7.3 8.7 7.4 7.3 11.1 12.3 6.9 12.3 9.0 8.3 8.3 7.5 6.5 8.5 12.3 11.5 19.7 11.2 8.3 6.8 13.9 5.9 8.8 12.1 8.1 10.2 6.2 7.5 13.0 10.1 6.4 13.0 10.4 10.6 8.2 13.8 10.7 13.7 6.4 16.4 14.7 5.2 15.9 8.4 37.5 12.6 11.5 6.7 8.3 10.1 17.4 6.2 10.6 32.9 8.9 7.9 2.5 4.0 17.5 8.8 4.9 12.9 8.8 20.3 19.4 13.3 11.5 5.5 17.5 28.2 12.2 14.4 5.3 20.2 9.9 10.0 29.8 12.6 3.7 9.9 10.4 3.0 4.4 10.5 6.0 4.9 6.1 12.4 16.9 15.2 5.7 15.5 15.9 14.2 14.5 24.5 14.8 15.1 13.7 18.1 7.9 8.4 14.6 6.8 11.0 25.9 10.0 10.4 18.6 11.6 6.8 16.9 10.9 11.0 14.8 6.4 10.3 13.3 6.0 8.1 12.4 1.3 3.7 6.7 10.4 4.2 14.6 12.6 11.1 13.0 4.9 10.0 9.1 10.9 3.3 10.1 8.3 11.5 17.4 6.2 8.7 10.4 16.0 10.0 7.5 6.5 11.2 8.3 8.1 6.4 0.0 8.3 13.4 12.1 10.5 6.8 6.3 12.7 0.0 3.4 5.2 0.0 16.7 3.3 18.9 2.5 8.2 15.4 0.0 11.0 25.5 7.4 11.2 10.3 4.0 11.7 17.5 10.9 4.3 2.4 2.7 3.1 7.3 13.5 55.1 9.2 4.2 16.3 5.8 7.4 5.0 10.0 19.4 12.7 9.2 22.0 11.2 14.9 13.8 12.4 9.1 TRAM2 KIAA0057 ENSG00000065308 "Translocation associated membrane protein 2" Q15035 6 52497402-52576915 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 84.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 54.4;ASC TERT1: 58.3;fHDF/TERT166: 52.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA035092, HPA057925" Approved Approved Cytosol NA NA Cytosol "HPA035092: AB_10610562, HPA057925: AB_2683557" "unprognostic (2.32e-2)" "unprognostic (2.19e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (1.12e-1)" "unprognostic (4.07e-2)" "unprognostic (8.90e-3)" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.03e-1)" "unprognostic (3.01e-1)" "unprognostic (5.05e-1)" "prognostic unfavorable (1.41e-9)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "unprognostic (6.64e-2)" "unprognostic (1.19e-2)" 17.3 4.9 2.0 11.8 3.7 2.7 29.4 2.0 3.3 13.3 12.5 4.3 4.4 9.2 12.7 9.0 8.3 11.5 11.8 10.5 3.3 2.2 7.7 23.7 12.6 13.1 4.0 2.2 15.6 6.8 1.9 4.0 46.7 6.0 9.9 10.2 12.0 6.2 4.0 6.3 7.6 15.9 17.6 5.3 20.0 8.4 11.6 2.7 4.9 11.7 6.0 12.1 14.0 19.6 3.6 3.1 2.8 5.4 2.0 2.8 1.8 9.1 4.1 4.8 4.7 54.4 58.3 8.4 27.0 27.4 22.7 21.1 8.8 1.9 2.2 4.5 52.3 16.2 2.0 3.1 16.9 28.7 5.0 1.6 4.9 4.1 11.1 15.5 1.2 2.7 21.1 1.7 19.8 8.8 33.2 26.0 1.9 3.0 16.5 32.4 3.3 1.7 3.6 2.2 3.6 1.8 2.2 12.6 18.5 5.4 1.5 1.1 1.8 6.2 2.8 6.5 10.6 4.3 2.6 41.1 38.2 8.3 13.7 14.7 11.3 19.2 6.4 13.9 3.3 23.2 0.2 2.8 2.8 2.8 3.4 1.5 3.6 2.2 1.7 3.1 2.0 1.2 2.0 0.8 2.0 5.4 1.5 0.8 1.8 2.0 3.7 2.0 3.3 3.3 2.2 4.0 2.2 6.0 2.7 6.0 2.7 11.5 2.5 7.2 3.0 7.1 5.1 5.3 4.5 7.0 23.6 31.3 3.3 3.4 31.2 13.7 4.1 23.3 2.7 25.0 27.7 2.3 2.3 25.6 13.0 4.8 8.6 23.4 12.1 84.2 19.2 4.2 25.3 0.0 15.0 1.7 5.6 0.0 21.9 2.9 13.7 12.9 12.0 22.4 4.9 3.6 17.3 6.4 4.7 1.4 TRAPPC4 "PTD009, SBDN, TRS23" ENSG00000196655 "Trafficking protein particle complex 4" Q9Y296 11 119018432-119025454 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039752, HPA041371" Approved Approved Cytosol NA NA Cytosol "HPA039752: AB_2676664, HPA041371: AB_2677439" "unprognostic (5.26e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (1.18e-2)" "unprognostic (9.42e-2)" "unprognostic (7.12e-3)" "prognostic unfavorable (2.03e-5)" "unprognostic (1.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.36e-2)" "unprognostic (4.34e-2)" "unprognostic (2.01e-2)" "unprognostic (7.49e-3)" "unprognostic (3.64e-1)" "unprognostic (1.17e-1)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" 20.4 26.8 17.1 11.8 21.2 16.3 14.8 15.6 20.1 16.1 20.4 16.1 33.7 20.4 13.6 20.4 16.3 14.3 19.4 15.4 16.1 20.1 30.1 20.3 16.3 15.3 17.5 16.2 16.4 19.4 11.9 21.1 16.2 16.5 20.2 13.8 16.2 14.4 24.8 26.4 12.7 23.8 14.5 17.1 15.5 18.1 19.6 12.1 16.4 18.2 10.0 18.1 18.1 10.6 29.9 28.6 39.7 28.0 26.3 47.2 29.4 7.8 8.1 9.2 9.5 11.3 7.9 4.3 31.5 17.3 19.3 15.5 18.7 3.2 9.1 22.3 11.7 14.2 7.4 14.1 11.5 14.8 16.4 8.5 15.3 7.8 20.5 16.3 12.2 7.7 11.4 10.4 18.5 14.0 13.0 16.7 10.9 17.0 3.6 11.1 17.9 13.9 11.7 7.3 16.2 22.2 12.6 7.2 10.9 13.4 10.3 3.5 8.6 6.1 6.9 7.6 11.5 28.3 11.0 12.3 5.3 10.3 6.6 10.2 5.0 9.5 22.7 5.9 9.8 8.7 29.8 20.8 39.7 28.9 22.9 29.3 29.9 33.7 32.9 20.0 26.7 31.4 34.0 17.9 26.3 28.0 28.6 47.2 29.4 17.1 21.2 15.6 20.1 16.1 20.1 17.5 16.2 16.5 12.1 35.7 33.8 45.4 44.7 45.6 57.7 26.6 40.8 57.6 26.1 68.0 13.7 80.8 119.3 82.0 34.8 45.8 33.3 23.3 66.2 46.8 39.3 43.2 60.1 17.8 69.7 36.5 64.9 38.6 20.9 10.4 41.1 30.8 28.7 109.2 29.3 83.4 80.0 31.7 57.3 132.7 51.2 45.3 43.2 88.9 76.0 51.6 73.0 53.2 32.6 39.9 TREX1 "AGS1, DRN3" ENSG00000213689 "Three prime repair exonuclease 1" Q9NSU2 3 48465811-48467645 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Exonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 8.0;Cardiomyocytes: 5.0;Melanocytes: 23.6;Smooth muscle cells: 7.6;Suprabasal keratinocytes: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 30.9" "Low region specificity" "Detected in all" "HPA035437, HPA046721" Supported Supported Cytosol NA NA Cytosol "HPA035437: AB_10672092, HPA046721: AB_2732531" 14.2 14.3 16.7 14.6 10.6 20.7 17.2 13.0 16.9 13.4 11.0 12.8 17.5 10.3 8.1 14.9 16.6 14.5 12.3 9.8 14.4 14.2 11.6 12.7 12.5 26.2 14.6 17.4 7.3 13.0 6.8 31.2 11.6 11.2 15.4 9.3 10.8 32.2 19.3 10.8 22.9 10.9 8.2 12.6 25.5 12.4 4.6 10.1 18.5 7.4 18.3 21.7 13.3 10.6 24.9 35.5 23.3 41.8 8.6 13.1 20.1 8.0 7.4 6.2 4.4 7.7 7.9 0.0 2.6 13.1 22.0 30.9 0.1 9.6 9.5 5.4 11.1 20.8 9.4 0.4 11.8 3.1 8.0 0.7 5.5 26.5 0.4 9.7 5.0 3.9 6.9 1.1 11.1 4.4 4.5 9.3 6.6 0.0 14.6 9.3 0.1 7.0 3.6 0.0 4.7 4.6 5.8 1.6 18.5 5.8 1.6 0.0 3.7 9.6 13.0 6.3 0.4 0.4 8.4 9.8 4.1 3.9 8.7 6.1 11.8 6.8 4.0 9.1 10.7 3.3 2.1 41.8 3.0 9.8 32.5 5.6 24.6 13.1 9.4 35.5 24.9 12.4 10.3 23.3 8.6 24.3 28.0 11.6 20.1 16.7 10.6 13.0 16.9 14.4 14.2 14.6 17.4 11.2 10.1 0.0 0.3 0.0 0.0 8.0 0.0 5.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 12.2 0.0 0.0 0.0 0.0 TRIM39 RNF23 ENSG00000204599 "Tripartite motif containing 39" Q9HCM9 6 30326479-30343729 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA051120, HPA059496" Uncertain Supported Cytosol NA NA Cytosol "HPA051120: AB_2681348, HPA059496: AB_2684040" "unprognostic (2.90e-1)" "unprognostic (1.61e-2)" "unprognostic (2.79e-2)" "unprognostic (2.86e-2)" "unprognostic (6.38e-2)" "unprognostic (4.55e-2)" "unprognostic (1.46e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-1)" "unprognostic (9.44e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.30e-2)" "unprognostic (4.69e-2)" "unprognostic (6.35e-3)" "unprognostic (1.46e-1)" "unprognostic (1.06e-1)" "unprognostic (2.39e-3)" 8.6 7.6 5.2 14.3 6.4 11.8 7.4 8.6 7.6 10.2 11.2 7.3 9.7 7.1 10.0 15.2 11.9 8.5 13.6 6.1 5.4 5.5 7.6 9.6 11.1 6.7 7.7 6.3 10.3 9.1 8.9 11.4 11.6 7.1 7.9 7.1 11.4 8.2 15.5 9.9 6.5 10.9 8.8 6.0 13.1 8.0 14.1 7.2 7.8 8.9 8.3 10.1 9.1 12.3 3.4 1.6 8.4 2.5 4.4 5.2 2.1 4.4 0.2 3.9 6.9 1.8 1.8 4.0 2.1 2.5 3.1 2.8 5.3 0.6 5.7 4.1 3.9 1.9 1.5 4.4 3.1 3.2 4.4 4.9 4.5 0.7 1.9 4.0 6.7 5.1 2.1 2.6 3.9 4.3 4.7 1.9 4.9 6.7 4.6 4.0 4.0 1.4 1.4 5.2 1.9 3.3 3.1 0.8 4.3 3.3 4.3 8.4 4.1 1.6 3.3 4.0 3.9 4.5 1.8 1.7 3.4 2.7 4.1 6.9 8.4 10.1 5.9 2.0 2.4 5.2 1.4 1.7 6.8 5.2 2.5 4.6 3.4 3.7 3.8 1.6 3.3 4.4 4.1 8.4 4.4 2.4 1.2 2.9 2.1 5.2 6.4 8.6 7.6 5.4 5.5 7.7 6.3 7.1 7.2 3.0 7.4 11.5 5.5 3.3 4.9 5.2 2.5 5.3 3.4 1.8 5.9 4.0 6.6 4.2 2.7 3.6 5.8 0.0 5.3 4.8 4.4 3.2 5.7 3.9 2.9 3.2 5.2 6.7 7.2 6.6 2.6 4.4 3.3 3.6 4.4 6.5 5.1 8.6 4.2 3.3 7.7 0.0 5.0 20.2 8.1 3.6 8.4 13.8 3.7 4.7 TRIM39-RPP21 ENSG00000248167 "TRIM39-RPP21 readthrough" 6 30328907-30346854 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 1.8;testis: 1.2" "Group enriched" "Detected in some" 10 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.3;Club cells: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.4;LHCN-M2: 2.2;MCF7: 1.8" HPA051120 Uncertain Approved Cytosol NA NA Cytosol "HPA051120: AB_2681348" "unprognostic (1.20e-1)" "unprognostic (7.35e-2)" "unprognostic (2.56e-1)" "unprognostic (1.60e-1)" "unprognostic (4.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.56e-1)" "unprognostic (5.84e-4)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (6.89e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TRIM40 RNF35 ENSG00000204614 "Tripartite motif containing 40" Q6P9F5 6 30136108-30148735 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 13.5;placenta: 39.4" "Group enriched" "Detected in some" 7 "Enterocytes: 3.6;Intestinal endocrine cells: 1.7;Paneth cells: 3.5;Spermatocytes: 1.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.7;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "HEL: 5.1" "Region enriched" "Detected in single" 19 "thalamus: 3.4" "Low region specificity" "Detected in all" HPA043818 Uncertain Approved Cytosol NA NA Cytosol "HPA043818: AB_10963090" "unprognostic (2.88e-1)" "unprognostic (5.20e-2)" "unprognostic (4.11e-1)" "unprognostic (1.13e-1)" "unprognostic (1.77e-1)" "unprognostic (4.84e-2)" 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.1 0.3 2.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.2 0.0 TRIM47 "GOA, RNF100" ENSG00000132481 "Tripartite motif containing 47" Q96LD4 17 75874161-75878575 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 23.7;RPTEC TERT1: 18.0;U-266/70: 20.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014933 Uncertain Supported Cytosol NA NA Cytosol "HPA014933: AB_10603219" "prognostic favorable (6.54e-4)" "unprognostic (8.42e-2)" "unprognostic (1.42e-1)" "unprognostic (2.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (5.59e-5)" "unprognostic (2.08e-2)" "unprognostic (9.18e-3)" "unprognostic (2.74e-1)" "unprognostic (1.18e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.69e-5)" "unprognostic (3.94e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-2)" "unprognostic (9.98e-2)" 18.8 5.2 11.2 11.6 14.3 1.3 51.5 5.9 26.9 12.5 14.9 10.4 2.6 16.0 16.1 9.5 15.3 9.0 15.9 11.3 11.3 8.5 17.6 8.8 11.2 15.4 14.9 9.4 11.6 18.4 14.5 4.6 5.3 12.4 11.0 9.0 6.2 13.4 9.8 9.3 16.3 9.4 19.9 11.3 15.6 19.7 7.5 13.2 2.6 6.5 13.3 8.1 20.7 13.5 3.5 1.7 1.8 0.0 2.9 7.2 0.7 10.2 7.7 0.0 0.0 1.7 1.8 0.2 0.4 0.8 0.6 0.5 1.4 5.3 0.0 6.8 0.3 5.3 11.8 1.9 2.8 0.0 6.6 4.8 0.0 5.2 14.0 2.8 0.0 0.0 1.5 0.8 1.2 1.0 0.5 5.3 0.8 1.0 15.8 0.3 1.7 1.0 0.1 0.8 4.0 15.0 0.7 0.9 23.7 18.0 0.3 3.0 0.2 3.1 15.1 4.0 0.4 1.8 0.3 7.9 9.5 5.9 0.9 3.6 20.5 5.8 1.1 4.1 0.0 0.8 0.0 0.0 1.8 2.6 0.0 6.8 3.5 6.0 3.3 0.2 2.0 4.0 2.5 0.0 2.9 0.0 1.7 7.2 0.7 11.2 14.3 5.9 12.8 11.3 8.5 14.9 9.4 12.4 13.2 14.9 4.8 3.2 36.4 16.0 5.7 4.4 28.1 8.1 10.3 15.7 0.0 0.3 16.6 54.8 0.4 25.1 22.2 0.0 66.8 1.1 13.6 34.6 21.9 8.3 52.4 0.0 8.1 43.6 4.5 0.4 31.7 8.0 40.5 4.6 12.3 10.9 77.6 2.9 18.0 50.6 0.8 32.3 26.4 0.3 2.7 13.9 0.7 3.9 10.0 15.6 TRIM5 "RNF88, TRIM5alpha" ENSG00000132256 "Tripartite motif containing 5" Q9C035 11 5663557-5938619 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB013497, HPA023420, HPA023422" Approved Supported Cytosol NA NA Cytosol "CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379" "unprognostic (2.60e-1)" "unprognostic (9.62e-2)" "unprognostic (2.04e-2)" "unprognostic (1.41e-2)" "unprognostic (6.88e-2)" "unprognostic (4.74e-3)" "unprognostic (5.48e-3)" "unprognostic (5.82e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (8.54e-3)" "unprognostic (1.64e-1)" "unprognostic (2.20e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (6.12e-2)" 12.5 15.0 3.7 11.6 6.7 3.0 10.7 2.4 5.1 14.2 8.5 4.8 20.1 8.4 16.1 19.9 12.0 11.9 9.9 7.8 5.6 2.9 15.1 16.2 15.2 9.2 6.5 2.9 15.3 24.8 6.1 9.2 12.2 8.8 11.8 8.3 11.8 22.0 12.4 3.0 6.5 13.2 12.0 9.0 19.8 9.5 7.7 6.5 24.9 20.5 7.9 13.3 14.8 12.3 3.9 11.7 13.8 9.8 5.9 5.4 4.6 4.7 7.3 12.5 8.7 13.9 12.8 3.7 10.1 18.8 20.6 27.9 7.4 9.4 3.0 7.9 9.9 16.6 7.8 10.1 14.7 9.3 6.5 2.8 9.1 5.0 5.9 12.3 6.7 9.8 9.7 13.2 6.8 18.1 12.8 31.7 6.6 9.5 6.2 17.3 2.2 5.5 3.1 5.7 7.0 5.1 8.6 2.7 0.8 14.3 9.0 0.3 0.7 7.1 10.3 4.4 12.7 5.3 3.9 23.9 9.7 12.9 1.8 2.4 5.5 3.9 1.2 9.0 4.5 10.0 10.2 9.8 12.9 5.4 9.8 5.3 3.9 4.1 4.3 11.7 3.9 3.4 4.9 13.8 5.9 9.2 9.7 3.3 4.6 3.7 6.7 2.4 5.1 5.6 2.9 6.5 2.9 8.8 6.5 6.0 9.4 12.9 8.1 4.6 0.1 4.8 2.5 2.7 13.6 10.4 0.0 6.5 5.0 10.5 3.2 11.6 5.9 0.0 7.7 8.4 8.9 11.0 0.0 11.1 5.7 0.0 1.2 13.5 11.5 2.3 7.2 7.7 3.3 1.8 8.6 5.7 9.0 3.5 7.1 5.7 0.0 19.4 6.8 5.8 3.6 4.6 6.5 5.7 5.6 8.2 TRIM50 "FLJ32804, TRIM50A" ENSG00000146755 "Tripartite motif containing 50" Q86XT4 7 73312539-73328082 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "pancreas: 17.2;stomach 1: 22.8" "Cell type enhanced" "Detected in some" 14 "Distal tubular cells: 1.7;Early spermatids: 1.9;Spermatocytes: 4.4;Spermatogonia: 4.5" "Group enriched" "Detected in some" 8 "liver cancer: 2.9;renal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "Hep G2: 12.3" "HPA019862, HPA047843" Uncertain Approved Cytosol NA NA Cytosol "HPA019862: AB_1858305, HPA047843: AB_2680176" "unprognostic (1.93e-1)" "unprognostic (3.93e-1)" "unprognostic (1.07e-2)" "unprognostic (5.96e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.49e-1)" "unprognostic (3.04e-3)" "unprognostic (2.63e-2)" "unprognostic (2.00e-1)" "unprognostic (2.13e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.36e-7)" "unprognostic (3.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.20e-1)" "unprognostic (2.25e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 17.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 1.0 0.0 0.0 0.1 22.8 4.4 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 12.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 1.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 4.4 4.5 0.0 0.1 0.0 0.0 0.0 TRIM73 TRIM50B ENSG00000178809 "Tripartite motif containing 73" Q86UV7 7 75395063-75410996 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "stomach 1: 11.5" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 20.3;Cone photoreceptor cells: 17.7;Horizontal cells: 30.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.9;Hep G2: 13.3" "HPA047843, HPA051845" Uncertain Uncertain Cytosol NA NA Cytosol "HPA047843: AB_2680176, HPA051845: AB_2681635" "unprognostic (1.01e-2)" "unprognostic (9.85e-5)" "unprognostic (4.72e-3)" "unprognostic (9.44e-3)" "unprognostic (2.49e-1)" "unprognostic (1.48e-2)" "unprognostic (1.25e-3)" "unprognostic (9.17e-3)" "unprognostic (1.41e-1)" "unprognostic (2.80e-1)" "unprognostic (5.46e-3)" "unprognostic (6.79e-2)" "unprognostic (4.18e-2)" "unprognostic (9.67e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-3)" 1.9 1.6 0.3 1.2 0.9 2.4 1.6 4.0 0.6 2.4 0.6 4.2 1.7 0.3 0.3 3.8 1.0 0.9 0.4 0.5 1.7 2.3 1.1 2.3 0.2 2.3 7.2 1.3 1.7 0.1 2.1 0.0 1.9 1.9 2.6 2.4 2.2 0.0 0.5 1.8 11.5 5.4 2.4 0.2 0.7 1.3 1.3 1.4 2.0 0.8 1.7 2.2 1.3 1.3 4.1 1.7 2.5 0.0 0.9 0.6 0.5 0.1 0.1 1.0 0.0 2.0 2.3 0.4 0.2 0.3 1.4 0.3 0.0 0.2 5.1 7.9 1.5 3.1 13.3 0.9 0.8 5.6 2.3 0.0 0.3 0.4 1.2 0.1 3.3 0.7 6.5 0.0 0.9 2.1 2.7 0.2 0.3 1.4 3.6 0.2 1.2 0.4 0.0 2.1 1.6 2.6 0.9 2.1 0.7 0.6 2.4 1.6 1.1 1.9 1.7 1.1 3.1 1.8 2.4 1.7 3.3 1.5 1.1 0.8 0.7 2.2 0.6 1.2 1.1 1.3 0.4 0.4 1.3 2.1 1.6 2.0 1.7 0.2 1.4 2.0 1.3 0.0 0.3 1.9 2.2 0.8 20.3 2.0 2.5 5.3 3.4 5.2 17.7 1.9 5.0 1.6 5.0 2.2 2.0 0.0 4.0 0.6 1.3 2.7 0.0 1.8 2.5 30.2 4.7 3.1 1.0 8.5 6.1 1.7 1.7 1.0 4.0 9.5 3.1 4.0 3.5 2.9 12.6 0.0 1.1 9.4 2.7 1.8 0.9 4.5 3.3 2.4 TRIM74 "MGC45440, TRIM50C" ENSG00000155428 "Tripartite motif containing 74" Q86UV6 7 72959485-72969466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 10.9" "Cell type enhanced" "Detected in single" 22 "Ciliated cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.7;Hep G2: 5.4" HPA047843 Approved Cytosol NA NA Cytosol "HPA047843: AB_2680176" "unprognostic (8.78e-3)" "unprognostic (3.78e-4)" "unprognostic (5.84e-3)" "unprognostic (1.95e-2)" "unprognostic (1.03e-1)" "unprognostic (8.26e-2)" "unprognostic (3.58e-2)" "unprognostic (1.26e-3)" "unprognostic (1.65e-2)" "unprognostic (3.68e-1)" "unprognostic (8.13e-3)" "unprognostic (1.98e-2)" "unprognostic (7.78e-2)" "unprognostic (7.05e-2)" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (1.12e-3)" 1.1 1.6 0.6 1.0 1.4 1.7 1.0 4.8 0.7 1.1 0.5 2.4 1.3 2.5 0.4 2.3 0.8 0.5 0.6 0.8 1.3 2.3 0.6 1.9 0.4 1.7 5.0 0.2 1.6 0.1 1.6 0.5 1.2 1.0 0.8 1.5 1.2 0.8 0.7 1.6 10.9 6.0 1.5 0.5 0.4 1.0 2.2 0.2 0.7 0.1 0.0 1.1 0.0 0.0 0.3 1.4 1.5 0.5 0.0 0.0 0.8 0.0 0.2 0.5 2.0 1.5 1.0 0.2 0.0 0.5 0.7 0.1 0.1 0.1 0.8 7.7 1.2 0.0 5.4 0.2 2.4 3.3 0.8 0.3 0.0 0.4 1.1 0.0 1.9 1.0 4.6 0.1 2.2 0.9 3.8 0.1 0.0 1.7 1.7 0.6 0.8 2.2 0.8 0.6 0.7 0.8 0.0 1.7 0.2 0.1 1.1 2.7 0.3 1.0 0.5 0.0 3.5 2.7 0.6 1.2 1.4 0.7 0.7 0.0 0.7 1.0 0.0 1.1 2.2 0.7 0.2 0.0 0.1 0.8 0.2 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 TRMT61B FLJ20628 ENSG00000171103 "TRNA methyltransferase 61B" Q9BVS5 2 28849821-28870301 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026747, HPA026751" Enhanced Uncertain Cytosol NA NA Cytosol "HPA026747: AB_1848782, HPA026751: AB_1848784" "unprognostic (1.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.63e-3)" "unprognostic (2.05e-2)" "unprognostic (3.32e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.36e-2)" "unprognostic (2.55e-2)" "unprognostic (2.77e-1)" "unprognostic (2.52e-2)" "unprognostic (2.52e-2)" "prognostic favorable (9.61e-5)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (5.38e-2)" "unprognostic (2.34e-1)" 11.6 19.5 20.4 12.8 22.5 10.9 18.5 33.7 21.0 13.8 11.7 17.4 10.9 19.2 15.6 20.4 12.6 11.8 10.1 16.3 17.2 18.4 19.8 16.9 9.0 13.8 17.0 15.6 13.7 10.0 21.1 25.4 12.2 17.8 15.2 13.2 14.2 12.6 11.8 17.9 11.9 18.6 14.4 14.7 13.2 12.4 14.6 18.7 12.6 12.8 10.4 14.5 14.8 10.8 11.9 6.8 2.7 7.0 13.9 12.4 6.3 17.9 10.8 11.0 19.4 15.0 12.9 13.3 10.7 13.3 13.7 12.8 12.3 9.7 19.0 9.9 9.3 16.4 14.1 15.3 13.0 14.2 14.2 10.3 5.8 8.9 16.1 17.1 12.2 6.6 13.1 14.5 10.8 14.8 10.1 13.0 12.5 11.7 7.3 11.2 7.1 10.8 18.6 20.3 21.4 17.4 8.1 17.7 16.4 11.9 11.7 18.6 19.8 11.5 18.2 17.5 9.6 9.3 4.3 10.2 9.2 15.4 9.0 13.4 9.1 14.9 29.5 12.1 18.4 12.2 0.0 6.6 2.7 9.8 7.0 12.1 11.9 11.1 10.5 6.4 11.6 12.4 8.9 0.9 13.9 5.7 6.8 11.6 6.3 20.4 22.5 33.7 21.0 17.2 18.4 17.0 15.6 17.8 18.7 14.9 5.4 12.0 9.6 16.1 9.9 2.0 10.2 12.0 9.1 8.7 5.9 17.9 13.3 12.4 6.3 6.8 7.1 0.0 8.9 13.0 9.9 6.1 9.2 8.3 8.0 6.4 4.6 1.3 6.9 2.7 8.1 7.1 6.8 10.0 9.5 9.1 9.0 9.9 9.9 23.8 20.7 6.5 9.5 21.8 9.6 13.8 7.3 7.9 13.3 6.5 TRPC4AP "C20orf188, dJ756N5.2, DKFZp586C1223, DKFZP727M231, PPP1R158, TRRP4AP" ENSG00000100991 "Transient receptor potential cation channel subfamily C member 4 associated protein" Q8TEL6 20 35002404-35092871 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051197, HPA065061" Uncertain Approved Cytosol NA NA Cytosol "HPA051197: AB_2681384, HPA065061: AB_2685416" "unprognostic (3.00e-1)" "unprognostic (1.61e-1)" "unprognostic (4.06e-2)" "unprognostic (2.08e-2)" "unprognostic (2.40e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.25e-8)" "unprognostic (1.33e-1)" "unprognostic (5.56e-2)" "unprognostic (2.58e-1)" "unprognostic (1.95e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (3.38e-1)" "unprognostic (3.19e-2)" "unprognostic (5.14e-3)" "unprognostic (1.10e-1)" 36.5 43.3 26.3 30.1 38.2 51.4 35.1 36.7 48.3 27.7 31.9 64.0 36.9 30.7 33.9 31.8 31.5 28.4 30.1 30.1 29.0 31.0 30.4 41.9 38.7 32.3 43.5 34.0 30.4 45.3 41.3 47.9 48.1 43.6 32.9 31.6 29.2 39.9 33.1 50.5 35.0 31.8 32.5 31.9 43.7 37.3 24.5 38.8 46.9 34.8 23.0 34.9 29.0 28.5 10.9 23.2 28.6 20.9 14.2 15.9 13.3 16.3 20.0 17.9 18.4 27.8 26.8 27.5 26.6 31.3 30.6 35.3 43.7 24.5 15.3 25.5 30.7 31.3 21.9 16.2 37.9 23.7 8.1 12.6 39.1 17.2 39.9 27.7 22.6 26.8 29.7 24.0 22.9 19.7 32.2 33.8 31.9 18.3 18.5 24.3 12.3 27.3 25.6 14.1 15.1 27.4 17.2 25.8 15.6 26.3 21.4 15.9 16.0 28.6 48.7 18.6 22.3 17.6 18.5 33.1 38.2 17.3 20.5 15.8 17.0 9.1 12.8 41.2 11.3 19.4 16.4 16.7 28.1 14.8 18.3 15.8 10.9 12.4 15.9 23.2 10.1 11.0 11.5 28.6 14.2 20.9 10.1 14.0 13.3 26.3 38.2 36.7 48.3 29.0 31.0 43.5 34.0 43.6 38.8 17.9 13.1 18.6 13.7 13.5 24.8 11.2 10.2 9.4 11.4 19.2 74.6 43.4 3.3 26.2 11.1 23.8 26.9 0.0 24.0 36.5 21.0 20.5 19.6 18.1 32.7 63.5 19.7 17.2 20.0 5.5 23.6 23.9 11.8 25.2 22.2 25.3 31.2 21.0 21.5 8.7 28.4 38.8 17.9 22.6 25.3 13.8 57.2 20.3 20.9 18.7 TSC1 "hamartin, KIAA0243, LAM, TSC" ENSG00000165699 "TSC complex subunit 1" Q92574 9 132891348-132946874 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 99.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011568, CAB012481, HPA074132" Supported Enhanced Cytosol NA NA Cytosol "CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666" "unprognostic (1.88e-1)" "unprognostic (1.51e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-1)" "unprognostic (6.67e-2)" "unprognostic (4.23e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.96e-2)" "unprognostic (3.48e-2)" "unprognostic (1.24e-1)" "prognostic favorable (8.01e-4)" "unprognostic (1.84e-2)" "prognostic favorable (7.91e-4)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 10.4 13.6 15.8 8.8 26.8 13.6 11.4 32.1 28.3 12.7 10.8 22.6 7.9 9.1 14.6 12.3 10.9 12.4 9.7 17.6 13.0 12.1 13.1 9.4 11.6 10.2 12.5 15.1 21.2 12.1 15.9 19.5 15.8 21.1 11.8 12.6 13.1 11.6 10.4 20.0 13.8 11.2 14.2 12.4 13.7 10.6 36.2 14.9 10.5 16.2 8.6 14.2 10.9 11.1 2.8 3.1 4.8 7.0 4.9 7.1 2.6 6.2 7.4 10.1 8.3 10.4 9.9 19.0 8.4 13.6 8.8 8.7 12.5 7.3 14.6 3.7 16.0 13.4 16.2 11.9 8.5 9.0 7.0 6.3 4.6 14.7 10.2 12.4 6.8 6.3 10.7 6.4 11.2 13.8 8.8 10.1 13.0 8.1 8.0 10.0 11.5 6.1 5.8 13.9 9.2 6.2 7.4 19.1 8.2 3.9 8.2 5.1 7.8 9.8 6.1 4.8 12.5 11.1 4.0 10.4 14.4 8.7 8.6 5.7 4.5 10.0 14.2 8.2 4.0 6.4 4.1 4.4 4.8 6.5 7.0 7.1 1.9 3.6 5.7 3.1 2.8 5.9 5.3 1.7 4.9 3.2 1.8 5.7 2.6 15.8 26.8 32.1 28.3 13.0 12.1 12.5 15.1 21.1 14.9 20.8 25.6 10.8 4.8 6.6 26.0 26.6 7.6 21.4 12.5 10.4 35.3 12.8 11.6 9.5 39.6 8.7 6.3 0.0 6.2 19.5 9.1 6.5 8.1 5.0 7.8 23.8 16.1 12.3 8.7 99.6 14.4 7.4 11.8 8.2 7.9 10.4 10.9 8.4 10.6 7.5 25.2 19.4 8.0 18.9 17.8 7.5 17.6 7.1 9.9 6.5 TSC2 "LAM, PPP1R160, TSC4, tuberin" ENSG00000103197 "TSC complex subunit 2" P49815 16 2047465-2089487 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "GTPase activation" "Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002225, HPA030409, HPA049679" Approved Enhanced Cytosol NA NA Cytosol "CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848" "unprognostic (2.80e-1)" "unprognostic (1.01e-1)" "unprognostic (1.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-3)" "unprognostic (2.04e-2)" "unprognostic (6.05e-3)" "unprognostic (3.43e-1)" "unprognostic (8.94e-2)" "prognostic favorable (5.06e-4)" "unprognostic (4.32e-2)" "unprognostic (3.91e-2)" "unprognostic (2.14e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-2)" "unprognostic (8.96e-2)" 13.9 11.9 16.9 12.4 20.0 10.9 13.2 35.1 26.9 20.5 17.0 19.4 17.9 14.0 20.1 12.2 13.0 18.6 15.0 14.0 13.3 8.8 11.8 9.8 12.7 10.1 13.8 14.7 21.1 16.1 20.0 18.1 10.6 14.6 13.8 10.8 16.7 22.9 19.6 31.7 14.5 13.2 13.5 11.4 12.9 16.6 21.4 12.9 14.1 20.1 11.3 10.9 18.0 14.0 4.7 5.6 7.7 4.9 3.6 7.0 3.7 7.2 11.6 16.1 18.2 19.2 16.2 13.6 17.4 11.9 13.1 11.2 13.9 13.8 10.9 15.5 14.3 6.1 12.0 9.6 12.6 9.8 8.3 15.8 10.3 22.5 5.7 13.2 12.8 12.5 19.1 8.0 10.6 7.9 15.8 12.3 7.9 10.0 9.8 11.6 14.4 15.2 3.7 16.7 5.4 11.4 24.2 17.6 13.9 5.3 6.5 12.2 23.1 24.8 16.4 8.8 16.7 15.0 9.5 19.4 13.8 9.4 12.3 8.8 21.9 21.8 21.8 5.7 5.2 16.3 6.2 4.9 5.4 7.0 4.7 6.7 4.4 4.4 4.1 5.6 4.7 3.1 4.8 7.7 3.6 3.7 1.5 3.2 3.7 16.9 20.0 35.1 26.9 13.3 8.8 13.8 14.7 14.6 12.9 23.8 17.6 14.9 7.2 8.1 44.2 38.9 20.4 9.4 10.3 19.2 88.4 10.1 3.3 12.8 11.0 19.5 25.8 0.0 12.2 6.5 14.6 9.4 8.1 29.2 9.8 42.9 31.2 34.4 10.5 22.4 26.2 16.6 8.5 7.2 23.8 24.1 15.9 17.5 24.4 6.7 69.1 12.9 11.8 19.4 39.6 8.5 7.8 20.0 24.7 9.2 TSC22D2 "KIAA0669, TILZ4a, TILZ4b, TILZ4c" ENSG00000196428 "TSC22 domain family member 2" O75157 3 150408335-150466431 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 132.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004926 Approved Approved Cytosol NA NA Cytosol "HPA004926: AB_1080401" "unprognostic (4.65e-2)" "unprognostic (1.54e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.74e-4)" "unprognostic (2.49e-1)" "unprognostic (2.65e-2)" "unprognostic (1.89e-1)" "unprognostic (1.09e-2)" "unprognostic (7.63e-2)" "unprognostic (2.59e-1)" "unprognostic (2.28e-3)" "unprognostic (8.32e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (1.10e-2)" "unprognostic (4.86e-1)" "unprognostic (1.10e-2)" "unprognostic (3.49e-1)" 22.4 13.5 15.3 18.6 15.2 33.3 13.7 20.5 28.2 15.5 14.3 12.3 10.0 6.7 25.3 16.5 23.0 13.4 25.0 23.7 14.2 13.2 17.3 31.7 15.5 10.6 15.9 14.6 16.4 12.2 11.7 12.8 17.8 14.5 14.0 13.9 12.6 11.3 18.5 17.3 10.9 13.8 28.2 13.7 14.0 15.7 23.9 15.7 19.4 15.3 11.6 10.9 16.7 23.8 4.1 2.9 5.6 6.9 5.0 4.8 2.7 20.4 2.8 9.1 8.7 12.0 5.9 26.4 20.4 7.8 15.1 18.7 11.3 10.3 6.7 11.8 15.3 31.0 8.7 9.1 7.5 30.2 5.3 5.1 7.1 5.2 5.7 13.7 4.3 5.0 10.8 5.8 9.8 14.8 9.1 9.4 3.3 12.2 11.1 10.4 7.2 4.6 5.4 11.7 6.1 5.7 4.9 16.7 7.9 9.6 12.1 5.3 4.7 9.4 5.0 19.9 11.5 4.8 5.8 15.0 10.0 10.4 11.8 18.8 15.0 2.9 9.3 6.8 13.3 5.8 1.2 3.5 4.4 3.0 4.2 4.8 3.0 3.8 3.2 2.8 4.1 2.9 2.9 5.6 5.0 6.9 2.9 1.5 2.7 15.3 15.2 20.5 28.2 14.2 13.2 15.9 14.6 14.5 15.7 59.6 31.5 11.2 64.3 132.2 16.9 39.2 20.4 6.7 18.2 12.2 27.5 21.8 14.9 13.1 15.0 26.3 47.3 0.0 12.1 24.7 49.4 47.1 65.6 35.1 16.5 15.9 30.3 25.8 19.9 21.3 17.3 22.5 40.5 19.8 28.2 31.8 19.0 38.6 14.2 8.1 19.8 12.9 46.4 36.3 24.4 94.6 45.9 15.2 23.5 72.6 TSC22D4 "THG-1, TILZ2" ENSG00000166925 "TSC22 domain family member 4" Q9Y3Q8 7 100463359-100479279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.2" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 493.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006757 Uncertain Approved Cytosol NA NA Cytosol "HPA006757: AB_1080403" "unprognostic (2.34e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (2.66e-4)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (9.45e-4)" "unprognostic (9.96e-2)" "unprognostic (1.27e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (3.36e-1)" "unprognostic (1.09e-1)" "unprognostic (1.54e-2)" "unprognostic (3.84e-2)" "unprognostic (7.36e-2)" "unprognostic (3.81e-3)" 11.2 11.9 77.8 16.4 83.5 32.4 7.7 17.8 92.4 9.7 9.9 96.1 3.4 12.4 9.1 6.2 10.3 9.9 8.0 10.2 69.5 53.8 8.9 5.1 10.2 18.7 97.2 40.6 11.7 9.7 8.8 7.1 12.2 60.5 11.5 6.2 11.8 49.2 13.0 7.8 17.2 12.5 8.0 89.8 24.0 11.7 8.0 62.3 6.7 5.8 1.7 12.2 8.6 5.7 6.9 7.5 32.2 11.4 10.2 13.8 8.8 12.3 9.3 3.2 10.6 11.3 13.5 6.0 9.4 15.9 9.1 8.4 4.9 7.6 11.2 11.2 7.6 20.8 9.6 3.8 8.5 3.2 19.2 7.7 10.0 9.8 4.2 18.1 13.2 26.8 15.2 7.7 10.5 10.5 10.8 18.7 9.0 22.1 20.7 7.3 22.5 16.5 60.8 4.3 10.9 13.3 27.3 2.5 15.5 7.5 6.8 2.7 7.5 13.0 25.0 19.6 5.5 7.0 19.6 15.5 12.4 12.6 30.2 6.9 13.0 12.3 7.9 11.4 20.4 14.9 5.0 10.9 15.6 11.7 11.4 9.1 6.9 10.0 10.8 7.2 6.6 9.6 10.0 32.2 10.2 10.8 7.5 13.8 8.8 77.8 83.5 17.8 65.4 69.5 53.8 97.2 40.6 60.5 62.3 11.9 6.2 54.1 32.3 29.1 13.9 11.6 45.9 4.0 4.5 38.4 5.9 27.8 116.0 50.9 1.4 25.1 57.3 0.0 29.7 30.6 33.2 48.6 16.1 9.5 68.0 17.5 32.2 43.6 53.1 3.1 42.3 43.7 52.3 86.6 28.4 493.0 47.4 43.5 37.4 15.9 11.6 45.3 36.0 0.9 3.6 29.5 66.1 90.8 30.2 50.5 TSGA10 "CEP4L, CT79" ENSG00000135951 "Testis specific 10" Q9BZW7 2 98997261-99154964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 55.7" "Group enriched" "Detected in many" 6 "Ciliated cells: 127.2;Early spermatids: 359.6;Late spermatids: 192.4;Spermatocytes: 112.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036879 Approved Cytosol NA NA Cytosol "HPA036879: AB_10671715" "unprognostic (1.71e-3)" "unprognostic (6.68e-2)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (4.95e-2)" "unprognostic (3.69e-2)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-5)" "unprognostic (2.32e-1)" "unprognostic (2.82e-6)" "unprognostic (1.06e-2)" "unprognostic (9.91e-3)" "unprognostic (9.79e-2)" "unprognostic (8.37e-4)" 2.2 2.2 4.9 1.7 7.1 1.7 2.6 9.5 6.4 2.5 2.0 6.1 2.7 2.1 2.3 3.6 1.7 15.1 2.2 1.3 4.7 3.4 3.3 1.6 2.9 2.1 5.9 4.5 1.7 3.2 2.9 12.2 1.5 4.7 2.2 2.5 1.0 2.3 1.8 1.1 3.1 1.7 1.3 4.2 1.9 2.5 55.7 6.6 1.8 4.5 0.7 1.9 2.3 2.3 2.5 1.2 0.6 0.7 2.3 3.5 0.9 1.4 0.5 2.5 0.9 1.5 1.5 1.9 0.0 0.1 0.4 0.5 0.3 1.8 1.4 0.6 0.0 1.0 0.4 0.5 0.2 0.7 1.7 1.5 0.1 0.0 0.5 0.2 1.0 3.6 1.8 2.1 0.2 0.3 1.5 0.0 1.6 0.0 0.1 1.6 0.3 0.5 0.5 0.4 0.6 0.4 0.6 0.3 0.4 9.0 1.4 3.5 0.4 1.7 1.5 0.2 3.0 0.4 0.5 0.8 0.4 0.9 0.1 0.3 1.2 0.3 0.3 0.8 2.2 0.9 0.3 0.7 0.6 1.9 0.1 2.1 2.1 2.2 2.6 0.1 2.5 3.5 2.1 0.0 2.3 0.0 1.2 2.2 0.9 4.9 7.1 9.5 6.4 4.7 3.4 5.9 4.5 4.7 6.6 3.0 8.6 9.1 8.8 3.2 17.9 6.2 15.3 127.2 18.2 22.7 27.5 5.7 21.6 6.4 359.6 3.4 5.1 0.0 9.3 3.7 3.6 8.1 4.7 6.6 3.9 19.1 14.9 2.5 2.4 192.4 10.3 2.9 1.7 4.6 7.3 15.4 5.1 11.4 9.2 11.0 34.3 6.5 2.7 112.7 30.1 3.9 7.8 5.9 8.3 8.4 TSNARE1 FLJ31164 ENSG00000171045 "T-SNARE domain containing 1" Q96NA8 8 142212080-142403240 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 18.8" HPA074249 Approved Approved Cytosol NA NA Cytosol "HPA074249: " "unprognostic (2.92e-2)" "unprognostic (1.44e-1)" "unprognostic (3.94e-3)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (1.09e-2)" "unprognostic (1.48e-2)" "unprognostic (3.72e-3)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.87e-3)" "unprognostic (1.66e-1)" "unprognostic (6.26e-2)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "prognostic favorable (7.33e-4)" 9.0 8.4 14.3 10.1 14.3 5.3 9.0 14.4 18.4 11.2 8.9 15.6 7.4 15.2 12.6 10.5 7.4 13.2 8.2 7.2 8.6 8.0 8.6 6.6 9.2 8.2 12.7 12.9 17.9 24.3 9.0 9.8 4.8 11.6 10.5 4.3 10.5 17.1 11.5 11.7 31.9 16.5 7.4 8.4 13.2 11.3 8.9 14.3 6.3 12.3 6.5 9.7 9.3 8.8 1.2 1.5 3.9 5.0 1.2 2.3 1.4 5.0 5.0 3.3 4.1 2.6 2.4 10.4 1.5 2.4 1.5 1.6 1.5 5.5 2.7 8.2 1.2 2.6 4.5 1.5 5.2 0.6 3.0 4.7 2.9 1.2 5.4 6.9 7.1 7.4 4.6 4.9 0.0 3.5 3.1 1.6 14.2 6.0 0.3 1.0 6.6 5.9 6.4 3.3 5.0 11.9 0.0 1.7 4.5 2.9 6.2 13.7 8.3 6.7 5.6 9.9 1.7 3.7 6.4 4.1 2.4 6.6 4.5 3.1 0.4 2.0 4.2 4.5 18.8 2.5 3.9 1.3 0.3 2.3 5.0 1.6 0.8 1.3 0.6 1.5 1.2 0.5 0.9 0.1 1.2 3.5 0.0 1.5 1.4 14.3 14.3 14.4 18.4 8.6 8.0 12.7 12.9 11.6 14.3 0.0 1.4 0.0 1.9 3.9 2.0 3.1 2.5 2.7 0.0 1.8 2.0 0.2 3.3 1.4 1.8 1.4 1.3 0.0 1.6 1.5 0.6 1.2 0.0 1.1 1.7 0.0 1.7 1.3 3.0 3.9 0.9 1.2 3.3 1.8 0.7 2.9 1.4 0.0 1.4 1.4 0.7 0.0 1.3 3.9 3.2 6.6 0.2 2.2 0.8 0.9 TSPY1 "CT78, TSPY" ENSG00000258992 "Testis specific protein, Y-linked 1" Q01534 Y 9466955-9469748 "Disease related genes, Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 105 "testis: 10.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 361 "U-266/70: 64.9;U-266/84: 60.7" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.9 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 TSPY10 ENSG00000236424 "Testis specific protein, Y-linked 10" Y 9527880-9530682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 6.3" "Cell type enriched" "Detected in single" 14 "Spermatogonia: 8.6" "Cancer enriched" "Detected in single" 13 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-266/84: 36.6" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (5.36e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.6 0.0 0.0 0.0 0.0 0.0 TSPY2 TSPYQ1 ENSG00000168757 "Testis specific protein, Y-linked 2" A6NKD2 Y 6246223-6249019 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 104 "testis: 13.5" "Cell type enriched" "Detected in some" 8 "Spermatogonia: 26.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 426 "U-266/70: 41.9;U-266/84: 43.2" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (3.69e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 26.0 0.0 0.0 0.0 0.0 0.0 TSPY3 CT78 ENSG00000228927 "Testis specific protein, Y-linked 3" P0CV98 Y 9398421-9401223 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "testis: 7.6" "Cell type enriched" "Detected in single" 25 "Spermatogonia: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 75 "U-266/70: 50.9;U-266/84: 46.1" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (4.19e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 50.9 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.0 0.0 TSPY4 ENSG00000233803 "Testis specific protein, Y-linked 4" "P0CV99, P0CW01" Y 9337464-9340284 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 222 "testis: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 604 "U-266/70: 178.3;U-266/84: 187.8" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 178.3 187.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 TSPY8 ENSG00000229549 "Testis specific protein, Y-linked 8" P0CW00 Y 9357797-9360599 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 4.1" "Cell type enriched" "Detected in single" 12 "Spermatogonia: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 230 "U-266/84: 77.1" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 77.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.9 0.0 0.0 0.0 0.0 0.0 TTC1 TPR1 ENSG00000113312 "Tetratricopeptide repeat domain 1" Q99614 5 160009113-160065543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036557, HPA057502" Approved Enhanced Cytosol NA NA Cytosol "HPA036557: AB_10670112, HPA057502: AB_2683450" "unprognostic (4.34e-3)" "unprognostic (2.26e-2)" "unprognostic (3.05e-2)" "unprognostic (7.38e-2)" "unprognostic (6.62e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (8.29e-2)" "unprognostic (2.38e-1)" "unprognostic (5.50e-2)" "unprognostic (2.31e-1)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (6.16e-2)" 25.3 28.0 44.4 21.0 36.0 14.3 25.4 31.4 44.9 21.7 25.2 25.4 16.8 16.9 21.3 38.4 24.8 21.0 16.6 33.9 41.7 42.9 31.3 27.7 20.5 26.9 48.9 33.9 23.7 16.0 25.7 23.9 22.0 56.7 22.0 29.4 15.9 23.7 25.1 50.5 21.6 20.6 26.7 37.4 25.2 19.7 20.3 26.6 27.4 26.8 20.0 33.5 25.9 18.0 46.0 38.4 54.2 41.3 43.2 45.3 52.8 24.6 25.8 19.4 32.3 23.0 16.6 22.0 27.8 24.7 30.6 36.4 36.2 28.9 25.4 54.4 23.7 41.7 19.6 25.6 38.0 49.4 47.0 27.2 22.7 20.5 26.0 32.6 37.6 19.1 15.5 25.3 27.0 22.6 22.6 36.6 22.7 21.6 25.4 34.7 19.3 27.2 29.6 21.9 20.2 26.5 26.4 27.1 28.0 38.6 23.3 16.0 18.0 19.2 23.0 51.2 19.0 36.4 36.6 25.7 20.4 17.6 18.1 42.7 18.3 33.3 24.7 28.2 43.0 26.4 47.0 39.1 52.4 32.4 41.3 40.4 46.0 38.4 37.6 38.4 40.6 35.6 39.4 54.2 43.2 39.0 34.1 45.3 52.8 44.4 36.0 31.4 44.9 41.7 42.9 48.9 33.9 56.7 26.6 62.5 43.2 61.0 31.3 41.8 35.3 213.0 38.2 119.1 63.7 43.6 19.6 89.8 137.6 100.6 91.3 58.7 48.5 70.0 92.5 63.6 46.1 30.3 78.8 57.2 77.4 33.4 33.9 48.5 45.7 22.8 43.4 66.2 27.0 80.2 40.1 73.1 84.8 45.2 60.1 114.2 37.9 58.2 62.8 148.9 94.5 41.4 83.5 54.3 45.5 19.2 TTC38 FLJ20699 ENSG00000075234 "Tetratricopeptide repeat domain 38" Q5R3I4 22 46267961-46294008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 59.8;liver: 92.8" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 78.3;Hepatocytes: 110.0;Proximal tubular cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 36.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.1;NK-cells: 13.5;T-cells: 36.0" "Cell line enhanced" "Detected in many" "Hep G2: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029302, HPA075893" Approved Approved Cytosol NA NA 19000 Cytosol "HPA029302: AB_10601704, HPA075893: " "unprognostic (7.78e-2)" "unprognostic (5.85e-2)" "unprognostic (4.92e-3)" "prognostic favorable (3.21e-6)" "unprognostic (8.34e-2)" "unprognostic (6.38e-2)" "unprognostic (8.72e-2)" "unprognostic (3.62e-2)" "unprognostic (9.45e-2)" "unprognostic (7.22e-2)" "unprognostic (1.12e-1)" "unprognostic (5.66e-2)" "unprognostic (7.34e-3)" "unprognostic (9.02e-2)" "unprognostic (4.12e-1)" "unprognostic (4.97e-1)" "unprognostic (8.33e-2)" 10.5 8.1 3.8 8.8 5.0 16.1 14.0 3.9 4.4 5.5 31.6 5.5 6.2 31.2 6.6 5.0 6.7 5.9 15.0 10.9 3.8 3.3 47.2 92.8 5.3 5.0 6.0 2.2 10.0 19.8 3.0 5.9 3.1 5.3 8.7 12.9 7.5 10.4 6.9 8.6 3.9 59.8 5.2 3.9 8.4 9.1 2.5 5.5 1.0 8.2 4.7 4.2 5.3 5.8 0.9 4.0 10.1 4.3 13.5 36.0 13.4 5.6 6.3 8.0 16.7 7.5 6.5 8.1 8.4 5.5 9.1 7.2 10.3 4.2 0.0 5.4 8.5 3.6 5.2 8.0 6.7 3.3 12.7 18.0 7.5 14.1 35.4 10.5 4.1 29.5 11.2 3.5 4.1 4.8 6.3 7.6 0.1 5.5 9.4 5.8 5.6 0.1 13.1 6.1 10.6 6.3 0.0 3.9 3.8 6.2 6.6 1.4 11.3 11.5 7.9 6.2 3.8 12.7 8.4 8.9 6.5 7.2 5.0 5.2 7.3 4.3 0.8 4.3 6.5 6.6 10.1 4.3 8.0 36.0 4.1 3.9 0.9 3.5 16.0 4.0 0.7 1.5 15.4 2.9 13.5 3.0 1.6 1.6 13.4 3.8 5.0 3.9 4.4 3.8 3.3 6.0 2.2 5.3 5.5 0.0 6.9 6.0 4.9 3.0 2.5 8.7 30.6 4.0 3.4 8.7 5.9 8.8 19.9 8.8 0.1 7.2 78.3 0.0 8.9 7.4 5.2 8.0 17.3 110.0 11.4 4.8 20.1 8.0 11.1 0.7 6.9 8.7 5.0 16.2 36.7 9.0 10.3 45.8 13.1 122.9 4.9 6.5 5.2 1.7 4.3 7.2 5.4 35.9 47.2 4.2 TTF2 "HuF2, ZGRF6" ENSG00000116830 "Transcription termination factor 2" Q9UNY4 1 117060303-117107453 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005776, HPA070762" Approved Supported Cytosol NA Yes Cytosol "HPA005776: AB_1080416, HPA070762: AB_2686307" "unprognostic (1.82e-1)" "unprognostic (2.18e-1)" "unprognostic (3.29e-3)" "unprognostic (2.01e-3)" "unprognostic (4.90e-2)" "unprognostic (3.41e-3)" "unprognostic (5.27e-4)" "unprognostic (7.96e-2)" "unprognostic (1.92e-2)" "unprognostic (3.33e-1)" "unprognostic (4.64e-2)" "unprognostic (9.52e-3)" "unprognostic (7.34e-3)" "unprognostic (1.48e-3)" "unprognostic (7.73e-2)" "unprognostic (3.50e-1)" "unprognostic (3.65e-2)" 5.7 9.4 5.4 8.5 8.4 6.6 6.0 0.9 5.2 5.9 7.0 8.4 2.6 6.0 5.9 2.3 9.8 4.5 3.9 5.8 4.6 3.8 3.9 3.1 4.7 11.5 12.0 2.1 5.5 5.5 6.7 10.7 4.9 7.2 5.0 8.1 4.2 6.5 3.6 8.4 6.9 5.7 6.8 7.7 6.8 5.4 6.3 8.0 25.1 5.2 7.8 17.8 6.4 6.5 3.7 5.9 3.2 6.3 5.3 6.1 2.5 12.7 4.7 9.5 13.4 3.8 3.3 11.9 6.8 3.2 10.1 9.0 6.6 2.2 15.5 10.6 4.5 11.3 13.3 16.8 8.8 15.6 11.9 11.8 13.2 9.1 8.3 2.7 19.3 15.3 3.8 3.4 7.4 13.9 2.5 6.8 12.3 10.1 14.2 7.6 19.5 12.8 12.0 14.9 12.2 9.5 18.5 35.1 6.8 6.1 5.8 8.2 3.4 10.3 10.3 3.8 7.6 5.6 7.9 6.9 6.4 13.6 15.0 14.8 6.5 5.6 19.1 4.3 14.7 25.6 1.8 5.2 3.2 3.0 6.3 2.9 3.7 3.5 4.7 5.9 3.5 3.6 4.1 0.9 5.3 3.6 3.3 6.1 2.5 5.4 8.4 0.9 5.2 4.6 3.8 12.0 2.1 7.2 8.0 6.0 5.4 18.8 8.6 11.7 5.7 5.6 5.1 4.0 6.8 12.2 7.9 5.8 5.0 5.8 5.9 7.2 5.9 0.0 6.9 7.2 5.2 10.8 9.2 2.5 9.7 11.1 4.7 4.9 5.6 5.4 6.1 12.0 6.8 24.4 7.5 5.3 6.7 2.9 3.9 2.7 6.4 0.0 10.3 6.6 9.3 12.5 3.2 8.7 11.0 15.2 TULP2 "CT65, TUBL2" ENSG00000104804 "Tubby like protein 2" O00295 19 48880965-48898733 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.6;testis: 25.5" "Group enriched" "Detected in some" 43 "Early spermatids: 174.6;Late spermatids: 168.8" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 6.6" "Cell line enhanced" "Detected in some" "BEWO: 5.5;U-266/70: 6.4;U-266/84: 6.9" "Not detected" "Not detected" HPA075828 Approved Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA075828: " "unprognostic (9.97e-2)" "unprognostic (5.55e-3)" "unprognostic (1.15e-1)" "unprognostic (9.39e-2)" "unprognostic (1.69e-4)" "unprognostic (6.79e-4)" "unprognostic (1.07e-2)" "unprognostic (2.57e-1)" "unprognostic (5.94e-3)" "unprognostic (1.08e-2)" "unprognostic (9.82e-2)" "unprognostic (1.33e-1)" "unprognostic (4.59e-4)" "unprognostic (6.37e-2)" "unprognostic (1.63e-1)" "unprognostic (1.08e-1)" "unprognostic (1.97e-1)" 0.2 0.3 0.2 0.2 0.2 4.3 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.8 0.8 0.5 0.6 0.5 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 1.3 0.2 0.0 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.0 0.2 25.5 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 6.6 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 1.1 1.9 0.9 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.9 0.9 1.8 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.7 0.0 0.9 0.0 1.1 0.0 0.0 0.0 0.1 0.0 6.4 6.9 0.3 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 6.6 0.0 0.0 0.2 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 174.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.8 168.8 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.1 1.4 0.4 0.0 0.0 0.0 0.0 TXLNG "CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX" ENSG00000086712 "Taxilin gamma" Q9NUQ3 X 16786427-16844519 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000297, HPA000841" Approved Approved Cytosol NA NA Cytosol "HPA000297: AB_1078590, HPA000841: AB_1078589" "unprognostic (2.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.27e-3)" "unprognostic (4.78e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (6.33e-6)" "unprognostic (2.61e-2)" "unprognostic (5.27e-3)" "unprognostic (6.96e-2)" "unprognostic (3.61e-2)" "unprognostic (1.40e-2)" "unprognostic (1.58e-3)" "unprognostic (2.04e-2)" "unprognostic (2.22e-1)" "unprognostic (8.62e-2)" "unprognostic (6.00e-3)" 16.2 20.1 14.4 13.5 17.5 14.9 14.0 24.9 19.9 13.2 11.1 5.6 13.0 9.9 12.0 8.4 8.4 12.0 9.1 6.9 12.4 10.1 9.4 9.6 9.2 13.8 11.8 10.1 21.1 10.3 13.9 20.1 6.9 12.8 8.6 7.5 5.4 8.4 17.2 17.3 7.4 8.6 10.3 11.2 8.8 8.9 7.1 17.4 6.0 12.8 5.5 13.5 13.6 23.8 6.5 3.4 1.6 3.0 4.3 7.4 3.4 12.1 7.6 7.4 12.9 13.5 7.4 3.9 4.9 4.7 5.6 5.5 10.6 7.3 25.6 12.4 2.7 16.2 7.9 25.1 16.0 10.1 7.8 30.5 9.2 10.5 6.8 5.6 13.6 6.6 4.3 7.8 13.0 23.6 7.6 7.0 10.6 17.5 7.6 4.3 7.3 12.4 7.6 21.9 8.1 8.9 8.6 10.0 21.2 4.5 6.1 11.9 8.7 11.3 10.8 9.0 13.2 13.1 5.6 3.4 3.5 4.7 12.4 8.4 8.0 12.2 26.0 4.5 9.0 3.5 1.0 3.0 1.6 5.3 2.2 6.7 6.1 5.7 6.0 3.3 6.5 6.9 7.4 1.1 4.3 2.5 3.4 5.8 3.4 14.4 17.5 24.9 19.9 12.4 10.1 11.8 10.1 12.8 17.4 14.9 16.1 17.2 49.4 36.5 34.3 11.5 12.7 14.7 31.8 8.7 5.9 12.4 18.3 14.9 2.7 11.1 8.0 23.3 14.5 11.5 21.3 27.3 12.7 15.6 8.2 27.0 13.8 12.9 6.5 1.5 25.0 8.7 16.9 4.6 12.6 12.9 13.0 5.8 19.8 14.6 21.3 6.5 16.8 12.9 38.1 30.5 18.3 20.0 15.2 24.5 TXNDC9 APACD ENSG00000115514 "Thioredoxin domain containing 9" O14530 2 99318982-99340702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031844, HPA031845, HPA031846" Approved Enhanced Cytosol NA NA Cytosol "HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916" "unprognostic (3.63e-3)" "unprognostic (4.26e-2)" "unprognostic (7.28e-2)" "unprognostic (3.12e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (9.63e-7)" "unprognostic (2.06e-2)" "unprognostic (9.09e-2)" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.32e-1)" "unprognostic (2.47e-3)" "unprognostic (2.03e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" 29.2 20.7 16.8 17.8 19.4 13.0 25.9 20.1 25.3 23.4 21.1 13.8 14.9 15.2 19.0 23.9 28.8 15.8 15.7 23.9 18.1 20.8 42.9 33.3 17.0 22.3 19.0 13.9 20.4 15.1 13.3 27.6 33.9 27.3 19.5 23.3 9.3 19.4 15.3 22.8 16.2 21.6 21.4 22.1 32.3 16.7 14.9 17.5 39.6 21.2 28.1 27.8 20.4 18.3 32.6 28.9 45.2 36.7 35.2 41.8 40.2 25.6 8.3 21.3 10.4 20.6 20.9 22.9 29.6 27.4 31.3 30.5 22.8 19.8 19.4 23.8 26.0 28.7 18.6 19.3 30.7 37.1 14.1 16.4 21.0 11.8 26.0 19.8 25.1 15.6 19.1 27.6 26.3 19.6 16.6 35.7 11.9 24.0 18.2 36.6 13.0 14.7 22.0 15.6 16.1 22.8 11.0 19.4 18.7 44.3 19.9 13.2 10.8 14.1 19.8 31.3 26.4 22.7 20.3 24.5 23.1 22.5 14.3 20.7 7.5 11.5 23.4 18.9 26.1 20.8 45.2 27.6 28.2 29.1 28.5 36.3 32.6 34.7 32.9 28.9 26.0 32.9 32.8 26.8 35.2 36.7 28.8 41.8 40.2 16.8 19.4 20.1 25.3 18.1 20.8 19.0 13.9 27.3 17.5 8.9 11.2 34.3 26.2 31.3 9.8 26.2 20.4 34.8 25.0 34.9 7.9 67.9 71.3 76.6 55.0 37.9 22.2 46.7 60.7 67.0 32.9 22.6 17.3 22.4 50.5 12.7 20.1 34.4 28.6 13.8 25.6 31.6 25.3 60.5 22.3 19.7 68.9 20.1 21.9 96.4 16.6 25.8 20.6 25.2 41.2 34.0 68.0 35.0 23.0 21.2 TXNL1 "TRP32, Txl, TXNL" ENSG00000091164 "Thioredoxin like 1" O43396 18 56597208-56651600 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002828, HPA002829, CAB016446" Supported Supported Enhanced Cytosol NA Yes 1500000 Cytosol "CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359" "unprognostic (2.05e-1)" "unprognostic (2.97e-1)" "unprognostic (3.38e-3)" "unprognostic (4.54e-2)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (9.62e-6)" "unprognostic (1.83e-1)" "unprognostic (1.03e-2)" "prognostic favorable (6.26e-5)" "unprognostic (1.44e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-3)" "unprognostic (1.24e-1)" "unprognostic (1.26e-1)" "unprognostic (2.62e-1)" "unprognostic (1.51e-1)" 20.5 31.9 27.9 17.8 30.0 34.0 24.4 20.6 34.5 22.5 20.1 21.5 17.3 20.1 22.1 33.8 29.6 18.0 19.8 37.2 27.7 28.5 28.0 38.5 16.4 21.7 27.7 22.8 26.1 34.3 21.5 23.3 26.8 32.1 23.1 21.6 17.6 22.4 20.9 64.4 17.6 21.1 26.5 23.4 20.4 24.0 19.3 21.1 22.3 96.0 27.7 23.3 27.7 18.9 22.2 29.9 39.0 35.3 23.4 23.0 30.9 24.8 24.6 33.3 34.3 29.0 42.5 23.7 29.7 30.6 38.4 32.6 21.8 24.6 27.1 26.5 32.3 27.8 31.0 31.5 26.9 39.8 27.6 14.4 37.1 20.6 40.8 34.0 54.0 24.2 32.2 27.9 36.1 33.2 40.6 30.8 20.8 27.1 45.5 38.8 23.9 31.2 35.3 24.1 17.3 26.5 25.5 22.5 47.0 44.8 38.9 27.7 25.3 16.9 23.7 28.1 27.7 25.9 29.0 24.4 40.4 21.3 14.0 28.9 44.2 47.3 42.3 26.3 41.4 29.5 39.0 35.3 25.3 15.9 29.6 21.7 22.2 19.7 20.8 29.9 19.3 19.4 19.6 26.5 23.4 27.9 25.5 23.0 30.9 27.9 30.0 20.6 34.5 27.7 28.5 27.7 22.8 32.1 21.1 53.6 38.7 77.2 102.3 119.4 77.4 92.0 48.4 57.6 61.4 27.9 131.6 212.5 92.9 122.4 165.3 62.6 79.4 46.7 112.7 104.6 91.2 91.6 51.9 68.4 133.8 54.0 72.8 56.4 76.0 218.7 71.9 78.2 62.4 131.7 97.3 59.0 117.2 83.1 78.8 104.9 82.7 64.7 97.8 196.1 99.4 110.2 299.9 68.2 101.2 105.2 TYK2 JTK1 ENSG00000105397 "Tyrosine kinase 2" P29597 19 10350529-10380676 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 63.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005157 Uncertain Approved Cytosol NA NA Cytosol "HPA005157: AB_1858480" "unprognostic (1.60e-2)" "unprognostic (6.12e-3)" "unprognostic (3.67e-2)" "prognostic favorable (9.62e-4)" "unprognostic (7.61e-2)" "prognostic favorable (1.05e-5)" "unprognostic (1.20e-2)" "unprognostic (6.16e-3)" "unprognostic (4.93e-2)" "unprognostic (1.90e-2)" "prognostic favorable (1.02e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.10e-3)" "unprognostic (1.78e-1)" "unprognostic (4.19e-1)" "prognostic favorable (4.16e-4)" 16.8 19.0 22.9 36.0 22.6 49.4 17.5 24.4 23.9 17.8 19.4 26.7 13.9 20.0 19.3 20.2 15.0 16.8 21.8 17.0 18.3 14.0 24.0 34.4 27.5 31.5 24.7 17.4 20.0 21.3 19.0 24.8 13.9 19.1 21.1 18.6 21.6 24.4 15.4 15.6 24.4 23.8 16.7 17.9 47.9 18.5 6.4 22.8 33.9 20.9 13.5 34.7 16.7 15.1 5.8 15.8 22.9 13.4 5.3 9.1 7.3 8.6 12.7 7.6 11.9 10.1 14.3 7.3 11.9 12.2 15.1 16.7 9.7 5.8 13.2 14.1 13.3 10.4 8.8 9.2 14.0 8.0 23.3 14.2 24.4 25.3 23.9 15.9 10.2 28.2 13.8 9.9 17.2 10.2 9.5 14.6 17.5 10.2 37.0 13.3 27.3 15.0 63.2 2.4 8.6 22.2 15.0 6.5 13.5 12.3 28.0 7.2 8.8 11.6 12.3 8.5 6.2 6.8 17.4 12.4 20.4 7.3 23.5 14.0 30.5 23.7 12.1 10.2 21.4 11.4 6.6 13.4 17.0 9.1 10.2 5.9 5.6 5.5 8.1 15.8 5.8 3.8 5.1 22.9 5.3 9.7 9.0 6.8 7.3 22.9 22.6 24.4 23.9 18.3 14.0 24.7 17.4 19.1 22.8 11.9 19.9 6.7 4.8 6.0 8.4 23.6 12.7 5.3 10.3 8.7 3.9 6.0 44.7 6.5 1.4 7.5 10.2 0.0 9.5 6.9 9.4 5.5 18.5 20.2 13.0 0.0 4.6 14.1 30.7 6.4 6.9 18.0 15.1 15.4 8.3 7.4 9.1 11.5 9.2 19.5 9.7 0.0 8.6 1.4 4.3 6.4 5.6 19.2 9.0 4.9 UBAC2 "FLJ30548, PHGDHL1, RP11-178C10.1" ENSG00000134882 "UBA domain containing 2" Q8NBM4 13 99200774-99386434 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013448 Approved Approved Cytosol NA NA Cytosol "HPA013448: AB_1855301" "unprognostic (7.04e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (7.30e-3)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" "unprognostic (9.48e-3)" "unprognostic (6.50e-3)" "unprognostic (1.58e-1)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (6.44e-2)" "unprognostic (6.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.16e-1)" "unprognostic (6.08e-2)" "unprognostic (3.26e-2)" 16.7 15.6 9.1 15.6 10.4 11.0 24.2 8.2 13.9 14.6 14.6 10.0 18.3 16.7 17.2 17.1 29.6 18.1 15.4 15.5 11.0 7.6 15.1 20.0 20.6 36.5 8.2 10.1 15.1 25.5 11.8 9.5 22.1 9.8 11.1 14.6 11.9 19.5 13.7 26.9 26.3 17.6 13.8 11.7 13.4 14.9 24.8 8.1 21.6 20.6 17.3 24.5 17.2 15.8 25.3 23.9 24.7 23.1 31.3 37.5 31.8 13.1 8.3 6.3 9.1 16.0 17.4 15.2 6.9 24.7 12.6 9.8 8.0 28.6 5.5 12.3 10.5 7.8 12.1 9.1 11.8 7.3 9.3 9.0 9.1 4.4 4.9 13.6 11.4 7.0 13.5 14.9 7.2 22.8 16.7 11.0 10.5 8.0 2.8 10.2 3.5 8.7 2.9 7.9 27.4 6.5 7.0 5.5 4.0 8.6 6.7 6.8 10.1 5.7 17.2 10.0 10.5 11.5 36.8 7.8 4.9 4.9 5.1 7.5 3.9 3.3 1.9 10.7 17.7 9.6 20.8 23.1 17.3 27.3 22.1 37.5 19.6 23.4 27.3 18.6 25.3 32.7 32.2 24.7 31.3 21.2 23.9 15.1 31.8 9.1 10.4 8.2 13.9 11.0 7.6 8.2 10.1 9.8 8.1 6.0 18.4 15.9 23.5 24.2 26.2 19.7 17.8 25.4 14.8 22.7 25.5 99.9 19.9 38.6 19.2 23.6 34.4 0.0 30.4 70.7 31.5 23.0 21.9 25.0 43.6 30.2 8.1 12.9 33.8 16.7 32.5 40.2 28.7 16.2 26.9 44.7 25.3 35.1 47.7 18.3 21.9 32.3 24.0 59.0 37.8 29.0 110.8 50.4 33.9 23.3 UBAP2 "bA176F3.5, FLJ22435, KIAA1491" ENSG00000137073 "Ubiquitin associated protein 2" Q5T6F2 9 33921693-34048949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021684 Approved Approved Cytosol NA NA Cytosol "HPA021684: AB_2211887" "unprognostic (2.71e-1)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "prognostic favorable (8.59e-4)" "unprognostic (1.75e-1)" "unprognostic (9.76e-3)" "prognostic favorable (1.95e-4)" "unprognostic (8.06e-2)" "unprognostic (2.39e-1)" "unprognostic (2.95e-1)" "unprognostic (8.77e-2)" 13.0 23.8 11.8 13.9 12.8 17.0 11.6 15.1 14.5 11.6 11.9 12.8 9.4 10.0 18.6 10.8 16.8 10.7 10.5 11.5 10.4 8.6 12.7 9.5 11.6 11.0 8.4 10.7 15.2 13.5 13.4 18.2 18.3 11.5 12.7 14.4 12.3 17.6 11.7 38.1 18.4 9.7 12.2 10.6 10.4 12.0 27.5 11.5 24.7 15.4 21.0 19.2 11.6 13.6 4.7 6.8 4.7 10.5 7.5 8.2 3.3 18.2 16.9 12.2 15.4 12.1 10.7 14.7 14.7 9.2 15.2 14.8 22.8 9.7 21.3 4.7 12.2 11.7 10.7 20.5 16.1 17.0 15.6 10.0 11.8 21.5 24.9 9.9 26.7 19.1 9.9 13.7 19.3 13.5 8.0 12.2 13.1 16.2 17.6 13.7 12.2 19.8 45.4 13.0 10.3 13.3 15.4 7.6 13.5 14.7 13.8 12.6 8.7 17.4 14.2 4.3 12.8 12.6 12.0 14.3 9.1 12.3 10.7 16.3 6.8 14.2 22.9 10.0 10.3 22.5 2.6 4.3 4.7 3.9 5.2 8.2 4.7 4.8 5.4 5.0 2.5 4.3 5.8 2.6 7.5 10.5 6.8 5.3 3.3 11.8 12.8 15.1 14.5 10.4 8.6 8.4 10.7 11.5 11.5 50.6 20.2 9.0 24.4 25.0 26.2 52.5 10.2 21.4 35.2 12.2 56.9 37.2 3.3 18.9 83.6 26.8 12.7 23.3 17.1 31.0 14.7 20.0 13.9 11.6 14.4 15.9 24.1 12.9 14.3 60.5 28.1 14.3 25.3 17.2 25.5 15.1 23.5 28.1 23.0 14.0 28.1 25.8 15.5 69.4 62.7 27.1 61.0 10.2 24.8 20.2 UBE2F NCE2 ENSG00000184182 "Ubiquitin conjugating enzyme E2 F (putative)" Q969M7 2 237966827-238042782 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Extravillous trophoblasts: 231.1;monocytes: 312.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037444 Approved Approved Cytosol NA NA Cytosol "HPA037444: AB_10672491" "unprognostic (1.73e-1)" "unprognostic (1.65e-1)" "unprognostic (3.80e-2)" "unprognostic (6.92e-3)" "unprognostic (3.39e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (3.43e-3)" "unprognostic (6.64e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.59e-7)" "unprognostic (2.04e-2)" "unprognostic (6.39e-2)" "unprognostic (3.60e-2)" "unprognostic (2.51e-1)" 14.5 18.4 21.3 13.6 17.6 19.9 17.2 12.2 19.8 16.7 15.8 17.7 12.3 13.6 14.7 32.2 25.0 11.0 16.3 34.6 20.2 21.6 14.6 24.1 12.9 26.4 23.4 10.1 10.4 62.8 16.3 13.2 22.2 24.2 14.9 19.6 11.4 15.3 18.2 32.1 10.3 17.9 20.2 20.2 14.6 15.1 13.9 16.8 15.8 32.9 17.4 17.7 18.7 16.4 10.9 23.1 35.6 30.0 39.9 29.1 24.6 13.5 7.7 17.8 18.2 23.2 28.3 25.2 12.7 18.3 14.4 14.8 8.4 8.7 7.0 4.6 28.5 31.4 11.5 20.1 27.7 22.6 10.6 7.8 9.6 9.8 27.4 29.2 4.0 22.7 16.2 45.8 19.0 29.0 13.4 25.5 33.0 29.3 4.5 26.0 20.3 10.9 17.7 19.6 19.5 11.8 13.3 11.8 12.4 21.7 5.7 11.9 17.8 14.9 11.3 23.6 31.2 10.2 16.8 15.8 15.9 14.0 18.0 13.6 5.6 4.3 13.7 18.8 12.2 11.7 35.6 21.0 25.2 29.1 27.6 11.5 10.9 19.9 17.6 18.6 10.1 18.6 18.8 15.6 39.9 30.0 23.1 20.5 24.6 21.3 17.6 12.2 19.8 20.2 21.6 23.4 10.1 24.2 16.8 6.0 20.2 41.4 18.8 28.8 21.7 44.5 28.1 24.1 5.7 26.2 7.9 72.4 48.0 42.5 17.3 25.5 37.0 70.0 68.9 231.1 37.6 41.8 20.8 40.0 129.2 25.4 40.1 23.9 54.8 47.2 23.9 61.5 33.7 312.0 46.7 15.8 69.1 29.2 29.0 52.2 19.3 38.8 35.6 90.0 52.7 35.3 54.9 47.3 30.7 31.1 UBE2L6 UBCH8 ENSG00000156587 "Ubiquitin conjugating enzyme E2 L6" O14933 11 57551656-57568284 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hofbauer cells: 148.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003328, CAB073407" Enhanced Approved Cytosol NA NA 34000 Cytosol "CAB073407: , HPA003328: AB_1858539" "prognostic favorable (6.75e-4)" "unprognostic (2.10e-2)" "unprognostic (1.09e-2)" "unprognostic (2.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (1.36e-2)" "unprognostic (1.37e-3)" "prognostic unfavorable (4.88e-4)" "unprognostic (3.07e-2)" "unprognostic (1.02e-2)" "unprognostic (1.28e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" "unprognostic (6.42e-2)" 31.1 31.0 32.0 34.1 28.6 30.4 40.4 18.2 25.6 23.3 19.1 17.0 17.1 19.0 21.9 30.0 19.9 28.6 27.4 18.4 23.5 27.4 28.3 55.1 50.5 45.0 28.9 20.4 27.1 21.8 17.9 18.5 21.7 25.8 26.0 18.8 18.7 42.8 22.2 10.1 15.9 23.5 28.3 23.6 47.9 21.4 7.7 23.6 44.0 33.6 15.1 34.4 33.0 49.0 49.2 53.6 113.6 83.4 61.2 66.4 112.6 8.7 4.4 15.0 4.7 31.7 39.5 1.6 5.1 30.5 45.2 58.9 1.6 22.8 28.1 18.1 15.5 39.1 7.0 6.4 16.8 9.6 25.5 0.2 27.6 0.0 6.3 58.7 6.3 9.2 42.2 3.9 21.2 5.8 16.8 14.2 29.7 1.2 19.5 8.1 11.1 42.6 15.3 3.9 0.0 5.6 37.7 9.1 19.2 12.1 9.8 0.3 7.8 10.2 0.8 22.4 2.7 11.2 3.2 5.2 9.4 3.3 7.1 1.6 26.6 26.8 0.5 26.4 16.0 2.0 56.7 71.6 62.5 51.2 83.4 56.4 49.2 53.4 53.4 53.6 39.7 46.5 48.8 113.6 61.2 68.3 34.0 66.4 112.6 32.0 28.6 18.2 25.6 23.5 27.4 28.9 20.4 25.8 23.6 26.8 17.4 54.4 23.2 20.7 10.2 5.2 28.1 24.1 27.3 12.2 3.9 3.0 54.7 68.9 3.6 46.7 22.7 23.3 57.3 31.0 37.7 34.1 53.1 27.3 148.0 12.7 23.0 41.1 54.9 9.6 44.5 69.1 8.5 44.1 29.8 31.5 45.0 31.7 31.5 19.8 3.9 25.8 41.2 1.9 6.0 24.2 2.9 74.7 21.7 24.6 UGGT1 "HUGT1, UGCGL1" ENSG00000136731 "UDP-glucose glycoprotein glucosyltransferase 1" Q9NYU2 2 128091200-128195677 "Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012761, HPA015127" Enhanced Uncertain Cytosol NA NA 3800000 Cytosol "HPA012761: AB_1858597, HPA015127: AB_1858596" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "unprognostic (4.63e-2)" "unprognostic (6.45e-2)" "unprognostic (7.03e-3)" "unprognostic (3.13e-2)" "unprognostic (3.02e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-3)" "unprognostic (7.05e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.86e-1)" "unprognostic (1.50e-1)" "unprognostic (2.23e-2)" "unprognostic (8.38e-3)" 13.7 14.7 7.6 16.4 10.2 23.8 11.3 10.7 10.8 12.7 15.2 10.0 21.1 11.4 12.3 26.3 13.1 10.6 11.3 13.0 7.7 7.9 13.7 33.4 13.9 14.6 11.0 5.7 10.4 44.1 13.4 11.2 22.1 9.1 11.7 13.5 9.7 15.5 20.5 19.3 11.1 17.4 8.9 9.0 16.1 13.0 9.9 9.5 24.3 13.8 6.4 15.7 11.4 11.0 6.3 7.4 8.8 6.2 4.7 5.9 2.8 16.5 5.8 11.1 23.8 14.6 11.7 16.9 19.1 8.4 6.4 5.8 12.8 12.3 23.5 7.7 14.0 5.8 12.3 8.4 8.3 13.1 14.9 4.0 20.6 7.6 39.1 14.5 27.5 13.0 8.5 6.6 12.9 11.8 12.8 14.9 9.8 13.2 12.8 13.5 11.6 11.1 15.8 19.6 11.7 6.0 9.1 10.6 10.0 11.8 12.3 5.8 8.8 13.2 18.1 11.2 11.9 7.1 19.5 20.5 17.7 12.1 10.1 13.6 13.4 18.6 10.8 15.0 15.1 16.3 7.1 6.2 5.4 5.9 6.0 5.8 4.0 4.8 5.3 4.5 6.3 4.1 5.9 8.8 4.7 5.7 7.4 3.8 2.8 7.6 10.2 10.7 10.8 7.7 7.9 11.0 5.7 9.1 9.5 32.8 24.8 6.7 4.9 7.2 20.0 14.1 17.8 6.7 25.0 3.5 21.6 9.5 1.7 12.2 7.0 11.3 19.4 0.0 16.8 15.8 10.8 11.7 10.5 33.0 14.7 19.1 21.9 19.6 23.0 1.8 13.8 15.5 13.5 12.6 20.8 9.7 18.4 10.5 12.7 8.7 18.9 6.5 11.1 8.9 8.1 9.4 9.0 13.8 17.5 9.8 ULK1 "ATG1, ATG1A" ENSG00000177169 "Unc-51 like autophagy activating kinase 1" O75385 12 131894651-131923167 "Enzymes, Plasma proteins, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 50.9;Rod photoreceptor cells: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.9;plasmacytoid DC: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063990 Approved Cytosol NA NA Cytosol "HPA063990: AB_2685167" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (2.52e-3)" "unprognostic (2.21e-3)" "unprognostic (8.01e-3)" "unprognostic (5.48e-2)" "unprognostic (2.74e-2)" "unprognostic (5.04e-3)" "unprognostic (3.94e-3)" "unprognostic (2.03e-2)" "unprognostic (9.09e-3)" "unprognostic (8.19e-2)" "unprognostic (6.25e-2)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.82e-2)" "unprognostic (3.16e-1)" 10.9 18.6 14.6 9.2 49.6 33.2 8.9 24.0 24.4 14.4 11.8 6.9 13.3 11.7 16.5 10.7 9.8 10.6 16.2 17.4 11.5 8.3 9.0 15.8 9.0 8.3 7.9 12.0 18.2 59.6 13.8 23.8 17.2 11.6 13.4 4.0 13.9 18.1 13.4 33.4 24.3 11.5 10.2 5.4 16.5 11.4 11.4 11.4 13.8 10.7 9.6 6.5 12.1 10.9 0.6 6.4 6.9 1.7 0.2 0.8 0.6 5.2 16.9 7.8 9.7 3.5 2.9 10.7 8.3 6.0 3.6 2.9 3.6 5.4 1.4 8.8 5.8 7.2 5.2 1.7 3.3 1.0 5.6 10.2 3.5 13.8 4.9 6.6 2.5 7.8 5.3 9.1 3.9 1.6 9.9 4.4 10.8 4.6 4.2 2.3 11.9 15.6 14.7 8.6 2.4 16.2 11.8 2.8 6.9 2.1 6.5 19.9 11.0 8.9 9.2 4.6 8.3 13.9 17.1 8.3 8.5 5.1 14.8 3.8 18.6 6.7 1.9 14.4 4.4 9.8 0.2 1.7 2.3 0.8 0.7 0.2 0.1 0.7 0.7 0.3 0.6 0.5 0.5 6.9 0.2 0.7 6.4 0.5 0.6 14.6 49.6 24.0 24.4 11.5 8.3 7.9 12.0 11.6 11.4 14.9 16.7 11.8 5.7 12.8 23.0 18.0 17.8 4.0 11.4 7.0 37.3 4.0 1.7 8.0 0.7 12.0 5.2 0.0 10.9 2.6 9.3 12.0 3.5 23.1 4.8 50.9 18.4 6.2 11.9 1.9 11.5 5.4 5.0 3.6 15.4 12.6 18.3 7.0 14.9 2.4 87.3 12.9 10.3 3.9 5.9 16.9 14.4 8.3 8.3 6.9 UMPS ENSG00000114491 "Uridine monophosphate synthetase" P11172 3 124730366-124749273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 91.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036178, HPA036179" Uncertain Approved Cytosol NA NA Cytosol "HPA036178: AB_10673002, HPA036179: AB_10673615" "unprognostic (6.41e-2)" "unprognostic (6.70e-2)" "unprognostic (1.79e-2)" "unprognostic (1.13e-3)" "unprognostic (2.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.15e-3)" "unprognostic (5.51e-2)" "unprognostic (4.85e-3)" "unprognostic (1.43e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.18e-2)" "unprognostic (1.58e-2)" "unprognostic (1.91e-1)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 8.4 12.2 4.9 6.8 6.8 4.8 8.0 9.3 7.6 5.9 9.1 8.5 5.2 8.4 6.8 6.7 13.2 8.2 6.6 3.6 4.0 3.9 9.6 20.7 5.2 10.1 7.3 3.6 8.9 19.0 9.5 9.3 11.6 4.7 6.4 7.1 6.4 8.9 4.0 10.9 9.5 8.5 5.5 5.9 9.8 8.3 6.8 6.2 10.6 7.4 12.0 9.3 7.8 6.4 16.6 13.1 4.6 9.8 10.2 13.0 7.9 1.4 4.4 5.0 2.1 3.0 3.5 5.3 7.5 2.3 3.2 2.7 3.8 2.0 3.8 8.3 2.9 6.6 8.4 7.1 2.5 5.0 4.4 4.1 7.8 2.8 2.6 2.6 8.2 5.9 3.9 2.3 2.0 3.9 1.9 1.4 7.7 3.5 1.8 2.3 3.4 10.0 1.6 11.1 3.9 2.8 6.6 6.0 3.2 2.5 2.5 4.0 2.6 11.3 4.0 4.2 3.8 4.0 3.0 14.4 2.5 5.0 6.9 3.0 7.5 10.2 10.5 2.8 3.4 2.5 4.5 9.0 4.6 12.5 9.8 12.1 13.7 8.9 11.3 13.1 16.6 13.0 10.4 0.6 10.2 8.0 9.7 10.3 7.9 4.9 6.8 9.3 5.7 4.0 3.9 7.3 3.6 4.7 6.2 6.0 7.8 5.2 15.9 14.1 8.0 5.7 12.7 22.7 10.3 8.7 3.9 56.7 24.9 23.5 3.1 13.4 10.4 0.0 26.6 27.5 9.3 9.3 11.5 28.8 19.3 4.8 9.2 8.0 5.4 3.9 12.7 9.6 3.3 21.6 9.4 10.1 19.5 7.0 13.1 19.5 7.7 12.9 9.9 19.7 30.7 16.7 91.3 12.8 15.8 15.5 UNC45B "CMYA4, UNC45" ENSG00000141161 "Unc-45 myosin chaperone B" Q8IWX7 17 35147817-35189345 "Disease related genes, Predicted intracellular proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 181.6" "Group enriched" "Detected in some" 5 "head and neck cancer: 0.9;testis cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5" "Lineage enriched" "Detected in single" 10 "T-cells: 3.5" "Group enriched" "Detected in some" 11 "BEWO: 4.7;HSkMC: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017861 Approved Cytosol NA NA Cytosol "HPA017861: AB_1847012" "unprognostic (7.17e-2)" "unprognostic (6.47e-3)" "unprognostic (9.36e-3)" "unprognostic (2.93e-1)" "unprognostic (1.49e-3)" "unprognostic (5.30e-2)" "unprognostic (3.07e-1)" "unprognostic (1.09e-2)" "unprognostic (5.46e-2)" "unprognostic (2.40e-2)" "unprognostic (8.46e-2)" "unprognostic (6.73e-2)" "unprognostic (1.13e-6)" "unprognostic (6.77e-2)" "unprognostic (5.05e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.9 0.0 0.3 48.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.9 0.2 62.5 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.2 23.2 1.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 3.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.5 0.2 2.9 0.0 0.7 1.8 0.0 0.0 0.4 2.0 0.2 0.3 0.3 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 181.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 42.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.0 UNG "DGU, HIGM4, UDG, UNG1, UNG2" ENSG00000076248 "Uracil DNA glycosylase" P13051 12 109097574-109110992 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 64.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB011605 Uncertain Approved Cytosol NA Yes Cytosol "CAB011605: AB_778737" "unprognostic (4.38e-2)" "unprognostic (3.82e-3)" "unprognostic (1.03e-2)" "unprognostic (1.33e-2)" "unprognostic (4.64e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.40e-4)" "unprognostic (5.68e-3)" "prognostic unfavorable (3.06e-4)" "unprognostic (4.66e-2)" "unprognostic (8.78e-3)" "unprognostic (1.91e-1)" "unprognostic (1.35e-3)" "unprognostic (2.57e-2)" "unprognostic (4.50e-1)" "unprognostic (1.40e-2)" "unprognostic (6.89e-2)" 16.3 44.1 17.0 19.4 17.0 10.0 22.8 10.5 14.4 13.5 20.3 10.2 21.4 12.6 11.8 10.8 22.5 11.8 11.0 15.4 13.5 13.1 20.4 23.3 7.1 12.1 19.6 12.2 12.3 12.7 17.3 8.9 18.6 12.0 12.9 22.1 10.7 16.6 19.7 29.1 22.5 13.5 11.0 19.7 13.2 12.3 35.6 9.8 35.1 25.1 19.8 19.0 11.5 14.4 9.8 3.9 5.8 3.0 8.7 19.5 7.9 20.1 20.7 20.0 18.1 33.3 9.6 19.1 11.9 8.2 18.9 14.5 16.4 13.9 26.5 18.0 10.7 9.9 12.8 22.0 12.4 18.4 22.4 40.9 25.9 12.0 27.7 5.0 38.4 16.0 8.6 11.4 9.0 5.0 15.1 13.6 31.9 20.9 8.9 12.7 25.2 35.3 45.4 35.5 32.9 32.0 32.6 30.1 22.6 11.8 25.5 28.5 15.8 21.5 18.5 10.4 27.2 34.5 18.0 7.0 16.4 14.7 10.8 16.5 17.3 37.2 50.3 12.5 25.9 20.0 5.8 1.5 2.7 13.4 3.0 19.5 9.8 15.9 15.5 3.9 9.2 10.3 11.5 0.0 8.7 3.0 2.8 14.0 7.9 17.0 17.0 10.5 14.4 13.5 13.1 19.6 12.2 12.0 9.8 0.0 4.5 6.7 10.0 16.0 2.6 10.6 7.6 2.7 2.3 40.1 3.9 41.8 16.6 11.9 3.2 11.6 7.3 0.0 5.5 24.6 10.3 5.9 7.0 20.3 15.7 4.8 8.1 14.7 2.9 3.4 13.0 4.5 13.5 5.4 18.2 11.8 5.9 7.0 13.8 14.6 3.0 6.5 9.0 18.6 64.3 18.2 17.0 17.8 34.2 7.6 UNKL "C16orf28, FLJ23360, ZC3H5L, ZC3HDC5L" ENSG00000059145 "Unkempt family like zinc finger" Q9H9P5 16 1363205-1414751 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055801, HPA073949" Uncertain Supported Cytosol NA NA Cytosol "HPA055801: AB_2682926, HPA073949: AB_2686647" "unprognostic (5.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (8.88e-2)" "unprognostic (4.08e-2)" "unprognostic (1.82e-2)" "unprognostic (3.90e-3)" "unprognostic (8.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.56e-2)" "unprognostic (4.85e-3)" "unprognostic (1.13e-1)" "unprognostic (3.86e-3)" "unprognostic (1.89e-1)" "unprognostic (6.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.55e-1)" 9.6 10.0 14.0 10.4 12.9 12.1 10.1 27.9 16.3 10.5 7.3 9.3 10.2 11.0 15.2 7.9 6.0 11.0 5.0 5.7 12.2 4.5 6.3 4.8 9.1 11.7 9.2 8.3 18.9 10.1 6.5 7.2 9.0 10.1 10.5 4.4 9.3 12.3 12.7 14.4 10.5 10.6 7.2 5.6 14.3 9.9 8.4 11.7 11.0 11.7 7.0 7.6 10.8 9.3 1.9 3.2 7.6 2.1 2.4 3.7 1.3 3.4 9.1 2.0 5.2 1.8 2.0 16.3 8.7 2.6 2.5 2.0 6.7 7.4 1.3 18.5 3.0 4.2 6.3 2.7 0.8 1.7 15.9 7.8 2.3 9.4 6.0 1.2 1.3 5.6 2.5 1.2 3.8 1.6 3.0 4.4 3.8 7.2 4.8 1.1 5.3 3.8 4.2 5.8 1.5 10.3 10.3 1.9 9.4 1.5 0.7 7.0 4.2 4.4 3.2 0.6 1.8 5.1 2.2 3.8 5.4 7.8 4.5 3.6 10.3 5.7 6.1 4.4 2.9 6.0 5.7 2.1 4.5 3.7 0.7 2.1 1.5 1.5 0.9 0.7 1.9 2.8 1.4 7.6 2.4 0.7 3.2 1.6 1.3 14.0 12.9 27.9 16.3 12.2 4.5 9.2 8.3 10.1 11.7 6.0 6.9 20.6 5.4 4.8 28.5 2.0 5.1 8.1 10.3 5.2 13.7 10.0 1.7 4.7 4.6 6.8 5.5 0.0 2.6 5.5 6.2 14.2 4.7 5.8 3.6 6.4 3.5 9.8 5.3 14.1 15.3 5.8 6.8 9.0 7.4 18.0 6.4 7.8 14.5 1.4 35.2 6.5 6.4 11.7 20.4 7.2 17.2 8.7 3.8 4.3 URGCP "DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4" ENSG00000106608 "Upregulator of cell proliferation" Q8TCY9 7 43875894-43926411 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019879, HPA020134, HPA029468" Approved Supported Cytosol NA NA Cytosol "HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831" "unprognostic (5.66e-2)" "unprognostic (1.10e-3)" "unprognostic (1.18e-1)" "unprognostic (2.75e-1)" "unprognostic (2.21e-3)" "unprognostic (2.42e-2)" "unprognostic (3.74e-2)" "unprognostic (1.26e-1)" "unprognostic (3.79e-1)" "unprognostic (2.21e-1)" "unprognostic (3.23e-3)" "unprognostic (3.71e-1)" "prognostic favorable (1.90e-4)" "unprognostic (1.56e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (1.69e-3)" 13.7 27.1 18.5 13.4 21.4 8.6 13.4 28.3 29.5 15.8 18.2 18.6 14.8 22.2 18.3 15.1 13.8 15.6 11.6 19.3 18.3 15.9 20.4 21.3 12.1 9.5 13.8 19.5 21.6 18.4 22.5 22.1 14.4 17.9 17.7 19.6 19.8 18.4 17.1 26.8 17.4 21.0 19.1 10.9 13.8 12.8 7.0 17.2 8.3 14.6 7.9 12.5 15.0 12.3 6.1 9.8 5.8 7.5 2.6 11.9 6.1 13.7 12.8 5.1 16.6 14.1 13.1 5.0 15.2 30.2 18.5 18.9 10.7 11.3 8.2 8.6 16.3 28.2 22.2 14.6 12.2 18.3 15.4 8.4 5.5 12.7 9.2 15.0 8.6 10.7 9.9 15.1 14.6 14.2 12.1 9.2 9.6 13.9 6.4 12.4 10.5 8.9 7.3 9.8 16.5 12.2 12.5 7.1 11.3 17.7 14.0 13.6 23.0 17.2 25.7 8.0 9.1 13.0 10.3 8.5 10.5 4.6 11.6 12.6 17.6 25.6 10.2 12.2 13.6 19.8 2.6 4.5 5.8 9.0 7.3 9.9 6.1 9.6 11.9 9.8 5.6 10.6 9.3 0.5 2.6 7.5 1.5 9.6 6.1 18.5 21.4 28.3 29.5 18.3 15.9 13.8 19.5 17.9 17.2 3.0 8.6 8.3 10.9 9.8 24.6 17.1 10.2 9.4 5.7 12.2 7.9 5.1 14.9 11.7 1.1 9.0 34.1 0.0 11.4 10.5 13.0 11.7 6.9 22.7 5.5 15.9 8.1 12.3 3.3 3.1 17.0 7.0 11.8 4.6 11.9 11.1 13.4 15.0 17.7 20.9 19.9 6.5 12.5 5.4 5.5 12.9 2.9 6.9 12.2 12.7 USH1C "AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C" ENSG00000006611 "USH1 protein network component harmonin" Q9Y6N9 11 17493895-17544416 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Hearing" "Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 26.0;intestine: 57.0;kidney: 22.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 240.3;Muller glia cells: 140.5;Paneth cells: 192.9;Proximal tubular cells: 119.4;Undifferentiated cells: 94.1" "Group enriched" "Detected in many" 7 "colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 31.4;HeLa: 11.2;OE19: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013690, HPA027398, HPA027492, HPA028033" Enhanced Enhanced Cytosol No NA Cytosol "CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782" "unprognostic (3.60e-2)" "unprognostic (6.19e-2)" "unprognostic (2.36e-1)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.51e-2)" "unprognostic (9.65e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (1.62e-1)" "unprognostic (2.61e-1)" 0.1 0.1 1.6 4.3 7.1 0.0 0.0 0.8 3.3 0.1 23.8 6.2 0.0 40.5 0.0 6.3 0.0 1.3 26.0 0.3 5.0 2.3 22.1 0.4 0.0 0.0 4.8 1.9 0.3 2.1 0.0 5.2 0.0 3.5 0.1 20.7 1.8 0.0 0.1 0.0 0.0 57.0 0.9 10.2 0.0 11.5 0.2 3.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 31.4 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 7.1 0.8 2.3 5.0 2.3 4.8 1.9 3.5 3.6 0.0 0.0 0.8 0.0 0.0 0.7 0.6 48.4 0.0 1.2 5.2 2.0 0.0 18.3 18.8 1.0 0.0 240.3 0.0 25.0 0.0 0.0 0.0 4.6 0.0 0.0 1.6 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.4 140.5 34.3 192.9 0.0 119.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 94.1 0.0 USP25 USP21 ENSG00000155313 "Ubiquitin specific peptidase 25" Q9UHP3 21 15730025-15880069 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 124.6;Late spermatids: 145.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018297, HPA024142" Approved Supported Cytosol NA NA Cytosol "HPA018297: AB_1858672, HPA024142: AB_1858673" "unprognostic (6.35e-2)" "unprognostic (1.50e-1)" "unprognostic (6.90e-2)" "unprognostic (6.29e-2)" "unprognostic (1.39e-1)" "unprognostic (2.88e-2)" "unprognostic (3.91e-2)" "unprognostic (1.65e-1)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (2.33e-2)" "unprognostic (1.40e-1)" "unprognostic (8.24e-3)" "unprognostic (2.34e-3)" "unprognostic (4.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.32e-2)" 14.9 8.5 11.0 14.2 15.5 12.4 28.7 11.3 11.1 17.5 11.8 6.6 17.8 6.5 20.7 14.5 12.6 10.6 10.1 17.8 9.9 5.8 12.9 10.4 22.1 14.8 7.6 7.1 14.5 8.2 8.1 8.4 17.7 7.7 12.9 8.6 7.8 11.4 13.6 56.3 8.3 12.3 19.2 7.3 11.6 9.0 26.1 7.5 16.5 10.5 14.6 9.6 13.8 18.1 3.1 2.8 5.8 2.9 2.3 7.2 1.6 13.2 10.0 9.5 1.4 17.6 26.3 11.2 9.5 9.5 7.1 9.0 8.8 7.6 14.3 14.1 15.0 10.8 7.1 7.3 12.6 9.9 14.2 8.4 11.7 10.6 6.7 29.2 15.4 5.4 17.0 15.4 11.4 33.2 18.7 24.9 13.1 15.0 27.1 12.8 5.5 17.6 2.9 11.7 5.3 8.9 13.5 8.8 10.8 19.3 3.6 2.1 5.7 13.6 11.5 8.8 12.1 6.1 9.1 23.6 11.1 7.2 11.6 5.3 7.9 4.8 11.4 7.2 6.9 8.1 0.0 2.9 3.6 4.0 2.8 4.4 3.1 3.4 7.2 2.5 2.2 3.2 4.8 5.8 2.3 2.5 2.8 4.4 1.6 11.0 15.5 11.3 11.1 9.9 5.8 7.6 7.1 7.7 7.5 53.6 22.7 11.5 16.1 15.1 5.7 52.1 10.2 25.4 31.8 21.0 3.9 27.3 5.0 7.8 124.6 19.1 12.8 0.0 11.4 6.8 16.0 19.0 5.8 17.3 11.9 4.8 9.2 17.2 23.7 145.9 17.5 18.8 15.1 6.4 11.9 4.2 10.4 7.0 12.0 12.2 6.0 19.4 15.5 9.8 5.3 16.8 27.7 17.5 10.2 20.5 USP31 KIAA1203 ENSG00000103404 "Ubiquitin specific peptidase 31" Q70CQ4 16 23061406-23149270 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 55.8;Basal keratinocytes: 59.3;Spermatogonia: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006937 Uncertain Approved Cytosol NA NA Cytosol "HPA006937: AB_1080523" "unprognostic (6.45e-2)" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.43e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.52e-1)" "unprognostic (6.15e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.41e-5)" "unprognostic (5.59e-2)" "unprognostic (3.75e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-3)" 6.3 5.3 11.2 4.0 16.6 7.1 8.7 12.7 16.5 10.9 4.9 19.7 2.6 3.7 15.3 7.7 9.3 6.5 4.1 11.0 9.0 6.3 6.2 7.7 7.3 3.6 24.6 8.1 3.7 6.3 20.6 10.4 7.4 17.4 9.6 4.9 2.8 6.0 8.5 10.9 15.9 3.4 14.2 14.8 2.8 3.5 20.7 19.3 1.7 4.2 2.4 4.9 13.4 9.5 0.5 0.8 0.6 1.3 0.1 2.1 0.2 9.5 10.1 2.9 4.0 5.3 4.2 2.7 3.3 3.0 4.3 5.2 6.4 5.8 3.2 3.6 4.2 7.0 12.6 7.2 13.1 7.1 2.3 2.9 1.3 5.8 13.4 6.7 3.3 3.6 3.5 11.3 8.0 18.5 1.6 7.6 3.2 3.9 10.0 5.8 6.5 1.6 2.8 5.8 3.2 3.1 7.9 8.2 6.4 6.4 14.3 7.8 5.1 5.2 10.3 2.9 3.4 4.1 7.4 4.5 8.8 6.5 4.4 9.0 3.3 5.4 3.4 6.3 4.5 3.5 0.1 0.7 0.6 0.8 0.3 2.1 0.1 0.7 1.5 0.8 0.5 0.8 0.8 0.1 0.1 1.3 0.2 1.3 0.2 11.2 16.6 12.7 16.5 9.0 6.3 24.6 8.1 17.4 19.3 6.0 3.0 6.1 55.8 59.3 12.6 9.2 10.2 8.1 7.9 5.2 2.0 11.1 0.0 6.1 3.6 14.6 1.4 0.0 7.2 6.2 5.4 14.2 1.1 25.0 4.2 0.0 4.6 7.4 3.1 8.9 7.2 2.9 6.8 1.0 3.5 4.8 7.6 0.0 4.2 9.1 7.4 19.4 7.1 23.8 60.3 23.2 6.3 1.3 5.2 19.5 VARS VARS2 ENSG00000204394 "Valyl-tRNA synthetase" P26640 6 31777518-31795953 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 205.7;Late spermatids: 188.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.2;U-266/84: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046710 Approved Enhanced Cytosol NA NA 23000 Cytosol "HPA046710: AB_2679765" "unprognostic (1.86e-2)" "prognostic unfavorable (7.25e-4)" "unprognostic (2.19e-1)" "unprognostic (2.07e-1)" "unprognostic (2.49e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.86e-4)" "prognostic unfavorable (6.90e-4)" "unprognostic (3.20e-1)" "unprognostic (2.76e-1)" "unprognostic (4.72e-1)" "unprognostic (1.28e-1)" "unprognostic (1.09e-2)" "unprognostic (1.98e-1)" "unprognostic (1.69e-1)" "unprognostic (3.85e-2)" "unprognostic (2.59e-1)" 11.7 11.4 8.9 12.0 9.5 9.1 18.3 7.6 14.0 8.1 11.3 7.3 5.0 12.8 13.5 6.7 14.2 10.2 8.1 9.5 6.4 6.8 9.5 22.7 11.5 24.2 8.3 9.7 9.6 19.2 15.6 15.0 8.5 8.6 7.7 9.4 6.1 9.1 5.9 30.6 14.3 10.3 13.2 8.7 14.4 15.2 40.6 7.5 10.9 8.2 13.2 11.8 9.7 8.5 1.6 1.5 0.6 1.2 2.4 1.0 0.9 2.2 2.0 3.2 6.4 3.6 2.8 8.7 8.8 2.7 6.6 4.0 2.6 1.4 7.7 10.9 5.5 5.0 2.4 10.2 6.7 4.0 5.6 14.4 3.8 5.1 6.1 4.7 15.3 12.6 4.2 2.4 2.6 6.1 1.9 3.3 3.5 10.6 10.5 4.2 3.5 6.9 0.7 6.1 3.2 4.3 9.0 1.7 25.2 5.1 2.9 3.9 1.5 0.7 8.6 3.7 2.2 5.2 6.1 1.1 4.6 4.2 6.1 14.5 15.0 25.9 6.3 3.3 3.1 5.1 0.0 0.6 0.6 1.0 1.2 1.0 1.6 0.6 0.4 1.1 1.1 0.8 0.8 0.0 2.4 1.0 1.5 0.6 0.9 8.9 9.5 7.6 14.0 6.4 6.8 8.3 9.7 8.6 7.5 6.0 8.2 11.1 8.3 7.3 7.0 7.8 7.6 8.1 9.1 15.7 5.9 19.8 8.3 30.5 205.7 9.2 18.8 23.3 36.1 40.7 10.4 7.3 9.2 21.9 26.7 1.6 22.5 6.2 9.2 188.8 19.2 12.0 6.8 10.0 12.5 7.2 28.7 5.8 12.7 11.4 12.4 19.4 8.1 24.4 29.8 11.3 13.8 6.9 19.2 7.0 VASH2 FLJ12505 ENSG00000143494 "Vasohibin 2" Q86V25 1 212950520-212992037 "Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.2" "Group enriched" "Detected in some" 12 "Early spermatids: 75.2;Late spermatids: 59.3" "Cancer enhanced" "Detected in many" "testis cancer: 3.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "AF22: 9.6;AN3-CA: 11.7;NTERA-2: 18.4;RH-30: 54.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045820 Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA045820: " "unprognostic (2.22e-1)" "unprognostic (1.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.29e-2)" "unprognostic (1.28e-1)" "unprognostic (1.57e-2)" "unprognostic (1.25e-2)" "unprognostic (4.04e-2)" "unprognostic (2.59e-3)" "unprognostic (3.50e-2)" "unprognostic (2.45e-1)" "unprognostic (6.58e-2)" "unprognostic (1.84e-5)" "unprognostic (1.95e-3)" "unprognostic (2.74e-1)" "unprognostic (6.85e-2)" "unprognostic (6.81e-4)" 3.1 0.7 2.6 5.8 6.0 1.4 3.7 1.1 4.8 3.3 1.4 0.1 1.0 1.3 4.2 3.8 7.8 1.5 4.9 2.8 1.5 1.8 1.1 0.8 2.2 3.8 1.2 1.7 1.8 0.8 1.8 7.7 1.4 3.6 7.7 1.2 5.7 1.6 1.6 1.6 1.2 2.0 3.5 1.1 2.1 1.3 23.2 1.1 9.7 1.2 3.1 3.7 2.9 6.3 0.2 3.2 0.0 0.0 0.0 0.4 0.0 0.1 0.6 9.6 11.7 0.1 0.0 1.5 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.1 0.0 0.2 0.0 3.9 0.0 0.4 7.7 1.4 0.7 0.5 0.5 0.0 0.0 0.1 1.5 0.0 0.5 0.0 0.2 0.1 4.4 0.0 2.3 0.8 0.1 4.9 0.6 18.4 0.0 1.4 2.9 54.2 0.5 0.0 0.7 2.2 3.4 1.2 0.1 0.1 5.2 1.8 0.3 0.0 0.4 1.1 0.2 0.5 1.3 2.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 3.2 0.4 0.0 2.6 6.0 1.1 4.8 1.5 1.8 1.2 1.7 3.6 1.1 0.0 0.6 0.0 0.7 1.3 1.9 0.8 0.0 1.4 0.0 0.0 2.0 0.1 0.0 0.5 75.2 0.3 0.0 0.0 0.2 0.2 5.8 1.4 0.0 0.0 0.2 1.6 1.2 0.0 0.3 59.3 0.3 1.3 0.0 1.0 0.0 0.8 0.1 0.0 0.7 0.3 2.1 0.0 1.7 1.0 1.0 1.4 0.0 0.0 0.0 0.4 VAT1L KIAA1576 ENSG00000171724 "Vesicle amine transport 1 like" Q9HCJ6 16 77788530-77980107 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 57.3;brain: 47.1;retina: 32.1" "Group enriched" "Detected in some" 15 "Horizontal cells: 281.3;Muller glia cells: 83.1" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 9.4;BJ hTERT+: 27.7;fHDF/TERT166: 15.1;NTERA-2: 32.6;U-87 MG: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044061, CAB046032, HPA061138" Enhanced Approved Cytosol NA NA Cytosol "CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: " "unprognostic (1.49e-2)" "unprognostic (8.74e-3)" "unprognostic (8.80e-3)" "unprognostic (3.39e-2)" "unprognostic (3.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (8.57e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.01e-6)" "unprognostic (2.50e-2)" "unprognostic (6.53e-2)" "unprognostic (1.19e-1)" "unprognostic (5.96e-2)" 1.1 57.3 7.9 3.0 41.3 1.2 1.0 28.4 20.1 1.3 3.4 5.7 0.0 2.4 1.8 6.3 2.0 1.4 3.8 12.7 3.8 47.1 5.3 1.4 0.9 1.0 8.4 12.7 0.9 2.1 0.6 1.5 2.0 27.2 0.8 5.2 32.1 0.9 1.0 0.6 0.6 3.1 2.6 15.4 0.7 1.7 2.1 5.8 0.0 2.0 0.0 2.4 1.4 0.4 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 3.2 0.0 0.0 1.1 27.7 0.3 0.3 0.0 0.0 0.0 0.0 15.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 32.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.4 0.0 6.0 0.0 7.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 41.3 28.4 9.1 3.8 47.1 8.4 12.7 27.2 5.8 0.0 0.0 0.0 0.0 0.0 7.2 8.7 5.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 281.3 2.9 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 83.1 0.1 0.0 0.0 0.0 11.8 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 VAV1 VAV ENSG00000141968 "Vav guanine nucleotide exchange factor 1" P15498 19 6772714-6857366 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.7;bone marrow: 25.7;lymphoid tissue: 43.1" "Group enriched" "Detected in many" 5 "B-cells: 26.9;granulocytes: 34.6;Hofbauer cells: 42.9;Kupffer cells: 22.9;Macrophages: 27.7;T-cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 31.3;Karpas-707: 35.7;MOLT-4: 33.9;REH: 22.5;THP-1: 26.3;U-266/70: 21.4;U-266/84: 25.9;U-937: 28.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001864, HPA005925" Enhanced Approved Cytosol NA NA 30000 Cytosol "HPA001864: AB_1858722, HPA005925: " "unprognostic (2.93e-1)" "unprognostic (1.96e-1)" "unprognostic (1.80e-1)" "unprognostic (1.01e-1)" "unprognostic (6.82e-2)" "unprognostic (1.13e-2)" "unprognostic (5.62e-1)" "unprognostic (1.97e-1)" "unprognostic (1.30e-2)" "unprognostic (1.90e-2)" "unprognostic (3.56e-2)" "unprognostic (8.58e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (9.55e-2)" "unprognostic (1.78e-1)" "unprognostic (6.57e-2)" "unprognostic (3.28e-1)" 5.1 3.0 3.1 19.0 5.6 25.7 2.3 0.7 2.2 1.7 3.5 4.0 0.3 2.8 1.9 2.6 2.6 2.6 3.1 3.3 2.5 3.0 2.7 2.6 8.5 25.1 5.3 1.2 2.0 1.5 5.2 1.8 4.4 3.5 3.2 3.7 2.3 5.8 1.1 0.8 1.4 10.7 2.6 8.7 37.1 2.5 1.5 4.8 43.1 2.0 1.2 20.0 6.1 2.4 9.3 10.5 25.7 22.8 11.5 14.7 10.5 0.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.9 15.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.5 18.6 0.0 0.0 0.0 18.0 31.3 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.7 35.7 0.0 2.6 33.9 10.3 0.0 0.0 0.0 22.5 0.0 12.1 0.6 0.0 0.0 0.0 0.0 5.1 0.0 0.0 2.2 26.3 0.0 0.0 0.4 0.0 0.0 21.4 25.9 17.5 0.0 28.4 0.0 0.9 11.5 11.9 14.7 18.8 10.5 9.3 10.7 12.7 10.5 9.2 11.8 10.6 25.7 11.5 22.8 9.0 8.5 10.5 3.1 5.6 0.7 2.2 2.5 3.0 5.3 1.2 3.5 4.8 3.0 4.8 26.9 0.5 1.1 0.2 0.7 0.0 5.3 1.2 0.0 0.0 0.4 0.0 5.1 3.2 1.1 0.0 0.0 0.3 0.6 1.2 0.2 34.6 0.0 42.9 0.0 1.2 1.3 22.9 1.3 0.0 27.7 1.7 1.8 0.9 0.0 5.9 5.8 0.0 0.0 0.0 0.0 0.3 1.2 0.9 0.6 1.1 25.5 2.1 0.6 VCPKMT "C14orf138, METTL21D, VCP-KMT" ENSG00000100483 "Valosin containing protein lysine methyltransferase" Q9H867 14 50108632-50116600 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001146, HPA076561" Uncertain Supported Cytosol NA NA Cytosol "HPA001146: AB_1845558, HPA076561: AB_2732312" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.05e-2)" "unprognostic (3.86e-1)" "unprognostic (3.54e-1)" "unprognostic (4.74e-2)" "unprognostic (9.97e-2)" "prognostic favorable (2.40e-4)" "unprognostic (8.20e-2)" "unprognostic (1.74e-1)" "unprognostic (4.90e-2)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (6.79e-4)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (6.27e-2)" 5.2 7.6 7.6 9.5 16.9 12.6 6.0 15.3 14.0 6.3 5.8 6.3 3.7 5.4 9.8 8.3 10.5 5.8 7.1 4.6 9.9 7.1 6.2 6.9 5.7 10.9 7.1 6.3 5.1 6.3 6.2 8.6 4.8 12.0 5.0 5.4 4.5 5.1 5.4 4.8 8.1 5.9 8.6 5.7 9.2 7.0 11.0 7.4 10.6 7.4 5.2 12.5 7.9 6.1 17.1 3.8 6.1 3.1 8.0 8.4 3.4 4.1 4.8 4.2 5.7 3.1 3.6 5.1 4.4 4.7 5.0 3.7 2.7 5.3 13.9 3.1 3.1 1.2 8.9 5.5 7.6 5.0 6.8 3.5 2.6 2.1 3.2 4.5 7.1 3.9 2.5 4.4 5.3 5.6 3.3 5.9 4.9 3.2 6.1 3.8 5.8 14.3 7.1 4.4 6.4 7.9 9.9 8.4 3.6 6.2 6.5 7.6 9.1 6.6 1.9 7.4 3.9 4.7 6.4 1.7 8.1 6.4 2.8 4.7 5.8 11.6 5.3 2.8 6.2 3.9 6.1 2.0 0.0 6.5 3.1 7.6 17.1 6.3 7.8 2.5 14.5 7.5 8.4 0.6 8.0 1.4 3.8 5.2 3.4 7.6 16.9 15.3 14.0 9.9 7.1 7.1 6.3 12.0 7.4 11.9 9.8 20.4 14.7 27.0 6.7 3.5 0.0 6.7 11.4 7.0 9.8 9.1 8.3 5.6 28.7 4.9 6.2 0.0 5.0 6.7 10.4 12.2 17.3 6.6 4.4 1.6 5.2 7.4 6.0 5.8 6.9 8.3 10.1 9.0 7.3 4.0 4.5 6.5 4.6 4.7 7.3 0.0 10.3 12.0 12.9 32.6 9.6 14.6 4.8 14.8 VPS11 "PEP5, RNF108" ENSG00000160695 "VPS11, CORVET/HOPS core subunit" Q9H270 11 119067692-119081978 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039020 Approved Approved Cytosol NA NA Cytosol "HPA039020: AB_10674847" "unprognostic (6.97e-2)" "unprognostic (3.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-2)" "unprognostic (1.43e-2)" "unprognostic (1.28e-1)" "unprognostic (2.59e-3)" "unprognostic (1.11e-1)" "unprognostic (3.21e-1)" "unprognostic (9.17e-2)" "unprognostic (6.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (1.44e-4)" "unprognostic (4.07e-2)" "unprognostic (4.05e-2)" "unprognostic (2.71e-2)" "unprognostic (2.25e-1)" 6.2 7.3 5.3 5.3 10.2 10.2 6.5 5.6 16.3 6.7 4.6 11.3 4.5 4.8 6.6 6.9 5.1 8.2 5.6 5.5 4.7 6.3 3.4 6.2 7.4 5.7 7.9 8.6 6.5 12.5 8.3 8.4 9.4 6.6 5.2 8.6 5.8 7.5 5.5 7.5 4.6 7.5 3.2 6.3 4.4 5.2 5.4 9.3 8.6 3.4 6.7 6.0 0.9 9.8 17.8 15.7 15.2 12.8 14.3 12.0 5.7 5.7 6.7 4.9 13.4 12.6 6.7 7.0 9.6 9.1 9.1 9.3 10.8 7.9 10.2 13.5 14.7 9.6 8.1 9.6 7.2 8.3 5.6 17.7 7.2 9.7 17.6 10.2 11.1 13.6 10.6 13.9 7.3 12.8 11.5 9.0 12.6 12.9 10.7 14.1 7.9 9.4 2.9 9.7 10.7 9.3 9.1 5.2 8.7 11.9 4.8 8.1 8.5 11.0 7.7 6.7 17.2 8.8 10.2 8.9 3.7 3.7 5.2 6.1 5.5 7.1 6.0 12.8 7.6 15.7 15.2 12.8 13.2 11.6 14.3 9.8 11.5 12.5 17.8 9.8 10.8 13.1 3.0 12.8 14.5 7.6 12.9 12.0 6.0 10.9 8.0 4.2 2.6 11.2 5.5 5.1 6.7 13.6 8.7 11.8 8.9 8.3 6.7 6.7 9.8 7.9 0.0 8.8 5.8 6.6 2.8 15.0 4.7 14.9 4.8 9.2 11.6 14.3 1.4 15.8 10.8 6.8 10.8 10.9 9.5 6.7 7.0 14.5 9.1 14.2 12.9 8.9 8.6 6.5 4.3 11.8 9.6 7.9 3.1 VSNL1 "HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1" ENSG00000163032 "Visinin like 1" P62760 2 17539126-17657018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 165.7" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 23.4;Cardiomyocytes: 27.7;Club cells: 29.6;Hepatocytes: 16.8;Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 44.2;Hep G2: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053808 Approved Cytosol NA NA Cytosol "HPA053808: AB_2682270" "unprognostic (1.04e-1)" "unprognostic (7.90e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (6.90e-4)" "unprognostic (4.90e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (4.66e-2)" "unprognostic (2.99e-1)" "unprognostic (1.65e-1)" "unprognostic (2.18e-1)" "unprognostic (5.14e-4)" "unprognostic (3.26e-2)" "unprognostic (1.23e-1)" "unprognostic (6.19e-3)" "unprognostic (1.51e-2)" 1.4 13.6 36.5 1.7 48.8 1.2 3.9 91.6 165.7 1.8 3.0 3.3 0.0 1.3 1.7 1.2 18.0 1.9 1.3 17.5 34.8 27.9 2.0 10.5 2.4 1.2 19.9 66.1 2.8 1.7 1.2 0.2 3.4 64.0 3.0 3.6 0.1 3.2 1.5 1.7 5.2 1.3 1.6 7.1 1.3 1.7 1.5 1.4 0.0 1.5 3.1 4.1 2.3 3.4 0.1 0.7 0.2 0.1 0.1 0.5 0.1 0.2 0.0 0.5 8.0 0.9 1.3 0.0 0.0 0.0 0.0 0.2 0.1 4.8 0.0 0.0 0.0 0.0 44.2 0.3 1.5 0.0 0.0 0.2 0.0 0.0 44.7 0.0 0.0 0.1 0.3 2.3 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 8.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 3.6 3.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.6 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.2 0.1 0.1 0.7 0.0 0.1 36.5 48.8 91.6 138.6 34.8 27.9 19.9 66.1 64.0 1.4 0.0 0.3 0.0 23.4 16.3 6.9 27.7 2.5 0.0 29.6 0.0 0.0 0.3 1.7 0.0 3.9 0.7 0.0 0.0 0.2 0.1 5.8 4.9 0.0 16.8 0.5 3.2 1.2 0.0 0.3 4.7 0.6 0.0 3.3 1.0 4.0 3.2 0.3 0.0 0.0 1.4 10.5 0.0 1.4 1.8 0.6 17.7 0.3 0.7 4.1 8.8 WARS "IFI53, IFP53" ENSG00000140105 "Tryptophanyl-tRNA synthetase" P23381 14 100333788-100376805 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 142.8;thyroid gland: 157.0" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "intermediate monocyte: 131.2;non-classical monocyte: 142.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 118.8;SK-MEL-30: 143.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005573, HPA018944" Enhanced Enhanced Cytosol No No 53000000 Cytosol "HPA005573: AB_2667366, HPA018944: AB_2669986" "unprognostic (5.36e-2)" "unprognostic (5.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.54e-1)" "unprognostic (2.30e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.14e-2)" "unprognostic (4.26e-2)" "prognostic favorable (1.94e-4)" "unprognostic (4.84e-2)" "unprognostic (3.21e-1)" "unprognostic (3.53e-3)" "unprognostic (1.37e-1)" "unprognostic (9.45e-2)" "unprognostic (1.62e-1)" "unprognostic (5.92e-3)" 42.5 23.3 14.5 53.9 20.1 17.0 20.6 10.7 25.4 11.1 19.1 13.3 7.1 12.7 16.5 20.5 17.8 14.5 13.7 32.0 17.8 18.7 24.6 17.9 68.5 35.3 16.9 14.8 12.1 15.6 9.4 23.5 89.6 28.2 16.4 21.0 23.5 15.7 11.7 22.3 9.3 19.8 21.0 15.7 51.6 19.8 23.7 9.4 20.9 157.0 19.2 22.7 24.0 13.8 5.6 27.7 51.8 142.8 3.3 3.4 46.4 11.1 10.6 7.0 40.7 10.1 14.4 11.2 14.4 27.9 31.0 39.2 6.9 10.0 12.1 13.5 34.3 7.6 19.0 20.2 16.4 20.0 19.2 5.8 7.8 8.1 8.5 118.8 22.2 12.8 16.3 23.6 18.0 37.5 9.4 27.8 8.2 24.4 32.1 13.2 21.3 7.6 10.4 7.0 11.4 19.3 6.4 11.0 7.7 15.1 9.8 18.7 10.9 8.6 7.5 143.4 9.4 19.1 28.2 18.4 3.3 7.5 33.9 7.5 62.6 31.8 22.5 37.4 17.3 30.2 6.1 39.5 51.8 3.4 131.2 3.1 5.6 2.8 3.1 27.7 4.1 2.0 2.4 14.1 3.3 142.8 4.2 3.3 46.4 14.5 20.1 10.7 25.4 17.8 18.7 16.9 14.8 28.2 9.4 23.8 39.7 41.6 6.7 12.9 9.0 12.1 7.6 30.8 29.6 21.0 19.6 14.6 13.3 29.0 112.5 76.4 8.5 0.0 56.4 9.8 20.5 12.1 29.0 14.9 40.6 7.9 14.3 87.8 44.2 82.6 10.6 72.8 8.5 71.3 14.1 9.3 34.3 7.2 12.7 15.3 15.8 19.4 21.7 69.3 20.9 10.7 13.8 10.2 10.1 11.4 WBP1 WBP-1 ENSG00000239779 "WW domain binding protein 1" Q96G27 2 74458329-74460891 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 21.4;monocytes: 9.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057067 Approved Approved Cytosol No No Cytosol "HPA057067: AB_2683326" "unprognostic (5.94e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (6.05e-2)" "unprognostic (2.98e-1)" "unprognostic (1.11e-1)" "unprognostic (5.80e-2)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "prognostic favorable (6.83e-4)" "unprognostic (1.17e-2)" "unprognostic (1.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (6.36e-4)" 17.6 23.5 37.6 12.6 34.8 15.1 18.1 12.1 27.5 22.4 14.9 34.4 23.6 15.9 19.2 26.1 19.0 31.0 20.6 21.2 30.9 22.7 23.0 26.4 15.4 15.5 28.6 17.2 27.6 35.9 27.7 22.1 15.4 20.8 29.8 10.2 32.1 49.1 25.5 15.3 19.7 15.8 16.4 25.2 14.7 17.9 10.6 17.0 40.5 36.0 17.2 17.6 18.7 19.2 19.2 30.3 15.3 18.5 21.5 24.0 16.5 6.1 29.3 17.8 20.1 22.8 17.5 13.4 6.6 12.3 6.6 5.4 15.2 11.7 6.0 11.8 15.2 10.1 9.1 7.2 17.1 6.4 23.7 17.0 8.4 13.8 21.3 14.6 3.0 8.3 24.6 18.3 8.8 13.1 31.8 13.1 15.9 3.3 21.5 16.7 41.7 10.3 7.7 12.7 16.1 15.6 10.4 20.1 9.0 17.5 26.0 10.5 26.4 8.8 14.6 18.1 16.6 19.5 8.1 8.1 16.0 13.2 6.2 6.4 32.9 11.4 7.0 17.2 7.9 14.1 15.3 18.5 12.2 18.1 14.2 15.9 19.2 16.0 17.6 19.4 18.8 22.4 19.4 13.0 21.5 12.0 30.3 24.0 16.5 37.6 34.8 12.1 27.5 30.9 22.7 28.6 17.2 20.8 17.0 3.0 3.4 0.0 0.4 0.8 1.7 0.4 0.0 21.4 5.7 1.8 2.0 1.1 1.7 4.1 1.3 1.1 3.4 0.0 3.5 1.2 1.2 1.6 1.1 0.8 1.4 0.0 1.7 0.6 3.5 1.3 2.0 1.4 0.0 9.0 4.4 1.5 5.0 3.5 1.1 3.1 1.8 0.0 1.2 0.1 0.2 1.1 1.5 1.5 4.5 0.3 WBP2NL "FLJ26145, GRAMD7, MGC26816, PAWP" ENSG00000183066 "WBP2 N-terminal like" Q6ICG8 22 41998725-42058456 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 24.8" "Group enriched" "Detected in many" 16 "Early spermatids: 223.5;Late spermatids: 587.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;HDLM-2: 1.0;HHSteC: 1.1;HSkMC: 1.1;THP-1: 1.6" HPA048557 Enhanced Approved Cytosol NA NA Cytosol "HPA048557: AB_2680440" "unprognostic (1.90e-2)" "unprognostic (2.25e-4)" "unprognostic (2.77e-3)" "unprognostic (6.12e-2)" "unprognostic (6.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (9.84e-4)" "unprognostic (3.31e-2)" "unprognostic (4.19e-2)" "unprognostic (1.79e-1)" "unprognostic (2.06e-1)" "unprognostic (2.85e-3)" "unprognostic (9.36e-5)" 1.1 0.9 3.0 1.2 2.9 0.6 2.4 3.6 4.6 0.9 0.9 3.2 1.8 0.8 1.4 4.1 0.8 2.0 1.1 0.8 2.3 1.2 1.2 0.9 1.3 1.1 2.0 2.4 2.4 2.8 2.6 2.4 0.8 2.8 1.3 1.0 2.0 1.9 1.5 0.8 1.6 1.0 0.9 3.7 1.0 1.1 24.8 3.3 0.0 2.3 0.0 1.1 0.9 1.7 1.1 1.5 0.0 0.6 0.4 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.5 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 0.0 0.0 0.9 0.4 0.0 1.5 1.1 0.3 0.3 0.0 0.4 0.2 0.6 1.4 0.2 3.0 2.9 3.6 4.6 2.3 1.2 2.0 2.4 2.8 3.3 0.0 3.2 2.0 1.2 0.3 16.2 0.7 2.5 0.0 5.7 0.0 19.6 1.8 3.3 0.9 223.5 0.7 2.0 0.0 1.2 0.9 0.3 0.9 0.0 1.5 1.2 9.5 4.6 2.5 4.6 587.8 6.1 2.1 1.7 0.0 1.9 2.8 0.9 3.7 5.3 1.5 20.6 0.0 0.8 25.5 15.6 0.6 1.6 2.5 1.7 0.9 WDR34 "bA216B9.3, DIC5, FAP133, MGC20486" ENSG00000119333 "WD repeat domain 34" Q96EX3 9 128633661-128656787 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 159.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 19.1;naive B-cell: 25.3" "Lineage enriched" "Detected in many" 4 "B-cells: 25.3" "Cell line enhanced" "Detected in all" "MCF7: 89.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040764, HPA041091" Approved Approved Cytosol NA Yes Cytosol "HPA040764: AB_10795625, HPA041091: AB_10796237" "unprognostic (1.45e-1)" "prognostic favorable (1.63e-4)" "unprognostic (2.55e-1)" "prognostic favorable (7.01e-5)" "unprognostic (2.27e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (8.79e-4)" "unprognostic (6.04e-2)" "unprognostic (4.39e-1)" "unprognostic (3.65e-1)" "unprognostic (8.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-3)" "unprognostic (2.06e-2)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 6.3 23.0 8.2 16.9 9.0 23.4 21.3 4.2 12.3 12.6 13.6 7.4 24.1 17.3 11.4 19.9 17.3 24.4 24.2 13.6 8.0 9.1 23.6 16.0 14.4 9.1 5.6 8.0 13.1 23.9 14.8 18.2 15.1 14.2 14.5 8.3 11.2 21.6 24.1 7.3 12.3 14.3 9.2 6.2 11.6 16.1 51.0 7.1 42.1 33.1 17.8 13.7 8.6 11.2 25.3 5.6 0.9 2.5 2.0 2.8 1.9 23.2 42.1 11.4 16.6 2.5 3.7 33.5 10.3 6.8 14.1 9.0 20.7 42.3 8.8 7.1 6.2 13.3 38.9 9.9 10.7 3.5 20.0 8.9 5.6 29.9 10.5 3.1 8.8 9.0 1.7 5.4 14.1 4.0 5.2 9.6 24.2 17.3 7.4 7.4 89.2 31.9 22.6 14.0 19.7 26.2 34.5 14.4 28.8 8.8 7.7 27.5 22.3 31.2 28.7 7.5 3.1 49.2 8.6 6.2 17.2 25.6 20.6 19.2 8.6 21.0 8.2 15.4 8.8 15.6 0.9 0.5 0.2 0.8 0.8 1.2 19.1 1.5 2.1 1.4 25.3 0.6 0.9 0.4 2.0 2.5 5.6 2.8 1.9 8.2 9.0 4.2 12.3 8.0 9.1 5.6 8.0 14.2 7.1 44.7 36.9 20.1 22.9 11.9 2.1 18.2 53.5 68.3 44.3 33.2 0.0 49.8 69.6 49.2 78.8 9.8 97.6 23.3 49.4 74.8 25.8 19.9 14.9 50.3 18.9 3.2 54.1 14.1 3.8 159.5 19.0 5.3 21.9 2.8 42.2 17.0 36.8 31.3 18.7 64.3 11.3 12.9 11.7 106.6 71.8 10.2 31.2 7.2 46.6 15.9 WDR59 FLJ12270 ENSG00000103091 "WD repeat domain 59" Q6PJI9 16 74871367-75000173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041084, HPA048218" Approved Approved Cytosol NA NA Cytosol "HPA041084: AB_10793867, HPA048218: AB_2680318" "unprognostic (3.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (4.16e-2)" "unprognostic (6.14e-2)" "unprognostic (3.99e-1)" "unprognostic (2.28e-2)" "unprognostic (8.83e-2)" "unprognostic (3.43e-1)" "unprognostic (2.37e-2)" "unprognostic (4.21e-3)" "unprognostic (3.25e-3)" "unprognostic (2.05e-2)" "unprognostic (9.08e-2)" "unprognostic (3.88e-2)" "unprognostic (1.78e-1)" "unprognostic (5.61e-2)" 10.1 16.8 24.2 13.5 27.4 14.7 15.2 29.0 27.6 14.4 13.6 23.8 17.4 13.7 19.9 23.4 15.2 14.9 13.7 16.2 22.3 17.6 17.5 31.3 11.5 12.3 24.7 19.1 23.3 15.1 30.3 28.7 17.9 22.9 15.0 15.4 13.6 15.5 14.5 22.9 21.9 15.9 16.2 19.7 15.0 14.5 14.0 30.6 17.7 22.4 7.3 16.2 13.0 15.0 3.5 1.6 1.5 1.6 2.0 7.6 1.0 8.2 12.7 14.8 14.1 11.7 10.6 12.6 5.3 9.2 11.4 13.1 17.1 14.6 11.5 5.8 9.8 10.7 13.3 11.7 12.6 16.3 6.9 12.5 14.8 8.2 27.6 7.1 10.6 18.0 12.2 10.3 13.7 13.2 14.7 11.7 28.4 21.7 5.8 5.4 24.2 16.3 19.1 11.8 18.0 5.2 16.4 6.5 9.5 12.3 7.4 9.1 10.0 15.1 8.8 6.7 16.4 13.3 9.4 10.1 7.1 11.0 8.1 4.5 11.1 15.0 25.2 12.6 7.5 7.7 1.3 1.5 1.4 2.4 0.8 7.6 3.5 4.2 3.4 0.9 2.6 2.8 3.1 1.5 2.0 1.6 1.6 1.9 1.0 24.2 27.4 29.0 27.6 22.3 17.6 24.7 19.1 22.9 30.6 14.9 13.9 15.2 16.6 19.9 38.3 14.9 25.5 20.1 15.9 21.0 58.9 29.8 8.3 11.4 31.1 10.5 13.6 0.0 8.4 15.3 12.7 14.4 12.7 21.2 9.3 19.1 21.2 18.4 13.0 58.8 12.4 11.8 8.5 15.4 11.8 13.3 10.6 14.0 11.0 16.8 51.1 19.4 8.2 15.6 15.2 21.1 39.6 10.7 14.0 21.7 WHAMM "KIAA1971, WHAMM1, WHDC1" ENSG00000156232 "WAS protein homolog associated with actin, golgi membranes and microtubules" Q8TF30 15 82809628-82836108 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 44.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039690, HPA040231" Supported Supported Cytosol NA NA Cytosol "HPA039690: AB_10795405, HPA040231: AB_10795361" "unprognostic (7.98e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (8.56e-2)" "unprognostic (6.68e-2)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.37e-2)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.20e-2)" 10.6 6.6 7.9 9.8 11.7 44.5 10.1 14.0 9.5 8.7 8.8 11.2 7.7 8.8 8.5 6.7 10.2 7.3 6.6 7.4 10.1 5.3 9.5 11.4 10.7 9.6 10.7 8.0 10.9 9.3 16.7 7.9 8.9 13.9 10.1 8.2 7.6 9.3 7.5 23.3 12.0 10.6 12.0 12.3 11.9 8.3 5.5 14.3 8.3 9.6 6.6 11.0 11.1 13.1 3.2 2.4 5.0 1.6 5.8 3.2 0.9 4.1 4.2 2.6 4.0 8.6 6.0 4.5 5.8 5.8 6.4 6.4 2.8 7.6 9.0 7.2 5.3 6.1 9.2 8.1 4.7 4.2 2.9 4.6 5.1 4.8 4.0 8.8 3.7 6.1 5.9 6.4 3.0 6.3 6.5 4.5 4.3 4.6 11.9 6.3 3.1 3.0 5.3 1.1 5.1 2.6 4.5 5.7 2.5 11.0 16.8 2.6 2.1 8.9 5.9 5.9 5.7 4.0 7.9 7.1 8.5 3.0 5.7 6.5 12.9 7.2 4.4 6.0 5.1 5.3 5.0 1.6 1.3 3.2 1.1 2.9 2.6 3.1 2.4 1.0 3.2 2.9 2.9 3.6 5.8 1.1 2.4 2.4 0.9 7.9 11.7 14.0 9.5 10.1 5.3 10.7 8.0 13.9 14.3 14.9 12.9 35.0 39.1 23.6 15.2 13.6 7.6 5.3 7.9 19.2 13.7 12.0 5.0 7.7 5.5 16.4 14.8 0.0 8.9 13.6 13.1 41.0 10.4 11.5 16.5 22.3 6.4 16.5 10.2 2.4 16.1 17.9 18.6 9.0 16.6 17.7 11.0 14.1 22.3 8.6 17.7 32.3 15.6 22.8 30.6 22.0 21.3 26.3 12.3 64.2 WISP1 "CCN4, WISP-1, WISP1-OT1, WISP1-UT1" ENSG00000104415 "WNT1 inducible signaling pathway protein 1" O95388 8 133191039-133231690 "Cancer-related genes, Predicted secreted proteins" "Cell adhesion, Wnt signaling pathway" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 1.6;Fibroblasts: 2.1;Sertoli cells: 6.5;Smooth muscle cells: 2.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 8.1;HSkMC: 45.6;hTEC/SVTERT24-B: 26.0;U-2197: 24.9" "Region enriched" "Detected in single" 6 "olfactory region: 11.9" "Low region specificity" "Detected in single" "HPA007121, CAB012205" Uncertain Approved Cytosol "Secreted to extracellular matrix" NA NA Cytosol "CAB012205: , HPA007121: AB_1858844" "unprognostic (7.77e-2)" "unprognostic (2.05e-1)" "unprognostic (3.30e-2)" "unprognostic (3.20e-1)" "unprognostic (7.72e-2)" "unprognostic (6.63e-2)" "unprognostic (8.61e-3)" "unprognostic (3.26e-2)" "unprognostic (2.07e-3)" "unprognostic (1.41e-3)" "unprognostic (3.01e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (7.52e-3)" "unprognostic (2.55e-3)" "unprognostic (6.03e-2)" "unprognostic (5.67e-3)" 4.2 11.0 0.6 7.7 1.6 0.0 2.3 0.6 2.9 14.7 3.9 1.0 0.0 1.2 18.5 6.4 2.2 6.5 8.5 4.0 0.7 0.3 18.0 2.9 8.9 13.4 0.8 0.4 13.0 1.0 0.2 2.7 3.5 1.2 3.4 0.9 4.5 1.3 4.2 2.0 1.6 3.9 14.4 6.2 14.6 3.8 3.7 0.4 0.3 1.3 2.7 4.2 14.4 4.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 1.7 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 45.6 0.0 26.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 6.0 0.3 24.9 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 1.6 0.6 2.9 0.7 0.3 0.8 0.4 1.2 0.4 0.0 0.3 0.0 0.7 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 2.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 WNK1 "HSAN2, HSN2, PPP1R167, PRKWNK1" ENSG00000060237 "WNK lysine deficient protein kinase 1" Q9H4A3 12 752593-911452 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046541, HPA059157" Enhanced Supported Cytosol NA NA Cytosol "HPA046541: AB_2679690, HPA059157: AB_2683935" "unprognostic (1.40e-1)" "unprognostic (1.54e-2)" "unprognostic (4.82e-2)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (7.68e-2)" "unprognostic (1.05e-3)" "unprognostic (1.57e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.67e-4)" "unprognostic (1.84e-1)" "unprognostic (2.49e-1)" "unprognostic (4.38e-1)" "unprognostic (1.40e-1)" "unprognostic (1.32e-1)" "unprognostic (5.17e-2)" "unprognostic (1.30e-2)" 30.0 12.4 49.3 19.1 47.5 28.9 45.4 22.5 36.7 21.2 12.6 42.6 10.6 8.5 15.9 19.4 45.5 16.9 16.5 38.5 53.7 36.4 45.6 18.0 33.0 34.3 62.3 27.1 18.5 11.3 29.1 12.7 20.3 41.4 17.1 14.3 12.0 15.4 20.3 43.4 31.3 10.3 22.3 82.8 16.9 15.7 23.8 38.8 23.9 16.7 17.4 24.5 18.9 26.5 3.7 2.6 10.9 7.1 2.1 5.2 1.9 14.1 26.8 35.4 3.3 25.6 24.6 13.5 14.1 17.0 15.3 14.3 15.0 16.1 20.0 5.0 30.2 18.6 10.7 23.9 16.3 21.6 34.5 14.3 44.5 35.6 13.0 18.8 24.0 19.4 19.0 24.8 25.3 45.4 17.0 20.7 18.8 20.3 48.2 23.1 13.0 43.2 4.0 28.9 12.0 6.4 20.6 39.3 5.3 22.0 30.6 10.3 12.1 32.9 21.4 9.5 49.5 23.5 24.7 22.8 19.0 22.0 26.6 20.7 7.4 12.2 30.2 18.1 12.7 15.4 0.9 2.7 2.6 3.8 4.0 5.2 3.0 4.3 3.6 2.6 3.7 2.3 4.1 10.9 2.1 7.1 1.7 4.9 1.9 49.3 47.5 22.5 36.7 53.7 36.4 62.3 27.1 41.4 38.8 95.3 107.5 34.5 38.1 100.2 81.8 197.8 58.6 61.6 53.4 85.5 141.4 27.8 72.9 26.9 18.6 99.1 21.1 210.2 21.1 25.9 54.1 46.4 50.8 62.5 49.6 79.4 56.4 45.4 101.9 17.5 57.2 66.8 35.4 48.7 24.6 57.2 32.3 29.8 52.3 16.5 92.4 12.9 41.9 139.7 38.1 118.8 23.8 69.2 21.9 46.1 WNK2 "KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43" ENSG00000165238 "WNK lysine deficient protein kinase 2" Q9Y3S1 9 93184916-93320572 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 101.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "Daudi: 11.5;Hep G2: 18.8;SCLC-21H: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015555, HPA016519, CAB017813" Enhanced Approved Cytosol NA NA Cytosol "CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380" "unprognostic (5.02e-2)" "unprognostic (1.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.04e-1)" "unprognostic (1.79e-3)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.31e-3)" "unprognostic (2.23e-1)" "unprognostic (4.48e-3)" "unprognostic (6.51e-2)" "unprognostic (1.44e-1)" "unprognostic (4.38e-4)" "unprognostic (1.62e-1)" 0.0 0.7 3.9 0.9 3.8 0.0 1.2 9.5 7.2 0.7 7.5 7.4 1.3 1.5 2.1 6.6 0.1 21.9 4.0 4.2 0.0 0.0 0.0 0.0 2.6 0.0 18.3 0.8 7.5 0.9 4.9 4.8 19.5 5.5 23.7 3.0 6.2 1.6 1.1 0.5 3.0 1.5 0.0 0.0 1.0 0.1 0.0 0.0 1.9 0.0 0.0 0.3 0.0 4.4 4.0 2.9 8.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.6 0.1 11.5 1.5 0.0 0.8 0.2 6.5 0.0 0.0 0.0 7.5 0.0 3.5 18.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.3 0.0 0.0 6.0 0.1 0.1 7.3 4.4 0.2 0.0 0.0 9.3 0.0 0.7 23.9 9.4 1.5 6.5 0.6 0.8 0.8 1.3 0.1 0.0 3.1 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 8.1 1.1 57.3 56.7 30.6 5.3 9.1 0.0 151.2 11.9 0.0 11.7 0.9 0.5 34.4 0.0 8.0 5.6 1.1 12.9 0.0 0.0 2.9 1.6 31.2 0.6 1.0 1.9 0.9 0.0 1.7 1.0 57.9 60.6 3.3 42.1 5.6 0.7 101.2 12.9 4.4 0.4 6.6 4.8 13.0 0.0 51.8 6.4 XPNPEP1 "XPNPEP, XPNPEPL, XPNPEPL1" ENSG00000108039 "X-prolyl aminopeptidase 1" Q9NQW7 10 109864766-109923553 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025196, HPA030419, HPA030420, HPA030422" Supported Enhanced Cytosol NA NA 760000 Cytosol "CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783" "unprognostic (3.17e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.46e-1)" "unprognostic (2.01e-3)" "prognostic unfavorable (2.12e-5)" "unprognostic (8.03e-2)" "unprognostic (2.10e-2)" "unprognostic (1.88e-1)" "unprognostic (4.89e-2)" "unprognostic (7.61e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (5.18e-2)" 16.6 14.7 13.4 16.1 18.9 12.8 13.6 14.8 22.2 15.7 20.6 19.5 14.1 33.2 17.5 16.1 17.8 15.8 20.3 17.8 13.7 11.4 18.3 21.0 14.8 14.9 13.8 14.0 17.8 46.0 14.9 15.9 19.0 17.2 16.0 26.9 15.6 19.6 11.3 18.5 20.4 38.6 18.6 11.9 18.0 16.8 15.1 12.0 9.9 15.7 15.2 24.2 14.1 13.8 5.5 24.0 10.0 21.0 14.7 10.6 13.4 25.5 11.2 18.0 24.5 29.4 27.6 13.8 14.2 29.1 21.4 23.2 21.8 22.0 36.5 12.3 21.9 10.9 13.6 14.2 17.6 21.0 10.8 13.7 24.3 7.3 9.0 20.5 18.9 20.3 27.2 10.9 23.5 20.9 32.9 35.1 23.7 7.9 11.7 27.1 8.6 13.5 11.8 7.0 19.4 12.2 15.1 36.3 6.5 27.2 8.0 5.5 20.9 12.4 7.9 23.8 20.5 9.6 17.7 18.0 8.7 11.4 13.8 12.5 19.9 9.7 31.2 20.6 26.5 6.9 10.0 13.7 5.6 10.6 21.0 7.3 5.5 7.0 9.5 24.0 4.8 5.0 6.6 1.1 14.7 17.5 18.8 7.5 13.4 13.4 18.9 14.8 22.2 13.7 11.4 13.8 14.0 17.2 12.0 6.0 15.6 11.9 11.4 7.9 19.1 15.7 20.4 12.0 10.3 3.5 5.9 33.7 14.9 29.4 4.5 12.1 36.7 0.0 63.7 24.7 19.7 19.6 10.5 9.6 27.2 25.4 16.1 16.5 16.1 4.1 17.0 17.4 8.5 39.7 34.2 24.9 47.2 35.3 28.0 18.8 18.4 12.9 8.8 8.4 37.1 7.5 21.1 20.8 34.1 19.3 YAE1D1 "C7orf36, GK003" ENSG00000241127 "Yae1 domain containing 1" Q9NRH1 7 39566376-39610320 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019226, HPA031249" Uncertain Approved Cytosol NA NA Cytosol "HPA019226: AB_1845759, HPA031249: AB_2673807" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (8.73e-3)" "unprognostic (1.57e-1)" "unprognostic (8.75e-2)" "unprognostic (4.30e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (3.04e-3)" "unprognostic (1.17e-2)" "unprognostic (1.45e-2)" "unprognostic (2.39e-2)" "unprognostic (1.67e-2)" "unprognostic (6.54e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-3)" 11.9 17.3 24.1 14.2 26.0 2.7 20.2 28.6 23.6 16.5 20.3 15.9 16.3 15.7 19.5 26.2 15.9 18.4 12.6 17.8 19.1 17.4 17.3 13.0 12.2 10.1 20.1 20.3 25.2 13.2 16.9 27.6 12.5 18.1 15.6 22.8 10.9 15.2 14.5 14.1 12.1 22.2 17.8 21.1 11.2 15.2 20.9 23.4 9.9 16.7 8.6 10.2 15.2 13.6 12.2 8.0 12.0 5.2 7.5 19.2 6.6 11.6 7.8 16.7 18.3 13.2 13.5 9.9 17.2 15.2 15.9 18.1 6.6 7.0 6.6 8.5 14.4 27.5 12.3 15.7 12.0 15.6 6.5 13.0 6.1 9.7 12.9 12.0 6.2 4.6 12.3 10.0 16.6 18.7 9.6 13.8 5.9 19.2 3.0 13.8 8.2 5.1 12.6 36.8 14.8 9.3 7.0 9.8 7.6 15.1 10.9 21.2 24.0 14.1 19.7 18.1 19.3 17.7 12.1 9.2 8.4 15.6 10.2 14.8 9.8 20.7 14.3 10.0 14.3 24.4 12.0 5.0 6.3 8.3 5.2 9.0 12.2 10.7 12.0 5.7 11.4 19.2 13.5 0.5 7.5 3.8 8.0 11.5 6.6 24.1 26.0 28.6 23.6 19.1 17.4 20.1 20.3 18.1 23.4 6.0 5.6 3.4 6.2 4.2 12.8 14.9 5.1 28.1 23.9 15.7 2.0 13.0 28.2 12.3 33.7 10.5 17.3 0.0 10.7 11.2 12.2 4.5 9.2 7.8 8.6 3.2 8.6 4.3 4.0 12.1 20.8 3.4 5.0 4.6 21.5 18.3 12.6 11.4 20.1 21.4 11.2 6.5 11.3 33.4 26.0 5.0 4.2 6.9 13.6 3.1 YARS "tyrRS, YRS, YTS" ENSG00000134684 "Tyrosyl-tRNA synthetase" P54577 1 32775237-32818153 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017936, HPA018950, HPA018954" Enhanced Enhanced Cytosol No No 230000 Cytosol "HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915" "unprognostic (4.05e-2)" "unprognostic (2.52e-1)" "unprognostic (4.21e-1)" "unprognostic (4.78e-2)" "unprognostic (9.54e-2)" "unprognostic (3.38e-3)" "prognostic unfavorable (6.97e-11)" "unprognostic (5.05e-2)" "unprognostic (6.29e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (1.02e-11)" "unprognostic (3.57e-3)" "unprognostic (1.02e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (6.57e-4)" 16.6 36.3 22.8 22.8 40.6 17.4 13.9 26.6 43.1 14.6 17.5 16.3 22.4 17.1 14.2 15.5 24.1 14.4 11.2 15.5 24.9 28.3 14.1 29.6 21.3 23.2 24.9 27.4 21.2 54.8 19.3 13.9 17.5 26.7 12.7 21.9 11.2 23.5 25.7 27.3 16.5 14.9 22.7 22.7 14.6 25.9 20.9 26.0 15.2 30.0 16.8 29.6 17.0 28.0 9.9 17.8 20.9 13.4 36.5 24.3 17.1 28.8 15.1 15.9 38.3 19.8 22.8 17.0 29.8 24.7 24.5 31.3 17.9 19.9 52.5 11.8 30.9 20.0 17.0 48.4 35.1 38.8 22.1 19.2 48.1 22.9 16.8 65.2 37.9 29.1 22.6 43.7 38.7 98.6 17.7 24.8 42.5 52.9 55.6 21.0 14.9 42.5 20.8 29.0 29.5 20.9 37.2 15.2 44.1 17.6 14.5 30.7 18.9 16.2 19.1 55.0 19.0 19.1 41.3 20.1 14.9 26.6 30.2 24.6 44.9 47.9 49.1 37.3 52.9 40.9 20.9 12.7 6.6 24.3 13.4 23.9 9.9 14.5 22.3 17.8 8.1 10.8 16.5 3.0 36.5 12.4 10.2 15.6 17.1 22.8 40.6 26.6 43.1 24.9 28.3 24.9 27.4 26.7 26.0 20.8 45.6 14.5 22.1 22.2 19.3 14.9 5.1 34.8 34.2 8.7 25.5 36.7 3.3 30.4 14.4 19.0 12.8 0.0 71.3 38.8 20.0 22.9 12.8 23.3 35.7 30.2 16.7 7.4 22.2 12.4 11.8 21.1 13.5 35.1 12.7 10.8 50.1 3.5 10.6 9.8 19.8 12.9 24.5 26.7 19.4 21.3 31.5 33.0 17.5 30.1 YBX3 "CSDA, CSDA1, dbpA, ZONAB" ENSG00000060138 "Y-box binding protein 3" P16989 12 10699089-10723312 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 612.6" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 961.9;Early spermatids: 1123.4;Urothelial cells: 1185.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 9.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034838 Approved Supported Cytosol NA NA 56000 Cytosol "HPA034838: AB_10670980" "unprognostic (1.93e-2)" "unprognostic (6.20e-2)" "unprognostic (3.56e-1)" "unprognostic (3.61e-2)" "unprognostic (4.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-1)" "unprognostic (2.41e-1)" "unprognostic (3.23e-3)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.17e-13)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.44e-1)" 23.8 5.0 3.0 6.4 6.0 11.2 15.9 2.1 4.6 12.4 14.3 2.0 3.7 3.2 8.5 14.7 25.0 8.4 6.7 91.6 3.2 1.7 7.6 6.5 17.2 6.8 5.5 0.8 17.2 20.6 1.3 8.1 9.5 6.2 12.4 5.3 6.2 12.9 6.8 612.6 29.9 5.0 14.9 5.8 8.6 9.5 30.2 4.1 4.5 18.5 54.2 12.0 27.2 24.6 9.5 4.5 1.0 5.7 0.9 2.3 1.4 18.0 15.8 7.1 23.1 29.7 55.0 51.9 28.2 24.1 24.2 22.8 27.7 43.8 17.7 9.5 22.5 17.3 34.7 30.4 58.7 21.0 0.1 54.6 14.6 22.3 16.9 37.1 26.2 1.6 63.4 76.3 22.4 73.8 26.1 55.5 26.6 19.7 0.0 25.9 19.2 21.6 22.6 71.6 17.2 13.0 12.2 32.5 20.0 32.7 23.9 8.8 0.0 21.4 21.3 26.2 51.6 6.1 20.7 36.3 16.6 46.6 17.7 31.7 0.1 5.8 2.0 22.8 0.0 17.7 0.0 5.7 0.0 0.7 5.4 0.0 1.6 0.0 2.1 4.5 9.5 0.1 2.3 1.0 0.9 3.0 0.2 0.1 1.4 3.0 6.0 2.1 4.6 3.2 1.7 5.5 0.8 6.2 4.1 140.0 176.5 92.6 961.9 679.4 30.6 444.3 50.9 175.3 168.4 137.9 84.4 126.8 112.7 102.4 1123.4 256.4 56.1 654.1 122.3 76.8 207.6 567.0 61.2 16.3 93.4 15.9 64.9 106.2 162.4 213.4 245.1 187.6 246.3 24.4 118.1 52.5 144.1 38.6 210.4 172.9 294.1 122.9 393.5 248.3 90.5 918.2 105.2 24.0 146.4 1185.0 Z83844.3 ENSG00000285304 22 37639693-37666932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA000757 Approved Approved Cytosol NA NA Cytosol "HPA000757: AB_1079951" 2.4 0.1 1.8 12.3 2.7 8.5 1.0 2.4 3.5 3.7 7.5 2.0 0.9 8.4 1.3 2.0 11.6 1.9 2.4 1.0 1.5 0.3 1.0 3.7 8.2 1.7 1.5 2.5 0.9 2.8 0.0 6.0 1.8 3.5 5.7 1.4 4.4 2.8 0.0 2.2 12.5 2.6 2.5 13.4 1.6 0.9 2.4 10.5 0.3 10.4 16.3 4.6 2.0 1.6 3.6 0.1 2.7 1.7 2.6 1.5 9.2 1.6 5.3 3.3 1.5 4.6 5.9 2.7 8.5 10.1 10.6 7.4 2.3 6.7 1.1 3.0 3.3 8.0 5.7 13.9 3.2 6.9 5.1 14.0 0.2 7.4 3.0 21.4 19.3 5.4 6.6 11.8 1.1 4.8 0.6 4.3 4.0 5.0 0.4 11.2 0.9 2.0 5.4 16.0 1.3 8.7 3.6 5.5 1.1 3.3 3.0 5.5 0.7 3.5 6.1 3.9 4.6 10.7 1.2 1.5 5.5 0.7 0.0 9.1 3.4 6.1 3.6 14.8 10.1 0.0 2.7 0.1 2.2 1.3 1.8 1.6 1.4 2.1 3.6 0.9 2.6 1.6 0.0 1.7 2.7 2.2 2.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZC3H15 LEREPO4 ENSG00000065548 "Zinc finger CCCH-type containing 15" Q8WU90 2 186486156-186509363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031099, HPA031100, HPA031101" Enhanced Enhanced Cytosol NA Yes Cytosol "HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669" "unprognostic (1.51e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (2.24e-1)" "unprognostic (3.11e-3)" "unprognostic (5.92e-2)" "unprognostic (8.15e-2)" "prognostic unfavorable (1.48e-7)" "unprognostic (9.08e-3)" "unprognostic (4.95e-2)" "prognostic favorable (3.98e-4)" "prognostic unfavorable (9.75e-4)" "unprognostic (5.72e-3)" "unprognostic (5.69e-2)" "unprognostic (1.87e-1)" "unprognostic (1.82e-1)" "unprognostic (8.89e-2)" "unprognostic (3.45e-2)" 25.2 31.1 35.7 25.2 40.1 67.3 38.0 32.9 52.6 24.7 24.7 10.5 30.2 29.0 25.1 30.7 28.2 19.8 22.6 25.2 60.0 35.4 32.8 40.3 20.3 29.5 32.3 33.5 24.5 32.7 26.9 35.3 29.4 51.6 24.3 28.9 10.7 25.8 26.2 58.0 27.0 29.9 27.4 43.4 28.5 23.3 23.7 21.7 28.3 30.5 19.0 30.1 30.0 38.8 32.8 31.1 28.3 39.1 32.5 36.9 22.4 27.2 18.5 22.9 29.4 26.1 26.5 34.4 30.4 20.8 28.2 25.5 53.9 22.1 37.2 27.9 21.5 36.2 19.9 42.1 37.1 40.0 33.8 32.2 53.4 28.6 59.6 35.3 54.3 32.8 21.6 41.2 30.6 43.6 24.9 30.2 23.2 51.0 29.2 29.4 24.5 34.6 38.8 43.2 36.0 46.9 27.7 31.0 34.6 35.7 33.3 27.7 20.4 19.2 26.3 43.9 36.0 18.5 39.6 25.9 31.9 27.6 19.5 36.2 25.5 42.7 53.2 28.3 38.6 27.8 28.3 27.5 26.9 27.2 34.0 33.7 32.8 33.8 34.5 31.1 24.7 31.5 33.2 16.8 32.5 39.1 27.5 36.9 22.4 35.7 40.1 32.9 52.6 60.0 35.4 32.3 33.5 51.6 21.7 68.5 78.9 141.2 127.1 188.5 73.2 87.6 66.2 78.9 102.4 109.9 56.9 114.7 217.2 91.2 123.7 87.8 121.8 46.7 90.4 141.8 94.0 129.7 109.7 114.6 109.7 54.0 97.5 65.7 86.1 224.0 72.8 100.6 60.8 118.2 99.1 80.5 96.4 97.7 82.0 189.8 120.6 32.3 103.2 184.4 186.8 182.8 148.5 83.7 117.5 153.1 ZC3H7A "FLJ20318, HSPC055, ZC3H7, ZC3HDC7" ENSG00000122299 "Zinc finger CCCH-type containing 7A" Q8IWR0 16 11750586-11797267 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040808, HPA059849" Supported Cytosol NA NA Cytosol "HPA040808: AB_10794150, HPA059849: AB_2684141" "unprognostic (2.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.07e-1)" "unprognostic (5.64e-2)" "unprognostic (2.07e-2)" "unprognostic (5.75e-2)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (9.16e-2)" "unprognostic (1.44e-1)" "unprognostic (2.27e-2)" "unprognostic (7.27e-3)" "unprognostic (6.00e-2)" "unprognostic (1.05e-2)" "unprognostic (1.50e-2)" "unprognostic (3.55e-2)" 22.9 19.6 18.3 16.6 18.8 27.3 21.2 25.6 19.1 19.2 18.4 18.4 21.4 14.2 24.4 17.0 13.5 19.2 17.5 15.8 16.9 11.9 19.4 18.0 23.6 21.7 19.0 16.6 25.5 21.3 25.4 20.2 21.3 16.8 20.8 16.5 23.1 22.6 22.5 32.9 15.1 19.1 25.6 18.1 23.3 17.9 8.9 19.3 32.9 23.5 13.5 21.8 20.7 17.1 12.8 10.5 16.0 23.5 17.5 19.2 7.1 13.5 7.0 24.6 13.4 17.2 17.2 9.9 21.8 21.9 16.6 20.5 7.7 11.9 19.0 13.7 25.8 10.6 8.8 13.8 21.1 24.0 14.9 15.8 8.2 14.2 12.9 24.5 18.7 18.0 19.4 11.8 15.5 29.4 19.4 20.7 17.4 13.3 17.2 23.9 10.6 14.1 9.5 14.4 9.4 6.4 20.6 13.8 13.5 15.5 10.5 18.9 15.0 17.6 17.0 21.7 15.3 12.4 12.3 19.5 19.4 11.9 26.1 14.6 13.8 10.4 28.3 14.2 14.0 49.7 12.3 10.7 16.0 12.5 14.4 17.1 12.8 16.1 13.3 10.5 12.2 19.2 13.4 13.3 17.5 23.5 8.4 19.0 7.1 18.3 18.8 25.6 19.1 16.9 11.9 19.0 16.6 16.8 19.3 59.6 31.3 29.2 13.0 13.4 27.9 35.0 12.7 41.5 44.3 14.0 51.1 13.1 13.3 15.2 2.6 30.8 15.1 0.0 19.7 12.6 18.4 17.4 17.4 17.4 12.4 50.9 20.1 31.9 39.2 3.1 30.2 26.3 18.6 29.7 23.1 26.0 19.5 18.6 33.6 12.8 48.6 19.4 20.6 16.7 8.8 13.8 6.3 27.3 16.0 14.2 ZC3H7B "DKFZp434K0920, FLJ13787, KIAA1031, RoXaN" ENSG00000100403 "Zinc finger CCCH-type containing 7B" Q9UGR2 22 41301522-41360147 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001784, HPA076092" Uncertain Uncertain Cytosol NA NA Cytosol "HPA001784: AB_1080637, HPA076092: " "unprognostic (1.71e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-2)" "unprognostic (3.53e-2)" "unprognostic (3.35e-2)" "unprognostic (5.66e-2)" "unprognostic (3.73e-2)" "unprognostic (7.92e-2)" "unprognostic (7.12e-2)" "unprognostic (7.73e-2)" "unprognostic (1.39e-2)" "unprognostic (3.19e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.43e-2)" "unprognostic (2.92e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-1)" 21.7 31.9 31.0 14.7 24.9 10.9 13.4 30.0 45.6 17.8 13.3 24.2 13.7 18.8 19.0 11.3 15.1 21.3 14.4 17.1 30.5 20.2 21.3 29.0 18.4 14.9 24.5 27.8 34.3 23.9 41.7 21.9 14.4 29.4 18.8 10.7 20.4 32.8 22.7 17.2 15.4 19.6 16.6 21.7 19.4 16.1 9.8 28.0 13.1 37.2 9.2 11.7 14.4 11.8 1.9 1.5 0.5 0.6 1.4 1.4 0.3 22.2 12.5 16.6 10.0 15.3 13.9 19.5 25.6 27.4 21.4 16.9 13.5 9.3 12.6 31.6 35.5 12.0 15.2 14.0 24.0 11.0 28.8 23.1 11.3 15.4 17.2 20.5 21.6 9.9 17.4 13.8 18.4 22.6 18.3 23.1 10.0 22.6 7.0 18.0 22.5 16.9 11.2 11.9 16.9 9.5 26.1 10.5 14.4 18.2 16.0 10.8 8.1 23.5 14.4 12.1 12.1 9.5 14.6 46.1 21.0 22.0 6.4 15.6 12.3 6.8 12.7 17.6 10.7 18.1 0.0 0.6 0.5 1.0 0.4 1.0 1.9 1.2 1.1 0.5 1.8 1.4 0.9 0.0 1.4 0.2 1.5 0.9 0.3 31.0 24.9 30.0 45.6 30.5 20.2 24.5 27.8 29.4 28.0 11.9 20.3 13.7 10.3 6.4 20.6 8.3 22.9 12.0 18.2 21.0 17.7 7.7 6.6 13.0 0.7 16.5 13.8 0.0 11.2 7.7 10.8 15.7 8.1 35.4 10.0 39.7 32.2 20.3 10.8 2.4 30.8 7.4 11.8 16.2 13.6 7.8 16.5 5.8 27.3 16.7 22.5 19.4 12.5 1.9 5.1 5.1 5.1 8.3 16.9 13.7 ZC3HAV1L "C7orf39, MGC14289" ENSG00000146858 "Zinc finger CCCH-type containing, antiviral 1 like" Q96H79 7 139025706-139036029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "granulocytes: 4.6;Leydig cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "basophil: 10.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 10.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020386, HPA050741" Uncertain Enhanced Cytosol NA NA Cytosol "HPA020386: AB_2257412, HPA050741: AB_2681224" "unprognostic (1.12e-1)" "prognostic unfavorable (7.35e-4)" "unprognostic (3.07e-2)" "unprognostic (1.50e-1)" "unprognostic (6.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (8.51e-2)" "unprognostic (3.34e-3)" "unprognostic (2.07e-1)" "unprognostic (3.44e-2)" "unprognostic (2.00e-2)" "unprognostic (1.49e-3)" "unprognostic (5.04e-2)" "unprognostic (2.88e-1)" "unprognostic (1.84e-2)" "unprognostic (3.08e-3)" 8.2 6.1 2.9 3.1 4.7 1.5 9.4 1.1 3.0 14.7 6.6 2.0 5.0 4.2 10.3 9.7 8.6 7.4 5.6 4.7 2.0 2.4 6.2 1.9 5.3 3.0 1.6 1.7 20.2 9.9 4.4 12.2 14.1 2.0 12.0 4.4 8.4 5.9 10.1 3.0 11.6 4.4 8.8 1.8 6.0 4.5 4.4 2.1 10.5 17.4 5.6 6.2 9.0 9.1 1.0 0.3 10.7 0.3 0.3 0.4 0.3 9.1 7.5 5.5 18.5 4.7 7.2 0.2 4.5 2.0 3.4 4.7 12.4 5.3 0.2 6.6 4.9 0.0 6.6 7.7 1.8 10.4 5.4 0.1 11.7 7.3 4.2 3.7 0.1 4.3 5.5 3.0 5.1 2.4 0.2 5.7 5.8 5.0 0.3 6.9 0.0 12.3 7.0 1.0 1.2 4.8 13.0 18.8 0.1 3.1 5.0 3.7 16.9 11.2 1.6 6.9 1.2 6.9 4.8 8.0 6.2 5.5 2.1 0.0 0.3 0.0 0.2 3.5 0.1 5.7 10.7 0.3 1.3 0.2 0.1 0.3 0.6 0.4 0.4 0.2 1.0 0.3 0.4 0.8 0.3 0.1 0.3 0.3 0.3 2.9 4.7 1.1 3.0 2.0 2.4 1.6 1.7 2.0 2.1 0.0 0.0 0.0 0.7 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.5 0.8 0.5 4.6 0.0 0.7 0.0 0.0 0.0 0.8 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.2 0.0 1.4 0.3 0.0 0.0 1.4 0.0 0.6 0.9 0.6 0.0 0.0 0.4 ZDHHC1 "C16orf1, HSU90653, ZNF377" ENSG00000159714 "Zinc finger DHHC-type containing 1" Q8WTX9 16 67394419-67416833 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 24.6;Late spermatids: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC diff: 13.6;ASC TERT1: 15.1;U-138 MG: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042531, HPA048659" Uncertain Approved Cytosol NA NA Cytosol "HPA042531: AB_2678041, HPA048659: AB_2680483" "unprognostic (8.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.05e-3)" "prognostic favorable (1.25e-6)" "unprognostic (1.68e-2)" "unprognostic (9.33e-2)" "unprognostic (6.03e-2)" "unprognostic (1.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" "prognostic favorable (5.99e-4)" "unprognostic (2.17e-1)" "prognostic favorable (1.55e-6)" "unprognostic (2.10e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (5.63e-3)" 9.6 6.3 4.3 3.9 6.6 0.5 10.2 5.3 10.5 16.9 7.4 5.5 7.9 3.8 13.5 16.4 6.3 22.6 14.0 6.2 4.5 3.7 11.2 3.8 7.8 4.9 5.3 3.5 17.1 16.2 11.5 14.0 15.1 6.5 11.6 3.2 11.2 14.7 12.1 8.0 10.8 3.9 9.3 3.3 10.1 6.2 25.7 2.6 0.6 31.3 9.3 4.9 6.9 9.7 0.0 2.4 0.3 3.6 0.0 0.0 0.8 5.1 6.2 1.5 8.2 13.6 15.1 0.0 2.9 11.1 2.9 3.5 0.0 3.2 0.0 1.3 5.2 3.0 3.3 0.5 0.5 0.6 1.6 4.7 0.4 0.1 0.4 6.9 0.3 4.3 7.2 6.4 3.2 0.9 6.9 3.8 0.0 0.0 0.0 2.0 0.5 0.0 0.0 3.0 2.0 0.1 0.0 0.1 0.0 4.2 3.1 2.2 7.5 0.5 0.2 6.7 0.6 2.1 1.2 5.0 13.1 2.1 6.3 3.5 1.5 0.3 0.0 8.0 0.1 5.4 0.0 2.6 0.0 0.0 3.6 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.8 4.3 6.6 5.3 10.5 4.5 3.7 5.3 3.5 6.5 2.6 0.0 0.0 0.0 5.5 6.4 2.4 0.8 15.3 1.4 1.2 7.0 3.9 1.4 8.3 2.9 24.6 4.5 2.1 0.0 3.4 0.1 6.6 6.0 0.0 1.6 2.0 3.2 8.6 7.4 15.2 44.2 13.6 1.3 5.0 0.0 12.5 8.3 2.2 3.5 10.3 5.1 0.3 0.0 6.4 8.7 5.1 6.1 4.8 0.0 6.2 4.4 ZER1 "C9orf60, Hzyg, ZYG, ZYG11BL" ENSG00000160445 "Zyg-11 related cell cycle regulator" Q7Z7L7 9 128729786-128772414 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048464 Approved Cytosol NA NA Cytosol "HPA048464: AB_2756306" "unprognostic (1.37e-1)" "prognostic favorable (1.18e-6)" "unprognostic (9.11e-3)" "unprognostic (2.36e-2)" "unprognostic (7.46e-2)" "unprognostic (9.35e-2)" "unprognostic (2.18e-1)" "unprognostic (4.81e-3)" "unprognostic (3.65e-1)" "unprognostic (4.90e-3)" "unprognostic (6.65e-3)" "unprognostic (1.69e-1)" "prognostic favorable (5.15e-11)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.14e-1)" 15.4 17.1 36.0 9.7 32.0 12.0 12.5 28.0 45.3 15.9 18.2 19.7 11.3 27.4 16.7 12.3 23.8 21.9 14.4 29.9 27.0 28.5 15.7 11.1 16.5 10.4 19.9 34.2 22.1 22.0 24.1 18.2 13.1 29.1 20.6 11.0 14.7 21.9 22.2 40.3 17.4 25.3 14.0 13.5 12.5 14.1 25.8 18.8 16.9 19.0 8.5 9.3 17.9 12.6 5.0 5.7 15.8 5.8 5.5 7.7 4.9 8.8 9.8 6.5 8.9 19.5 13.5 18.0 8.5 14.8 11.9 9.7 8.8 10.1 5.5 9.7 14.9 8.9 19.5 7.1 12.7 5.0 10.9 9.4 3.8 17.4 6.4 15.3 5.5 10.6 16.8 19.2 12.0 8.5 16.2 10.1 11.1 6.8 12.1 8.1 33.7 10.4 6.2 6.5 12.4 12.7 9.5 8.7 20.8 8.9 12.0 12.7 9.6 14.4 18.5 9.8 7.9 27.0 6.6 11.3 9.8 4.4 12.5 5.1 15.2 14.1 4.3 14.5 3.3 7.1 10.9 3.7 10.0 5.6 5.6 7.7 3.8 5.8 7.2 3.9 5.0 6.5 5.9 15.8 5.5 5.8 5.7 5.3 4.9 36.0 32.0 28.0 45.3 27.0 28.5 19.9 34.2 29.1 18.8 11.9 15.6 2.4 3.3 2.5 19.4 19.8 5.1 10.7 2.3 5.2 13.7 3.9 1.7 4.4 4.2 5.8 24.2 0.0 8.2 2.1 4.9 6.4 10.3 6.8 5.1 20.6 6.9 8.6 6.6 1.3 10.3 3.2 8.5 10.8 14.0 10.3 6.5 21.0 9.9 9.9 12.2 12.9 4.2 10.2 3.1 5.1 7.1 3.3 8.9 2.3 ZFP30 "KIAA0961, ZNF745" ENSG00000120784 "ZFP30 zinc finger protein" Q9Y2G7 19 37613749-37692337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030606 Uncertain Approved Cytosol NA NA Cytosol "HPA030606: AB_10602684" "unprognostic (1.86e-2)" "unprognostic (3.00e-2)" "unprognostic (1.09e-3)" "unprognostic (3.64e-2)" "unprognostic (6.10e-3)" "unprognostic (1.14e-2)" "unprognostic (1.96e-2)" "unprognostic (1.75e-1)" "unprognostic (5.62e-3)" "unprognostic (7.03e-2)" "unprognostic (2.72e-2)" "unprognostic (5.96e-2)" "prognostic favorable (3.86e-4)" "unprognostic (3.01e-1)" "unprognostic (4.92e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-3)" 5.0 6.6 10.2 5.4 15.3 1.7 8.3 20.0 12.3 6.1 5.5 6.5 5.5 3.8 8.5 6.9 6.0 7.4 4.6 5.3 8.0 7.1 6.0 4.1 5.4 6.4 11.2 9.4 9.4 6.3 9.5 10.7 7.5 9.6 8.0 5.0 5.0 5.3 8.0 5.2 9.3 4.9 11.3 10.9 6.6 5.3 16.5 10.6 6.1 10.8 1.9 6.4 5.9 9.2 4.3 2.0 4.9 1.3 5.8 4.0 2.1 6.6 5.7 9.6 13.5 5.2 5.1 2.9 6.9 6.4 5.2 5.6 4.7 1.1 0.0 7.1 6.2 4.2 2.5 9.5 3.6 5.3 10.1 3.7 6.6 7.2 3.6 3.9 0.9 5.1 3.8 5.7 4.5 6.9 4.2 3.0 4.7 5.0 0.1 6.7 3.0 7.1 3.4 2.0 0.8 4.0 2.9 12.5 0.1 3.2 11.1 10.7 11.6 8.1 3.2 2.5 3.9 4.3 1.8 5.8 7.1 24.0 3.3 6.9 3.7 3.8 4.3 0.0 0.0 5.3 4.9 1.2 2.8 2.8 1.3 3.7 1.3 3.1 2.4 0.9 4.3 3.8 4.0 0.9 5.8 0.4 2.0 2.3 2.1 10.2 15.3 20.0 12.3 8.0 7.1 11.2 9.4 9.6 10.6 6.0 2.6 2.7 1.2 0.7 10.9 6.3 2.5 2.7 3.4 3.5 3.9 2.1 1.7 2.4 43.5 2.8 0.9 0.0 2.0 1.2 3.0 1.7 9.2 0.9 2.0 7.9 4.1 3.7 1.6 11.7 6.9 1.1 0.0 1.8 4.2 5.2 1.6 0.0 6.0 2.1 8.0 6.5 3.1 5.9 3.3 0.4 0.7 3.1 1.7 0.7 ZGRF1 "C4orf21, FLJ11331" ENSG00000138658 "Zinc finger GRF-type containing 1" Q86YA3 4 112539333-112636995 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.0" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 19.0;Spermatocytes: 17.1;Spermatogonia: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA030704, HPA030706" Uncertain Approved Cytosol NA NA Cytosol "HPA030704: AB_2673577, HPA030706: AB_10601784" "unprognostic (8.48e-2)" "unprognostic (6.17e-2)" "unprognostic (9.51e-2)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (1.84e-3)" "unprognostic (5.83e-3)" "unprognostic (1.45e-1)" "unprognostic (5.89e-4)" "unprognostic (4.74e-2)" "unprognostic (4.30e-2)" "unprognostic (3.72e-3)" "unprognostic (7.60e-10)" "unprognostic (3.45e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (2.02e-4)" 2.5 1.8 3.3 4.9 4.8 13.8 2.8 13.8 6.5 2.5 2.4 0.5 0.1 2.6 2.6 1.5 3.0 2.1 1.3 1.5 3.1 1.0 1.6 1.6 2.7 5.0 2.5 3.3 3.2 2.2 0.9 4.5 3.5 3.5 2.1 3.1 1.1 2.7 2.3 2.9 3.0 3.2 2.1 4.2 3.8 2.6 7.3 4.1 17.0 2.7 2.2 5.8 2.1 2.5 2.5 2.8 1.3 2.9 1.1 1.6 0.4 3.7 2.7 9.4 6.6 0.7 1.3 3.6 6.7 2.8 6.8 6.1 5.2 5.6 9.8 2.0 2.0 2.8 3.0 9.7 3.5 7.8 5.3 2.5 6.1 4.3 1.6 0.3 13.7 4.1 0.6 0.4 8.5 2.3 0.9 2.7 10.5 8.7 11.1 4.6 6.1 18.3 5.0 4.9 3.9 3.3 10.3 14.0 3.3 1.2 3.3 4.4 7.4 3.0 4.1 1.2 7.2 1.9 4.0 3.2 8.6 8.4 4.5 5.3 4.2 7.3 13.1 3.9 4.7 4.8 0.0 0.6 1.3 1.0 2.9 0.6 1.3 0.5 0.2 0.1 2.5 1.6 1.6 0.9 1.1 0.7 2.8 1.0 0.4 3.3 4.8 13.8 6.5 3.1 1.0 2.5 3.3 3.5 4.1 0.0 2.2 6.4 1.2 0.0 9.0 2.0 0.0 1.4 6.8 1.8 7.9 1.9 0.0 0.8 2.3 0.7 0.7 0.0 0.4 2.7 1.4 1.0 2.3 0.4 1.5 4.8 1.2 0.0 1.0 1.4 0.6 2.6 0.0 0.0 1.1 2.0 0.5 0.9 2.1 0.3 19.0 0.0 0.8 17.1 11.5 0.0 0.7 2.2 1.2 0.4 ZNF135 "pHZ-17, ZNF61, ZNF78L1" ENSG00000176293 "Zinc finger protein 135" P52742 19 58059239-58086310 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 15.7;Distal tubular cells: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 6.7;MOLT-4: 7.0;T-47d: 8.2" "Low region specificity" "Detected in all" HPA006961 Approved Approved Cytosol NA NA Cytosol "HPA006961: AB_1080670" "unprognostic (4.87e-2)" "unprognostic (7.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.96e-1)" "unprognostic (1.01e-1)" "unprognostic (6.54e-2)" "unprognostic (1.70e-1)" "unprognostic (5.85e-2)" "unprognostic (9.18e-3)" "unprognostic (1.20e-2)" "unprognostic (1.01e-3)" "unprognostic (2.34e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (1.93e-1)" "unprognostic (1.64e-1)" "unprognostic (1.25e-1)" 4.6 3.5 8.4 3.1 13.7 1.7 8.6 7.3 10.6 7.9 5.4 12.0 4.5 1.9 11.8 11.2 3.9 8.6 5.7 4.5 6.4 5.2 5.9 1.1 3.8 2.9 6.4 9.1 15.9 3.3 21.4 11.0 5.3 8.1 8.6 3.0 9.5 3.0 7.6 2.6 6.2 2.7 9.6 5.3 4.9 3.4 8.9 10.4 7.3 10.6 1.2 3.2 6.4 5.1 3.9 3.9 3.4 0.2 4.5 3.7 0.8 0.0 0.0 1.5 0.0 0.1 0.0 0.0 3.7 0.0 5.1 0.3 0.0 0.2 0.0 3.9 5.5 3.0 0.2 0.0 0.0 5.7 0.0 6.0 0.0 0.0 0.0 2.3 0.0 6.2 6.7 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 7.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 2.7 4.4 5.8 0.2 0.0 0.0 0.0 5.9 8.2 0.0 0.0 0.0 3.4 0.0 0.0 0.3 2.4 0.0 0.0 0.0 2.9 0.0 0.1 3.4 0.0 0.2 0.2 0.9 0.3 0.3 1.7 3.9 3.7 2.1 0.1 4.5 0.0 3.9 0.2 0.8 8.4 13.7 7.3 10.6 6.4 5.2 6.4 9.1 8.1 10.4 0.0 0.6 0.0 2.4 2.1 10.7 5.3 2.5 5.3 1.2 8.7 15.7 0.8 18.3 5.3 11.1 2.4 0.0 0.0 0.6 0.1 1.5 2.5 4.7 0.2 0.5 14.3 2.4 6.2 0.3 8.2 7.2 0.0 1.7 0.0 1.0 7.1 0.3 0.0 6.3 2.1 14.4 0.0 3.1 8.9 7.2 2.8 0.6 1.0 0.6 1.3 ZNF23 "KOX16, Zfp612, ZNF359, ZNF612" ENSG00000167377 "Zinc finger protein 23" P17027 16 71447597-71463095 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 6.0;Ciliated cells: 16.0;Club cells: 5.7;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023534 Uncertain Approved Cytosol NA NA Cytosol "HPA023534: AB_1859140" "unprognostic (8.49e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" "unprognostic (9.89e-3)" "unprognostic (2.12e-1)" "unprognostic (8.37e-3)" "unprognostic (2.19e-2)" "unprognostic (2.62e-3)" "unprognostic (3.65e-1)" "unprognostic (6.94e-2)" "unprognostic (9.59e-2)" "unprognostic (6.04e-2)" 7.1 5.5 8.5 6.3 11.5 5.6 7.7 16.4 14.3 6.7 8.1 5.1 4.6 5.5 9.3 14.9 6.1 10.3 5.2 6.0 11.6 9.6 7.6 6.5 8.7 9.5 11.3 13.9 11.4 6.1 11.1 19.5 5.5 11.4 8.4 7.6 8.4 6.4 8.0 7.4 8.5 6.4 11.4 8.8 8.2 6.0 8.7 9.6 5.4 10.2 7.0 9.5 7.4 7.3 4.6 4.2 1.7 3.6 4.0 4.9 1.8 4.7 4.1 10.4 7.5 5.9 5.5 6.4 11.5 8.5 7.7 5.6 5.4 5.2 10.2 3.1 7.5 6.8 3.5 6.1 6.8 6.9 2.4 4.4 5.6 4.0 4.1 5.9 10.3 4.0 6.5 5.2 8.0 13.9 8.4 2.3 5.2 8.3 3.1 7.2 11.1 4.0 4.9 8.8 2.3 3.7 2.7 3.1 3.1 5.4 4.1 8.3 8.8 3.8 2.8 3.0 4.5 3.6 4.8 9.6 16.1 4.5 4.4 7.5 5.4 6.3 14.4 12.2 4.3 8.8 1.7 1.8 1.2 4.5 3.6 3.9 3.0 2.5 4.9 2.5 4.6 4.9 3.8 0.0 4.0 2.0 4.2 4.1 1.8 8.5 11.5 16.4 14.3 11.6 9.6 11.3 13.9 11.4 9.6 6.0 2.9 0.5 0.2 0.2 2.2 0.3 0.0 16.0 5.7 0.0 5.9 0.2 1.7 1.8 0.1 0.1 0.4 0.0 0.9 0.3 0.2 0.2 2.3 0.8 0.3 3.2 0.0 1.8 0.0 0.0 0.6 0.1 0.0 0.0 1.0 1.3 1.2 0.3 0.0 0.0 3.3 0.0 0.4 1.8 1.2 0.0 0.0 0.0 1.3 0.1 ZNF70 "Cos17, MGC48959" ENSG00000187792 "Zinc finger protein 70" Q9UC06 22 23738678-23751092 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018821 Uncertain Approved Cytosol NA NA Cytosol "HPA018821: AB_1859423" "unprognostic (3.17e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" "unprognostic (8.49e-3)" "unprognostic (1.08e-1)" "unprognostic (2.80e-2)" "unprognostic (6.07e-3)" "unprognostic (2.18e-3)" "unprognostic (9.93e-2)" "unprognostic (6.20e-2)" "unprognostic (1.73e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-2)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (4.36e-2)" "unprognostic (5.69e-2)" 5.5 5.0 8.4 7.6 8.5 5.5 5.5 14.3 10.3 7.5 5.5 8.2 10.7 3.4 7.8 8.7 3.6 7.4 5.9 6.3 8.6 3.8 4.1 3.0 4.7 4.9 7.1 5.7 15.3 6.5 10.1 6.2 4.5 7.1 5.9 4.8 9.0 7.2 8.4 9.1 4.3 5.1 7.0 4.9 5.2 5.1 4.7 10.9 3.9 6.7 1.1 5.6 5.8 5.4 1.5 1.6 4.2 1.0 2.0 1.2 0.4 1.9 2.5 4.8 5.0 7.1 3.5 1.6 1.8 3.6 4.1 5.9 2.4 1.4 2.7 1.2 3.8 2.7 2.2 3.3 2.4 5.3 1.8 3.1 5.2 4.5 2.2 4.3 4.7 4.5 3.4 1.6 5.5 4.6 5.4 3.2 2.1 1.9 4.0 3.1 2.7 2.7 2.4 1.2 1.8 1.1 11.4 4.6 0.6 1.5 2.6 2.7 3.4 2.7 3.5 2.1 3.6 1.7 2.2 4.3 4.6 5.8 3.0 2.0 4.1 0.7 2.6 4.0 2.2 3.9 4.2 1.0 0.9 1.0 0.8 0.6 0.8 1.0 0.6 0.5 1.5 1.1 1.2 3.2 2.0 0.8 1.6 0.4 0.4 8.4 8.5 14.3 10.3 8.6 3.8 7.1 5.7 7.1 10.9 0.0 3.2 0.0 0.8 0.3 4.0 2.3 2.5 6.7 3.4 3.5 9.8 0.4 0.0 1.1 1.1 1.0 0.3 0.0 1.0 0.5 1.8 0.6 1.1 0.5 0.7 6.4 1.2 4.3 1.2 2.1 5.8 0.4 0.0 1.0 0.3 2.8 0.4 0.0 3.9 0.6 4.5 6.5 0.8 2.1 2.1 0.0 0.2 0.5 0.6 0.7 ZNF764 MGC13138 ENSG00000169951 "Zinc finger protein 764" Q96H86 16 30553764-30558498 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003203 Uncertain Approved Cytosol NA NA Cytosol "HPA003203: AB_1080753" "unprognostic (9.48e-3)" "unprognostic (2.04e-2)" "unprognostic (2.47e-2)" "prognostic favorable (6.84e-4)" "unprognostic (6.62e-2)" "unprognostic (9.75e-3)" "unprognostic (8.26e-3)" "unprognostic (2.64e-3)" "unprognostic (2.00e-1)" "unprognostic (3.64e-1)" "unprognostic (1.77e-3)" "unprognostic (3.43e-2)" "unprognostic (3.55e-1)" "unprognostic (2.87e-1)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (3.05e-1)" 9.4 9.0 12.0 8.0 9.9 9.8 7.4 19.5 11.3 9.4 8.7 10.0 9.7 13.0 10.6 4.4 7.1 9.5 10.8 9.7 10.5 6.1 8.1 11.2 6.8 11.3 10.6 7.4 12.5 8.9 10.6 12.5 6.1 9.9 9.7 8.4 8.3 7.9 7.1 9.4 6.8 11.7 6.4 5.9 11.1 14.0 11.3 10.4 14.9 7.6 6.1 8.1 7.5 7.6 4.1 3.1 6.2 2.7 10.8 6.3 2.5 2.9 3.4 7.1 6.8 3.1 3.1 4.2 3.7 3.1 3.7 2.8 2.8 2.8 5.4 4.5 2.2 2.2 4.2 3.8 2.5 2.9 5.9 9.9 3.5 4.2 5.1 3.7 3.4 5.8 2.4 3.1 3.0 4.1 4.8 3.3 13.3 6.6 6.3 3.3 6.5 9.5 5.5 4.2 1.8 4.8 13.1 3.0 7.0 3.0 1.5 13.7 10.5 2.6 6.0 3.5 4.5 5.2 6.3 2.9 4.9 2.8 2.8 3.7 8.5 5.8 4.5 3.6 4.8 6.9 3.4 2.1 6.2 4.9 2.6 6.3 2.9 4.9 5.9 2.7 4.1 5.1 4.8 2.1 10.8 2.7 3.1 3.1 2.5 12.0 9.9 19.5 11.3 10.5 6.1 10.6 7.4 9.9 10.4 0.0 2.7 4.7 2.0 1.4 5.1 3.6 5.1 8.1 4.5 1.8 0.0 2.3 0.0 2.9 0.4 2.9 4.0 0.0 2.6 1.8 2.3 2.3 1.1 2.4 3.0 1.6 2.4 2.5 3.5 0.2 3.1 2.2 0.0 3.6 3.9 2.7 3.3 10.5 2.5 2.0 5.0 6.5 3.1 10.3 3.9 0.4 0.8 4.9 3.9 1.1 ZNF772 DKFZp686I1569 ENSG00000197128 "Zinc finger protein 772" Q68DY9 19 57466663-57477570 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 21.7" "Low region specificity" "Detected in all" HPA031312 Uncertain Approved Cytosol NA NA Cytosol "HPA031312: AB_10603941" "unprognostic (2.30e-2)" "unprognostic (5.96e-2)" "unprognostic (1.12e-1)" "unprognostic (1.82e-1)" "unprognostic (1.83e-1)" "unprognostic (3.73e-2)" "unprognostic (2.24e-1)" "unprognostic (2.35e-1)" "unprognostic (6.31e-3)" "unprognostic (1.27e-1)" "unprognostic (2.50e-2)" "unprognostic (5.01e-2)" "prognostic favorable (1.02e-6)" "unprognostic (7.99e-2)" "unprognostic (3.75e-1)" "unprognostic (1.43e-1)" "unprognostic (7.93e-2)" 3.4 8.3 11.0 2.5 14.5 2.2 7.9 21.2 11.8 5.4 3.9 8.1 3.9 3.0 3.9 9.5 4.8 8.8 4.2 10.3 9.3 6.9 6.9 4.1 4.8 5.0 8.9 10.2 10.6 4.6 18.9 19.2 6.9 8.0 7.6 2.6 8.6 6.2 7.1 15.7 6.8 3.7 4.0 6.4 7.6 4.0 5.8 9.6 7.4 14.9 3.0 6.3 5.2 3.6 7.6 3.3 2.2 2.4 3.4 4.4 1.9 2.2 1.7 9.1 3.8 2.5 5.3 4.1 3.9 4.8 6.3 21.7 0.5 2.4 0.2 2.9 3.3 2.8 0.2 1.9 5.1 7.7 0.0 14.0 7.1 0.8 2.3 3.3 0.8 7.6 4.4 2.2 4.2 8.8 6.0 4.6 2.9 2.1 1.4 5.7 1.6 1.0 1.8 5.6 0.5 4.3 1.9 11.6 7.1 2.9 5.5 9.6 6.0 0.1 2.1 2.9 6.5 6.2 4.5 2.2 5.9 3.9 1.3 4.0 9.1 15.6 2.6 1.3 0.2 5.7 0.3 2.4 2.2 0.8 1.8 2.9 4.3 2.2 0.9 3.3 7.6 4.4 2.3 1.2 3.4 1.7 1.6 0.6 1.9 11.0 14.5 21.2 11.8 9.3 6.9 8.9 10.2 8.0 9.6 6.0 1.6 1.3 0.3 0.6 6.8 3.9 2.5 1.4 1.2 15.7 5.9 2.0 0.0 1.5 0.0 3.3 0.7 0.0 0.3 0.8 0.4 1.2 2.3 2.4 2.1 6.4 2.4 2.5 4.1 0.9 0.6 1.7 0.0 1.0 1.9 5.0 0.8 0.0 2.1 1.7 8.0 0.0 1.0 0.5 1.1 1.0 1.5 0.0 1.8 0.8 ZNF785 FLJ32130 ENSG00000197162 "Zinc finger protein 785" A8K8V0 16 30573740-30585771 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004010 Approved Cytosol NA NA Cytosol "HPA004010: " "unprognostic (2.85e-2)" "unprognostic (1.29e-1)" "unprognostic (8.25e-2)" "unprognostic (2.47e-1)" "unprognostic (2.35e-1)" "unprognostic (4.15e-2)" "unprognostic (2.54e-4)" "prognostic favorable (8.99e-4)" "unprognostic (1.55e-1)" "unprognostic (2.08e-1)" "prognostic favorable (2.03e-5)" "unprognostic (3.37e-2)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (3.13e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-2)" 5.9 8.7 15.8 7.9 13.6 4.8 8.3 26.8 16.6 10.9 7.7 14.7 8.7 14.2 12.4 9.8 6.9 10.2 8.3 6.2 12.6 7.6 7.8 6.1 6.5 8.7 15.7 12.2 14.7 9.1 11.9 12.7 6.1 11.8 10.8 8.2 10.8 10.5 9.5 9.2 12.6 10.7 7.5 9.5 9.5 12.4 3.9 19.2 8.8 9.9 4.3 8.8 10.4 9.6 5.1 5.4 4.9 5.1 3.3 3.5 1.0 4.9 0.4 4.8 6.4 6.1 6.8 1.5 4.3 3.9 4.5 3.4 6.7 7.9 5.1 5.2 4.1 0.3 7.1 0.1 2.8 2.7 3.4 1.3 6.2 13.7 1.5 4.5 0.5 10.8 4.4 6.2 3.0 2.8 3.8 4.8 0.9 5.8 6.4 4.1 8.6 6.2 5.8 2.8 1.9 2.8 16.3 5.5 2.5 4.2 5.1 13.4 9.5 3.6 4.5 2.6 3.0 5.6 5.3 7.1 1.8 4.8 4.0 0.3 0.9 2.7 2.1 5.8 3.8 7.3 4.7 2.6 1.0 2.3 1.6 2.5 5.1 2.8 1.9 1.9 3.1 3.5 2.7 4.9 3.3 5.1 5.4 3.3 1.0 15.8 13.6 26.8 16.6 12.6 7.6 15.7 12.2 11.8 19.2 0.0 4.3 4.3 6.6 0.9 9.3 1.4 5.1 5.3 2.3 7.0 19.6 1.1 5.0 3.0 0.1 5.1 5.2 0.0 3.0 0.9 3.3 5.7 0.0 3.0 2.3 12.7 11.5 2.5 4.1 0.0 12.4 4.1 5.0 1.8 4.7 5.2 3.5 8.4 12.4 1.5 12.4 0.0 3.1 4.2 1.3 2.3 0.7 4.4 6.3 3.7 ZNF852 ENSG00000178917 "Zinc finger protein 852" Q6ZMS4 3 44498970-44510636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 4.8;Ciliated cells: 6.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048312, HPA049885, HPA071850" Uncertain Approved Cytosol NA NA Cytosol "HPA048312: AB_2680352, HPA049885: AB_2680933, HPA071850: AB_2686458" "unprognostic (2.64e-1)" "unprognostic (2.62e-1)" "unprognostic (5.93e-3)" "unprognostic (1.73e-1)" "unprognostic (2.29e-2)" "unprognostic (1.30e-3)" "unprognostic (3.47e-2)" "unprognostic (2.55e-2)" "unprognostic (5.11e-2)" "unprognostic (1.43e-1)" "unprognostic (3.80e-2)" "unprognostic (1.03e-1)" "unprognostic (6.62e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (8.05e-2)" "unprognostic (1.11e-2)" 3.8 4.0 5.0 4.7 5.4 3.1 4.7 12.9 6.9 4.6 4.0 3.2 4.6 3.6 5.2 3.7 3.6 4.2 3.1 3.3 4.8 2.1 4.0 3.7 4.8 4.8 5.5 3.9 6.4 10.3 9.0 13.5 4.7 5.4 5.6 5.8 4.2 8.8 4.6 2.9 4.6 5.4 7.0 4.7 5.1 6.0 2.9 4.6 7.1 4.4 2.5 6.3 5.0 6.1 2.4 2.7 1.4 1.3 0.7 1.8 0.4 0.8 1.4 3.4 5.9 0.8 2.0 2.4 0.9 1.2 1.6 2.7 1.8 1.0 2.9 0.7 1.0 0.9 0.9 3.7 0.9 2.3 2.3 1.7 2.6 5.8 1.5 1.5 2.9 5.3 0.8 1.9 2.4 0.8 2.1 1.4 2.9 3.2 1.6 1.7 0.2 2.5 2.4 1.9 0.9 0.7 1.3 3.5 1.3 1.1 2.9 2.9 2.1 1.8 0.8 0.8 6.0 1.9 2.7 1.8 2.2 2.4 1.3 0.9 2.4 1.5 1.5 0.7 2.2 1.4 0.0 0.6 1.4 0.6 1.3 1.0 2.4 1.1 0.7 0.5 1.6 1.0 1.8 0.9 0.7 0.3 2.7 0.1 0.4 5.0 5.4 12.9 6.9 4.8 2.1 5.5 3.9 5.4 4.6 0.0 4.8 0.0 0.7 3.0 1.7 1.6 0.0 6.7 1.2 0.0 2.0 0.7 3.3 1.4 0.0 0.7 0.8 0.0 1.2 0.9 0.6 0.6 1.1 1.0 0.6 1.6 0.0 2.5 0.0 0.0 0.6 1.4 1.7 1.8 0.3 2.5 1.4 0.0 1.1 0.6 1.4 0.0 0.8 2.6 1.5 1.6 0.2 0.0 0.6 0.7 ZSWIM6 KIAA1577 ENSG00000130449 "Zinc finger SWIM-type containing 6" Q9HCJ5 5 61332273-61546170 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal glandular cells: 75.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 24.1" "Low region specificity" "Detected in all" HPA035938 Uncertain Approved Cytosol NA NA Cytosol "HPA035938: AB_10672077" "unprognostic (2.22e-1)" "unprognostic (2.08e-2)" "unprognostic (1.12e-1)" "unprognostic (2.10e-1)" "unprognostic (2.70e-1)" "unprognostic (6.69e-2)" "unprognostic (2.00e-1)" "unprognostic (6.96e-3)" "unprognostic (6.16e-2)" "unprognostic (1.40e-2)" "unprognostic (2.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.68e-2)" "unprognostic (7.50e-3)" "unprognostic (1.11e-1)" "unprognostic (3.63e-1)" "unprognostic (1.99e-1)" 14.1 10.0 14.4 14.9 22.9 6.3 8.8 13.1 18.0 9.0 15.8 40.1 8.2 10.4 9.2 10.3 12.6 10.2 17.0 7.1 15.0 12.2 8.0 13.6 17.4 9.4 25.2 10.6 11.5 12.6 19.4 9.7 13.6 20.4 12.5 19.1 17.7 10.3 12.1 5.2 8.2 12.4 11.1 19.4 11.6 17.2 12.5 25.9 11.2 10.4 5.9 8.7 10.4 11.8 1.2 3.4 4.4 3.2 0.9 0.9 0.5 3.2 4.3 20.2 1.4 4.3 8.0 1.7 4.4 4.0 4.9 7.6 1.7 5.3 0.8 3.9 5.5 7.8 2.8 4.4 5.4 7.0 13.6 4.2 1.6 8.4 0.9 5.8 1.0 2.3 5.8 4.0 11.5 10.0 6.8 12.0 1.8 0.4 16.6 20.0 2.3 0.8 2.1 3.1 0.9 3.3 6.4 5.9 24.1 8.1 4.2 4.1 6.5 10.4 0.6 4.0 8.2 1.8 4.2 16.7 4.1 5.3 5.7 6.2 2.9 0.4 1.8 6.3 1.3 8.7 1.5 3.1 1.2 0.2 2.4 0.9 0.6 0.3 0.4 1.5 1.2 0.4 0.3 4.4 0.9 3.2 3.4 0.4 0.5 14.4 22.9 13.1 18.0 15.0 12.2 25.2 10.6 20.4 25.9 23.8 13.0 12.8 75.8 42.1 7.5 9.9 17.8 33.5 31.8 10.4 9.8 0.4 1.7 11.1 8.4 18.0 27.5 0.0 11.1 0.2 30.2 39.2 13.9 6.0 22.1 7.9 13.6 28.3 63.4 6.9 5.2 33.2 15.1 5.4 25.1 19.3 14.8 22.8 6.0 4.0 5.1 6.5 22.7 14.9 19.8 34.9 1.1 3.2 18.0 40.6 ZSWIM7 SWS1 ENSG00000214941 "Zinc finger SWIM-type containing 7" Q19AV6 17 15976560-15999717 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054681 Uncertain Uncertain Cytosol NA NA Cytosol "HPA054681: AB_2682572" "unprognostic (3.07e-2)" "unprognostic (5.51e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.54e-5)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (4.23e-2)" "unprognostic (1.84e-2)" "unprognostic (8.56e-2)" "unprognostic (2.45e-3)" "unprognostic (8.80e-3)" "unprognostic (1.70e-1)" 10.0 16.2 14.3 11.5 21.7 7.0 21.5 9.8 28.7 9.4 10.3 9.8 13.8 13.2 11.5 14.2 11.6 11.2 8.8 18.7 17.4 13.8 15.2 14.4 13.6 13.8 16.9 12.2 14.3 13.9 8.6 15.5 10.2 16.5 9.6 9.1 9.9 14.0 13.1 49.2 13.8 9.3 11.2 22.1 12.2 10.5 10.8 12.1 6.2 12.1 8.4 7.3 11.4 11.2 17.2 26.0 15.2 17.2 10.0 12.6 12.2 10.1 14.9 8.1 18.6 3.3 3.1 9.4 6.9 2.6 7.3 5.4 2.8 3.0 4.9 6.1 7.5 2.2 3.3 2.5 5.5 3.5 5.0 9.1 5.5 6.9 5.7 7.7 4.4 9.3 7.5 9.9 4.0 6.9 1.1 9.3 12.8 3.5 2.7 3.7 13.8 15.2 10.5 4.9 14.9 8.9 9.7 19.8 7.6 6.6 5.6 2.7 11.8 10.6 10.7 6.9 21.8 7.7 1.1 13.1 11.9 4.1 3.1 5.9 1.3 3.6 5.6 10.2 5.6 10.1 15.2 17.2 7.0 8.9 16.1 9.3 17.2 10.4 8.5 26.0 14.3 12.6 12.0 1.0 10.0 11.3 16.1 7.5 12.2 14.3 21.7 9.8 28.7 17.4 13.8 16.9 12.2 16.5 12.1 32.8 55.7 24.4 28.2 22.8 38.5 59.6 68.8 41.5 26.1 38.4 58.9 74.3 72.9 53.3 8.3 29.2 35.8 0.0 45.1 51.4 24.4 30.3 54.3 39.8 44.0 17.5 48.8 32.5 52.9 9.8 42.0 43.4 52.3 18.0 36.4 46.9 43.1 35.1 37.4 102.1 54.4 25.8 26.9 89.2 59.4 24.1 60.9 27.9 31.8 20.3